PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lee, MJE; Veiseh, O; Bhattarai, N; Sun, C; Hansen, SJ; Ditzler, S; Knoblaugh, S; Lee, D; Ellenbogen, R; Zhang, MQ; Olson, JM				Lee, Michelle Jeung-Eun; Veiseh, Omid; Bhattarai, Narayan; Sun, Conroy; Hansen, Stacey J.; Ditzler, Sally; Knoblaugh, Sue; Lee, Donghoon; Ellenbogen, Richard; Zhang, Miqin; Olson, James M.			Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method	PLOS ONE			English	Article							TUMOR; CHALLENGES	Background: Recent advances in nanotechnology have led to the development of biocompatible nanoparticles for in vivo molecular imaging and targeted therapy. Many nanoparticles have undesirable tissue distribution or unacceptably low serum half-lives. Pharmacokinetic (PK) and biodistribution studies can help inform decisions determining particle size, coatings, or other features early in nanoparticle development. Unfortunately, these studies are rarely done in a timely fashion because many nanotechnology labs lack the resources and expertise to synthesize radioactive nanoparticles and evaluate them in mice. Methodology/Principal Findings: To address this problem, we developed an economical, radioactivity-free method for assessing serum half-life and tissue distribution of nanoparticles in mice. Iron oxide nanoparticles coated with chitosan and polyethylene glycol that utilize chlorotoxin as a targeting molecule have a serum half-life of 7-8 hours and the particles remain stable for extended periods of time in physiologic fluids and in vivo. Nanoparticles preferentially distribute to spleen and liver, presumably due to reticuloendothelial uptake. Other organs have very low levels of nanoparticles, which is ideal for imaging most cancers in the future. No acute toxicity was attributed to the nanoparticles. Conclusions/Significance: We report here a simple near-infrared fluorescence based methodology to assess PK properties of nanoparticles in order to integrate pharmacokinetic data into early nanoparticle design and synthesis. The nanoparticles tested demonstrate properties that are excellent for future clinical imaging strategies and potentially suitable for targeted therapy.	[Lee, Michelle Jeung-Eun; Hansen, Stacey J.; Ditzler, Sally; Olson, James M.] Univ Washington, Div Clin Res, Seattle, WA 98195 USA; [Knoblaugh, Sue] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Lee, Michelle Jeung-Eun; Olson, James M.] Univ Washington, Neurobiol & Behav Program, Seattle, WA 98195 USA; [Veiseh, Omid; Bhattarai, Narayan; Sun, Conroy; Zhang, Miqin] Univ Washington, Dept Mat Sci, Seattle, WA 98195 USA; [Lee, Donghoon] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Ellenbogen, Richard; Zhang, Miqin] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Olson, James M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ellenbogen, Richard; Olson, James M.] Seattle Childrens Hosp, Seattle, WA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Lee, MJE (corresponding author), Univ Washington, Div Clin Res, Seattle, WA 98195 USA.	jolson@fhcrc.org	Sun, Conroy/B-5611-2013; Veiseh, Omid/A-9972-2012; Veiseh, Omid/N-1137-2019; Veiseh, Omid/GLS-9547-2022; Sun, Conroy/S-3222-2019; Zhang, Miqin/F-5537-2010	Sun, Conroy/0000-0001-5193-6907; Veiseh, Omid/0000-0003-1153-8079; Sun, Conroy/0000-0001-5193-6907; Zhang, Miqin/0000-0001-8974-1494; Bhattarai, Narayan/0000-0002-0583-7913	National Institutes of Health [R01 CA119408, R01 CA134213, R01 EB006043, R01 CA112350]; Seattle Children's Hospital Neuro-Oncology Endowment; NATIONAL CANCER INSTITUTE [R01CA135491, R01CA134213, R01CA112350, R01CA119408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seattle Children's Hospital Neuro-Oncology Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R01 CA119408, R01 CA134213, R01 EB006043, R01 CA112350 and the Seattle Children's Hospital Neuro-Oncology Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Emerich DF, 2006, BIOMOL ENG, V23, P171, DOI 10.1016/j.bioeng.2006.05.026; Fang C, 2009, SMALL, V5, P1637, DOI 10.1002/smll.200801647; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d; Kaul G, 2004, J DRUG TARGET, V12, P585, DOI 10.1080/10611860400013451; Kircher MF, 2003, CANCER RES, V63, P8122; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Rossin R, 2005, J NUCL MED, V46, P1210; Sanhai WR, 2008, NAT NANOTECHNOL, V3, P242, DOI 10.1038/nnano.2008.114; Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070; Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157	14	77	91	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9536	10.1371/journal.pone.0009536	http://dx.doi.org/10.1371/journal.pone.0009536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209054	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100016
J	Singh, R; Singh, S; Sharma, PK; Singh, UP; Briles, DE; Hollingshead, SK; Lillard, JW				Singh, Rajesh; Singh, Shailesh; Sharma, Praveen K.; Singh, Udai P.; Briles, David E.; Hollingshead, Susan K.; Lillard, James W., Jr.			Helper T Cell Epitope-Mapping Reveals MHC-Peptide Binding Affinities That Correlate with T Helper Cell Responses to Pneumococcal Surface Protein A	PLOS ONE			English	Article							CLASS-II MOLECULES; HLA-DR ANTIGENS; STREPTOCOCCUS-PNEUMONIAE; INVARIANT CHAIN; CATHEPSIN-S; IN-VIVO; ASPARAGINYL ENDOPEPTIDASE; STRUCTURAL POLYMORPHISM; MURINE MODEL; BETA-CHAIN	Understanding the requirements for protection against pneumococcal carriage and pneumonia will greatly benefit efforts in controlling these diseases. Several proteins and polysaccharide capsule have recently been implicated in the virulence of and protective immunity against Streptococcus pneumonia. Pneumococcal surface protein A (PspA) is highly conserved among S. pneumonia strains, inhibits complement activation, binds lactoferrin, elicits protective systemic immunity against pneumococcal infection, and is necessary for full pneumococcal virulence. Identification of PspA peptides that optimally bind human leukocyte antigen (HLA) would greatly contribute to global vaccine efforts, but this is hindered by the multitude of HLA polymorphisms. Here, we have used an experimental data set of 54 PspA peptides and in silico methods to predict peptide binding to HLA and murine major histocompatibility complex (MHC) class II. We also characterized spleen- and cervical lymph node (CLN)-derived helper T lymphocyte (HTL) cytokine responses to these peptides after S. pneumonia strain EF3030-challenge in mice. Individual, yet overlapping peptides, 15 amino acids in length revealed residues 199 to 246 of PspA (PspA(199-246)) consistently caused the greatest IFN-gamma, IL-2, IL-5 and proliferation as well as moderate IL-10 and IL-4 responses by ex vivo stimulated splenic and CLN CD4(+) T cells isolated from S. pneumonia strain EF3030-challeged F(1) (B6xBALB/c) mice. IEDB, RANKPEP, SVMHC, MHCPred, and SYFPEITHI in silico analysis tools revealed peptides in PspA(199-246) also interact with a broad range of HLA-DR, -DQ, and -DP allelles. These data suggest that predicted MHC class II-peptide binding affinities do not always correlate with T helper (Th) cytokine or proliferative responses to PspA peptides, but when used together with in vivo validation can be a useful tool to choose candidate pneumococcal HTL epitopes.	[Singh, Rajesh; Lillard, James W., Jr.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Singh, Shailesh; Sharma, Praveen K.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Singh, Udai P.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Briles, David E.; Hollingshead, Susan K.] Univ Alabama, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Morehouse School of Medicine; University of Louisville; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Alabama System; University of Alabama Birmingham	Singh, R (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	lillard@msm.edu	Sharma, Praveen/M-2810-2014	Sharma, Praveen/0000-0002-7020-3570; Singh, Udai/0000-0002-7048-4325	National Institutes of Health [AI057808, GM09248, MD00525, RR03034]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the National Institutes of Health Grants AI057808, GM09248, MD00525, and RR03034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABERGE IS, 1995, MICROB PATHOGENESIS, V18, P141, DOI 10.1016/S0882-4010(95)90125-6; Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIGORENA S, 1995, J EXP MED, V181, P1729, DOI 10.1084/jem.181.5.1729; Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BONO MR, 1982, NATURE, V299, P836, DOI 10.1038/299836a0; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Castellino F, 1998, J IMMUNOL, V161, P4048; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; CORTE G, 1981, P NATL ACAD SCI-BIOL, V78, P534, DOI 10.1073/pnas.78.1.534; Costantino HR, 2002, J PHARM SCI-US, V91, P388, DOI 10.1002/jps.10059; Cunha-Neto E, 1999, BRAZ J MED BIOL RES, V32, P199, DOI 10.1590/S0100-879X1999000200008; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; Ertl HCJ, 1996, J IMMUNOL, V156, P3579; Fuchs PFJ, 2005, PROTEINS, V59, P828, DOI 10.1002/prot.20461; FullerEspie SL, 1997, CELL IMMUNOL, V177, P49, DOI 10.1006/cimm.1997.1081; GREGERSEN PK, 1989, LAB INVEST, V61, P5; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hooper DC, 2001, EMERG INFECT DIS, V7, P337, DOI 10.3201/eid0702.010239; HURLEY CK, 1982, J IMMUNOL, V129, P2103; Jedrzejas MJ, 2001, J BIOL CHEM, V276, P33121, DOI 10.1074/jbc.M103304200; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kadioglu A, 2000, INFECT IMMUN, V68, P2390, DOI 10.1128/IAI.68.4.2390-2390.2000; Kang CI, 2009, CLIN EXP IMMUNOL, V156, P552, DOI 10.1111/j.1365-2249.2009.03925.x; Kang H, 2005, INT J ONCOL, V26, P1429; Kaur H, 2002, BIOINFORMATICS, V18, P1508, DOI 10.1093/bioinformatics/18.11.1508; Khan AQ, 2002, INFECT IMMUN, V70, P749, DOI 10.1128/IAI.70.2.749-761.2002; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lynch JM, 2003, INFECT IMMUN, V71, P4780, DOI 10.1128/IAI.71.8.4780-4788.2003; Mack DG, 1999, INT J PARASITOL, V29, P1351, DOI 10.1016/S0020-7519(99)00152-6; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; Manoury B, 2002, NAT IMMUNOL, V3, P169, DOI 10.1038/ni754; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; MCDANIEL LS, 1987, J EXP MED, V165, P381, DOI 10.1084/jem.165.2.381; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MEISTER GE, 1995, VACCINE, V13, P581, DOI 10.1016/0264-410X(94)00014-E; MENAHEM S, 1992, PEDIATR CARDIOL, V13, P214, DOI 10.1007/BF00838779; Morita JY, 2002, CLIN INFECT DIS, V35, P420, DOI 10.1086/341897; Murtaugh MP, 2009, DEV COMP IMMUNOL, V33, P344, DOI 10.1016/j.dci.2008.06.014; Nasrin D, 1999, J PAEDIATR CHILD H, V35, P558, DOI 10.1046/j.1440-1754.1999.00416.x; OTTENHOFF THM, 1990, EUR J IMMUNOL, V20, P2347, DOI 10.1002/eji.1830201027; Palaniappan R, 2006, J IMMUNOL, V176, P2346, DOI 10.4049/jimmunol.176.4.2346; Palaniappan R, 2005, INFECT IMMUN, V73, P1006, DOI 10.1128/IAI.73.2.1006-1013.2005; Parry CS, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-44; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; RAMMENSEE HG, 1995, CURR OPIN IMMUNOL, V7, P85, DOI 10.1016/0952-7915(95)80033-6; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Richter SS, 2002, CLIN INFECT DIS, V34, P330, DOI 10.1086/338065; Ridgway WM, 1999, CURR OPIN IMMUNOL, V11, P638, DOI 10.1016/S0952-7915(99)00030-8; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rosloniec EF, 1998, J IMMUNOL, V160, P2573; Rubins JB, 1997, INFECT IMMUN, V65, P2975, DOI 10.1128/IAI.65.7.2975-2977.1997; SHACKELFORD DA, 1980, J EXP MED, V151, P144, DOI 10.1084/jem.151.1.144; SILVER J, 1979, TRANSPLANT P, V11, P1743; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Tsuchiya K, 2008, ANN OTO RHINOL LARYN, V117, P630, DOI 10.1177/000348940811700814; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; WALKER LE, 1980, MOL IMMUNOL, V17, P1443, DOI 10.1016/0161-5890(80)90169-8; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; WEIGENT DA, 1986, MICROB PATHOGENESIS, V1, P399, DOI 10.1016/0882-4010(86)90071-9; YU JJ, 2009, CLIN VACCINE IMMUNOL; Yu XH, 2004, J ALLERGY CLIN IMMUN, V114, P328, DOI 10.1016/j.jaci.2004.04.051	76	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9432	10.1371/journal.pone.0009432	http://dx.doi.org/10.1371/journal.pone.0009432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195541	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924300019
J	Goel, A; Nagasaka, T; Hamelin, R; Boland, CR				Goel, Ajay; Nagasaka, Takeshi; Hamelin, Richard; Boland, C. Richard			An Optimized Pentaplex PCR for Detecting DNA Mismatch Repair-Deficient Colorectal Cancers	PLOS ONE			English	Article							MICROSATELLITE-INSTABILITY STATUS; MONONUCLEOTIDE REPEATS; COLON-CANCER; TUMORS; MUTATION; HMLH1	Purpose: Microsatellite instability (MSI) is used to screen colorectal cancers (CRC) for Lynch Syndrome, and to predict outcome and response to treatment. The current technique for measuring MSI requires DNA from normal and neoplastic tissues, and fails to identify tumors with specific DNA mismatch repair (MMR) defects. We tested a panel of five quasi-monomorphic mononucleotide repeat markers amplified in a single multiplex PCR reaction (pentaplex PCR) to detect MSI. Experimental Design: We investigated a cohort of 213 CRC patients, comprised of 114 MMR-deficient and 99 MMR-proficient tumors. Immunohistochemical (IHC) analysis evaluated the expression of MLH1, MSH2, PMS2 and MSH6. MSI status was defined by differences in the quasi-monomorphic variation range (QMVR) from a pool of normal DNA samples, and measuring differences in allele lengths in tumor DNA. Results: Amplification of 426 normal alleles allowed optimization of the QMVR at each marker, and eliminated the requirement for matched reference DNA to define MSI in each sample. Using >= 2/5 unstable markers as the criteria for MSI resulted in a sensitivity of 95.6% (95% CI = 90.1-98.1%) and a positive predictive value of 100% (95% CI = 96.6%-100%). Detection of MSH6-deficiency was limited using all techniques. Data analysis with a three-marker panel (BAT26, NR21 and NR27) was comparable in sensitivity (97.4%) and positive predictive value (96.5%) to the five marker panel. Both approaches were superior to the standard approach to measuring MSI. Conclusions: An optimized pentaplex (or triplex) PCR offers a facile, robust, very inexpensive, highly sensitive, and specific assay for the identification of MSI in CRC.	[Goel, Ajay; Nagasaka, Takeshi; Boland, C. Richard] Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX USA; [Goel, Ajay; Nagasaka, Takeshi; Boland, C. Richard] Charles A Sammons Canc Ctr, Dallas, TX USA; [Hamelin, Richard] INSERM, U762, Paris, France	Baylor University; Baylor University Medical Center; Baylor University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Goel, A (corresponding author), Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol, Dallas, TX USA.	ajayg@baylorhealth.edu; rickbo@baylorhealth.edu		Nagasaka, Takeshi/0000-0002-4236-350X; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [RO1 CA 72851, RO1 CA 129286]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA072851, R01CA129286] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants RO1 CA 72851 (to CRB) and RO1 CA 129286 (to AG and CRB) from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Buhard O, 2004, DIS MARKERS, V20, P251, DOI 10.1155/2004/159347; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Kane MF, 1997, CANCER RES, V57, P808; Laghi L, 2008, ONCOGENE, V27, P6313, DOI 10.1038/onc.2008.217; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Pastrello C, 2006, EUR J HUM GENET, V14, P63, DOI 10.1038/sj.ejhg.5201517; Perucho M, 1999, CANCER RES, V59, P249; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Verma L, 1999, J MED GENET, V36, P678; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033	18	113	119	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9393	10.1371/journal.pone.0009393	http://dx.doi.org/10.1371/journal.pone.0009393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195377	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924200015
J	Lavebratt, C; Sjoholm, LK; Soronen, P; Paunio, T; Vawter, MP; Bunney, WE; Adolfsson, R; Forsell, Y; Wu, JC; Kelsoe, JR; Partonen, T; Schalling, M				Lavebratt, Catharina; Sjoholm, Louise K.; Soronen, Pia; Paunio, Tiina; Vawter, Marquis P.; Bunney, William E.; Adolfsson, Rolf; Forsell, Yvonne; Wu, Joseph C.; Kelsoe, John R.; Partonen, Timo; Schalling, Martin			CRY2 Is Associated with Depression	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; SEASONAL AFFECTIVE-DISORDER; BLUE-LIGHT PHOTORECEPTORS; REST-ACTIVITY DISTURBANCES; BIPOLAR-I-DISORDER; CIRCADIAN-CLOCK; SUPRACHIASMATIC NUCLEUS; CANDIDATE GENES; MELATONIN SUPPRESSION; MOOD	Background: Abnormalities in the circadian clockwork often characterize patients with major depressive and bipolar disorders. Circadian clock genes are targets of interest in these patients. CRY2 is a circadian gene that participates in regulation of the evening oscillator. This is of interest in mood disorders where a lack of switch from evening to morning oscillators has been postulated. Principal Findings: We observed a marked diurnal variation in human CRY2 mRNA levels from peripheral blood mononuclear cells and a significant up-regulation (P = 0.020) following one-night total sleep deprivation, a known antidepressant. In depressed bipolar patients, levels of CRY2 mRNA were decreased (P = 0.029) and a complete lack of increase was observed following sleep deprivation. To investigate a possible genetic contribution, we undertook SNP genotyping of the CRY2 gene in two independent population-based samples from Sweden (118 cases and 1011 controls) and Finland (86 cases and 1096 controls). The CRY2 gene was significantly associated with winter depression in both samples (haplotype analysis in Swedish and Finnish samples: OR = 1.8, P = 0.0059 and OR = 1.8, P = 0.00044, respectively). Conclusions: We propose that a CRY2 locus is associated with vulnerability for depression, and that mechanisms of action involve dysregulation of CRY2 expression.	[Lavebratt, Catharina; Sjoholm, Louise K.; Schalling, Martin] Karolinska Univ, Hosp Solna, Karolinska Inst, Neurogenet Unit,Dept Mol Med & Surg, Stockholm, Sweden; [Soronen, Pia; Paunio, Tiina] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Publ Hlth Genom Unit, Helsinki, Finland; [Vawter, Marquis P.; Bunney, William E.; Wu, Joseph C.] Univ Calif Irvine, Sch Med, Dept Psychiat & Human Behav, Funct Genom Lab, Irvine, CA 92717 USA; [Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [Forsell, Yvonne] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Kelsoe, John R.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Mood Depress & Suicidal Behaviour Unit, Helsinki, Finland	Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare; University of California System; University of California Irvine; Umea University; Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego; Finland National Institute for Health & Welfare	Lavebratt, C (corresponding author), Karolinska Univ, Hosp Solna, Karolinska Inst, Neurogenet Unit,Dept Mol Med & Surg, Stockholm, Sweden.	catharina.lavebratt@ki.se	Schalling, Martin/F-1518-2015; Forsell, Yvonne/ABB-8879-2020; Partonen, Timo/G-1105-2012	Schalling, Martin/0000-0001-5011-2922; Partonen, Timo/0000-0003-1951-2455; Lavebratt, Catharina/0000-0003-4987-2718; Adolfsson, Rolf/0000-0001-9785-8473	Academy of Finland [201097, 210262, 203425]; Helsinki University Central Hospital [TYH538]; Swedish Research Council [2005-6245, 2006-4670]; Stockholm County Council; Karolinska Institutet Foundations; National Center for Research Resource [M01 RR00827]; National Institute of Mental Health [MH 024370]; William Lion Penzner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet Foundations(Karolinska Institutet); National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); William Lion Penzner Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by grants from Academy of Finland (#201097 and #210262, www.aka.fi) and The Finnish Medical Foundation to Dr. Partonen, from Academy of Finland (#203425, www. suomenlaaketieteensaatio.fi) and Helsinki University Central Hospital (TYH538) to Dr. Paunio, from the Swedish Research Council (2005-6245, 2006-4670, www.vr.se), the Stockholm County Council (ALF, www. forskningsstod.sll.se) and Karolinska Institutet Foundations (www.ki.se) to Drs. Lavebratt and Schalling, by Public Health Service research grant M01 RR00827 from the National Center for Research Resource (www.ncrr.nih.gov) to UCI, Biomarker research grant MH 024370 to Dr. Vawter from the National Institute of Mental Health (www.nimh.nih.gov), and from the William Lion Penzner Foundation to Drs. Vawter and Bunney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buijs RM, 1999, EUR J NEUROSCI, V11, P1535, DOI 10.1046/j.1460-9568.1999.00575.x; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; CZEISLER CA, 1987, PSYCHIAT CLIN N AM, V10, P687; Daan S, 2001, J BIOL RHYTHM, V16, P105, DOI 10.1177/074873001129001809; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; de la Iglesia HO, 2002, NEUROREPORT, V13, P857, DOI 10.1097/00001756-200205070-00024; ELSASS P, 1979, ACTA PSYCHIAT SCAND, V60, P263, DOI 10.1111/j.1600-0447.1979.tb00274.x; FAEDDA GL, 1993, ARCH GEN PSYCHIAT, V50, P17; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Glod CA, 1997, J AM ACAD CHILD PSY, V36, P188, DOI 10.1097/00004583-199702000-00009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Kanazawa T, 2008, AM J MED GENET B, V147B, P686, DOI 10.1002/ajmg.b.30664; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; LAVEBRATT C, 2009, AM J MED GENE B 0819; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lewy AJ, 2006, P NATL ACAD SCI USA, V103, P7414, DOI 10.1073/pnas.0602425103; Lincoln GA, 2003, J NEUROENDOCRINOL, V15, P390, DOI 10.1046/j.1365-2826.2003.00990.x; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lundberg I, 2005, SOC PSYCH PSYCH EPID, V40, P475, DOI 10.1007/s00127-005-0911-4; Luo AH, 2009, EUR J NEUROSCI, V29, P748, DOI 10.1111/j.1460-9568.2008.06606.x; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Miyazaki K, 2004, BIOCHEM J, V380, P95, DOI 10.1042/BJ20031308; Niculescu AB, 2000, PHYSIOL GENOMICS, V4, P83, DOI 10.1152/physiolgenomics.2000.4.1.83; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Nurnberger JI, 2000, ARCH GEN PSYCHIAT, V57, P572, DOI 10.1001/archpsyc.57.6.572; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Ozgur S, 2003, BIOCHEMISTRY-US, V42, P2926, DOI 10.1021/bi026963n; Partonen T, 1998, LANCET, V352, P1369, DOI 10.1016/S0140-6736(98)01015-0; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; SOUETRE E, 1989, PSYCHIAT RES, V28, P263, DOI 10.1016/0165-1781(89)90207-2; Spoelstra K, 2008, J COMP PHYSIOL A, V194, P235, DOI 10.1007/s00359-007-0301-3; Sprouse J, 2006, BIOL PSYCHIAT, V60, P896, DOI 10.1016/j.biopsych.2006.03.003; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Teicher MH, 1997, ARCH GEN PSYCHIAT, V54, P124; THOMPSON C, 1990, LANCET, V336, P703, DOI 10.1016/0140-6736(90)92202-S; Thompson C, 1997, BRIT J PSYCHIAT, V170, P431, DOI 10.1192/bjp.170.5.431; Thompson CL, 2002, ONCOGENE, V21, P9043, DOI 10.1038/sj.onc.1205958; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	73	98	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9407	10.1371/journal.pone.0009407	http://dx.doi.org/10.1371/journal.pone.0009407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195522	Green Published, gold			2022-12-27	WOS:000274924200027
J	Retamal, P; Castillo-Ruiz, M; Villagra, NA; Morgado, J; Mora, GC				Retamal, Patricio; Castillo-Ruiz, Mario; Villagra, Nicolas A.; Morgado, Juan; Mora, Guido C.			Modified Intracellular-Associated Phenotypes in a Recombinant Salmonella Typhi Expressing S. Typhimurium SPI-3 Sequences	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; COMPARATIVE GENOMICS; ESCHERICHIA-COLI; CHOLERA-TOXIN; H-NS; MYCOBACTERIUM-TUBERCULOSIS; SEROTYPE TYPHIMURIUM; VIRULENCE FACTOR; GENE; MGTC	A bioinformatics comparison of Salmonella Pathogenicity Island 3 sequences from S. Typhi and S. Typhimurium serovars showed that ten genes are highly conserved. However three of them are pseudogenes in S. Typhi. Our aim was to understand what functions are lost in S. Typhi due to pseudogenes by constructing a S. Typhi genetic hybrid carrying the SPI-3 region of S. Typhimurium instead of its own SPI-3. We observed that under stressful conditions the hybrid strain showed a clear impairment in resistance to hydrogen peroxide and decreased survival within U937 culture monocytes. We hypothesized that the marT-fidL operon, encoded in SPI-3, was responsible for the new phenotypes because marT is a pseudogen in S. Typhi and has a demonstrated role as a transcriptional regulator in S. Typhimurium. Therefore we cloned and transferred the S. Typhimurium marT-fidL operon into S. Typhi and confirmed that invasion of monocytes was dramatically decreased. Finally, our findings suggest that the genomic and functional differences between SPI-3 sequences have implications in the host specificity of Typhi and Typhimurium serovars.	[Retamal, Patricio] Univ Chile, Dept Med Prevent Anim, Santiago, Chile; [Castillo-Ruiz, Mario; Villagra, Nicolas A.; Morgado, Juan; Mora, Guido C.] Univ Andres Bello, Dept Ciencias Biol, Santiago, Chile	Universidad de Chile; Universidad Andres Bello	Retamal, P (corresponding author), Univ Chile, Dept Med Prevent Anim, Santiago, Chile.	gmora@unab.cl	Retamal, Patricio/G-3054-2013	Retamal, Patricio/0000-0001-8597-9550; Castillo-Ruiz, Mario/0000-0002-0005-408X	FONDECYT [1060999]; UNAB [0404]; CONICYT; PUC	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); UNAB; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); PUC	This study was supported by FONDECYT grant 1060999, UNAB grant 0404 and predoctoral fellowships from CONICYT and PUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amavisit P, 2003, J BACTERIOL, V185, P3624, DOI 10.1128/JB.185.12.3624-3635.2003; Baker S, 2007, CLIN INFECT DIS, V45, pS29, DOI 10.1086/518143; Blanc-Potard AB, 2003, J MOL EVOL, V57, P479, DOI 10.1007/s00239-003-2496-4; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Bucarey SA, 2005, INFECT IMMUN, V73, P6210, DOI 10.1128/IAI.73.10.6210-6219.2005; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chaudhuri RR, 2004, NUCLEIC ACIDS RES, V32, pD296, DOI 10.1093/nar/gkh031; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Contreras I, 1997, MICROBIOL-UK, V143, P2665, DOI 10.1099/00221287-143-8-2665; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorsey CW, 2005, MOL MICROBIOL, V57, P196, DOI 10.1111/j.1365-2958.2005.04666.x; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; FRITZ G, 2009, J MOL BIOL; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; Moncrief MBC, 1998, INFECT IMMUN, V66, P3802, DOI 10.1128/IAI.66.8.3802-3809.1998; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pfau JD, 1996, MOL MICROBIOL, V20, P213, DOI 10.1111/j.1365-2958.1996.tb02502.x; Pfau JD, 1998, J BACTERIOL, V180, P4724, DOI 10.1128/JB.180.17.4724-4733.1998; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Sambrook J., 2002, MOL CLONING LAB MANU; Santiviago CA, 2001, MICROBIOL-SGM, V147, P1897, DOI 10.1099/00221287-147-7-1897; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Tukel C, 2007, J BACTERIOL, V189, P3922, DOI 10.1128/JB.01746-06; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x	32	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9394	10.1371/journal.pone.0009394	http://dx.doi.org/10.1371/journal.pone.0009394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195364	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924200016
J	Zijnge, V; van Leeuwen, MBM; Degener, JE; Abbas, F; Thurnheer, T; Gmur, R; Harmsen, HJM				Zijnge, Vincent; van Leeuwen, M. Barbara M.; Degener, John E.; Abbas, Frank; Thurnheer, Thomas; Gmuer, Rudolf; Harmsen, Hermie J. M.			Oral Biofilm Architecture on Natural Teeth	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DENTAL PLAQUE; OLIGONUCLEOTIDE PROBES; FUSOBACTERIUM-NUCLEATUM; ACTINOMYCES-NAESLUNDII; DIRECT VISUALIZATION; PERIODONTAL HEALTH; IDENTIFICATION; LOCALIZATION; BACTERIA	Periodontitis and caries are infectious diseases of the oral cavity in which oral biofilms play a causative role. Moreover, oral biofilms are widely studied as model systems for bacterial adhesion, biofilm development, and biofilm resistance to antibiotics, due to their widespread presence and accessibility. Despite descriptions of initial plaque formation on the tooth surface, studies on mature plaque and plaque structure below the gum are limited to landmark studies from the 1970s, without appreciating the breadth of microbial diversity in the plaque. We used fluorescent in situ hybridization to localize in vivo the most abundant species from different phyla and species associated with periodontitis on seven embedded teeth obtained from four different subjects. The data showed convincingly the dominance of Actinomyces sp., Tannerella forsythia, Fusobacterium nucleatum, Spirochaetes, and Synergistetes in subgingival plaque. The latter proved to be new with a possibly important role in host-pathogen interaction due to its localization in close proximity to immune cells. The present study identified for the first time in vivo that Lactobacillus sp. are the central cells of bacterial aggregates in subgingival plaque, and that Streptococcus sp. and the yeast Candida albicans form corncob structures in supragingival plaque. Finally, periodontal pathogens colonize already formed biofilms and form microcolonies therein. These in vivo observations on oral biofilms provide a clear vision on biofilm architecture and the spatial distribution of predominant species.	[Zijnge, Vincent; Abbas, Frank] Univ Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands; [Zijnge, Vincent; Degener, John E.; Harmsen, Hermie J. M.] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [van Leeuwen, M. Barbara M.] Univ Groningen, Dept Biomed Engn, Groningen, Netherlands; [Thurnheer, Thomas; Gmuer, Rudolf] Univ Zurich, Inst Oral Biol, Zurich, Switzerland	University of Groningen; University of Groningen; University of Groningen; University of Zurich	Zijnge, V (corresponding author), Univ Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands.	h.j.m.harmsen@med.umcg.nl		Thurnheer, Thomas/0000-0002-8615-8209	University Medical Center of the University of Groningen	University Medical Center of the University of Groningen	This work was supported by the Junior Scientific Master class program of the University Medical Center of the University of Groningen. RG and TT were supported by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Auschill TM, 2001, ARCH ORAL BIOL, V46, P471, DOI 10.1016/S0003-9969(00)00136-9; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; Busscher H J, 1997, Adv Dent Res, V11, P24; Daly K, 2003, FEMS MICROBIOL ECOL, V44, P243, DOI 10.1016/S0168-6496(03)00032-1; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gmur R, 2007, J MICROBIOL METH, V69, P402, DOI 10.1016/j.mimet.2006.12.012; Gmur R, 2004, EUR J ORAL SCI, V112, P33, DOI 10.1111/j.0909-8836.2004.00103.x; Gmur R, 2002, MICROBIOL-SGM, V148, P1379, DOI 10.1099/00221287-148-5-1379; Guggenheim M, 2001, APPL ENVIRON MICROB, V67, P1343, DOI 10.1128/AEM.67.3.1343-1350.2001; Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P1327, DOI 10.1111/j.1462-2920.2009.01949.x; Kampinga G A, 2002, Ned Tijdschr Geneeskd, V146, P73; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; LAI CH, 1975, INFECT IMMUN, V11, P200, DOI 10.1128/IAI.11.1.200-210.1975; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Moter A, 1998, J CLIN MICROBIOL, V36, P1399, DOI 10.1128/JCM.36.5.1399-1403.1998; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Netuschil L, 1998, ARCH ORAL BIOL, V43, P277, DOI 10.1016/S0003-9969(97)00121-0; Noiri Y, 2001, J DENT RES, V80, P1930, DOI 10.1177/00220345010800101301; Noiri Y, 1997, J PERIODONTAL RES, V32, P598, DOI 10.1111/j.1600-0765.1997.tb00937.x; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reese S, 2007, MICROSC RES TECHNIQ, V70, P816, DOI 10.1002/jemt.20471; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Takahashi N, 1999, CRIT REV ORAL BIOL M, V10, P487, DOI 10.1177/10454411990100040501; Vartoukian SR, 2009, APPL ENVIRON MICROB, V75, P3777, DOI 10.1128/AEM.02763-08; Wecke J, 2000, FEMS MICROBIOL LETT, V191, P95, DOI 10.1016/S0378-1097(00)00376-1; Wildeboer-Veloo ACM, 2007, CLIN MICROBIOL INFEC, V13, P985, DOI 10.1111/j.1469-0691.2007.01803.x; Wood SR, 2000, J DENT RES, V79, P21, DOI 10.1177/00220345000790010201; WYSS C, 1989, INFECT IMMUN, V57, P1757, DOI 10.1128/IAI.57.6.1757-1759.1989; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zaura-Arite E, 2001, J DENT RES, V80, P1436, DOI 10.1177/00220345010800051001; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	46	387	403	6	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9321	10.1371/journal.pone.0009321	http://dx.doi.org/10.1371/journal.pone.0009321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195365	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200005
J	Spencer, JL; Bernanke, JA; Buczek-Thomas, JA; Nugent, MA				Spencer, Jean L.; Bernanke, Joel A.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.			A Computational Approach for Deciphering the Organization of Glycosaminoglycans	PLOS ONE			English	Article							HEPARAN-SULFATE; STRUCTURAL FEATURES; SEQUENCE-ANALYSIS; DOMAIN-STRUCTURE; LIGAND-BINDING; FINE-STRUCTURE; SPECIFICITY; INHIBITION; MODEL; OLIGOSACCHARIDES	Background: Increasing evidence has revealed important roles for complex glycans as mediators of normal and pathological processes. Glycosaminoglycans are a class of glycans that bind and regulate the function of a wide array of proteins at the cell-extracellular matrix interface. The specific sequence and chemical organization of these polymers likely define function; however, identification of the structure-function relationships of glycosaminoglycans has been met with challenges associated with the unique level of complexity and the nontemplate-driven biosynthesis of these biopolymers. Methodology/Principal Findings: To address these challenges, we have devised a computational approach to predict fine structure and patterns of domain organization of the specific glycosaminoglycan, heparan sulfate (HS). Using chemical composition data obtained after complete and partial digestion of mixtures of HS chains with specific degradative enzymes, the computational analysis produces populations of theoretical HS chains with structures that meet both biosynthesis and enzyme degradation rules. The model performs these operations through a modular format consisting of input/output sections and three routines called chainmaker, chainbreaker, and chainsorter. We applied this methodology to analyze HS preparations isolated from pulmonary fibroblasts and epithelial cells. Significant differences in the general organization of these two HS preparations were observed, with HS from epithelial cells having a greater frequency of highly sulfated domains. Epithelial HS also showed a higher density of specific HS domains that have been associated with inhibition of neutrophil elastase. Experimental analysis of elastase inhibition was consistent with the model predictions and demonstrated that HS from epithelial cells had greater inhibitory activity than HS from fibroblasts. Conclusions/Significance: This model establishes the conceptual framework for a new class of computational tools to use to assess patterns of domain organization within glycosaminoglycans. These tools will provide a means to consider high-level chain organization in deciphering the structure-function relationships of polysaccharides in biology.	[Spencer, Jean L.; Bernanke, Joel A.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Spencer, Jean L.; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Nugent, Matthew A.] Boston Univ, Dept Biomed Engn, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Spencer, JL (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	spencerj@bu.edu		Buczek-Thomas, JoAnn/0000-0003-2784-9453; Bernanke, Joel/0000-0003-2507-6282; Spencer, Jean/0000-0001-7822-4619; Nugent, Matthew/0000-0002-8630-4712	US National Institutes of Health [HL56200, HL088672]; Massachusetts Lions Eye Research Fund, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572, R01HL056200] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the US National Institutes of Health (HL56200, HL088672) and by a departmental grant from the Massachusetts Lions Eye Research Fund, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afreixo V, 2004, DIGIT SIGNAL PROCESS, V14, P523, DOI 10.1016/j.dsp.2004.08.001; Alberts B., 1994, MOL BIOL CELL; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BOURIN MC, 1993, BIOCHEM J, V289, P313, DOI 10.1042/bj2890313; Buczek-Thomas JA, 2008, J CELL BIOCHEM, V105, P108, DOI 10.1002/jcb.21803; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COHEN DM, 1990, BIOPOLYMERS, V30, P733, DOI 10.1002/bip.360300708; Conrad H.E., 1998, HEPARIN BINDING PROT, V1st ed., P527; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fiore MM, 2001, BIOCHEM BIOPH RES CO, V284, P384, DOI 10.1006/bbrc.2001.4978; Forsten KE, 1997, J CELL PHYSIOL, V172, P209, DOI 10.1002/(SICI)1097-4652(199708)172:2<209::AID-JCP8>3.0.CO;2-S; FOSTER JA, 1990, J BIOL CHEM, V265, P15544; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; GALLAGHER JT, 1992, ADV EXP MED BIOL, V313, P49; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Guerrini M, 2002, GLYCOBIOLOGY, V12, P713, DOI 10.1093/glycob/cwf084; Hvala N, 2005, COMPUT CHEM ENG, V29, P1507, DOI 10.1016/j.compchemeng.2004.11.013; KATO M, 1994, J BIOL CHEM, V269, P18881; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Levine RA, 1998, EXP CELL RES, V239, P264, DOI 10.1006/excr.1997.3898; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; LINHARDT RJ, 1982, BIOCHIM BIOPHYS ACTA, V702, P197; LINHARDT RJ, 1989, BIOCHEMISTRY-US, V28, P2888, DOI 10.1021/bi00433a021; LINHARDT RJ, 1985, BIOCHEMISTRY-US, V24, P7805, DOI 10.1021/bi00347a045; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P10301, DOI 10.1073/pnas.97.19.10301; Park Y, 1997, BBA-PROTEIN STRUCT M, V1337, P217, DOI 10.1016/S0167-4838(96)00167-7; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rackovsky S, 1998, P NATL ACAD SCI USA, V95, P8580, DOI 10.1073/pnas.95.15.8580; RADOFF S, 1984, J BIOL CHEM, V259, P166; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Saad OM, 2005, ANAL CHEM, V77, P5902, DOI 10.1021/ac050793d; SANDERSON RD, 1994, J BIOL CHEM, V269, P13100; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359; Skidmore MA, 2006, J CHROMATOGR A, V1135, P52, DOI 10.1016/j.chroma.2006.09.064; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Stringer SE, 2002, BLOOD, V100, P1543, DOI 10.1182/blood.V100.5.1543.h81702001543_1543_1550; THOMPSON AB, 1995, EUR RESPIR J, V8, P127, DOI 10.1183/09031936.95.08010127; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767; Volpi N, 1996, BBA-GEN SUBJECTS, V1290, P299, DOI 10.1016/0304-4165(96)00033-5; WALSH RL, 1991, CLIN SCI, V81, P341, DOI 10.1042/cs0810341; Westling C, 2002, J BIOL CHEM, V277, P49247, DOI 10.1074/jbc.M209139200; YAMADA S, 1995, J BIOL CHEM, V270, P8696; Zaia J, 2008, CHEM BIOL, V15, P881, DOI 10.1016/j.chembiol.2008.07.016; [No title captured]	64	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9389	10.1371/journal.pone.0009389	http://dx.doi.org/10.1371/journal.pone.0009389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186334	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000025
J	Kim, HJ; Choi, MY; Kim, HJ; Llinas, M				Kim, Hyun Jin; Choi, Moo Young; Kim, Hyung J.; Llinas, Miguel			Conformational Dynamics and Ligand Binding in the Multi-Domain Protein PDC109	PLOS ONE			English	Article							BOVINE SEMINAL PLASMA; CATION-PI INTERACTIONS; BULL SPERM BINDING; MOLECULAR-DYNAMICS; FREE-ENERGY; OVIDUCTAL EPITHELIUM; MATRIX METALLOPROTEINASE-2; THERMAL-STABILITY; MAJOR PROTEINS; MEAN FORCE	PDC109 is a modular multi-domain protein with two fibronectin type II (Fn2) repeats joined by a linker. It plays a major role in bull sperm binding to the oviductal epithelium through its interactions with phosphorylcholines (PhCs), a head group of sperm cell membrane lipids. The crystal structure of the PDC109-PhC complex shows that each PhC binds to the corresponding Fn2 domain, while the two domains are on the same face of the protein. Long timescale explicit solvent molecular dynamics (MD) simulations of PDC109, in the presence and absence of PhC, suggest that PhC binding strongly correlates with the relative orientation of choline-phospholipid binding sites of the two Fn2 domains; unless the two domains tightly bind PhCs, they tend to change their relative orientation by deforming the flexible linker. The effective PDC109-PhC association constant of 28 M-1, estimated from their potential of mean force is consistent with the experimental result. Principal component analysis of the long timescale MD simulations was compared to the significantly less expensive normal mode analysis of minimized structures. The comparison indicates that difference between relative domain motions of PDC109 with bound and unbound PhC is captured by the first principal component in the principal component analysis as well as the three lowest normal modes in the normal mode analysis. The present study illustrates the use of detailed MD simulations to clarify the energetics of specific ligand-domain interactions revealed by a static crystallographic model, as well as their influence on relative domain motions in a multi-domain protein.	[Kim, Hyun Jin; Kim, Hyung J.; Llinas, Miguel] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; [Choi, Moo Young] Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea; [Choi, Moo Young] Seoul Natl Univ, Ctr Theoret Phys, Seoul, South Korea; [Kim, Hyung J.] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea	Carnegie Mellon University; Seoul National University (SNU); Seoul National University (SNU); Korea Institute for Advanced Study (KIAS)	Kim, HJ (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	hjkim@cmu.edu; llinas@andrew.cmu.edu	Kim, Hyung/S-3066-2016	Kim, Hyung/0000-0003-4334-1879; Choi, MooYoung/0000-0001-8070-7716	National Science Foundation (NSF) Chemistry [(CHE)-0098062]; National Institutes of Health (NIH) [HL-29409, GM-067964]; Korea Science and Engineering Foundation (KOSEF); NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC);  [MCB070055P];  [MCB090046P]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067964] Funding Source: NIH RePORTER	National Science Foundation (NSF) Chemistry(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC)(National Science Foundation (NSF)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Science Foundation (NSF) Chemistry (CHE)-0098062, National Institutes of Health (NIH) HL-29409 and GM-067964, Korea Science and Engineering Foundation (KOSEF). NSF through TeraGrid resources provided by Pittsburgh Supercomputing Center (PSC), grant MCB070055P and MCB090046P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbazhagan V, 2005, FEBS LETT, V579, P2933, DOI 10.1016/j.febslet.2005.04.046; BANYAI L, 1990, EUR J BIOCHEM, V193, P801, DOI 10.1111/j.1432-1033.1990.tb19403.x; Braun T, 2009, NAT NANOTECHNOL, V4, P179, DOI [10.1038/NNANO.2008.398, 10.1038/nnano.2008.398]; Brewerton SC, 2008, CURR OPIN DRUG DISC, V11, P356; Briknarova K, 2001, J BIOL CHEM, V276, P27613, DOI 10.1074/jbc.M101105200; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CALVETE JJ, 1994, FEBS LETT, V350, P203, DOI 10.1016/0014-5793(94)00768-3; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4; Chipot C, 1996, J AM CHEM SOC, V118, P2998, DOI 10.1021/ja950302e; CONSTANTINE KL, 1992, J MOL BIOL, V223, P281, DOI 10.1016/0022-2836(92)90731-X; Cubero E, 1998, P NATL ACAD SCI USA, V95, P5976, DOI 10.1073/pnas.95.11.5976; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; De Los Rios P, 2005, BIOPHYS J, V89, P14, DOI 10.1529/biophysj.104.055004; Derrick TS, 2002, J MAGN RESON, V155, P217, DOI 10.1006/jmre.2002.2513; DESNOYERS L, 1992, J BIOL CHEM, V267, P10149; Douglas JT, 2002, BIOCHEMISTRY-US, V41, P3302, DOI 10.1021/bi016018j; EDDY T, 2009, J MOL STRUC-THEOCHEM, V898, P31; ESSMANN U, 1995, J COMP PHYS, V15, P8577; Felder C, 2001, J PHYS CHEM A, V105, P1326, DOI 10.1021/jp002933n; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gasset M, 1997, EUR J BIOCHEM, V250, P735, DOI 10.1111/j.1432-1033.1997.00735.x; Gasset M, 2000, ARCH BIOCHEM BIOPHYS, V374, P241, DOI 10.1006/abbi.1999.1593; Gerwig GJ, 1996, FEBS LETT, V387, P99, DOI 10.1016/0014-5793(96)00448-6; Greube A, 2001, BIOCHEMISTRY-US, V40, P8326, DOI 10.1021/bi010552+; Grubmuller H., SOLVATE 1 0; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; Gwathmey TM, 2003, BIOL REPROD, V69, P809, DOI 10.1095/biolreprod.102.010827; HART TN, 1992, PROTEINS, V13, P206, DOI 10.1002/prot.340130304; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jelinkova P, 2004, COLLECT CZECH CHEM C, V69, P616, DOI 10.1135/cccc20040616; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Lee MS, 2006, BIOPHYS J, V90, P864, DOI 10.1529/biophysj.105.071589; Lefebvre R, 1997, BIOL REPROD, V56, P1198, DOI 10.1095/biolreprod56.5.1198; LINSE P, 1993, J AM CHEM SOC, V115, P8793, DOI 10.1021/ja00072a037; LLINAS M, 1973, STRUCT BOND, V17, P135; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; MANJUNATH P, 1994, BIOCHEM J, V303, P121, DOI 10.1042/bj3030121; MANJUNATH P, 1987, BIOCHEM J, V241, P685, DOI 10.1042/bj2410685; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McLaughlin SH, 2002, PROTEIN SCI, V11, P1926, DOI 10.1110/ps.5000102; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Michel J, 2006, J MED CHEM, V49, P7427, DOI 10.1021/jm061021s; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Moreau R, 1999, BBA-MOL CELL BIOL L, V1438, P175, DOI 10.1016/S1388-1981(99)00049-9; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Muller P, 1998, EUR BIOPHYS J BIOPHY, V27, P33, DOI 10.1007/s002490050108; Pavani P, 2008, RES J BIOTECHNOL, V3, P18; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramakrishnan M, 2001, BIOPHYS J, V81, P2215, DOI 10.1016/S0006-3495(01)75869-9; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Roche O, 2001, J MED CHEM, V44, P3592, DOI 10.1021/jm000467k; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; Romero A, 1997, PROTEINS, V28, P454, DOI 10.1002/(SICI)1097-0134(199707)28:3<454::AID-PROT14>3.0.CO;2-G; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shim Y, 2008, J PHYS CHEM B, V112, P2637, DOI 10.1021/jp710128p; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; STRAATSMA TP, 1986, MOL PHYS, V57, P89, DOI 10.1080/00268978600100071; Suarez SS, 1998, BIOL REPROD, V59, P39, DOI 10.1095/biolreprod59.1.39; Sun Y, 1998, J COMPUT AID MOL DES, V12, P597, DOI 10.1023/A:1008036704754; Swamy MJ, 2004, CURR SCI INDIA, V87, P203; Tannert A, 2007, EUR BIOPHYS J BIOPHY, V36, P461, DOI 10.1007/s00249-006-0105-3; Thomas CJ, 2003, BIOPHYS J, V84, P3037, DOI 10.1016/S0006-3495(03)70029-0; Tillett ML, 1999, J BIOMOL NMR, V13, P223, DOI 10.1023/A:1008301324954; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wah DA, 2002, STRUCTURE, V10, P505, DOI 10.1016/S0969-2126(02)00751-7; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Zavodszky MI, 2009, J COMPUT AID MOL DES, V23, P289, DOI 10.1007/s10822-008-9258-8	74	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9180	10.1371/journal.pone.0009180	http://dx.doi.org/10.1371/journal.pone.0009180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174627	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700006
J	Samuel, AS; Paldurai, A; Kumar, S; Collins, PL; Samal, SK				Samuel, Arthur S.; Paldurai, Anandan; Kumar, Sachin; Collins, Peter L.; Samal, Siba K.			Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; UNTRANSLATED REGIONS; VIRUS M; RNA; PROTEIN; NEURAMINIDASE; REPLICATION; DOMAIN; RULE; GENE	Background: Avian paramyxoviruses (APMV) consist of nine known serotypes. The genomes of representatives of all APMV serotypes except APMV type 5 have recently been fully sequenced. Here, we report the complete genome sequence of the APMV-5 prototype strain budgerigar/Kunitachi/74. Methodology/Principal Findings: APMV-5 Kunitachi virus is unusual in that it lacks a virion hemagglutinin and does not grow in the allantoic cavity of embryonated chicken eggs. However, the virus grew in the amniotic cavity of embryonated chicken eggs and in twelve different established cell lines and two primary cell cultures. The genome is 17,262 nucleotides (nt) long, which is the longest among members of genus Avulavirus, and encodes six non-overlapping genes in the order of 3'N-P/V/W-M-F-HN-L-5' with intergenic regions of 4-57 nt. The genome length follows the 'rule of six' and contains a 55-nt leader sequence at the 3' end and a 552 nt trailer sequence at the 59 end. The phosphoprotein (P) gene contains a conserved RNA editing site and is predicted to encode P, V, and W proteins. The cleavage site of the F protein (G-K-R-K-K-R down arrow F) conforms to the cleavage site motif of the ubiquitous cellular protease furin. Consistent with this, exogenous protease was not required for virus replication in vitro. However, the intracerebral pathogenicity index of APMV-5 strain Kunitachi in one-day-old chicks was found to be zero, indicating that the virus is avirulent for chickens despite the presence of a polybasic F cleavage site. Conclusions/Significance: Phylogenetic analysis of the sequences of the APVM-5 genome and proteins versus those of the other APMV serotypes showed that APMV-5 is more closely related to APMV-6 than to the other APMVs. Furthermore, these comparisons provided evidence of extensive genome-wide divergence that supports the classification of the APMVs into nine separate serotypes. The structure of the F cleavage site does not appear to be a reliable indicator of virulence among APMV serotypes 2-9. The availability of sequence information for all known APMV serotypes will facilitate studies in epidemiology and vaccinology.	[Samuel, Arthur S.; Paldurai, Anandan; Kumar, Sachin; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Collins, Peter L.] NIAID, Infect Dis Lab, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samuel, AS (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu			National Institute of Allergy and Infectious Diseases (NIAID) [N01A060009]; NIAID; National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infectious Diseases (NIAID) contract no. N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1982, AVIAN PATHOL, V11, P179, DOI 10.1080/03079458208436091; ALEXANDER DJ, 1982, WORLD POULTRY SCI J, V38, P97, DOI 10.1079/WPS19820008; ALEXANDER DJ, 2003, AVIAN PARAMYXOVIRUSE, P88; Anderson DE, 2008, J VIROL, V82, P10510, DOI 10.1128/JVI.01419-08; Beck I, 2003, VACCINE, V21, P1006, DOI 10.1016/S0264-410X(02)00552-2; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chang PC, 2001, J GEN VIROL, V82, P2157, DOI 10.1099/0022-1317-82-9-2157; COLEMAN NA, 1993, VIROLOGY, V195, P596, DOI 10.1006/viro.1993.1411; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; GOUGH RE, 1993, VET REC, V133, P123, DOI 10.1136/vr.133.5.123-a; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Jack PJM, 2005, J VIROL, V79, P10690, DOI 10.1128/JVI.79.16.10690-10700.2005; Jung A, 2009, J AVIAN MED SURG, V23, P205, DOI 10.1647/2008-022.1; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUMAR S, 2008, VIRUS RES; Lamb R. A, 2005, VIRUS TAXONOMY CLASS, P655; LAMB RA, 1977, VIROLOGY, V81, P382, DOI 10.1016/0042-6822(77)90154-4; Langedijk JPM, 1997, J VIROL, V71, P6155, DOI 10.1128/JVI.71.8.6155-6167.1997; Li Z, 2006, VIROLOGY, V346, P219, DOI 10.1016/j.virol.2005.10.039; Lin Y, 2005, VIROLOGY, V338, P270, DOI 10.1016/j.virol.2005.05.014; Malur AG, 2002, J VIROL, V76, P8101, DOI 10.1128/JVI.76.16.8101-8109.2002; Miller PJ, 2003, VIROLOGY, V317, P330, DOI 10.1016/j.virol.2003.08.013; MIRZA AM, 1994, J VIROL, V68, P5093, DOI 10.1128/JVI.68.8.5093-5099.1994; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; MUSTAFFABABJEE A, 1974, AVIAN DIS, V18, P226, DOI 10.2307/1589130; Nayak B, 2008, VIROL J, V5, DOI [10.1186/1743-422X-5-124, 10.1186/1743-422x-5-124]; NEROME K, 1978, J GEN VIROL, V38, P293, DOI 10.1099/0022-1317-38-2-293; NYLUND S, 2007, VIROLOGY; Paldurai A, 2009, VIRUS RES, V142, P144, DOI 10.1016/j.virusres.2009.02.003; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; POCH O, 1990, J GEN VIROL, V71, P1153, DOI 10.1099/0022-1317-71-5-1153; PURCHASE HG, 1990, LAB MANUAL ISOLATION, P240; Samal SK, 1996, J VIROL, V70, P5075, DOI 10.1128/JVI.70.8.5075-5082.1996; Samuel AS, 2009, VIRUS RES, V142, P10, DOI 10.1016/j.virusres.2008.12.016; Schmitt AP, 2005, J VIROL, V79, P2988, DOI 10.1128/JVI.79.5.2988-2997.2005; Schnell MJ, 1995, VIROLOGY, V214, P522, DOI 10.1006/viro.1995.0063; SHIODA T, 1986, NUCLEIC ACIDS RES, V14, P1545, DOI 10.1093/nar/14.4.1545; Subbiah M, 2008, VIRUS RES, V137, P40, DOI 10.1016/j.virusres.2008.05.012; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Takimoto T, 2000, VIROLOGY, V270, P208, DOI 10.1006/viro.2000.0263; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Weingartl HM, 2003, J CLIN MICROBIOL, V41, P1280, DOI 10.1128/JCM.41.3.1280-1284.2003; Xiao S, 2009, VIRUS RES, V145, P80, DOI 10.1016/j.virusres.2009.06.003; Yan YQ, 2009, J VIROL, V83, P5943, DOI 10.1128/JVI.00188-09; Yu M, 1998, J GEN VIROL, V79, P1775, DOI 10.1099/0022-1317-79-7-1775	50	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9269	10.1371/journal.pone.0009269	http://dx.doi.org/10.1371/journal.pone.0009269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174645	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590600022
J	Khankin, EV; Mutter, WP; Tamez, H; Yuan, HT; Karumanchi, SA; Thadhani, R				Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth; Thadhani, Ravi			Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INCIDENT HEMODIALYSIS-PATIENTS; TRANSFERRIN RECEPTOR; INDUCED DIFFERENTIATION; STIMULATING AGENTS; ANEMIA MANAGEMENT; ENDOTHELIAL-CELLS; DIALYSIS PATIENTS; EPOETIN-ALPHA; VITAMIN-D	Background: Erythropoietin is a growth factor commonly used to manage anemia in patients with chronic kidney disease. A significant clinical challenge is relative resistance to erythropoietin, which leads to use of successively higher erythropoietin doses, failure to achieve target hemoglobin levels, and increased risk of adverse outcomes. Erythropoietin acts through the erythropoietin receptor (EpoR) present in erythroblasts. Alternative mRNA splicing produces a soluble form of EpoR (sEpoR) found in human blood, however its role in anemia is not known. Methods and Findings: Using archived serum samples obtained from subjects with end stage kidney disease we show that sEpoR is detectable as a 27kDa protein in the serum of dialysis patients, and that higher serum sEpoR levels correlate with increased erythropoietin requirements. Soluble EpoR inhibits erythropoietin mediated signal transducer and activator of transcription 5 (Stat5) phosphorylation in cell lines expressing EpoR. Importantly, we demonstrate that serum from patients with elevated sEpoR levels blocks this phosphorylation in ex vivo studies. Finally, we show that sEpoR is increased in the supernatant of a human erythroleukaemia cell line when stimulated by inflammatory mediators such as interleukin-6 and tumor necrosis factor alpha implying a link between inflammation and erythropoietin resistance. Conclusions: These observations suggest that sEpoR levels may contribute to erythropoietin resistance in end stage renal disease, and that sEpoR production may be mediated by pro-inflammatory cytokines.	[Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector; Yuan, Hai-Tao; Karumanchi, S. Ananth; Thadhani, Ravi] Harvard Univ, Sch Med, Boston, MA USA; [Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute	Khankin, EV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	sananth@bidmc.harvard.edu	Karumanchi, Subbian Ananth/AAI-1694-2021; Khankin, Eli/M-7648-2013	Khankin, Eliyahu/0000-0002-1695-7267	Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Satellite Research; Normon S. Coplon Grant	Beth Israel Deaconess Medical Center; Massachusetts General Hospital(General Electric); Satellite Research; Normon S. Coplon Grant	This work was supported by Department of Medicine seed funds from the Beth Israel Deaconess Medical Center and the Massachusetts General Hospital. S. A. K. is an investigator of the Howard Hughes Medical Institute. Work was also funded by Satellite Research, Normon S. Coplon Grant to W. P. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 1997, AM J KIDNEY DIS, V30, P532, DOI 10.1016/S0272-6386(97)90313-9; Arcasoy MO, 2003, BIOCHEM BIOPH RES CO, V307, P999, DOI 10.1016/S0006-291X(03)01303-2; BARRON C, 1994, GENE, V147, P263, DOI 10.1016/0378-1119(94)90078-7; BAYNES RD, 1993, BLOOD, V82, P2088; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brunelli SM, 2008, CLIN J AM SOC NEPHRO, V3, P1733, DOI 10.2215/CJN.02390508; Buck I, 2008, BIOCHEM PHARMACOL, V76, P1229, DOI 10.1016/j.bcp.2008.08.025; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Chen CM, 2001, J BIOL CHEM, V276, P38518, DOI 10.1074/jbc.M105702200; Chen HH, 2008, J NEPHROL, V21, P543; Chiang WC, 2002, CLIN NEPHROL, V58, P363; Coyne DW, 2008, SEMIN DIALYSIS, V21, P212, DOI 10.1111/j.1525-139X.2008.00423.x; Daschner M, 1999, CLIN NEPHROL, V52, P246; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eleftheriadis T, 2006, ACTA HAEMATOL-BASEL, V116, P238, DOI 10.1159/000095873; FERRO FE, 1993, J BIOL CHEM, V268, P5741; Goodnough LT, 2007, EXP HEMATOL, V35, P167, DOI 10.1016/j.exphem.2007.01.026; Greenwood RN, 2003, KIDNEY INT, V64, pS78, DOI 10.1046/j.1523-1755.64.s87.12.x; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Harris KW, 1996, AM J HEMATOL, V52, P8, DOI 10.1002/(SICI)1096-8652(199605)52:1<8::AID-AJH2>3.0.CO;2-Z; Horl WH, 2002, NEPHROL DIAL TRANSPL, V17, P35, DOI 10.1093/ndt/17.suppl_11.35; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Johnson DW, 2007, NEPHROLOGY, V12, P321, DOI 10.1111/j.1440-1797.2007.00810.x; JONES SS, 1990, BLOOD, V76, P31; Joyeux-Faure M, 2007, J PHARMACOL EXP THER, V323, P759, DOI 10.1124/jpet.107.127357; Kalantar-Zadeh K, 2009, AM J KIDNEY DIS, V53, P823, DOI 10.1053/j.ajkd.2008.12.040; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; Kaysen GA, 2006, AM J KIDNEY DIS, V47, P157, DOI 10.1053/j.ajkd.2005.09.013; Keithi-Reddy SR, 2008, KIDNEY INT, V74, P782, DOI 10.1038/ki.2008.245; Krosl J, 1996, J BIOL CHEM, V271, P27432, DOI 10.1074/jbc.271.44.27432; Kubota Y, 2001, EMBO J, V20, P5666, DOI 10.1093/emboj/20.20.5666; KURAMOCHI H, 1990, CHEM PHARM BULL, V38, P123; Lacson E, 2008, AM J KIDNEY DIS, V52, P1104, DOI 10.1053/j.ajkd.2008.07.026; Lee PS, 2009, J AM SOC NEPHROL, V20, P1140, DOI 10.1681/ASN.2008091008; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maruyama H, 2004, J GENE MED, V6, P228, DOI 10.1002/jgm.485; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; NAGAO M, 1992, BIOCHEM BIOPH RES CO, V188, P888, DOI 10.1016/0006-291X(92)91139-H; Navaneethan SD, 2006, J NEPHROL, V19, P640; Neumann D, 1996, BIOCHEM J, V313, P391, DOI 10.1042/bj3130391; Paoletti E, 2006, J AM SOC NEPHROL, V17, pS74, DOI 10.1681/ASN.2005121325; Pisoni RL, 2004, AM J KIDNEY DIS, V44, P94, DOI 10.1053/j.ajkd.2004.03.023; Priyadarshi A, 2006, SEMIN DIALYSIS, V19, P273, DOI 10.1111/j.1525-139X.2006.00172.x; Rossert J, 2005, NEPHROL DIAL TRANSPL, V20, P1025, DOI 10.1093/ndt/gfh800; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Soliz J, 2007, J PHYSIOL-LONDON, V583, P329, DOI 10.1113/jphysiol.2007.133454; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Stenvinkel P, 2002, NEPHROL DIAL TRANSPL, V17, P32, DOI 10.1093/ndt/17.suppl_5.32; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; Tarng DC, 2002, NEPHROL DIAL TRANSPL, V17, P1063, DOI 10.1093/ndt/17.6.1063; TODOKORO K, 1991, GENE, V106, P283; Tsuchihashi D, 2008, THER APHER DIAL, V12, P226, DOI 10.1111/j.1744-9987.2008.00578.x; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Westphal G, 2002, CLIN EXP MED, V2, P45, DOI 10.1007/s102380200006; WINKELMANN JC, 1990, BLOOD, V76, P24; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002; YET MG, 1993, BLOOD, V82, P1713, DOI 10.1182/blood.V82.6.1713.bloodjournal8261713; Yoshida S, 1996, BLOOD, V88, P3246, DOI 10.1182/blood.V88.8.3246.bloodjournal8883246; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002	65	37	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9246	10.1371/journal.pone.0009246	http://dx.doi.org/10.1371/journal.pone.0009246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169072	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500024
J	Kostecki, JS; Li, HM; Turner, RJ; DeLisa, MP				Kostecki, Jan S.; Li, Haiming; Turner, Raymond J.; DeLisa, Matthew P.			Visualizing Interactions along the Escherichia coli Twin-Arginine Translocation Pathway Using Protein Fragment Complementation	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FOLDING QUALITY-CONTROL; LEADER-BINDING PROTEIN; TRANSPORT SYSTEM; SIGNAL PEPTIDE; TATA COMPONENT; LIVING CELLS; DIFFERENTIAL INTERACTIONS; SECRETORY PATHWAY; COMMON PRINCIPLES	The twin-arginine translocation (Tat) pathway is well known for its ability to export fully folded substrate proteins out of the cytoplasm of Gram-negative and Gram-positive bacteria. Studies of this mechanism in Escherichia coli have identified numerous transient protein-protein interactions that guide export-competent proteins through the Tat pathway. To visualize these interactions, we have adapted bimolecular fluorescence complementation (BiFC) to detect protein-protein interactions along the Tat pathway of living cells. Fragments of the yellow fluorescent protein (YFP) were fused to soluble and transmembrane factors that participate in the translocation process including Tat substrates, Tat-specific proofreading chaperones and the integral membrane proteins TatABC that form the translocase. Fluorescence analysis of these YFP chimeras revealed a wide range of interactions such as the one between the Tat substrate dimethyl sulfoxide reductase (DmsA) and its dedicated proofreading chaperone DmsD. In addition, BiFC analysis illuminated homo- and hetero-oligomeric complexes of the TatA, TatB and TatC integral membrane proteins that were consistent with the current model of translocase assembly. In the case of TatBC assemblies, we provide the first evidence that these complexes are co-localized at the cell poles. Finally, we used this BiFC approach to capture interactions between the putative Tat receptor complex formed by TatBC and the DmsA substrate or its dedicated chaperone DmsD. Our results demonstrate that BiFC is a powerful approach for studying cytoplasmic and inner membrane interactions underlying bacterial secretory pathways.	[Kostecki, Jan S.; DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Li, Haiming; Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA	Cornell University; University of Calgary; Cornell University	Kostecki, JS (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019; Turner, Raymond J./M-3961-2015	Turner, Raymond J./0000-0002-9263-0776; DeLisa, Matthew/0000-0003-3226-1566	Canadian Institutes of Health; National Science Foundation (NSF) [CBET 0448090]; New York State Foundation for Science, Technology and Innovation (NYSTAR)	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF)(National Science Foundation (NSF)); New York State Foundation for Science, Technology and Innovation (NYSTAR)	This material is based upon work supported by a Canadian Institutes of Health Research Operating grant (to R.J.T.) and a National Science Foundation (NSF) CAREER Award (CBET 0448090) and a New York State Foundation for Science, Technology and Innovation (NYSTAR) James D. Watson Young Investigator Award (to M. P. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Chan CS, 2008, BIOCHEMISTRY-US, V47, P2749, DOI 10.1021/bi702138a; Chan CS, 2009, J BACTERIOL, V191, P2091, DOI 10.1128/JB.00949-08; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Driessen AJM, 1998, CURR OPIN MICROBIOL, V1, P216, DOI 10.1016/S1369-5274(98)80014-3; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Feilmeier BJ, 2000, J BACTERIOL, V182, P4068, DOI 10.1128/JB.182.14.4068-4076.2000; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2004, J BACTERIOL, V186, P7467, DOI 10.1128/JB.186.22.7467-7473.2004; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868; Ilbert M, 2004, MICROBIOL-SGM, V150, P935, DOI 10.1099/mic.0.26909-0; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Jack RL, 2005, BIOCHEM SOC T, V33, P105, DOI 10.1042/BST0330105; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; Matos CFRO, 2008, EMBO J, V27, P2055, DOI 10.1038/emboj.2008.132; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Papish AL, 2003, J BIOL CHEM, V278, P32501, DOI 10.1074/jbc.M301076200; Perez-Rodriguez R, 2007, J MOL BIOL, V367, P715, DOI 10.1016/j.jmb.2007.01.027; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Richter S, 2007, J BIOL CHEM, V282, P33257, DOI 10.1074/jbc.M703303200; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Russell DW, 2001, MOL CLONING LAB MANU; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Santini CL, 2001, J BIOL CHEM, V276, P8159, DOI 10.1074/jbc.C000833200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shyu YJ, 2008, NAT PROTOC, V3, P1693, DOI 10.1038/nprot.2008.157; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stuart RA, 2000, NATURE, V406, P575, DOI 10.1038/35020668; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Waraho D, 2009, P NATL ACAD SCI USA, V106, P3692, DOI 10.1073/pnas.0704048106; Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699; Wilson CG, 2004, NAT METHODS, V1, P255, DOI 10.1038/nmeth1204-255	70	33	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9225	10.1371/journal.pone.0009225	http://dx.doi.org/10.1371/journal.pone.0009225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169075	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500007
J	Fauque, P; Mondon, F; Letourneur, F; Ripoche, MA; Journot, L; Barbaux, S; Dandolo, L; Patrat, C; Wolf, JP; Jouannet, P; Jammes, H; Vaiman, D				Fauque, Patricia; Mondon, Francoise; Letourneur, Franck; Ripoche, Marie-Anne; Journot, Laurent; Barbaux, Sandrine; Dandolo, Luisa; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre; Jammes, Helene; Vaiman, Daniel			In Vitro Fertilization and Embryo Culture Strongly Impact the Placental Transcriptome in the Mouse Model	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; INTRACYTOPLASMIC SPERM INJECTION; SILVER-RUSSELL-SYNDROME; ASSISTED REPRODUCTIVE TECHNOLOGIES; MAJOR BIRTH-DEFECTS; GENE-EXPRESSION; IMPRINTED GENES; CHILDREN BORN; CONGENITAL-MALFORMATIONS; DNA-METHYLATION	Background: Assisted Reproductive Technologies (ART) are increasingly used in humans; however, their impact is now questioned. At blastocyst stage, the trophectoderm is directly in contact with an artificial medium environment, which can impact placental development. This study was designed to carry out an in-depth analysis of the placental transcriptome after ART in mice. Methodology/Principal Findings: Blastocysts were transferred either (1) after in vivo fertilization and development (control group) or (2) after in vitro fertilization and embryo culture. Placentas were then analyzed at E10.5. Six percent of transcripts were altered at the two-fold threshold in placentas of manipulated embryos, 2/3 of transcripts being down-regulated. Strikingly, the X-chromosome harbors 11% of altered genes, 2/3 being induced. Imprinted genes were modified similarly to the X. Promoter composition analysis indicates that FOXA transcription factors may be involved in the transcriptional deregulations. Conclusions: For the first time, our study shows that in vitro fertilization associated with embryo culture strongly modify the placental expression profile, long after embryo manipulations, meaning that the stress of artificial environment is memorized after implantation. Expression of X and imprinted genes is also greatly modulated probably to adapt to adverse conditions. Our results highlight the importance of studying human placentas from ART.	[Fauque, Patricia; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre] Hop Cochin, Serv Histol Embryol, F-75674 Paris, France; [Fauque, Patricia; Mondon, Francoise; Letourneur, Franck; Ripoche, Marie-Anne; Barbaux, Sandrine; Dandolo, Luisa; Patrat, Catherine; Wolf, Jean-Philippe; Jouannet, Pierre; Jammes, Helene; Vaiman, Daniel] Univ Paris 05, Paris, France; [Fauque, Patricia; Mondon, Francoise; Ripoche, Marie-Anne; Barbaux, Sandrine; Dandolo, Luisa; Jammes, Helene; Vaiman, Daniel] CNRS, INSERM, Dept Genet & Dev, Inst Cochin,Equipe 21,U567,UMR 8104, Paris, France; [Journot, Laurent] Inst Genom Fonct, Montpellier, France; [Jammes, Helene] INRA, ENVA, UMR1198, Jouy En Josas, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fauque, P (corresponding author), Hop Cochin, Serv Histol Embryol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	patricia.fauque@cch.aphp.fr	Barbaux, Sandrine C/B-2878-2019; Journot, Laurent/T-9652-2018; Vaiman, Daniel/O-6030-2015	Barbaux, Sandrine C/0000-0002-8204-1855; Journot, Laurent/0000-0003-3499-8887; Vaiman, Daniel/0000-0002-1915-0717	Fond d'Aide la Recherche d'Organon [ALA-570/06]; Agence de Biomedecine [06.21.DPM OMA 09]	Fond d'Aide la Recherche d'Organon; Agence de Biomedecine	Funding: This research was supported by grants from the "Fond d'Aide la Recherche d'Organon" (ALA-570/06) and from the "Agence de Biomedecine" (06.21.DPM OMA 09), France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras Nagy M. G., 2003, MANIPULATING MOUSE E, V3rd; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Bowdin S, 2007, HUM REPROD, V22, P3237, DOI 10.1093/humrep/dem268; Buffat C, 2007, ENDOCRINOLOGY, V148, P5549, DOI 10.1210/en.2007-0765; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Douzgou S, 2008, PEDIATR DEVEL PATHOL, V11, P329, DOI 10.2350/08-04-0458.1; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; El-Chaar D, 2009, FERTIL STERIL, V92, P1557, DOI 10.1016/j.fertnstert.2008.08.080; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fortier AL, 2008, HUM MOL GENET, V17, P1653, DOI 10.1093/hmg/ddn055; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Giritharan G, 2007, REPRODUCTION, V134, P63, DOI 10.1530/REP-06-0247; Gomes MV, 2007, AM J MED GENET A, V143A, P625, DOI 10.1002/ajmg.a.31628; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hohn HP, 2002, CELLS TISSUES ORGANS, V172, P218, DOI 10.1159/000066965; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Husslein H, 2009, PLACENTA, V30, P284, DOI 10.1016/j.placenta.2008.12.002; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KATARI S, 2009, HUM MOL GENET; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Klemetti R, 2005, FERTIL STERIL, V84, P1300, DOI 10.1016/j.fertnstert.2005.03.085; Kovalevsky G, 2003, FERTIL STERIL, V79, P1270, DOI 10.1016/S0015-0282(03)00397-2; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Li T, 2005, MOL HUM REPROD, V11, P631, DOI 10.1093/molehr/gah230; Ludwig Hans, 2005, Arch Gynecol Obstet, V271, P1, DOI 10.1007/s00404-004-0711-1; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Manning M, 2000, MOL HUM REPROD, V6, P1049, DOI 10.1093/molehr/6.11.1049; Marin JJG, 2003, PLACENTA, V24, P431, DOI 10.1053/plac.2002.0951; Marin JJG, 2008, LIVER INT, V28, P435, DOI 10.1111/j.1478-3231.2008.01680.x; Martin-de-Lara F, 2008, TRANSGENIC RES, V17, P1131, DOI 10.1007/s11248-008-9214-3; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Merlob P, 2005, EUR J MED GENET, V48, P5, DOI 10.1016/j.ejmg.2005.01.019; Mondon F, 2005, PHYSIOL GENOMICS, V22, P99, DOI 10.1152/physiolgenomics.00276.2004; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Olson CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086; Orstavik KH, 2003, AM J HUM GENET, V72, P218, DOI 10.1086/346030; Polgar O, 2008, EXPERT OPIN DRUG MET, V4, P1, DOI 10.1517/17425255.4.1.1 ; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Rinaudo PF, 2006, FERTIL STERIL, V86, P1252, DOI 10.1016/j.fertnstert.2006.05.017; Rivera RM, 2008, HUM MOL GENET, V17, P1, DOI 10.1093/hmg/ddm280; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; TIERLING S, 2009, J MED GENET; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Wright Victoria Clay, 2008, Morbidity and Mortality Weekly Report, V57, P1	68	67	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9218	10.1371/journal.pone.0009218	http://dx.doi.org/10.1371/journal.pone.0009218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169163	gold, Green Published			2022-12-27	WOS:000274474700012
J	Larzabal, M; Mercado, EC; Vilte, DA; Salazar-Gonzalez, H; Cataldi, A; Navarro-Garcia, F				Larzabal, Mariano; Mercado, Elsa C.; Vilte, Daniel A.; Salazar-Gonzalez, Hector; Cataldi, Angel; Navarro-Garcia, Fernando			Designed Coiled-Coil Peptides Inhibit the Type Three Secretion System of Enteropathogenic Escherichia coli	PLOS ONE			English	Article							PROTEIN TRANSLOCATION SYSTEM; SMALL-MOLECULE INHIBITOR; III SECRETION; ENTEROCYTE EFFACEMENT; VIRULENCE FACTORS; BACTERIAL VIRULENCE; HEMOLYTIC-ACTIVITY; POTENT INHIBITORS; ESPA; DOMAIN	Background: Enteropathogenic E. coli (EPEC) and enterohemorrhagic E. coli (EHEC) are two categories of E. coli strains associated with human disease. A major virulence factor of both pathotypes is the expression of a type three secretion system (TTSS), responsible for their ability to adhere to gut mucosa causing a characteristic attaching and effacing lesion (A/E). The TTSS translocates effector proteins directly into the host cell that subvert mammalian cell biochemistry. Methods/Principal Findings: We examined synthetic peptides designed to inhibit the TTSS. CoilA and CoilB peptides, both representing coiled-coil regions of the translocator protein EspA, and CoilD peptide, corresponding to a coiled-coil region of the needle protein EscF, were effective in inhibiting the TTSS dependent hemolysis of red blood cells by the EPEC E2348/69 strain. CoilA and CoilB peptides also reduced the formation of actin pedestals by the same strain in HEp-2 cells and impaired the TTSS-mediated protein translocation into the epithelial cell. Interestingly, CoilA and CoilB were able to block EspA assembly, destabilizing the TTSS and thereby Tir translocation. This blockage of EspA polymerization by CoilA or CoilB peptides, also inhibited the correct delivery of EspB and EspD as detected by immunoblotting. Interestingly, electron microscopy of bacteria incubated with the CoilA peptide showed a reduction of the length of EspA filaments. Conclusions: Our data indicate that coiled-coil peptides can prevent the assembly and thus the functionality of the TTSS apparatus and suggest that these peptides could provide an attractive tool to block EPEC and EHEC pathogenesis.	[Larzabal, Mariano; Cataldi, Angel] INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Mercado, Elsa C.; Vilte, Daniel A.] INTA, Inst Patobiol, Buenos Aires, DF, Argentina; [Salazar-Gonzalez, Hector; Navarro-Garcia, Fernando] CINVESTAV, Dept Biol Celular, Mexico City 14000, DF, Mexico	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA); CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Larzabal, M (corresponding author), INTA, Inst Biotecnol, Buenos Aires, DF, Argentina.	acataldi@cnia.inta.gov.ar; fnavarro@cell.cinvestav.mx	Navarro-Garcia, Fernando/A-3980-2011	Larzabal, Mariano/0000-0002-1358-6982	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTO 2002 12923]; Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico [44660-M, 60714]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants PICTO 2002 12923 from the Agencia Nacional de Promocion Cientifica y Tecnologica and 44660-M and 60714 from Consejo Nacional de Ciencia y Tecnologica (CONACYT), Mexico to FN-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Burbaum JJ, 1997, CURR OPIN CHEM BIOL, V1, P72, DOI 10.1016/S1367-5931(97)80111-1; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Dahlgren MK, 2007, J MED CHEM, V50, P6177, DOI 10.1021/jm070741b; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; Delahay RM, 1999, J BIOL CHEM, V274, P35969, DOI 10.1074/jbc.274.50.35969; DeVinney R, 1999, CELL MOL LIFE SCI, V55, P961, DOI 10.1007/s000180050347; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Gauthier A, 2005, ANTIMICROB AGENTS CH, V49, P4101, DOI 10.1128/AAC.49.10.4101-4109.2005; Gioffre A, 2002, VET MICROBIOL, V87, P301, DOI 10.1016/S0378-1135(02)00079-2; Goldschmidt RM, 1997, CURR PHARM DESIGN, V3, P125; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kenny B, 1996, MOL MICROBIOL, V20, P313, DOI 10.1111/j.1365-2958.1996.tb02619.x; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; LEVINE MM, 1978, LANCET, V1, P1119; Liu H, 2002, MOL MICROBIOL, V45, P1557, DOI 10.1046/j.1365-2958.2002.03137.x; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mercado EC, 2004, J VET MED B, V51, P82, DOI 10.1111/j.1439-0450.2004.00729.x; Miliwebsky E., 2007, Rev. argent. microbiol., V39, P90; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; Vilte DA, 2008, CLIN VACCINE IMMUNOL, V15, P1208, DOI 10.1128/CVI.00027-08; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5; Wilson RK, 2001, CELL MICROBIOL, V3, P753, DOI 10.1046/j.1462-5822.2001.00159.x; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x	46	38	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9046	10.1371/journal.pone.0009046	http://dx.doi.org/10.1371/journal.pone.0009046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140230	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474400005
J	Miller, M; Donat, S; Rakette, S; Stehle, T; Kouwen, TRHM; Diks, SH; Dreisbach, A; Reilman, E; Gronau, K; Becher, D; Peppelenbosch, MP; van Dijl, JM; Ohlsen, K				Miller, Malgorzata; Donat, Stefanie; Rakette, Sonja; Stehle, Thilo; Kouwen, Thijs R. H. M.; Diks, Sander H.; Dreisbach, Annette; Reilman, Ewoud; Gronau, Katrin; Becher, Doerte; Peppelenbosch, Maikel P.; van Dijl, Jan Maarten; Ohlsen, Knut			Staphylococcal PknB as the First Prokaryotic Representative of the Proline-Directed Kinases	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; SERINE/THREONINE PROTEIN-KINASE; FIBRONECTIN-BINDING PROTEINS; YERSINIA YOPE CYTOTOXIN; BAX-DEPENDENT APOPTOSIS; STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PSEUDOMONAS-AERUGINOSA; ALVEOLAR MACROPHAGES	In eukaryotic cell types, virtually all cellular processes are under control of proline-directed kinases and especially MAP kinases. Serine/threonine kinases in general were originally considered as a eukaryote-specific enzyme family. However, recent studies have revealed that orthologues of eukaryotic serine/threonine kinases exist in bacteria. Moreover, various pathogenic species, such as Yersinia and Mycobacterium, require serine/threonine kinases for successful invasion of human host cells. The substrates targeted by bacterial serine/threonine kinases have remained largely unknown. Here we report that the serine/threonine kinase PknB from the important pathogen Staphylococcus aureus is released into the external milieu, which opens up the possibility that PknB does not only phosphorylate bacterial proteins but also proteins of the human host. To identify possible human targets of purified PknB, we studied in vitro phosphorylation of peptide microarrays and detected 68 possible human targets for phosphorylation. These results show that PknB is a proline-directed kinase with MAP kinase-like enzymatic activity. As the potential cellular targets for PknB are involved in apoptosis, immune responses, transport, and metabolism, PknB secretion may help the bacterium to evade intracellular killing and facilitate its growth. In apparent agreement with this notion, phosphorylation of the host-cell response coordinating transcription factor ATF-2 by PknB was confirmed by mass spectrometry. Taken together, our results identify PknB as the first prokaryotic representative of the proline-directed kinase/MAP kinase family of enzymes.	[Miller, Malgorzata; Kouwen, Thijs R. H. M.; Dreisbach, Annette; Reilman, Ewoud; van Dijl, Jan Maarten] Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [Miller, Malgorzata; Kouwen, Thijs R. H. M.; Diks, Sander H.; Dreisbach, Annette; Reilman, Ewoud; Peppelenbosch, Maikel P.; van Dijl, Jan Maarten] Univ Groningen, Groningen, Netherlands; [Donat, Stefanie; Ohlsen, Knut] Univ Wurzburg, Inst Mol Infekt Biol, Wurzburg, Germany; [Diks, Sander H.; Peppelenbosch, Maikel P.] Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Rakette, Sonja; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany; [Gronau, Katrin; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	University of Groningen; University of Groningen; University of Wurzburg; University of Groningen; Eberhard Karls University of Tubingen; Ernst Moritz Arndt Universitat Greifswald; Vanderbilt University	Miller, M (corresponding author), Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	j.m.van.dijl@med.umcg.nl	van Dijl, Jan Maarten/G-1205-2013; Becher, Doerte/B-4454-2015	Becher, Doerte/0000-0002-9630-5735; Peppelenbosch, Maikel/0000-0001-9112-6028	EU [LSHM-CT-2006-019064, LSHG-CT-2006-037469]; transnational SysMO initiative; European Science Foundation; Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research [04-EScope 01-011]; Top Institute [T4-213]; Deutsche Forschungsgemeinschaft [TR34]	EU(European Commission); transnational SysMO initiative; European Science Foundation(European Science Foundation (ESF)European Commission); Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Top Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding for this work was received from the EU (CEU projects LSHM-CT-2006-019064 and LSHG-CT-2006-037469), the transnational SysMO initiative through project BACELL SysMO, the European Science Foundation under the EUROCORES Programme EuroSCOPE, grant 04-EScope 01-011 from the Research Council for Earth and Life Sciences of the Netherlands Organization for Scientific Research, the Top Institute Pharma project T4-213, and the Deutsche Forschungsgemeinschaft (TR34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; BAUGHN RE, 1975, MED MICROBIOL IMMUN, V161, P243, DOI 10.1007/BF02122712; Bayles KW, 1998, INFECT IMMUN, V66, P336, DOI 10.1128/IAI.66.1.336-342.1998; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deftereos Savas P, 2009, Cases J, V2, P8293, DOI 10.4076/1757-1626-2-8293; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; ELLIOTT GR, 1982, ANTIMICROB AGENTS CH, V22, P781, DOI 10.1128/AAC.22.5.781; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Geipel U, 2009, INT J MED SCI, V6, P234; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; JAKAB GJ, 1976, J CLIN INVEST, V57, P1533, DOI 10.1172/JCI108423; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; KAPRAL FA, 1965, ANN NY ACAD SCI, V128, P285, DOI 10.1111/j.1749-6632.1965.tb11645.x; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Lammers A, 1999, FEMS MICROBIOL LETT, V180, P103, DOI 10.1111/j.1574-6968.1999.tb08783.x; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; MELLY MA, 1960, J EXP MED, V112, P1121, DOI 10.1084/jem.112.6.1121; Michailova L, 2000, INT J MED MICROBIOL, V290, P259; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Motley ST, 1999, INFECT IMMUN, V67, P5386, DOI 10.1128/IAI.67.10.5386-5394.1999; MUNOZDORADO J, 1993, J CELL BIOCHEM, V51, P29, DOI 10.1002/jcb.240510107; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsdotter-Augustinsson A, 2004, APMIS, V112, P109, DOI 10.1111/j.1600-0463.2004.apm1120205.x; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Novakova L, 2005, FEBS J, V272, P1243, DOI 10.1111/j.1742-4658.2005.04560.x; Pallova P, 2007, BIOCHEM BIOPH RES CO, V355, P526, DOI 10.1016/j.bbrc.2007.01.184; Park H, 2007, J IMMUNOL, V178, P6426, DOI 10.4049/jimmunol.178.10.6426; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1991, BIOCHEM SOC T, V19, P1131, DOI 10.1042/bst0191131; Sambrook J., 2002, MOL CLONING LAB MANU; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; TREUSCH AH, 2009, ISME J; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Weglarczyk K, 2004, INFECT IMMUN, V72, P2590, DOI 10.1128/IAI.72.5.2590-2597.2004; Westers L, 2008, PROTEOMICS, V8, P2704, DOI 10.1002/pmic.200800009; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; Wiley DJ, 2009, J BIOL CHEM, V284, P24744, DOI 10.1074/jbc.M109.010140; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	83	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9057	10.1371/journal.pone.0009057	http://dx.doi.org/10.1371/journal.pone.0009057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140229	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474400015
J	Siegal, M; Surian, L; Matsuo, A; Geraci, A; Iozzi, L; Okumura, Y; Itakura, S				Siegal, Michael; Surian, Luca; Matsuo, Ayumi; Geraci, Alessandra; Iozzi, Laura; Okumura, Yuko; Itakura, Shoji			Bilingualism Accentuates Children's Conversational Understanding	PLOS ONE			English	Article							LANGUAGE; YOUNG; MIND; PERFORMANCE	Background: Although bilingualism is prevalent throughout the world, little is known about the extent to which it influences children's conversational understanding. Our investigation involved children aged 3-6 years exposed to one or more of four major languages: English, German, Italian, and Japanese. In two experiments, we examined the children's ability to identify responses to questions as violations of conversational maxims (to be informative and avoid redundancy, to speak the truth, be relevant, and be polite). Principal Findings: In Experiment 1, with increasing age, children showed greater sensitivity to maxim violations. Children in Italy who were bilingual in German and Italian (with German as the dominant language L1) significantly outperformed Italian monolinguals. In Experiment 2, children in England who were bilingual in English and Japanese (with English as L1) significantly outperformed Japanese monolinguals in Japan with vocabulary age partialled out. Conclusions: As the monolingual and bilingual groups had a similar family SES background (Experiment 1) and similar family cultural identity (Experiment 2), these results point to a specific role for early bilingualism in accentuating children's developing ability to appreciate effective communicative responses.	[Siegal, Michael] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England; [Siegal, Michael; Iozzi, Laura] Univ Trieste, Dept Psychol, Trieste, Italy; [Surian, Luca; Geraci, Alessandra] Univ Trento, Dept Cognit Sci, Rovereto, Italy; [Surian, Luca; Geraci, Alessandra] Univ Trento, Ctr Mind Brain Studies CIMeC, Rovereto, Italy; [Matsuo, Ayumi] Univ Sheffield, Sch English Literature Language & Linguist, Sheffield, S Yorkshire, England; [Okumura, Yuko; Itakura, Shoji] Kyoto Univ, Dept Psychol, Kyoto, Japan	University of Sheffield; University of Trieste; University of Trento; University of Trento; University of Sheffield; Kyoto University	Siegal, M (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England.	M.Siegal@Sheffield.ac.uk	Geraci, Alessandra/ABC-5241-2020; Surian, Luca/Q-2947-2019; Matsuo, Ayumi/AAL-1173-2021	Geraci, Alessandra/0000-0003-1375-9190; Okumura, Yuko/0000-0002-2389-5818; Lauwereyns, Jan/0000-0003-0551-2550	EU [MEXC-CT-2005-024061]; British Academy [SG-41759]; Great Britain Sasakawa Foundation; Fondazione Benefica Kathleen Foreman-Casali; Italian Ministry of Education; Grants-in-Aid for Scientific Research [20330150] Funding Source: KAKEN	EU(European Commission); British Academy; Great Britain Sasakawa Foundation; Fondazione Benefica Kathleen Foreman-Casali; Italian Ministry of Education; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by an EU 6th Framework Marie Curie Chair (Project ALACODE -Contract MEXC-CT-2005-024061) and grants from the British Academy (SG-41759), Great Britain Sasakawa Foundation, Fondazione Benefica Kathleen Foreman-Casali, and the Italian Ministry of Education FIRB and PRIN programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, LIFE 2 LANGUAGES INT; BATES E, 1977, J COMMUN, V27, P104, DOI 10.1111/j.1460-2466.1977.tb01834.x; BATES E, 1976, LANGUAGE CONTENT ACQ; Bialystok E., 2004, HDB BILINGUALISM, P577; BIALYSTOK E, BILINGUALIS IN PRESS, DOI DOI 10.1017/S1366728909990423; Bialystok E., 2001, BILINGUALISM DEV LAN, DOI [10.1017/CBO9780511605963, DOI 10.1017/CBO9780511605963]; Bialystok E, 2009, DEVELOPMENTAL SCI, V12, P499, DOI 10.1111/j.1467-7687.2009.00868.x; Blum-Kulka S., 1997, DINNER TALK CULTURAL; Brown P., 1978, POLITENESS SOME UNIV; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Chouinard MM, 2007, MONOGR SOC RES CHILD, V72, P1; Clark E. V., 2003, 1 LANGUAGE ACQUISITI; Davies G, 2002, J AM HIST, V88, P1405, DOI 10.2307/2700603; DEARING R, 2007, LANGUAGE REV; Deuchar M, 1999, J CHILD LANG, V26, P461, DOI 10.1017/S0305000999003852; Dunn L. M., 1997, BRIT PICTURE VOCABUL; ERVINTRIPP S, 1976, LANG SOC, V5, P25, DOI 10.1017/S0047404500006849; Eskritt M, 2008, BRIT J DEV PSYCHOL, V26, P435, DOI 10.1348/026151007X253260; Gelman SA, 2009, ANNU REV PSYCHOL, V60, P115, DOI 10.1146/annurev.psych.59.103006.093659; GENESEE F, 1975, CHILD DEV, V46, P1010; Genesee Fred, 2007, HDB LANGUAGE DEV, P324, DOI DOI 10.1002/9780470757833.CH16; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; Goetz P.J., 2003, BILING-LANG COGN, V6, P1, DOI [10.1017/S1366728903001007, DOI 10.1017/S1366728903001007]; Grice Paul., 1989, STUDIES WAY WORDS; HAKUTA K, 1987, CHILD DEV, V58, P1372, DOI 10.1111/j.1467-8624.1987.tb01465.x; KASHIMA Y, 1995, J PERS SOC PSYCHOL, V69, P925, DOI 10.1037/0022-3514.69.5.925; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kovacs AM, 2009, DEVELOPMENTAL SCI, V12, P48, DOI 10.1111/j.1467-7687.2008.00742.x; Lakoff R., 1973, PAPERS 9 REGIONAL M, P292; LANZA E, 1992, J CHILD LANG, V19, P633, DOI 10.1017/S0305000900011600; Lillard A, 1998, PSYCHOL BULL, V123, P3, DOI 10.1037/0033-2909.123.1.3; Martin-Rhee MM, 2008, BILING-LANG COGN, V11, P81, DOI 10.1017/S1366728907003227; Mezzacappa E, 2004, CHILD DEV, V75, P1373, DOI 10.1111/j.1467-8624.2004.00746.x; Morton JB, 2007, DEVELOPMENTAL SCI, V10, P719, DOI 10.1111/j.1467-7687.2007.00623.x; Morton JB, 2009, DEVELOPMENTAL SCI, V12, P502, DOI 10.1111/j.1467-7687.2009.00867.x; Naito M, 2006, INT J BEHAV DEV, V30, P290, DOI 10.1177/0165025406063622; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Ochs E, 2006, NEW DIR CHILD ADOLES, V111, P35, DOI 10.1002/cad.153; OLler D. K., 2007, BLACKWELL HDB LANGUA, P368, DOI DOI 10.1002/9780470757833.CH18; Philipp AM, 2009, J EXP PSYCHOL LEARN, V35, P1187, DOI 10.1037/a0016376; Romaine Suzanne, 2001, HDB LINGUISTICS, P512; Rontu H, 2007, INT J BILINGUAL, V11, P337, DOI 10.1177/13670069070110040101; Rozin Paul, 2003, GASTRONOMICA J FOOD, V3, P63, DOI DOI 10.1525/GFC.2003.3.4.63; SCHIZZEROTTO A, 1993, CLASSI DISUGUAGLIANZ, P44; Siegal M., 2008, MARVELOUS MINDS DISC; Siegal M, 2004, TRENDS COGN SCI, V8, P534, DOI 10.1016/j.tics.2004.10.007; Siegal M, 2009, COGNITION, V110, P115, DOI 10.1016/j.cognition.2008.11.002; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Surian L, 2001, BRAIN LANG, V78, P224, DOI 10.1006/brln.2001.2465; Surian L, 1996, Cogn Neuropsychiatry, V1, P55, DOI 10.1080/135468096396703; SURIAN L, J CHILD LAN IN PRESS; UENO K, 1991, KAIGA GOI HATATTU KE; VIHMAN MM, 1985, J CHILD LANG, V12, P297, DOI 10.1017/S0305000900006450; Vinden PG, 1999, COGNITION EMOTION, V13, P19, DOI 10.1080/026999399379357; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018	55	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9004	10.1371/journal.pone.0009004	http://dx.doi.org/10.1371/journal.pone.0009004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554ZA	20140246	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000274474200006
J	Suits, MDL; Zhu, YP; Taylor, EJ; Walton, J; Zechel, DL; Gilbert, HJ; Davies, GJ				Suits, Michael D. L.; Zhu, Yanping; Taylor, Edward J.; Walton, Julia; Zechel, David L.; Gilbert, Harry J.; Davies, Gideon J.			Structure and Kinetic Investigation of Streptococcus pyogenes Family GH38 alpha-Mannosidase	PLOS ONE			English	Article							II INHIBITORS; PROTEIN; GLYCOSIDASE; MECHANISM; BINDING; CRYSTALLIZATION; OLIGOSACCHARIDES; PATHOGENESIS; SWAINSONINE; METASTASIS	Background: The enzymatic hydrolysis of alpha-mannosides is catalyzed by glycoside hydrolases (GH), termed alpha-mannosidases. These enzymes are found in different GH sequence-based families. Considerable research has probed the role of higher eukaryotic "GH38'' alpha-mannosides that play a key role in the modification and diversification of hybrid N-glycans; processes with strong cellular links to cancer and autoimmune disease. The most extensively studied of these enzymes is the Drosophila GH38 alpha-mannosidase II, which has been shown to be a retaining alpha-mannosidase that targets both alpha-1,3 and alpha-1,6 mannosyl linkages, an activity that enables the enzyme to process GlcNAc(Man)(5)(GlcNAc)(2) hybrid N-glycans to GlcNAc(Man)(3)(GlcNAc)(2). Far less well understood is the observation that many bacterial species, predominantly but not exclusively pathogens and symbionts, also possess putative GH38 alpha-mannosidases whose activity and specificity is unknown. Methodology/Principal Findings: Here we show that the Streptococcus pyogenes (M1 GAS SF370) GH38 enzyme (Spy1604; hereafter SpGH38) is an alpha-mannosidase with specificity for alpha-1,3 mannosidic linkages. The 3D X-ray structure of SpGH38, obtained in native form at 1.9 angstrom resolution and in complex with the inhibitor swainsonine (K-i 18 mu M) at 2.6 angstrom, reveals a canonical GH38 five-domain structure in which the catalytic "-1'' subsite shows high similarity with the Drosophila enzyme, including the catalytic Zn2+ ion. In contrast, the "leaving group'' subsites of SpGH38 display considerable differences to the higher eukaryotic GH38s; features that contribute to their apparent specificity. Conclusions/Significance: Although the in vivo function of this streptococcal GH38 alpha-mannosidase remains unknown, it is shown to be an alpha-mannosidase active on N-glycans. SpGH38 lies on an operon that also contains the GH84 hexosaminidase (Spy1600) and an additional putative glycosidase. The activity of SpGH38, together with its genomic context, strongly hints at a function in the degradation of host N- or possibly O-glycans. The absence of any classical signal peptide further suggests that SpGH38 may be intracellular, perhaps functioning in the subsequent degradation of extracellular host glycans following their initial digestion by secreted glycosidases.	[Suits, Michael D. L.; Taylor, Edward J.; Walton, Julia; Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zhu, Yanping; Gilbert, Harry J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zechel, David L.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Zhu, Yanping; Gilbert, Harry J.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England	University of York - UK; University System of Georgia; University of Georgia; Queens University - Canada; Newcastle University - UK	Suits, MDL (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Zechel, David/0000-0002-1570-599X; Taylor, Edward/0000-0003-4024-0976	Biotechnology and Biological Sciences Research Council [BB/G016127/1]; European Molecular Biology Organization; BBSRC [BB/G016127/1, BB/E000568/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000568/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Biotechnology and Biological Sciences Research Council grant BB/G016127/1, by the European Molecular Biology Organization. M. D. L. S. is an European Molecular Biology Laboratory long-term fellowship holder, and G. J. D. is a Royal Society/Wolfson Research Merit Award recipient. Y. Z. is supported by the Department for Innovation, Universities and Skills, United Kingdom; Newcastle University; and the Chinese Scholarship Council. D. Z. is supported by and Early Researcher Award from the province of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzari PM, 2006, ACTA CRYSTALLOGR D, V62, P1103, DOI 10.1107/S0907444906029775; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Crich D, 2004, ANGEW CHEM INT EDIT, V43, P5386, DOI 10.1002/anie.200453688; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; DAVIS BG, 2000, HAND GLOVE INVESTIGA, P134; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englebienne P, 2007, PROTEINS, V69, P160, DOI 10.1002/prot.21479; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiaux H, 2008, BIOORGAN MED CHEM, V16, P7337, DOI 10.1016/j.bmc.2008.06.021; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Granovsky M, 2000, NAT MED, V6, P306; Gridley JJ, 2000, J CHEM SOC PERK T 1, P1471, DOI 10.1039/a909165c; Guo HB, 2003, GLYCOBIOLOGY, V13, P867; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo J, 2006, ANGEW CHEM INT EDIT, V45, P5345, DOI 10.1002/anie.200600808; Handerson T, 2003, CANCER RES, V63, P5363; Heikinheimo P, 2003, J MOL BIOL, V327, P631, DOI 10.1016/S0022-2836(03)00172-4; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; ITO Y, 1994, ANGEW CHEM INT EDIT, V33, P1765, DOI 10.1002/anie.199417651; Karaveg K, 2005, J BIOL CHEM, V280, P16197, DOI 10.1074/jbc.M500119200; Kawatkar SP, 2006, J AM CHEM SOC, V128, P8310, DOI 10.1021/ja061216p; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar NS, 2008, PROTEINS, V71, P1484, DOI 10.1002/prot.21850; Kuntz DA, 2005, TETRAHEDRON-ASYMMETR, V16, P25, DOI 10.1016/j.tetasy.2004.11.057; Kuntz DA, 2008, BIOCHEMISTRY-US, V47, P10058, DOI 10.1021/bi8010785; Kuntz DA, 2009, CHEMBIOCHEM, V10, P268, DOI 10.1002/cbic.200800538; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2006, ACTA CRYSTALLOGR F, V62, P104, DOI 10.1107/S1744309105042508; Nerinckx W, 2006, ARKIVOC, P90, DOI 10.3998/ark.5550190.0007.d10; Numao S, 2003, J BIOL CHEM, V278, P48074, DOI 10.1074/jbc.M309249200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabouille C, 1999, J CELL SCI, V112, P3319; Sampaio MM, 2004, J BIOL CHEM, V279, P5537, DOI 10.1074/jbc.M310980200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah N, 2008, P NATL ACAD SCI USA, V105, P9570, DOI 10.1073/pnas.0802206105; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Sheldon WL, 2006, BIOCHEM J, V399, P241, DOI 10.1042/BJ20060307; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tarelli E, 1998, CARBOHYD RES, V312, P159, DOI 10.1016/S0008-6215(98)00246-8; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Watanabe Y, 2009, ACTA CRYSTALLOGR F, V65, P571, DOI 10.1107/S1744309109015826; Wen X, 2005, BIOCHEMISTRY-US, V44, P6729, DOI 10.1021/bi0500426; Zhong W, 2008, J AM CHEM SOC, V130, P8975, DOI 10.1021/ja711248y; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	63	35	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9006	10.1371/journal.pone.0009006	http://dx.doi.org/10.1371/journal.pone.0009006			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140249	Green Published, Green Accepted, gold			2022-12-27	WOS:000274474200007
J	Meir, O; Dvash, E; Werman, A; Rubinstein, M				Meir, Ofir; Dvash, Efrat; Werman, Ariel; Rubinstein, Menachem			C/EBP-beta Regulates Endoplasmic Reticulum Stress-Triggered Cell Death in Mouse and Human Models	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; GENE-EXPRESSION; ER STRESS; TUMOR-CELLS; SKIN TUMORIGENESIS; SURVIVAL; CANCER; APOPTOSIS; PROMOTES	Endoplasmic reticulum (ER) stress elicits the unfolded protein response (UPR), initially aimed at coping with the stress, but triggering cell death upon further stress. ER stress induces the C/EBP-H variant Liver-enriched Activating Protein (LAP), followed by the dominant-negative variant, Liver Inhibitory Protein (LIP). However, the distinct role of LAP and LIP in ER stress is unknown. We found that the kinetics of the ER stress-induced expression of LIP overlapped with that of the cell death in mouse B16 melanoma cells. Furthermore, inducible over-expression of LIP augmented ER stress-triggered cell death whereas over-expression of LAP attenuated cell death. Similar results were obtained in human 293T cells. Limited vasculature in tumors triggers hypoxia, nutrient shortage and accumulation of toxic metabolites, all of which eliciting continuous ER stress. We found that LAP promoted and LIP inhibited B16 melanoma tumor progression without affecting angiogenesis or accelerating the cell cycle. Rather, LAP attenuated, whereas LIP augmented tumor ER stress. We therefore suggest that C/EBP-H regulates the transition from the protective to the death-promoting phase of the UPR. We further suggest that the over-expression of LAP observed in many solid tumors promotes tumor progression by attenuating ER stress-triggered tumor cell death.	[Meir, Ofir; Dvash, Efrat; Werman, Ariel; Rubinstein, Menachem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Meir, O (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Menachem.rubinstein@weizmann.ac.il	Dvash, Efrat/P-5205-2015; Riesenfeld, Efrat Dvash/AAB-3343-2020	Dvash, Efrat/0000-0002-9503-2229; Riesenfeld, Efrat Dvash/0000-0002-9503-2229; Rubinstein, Menachem/0000-0002-3472-6614	Merck-Serono International SA; M. D. Moross Institute for Cancer Research	Merck-Serono International SA; M. D. Moross Institute for Cancer Research	This study was supported in part by Merck-Serono International SA and by the M. D. Moross Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; Arnett Brenda, 2003, Mol Cancer, V2, P21, DOI 10.1186/1476-4598-2-21; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; BUSTIN M, 2002, SCI STKE, pPE39; Chen C, 2004, J BIOL CHEM, V279, P27948, DOI 10.1074/jbc.M313920200; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Guerzoni C, 2006, BLOOD, V107, P4080, DOI 10.1182/blood-2005-08-3181; Halterman MW, 2008, MOL CELL NEUROSCI, V38, P125, DOI 10.1016/j.mcn.2008.01.014; Hersey P, 2008, PIGM CELL MELANOMA R, V21, P358, DOI 10.1111/j.1755-148X.2008.00467.x; Homma J, 2006, ONCOL REP, V15, P595; Kamaraju AK, 2004, J BIOL CHEM, V279, P3852, DOI 10.1074/jbc.M310443200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Li WL, 2005, CANCER RES, V65, P2592, DOI 10.1158/0008-5472.CAN-04-1532; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mukherjee D, 2001, HEPATOLOGY, V33, P1166, DOI 10.1053/jhep.2001.24032; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Regalo G, 2006, J PATHOL, V210, P398, DOI 10.1002/path.2063; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Shimizu Y, 2007, CANCER SCI, V98, P1706, DOI 10.1111/j.1349-7006.2007.00596.x; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sun L, 2005, CELL RES, V15, P770, DOI 10.1038/sj.cr.7290346; Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	45	43	51	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9516	10.1371/journal.pone.0009516	http://dx.doi.org/10.1371/journal.pone.0009516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209087	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400021
J	Tavel, JA				Tavel, Jorge A.		INSIGHT STALWART Study Grp	Effects of Intermittent IL-2 Alone or with Peri-Cycle Antiretroviral Therapy in Early HIV Infection: The STALWART Study	PLOS ONE			English	Article							CD4(+) CELL COUNTS; PHASE-II TRIAL; SUBCUTANEOUS INTERLEUKIN-2; INTRAVENOUS INTERLEUKIN-2; RANDOMIZED-TRIAL; T-LYMPHOCYTES; COMBINATION; MORTALITY; IMPACT	Background: The Study of Aldesleukin with and without antiretroviral therapy ( STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4(+) counts compared to no therapy. Methodology: Participants not on continuous ART with >= 300 CD4(+) cells/mm(3) were randomized to: no treatment; IL-2 for 5 consecutive days every 8 weeks for 3 cycles; or the same IL-2 regimen with 10 days of ART administered around each IL-2 cycle. CD4(+) counts, HIV RNA, and HIV progression events were collected monthly. Principal Findings: A total of 267 participants were randomized. At week 32, the mean CD4(+) count was 134 cells greater in the IL-2 alone group (p < 0.001), and 133 cells greater in the IL-2 plus ART group (p < 0.001) compared to the no therapy group. Twelve participants in the IL-2 groups compared to 1 participant in the group assigned to no therapy experienced an opportunistic event or died (HR 5.84, CI: 0.59 to 43.57; p = 0.009). Conclusions: IL-2 alone or with peri-cycle HAART increases CD4(+) counts but was associated with a greater number of opportunistic events or deaths compared to no therapy. These results call into question the immunoprotective significance of IL-2- induced CD4(+) cells.	[Tavel, Jorge A.; INSIGHT STALWART Study Grp] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tavel, JA (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jtavel@niaid.nih.gov	Emery, Sean/J-3825-2017; Rusconi, Stefano/H-9263-2012; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Rusconi, Stefano/0000-0002-0375-9990; Emery, Sean/0000-0001-6072-8309; Antunes, Francisco/0000-0001-7932-1154; Goetz, Matthew/0000-0003-4542-992X; Collins, Simon/0000-0002-3537-2432; Wolff, Marcelo/0000-0002-9956-8872; Lundgren, Jens/0000-0001-8901-7850; Hoy, Jennifer/0000-0002-6948-7086; Anderson, Jonathan/0000-0002-7316-428X; Tambussi, Giuseppe/0000-0002-0604-2960	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068641]; MRC [MC_U122886352] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068641] Funding Source: NIH RePORTER; Medical Research Council [MC_U122886352] Funding Source: researchfish	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	STALWART was supported by grants U01 AI068641 from the National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DI, 2002, J ACQ IMMUN DEF SYND, V29, P221, DOI 10.1097/00126334-200203010-00002; Arduino RC, 2004, CLIN INFECT DIS, V39, P115, DOI 10.1086/421775; Carr A, 1998, J INFECT DIS, V178, P992, DOI 10.1086/515653; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Davey RT, 1997, J INFECT DIS, V175, P781, DOI 10.1086/513971; Davey RT, 2000, JAMA-J AM MED ASSOC, V284, P183, DOI 10.1001/jama.284.2.183; Davey RT, 1999, J INFECT DIS, V179, P849, DOI 10.1086/314678; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Hengge UR, 1998, AIDS, V12, pF225, DOI 10.1097/00002030-199817000-00003; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kovacs JA, 2005, J CLIN INVEST, V115, P2139, DOI 10.1172/JCI23196; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Larsen CS, 2000, SCAND J INFECT DIS, V32, P153, DOI 10.1080/003655400750045259; Levy Y, 1999, LANCET, V353, P1923, DOI 10.1016/S0140-6736(98)07345-0; LEVY Y, 2009, 16 C RETR OPP INF MO; LOSSO M, 2009, 16 C RETR OPP INF MO; Losso MH, 2000, J INFECT DIS, V181, P1614, DOI 10.1086/315430; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Molina JM, 2009, J INFECT DIS, V200, P206, DOI 10.1086/599989; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pillay D, 2000, REV MED VIROL, V10, P231, DOI 10.1002/1099-1654(200007/08)10:4&lt;231::AID-RMV290&gt;3.0.CO;2-P; Ruxrungtham K, 2000, AIDS, V14, P2509, DOI 10.1097/00002030-200011100-00013; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Youle M, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010003	29	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9334	10.1371/journal.pone.0009334	http://dx.doi.org/10.1371/journal.pone.0009334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186278	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000003
J	Martz, JW; Parker, WG				Martz, Jeffrey W.; Parker, William G.			Revised Lithostratigraphy of the Sonsela Member (Chinle Formation, Upper Triassic) in the Southern Part of Petrified Forest National Park, Arizona	PLOS ONE			English	Article							COLORADO PLATEAU; NORTH-AMERICA; NEW-MEXICO; AGE; STRATIGRAPHY; SEQUENCE; STRATA; DOCKUM; USA	Background: Recent revisions to the Sonsela Member of the Chinle Formation in Petrified Forest National Park have presented a three-part lithostratigraphic model based on unconventional correlations of sandstone beds. As a vertebrate faunal transition is recorded within this stratigraphic interval, these correlations, and the purported existence of a depositional hiatus (the Tr-4 unconformity) at about the same level, must be carefully re-examined. Methodology/Principal Findings: Our investigations demonstrate the neglected necessity of walking out contacts and mapping when constructing lithostratigraphic models, and providing UTM coordinates and labeled photographs for all measured sections. We correct correlation errors within the Sonsela Member, demonstrate that there are multiple Flattops One sandstones, all of which are higher than the traditional Sonsela sandstone bed, that the Sonsela sandstone bed and Rainbow Forest Bed are equivalent, that the Rainbow Forest Bed is higher than the sandstones at the base of Blue Mesa and Agate Mesa, that strata formerly assigned to the Jim Camp Wash beds occur at two stratigraphic levels, and that there are multiple persistent silcrete horizons within the Sonsela Member. Conclusions/Significance: We present a revised five-part model for the Sonsela Member. The units from lowest to highest are: the Camp Butte beds, Lot's Wife beds, Jasper Forest bed (the Sonsela sandstone)/Rainbow Forest Bed, Jim Camp Wash beds, and Martha's Butte beds (including the Flattops One sandstones). Although there are numerous degradational/aggradational cycles within the Chinle Formation, a single unconformable horizon within or at the base of the Sonsela Member that can be traced across the entire western United States (the "Tr-4 unconformity") probably does not exist. The shift from relatively humid and poorly-drained to arid and well-drained climatic conditions began during deposition of the Sonsela Member (low in the Jim Camp Wash beds), well after the Carnian-Norian transition.	[Martz, Jeffrey W.; Parker, William G.] Petrified Forest Natl Pk, Div Resource Management, Petrified Forest, AZ USA		Martz, JW (corresponding author), Petrified Forest Natl Pk, Div Resource Management, Petrified Forest, AZ USA.	typothorax@gmail.com	Parker, William/AAV-8361-2021		Federal Lands Recreation Enhancement Act	Federal Lands Recreation Enhancement Act	The authors are currently employed by the National Park Service, and research was conducted during regular work hours. They therefore hold no copyright. Partial funding for this project was provided by the Federal Lands Recreation Enhancement Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS JP, 1958, NEW MEXICO GEOLOGICA, V9, P88; Ash S., 2001, P 6 FOSS RES C NAT P, P3; ASH SR, 1992, PALAEOGEOGR PALAEOCL, V96, P299, DOI 10.1016/0031-0182(92)90107-G; ASH SR, 1987, PETRIFIED FOREST NAT, P405; Ash SR, 2005, MESA SW MUSEUM B, V9, P53; Axsmith BJ, 2009, INT J PLANT SCI, V170, P657, DOI 10.1086/597782; BAZARD DR, 1991, J GEOPHYS RES-SOLID, V96, P9847, DOI 10.1029/91JB00336; BEER JJ, 2005, THESIS U MINNESOTA D; Billingsley G, 1985, MUSEUM NO ARIZONA B, V54, P3; BILLINGSLEY GH, 1985, GEOLOGIC MAP PETRIFI; BILODEAU WL, 1986, J GEOL, V94, P724, DOI 10.1086/629077; Blakey R.C., 1983, MESOZOIC PALEOGEOGRA, P57; BLAKEY RC, 1984, SEDIMENT GEOL, V38, P51, DOI 10.1016/0037-0738(84)90074-5; BLAKEY RC, 1988, SEDIMENT GEOL, V56, P3, DOI 10.1016/0037-0738(88)90050-4; Blakey RC, 2008, SEDIMENT BASIN WORLD, V5, P245, DOI 10.1016/S1874-5997(08)00007-5; BOWN TM, 1987, J SEDIMENT PETROL, V57, P587; BUSBYSPERA CJ, 1988, GEOLOGY, V16, P1121, DOI 10.1130/0091-7613(1988)016<1121:STMFTE>2.3.CO;2; CAMP CL, 1930, MEM U CALIF, V10, P174; Channell JET, 2003, PALAEOGEOGR PALAEOCL, V191, P65, DOI 10.1016/S0031-0182(02)006545; Cleveland DM, 2007, J SEDIMENT RES, V77, P909, DOI 10.2110/jsr.2007.082; Cooley M.E., 1958, PLATEAU, V31, P7; Cooley M. E, 1957, THESIS U ARIZONA TUS; CREBER GT, 1990, REV PALAEOBOT PALYNO, V63, P189, DOI 10.1016/0034-6667(90)90099-5; DEACON M.W., 1990, THESIS NO ARIZONA U; Demko TM, 1998, GEOLOGY, V26, P1119, DOI 10.1130/0091-7613(1998)026<1119:PTIIVI>2.3.CO;2; DEMKO TM, 1995, FOSSILS ARIZONA, P37; DEMKO TM, 1995, THESIS U ARIZONA TUS; Dickinson W.R., 1981, ARIZ GEOL SOC DIG, V14, P113; DUBIEL R F, 1991, Palaios, V6, P347, DOI 10.2307/3514963; Dubiel R.F., 1987, Journal of the Arizona-Nevada Academy of Science, V22, P35; Dubiel R. F., 1989, DAWN AGE DINOSAURS A, P177; Dubiel R.F., 1994, MESOZOIC SYSTEMS ROC, P133; DUBIEL R.F., 1999, NPSNRGRDGRDTR9903, P78; DUBIEL RF, 1994, PETRIFIED FOREST NAT, P6; DUBIEL RF, 1993, NEW MEXICO MUSEUM NA, V3, P117; DUBIEL RF, SEPM SPECIA IN PRESS; DUNAY RE, 1974, REV PALAEOBOT PALYNO, V17, P179, DOI 10.1016/0034-6667(74)90099-2; ESPREGEN WA, 1985, THESIS NO ARIZONA U; Frehlier A. P., 1986, THESIS TEXAS TECH U; Furin S, 2006, GEOLOGY, V34, P1009, DOI 10.1130/G22967A.1; GEHRELS GE, 1995, AM J SCI, V295, P18, DOI 10.2475/ajs.295.1.18; GOEBEL LA, 1936, CORRELATION FO UNPUB; GOOD SC, 1998, EON EVOLUTION PALEOB, P223; GREGORY HE, 1950, 220 US GEOL SOC; GREGORY HE, 1917, 93 US GOL SUURV; Harshbarger JW, 1957, 291 US GEOL SURV; Hazel J.E., 1994, US GEOLOGICAL SURVEY, V2000; Heckert A. B., 2002, NEW MEXICO MUSEUM NA, V21, P37; Heckert A.B., 1996, N M GEOL, V18, P61; HECKERT AB, 1998, 9801 NPSNRGRDGRDTR, P129; HECKERT AB, 1998, 9801 NPSNRGRDGRDTR, P125; HECKERT AB, 1997, THESIS U NEW MEXICO; Heckert AB., 2009, GEOL SOC AM ABSTR, V41, P123; HERRICK AS, 1999, THESIS U RHODE ISLAN; HUNT A P., 2005, GEOLOGY CHAMA BASIN, P357; Hunt Adrian P., 1993, Journal of the Arizona-Nevada Academy of Science, V27, P89; HUNT AP, 1995, NPSNRPONRTR9516, P89; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; JOHNS ME, 1988, THESIS NO ARIZONA U; KIERSCH GA, 1956, METALLIFEROUS MINERA, V1; KRAUS MJ, 1987, GEOLOGY, V15, P18, DOI 10.1130/0091-7613(1987)15<18:DPABCI>2.0.CO;2; KUTZBACH JE, 1989, J GEOPHYS RES-ATMOS, V94, P3341, DOI 10.1029/JD094iD03p03341; Lawton T.F., 1994, MESOZOIC SYSTEMS ROC, P1; Lehman T, 2005, J EARTH SYST SCI, V114, P325, DOI 10.1007/BF02702953; LEHMAN TM, 1994, NEW MEXICO BUREAU MI, V150, P37; LITWIN RJ, 1991, REV PALAEOBOT PALYNO, V68, P269, DOI 10.1016/0034-6667(91)90028-2; Long R.A., 1986, P161; Long R. A., 1995, NEW MEXICO MUSEUM NA, V4, P254; Long R. A., 1985, MUS NORTH ARIZ BULL, V47, P45; LOVE SE, 1993, THESIS U ABERDEEN AB; Lucas S.G., 1993, NEW MEXICO MUSEUM NA, V3, P327; Lucas SG, 1998, PALAEOGEOGR PALAEOCL, V143, P345; LUCAS SG, 2000, ALBERTIANA, V24, P30; LUCAS SG, 1989, NEW MEX GEOL SOC GUI, P191; LUCAS SG, 1993, MUSEUM NO ARIZONA B, V59, P27; LUCAS SG, 2007, NEW MEXICO MUSEUM NA, V40, P189; LUCAS SG, 1991, ALBERTIANA, V4, P11; LUCAS SG, 1995, NATL PARK SERVICE PA, P102; LUPE R, 1985, CIRCUM PACIFIC COUNC, V1, P263; MAY BA, 1988, THESIS TEXAS TECH U; MORALES, 1993, NM MUS NAT HIST SCI, V3, P75; Murry P.A., 1989, P29; Murry P.A., 1989, P375; MURRY PA, 1990, J GEOL, V98, P780, DOI 10.1086/629441; Muttoni G, 2004, GEOL SOC AM BULL, V116, P1043, DOI 10.1130/B25326.1; Muttoni G, 2010, PALAEOGEOGR PALAEOCL, V285, P1, DOI 10.1016/j.palaeo.2009.10.014; NEAL JT, 1996, SOL MIN RES I M PAP; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P271; Parker W.G., 2006, MUS NORTH ARIZ BULL, V62, P46; Parker W.G., 2005, MESA SW MUSEUM B, V11, P34; PARKER WG, 2006, MUSEUM NO ARIZONA B, V62, P126; Parker W, 2009, J VERTEBR PALEONTOL, V29, p162A; PARRISH JM, 1989, PALAEOGEOGR PALAEOCL, V72, P227; PARRISH JT, 1988, SEDIMENT GEOL, V56, P261, DOI 10.1016/0037-0738(88)90056-5; Pipiringos G.N., 1978, PRINCIPAL UNCONFORMI; RAUCCI JJ, 2006, MUSEUM NO ARIZONA B, V62, P157; REESIDE JB, 1957, GEOL SOC AM BULL, V68, P1451, DOI 10.1130/0016-7606(1957)68[1451:COTTFO]2.0.CO;2; REPENNING CA, 1969, 521 US GEOL SURV; Riggs NR, 2003, GEOL SOC AM BULL, V115, P1315, DOI 10.1130/B25254.1; Riggs NR, 1996, SCIENCE, V273, P97, DOI 10.1126/science.273.5271.97; Roadifer J.E, 1966, THESIS U ARIZONA TUS; SIMMS MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P352; Smith D.G., 2001, PENNAKS FRESHWATER I; Stagner H. R., 1941, CARNEGIE I WASHINGTO, V526, P9; Stewart J.H., 1972, US GEOLOGICAL SURVEY, V690, P336; STEWART JH, 1986, GEOLOGY, V14, P567, DOI 10.1130/0091-7613(1986)14<567:LTPOTS>2.0.CO;2; Stewart JH, 1957, AAPG BULL, V41, P441; STEWART JH, 1972, MUSEUM NO ARIZONA B, V47, P75; STOCKER MR, 2008, THESIS U IOWA IOWA, P220; TANNER LH, 2003, GEOLOGY ZUNI PLATEAU, P269; Therrien F, 2000, PALAIOS, V15, P194, DOI 10.2307/3515642; THERRIEN F, 1999, NPSNRPOGRTR993, P101; West Texas Geological Society, 1949, E W CROSS SECTION SO; Wooden J.L., 2009, GEOLOGICAL SOC AM AB, V41, P540; Woody D.T., 2006, ARIZONA MUSEUM NO AR, V62, P17, DOI DOI 10.1007/S00114-007-0291-6; Woody D, 2004, J VERTEBR PALEONTOL, V24, p132A; WOODY DT, 2003, THESIS MUSEUM NO ARI	117	60	64	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9329	10.1371/journal.pone.0009329	http://dx.doi.org/10.1371/journal.pone.0009329			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174475	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923700026
J	Montine, TJ; Sonnen, JA; Milne, G; Baker, LD; Breitner, JCS				Montine, Thomas J.; Sonnen, Joshua A.; Milne, Ginger; Baker, Laura D.; Breitner, John C. S.			Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PROSTAGLANDIN E-2; RISK; CYCLOOXYGENASE-2; PREVENTION; INHIBITORS; COX-2; ISOPROSTANE; VALDECOXIB; CELECOXIB	Results from prevention trials, including the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT), have fueled discussion about the cardiovascular (CV) risks associated with non-steroidal anti-inflammatory drugs (NSAIDs). We tested the hypotheses that (i) adverse CV events reported among ADAPT participants (aged 70 years and older) are associated with increased ratio of urine 11-dehydrothromboxane B(2) (Tx-M) to 2'3-donor-6-keto-PGF1 (PGI-M) attributable to NSAID treatments; (ii) coincident use of aspirin (ASA) would attenuate NSAID-induced changes in Tx-M/PGI-M ratio; and (iii) use of NSAIDs and/or ASA would not alter urine or plasma concentrations of F(2)-isoprostanes (IsoPs), in vivo biomarkers of free radical damage. We quantified urine Tx- M and PGI-M, and urine and plasma F(2)-IsoPs from 315 ADAPT participants using stable isotope dilution assays with gas chromatography/mass spectrometry, and analyzed these data by randomized drug assignment and self-report compliance as well as ASA use. Adverse CV events were significantly associated with higher urine Tx-M/PGI-M ratio, which seemed to derive mainly from lowered PGI-M. Participants taking ASA alone had reduced urine TxM/PGI-M compared to no ASA or NSAID; however, participants taking NSAIDs plus ASA did not have reduced urine Tx-M/PGI-M ratio compared to NSAIDs alone. Neither NSAID nor ASA use altered plasma or urine F(2)-IsoPs. These data suggest a possible mechanism for the increased risk of CV events reported in ADAPT participants assigned to NSAIDs, and suggest that the changes in the Tx-M/PGI-M ratio was not substantively mitigated by coincident use of ASA in individuals 70 years or older.	[Montine, Thomas J.; Sonnen, Joshua A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Baker, Laura D.; Breitner, John C. S.] Puget Sound Vet Affairs Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Milne, Ginger] Vanderbilt Univ, Med Ctr, Nashville, TN USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; Vanderbilt University	Montine, TJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	tmontine@uw.edu	Milne, Ginger/D-7648-2014; Sonnen, Joshua Aaron/H-3738-2016; Sonnen, Joshua/AAT-5788-2021	Milne, Ginger/0000-0003-3890-151X; Sonnen, Joshua Aaron/0000-0001-9267-8705; 	National Institute on Aging and the Nancy [AG05136, AG24010, AG24011, AG15477]; Buster Alvord Endowment; NATIONAL INSTITUTE ON AGING [U01AG015477, P50AG005136, R01AG024011, R01AG024010] Funding Source: NIH RePORTER	National Institute on Aging and the Nancy; Buster Alvord Endowment; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by grants AG05136, AG24010, AG24011, and AG15477 from the National Institute on Aging and the Nancy and Buster Alvord Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33; Bresalier RS, 2005, AM J CARDIOL, V96, P1589, DOI 10.1016/j.amjcard.2005.09.069; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Furberg CD, 2005, CIRCULATION, V111, P249, DOI 10.1161/01.CIR.0000155081.76164.17; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024; Klein T, 1997, J PHARMACOL EXP THER, V282, P1658; McAdam BF, 2005, CIRCULATION, V112, P1024, DOI 10.1161/CIRCULATIONAHA.105.542696; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Nussmeier NA, 2005, NEW ENGL J MED, V352, P1081, DOI 10.1056/NEJMoa050330; Penglis PS, 2000, J IMMUNOL, V165, P1605, DOI 10.4049/jimmunol.165.3.1605; PRATICO D, 1995, J BIOL CHEM, V270, P9800, DOI 10.1074/jbc.270.17.9800; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Szekely CA, 2007, INT REV PSYCHIATR, V19, P693, DOI 10.1080/09540260701797944; Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501	17	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9340	10.1371/journal.pone.0009340	http://dx.doi.org/10.1371/journal.pone.0009340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174466	Green Submitted, Green Published, gold			2022-12-27	WOS:000274923700029
J	Zhang, H; Tully, DC; Hoffmann, FG; He, J; Kankasa, C; Wood, C				Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Kankasa, Chipepo; Wood, Charles			Restricted Genetic Diversity of HIV-1 Subtype C Envelope Glycoprotein from Perinatally Infected Zambian Infants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; NEUTRALIZING ANTIBODY-RESPONSES; AMINO-ACID SITES; VERTICAL TRANSMISSION; ESCAPE VARIANTS; DNA-SEQUENCES; ENV; SELECTION; RECOMBINATION	Background: Mother-to-child transmission of HIV-1 remains a significant problem in the resource-constrained settings where anti-retroviral therapy is still not widely available. Understanding the earliest events during HIV-1 transmission and characterizing the newly transmitted or founder virus is central to intervention efforts. In this study, we analyzed the viral env quasispecies of six mother-infant transmission pairs (MIPs) and characterized the genetic features of envelope glycoprotein that could influence HIV-1 subtype C perinatal transmission. Methodology and Findings: The V1-V5 region of env was amplified from 6 MIPs baseline samples and 334 DNA sequences in total were analyzed. A comparison of the viral population derived from the mother and infant revealed a severe genetic bottleneck occurring during perinatal transmission, which was characterized by low sequence diversity in the infant. Phylogenetic analysis indicates that most likely in all our infant subjects a single founder virus was responsible for establishing infection. Furthermore, the newly transmitted viruses from the infant had significantly fewer potential N-linked glycosylation sites in Env V1-V5 region and showed a propensity to encode shorter variable loops compared to the nontransmitted viruses. In addition, a similar intensity of selection was seen between mothers and infants with a higher rate of synonymous (dS) compared to nonsynonymous (dN) substitutions evident (dN/dS<1). Conclusions: Our results indicate that a strong genetic bottleneck occurs during perinatal transmission of HIV-1 subtype C. This is evident through population diversity and phylogenetic patterns where a single viral variant appears to be responsible for infection in the infants. As a result the newly transmitted viruses are less diverse and harbored significantly less glycosylated envelope. This suggests that viruses with the restricted glycosylation in envelope glycoprotein appeared to be preferentially transmitted during HIV-1 subtype C perinatal transmission. In addition, our findings also indicated that purifying selection appears to predominate in shaping the early intrahost evolution of HIV-1 subtype C envelope sequences.	[Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Zhang, Hong; Tully, Damien C.; Hoffmann, Federico G.; He, Jun; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Kankasa, Chipepo] Univ Teaching Hosp, Dept Pediat, Lusaka, Zambia	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Zambia	Zhang, H (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA.	cwood@unlnotes.unl.edu	Wood, Charles/AAH-4536-2021; Hoffmann, Federico/B-7134-2009	Tully, Damien/0000-0002-7620-9340; Hoffmann, Federico/0000-0001-5056-4929; Wood, Charles/0000-0002-4256-1530	Public Health Service [CA75903]; Fogarty Training [TW001429]; NCRR COBRE [RR15635]; University of Nebraska-Lincoln;  [P20 RR15635]; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty Training; NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Nebraska-Lincoln; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Public Health Service grants CA75903, Fogarty Training grant TW001429 and NCRR COBRE grant RR15635 to C. W.; Layman Award from the University of Nebraska-Lincoln and P20 RR15635 to H. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; AHMAD N, 1995, J VIROL, V69, P1001, DOI 10.1128/JVI.69.2.1001-1012.1995; Anisimova M, 2003, GENETICS, V164, P1229; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Dickover R, 2006, J VIROL, V80, P6525, DOI 10.1128/JVI.02658-05; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; KLIKS SC, 1994, JAMA-J AM MED ASSOC, V272, P467, DOI 10.1001/jama.272.6.467; Kong XH, 2008, J VIROL, V82, P11609, DOI 10.1128/JVI.00952-08; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAMERS SL, 1994, J CLIN INVEST, V93, P380, DOI 10.1172/JCI116970; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; LUZURIAGA K, 1995, J IMMUNOL, V154, P433; Luzuriaga Katherine, 2002, AIDS Reviews, V4, P21; Mantina H, 2001, INT J CANCER, V94, P749, DOI 10.1002/ijc.1529; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Rousseau CM, 2003, J INFECT DIS, V187, P741, DOI 10.1086/374273; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; SCARLATTI G, 1993, P NATL ACAD SCI USA, V90, P1721, DOI 10.1073/pnas.90.5.1721; SCARLATTI G, 1993, AIDS, V7, pS45, DOI 10.1097/00002030-199311002-00010; Scott ZA, 2001, J IMMUNOL, V167, P7134, DOI 10.4049/jimmunol.167.12.7134; Shriner D, 2003, GENET RES, V81, P115, DOI 10.1017/S0016672303006128; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tso FY, 2009, AIDS, V23, P1817, DOI 10.1097/QAD.0b013e32832f3da6; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zhang H, 2002, AIDS RES HUM RETROV, V18, P1415, DOI 10.1089/088922202320935492; ZHANG H, 2009, VIROLOGY; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang X, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/003	50	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9294	10.1371/journal.pone.0009294	http://dx.doi.org/10.1371/journal.pone.0009294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174636	Green Published, gold			2022-12-27	WOS:000274654700021
J	Maggini, J; Mirkin, G; Bognanni, I; Holmberg, J; Piazzon, IM; Nepomnaschy, I; Costa, H; Canones, C; Raiden, S; Vermeulen, M; Geffner, JR				Maggini, Julian; Mirkin, Gerardo; Bognanni, Ianina; Holmberg, Josefina; Piazzon, Isabel M.; Nepomnaschy, Irene; Costa, Hector; Canones, Cristian; Raiden, Silvina; Vermeulen, Monica; Geffner, Jorge R.			Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile	PLOS ONE			English	Article							IL-12 P40 HOMODIMER; STEM-CELLS; INTERFERON-GAMMA; APOPTOTIC CELLS; IFN-GAMMA; T-CELLS; ALTERNATIVE ACTIVATION; INTERLEUKIN (IL)-12; DENDRITIC CELLS; CHAGAS-DISEASE	In recent years it has become clear that the therapeutic properties of bone marrow-derived mesenchymal stromal cells (MSC) are related not only to their ability to differentiate into different lineages but also to their capacity to suppress the immune response. We here studied the influence of MSC on macrophage function. Using mouse thioglycolate-elicited peritoneal macrophages (M) stimulated with LPS, we found that MSC markedly suppressed the production of the inflammatory cytokines TNF-alpha, IL-6, IL-12p70 and interferon-gamma while increased the production of IL-10 and IL-12p40. Similar results were observed using supernatants from MSC suggesting that factor(s) constitutively released by MSC are involved. Supporting a role for PGE(2) we observed that acetylsalicylic acid impaired the ability of MSC to inhibit the production of inflammatory cytokines and to stimulate the production of IL-10 by LPS-stimulated M. Moreover, we found that MSC constitutively produce PGE(2) at levels able to inhibit the production of TNF-alpha and IL-6 by activated M. MSC also inhibited the up-regulation of CD86 and MHC class II in LPS-stimulated M impairing their ability to activate antigen-specific T CD4+ cells. On the other hand, they stimulated the uptake of apoptotic thymocytes by M. Of note, MSC turned M into cells highly susceptible to infection with the parasite Trypanosoma cruzi increasing more than 5-fold the rate of M infection. Using a model of inflammation triggered by s.c. implantation of glass cylinders, we found that MSC stimulated the recruitment of macrophages which showed a low expression of CD86 and the MHC class II molecule la(b) and a high ability to produce IL-10 and IL-12p40, but not IL-12 p70. In summary, our results suggest that MSC switch M into a regulatory profile characterized by a low ability to produce inflammatory cytokines, a high ability to phagocyte apoptotic cells, and a marked increase in their susceptibility to infection by intracellular pathogens.	[Maggini, Julian; Bognanni, Ianina; Holmberg, Josefina; Piazzon, Isabel M.; Nepomnaschy, Irene; Costa, Hector; Canones, Cristian; Raiden, Silvina; Vermeulen, Monica; Geffner, Jorge R.] Acad Nacl Med Buenos Aires, Inst Invest Hematol, Buenos Aires, DF, Argentina; [Mirkin, Gerardo; Geffner, Jorge R.] Univ Buenos Aires, Fac Med, Dept Microbiol Immunol & Parasitol, Buenos Aires, DF, Argentina; [Geffner, Jorge R.] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires; University of Buenos Aires	Geffner, JR (corresponding author), Acad Nacl Med Buenos Aires, Inst Invest Hematol, Buenos Aires, DF, Argentina.	geffnerj@fibertel.com.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET); Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica; Fundacion YPF (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion YPF (Argentina)	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas(CONICET), the Buenos Aires University School of Medicine, the Agencia Nacional de Promocion Cientifica y Tecnologica, and Fundacion YPF (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bogdan C, 2006, TRENDS IMMUNOL, V27, P282, DOI 10.1016/j.it.2006.04.004; CAPPA SMG, 1981, MEDICINA-BUENOS AIRE, V41, P119; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; COLIGAN JE, 1994, CURRENT PROTOCOLS IM, V3; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; DAIS F, 2007, CURR OPIN ONCOL, V19, P650; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; Dobreva ZG, 2008, CYTOKINE, V43, P76, DOI 10.1016/j.cyto.2008.04.003; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; GERMANN T, 1995, IMMUNOL TODAY, V16, P500, DOI 10.1016/0167-5699(95)80035-2; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Holscher C, 1998, INFECT IMMUN, V66, P1208; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Maccario R, 2005, HAEMATOLOGICA, V90, P516; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MIRKIN GA, 1994, CLIN IMMUNOL IMMUNOP, V73, P69, DOI 10.1006/clin.1994.1171; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puddu P, 1997, J IMMUNOL, V159, P3490; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rasmusson I, 2003, TRANSPLANTATION, V76, P1208, DOI 10.1097/01.TP.0000082540.43730.80; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Rossi AG, 1998, J IMMUNOL, V160, P3562; Sardinha LR, 2006, INFECT IMMUN, V74, P2031, DOI 10.1128/IAI.74.4.2031-2042.2006; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; Traggiai E, 2008, STEM CELLS, V26, P562, DOI 10.1634/stemcells.2007-0528; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Yang Yi-Wu, 2008, Zhonghua Xue Ye Xue Za Zhi, V29, P540	57	420	439	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9252	10.1371/journal.pone.0009252	http://dx.doi.org/10.1371/journal.pone.0009252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169081	Green Submitted, gold, Green Published			2022-12-27	WOS:000274590500027
J	Dahl, JA; Reiner, AH; Klungland, A; Wakayama, T; Collas, P				Dahl, John Arne; Reiner, Andrew H.; Klungland, Arne; Wakayama, Teruhiko; Collas, Philippe			Histone H3 Lysine 27 Methylation Asymmetry on Developmentally-Regulated Promoters Distinguish the First Two Lineages in Mouse Preimplantation Embryos	PLOS ONE			English	Article							CHROMATIN IMMUNOPRECIPITATION ASSAY; STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; HUMAN GENOME; CHIP-CHIP; MU-CHIP; PLURIPOTENT; FATE; DIFFERENTIATION	First lineage specification in the mammalian embryo leads to formation of the inner cell mass (ICM) and trophectoderm (TE), which respectively give rise to embryonic and extraembryonic tissues. We show here that this first differentiation event is accompanied by asymmetric distribution of trimethylated histone H3 lysine 27 (H3K27me3) on promoters of signaling and developmentally-regulated genes in the mouse ICM and TE. A genome-wide survey of promoter occupancy by H3K4me3 and H3K27me3 indicates that both compartments harbor promoters enriched in either modification, and promoters co-enriched in trimethylated H3K4 and H3K27 linked to developmental and signaling functions. The majority of H3K4/K27me3 co-enriched promoters are distinct between the two lineages, primarily due to differences in the distribution of H3K27me3. Derivation of embryonic stem cells leads to significant losses and gains of H3K4/K27me3 co-enriched promoters relative to the ICM, with distinct contributions of (de) methylation events on K4 and K27. Our results show histone trimethylation asymmetry on promoters in the first two developmental lineages, and highlight an epigenetic skewing associated with embryonic stem cell derivation.	[Dahl, John Arne; Reiner, Andrew H.; Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Dahl, John Arne; Reiner, Andrew H.; Collas, Philippe] Norwegian Ctr Stem Cell Res, Oslo, Norway; [Klungland, Arne] Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway; [Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo, Japan	University of Oslo; University of Oslo; RIKEN	Dahl, JA (corresponding author), Oslo Univ Hosp, Inst Med Microbiol, Ctr Mol Biol & Neurosci, Oslo, Norway.	philippe.collas@medisin.uio.no	Klungland, Arne/X-1233-2019	Klungland, Arne/0000-0001-7274-3661	Ministry of Education, Science, Sports, Culture and Technology of Japan [15080211]; Research Council of Norway	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Council of Norway(Research Council of Norway)	This work was funded by a Grant-in-Aid for Scientific Research in Priority Areas (15080211) from the Ministry of Education, Science, Sports, Culture and Technology of Japan (T. W.), and by the Research Council of Norway (P. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo LG, 2008, CANCER RES, V68, P2641, DOI 10.1158/0008-5472.CAN-07-5590; Albert M, 2009, CURR OPIN GENET DEV, V19, P113, DOI 10.1016/j.gde.2009.03.004; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Collas P, 2008, FRONT BIOSCI-LANDMRK, V13, P929, DOI 10.2741/2733; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dahl JA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r13; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sharov AA, 2007, CELL STEM CELL, V1, P237, DOI 10.1016/j.stem.2007.08.015; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; VerMilyea MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006086; Wakayama S, 2005, J REPROD DEVELOP, V51, P765, DOI 10.1262/jrd.17061; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	46	77	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9150	10.1371/journal.pone.0009150	http://dx.doi.org/10.1371/journal.pone.0009150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161773	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442700014
J	Ventura, E; Sassi, F; Parodi, A; Balza, E; Borsi, L; Castellani, P; Carnemolla, B; Zardi, L				Ventura, Elisa; Sassi, Francesca; Parodi, Arianna; Balza, Enrica; Borsi, Laura; Castellani, Patrizia; Carnemolla, Barbara; Zardi, Luciano			Alternative Splicing of the Angiogenesis Associated Extra-Domain B of Fibronectin Regulates the Accessibility of the B-C Loop of the Type III Repeat 8	PLOS ONE			English	Article							ED-B; MESSENGER-RNA; ONCOFETAL FIBRONECTIN; TARGETED DELIVERY; CRYPTIC SEQUENCE; ISOFORM; MARKER; ANTIBODIES; REGION; MOLECULE	Background: Fibronectin (FN) is a multi-domain molecule involved in many cellular processes, including tissue repair, embryogenesis, blood clotting, and cell migration/adhesion. The biological activities of FN are mediated by exposed loops located mainly at the interdomain interfaces that interact with various molecules such as, but not only, integrins. Different FN isoforms arise from the alternative splicing of the pre-mRNA. In malignancies, the splicing pattern of FN pre-mRNA is altered; in particular, the FN isoform containing the extra-domain B (ED-B), a complete FN type III repeat constituted by 91 residues, is undetectable in normal adult tissues, but exhibits a much greater expression in fetal and tumor tissues, and is accumulated around neovasculature during angiogenic processes, thus making ED-B one of the best markers and targets of angiogenesis. The functions of ED-B are still unclear; however, it has been postulated that the insertion of an extra-domain such as ED-B modifies the domain-domain interface and may unmask loops that are otherwise cryptic, thus giving FN new potential activities. Methodology: We used the mAb C6, which reacts with ED-B containing FN, but not with ED-B-free FN and various recombinant FN fragments containing mutations, to precisely localize the epitopes recognized by the mAb C6. Conclusion: We formally demonstrated that the inclusion of the alternatively spliced angiogenesis-associated ED-B leads to the unmasking of the FNIII 8 B-C loop that is cryptic in FN molecules lacking ED-B. Thus, the mAb C6, in addition to providing a new reagent for angiogenesis targeting, represents a new tool for the study of the potential biological functions of the B-C loop of the repeat FNIII 8 that is unmasked during angiogenic processes.	[Ventura, Elisa; Sassi, Francesca; Parodi, Arianna; Zardi, Luciano] CBA Adv Biotechnol Ctr, Lab Recombinant Therapeut Prot, Genoa, Italy; [Balza, Enrica; Borsi, Laura; Castellani, Patrizia] Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy; [Carnemolla, Barbara] Ist Nazl Ric Canc, Immunol Lab, I-16132 Genoa, Italy	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Ventura, E (corresponding author), CBA Adv Biotechnol Ctr, Lab Recombinant Therapeut Prot, Genoa, Italy.	zardi43@yahoo.it	Castellani, Patrizia/J-7333-2018	Castellani, Patrizia/0000-0002-6326-5853; Ventura, Elisa/0000-0002-5999-7613	LIMONTE, Regione Liguria and Piemonte, Genoa, Italy; European Union [LSHC-CT-2006-037489-ImmunoPDT]; Istituto Superiore della Sanita, Rome, Italy [ISS2006]; Italian Ministry of Health, Rome, Italy [RF-IST-2006-384590, RFSP-2006-3-339960]; Programma oncologico di medicina molecolare: i tumori femminili; Alleanza Contro il Cancro [ACC2007];  [IST/IEO 2007]	LIMONTE, Regione Liguria and Piemonte, Genoa, Italy; European Union(European Commission); Istituto Superiore della Sanita, Rome, Italy; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy); Programma oncologico di medicina molecolare: i tumori femminili; Alleanza Contro il Cancro; 	This research was supported by grants from: LIMONTE, Regione Liguria and Piemonte, Genoa, Italy (to L. Z.); European Union grant no. FP6 LSHC-CT-2006-037489-ImmunoPDT (to L. Z.); Istituto Superiore della Sanita, Rome, Italy grant no. ISS2006 Rare Diseases, (to B. C. and L. B.), Italian Ministry of Health, Rome, Italy grant no RF-IST-2006-384590 (to L. B.), grant no RFSP-2006-3-339960 (to B. C.) and grant no IST/IEO 2007(to L. B.) and Programma oncologico di medicina molecolare: i tumori femminili (to B. C.), and Alleanza Contro il Cancro grant no. ACC2007 (to L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALZA E, 1988, FEBS LETT, V228, P42, DOI 10.1016/0014-5793(88)80580-5; Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; BORSI L, 1995, J BIOL CHEM, V270, P6243, DOI 10.1074/jbc.270.11.6243; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; Carnemolla B, 1996, INT J CANCER, V68, P397, DOI 10.1002/(SICI)1097-0215(19961104)68:3<397::AID-IJC20>3.3.CO;2-D; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Castellani P, 2002, AM J PATHOL, V161, P1695, DOI 10.1016/S0002-9440(10)64446-X; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Fattorusso R, 1999, STRUCTURE, V7, P381, DOI 10.1016/S0969-2126(99)80051-3; GUTMAN A, 1987, P NATL ACAD SCI USA, V84, P7179, DOI 10.1073/pnas.84.20.7179; Hynes RO, 1990, FIBRONECTINS; Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Mariani G, 1997, CANCER, V80, P2378, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2378::AID-CNCR7>3.0.CO;2-7; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Yamada K.M., 1996, MOL CELLULAR BIOL WO, P51; ZARDI L, 1982, EMBO J, V1, P929, DOI 10.1002/j.1460-2075.1982.tb01273.x; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	28	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9145	10.1371/journal.pone.0009145	http://dx.doi.org/10.1371/journal.pone.0009145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161770	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442700009
J	Menendez, C; Bardaji, A; Sigauque, B; Sanz, S; Aponte, JJ; Mabunda, S; Alonso, PL				Menendez, Clara; Bardaji, Azucena; Sigauque, Betuel; Sanz, Sergi; Aponte, John J.; Mabunda, Samuel; Alonso, Pedro L.			Malaria Prevention with IPTp during Pregnancy Reduces Neonatal Mortality	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; SULFADOXINE-PYRIMETHAMINE; CHLOROQUINE PROPHYLAXIS; ACID SUPPLEMENTATION; CASE-MANAGEMENT; WESTERN UGANDA; RURAL AREA; EFFICACY; KENYA	Background: In the global context of a reduction of under-five mortality, neonatal mortality is an increasingly relevant component of this mortality. Malaria in pregnancy may affect neonatal survival, though no strong evidence exists to support this association. Methods: In the context of a randomised, placebo-controlled trial of intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine (SP) in 1030 Mozambican pregnant women, 997 newborns were followed up until 12 months of age. There were 500 live borns to women who received placebo and 497 to those who received SP. Findings: There were 58 infant deaths; 60.4% occurred in children born to women who received placebo and 39.6% to women who received IPTp (p = 0.136). There were 25 neonatal deaths; 72% occurred in the placebo group and 28% in the IPTp group (p = 0.041). Of the 20 deaths that occurred in the first week of life, 75% were babies born to women in the placebo group and 25% to those in the IPTp group (p = 0.039). IPTp reduced neonatal mortality by 61.3% (95% CI 7.4%, 83.8%); p = 0.024]. Conclusions: Malaria prevention with SP in pregnancy can reduce neonatal mortality. Mechanisms associated with increased malaria infection at the end of pregnancy may explain the excess mortality in the malaria less protected group. Alternatively, SP may have reduced the risk of neonatal infections. These findings are of relevance to promote the implementation of IPTp with SP, and provide insights into the understanding of the pathophysiological mechanisms through which maternal malaria affects fetal and neonatal health. Trial Registration: ClinicalTrials.gov NCT00209781	[Menendez, Clara; Bardaji, Azucena; Sanz, Sergi; Aponte, John J.; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain; [Menendez, Clara; Sigauque, Betuel; Aponte, John J.; Alonso, Pedro L.] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [Sigauque, Betuel] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Sigauque, Betuel] Natl Directorate Hlth, Maputo, Mozambique; [Mabunda, Samuel] Minist Hlth, Natl Malaria Control Program, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica	Menendez, C (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, IDIBAPS, Barcelona, Spain.	menendez@clinic.ub.es	Alonso, Pedro L/AAZ-3645-2020; Bardají, Azucena/AAE-9145-2019; Alonso, Azucena Bardají/V-5978-2018; Menéndez, Clara/Q-3446-2016; Sanz, Sergi/AAY-7211-2020	Alonso, Pedro L/0000-0003-3292-3443; Alonso, Azucena Bardají/0000-0002-5135-0540; Menéndez, Clara/0000-0002-2641-6907; Sanz Bravo, Sergi/0000-0001-5010-4527	Banco de Bilbao, Vizcaya; Argentaria Foundation [BBVA 02-0]; Centro de Investigacao em Saude de Manhic, a(CISM); Spanish Agency for International Cooperation	Banco de Bilbao, Vizcaya; Argentaria Foundation; Centro de Investigacao em Saude de Manhic, a(CISM); Spanish Agency for International Cooperation(Spanish Government)	The study received financial support from the Banco de Bilbao, Vizcaya, Argentaria Foundation (grant number BBVA 02-0). The Centro de Investigacao em Saude de Manhic, a(CISM), receives major core funding from the Spanish Agency for International Cooperation (AECI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PLSF, POPULATION HLTH DEV, V1; Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO;2; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brentlinger PE, 2007, B WORLD HEALTH ORGAN, V85, P873, DOI 10.2471/BLT.06.033381; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; DAlessandro U, 1996, T ROY SOC TROP MED H, V90, P487, DOI 10.1016/S0035-9203(96)90289-8; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Gamble C, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003755.PUB2; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leach A, 1999, ANN TROP PAEDIATR, V19, P33, DOI 10.1080/02724939992617; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Ndyomugyenyi R, 2000, ANN TROP MED PARASIT, V94, P759, DOI 10.1080/00034980020015189; Ndyomugyenyi R, 2000, T ROY SOC TROP MED H, V94, P413, DOI 10.1016/S0035-9203(00)90125-1; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; *WHO, 2009, GLOB HLTH STAT 2009; WHO, 2019, INT STAT CLASS DIS R, V10th; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2006, AFRMAL0401 WHO REG O	32	81	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9438	10.1371/journal.pone.0009438	http://dx.doi.org/10.1371/journal.pone.0009438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195472	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000008
J	Yordanova, J; Kolev, V; Wagner, U; Verleger, R				Yordanova, Juliana; Kolev, Vasil; Wagner, Ullrich; Verleger, Rolf			Differential Associations of Early- and Late-Night Sleep with Functional Brain States Promoting Insight to Abstract Task Regularity	PLOS ONE			English	Article							TERM-MEMORY RETRIEVAL; VISUOSPATIAL ATTENTION; PHASE SYNCHRONIZATION; SPATIAL ATTENTION; OCCIPITAL CORTEX; ALPHA-FREQUENCY; NEURAL ACTIVITY; EEG POTENTIALS; SUDDEN INSIGHT; BETA-ACTIVITY	Background: Solving a task with insight has been associated with occipital and right-hemisphere activations. The present study tested the hypothesis if sleep-related alterations in functional activation states modulate the probability of insight into a hidden abstract regularity of a task. Methodology: State-dependent functional activation was measured by beta and alpha electroencephalographic (EEG) activity and spatial synchronization. Task-dependent functional activation was assessed by slow cortical potentials (SPs). EEG parameters during the performance of the Number Reduction Task (NRT) were compared between before sleep and after sleep sessions. In two different groups, the relevant sleep occurred either in the first or in the second half of the night, dominated by slow wave sleep (SWS) or by rapid eye movement (REM) sleep. Principal Findings: Changes in EEG parameters only occurred in the early-night group, not in the late-night group and indicated occipital and right-hemisphere functional alterations. These changes were associated with off-line consolidation of implicit task representations and with the amount of SWS but they did not predict subsequent insight. The gain of insight was, however, independently associated with changes of spectral beta and alpha measures only in those subjects from the two sleep groups who would subsequently comprehend the hidden regularity of the task. Insight-related enhancement of right frontal asymmetry after sleep did not depend on sleep stages. Significance: It is concluded that off-line restructuring of implicit information during sleep is accompanied by alterations of functional activation states after sleep. This mechanism is promoted by SWS but not by REM sleep and may contribute to attaining insight after sleep. Original neurophysiologic evidence is provided for alterations of the functional activation brain states after sleep. These alterations are associated with a decrease in controlled processing within the visual system and with an increase in the functional connectivity of the right hemisphere, and are supported by SWS in the first half of the night.	[Yordanova, Juliana; Kolev, Vasil; Wagner, Ullrich; Verleger, Rolf] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Yordanova, Juliana; Kolev, Vasil] Bulgarian Acad Sci, Inst Neurobiol, Dept Cognit Psychophysiol, Sofia, Bulgaria; [Wagner, Ullrich] Med Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; [Wagner, Ullrich] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	University of Lubeck; Bulgarian Academy of Sciences; University of Lubeck; Bangor University	Yordanova, J (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	jyord@gmx.net	Sanguansri, Luz/B-6630-2011; Kolev, Vasil/B-4595-2008; Yordanova, Juliana/I-4690-2014	Sanguansri, Luz/0000-0003-1908-7604; Kolev, Vasil/0000-0002-2694-2149; Yordanova, Juliana/0000-0003-4500-1122	Deutsche Forschungsgemeinschaft [DFG-SFB654/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG-SFB654/1-1), http://www.sfb654.uni-luebeck.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni F, 1996, ELECTROEN CLIN NEURO, V98, P363, DOI 10.1016/0013-4694(96)00284-2; Bekisz M, 2003, EUR J NEUROSCI, V17, P421, DOI 10.1046/j.1460-9568.2003.02454.x; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2008, EXP BRAIN RES, V185, P11, DOI 10.1007/s00221-007-1127-5; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Drosopoulos S, 2005, LEARN MEMORY, V12, P44, DOI 10.1101/lm.83805; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Ericsson K.A., 1993, PROTOCOL ANAL VERBAL; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FOWLER MJ, 1973, SCIENCE, V179, P302, DOI 10.1126/science.179.4070.302; Frensch PA, 2002, ATTENTION IMPLICIT L, P335; Friedman RS, 2005, J PERS SOC PSYCHOL, V88, P263, DOI 10.1037/0022-3514.88.2.263; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Haider H, 2007, METHODS, V42, P49, DOI 10.1016/j.ymeth.2006.12.004; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Howard-Jones PA, 2005, COGNITIVE BRAIN RES, V25, P240, DOI 10.1016/j.cogbrainres.2005.05.013; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Khader P, 2005, NEUROIMAGE, V27, P805, DOI 10.1016/j.neuroimage.2005.05.006; Khader P, 2008, INT J PSYCHOPHYSIOL, V67, P252, DOI 10.1016/j.ijpsycho.2007.05.018; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LANG S, 2006, J COGNITIVE NEUROSCI, V18, P1; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; METCALFE J, 1987, MEM COGNITION, V15, P238, DOI 10.3758/BF03197722; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P19, DOI 10.1016/S0079-6123(06)59002-8; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Rechtschaffen A, 1968, NIH PUBL, V204; Rektor I, 2006, PROG BRAIN RES, V159, P311, DOI 10.1016/S0079-6123(06)59021-1; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rihs TA, 2009, NEUROIMAGE, V44, P190, DOI 10.1016/j.neuroimage.2008.08.022; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Rose M, 2005, J COGNITIVE NEUROSCI, V17, P918, DOI 10.1162/0898929054021193; Rose M, 2004, LEARN MEMORY, V11, P145, DOI 10.1101/lm.67204; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; ROSLER F, 1995, J COGNITIVE NEUROSCI, V7, P51, DOI 10.1162/jocn.1995.7.1.51; Rosler F, 1997, BIOL PSYCHOL, V45, P109, DOI 10.1016/S0301-0511(96)05225-8; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUCHKIN DS, 1988, HUMAN EVENT RELATED, V3, P7; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Schurmann M, 2003, COGNITIVE BRAIN RES, V16, P348, DOI 10.1016/S0926-6410(02)00303-8; Smith RW, 1996, J EXP PSYCHOL LEARN, V22, P1443, DOI 10.1037/0278-7393.22.6.1443; Sternberg R. J, 1995, NATURE INSIGHT; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stringaris AK, 2006, NEUROIMAGE, V33, P784, DOI 10.1016/j.neuroimage.2006.06.057; Suffczynski P, 2001, INT J PSYCHOPHYSIOL, V43, P25, DOI 10.1016/S0167-8760(01)00177-5; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Urbano A, 1998, ELECTROEN CLIN NEURO, V106, P477, DOI 10.1016/S0013-4694(97)00150-8; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Verleger R, 1996, ELECTROEN CLIN NEURO, V99, P444, DOI 10.1016/S0013-4694(96)95645-X; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Vuilleumier PO, 2000, BRAIN, V123, P1263, DOI 10.1093/brain/123.6.1263; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wagner U, 2003, BIOL PSYCHOL, V62, P197, DOI 10.1016/S0301-0511(02)00125-4; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Woltz DJ, 1996, J EXP PSYCHOL LEARN, V22, P438, DOI 10.1037/0278-7393.22.2.438; Worden MS, 2000, J NEUROSCI, V20; Wrobel A, 2000, ACTA NEUROBIOL EXP, V60, P247; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042; Yordanova J, 2008, LEARN MEMORY, V15, P508, DOI 10.1101/lm.897908; Yordanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005675; Zhuang P, 1997, ELECTROEN CLIN NEURO, V102, P374, DOI 10.1016/S0013-4694(96)96030-7	84	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9442	10.1371/journal.pone.0009442	http://dx.doi.org/10.1371/journal.pone.0009442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	561RS	20195475	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000011
J	de Oliveira, T; Pillay, D; Gifford, RJ				de Oliveira, Tulio; Pillay, Deenan; Gifford, Robert J.		UK Collaborative Grp HIV Drug Resi	The HIV-1 Subtype C Epidemic in South America Is Linked to the United Kingdom	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; K65R RESISTANCE; HIGH-THROUGHPUT; BRAZIL; SURVEILLANCE; RECOMBINANTS; PREVALENCE; SEQUENCES	Background: The global spread of HIV-1 has been accompanied by the emergence of genetically distinct viral strains. Over the past two decades subtype C viruses, which predominate in Southern and Eastern Africa, have spread rapidly throughout parts of South America. Phylogenetic studies indicate that subtype C viruses were introduced to South America through a single founder event that occurred in Southern Brazil. However, the external route via which subtype C viruses spread to the South American continent has remained unclear. Methodology/Principal Findings: We used automated genotyping to screen 8,309 HIV-1 subtype C pol gene sequences sampled within the UK for isolates genetically linked to the subtype C epidemic in South America. Maximum likelihood and Bayesian approaches were used to explore the phylogenetic relationships between 54 sequences identified in this screen, and a set of globally sampled subtype C reference sequences. Phylogenetic trees disclosed a robustly supported relationship between sequences from Brazil, the UK and East Africa. A monophyletic cluster comprised exclusively of sequences from the UK and Brazil was identified and dated to approximately the early 1980s using a Bayesian coalescent-based method. A sub-cluster of 27 sequences isolated from homosexual men of UK origin was also identified and dated to the early 1990s. Conclusions: Phylogenetic, demographic and temporal data support the conclusion that the UK was a crucial staging post in the spread of subtype C from East Africa to South America. This unexpected finding demonstrates the role of diffuse international networks in the global spread of HIV-1 infection, and the utility of globally sampled viral sequence data in revealing these networks. Additionally, we show that subtype C viruses are spreading within the UK amongst men who have sex with men.	[de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Pillay, Deenan] UCL, Dept Infect, London, England; [Pillay, Deenan] Hlth Protect Agcy, Ctr Infect, Colindale, England; [Gifford, Robert J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Kwazulu Natal; University of London; University College London; Health Protection Agency; University of Oxford	de Oliveira, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Durban, South Africa.	rgifford@adarc.org	Anderson, Jane/A-1632-2012	Anderson, Jane/0000-0001-5294-8707; Gifford, Robert/0000-0003-4028-9884; delpech, valerie/0000-0002-9952-8109; Kellam, Paul/0000-0003-3166-4734; Easterbrook, Philippa/0000-0002-2603-5418	Wellcome Trust [082384/Z/07/Z]; European Union [SANTE 2007 147-790]; MRC [G0900274] Funding Source: UKRI; Medical Research Council [G0900274] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Tulio de Oliveira is funded by the Wellcome Trust (082384/Z/07/Z) and the European Union (SANTE 2007 147-790). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; *BBC, 2005, PEOPL AR I PUBL POL; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; Brigido LFM, 2007, AIDS RES HUM RETROV, V23, P1579, DOI 10.1089/aid.2007.0102; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Dougan S, 2005, BRIT MED J, V330, P1303, DOI 10.1136/bmj.38393.572188.EB; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EVANS Y, 2007, BRAZILIANS LONDON; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; Gifford R, 2006, AIDS, V20, P1521, DOI 10.1097/01.aids.0000237368.64488.ae; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Health Protection Agency (HPA), 2008, SEX TRANSM INF YOUNG; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rogstad KE, 2004, BRIT MED J, V329, P214, DOI 10.1136/bmj.329.7459.214; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan CE, 2007, AIDS RES HUM RETROV, V23, P941, DOI 10.1089/aid.2007.0043; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Salminen MO, 1996, AIDS RES HUM RETROV, V12, P1329, DOI 10.1089/aid.1996.12.1329; Santos AF, 2007, JAIDS-J ACQ IMM DEF, V45, P328; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares MA, 2003, AIDS, V17, P11, DOI 10.1097/00002030-200301030-00004; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tatt ID, 2004, JAIDS-J ACQ IMM DEF, V36, P1092, DOI 10.1097/00126334-200408150-00013; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; Thomson MM, 2005, AIDS REV, V7, P210; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	37	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9311	10.1371/journal.pone.0009311	http://dx.doi.org/10.1371/journal.pone.0009311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174561	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700015
J	Tagmount, A; Wang, M; Lindquist, E; Tanaka, Y; Teranishi, KS; Sunagawa, S; Wong, M; Stillman, JH				Tagmount, Abderrahmane; Wang, Mei; Lindquist, Erika; Tanaka, Yoshihiro; Teranishi, Kristen S.; Sunagawa, Shinichi; Wong, Mike; Stillman, Jonathon H.			The Porcelain Crab Transcriptome and PCAD, the Porcelain Crab Microarray and Sequence Database	PLOS ONE			English	Article							THERMAL TOLERANCE LIMITS; GENUS PETROLISTHES; IMPLEMENTATION; IDENTIFICATION; ACCLIMATION; DAPHNIA; STRESS	Background: With the emergence of a completed genome sequence of the freshwater crustacean Daphnia pulex, construction of genomic-scale sequence databases for additional crustacean sequences are important for comparative genomics and annotation. Porcelain crabs, genus Petrolisthes, have been powerful crustacean models for environmental and evolutionary physiology with respect to thermal adaptation and understanding responses of marine organisms to climate change. Here, we present a large-scale EST sequencing and cDNA microarray database project for the porcelain crab Petrolisthes cinctipes. Methodology/Principal Findings: A set of similar to 30K unique sequences (UniSeqs) representing similar to 19K clusters were generated from similar to 98K high quality ESTs from a set of tissue specific non-normalized and mixed-tissue normalized cDNA libraries from the porcelain crab Petrolisthes cinctipes. Homology for each UniSeq was assessed using BLAST, InterProScan, GO and KEGG database searches. Approximately 66% of the UniSeqs had homology in at least one of the databases. All EST and UniSeq sequences along with annotation results and coordinated cDNA microarray datasets have been made publicly accessible at the Porcelain Crab Array Database (PCAD), a feature-enriched version of the Stanford and Longhorn Array Databases. Conclusions/Significance: The EST project presented here represents the third largest sequencing effort for any crustacean, and the largest effort for any crab species. Our assembly and clustering results suggest that our porcelain crab EST data set is equally diverse to the much larger EST set generated in the Daphnia pulex genome sequencing project, and thus will be an important resource to the Daphnia research community. Our homology results support the pancrustacea hypothesis and suggest that Malacostraca may be ancestral to Branchiopoda and Hexapoda. Our results also suggest that our cDNA microarrays cover as much of the transcriptome as can reasonably be captured in EST library sequencing approaches, and thus represent a rich resource for studies of environmental genomics.	[Tagmount, Abderrahmane; Tanaka, Yoshihiro; Teranishi, Kristen S.; Stillman, Jonathon H.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Tagmount, Abderrahmane; Tanaka, Yoshihiro; Teranishi, Kristen S.; Stillman, Jonathon H.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Wang, Mei; Lindquist, Erika] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Sunagawa, Shinichi] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Wong, Mike] San Francisco State Univ, Ctr Comp Life Sci, San Francisco, CA 94132 USA; [Stillman, Jonathon H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced; California State University System; San Francisco State University; University of California System; University of California Berkeley	Tagmount, A (corresponding author), San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA.	stillmaj@sfsu.edu	Sunagawa, Shinichi/Q-5950-2019	Sunagawa, Shinichi/0000-0003-3065-0314; Stillman, Jonathon/0000-0002-4783-3830	National Science Foundation NSF-IOB [IOB 0533920]; San Francisco State University Center for Computing in the Life Sciences; San Francisco State University; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [W-7405-ENG-36]	National Science Foundation NSF-IOB(National Science Foundation (NSF)); San Francisco State University Center for Computing in the Life Sciences; San Francisco State University; University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was supported by National Science Foundation NSF-IOB 0533920 to J.H.S. (http://www.nsf.gov), a San Francisco State University Center for Computing in the Life Sciences Mini-Grant to J.H.S. (http://cs.sfsu.edu/ccls/), a San Francisco State University Presidential Mini-Grant to J.H.S. (http://www.sfsu.edu), and DNA sequencing was performed as a part of a 2006 Community Sequencing Project (http://www.jgi.doe.gov/sequencing/cspseqplans2006.html), under the auspices of the US Department of Energy's Office of Science, Biological, and Environmental Research Program, and by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under Contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under Contract No. W-7405-ENG-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Colbourne JK, 2005, INTEGR COMP BIOL, V45, P979; Colbourne JK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-217; Cook CE, 2005, P ROY SOC B-BIOL SCI, V272, P1295, DOI 10.1098/rspb.2004.3042; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Forment J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-5; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; HAIG JANET, 1960, ALLAN HANCOCK PACIFIC EXPED, V24, P1; Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32; Lenz PH, 2000, J COMP PHYSIOL A, V186, P337, DOI 10.1007/s003590050434; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; Schaack S, 2008, MOL ECOL, V17, P1634, DOI 10.1111/j.1365-294X.2008.03698.x; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stillman JH, 2004, INT CONGR SER, V1275, P267, DOI 10.1016/j.ics.2004.09.034; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Stillman JH, 1996, J EXP BIOL, V199, P1845; Stillman JH, 2001, MOL PHYLOGENET EVOL, V19, P236, DOI 10.1006/mpev.2001.0924; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Stillman JH, 2006, INTEGR COMP BIOL, V46, P919, DOI 10.1093/icb/icl007; Stillman JH, 2009, MOL ECOL, V18, P4206, DOI 10.1111/j.1365-294X.2009.04354.x; Stillman JH, 2008, INTEGR COMP BIOL, V48, P852, DOI 10.1093/icb/icn096; Teranishi KS, 2007, COMP BIOCHEM PHYS D, V2, P53, DOI 10.1016/j.cbd.2006.11.002; Ungerer MC, 2008, HEREDITY, V100, P178, DOI 10.1038/sj.hdy.6800992; Waggett RJ, 2008, J EXP MAR BIOL ECOL, V361, P111, DOI 10.1016/j.jembe.2008.05.006	38	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9327	10.1371/journal.pone.0009327	http://dx.doi.org/10.1371/journal.pone.0009327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174471	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923700025
J	Dong, X; Foteinou, PT; Calvano, SE; Lowry, SF; Androulakis, IP				Dong, Xu; Foteinou, Panagiota T.; Calvano, Steven E.; Lowry, Stephen F.; Androulakis, Ioannis P.			Agent-Based Modeling of Endotoxin-Induced Acute Inflammatory Response in Human Blood Leukocytes	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TRANSLATIONAL SYSTEMS BIOLOGY; KINASE IKK; MACROPHAGES; SEPSIS; ACTIVATION; SIMULATION; EXPRESSION; SHOCK	Background: Inflammation is a highly complex biological response evoked by many stimuli. A persistent challenge in modeling this dynamic process has been the (nonlinear) nature of the response that precludes the single-variable assumption. Systems-based approaches offer a promising possibility for understanding inflammation in its homeostatic context. In order to study the underlying complexity of the acute inflammatory response, an agent-based framework is developed that models the emerging host response as the outcome of orchestrated interactions associated with intricate signaling cascades and intercellular immune system interactions. Methodology/Principal Findings: An agent-based modeling (ABM) framework is proposed to study the nonlinear dynamics of acute human inflammation. The model is implemented using NetLogo software. Interacting agents involve either inflammation-specific molecules or cells essential for the propagation of the inflammatory reaction across the system. Spatial orientation of molecule interactions involved in signaling cascades coupled with the cellular heterogeneity are further taken into account. The proposed in silico model is evaluated through its ability to successfully reproduce a self-limited inflammatory response as well as a series of scenarios indicative of the nonlinear dynamics of the response. Such scenarios involve either a persistent (non) infectious response or innate immune tolerance and potentiation effects followed by perturbations in intracellular signaling molecules and cascades. Conclusions/Significance: The ABM framework developed in this study provides insight on the stochastic interactions of the mediators involved in the propagation of endotoxin signaling at the cellular response level. The simulation results are in accordance with our prior research effort associated with the development of deterministic human inflammation models that include transcriptional dynamics, signaling, and physiological components. The hypothetical scenarios explored in this study would potentially improve our understanding of how manipulating the behavior of the molecular species could manifest into emergent behavior of the overall system.	[Dong, Xu; Foteinou, Panagiota T.; Androulakis, Ioannis P.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA; [Calvano, Steven E.; Lowry, Stephen F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Dong, X (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA.	yannis@rci.rutgers.edu			National Science Foundation [0519563]; Environmental Protection Agency [GAD-R832721-010-RRA]; Busch Biomedical Research; National Institutes of Health [GM34695]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034695, R01GM034695] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); Busch Biomedical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D., P. T. F., and I. P. A. acknowledge support from the National Science Foundation grant 0519563, the Environmental Protection Agency grant GAD-R832721-010-RRA, and a Busch Biomedical Research grant. S. E. C. and S. F. L. are supported in part from National Institutes of Health GM34695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2006, J CRIT CARE, V21, P105, DOI 10.1016/j.jcrc.2005.11.012; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; An G, 2007, J CRIT CARE, V22, P169, DOI 10.1016/j.jcrc.2006.12.011; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Baldazzi V, 2006, CELL IMMUNOL, V244, P77, DOI 10.1016/j.cellimm.2006.12.006; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bosshart H, 2007, ANN NY ACAD SCI, V1096, P1, DOI 10.1196/annals.1397.064; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cook JA, 1998, ANN NY ACAD SCI, V851, P426, DOI 10.1111/j.1749-6632.1998.tb09020.x; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Folcik VA, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-39; FOTEINOU P, 2007, J CRITICAL CARE, V22, P337; Foteinou PT, 2009, CTS-CLIN TRANSL SCI, V2, P85, DOI 10.1111/j.1752-8062.2008.00051.x; Foteinou PT, 2009, MATH BIOSCI, V217, P27, DOI 10.1016/j.mbs.2008.09.003; Foteinou PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004706; Funk GA, 2005, J THEOR BIOL, V233, P221, DOI 10.1016/j.jtbi.2004.10.004; Gri G, 1998, J BIOL CHEM, V273, P6431, DOI 10.1074/jbc.273.11.6431; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gupta S, 2005, INT J BIOCHEM CELL B, V37, P1034, DOI 10.1016/j.biocel.2004.08.013; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kataoka M, 2004, DIABETES RES CLIN PR, V64, P51, DOI 10.1016/j.diabres.2003.10.009; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kiehl TR, 2004, BIOINFORMATICS, V20, P316, DOI 10.1093/bioinformatics/btg409; Klaitman V, 2003, ISRAEL MED ASSOC J, V5, P51; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Louzoun Y, 2001, PHYSICA A, V297, P242, DOI 10.1016/S0378-4371(01)00201-1; Lowry SF, 2008, J LEUKOCYTE BIOL, V83, P553, DOI 10.1189/jlb.0607377; Mackay CR, 2000, J EXP MED, V192, pF31, DOI 10.1084/jem.192.11.F31; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; MCKNIGHT AJ, 1994, J IMMUNOL, V152, P2172; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monick MM, 2002, EUR RESPIR J, V20, P210, DOI 10.1183/09031936.02.00252001; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Murai T, 1996, FEMS IMMUNOL MED MIC, V13, P269; Neugebauer EAM, 2001, SHOCK, V16, P252, DOI 10.1097/00024382-200116040-00003; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Pogson M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002367; Protti A, 2007, NOVART FDN SYMP, V280, P160; Protti A, 2007, NOVART FDN SYMP, V280, P16; Protti Alessandro, 2007, Novartis Found Symp, V280, P7; Ramakrishnan N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000122; Romaschin Alexander D, 1998, Sepsis (Boston), V2, P119, DOI 10.1023/A:1009769923763; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Santoni D, 2008, BIOINFORMATICS, V24, P1374, DOI 10.1093/bioinformatics/btn135; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tetta C, 2005, Crit Care Resusc, V7, P32; Ting AY, 2002, SCIENCE, V298, P1189, DOI 10.1126/science.1079331; VODOVOTZ Y, 2008, MATH BIOSCI; Vodovotz Y, 2006, SHOCK, V26, P235, DOI 10.1097/01.shk.0000225413.13866.fo; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wells CA, 2005, J LEUKOCYTE BIOL, V78, P9, DOI 10.1189/jlb.1204710; XING Z, 1994, AM J RESP CELL MOL, V10, P148, DOI 10.1165/ajrcmb.10.2.8110470; Yamakawa T, 1999, ENDOCRINOLOGY, V140, P3562, DOI 10.1210/en.140.8.3562; Yang E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-10; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433; ZHOU YL, 1994, J LEUKOCYTE BIOL, V56, P507, DOI 10.1002/jlb.56.4.507	72	51	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9249	10.1371/journal.pone.0009249	http://dx.doi.org/10.1371/journal.pone.0009249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174629	gold, Green Published, Green Submitted			2022-12-27	WOS:000274654700009
J	Alves, NC; Bailey, CDC; Nashmi, R; Lambe, EK				Alves, Nyresa C.; Bailey, Craig D. C.; Nashmi, Raad; Lambe, Evelyn K.			Developmental Sex Differences in Nicotinic Currents of Prefrontal Layer VI Neurons in Mice and Rats	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; THALAMIC RETICULAR NUCLEUS; ACETYLCHOLINE-RECEPTORS; CEREBRAL-CORTEX; MESSENGER-RNA; FEMALE RATS; BRAIN; PLASTICITY; SUBUNIT; AGE	Background: There is a large sex difference in the prevalence of attention deficit disorder; yet, relatively little is known about sex differences in the development of prefrontal attention circuitry. In male rats, nicotinic acetylcholine receptors excite corticothalamic neurons in layer VI, which are thought to play an important role in attention by gating the sensitivity of thalamic neurons to incoming stimuli. These nicotinic currents in male rats are significantly larger during the first postnatal month when prefrontal circuitry is maturing. The present study was undertaken to investigate whether there are sex differences in the nicotinic currents in prefrontal layer VI neurons during development. Methodology/Principal Findings: Using whole cell recording in prefrontal brain slice, we examined the inward currents elicited by nicotinic stimulation in male and female rats and two strains of mice. We found a prominent sex difference in the currents during the first postnatal month when males had significantly greater nicotinic currents in layer VI neurons compared to females. These differences were apparent with three agonists: acetylcholine, carbachol, and nicotine. Furthermore, the developmental sex difference in nicotinic currents occurred despite male and female rodents displaying a similar pattern and proportion of layer VI neurons possessing a key nicotinic receptor subunit. Conclusions/Significance: This is the first illustration at a cellular level that prefrontal attention circuitry is differently affected by nicotinic receptor stimulation in males and females during development. This transient sex difference may help to define the cellular and circuit mechanisms that underlie vulnerability to attention deficit disorder.	[Alves, Nyresa C.; Bailey, Craig D. C.; Lambe, Evelyn K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Nashmi, Raad] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Lambe, Evelyn K.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada	University of Toronto; University of Victoria; University of Toronto	Alves, NC (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	evelyn.lambe@utoronto.ca	Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090; Bailey, Craig/0000-0002-4320-6872; Nashmi, Raad/0000-0001-6596-2620	CIHR [MOP 89825]; Canadian Foundation for Innovation; Canada Research Chairs program	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs program(Canada Research Chairs)	This research was supported by grants to EKL from CIHR (MOP 89825), the Canadian Foundation for Innovation, and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; BERTRAND D, 1991, NEUROREPORT, V2, P277, DOI 10.1097/00001756-199105000-00016; Brown RT, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e43; Chen XQ, 2005, J NEUROSCI RES, V79, P114, DOI 10.1002/jnr.20323; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Cuffe Steven P, 2005, J Atten Disord, V9, P392, DOI 10.1177/1087054705280413; Das A, 2001, LIFE SCI, V68, P1545, DOI 10.1016/S0024-3205(01)00950-X; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; Espeseth T, 2007, NEUROSCIENCE, V147, P974, DOI 10.1016/j.neuroscience.2007.04.027; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; FUNG YK, 1989, PHARMACOL BIOCHEM BE, V33, P1, DOI 10.1016/0091-3057(89)90419-X; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gan WQ, 2008, NICOTINE TOB RES, V10, P1293, DOI 10.1080/14622200802239132; HATCHELL PC, 1980, PSYCHOPHARMACOLOGY, V71, P45, DOI 10.1007/BF00433251; Heath CJ, 2009, NEUROPHARMACOLOGY, V56, P254, DOI 10.1016/j.neuropharm.2008.07.020; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; Jacobsen LK, 2007, NEUROPSYCHOPHARMACOL, V32, P2453, DOI 10.1038/sj.npp.1301398; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Kassam SM, 2008, J NEUROSCI, V28, P8756, DOI 10.1523/JNEUROSCI.2645-08.2008; KATO J, 1984, J STEROID BIOCHEM, V20, P147; King SL, 2003, J NEUROSCI, V23, P3837; Kohchi C, 1998, BRAIN RES, V801, P233, DOI 10.1016/S0006-8993(98)00585-X; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; KRISTT DA, 1991, BRAIN RES BULL, V26, P789, DOI 10.1016/0361-9230(91)90176-K; Kuczewski N, 2005, EUR J NEUROSCI, V21, P1807, DOI 10.1111/j.1460-9568.2005.04014.x; KYEREMATEN GA, 1988, DRUG METAB DISPOS, V16, P823; Lambers DS, 1996, SEMIN PERINATOL, V20, P115, DOI 10.1016/S0146-0005(96)80079-6; Langley K, 2005, Minerva Pediatr, V57, P359; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Nashmi R, 2007, J NEUROSCI, V27, P8202, DOI 10.1523/JNEUROSCI.2199-07.2007; Nishimura A, 2002, INT J DEV NEUROSCI, V20, P481, DOI 10.1016/S0736-5748(02)00078-3; Paxinos G., 2001, MOUSE BRAIN STEREOTA; REZVANI K, 2009, J MOL NEUROSCI; RIBARY U, 1989, J PHARMACOL EXP THER, V248, P786; Rigbi A, 2008, GENES BRAIN BEHAV, V7, P164, DOI 10.1111/j.1601-183X.2007.00329.x; Robertson RT, 1998, CEREB CORTEX, V8, P142, DOI 10.1093/cercor/8.2.142; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; ROSECRANS JA, 1972, ARCH INT PHARMACOD T, V196, P46; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schmitz M, 2006, J AM ACAD CHILD PSY, V45, P1338, DOI 10.1097/S0890-8567(09)61916-X; Shacka JJ, 1998, DEV BRAIN RES, V109, P67, DOI 10.1016/S0165-3806(98)00058-3; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Sherman SM, 2006, TRENDS NEUROSCI, V29, P295, DOI 10.1016/j.tins.2006.05.005; Sherren N, 2005, NEUROSCIENCE, V136, P445, DOI 10.1016/j.neuroscience.2005.08.053; SHUGHRUE PJ, 1991, DEV BRAIN RES, V59, P143, DOI 10.1016/0165-3806(91)90094-Y; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V130, P3650, DOI 10.1210/en.130.6.3650; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Sullivan RM, 2003, BEHAV BRAIN RES, V146, P43, DOI 10.1016/j.bbr.2003.09.015; Todd RD, 2003, MOL PSYCHIATR, V8, P103, DOI 10.1038/sj.mp.4001257; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; VALERA S, 1992, P NATL ACAD SCI USA, V89, P9949, DOI 10.1073/pnas.89.20.9949; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Winzer-Serhan UH, 2005, J COMP NEUROL, V481, P19, DOI 10.1002/cne.20357; Zhang LM, 2004, J NEUROPHYSIOL, V91, P759, DOI 10.1152/jn.00624.2003; Zikopoulos B, 2006, J NEUROSCI, V26, P7348, DOI 10.1523/JNEUROSCI.5511-05.2006; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	57	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9261	10.1371/journal.pone.0009261	http://dx.doi.org/10.1371/journal.pone.0009261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174655	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590600016
J	Ji, HZ; Masse, N; Tyler, S; Liang, B; Li, Y; Merks, H; Graham, M; Sandstrom, P; Brooks, J				Ji, Hezhao; Masse, Nathalie; Tyler, Shaun; Liang, Ben; Li, Yang; Merks, Harriet; Graham, Morag; Sandstrom, Paul; Brooks, James			HIV Drug Resistance Surveillance Using Pooled Pyrosequencing	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; VARIANTS	Background: Surveillance for HIV transmitted drug resistance (TDR) is performed using HIV genotype results from individual specimens. Pyrosequencing, through its massive parallel sequencing ability, can analyze large numbers of specimens simultaneously. Instead of using pyrosequencing conventionally, to sequence a population of viruses within an individual, we interrogated a single combined pool of surveillance specimens to demonstrate that it is possible to determine TDR rates in HIV protease from a population of individuals. Methodology/Principal Findings: The protease region from 96 treatment naive, HIV+ serum specimens was genotyped using standard Sanger sequencing method. The 462 bp protease amplicons from these specimens were pooled in equimolar concentrations and re-sequenced using the GS FLX Titanium system. The nucleotide (NT) and amino acid (AA) differences from the reference sequence, along with TDR mutations, detected by each method were compared. In the protease sequence, there were 212 nucleotide and 81 AA differences found using conventional sequencing and 345 nucleotide and 168 AA differences using pyrosequencing. All nucleotide and amino acid polymorphisms found at frequencies >= 5% in pyrosequencing were detected using both methods with the rates of variation highly correlated. Using Sanger sequencing, two TDR mutations, M46L and I84V, were each detected as mixtures at a frequency of 1.04% (1/96). These same TDR mutations were detected by pyrosequencing with a prevalence of 0.29% and 0.34% respectively. Phylogenetic analysis established that the detected low frequency mutations arose from the same single specimens that were found to contain TDR mutations by Sanger sequencing. Multiple clinical protease DR mutations present at higher frequencies were concordantly identified using both methods. Conclusions/Significance: We show that pyrosequencing pooled surveillance specimens can cost-competitively detect protease TDR mutations when compared with conventional methods. With few modifications, the method described here can be used to determine population rates of TDR in both protease and reverse transcriptase. Furthermore, this pooled pyrosequencing technique may be generalizable to other infectious agents where a survey of DR rates is required.	[Ji, Hezhao; Masse, Nathalie; Li, Yang; Merks, Harriet; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Microbiol Lab, Ottawa, ON, Canada; [Tyler, Shaun; Graham, Morag] Publ Hlth Agcy Canada, Genom Core Facil, Natl Microbiol Lab, Winnipeg, MB, Canada; [Liang, Ben; Graham, Morag] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba	Ji, HZ (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Natl Microbiol Lab, Ottawa, ON, Canada.	james_brooks@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407; Ji, Hezhao/0000-0002-5451-6294	Government of Canada	Government of Canada(CGIAR)	This work funded by the Government of Canada through the Federal Initiative to Address HIV/AIDS in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*454 LIF SCI CORP, 2009, TECHN B 454 LIF SCI; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2006, CURR OPIN INFECT DIS, V19, P607, DOI 10.1097/QCO.0b013e3280109ff1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Myatt M, 2008, ANTIVIR THER, V13, P37; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	17	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9263	10.1371/journal.pone.0009263	http://dx.doi.org/10.1371/journal.pone.0009263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174661	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590600018
J	Langer, N; Beeli, G; Jancke, L				Langer, Nicolas; Beeli, Gian; Jaencke, Lutz			When the Sun Prickles Your Nose: An EEG Study Identifying Neural Bases of Photic Sneezing	PLOS ONE			English	Article							LOCALIZATION; INSULA; REFLEX; CONNECTIVITY; INTEGRATION; POTENTIALS; ACTIVATION; RESPONSES; DYNAMICS; DISGUST	Background: Exposure to bright light such as sunlight elicits a sneeze or prickling sensation in about one of every four individuals. This study presents the first scientific examination of this phenomenon, called 'the photic sneeze reflex'. Methodology and Principal Findings: In the present experiment, 'photic sneezers' and controls were exposed to a standard checkerboard stimulus (block 1) and bright flashing lights (block 2) while their EEG (electro-encephalogram) was recorded. Remarkably, we found a generally enhanced excitability of the visual cortex (mainly in the cuneus) to visual stimuli in 'photic sneezers' compared with control subjects. In addition, a stronger prickling sensation in the nose of photic sneezers was found to be associated with activation in the insula and stronger activation in the secondary somatosensory cortex. Conclusion: We propose that the photic sneeze phenomenon might be the consequence of higher sensitivity to visual stimuli in the visual cortex and of co-activation of somatosensory areas. The 'photic sneeze reflex' is therefore not a classical reflex that occurs only at a brainstem or spinal cord level but, in stark contrast to many theories, involves also specific cortical areas.	[Langer, Nicolas; Beeli, Gian; Jaencke, Lutz] Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland	University of Zurich	Langer, N (corresponding author), Univ Zurich, Inst Psychol, Div Neuropsychol, Zurich, Switzerland.	n.langer@psychologie.uzh.ch	Jäncke, Lutz/C-3792-2009; Jancke, Lutz/D-2910-2013	Jäncke, Lutz/0000-0002-8115-4890; Jancke, Lutz/0000-0003-2110-9067	Swiss National Science Foundation (SNF)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Funding: Swiss National Science Foundation (SNF) - The SNF is the national non-profit funding organization controlled by the Swiss government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; BECKMAN L, 1983, HUM HERED, V33, P390, DOI 10.1159/000153407; BENBOW EW, 1991, BRIT J OPHTHALMOL, V75, P447, DOI 10.1136/bjo.75.7.447-a; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; BREITENBACH RA, 1993, MIL MED, V158, P806, DOI 10.1093/milmed/158.12.806; Brooks JCW, 2007, PAIN, V128, P1, DOI 10.1016/j.pain.2006.12.025; Brubaker AP, 1919, J AMER MED ASSOC, V73, P585, DOI 10.1001/jama.1919.02610340017004; BUCKLEY B, 1991, ARCH DIS CHILD, V66, P908, DOI 10.1136/adc.66.7.908-d; Chen YH, 2009, NEUROIMAGE, V47, P1921, DOI 10.1016/j.neuroimage.2009.04.093; Collie W R, 1978, Birth Defects Orig Artic Ser, V14, P361; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; EVERETT HC, 1964, NEUROLOGY, V14, P483, DOI 10.1212/WNL.14.5.483; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Fink JN, 2001, NEUROLOGY, V56, P138; FORRESTER JM, 1985, HUM HERED, V35, P113, DOI 10.1159/000153527; Haalman I, 1997, HUM BRAIN MAPP, V5, P249, DOI 10.1002/(SICI)1097-0193(1997)5:4<249::AID-HBM8>3.0.CO;2-3; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; LANG DM, 1987, JAMA-J AM MED ASSOC, V257, P1330, DOI 10.1001/jama.1987.03390100068019; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; Munte TF, 2010, BRAIN RES, V1307, P78, DOI 10.1016/j.brainres.2009.10.044; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Noesselt T, 2002, NEURON, V35, P575, DOI 10.1016/S0896-6273(02)00781-X; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PEROUTKA SJ, 1984, NEW ENGL J MED, V310, P599; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; SEDAN J, 1954, Rev Otoneuroophtalmol, V26, P123; Seijo-Martinez M, 2006, J NEUROL NEUROSUR PS, V77, P559, DOI 10.1136/jnnp.2005.068601; Skrandies W, 1980, Prog Brain Res, V54, P291, DOI 10.1016/S0079-6123(08)61637-4; Songu Murat, 2009, Ther Adv Respir Dis, V3, P131, DOI 10.1177/1753465809340571; Stolarova M, 2006, CEREB CORTEX, V16, P876, DOI 10.1093/cercor/bhj031; Suranyi L, 2001, NEUROLOGY, V57, P161, DOI 10.1212/WNL.57.1.161; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; VENTURA V, 2004, J CLIMATE IN PRESS; WHITMAN BW, 1993, NEUROLOGY, V43, P868, DOI 10.1212/WNL.43.5.868; Zaehle T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.008.2009	48	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9208	10.1371/journal.pone.0009208	http://dx.doi.org/10.1371/journal.pone.0009208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169159	Green Published, gold			2022-12-27	WOS:000274474700007
J	Walsh, AW; Langley, DR; Colonno, RJ; Tenney, DJ				Walsh, Ann W.; Langley, David R.; Colonno, Richard J.; Tenney, Daniel J.			Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE ACTIVITY; NUCLEOSIDE-NAIVE PATIENTS; IN-VITRO; WILD-TYPE; LAMIVUDINE RESISTANCE; DNA; REPLICATION; INHIBITION; MUTATIONS	Background: Entecavir (ETV) is a deoxyguanosine analog competitive inhibitor of hepatitis B virus (HBV) polymerase that exhibits delayed chain termination of HBV DNA. A high barrier to entecavir-resistance (ETVr) is observed clinically, likely due to its potency and a requirement for multiple resistance changes to overcome suppression. Changes in the HBV polymerase reverse-transcriptase (RT) domain involve lamivudine-resistance (LVDr) substitutions in the conserved YMDD motif (M204V/I +/- L180M), plus an additional ETV-specific change at residues T184, S202 or M250. These substitutions surround the putative dNTP binding site or primer grip regions of the HBV RT. Methods/Principal Findings: To determine the mechanistic basis for ETVr, wildtype, lamivudine-resistant (M204V, L180M) and ETVr HBVs were studied using in vitro RT enzyme and cell culture assays, as well as molecular modeling. Resistance substitutions significantly reduced ETV incorporation and chain termination in HBV DNA and increased the ETV-TP inhibition constant (K-i) for HBV RT. Resistant HBVs exhibited impaired replication in culture and reduced enzyme activity (k(cat)) in vitro. Molecular modeling of the HBV RT suggested that ETVr residue T184 was adjacent to and stabilized S202 within the LVDr YMDD loop. ETVr arose through steric changes at T184 or S202 or by disruption of hydrogen-bonding between the two, both of which repositioned the loop and reduced the ETV-triphosphate (ETV-TP) binding pocket. In contrast to T184 and S202 changes, ETVr at primer grip residue M250 was observed during RNA-directed DNA synthesis only. Experimentally, M250 changes also impacted the dNTP-binding site. Modeling suggested a novel mechanism for M250 resistance, whereby repositioning of the primer-template component of the dNTP-binding site shifted the ETV-TP binding pocket. No structural data are available to confirm the HBV RT modeling, however, results were consistent with phenotypic analysis of comprehensive substitutions of each ETVr position. Conclusions: Altogether, ETVr occurred through exclusion of ETV-TP from the dNTP-binding site, through different, novel mechanisms that involved lamivudine-resistance, ETV-specific substitutions, and the primer-template.	[Walsh, Ann W.; Langley, David R.; Colonno, Richard J.; Tenney, Daniel J.] Bristol Myers Squibb Inc, Res & Dev, Wallingford, CT USA	Bristol-Myers Squibb	Walsh, AW (corresponding author), Bristol Myers Squibb Inc, Res & Dev, Wallingford, CT USA.	david.langley@bms.com; daniel.tenney@bms.com		Langley, David/0000-0002-0820-3190	Bristol-Myers Squibb, Inc	Bristol-Myers Squibb, Inc(Bristol-Myers Squibb)	The work described in this paper was funded by Bristol-Myers Squibb, Inc. All authors were employees of Bristol-Myers Squibb at the time of the work and in this respect the company had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Baldick CJ, 2008, J HEPATOL, V48, P895, DOI 10.1016/j.jhep.2007.12.024; Baldick CJ, 2008, HEPATOLOGY, V47, P1473, DOI 10.1002/hep.22211; Bartholomeusz A, 2004, ANTIVIR THER, V9, P149; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunelle MN, 2007, ANTIMICROB AGENTS CH, V51, P2240, DOI 10.1128/AAC.01440-06; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chin R, 2001, ANTIMICROB AGENTS CH, V45, P2495, DOI 10.1128/AAC.45.9.2495-2501.2001; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Domaoal RA, 2008, J BIOL CHEM, V283, P5452, DOI 10.1074/jbc.M707834200; Dominy BN, 1999, J PHYS CHEM B, V103, P3765, DOI 10.1021/jp984440c; FALLOWS DA, 1995, J VIROL, V69, P3067, DOI 10.1128/JVI.69.5.3067-3073.1995; Favre D, 2008, ALTEX-ALTERN TIEREXP, V25, P197; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fung SK, 2005, J HEPATOL, V43, P937, DOI 10.1016/j.jhep.2005.05.037; Gaillard RK, 2002, ANTIMICROB AGENTS CH, V46, P1005, DOI 10.1128/AAC.46.4.1005-1013.2002; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; HESS G, 1980, J MED VIROL, V5, P309, DOI 10.1002/1096-9071(1980)5:4&lt;309::AID-JMV1890050407&gt;3.0.CO;2-L; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Innaimo SF, 1997, ANTIMICROB AGENTS CH, V41, P1444, DOI 10.1128/AAC.41.7.1444; KAPLAN PM, 1976, J VIROL, V17, P885, DOI 10.1128/JVI.17.3.885-893.1976; LANFORD RE, 1995, J VIROL, V69, P4431, DOI 10.1128/JVI.69.7.4431-4439.1995; Langley DR, 2007, J VIROL, V81, P3992, DOI 10.1128/JVI.02395-06; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Lin PF, 2008, ANTIMICROB AGENTS CH, V52, P1759, DOI 10.1128/AAC.01313-07; Ling R, 1999, J GEN VIROL, V80, P601, DOI 10.1099/0022-1317-80-3-601; Ling R, 1996, HEPATOLOGY, V24, P711, DOI 10.1053/jhep.1996.v24.pm0008781347; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MCMILLAN JS, 1995, HEPATOLOGY, V22, P36, DOI 10.1016/0270-9139(95)90350-X; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; NILSSON L, 1986, J COMPUT CHEM, V7, P591, DOI 10.1002/jcc.540070502; NORDENFELT E, 1980, ACTA PATH MICRO IM B, V88, P169; OBERG B, 1989, PHARMACOL THERAPEUT, V40, P213, DOI 10.1016/0163-7258(89)90097-1; Ono-Nita SK, 1999, HEPATOLOGY, V29, P939, DOI 10.1002/hep.510290340; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; SCHINAZI RF, 1993, ANTIMICROB AGENTS CH, V37, P875, DOI 10.1128/AAC.37.4.875; Seifer M, 1998, J VIROL, V72, P2765, DOI 10.1128/JVI.72.4.2765-2776.1998; Seifer M, 1998, ANTIMICROB AGENTS CH, V42, P3200, DOI 10.1128/AAC.42.12.3200; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Tatti KM, 2002, ANTIVIR RES, V55, P141, DOI 10.1016/S0166-3542(02)00019-0; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tenney DJ, 2007, ANTIMICROB AGENTS CH, V51, P902, DOI 10.1128/AAC.00833-06; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Tenney DJ, 2004, ANTIMICROB AGENTS CH, V48, P3498, DOI 10.1128/AAC.48.9.3498-3507.2004; TIDOR B, 1983, J BIOMOL STRUCT DYN, V1, P231, DOI 10.1080/07391102.1983.10507437; Tipples GA, 1996, HEPATOLOGY, V24, P714, DOI 10.1053/jhep.1996.v24.pm0008781348; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Urban S, 2001, P NATL ACAD SCI USA, V98, P4984, DOI 10.1073/pnas.091324398; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Wilson JE, 1996, J BIOL CHEM, V271, P13656, DOI 10.1074/jbc.271.23.13656; Yadav V, 2004, BIOORG MED CHEM LETT, V14, P4313, DOI 10.1016/j.bmcl.2004.05.075	59	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9195	10.1371/journal.pone.0009195	http://dx.doi.org/10.1371/journal.pone.0009195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169198	gold, Green Submitted, Green Published			2022-12-27	WOS:000274474600015
J	Su, PT; Yen, PW; Wang, SH; Lin, CH; Chiou, A; Syu, WJ				Su, Pin-Tzu; Yen, Pei-Wen; Wang, Shao-Hung; Lin, Chi-Hung; Chiou, Arthur; Syu, Wan-Jr			Factors Affecting Daughter Cells' Arrangement during the Early Bacterial Divisions	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE; PROTEIN; LIPOPROTEIN; PAL; LIPOPOLYSACCHARIDE; CONTRIBUTE; REGULATOR; CURLI	On agar plates, daughter cells of Escherichia coli mutually slide and align side-by-side in parallel during the first round of binary fission. This phenomenon has been previously attributed to an elastic material that restricts apparently separated bacteria from being in string. We hypothesize that the interaction between bacteria and the underneath substratum may affect the arrangement of the daughter bacteria. To test this hypothesis, bacterial division on hyaluronic acid ( HA) gel, as an alternative substratum, was examined. Consistent with our proposition, the HA gel differs from agar by suppressing the typical side-by-side alignments to a rare population. Examination of bacterial surface molecules that may contribute to the daughter cells' arrangement yielded an observation that, with disrupted lpp, the E. coli daughter cells increasingly formed non-typical patterns, i.e. neither sliding side-by-side in parallel nor forming elongated strings. Therefore, our results suggest strongly that the early cell patterning is affected by multiple interaction factors. With oscillatory optical tweezers, we further demonstrated that the interaction force decreased in bacteria without Lpp, a result substantiating our notion that the side-by-side sliding phenomenon directly reflects the strength of in-situ interaction between bacteria and substratum.	[Su, Pin-Tzu; Wang, Shao-Hung; Lin, Chi-Hung; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yen, Pei-Wen; Lin, Chi-Hung; Chiou, Arthur] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Su, PT (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	aechiou@ym.edu.tw; wjsyu@ym.edu.tw	wang, shaohung/E-4017-2015	wang, shaohung/0000-0002-6824-0372	Ministry of Education, Aim for the Top University Plan; National Science Council, Republic of China (Taiwan) [NSC98-2320-B-010-005-MY3;, NSC98-2627-M-010-003, NSC98-2627-M-010-002, NSC 97-2627-M-010-004]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council, Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported in part by a grant from Ministry of Education, Aim for the Top University Plan and Grants NSC98-2320-B-010-005-MY3; (http://english.moe.gov.tw/) and NSC98-2627-M-010-003, NSC98-2627-M-010-002 and NSC 97-2627-M-010-004 from the National Science Council, Republic of China (Taiwan) (http://web1.nsc.gov.tw/).	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; DONACHIE WD, 1970, NATURE, V227, P1220, DOI 10.1038/2271220a0; Fukuoka H, 2007, J MOL BIOL, V367, P692, DOI 10.1016/j.jmb.2007.01.015; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; GRAHAMSMITH GS, 1910, PARASITOLOGY, V3, P17; INOUYE M, 1972, J BIOL CHEM, V247, P8154; KEIJI S, 1997, APPL PHYS LETT, V71, P37; LEE DG, 2009, UROLOGY; Liu SL, 2007, OPT EXPRESS, V15, P2713, DOI 10.1364/OE.15.002713; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Palmer J, 2007, J IND MICROBIOL BIOT, V34, P577, DOI 10.1007/s10295-007-0234-4; PARSONS CL, 1979, INFECT IMMUN, V24, P552, DOI 10.1128/IAI.24.2.552-557.1979; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sha J, 2004, INFECT IMMUN, V72, P3987, DOI 10.1128/IAI.72.7.3987-4003.2004; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SHAPIRO JA, 1995, BIOESSAYS, V17, P597, DOI 10.1002/bies.950170706; SHAPIRO JA, 1989, J BACTERIOL, V171, P5963, DOI 10.1128/jb.171.11.5963-5974.1989; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; SUZUKI H, 1978, MOL GEN GENET, V167, P1; Tomihata K, 1997, J BIOMED MATER RES, V37, P243; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Veening JW, 2006, J BACTERIOL, V188, P3099, DOI 10.1128/JB.188.8.3099-3109.2006; Wei MT, 2008, OPT EXPRESS, V16, P8594, DOI 10.1364/OE.16.008594; Wei MT, 2007, OPT EXPRESS, V15, P11020, DOI 10.1364/OE.15.011020; Wei MT, 2005, OPT EXPRESS, V13, P5798, DOI 10.1364/OPEX.13.005798; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	37	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9147	10.1371/journal.pone.0009147	http://dx.doi.org/10.1371/journal.pone.0009147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161768	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442700011
J	Yorzinski, JL; Platt, ML				Yorzinski, Jessica L.; Platt, Michael L.			Same-Sex Gaze Attraction Influences Mate-Choice Copying in Humans	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; FEMALES COPY; SELECTION; TRANSMISSION; PREFERENCE; MODELS; BEAUTY; CORTEX	Mate-choice copying occurs when animals rely on the mating choices of others to inform their own mating decisions. The proximate mechanisms underlying mate-choice copying remain unknown. To address this question, we tracked the gaze of men and women as they viewed a series of photographs in which a potential mate was pictured beside an opposite-sex partner; the participants then indicated their willingness to engage in a long-term relationship with each potential mate. We found that both men and women expressed more interest in engaging in a relationship with a potential mate if that mate was paired with an attractive partner. Men and women's attention to partners varied with partner attractiveness and this gaze attraction influenced their subsequent mate choices. These results highlight the prevalence of non-independent mate choice in humans and implicate social attention and reward circuitry in these decisions.	[Yorzinski, Jessica L.] Univ Calif Davis, Anim Behav Grad Grp, Dept Ecol & Evolut, Davis, CA 95616 USA; [Yorzinski, Jessica L.; Platt, Michael L.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Platt, Michael L.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	University of California System; University of California Davis; Duke University; Duke University	Yorzinski, JL (corresponding author), Univ Calif Davis, Anim Behav Grad Grp, Dept Ecol & Evolut, Davis, CA 95616 USA.	jyorzinski@ucdavis.edu			National Science Foundation; National Academy of Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086712] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Academy of Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JLY was funded by a National Science Foundation Graduate Research Fellowship and a Grant-In-Aid of Research from the National Academy of Sciences (administered by Sigma-Xi, The Scientific Research Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alonzo SH, 2008, ANIM BEHAV, V75, P1715, DOI 10.1016/j.anbehav.2007.09.031; BOESCH C, 1991, ANIM BEHAV, V41, P530, DOI 10.1016/S0003-3472(05)80857-7; Bower AB, 2001, J ADVERTISING, V30, P1; Buss D.M., 2006, PSIHOLOGIJSKE TEME, V15, P239; Buss DM, 1998, J SEX RES, V35, P19, DOI 10.1080/00224499809551914; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; DUGATKIN LA, 1992, P ROY SOC B-BIOL SCI, V249, P179, DOI 10.1098/rspb.1992.0101; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Freeberg TM, 2000, BEHAV PROCESS, V51, P177, DOI 10.1016/S0376-6357(00)00127-3; GALEF BG, 1988, PHYSIOL BEHAV, V42, P119, DOI 10.1016/0031-9384(88)90285-5; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Gibson RM, 1991, BEHAV ECOL, V2, P165, DOI 10.1093/beheco/2.2.165; Hassebrauck M, 1998, EVOL HUM BEHAV, V19, P111, DOI 10.1016/S1090-5138(98)00002-6; Jones BC, 2007, P ROY SOC B-BIOL SCI, V274, P899, DOI 10.1098/rspb.2006.0205; KIRKPATRICK M, 1994, BEHAV ECOL SOCIOBIOL, V34, P443; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Laidre ME, 2009, J COMP PSYCHOL, V123, P34, DOI 10.1037/a0013129; Little AC, 2008, EVOL HUM BEHAV, V29, P140, DOI 10.1016/j.evolhumbehav.2007.11.007; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Schliep F, 1996, IEEE PHOTONIC TECH L, V8, P107, DOI 10.1109/68.475794; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WADE MJ, 1990, P NATL ACAD SCI USA, V87, P5749, DOI 10.1073/pnas.87.15.5749; Waynforth D, 2007, HUM NATURE-INT BIOS, V18, P264, DOI 10.1007/s12110-007-9004-2; Westneat DF, 2000, ANIM BEHAV, V59, P467, DOI 10.1006/anbe.1999.1341; White DJ, 1999, ANIM BEHAV, V57, P465, DOI 10.1006/anbe.1998.1015	29	39	40	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9115	10.1371/journal.pone.0009115	http://dx.doi.org/10.1371/journal.pone.0009115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NV	20161739	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600013
J	Aste-Amezaga, M; Zhang, NY; Lineberger, JE; Arnold, BA; Toner, TJ; Gu, MC; Huang, LY; Vitelli, S; Vo, KT; Haytko, P; Zhao, JZ; Baleydier, F; L'Heureux, S; Wang, HF; Gordon, WR; Thoryk, E; Andrawes, MB; Tiyanont, K; Stegmaier, K; Roti, G; Ross, KN; Franlin, LL; Wang, H; Wang, FB; Chastain, M; Bett, AJ; Audoly, LP; Aster, JC; Blacklow, SC; Huber, HE				Aste-Amezaga, Miguel; Zhang, Ningyan; Lineberger, Janet E.; Arnold, Beth A.; Toner, Timothy J.; Gu, Mingcheng; Huang, Lingyi; Vitelli, Salvatore; Vo, Kim T.; Haytko, Peter; Zhao, Jing Zhang; Baleydier, Frederic; L'Heureux, Sarah; Wang, Hongfang; Gordon, Wendy R.; Thoryk, Elizabeth; Andrawes, Marie Blanke; Tiyanont, Kittichoat; Stegmaier, Kimberly; Roti, Giovanni; Ross, Kenneth N.; Franlin, Laura L.; Wang, Hui; Wang, Fubao; Chastain, Michael; Bett, Andrew J.; Audoly, Laurent P.; Aster, Jon C.; Blacklow, Stephen C.; Huber, Hans E.			Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors	PLOS ONE			English	Article							GAMMA-SECRETASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER; PROTEOLYTIC ACTIVATION; THERAPEUTIC TARGET; PANCREATIC-CANCER; REGULATORY REGION; STRUCTURAL BASIS; MAMMALIAN NOTCH; MODIFIES NOTCH	Background: Notch receptors normally play a key role in guiding a variety of cell fate decisions during development and differentiation of metazoan organisms. On the other hand, dysregulation of Notch1 signaling is associated with many different types of cancer as well as tumor angiogenesis, making Notch1 a potential therapeutic target. Principal Findings: Here we report the in vitro activities of inhibitory Notch1 monoclonal antibodies derived from cell-based and solid-phase screening of a phage display library. Two classes of antibodies were found, one directed against the EGF-repeat region that encompasses the ligand-binding domain (LBD), and the second directed against the activation switch of the receptor, the Notch negative regulatory region (NRR). The antibodies are selective for Notch1, inhibiting Jag2-dependent signaling by Notch1 but not by Notch 2 and 3 in reporter gene assays, with EC50 values as low as 5 +/- 3 nM and 0.13 +/- 0.09 nM for the LBD and NRR antibodies, respectively, and fail to recognize Notch4. While more potent, NRR antibodies are incomplete antagonists of Notch1 signaling. The antagonistic activity of LBD, but not NRR, antibodies is strongly dependent on the activating ligand. Both LBD and NRR antibodies bind to Notch1 on human tumor cell lines and inhibit the expression of sentinel Notch target genes, including HES1, HES5, and DTX1. NRR antibodies also strongly inhibit ligand-independent signaling in heterologous cells transiently expressing Notch1 receptors with diverse NRR "class I" point mutations, the most common type of mutation found in human T-cell acute lymphoblastic leukemia (T-ALL). In contrast, NRR antibodies failed to antagonize Notch1 receptors bearing rare "class II" or "class III" mutations, in which amino acid insertions generate a duplicated or constitutively sensitive metalloprotease cleavage site. Signaling in T-ALL cell lines bearing class I mutations is partially refractory to inhibitory antibodies as compared to cell-penetrating gamma-secretase inhibitors. Conclusions/Significance: Antibodies that compete with Notch1 ligand binding or that bind to the negative regulatory region can act as potent inhibitors of Notch1 signaling. These antibodies may have clinical utility for conditions in which inhibition of signaling by wild-type Notch1 is desired, but are likely to be of limited value for treatment of T-ALLs associated with aberrant Notch1 activation.	[Aste-Amezaga, Miguel; Zhang, Ningyan; Lineberger, Janet E.; Arnold, Beth A.; Toner, Timothy J.; Gu, Mingcheng; Huang, Lingyi; Vitelli, Salvatore; Vo, Kim T.; Haytko, Peter; Zhao, Jing Zhang; Franlin, Laura L.; Wang, Hui; Wang, Fubao; Audoly, Laurent P.; Huber, Hans E.] Merck Res Labs, Dept Biol Res, West Point, PA 19486 USA; [Thoryk, Elizabeth; Bett, Andrew J.] Merck Res Labs, Dept Vaccines, West Point, PA USA; [Chastain, Michael] Merck Res Labs, Dept Mol Profiling & Pharmacol, West Point, PA USA; [Baleydier, Frederic; L'Heureux, Sarah; Wang, Hongfang; Gordon, Wendy R.; Andrawes, Marie Blanke; Tiyanont, Kittichoat; Aster, Jon C.; Blacklow, Stephen C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Stegmaier, Kimberly; Roti, Giovanni] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Stegmaier, Kimberly; Ross, Kenneth N.] Broad Inst, Canc Program, Cambridge, MA USA	Merck & Company; Merck & Company; Merck & Company; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Aste-Amezaga, M (corresponding author), Merck Res Labs, Dept Biol Res, West Point, PA 19486 USA.	jose_asteamezaga@merck.com	Roti, Giovanni/A-4234-2015; Baleydier, Frederic/AAX-2554-2020	Roti, Giovanni/0000-0002-8664-950X; Zhang, Ningyan/0000-0002-4348-2180; Gordon, Wendy/0000-0001-7696-5560	NIH (National Institutes of Health) [P01 119070, R01 CA092433]; Leukemia and Lymphoma Society; William Lawrence and Blanche Hughes Foundation; NATIONAL CANCER INSTITUTE [R01CA092433, P01CA119070, R56CA092433] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); William Lawrence and Blanche Hughes Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported in part by NIH (National Institutes of Health) grants P01 119070 and R01 CA092433 (JCA, SCB), a SCOR (Specialized Center of Research) award from the Leukemia and Lymphoma Society (JCA, SCB, KS), and the William Lawrence and Blanche Hughes Foundation (JCA, SCB, KS). WRG is a Leukemia and Lymphoma Society special fellow. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RECHSTEINER M, 1988, ADV ENZYME REGUL, V27, P135; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rizzo P, 2009, ADV ENZYME REGUL, V49, P134, DOI 10.1016/j.advenzreg.2009.01.008; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Shutter JR, 2000, GENE DEV, V14, P1313; Siemers ER, 2006, NEUROLOGY, V66, P602, DOI 10.1212/01.WNL.0000198762.41312.E1; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; TAMMAM J, 2009, BR J PHARM IN PRESS; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vardar D, 2003, BIOCHEMISTRY-US, V42, P7061, DOI 10.1021/bi034156y; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yu Hai, 2007, Ai Zheng, V26, P148	68	136	150	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9094	10.1371/journal.pone.0009094	http://dx.doi.org/10.1371/journal.pone.0009094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161710	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442500006
J	Thera, MA; Doumbo, OK; Coulibaly, D; Laurens, MB; Kone, AK; Guindo, AB; Traore, K; Sissoko, M; Diallo, DA; Diarra, I; Kouriba, B; Daou, M; Dolo, A; Baby, M; Sissoko, MS; Sagara, I; Niangaly, A; Traore, I; Olotu, A; Godeaux, O; Leach, A; Dubois, MC; Ballou, WR; Cohen, J; Thompson, D; Dube, T; Soisson, L; Diggs, CL; Takala, SL; Lyke, KE; House, B; Lanar, DE; Dutta, S; Heppner, DG; Plowe, CV				Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Laurens, Matthew B.; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Sissoko, Mady; Diallo, Dapa A.; Diarra, Issa; Kouriba, Bourema; Daou, Modibo; Dolo, Amagana; Baby, Mounirou; Sissoko, Mahamadou S.; Sagara, Issaka; Niangaly, Amadou; Traore, Idrissa; Olotu, Ally; Godeaux, Olivier; Leach, Amanda; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe; Thompson, Darby; Dube, Tina; Soisson, Lorraine; Diggs, Carter L.; Takala, Shannon L.; Lyke, Kirsten E.; House, Brent; Lanar, David E.; Dutta, Sheetij; Heppner, D. Gray; Plowe, Christopher V.			Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; BLOOD-STAGE VACCINE; FALCIPARUM-MALARIA; IMMUNE-RESPONSES; IN-VITRO; ANTIBODIES; INHIBIT; ADULTS; CANDIDATE; EXPRESSION	Background: The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum malaria. Methodology/Principal Findings: A Phase 1 double blind randomized controlled dose escalation trial was conducted in Bandiagara, Mali, West Africa, a rural town with intense seasonal transmission of Plasmodium falciparum malaria. The malaria vaccine FMP2.1/AS02(A) is a recombinant protein (FMP2.1) based on apical membrane antigen 1 (AMA1) from the 3D7 clone of P. falciparum, formulated in the Adjuvant System AS02(A). The comparator vaccine was a cell-culture rabies virus vaccine (RabAvert (R)). One hundred healthy Malian children aged 1-6 years were recruited into 3 cohorts and randomized to receive either 10 mu g FMP2.1 in 0.1 mL AS02(A), or 25 mu g FMP2.1 in 0.25 mL AS02(A), or 50 mu g FMP2.1 50 mg in 0.5 mL AS02(A), or rabies vaccine. Three doses of vaccine were given at 0, 1 and 2 months, and children were followed for 1 year. Solicited symptoms were assessed for 7 days and unsolicited symptoms for 30 days after each vaccination. Serious adverse events were assessed throughout the study. Transient local pain and swelling were common and more frequent in all malaria vaccine dosage groups than in the comparator group, but were acceptable to parents of participants. Levels of anti-AMA1 antibodies measured by ELISA increased significantly (at least 100-fold compared to baseline) in all 3 malaria vaccine groups, and remained high during the year of follow up. Conclusion/Significance: The FMP2.1/AS02(A) vaccine had a good safety profile, was well-tolerated, and induced high and sustained antibody levels in malaria-exposed children. This malaria vaccine is being evaluated in a Phase 2 efficacy trial in children at this site.	[Thera, Mahamadou A.; Doumbo, Ogobara K.; Coulibaly, Drissa; Kone, Abdoulaye K.; Guindo, Ando B.; Traore, Karim; Sissoko, Mady; Diallo, Dapa A.; Diarra, Issa; Kouriba, Bourema; Daou, Modibo; Dolo, Amagana; Baby, Mounirou; Sissoko, Mahamadou S.; Sagara, Issaka; Niangaly, Amadou; Traore, Idrissa] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Laurens, Matthew B.; Takala, Shannon L.; Lyke, Kirsten E.; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Olotu, Ally; Godeaux, Olivier; Leach, Amanda; Dubois, Marie-Claude; Ballou, W. Ripley; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Thompson, Darby; Dube, Tina] EMMES Corp, Rockville, MD USA; [Soisson, Lorraine; Diggs, Carter L.] US Agcy Int Dev, Malaria Vaccine Dev Program, Washington, DC 20523 USA; [House, Brent; Lanar, David E.; Dutta, Sheetij; Heppner, D. Gray] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA	University of Bamako; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; GlaxoSmithKline; Emmes Corporation; United States Agency for International Development (USAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Thera, MA (corresponding author), Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali.	cplowe@medicine.umaryland.edu	Leach, Amanda/AAS-1120-2020; Lanar, David E/B-3560-2011; Laurens, Matthew/E-7293-2013	Leach, Amanda/0000-0002-7114-9967; Laurens, Matthew/0000-0003-3874-581X; Takala-Harrison, Shannon/0000-0003-4674-8500; Traore, Karim/0000-0002-9553-6611; Thera, Mahamadou A/0000-0002-2679-035X	National Institute of Allergy and Infectious Diseases (NIAID) [N01AI85346, U19AI065683]; Fogarty International Center, National Institutes of Health [D43TW001589]; United States Department of Defense [W81XWH-06-1-0427]; United States Agency for International Development (USAID); Doris Duke Charitable Foundation; Howard Hughes Medical Institute; FOGARTY INTERNATIONAL CENTER [D43TW001589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085346, U19AI065683] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); United States Department of Defense(United States Department of Defense); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Site development and the conduct of the trial were supported by contract N01AI85346 and cooperative agreement U19AI065683 from the National Institute of Allergy and Infectious Diseases (NIAID), grant D43TW001589 from the Fogarty International Center, National Institutes of Health, and contract W81XWH-06-1-0427 from the United States Department of Defense and the United States Agency for International Development (USAID). Data management was provided by the EMMES Corporation through a contract with NIAID. Vaccine production and laboratory assays were supported by USAID, Washington, D. C. and by the Military Infectious Diseases Research Program, Fort Detrick, Maryland. Program staff from NIAID (the primary funder) contributed to study design discussions but played no role in the data collection and analysis, decision to publish, or preparation of the manuscript. Coauthors LS and CD from USAID (a secondary funder) contributed to both protocol design and manuscript preparation. CVP is supported by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and by the Howard Hughes Medical Institute.	Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; Diallo DA, 2005, CLIN INFECT DIS, V41, P255, DOI 10.1086/430707; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Lyke KE, 2004, VACCINE, V22, P3169, DOI 10.1016/j.vaccine.2004.01.054; Lyke KE, 2009, VACCINE, V27, P2171, DOI 10.1016/j.vaccine.2009.01.097; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Polhemus ME, 2007, VACCINE, V25, P4203, DOI 10.1016/j.vaccine.2007.03.012; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; SOLTYSIK S, 1993, ANN NY ACAD SCI, V690, P392; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; Thera MA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010034; THOMAS AW, 1994, AM J TROP MED HYG, V51, P730, DOI 10.4269/ajtmh.1994.51.730; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032	32	43	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9041	10.1371/journal.pone.0009041	http://dx.doi.org/10.1371/journal.pone.0009041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140214	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474400003
J	Philipot, O; Joliot, V; Ait-Mohamed, O; Pellentz, C; Robin, P; Fritsch, L; Ait-Si-Ali, S				Philipot, Ophelie; Joliot, Veronique; Ait-Mohamed, Ouardia; Pellentz, Celine; Robin, Philippe; Fritsch, Lauriane; Ait-Si-Ali, Slimane			The Core Binding Factor CBF Negatively Regulates Skeletal Muscle Terminal Differentiation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; IN-VIVO; MYOGENIC DIFFERENTIATION; HEMATOPOIETIC-CELLS; NERVOUS-SYSTEM; STEM-CELLS; BETA-SMMHC; GENE	Background: Core Binding Factor or CBF is a transcription factor composed of two subunits, Runx1/AML-1 and CBF beta or CBF beta. CBF was originally described as a regulator of hematopoiesis. Methodology/Principal Findings: Here we show that CBF is involved in the control of skeletal muscle terminal differentiation. Indeed, downregulation of either Runx1 or CBF beta protein level accelerates cell cycle exit and muscle terminal differentiation. Conversely, overexpression of CBF beta in myoblasts slows terminal differentiation. CBF interacts directly with the master myogenic transcription factor MyoD, preferentially in proliferating myoblasts, via Runx1 subunit. In addition, we show a preferential recruitment of Runx1 protein to MyoD target genes in proliferating myoblasts. The MyoD/CBF complex contains several chromatin modifying enzymes that inhibits MyoD activity, such as HDACs, Suv39h1 and HP1 beta. When overexpressed, CBF beta induced an inhibition of activating histone modification marks concomitant with an increase in repressive modifications at MyoD target promoters. Conclusions/Significance: Taken together, our data show a new role for Runx1/CBF beta in the control of the proliferation/differentiation in skeletal myoblasts.	CNRS, Inst Andre Lwoff, FRE2944, Villejuif, France; Univ Paris 11, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Philipot, O (corresponding author), CNRS, Epigenet & Destin Cellulaire UMR7216, Paris, France.	slimane.aitsiali@univ-paris-diderot.fr			Association Francaise contre les Myopathies (AFM); Fondation Bettencourt-Schueller; Agence Nationale de la Recherche (ANR); Ligue Nationale contre le Cancer; Association pour la Recherche sur le Cancer (ARC); CNRS; Universite Paris-Sud; Universite Paris Diderot; Ministere de la Recherche; "Programme franco-algerien de formation superieure en France''	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Bettencourt-Schueller; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Sud; Universite Paris Diderot; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); "Programme franco-algerien de formation superieure en France''	This work was supported by the Association Francaise contre les Myopathies (AFM); the Fondation Bettencourt-Schueller; the Agence Nationale de la Recherche (ANR); the Ligue Nationale contre le Cancer; the Association pour la Recherche sur le Cancer (ARC), the CNRS; the Universite Paris-Sud and the Universite Paris Diderot. PO was recipient of fellowships from the Ministere de la Recherche and the ARC. AO was recipient of a fellowship from the "Programme franco-algerien de formation superieure en France''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Andreu N, 2006, J HUM GENET, V51, P92, DOI 10.1007/s10038-005-0328-7; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Britos-Bray M, 1998, BLOOD, V92, P4344, DOI 10.1182/blood.V92.11.4344.423a01_4344_4352; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Cao WS, 1998, J BIOL CHEM, V273, P31534, DOI 10.1074/jbc.273.47.31534; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chiba N, 1997, ONCOGENE, V14, P2543, DOI 10.1038/sj.onc.1201109; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gersbach CA, 2004, EXP CELL RES, V300, P406, DOI 10.1016/j.yexcr.2004.07.031; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hewitt J, 2008, ENDOCRINOLOGY, V149, P3698, DOI 10.1210/en.2007-1556; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Ito H, 2001, EXP CELL RES, V266, P213, DOI 10.1006/excr.2001.5220; Komaki M, 2004, J CELL SCI, V117, P1457, DOI 10.1242/jcs.00965; Komori T, 1998, CURR OPIN GENET DEV, V8, P494, DOI 10.1016/S0959-437X(98)80123-8; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Levanon D, 1996, DNA CELL BIOL, V15, P175, DOI 10.1089/dna.1996.15.175; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal AK, 2006, EMBO J, V25, P3323, DOI 10.1038/sj.emboj.7601229; Meyers S, 1996, ONCOGENE, V13, P303; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; Raveh E, 2006, MECH DEVELOP, V123, P842, DOI 10.1016/j.mod.2006.08.002; Reed-Inderbitzin E, 2006, ONCOGENE, V25, P5777, DOI 10.1038/sj.onc.1209591; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133; Smith RC, 1997, CIRCULATION, V96, P1899, DOI 10.1161/01.CIR.96.6.1899; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Taniuchi I, 2004, ONCOGENE, V23, P4341, DOI 10.1038/sj.onc.1207671; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wotton SF, 2004, ONCOGENE, V23, P5476, DOI 10.1038/sj.onc.1207729; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang LS, 2008, BLOOD, V111, P1193, DOI 10.1182/blood-2007-08-109702; ZHU XJ, 1994, MOL CELL BIOL, V14, P8051, DOI 10.1128/MCB.14.12.8051	59	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9425	10.1371/journal.pone.0009425	http://dx.doi.org/10.1371/journal.pone.0009425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195544	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300013
J	Watve, MM; Dahanukar, N; Watve, MG				Watve, Mukta M.; Dahanukar, Neelesh; Watve, Milind G.			Sociobiological Control of Plasmid Copy Number in Bacteria	PLOS ONE			English	Article							CONJUGATIVE TRANSFER; REPLICATION; EVOLUTION; MAINTENANCE; RESISTANCE; MECHANISMS; SELECTION; HOST	All genes critical for plasmid replication regulation are located on the plasmid rather than on the host chromosome. It is possible therefore that there can be copy-up "cheater'' mutants. In spite of this possibility, low copy number plasmids appear to exist stably in host populations. We examined this paradox using a multilevel selection model. Simulations showed that, a slightly higher copy number mutant could out-compete the wild type. Consequently, another mutant with still higher copy number could invade the first invader. However, the realized benefit of increasing intra-host fitness was saturating whereas that of inter-host fitness was exponential. As a result, above a threshold, intra-host selection was overcompensated by inter-host selection and the low copy number wild type plasmid could back invade a very high copy number plasmid. This led to a rock-paper-scissor (RPS) like situation that allowed the coexistence of plasmids with varied copy numbers. Furthermore, another type of cheater that had lost the genes required for conjugation but could hitchhike on a conjugal plasmid, could further reduce the advantage of copy-up mutants. These sociobiological interactions may compliment molecular mechanisms of replication regulation in stabilizing the copy numbers.	[Watve, Mukta M.; Dahanukar, Neelesh; Watve, Milind G.] Indian Inst Sci Educ & Res, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, MM (corresponding author), Indian Inst Sci Educ & Res, Pune, Maharashtra, India.	milind@iiserpune.ac.in	Dahanukar, Neelesh/B-2816-2012	Dahanukar, Neelesh/0000-0001-7162-9023				Abhyankar MM, 2004, J BIOL CHEM, V279, P6711, DOI 10.1074/jbc.M312052200; Acebo P, 1996, FEMS MICROBIOL LETT, V140, P85; Andrup L, 1998, PLASMID, V40, P30, DOI 10.1006/plas.1998.1346; Bergstrom CT, 2000, GENETICS, V155, P1505; CHATTORAJ D, 1984, P NATL ACAD SCI-BIOL, V81, P6456, DOI 10.1073/pnas.81.20.6456; Corchero JL, 1998, BIOTECHNOL BIOENG, V58, P625, DOI 10.1002/(SICI)1097-0290(19980620)58:6<625::AID-BIT8>3.3.CO;2-1; Dahlberg C, 2003, GENETICS, V165, P1641; Das N, 2005, P NATL ACAD SCI USA, V102, P2856, DOI 10.1073/pnas.0409790102; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dionisio F, 2005, BIOL LETT-UK, V1, P250, DOI 10.1098/rsbl.2004.0275; FLETT F, 1981, J GEN MICROBIOL, V125, P123; FRETER R, 1983, INFECT IMMUN, V39, P60, DOI 10.1128/IAI.39.1.60-84.1983; GELDER LD, 2007, MICROBIOL, V153, P452; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Lili LN, 2007, GENETICS, V177, P399, DOI 10.1534/genetics.107.077420; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Paulsson J, 2002, GENETICS, V161, P1373; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; PROJAN SJ, 1987, J BACTERIOL, V169, P5131, DOI 10.1128/jb.169.11.5131-5139.1987; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Smith MA, 1998, CAN J MICROBIOL, V44, P351, DOI 10.1139/cjm-44-4-351; Summers D.K., 1996, BIOL PLASMIDS; Udo EE, 1997, ANTIMICROB AGENTS CH, V41, P693, DOI 10.1128/AAC.41.3.693; Velmurugan S, 2003, J BIOSCIENCES, V28, P623, DOI 10.1007/BF02703338; WILLIAMS PA, 2004, MICROBIOL TODAY, V31, P168; Yarmolinsky MB, 2000, MOL MICROBIOL, V38, P1, DOI 10.1046/j.1365-2958.2000.02127.x; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003	33	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9328	10.1371/journal.pone.0009328	http://dx.doi.org/10.1371/journal.pone.0009328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195362	gold, Green Submitted, Green Published			2022-12-27	WOS:000274924200006
J	Takano, Y; Takahashi, N; Tanaka, D; Hironaka, N				Takano, Yuji; Takahashi, Nobuaki; Tanaka, Daisuke; Hironaka, Naoyuki			Big Losses Lead to Irrational Decision-Making in Gambling Situations: Relationship between Deliberation and Impulsivity	PLOS ONE			English	Article							SENSATION-SEEKING; COCAINE ABUSERS; DELAYED REWARDS; FRONTAL-CORTEX; PERSONALITY; IMPAIRMENT; BEHAVIOR; ALCOHOL; ANXIETY; MODEL	In gambling situations, we found a paradoxical reinforcing effect of high-risk decision-making after repeated big monetary losses. The computerized version of the Iowa Gambling Task (Bechara et al., 2000), which contained six big loss cards in deck B', was conducted on normal healthy college students. The results indicated that the total number of selections from deck A' and deck B' decreased across trials. However, there was no decrease in selections from deck B'. Detailed analysis of the card selections revealed that some people persisted in selecting from the "risky'' deck B' as the number of big losses increased. This tendency was prominent in self-rated deliberative people. However, they were implicitly impulsive, as revealed by the matching familiar figure test. These results suggest that the gap between explicit deliberation and implicit impulsivity drew them into pathological gambling.	[Takano, Yuji; Takahashi, Nobuaki; Hironaka, Naoyuki] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, SHIMOJO Implicit Brain Funct Project, Atsugi, Kanagawa, Japan; [Tanaka, Daisuke] Tottori Univ, Fac Reg Sci, Dept Reg Educ, Tottori 680, Japan	Japan Science & Technology Agency (JST); Tottori University	Takano, Y (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol, SHIMOJO Implicit Brain Funct Project, Atsugi, Kanagawa, Japan.	ytakano@shimojo.jst.go.jp		Takano, Yuji/0000-0001-8624-6922	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Japan Science and Technology Agency. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adida M, 2008, BIPOLAR DISORD, V10, P829, DOI 10.1111/j.1399-5618.2008.00618.x; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bickel WK, 1999, PSYCHOPHARMACOLOGY, V146, P447, DOI 10.1007/PL00005490; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; CARRILLODELAPENA MT, 1993, PERCEPT MOTOR SKILL, V77, P567, DOI 10.2466/pms.1993.77.2.567; Chiu YC, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-37; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Costa P.T., 1985, NEO PERSONALITY INVE; Cote Denis, 2003, J Gambl Stud, V19, P433, DOI 10.1023/A:1026384011003; COVENTRY KR, 1993, ADDICTION, V88, P541, DOI 10.1111/j.1360-0443.1993.tb02061.x; Crean JP, 2000, EXP CLIN PSYCHOPHARM, V8, P155, DOI 10.1037/1064-1297.8.2.155; DAVIDSON WB, 1984, J PERS ASSESS, V48, P478, DOI 10.1207/s15327752jpa4805_4; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Evans CEY, 2004, BRAIN COGNITION, V54, P240, DOI 10.1016/j.bandc.2004.02.022; Fernandez-Aranda F, 2008, PSYCHIAT RES, V157, P147, DOI 10.1016/j.psychres.2007.02.011; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gonzalez R, 2007, J CLIN EXP NEUROPSYC, V29, P155, DOI 10.1080/13803390600582446; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Iwata N, 1998, PSYCHOL REP, V82, P651, DOI 10.2466/PR0.82.2.651-656; KAGAN J, 1964, PSYCHOL MONOGR, V78, P1; Kelly TH, 2006, PSYCHOPHARMACOLOGY, V189, P17, DOI 10.1007/s00213-006-0487-z; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Maner JK, 2006, BEHAV THER, V37, P181, DOI 10.1016/j.beth.2005.11.003; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Morgan MJ, 1998, NEUROPSYCHOPHARMACOL, V19, P252, DOI 10.1016/S0893-133X(98)00012-8; Haaland VO, 2007, J INT NEUROPSYCH SOC, V13, P699, DOI 10.1017/S1355617707070890; Petry NM, 2002, PSYCHOPHARMACOLOGY, V162, P425, DOI 10.1007/s00213-002-1115-1; Poikolainen K, 2000, ALCOHOL ALCOHOLISM, V35, P190, DOI 10.1093/alcalc/35.2.190; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; Schilt T, 2009, PSYCHOPHARMACOLOGY, V203, P519, DOI 10.1007/s00213-008-1398-y; Shimonaka Y., 1998, JAPANESE J PERSONAL, V6, P138, DOI [10.2132/jjpjspp.6.2_138, DOI 10.2132/JJPJSPP.6.2_138]; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; Smoski MJ, 2008, J BEHAV THER EXP PSY, V39, P567, DOI 10.1016/j.jbtep.2008.01.004; SONUGABARKE EJS, 1994, J CHILD PSYCHOL PSYC, V35, P1247, DOI 10.1111/j.1469-7610.1994.tb01232.x; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; Taylor CT, 2008, J ANXIETY DISORD, V22, P868, DOI 10.1016/j.janxdis.2007.09.001; TERASAKI M, 1988, PERS INDIV DIFFER, V9, P87, DOI 10.1016/0191-8869(88)90033-5; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004; YAMAGUCHI M, 2007, JAPANESE J RES EMOTI, V14, P129; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	44	14	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9368	10.1371/journal.pone.0009368	http://dx.doi.org/10.1371/journal.pone.0009368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SV	20186323	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000011
J	Croy, I; Schellong, J; Gerber, J; Joraschky, P; Iannilli, E; Hummel, T				Croy, Ilona; Schellong, Julia; Gerber, Johannes; Joraschky, Peter; Iannilli, Emilia; Hummel, Thomas			Women with a History of Childhood Maltreatment Exhibit more Activation in Association Areas Following Non-Traumatic Olfactory Stimuli: A fMRI Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE CORTEX; CEREBRAL-BLOOD-FLOW; ODOR IDENTIFICATION; SYMPTOM PROVOCATION; TRAUMATIC MEMORIES; WORKING-MEMORY; NORMATIVE DATA; SEXUAL-ABUSE; PTSD	Background: The aim of this study was investigating how women with a history of childhood maltreatment (CM) process non-threatening and non-trauma related olfactory stimuli. The focus on olfactory perception is based on the overlap of brain areas often proposed to be affected in CM patients and the projection areas of the olfactory system, including the amygdala, orbitofrontal cortex, insula and hippocampus. Methods: Twelve women with CM and 10 controls participated in the study. All participants were, or have been, patients in a psychosomatic clinic. Participants underwent a fMRI investigation during olfactory stimulation with a neutral (coffee) and a pleasant (peach) odor. Furthermore, odor threshold and odor identification (Sniffin' Sticks) were tested. Principal Findings: Both groups showed normal activation in the olfactory projection areas. However, in the CM-group we found additionally enhanced activation in multiple, mainly neocortical, areas that are part of those involved in associative networks. These include the precentral frontal lobe, inferior and middle frontal structures, posterior parietal lobe, occipital lobe, and the posterior cingulate cortex. Conclusions: The results indicate that in this group of patients, CM was associated with an altered processing of olfactory stimuli, but not development of a functional olfactory deficit. This complements other studies on CM insofar as we found the observed pattern of enhanced activation in associative and emotional regions even following non-traumatic olfactory cues.	[Croy, Ilona; Schellong, Julia; Joraschky, Peter] Univ Dresden, Sch Med, Dept Psychosomat Therapy, Dresden, Germany; [Croy, Ilona; Iannilli, Emilia; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany; [Gerber, Johannes] Univ Dresden, Sch Med, Dept Neuroradiol, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden	Croy, I (corresponding author), Univ Dresden, Sch Med, Dept Psychosomat Therapy, Dresden, Germany.	ilona.croy@tu-dresden.de	Gerber, Johannes/U-4918-2019; Iannilli, Emilia/H-6776-2019	Gerber, Johannes/0000-0001-7465-8700; Iannilli, Emilia/0000-0001-6871-3769; Croy, Ilona/0000-0002-0361-5559	University of Dresden Medical School	University of Dresden Medical School	This work was supported by a grant from the University of Dresden Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Beck A.T., 1987, BECK DEPRESSION INVE; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2003, NEUROSCI BIOBEHAV R, V27, P103, DOI 10.1016/S0149-7634(03)00013-7; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Fonagy P, 1996, J CONSULT CLIN PSYCH, V64, P22, DOI 10.1037/0022-006X.64.1.22; Gast U, 2001, DTSCH BEARBEITUNG CH; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Grawe K., 2004, NEUROPSYCHOTHERAPIE; GREENLEE JDW, 2004, FUNCTIONAL CONNECTIO, P1153; Hautzinger M., 1995, BECK DEPRESSIONS INV; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Liberzon I, 2003, STRESS, V6, P151, DOI 10.1080/1025389031000136242; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; MAERCKER A, 2003, ANGSTDIAGNOSTIK; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Osaka M, 2003, NEUROIMAGE, V18, P789, DOI 10.1016/S1053-8119(02)00032-0; Savic I, 1997, ARCH NEUROL-CHICAGO, V54, P162, DOI 10.1001/archneur.1997.00550140038010; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Sobel N., 2003, HDB OLFACTION GUSTAT; Talairach J., 1988, COPLANAR STEREOTAXIC; Vermetten E, 2006, AM J PSYCHIAT, V163, P630, DOI 10.1176/appi.ajp.163.4.630; Vermetten E, 2007, PSYCHOPHARMACOL BULL, V40, P8; WENIGER G, 2008, AMYGDALA HIPPOCAMPAL, P281; Wittchen HU, 1999, GESUNDHEITSWESEN, V61, pS216; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; ZATORRE RJ, 1991, BRAIN, V114, P71; Zubieta JK, 1999, J PSYCHIAT RES, V33, P259, DOI 10.1016/S0022-3956(98)00060-0	45	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9362	10.1371/journal.pone.0009362	http://dx.doi.org/10.1371/journal.pone.0009362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179758	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923900022
J	Parlakian, A; Gomaa, I; Solly, S; Arandel, L; Mahale, A; Born, G; Marazzi, G; Sassoon, D				Parlakian, Ara; Gomaa, Iman; Solly, Sounkary; Arandel, Ludovic; Mahale, Alka; Born, Gustav; Marazzi, Giovanna; Sassoon, David			Skeletal Muscle Phenotypically Converts and Selectively Inhibits Metastatic Cells in Mice	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; A3 ADENOSINE RECEPTOR; MELANOMA-CELLS; MALIGNANT-MELANOMA; STEM-CELLS; CANCER METASTASIS; TRANSFORMATION EFFECTOR; ORGAN MICROENVIRONMENT; CUTANEOUS MELANOMA; ADHESION MOLECULE	Skeletal muscle is rarely a site of malignant metastasis; the molecular and cellular basis for this rarity is not understood. We report that myogenic cells exert pronounced effects upon co-culture with metastatic melanoma (B16-F10) or carcinoma (LLC1) cells including conversion to the myogenic lineage in vitro and in vivo, as well as inhibition of melanin production in melanoma cells coupled with cytotoxic and cytostatic effects. No effect is seen with non-tumorigenic cells. Tumor suppression assays reveal that the muscle-mediated tumor suppressor effects do not generate resistant clones but function through the down-regulation of the transcription factor MiTF, a master regulator of melanocyte development and a melanoma oncogene. Our findings point to skeletal muscle as a source of therapeutic agents in the treatment of metastatic cancers.	[Parlakian, Ara; Gomaa, Iman; Solly, Sounkary; Arandel, Ludovic; Marazzi, Giovanna; Sassoon, David] Univ Paris 06, INSERM, UMR S 787, Myol Grp, Paris, France; [Born, Gustav] Univ London, William Harvey Res Inst, London, England; [Mahale, Alka] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; Queen Mary University London; Icahn School of Medicine at Mount Sinai	Parlakian, A (corresponding author), Univ Paris 06, INSERM, UMR S 787, Myol Grp, Paris, France.	david.a.sassoon@gmail.com	SASSOON, David A/G-2502-2013	SASSOON, David A/0000-0001-6074-048X; Gomaa, Iman/0000-0003-0295-2518; Marazzi, giovanna/0000-0002-5388-1038; ARA, PARLAKIAN/0000-0002-0928-2185	National Institutes of Health [PO1 CA80058]; French Ministry of Research 'Chaire d'Excellence'; Weston Foundation Fellowship; Association Francaise contre les Myopathies (AFM); NATIONAL CANCER INSTITUTE [P01CA080058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research 'Chaire d'Excellence'; Weston Foundation Fellowship; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (National Cancer Institute PO1 CA80058) and the French Ministry of Research 'Chaire d'Excellence' to D. S. A. P. is the recipient of a Weston Foundation Fellowship. The Myology Group is the beneficiary of a Strategic Plan Support from the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou G, 2000, ONCOLOGY-BASEL, V58, P83, DOI 10.1159/000012083; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bar-Yehuda S, 2001, NEOPLASIA, V3, P125, DOI 10.1038/sj.neo.7900138; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; BOYLAN MO, 1991, J CELL BIOCHEM, V46, P199, DOI 10.1002/jcb.240460303; Brooks SV, 2003, ADV PHYSIOL EDUC, V27, P171, DOI [10.1152/advan.00025.2003, 10.1152/advan.2003.27.4.171]; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; BYSTRYN JC, 1987, ARCH DERMATOL, V123, P1053, DOI 10.1001/archderm.123.8.1053; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Constant JS, 2000, WOUND REPAIR REGEN, V8, P353, DOI 10.1046/j.1524-475x.2000.00353.x; CRISSMAN JD, 1986, PATHOL ANNU, V21, P29; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Djaldetti M, 1996, CLIN EXP METASTAS, V14, P189; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Ehrhardt J, 2005, CURR OPIN NEUROL, V18, P548, DOI 10.1097/01.wco.0000177382.62156.82; Ewing J., 1928, METASTASIS NEOPLASTI; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; FIDLER IJ, PRINCIPLES CANC BIOL; FIGARELLABRANGER D, 1990, J NEUROL SCI, V98, P21, DOI 10.1016/0022-510X(90)90179-Q; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Fishman P, 1998, CANCER RES, V58, P3181; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GREIG RG, 1986, CANCER METAST REV, V5, P3, DOI 10.1007/BF00049527; Grichnik JM, 2006, J INVEST DERMATOL, V126, P1214, DOI 10.1038/sj.jid.5700240; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Herring CL, 1998, CLIN ORTHOP RELAT R, P272; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Inoue-Narita T, 2008, CANCER RES, V68, P5760, DOI 10.1158/0008-5472.CAN-08-0889; Jackson KA, 2004, STEM CELLS, V22, P180, DOI 10.1634/stemcells.22-2-180; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; KIZAKI H, 1988, J IMMUNOL, V141, P1652; Klein CA, 2004, CELL CYCLE, V3, P29; KLEIN CA, 2008, EUR J CANC; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Luo CH, 2002, CHINESE MED J-PEKING, V115, P1645; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; MOULY V, 1993, NEUROMUSCULAR DISORD, V3, P371, DOI 10.1016/0960-8966(93)90080-4; Nakamura K, 2002, LIFE SCI, V70, P791, DOI 10.1016/S0024-3205(01)01454-0; NETLAND PA, 1984, SCIENCE, V224, P1113, DOI 10.1126/science.6372098; NETLAND PA, 1985, J CELL BIOL, V101, P720, DOI 10.1083/jcb.101.3.720; NORDLUND JJ, 1983, J AM ACAD DERMATOL, V9, P689, DOI 10.1016/S0190-9622(83)70182-9; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Reilly FM, 2001, J AM ACAD DERMATOL, V45, P414, DOI 10.1067/mjd.2001.117526; Obata H, 2002, CLIN ORTHOP RELAT R, P212; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Olie RA, 2001, DRUG RESIST UPDATE, V4, P9, DOI 10.1054/drup.2001.0181; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Plaza JA, 2008, CANCER-AM CANCER SOC, V112, P193, DOI 10.1002/cncr.23151; Plummer RS, 2008, MODERN PATHOL, V21, P525, DOI 10.1038/modpathol.3801019; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; POSTE G, 1980, CANCER RES, V40, P1636; Pouyssegur J, 2001, Novartis Found Symp, V240, P186; Rambow F, 2008, PIGM CELL MELANOMA R, V21, P147, DOI 10.1111/j.1755-148X.2008.00442.x; Razak Albiruni Ryan Abdul, 2007, MedGenMed, V9, P20; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Salti GI, 2000, CANCER RES, V60, P5012; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Schriek G, 2005, MELANOMA RES, V15, P225, DOI 10.1097/00008390-200508000-00001; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; SEELY S, 1980, MED HYPOTHESES, V6, P133, DOI 10.1016/0306-9877(80)90079-1; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SUDO A, 1993, CLIN ORTHOP RELAT R, P213; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wang E, 2006, J INVEST DERMATOL, V126, P1372, DOI 10.1038/sj.jid.5700193; WEISS L, 1989, CELL BIOPHYS, V14, P187, DOI 10.1007/BF02797133; Willis RA, 1973, SPREAD TUMOURS HUMAN, P279; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465; ZARBL H, 1991, ENVIRON HEALTH PERSP, V93, P83, DOI 10.2307/3431174; Zhang WH, 2006, NEOPLASIA, V8, P543, DOI 10.1593/neo.05655; Zhao Wanzhou, 2001, Cancer Letters, V162, pS49, DOI 10.1016/S0304-3835(00)00656-X; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	102	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9299	10.1371/journal.pone.0009299	http://dx.doi.org/10.1371/journal.pone.0009299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174581	Green Published, Green Submitted, gold			2022-12-27	WOS:000274654700023
J	Brolund, A; Sundqvist, M; Kahlmeter, G; Grape, M				Brolund, Alma; Sundqvist, Martin; Kahlmeter, Gunnar; Grape, Malin			Molecular Characterisation of Trimethoprim Resistance in Escherichia coli and Klebsiella pneumoniae during a Two Year Intervention on Trimethoprim Use	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ANTIMICROBIAL RESISTANCE; GENE CASSETTES; DFR GENES; SULFONAMIDE RESISTANCE; INTEGRONS; SUSCEPTIBILITY; PREVALENCE; PLASMIDS; BACTERIA	Background: Trimethoprim resistance is increasing in Enterobacteriaceae. In 2004-2006 an intervention on trimethoprim use was conducted in Kronoberg County, Sweden, resulting in 85% reduction in trimethoprim prescriptions. We investigated the distribution of dihydrofolate reductase (dfr) genes and integrons in Escherichia coli and Klebsiella pneumoniae and the effect of the intervention on this distribution. Methodology/Principal Findings: Consecutively isolated E. coli (n = 320) and K. pneumoniae (n = 54) isolates phenotypicaly resistant to trimethoprim were studied. All were investigated for the presence of dfrA1, dfrA5, dfrA7, dfrA8, dfrA12, dfrA14, dfrA17 and integrons class I and II. Isolates negative for the seven dfr genes (n = 12) were also screened for dfr2d, dfrA3, dfrA9, dfrA10, dfrA24 and dfrA26. These genes accounted for 96% of trimethoprim resistance in E. coli and 69% in K. pneumoniae. The most prevalent was dfrA1 in both species. This was followed by dfrA17 in E. coli which was only found in one K. pneumoniae isolate. Class I and II Integrons were more common in E. coli (85%) than in K. pneumoniae (57%). The distribution of dfr-genes did not change during the course of the 2-year intervention. Conclusions/Significance: The differences observed between the studied species in terms of dfr gene and integron prevalence indicated a low rate of dfr gene transfer between these two species and highlighted the possible role of narrow host range plasmids in the spread of trimethoprim resistance. The stability of dfr genes, despite large changes in the selective pressure, indirectly suggests a low fitness cost of dfr gene carriage.	[Brolund, Alma; Grape, Malin] Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sundqvist, Martin; Kahlmeter, Gunnar] Cent Hosp Vaxjo, Dept Clin Microbiol, Vaxjo, Sweden; [Sundqvist, Martin] Uppsala Univ, Dept Med Sci, Div Infect Dis, Uppsala, Sweden; [Kahlmeter, Gunnar] Uppsala Univ, Dept Med Sci, Div Clin Bacteriol, Uppsala, Sweden	Karolinska Institutet; Uppsala University; Uppsala University	Brolund, A (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	alma.brolund@smi.se			Research and Development Unit; Kronoberg County Council; Scandinavian Society of Antimicrobial Chemotherapy	Research and Development Unit; Kronoberg County Council; Scandinavian Society of Antimicrobial Chemotherapy	This work was partly financed by nonrestricted grants from the Research and Development Unit, Kronoberg County Council and The Scandinavian Society of Antimicrobial Chemotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram Mohammed, 2007, Ann Clin Microbiol Antimicrob, V6, P4, DOI 10.1186/1476-0711-6-4; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Butler CC, 2006, BRIT J GEN PRACT, V56, P686; Dionisio F, 2002, GENETICS, V162, P1525; Grape M, 2007, CLIN MICROBIOL INFEC, V13, P1112, DOI 10.1111/j.1469-0691.2007.01807.x; Grape M, 2007, ANTIMICROB AGENTS CH, V51, P1863, DOI 10.1128/AAC.01273-06; Grape M, 2005, CLIN MICROBIOL INFEC, V11, P185, DOI 10.1111/j.1469-0691.2004.01059.x; HUOVINEN P, 1995, ANTIMICROB AGENTS CH, V39, P279, DOI 10.1128/AAC.39.2.279; Joneberg J, 2003, INT J ANTIMICROB AG, V21, P525, DOI 10.1016/S0924-8579(03)00053-0; Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P128, DOI 10.1093/jac/dkg280; KARAH N, 2008, 18 ECCMID BARC; Kerrn MB, 2002, J ANTIMICROB CHEMOTH, V50, P513, DOI 10.1093/jac/dkf164; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; OLSSONLILJEQUIS.B, 2008, REPORT SWEDISH ANTIM; Randrianirina F, 2007, J ANTIMICROB CHEMOTH, V59, P309, DOI 10.1093/jac/dkl466; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; Sundqvist M, 2009, J ANTIMICROB CHEMOTH; White PA, 2000, FEMS MICROBIOL LETT, V182, P265, DOI 10.1111/j.1574-6968.2000.tb08906.x; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Yu HS, 2004, J ANTIMICROB CHEMOTH, V53, P445, DOI 10.1093/jac/dkh097	24	54	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9233	10.1371/journal.pone.0009233	http://dx.doi.org/10.1371/journal.pone.0009233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169085	gold, Green Submitted, Green Published			2022-12-27	WOS:000274590500015
J	Barth, M; Schultze, M; Schuster, CM; Strauss, R				Barth, Martin; Schultze, Michael; Schuster, Christoph M.; Strauss, Roland			Circadian Plasticity in Photoreceptor Cells Controls Visual Coding Efficiency in Drosophila melanogaster	PLOS ONE			English	Article							LIGHT-INDUCED DEGRADATION; OPTIC LOBE; LAMINA GANGLIONARIS; RHYTHMIC CHANGES; CLOCKS; OSCILLATOR; TIMELESS; MUTANTS; NEURONS; GENE	In the fly Drosophila melanogaster, neuronal plasticity of synaptic terminals in the first optic neuropil, or lamina, depends on early visual experience within a critical period after eclosion [1]. The current study revealed two additional and parallel mechanisms involved in this type of synaptic terminal plasticity. First, an endogenous circadian rhythm causes daily oscillations in the volume of photoreceptor cell terminals. Second, daily visual experience precisely modulates the circadian time course and amplitude of the volume oscillations that the photoreceptor-cell terminals undergo. Both mechanisms are separable in their molecular basis. We suggest that the described neuronal plasticity in Drosophila ensures continuous optimal performance of the visual system over the course of a 24 h-day. Moreover, the sensory system of Drosophila cannot only account for predictable, but also for acute, environmental changes. The volumetric changes in the synaptic terminals of photoreceptor cells are accompanied by circadian and light-induced changes of presynaptic ribbons as well as extensions of epithelial glial cells into the photoreceptor terminals, suggesting that the architecture of the lamina is altered by both visual exposure and the circadian clock. Clock-mutant analysis and the rescue of PER protein rhythmicity exclusively in all R1-6 cells revealed that photoreceptor-cell plasticity is autonomous and sufficient to control visual behavior. The strength of a visually guided behavior, the optomotor turning response, co-varies with synaptic-terminal volume oscillations of photoreceptor cells when elicited at low light levels. Our results show that behaviorally relevant adaptive processing of visual information is performed, in part, at the level of visual input level.	[Barth, Martin; Schultze, Michael; Schuster, Christoph M.; Strauss, Roland] Max Planck Soc MPG, Friedrich Miescher Lab, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society	Barth, M (corresponding author), Max Planck Soc MPG, Friedrich Miescher Lab, Tubingen, Germany.	rstrauss@uni-mainz.de			Max-Planck-Society; BMBF [FKZ 0311855]; Deutsche Forschungsgemeinschaft	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by the Max-Planck-Society, a BMBF Biofuture grant to R. S. (FKZ 0311855), and a Deutsche Forschungsgemeinschaft grant to M. B. http://www.bmbf.de/, http://www.dfg.de/, http://www.mpg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth M, 1997, J NEUROSCI, V17, P1493; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BULT R, 1993, J BIOL RHYTHM, V8, P311, DOI 10.1177/074873049300800404; BURNSIDE B, 1993, EXP EYE RES, V57, P709, DOI 10.1006/exer.1993.1179; CHAMBERLAIN SC, 1979, SCIENCE, V206, P361, DOI 10.1126/science.482946; Cheng YZ, 1998, J NEUROSCI, V18, P741; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Giebultowicz JM, 2001, PHILOS T R SOC B, V356, P1791, DOI 10.1098/rstb.2001.0960; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; GOTZ KG, 1979, BIOL CYBERN, V35, P101, DOI 10.1007/BF00337435; Hausen K., 1984, PHOTORECEPTION VISIO, P523, DOI [10.1007/978-1-4613-2743-1_15, DOI 10.1007/978-1-4613-2743-1_15]; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Meinertzhagen IA, 1996, TRENDS NEUROSCI, V19, P285, DOI 10.1016/S0166-2236(96)10033-3; Meinertzhagen IA, 2001, ADV INSECT PHYSIOL, V28, P84, DOI 10.1016/S0065-2806(01)28009-6; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pyza E, 2004, J NEUROBIOL, V59, P205, DOI 10.1002/neu.10307; Pyza E, 1999, J NEUROBIOL, V40, P77, DOI 10.1002/(SICI)1097-4695(199907)40:1<77::AID-NEU7>3.0.CO;2-0; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Rybak J, 1997, EUR J NEUROSCI, V9, P319, DOI 10.1111/j.1460-9568.1997.tb01402.x; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P213, DOI 10.1007/BF01148463; SAINTMARIE RL, 1983, J NEUROCYTOL, V12, P243, DOI 10.1007/BF01148464; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; Strauss R, 2001, J COMP PHYSIOL A, V187, P617, DOI 10.1007/s003590100234; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; ZERR DM, 1990, J NEUROSCI, V10, P2749	37	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9217	10.1371/journal.pone.0009217	http://dx.doi.org/10.1371/journal.pone.0009217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169158	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474700011
J	Janic, B; Guo, AM; Iskander, ASM; Varma, NRS; Scicli, AG; Arbab, AS				Janic, Branislava; Guo, Austin M.; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Scicli, Alfonso G.; Arbab, Ali S.			Human Cord Blood-Derived AC133+Progenitor Cells Preserve Endothelial Progenitor Characteristics after Long Term In Vitro Expansion	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CD34(+) CELLS; DIFFERENTIATION; ANGIOGENESIS; NEOVASCULARIZATION; IDENTIFICATION; TRAFFICKING; HIERARCHY; CULTURES; AC133	Background: Stem cells/progenitors are central to the development of cell therapy approaches for vascular ischemic diseases. The crucial step in rescuing tissues from ischemia is improvement of vascularization that can be achieved by promoting neovascularization. Endothelial progenitor cells (EPCs) are the best candidates for developing such an approach due to their ability to self-renew, circulate and differentiate into mature endothelial cells (ECs). Studies showed that intravenously administered progenitors isolated from bone marrow, peripheral or cord blood home to ischemic sites. However, the successful clinical application of such transplantation therapy is limited by low quantities of EPCs that can be generated from patients. Hence, the ability to amplify the numbers of autologous EPCs by long term in vitro expansion while preserving their angiogenic potential is critically important for developing EPC based therapies. Therefore, the objective of this study was to evaluate the capacity of cord blood (CB)-derived AC133+ cells to differentiate, in vitro, towards functional, mature endothelial cells (ECs) after long term in vitro expansion.	[Janic, Branislava; Iskander, A. S. M.; Varma, Nadimpalli Ravi S.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Guo, Austin M.] Henry Ford Hosp, Dept Womens Hlth Serv, Detroit, MI 48202 USA; [Scicli, Alfonso G.] Henry Ford Hosp, Dept Eye Care Serv Res, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Janic, B (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	bjanic@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		National Institutes of Health (NIH) [R21NS058589, R21CA129801, R01CA122031]; American Heart Association [09SDG2230011]; NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was funded by National Institutes of Health (NIH) grant R21NS058589, National Institutes of Health (NIH) grant R21CA129801, National Institutes of Health (NIH) grant R01CA122031 and American Heart Association 09SDG2230011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bonanno G, 2007, TRANSFUSION, V47, P280, DOI 10.1111/j.1537-2995.2007.01104.x; Burciaga-Nava JA, 2009, IN VITRO CELL DEV-AN, V45, P15, DOI 10.1007/s11626-008-9146-5; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Duan Hua-Xin, 2008, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V16, P387; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Fibbe WE, 2001, ANN NY ACAD SCI, V938, P9; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Gehling UM, 2000, BLOOD, V95, P3106; Goussetis E, 2000, J HEMATOTH STEM CELL, V9, P827, DOI 10.1089/152581600750062255; Gross P, 2004, Rocz Akad Med Bialymst, V49, P174; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; HLADOVEC J, 1978, KLIN WOCHENSCHR, V56, P1033, DOI 10.1007/BF01476669; HLADOVEC J, 1978, PHYSIOL BOHEMOSLOV, V27, P140; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Kawamoto A, 2003, CIRCULATION, V107, P461, DOI 10.1161/01.CIR.0000046450.89986.50; Kawamoto A, 2001, CIRCULATION, V103, P634; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; Kuci S, 2008, CELL PROLIFERAT, V41, P12, DOI 10.1111/j.1365-2184.2007.00502.x; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Ma Gang, 2008, Zhonghua Zheng Xing Wai Ke Za Zhi, V24, P144; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moise KJ, 2005, OBSTET GYNECOL, V106, P1393, DOI 10.1097/01.AOG.0000188388.84901.e4; Neumuller J, 2006, HISTOCHEM CELL BIOL, V126, P649, DOI 10.1007/s00418-006-0201-6; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; RISAU W, 1988, DEVELOPMENT, V102, P471; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3; Senegaglia AC, 2008, REV BRAS CIR CARDIOV, V23, P467, DOI 10.1590/S0102-76382008000400003; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; SOWEMIMOCOKER SO, 1989, AM J HEMATOL, V31, P263, DOI 10.1002/ajh.2830310409; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; TERRANOVA VP, 1985, J CELL BIOL, V101, P2330, DOI 10.1083/jcb.101.6.2330; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Werner C, 2008, BIOCHEM BIOPH RES CO, V377, P331, DOI 10.1016/j.bbrc.2008.09.081; Yang C, 2004, THROMB HAEMOSTASIS, V91, P1202, DOI 10.1160/TH03-06-0378; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zangiacomi V, 2008, STEM CELLS DEV, V17, P1005, DOI 10.1089/scd.2007.0248	51	38	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9173	10.1371/journal.pone.0009173	http://dx.doi.org/10.1371/journal.pone.0009173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161785	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442800019
J	Zimmermann, B; Gesell, T; Chen, D; Lorenz, C; Schroeder, R				Zimmermann, Bob; Gesell, Tanja; Chen, Doris; Lorenz, Christina; Schroeder, Renee			Monitoring Genomic Sequences during SELEX Using High-Throughput Sequencing: Neutral SELEX	PLOS ONE			English	Article							RNA SECONDARY STRUCTURES; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; NONCODING RNAS; DINUCLEOTIDE; APTAMERS; BINDING; TRANSLATION; EXPRESSION; STABILITY	Background: SELEX is a well established in vitro selection tool to analyze the structure of ligand-binding nucleic acid sequences called aptamers. Genomic SELEX transforms SELEX into a tool to discover novel, genomically encoded RNA or DNA sequences binding a ligand of interest, called genomic aptamers. Concerns have been raised regarding requirements imposed on RNA sequences undergoing SELEX selection. Methodology/Principal Findings: To evaluate SELEX and assess the extent of these effects, we designed and performed a Neutral SELEX experiment omitting the selection step, such that the sequences are under the sole selective pressure of SELEX's amplification steps. Using high-throughput sequencing, we obtained thousands of full-length sequences from the initial genomic library and the pools after each of the 10 rounds of Neutral SELEX. We compared these to sequences obtained from a Genomic SELEX experiment deriving from the same initial library, but screening for RNAs binding with high affinity to the E. coli regulator protein Hfq. With each round of Neutral SELEX, sequences became less stable and changed in nucleotide content, but no sequences were enriched. In contrast, we detected substantial enrichment in the Hfq-selected set with enriched sequences having structural stability similar to the neutral sequences but with significantly different nucleotide selection. Conclusions/Significance: Our data indicate that positive selection in SELEX acts independently of the neutral selective requirements imposed on the sequences. We conclude that Genomic SELEX, when combined with high-throughput sequencing of positively and neutrally selected pools, as well as the gnomic library, is a powerful method to identify genomic aptamers.	[Zimmermann, Bob; Gesell, Tanja; Chen, Doris; Lorenz, Christina; Schroeder, Renee] Univ Vienna, Max F Perutz Labs, Dept Biochem, Vienna, Austria; [Gesell, Tanja] Med Univ Vienna, Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat Vienna, Vienna, Austria; [Gesell, Tanja] Univ Vet Med, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna	Zimmermann, B (corresponding author), Univ Vienna, Max F Perutz Labs, Dept Biochem, Vienna, Austria.	renee.schroeder@univie.ac.at		Chen, Doris/0000-0001-8835-0280; Gesell, Tanja/0000-0002-0733-7605	Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich	Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich	This work was supported by funding from the Bundesministerium fur Wissenschaft und Forschung program Genomforschung in Osterreich (http://www.gen-au.at/) [projects noncoding RNA and Bioinformatics Integration Network III to T.G., R.S. and Arndt von Haeseler, project RNomics to D.C.]; Wiener Wissenschafts-, Forschungs- and Technologiefonds(http://www.wwtf.at/) [to T.G. and Arndt von Haessler]; and Fonds zur Forderung der wissenschaftlichen Forschung (http://www.fwf.ac.at/) [W1207 RNA Biologie to B.Z. and 17 SFB to D.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; BORER PN, 1974, J MOL BIOL, V86, P843, DOI 10.1016/0022-2836(74)90357-X; CHEN JH, 1990, COMPUT APPL BIOSCI, V6, P7; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Gesell T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-248; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Hallegger M, 2006, RNA, V12, P1993, DOI 10.1261/rna.125506; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; LE SY, 1989, NUCLEIC ACIDS RES, V17, P6143, DOI 10.1093/nar/17.15.6143; LORENZ C, 2010, NUCL ACIDS IN PRESS; Lorenz C, 2006, NAT PROTOC, V1, P2204, DOI 10.1038/nprot.2006.372; Meyers LA, 2004, J MOL EVOL, V58, P681, DOI 10.1007/s00239-004-2590-2; R_Development_Core_Team, 2008, R FDN STAT COMP; Suess B, 2003, NUCLEIC ACIDS RES, V31, P1853, DOI 10.1093/nar/gkg285; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weigand JE, 2008, RNA, V14, P89, DOI 10.1261/rna.772408	24	62	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9169	10.1371/journal.pone.0009169	http://dx.doi.org/10.1371/journal.pone.0009169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161784	Green Published, gold			2022-12-27	WOS:000274442800015
J	Li, GQ; Wang, ZQ; Miskimen, KL; Zhang, Y; Tse, W; Bunting, KD				Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Zhang, Yi; Tse, William; Bunting, Kevin D.			Gab2 Promotes Hematopoietic Stem Cell Maintenance and Self-Renewal Synergistically with STAT5	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; BONE-MARROW; EXPRESSION; THROMBOPOIETIN; QUIESCENCE; CYTOKINE; DEFECTS; PATHWAY; SHP-2; RESPONSIVENESS	Background: Grb2-associated binding (Gab) adapter proteins play major roles in coordinating signaling downstream of hematopoietic cytokine receptors. In hematopoietic cells, Gab2 can modulate phosphatidylinositol-3 kinase and mitogen associated protein kinase activities and regulate the long-term multilineage competitive repopulating activity of hematopoietic stem cells (HSCs). Gab2 may also act in a linear pathway upstream or downstream of signal transducer and activator of transcription-5 (STAT5), a major positive regulator of HSC function. Therefore, we aimed to determine whether Gab2 and STAT5 function in hematopoiesis in a redundant or non-redundant manner. Methodology/Principal Findings: To do this we generated Gab2 mutant mice with heterozygous and homozygous deletions of STAT5. In heterozygous STAT5 mutant mice, deficiencies in HSC/multipotent progenitors were reflected by decreased long-term repopulating activity. This reduction in repopulation function was mirrored in the reduced growth response to early-acting cytokines from sorted double mutant c-Kit(+)Lin(-)Sca-1(+) (KLS) cells. Importantly, in non-ablated newborn mice, the host steady-state engraftment ability was impaired by loss of Gab2 in heterozygous STAT5 mutant background. Fetal liver cells isolated from homozygous STAT5 mutant mice lacking Gab2 showed significant reduction in HSC number (KLS CD150(+)CD48(-)), reduced HSC survival, and dramatic loss of self-renewal potential as measured by serial transplantation. Conclusions/Significance: These data demonstrate new functions for Gab2 in hematopoiesis in a manner that is non-redundant with STAT5. Furthermore, important synergy between STAT5 and Gab2 was observed in HSC self-renewal, which might be exploited to optimize stem cell-based therapeutics.	[Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Zhang, Yi; Tse, William; Bunting, Kevin D.] Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Li, Geqiang; Wang, Zhengqi; Miskimen, Kristy L.; Tse, William; Bunting, Kevin D.] Ctr Stem Cell & Regenerat Med, Cleveland, OH USA; [Bunting, Kevin D.] Case Comprehens Canc Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University	Li, GQ (corresponding author), Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA.	kdb10@case.edu			National Institutes of Health (NIH) [R01DK059380]; Center for Stem Cell and Regenerative Medicine; Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center [P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Stem Cell and Regenerative Medicine; Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) R01DK059380, http://www2.niddk.nih.gov/ (K. D. Bunting), The Center for Stem Cell and Regenerative Medicine, and the Flow Cytometry and Radiation Resources Core Facilities of the Case Comprehensive Cancer Center (P30CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, J IMMUNOL, V173, P3962, DOI 10.4049/jimmunol.173.6.3962; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Bradley HL, 2004, BLOOD, V103, P2965, DOI 10.1182/blood-2003-08-2963; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Bunting KD, 2002, BLOOD, V99, P479, DOI 10.1182/blood.V99.2.479; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Couldrey C, 2005, BLOOD, V105, P1476, DOI 10.1182/blood-2004-06-2302; Crouin C, 2001, FEBS LETT, V495, P148, DOI 10.1016/S0014-5793(01)02373-0; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; Liu G, 2007, EXP HEMATOL, V35, P1684, DOI 10.1016/j.exphem.2007.08.026; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Moon JJ, 2004, J BIOL CHEM, V279, P5520, DOI 10.1074/jbc.M308998200; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Shelburne CP, 2003, BLOOD, V102, P1290, DOI 10.1182/blood-2002-11-3490; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Wang ZQ, 2009, BLOOD, V113, P4856, DOI 10.1182/blood-2008-09-181107; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yu WM, 2002, BLOOD, V99, P2351, DOI 10.1182/blood.V99.7.2351; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang YD, 2007, J COMPUT NONLIN DYN, V2, P124, DOI 10.1115/1.2447190	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9152	10.1371/journal.pone.0009152	http://dx.doi.org/10.1371/journal.pone.0009152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161778	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442700016
J	Li, GL; Ma, J; Zhang, LX				Li, Guoliang; Ma, Jian; Zhang, Louxin			Greedy Selection of Species for Ancestral State Reconstruction on Phylogenies: Elimination Is Better than Insertion	PLOS ONE			English	Article							GENOMIC SEQUENCES; MAXIMUM PARSIMONY; CHARACTER STATES; EVOLUTION; INFERENCE; ACCURACY	Accurate reconstruction of ancestral character states on a phylogeny is crucial in many genomics studies. We study how to select species to achieve the best reconstruction of ancestral character states on a phylogeny. We first show that the marginal maximum likelihood has the monotonicity property that more taxa give better reconstruction, but the Fitch method does not have it even on an ultrametric phylogeny. We further validate a greedy approach for species selection using simulation. The validation tests indicate that backward greedy selection outperforms forward greedy selection. In addition, by applying our selection strategy, we obtain a set of the ten most informative species for the reconstruction of the genomic sequence of the so-called boreoeutherian ancestor of placental mammals. This study has broad relevance in comparative genomics and paleogenomics since limited research resources do not allow researchers to sequence the large number of descendant species required to reconstruct an ancestral sequence.	[Li, Guoliang] Genome Inst Singapore, Singapore, Singapore; [Ma, Jian] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Zhang, Louxin] Natl Univ Singapore, Dept Math, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore	Li, GL (corresponding author), Genome Inst Singapore, Singapore, Singapore.	matzlx@nus.edu.sg	Zhang, Louxin/M-4865-2016; Ma, Jian/A-9838-2008; Li, Guoliang/D-8014-2012	Zhang, Louxin/0000-0003-0260-824X; Ma, Jian/0000-0002-4202-5834; Li, Guoliang/0000-0003-1601-6640	ARF [R146-000-109-112]	ARF	The research was partially supported by the ARF grant R146-000-109-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA ML, 1984, MOL BIOL EVOL, V1, P442; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chindelevitch Leonid, 2006, Journal of Bioinformatics and Computational Biology, V4, P721, DOI 10.1142/S0219720006002168; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Elias I, 2007, J COMPUT BIOL, V14, P216, DOI 10.1089/cmb.2006.0101; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fischer M, 2009, J THEOR BIOL, V260, P290, DOI 10.1016/j.jtbi.2009.06.010; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Hall BG, 2006, P NATL ACAD SCI USA, V103, P5431, DOI 10.1073/pnas.0508991103; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JH, 1996, SYST BIOL, V45, P363, DOI 10.2307/2413570; Koshi JM, 1996, J MOL EVOL, V42, P313, DOI 10.1007/BF02198858; Kuang DH, 2006, P NATL ACAD SCI USA, V103, P14050, DOI 10.1073/pnas.0604717103; Li GL, 2008, SYST BIOL, V57, P647, DOI 10.1080/10635150802203898; Liberles DA., 2007, ANCESTRAL SEQUENCE R; Lucena B, 2005, SYST BIOL, V54, P693, DOI 10.1080/10635150590950344; MAAULIFFE JD, 2005, P NATL AM SCI US, V102, P7900; Maddison WP, 1995, SYST BIOL, V44, P474, DOI 10.2307/2413655; Mooers AO, 2004, SYST BIOL, V53, P809, DOI 10.1080/10635150490502595; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pardi F, 2005, PLOS GENET, V1, P672, DOI 10.1371/journal.pgen.0010071; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; PAULING L, 1963, ACTA CHEM SCAND, V17, P9, DOI 10.3891/acta.chem.scand.17s-0009; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Salisbury BA, 2001, SYST BIOL, V50, P557, DOI 10.1080/106351501750435103; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Schultz TR, 1996, EVOLUTION, V50, P504, DOI 10.1111/j.1558-5646.1996.tb03863.x; Steel M.A., 1999, ANN COMB, V3, P103; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tuller T, 2009, LECT N BIOINFORMAT, V5817, P164, DOI 10.1007/978-3-642-04744-2_14; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; YANG ZH, 1995, GENETICS, V141, P1641; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e8985	10.1371/journal.pone.0008985	http://dx.doi.org/10.1371/journal.pone.0008985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140213	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474400002
J	Yuen, DA; Connelly, KA; Advani, A; Liao, C; Kuliszewski, MA; Trogadis, J; Thai, K; Advani, SL; Zhang, Y; Kelly, DJ; Leong-Poi, H; Keating, A; Marsden, PA; Stewart, DJ; Gilbert, RE				Yuen, Darren A.; Connelly, Kim A.; Advani, Andrew; Liao, Christine; Kuliszewski, Michael A.; Trogadis, Judy; Thai, Kerri; Advani, Suzanne L.; Zhang, Yuan; Kelly, Darren J.; Leong-Poi, Howard; Keating, Armand; Marsden, Philip A.; Stewart, Duncan J.; Gilbert, Richard E.			Culture-Modified Bone Marrow Cells Attenuate Cardiac and Renal Injury in a Chronic Kidney Disease Rat Model via a Novel Antifibrotic Mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ACUTE TUBULAR INJURY; DIABETIC-NEPHROPATHY; TGF-BETA; ANGIOTENSIN-II; DIASTOLIC DYSFUNCTION; FIBROTIC RESPONSE; PROGENITOR CELLS; STROMAL CELLS; HUMAN HEART	Background: Most forms of chronic kidney disease are characterized by progressive renal and cardiac fibrosis leading to dysfunction. Preliminary evidence suggests that various bone marrow-derived cell populations have antifibrotic effects. In exploring the therapeutic potential of bone marrow derived cells in chronic cardio-renal disease, we examined the antifibrotic effects of bone marrow-derived culture modified cells (CMCs) and stromal cells (SCs). Methodology/Principal Findings: In vitro, CMC-conditioned medium, but not SC-conditioned medium, inhibited fibroblast collagen production and cell signalling in response to transforming growth factor-beta. The antifibrotic effects of CMCs and SCs were then evaluated in the 5/6 nephrectomy model of chronic cardio-renal disease. While intravascular infusion of 10(6) SCs had no effect, 10(6) CMCs reduced renal fibrosis compared to saline in the glomeruli (glomerulosclerosis index: 0.8 +/- 0.1 v 1.9 +/- 0.2 arbitrary units) and the tubulointersitium (% area type IV collagen: 1.2 +/- 0.3 v 8.4 +/- 2.0, p < 0.05 for both). Similarly, 10(6) CMCs reduced cardiac fibrosis compared to saline (% area stained with picrosirius red: 3.2 +/- 0.3 v 5.1 +/- 0.4, p < 0.05), whereas 10(6) SCs had no effect. Structural changes induced by CMC therapy were accompanied by improved function, as reflected by reductions in plasma creatinine (58 +/- 3 v 81 +/- 11 mu mol/L), urinary protein excretion (9x/41 v 646/41 mg/day), and diastolic cardiac stiffness (left ventricular end-diastolic pressure-volume relationship: 0.030 +/- 0.003 v 0.058 +/- 0.011 mm Hg/mu L, p < 0.05 for all). Despite substantial improvements in structure and function, only rare CMCs were present in the kidney and heart, whereas abundant CMCs were detected in the liver and spleen. Conclusions/Significance: Together, these findings provide the first evidence suggesting that CMCs, but not SCs, exert a protective action in cardio-renal disease and that these effects may be mediated by the secretion of diffusible anti-fibrotic factor(s).	[Yuen, Darren A.; Connelly, Kim A.; Advani, Andrew; Liao, Christine; Kuliszewski, Michael A.; Trogadis, Judy; Thai, Kerri; Advani, Suzanne L.; Leong-Poi, Howard; Marsden, Philip A.; Gilbert, Richard E.] Univ Toronto, St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst,Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Zhang, Yuan; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Keating, Armand] Univ Toronto, Princess Margaret Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Stewart, Duncan J.] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; St Vincent's Hospital Melbourne; University of Melbourne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital Research Institute	Yuen, DA (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Li Ka Shing Knowledge Inst,Keenan Res Ctr, Toronto, ON M5B 1W8, Canada.	richard.gilbert@utoronto.ca	Connelly, Kim A/S-5160-2017; Marsden, Philip A/B-1441-2012	Connelly, Kim A/0000-0002-1031-3137; Kelly, Darren/0000-0003-4850-3929	Canadian Institutes of Health Research (CIHR; Physicians' Services Incorporated Foundation of Ontario; KRESCENT; Heart and Stroke Foundation of Ontario; Canadian Diabetes Association.; Ministry of Research and Innovation, Ontario, Canada	Canadian Institutes of Health Research (CIHR(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation of Ontario; KRESCENT; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Diabetes Association.; Ministry of Research and Innovation, Ontario, Canada(Ministry of Research and Innovation, Ontario)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and the Physicians' Services Incorporated Foundation of Ontario. Dr. Yuen is supported by a KRESCENT postdoctoral fellowship. Dr. Gilbert is supported by a generous donation from George and Diane Mara. Dr. Connelly is supported by a Clinician Scientist award from the Heart and Stroke Foundation of Ontario. Dr. Advani is supported by a Clinician Scientist award from the Canadian Diabetes Association. Dr. Leong- Poi is supported by a Phase II Clinician Scientist Award from the Heart and Stroke Foundation of Ontario and an Early Researcher Award from the Ministry of Research and Innovation, Ontario, Canada. Dr. Keating holds the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation at the University Health Network and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, P NATL ACAD SCI USA, V104, P14448, DOI 10.1073/pnas.0703577104; Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Campbell AIM, 1999, AM J RESP CELL MOL, V21, P567, DOI 10.1165/ajrcmb.21.5.3640; Caplice NM, 2005, NAT CLIN PRACT CARD, V2, P37, DOI 10.1038/ncpcardio0073; Connelly KA, 2007, CARDIOVASC RES, V76, P280, DOI 10.1016/j.cardiores.2007.06.022; Connelly KA, 2006, AM J PHYSIOL-HEART C, V290, pH1699, DOI 10.1152/ajpheart.00577.2005; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutly AE, 2006, LAB INVEST, V86, P409, DOI 10.1038/labinvest.3700399; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gross ML, 2008, SEMIN DIALYSIS, V21, P308, DOI 10.1111/j.1525-139X.2008.00454.x; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kelly DJ, 2005, J AM SOC NEPHROL, V16, P1654, DOI 10.1681/ASN.2004070578; Kelly DJ, 2004, J AM SOC NEPHROL, V15, P2619, DOI 10.1097/01.ASN.0000139066.77892.04; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kupfahl C, 2000, CARDIOVASC RES, V46, P463, DOI 10.1016/S0008-6363(00)00037-7; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Lapointe N, 2002, J AM COLL CARDIOL, V39, P1692, DOI 10.1016/S0735-1097(02)01837-5; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lopez B, 2008, KIDNEY INT, V74, pS19, DOI 10.1038/ki.2008.512; Martin J, 2005, CARDIOVASC RES, V65, P694, DOI 10.1016/j.cardiores.2004.10.041; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Olfert ED, 1993, GUIDE CARE USE EXPT; Orlic D, 2001, ANN NY ACAD SCI, V938, P221; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; PARFREY PS, 1991, J AM SOC NEPHROL, V2, P2; Sakharova OV, 2001, CURR OPIN NEPHROL HY, V10, P727, DOI 10.1097/00041552-200111000-00001; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012; Wu LL, 1997, KIDNEY INT, V51, P1553, DOI 10.1038/ki.1997.214; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	57	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9543	10.1371/journal.pone.0009543	http://dx.doi.org/10.1371/journal.pone.0009543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209052	Green Published, gold			2022-12-27	WOS:000275197100022
J	Silver, KL; Zhong, K; Leke, RGF; Taylor, DW; Kain, KC				Silver, Karlee L.; Zhong, Kathleen; Leke, Rose G. F.; Taylor, Diane Wallace; Kain, Kevin C.			Dysregulation of Angiopoietins Is Associated with Placental Malaria and Low Birth Weight	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTRAUTERINE GROWTH RESTRICTION; PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; ENDOTHELIAL-CELLS; PRETERM DELIVERY; INFANT-MORTALITY; CEREBRAL MALARIA; FACTOR-ALPHA; PREGNANCY	Background: Placental malaria (PM) is associated with adverse pregnancy outcomes including low birth weight (LBW). However, the precise mechanisms by which PM induces LBW are poorly defined. Based on the essential role of angiopoietin (ANG)-1 and -2 in normal placental vascular development, we hypothesized that PM may result in the dysregulation of angiopoietins and thereby contribute to LBW outcomes. Methods and Findings: In a mouse model of PM, we show that Plasmodium berghei ANKA infection of pregnant mice resulted in dysregulated angiopoietin levels and fetal growth restriction. PM lead to decreased ANG-1, increased ANG-2, and an elevated ratio of ANG-2/ANG-1 in the placenta and the serum. These observations were extended to malaria-exposed pregnant women: In a study of primigravid women prospectively followed over the course of pregnancy, Plasmodium falciparum infection was associated with a decrease in maternal plasma ANG-1 levels (P = 0.031) and an increase in the ANG2: ANG-1 ratio (P = 0.048). ANG-1 levels recovered with successful treatment of peripheral parasitemia (P = 0.010). In a cross-sectional study of primigravidae at delivery, angiopoietin dysregulation was associated with PM (P = 0.002) and LBW (P = 0.041). Women with PM who delivered LBW infants had increased ANG-2: ANG-1 ratios (P = 0.002) compared to uninfected women delivering normal birth weight infants. Conclusions: These data support the hypothesis that dysregulation of angiopoietins is associated with PM and LBW outcomes, and suggest that ANG-1 and ANG-2 levels may be clinically informative biomarkers to identify P. falciparum-infected mothers at risk of LBW deliveries.	[Silver, Karlee L.; Zhong, Kathleen; Kain, Kevin C.] Univ Toronto, Univ Hlth Network, McLaughlin Ctr Mol Med, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada; [Leke, Rose G. F.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Taylor, Diane Wallace] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Taylor, Diane Wallace] Univ Hawaii, John A Burns Sch Med, Dept Trop Med, Honolulu, HI 96822 USA; [Kain, Kevin C.] Univ Toronto, Toronto Gen Hosp, Dept Med, Div Infect Dis,Trop Dis Unit, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Yaounde I; Georgetown University; University of Hawaii System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Silver, KL (corresponding author), Univ Toronto, Univ Hlth Network, McLaughlin Ctr Mol Med, McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada.	kevin.kain@uhn.on.ca		Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research (CIHR) [MT-13721]; CIHR Team Grant in Malaria (KCK); Genome Canada through the Ontario Genomics Institute (KCK); National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [5UO1AI43888]; CIHR Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI043888] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Team Grant in Malaria (KCK)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute (KCK)(Genome Canada); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR Canada Research Chair(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (MT-13721 (KCK)), CIHR Team Grant in Malaria (KCK) and Genome Canada through the Ontario Genomics Institute (KCK). Recruitment of women in Cameroon was supported by a National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (5UO1AI43888 (DWT)). KCK is supported as a CIHR Canada Research Chair, and KLS is supported by a CIHR Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APELSARID L, 2009, ARCH GYNECOL OBSTET; Arbeille P, 2003, PARASITOLOGY, V126, P513, DOI 10.1017/S0031182003003160; Babischkin JS, 2007, PLACENTA, V28, P212, DOI 10.1016/j.placenta.2006.02.003; BOLIN M, 2009, AM J HYPERTENS; Brabin BJ, 2005, J REPROD IMMUNOL, V65, P1, DOI 10.1016/j.jri.2004.09.006; CLARK IA, 1988, AM J TROP MED HYG, V39, P246, DOI 10.4269/ajtmh.1988.39.246; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Davison BB, 2006, J INFECT DIS, V194, P123, DOI 10.1086/504694; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Dunk C, 2000, AM J PATHOL, V156, P2185, DOI 10.1016/S0002-9440(10)65089-4; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyatt HL, 2001, T ROY SOC TROP MED H, V95, P569, DOI 10.1016/S0035-9203(01)90082-3; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Hirokoshi K, 2005, AM J HYPERTENS, V18, P1181, DOI 10.1016/j.amjhyper.2005.03.745; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kingdom JCP, 1997, PLACENTA, V18, P613, DOI 10.1016/S0143-4004(97)90000-X; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lackman F, 2001, AM J OBSTET GYNECOL, V184, P946, DOI 10.1067/mob.2001.111719; LEKE RFG, 2002, J CAMEROON ACAD SCI, V2, P203; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lucchi NW, 2006, PLACENTA, V27, P384, DOI 10.1016/j.placenta.2005.04.009; MacDorman M F, 1999, Natl Vital Stat Rep, V47, P1; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McElrath TF, 2008, AM J EPIDEMIOL, V168, P980, DOI 10.1093/aje/kwn202; Morken NH, 2006, AM J OBSTET GYNECOL, V195, P154, DOI 10.1016/j.ajog.2006.01.019; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Ong S, 2000, BEST PRACT RES CL OB, V14, P969, DOI 10.1053/beog.2000.0138; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Schiessl B, 2009, PLACENTA, V30, P79, DOI 10.1016/j.placenta.2008.10.004; Seval Y, 2008, PLACENTA, V29, P809, DOI 10.1016/j.placenta.2008.06.009; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Thevenon AD, 2009, INFECT IMMUN, V77, P1483, DOI 10.1128/IAI.01069-08; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2007, BJOG-INT J OBSTET GY, V114, P1427, DOI 10.1111/j.1471-0528.2007.01511.x; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4	59	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9481	10.1371/journal.pone.0009481	http://dx.doi.org/10.1371/journal.pone.0009481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208992	Green Published, gold, Green Submitted			2022-12-27	WOS:000274997100020
J	Androutsellis-Theotokis, A; Rueger, MA; Park, DM; Boyd, JD; Padmanabhan, R; Campanati, L; Stewart, CV; LeFranc, Y; Plenz, D; Walbridge, S; Lonser, RR; McKay, RDG				Androutsellis-Theotokis, Andreas; Rueger, Maria A.; Park, Deric M.; Boyd, Justin D.; Padmanabhan, Raji; Campanati, Loraine; Stewart, Craig V.; LeFranc, Yann; Plenz, Dietmar; Walbridge, Stuart; Lonser, Russell R.; McKay, Ronald D. G.			Angiogenic Factors Stimulate Growth of Adult Neural Stem Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; IN-VIVO; DENTATE GYRUS; PROGENITOR PROLIFERATION; MAMMALIAN FOREBRAIN; ISCHEMIC-STROKE; MOUSE BRAIN; NEUROGENESIS; NEURONS	Background: The ability to grow a uniform cell type from the adult central nervous system (CNS) is valuable for developing cell therapies and new strategies for drug discovery. The adult mammalian brain is a source of neural stem cells (NSC) found in both neurogenic and non-neurogenic zones but difficulties in culturing these hinders their use as research tools [1,2,3,4,5,6]. Methodology/Principal Findings: Here we show that NSCs can be efficiently grown in adherent cell cultures when angiogenic signals are included in the medium. These signals include both anti-angiogenic factors (the soluble form of the Notch receptor ligand, DII4) and pro-angiogenic factors (the Tie-2 receptor ligand, Angiopoietin 2). These treatments support the self renewal state of cultured NSCs and expression of the transcription factor Hes3, which also identifies the cancer stem cell population in human tumors. In an organotypic slice model, angiogenic factors maintain vascular structure and increase the density of dopamine neuron processes. Conclusions/Significance: We demonstrate new properties of adult NSCs and a method to generate efficient adult NSC cultures from various central nervous system areas. These findings will help establish cellular models relevant to cancer and regeneration.	[Androutsellis-Theotokis, Andreas; Rueger, Maria A.; Park, Deric M.; Boyd, Justin D.; Campanati, Loraine; McKay, Ronald D. G.] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Walbridge, Stuart; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Stewart, Craig V.; LeFranc, Yann; Plenz, Dietmar] NIMH, Lab Syst Neurosci, NIH, Bethesda, MD 20892 USA; [Padmanabhan, Raji] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Androutsellis-Theotokis, A (corresponding author), Acad Athens, Biomed Res Fdn, Athens, Greece.	AndreasTheotokis@gmail.com	Park, Deric/C-5675-2013; Campanati, Loraine/V-2632-2018; Neurociencia, Inct/I-1011-2013	Campanati, Loraine/0000-0001-9172-1951; Boyd, Justin/0000-0002-5197-4724; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	National Institute of Neurological Disorders; Stroke at the National Institutes of Health; Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981, ZIANS003051, ZIANS002881] Funding Source: NIH RePORTER	National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; National Parkinson's Foundation; Tuchman Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health, the Michael J. Fox Foundation, the National Parkinson's Foundation, and the Tuchman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Androutsellis-Theotokis A, 2008, COLD SH Q B, V73, P403, DOI 10.1101/sqb.2008.73.018; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Craig CG, 1996, J NEUROSCI, V16, P2649; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu JL, 1998, J NEUROSCI, V18, P7768; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Plenz D, 1998, J NEUROSCI, V18, P266; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Routsellis-Theotokis Andreas, 2008, V438, P31, DOI 10.1007/978-1-59745-133-8_4; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027	44	36	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9414	10.1371/journal.pone.0009414	http://dx.doi.org/10.1371/journal.pone.0009414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195471	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000007
J	Gao, N; Kumar, A; Jyot, J; Yu, FS				Gao, Nan; Kumar, Ashok; Jyot, Jeevan; Yu, Fu-Shin			Flagellin-Induced Corneal Antimicrobial Peptide Production and Wound Repair Involve a Novel NF-kappa B-Independent and EGFR-Dependent Pathway	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PSEUDOMONAS-AERUGINOSA FLAGELLIN; INNATE IMMUNE-RESPONSE; GROWTH-FACTOR RECEPTOR; EPITHELIAL INFLAMMATORY RESPONSES; URINARY-TRACT-INFECTION; HB-EGF; BACTERIAL FLAGELLIN; MD-2 EXPRESSION; GENE-EXPRESSION	Background: The bacterial protein flagellin plays a major role in stimulating mucosal surface innate immune response to bacterial infection and uniquely induces profound cytoprotection against pathogens, chemicals, and radiation. This study sought to determine signaling pathways responsible for the flagellin-induced inflammatory and cytoprotective effects on human corneal epithelial cells (HCECs). Methodology/Principal Findings: Flagellin purified from Pseudomonas aeruginosa (strain PAK) or live bacteria were used to challenge cultured HCECs. The activation of signaling pathways was assessed with Western blot, and the secretion of cytokine/chemokine and production of antimicrobial peptides (AMPs) were measured with ELISA and dot blot, respectively. Effects of flagellin on wound healing were assessed in cultured porcine corneas. L94A (a site mutation in TLR5 binding region) flagellin and PAK expressing L94A flagellin were unable to stimulate NF-kappa B activation, but were potent in eliciting EGFR signaling in a TGF-alpha-related pathway in HCECs. Concomitant with the lack of NF-kappa B activation, L94A flagellin was ineffective in inducing IL-6 and IL-8 production in HCECs. Surprisingly, the secretion of two inducible AMPs, LL-37 and hBD2, was not affected by L94A mutation. Similar to wild-type flagellin, L94A induced epithelial wound closure in cultured porcine cornea through maintaining EGFR-mediated signaling. Conclusions/Significance: Our data suggest that inflammatory response mediated by NF-kappa B can be uncoupled from epithelial innate defense machinery (i e., AMP expression) and major epithelial proliferation/repair pathways mediated by EGFR, and that flagellin and its derivatives may have broad therapeutic applications in cytoprotection and in controlling infection in the cornea and other mucosal tissues.	[Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA; [Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Anat, Detroit, MI USA; [Gao, Nan; Kumar, Ashok; Yu, Fu-Shin] Wayne State Univ, Sch Med, Dept Cell Biol, Detroit, MI USA; [Jyot, Jeevan] Univ Florida, Dept Med Infect Dis, Gainesville, FL USA	Wayne State University; Wayne State University; Wayne State University; State University System of Florida; University of Florida	Gao, N (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI 48202 USA.	fyu@med.wayne.edu			NIH [R01 EY017960, EY010869, P30EY004068]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY004068, R01EY017960, R01EY010869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants R01 EY017960, EY010869, as well as P30EY004068 and Research to Prevent Blindness (Unrestricted grant to KEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Bhattacharjee Y, 2008, SCIENCE, V320, P163, DOI 10.1126/science.320.5873.163; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; CAMPODONICO VL, 2009, INFECT IMMUN; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; Diamond G, 2008, J DENT RES, V87, P915, DOI 10.1177/154405910808701011; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Du JW, 2006, INVEST OPHTH VIS SCI, V47, P4810, DOI 10.1167/iovs.06-0250; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Kumar A, 2007, INVEST OPHTH VIS SCI, V48, P4664, DOI 10.1167/iovs.07-0473; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mayer AK, 2007, ARCH IMMUNOL THER EX, V55, P353, DOI 10.1007/s00005-007-0041-7; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; McNamara N, 2006, AM J RESP CELL MOL, V34, P653, DOI 10.1165/rcmb.2005-0441OC; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Michelsen KS, 2007, CURR OPIN HEMATOL, V14, P48, DOI 10.1097/00062752-200701000-00010; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Ni MJ, 2008, FEMS IMMUNOL MED MIC, V54, P177, DOI 10.1111/j.1574-695X.2008.00461.x; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Randhawa AK, 2008, EXPERT REV ANTI-INFE, V6, P479, DOI 10.1586/14787210.6.4.479; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; RUDNER XWL, 1992, CURR EYE RES, V11, P727, DOI 10.3109/02713689209000747; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Steiner TS, 2007, INFECT IMMUN, V75, P545, DOI 10.1128/IAI.01506-06; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P636, DOI 10.1167/iovs.06-0203; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Yu FSX, 2006, INVEST OPHTH VIS SCI, V47, P1255, DOI 10.1167/iovs.05-0956; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zhang J, 2009, IMMUNOL CELL BIOL, V87, P141, DOI 10.1038/icb.2008.75; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	64	30	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9351	10.1371/journal.pone.0009351	http://dx.doi.org/10.1371/journal.pone.0009351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195469	Green Submitted, Green Published, gold			2022-12-27	WOS:000274997000002
J	Hofreiter, M; Kreuz, E; Eriksson, J; Schubert, G; Hohmann, G				Hofreiter, Michael; Kreuz, Eva; Eriksson, Jonas; Schubert, Grit; Hohmann, Gottfried			Vertebrate DNA in Fecal Samples from Bonobos and Gorillas: Evidence for Meat Consumption or Artefact?	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SALONGA NATIONAL-PARK; PAN-PANISCUS; WILD CHIMPANZEES; ANCIENT DNA; IDENTIFICATION; TROGLODYTES; COOPERATION; BEHAVIOR; DIET	Background: Deciphering the behavioral repertoire of great apes is a challenge for several reasons. First, due to their elusive behavior in dense forest environments, great ape populations are often difficult to observe. Second, members of the genus Pan are known to display a great variety in their behavioral repertoire; thus, observations from one population are not necessarily representative for other populations. For example, bonobos (Pan paniscus) are generally believed to consume almost no vertebrate prey. However, recent observations show that at least some bonobo populations may consume vertebrate prey more commonly than previously believed. We investigated the extent of their meat consumption using PCR amplification of vertebrate mitochondrial DNA (mtDNA) segments from DNA extracted from bonobo feces. As a control we also attempted PCR amplifications from gorilla feces, a species assumed to be strictly herbivorous. Principal Findings: We found evidence for consumption of a variety of mammalian species in about 16% of the samples investigated. Moreover, 40% of the positive DNA amplifications originated from arboreal monkeys. However, we also found duiker and monkey mtDNA in the gorilla feces, albeit in somewhat lower percentages. Notably, the DNA sequences isolated from the two ape species fit best to the species living in the respective regions. This result suggests that the sequences are of regional origin and do not represent laboratory contaminants. Conclusions: Our results allow at least three possible and mutually not exclusive conclusions. First, all results may represent contamination of the feces by vertebrate DNA from the local environment. Thus, studies investigating a species' diet from feces DNA may be unreliable due to the low copy number of DNA originating from diet items. Second, there is some inherent difference between the bonobo and gorilla feces, with only the later ones being contaminated. Third, similar to bonobos, for which the consumption of monkeys has only recently been documented, the gorilla population investigated (for which very little observational data are as yet available) may occasionally consume small vertebrates. Although the last explanation is speculative, it should not be discarded a-priori given that observational studies continue to unravel new behaviors in great ape species.	[Hofreiter, Michael; Kreuz, Eva] Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany; [Hofreiter, Michael] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Eriksson, Jonas; Schubert, Grit; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Eriksson, Jonas] Uppsala Univ, EBC, Uppsala, Sweden	Max Planck Society; University of York - UK; Max Planck Society; Uppsala University	Hofreiter, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Res Grp Mol Ecol, Leipzig, Germany.	msh503@york.ac.uk	Hofreiter, Michael/A-3996-2017	Hofreiter, Michael/0000-0003-0441-4705	Max Planck Society	Max Planck Society(Max Planck Society)	This work was funded by the Max Planck Society (http://www.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P1, DOI 10.1017/CBO9780511606397.002; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; FURUICHI T, 1994, BEHAVIOUR, V130, P211, DOI 10.1163/156853994X00532; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Goodall J., 1986, CHIMPANZEES GOMBE PA; HOHMANN G, 1993, FOLIA PRIMATOL, V60, P225, DOI 10.1159/000156695; Hohmann G., 1996, FOOD STATUS QUEST, P47; Hohmann G., 2003, PAN AFRICAN NEWS, V10; Hohmann G, 2008, FOLIA PRIMATOL, V79, P103, DOI 10.1159/000110679; IHOBE H, 1992, PRIMATES, V33, P247, DOI 10.1007/BF02382754; Kano T., 1992, LAST APE PYGMY CHIMP; Kilger C, 1997, BIOTECHNIQUES, V22, P412, DOI 10.2144/97223bm08; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; McGrew William, 2004, CULTURED CHIMPANZEE; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Murphy MA, 2003, MOL ECOL, V12, P2261, DOI 10.1046/j.1365-294X.2003.01863.x; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; POPOVICH DG, 1997, MANAGEMENT GORILLAS, P138; Shanks OC, 2005, J ARCHAEOL SCI, V32, P27, DOI 10.1016/j.jas.2004.06.004; Stanford CB, 1996, AM ANTHROPOL, V98, P96, DOI 10.1525/aa.1996.98.1.02a00090; Stanford CB, 1998, BEHAVIOUR, V135, P513, DOI 10.1163/156853998793066212; Surbeck M, 2008, CURR BIOL, V18, pR906, DOI 10.1016/j.cub.2008.08.040; Surbeck M, 2009, AM J PRIMATOL, V71, P171, DOI 10.1002/ajp.20634; TUTIN CEG, 1992, AM J PRIMATOL, V28, P29, DOI 10.1002/ajp.1350280103; Vervaecke H, 2000, PRIMATES, V41, P249, DOI 10.1007/BF02557595; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wrangham R.W., 1986, P352; [No title captured]	38	21	21	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9419	10.1371/journal.pone.0009419	http://dx.doi.org/10.1371/journal.pone.0009419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195539	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000274924300009
J	Brochu, CA; Njau, J; Blumenschine, RJ; Densmore, LD				Brochu, Christopher A.; Njau, Jackson; Blumenschine, Robert J.; Densmore, Llewellyn D.			A New Horned Crocodile from the Plio-Pleistocene Hominid Sites at Olduvai Gorge, Tanzania	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CROCODYLUS-NILOTICUS; LATE NEOGENE; LAND-USE; HOMO; VERTEBRATE; MORPHOLOGY; MITOCHONDRIAL; DIVERGENCE; MADAGASCAR	Background: The fossil record reveals surprising crocodile diversity in the Neogene of Africa, but relationships with their living relatives and the biogeographic origins of the modern African crocodylian fauna are poorly understood. A Plio-Pleistocene crocodile from Olduvai Gorge, Tanzania, represents a new extinct species and shows that high crocodylian diversity in Africa persisted after the Miocene. It had prominent triangular "horns'' over the ears and a relatively deep snout, these resemble those of the recently extinct Malagasy crocodile Voay robustus, but the new species lacks features found among osteolaemines and shares derived similarities with living species of Crocodylus. Methodology/Principal Findings: The holotype consists of a partial skull and skeleton and was collected on the surface between two tuffs dated to approximately 1.84 million years (Ma), in the same interval near the type localities for the hominids Homo habilis and Australopithecus boisei. It was compared with previously-collected material from Olduvai Gorge referable to the same species. Phylogenetic analysis places the new form within or adjacent to crown Crocodylus. Conclusions/Significance: The new crocodile species was the largest predator encountered by our ancestors at Olduvai Gorge, as indicated by hominid specimens preserving crocodile bite marks from these sites. The new species also reinforces the emerging view of high crocodylian diversity throughout the Neogene, and it represents one of the few extinct species referable to crown genus Crocodylus.	[Brochu, Christopher A.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Njau, Jackson] Univ Calif Berkeley, Dept Integrat Biol, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [Njau, Jackson] Natl Museum Nat Hist, Arusha, Tanzania; [Blumenschine, Robert J.] Rutgers State Univ, Dept Anthropol, Ctr Human Evolutionary Studies, New Brunswick, NJ 08903 USA; [Densmore, Llewellyn D.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	University of Iowa; University of California System; University of California Berkeley; Rutgers State University New Brunswick; Texas Tech University System; Texas Tech University	Brochu, CA (corresponding author), Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA.	chris-brochu@uiowa.edu			National Science Foundation [NSF DEB 0444133, NSF DEB 0228648]; Wenner-Gren Foundation; Rutgers University Center; National Geographic Committee	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Rutgers University Center; National Geographic Committee(National Geographic Society)	National Science Foundation (www.nsf.gov): NSF DEB 0444133, NSF DEB 0228648. Wenner-Gren Foundation for Anthropological Research (www.wennergren.org). Rutgers University Center for Human Evolutionary Studies (evolution.rutgers.edu). National Geographic Committee for Research and Exploration (www.nationalgeographic.com/field/grants-programs/cre.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrasar Eduardo Llinas, 2003, Annales de Paleontologie, V89, P103, DOI 10.1016/S0753-3969(03)00006-5; Agrasar EL, 2004, GEODIVERSITAS, V26, P309; AOKI R, 1992, AFRICAN STUDY MONOGR, V17, P67; BARBOUR T, 1918, B MUS COMP ZOOL HARV, V14, P479; BELL CJ, QUATERNARY IN PRESS; Bickelmann C, 2009, FOSS REC, V12, P13, DOI 10.1002/mmng.200800007; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BLUMENSCHINE RJ, ENV HOMININ IN PRESS; Boulenger GA, 1920, CR HEBD ACAD SCI, V170, P913; BRAZAITIS P, 1973, Zoologica (New York), V58, P59; BRAZAITIS P, 1973, ZOOLOGICA; Brochu CA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P9; Brochu CA, 2000, COPEIA, P657, DOI 10.1643/0045-8511(2000)000[0657:PRADTO]2.0.CO;2; Brochu CA, 2003, ANNU REV EARTH PL SC, V31, P357, DOI 10.1146/annurev.earth.31.100901.141308; Brochu C, 2008, J VERTEBR PALEONTOL, V28, p57A; Brochu CA, 2007, ZOOL J LINN SOC-LOND, V150, P835, DOI 10.1111/j.1096-3642.2007.00315.x; Brochu CA, 2006, COPEIA, P149; Brunet M, 2000, J VERTEBR PALEONTOL, V20, P205, DOI 10.1671/0272-4634(2000)020[0205:CDOAVF]2.0.CO;2; BUFFETAUT E, 1984, NEUES JB GEOLOGIE PA, P513; COLBERT EH, 1946, COPEIA, P12; Delfino M, 2004, RIV ITAL PALEONTOL S, V110, P51, DOI 10.13130/2039-4942/5764; Delfino M, 2008, J PALEONTOL, V82, P336, DOI 10.1666/06-079.1; Delfino M, 2007, ZOOL J LINN SOC-LOND, V149, P293; Dempsey P, 2009, NATURE, V461, P341, DOI 10.1038/461341a; DENSMORE LD, 1991, COPEIA, P602, DOI 10.2307/1446388; DENSMORE LD, 1983, EVOL BIOL, V16, P397; Eaton MJ, 2009, MOL PHYLOGENET EVOL, V50, P496, DOI 10.1016/j.ympev.2008.11.009; Fourtau R, 1920, CONTRIBUTION ETUDE V; FUCHS K, 1974, Salamandra, V10, P107; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Ghinassi M, 2009, PALAEOGEOGR PALAEOCL, V280, P415, DOI 10.1016/j.palaeo.2009.06.029; Ginsburg L., 1978, GE OLOGIE ME DITERRA, V5, P291; Goloboff P.A., 2008, TNT TREE ANAL USING; Harrison T, 1997, NEOGENE PALEONTOLOGY, P361; Hecht Max K., 1987, P101; HEKKALA ER, CONSERVATIO IN PRESS; Ji Xue-Feng, 2006, Acta Zoologica Sinica, V52, P810; Joleaud M.L., 1930, CROCODILIENS PLIOCEN, P411; Joordens JCA, 2009, J HUM EVOL, V57, P656, DOI 10.1016/j.jhevol.2009.06.003; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; LEAKEY LSB, 1965, OLDUVAI GORGE 1951 6, V1, P70; LEAKEY LSB, 1959, NATURE; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Maccagno A. M., 1952, Rendiconti Accademia Nazionale dei XL (4), V3, P73; MACCAGNO AM, 1948, ATTI R ACCAD 8 SFMN, V1, P63; McAliley LR, 2006, MOL PHYLOGENET EVOL, V39, P16, DOI 10.1016/j.ympev.2006.01.012; Mook CC, 1921, B AM MUS NAT HIST, V44, P25; MOOK CHARLES C., 1927, AMER MUS NOVITATES, V289, P1; Muller L., 1923, Palaeontologia Hungarica, V1, P109; Nesbitt SJ, 2008, J VERTEBR PALEONTOL, V28, P1063, DOI 10.1671/0272-4634-28.4.1063; Njau J., J HUMAN EVO IN PRESS; Njau J. K., 2006, J HUM EVOL, V50, P102; NJAU JK, 2007, PALEOANTHROPOLOGY, pA21; OWEN R, 1850, PHIL T ROY SOC LON 1, V27, P521; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Pickford M., 1994, GEOLOGY PALAEOBIOLOG, VII, P137; Pickford Martin, 1996, Annales de Paleontologie, V82, P235; Pickford Martin, 2003, Geological Survey of Namibia Memoir, V19, P51; Pickford Martin, 2000, Annales de Paleontologie, V86, P59, DOI 10.1016/S0753-3969(00)88724-8; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; Rauhe M, 1999, FOSSIL VERTEBRATES OF ARABIA, P163; Ray DA, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P58; Ristori G., 1890, RENDICONTI I STUDI S, P1; Schmitz A, 2003, CR PALEVOL, V2, P703, DOI 10.1016/j.crpv.2003.07.002; SCHRENK F, 1995, J HUM EVOL, V28, P59, DOI 10.1006/jhev.1995.1006; Storrs Glenn W., 2003, P137; SUSMAN RL, 1982, SCIENCE, V217, P931, DOI 10.1126/science.217.4563.931; Swinton W. E., 1926, Uganda Geol Surv Dept Occ Paper, V2, P37; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TCHERNOV E, 1978, Palaeontology (Oxford), V21, P857; Tchernov E., 1986, EVOLUTION CROCODILES; Tobias P.V., 1991, HOMO HABILIS SKULLS, V4a et 4b; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; WERMUTH H, 1953, MITT ZOOL MUS BERLIN, V29, P376; White PS, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P29; Willis RE, 2009, MOL PHYLOGENET EVOL, V53, P1049, DOI 10.1016/j.ympev.2009.09.003; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	78	55	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9333	10.1371/journal.pone.0009333	http://dx.doi.org/10.1371/journal.pone.0009333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195356	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924200008
J	Senn, N; Maraga, S; Sie, A; Rogerson, SJ; Reeder, JC; Siba, P; Mueller, I				Senn, Nicolas; Maraga, Seri; Sie, Albert; Rogerson, Stephen J.; Reeder, John C.; Siba, Peter; Mueller, Ivo			Population Hemoglobin Mean and Anemia Prevalence in Papua New Guinea: New Metrics for Defining Malaria Endemicity?	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PARVOVIRUS B19; YOUNG-CHILDREN; VITAMIN-A; EPIDEMIOLOGY; HIGHLANDS; MORBIDITY; INFECTIONS; PATTERNS; PARASITEMIA	Background: The hypothesis is that hemoglobin-based metrics are useful tools for estimating malaria endemicity and for monitoring malaria control strategies. The aim of this study is to compare population hemoglobin mean and anemia prevalence to established indicators of malaria endemicity, including parasite rates, rates of enlarged spleens in children, and records of (presumptive) malaria diagnosis among populations living with different levels of malaria transmission. Methodology/Principal Findings: Convenience sample, multisite cross-sectional household surveys conducted in Papua New Guinea. Correlations (r(2)) between population Hb mean and anemia prevalence and altitude, parasite rate, and spleen rate were investigated in children ages 2 to 10 years, and in the general population; 21,664 individuals from 156 different communities were surveyed. Altitude ranged from 5 to 2120 meters. In young children, correlations between altitude and parasite rate, population Hb mean, anemia prevalence, and spleen rate were high (r(2) : -0.77, 0.73, -0.81, and -0.68; p < 0.001). In the general population, correlations between altitude and population Hb mean and anemia prevalence were 0.83 and 0.85, respectively. Among young children, parasite rate correlated highly with anemia prevalence, population Hb mean, and spleen rate (r(2) : 0.81, -0.81, and 0.86; p < 0.001). Population Hb mean (corrected for direct altitude effects) increased with altitude, from 10.5 g/dl at <500 m to 12.8 g/dl at >1500 m (p < 0.001). Conclusions/Significance: In PNG, where Plasmodium vivax accounts for an important part of all malaria infections, population hemoglobin mean and anemia prevalence correlate well with altitude, parasite, and spleen rates. Hb measurement is simple and affordable, and may be a useful new tool, alone or in association with other metrics, for estimating malaria endemicity and monitoring effectiveness of malaria control programs. Further prospective studies in areas with different malaria epidemiology and different factors contributing to the burden of anemia are warranted to investigate the usefulness of Hb metrics in monitoring malaria transmission intensity.	[Senn, Nicolas; Maraga, Seri; Sie, Albert; Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Senn, Nicolas; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Senn, Nicolas] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Reeder, John C.] Burnet Inst, Melbourne, Vic, Australia	PNG Institute Of Medical Research; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute; Burnet Institute	Senn, N (corresponding author), Papua New Guinea Inst Med Res, POB 60, Goroka, Papua N Guinea.	nicolas.senn@gmail.com	Mueller, Ivo/C-7251-2013	Mueller, Ivo/0000-0001-6554-6889; Rogerson, Stephen/0000-0003-4287-1982; Reeder, John/0000-0003-1395-1289	Papua New Guinea Institute of Medical Research	Papua New Guinea Institute of Medical Research	Internally funded by the Papua New Guinea Institute of Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2004, COCHRANE DB SYST REV; BARNISH G, 1992, SMALL COSMOS RES MON, P345; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; BRABIN L, 1988, T ROY SOC TROP MED H, V82, P671, DOI 10.1016/0035-9203(88)90191-5; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; CDC, 1989, MMWR-MORBID MORTAL W, V38, P400; Cusick SE, 2005, AM J CLIN NUTR, V82, P406, DOI 10.1093/ajcn/82.2.406; DEMPSTER T, 1848, NOTES APPL TEST ORGA; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Edwards Keith N., 2000, Papua New Guinea Medical Journal, V43, P38; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Genton B, 1998, AM J CLIN NUTR, V68, P734, DOI 10.1093/ajcn/68.3.734; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; HEDBERG K, 1993, AM J TROP MED HYG, V48, P365, DOI 10.4269/ajtmh.1993.48.365; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; Koram KA, 2003, TROP MED INT HEALTH, V8, P793, DOI 10.1046/j.1365-3156.2003.01092.x; MARAGA S, PNG MED J IN PRESS; McElroy PD, 2000, AM J TROP MED HYG, V62, P504, DOI 10.4269/ajtmh.2000.62.504; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; MEREMIKWU MM, 2008, COCHRANE DATABASE SY; METZ J, 2008, FOOD NUTR B      JUN, pS74; Mgone CS, 1996, T ROY SOC TROP MED H, V90, P228, DOI 10.1016/S0035-9203(96)90223-0; Mueller I, 2001, ANN HUM BIOL, V28, P263, DOI 10.1080/030144601300119089; Mueller Ivo, 2003, Papua New Guinea Medical Journal, V46, P166; Mueller Ivo, 2003, Papua New Guinea Medical Journal, V46, P16; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Mueller Ivo, 2007, Papua New Guinea Medical Journal, V50, P123; Mueller Ivo, 2007, Papua New Guinea Medical Journal, V50, P111; Mueller Ivo, 2006, Papua New Guinea Medical Journal, V49, P115; Mueller Ivo, 2004, Papua New Guinea Medical Journal, V47, P159; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Ogbonna A, 2008, T ROY SOC TROP MED H, V102, P621, DOI 10.1016/j.trstmh.2008.03.024; PALEK J, 1993, SEMIN HEMATOL, V30, P249; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; PRITCHARD D, 1990, PARASITOLOGY     APR, P317; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Ruiz-Arguelles GJ, 2006, BLOOD, V108, P2131, DOI 10.1182/blood-2006-04-016352; SERJEANTSON SW, 1992, SMALL COSMOS RES MON, P198; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2; Shekalaghe S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-69; SHERAL SP, 2004, AM J HEMATOL, V75, P1; SHIELD J M, 1980, Papua New Guinea Medical Journal, V23, P157; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; Wildig J, 2007, AM J TROP MED HYG, V77, P354, DOI 10.4269/ajtmh.2007.77.354; Wildig J, 2006, J INFECT DIS, V194, P146, DOI 10.1086/505082; YEKUTIEL P, 1960, Bull World Health Organ, V22, P669	58	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9375	10.1371/journal.pone.0009375	http://dx.doi.org/10.1371/journal.pone.0009375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195369	Green Published, gold			2022-12-27	WOS:000274924200011
J	Sirovich, L; Stoeckle, MY; Zhang, Y				Sirovich, Lawrence; Stoeckle, Mark Y.; Zhang, Yu			Structural Analysis of Biodiversity	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTIONS; DNA; NUMBER	Large, recently-available genomic databases cover a wide range of life forms, suggesting opportunity for insights into genetic structure of biodiversity. In this study we refine our recently-described technique using indicator vectors to analyze and visualize nucleotide sequences. The indicator vector approach generates correlation matrices, dubbed Klee diagrams, which represent a novel way of assembling and viewing large genomic datasets. To explore its potential utility, here we apply the improved algorithm to a collection of almost 17000 DNA barcode sequences covering 12 widely-separated animal taxa, demonstrating that indicator vectors for classification gave correct assignment in all 11000 test cases. Indicator vector analysis revealed discontinuities corresponding to species-and higher-level taxonomic divisions, suggesting an efficient approach to classification of organisms from poorly-studied groups. As compared to standard distance metrics, indicator vectors preserve diagnostic character probabilities, enable automated classification of test sequences, and generate high-information density single-page displays. These results support application of indicator vectors for comparative analysis of large nucleotide data sets and raise prospect of gaining insight into broad-scale patterns in the genetic structure of biodiversity.	[Sirovich, Lawrence; Zhang, Yu] Mt Sinai Sch Med, Lab Appl Math, New York, NY 10029 USA; [Stoeckle, Mark Y.] Rockefeller Univ, Program Human Environm, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Rockefeller University	Sirovich, L (corresponding author), Mt Sinai Sch Med, Lab Appl Math, New York, NY 10029 USA.	lsirovich@rockefeller.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	NIH/NEI [EY16224]; NIH/NIGMS [1 P50 GM071558]; Alfred P. Sloan Foundation [2009-5-22]; NATIONAL EYE INSTITUTE [R01EY016224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LS received funding from NIH/NEI EY16224, NIH/NIGMS 1 P50 GM071558 and The Alfred P. Sloan Foundation, 2009-5-22 DNAB. YZ received funding from NIH/NIGMS 1 P50 GM071558 and The Alfred P. Sloan Foundation, 2009-5-22 DNAB.	Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; Bryant D, 2005, J CLASSIF, V22, P3, DOI 10.1007/s00357-005-0003-x; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Caterino MS, 2001, SYST BIOL, V50, P106, DOI 10.1080/106351501750107530; Chapman A, 2009, NUMBERS LIVING SPECI; DEROSNAY J, 1979, MACROSCOPE NEW WORLD; Eldredge N., 1972, P82; GASCUEL O, 1994, MOL BIOL EVOL, V11, P961; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KALLERSJO M, 1988, PLANT SYST EVOL, V213, P259; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Mihaescu R, 2009, ALGORITHMICA, V54, P1, DOI 10.1007/s00453-007-9116-4; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; PETERSEN K, 1990, ERGODIC THEORY CAMBR; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 2006, BIOINFORMATICS, V22, P1004, DOI 10.1093/bioinformatics/btl044; Sirovich L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007051; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; 2009, AMERICAN ORNITHOLOGI	27	37	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9266	10.1371/journal.pone.0009266	http://dx.doi.org/10.1371/journal.pone.0009266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195371	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924200001
J	Rorie, AE; Gao, J; McClelland, JL; Newsome, WT				Rorie, Alan E.; Gao, Juan; McClelland, James L.; Newsome, William T.			Integration of Sensory and Reward Information during Perceptual Decision-Making in Lateral Intraparietal Cortex (LIP) of the Macaque Monkey	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SACCADIC EYE-MOVEMENTS; VISUAL AREA MT; DISCRIMINATION TASK; SUPERIOR COLLICULUS; MOTION PERCEPTION; SPATIAL ATTENTION; MATCHING BEHAVIOR; STOCHASTIC-MODELS; NEURONAL-ACTIVITY	Single neurons in cortical area LIP are known to carry information relevant to both sensory and value-based decisions that are reported by eye movements. It is not known, however, how sensory and value information are combined in LIP when individual decisions must be based on a combination of these variables. To investigate this issue, we conducted behavioral and electrophysiological experiments in rhesus monkeys during performance of a two-alternative, forced-choice discrimination of motion direction (sensory component). Monkeys reported each decision by making an eye movement to one of two visual targets associated with the two possible directions of motion. We introduced choice biases to the monkeys' decision process (value component) by randomly interleaving balanced reward conditions (equal reward value for the two choices) with unbalanced conditions (one alternative worth twice as much as the other). The monkeys' behavior, as well as that of most LIP neurons, reflected the influence of all relevant variables: the strength of the sensory information, the value of the target in the neuron's response field, and the value of the target outside the response field. Overall, detailed analysis and computer simulation reveal that our data are consistent with a two-stage drift diffusion model proposed by Diederich and Bussmeyer [1] for the effect of payoffs in the context of sensory discrimination tasks. Initial processing of payoff information strongly influences the starting point for the accumulation of sensory evidence, while exerting little if any effect on the rate of accumulation of sensory evidence.	[Rorie, Alan E.; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Rorie, Alan E.; Newsome, William T.] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Gao, Juan; McClelland, James L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Rorie, AE (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	bill@monkeybiz.stanford.edu	McClelland, James L/F-6004-2011; Newsome, William T./W-7171-2019	McClelland, James/0000-0002-8217-405X	Air Force Research Laboratory [FA9550-07-1-0537]; Howard Hughes Medical Institute (HHMI)	Air Force Research Laboratory; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute)	The research was funded by the Air Force Research Laboratory, under agreement number FA9550-07-1-0537, and by the Howard Hughes Medical Institute (HHMI). WN is an HHMI Investigator. AR was supported by an HHMI predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Balleine BW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P367, DOI 10.1016/B978-0-12-374176-9.00024-5; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Boucher L, 2007, PSYCHOL REV, V114, P376, DOI 10.1037/0033-295X.114.2.376; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Cavanaugh J, 2006, J NEUROSCI, V26, P11347, DOI 10.1523/JNEUROSCI.2376-06.2006; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corrado GS, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P463, DOI 10.1016/B978-0-12-374176-9.00030-0; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Diederich A, 1997, J MATH PSYCHOL, V41, P260, DOI 10.1006/jmps.1997.1167; Diederich A, 2008, PERCEPT PSYCHOPHYS, V70, P229, DOI 10.3758/PP.70.2.229; Diederich A, 2006, PERCEPT PSYCHOPHYS, V68, P194, DOI 10.3758/BF03193669; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Ditterich J, 2006, EUR J NEUROSCI, V24, P3628, DOI 10.1111/j.1460-9568.2006.05221.x; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goldberg ME, 2006, PROG BRAIN RES, V155, P157, DOI 10.1016/S0079-6123(06)55010-1; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Gottlieb J, 2009, NEUROBIOL LEARN MEM, V91, P121, DOI 10.1016/j.nlm.2008.09.013; Green D. M., 1966, SIGNAL DETECTION PSY; Grossberg S, 2008, VISION RES, V48, P1345, DOI 10.1016/j.visres.2008.02.019; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hays AV, 1982, WESCON C P, V2, P1; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2009, EXP BRAIN RES, V192, P479, DOI 10.1007/s00221-008-1557-8; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Kusunoki M, 2000, VISION RES, V40, P1459, DOI 10.1016/S0042-6989(99)00212-6; Laming DR, 1968, INFORM THEORY CHOICE; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Lee D, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P481, DOI 10.1016/B978-0-12-374176-9.00031-2; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt M, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P441, DOI 10.1016/B978-0-12-374176-9.00029-4; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rangel A, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P425, DOI 10.1016/B978-0-12-374176-9.00028-2; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vickers D., 2000, NONLINEAR DYNAMICS P, V4, P1, DOI DOI 10.1023/A:1009571011764; Vickers D., 1979, DECISION PROCESSES V; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	81	135	135	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9308	10.1371/journal.pone.0009308	http://dx.doi.org/10.1371/journal.pone.0009308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174574	gold, Green Published			2022-12-27	WOS:000274923700012
J	Chaudhary, N; Staab, JF; Marr, KA				Chaudhary, Neelkamal; Staab, Janet F.; Marr, Kieren A.			Healthy Human T-Cell Responses to Aspergillus fumigatus Antigens	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; GENERATION; EXPRESSION; SUSCEPTIBILITY; INVOLVEMENT; GLIOTOXIN; IMMUNITY; PROTEIN; EPITOPE; MICE	Background: Aspergillus fumigatus is associated with both invasive and allergic pulmonary diseases, in different hosts. The organism is inhaled as a spore, which, if not cleared from the airway, germinates into hyphal morphotypes that are responsible for tissue invasion and resultant inflammation. Hyphae secrete multiple products that function as antigens, evoking both a protective (T(H)1-T(H)17) and destructive allergic (T(H)2) immunity. How Aspergillus allergens (Asp f proteins) participate in the development of allergic sensitization is unknown. Methodology/Principal Findings: To determine whether Asp f proteins are strictly associated with T(H)2 responses, or represent soluble hyphal products recognized by healthy hosts, human T cell responses to crude and recombinant products were characterized by ELISPOT. While responses (number of spots producing IFN-gamma, IL-4 or IL-17) to crude hyphal antigen preparations were weak, responses to recombinant Asp f proteins were higher. Recombinant allergens stimulated cells to produce IFN-gamma more so than IL-4 or IL-17. Volunteers exhibited a diverse CD4+ and CD8+ T cell antigen recognition profile, with prominent CD4 T(H)1-responses to Asp f3 (a putative peroxismal membrane protein), Asp f9/16 (cell wall glucanase), Asp f11 (cyclophilin type peptidyl-prolyl isomerase) and Asp f22 (enolase). Strong IFN-gamma responses were reproduced in most subjects tested over 6 month intervals. Conclusions: Products secreted after conidial germination into hyphae are differentially recognized by protective T cells in healthy, non-atopic individuals. Defining the specificity of the human T cell repertoire, and identifying factors that govern early responses may allow for development of novel diagnostics and therapeutics for both invasive and allergic Aspergillus diseases.	[Chaudhary, Neelkamal; Staab, Janet F.; Marr, Kieren A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Marr, Kieren A.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Chaudhary, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	kmarr4@jhmi.edu			National Institutes of Health [R01 AI067710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant R01 AI067710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CHEST, V135, P805, DOI 10.1378/chest.08-2586; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Banerjee B, 2003, FRONT BIOSCI-LANDMRK, V8, pS128, DOI 10.2741/982; Banerjee B, 2001, CLIN EXP ALLERGY, V31, P761, DOI 10.1046/j.1365-2222.2001.01076.x; Beck O, 2008, J IMMUNOL METHODS, V335, P41, DOI 10.1016/j.jim.2008.02.014; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Bozza S, 2002, MICROBES INFECT, V4, P1281, DOI 10.1016/S1286-4579(02)00007-2; Braun RP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-54; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Chauhan B, 2000, J ALLERGY CLIN IMMUN, V106, P723, DOI 10.1067/mai.2000.109913; Chauhan B, 1996, J CLIN INVEST, V97, P2324, DOI 10.1172/JCI118675; COLIGAN J, CURRENT PROTOCOLS PR; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gigliotti F, 2006, INFECT IMMUN, V74, P6310, DOI 10.1128/IAI.00668-06; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ito JI, 2006, INFECT IMMUN, V74, P5075, DOI 10.1128/IAI.00815-06; Knutsen AP, 2004, ALLERGY, V59, P198, DOI 10.1046/j.1398-9995.2003.00310.x; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lehrnbecher T, 2009, MED MYCOL, V47, pS170, DOI 10.1080/13693780802169120; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lindell DM, 2005, J IMMUNOL, V174, P7920, DOI 10.4049/jimmunol.174.12.7920; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; Nickel P, 2009, TRANSPL IMMUNOL, V20, P238, DOI 10.1016/j.trim.2008.11.002; Nierman WC, 2005, MED MYCOL, V43, pS3, DOI 10.1080/13693780400029049; Ohnishi M, 2005, BRIT J HAEMATOL, V131, P472, DOI 10.1111/j.1365-2141.2005.05800.x; Orciuolo E, 2007, J LEUKOCYTE BIOL, V82, P839, DOI 10.1189/jlb.0207090; Orsborn KI, 2006, INFECT IMMUN, V74, P1865, DOI 10.1128/IAI.74.3.1865-1872.2006; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Potenza L, 2007, LEUKEMIA, V21, P578, DOI 10.1038/sj.leu.2404504; Priyadarsiny P, 2003, MOL CELL BIOCHEM, V252, P157, DOI 10.1023/A:1025594620152; Ramadan G, 2005, CLIN EXP IMMUNOL, V139, P257, DOI 10.1111/j.1365-2249.2005.02699.x; Ramadan G, 2005, CLIN EXP IMMUNOL, V140, P81, DOI 10.1111/j.1365-2249.2005.02738.x; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Sainz J, 2007, HUM IMMUNOL, V68, P41, DOI 10.1016/j.humimm.2006.10.011; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shimizu K, 2001, GENETICS, V157, P591; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tramsen L, 2009, BONE MARROW TRANSPL, V43, P13, DOI 10.1038/bmt.2008.271; van Deventer Hanneke J., 1996, Clin Microbiol Infect, V2, P36; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	46	75	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9036	10.1371/journal.pone.0009036	http://dx.doi.org/10.1371/journal.pone.0009036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174463	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600002
J	Geisler, BP; Schuur, JD; Pallin, DJ				Geisler, Benjamin P.; Schuur, Jeremiah D.; Pallin, Daniel J.			Estimates of Electronic Medical Records in US Emergency Departments	PLOS ONE			English	Article							INFORMATION-TECHNOLOGY; CARE; ERRORS; SYSTEM	Background: Policymakers advocate universal electronic medical records (EMRs) and propose incentives for "meaningful use'' of EMRs. Though emergency departments (EDs) are particularly sensitive to the benefits and unintended consequences of EMR adoption, surveillance has been limited. We analyze data from a nationally representative sample of US EDs to ascertain the adoption of various EMR functionalities. Methodology/Principal Findings: We analyzed data from the National Hospital Ambulatory Medical Care Survey, after pooling data from 2005 and 2006, reporting proportions with 95% confidence intervals (95% CI). In addition to reporting adoption of various EMR functionalities, we used logistic regression to ascertain patient and hospital characteristics predicting "meaningful use,'' defined as a "basic'' system (managing demographic information, computerized provider order entry, and lab and imaging results). We found that 46% (95% CI 39-53%) of US EDs reported having adopted EMRs. Computerized provider order entry was present in 21% (95% CI 16-27%), and only 15% (95% CI 10-20%) had warnings for drug interactions or contraindications. The "basic'' definition of "meaningful use'' was met by 17% (95% CI 13-21%) of EDs. Rural EDs were substantially less likely to have a "basic'' EMR system than urban EDs (odds ratio 0.19, 95% CI 0.06-0.57, p = 0.003), and Midwestern (odds ratio 0.37, 95% CI 0.16-0.84, p = 0.018) and Southern (odds ratio 0.47, 95% CI 0.26-0.84, p = 0.011) EDs were substantially less likely than Northeastern EDs to have a "basic'' system. Conclusions/Significance: EMRs are becoming more prevalent in US EDs, though only a minority use EMRs in a "meaningful'' way, no matter how "meaningful'' is defined. Rural EDs are less likely to have an EMR than metropolitan EDs, and Midwestern and Southern EDs are less likely to have an EMR than Northeastern EDs. We discuss the nuances of how to define "meaningful use,'' and the importance of considering not only adoption, but also full implementation and consequences.	[Geisler, Benjamin P.] Harvard Univ, Sch Med, Inst Technol Assessment, Boston, MA 02115 USA; [Geisler, Benjamin P.] Harvard Univ, Sch Med, Div Oncol, Boston, MA USA; [Geisler, Benjamin P.] Univ Hlth Sci Med Informat & Technol, Inst Publ Hlth Med Decis Making & Hlth Technol As, Hall In Tirol, Austria; [Schuur, Jeremiah D.; Pallin, Daniel J.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Schuur, Jeremiah D.; Pallin, Daniel J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Pallin, Daniel J.] Childrens Hosp Boston, Div Emergency Med, Boston, MA USA; [Pallin, Daniel J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Geisler, BP (corresponding author), Harvard Univ, Sch Med, Inst Technol Assessment, Boston, MA 02115 USA.	ben.geisler@gmail.com	Geisler, Benjamin P./A-9244-2010; Pallin, Daniel J/H-6382-2013	Geisler, Benjamin P./0000-0003-1704-6067; Pallin, Daniel J/0000-0002-8517-9702				Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; Burt Catharine W, 2005, Adv Data, P1; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Hing E, 2003, INQUIRY-J HEALTH CAR, V40, P401, DOI 10.5034/inquiryjrnl_40.4.401; Jha A. K., 2009, N ENGL J MED; *NAT CTR HLTH STAT, 2006, PUBL US DAT FIL DOC; Pallin D, 2003, ACAD EMERG MED, V10, P848, DOI 10.1197/aemj.10.8.848; PALLIN DJ, 2009, J EMERG MED; PARK PJ, 2009, J EMERG MED, V37	11	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9274	10.1371/journal.pone.0009274	http://dx.doi.org/10.1371/journal.pone.0009274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556KU	20174660	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590600027
J	Hasegawa, K; Miwa, S; Tsutsumiuchi, K; Miwa, J				Hasegawa, Koichi; Miwa, Satsuki; Tsutsumiuchi, Kaname; Miwa, Johji			Allyl Isothiocyanate that Induces GST and UGT Expression Confers Oxidative Stress Resistance on C. elegans, as Demonstrated by Nematode Biosensor	PLOS ONE			English	Article							LIFE-SPAN; RESPONSIVE GENES; INNATE IMMUNITY; CAENORHABDITIS; SULFORAPHANE; ACRYLAMIDE; INDUCTION; ENZYMES; CELLS; DETOXIFICATION	Background: Electrophilic xenobiotics and endogenous products from oxidative stresses induce the glutathione S-transferases (GSTs), which form a large family within the phase II enzymes over both animal and plant kingdoms. The GSTs thus induced in turn detoxify these external as well as internal stresses. Because these stresses are often linked to ageing and damage to health, the induction of phase II enzymes without causing adverse effects would be beneficial in slowing down ageing and keeping healthy conditions. Methodology/Principal Findings: We have tested this hypothesis by choosing allyl isothiocyanate (AITC), a functional ingredient in wasabi, as a candidate food ingredient that induces GSTs without causing adverse effects on animals' lives. To monitor the GST induction, we constructed a gst::gfp fusion gene and used it to transform Caenorhabditis elegans for use as a nematode biosensor. With the nematode biosensor, we found that AITC induced GST expression and conferred tolerance on the nematode against various oxidative stresses. We also present evidence that the transcription factor SKN-1 is involved in regulating the GST expression induced by AITC. Conclusions/Significance: We show the applicability of the nematode biosensor for discovering and evaluating functional food substances and chemicals that would provide anti-ageing or healthful benefits.	[Hasegawa, Koichi; Miwa, Satsuki; Tsutsumiuchi, Kaname; Miwa, Johji] Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan	Chubu University	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Aichi, Japan.	miwa@isc.chubu.ac.jp			Japan Science and Technology (JST); Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology; Chubu University	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chubu University	This work was supported by a Japan Science and Technology (JST) research fund to J. M., a Japan Society for the Promotion of Science (JSPS) research fund to K. H. of the Japanese Ministry of Education, Culture, Sports, Science and Technology, and a Chubu University Special Fund to J. M.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bock KW, 2003, BIOCHEM PHARMACOL, V66, P691, DOI 10.1016/S0006-2952(03)00296-X; Borek V, 1998, J AGR FOOD CHEM, V46, P5318, DOI 10.1021/jf9805754; BRENNER S, 1974, GENETICS, V77, P71; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Buskov S, 2002, J AGR FOOD CHEM, V50, P690, DOI 10.1021/jf010470s; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hasegawa K, 2004, TOXICOL LETT, V152, P183, DOI 10.1016/j.toxlet.2004.04.037; Hasegawa K, 2008, TOXICOL SCI, V101, P215, DOI 10.1093/toxsci/kfm276; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; HUNDLE BS, 1992, P NATL ACAD SCI USA, V89, P9321, DOI 10.1073/pnas.89.19.9321; *IARC, 1999, IARC MON EV CARC RIS, V73, P37; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; KAMPKOTTER A, 2006, PHARM RES, V55, P139; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kurz CL, 2004, AGING CELL, V3, P185, DOI 10.1111/j.1474-9728.2004.00108.x; Kushad MM, 1999, J AGR FOOD CHEM, V47, P1541, DOI 10.1021/jf980985s; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Maduro M, 1996, GENE, V183, P77, DOI 10.1016/S0378-1119(96)00491-X; Masutomi N, 2001, TOXICOL PATHOL, V29, P617, DOI 10.1080/019262301753385942; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; RIDDLE D.L., 1997, C ELEGANS, P1; Stiernagle T., 1999, C ELEGANS PRACTICAL, P51; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhang YS, 2006, J AGR FOOD CHEM, V54, P9370, DOI 10.1021/jf062109h; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	48	32	38	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9267	10.1371/journal.pone.0009267	http://dx.doi.org/10.1371/journal.pone.0009267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174640	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600020
J	Katare, RG; Ando, M; Kakinuma, Y; Sato, T				Katare, Rajesh G.; Ando, Motonori; Kakinuma, Yoshihiko; Sato, Takayuki			Engineered Heart Tissue: A Novel Tool to Study the Ischemic Changes of the Heart In Vitro	PLOS ONE			English	Article							PERMEABILITY TRANSITION-PORE; PROTECTS; INHIBITION	Background: Understanding the basic mechanisms and prevention of any disease pattern lies mainly on development of a successful experimental model. Recently, engineered heart tissue (EHT) has been demonstrated to be a useful tool in experimental transplantation. Here, we demonstrate a novel function for the spontaneously contracting EHT as an experimental model in studying the acute ischemia-induced changes in vitro. Methodology/Principal Findings: EHT was constructed by mixing cardiomyocytes isolated from the neonatal rats and cultured in a ring-shaped scaffold for five days. This was followed by mechanical stretching of the EHT for another one week under incubation. Fully developed EHT was subjected to hypoxia with 1% O-2 for 6 hours after treating them with cell protective agents such as cyclosporine A (CsA) and acetylcholine (ACh). During culture, EHT started to show spontaneous contractions that became more synchronous following mechanical stretching. This was confirmed by the increased expression of gap junctional protein connexin 43 and improved action potential recordings using an optical mapping system after mechanical stretching. When subjected to hypoxia, EHT demonstrated conduction defects, dephosphorylation of connexin-43, and down-regulation of cell survival proteins identical to the adult heart. These effects were inhibited by treating the EHT with cell protective agents. Conclusions/Significance: Under hypoxic conditions, the EHT responds similarly to the adult myocardium, thus making EHT a promising material for the study of cardiac functions in vitro.	[Katare, Rajesh G.; Ando, Motonori; Kakinuma, Yoshihiko; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nankoku, Kochi, Japan	Kochi University	Katare, RG (corresponding author), Univ Bristol, Bristol Heart Inst, Bristol, Avon, England.	katarerajesh@yahoo.com		Katare, Rajesh/0000-0001-5419-7935; Kakinuma, Yoshihiko/0000-0001-5470-9128	Ministry of Health, Labor, and Welfare of Japan [H14-NANO-002, H16-NANO-005]; Ministry of Education, Science, Sports, and Culture of Japan [15300165, 17790892]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Health and Labor Sciences Research Grant (H14-NANO-002, H16-NANO-005) from the Ministry of Health, Labor, and Welfare of Japan, and by a Grant-in-Aid for Scientific Research (15300165, 17790892) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Hasenfuss G, 1998, CARDIOVASC RES, V39, P60, DOI 10.1016/S0008-6363(98)00110-2; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Katare RG, 2009, J THORAC CARDIOV SUR, V137, P223, DOI 10.1016/j.jtcvs.2008.08.020; Katare RG, 2007, CAN J PHYSIOL PHARM, V85, P979, DOI 10.1139/Y07-071; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; LESMAN A, 2009, TISSUE ENG A; Lin JW, 2008, AM J PHYSIOL-HEART C, V294, pH58, DOI 10.1152/ajpheart.00631.2007; Migneco F, 2008, REGEN MED, V3, P399, DOI 10.2217/17460751.3.3.399; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Rajesh KG, 2003, TRANSPLANTATION, V76, P1314, DOI 10.1097/01.TP.0000085660.93090.79; Rajesh KG, 2003, CARDIOVASC RES, V59, P297, DOI 10.1016/S0008-6363(03)00358-4; Shimizu T, 2009, CURR PHARM DESIGN, V15, P2807, DOI 10.2174/138161209788923822; SILL B, 2009, J VIS EXP; SONG H, 2009, P NATL ACAD SCI US; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	22	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9275	10.1371/journal.pone.0009275	http://dx.doi.org/10.1371/journal.pone.0009275			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174664	gold, Green Submitted, Green Published			2022-12-27	WOS:000274590600028
J	Gwinn, DM; Asara, JM; Shaw, RJ				Gwinn, Dana M.; Asara, John M.; Shaw, Reuben J.			Raptor is Phosphorylated by cdc2 during Mitosis	PLOS ONE			English	Article							CELL-CYCLE; MAMMALIAN TARGET; PROTEIN-KINASE; RAPAMYCIN MTOR; S6 KINASE-1; COMPLEX; GROWTH; 4E-BP1; TRANSLATION; INHIBITOR	Background: The appropriate control of mitotic entry and exit is reliant on a series of interlocking signaling events that coordinately drive the biological processes required for accurate cell division. Overlaid onto these signals that promote orchestrated cell division are checkpoints that ensure appropriate mitotic spindle formation, a lack of DNA damage, kinetochore attachment, and that each daughter cell has the appropriate complement of DNA. We recently discovered that AMP-activated protein kinase (AMPK) modulates the G2/M phase of cell cycle progression in part through its suppression of mammalian target of rapamycin (mTOR) signaling. AMPK directly phosphorylates the critical mTOR binding partner raptor inhibiting mTORC1 (mTOR-raptor rapamycin sensitive mTOR kinase complex 1). As mTOR has been previously tied to mitotic control, we examined further how raptor may contribute to this process. Methodology/Principal Findings: We have discovered that raptor becomes highly phosphorylated in cells in mitosis. Utilizing tandem mass spectrometry, we identified a number of novel phosphorylation sites in raptor, and using phosphospecific antibodies demonstrated that raptor becomes phosphorylated on phospho-serine/threonine-proline sites in mitosis. A combination of site-directed mutagenesis in a tagged raptor cDNA and analysis with a series of new phosphospecific antibodies generated against different sites in raptor revealed that Serine 696 and Threonine 706 represent two key sites in raptor phosphorylated in mitosis. We demonstrate that the mitotic cyclin-dependent kinase cdc2/CDK1 is the kinase responsible for phosphorylating these sites, and its mitotic partner Cyclin B efficiently coimmunoprecipitates with raptor in mitotic cells. Conclusions/Significance: This study demonstrates that the key mTOR binding partner raptor is directly phosphorylated during mitosis by cdc2. This reinforces previous studies suggesting that mTOR activity is highly regulated and important for mitotic progression, and points to a direct modulation of the mTORC1 complex during mitosis.	[Gwinn, Dana M.; Shaw, Reuben J.] Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Howard Hughes Medical Institute; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Gwinn, DM (corresponding author), Dulbecco Ctr Canc Res, Mol & Cell Biol Lab, La Jolla, CA USA.	shaw@salk.edu			National Institutes of Health [P01 CA120964, R01 DK080425]; American Cancer Society; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part from grants from the National Institutes of Health to R.J.S. and J.M.A. (P01 CA120964), and to R.J.S. (R01 DK080425); and from the American Cancer Society (R.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FOSTER KG, 2009, J BIOL CHEM; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Greenberg VL, 2005, ONCOGENE, V24, P4851, DOI 10.1038/sj.onc.1208624; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nakashima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002223; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200; Smith EM, 2008, EMBO J, V27, P1005, DOI 10.1038/emboj.2008.39; THOREEN CC, 2009, J BIOL CHEM; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	33	49	51	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9197	10.1371/journal.pone.0009197	http://dx.doi.org/10.1371/journal.pone.0009197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169205	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600017
J	Touboul, J; Destexhe, A				Touboul, Jonathan; Destexhe, Alain			Can Power-Law Scaling and Neuronal Avalanches Arise from Stochastic Dynamics?	PLOS ONE			English	Article							DISTRIBUTIONS; TESTS	The presence of self-organized criticality in biology is often evidenced by a power-law scaling of event size distributions, which can be measured by linear regression on logarithmic axes. We show here that such a procedure does not necessarily mean that the system exhibits self-organized criticality. We first provide an analysis of multisite local field potential (LFP) recordings of brain activity and show that event size distributions defined as negative LFP peaks can be close to power-law distributions. However, this result is not robust to change in detection threshold, or when tested using more rigorous statistical analyses such as the Kolmogorov-Smirnov test. Similar power-law scaling is observed for surrogate signals, suggesting that power-law scaling may be a generic property of thresholded stochastic processes. We next investigate this problem analytically, and show that, indeed, stochastic processes can produce spurious power-law scaling without the presence of underlying self-organized criticality. However, this power-law is only apparent in logarithmic representations, and does not survive more rigorous analysis such as the Kolmogorov-Smirnov test. The same analysis was also performed on an artificial network known to display self-organized criticality. In this case, both the graphical representations and the rigorous statistical analysis reveal with no ambiguity that the avalanche size is distributed as a power-law. We conclude that logarithmic representations can lead to spurious power-law scaling induced by the stochastic nature of the phenomenon. This apparent power-law scaling does not constitute a proof of self-organized criticality, which should be demonstrated by more stringent statistical tests.	[Touboul, Jonathan] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Touboul, Jonathan] Rockefeller Univ, Phys Math Lab, New York, NY USA; [Destexhe, Alain] CNRS, UPR 2191, UNIC, Gif Sur Yvette, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rockefeller University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Touboul, J (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jonathan.touboul@rockefeller.edu		Destexhe, Alain/0000-0001-7405-0455	National Science Foundation (NSF) [DMS0817131]; Centre National de la Recherche Scientifique (CNRS); National Research Agency (ANR); European Community (FACETS project)	National Science Foundation (NSF)(National Science Foundation (NSF)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Research Agency (ANR)(French National Research Agency (ANR)); European Community (FACETS project)(European Commission)	This work was funded by the National Science Foundation (NSF) grant DMS0817131 and the Centre National de la Recherche Scientifique (CNRS), National Research Agency (ANR) (grant HR-CORTEX) and the European Community (FACETS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili A, 2005, STOCH MODELS, V21, P967, DOI 10.1080/15326340500294702; Arnold BC., 1983, PARETO DISTRIBUTIONS; Bak P., 1996, NATURE WORKS SCI SEL; Barndorff-Nielsen O.E., 1995, INFERENCE ASYMPTOTIC; Bauke H, 2007, EUR PHYS J B, V58, P167, DOI 10.1140/epjb/e2007-00219-y; Bedard C, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051911; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Billingsley Patrick, 1999, CONVERGENCE PROBABIL, V2nd; Boes, 1963, INTRO THEORY STAT; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Grunwald P. D., 2007, MINIMUM DESCRIPTION; HENNIG M, 2009, J NEUROSCIENCE, V29; Jensen H., 1998, SELF ORGANIZED CRITI; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Muniruzzaman A, 1957, B CALCUTTA STAT ASS, V7, P115; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; PETERMANN T, 2009, P NATL ACAD SCI, V106; PLESSER HE, 1999, THESIS G AUGUST U GO; Schrodinger E, 1915, PHYS Z, V16, P289; STERIADE M, 2001, J NEUROPHYSIOLOGY, V86; STOEV S, 2006, MATHST0609163 ARXIV; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Touboul J, 2007, J PHYSIOL-PARIS, V101, P78, DOI 10.1016/j.jphysparis.2007.10.008; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	28	117	117	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e8982	10.1371/journal.pone.0008982	http://dx.doi.org/10.1371/journal.pone.0008982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161798	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000274442800002
J	Hilber, AM; Francis, SC; Chersich, M; Scott, P; Redmond, S; Bender, N; Miotti, P; Temmerman, M; Low, N				Hilber, Adriane Martin; Francis, Suzanna C.; Chersich, Matthew; Scott, Pippa; Redmond, Shelagh; Bender, Nicole; Miotti, Paolo; Temmerman, Marleen; Low, Nicola			Intravaginal Practices, Vaginal Infections and HIV Acquisition: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUALLY-TRANSMITTED-DISEASES; SOUTH-AFRICAN WOMEN; BACTERIAL VAGINOSIS; HETEROSEXUAL TRANSMISSION; ZIMBABWEAN WOMEN; CONTROLLED-TRIAL; INCREASED RISK; DRY SEX; MICROBICIDES	Background: Intravaginal practices are commonly used by women to manage their vaginal health and sexual life. These practices could, however, affect intravaginal mucosal integrity. The objectives of this study were to examine evidence for associations between: intravaginal practices and acquisition of HIV infection; intravaginal practices and vaginal infections; and vaginal infections and HIV acquisition. Methodology/Principal Findings: We conducted a systematic review of prospective longitudinal studies, searching 15 electronic databases of journals and abstracts from two international conferences to 31(st) January 2008. Relevant articles were selected and data extracted in duplicate. Results were examined visually in forest plots and combined using random effects meta-analysis where appropriate. Of 2120 unique references we included 22 publications from 15 different studies in sub-Saharan Africa and the USA. Seven publications from five studies examined a range of intravaginal practices and HIV infection. No specific vaginal practices showed a protective effect against HIV or vaginal infections. Insertion of products for sex was associated with HIV in unadjusted analyses; only one study gave an adjusted estimate, which showed no association (hazard ratio 1.09, 95% confidence interval, Cl 0.71, 1.67). HIV incidence was higher in women reporting intravaginal cleansing but confidence intervals were wide and heterogeneity high (adjusted hazard ratio 1.88, 95% Cl 0.53, 6.69, I-2 83.2%). HIV incidence was higher in women with bacterial vaginosis (adjusted effect 1.57, 95% Cl 1.26, 1.94, I-2 19.0%) and Trichomonas vaginalis (adjusted effect 1.64, 95% Cl 1.28, 2.09, I-2 0.0%). Conclusions/Significance: A pathway linking intravaginal cleaning practices with vaginal infections that increase susceptibility to HIV infection is plausible but conclusive evidence is lacking. Intravaginal practices do not appear to protect women from vaginal infections or HIV and some might be harmful.	[Hilber, Adriane Martin; Scott, Pippa; Redmond, Shelagh; Bender, Nicole; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Francis, Suzanna C.] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Chersich, Matthew; Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium; [Chersich, Matthew] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Miotti, Paolo] US Natl Inst Hlth, Off AIDS Res, Bethesda, MD USA	University of Bern; University of London; London School of Hygiene & Tropical Medicine; Ghent University; University of Witwatersrand; National Institutes of Health (NIH) - USA	Hilber, AM (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	low@ispm.unibe.ch	Bender, Nicole/C-2237-2009; Low, Nicola/H-4718-2019	Low, Nicola/0000-0003-4817-8986; chersich, matthew/0000-0002-4320-9168; Bender, Nicole/0000-0002-3838-587X; Francis, Suzanna Carter/0000-0002-3724-4813; Scott, Pippa/0000-0003-0849-1812	Office of AIDS Research, National Institutes of Health, United States of America; MRC [G0700837, G0701039] Funding Source: UKRI; Medical Research Council [G0701039, G0700837] Funding Source: researchfish	Office of AIDS Research, National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for the study was provided by the Office of AIDS Research, National Institutes of Health, United States of America (http://www.oar.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Beksinska ME, 1999, SEX TRANSM INFECT, V75, P178, DOI 10.1136/sti.75.3.178; Brown JE, 2000, SEX TRANSM DIS, V27, P183, DOI 10.1097/00007435-200004000-00001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRANCIS S, 2007, INT SOC STD RES M 29; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Grimley DM, 2005, SEX TRANSM DIS, V32, P752, DOI 10.1097/01.olq.0000190018.58079.05; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hester RA, 2003, J WOMEN HEALTH GEN-B, V12, P487, DOI 10.1089/154099903766651612; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilber AM, 2007, SEX TRANSM INFECT, V83, P505, DOI 10.1136/sti.2007.028597; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; HIRA SK, 1990, J PEDIATR-US, V117, P421, DOI 10.1016/S0022-3476(05)81084-4; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Karim SA, 2009, 16 C RETR OPP INF MO; Kilmarx PH, 1998, AIDS, V12, P767, DOI 10.1097/00002030-199807000-00013; Kissinger P, 2006, SEX TRANSM DIS, V33, P445, DOI 10.1097/01.olq.0000204511.84485.4c; Kleinschmidt I, 2007, CONTRACEPTION, V75, P461, DOI 10.1016/j.contraception.2007.02.002; Knol MJ, 2008, AM J EPIDEMIOL, V168, P1073, DOI 10.1093/aje/kwn217; Kumwenda N, 2006, SEX TRANSM DIS, V33, P646, DOI 10.1097/01.olq.0000223283.27142.9f; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; Mbikusita-Lewanika M, 2009, PSYCHOL HEALTH MED, V14, P227, DOI 10.1080/13548500802270364; McClelland RS, 2008, SEX TRANSM DIS, V35, P617, DOI 10.1097/OLQ.0b013e31816907fa; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Myer L, 2006, AM J EPIDEMIOL, V163, P552, DOI 10.1093/aje/kwj071; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; Myer L, 2004, SEX TRANSM DIS, V31, P174, DOI 10.1097/01.OLQ.0000114942.41998.58; Nagot N, 2007, SEX TRANSM INFECT, V83, P365, DOI 10.1136/sti.2007.024794; *NAT I CLIN EXC, 2006, GUID DEV METH INF NA; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Riedner G, 2006, AIDS, V20, P609, DOI 10.1097/01.aids.0000210616.90954.47; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van de Wijgert J, 2006, AIDS, V20, P1347, DOI 10.1097/01.aids.0000232252.74157.f9; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; van de Wijgert JHHM, 2000, J INFECT DIS, V181, P587, DOI 10.1086/315227; van de Wijgert JHHM, 2000, J ACQ IMMUN DEF SYND, V24, P62; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Vincent KL, 2009, SEX TRANSM DIS, V36, P312, DOI 10.1097/OLQ.0b013e31819496e4	49	74	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9119	10.1371/journal.pone.0009119	http://dx.doi.org/10.1371/journal.pone.0009119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161749	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000274442600017
J	Weisfelt, M; de Gans, J; van der Ende, A; van de Beek, D				Weisfelt, Martijn; de Gans, Jan; van der Ende, Arie; van de Beek, Diederik			Community-Acquired Bacterial Meningitis in Alcoholic Patients	PLOS ONE			English	Article							PRACTICE GUIDELINES; CLINICAL-FEATURES; ADULTS; CONSUMPTION; DEXAMETHASONE; DAMAGE	Background: Alcoholism is associated with susceptibility to infectious disease, particularly bacterial pneumonia. In the present study we described characteristics in alcoholic patients with bacterial meningitis and delineate the differences with findings in non-alcoholic adults with bacterial meningitis. Methods and Principal Findings: This was a prospective nationwide observational cohort study including patients aged > 16 years who had bacterial meningitis confirmed by culture of cerebrospinal fluid (696 episodes of bacterial meningitis occurring in 671 patients). Alcoholism was present in 27 of 686 recorded episodes of bacterial meningitis (4%) and alcoholics were more often male than non-alcoholics (82% vs 48%, P = 0.001). A higher proportion of alcoholics had underlying pneumonia (41% vs 11% P < 0.001). Alcoholics were more likely to have meningitis due to infection with Streptococcus pneumoniae (70% vs 50%, P = 0.01) and Listeria monocytogenes (19% vs 4%, P = 0.005), whereas Neisseria meningitidis was more common in non-alcoholic patients (39% vs 4%, P = 0.01). A large proportion of alcoholics developed complications during clinical course (82% vs 62%, as compared with non-alcoholics; P = 0.04), often cardiorespiratory failure (52% vs 28%, as compared with non-alcoholics; P = 0.01). Alcoholic patients were at risk for unfavourable outcome (67% vs 33%, as compared with non-alcoholics; P < 0.001). Conclusions and Significance: Alcoholic patients are at high risk for complications resulting in high morbidity and mortality. They are especially at risk for cardiorespiratory failure due to underlying pneumonia, and therefore, aggressive supportive care may be crucial in the treatment of these patients.	[Weisfelt, Martijn] Kennemer Gasthuis, Dept Neurol, Haarlem, Netherlands; [de Gans, Jan] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Dept Neurol,Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Dept Microbiol,Ctr Infect & Immun Amsterdam CINIM, NL-1105 AZ Amsterdam, Netherlands	Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Weisfelt, M (corresponding author), Kennemer Gasthuis, Dept Neurol, Haarlem, Netherlands.	D.vandeBeek@amc.uva.nl	van der Ende, Arie/A-4346-2012; van de Beek, Diederik/Y-2713-2019; van de beek, diederik/A-2935-2010	van de Beek, Diederik/0000-0002-4571-044X; van der Ende, Arie/0000-0003-1298-3086	Roche Pharmaceuticals, The Netherlands	Roche Pharmaceuticals, The Netherlands(Netherlands GovernmentRoche Holding)	Funding: The Dutch Meningitis Cohort Study was in part supported by a research grant of Roche Pharmaceuticals, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batty GD, 2009, J PSYCHOSOM RES, V66, P317, DOI 10.1016/j.jpsychores.2008.09.021; Brand RM, 2009, J IMMUNOL, V182; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Culebras A, 1997, STROKE, V28, P1480, DOI 10.1161/01.STR.28.7.1480; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Delgado-Rodriguez M, 2003, BRIT J SURG, V90, P1287, DOI 10.1002/bjs.4186; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; ENZMANN DR, 1983, RADIOLOGY, V146, P703, DOI 10.1148/radiology.146.3.6828685; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; JENNETT B, 1975, LANCET, V1, P480; Lau A, 2009, ANESTH ANALG, V108, P916, DOI 10.1213/ane.0b013e318193fd89; MANDEL G, 2005, PRINCIPLES PRACTICE; McMillan DA, 2001, CLIN INFECT DIS, V33, P969, DOI 10.1086/322612; MOORE RD, 1989, JAMA-J AM MED ASSOC, V261, P403, DOI 10.1001/jama.261.3.403; *NETH REF LAB BACT, 2005, BACT MEN NETH ANN RE; *NIAAA, STRAT PLAN RES 2006; Pauwels A, 1997, J HEPATOL, V27, P830, DOI 10.1016/S0168-8278(97)80320-0; PILLAI R, 1990, ALCOHOL ALCOHOLISM, V25, P711, DOI 10.1093/oxfordjournals.alcalc.a045069; ROORD JJ, 1997, CONSENSUS BIJEENKOMS; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; TUNKEL AR, 2001, BACTERIAL MENINGITIS; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2002, J ANTIMICROB CHEMOTH, V49, P661, DOI 10.1093/jac/49.4.661; van de Beek D, 2004, ANN INTERN MED, V141, P327, DOI 10.7326/0003-4819-141-4-200408170-00028; van de Beek D, 2006, NAT CLIN PRACT NEURO, V2, P504, DOI 10.1038/ncpneuro0265; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Weisfelt M, 2007, EXPERT OPIN PHARMACO, V8, P1493, DOI 10.1517/14656566.8.10.1493	31	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9102	10.1371/journal.pone.0009102	http://dx.doi.org/10.1371/journal.pone.0009102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161709	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442500009
J	Spiegelhalter, C; Tosch, V; Hentsch, D; Koch, M; Kessler, P; Schwab, Y; Laporte, J				Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn			From Dynamic Live Cell Imaging to 3D Ultrastructure: Novel Integrated Methods for High Pressure Freezing and Correlative Light-Electron Microscopy	PLOS ONE			English	Article							CRYOELECTRON TOMOGRAPHY; AMPHIPHYSIN-2 BIN1; FLUORESCENCE; SUSPENSIONS; IMMUNOCYTOCHEMISTRY; PHOTOOXIDATION; CRYOSECTIONS; RESOLUTION; SUBSTRATE; APPARATUS	Background: In cell biology, the study of proteins and organelles requires the combination of different imaging approaches, from live recordings with light microscopy (LM) to electron microscopy (EM). Methodology: To correlate dynamic events in adherent cells with both ultrastructural and 3D information, we developed a method for cultured cells that combines confocal time-lapse images of GFP-tagged proteins with electron microscopy. With laser micro-patterned culture substrate, we created coordinates that were conserved at every step of the sample preparation and visualization processes. Specifically designed for cryo-fixation, this method allowed a fast freezing of dynamic events within seconds and their ultrastructural characterization. We provide examples of the dynamic oligomerization of GFP-tagged myotubularin (MTM1) phosphoinositides phosphatase induced by osmotic stress, and of the ultrastructure of membrane tubules dependent on amphiphysin 2 (BIN1) expression. Conclusion: Accessible and versatile, we show that this approach is efficient to routinely correlate functional and dynamic LM with high resolution morphology by EM, with immuno-EM labeling, with 3D reconstruction using serial immuno-EM or tomography, and with scanning-EM.	[Spiegelhalter, Coralie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick] IGBMC, Imaging Ctr, Illkirch Graffenstaden, France; [Tosch, Valerie; Laporte, Jocelyn] IGBMC, Dept Neurobiol & Genet, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Spiegelhalter, Coralie; Tosch, Valerie; Hentsch, Didier; Koch, Marc; Kessler, Pascal; Schwab, Yannick; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [Tosch, Valerie; Laporte, Jocelyn] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Spiegelhalter, C (corresponding author), IGBMC, Imaging Ctr, Illkirch Graffenstaden, France.	yschwab@igbmc.fr; jocelyn@igbmc.fr	Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012; Kessler, Pascal/ABF-6615-2021	Schwab, Yannick/0000-0001-8027-1836; Spiegelhalter, Coralie/0000-0001-6372-1647; Koch, Marc/0000-0002-2678-235X	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University of Strasbourg (UdS); College de France; Association Francaise contre les Myopathies (AFM); Fondation Recherche Medicale [FRM DEQ20071210538]; Agence Nationale de la Recherche [ANR-07-BLAN-0065-03, ANR-08-GENOPAT-005]; E-rare program	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg (UdS)(European Commission); College de France; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Recherche Medicale; Agence Nationale de la Recherche(French National Research Agency (ANR)); E-rare program	This study was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), the University of Strasbourg (UdS), the College de France, the Association Francaise contre les Myopathies (AFM), Fondation Recherche Medicale (FRM DEQ20071210538), Agence Nationale de la Recherche (ANR-07-BLAN-0065-03, ANR-08-GENOPAT-005) and the E-rare program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRONSKAIA AV, 2008, J STRUCT BIOL; Auinger S, 2008, METHOD CELL BIOL, V88, P257, DOI 10.1016/S0091-679X(08)00414-7; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Colombelli Julien, 2008, V457, P203, DOI 10.1007/978-1-59745-261-8_15; Darcy KJ, 2006, NAT PROTOC, V1, P988, DOI 10.1038/nprot.2006.146; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Gruska M, 2008, J STRUCT BIOL, V161, P384, DOI 10.1016/j.jsb.2007.10.008; Hess MW, 2000, J STRUCT BIOL, V130, P63, DOI 10.1006/jsbi.2000.4230; HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x; Jimenez N, 2006, J MICROSC-OXFORD, V221, P216, DOI 10.1111/j.1365-2818.2006.01558.x; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Lucic V, 2007, J STRUCT BIOL, V160, P146, DOI 10.1016/j.jsb.2007.08.014; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Mironov AA, 2000, TRENDS CELL BIOL, V10, P349, DOI 10.1016/S0962-8924(00)01787-6; Monaghan P, 1998, J MICROSC-OXFORD, V192, P248, DOI 10.1046/j.1365-2818.1998.00387.x; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Sartori A, 2007, J STRUCT BIOL, V160, P135, DOI 10.1016/j.jsb.2007.07.011; Sawaguchi A, 2003, J MICROSC-OXFORD, V212, P13, DOI 10.1046/j.1365-2818.2003.01225.x; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Verkade P, 2008, J MICROSC-OXFORD, V230, P317, DOI 10.1111/j.1365-2818.2008.01989.x; Vicidomini G, 2008, TRAFFIC, V9, P1828, DOI 10.1111/j.1600-0854.2008.00815.x	37	57	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9014	10.1371/journal.pone.0009014	http://dx.doi.org/10.1371/journal.pone.0009014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140253	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200010
J	Sommerfeld, MR; Muller, G; Tschank, G; Seipke, G; Habermann, P; Kurrle, R; Tennagels, N				Sommerfeld, Mark R.; Mueller, Guenter; Tschank, Georg; Seipke, Gerhard; Habermann, Paul; Kurrle, Roland; Tennagels, Norbert			In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites	PLOS ONE			English	Article							RECEPTOR ISOFORM-A; GROWTH-FACTOR-II; ANALOG GLARGINE; IGF-II; SUBCUTANEOUS INJECTION; HYBRID RECEPTORS; LIGAND-BINDING; NPH INSULIN; AFFINITY; CANCER	In Background: Insulin glargine (Lantus (R)) is a long-acting basal insulin analog that demonstrates effective day-long glycemic control and a lower incidence of hypoglycemia than NPH insulin. After subcutaneous injection insulin glargine is partly converted into the two main metabolites M1 ([GlyA(21)] insulin) and M2 ([GlyA(21), des-Thr(B30)]insulin). The aim of this study was to characterize the glargine metabolites in vitro with regard to their insulin receptor (IR) and IGF-1 receptor (IGF1R) binding and signaling properties as well as their metabolic and mitogenic activities. Methods: The affinity of human insulin, insulin glargine and its metabolites to the IR isoforms A and B or IGF1R was analyzed in a competitive binding assay using SPA technology. Receptor autophosphorylation activities were studied via In-Cell Western in CHO and MEF cells overexpressing human IR-A and IR-B or IGF1R, respectively. The metabolic response of the insulins was studied as stimulation of lipid synthesis using primary rat adipocytes. Thymidine incorporation in Saos-2 cells was used to characterize the mitogenic activity. Conclusions: The binding of insulin glargine and its metabolites M1 and M2 to the IR were similar and correlated well with their corresponding autophosphorylation and metabolic activities in vitro. No differences were found towards the two IR isoforms A or B. Insulin glargine showed a higher affinity for IGF1R than insulin, resulting in a lower EC50 value for autophosphorylation of the receptor and a more potent stimulation of thymidine incorporation in Saos-2 cells. In contrast, the metabolites M1 and M2 were significantly less active in binding to and activation of the IGF1R and their mitogenicity in Saos-2 cells was equal to human insulin. These findings strongly support the idea that insulin glargine metabolites contribute with the same potency as insulin glargine to blood glucose control but lead to significantly reduced growth-promoting activity.	[Sommerfeld, Mark R.; Mueller, Guenter; Tschank, Georg; Kurrle, Roland; Tennagels, Norbert] Sanofi Aventis Deutschland GmbH, Res & Dev TD Metab, Frankfurt, Germany; [Seipke, Gerhard; Habermann, Paul] Sanofi Aventis Deutschland GmbH, Proc Dev Biotechnol, Frankfurt, Germany	Sanofi-Aventis; Sanofi-Aventis	Sommerfeld, MR (corresponding author), Sanofi Aventis Deutschland GmbH, Res & Dev TD Metab, Frankfurt, Germany.	Norbert.Tennagels@sanofi-aventis.com		Muller, Gunter/0000-0001-6178-8215	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	This work was funded by Sanofi-Aventis. The funders had a role in the decision to publish but no role in study design, data collection and analysis or preparation of the manuscript.	Agin A, 2007, DIABETES METAB, V33, P205, DOI 10.1016/j.diabet.2006.12.002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baus D, 2008, CELL SIGNAL, V20, P2237, DOI 10.1016/j.cellsig.2008.08.010; Becker RHA, 2008, DIABETES OBES METAB, V10, P1105, DOI 10.1111/j.1463-1326.2008.00874.x; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Berchtold H, 1999, BIOPOLYMERS, V51, P165, DOI 10.1002/(SICI)1097-0282(1999)51:2<165::AID-BIP6>3.3.CO;2-O; Brange J, 1999, ADV DRUG DELIVER REV, V35, P307, DOI 10.1016/S0169-409X(98)00079-9; BRANGE J, 1990, DIABETES CARE, V13, P923, DOI 10.2337/diacare.13.9.923; Chantelau Ernst, 2009, Archives of Physiology and Biochemistry, V115, P47, DOI 10.1080/13813450802709029; COOK N, 2002, CURR PROTOC PROTEIN, pCH19; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Dideriksen LH, 1992, DIABETES S1, V41, p143A; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Eckardt Kristin, 2008, Archives of Physiology and Biochemistry, V114, P45, DOI 10.1080/13813450801983369 ; *EMEA, 2000, EPAR AUTH MED PROD H; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Frick W, 1998, BIOCHEMISTRY-US, V37, P13421, DOI 10.1021/bi9806201; Frystyk J, 2004, GROWTH HORM IGF RES, V14, P337, DOI 10.1016/j.ghir.2004.06.001; GAMMELTOFT S, 1984, PHYSIOL REV, V64, P1321, DOI 10.1152/physrev.1984.64.4.1321; Gerich J, 2006, DIABETES TECHNOL THE, V8, P237, DOI 10.1089/dia.2006.8.237; Goykhman S, 2009, EXPERT OPIN PHARMACO, V10, P705, DOI [10.1517/14656560902775677 , 10.1517/14656560902775677]; Hansen BF, 1996, BIOCHEM J, V315, P271; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Heise T, 2002, DIABETIC MED, V19, P490, DOI 10.1046/j.1464-5491.2002.00723.x; Hennige AM, 1999, DIABETOLOGIA, V42, pA178; HILGENFELD R, 1992, DIABETOLOGIA, V35, pA193; Home PD, 2002, DIABETES-METAB RES, V18, pS57, DOI 10.1002/dmrr.317; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; Kuerzel GU, 2003, CURR MED RES OPIN, V19, P34, DOI 10.1185/030079902125001416; Kuerzel GU, 2001, DIABETOLOGIA, V44, pA208; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Le Roith D, 2007, DIABETES-METAB RES, V23, P593, DOI 10.1002/dmrr.776; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Levien TL, 2002, ANN PHARMACOTHER, V36, P1019; Liefvendahl E, 2008, HORM METAB RES, V40, P369, DOI 10.1055/s-2008-1062739; Monzavi R, 2002, BEST PRACT RES CL EN, V16, P433, DOI 10.1053/beem.2002.0212; MULLER G, 1993, DIABETES, V42, P1852, DOI 10.2337/diabetes.42.12.1852; MULLER G, 2007, DRUG DISCOVERY EVALU, P1323; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Rissler K, 1996, J CHROMATOGR B, V679, P21, DOI 10.1016/0378-4347(96)00022-9; Rosskamp RH, 1999, DIABETES CARE, V22, pB109; Sandow Juergen, 2009, Archives of Physiology and Biochemistry, V115, P72, DOI 10.1080/13813450902835690; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SEIPKE G, 2000, END SOC 82 ANN M 200; Serrano R, 2005, J MOL ENDOCRINOL, V34, P153, DOI 10.1677/jme.1.01635; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Staiger K, 2007, HORM METAB RES, V39, P65, DOI 10.1055/s-2007-957352; Stammberger I, 2002, INT J TOXICOL, V21, P171, DOI 10.1080/10915810290096306; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132	59	101	106	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9540	10.1371/journal.pone.0009540	http://dx.doi.org/10.1371/journal.pone.0009540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209060	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100020
J	Tong, JC; Simarmata, D; Lin, RTP; Renia, L; Ng, LFP				Tong, Joo Chuan; Simarmata, Diane; Lin, Raymond T. P.; Renia, Laurent; Ng, Lisa F. P.			HLA Class I Restriction as a Possible Driving Force for Chikungunya Evolution	PLOS ONE			English	Article							T-CELL EPITOPES; VIRUS-INFECTION; DENGUE; REEMERGENCE; THAILAND; SEQUENCE; FEATURES; DATABASE; BIOLOGY; BINDING	After two decades of quiescence, epidemic resurgence of Chikungunya fever (CHIKF) was reported in Africa, several islands in the Indian Ocean, South-East Asia and the Pacific causing unprecedented morbidity with some cases of fatality. Early phylogenetic analyses based on partial sequences of Chikungunya virus (CHIKV) have led to speculation that the virus behind recent epidemics may result in greater pathogenicity. To understand the reasons for these new epidemics, we first performed extensive analyses of existing CHIKV sequences from its introduction in 1952 to 2009. Our results revealed the existence of a continuous genotypic lineage, suggesting selective pressure is active in CHIKV evolution. We further showed that CHIKV is undergoing mild positive selection, and that site-specific mutations may be driven by cell-mediated immune pressure, with occasional changes that resulted in the loss of human leukocyte antigen (HLA) class I-restricting elements. These findings provide a basis to understand Chikungunya virus evolution and reveal the power of post-genomic analyses to understand CHIKV and other viral epidemiology. Such an approach is useful for studying the impact of host immunity on pathogen evolution, and may help identify appropriate antigens suitable for subunit vaccine formulations.	[Tong, Joo Chuan] Inst Infocomm Res, Data Min Dept, Singapore, Singapore; [Tong, Joo Chuan; Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Simarmata, Diane; Renia, Laurent; Ng, Lisa F. P.] Singapore Immunol Network, Singapore, Singapore; [Lin, Raymond T. P.] Minist Hlth, Communicable Dis Div, Natl Publ Hlth Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Ministry of Health-Singapore	Tong, JC (corresponding author), Inst Infocomm Res, Data Min Dept, Singapore, Singapore.	jctong@i2r.a-star.edu.sg; lisa_ng@immunol.a-star.edu.sg	Renia, Laurent/E-2117-2011	Renia, Laurent/0000-0003-0349-1557; Ng, Lisa/0000-0003-4071-5222	Agency of Science, Technology and Research (A*STAR)	Agency of Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	The work was supported by a joint council office (JCO) research grant of the Agency of Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; BARNARD JM, 1992, J CHEM INF COMP SCI, V32, P644, DOI 10.1021/ci00010a010; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; DECAMPOSLIMA PO, 1994, J EXP MED, V179, P1297, DOI 10.1084/jem.179.4.1297; Dudley ME, 2003, NAT REV CANCER, V3, P666, DOI 10.1038/nrc1167; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P1022, DOI 10.4269/ajtmh.1969.18.1022; HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P997, DOI 10.4269/ajtmh.1969.18.997; HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3; Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001; Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Khan AM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S4; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; Kowalzik S, 2008, MED MICROBIOL IMMUN, V197, P381, DOI 10.1007/s00430-008-0090-5; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; RAO T. R., 1966, Science and Culture, V32, P215; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SURTEES G, 1970, T ROY SOC TROP MED H, V64, P511, DOI 10.1016/0035-9203(70)90071-4; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Udhayakumar V, 1997, EUR J IMMUNOL, V27, P1952, DOI 10.1002/eji.1830270819; WHO, 2006, WKLY EPIDEMIOL REC, V81, P105; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9291	10.1371/journal.pone.0009291	http://dx.doi.org/10.1371/journal.pone.0009291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195467	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000001
J	Szmaragd, C; Wilson, AJ; Carpenter, S; Wood, JLN; Mellor, PS; Gubbins, S				Szmaragd, Camille; Wilson, Anthony J.; Carpenter, Simon; Wood, James L. N.; Mellor, Philip S.; Gubbins, Simon			The Spread of Bluetongue Virus Serotype 8 in Great Britain and Its Control by Vaccination	PLOS ONE			English	Article							TRANSMISSION; INFECTION; EPIDEMIC; EUROPE; SHEEP	Background: Bluetongue (BT) is a viral disease of ruminants transmitted by Culicoides biting midges and has the ability to spread rapidly over large distances. In the summer of 2006, BTV serotype 8 (BTV-8) emerged for the first time in northern Europe, resulting in over 2000 infected farms by the end of the year. The virus subsequently overwintered and has since spread across much of Europe, causing tens of thousands of livestock deaths. In August 2007, BTV-8 reached Great Britain (GB), threatening the large and valuable livestock industry. A voluntary vaccination scheme was launched in GB in May 2008 and, in contrast with elsewhere in Europe, there were no reported cases in GB during 2008. Methodology/Principal Findings: Here, we use carefully parameterised mathematical models to investigate the spread of BTV in GB and its control by vaccination. In the absence of vaccination, the model predicted severe outbreaks of BTV, particularly for warmer temperatures. Vaccination was predicted to reduce the severity of epidemics, with the greatest reduction achieved for high levels (95%) of vaccine uptake. However, even at this level of uptake the model predicted some spread of BTV. The sensitivity of the predictions to vaccination parameters (time to full protection in cattle, vaccine efficacy), the shape of the transmission kernel and temperature dependence in the transmission of BTV between farms was assessed. Conclusions/Significance: A combination of lower temperatures and high levels of vaccine uptake (>80%) in the previously-affected areas are likely to be the major contributing factors in the control achieved in England in 2008. However, low levels of vaccination against BTV-8 or the introduction of other serotypes could result in further, potentially severe outbreaks in future.	[Szmaragd, Camille; Wilson, Anthony J.; Carpenter, Simon; Mellor, Philip S.; Gubbins, Simon] Inst Anim Hlth, Div Epidemiol, Pirbright Lab, Surrey, England; [Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge Infect Dis Consortium, Cambridge, Cambs, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Cambridge	Szmaragd, C (corresponding author), Univ Bristol, Sch Clin Vet Sci, Lower Langford, Somerset, England.	Camille.Szmaragd@bristol.ac.uk	Carpenter, Simon T/C-2718-2013; Wood, James/A-1626-2008	Carpenter, Simon T/0000-0001-5775-045X; Wood, James/0000-0002-0258-3188; Wilson, Anthony/0000-0002-2000-2914; Gubbins, Simon/0000-0003-0538-4173	Biotechnology and Biological Sciences Research Council (BBSRC [BBS/B/00603]; Department for Environment, Food and Rural Affairs (Defra [SE4104]; BBSRC [IAH1320]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001320, BBS/E/I/00001409, BBS/B/00603] Funding Source: researchfish; BBSRC [BBS/E/I/00001320, BBS/E/I/00001409] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs (Defra(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC; grant number BBS/B/00603) and the Department for Environment, Food and Rural Affairs (Defra; grant number SE4104) through the Combating Viral Diseases of Livestock (CVDL) initiative. SG also acknowledges additional funding from BBSRC (grant number IAH1320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Carpenter S, 2006, J MED ENTOMOL, V43, P73, DOI 10.1603/0022-2585(2006)043[0073:OSTBVO]2.0.CO;2; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; De Clercq K, 2008, TRANSBOUND EMERG DIS, V55, P352, DOI 10.1111/j.1865-1682.2008.01044.x; De Clercq K, 2008, VET REC, V162, P564, DOI 10.1136/vr.162.17.564; *DEP ENV FOOD RUR, DECL PROT ZON SURV Z; *DEP ENV FOOD RUR, UK BLUET VACC ROLL O; *DEP ENV FOOD RUR, 2008, REP DISTR BLUET INF; Elbers ARW, 2008, PREV VET MED, V87, P31, DOI 10.1016/j.prevetmed.2008.06.003; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Hamers C, 2009, VET REC, V165, P369, DOI 10.1136/vr.165.13.369; Mellor PS, 2008, PREV VET MED, V87, P4, DOI 10.1016/j.prevetmed.2008.06.002; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2009, BIOL ANIM INFECT, P1; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; OURA C, 2009, VACCINE IN PRESS; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; *UK MET OFF, 2009, MIDAS LAND SURF STAT; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wilson A, 2008, PARASITOL RES, V103, pS69, DOI 10.1007/s00436-008-1053-x	25	54	54	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9353	10.1371/journal.pone.0009353	http://dx.doi.org/10.1371/journal.pone.0009353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179768	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900017
J	Dejean, A; Fisher, BL; Corbara, B; Rarevohitra, R; Randrianaivo, R; Rajemison, B; Leponce, M				Dejean, Alain; Fisher, Brian L.; Corbara, Bruno; Rarevohitra, Raymond; Randrianaivo, Richard; Rajemison, Balsama; Leponce, Maurice			Spatial Distribution of Dominant Arboreal Ants in a Malagasy Coastal Rainforest: Gaps and Presence of an Invasive Species	PLOS ONE			English	Article							COMPETITIVE ABILITY; SUPERCOLONIES; AGGRESSION; DIVERSITY; ABUNDANCE; SEX	We conducted a survey along three belt transects located at increasing distances from the coast to determine whether a non-random arboreal ant assemblage, such as an ant mosaic, exists in the rainforest on the Masoala Peninsula, Madagascar. In most tropical rainforests, very populous colonies of territorially dominant arboreal ant species defend absolute territories distributed in a mosaic pattern. Among the 29 ant species recorded, only nine had colonies large enough to be considered potentially territorially dominant; the remaining species had smaller colonies and were considered non-dominant. Nevertheless, the null-model analyses used to examine the spatial structure of their assemblages did not reveal the existence of an ant mosaic. Inland, up to 44% of the trees were devoid of dominant arboreal ants, something not reported in other studies. While two Crematogaster species were not associated with one another, Brachymyrmex cordemoyi was positively associated with Technomyrmex albipes, which is considered an invasive species-a non-indigenous species that has an adverse ecological effect on the habitats it invades. The latter two species and Crematogaster ranavalonae were mutually exclusive. On the other hand, all of the trees in the coastal transect and at least 4 km of coast were occupied by T. albipes, and were interconnected by columns of workers. Technomyrmex albipes workers collected from different trees did not attack each other during confrontation tests, indicating that this species has formed a supercolony along the coast. Yet interspecific aggressiveness did occur between T. albipes and Crematogaster ranavalonae, a native species which is likely territorially dominant based on our intraspecific confrontation tests. These results suggest that the Masoala rainforest is threatened by a potential invasion by T. albipes, and that the penetration of this species further inland might be facilitated by the low density of native, territorially dominant arboreal ants normally able to limit its progression.	[Dejean, Alain] CNRS, Unite Mixte Rech 8172, Kourou, France; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Corbara, Bruno] Univ Blaise Pascal, CNRS, Lab Microorganismes Genome & Environm, Unite Mixte Rech 6023, Aubiere, France; [Rarevohitra, Raymond] Dept Rech Forestieres & Piscicoles, Antananarivo, Madagascar; [Leponce, Maurice] Inst Royal Sci Nat Belgique, Biol Evaluat Sect, B-1040 Brussels, Belgium	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; California Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dejean, A (corresponding author), CNRS, Unite Mixte Rech 8172, Campus Agron,BP 709, Kourou, France.	alain.dejean@wanadoo.fr		CORBARA, Bruno/0000-0003-4232-8234; Dejean, Alain/0000-0002-3561-2248; Fisher, Brian/0000-0002-4653-3270	Solvay S.A.; Direct For Biological Sciences [0842395] Funding Source: National Science Foundation	Solvay S.A.(Solvay SA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was conducted during the 5th Operation canopee as part of a project set up by Pro-Natura International and Ocean Vert sponsored by Solvay S.A. through the SolVin-Bretzel programme. We would also like to thank Francis Halle and Olivier Pascal for inviting us to participate in this operation. We are grateful to Nicolas Lochu and Jean-Yves Serein who gathered samples from the canopy using the single rope technique and to Andrea Dejean for proofreading the first version of the manuscript.	Abbott KL, 2007, BIOL INVASIONS, V9, P453, DOI 10.1007/s10530-006-9052-2; Abbott KL, 2006, DIVERS DISTRIB, V12, P101, DOI 10.1111/j.1366-9516.2006.00193.x; Basset Y, 2003, ARTHROPODS TROPICAL, P474; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; Bluthgen N, 2003, OECOLOGIA, V137, P426, DOI 10.1007/s00442-003-1347-8; Bolton Barry, 2007, Contributions of the American Entomological Institute, V35, P1; BOOSMA JJ, 2003, GENES BEHAV EVOLUTIO, P131; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2008, BASIC APPL ECOL, V9, P316, DOI 10.1016/j.baae.2007.03.001; DJIETOLORDON C, 2005, BIOTROPICA, V37, P420; Fadamiro HY, 2009, ECOL ENTOMOL, V34, P427, DOI 10.1111/j.1365-2311.2009.01102.x; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2000, ECOSIM NULL MODELS S; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Hunt JH, 2003, SCIENCE, V300, P916, DOI 10.1126/science.1085065; Kenne M, 2003, J ECON ENTOMOL, V96, P251, DOI 10.1603/0022-0493-96.2.251; Le Breton J, 2005, J TROP ECOL, V21, P93, DOI 10.1017/S0266467404002019; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; Majer Jonathan D., 1993, P115; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Pfeiffer M, 2008, ECOGRAPHY, V31, P21, DOI 10.1111/j.2007.0906-7590.05172.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Sulaiman SFM, 1997, ACTA HORTIC, P475, DOI 10.17660/ActaHortic.1997.425.51; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; ter Steege H, 1998, BIOTROPICA, V30, P496, DOI 10.1111/j.1744-7429.1998.tb00087.x; TERAYAMA M, 1989, B TOHO GAKUEN, V3, P1; TSUJI K, 1994, BEHAV ECOL SOCIOBIOL, V34, P157, DOI 10.1007/BF00167740; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100	38	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9319	10.1371/journal.pone.0009319	http://dx.doi.org/10.1371/journal.pone.0009319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174474	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700021
J	Verykokakis, M; Boos, MD; Bendelac, A; Adams, EJ; Pereira, P; Kee, BL				Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Adams, Erin J.; Pereira, Pablo; Kee, Barbara L.			Inhibitor of DNA Binding 3 Limits Development of Murine Slam-Associated Adaptor Protein-Dependent "Innate'' gamma delta T cells	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; TEC FAMILY KINASES; TCR-ALPHA-BETA; LYMPHOCYTE DEVELOPMENT; THYMOCYTE DEVELOPMENT; LINEAGE COMMITMENT; ADULT MICE; V(D)J RECOMBINATION; POSITIVE SELECTION	Background: Id3 is a dominant antagonist of E protein transcription factor activity that is induced by signals emanating from the alpha beta and gamma delta T cell receptor (TCR). Mice lacking Id3 were previously shown to have subtle defects in positive and negative selection of TCR alpha beta(+) T lymphocytes. More recently, Id3(-/-) mice on a C57BL/6 background were shown to have a dramatic expansion of gamma delta T cells. Methodology/Principal Findings: Here we report that mice lacking Id3 have reduced thymocyte numbers but increased production of gamma delta T cells that express a V gamma 1.1(+)V delta 6.3(+) receptor with restricted junctional diversity. These V gamma 1.1(+)V delta 6.3(+) T cells have multiple characteristics associated with "innate'' lymphocytes such as natural killer T (NKT) cells including an activated phenotype, expression of the transcription factor PLZF, and rapid production of IFNg and interleukin-4. Moreover, like other "innate'' lymphocyte populations, development of Id3(-/-) V gamma 1.1(+)V delta 6.3(+) T cells requires the signaling adapter protein SAP. Conclusions: Our data provide novel insight into the requirements for development of V gamma 1.1(+)V delta 6.3(+) T cells and indicate a role for Id3 in repressing the response of "innate'' gamma delta T cells to SAP-mediated expansion or survival.	[Verykokakis, Mihalis; Bendelac, Albert; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Verykokakis, Mihalis; Boos, Markus D.; Bendelac, Albert; Adams, Erin J.; Kee, Barbara L.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Bendelac, Albert] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Adams, Erin J.] Univ Chicago, Dept Biochem, Chicago, IL 60637 USA; [Pereira, Pablo] Inst Pasteur, Unite Dev Lymphocytes, Paris, France; [Pereira, Pablo] INSERM, U668, Paris, France	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Verykokakis, M (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu	Pereira, Pablo/M-7224-2014	Pereira, Pablo/0000-0003-1784-2776	National Institutes of Health [R01 CA099978, R01 AI073922, T32 GM07281]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA099978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (R01 CA099978, R01 AI073922 and T32 GM07281) and a Leukemia and Lymphoma Society Scholar Award (http://www.lls.org/hm_lls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 2007, IMMUNITY, V27, P871, DOI 10.1016/j.immuni.2007.11.015; Alonzo ES, 2009, J IMMUNOL; Aono A, 2000, IMMUNOLOGY, V99, P489, DOI 10.1046/j.1365-2567.2000.00987.x; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bain G, 1999, J EXP MED, V190, P1605, DOI 10.1084/jem.190.11.1605; Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Bain G, 1998, SEMIN IMMUNOL, V10, P143, DOI 10.1006/smim.1998.0116; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; CAPONE M, 1995, J IMMUNOL, V154, P5165; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Engel I, 2001, J EXP MED, V194, P733, DOI 10.1084/jem.194.6.733; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; GARMAN RD, 1986, P NATL ACAD SCI USA, V83, P3987, DOI 10.1073/pnas.83.11.3987; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Grigoriadou K, 2003, J IMMUNOL, V171, P2413, DOI 10.4049/jimmunol.171.5.2413; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jones ME, 2007, IMMUNITY, V27, P860, DOI 10.1016/j.immuni.2007.10.014; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Li W, 2007, IMMUNITY, V27, P763, DOI 10.1016/j.immuni.2007.10.008; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Meresse B, 2006, J EXP MED, V203, P1343, DOI 10.1084/jem.20060028; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; O'Brien RL, 2007, IMMUNOL REV, V215, P77, DOI 10.1111/j.1600-065X.2006.00477.x; Pan LH, 1999, MOL CELL BIOL, V19, P5969; Pereira P, 2000, EUR J IMMUNOL, V30, P1988, DOI 10.1002/1521-4141(200007)30:7<1988::AID-IMMU1988>3.0.CO;2-W; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Rivera RR, 2000, IMMUNITY, V12, P17, DOI 10.1016/S1074-7613(00)80155-7; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stewart CA, 2007, EUR J IMMUNOL, V37, P1442, DOI 10.1002/eji.200737354; Taghon T, 2008, SEMIN IMMUNOPATHOL, V30, P383, DOI 10.1007/s00281-008-0134-3; UEDAHAYAKAWA I, 2009, J IMMUNOL IN PRESS; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x	63	70	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9303	10.1371/journal.pone.0009303	http://dx.doi.org/10.1371/journal.pone.0009303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174563	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923700010
J	Beck, SM; Locke, HS; Savine, AC; Jimura, K; Braver, TS				Beck, Stefanie M.; Locke, Hannah S.; Savine, Adam C.; Jimura, Koji; Braver, Todd S.			Primary and Secondary Rewards Differentially Modulate Neural Activity Dynamics during Working Memory	PLOS ONE			English	Article							HUMAN ORBITOFRONTAL CORTEX; COGNITIVE CONTROL; TRANSIENT; BRAIN; MECHANISMS; ACTIVATION; DOPAMINE; FMRI; BEHAVIOR; VALENCE	Background: Cognitive control and working memory processes have been found to be influenced by changes in motivational state. Nevertheless, the impact of different motivational variables on behavior and brain activity remains unclear. Methodology/Principal Findings: The current study examined the impact of incentive category by varying on a within-subjects basis whether performance during a working memory task was reinforced with either secondary (monetary) or primary (liquid) rewards. The temporal dynamics of motivation-cognition interactions were investigated by employing an experimental design that enabled isolation of sustained and transient effects. Performance was dramatically and equivalently enhanced in each incentive condition, whereas neural activity dynamics differed between incentive categories. The monetary reward condition was associated with a tonic activation increase in primarily right-lateralized cognitive control regions including anterior prefrontal cortex (PFC), dorsolateral PFC, and parietal cortex. In the liquid condition, the identical regions instead showed a shift in transient activation from a reactive control pattern (primary probe-based activation) during no-incentive trials to proactive control (primary cue-based activation) during rewarded trials. Additionally, liquid-specific tonic activation increases were found in subcortical regions (amygdala, dorsal striatum, nucleus accumbens), indicating an anatomical double dissociation in the locus of sustained activation. Conclusions/Significance: These different activation patterns suggest that primary and secondary rewards may produce similar behavioral changes through distinct neural mechanisms of reinforcement. Further, our results provide new evidence for the flexibility of cognitive control, in terms of the temporal dynamics of activation.	[Beck, Stefanie M.; Locke, Hannah S.; Savine, Adam C.; Jimura, Koji; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Beck, Stefanie M.] Tech Univ Dresden, Dept Psychol, D-8027 Dresden, Germany	Washington University (WUSTL); Technische Universitat Dresden	Beck, SM (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	tbraver@artsci.wustl.edu		Braver, Todd/0000-0002-2631-3393	National Institutes of Health [RO1 MH066078, R21 DA027821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health grants RO1 MH066078 and R21 DA027821. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Balota DA, 2007, BEHAV RES METHODS, V39, P445, DOI 10.3758/BF03193014; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; CONTURO TE, 1996, SOC NEUR ABSTR, V26, P7; Delgado MR, 2006, SOC COGN AFFECT NEUR, V1, P250, DOI 10.1093/scan/nsl025; Emery L, 2008, NEUROIMAGE, V42, P1577, DOI 10.1016/j.neuroimage.2008.06.021; Engelmann JB, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.004.2009; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Gilbert Alison M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P540, DOI 10.3758/CABN.4.4.540; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; JIMURA K, PREFRONTAL COR UNPUB; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MISCHEL W, 1972, J PERS SOC PSYCHOL, V21, P204, DOI 10.1037/h0032198; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Snyder A.Z., 1996, QUANTIFICATION BRAIN; Speer NK, 2003, COGN AFFECT BEHAV NE, V3, P155, DOI 10.3758/CABN.3.3.155; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 2004, NEUROIMAGE, V21, P1045, DOI 10.1016/j.neuroimage.2003.10.032; VALENTIN VV, 2009, J NEUROPHYS IN PRESS; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	55	92	97	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9251	10.1371/journal.pone.0009251	http://dx.doi.org/10.1371/journal.pone.0009251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556KT	20169080	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500026
J	Patnaik, SK; Kannisto, E; Yendamuri, S				Patnaik, Santosh Kumar; Kannisto, Eric; Yendamuri, Sai			Overexpression of MicroRNA miR-30a or miR-191 in A549 Lung Cancer or BEAS-2B Normal Lung Cell Lines Does Not Alter Phenotype	PLOS ONE			English	Article							SOLID TUMORS; EXPRESSION; IDENTIFICATION; PROGNOSIS; TARGETS; ADENOCARCINOMA; ESTABLISHMENT; SIGNATURES; PROFILES; GENES	Background: MicroRNAs (miRNAs) are small, noncoding RNAs (ribonucleic acids) that regulate translation. Several miRNAs have been shown to be altered in whole cancer tissue compared to normal tissue when quantified by microarray. Based on previous such evidence of differential expression, we chose to study the functional significance of miRNAs miR-30a and -191 alterations in human lung cancer. Methodology/Principal Findings: The functional significance of miRNAs miR-30a and -191 was studied by creating stable transfectants of the lung adenocarcinoma cell line A549 and the immortalized bronchial epithelial cell line BEAS-2B with modest overexpression of miR-30a or -191 using a lentiviral system. When compared to the corresponding controls, both cell lines overexpressing miR-30a or -191 do not demonstrate any significant changes in cell cycle distribution, cell proliferation, adherent colony formation, soft agar colony formation, xenograft formation in a subcutaneous SCID mouse model, and drug sensitivity to doxorubicin and cisplatin. There is a modest increase in cell migration in cell lines overexpressing miR-30a compared to their controls. Conclusions/Significance: Overexpression of miR-30a or -191 does not lead to an alteration in cell cycle, proliferation, xenograft formation, and chemosensitivity of A549 and BEAS-2B cell lines. Using microarray data from whole tumors to select specific miRNAs for functional study may be a suboptimal strategy.	[Patnaik, Santosh Kumar; Kannisto, Eric; Yendamuri, Sai] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Yendamuri, Sai] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patnaik, SK (corresponding author), Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.	sai.yendamuri@roswellpark.org		Yendamuri, Sai/0000-0001-6654-3487	Thoracic Surgery Foundation for Research and Education; Cancer and Leukemia Group B; Buswell Foundation; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Thoracic Surgery Foundation for Research and Education; Cancer and Leukemia Group B; Buswell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work is supported by research grants from the Thoracic Surgery Foundation for Research and Education and the Cancer and Leukemia Group B; SY is supported by a fellowship from the Buswell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; KE Y, 1989, AM J PATHOL, V134, P979; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	18	31	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9219	10.1371/journal.pone.0009219	http://dx.doi.org/10.1371/journal.pone.0009219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169152	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474700013
J	Gruber, A; Manimekalai, MSS; Balakrishna, AM; Hunke, C; Jeyakanthan, J; Preiser, PR; Gruber, G				Grueber, Ardina; Manimekalai, Malathy S. S.; Balakrishna, Asha M.; Hunke, Cornelia; Jeyakanthan, Jeyaraman; Preiser, Peter R.; Grueber, Gerhard			Structural Determination of Functional Units of the Nucleotide Binding Domain (NBD94) of the Reticulocyte Binding Protein Py235 of Plasmodium yoelii	PLOS ONE			English	Article							RED-BLOOD-CELLS; SECONDARY STRUCTURE; CIRCUMSPOROZOITE PROTEIN; ERYTHROCYTE INVASION; PHENOTYPIC VARIATION; RHOPTRY-PROTEIN; ATP SYNTHASE; SUBUNIT-A; PARASITE; VIVAX	Background: Invasion of the red blood cells (RBC) by the merozoite of malaria parasites involves a large number of receptor ligand interactions. The reticulocyte binding protein homologue family (RH) plays an important role in erythrocyte recognition as well as virulence. Recently, it has been shown that members of RH in addition to receptor binding may also have a role as ATP/ADP sensor. A 94 kDa region named Nucleotide-Binding Domain 94 (NBD94) of Plasmodium yoelii YM, representative of the putative nucleotide binding region of RH, has been demonstrated to bind ATP and ADP selectively. Binding of ATP or ADP induced nucleotide-dependent structural changes in the C-terminal hinge-region of NBD94, and directly impacted on the RBC binding ability of RH. Methodology/Principals Findings: In order to find the smallest structural unit, able to bind nucleotides, and its coupling module, the hinge region, three truncated domains of NBD94 have been generated, termed NBD94(444-547), NBD94(566-663) and NBD94(674-793), respectively. Using fluorescence correlation spectroscopy NBD94(444-547) has been identified to form the smallest nucleotide binding segment, sensitive for ATP and ADP, which became inhibited by 4-Chloro-7-nitrobenzofurazan. The shape of NBD94(444-547) in solution was calculated from small-angle X-ray scattering data, revealing an elongated molecule, comprised of two globular domains, connected by a spiral segment of about 73.1 angstrom in length. The high quality of the constructs, forming the hinge-region, NBD94(566-663) and NBD94(674-793) enabled to determine the first crystallographic and solution structure, respectively. The crystal structure of NBD94(566-663) consists of two helices with 97.8 angstrom and 48.6 angstrom in length, linked by a loop. By comparison, the low resolution structure of NBD94(674-793) in solution represents a chair-like shape with three architectural segments. Conclusions: These structures give the first insight into how nucleotide binding impacts on the overall structure of RH and demonstrates the potential use of this region as a novel drug target.	[Grueber, Ardina; Manimekalai, Malathy S. S.; Balakrishna, Asha M.; Hunke, Cornelia; Preiser, Peter R.; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Jeyakanthan, Jeyaraman] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Synchrotron Radiation Research Center	Gruber, A (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ggrueber@ntu.edu.sg	Manikkoth Balakrishna, Asha/AFP-1973-2022; Preiser, Peter R/A-2201-2011	Manikkoth Balakrishna, Asha/0000-0001-5239-9015; , Peter/0000-0003-4331-7000; Jeyakanthan, Jeyaraman/0000-0002-4594-9610	A*STAR BMRC [06/1/22/19/456, 06/1/22/19/467]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR))	This research was supported by A*STAR BMRC (06/1/22/19/456 and 06/1/22/19/467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOULIN C, 1986, NUCL INSTRUM METH A, V249, P399, DOI 10.1016/0168-9002(86)90694-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DLUZEWSKI AR, 1983, PARASITOLOGY, V87, P429, DOI 10.1017/S0031182000082950; DLUZEWSKI AR, 1983, MOL BIOCHEM PARASIT, V9, P145, DOI 10.1016/0166-6851(83)90106-8; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Ellsworth ML, 2004, MED SCI SPORT EXER, V36, P35, DOI 10.1249/01.MSS.0000106284.80300.B2; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; GOLENDA CF, 1990, J HISTOCHEM CYTOCHEM, V38, P475, DOI 10.1177/38.4.2181019; Gruber G, 2002, BIOCHEM BIOPH RES CO, V298, P383, DOI 10.1016/S0006-291X(02)02468-3; Gruner AC, 2004, MICROBES INFECT, V6, P864, DOI 10.1016/j.micinf.2004.04.004; Guinier A., 1955, SMALL ANGLE SCATTERI; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Iyer JK, 2007, MOL MICROBIOL, V65, P333, DOI 10.1111/j.1365-2958.2007.05786.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MEIS JFGM, 1992, PARASITOL RES, V78, P165, DOI 10.1007/BF00931660; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Ogun SA, 2000, EXP PARASITOL, V95, P187, DOI 10.1006/expr.2000.4535; OLSON JA, 1982, J CELL BIOL, V95, P757, DOI 10.1083/jcb.95.3.757; Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9; OSIPCHUK Y, 1992, NATURE, V359, P241, DOI 10.1038/359241a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Ramalingam JK, 2008, J BIOL CHEM, V283, P36386, DOI 10.1074/jbc.M803102200; RANGACHARI K, 1989, MOL BIOCHEM PARASIT, V34, P63, DOI 10.1016/0166-6851(89)90020-0; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schafer HJ, 2001, BIOCHEM BIOPH RES CO, V286, P1218, DOI 10.1006/bbrc.2001.5502; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; SUTTON R, 1985, EUR J BIOCHEM, V148, P551, DOI 10.1111/j.1432-1033.1985.tb08875.x; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Svergun DI, 2000, BIOCHEMISTRY-US, V39, P10677, DOI 10.1021/bi000865p; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TRIGLIA T, 2009, CELL MICROB IN PRESS; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x	67	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9146	10.1371/journal.pone.0009146	http://dx.doi.org/10.1371/journal.pone.0009146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161776	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442700010
J	Uys, C; Hamer, M; Slotow, R				Uys, Charmaine; Hamer, Michelle; Slotow, Rob			Step Process for Selecting and Testing Surrogates and Indicators of Afrotemperate Forest Invertebrate Diversity	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; AGRICULTURAL LANDSCAPES; EPIGAEIC INVERTEBRATES; HABITAT DISTURBANCE; SPECIES RICHNESS; TAXA; CONSERVATION; ASSEMBLAGES; SCORPIONIDA; STRATEGIES	Background: The diversity and complexity of invertebrate communities usually result in their exclusion from conservation activities. Here we provide a step process for assessing predominantly ground-dwelling Afrotemperate forest invertebrates' (earthworms, centipedes, millipedes, ants, molluscs) potential as surrogates for conservation and indicators for monitoring. We also evaluated sampling methods (soil and litter samples, pitfall traps, active searching quadrats and tree beating) and temporal (seasonal) effects. Methodology/Principal Findings: Lack of congruence of species richness across taxa indicated poor surrogacy potential for any of the focus taxa. Based on abundance and richness, seasonal stability, and ease of sampling, molluscs were the most appropriate taxon for use in monitoring of disturbance impacts. Mollusc richness was highest in March (Antipodal late summer wet season). The most effective and efficient methods were active searching quadrats and searching litter samples. We tested the effectiveness of molluscs as indicators for monitoring by contrasting species richness and community structure in burned relative to unburned forests. Both species richness and community structure changed significantly with burning. Some mollusc species (e. g. Macroptychia africana) showed marked negative responses to burning, and these species have potential for use as indicators. Conclusions/Significance: Despite habitat type (i.e., Afrotemperate forest) being constant, species richness and community structure varied across forest patches. Therefore, in conservation planning, setting targets for coarse filter features (e. g., habitat type) requires fine filter features (e. g., localities for individual species). This is especially true for limited mobility taxa such as those studied here. Molluscs have high potential for indicators for monitoring, and this requires broader study.	[Uys, Charmaine; Hamer, Michelle; Slotow, Rob] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, Kwazulunatal, South Africa	University of Kwazulu Natal	Uys, C (corresponding author), Univ Cape Town, Dept Zool, ZA-7700 Rondebosch, Western Cape, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	National Research Foundation	National Research Foundation	Financial support for this study was provided by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTI D, 2005, ANTBASE; Andersen AN, 1999, J INSECT CONSERV, V3, P61; Andersen AN, 2004, AUSTRAL ECOL, V29, P87, DOI 10.1111/j.1442-9993.2004.01362.x; Andersen AN, 2004, FRONT ECOL ENVIRON, V2, P291; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bilton DT, 2006, FRESHWATER BIOL, V51, P578, DOI 10.1111/j.1365-2427.2006.01505.x; CLARKE KR, 2001, PRIMER VERSION 5; Didham RK, 2003, ARTHROPODS OF TROPICAL FORESTS, P28; Druce D, 2004, AFR ZOOL, V39, P293; Druce D, 2007, AFR ZOOL, V42, P204, DOI 10.3377/1562-7020(2007)42[204:POMDCC]2.0.CO;2; Emberton KC, 1996, MALACOLOGIA, V38, P203; Fontaine B, 2007, DIVERS DISTRIB, V13, P725, DOI 10.1111/j.1472-4642.2007.00376.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOVENDER V, 2009, THESIS U KWAZULU NAT; Hamer M. L., 1997, Annals of the Natal Museum, V38, P283; Hamer M. L., 1998, Annals of the Natal Museum, V39, P11; Hamer ML, 2002, AFR ENTOMOL, V10, P29; Hemp A, 2009, AFR J ECOL, V47, P3, DOI 10.1111/j.1365-2028.2008.01043.x; Herbert D, 2004, FIELD GUIDE LAND SNA; HORN JL, 2007, AFRICAN ZOOLOGY, V42, P171; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hurlbert SH, 2004, OIKOS, V104, P591, DOI 10.1111/j.0030-1299.2004.12752.x; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Kati V, 2004, CONSERV BIOL, V18, P667, DOI 10.1111/j.1523-1739.2004.00465.x; Kotze DJ, 1999, J INSECT CONSERV, V3, P125, DOI 10.1023/A:1009660601372; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Lawes MJ, 2005, BIOTROPICA, V37, P109, DOI 10.1111/j.1744-7429.2005.04054.x; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Lawrence R. F., 1984, CENTIPEDES MILLIPEDE; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; LOVELL S, 2010, AUSTR ECOLO IN PRESS; Lovell S, 2007, BIOL CONSERV, V139, P113, DOI 10.1016/j.biocon.2007.06.008; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; MESIBOV R, 1995, BIODIVERS CONSERV, V4, P429, DOI 10.1007/BF00058426; MUCINA L, 2006, VEGETATION S AFRICA, V19, pCH12; New TR, 2000, J INSECT CONSERV, V4, P153, DOI 10.1023/A:1009668817271; New TR, 1999, J INSECT CONSERV, V3, P251, DOI 10.1023/A:1009697104759; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Parr CL, 2002, AFR ENTOMOL, V10, P101; Pickford G. E., 1937, MONOGRAPH ACANTHODRI; Plisko Jadwiga Danuta, 2003, African Invertebrates, V44, P279; Pocock MJO, 2008, J APPL ECOL, V45, P151, DOI 10.1111/j.1365-2664.2007.01361.x; Ponder W. F., 1999, OTHER 99 CONSERVATIO; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricketts TH, 2002, BIOL CONSERV, V103, P361, DOI 10.1016/S0006-3207(01)00147-1; Rohr JR, 2007, CONSERV BIOL, V21, P422, DOI 10.1111/j.1523-1739.2006.00578.x; Sauberer N, 2004, BIOL CONSERV, V117, P181, DOI 10.1016/S0006-3207(03)00291-X; Schulze RE., 1997, S AFRICAN ATLAS AGRO; Scott WA, 2003, BIOL CONSERV, V110, P197, DOI 10.1016/S0006-3207(02)00189-1; Slotow R, 2000, S AFR J SCI, V96, P222; Stanisic J, 2007, MALACOLOGIA, V49, P445, DOI 10.4002/0076-2997-49.2.445; Summerville KS, 2004, BIOL CONSERV, V116, P9, DOI 10.1016/S0006-3207(03)00168-X; Underwood EC, 2006, BIOL CONSERV, V132, P166, DOI 10.1016/j.biocon.2006.03.022; Uys C, 2009, AFR J ECOL, V47, P341, DOI 10.1111/j.1365-2028.2008.00968.x; Ward DF, 2004, NEW ZEAL J ECOL, V28, P151	59	15	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9100	10.1371/journal.pone.0009100	http://dx.doi.org/10.1371/journal.pone.0009100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161757	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600007
J	Wiley, JC; Meabon, JS; Frankowski, H; Smith, EA; Schecterson, LC; Bothwell, M; Ladiges, WC				Wiley, Jesse C.; Meabon, James S.; Frankowski, Harald; Smith, Elise A.; Schecterson, Leslayann C.; Bothwell, Mark; Ladiges, Warren C.			Phenylbutyric Acid Rescues Endoplasmic Reticulum Stress-Induced Suppression of APP Proteolysis and Prevents Apoptosis in Neuronal Cells	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE COMPLEX; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; BETA-SECRETASE; MOUSE MODEL; PRESENILIN MUTATIONS; ALPHA-SECRETASE; ER STRESS; IN-VIVO	Background: The familial and sporadic forms of Alzheimer's disease (AD) have an identical pathology with a severe disparity in the time of onset [1]. The pathological similarity suggests that epigenetic processes may phenocopy the Familial Alzheimer's disease (FAD) mutations within sporadic AD. Numerous groups have demonstrated that FAD mutations in presenilin result in 'loss of function' of gamma-secretase mediated APP cleavage [2,3,4,5]. Accordingly, ER stress is prominent within the pathologically impacted brain regions in AD patients [6] and is reported to inhibit APP trafficking through the secretory pathway [7,8]. As the maturation of APP and the cleaving secretases requires trafficking through the secretory pathway [9,10,11], we hypothesized that ER stress may block trafficking requisite for normal levels of APP cleavage and that the small molecular chaperone 4-phenylbutyrate (PBA) may rescue the proteolytic deficit. Methodology/Principal Findings: The APP-Gal4VP16/Gal4-reporter screen was stably incorporated into neuroblastoma cells in order to assay gamma-secretase mediated APP proteolysis under normal and pharmacologically induced ER stress conditions. Three unrelated pharmacological agents (tunicamycin, thapsigargin and brefeldin A) all repressed APP proteolysis in parallel with activation of unfolded protein response (UPR) signaling-a biochemical marker of ER stress. Co-treatment of the gamma-secretase reporter cells with PBA blocked the repressive effects of tunicamycin and thapsigargin upon APP proteolysis, UPR activation, and apoptosis. In unstressed cells, PBA stimulated gamma-secretase mediated cleavage of APP by 8-10 fold, in the absence of any significant effects upon amyloid production, by promoting APP trafficking through the secretory pathway and the stimulation of the non-pathogenic alpha/gamma-cleavage. Conclusions/Significance: ER stress represses gamma-secretase mediated APP proteolysis, which replicates some of the proteolytic deficits associated with the FAD mutations. The small molecular chaperone PBA can reverse ER stress induced effects upon APP proteolysis, trafficking and cellular viability. Pharmaceutical agents, such as PBA, that stimulate alpha/gamma-cleavage of APP by modifying intracellular trafficking should be explored as AD therapeutics.	[Wiley, Jesse C.; Smith, Elise A.; Ladiges, Warren C.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Meabon, James S.; Frankowski, Harald; Schecterson, Leslayann C.; Bothwell, Mark] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wiley, JC (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	jwiley@u.washington.edu	Longo, Kenneth A/A-5631-2010	SCHECTERSON, LESLAYANN/0000-0002-3896-998X; Bothwell, Mark/0000-0001-5423-2702	Alzheimer's Association [NIRG-07-59865]	Alzheimer's Association(Alzheimer's Association)	This work was funded by a New Investigator Award from the Alzheimer's Association (NIRG-07-59865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BASSERI S, 2009, J LIPID RES; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Domingues SCTS, 2007, ANN NY ACAD SCI, V1096, P184, DOI 10.1196/annals.1397.085; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Hu QB, 2005, J BIOL CHEM, V280, P12548, DOI 10.1074/jbc.M411855200; HUNZIKER W, 1992, FEBS LETT, V307, P93, DOI 10.1016/0014-5793(92)80908-Y; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jung M, 2001, CURR MED CHEM, V8, P1505, DOI 10.2174/0929867013372058; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Nakayama K, 2008, NEUROSCI LETT, V444, P127, DOI 10.1016/j.neulet.2008.08.034; Nishitsuji K, 2009, AM J PATHOL, V174, P957, DOI 10.2353/ajpath.2009.080480; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; OZAKI T, 2006, BIOCH BIOPHYS RES CO; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; RICOBARAZA A, 2009, NEUROPSYCHOPHARMACOL; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheper W, 2009, CURR MED CHEM, V16, P615, DOI 10.2174/092986709787458506; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; van den Brandt J, 2004, EUR J IMMUNOL, V34, P1405, DOI 10.1002/eji.200324735; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wiley JC, 2007, J BIOL CHEM, V282, P33313, DOI 10.1074/jbc.M706024200; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yang Z, 2006, J BIOL CHEM, V281, P4207, DOI 10.1074/jbc.M508445200	59	60	65	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9135	10.1371/journal.pone.0009135	http://dx.doi.org/10.1371/journal.pone.0009135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161760	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600031
J	Do, T; Gilbert, SC; Clark, D; Ali, F; Parolo, CCF; Maltz, M; Russell, RR; Holbrook, P; Wade, WG; Beighton, D				Do, Thuy; Gilbert, Steven C.; Clark, Douglas; Ali, Farida; Parolo, Clarissa C. Fatturi; Maltz, Marisa; Russell, Roy R.; Holbrook, Peter; Wade, William G.; Beighton, David			Generation of Diversity in Streptococcus mutans Genes Demonstrated by MLST	PLOS ONE			English	Article							CLONAL POPULATION-STRUCTURE; POLYMERASE-CHAIN-REACTION; SEQUENCE TYPING SCHEME; ORAL STREPTOCOCCI; RAPID IDENTIFICATION; MOLECULAR EVOLUTION; DNA; RECOMBINATION; SEROTYPE; STRAINS	Streptococcus mutans, consisting of serotypes c, e, f and k, is an oral aciduric organism associated with the initiation and progression of dental caries. A total of 135 independent Streptococcus mutans strains from caries-free and caries-active subjects isolated from various geographical locations were examined in two versions of an MLST scheme consisting of either 6 housekeeping genes [accC (acetyl-CoA carboxylase biotin carboxylase subunit), gki (glucokinase), lepA (GTP-binding protein), recP (transketolase), sodA (superoxide dismutase), and tyrS (tyrosyl-tRNA synthetase)] or the housekeeping genes supplemented with 2 extracellular putative virulence genes [gtfB (glucosyltransferase B) and spaP (surface protein antigen I/II)] to increase sequence type diversity. The number of alleles found varied between 20 (lepA) and 37 (spaP). Overall, 121 sequence types (STs) were defined using the housekeeping genes alone and 122 with all genes. However pi, nucleotide diversity per site, was low for all loci being in the range 0.019-0.007. The virulence genes exhibited the greatest nucleotide diversity and the recombination/mutation ratio was 0.67 [95% confidence interval 0.3-1.15] compared to 8.3 [95% confidence interval 5.0-14.5] for the 6 concatenated housekeeping genes alone. The ML trees generated for individual MLST loci were significantly incongruent and not significantly different from random trees. Analysis using ClonalFrame indicated that the majority of isolates were singletons and no evidence for a clonal structure or evidence to support serotype c strains as the ancestral S. mutans strain was apparent. There was also no evidence of a geographical distribution of individual isolates or that particular isolate clusters were associated with caries. The overall low sequence diversity suggests that S. mutans is a newly emerged species which has not accumulated large numbers of mutations but those that have occurred have been shuffled as a consequence of intra-species recombination generating genotypes which can be readily distinguished by sequence analysis.	[Do, Thuy; Gilbert, Steven C.; Clark, Douglas; Ali, Farida; Wade, William G.; Beighton, David] Kings Coll London, Inst Dent, Infect Res Grp, London WC2R 2LS, England; [Parolo, Clarissa C. Fatturi; Maltz, Marisa] Univ Fed Rio Grande do Sul, Fac Dent, Dept Social & Prevent Med, Porto Alegre, RS, Brazil; [Russell, Roy R.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Holbrook, Peter] Univ Iceland, Fac Odontol, Reykjavik, Iceland	University of London; King's College London; Universidade Federal do Rio Grande do Sul; Newcastle University - UK; University of Iceland	Do, T (corresponding author), Kings Coll London, Inst Dent, Infect Res Grp, London WC2R 2LS, England.	david.beighton@kcl.ac.uk	Russell, Roy/A-1685-2008	Parolo, Clarissa/0000-0001-6477-4521; Wade, William/0000-0003-2685-826X	Wellcome Trust [076381]; Department of Health via the National Institute for Health Research (NIHR); Comprehensive Biomedical Research Centre; NHS Foundation Trust; Brazilian Ministry of Science and Technology [480841/2007-1]; Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Comprehensive Biomedical Research Centre; NHS Foundation Trust; Brazilian Ministry of Science and Technology; Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The project was supported by the Wellcome Trust [Supported Grant 076381], the Department of Health via the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre award to Guy's National Health Service (NHS) Foundation Trust in partnership with King's College Hospital NHS Foundation Trust, the Brazilian Ministry of Science and Technology, through its National Council of Research (CNPq) agency (grant 480841/2007-1) and the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; BEIGHTON D, 1991, CARIES RES, V25, P174, DOI 10.1159/000261363; BERKOWITZ RJ, 1985, ARCH ORAL BIOL, V30, P377, DOI 10.1016/0003-9969(85)90014-7; Bratthall D, 1972, Odontol Revy Suppl, V23, P1; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Caufield PW, 2007, J BACTERIOL, V189, P1238, DOI 10.1128/JB.01183-06; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P1918; CAUFIELD PW, 1989, J CLIN MICROBIOL, V27, P274, DOI 10.1128/JCM.27.2.274-278.1989; Chen Z, 2007, FEMS MICROBIOL LETT, V272, P154, DOI 10.1111/j.1574-6968.2007.00756.x; Coffey TJ, 2006, APPL ENVIRON MICROB, V72, P1420, DOI 10.1128/AEM.72.2.1420-1428.2006; DAVEY AL, 1984, ARCH ORAL BIOL, V29, P453, DOI 10.1016/0003-9969(84)90026-8; de las Rivas B, 2006, MICROBIOL-SGM, V152, P85, DOI 10.1099/mic.0.28482-0; Delorme C, 2007, J BACTERIOL, V189, P1330, DOI 10.1128/JB.01058-06; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Do T, 2009, MICROBIOL-SGM, V155, P2593, DOI 10.1099/mic.0.027284-0; Edwards MT, 2008, MICROBIOL-SGM, V154, P852, DOI 10.1099/mic.0.2007/012336-0; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Gronroos L, 2000, CARIES RES, V34, P474, DOI 10.1159/000016626; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igarashi T, 1996, MICROBIOL IMMUNOL, V40, P867, DOI 10.1111/j.1348-0421.1996.tb01152.x; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lachenauer CS, 2000, P NATL ACAD SCI USA, V97, P9630, DOI 10.1073/pnas.97.17.9630; Li Y, 1998, ORAL MICROBIOL IMMUN, V13, P17, DOI 10.1111/j.1399-302X.1998.tb00745.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MA JKC, 1991, INFECT IMMUN, V59, P2686, DOI 10.1128/IAI.59.8.2686-2694.1991; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marsh P D, 1994, Adv Dent Res, V8, P263; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; Mineyama R, 2007, MICROBIOL RES, V162, P244, DOI 10.1016/j.micres.2006.06.014; Nakano K, 2004, J CLIN MICROBIOL, V42, P4925, DOI 10.1128/JCM.42.11.4925-4930.2004; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.42.1.198-202.2004; Nakano K, 2007, J CLIN MICROBIOL, V45, P2616, DOI 10.1128/JCM.02343-06; Oha T, 2000, ORAL MICROBIOL IMMUN, V15, P258, DOI 10.1034/j.1399-302x.2000.150408.x; PERCH B, 1974, ACTA PATH MICRO IM B, VB 82, P357; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; SAARELA M, 1993, J CLIN MICROBIOL, V31, P584, DOI 10.1128/JCM.31.3.584-587.1993; Saarela M, 1996, ARCH ORAL BIOL, V41, P821, DOI 10.1016/S0003-9969(96)00049-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shibata Y, 2003, J CLIN MICROBIOL, V41, P4107, DOI 10.1128/JCM.41.9.4107-4112.2003; SMITH JM, 1994, J MOL EVOL, V39, P123; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toi CS, 2005, ANTON LEEUW INT J G, V88, P75, DOI 10.1007/s10482-005-1674-3; Truong TL, 2000, J MED MICROBIOL, V49, P63, DOI 10.1099/0022-1317-49-1-63; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wan AKL, 2001, J DENT RES, V80, P2060, DOI 10.1177/00220345010800120701; Waterhouse JC, 2007, ORAL MICROBIOL IMMUN, V22, P216, DOI 10.1111/j.1399-302X.2007.00330.x; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0; Whiley RA, 1998, ORAL MICROBIOL IMMUN, V13, P195, DOI 10.1111/j.1399-302X.1998.tb00698.x	63	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9073	10.1371/journal.pone.0009073	http://dx.doi.org/10.1371/journal.pone.0009073			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140210	gold, Green Published			2022-12-27	WOS:000274442400012
J	Jenkins, R; Kydd, R; Mullen, P; Thomson, K; Sculley, J; Kuper, S; Carroll, J; Gureje, O; Hatcher, S; Brownie, S; Carroll, C; Hollins, S; Wong, ML				Jenkins, Rachel; Kydd, Robert; Mullen, Paul; Thomson, Kenneth; Sculley, James; Kuper, Susan; Carroll, Joanna; Gureje, Oye; Hatcher, Simon; Brownie, Sharon; Carroll, Christopher; Hollins, Sheila; Wong, Mai Luen			International Migration of Doctors, and Its Impact on Availability of Psychiatrists in Low and Middle Income Countries	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BRAIN-DRAIN; HEALTH-PROFESSIONALS; PHYSICIANS; SERVICES	Background: Migration of health professionals from low and middle income countries to rich countries is a large scale and long-standing phenomenon, which is detrimental to the health systems in the donor countries. We sought to explore the extent of psychiatric migration. Methods: In our study, we use the respective professional databases in each country to establish the numbers of psychiatrists currently registered in the UK, US, New Zealand, and Australia who originate from other countries. We also estimate the impact of this migration on the psychiatrist population ratios in the donor countries. Findings: We document large numbers of psychiatrists currently registered in the UK, US, New Zealand and Australia originating from India (4687 psychiatrists), Pakistan (1158), Bangladesh (149), Nigeria (384), Egypt (484), Sri Lanka (142), Philippines (1593). For some countries of origin, the numbers of psychiatrists currently registered within high-income countries' professional databases are very small (e. g., 5 psychiatrists of Tanzanian origin registered in the 4 high-income countries we studied), but this number is very significant compared to the 15 psychiatrists currently registered in Tanzania). Without such emigration, many countries would have more than double the number of psychiatrists per 100, 000 population (e. g. Bangladesh, Myanmar, Afghanistan, Egypt, Syria, Lebanon); and some countries would have had five to eight times more psychiatrists per 100,000 (e. g. Philippines, Pakistan, Sri Lanka, Liberia, Nigeria and Zambia). Conclusions: Large numbers of psychiatrists originating from key low and middle income countries are currently registered in the UK, US, New Zealand and Australia, with concomitant impact on the psychiatrist/population ratio n the originating countries. We suggest that creative international policy approaches are needed to ensure the individual migration rights of health professionals do not compromise societal population rights to health, and that there are public and fair agreements between countries within an internationally agreed framework.	[Jenkins, Rachel; Wong, Mai Luen] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England; [Kydd, Robert] Univ Auckland, Dept Psychiat & Behav Sci, Auckland 1, New Zealand; [Mullen, Paul] Monash Univ, Dept Forens Sci, Clayton, Vic 3800, Australia; [Thomson, Kenneth] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Sculley, James] S Carolina Sch Med, Dept Neuropsychiat & Behav Sci, Columbia, SC USA; [Kuper, Susan] Amer Psychiat Assoc, Dept Memberships, Arlington, VA USA; [Carroll, Joanna] Royal Coll Psychiatrists, Dept Int Affairs, London SW1X 8PG, England; [Gureje, Oye] Univ Ibadan, Dept Psychiat, Ibadan, Nigeria; [Hatcher, Simon] Univ Auckland, Dept Med & Hlth Sci, Auckland 1, New Zealand; [Brownie, Sharon] Royal Australian & New Zealand Coll Psychiatrists, Canberra, ACT, Australia; [Carroll, Christopher] US Dept HHS, Washington, DC 20201 USA; [Hollins, Sheila] Royal Coll Psychiatrists, Deanery Dept, London SW1X 8PG, England	University of London; King's College London; University of Auckland; Monash University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of South Carolina; University of Ibadan; University of Auckland	Jenkins, R (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England.	r.jenkins@iop.kcl.ac.uk	Brownie, Dr Sharon M/U-9754-2019; Adewuya, Abiodun/N-4997-2017; Gureje, Oye/J-1183-2014; Jenkins, Rachel/H-2953-2019; Jenkins, Rachel/E-4287-2010	Brownie, Dr Sharon M/0000-0001-7204-2451; Adewuya, Abiodun/0000-0002-7611-6953; Gureje, Oye/0000-0003-0094-5947; Jenkins, Rachel/0000-0002-2958-0331; Jenkins, Rachel/0000-0002-2958-0331; Hatcher, Simon/0000-0003-3117-2350				[Anonymous], 2006, WORK TOG HLTH; BUCHAN J., 2006, NURSE MIGRATION COMM; BUCHAN J, 2005, TRENDS FUTURE UNCERT; BUCHAN J, 2006, BOOM BUST UK NURSING; Buchan J., 2004, INT RECRUITMENT HLTH; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Dambisya YM, 2007, REV NONFINANCIAL INC; Dovlo D., 2004, I FUT STUD WORKSH GL; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; Emeagwali P., 2010, THE BRAIN DRAIN; GILLON R, 1993, PRINCIPLES HLTH CARE; Global Health Workforce Alliance, 2008, SCAL SAV LIV TASKF S; Gureje O, 2009, WORLD PSYCHIATRY, V8, P115; Hagopian A, 2005, SOC SCI MED, V61, P1750, DOI 10.1016/j.socscimed.2005.03.027; Hagopian A, 2007, ANN FAM MED, V5, P483, DOI 10.1370/afm.787; Hagopian Amy, 2004, Hum Resour Health, V2, P17, DOI 10.1186/1478-4491-2-17; Jenkins R., 2002, DEV NATL MENTAL HLTH; Jenkins Rachel, 2003, World Psychiatry, V2, P14; Johnson K, 2006, ACAD MED, V81, P179, DOI 10.1097/00001888-200602000-00019; KLEIN D, 2009, INT FAMILY MED, V41, P197; LORENZO FME, 2005, PHILIPPINE CASE STUD; Mahroum S, 2001, INT MIGR, V39, P27, DOI 10.1111/1468-2435.00170; MARILYN ELF, 2007, HEALTH SERV RES, V42, P1406; Martineau T, 2004, HEALTH POLICY, V70, P1, DOI 10.1016/j.healthpol.2004.01.006; Mejia A., 1979, PHYS NURSE MIGRATION; Mills EJ, 2008, LANCET, V371, P685, DOI 10.1016/S0140-6736(08)60308-6; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; MURTHY S, 2005, INT PSYCHIAT, P5; NDETEI D, 2004, INT PSYCHIAT, P15; Ogilvie L, 2007, NURS INQ, V14, P114, DOI 10.1111/j.1440-1800.2007.00358.x; Perrin ME, 2007, INT NURS REV, V54, P219, DOI 10.1111/j.1466-7657.2007.00567.x; ROSS S, 2005, INT NURS REV, P553; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Simoens S., 2005, TACKLING NURSE SHORT; Stalker P., 2000, WORKERS FRONTIERS IM; Stilwell Barbara, 2003, Hum Resour Health, V1, P8, DOI 10.1186/1478-4491-1-8; TAN JG, 2006, MASS MIGRATION PHILL; WHO, 2001, WORLD HLTH REPORT 20	39	55	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9049	10.1371/journal.pone.0009049	http://dx.doi.org/10.1371/journal.pone.0009049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554ZB	20140216	gold, Green Accepted, Green Published			2022-12-27	WOS:000274474400008
J	Tanzer, M; Balluff, B; Distler, J; Hale, K; Leodolter, A; Rocken, C; Molnar, B; Schmid, R; Lofton-Day, C; Schuster, T; Ebert, MPA				Taenzer, Marc; Balluff, Benjamin; Distler, Juergen; Hale, Kari; Leodolter, Andreas; Roecken, Christoph; Molnar, Bela; Schmid, Roland; Lofton-Day, Catherine; Schuster, Tibor; Ebert, Matthias P. A.			Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions	PLOS ONE			English	Article							FECAL OCCULT BLOOD; DNA-METHYLATION; CANCER; COLITIS	Background: Screening for colorectal cancer (CRC) has shown to reduce cancer-related mortality, however, acceptance and compliance to current programmes are poor. Developing new, more acceptable non-invasive tests for the detection of cancerous and precancerous colorectal lesions would not only allow preselection of individuals for colonoscopy, but may also prevent cancer by removal of precancerous lesions. Methods: Plasma from 128 individuals (cohort I - exploratory study: 73 cases / 55 controls) was used to test the performance of a single marker, SEPT9, using a real-time quantitative PCR assay. To validate performance of SEPT9, plasma of 76 individuals (cohort II - validation study: 54 cases / 22 controls) was assessed. Additionally, improvement of predictive capability considering SEPT9 and additionally ALX4 methylation was investigated within these patients. Results: In both cohorts combined, methylation of SEPT9 was observed in 9% of controls (3/33), 29% of patients with colorectal precancerous lesions (27/94) and 73% of colorectal cancer patients (24/33). The presence of both SEPT9 and ALX4 markers was analysed in cohort II and was observed in 5% of controls (1/22) and 37% of patients with polyps (18/49). Interestingly, also 3/5 (60%) patients with colorectal cancer were tested positive by the two marker panel in plasma. Conclusions: While these data confirm the detection rate of SEPT9 as a biomarker for colorectal cancer, they also show that methylated DNA from advanced precancerous colorectal lesions can be detected using a panel of two DNA methylation markers, ALX4 and SEPT9. If confirmed in larger studies these data indicate that screening for colorectal precancerous lesions with a blood-based test may be as feasible as screening for invasive cancer.	[Taenzer, Marc; Balluff, Benjamin; Schmid, Roland; Ebert, Matthias P. A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany; [Distler, Juergen; Hale, Kari; Lofton-Day, Catherine] Epigenomics Inc, Seattle, WA USA; [Leodolter, Andreas] Jung Stilling Krankenhaus, Dept Med, Siegen, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, D-2300 Kiel, Germany; [Molnar, Bela] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary; [Schuster, Tibor] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, D-8000 Munich, Germany	Technical University of Munich; University of Kiel; Semmelweis University; Technical University of Munich	Tanzer, M (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany.	Matthias.Ebert@lrz.tum.de	Röcken, Christoph/A-9239-2010	Röcken, Christoph/0000-0002-6989-8002	Deutsche Krebshilfe [107885]; Deutsche Forschungsgemeinschaft [SFB 824, TP B1]; Else Kroner Stiftung [P14/07//A104/06]; Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF) [Mobimed 01EZ0802]; BMBF [0315116B]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Stiftung; Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	M. Ebert is supported by grants from the Deutsche Krebshilfe (107885), the Deutsche Forschungsgemeinschaft (SFB 824, TP B1), the Else Kroner Stiftung (Nr P14/07//A104/06) and the Bundesministerium fur Bildung und Forschung - German Federal Ministry for Education and Research (BMBF) (Mobimed 01EZ0802). This study was also supported by a grant from the KMU-innovativ Initiative of the BMBF (No 0315116B) awarded to M. Ebert and J. Distler. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. J. Distler, C. Lofton-Day and K. Hale are employees of Epigenomics. Epigenomics did not provide funding for conduct of the experiments within this project. However, Epigenomcis provided information on the assays for methylation analysis which were developed by its employees. Analysis of the samples and interpretation of the data was performed independent of Epigenomics by the first and senior author. Epigenomics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cottrell SE, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh008; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Ebert MPA, 2006, GASTROENTEROLOGY, V131, P1418, DOI 10.1053/j.gastro.2006.08.034; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Howarth GF, 2002, AM J GASTROENTEROL, V97, P690; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Okamoto M, 2005, AM J TROP MED HYG, V73, P934; Petko Z, 2005, CLIN CANCER RES, V11, P1203; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Sobin, 2009, UICC TNM CLASSIFICAT; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Traverso G, 2002, NEW ENGL J MED, V346, P311, DOI 10.1056/NEJMoa012294; Walsh JME, 2003, JAMA-J AM MED ASSOC, V289, P1297, DOI 10.1001/jama.289.10.1297	22	129	145	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9061	10.1371/journal.pone.0009061	http://dx.doi.org/10.1371/journal.pone.0009061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140221	gold, Green Published			2022-12-27	WOS:000274474400017
J	Boyko, A; Blevins, T; Yao, YL; Golubov, A; Bilichak, A; Ilnytskyy, Y; Hollander, J; Meins, F; Kovalchuk, I				Boyko, Alex; Blevins, Todd; Yao, Youli; Golubov, Andrey; Bilichak, Andriy; Ilnytskyy, Yaroslav; Hollander, Jens; Meins, Frederick, Jr.; Kovalchuk, Igor			Transgenerational Adaptation of Arabidopsis to Stress Requires DNA Methylation and the Function of Dicer-Like Proteins	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; RNA BIOGENESIS; GENOMIC DNA; PICEA-ABIES; PLANTS; TEMPERATURE; RADIATION; PATHWAY; SIRNAS; MEMORY	Epigenetic states and certain environmental responses in mammals and seed plants can persist in the next sexual generation. These transgenerational effects have potential adaptative significance as well as medical and agronomic ramifications. Recent evidence suggests that some abiotic and biotic stress responses of plants are transgenerational. For example, viral infection of tobacco plants and exposure of Arabidopsis thaliana plants to UVC and flagellin can induce transgenerational increases in homologous recombination frequency (HRF). Here we show that exposure of Arabidopsis plants to stresses, including salt, UVC, cold, heat and flood, resulted in a higher HRF, increased global genome methylation, and higher tolerance to stress in the untreated progeny. This transgenerational effect did not, however, persist in successive generations. Treatment of the progeny of stressed plants with 5-azacytidine was shown to decrease global genomic methylation and enhance stress tolerance. Dicer-like (DCL) 2 and DCL3 encode Dicer activities important for small RNA-dependent gene silencing. Stress-induced HRF and DNA methylation were impaired in dcl2 and dcl3 deficiency mutants, while in dcl2 mutants, only stress-induced stress tolerance was impaired. Our results are consistent with the hypothesis that stress-induced transgenerational responses in Arabidopsis depend on altered DNA methylation and smRNA silencing pathways.	[Boyko, Alex; Yao, Youli; Golubov, Andrey; Bilichak, Andriy; Ilnytskyy, Yaroslav; Kovalchuk, Igor] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Blevins, Todd] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Hollander, Jens; Meins, Frederick, Jr.] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Hollander, Jens] Univ Ghent, Dept Mol Genet, B-9000 Ghent, Belgium	University of Lethbridge; Friedrich Miescher Institute for Biomedical Research; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Boyko, A (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada.	igor.kovalchuk@uleth.ca	Golubov, Andrey/P-7993-2019; Hollunder, Jens/G-6588-2016	Golubov, Andrey/0000-0003-0111-8273; Hollunder, Jens/0000-0003-3234-6762	Human Frontiers Research Program; National Science and Engineering Research Council of Canada	Human Frontiers Research Program; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Human Frontiers Research Program, National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Baubec T, 2009, PLANT J, V57, P542, DOI 10.1111/j.1365-313X.2008.03699.x; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Blodner C, 2007, PLANT CELL ENVIRON, V30, P165, DOI 10.1111/j.1365-3040.2006.01615.x; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bond DM, 2007, TRENDS PLANT SCI, V12, P211, DOI 10.1016/j.tplants.2007.03.010; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boyko A, 2006, PLANT CELL PHYSIOL, V47, P736, DOI 10.1093/pcp/pcj045; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Daxinger L, 2009, EMBO J, V28, P48, DOI 10.1038/emboj.2008.260; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Galloway LF, 2007, SCIENCE, V318, P1134, DOI 10.1126/science.1148766; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Hartung F, 2006, NUCLEIC ACIDS RES, V34, P4438, DOI 10.1093/nar/gkl576; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Ilnytskyy Y, 2004, MUTAT RES-GEN TOX EN, V559, P189, DOI 10.1016/j.mrgentox.2004.02.001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnsen O, 2005, NEW PHYTOL, V168, P589, DOI 10.1111/j.1469-8137.2005.01538.x; Kaina B, 2004, CYTOGENET GENOME RES, V104, P77, DOI 10.1159/000077469; Koturbash I, 2006, INT J RADIAT ONCOL, V66, P327, DOI 10.1016/j.ijrobp.2006.06.012; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kvaalen H, 2008, NEW PHYTOL, V177, P49, DOI 10.1111/j.1469-8137.2007.02222.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Pikaard CS, 2006, COLD SPRING HARB SYM, V71, P473, DOI 10.1101/sqb.2006.71.046; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Turunen M, 2005, ENVIRON POLLUT, V137, P390, DOI 10.1016/j.envpol.2005.01.030; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	48	314	337	5	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9514	10.1371/journal.pone.0009514	http://dx.doi.org/10.1371/journal.pone.0009514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209086	Green Published, gold, Green Accepted			2022-12-27	WOS:000275063400019
J	Liu, S				Liu, Song			Increasing Alternative Promoter Repertories Is Positively Associated with Differential Expression and Disease Susceptibility	PLOS ONE			English	Article							PSEUDOHYPOPARATHYROIDISM TYPE IB; IDIOPATHIC HYPEREOSINOPHILIC SYNDROME; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; TRANSCRIPTIONAL PROMOTER; BIOLOGICAL NETWORKS; MAMMALIAN GENOMES; NCBI GEO; CELLS; FUSION	Background: Alternative Promoter (AP) usages have been shown to enable diversified transcriptional regulation of individual gene in a context-specific (e. g., pathway, cell lineage, tissue type, and development stage et. ac.) way. Aberrant uses of APs have been directly linked to mechanism of certain human diseases. However, whether or not there exists a general link between a gene's AP repertoire and its expression diversity is currently unknown. The general relation between a gene's AP repertoire and its disease susceptibility also remains largely unexplored. Methodology/Principal Findings: Based on the differential expression ratio inferred from all human microarray data in NCBI GEO and the list of disease genes curated in public repositories, we systemically analyzed the general relation of AP repertoire with expression diversity and disease susceptibility. We found that genes with APs are more likely to be differentially expressed and/or disease associated than those with Single Promoter (SP), and genes with more APs are more likely differentially expressed and disease susceptible than those with less APs. Further analysis showed that genes with increased number of APs tend to have increased length in all aspects of gene structure including 3'UTR, be associated with increased duplicability, and have increased connectivity in protein-protein interaction network. Conclusions: Our genome-wide analysis provided evidences that increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.	[Liu, Song] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Liu, Song] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY 14260 USA; [Liu, Song] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Liu, S (corresponding author), Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA.	songliu@buffalo.edu			Health Research, Incorporated (HRI); Roswell Park Cancer Institute (RPCI)	Health Research, Incorporated (HRI); Roswell Park Cancer Institute (RPCI)	This work was supported by Health Research, Incorporated (HRI) affiliated with the Roswell Park Cancer Institute (RPCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Chiu IM, 2001, PROG NUCLEIC ACID RE, V70, P155, DOI 10.1016/S0079-6603(01)70016-5; CHOTANI MA, 1995, NUCLEIC ACIDS RES, V23, P434, DOI 10.1093/nar/23.3.434; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Hsu YC, 2009, DEV DYNAM, V238, P302, DOI 10.1002/dvdy.21753; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Juven-Gershon T, 2006, BIOCHEM SOC T, V34, P1047, DOI 10.1042/BST0341047; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lalande M, 2001, J CLIN INVEST, V107, P793, DOI 10.1172/JCI12645; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Landry JR, 2002, GENOMICS, V80, P499, DOI 10.1006/geno.2002.6863; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Linglart A, 2005, AM J HUM GENET, V76, P804, DOI 10.1086/429932; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MOSSELMAN S, 1994, CANCER RES, V54, P220; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MYERS RL, 1995, J BIOL CHEM, V270, P8257, DOI 10.1074/jbc.270.14.8257; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rouhi A, 2008, MAMM GENOME, V19, P517, DOI 10.1007/s00335-008-9133-x; Roumiantsev S, 2004, CANCER CELL, V5, P287, DOI 10.1016/S1535-6108(04)00053-4; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Sironi M, 2005, HUM MOL GENET, V14, P2533, DOI 10.1093/hmg/ddi257; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sun K, 2006, CLIN HEMORHEOL MICRO, V34, P103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinstein LS, 2007, PHARMACOL THERAPEUT, V115, P271, DOI 10.1016/j.pharmthera.2007.03.013; Weinstein LS, 1999, TRENDS ENDOCRIN MET, V10, P81, DOI 10.1016/S1043-2760(98)00124-6; Wilhelm BT, 2003, J IMMUNOL, V171, P4219, DOI 10.4049/jimmunol.171.8.4219; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zhu QQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-9	66	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9482	10.1371/journal.pone.0009482	http://dx.doi.org/10.1371/journal.pone.0009482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208995	Green Submitted, gold, Green Published			2022-12-27	WOS:000274997100021
J	Seet, LF; Su, R; Barathi, VA; Lee, WS; Poh, R; Heng, YM; Manser, E; Vithana, EN; Aung, T; Weaver, M; Sage, EH; Wong, TT				Seet, Li-Fong; Su, Roseline; Barathi, V. A.; Lee, Wing Sum; Poh, Rebekah; Heng, Yee Meng; Manser, Ed; Vithana, Eranga N.; Aung, Tin; Weaver, Matt; Sage, E. Helene; Wong, Tina T.			SPARC Deficiency Results in Improved Surgical Survival in a Novel Mouse Model of Glaucoma Filtration Surgery	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; TGF-BETA; NORMAL FIBROBLASTS; COLLAGEN MATRIX; EXPRESSION; ACTIVATION; MECHANISMS; MITOMYCIN; ENDOPHTHALMITIS; MYOFIBROBLASTS	Glaucoma is a disease frequently associated with elevated intraocular pressure that can be alleviated by filtration surgery. However, the post-operative subconjunctival scarring response which blocks filtration efficiency is a major hurdle to the achievement of long-term surgical success. Current application of anti-proliferatives to modulate the scarring response is not ideal as these often give rise to sight-threatening complications. SPARC (secreted protein, acidic and rich in cysteine) is a matricellular protein involved in extracellular matrix (ECM) production and organization. In this study, we investigated postoperative surgical wound survival in an experimental glaucoma filtration model in SPARC-null mice. Loss of SPARC resulted in a marked (87.5%) surgical wound survival rate compared to 0% in wild-type (WT) counterparts. The larger SPARC-null wounds implied that aqueous filtration through the subconjunctival space was more efficient in comparison to WT wounds. The pronounced increase in both surgical survival and filtration efficiency was associated with a less collagenous ECM, smaller collagen fibril diameter, and a loosely-organized subconjunctival matrix in the SPARC-null wounds. In contrast, WT wounds exhibited a densely packed collagenous ECM with no evidence of filtration capacity. Immunolocalization assays confirmed the accumulation of ECM proteins in the WT but not in the SPARC-null wounds. The observations in vivo were corroborated by complementary data performed on WT and SPARC-null conjunctival fibroblasts in vitro. These findings indicate that depletion of SPARC bestows an inherent change in post-operative ECM remodeling to favor wound maintenance. The evidence presented in this report is strongly supportive for the targeting of SPARC to increase the success of glaucoma filtration surgery.	[Seet, Li-Fong; Su, Roseline; Barathi, V. A.; Lee, Wing Sum; Poh, Rebekah; Wong, Tina T.] Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Grp, Singapore, Singapore; [Aung, Tin; Wong, Tina T.] Singapore Natl Eye Ctr, Dept Glaucoma, Singapore, Singapore; [Aung, Tin; Wong, Tina T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Heng, Yee Meng; Manser, Ed] ASTAR, Inst Med Biol, Singapore, Singapore; [Vithana, Eranga N.; Aung, Tin] Singapore Eye Res Inst, Ocular Genet Grp, Singapore, Singapore; [Weaver, Matt; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Seattle, WA USA	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; Singapore National Eye Center; Benaroya Research Institute; Virginia Mason Medical Center	Seet, LF (corresponding author), Singapore Eye Res Inst, Ocular Wound Healing & Therapeut Grp, Singapore, Singapore.	ttl_wong@hotmail.com	Manser, Edward/ABD-2301-2020		National Research Foundation Translational and Clinical Research (TCR) Programme Grant [R617/38/2008]; National Medical Research Council (NMRC) [R606/27/2008]; SingHealth Foundation [SHF/PD002/2006]	National Research Foundation Translational and Clinical Research (TCR) Programme Grant; National Medical Research Council (NMRC)(National Medical Research Council, Singapore); SingHealth Foundation(SingHealth)	This study is supported by the National Research Foundation Translational and Clinical Research (TCR) Programme Grant (R617/38/2008) and a research grant from the National Medical Research Council (NMRC, R606/27/2008) to T. Wong. L.-F. Seet is supported by a research grant from the SingHealth Foundation (SHF/PD002/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Deryugina EI, 1998, CANCER RES, V58, P3743; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Diegelmann RF, 1997, J UROLOGY, V157, P298, DOI 10.1016/S0022-5347(01)65364-3; EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P485, DOI 10.1167/iovs.03-0485; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Greenfield DS, 1996, ARCH OPHTHALMOL-CHIC, V114, P943, DOI 10.1001/archopht.1996.01100140151007; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Higginbotham EJ, 1996, OPHTHALMOLOGY, V103, P650, DOI 10.1016/S0161-6420(96)30639-8; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kanauchi M, 2000, DIABETOLOGIA, V43, P1076; KITAZAWA Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1693, DOI 10.1001/archopht.1991.01080120077030; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; KUHN C, 1995, AM J PATHOL, V147, P1759; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; McClung HM, 2007, NEUROSCI LETT, V419, P172, DOI 10.1016/j.neulet.2007.04.037; Mehta JS, 2008, CORNEA, V27, P722, DOI 10.1097/QAI.0b013e31815e92ac; Moretti FA, 2007, J BIOL CHEM, V282, P28057, DOI 10.1074/jbc.M611315200; Pichler RH, 1996, KIDNEY INT, V50, P1978, DOI 10.1038/ki.1996.520; Quigley HA, 2006, BR J OPHTHALMOL, V90, P151, DOI DOI 10.1136/BJ0.2005.081224; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; REDDICK R, 1985, ANN OPHTHALMOL, V17, P200; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; SCHIFFMAN J, 1989, AM J OPHTHALMOL, V108, P625; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SKUTA GL, 1992, OPHTHALMOLOGY, V99, P438; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zhou XD, 2002, ARTHRITIS RHEUM-US, V46, P2990, DOI 10.1002/art.10601; Zhou XD, 2006, ARTHRITIS RHEUM-US, V54, P2626, DOI 10.1002/art.21973	48	49	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9415	10.1371/journal.pone.0009415	http://dx.doi.org/10.1371/journal.pone.0009415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195533	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924300006
J	Tchernikov, I; Fallah, M				Tchernikov, Illia; Fallah, Mazyar			A Color Hierarchy for Automatic Target Selection	PLOS ONE			English	Article							TEMPORAL VISUAL AREA; MACAQUE MONKEY; MOTION; ATTENTION; NEURONS; CORTEX; MT; SEGMENTATION; ORIENTATION; DIRECTION	Visual processing of color starts at the cones in the retina and continues through ventral stream visual areas, called the parvocellular pathway. Motion processing also starts in the retina but continues through dorsal stream visual areas, called the magnocellular system. Color and motion processing are functionally and anatomically discrete. Previously, motion processing areas MT and MST have been shown to have no color selectivity to a moving stimulus; the neurons were colorblind whenever color was presented along with motion. This occurs when the stimuli are luminance-defined versus the background and is considered achromatic motion processing. Is motion processing independent of color processing? We find that motion processing is intrinsically modulated by color. Color modulated smooth pursuit eye movements produced upon saccading to an aperture containing a surface of coherently moving dots upon a black background. Furthermore, when two surfaces that differed in color were present, one surface was automatically selected based upon a color hierarchy. The strength of that selection depended upon the distance between the two colors in color space. A quantifiable color hierarchy for automatic target selection has wide-ranging implications from sports to advertising to human-computer interfaces.	[Tchernikov, Illia; Fallah, Mazyar] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Tchernikov, Illia; Fallah, Mazyar] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Fallah, Mazyar] Canadian Act & Percept Network, Toronto, ON, Canada	York University - Canada; York University - Canada	Tchernikov, I (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	mfallah@yorku.ca	Fallah, Mazyar/ABH-9906-2020	Fallah, Mazyar/0000-0001-5979-3955	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by an NSERC (http://www.nserc-crsng.gc.ca/) Discovery Grant to MF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Boynton R. M., 1979, HUMAN COLOR VISION; CAVANAGH P, 1991, VISION RES, V31, P2109, DOI 10.1016/0042-6989(91)90169-6; Conway BR, 2006, CEREB CORTEX, V16, P1604, DOI 10.1093/cercor/bhj099; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Croner LJ, 1997, VISION RES, V37, P1415, DOI 10.1016/S0042-6989(96)00299-4; Croner LJ, 1999, J NEUROSCI, V19, P3935; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; Hagemann N, 2008, PSYCHOL SCI, V19, P769, DOI 10.1111/j.1467-9280.2008.02155.x; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; HE ZJ, NATURE, V367, P173; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Thiele A, 1999, J NEUROSCI, V19, P6571; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5	23	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9338	10.1371/journal.pone.0009338	http://dx.doi.org/10.1371/journal.pone.0009338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195361	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924200009
J	Gamazon, ER; Zhang, W; Dolan, ME; Cox, NJ				Gamazon, Eric R.; Zhang, Wei; Dolan, M. Eileen; Cox, Nancy J.			Comprehensive Survey of SNPs in the Affymetrix Exon Array Using the 1000 Genomes Dataset	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; INDUCED CYTOTOXICITY; PHARMACOGENOMIC DISCOVERY; HAPLOTYPE MAP; VARIANTS; POPULATION; PROJECT; IMPACT; POLYMORPHISMS; SEQUENCES	Microarray gene expression data has been used in genome-wide association studies to allow researchers to study gene regulation as well as other complex phenotypes including disease risks and drug response. To reach scientifically sound conclusions from these studies, however, it is necessary to get reliable summarization of gene expression intensities. Among various factors that could affect expression profiling using a microarray platform, single nucleotide polymorphisms ( SNPs) in target mRNA may lead to reduced signal intensity measurements and result in spurious results. The recently released 1000 Genomes Project dataset provides an opportunity to evaluate the distribution of both known and novel SNPs in the International HapMap Project lymphoblastoid cell lines (LCLs). We mapped the 1000 Genomes Project genotypic data to the Affymetrix GeneChip Human Exon 1.0ST array (exon array), which had been used in our previous studies and for which gene expression data had been made publicly available. We also evaluated the potential impact of these SNPs on the differentially spliced probesets we had identified previously. Though the 1000 Genomes Project data allowed a comprehensive survey of the SNPs in this particular array, the same approach can certainly be applied to other microarray platforms. Furthermore, we present a detailed catalogue of SNP-containing probesets (exon-level) and transcript clusters (gene-level), which can be considered in evaluating findings using the exon array as well as benefit the design of follow-up experiments and data re-analysis.	[Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, Med Genet Sect, Chicago, IL 60637 USA; [Zhang, Wei; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Gamazon, ER (corresponding author), Univ Chicago, Dept Med, Med Genet Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	ncox@medicine.bsd.uchicago.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [U01GM61393]; National Institutes of Health/National Cancer Institute (NIH/NCI) [P50 CA125183]; University of Chicago Cancer Research Center Pilot; NIH/NIGMS [U01GM61374]; NATIONAL CANCER INSTITUTE [P50CA125183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374, U01GM061393] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Cancer Research Center Pilot; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded through the Pharmacogenetics of Anticancer Agents Research Group (http://www.pharmacogenetics.org/) by the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant U01GM61393, National Institutes of Health/National Cancer Institute (NIH/NCI) Breast SPORE P50 CA125183 and University of Chicago Cancer Research Center Pilot Project Program. Data deposits are supported by the NIH/NIGMS grant U01GM61374 (http://www.pharmgkb.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Auer Herbert, 2009, V509, P35, DOI 10.1007/978-1-59745-372-1_3; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Duan SW, 2008, BIOINFORMATION, V2, P469, DOI 10.6026/97320630002469; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GAMAZON E, PHARMACOGEN IN PRESS; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Huang RS, 2008, MOL CANCER THER, V7, P3038, DOI 10.1158/1535-7163.MCT-08-0248; Huang RS, 2008, CANCER RES, V68, P3161, DOI 10.1158/0008-5472.CAN-07-6381; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Takeuchi F, 2008, J HUM GENET, V53, P96, DOI 10.1007/s10038-007-0221-7; Tantoso E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-238; Taylor JA, 2006, CANCER EPIDEM BIOMAR, V15, P133, DOI 10.1158/1055-9965.EPI-05-0641; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Zhang W, 2008, CURR BIOINFORM, V3, P178, DOI 10.2174/157489308785909232; Zhang W, 2008, BIOINFORM BIOL INSIG, V2, P15; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang W, 2010, PHARMACOGENOMICS, V11, P249, DOI [10.2217/pgs.09.173, 10.2217/PGS.09.173]; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9366	10.1371/journal.pone.0009366	http://dx.doi.org/10.1371/journal.pone.0009366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186275	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924000009
J	Collins, SH; Kuo, AD				Collins, Steven H.; Kuo, Arthur D.			Recycling Energy to Restore Impaired Ankle Function during Human Walking	PLOS ONE			English	Article							GENERATING ELECTRICITY; MECHANICAL WORK; FOOT; COST; OPTIMIZATION; EXPENDITURE; ENERGETICS; LOCOMOTION; ECONOMY; FORCE	Background: Humans normally dissipate significant energy during walking, largely at the transitions between steps. The ankle then acts to restore energy during push-off, which may be the reason that ankle impairment nearly always leads to poorer walking economy. The replacement of lost energy is necessary for steady gait, in which mechanical energy is constant on average, external dissipation is negligible, and no net work is performed over a stride. However, dissipation and replacement by muscles might not be necessary if energy were instead captured and reused by an assistive device. Methodology/Principal Findings: We developed a microprocessor-controlled artificial foot that captures some of the energy that is normally dissipated by the leg and "recycles'' it as positive ankle work. In tests on subjects walking with an artificially-impaired ankle, a conventional prosthesis reduced ankle push-off work and increased net metabolic energy expenditure by 23% compared to normal walking. Energy recycling restored ankle push-off to normal and reduced the net metabolic energy penalty to 14%. Conclusions/Significance: These results suggest that reduced ankle push-off contributes to the increased metabolic energy expenditure accompanying ankle impairments, and demonstrate that energy recycling can be used to reduce such cost.	[Collins, Steven H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Kuo, Arthur D.] Univ Michigan, Dept Mech, Ann Arbor, MI 48109 USA; [Kuo, Arthur D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	Delft University of Technology; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, SH (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	s.h.collins@tudelft.nl	Kuo, Arthur/L-3359-2013	Kuo, Arthur/0000-0001-5233-9709; Collins, Steve/0000-0002-3997-3374	National Institutes of Health and the Department of Veterans Affairs	National Institutes of Health and the Department of Veterans Affairs	This work was supported by grants from the National Institutes of Health and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2006, J EXP BIOL, V209, P3953, DOI 10.1242/jeb.02455; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2009, GAIT POSTURE, V29, P59, DOI 10.1016/j.gaitpost.2008.06.010; Dean JC, 2009, J R SOC INTERFACE, V6, P561, DOI 10.1098/rsif.2008.0415; Doke J, 2005, J EXP BIOL, V208, P439, DOI 10.1242/jeb.01408; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J EXP BIOL, V205, P3717; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Geil MD, 2000, J BIOMECH, V33, P1745, DOI 10.1016/S0021-9290(00)00102-0; GOLDMAN RF, 1962, J APPL PHYSIOL, V17, P675, DOI 10.1152/jappl.1962.17.4.675; Hsu MJ, 2006, ARCH PHYS MED REHAB, V87, P123, DOI 10.1016/j.apmr.2005.07.310; Inman V., 1981, HUMAN WALKING; JOHNSON CL, 2001, Patent No. 6238437; KAZEROONI H, P IEEE INT C ROB AUT, P4353; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2005, SCIENCE, V309, P1686, DOI 10.1126/science.1118058; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; LEHMANN JF, 1993, ARCH PHYS MED REHAB, V74, P1225; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Prince F., 1994, IEEE Transactions on Rehabilitation Engineering, V2, P247, DOI 10.1109/86.340873; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Rome LC, 2005, SCIENCE, V309, P1725, DOI 10.1126/science.1111063; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; TORBURN L, 1995, J REHABIL RES DEV, V32, P111; Vanderpool MT, 2008, GAIT POSTURE, V28, P427, DOI 10.1016/j.gaitpost.2008.01.016; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Whittle M.W, 2014, GAIT ANAL INTRO; Winter DA., 1987, BIOMECHANICS MOTOR C; ZARRUGH MY, 1974, EUR J APPL PHYSIOL O, V33, P293, DOI 10.1007/BF00430237	33	136	138	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9307	10.1371/journal.pone.0009307	http://dx.doi.org/10.1371/journal.pone.0009307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174659	gold, Green Published			2022-12-27	WOS:000274590600031
J	Falkenberg, G; Fleissner, G; Schuchardt, K; Kuehbacher, M; Thalau, P; Mouritsen, H; Heyers, D; Wellenreuther, G; Fleissner, G				Falkenberg, Gerald; Fleissner, Gerta; Schuchardt, Kirsten; Kuehbacher, Markus; Thalau, Peter; Mouritsen, Henrik; Heyers, Dominik; Wellenreuther, Gerd; Fleissner, Guenther			Avian Magnetoreception: Elaborate Iron Mineral Containing Dendrites in the Upper Beak Seem to Be a Common Feature of Birds	PLOS ONE			English	Article							LIGHT-DEPENDENT MAGNETORECEPTION; MAGNETIC COMPASS; BIOGENIC MAGNETITE; TRIGEMINAL MEDIATION; ORIENTATION; ORGANIZATION; NAVIGATION; SYSTEM; RESPONSES; BEHAVIOR	The magnetic field sensors enabling birds to extract orientational information from the Earth's magnetic field have remained enigmatic. Our previously published results from homing pigeons have made us suggest that the iron containing sensory dendrites in the inner dermal lining of the upper beak are a candidate structure for such an avian magnetometer system. Here we show that similar structures occur in two species of migratory birds (garden warbler, Sylvia borin and European robin, Erithacus rubecula) and a non-migratory bird, the domestic chicken (Gallus gallus). In all these bird species, histological data have revealed dendrites of similar shape and size, all containing iron minerals within distinct subcellular compartments of nervous terminals of the median branch of the Nervus ophthalmicus. We also used microscopic X-ray absorption spectroscopy analyses to identify the involved iron minerals to be almost completely Fe III-oxides. Magnetite (Fe II/III) may also occur in these structures, but not as a major Fe constituent. Our data suggest that this complex dendritic system in the beak is a common feature of birds, and that it may form an essential sensory basis for the evolution of at least certain types of magnetic field guided behavior.	[Falkenberg, Gerald; Wellenreuther, Gerd] DESY, Hamburger Synchrotronstrahlungslab HASYLAB, D-2000 Hamburg, Germany; [Fleissner, Gerta; Schuchardt, Kirsten; Thalau, Peter; Fleissner, Guenther] Goethe Univ Frankfurt, Inst Zellbiol & Neurowissensch, Frankfurt, Germany; [Kuehbacher, Markus] Helmholtz Ctr Berlin Mat & Energy, Abt Elementanalyt, Berlin, Germany; [Mouritsen, Henrik; Heyers, Dominik] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Goethe University Frankfurt; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Carl von Ossietzky Universitat Oldenburg	Falkenberg, G (corresponding author), DESY, Hamburger Synchrotronstrahlungslab HASYLAB, Notkestr 85, D-2000 Hamburg, Germany.	fleissner@bio.uni-frankfurt.de	Heyers, Dominik/D-3885-2015; Mouritsen, Henrik/A-5401-2010	Heyers, Dominik/0000-0002-2831-6985; Mouritsen, Henrik/0000-0001-7082-4839	Deutsche Forschungsgemeinschaft [Fl 177/15-1, Fl 177/16-1]; HASYLAB at DESY, Hamburg [I-05-095, II-20060167]; Stiftung Polytechnische Gesellschaft, Frankfurt; Gemeinnutzige Hertie-Stiftung, Berlin; Alumni of the Goethe-University, Frankfurt; Volkswagenstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HASYLAB at DESY, Hamburg; Stiftung Polytechnische Gesellschaft, Frankfurt; Gemeinnutzige Hertie-Stiftung, Berlin; Alumni of the Goethe-University, Frankfurt; Volkswagenstiftung(Volkswagen)	The project is supported by grants from the Deutsche Forschungsgemeinschaft (Fl 177/15-1 and 16-1), http://www.dfg.de; from HASYLAB at DESY, Hamburg (I-05-095, II-20060167), http://www.desy.de; from the Stiftung Polytechnische Gesellschaft, Frankfurt a. M., http://www.sptg.de/; from the Gemeinnutzige Hertie-Stiftung, Berlin: ZEN-program, http://www.ghst.de; from the Alumni of the Goethe-University, Frankfurt a. M., http://www.vff.unifrankfurt.de; from the Volkswagenstiftung (Heisenberg-Professorship to H. M.), http://www.volkswagen-stiftung.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Beason RC, 1996, J EXP BIOL, V199, P1241; Beck W., 1988, P1955; Boles LC, 2003, NATURE, V421, P60, DOI 10.1038/nature01226; Cain SD, 2005, INTEGR COMP BIOL, V45, P539, DOI 10.1093/icb/45.3.539; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Dubbeldam JL, 1998, ARCH PHYSIOL BIOCHEM, V106, P338, DOI 10.1076/apab.106.5.338.4367; DUBBELDAM JL, 1998, CENTRAL NERVOUS SYST, V3, P1525; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153; FALKENBERG G, 2008, J PHYS C SE IN PRESS; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; FLEISSNER GE, 2008, HASYLAB ANN REPORT 2; Fleissner G, 2007, J ORNITHOL, V148, pS643, DOI 10.1007/s10336-007-0229-y; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Hautot D, 2003, P ROY SOC B-BIOL SCI, V270, pS62, DOI 10.1098/rsbl.2003.0012; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Holland RA, 2006, NATURE, V444, P702, DOI 10.1038/444702b; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; HUBER J, 2004, THESIS JL U GIESSEN; Janssens K.H.A., 2000, MICROSCOPIC XRAY FLU; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1992, P NATL ACAD SCI USA, V89, P7683, DOI 10.1073/pnas.89.16.7683; LIU Y., 2003, PIGMENT CELL RES, V16, P597, DOI [DOI 10.1034/J.1600-0749.2003.08378.X, 10.1034/j.1600-0749.2003.08378.x]; Lohmann KJ, 2004, NATURE, V428, P909, DOI 10.1038/428909a; MANN S, 1988, J EXP BIOL, V140, P35; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Phillips JB, 2006, ANIMAL SPATIAL COGNI; Schofield RMS, 2001, SCORPION BIOLOGY AND RESEARCH, P234; Schultheiss-Grassi PP, 1999, BBA-GEN SUBJECTS, V1426, P212, DOI 10.1016/S0304-4165(98)00160-3; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Solov'yov IA, 2007, BIOPHYS J, V93, P1493, DOI 10.1529/biophysj.107.105098; STAHL B, 2005, HASYLAB ANN REPORT 2; STAHL B, 2006, P 4 FALL C MET MET H, P63; Thalau P, 2007, NATURWISSENSCHAFTEN, V94, P813, DOI 10.1007/s00114-007-0259-6; Tian LX, 2007, BIOMETALS, V20, P197, DOI 10.1007/s10534-006-9027-x; Vacha M, 2006, J EXP BIOL, V209, P3882, DOI 10.1242/jeb.02456; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WILD JM, 1980, J COMP NEUROL, V192, P175, DOI 10.1002/cne.901920112; Wilke M, 2001, AM MINERAL, V86, P714; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2008, J EXP BIOL, V211, P3344, DOI 10.1242/jeb.020313; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2004, NATURWISSENSCHAFTEN, V91, P130, DOI 10.1007/s00114-003-0500-x; Wiltschko W, 1971, Vogelwarte, V26, P245; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Wiltschko W, 2009, P ROY SOC B-BIOL SCI, V276, P2227, DOI 10.1098/rspb.2009.0050; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	57	101	107	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9231	10.1371/journal.pone.0009231	http://dx.doi.org/10.1371/journal.pone.0009231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169083	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500013
J	Trimborn, M; Ghani, M; Walther, DJ; Dopatka, M; Dutrannoy, V; Busche, A; Meyer, F; Nowak, S; Nowak, J; Zabel, C; Klose, J; Esquitino, V; Garshasbi, M; Kuss, AW; Ropers, HH; Mueller, S; Poehlmann, C; Gavvovidis, I; Schindler, D; Sperling, K; Neitzel, H				Trimborn, Marc; Ghani, Mahdi; Walther, Diego J.; Dopatka, Monika; Dutrannoy, Veronique; Busche, Andreas; Meyer, Franziska; Nowak, Stefanie; Nowak, Jean; Zabel, Claus; Klose, Joachim; Esquitino, Veronica; Garshasbi, Masoud; Kuss, Andreas W.; Ropers, Hans-Hilger; Mueller, Susanne; Poehlmann, Charlotte; Gavvovidis, Ioannis; Schindler, Detlev; Sperling, Karl; Neitzel, Heidemarie			Establishment of a Mouse Model with Misregulated Chromosome Condensation due to Defective Mcph1 Function	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; MICROCEPHALIN; PROTEIN; CHECKPOINT; REPAIR; BRIT1/MCPH1; MUTATIONS; PHENOTYPE; SUGGEST	Mutations in the human gene MCPH1 cause primary microcephaly associated with a unique cellular phenotype with premature chromosome condensation (PCC) in early G2 phase and delayed decondensation post-mitosis (PCC syndrome). The gene encodes the BRCT-domain containing protein microcephalin/BRIT1. Apart from its role in the regulation of chromosome condensation, the protein is involved in the cellular response to DNA damage. We report here on the first mouse model of impaired Mcph1-function. The model was established based on an embryonic stem cell line from BayGenomics (RR0608) containing a gene trap in intron 12 of the Mcph1 gene deleting the C-terminal BRCT-domain of the protein. Although residual wild type allele can be detected by quantitative real-time PCR cell cultures generated from mouse tissues bearing the homozygous gene trap mutation display the cellular phenotype of misregulated chromosome condensation that is characteristic for the human disorder, confirming defective Mcph1 function due to the gene trap mutation. While surprisingly the DNA damage response (formation of repair foci, chromosomal breakage, and G2/M checkpoint function after irradiation) appears to be largely normal in cell cultures derived from Mcph1(gt/gt) mice, the overall survival rates of the Mcph1(gt/gt) animals are significantly reduced compared to wild type and heterozygous mice. However, we could not detect clear signs of premature malignant disease development due to the perturbed Mcph1 function. Moreover, the animals show no obvious physical phenotype and no reduced fertility. Body and brain size are within the range of wild type controls. Gene expression on RNA and protein level did not reveal any specific pattern of differentially regulated genes. To the best of our knowledge this represents the first mammalian transgenic model displaying a defect in mitotic chromosome condensation and is also the first mouse model for impaired Mcph1-function.	[Trimborn, Marc; Busche, Andreas; Meyer, Franziska] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Ghani, Mahdi; Dutrannoy, Veronique; Nowak, Stefanie; Nowak, Jean; Zabel, Claus; Klose, Joachim; Esquitino, Veronica; Poehlmann, Charlotte; Sperling, Karl; Neitzel, Heidemarie] Charite, Inst Human Genet, D-13353 Berlin, Germany; [Walther, Diego J.; Dopatka, Monika; Garshasbi, Masoud; Kuss, Andreas W.; Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Berlin, Germany; [Mueller, Susanne] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Gavvovidis, Ioannis; Schindler, Detlev] Univ Wurzburg, Inst Human Genet, Wurzburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg	Trimborn, M (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	heidemarie.neitzel@charite.de		Garshasbi, Masoud/0000-0002-5508-7903; Ghani, Mahdi/0000-0001-6455-7199; Gavvovidis, Ioannis/0000-0001-5644-9788; Busche, Andreas/0000-0003-1787-767X; Mueller, Susanne/0000-0002-5053-2211; Kuss, Andreas/0000-0002-9401-4627	Deutsche Forschungsgemeinschaft [NE 531/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by funding from the Deutsche Forschungsgemeinschaft (NE 531/5-3) to H. N. and K. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Berth M, 2007, APPL MICROBIOL BIOT, V76, P1223, DOI 10.1007/s00253-007-1128-0; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Chaplet M, 2006, CELL CYCLE, V5, P2579, DOI 10.4161/cc.5.22.3471; Diedrich M, 2008, PROTEOMICS, V8, P1266, DOI 10.1002/pmic.200700754; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Hartl D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002759; Huyton T, 2000, MUTAT RES-DNA REPAIR, V460, P319, DOI 10.1016/S0921-8777(00)00034-3; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Klose J, 1999, METH MOL B, V112, P147; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6; Mao L, 2008, J PROTEOME RES, V7, P3968, DOI 10.1021/pr800245x; Mao L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001218; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Neitzel H, 2002, AM J HUM GENET, V70, P1015, DOI 10.1086/339518; O'Driscoll M, 2006, CELL CYCLE, V5, P2339, DOI 10.4161/cc.5.20.3358; Pines J, 2001, NAT CELL BIOL, V3, pE3, DOI 10.1038/35050676; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Singh AP, 2000, CYTOGENET CELL GENET, V91, P253, DOI 10.1159/000056854; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Wu XL, 2009, CANCER RES, V69, P5531, DOI 10.1158/0008-5472.CAN-08-4834; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yang SZ, 2008, EMBO REP, V9, P907, DOI 10.1038/embor.2008.128; Zabel C, 2006, J PROTEOME RES, V5, P1948, DOI 10.1021/pr0601077; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481	36	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9242	10.1371/journal.pone.0009242	http://dx.doi.org/10.1371/journal.pone.0009242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169082	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500021
J	Yoder, L				Yoder, Lane			Explicit Logic Circuits Predict Local Properties of the Neocortex's Physiology and Anatomy	PLOS ONE			English	Article								Background: Two previous articles proposed an explicit model of how the brain processes information by its organization of synaptic connections. The family of logic circuits was shown to generate neural correlates of complex psychophysical phenomena in different sensory systems. Methodology/Principal Findings: Here it is shown that the most cost-effective architectures for these networks produce correlates of electrophysiological brain phenomena and predict major aspects of the anatomical structure and physiological organization of the neocortex. The logic circuits are markedly efficient in several respects and provide the foundation for all of the brain's combinational processing of information. Conclusions/Significance: At the local level, these networks account for much of the physical structure of the neocortex as well its organization of synaptic connections. Electronic implementations of the logic circuits may be more efficient than current electronic logic arrays in generating both Boolean and fuzzy logic.	Univ Hawaii, Dept Math, Honolulu, HI 96822 USA	University of Hawaii System	Yoder, L (corresponding author), Univ Hawaii, Dept Math, Honolulu, HI 96822 USA.	LDYoder@gmail.com						DUDEL J, 1983, HUMAN PHYSL, P177; Hales TC, 2005, ANN MATH, V162, P1065, DOI 10.4007/annals.2005.162.1065; HEIDEMANN SR, 1997, CELL BIOCHEM BIOPHYS, V27, P1085; Heimer L., 1994, HUMAN BRAIN SPINAL C; JONES EG, 1986, CEREB CORTEX, V5, P118; KANDEL ER, 2000, PRINCIPLES NEURAL SC, P327; Kepler J., 1966, NIVE SEXANGULA; Yoder L, 2005, COLOR RES APPL, V30, P252, DOI 10.1002/col.20121; Yoder L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004154	9	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9227	10.1371/journal.pone.0009227	http://dx.doi.org/10.1371/journal.pone.0009227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169077	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500009
J	Yamasaki, A; Saleh, A; Koussih, L; Muro, S; Halayko, AJ; Gounni, AS				Yamasaki, Akira; Saleh, Ali; Koussih, Latifa; Muro, Shigeo; Halayko, Andrew J.; Gounni, Abdelilah S.			IL-9 Induces CCL11 Expression via STAT3 Signalling in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							SERINE PHOSPHORYLATION; TRANSGENIC MICE; GENE-REGULATION; DNA-BINDING; INFLAMMATION; ACTIVATION; HYPERRESPONSIVENESS; TRANSFORMATION; RECEPTOR; TYROSINE	Background: Previous findings support the concept that IL-9 may play a significant role in mediating both pro-inflammatory and changes in airway responsiveness that characterizes the atopic asthmatic state. We previously demonstrated that human airway smooth muscle (ASM) cells express a functional IL-9R that mediate CCL11 expression. However, the signaling pathway governing this effect is not well understood. Methodology/Principal Findings: In this study, we showed that IL-9 mediated CCL11 expression in ASM cells does not rely on STAT6 or STAT5 but on STAT3 pathway. IL-9 induced rapid STAT3 activation in primary ASM cells that was not observed in case of STAT6 or STAT5. STAT3 binding to CCL11 promoter was also observed in vivo upon IL-9 stimulation of ASM cells. Disruption of STAT3 activity with SH2 domain binding inhibitory peptide results in significant reduction of IL-9 mediated CCL11 promoter activity. DN STAT3b over-expression in ASM cells, but not Ser 727 STAT3 or STAT6 DN, abolishes IL-9 mediated CCL11 promoter activity. Finally, STAT3 but not STAT6 silenced ASM cells showed significant reduction in IL-9 mediated CCL11 promoter activity and mRNA expression. Conclusion/Significance: Taken together, our results indicate that IL-9 mediated CCL11 via STAT3 signalling pathway may play a crucial role in airway inflammatory responses.	[Yamasaki, Akira; Saleh, Ali; Koussih, Latifa; Gounni, Abdelilah S.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Yamasaki, Akira; Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Halayko, Andrew J.] Univ Manitoba, Resp Sect, Winnipeg, MB, Canada; [Muro, Shigeo] Kyoto Univ Hosp, Dept Resp Med, Sakyo Ku, Kyoto 606, Japan	University of Manitoba; University of Manitoba; University of Manitoba; Kyoto University	Yamasaki, A (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020	Gounni, Abdelilah/0000-0003-1265-6560; Halayko, Andrew/0000-0002-7865-4552; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR) [MOP 5314]; Manitoba Health Research Council (MHRC) Research Chair; CIHR-National Training program in Allergy and Asthma	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC) Research Chair; CIHR-National Training program in Allergy and Asthma(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) grant # MOP 5314 and Manitoba Health Research Council (MHRC) Research Chair to ASG. AY was supported by the CIHR-National Training program in Allergy and Asthma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pinheiro AAD, 2007, J LEUKOCYTE BIOL, V81, P1102, DOI 10.1189/jlb.0906583; Alvarez de Morales M., 1999, ELECTRON T NUMER ANA, V9, P1; Baraldo S, 2003, AM J PHYSIOL-LUNG C, V284, pL1093, DOI 10.1152/ajplung.00300.2002; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; DAMERA G, 2008, PULM PHARM THER; Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001; Demoulin JB, 2000, FEBS LETT, V482, P200, DOI 10.1016/S0014-5793(00)02059-7; Demoulin JB, 2000, CANCER RES, V60, P3971; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Faffe DS, 2005, J ALLERGY CLIN IMMUN, V115, P514, DOI 10.1016/j.jaci.2004.11.033; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Ghaffar O, 1999, AM J RESP CRIT CARE, V159, P1933, DOI 10.1164/ajrccm.159.6.9805039; Gounni AS, 2004, J IMMUNOL, V173, P2771, DOI 10.4049/jimmunol.173.4.2771; Hamann KJ, 2000, AM J PHYSIOL-LUNG C, V278, pL618, DOI 10.1152/ajplung.2000.278.3.L618; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kung SKP, 2000, J VIROL, V74, P3668, DOI 10.1128/JVI.74.8.3668-3681.2000; Laporte JC, 2001, AM J RESP CRIT CARE, V164, P141, DOI 10.1164/ajrccm.164.1.2008060; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; McLane MP, 1998, AM J RESP CELL MOL, V19, P713, DOI 10.1165/ajrcmb.19.5.3457; Oliver Brian G, 2006, Allergol Int, V55, P215, DOI 10.2332/allergolint.55.215; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Saleh A, 2009, J IMMUNOL, V182, P3357, DOI 10.4049/jimmunol.0801882; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Soussi-Gounni A, 2001, J ALLERGY CLIN IMMUN, V107, P575, DOI 10.1067/mai.2001.114238; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI13696; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Ulbrecht M, 1997, J ALLERGY CLIN IMMUN, V99, P828, DOI 10.1016/S0091-6749(97)80018-8; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wen ZL, 1997, NUCLEIC ACIDS RES, V25, P2062, DOI 10.1093/nar/25.11.2062	38	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9178	10.1371/journal.pone.0009178	http://dx.doi.org/10.1371/journal.pone.0009178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169197	gold, Green Submitted, Green Published			2022-12-27	WOS:000274474600003
J	Miller, G; Neilan, M; Chia, R; Gheryani, N; Holt, N; Charbit, A; Wells, S; Tucci, V; Lalanne, Z; Denny, P; Fisher, EMC; Cheeseman, M; Askew, GN; Dear, TN				Miller, Gaynor; Neilan, Monica; Chia, Ruth; Gheryani, Nabeia; Holt, Natalie; Charbit, Annabelle; Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Fisher, Elizabeth M. C.; Cheeseman, Michael; Askew, Graham N.; Dear, T. Neil			ENU Mutagenesis Reveals a Novel Phenotype of Reduced Limb Strength in Mice Lacking Fibrillin 2	PLOS ONE			English	Article							MARFAN-SYNDROME; EXTRACELLULAR MICROFIBRILS; SKELETAL-MUSCLES; MOUSE; GENE; MUTATIONS; DRIVEN; SCREENS; FBN2; SY	Background: Fibrillins 1 (FBN1) and 2 (FBN2) are components of microfibrils, microfilaments that are present in many connective tissues, either alone or in association with elastin. Marfan's syndrome and congenital contractural arachnodactyly (CCA) result from dominant mutations in the genes FBN1 and FBN2 respectively. Patients with both conditions often present with specific muscle atrophy or weakness, yet this has not been reported in the mouse models. In the case of Fbn1, this is due to perinatal lethality of the homozygous null mice making measurements of strength difficult. In the case of Fbn2, four different mutant alleles have been described in the mouse and in all cases syndactyly was reported as the defining phenotypic feature of homozygotes. Methodology/Principal Findings: As part of a large-scale N-ethyl-N-nitrosourea (ENU) mutagenesis screen, we identified a mouse mutant, Mariusz, which exhibited muscle weakness along with hindlimb syndactyly. We identified an amber nonsense mutation in Fbn2 in this mouse mutant. Examination of a previously characterised Fbn2-null mutant, Fbn2(fp), identified a similar muscle weakness phenotype. The two Fbn2 mutant alleles complement each other confirming that the weakness is the result of a lack of Fbn2 activity. Skeletal muscle from mutants proved to be abnormal with higher than average numbers of fibres with centrally placed nuclei, an indicator that there are some regenerating muscle fibres. Physiological tests indicated that the mutant muscle produces significantly less maximal force, possibly as a result of the muscles being relatively smaller in Mariusz mice. Conclusions: These findings indicate that Fbn2 is involved in integrity of structures required for strength in limb movement. As human patients with mutations in the fibrillin genes FBN1 and FBN2 often present with muscle weakness and atrophy as a symptom, Fbn2-null mice will be a useful model for examining this aspect of the disease process further.	[Miller, Gaynor; Neilan, Monica; Gheryani, Nabeia; Dear, T. Neil] Univ Sheffield, Sch Med, Mammalian Genet Dis Unit, Sheffield, S Yorkshire, England; [Chia, Ruth; Charbit, Annabelle; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Holt, Natalie; Askew, Graham N.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Cheeseman, Michael; Dear, T. Neil] MRC, Mary Lyon Ctr, Harwell, Berks, England; [Wells, Sara; Tucci, Valter; Lalanne, Zuzanne; Denny, Paul; Cheeseman, Michael; Dear, T. Neil] MRC, Mammalian Genet Unit, Harwell, Berks, England; [Dear, T. Neil] St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England	University of Sheffield; University of London; University College London; University of Leeds; Saint James's University Hospital; University of Leeds	Miller, G (corresponding author), Univ Sheffield, Sch Med, Mammalian Genet Dis Unit, Sheffield, S Yorkshire, England.	t.n.dear@leeds.ac.uk	Miller, Gaynor/G-8917-2014; Fisher, Elizabeth MC/C-2168-2008; Chia, Ruth/AAF-4900-2021; Holt, Natalie/T-4685-2019	Fisher, Elizabeth MC/0000-0003-2850-9936; Chia, Ruth/0000-0002-4709-7423; Holt, Natalie/0000-0003-0006-1279; Tucci, Valter/0000-0002-3796-3826; Denny, Paul/0000-0003-4659-6893; Miller, Gaynor/0000-0003-4527-3814	MRC [G0500288, MC_UP_1502/1, MC_U142670371, MC_U142684172, MC_U142684175] Funding Source: UKRI; Medical Research Council [MC_U142684172, MC_UP_1502/1, MC_U142684175, G0500288, MC_U142670371] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Askew GN, 1997, J EXP BIOL, V200, P3119; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Barbaric I, 2007, ENVIRON MOL MUTAGEN, V48, P124, DOI 10.1002/em.20286; Behan WMH, 2003, J NEUROL NEUROSUR PS, V74, P633, DOI 10.1136/jnnp.74.5.633; Boregowda R, 2008, MATRIX BIOL, V27, P661, DOI 10.1016/j.matbio.2008.09.579; Browning VL, 2001, GENOMICS, V73, P291, DOI 10.1006/geno.2001.6523; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; Dean JCS, 2007, EUR J HUM GENET, V15, P724, DOI 10.1038/sj.ejhg.5201851; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Farah S, 1997, CLIN NEUROL NEUROSUR, V99, P66, DOI 10.1016/S0303-8467(96)00596-3; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Johnson KR, 1998, MAMM GENOME, V9, P889, DOI 10.1007/s003359900889; Keays DA, 2007, MAMM GENOME, V18, P123, DOI 10.1007/s00335-006-0065-z; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; MARSH RL, 1986, J EXP BIOL, V126, P63; MENDEZ J, 1960, METABOLISM, V9, P184; Percheron G, 2007, RHEUMATOLOGY, V46, P957, DOI 10.1093/rheumatology/kel450; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Ramirez F, 2009, J BIOL CHEM, V284, P14677, DOI 10.1074/jbc.R900004200; Ritty TM, 2002, ANAT RECORD, V268, P430, DOI 10.1002/ar.10175; Scola RH, 2001, ARQ NEURO-PSIQUIAT, V59, P259, DOI 10.1590/S0004-282X2001000200022; Stratil A, 2008, ANIM GENET, V39, P204, DOI 10.1111/j.1365-2052.2007.01678.x; Tucci V, 2007, NEUROSCIENCE, V147, P573, DOI 10.1016/j.neuroscience.2007.04.034; VILJOEN D, 1994, J MED GENET, V31, P640, DOI 10.1136/jmg.31.8.640	30	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9137	10.1371/journal.pone.0009137	http://dx.doi.org/10.1371/journal.pone.0009137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161761	Green Accepted, Green Published, gold			2022-12-27	WOS:000274442600033
J	Romito, A; Lonardo, E; Roma, G; Minchiotti, G; Ballabio, A; Cobellis, G				Romito, Antonio; Lonardo, Enza; Roma, Guglielmo; Minchiotti, Gabriella; Ballabio, Andrea; Cobellis, Gilda			Lack of Sik1 in Mouse Embryonic Stem Cells Impairs Cardiomyogenesis by Down-Regulating the Cyclin-Dependent Kinase Inhibitor p57(kip2)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROTEIN-KINASE; DIFFERENTIATION; HEART; EXIT; SPECIFICATION; DISEASE; GATA-4; ROLES	Sik1 (salt inducible kinase 1) is a serine/threonine kinase that belongs to the stress-and energy-sensing AMP-activated protein kinase family. During murine embryogenesis, sik1 marks the monolayer of future myocardial cells that will populate first the primitive ventricle, and later the primitive atrium suggesting its involvement in cardiac cell differentiation and/or heart development. Despite that observation, the involvement of sik1 in cardiac differentiation is still unknown. We examined the sik1 function during cardiomyocyte differentiation using the ES-derived embryoid bodies. We produced a null embryonic stem cell using a gene-trap cell line carrying an insertion in the sik1 locus. In absence of the sik1 protein, the temporal appearance of cardiomyocytes is delayed. Expression profile analysis revealed sik1 as part of a genetic network that controls the cell cycle, where the cyclin-dependent kinase inhibitor p57(Kip2) is directly involved. Collectively, we provided evidence that sik1-mediated effects are specific for cardiomyogenesis regulating cardiomyoblast cell cycle exit toward terminal differentiation.	[Romito, Antonio; Ballabio, Andrea; Cobellis, Gilda] Telethon Inst Genet & Med, Naples, Italy; [Lonardo, Enza; Minchiotti, Gabriella] CNR, Stem Cell Fate Lab, Inst Genet & Biophys, I-80125 Naples, Italy; [Roma, Guglielmo] Pompeu Fabra Univ UPF, Ctr Genom Regulat, Barcelona, Spain; [Cobellis, Gilda] Univ Naples 2, Dipartimento Patol Gen, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universita della Campania Vanvitelli	Romito, A (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	cobellis@tigem.it	BALLABIO, Andrea/AAL-2672-2020; Lonardo, Enza/A-8786-2011; lonardo, enza/AAI-5726-2020	BALLABIO, Andrea/0000-0003-1381-4604; Minchiotti, Gabriella/0000-0003-0225-9043; Lonardo, Enza/0000-0001-6654-1043; Cobellis, Gilda/0000-0003-2687-2272	EU [037627]; Italian Association for Cancer Research (AIRC); Telethon Foundation	EU(European Commission); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon Foundation(Fondazione Telethon)	Project was supported by the grant from 6th Framework of EU Commission, Contract no.: 037627 to A. B., A. R. and G. C. and the Italian Association for Cancer Research (AIRC) and Telethon Foundation grant to G. M. and E. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; ASAKURA A, 1995, DEV BIOL, V171, P386, DOI 10.1006/dbio.1995.1290; Barlow GM, 2001, GENET MED, V3, P91, DOI 10.1097/00125817-200103000-00002; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Brennan J, 1999, METH MOL B, V97, P123, DOI 10.1385/1-59259-270-8:123; Brooks Gavin, 2004, V296, P291; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cobellis G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni045; Grepin C, 1997, DEVELOPMENT, V124, P2387; Griffin KJP, 2000, DEV BIOL, V218, P235, DOI 10.1006/dbio.1999.9571; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kochilas LK, 1999, PEDIATR RES, V45, P635, DOI 10.1203/00006450-199905010-00004; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Politis PK, 2008, CELL CYCLE, V7, P691, DOI 10.4161/cc.7.6.5550; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stephenson A, 2004, GENOMICS, V83, P1105, DOI 10.1016/j.ygeno.2003.12.007; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Wobus A M, 2002, Methods Mol Biol, V185, P127; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	35	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9029	10.1371/journal.pone.0009029	http://dx.doi.org/10.1371/journal.pone.0009029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140255	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200015
J	Wakeel, A; Zhang, XF; McBride, JW				Wakeel, Abdul; Zhang, Xiaofeng; McBride, Jere W.			Mass Spectrometric Analysis of Ehrlichia chaffeensis Tandem Repeat Proteins Reveals Evidence of Phosphorylation and Absence of Glycosylation	PLOS ONE			English	Article							ANOMALOUS ELECTROPHORETIC BEHAVIOR; MAJOR IMMUNOREACTIVE PROTEIN; CHLAMYDIA-TRACHOMATIS TARP; TYROSINE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; ANAPLASMA-MARGINALE; ANTIBODY-RESPONSES; MEMBRANE-PROTEIN; ACIDIC PROTEIN	Background: Ehrlichia chaffeensis has a small subset of immunoreactive secreted, acidic (pI similar to 4), tandem repeat (TR)-containing proteins (TRPs), which exhibit abnormally large electrophoretic masses that have been associated with glycosylation of the TR domain. Methodology/Principal Findings: In this study, we examined the extent and nature of posttranslational modifications on the native TRP47 and TRP32 using mass spectrometry. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) demonstrated that the mass of native TRP47 (33,104.5 Da) and TRP32 (22,736.8 Da) were slightly larger (179- and 288-Da, respectively) than their predicted masses. The anomalous migration of native and recombinant TRP47, and the recombinant TR domain (C-terminal region) were normalized by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) modification of negatively charged carboxylates to neutral amides. Exhaustive tandem mass spectrometric analysis (92% coverage) performed on trypsin and Asp-N digested native TRP47 identified peptides consistent with their predicted masses. Two TRP47 peptides not identified were located in the normally migrating amino (N)-terminal region of TRP47 and contained predicted phosphorylation sites (tyrosine and serine residues). Moreover, native TRP47 was immunoprecipitated from E. chaffeensis-infected cell lysate with anti-phosphotyrosine (anti-pTyr) antibody. Conclusions/Significance: TRP47 and TRP32 are not modified by glycans and the substantial net negative charge of the ehrlichial TRPs, and particularly the highly acidic TRs present within the ehrlichial TRPs, is responsible for larger-than-predicted masses. Furthermore, this study provides evidence that the N-terminal region of the TRP47 is tyrosine phosphorylated.	[Wakeel, Abdul; Zhang, Xiaofeng; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wakeel, A (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	jemcbrid@utmb.edu			National Institute of Allergy and Infectious Diseases [AI 071145]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071145] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases (AI 071145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; Alves VS, 2005, BIOCHEM BIOPH RES CO, V332, P450, DOI 10.1016/j.bbrc.2005.04.151; Alves VS, 2004, BIOCHEM BIOPH RES CO, V314, P229, DOI 10.1016/j.bbrc.2003.12.086; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen SM, 1997, CLIN DIAGN LAB IMMUN, V4, P731, DOI 10.1128/CDLI.4.6.731-735.1997; CHEN SM, 1994, AM J TROP MED HYG, V50, P52, DOI 10.4269/ajtmh.1994.50.1.TM0500010052; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; de la Fuente J, 2004, VET MICROBIOL, V98, P313, DOI 10.1016/j.vetmic.2003.11.001; de la Fuente Jose, 2001, Animal Health Research Reviews, V2, P163; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Garcia-Garcia JC, 2004, INFECT IMMUN, V72, P3022, DOI 10.1128/IAI.72.5.3022-3030.2004; Garcia-Ortega L, 2005, ELECTROPHORESIS, V26, P3407, DOI 10.1002/elps.200500261; GRACEFFA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P46, DOI 10.1016/0003-9861(92)90639-E; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Hu XM, 2006, J PROTEOME RES, V5, P2396, DOI 10.1021/pr060209x; Jewett TJ, 2008, BIOCHEM BIOPH RES CO, V371, P339, DOI 10.1016/j.bbrc.2008.04.089; Jordan P, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-23; Kling DE, 1997, INFECT IMMUN, V65, P1462, DOI 10.1128/IAI.65.4.1462-1467.1997; Lee EH, 1998, INFECT IMMUN, V66, P2514, DOI 10.1128/IAI.66.6.2514-2520.1998; Lin M, 2004, CELL MICROBIOL, V6, P175, DOI 10.1046/j.1462-5822.2003.00355.x; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Luo T, 2008, INFECT IMMUN, V76, P1572, DOI 10.1128/IAI.01466-07; Luo T, 2009, CLIN VACCINE IMMUNOL, V16, P982, DOI 10.1128/CVI.00048-09; Mavromatis K, 2006, J BACTERIOL, V188, P4015, DOI 10.1128/JB.01837-05; McBride JW, 2007, INFECT IMMUN, V75, P74, DOI 10.1128/IAI.01494-06; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; McBride JW, 2000, INFECT IMMUN, V68, P13, DOI 10.1128/IAI.68.1.13-18.2000; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; McNally DJ, 2007, J BIOL CHEM, V282, P14463, DOI 10.1074/jbc.M611027200; Mehlitz A, 2008, FEMS MICROBIOL LETT, V289, P233, DOI 10.1111/j.1574-6968.2008.01390.x; Palmer GH, 2007, TRENDS PARASITOL, V23, P408, DOI 10.1016/j.pt.2007.07.008; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; RIKIHISA Y, 1994, J CLIN MICROBIOL, V32, P2107, DOI 10.1128/JCM.32.9.2107-2112.1994; Sarkar M, 2008, INFECT IMMUN, V76, P2090, DOI 10.1128/IAI.01594-07; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Shak JR, 2009, J BACTERIOL, V191, P6900, DOI 10.1128/JB.00706-09; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Sterba J, 2008, J BACTERIOL, V190, P2619, DOI 10.1128/JB.01885-07; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Storey JR, 1998, INFECT IMMUN, V66, P1356, DOI 10.1128/IAI.66.4.1356-1363.1998; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Troese MJ, 2009, INFECT IMMUN, V77, P1746, DOI 10.1128/IAI.01530-08; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Wakeel A, 2009, INFECT IMMUN, V77, P1734, DOI 10.1128/IAI.00027-09; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; WREN BW, 1991, MOL MICROBIOL, V5, P797, DOI 10.1111/j.1365-2958.1991.tb00752.x; Yu XJ, 1996, J CLIN MICROBIOL, V34, P2853, DOI 10.1128/JCM.34.11.2853-2855.1996	58	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9552	10.1371/journal.pone.0009552	http://dx.doi.org/10.1371/journal.pone.0009552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209062	Green Submitted, gold, Green Published			2022-12-27	WOS:000275197100026
J	Ding, F; Li, HH; Li, J; Myers, RM; Francke, U				Ding, Feng; Li, Hong Hua; Li, Jun; Myers, Richard M.; Francke, Uta			Neonatal Maternal Deprivation Response and Developmental Changes in Gene Expression Revealed by Hypothalamic Gene Expression Profiling in Mice	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; PITUITARY-ADRENAL-AXIS; GENOME MICROARRAY ANALYSIS; BREAST-CANCER METASTASIS; GERM-CELL DEVELOPMENT; SMALL NUCLEOLAR RNAS; NANOS PROTEINS; FOOD-INTAKE; MOUSE; RAT	Neonatal feeding problems are observed in several genetic diseases including Prader-Willi syndrome (PWS). Later in life, individuals with PWS develop hyperphagia and obesity due to lack of appetite control. We hypothesized that failure to thrive in infancy and later-onset hyperphagia are related and could be due to a defect in the hypothalamus. In this study, we performed gene expression microarray analysis of the hypothalamic response to maternal deprivation in neonatal wild-type and Snord116del mice, a mouse model for PWS in which a cluster of imprinted C/D box snoRNAs is deleted. The neonatal starvation response in both strains was dramatically different from that reported in adult rodents. Genes that are affected by adult starvation showed no expression change in the hypothalamus of 5 day-old pups after 6 hours of maternal deprivation. Unlike in adult rodents, expression levels of Nanos2 and Pdk4 were increased, and those of Pgpep1, Ndp, Brms1l, Mett10d, and Snx1 were decreased after neonatal deprivation. In addition, we compared hypothalamic gene expression profiles at postnatal days 5 and 13 and observed significant developmental changes. Notably, the gene expression profiles of Snord116del deletion mice and wild-type littermates were very similar at all time points and conditions, arguing against a role of Snord116 in feeding regulation in the neonatal period.	[Ding, Feng; Li, Hong Hua; Li, Jun; Myers, Richard M.; Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Ding, F (corresponding author), Xiamen Univ, Dept Biomed Sci, Sch Life Sci, Xiamen, Peoples R China.	ufrancke@stanford.edu	Ding, Feng/E-5112-2012; Ding, Feng/AAH-7335-2019	Li, Jun/0000-0001-6727-0812	NIH/NICHD; Foundation for Prader-Willi Research	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation for Prader-Willi Research	This work was supported by research grants (to U.F.) from the NIH/NICHD and the Foundation for Prader-Willi Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; BERTIN R, 1990, AM J PHYSIOL, V259, pR90, DOI 10.1152/ajpregu.1990.259.1.R90; Bittel DC, 2007, AM J MED GENET A, V143A, P422, DOI 10.1002/ajmg.a.31504; Bittel DC, 2007, AM J MED GENET A, V143A, P430, DOI 10.1002/ajmg.a.31606; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Cassidy S.B., 2005, MANAGEMENT GENETIC S, P429; CIRULLI F, 1992, PSYCHOBIOLOGY, V20, P143; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gecz J, 2006, EUR J HUM GENET, V14, P1233, DOI 10.1038/sj.ejhg.5201639; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Hedley BD, 2008, CLIN EXP METASTAS, V25, P727, DOI 10.1007/s10585-008-9184-0; HOFER MA, 1993, DEV PSYCHOBIOL, V26, P483, DOI 10.1002/dev.420260806; Holland A, 2003, LANCET, V362, P989, DOI 10.1016/S0140-6736(03)14370-X; HOLM VA, 1993, PEDIATRICS, V91, P398; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Jordan C, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-36; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Larrinaga G, 2005, NEUROSCI LETT, V383, P136, DOI 10.1016/j.neulet.2005.03.061; LAU C, 1984, PHYSIOL BEHAV, V33, P809, DOI 10.1016/0031-9384(84)90052-0; Li JY, 2002, J BIOL CHEM, V277, P9069, DOI 10.1074/jbc.M110467200; Lim CR, 2004, GENE, V333, P3, DOI 10.1016/j.gene.2004.02.026; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Malik SS, 2003, AM J PHYSIOL-REG I, V285, pR1366, DOI 10.1152/ajpregu.00280.2003; Meehan WJ, 2003, CLIN EXP METASTAS, V20, P45, DOI 10.1023/A:1022542519586; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Perlman JH, 1997, BIOCHEMISTRY-US, V36, P15670, DOI 10.1021/bi9713310; R CDT, 2008, R LANG ENV STAT COMP; Rinaman L, 2006, DEV PSYCHOBIOL, V48, P389, DOI 10.1002/dev.20146; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Schmidt M, 2004, J NEUROENDOCRINOL, V16, P52, DOI 10.1111/j.1365-2826.2004.01123.x; Schmidt MV, 2006, J NEUROENDOCRINOL, V18, P865, DOI 10.1111/j.1365-2826.2006.01482.x; Schmidt MV, 2008, J ENDOCRINOL, V197, P421, DOI 10.1677/JOE-07-0634; Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuda M, 2006, MECH DEVELOP, V123, P440, DOI 10.1016/j.mod.2006.04.002; Vannucci RC, 2000, SEMIN PERINATOL, V24, P107, DOI 10.1053/sp.2000.6361; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; White SM, 2004, AM J MED GENET A, V127A, P118, DOI 10.1002/ajmg.a.20674; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	58	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9402	10.1371/journal.pone.0009402	http://dx.doi.org/10.1371/journal.pone.0009402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195375	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924200023
J	Patel, BP; Safdar, A; Raha, S; Tarnopolsky, MA; Hamadeh, MJ				Patel, Barkha P.; Safdar, Adeel; Raha, Sandeep; Tarnopolsky, Mark A.; Hamadeh, Mazen J.			Caloric Restriction Shortens Lifespan through an Increase in Lipid Peroxidation, Inflammation and Apoptosis in the G93A Mouse, an Animal Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN-SUPEROXIDE-DISMUTASE; HEAT-SHOCK PROTEINS; SKELETAL-MUSCLE; OXIDATIVE STRESS; GENE-EXPRESSION; DIETARY RESTRICTION; MITOCHONDRIAL-DNA; UP-REGULATION; RADICAL GENERATION	Caloric restriction (CR) extends lifespan through a reduction in oxidative stress, delays the onset of morbidity and prolongs lifespan. We previously reported that long-term CR hastened clinical onset, disease progression and shortened lifespan, while transiently improving motor performance in G93A mice, a model of amyotrophic lateral sclerosis (ALS) that shows increased free radical production. To investigate the long-term CR-induced pathology in G93A mice, we assessed the mitochondrial bioenergetic efficiency and oxidative capacity (CS - citrate synthase content and activity, cytochrome c oxidase - COX activity and protein content of COX subunit-I and IV and UCP3- uncoupling protein 3), oxidative damage (MDA - malondialdehyde and PC - protein carbonyls), antioxidant enzyme capacity (Mn-SOD, Cu/Zn-SOD and catalase), inflammation (TNF-alpha), stress response (Hsp70) and markers of apoptosis (Bax, Bcl-2, caspase 9, cleaved caspase 9) in their skeletal muscle. At age 40 days, G93A mice were divided into two groups: Ad libitum (AL; n = 14; 7 females) or CR (n = 13; 6 females), with a diet equal to 60% of AL. COX/CS enzyme activity was lower in CR vs. AL male quadriceps (35%), despite a 2.3-fold higher COX-IV/CS protein content. UCP3 was higher in CR vs. AL females only. MnSOD and Cu/Zn-SOD were higher in CR vs. AL mice and CR vs. AL females. MDA was higher (83%) in CR vs. AL red gastrocnemius. Conversely, PC was lower in CR vs. AL red (62%) and white (30%) gastrocnemius. TNF-alpha was higher (52%) in CR vs. AL mice and Hsp70 was lower (62%) in CR vs. AL quadriceps. Bax was higher in CR vs. AL mice (41%) and CR vs. AL females (52%). Catalase, Bcl-2 and caspases did not differ. We conclude that CR increases lipid peroxidation, inflammation and apoptosis, while decreasing mitochondrial bioenergetic efficiency, protein oxidation and stress response in G93A mice.	[Patel, Barkha P.; Hamadeh, Mazen J.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Patel, Barkha P.; Hamadeh, Mazen J.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Safdar, Adeel; Raha, Sandeep; Tarnopolsky, Mark A.; Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Safdar, Adeel] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University; McMaster University; McMaster University	Patel, BP (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca	Patel, Barkha/AAJ-2355-2020; Raha, Sandeep/AAF-3655-2020	Raha, Sandeep/0000-0001-7307-3292; Safdar, Adeel/0000-0003-2469-0467; Hamadeh, Mazen/0000-0002-3511-4345; Safdar, Adeel/0000-0002-7453-7770	Hamilton Health Sciences; Hamilton Health Sciences Foundation New Investigator Fund; National Sciences and Engineering Research Council of Canada; York University-Faculty of Health; Hamilton Health Sciences Foundation William E. Noonan Research Career Award; Canadian Institute of Health Research - Institute of Aging Doctoral Research Award	Hamilton Health Sciences; Hamilton Health Sciences Foundation New Investigator Fund; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); York University-Faculty of Health; Hamilton Health Sciences Foundation William E. Noonan Research Career Award; Canadian Institute of Health Research - Institute of Aging Doctoral Research Award(Canadian Institutes of Health Research (CIHR))	This research was funded by Hamilton Health Sciences, Hamilton Health Sciences Foundation New Investigator Fund, the National Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and York University-Faculty of Health. M. J. Hamadeh was recipient of the Hamilton Health Sciences Foundation William E. Noonan Research Career Award. A. Safdar was recipient of the Canadian Institute of Health Research - Institute of Aging Doctoral Research Award (http://www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; BARJA G, 1994, COMP BIOCHEM PHYS B, V108, P501, DOI 10.1016/0305-0491(94)90103-1; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Batulan Z, 2003, J NEUROSCI, V23, P5789; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; BEHRENS WA, 1977, J BIOENERG BIOMEMBR, V9, P41, DOI 10.1007/BF00745042; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bogdanov MB, 1998, J NEUROCHEM, V71, P1321; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Corral LG, 1999, ANN RHEUM DIS, V58, P107, DOI 10.1136/ard.58.2008.i107; DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje; Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190; Gruber J, 2008, FRONT BIOSCI-LANDMRK, V13, P6554, DOI 10.2741/3174; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gursoy E, 2001, EXP BIOL MED, V226, P97, DOI 10.1177/153537020122600206; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; HAMADEH MJ, 2005, ANN NUTR METAB S1, V49, P164; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HILL JO, 1986, J NUTR, V116, P2000, DOI 10.1093/jn/116.10.2000; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003; Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003; Kalain R, 2006, J GERONTOL A-BIOL, V61, P211, DOI 10.1093/gerona/61.3.211; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kiaei M, 2006, J NEUROSCI, V26, P2467, DOI 10.1523/JNEUROSCI.5253-05.2006; Kim JD, 1996, FREE RADICAL BIO MED, V20, P83, DOI 10.1016/0891-5849(95)02023-3; KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Mahoney DJ, 2006, MUSCLE NERVE, V33, P809, DOI 10.1002/mus.20542; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V281, pE1333, DOI 10.1152/ajpendo.2001.281.6.E1333; Moien-Afshari F, 2008, DIABETOLOGIA, V51, P1327, DOI 10.1007/s00125-008-0996-x; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; Roy J, 1998, J NEUROSCI, V18, P9673; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sato A, 1998, BIOL PHARM BULL, V21, P1271, DOI 10.1248/bpb.21.1271; Selman C, 2003, EXP GERONTOL, V38, P897, DOI 10.1016/S0531-5565(03)00091-3; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Sen CK, 1997, J APPL PHYSIOL, V83, P189, DOI 10.1152/jappl.1997.83.1.189; Seng JE, 2003, TOXICOL APPL PHARM, V193, P281, DOI 10.1016/j.taap.2003.07.008; Shelke RRJ, 2003, FASEB J, V17, P494, DOI 10.1096/fj.02-0803fje; Simpson EP, 2003, CURR OPIN RHEUMATOL, V15, P730, DOI 10.1097/00002281-200311000-00008; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; SLOWIE LA, 1983, J AM DIET ASSOC, V83, P44; Stein O, 2003, BIOCHEM BIOPH RES CO, V308, P29, DOI 10.1016/S0006-291X(03)01313-5; Valle A, 2007, AM J PHYSIOL-CELL PH, V293, pC1302, DOI 10.1152/ajpcell.00203.2007; Vina J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wong LJC, 2007, MITOCHONDRION, V7, P45, DOI 10.1016/j.mito.2006.11.025; Wu AG, 2003, NEUROSCI LETT, V339, P166, DOI 10.1016/S0304-3940(03)00008-9; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007	95	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9386	10.1371/journal.pone.0009386	http://dx.doi.org/10.1371/journal.pone.0009386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195368	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924200013
J	Archin, NM; Cheema, M; Parker, D; Wiegand, A; Bosch, RJ; Coffin, JM; Eron, J; Cohen, M; Margolis, DM				Archin, Nancie M.; Cheema, Manzoor; Parker, Daniel; Wiegand, Ann; Bosch, Ronald J.; Coffin, John M.; Eron, Joseph; Cohen, Myron; Margolis, David M.			Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection	PLOS ONE			English	Article							THERAPEUTIC STRATEGIES; T-CELLS; EXPRESSION; TYPE-1; RESERVOIR; DEACETYLASES; INHIBITORS; REDUCE; SIZE	Background: Human immunodeficiency virus (HIV) infection that persists despite antiretroviral therapy (ART) is a daunting problem. Given the limited evidence that resting CD4+ T cell infection (RCI) is affected by the histone deacetylase (HDAC) inhibitor valproic acid (VPA), we measured the stability of RCI and residual viremia in patients who added VPA with or without raltegravir (RAL), or enfuvirtide (ENF) with or without VPA, to standard ART. Methods: Patients with plasma HIV RNA <50 c/mL added sustained-release VPA (Depakote ER (R)) twice daily, RAL 400 mg twice daily, or ENF 90 mcg twice daily. Change in RCI was measured by outgrowth assays. Low-level viremia was quantitated by single-copy plasma HIV RNA assay (SCA). Results: In three patients on standard ART a depletion of RCI was observed after 16 weeks of VPA, but this effect waned over up to 96 weeks of further VPA. In two patients ENF added to stable ART had no effect on RCI. Simultaneous intensification with ENF and addition of VPA had no effect on RCI frequency in one patient, and resulted in a 46% decline in a second. No significant depletion of RCI (>50%) was seen in six volunteers after the addition of RAL and VPA. In 4 of the 6 patients this lack of effect might be attributed to intermittent viremia, low VPA levels, or intermittent study therapy adherence. Overall, there was no effect of the addition of RAL or ENF on low-level viremia measured by SCA. Conclusions: The prospective addition of VPA and RAL, VPA and ENF, or ENF failed to progressively reduce the frequency of RCI, or ablate intermittent and low-level viremia. New approaches such as more potent HDAC inhibition, alone or in combination with intensified ART or other agents that may disrupt proviral latency must be pursued.	[Archin, Nancie M.; Cheema, Manzoor; Parker, Daniel; Eron, Joseph; Cohen, Myron; Margolis, David M.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Wiegand, Ann; Coffin, John M.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21701 USA; [Bosch, Ronald J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Archin, NM (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.	dmargo@med.unc.edu	Laboratory Core, HIV STD/AGD-7085-2022; Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002; Parker, Daniel/0000-0001-8512-1044	National Institutes of Health [AI45297, AI064074, R00046, U54RR024383, AI50410]; Trimeris/Roche Laboratories; F.M. Kirby Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045297, R56AI045297, P30AI050410, R01AI064074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trimeris/Roche Laboratories; F.M. Kirby Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the study was provided by National Institutes of Health grants AI45297 and AI064074 to DMM, R00046 and U54RR024383 to the UNC GCRC and CTSA, AI50410 to the UNC CFAR, and Trimeris/Roche Laboratories. J.M.C. was a Research Professor of the American Cancer Society with support from the F.M. Kirby Foundation. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck and Company, Incorporated, Trimeris Incorporated, Roche Pharmaceuticals, or Abbott Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Bowman MC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000970; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; GANDHI R, 2009, 16 ANN C RETR OPP IN; GHANDI R, 2009, 5 IAS C HIV PATH TRE; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sagot-Lerolle N, 2008, AIDS, V22, P1125, DOI 10.1097/QAD.0b013e3282fd6ddc; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	20	121	129	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9390	10.1371/journal.pone.0009390	http://dx.doi.org/10.1371/journal.pone.0009390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186346	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924000026
J	Mossberg, AK; Puchades, M; Halskau, O; Baumann, A; Lanekoff, I; Chao, YX; Martinez, A; Svanborg, C; Karlsson, R				Mossberg, Ann-Kristin; Puchades, Maja; Halskau, Oyvind; Baumann, Anne; Lanekoff, Ingela; Chao, Yinxia; Martinez, Aurora; Svanborg, Catharina; Karlsson, Roger			HAMLET Interacts with Lipid Membranes and Perturbs Their Structure and Integrity	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; PLASMA-MEMBRANE; MOLTEN-GLOBULE; MODEL MEMBRANES; TUMOR-CELLS; OLEIC ACID; BINDING; PROTEIN; VESICLES; CONFORMATIONS	Background: Cell membrane interactions rely on lipid bilayer constituents and molecules inserted within the membrane, including specific receptors. HAMLET ( human alpha-lactalbumin made lethal to tumor cells) is a tumoricidal complex of partially unfolded alpha-lactalbumin (HLA) and oleic acid that is internalized by tumor cells, suggesting that interactions with the phospholipid bilayer and/or specific receptors may be essential for the tumoricidal effect. This study examined whether HAMLET interacts with artificial membranes and alters membrane structure. Methodology/Principal Findings: We show by surface plasmon resonance that HAMLET binds with high affinity to surface adherent, unilamellar vesicles of lipids with varying acyl chain composition and net charge. Fluorescence imaging revealed that HAMLET accumulates in membranes of vesicles and perturbs their structure, resulting in increased membrane fluidity. Furthermore, HAMLET disrupted membrane integrity at neutral pH and physiological conditions, as shown by fluorophore leakage experiments. These effects did not occur with either native HLA or a constitutively unfolded Cys-Ala HLA mutant (rHLA(all-Ala)). HAMLET also bound to plasma membrane vesicles formed from intact tumor cells, with accumulation in certain membrane areas, but the complex was not internalized by these vesicles or by the synthetic membrane vesicles. Conclusions/Significance: The results illustrate the difference in membrane affinity between the fatty acid bound and fatty acid free forms of partially unfolded HLA and suggest that HAMLET engages membranes by a mechanism requiring both the protein and the fatty acid. Furthermore, HAMLET binding alters the morphology of the membrane and compromises its integrity, suggesting that membrane perturbation could be an initial step in inducing cell death.	[Mossberg, Ann-Kristin; Svanborg, Catharina] Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden; [Puchades, Maja; Lanekoff, Ingela; Karlsson, Roger] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Halskau, Oyvind; Baumann, Anne; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway; [Chao, Yinxia; Svanborg, Catharina] ASTAR, Singapore Immunol Network, Singapore, Singapore	Lund University; University of Gothenburg; University of Bergen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Mossberg, AK (corresponding author), Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden.	Catharina_Svanborg@immunol.a-star.edu.sg	Karlsson, Roger/A-7701-2010; Puchades, Maja/D-5835-2013; Karlsson, Roger/AFX-3165-2022; Martinez, Aurora/M-3088-2019	Puchades, Maja/0000-0002-4536-8197; Karlsson, Roger/0000-0002-5919-2639; Martinez, Aurora/0000-0003-1643-6506; Chao, Yinxia/0000-0003-1185-3511; Halskau, Oyvind/0000-0003-2517-1060; Lanekoff, Ingela/0000-0001-9040-3230	Swedish Cancer Society; Sharon D. Lund Foundation; Soderberg Foundation; Inga-Britt and Arne Lundberg Foundation; Medical Faculty (Lund University); Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Maggie Stephens Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Norwegian Cancer Society; Research Council of Norway; Wallenberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Sharon D. Lund Foundation; Soderberg Foundation; Inga-Britt and Arne Lundberg Foundation; Medical Faculty (Lund University); Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Maggie Stephens Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Wallenberg Foundation(European Commission)	This work was supported by the Swedish Cancer Society, the Sharon D. Lund Foundation grant, the Soderberg Foundation, the Inga-Britt and Arne Lundberg Foundation, the Medical Faculty (Lund University), the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Maggie Stephens Foundation, the HJ Forssman Foundation for Medical Research, the Royal Physiographic Society, Norwegian Cancer Society, the Research Council of Norway, and the Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Banuelos S, 1996, BIOCHEMISTRY-US, V35, P3892, DOI 10.1021/bi951468v; BANUELOS S, 1995, J BIOL CHEM, V270, P29910, DOI 10.1074/jbc.270.50.29910; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Bauer B, 2006, LANGMUIR, V22, P9329, DOI 10.1021/la060828k; Bauer B, 2009, ANGEW CHEM INT EDIT, V48, P1656, DOI 10.1002/anie.200803898; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BURGESS SW, 1992, BIOCHEMISTRY-US, V31, P2653, DOI 10.1021/bi00125a004; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; ELLENS H, 1984, BIOCHEMISTRY-US, V23, P1532, DOI 10.1021/bi00302a029; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Halskau O, 2005, J MOL BIOL, V349, P1072, DOI 10.1016/j.jmb.2005.04.020; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hamilton JA, 1998, J LIPID RES, V39, P467; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Kleinfeld AM, 2000, J MEMBRANE BIOL, V175, P79, DOI 10.1007/s002320001056; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; MAYER LD, 1986, CHEM PHYS LIPIDS, V40, P333, DOI 10.1016/0009-3084(86)90077-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; PENG ZY, 1995, BIOCHEMISTRY-US, V34, P3248, DOI 10.1021/bi00010a014; PETTERSSONKASTB.J, 2009, J MOL BIOL IN PRESS; Rodland I, 2005, BBA-BIOMEMBRANES, V1717, P11, DOI 10.1016/j.bbamem.2005.09.004; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	36	55	59	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9384	10.1371/journal.pone.0009384	http://dx.doi.org/10.1371/journal.pone.0009384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186341	Green Published, gold			2022-12-27	WOS:000274924000023
J	Laurent, M; Deschatrette, J; Wolfrom, CM				Laurent, Michel; Deschatrette, Jean; Wolfrom, Claire M.			Unmasking Chaotic Attributes in Time Series of Living Cell Populations	PLOS ONE			English	Article							HEPATOMA-CELLS; DYNAMICS; PROLIFERATION; OSCILLATIONS; TELOMERASE; RESISTANCE; GEOMETRY; MODEL	Background: Long-range oscillations of the mammalian cell proliferation rate are commonly observed both in vivo and in vitro. Such complicated dynamics are generally the result of a combination of stochastic events and deterministic regulation. Assessing the role, if any, of chaotic regulation is difficult. However, unmasking chaotic dynamics is essential for analysis of cellular processes related to proliferation rate, including metabolic activity, telomere homeostasis, gene expression, and tumor growth. Methodology/Principal Findings: Using a simple, original, nonlinear method based on return maps, we previously found a geometrical deterministic structure coordinating such fluctuations in populations of various cell types. However, nonlinearity and determinism are only necessary conditions for chaos; they do not by themselves constitute a proof of chaotic dynamics. Therefore, we used the same analytical method to analyze the oscillations of four well-known, low--dimensional, chaotic oscillators, originally designed in diverse settings and all possibly well-adapted to model the fluctuations of cell populations: the Lorenz, Rossler, Verhulst and Duffing oscillators. All four systems also display this geometrical structure, coordinating the oscillations of one or two variables of the oscillator. No such structure could be observed in periodic or stochastic fluctuations. Conclusion/Significance: Theoretical models predict various cell population dynamics, from stable through periodically oscillating to a chaotic regime. Periodic and stochastic fluctuations were first described long ago in various mammalian cells, but by contrast, chaotic regulation had not previously been evidenced. The findings with our nonlinear geometrical approach are entirely consistent with the notion that fluctuations of cell populations can be chaotically controlled.	[Laurent, Michel; Deschatrette, Jean; Wolfrom, Claire M.] Univ Paris 11, CNRS, INSERM,Unite Mixte Rech 8080, Lab Dynam Cellulaires & Modelisat,Unite Mixte Rec, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Laurent, M (corresponding author), Univ Paris 11, CNRS, INSERM,Unite Mixte Rech 8080, Lab Dynam Cellulaires & Modelisat,Unite Mixte Rec, F-91405 Orsay, France.	claire.wolfrom@u-psud.fr			Centre National de la Recherche Scientifique (CNRS); University Paris-Sud Orsay; Association Biologie du Cancer et Dynamiques complexes	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud Orsay; Association Biologie du Cancer et Dynamiques complexes	This work was supported by funding from the Centre National de la Recherche Scientifique (CNRS), University Paris-Sud Orsay, and the Association Biologie du Cancer et Dynamiques complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Chau NP, 2005, ANTICANCER RES, V25, P3279; DEMENEZES MA, 2001, INT J MOD PHYS C, V12, P1; DEMONGEOT J, 1987, LIFE SCI SERIES, V138, P255; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Deschatrette J., 2003, ComPlexUs, V1, P134, DOI 10.1159/000076101; Deschatrette J, 2004, ANTI-CANCER DRUG, V15, P671, DOI 10.1097/01.cad.0000136879.96680.bc; FRANCHIMONT C, 1982, BRIT J DERMATOL, V106, P305, DOI 10.1111/j.1365-2133.1982.tb01728.x; GATTI RA, 1973, BLOOD, V41, P771, DOI 10.1182/blood.V41.6.771.771; Haurie C, 1999, EXP HEMATOL, V27, P401, DOI 10.1016/S0301-472X(98)00061-7; Kaplan DT, 1997, STUD HEALTH TECHNOL, V35, P15; KHOKHA MK, 1994, DEV BIOL, V165, P545, DOI 10.1006/dbio.1994.1274; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Letaief N, 1995, J PHYS II, V5, P1883, DOI 10.1051/jp2:1995218; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; MACKEY MC, 2003, NONLINEAR DYNAMICS P, pCH9; Maigne J, 1998, IN VITRO CELL DEV-AN, V34, P163; MAUGHAN WZ, 1973, BLOOD, V41, P85, DOI 10.1182/blood.V41.1.85.85; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Ostby I, 2004, J MATH BIOL, V49, P501, DOI 10.1007/s00285-004-0274-6; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Popivanov D, 1999, MATH BIOSCI, V157, P303, DOI 10.1016/S0025-5564(98)10088-3; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; VANCE RR, 1978, AM NAT, V112, P797, DOI 10.1086/283324; Verhulst P., 1845, ACAD R SCI METR BR 2, V18, P1; Wolfrom C, 2004, EXP HEMATOL, V32, P822, DOI 10.1016/j.exphem.2004.06.005; Wolfrom C, 2000, J CELL SCI, V113, P1069; WOLFROM C, 2010, CELL PROLIF IN PRESS; Wolfrom C, 2007, FEBS LETT, V581, P125, DOI 10.1016/j.febslet.2006.12.007	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9346	10.1371/journal.pone.0009346	http://dx.doi.org/10.1371/journal.pone.0009346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179755	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900012
J	Gustafsson, M; Hornquist, M				Gustafsson, Mika; Hornquist, Michael			Gene Expression Prediction by Soft Integration and the Elastic Net-Best Performance of the DREAM3 Gene Expression Challenge	PLOS ONE			English	Article							EFFECTIVE DIMENSIONALITY; REGULATORY ASSOCIATIONS; NETWORK; REGRESSION; INFERENCE; SELECTION; DATABASE; SYSTEMS; LASSO; TOOLS	Background: To predict gene expressions is an important endeavour within computational systems biology. It can both be a way to explore how drugs affect the system, as well as providing a framework for finding which genes are interrelated in a certain process. A practical problem, however, is how to assess and discriminate among the various algorithms which have been developed for this purpose. Therefore, the DREAM project invited the year 2008 to a challenge for predicting gene expression values, and here we present the algorithm with best performance. Methodology/Principal Findings: We develop an algorithm by exploring various regression schemes with different model selection procedures. It turns out that the most effective scheme is based on least squares, with a penalty term of a recently developed form called the "elastic net". Key components in the algorithm are the integration of expression data from other experimental conditions than those presented for the challenge and the utilization of transcription factor binding data for guiding the inference process towards known interactions. Of importance is also a cross-validation procedure where each form of external data is used only to the extent it increases the expected performance. Conclusions/Significance: Our algorithm proves both the possibility to extract information from large-scale expression data concerning prediction of gene levels, as well as the benefits of integrating different data sources for improving the inference. We believe the former is an important message to those still hesitating on the possibilities for computational approaches, while the latter is part of an important way forward for the future development of the field of computational systems biology.	[Gustafsson, Mika; Hornquist, Michael] Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden	Linkoping University	Gustafsson, M (corresponding author), Linkoping Univ, Dept Sci & Technol, Norrkoping, Sweden.	michael.hornquist@liu.se			Center for Industrial Information Technology at Linkoping University [03.02]	Center for Industrial Information Technology at Linkoping University	This work was funded by Center for Industrial Information Technology at Linkoping University (http://www.isy.liu.se/ceniit/) under grant number 03.02. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Cho KH, 2007, IET SYST BIOL, V1, P149, DOI 10.1049/iet-syb:20060075; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Draper N.R., 1998, APPL REGRESSION ANAL; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FRIEDMAN J, J STAT SOFT IN PRESS; Gustafsson M, 2005, IEEE ACM T COMPUT BI, V2, P254, DOI 10.1109/TCBB.2005.35; Gustafsson M, 2009, IET SYST BIOL, V3, P219, DOI 10.1049/iet-syb.2008.0112; GUSTAFSSON M, 2009, COMPUTATIONAL METHOD, P476; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hornquist M, 2003, BIOSYSTEMS, V71, P311, DOI 10.1016/S0303-2647(03)00128-X; Hornquist M, 2002, BIOSYSTEMS, V65, P147, DOI 10.1016/S0303-2647(02)00011-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; NARULA SC, 1982, INT STAT REV, V50, P317, DOI 10.2307/1402501; Ruan JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008944; STOLOVITZKY G, 2009, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0009202; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Thorsson V, 2005, STAT APPL GENET MOL, V4; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani RJ, 2009, ANN APPL STAT, V3, P822, DOI 10.1214/08-AOAS224; WANG L, 2007, P IEEE INT C DAT MIN, P690; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9134	10.1371/journal.pone.0009134	http://dx.doi.org/10.1371/journal.pone.0009134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169069	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500002
J	Jenkins, HE; Woodroffe, R; Donnelly, CA				Jenkins, Helen E.; Woodroffe, Rosie; Donnelly, Christl A.			The Duration of the Effects of Repeated Widespread Badger Culling on Cattle Tuberculosis Following the Cessation of Culling	PLOS ONE			English	Article							BOVINE TUBERCULOSIS; MYCOBACTERIUM-BOVIS; IMPACT; REMOVAL; IRELAND; WELFARE; TB	Background: In the British Isles, control of cattle tuberculosis (TB) is hindered by persistent infection of wild badger (Meles meles) populations. A large-scale field trial-the Randomised Badger Culling Trial (RBCT)-previously showed that widespread badger culling produced modest reductions in cattle TB incidence during culling, which were offset by elevated TB risks for cattle on adjoining lands. Once culling was halted, beneficial effects inside culling areas increased, while detrimental effects on adjoining lands disappeared. However, a full assessment of the utility of badger culling requires information on the duration of culling effects. Methodology/Principal Findings: We monitored cattle TB incidence in and around RBCT areas after culling ended. We found that benefits inside culled areas declined over time, and were no longer detectable by three years post-culling. On adjoining lands, a trend suggesting beneficial effects immediately after the end of culling was insignificant, and disappeared after 18 months post-culling. From completion of the first cull to the loss of detectable effects (an average five-year culling period plus 2.5 years post-culling), cattle TB incidence was 28.7% lower (95% confidence interval [CI] 20.7 to 35.8% lower) inside ten 100 km(2) culled areas than inside ten matched no-culling areas, and comparable (11.7% higher, 95% CI: 13.0% lower to 43.4% higher, p = 0.39) on lands <= 2 km outside culled and no-culling areas. The financial costs of culling an idealized 150 km(2) area would exceed the savings achieved through reduced cattle TB, by factors of 2 to 3.5. Conclusions/Significance: Our findings show that the reductions in cattle TB incidence achieved by repeated badger culling were not sustained in the long term after culling ended and did not offset the financial costs of culling. These results, combined with evaluation of alternative culling methods, suggest that badger culling is unlikely to contribute effectively to the control of cattle TB in Britain.	[Jenkins, Helen E.; Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Woodroffe, Rosie] Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; Zoological Society of London	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	c.donnelly@imperial.ac.uk		Donnelly, Christl/0000-0002-0195-2463; Jenkins, Helen/0000-0003-4749-1591	United Kingdom Department of Environment, Food and Rural Affairs; Medical Research Council [G0600719B] Funding Source: researchfish	United Kingdom Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge the support of the United Kingdom Department of Environment, Food and Rural Affairs (Defra; http://www.defra.gov.uk/index.htm) for this work. CAD thanks the United Kingdom Medical Research Council (http://www.mrc.ac.uk/index.htm) for Centre funding. HEJ thanks the Medical Research Council for a studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Randomised Badger Culling Trial was implemented by the staff of Defra and its associated agencies. Defra funds the ongoing collection and storage of routine surveillance data, which were utilized in this study. Defra officials commented on a near-final draft of this manuscript.	Bourne J., 2007, BOVINE TB SCI EVIDEN; BOURNE J, 1998, 1 MIN AGR FISH FOOD; Cheeseman C.L., 1993, P78; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; *DEFR, 2005, COST BEN AN BADG MAN; *DEFRA, 2009, MONTHL PUBL NAT STAT; Defra, 2006, PUBL CONS CONTR SPRE; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; FERA, 2009, ASS REL LANDSC IS BA; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Kelly GE, 2008, EPIDEMIOL INFECT, V136, P1362, DOI 10.1017/S0950268807000027; KIRKWOOD JK, 2000, HUMANENESS MAFFS BAD; Krebs J., 1997, PB3423 HMSO; MacDonald DW, 2006, BIOL CONSERV, V131, P268, DOI 10.1016/j.biocon.2006.05.006; McGrath G, 2009, IRISH VET J, V62, P192, DOI 10.1186/2046-0481-62-3-192; MORRIS RS, 1994, VET MICROBIOL, V40, P153, DOI 10.1016/0378-1135(94)90053-1; Pope LC, 2007, MOL ECOL, V16, P4919, DOI 10.1111/j.1365-294X.2007.03553.x; *WELSH ASS GOV, 2009, STRAT COSTS TB COMP; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2005, ANIM WELFARE, V14, P19; Woodroffe R, 2005, ANIM WELFARE, V14, P11; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	29	74	76	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9090	10.1371/journal.pone.0009090	http://dx.doi.org/10.1371/journal.pone.0009090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161769	Green Published, gold			2022-12-27	WOS:000274442700004
J	Thuny, F; Richet, H; Casalta, JP; Angelakis, E; Habib, G; Raoult, D				Thuny, Franck; Richet, Herve; Casalta, Jean-Paul; Angelakis, Emmanouil; Habib, Gilbert; Raoult, Didier			Vancomycin Treatment of Infective Endocarditis Is Linked with Recently Acquired Obesity	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; GUT MICROBIOTA; GROWTH; LACTOBACILLUS; ANTIBIOTICS; PROBIOTICS; PROMOTERS; AVOPARCIN; INFANT; HEALTH	Background: Gut microbiota play a major role in digestion and energy conversion of nutrients. Antibiotics, such as avoparcin (a vancomycin analogue), and probiotics, such as Lactobacillus species, have been used to increase weight in farm animals. We tested the effect of antibiotics given for infective endocarditis (IE) on weight gain (WG). Methodology/Principal Findings: Forty-eight adults with a definite diagnosis of bacterial IE (antibiotic group) were compared with forty-eight age-matched controls without IE. Their body mass index (BMI) was collected at one month before the first symptoms and one year after hospital discharge. The BMI increased significantly and strongly in vancomycinplus-gentamycin-treated patients (mean [+/- SE] kg/m(2), + 2.3 [0.9], p = 0.03), but not in controls or in patients treated with other antibiotics. Seventeen patients had a BMI increase of >= 10%, and five of the antibiotic group developed obesity. The treatment by vancomycin-plus-gentamycin was an independent predictor of BMI increase of >= 10% (adjusted OR, 6.7; 95% CI, 1.37-33.0; p = 0.02), but not treatment with other antibiotics. Weight gain was particularly high in male patients older than 65 who did not undergo cardiac surgery. Indeed, all three vancomycin-treated patients with these characteristics developed obesity. Conclusions/Significance: A major and significant weight gain can occur after a six-week intravenous treatment by vancomycin plus gentamycin for IE with a risk of obesity, especially in males older than 65 who have not undergone surgery. We speculate on the role of the gut colonization by Lactobacillus sp, a microorganism intrinsically resistant to vancomycin, used as a growth promoter in animals, and found at a high concentration in the feces of obese patients. Thus, nutritional programs and weight follow-up should be utilized in patients under such treatment.	[Thuny, Franck; Richet, Herve; Angelakis, Emmanouil; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Thuny, Franck; Habib, Gilbert] Hop La Timone, Serv Cardiol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Thuny, F (corresponding author), Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, Marseille, France.	didier.raoult@gmail.com	Thuny, Franck/ABC-7157-2020; RAOULT, Didier/A-8434-2008; Thuny, Franck/GSD-2668-2022; Thuny, Franck/ABB-2408-2021; Angelakis, Emmanouil/A-9873-2015; Angelakis, Emmanouil/D-8039-2013	RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; Angelakis, Emmanouil/0000-0001-7327-5441				Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Acar J, 2000, CLIN MICROBIOL INFEC, V6, P477, DOI 10.1046/j.1469-0691.2000.00128.x; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bax JJ, 2006, J AM COLL CARDIOL, V48, P754, DOI 10.1016/j.jacc.2006.04.077; Botelho-Nevers E, 2009, ARCH INTERN MED, V169, P1290, DOI 10.1001/archinternmed.2009.192; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiofalo V, 2004, REPROD NUTR DEV, V44, P449, DOI 10.1051/rnd:2004051; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Delgado S, 2005, CURR MICROBIOL, V50, P202, DOI 10.1007/s00284-004-4431-3; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; DYER IA, 1980, J ANIM SCI, V51, P843, DOI 10.2527/jas1980.514843x; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Friedman JM, 2009, NATURE, V459, P340, DOI 10.1038/459340a; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Han E, 2009, INT J OBESITY, V33, P249, DOI 10.1038/ijo.2008.193; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Khan M, 2007, BRIT POULTRY SCI, V48, P732, DOI 10.1080/00071660701716222; LEY R, 2006, NATURE, V444, P1023; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Mudd AJ, 1996, LANCET, V348, P1454, DOI 10.1016/S0140-6736(04)70103-8; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Raoult D, 2008, EUR J CLIN MICROBIOL, V27, P631, DOI 10.1007/s10096-008-0490-x; Raoult D, 2008, NATURE, V454, P690, DOI 10.1038/454690c; ROSENBERG IH, 1974, AM J CLIN NUTR, V27, P304, DOI 10.1093/ajcn/27.3.304; Ammor MS, 2007, FOOD MICROBIOL, V24, P559, DOI 10.1016/j.fm.2006.11.001; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Ternak G, 2005, MED HYPOTHESES, V64, P14, DOI 10.1016/j.mehy.2004.08.003; Timmerman HM, 2005, J DAIRY SCI, V88, P2154, DOI 10.3168/jds.S0022-0302(05)72891-5; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vendt N, 2006, J HUM NUTR DIET, V19, P51, DOI 10.1111/j.1365-277X.2006.00660.x	38	108	111	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9074	10.1371/journal.pone.0009074	http://dx.doi.org/10.1371/journal.pone.0009074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161775	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442700003
J	Biswas, S; Reinhard, J; Oakeshott, J; Russell, R; Srinivasan, MV; Claudianos, C				Biswas, Sunita; Reinhard, Judith; Oakeshott, John; Russell, Robyn; Srinivasan, Mandyam V.; Claudianos, Charles			Sensory Regulation of Neuroligins and Neurexin I in the Honeybee Brain	PLOS ONE			English	Article							MUSHROOM BODIES; NEURAL LATERALIZATION; HEMISPHERE ADVANTAGE; INHIBITORY SYNAPSES; ALPHA-NEUREXINS; APIS-MELLIFERA; PLASTICITY; MEMORY; EXPERIENCE; DROSOPHILA	Background: Neurexins and neuroligins, which have recently been associated with neurological disorders such as autism in humans, are highly conserved adhesive proteins found on synaptic membranes of neurons. These binding partners produce a trans-synaptic bridge that facilitates maturation and specification of synapses. It is believed that there exists an optimal spatio-temporal code of neurexin and neuroligin interactions that guide synapse formation in the postnatal developing brain. Therefore, we investigated whether neuroligins and neurexin are differentially regulated by sensory input using a behavioural model system with an advanced capacity for sensory processing, learning and memory, the honeybee. Methodology/Principal Findings: Whole brain expression levels of neuroligin 1-5 (NLG1-5) and neurexin I (NrxI) were estimated by qRT-PCR analysis in three different behavioural paradigms: sensory deprivation, associative scent learning, and lateralised sensory input. Sensory deprived bees had a lower level of NLG1 expression, but a generally increased level of NLG2-5 and NrxI expression compared to hive bees. Bees that had undergone associative scent training had significantly increased levels of NrxI, NLG1 and NLG3 expression compared to untrained control bees. Bees that had lateralised sensory input after antennal amputation showed a specific increase in NLG1 expression compared to control bees, which only happened over time. Conclusions/Significance: Our results suggest that (1) there is a lack of synaptic pruning during sensory deprivation; (2) NLG1 expression increases with sensory stimulation; (3) concomitant changes in gene expression suggests NrxI interacts with all neuroligins; (4) there is evidence for synaptic compensation after lateralised injury.	[Biswas, Sunita; Reinhard, Judith; Srinivasan, Mandyam V.; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Biswas, Sunita] Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia; [Biswas, Sunita; Oakeshott, John; Russell, Robyn; Claudianos, Charles] Commonwealth Sci & Ind Res Org Entomol, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Australian Natl Univ, Australian Res Council, Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia	University of Queensland; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; University of Queensland	Biswas, S (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	c.claudianos@uq.edu.au	Srinivasan, Mandyam V/G-5571-2010; Oakeshott, John G/B-5365-2009; Russell, Robyn/C-5449-2008	Oakeshott, John G/0000-0001-8324-7874; Russell, Robyn/0000-0001-5600-3305; Claudianos, Charles/0000-0002-9799-9572; Muthukumarasamy, Srinivasan/0000-0002-2948-6206	Australian National University PhD Scholarship	Australian National University PhD Scholarship(Australian National University)	S. Biswas was supported by an Australian National University PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitz M, 2007, CEREB CORTEX, V17, P2573, DOI 10.1093/cercor/bhl163; ANDREW RJ, 1984, NEUROPSYCHOLOGIA, V22, P503, DOI 10.1016/0028-3932(84)90045-9; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; BENSON TE, 1984, J NEUROSCI, V4, P638; BICKER G, 1988, J NEUROSCI, V8, P2108; Biswas S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003542; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; BRADSHAW JL, 1981, BEHAV BRAIN SCI, V4, P51, DOI 10.1017/S0140525X00007548; Brown SM, 2004, J NEUROBIOL, V60, P40, DOI 10.1002/neu.20002; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Corballis MC, 2003, P BRIT ACAD, V106, P137; DAHLHAUS R, 2009, HIPPOCAMPUS; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DENENBERG VH, 1978, SCIENCE, V201, P1150, DOI 10.1126/science.684436; Devaud JM, 2003, J NEUROBIOL, V56, P1, DOI 10.1002/neu.10216; Devaud JM, 2003, J NEUROBIOL, V56, P13, DOI 10.1002/neu.10215; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Fahrbach SE, 2003, J NEUROBIOL, V57, P141, DOI 10.1002/neu.10256; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Frings H, 1944, J EXP ZOOL, V97, P123, DOI 10.1002/jez.1400970203; Funada M, 2004, NEUROSCI LETT, V359, P190, DOI 10.1016/j.neulet.2004.02.004; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Groh C, 2006, BRAIN BEHAV EVOLUT, V68, P1, DOI 10.1159/000092309; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; IFUNE CK, 1984, BEHAV NEURAL BIOL, V41, P231, DOI 10.1016/S0163-1047(84)90639-3; KANO M, 2009, CURR OPIN NEUROBIOL; Kucharski R., 2007, Invertebrate Neuroscience, V7, P99, DOI 10.1007/s10158-007-0045-3; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS RD, 1993, J CLIN EXP NEUROPSYC, V15, P487, DOI 10.1080/01688639308402573; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Rose JK, 2005, J NEUROSCI, V25, P7159, DOI 10.1523/JNEUROSCI.1833-05.2005; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; VALLORTIGARA G, 1992, NEUROPSYCHOLOGIA, V30, P761, DOI 10.1016/0028-3932(92)90080-6; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; WITHERS GS, 2007, DEV NEUROBIOL; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068	69	48	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9133	10.1371/journal.pone.0009133	http://dx.doi.org/10.1371/journal.pone.0009133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161754	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600030
J	Friesen, RHE; Koudstaal, W; Koldijk, MH; Weverling, GJ; Brakenhoff, JPJ; Lenting, PJ; Stittelaar, KJ; Osterhaus, ADME; Kompier, R; Goudsmit, J				Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Stittelaar, Koert J.; Osterhaus, Albert D. M. E.; Kompier, Ronald; Goudsmit, Jaap			New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets	PLOS ONE			English	Article							A H5N1 VIRUS; INFECTION; RESISTANCE; TRANSMISSION	Background: The urgent medical need for innovative approaches to control influenza is emphasized by the widespread resistance of circulating subtype H1N1 viruses to the leading antiviral drug oseltamivir, the pandemic threat posed by the occurrences of human infections with highly pathogenic avian H5N1 viruses, and indeed the evolving swine-origin H1N1 influenza pandemic. A recently discovered class of human monoclonal antibodies with the ability to neutralize a broad spectrum of influenza viruses (including H1, H2, H5, H6 and H9 subtypes) has the potential to prevent and treat influenza in humans. Here we report the latest efficacy data for a representative antibody of this novel class. Methodology/Principal Findings: We evaluated the prophylactic and therapeutic efficacy of the human monoclonal antibody CR6261 against lethal challenge with the highly pathogenic avian H5N1 virus in ferrets, the optimal model of human influenza infection. Survival rates, clinically relevant disease signs such as changes in body weight and temperature, virus replication in lungs and upper respiratory tract, as well as macro- and microscopic pathology were investigated. Prophylactic administration of 30 and 10 mg/kg CR6261 prior to viral challenge completely prevented mortality, weight loss and reduced the amount of infectious virus in the lungs by more than 99.9%, abolished shedding of virus in pharyngeal secretions and largely prevented H5N1-induced lung pathology. When administered therapeutically 1 day after challenge, 30 mg/kg CR6261 prevented death in all animals and blunted disease, as evidenced by decreased weight loss and temperature rise, reduced lung viral loads and shedding, and less lung damage. Conclusions/Significance: These data demonstrate the prophylactic and therapeutic efficacy of this new class of human monoclonal antibodies in a highly stringent and clinically relevant animal model of influenza and justify clinical development of this approach as intervention for both seasonal and pandemic influenza.	[Friesen, Robert H. E.; Koudstaal, Wouter; Koldijk, Martin H.; Weverling, Gerrit Jan; Brakenhoff, Just P. J.; Lenting, Peter J.; Kompier, Ronald; Goudsmit, Jaap] Crucell Holland BV, Leiden, Netherlands; [Stittelaar, Koert J.; Osterhaus, Albert D. M. E.] ViroClin BV, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.] ErasmusMC, Dept Virol, Rotterdam, Netherlands	Johnson & Johnson; Erasmus University Rotterdam; Erasmus MC	Friesen, RHE (corresponding author), Crucell Holland BV, Leiden, Netherlands.	robert.friesen@crucell.com	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Osterhaus, Albert/0000-0002-6074-1172	Crucell Holland BV	Crucell Holland BV	Funding: This work was funded by Crucell Holland BV (http://www.crucell.com). The funder had a role in study design, data analysis, decision to publish and preparation of the manuscript, but not in execution of the experiments and collection of the data.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; BARNARD DL, 2009, ANTIVIRAL RES; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDC, 2008, MMWR-MORBID MORTAL W, V57, P393; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; EKIERT DC, 2009, SCIENCE; Enserink M, 2009, SCIENCE, V323, P1162, DOI 10.1126/science.323.5918.1162; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hoelscher M, 2008, EXPERT OPIN DRUG DEL, V5, P1139, DOI 10.1517/17425247.5.10.1139 ; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Moscona A, 2008, ANNU REV MED, V59, P397, DOI 10.1146/annurev.med.59.061506.213121; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Ng WF, 2006, HUM PATHOL, V37, P381, DOI 10.1016/j.humpath.2006.01.015; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; *WHO, 2009, 211 WHO; World Health Organization, 2009, WORLD NOW START 2009	34	83	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9106	10.1371/journal.pone.0009106	http://dx.doi.org/10.1371/journal.pone.0009106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161706	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442500013
J	Oliveira-Martins, JB; Yusa, SI; Calella, AM; Bridel, C; Baumann, F; Dametto, P; Aguzzi, A				Oliveira-Martins, Jose B.; Yusa, Sei-ichi; Calella, Anna Maria; Bridel, Claire; Baumann, Frank; Dametto, Paolo; Aguzzi, Adriano			Unexpected Tolerance of alpha-Cleavage of the Prion Protein to Sequence Variations	PLOS ONE			English	Article							CREUTZFELDT-JAKOB DISEASE; NEURONAL CELL-LINE; NEUROBLASTOMA-CELLS; PROTEOLYTIC CLEAVAGE; IN-VIVO; SCRAPIE; PRP; MUTATION; DOMAINS; GENE	The cellular form of the prion protein, PrPC, undergoes extensive proteolysis at the alpha site (109K down arrow H110). Expression of non-cleavable PrPC mutants in transgenic mice correlates with neurotoxicity, suggesting that alpha-cleavage is important for PrPC physiology. To gain insights into the mechanisms of alpha-cleavage, we generated a library of PrPC mutants with mutations in the region neighbouring the alpha-cleavage site. The prevalence of C1, the carboxy adduct of alpha-cleavage, was determined for each mutant. In cell lines of disparate origin, C1 prevalence was unaffected by variations in charge and hydrophobicity of the region neighbouring the alpha-cleavage site, and by substitutions of the residues in the palindrome that flanks this site. Instead, alpha-cleavage was size-dependently impaired by deletions within the domain 106-119. Almost no cleavage was observed upon full deletion of this domain. These results suggest that alpha-cleavage is executed by an alpha-PrPase whose activity, despite surprisingly limited sequence specificity, is dependent on the size of the central region of PrPC.	[Oliveira-Martins, Jose B.; Yusa, Sei-ichi; Calella, Anna Maria; Bridel, Claire; Baumann, Frank; Dametto, Paolo; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Oliveira-Martins, JB (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Baumann, Frank/F-7737-2016; Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708	Swiss National Foundation; European Union; National Competence Center on Neural Plasticity and Repair; Stammbach foundation; Novartis Foundation; European Research Council; Portuguese Foundation for Science and Technology; Instituto Gulbenkian de Ciencia	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission); National Competence Center on Neural Plasticity and Repair; Stammbach foundation; Novartis Foundation(Novartis); European Research Council(European Research Council (ERC)European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Instituto Gulbenkian de Ciencia	Funding: This work was supported by the Swiss National Foundation, European Union contracts (PRIORITY and LUPAS), the National Competence Center on Neural Plasticity and Repair, the Stammbach foundation, and the Novartis Foundation. AA is the recipient of an Advanced Investigator Grant of the European Research Council. JBOM was supported by the Portuguese Foundation for Science and Technology and the Instituto Gulbenkian de Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Baumann G, 2002, J ENDOCRINOL, V174, P361, DOI 10.1677/joe.0.1740361; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BREMER J, 2010, NAT NEUROSC IN PRESS; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; GEY GO, 1952, CANCER RES, V12, P264; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim Y, 2008, TRANSBOUND EMERG DIS, V55, P105, DOI 10.1111/j.1865-1682.2007.00997.x; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Mayer BJ, 2001, J CELL SCI, V114, P1253; MEDORI R, 1992, NEUROLOGY, V42, P669, DOI 10.1212/WNL.42.3.669; Nishimura T, 2007, MICROBIOL IMMUNOL, V51, P457, DOI 10.1111/j.1348-0421.2007.tb03920.x; Ott D, 2008, PROTEIN ENG DES SEL, V21, P623, DOI 10.1093/protein/gzn042; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V326, P600, DOI 10.1016/j.bbrc.2004.11.092; Schlondorff J, 1999, J CELL SCI, V112, P3603; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; van Rheede T, 2003, MOL BIOL EVOL, V20, P111, DOI 10.1093/molbev/msg014; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Wang XD, 2002, J BIOL CHEM, V277, P50510, DOI 10.1074/jbc.M208738200; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Wegner C, 2002, J GEN VIROL, V83, P1237, DOI 10.1099/0022-1317-83-5-1237; Zhao HX, 2006, VIRUS RES, V115, P43, DOI 10.1016/j.virusres.2005.07.004	54	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9107	10.1371/journal.pone.0009107	http://dx.doi.org/10.1371/journal.pone.0009107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161712	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442500014
J	Ryckman, KK; Morken, NH; White, MJ; Velez, DR; Menon, R; Fortunato, SJ; Magnus, P; Williams, SM; Jacobsson, B				Ryckman, Kelli K.; Morken, Nils-Halvdan; White, Marquitta J.; Velez, Digna R.; Menon, Ramkumar; Fortunato, Stephen J.; Magnus, Per; Williams, Scott M.; Jacobsson, Bo			Maternal and Fetal Genetic Associations of PTGER3 and PON1 with Preterm Birth	PLOS ONE			English	Article							NORWEGIAN MOTHER; GESTATIONAL-AGE; CHILD COHORT; WEIGHT; RISK; PATTERNS; ALPHA	Objective: The purpose of this study was to identify associations between maternal and fetal genetic variants in candidate genes and spontaneous preterm birth (PTB) in a Norwegian population and to determine the effect size of those associations that corroborate a previous study of PTB. Methods: DNA from 434 mother-baby dyads (214 cases and 220 controls) collected from the Norwegian Mother and Child Cohort (MoBa) was examined for association between 1,430 single nucleotide polymorphisms in 143 genes and PTB. These results were compared to a previous study on European Americans (EA) from Centennial Women's Hospital in Nashville, TN, USA. Odds ratios for SNPs that corroborated the Cenntennial study were determined on the combined MoBa and Centennial studies. Results: In maternal samples the strongest results that corroborated the Centennial study were in the prostaglandin E receptor 3 gene (PTGER3; rs977214) (combined genotype p = 3x10(-4)). The best model for rs977214 was the AG/GG genotypes relative to the AA genotype and resulted in an OR of 0.55 (95% CI = 0.37-0.82, p = 0.003), indicating a protective effect. In fetal samples the most significant association in the combined data was rs854552 in the paraoxonase 1 gene (PON1) (combined allele p = 8x10(-4)). The best model was the TT genotype relative to the CC/CT genotypes, and resulted in an OR of 1.32 (95% CI = 1.13-1.53, p = 4x10(-4)). Conclusions: These studies identify single locus associations with preterm birth for both maternal and fetal genotypes in two populations of European ancestry.	[Ryckman, Kelli K.; White, Marquitta J.; Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ryckman, Kelli K.; White, Marquitta J.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Morken, Nils-Halvdan; Magnus, Per] Norwegian Inst Publ Hlth, Oslo, Norway; [Velez, Digna R.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Velez, Digna R.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA; [Menon, Ramkumar; Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA; [Menon, Ramkumar; Fortunato, Stephen J.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Jacobsson, Bo] Univ Oslo, Rikshosp, Dept Obstet & Gynecol, N-0027 Oslo, Norway; [Jacobsson, Bo] Sahlgrens Acad, Inst Clin Sci, Dept Obstet & Gynecol, Perinatal Ctr, Gothenburg, Sweden	Vanderbilt University; Vanderbilt University; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Miami; University of Miami; Emory University; University of Oslo; National Hospital Norway; University of Gothenburg	Ryckman, KK (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	smwilliams@chgr.mc.vanderbilt.edu	Velez Edwards, Digna/C-1090-2012; Williams, Scott/Q-4812-2019; Fortunato, Stephen J/L-7545-2013; Williams, Scott/B-9491-2012; Jacobsson, Bo/O-8007-2014	Williams, Scott/0000-0002-4835-9544; Jacobsson, Bo/0000-0001-5079-2374; Ryckman, Kelli/0000-0002-9496-4147	Norwegian Research Council [FRIMEDKLI-05 ES236011]; Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile [183220/S10]; Telemark Hospital Research Foundation; Southern Health Region in Norway [ALFGBG-5173, ALFGBG-11522]; Norwegian Ministry of Health, NIH/NIEHS [N01-ES-85433]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES085433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile; Telemark Hospital Research Foundation; Southern Health Region in Norway; Norwegian Ministry of Health, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from the Norwegian Research Council (FRIMEDKLI-05 ES236011), Norwegian Research Council FUGE -Functional Genomics at Norwegian Research Counsile (183220/S10), Telemark Hospital Research Foundation, The Southern Health Region in Norway, Swedish government grants to researchers in public health service (ALFGBG-5173 and ALFGBG-11522). The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health, NIH/NIEHS (grant no N01-ES-85433), NIH/NINDS (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso O, 1999, INT J EPIDEMIOL, V28, P695, DOI 10.1093/ije/28.4.695; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CARRHILL RA, 1985, BRIT J OBSTET GYNAEC, V92, P921, DOI 10.1111/j.1471-0528.1985.tb03071.x; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V385, P241, DOI 10.1016/j.bbrc.2009.05.049; Chen DF, 2004, EPIDEMIOLOGY, V15, P466, DOI 10.1097/01.ede.0000129509.59912.b2; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Girling J, 1998, CURR OPIN OBSTET GYN, V10, P135, DOI 10.1097/00001703-199804000-00010; Greene CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005639; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Koga S, 1991, ANN NY ACAD SCI, V622, P315; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; MACDORMAN M, 2008, TRENDS PRETERM RELAT; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Menon R, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.071; Menon R, 2007, REPROD SCI, V14, P253, DOI 10.1177/1933719107301336; Menon R, 2006, J SOC GYNECOL INVEST, V13, P531, DOI 10.1016/j.jsgi.2006.09.006; Menon R, 2006, AM J OBSTET GYNECOL, V195, P1240, DOI 10.1016/j.ajog.2006.05.037; Menon R, 2006, HUM HERED, V62, P107, DOI 10.1159/000096301; MITCHELL MD, 1990, PROSTAG LEUKOTR ESS, V41, P35, DOI 10.1016/0952-3278(90)90128-8; Morken NH, 2005, ACTA OBSTET GYN SCAN, V84, P558, DOI 10.1111/j.0001-6349.2005.00765.x; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Pennell CE, 2007, AM J OBSTET GYNECOL, V196, P107, DOI 10.1016/j.ajog.2006.03.109; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Ryckman KK, 2008, GENET EPIDEMIOL, V32, P600, DOI 10.1002/gepi.20342; Stephenson CD, 2005, J MATERN-FETAL NEO M, V18, P17, DOI 10.1080/14767050500123632; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; 2006, PRETERM BIRTH CAUSES	43	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9040	10.1371/journal.pone.0009040	http://dx.doi.org/10.1371/journal.pone.0009040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140262	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200022
J	Zhao, Y; Xu, DS; Jiang, YJ; Zhang, LW				Zhao, Yong; Xu, Dongsheng; Jiang, Yanjun; Zhang, Luwen			Dual Functions of Interferon Regulatory Factors 7C in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes	PLOS ONE			English	Article							MEMBRANE-PROTEIN 1; INNATE ANTIVIRAL RESPONSE; TRANSCRIPTION FACTORS; LATENT MEMBRANE-PROTEIN-1; LYMPHOMA CELLS; GROWTH TRANSFORMATION; POSITIVE FEEDBACK; ALPHA-INTERFERON; FACTOR RECEPTOR; HOST-DEFENSE	Epstein-Barr virus (EBV) infection is associated with several human malignancies. Interferon (IFN) regulatory factor 7 (IRF-7) has several splicing variants, and at least the major splicing variant (IRF-7A) has oncogenic potential and is associated with EBV transformation processes. IRF-7C is an alternative splicing variant with only the DNA-binding domain of IRF-7. Whether IRF-7C is present under physiological conditions and its functions in viral transformation are unknown. In this report, we prove the existence of IRF-7C protein and RNA in certain cells under physiological conditions, and find that high levels of IRF-7C are associated with EBV transformation of human primary B cells in vitro as well as EBV type III latency. EBV latent membrane protein 1 (LMP-1) stimulates IRF-7C expression in B lymphocytes. IRF-7C has oncogenic potential in rodent cells and partially restores the growth properties of EBV-transformed cells under a growth-inhibition condition. A tumor array experiment has identified six primary tumor specimens with high levels of IRF-7C protein-all of them are lymphomas. Furthermore, we show that the expression of IRF-7C is apparently closely associated with other IRF-7 splicing variants. IRF-7C inhibits the function of IRF-7 in transcriptional regulation of IFN genes. These data suggest that EBV may use splicing variants of IRF-7 for its transformation process in two strategies: to use oncogenic properties of various IRF-7 splicing variants, but use one of its splicing variants (IRF-7C) to block the IFN-induction function of IRF-7 that is detrimental for viral transformation. The work provides a novel relation of host/virus interactions, and has expanded our knowledge about IRFs in EBV transformation.	[Zhao, Yong; Xu, Dongsheng; Jiang, Yanjun; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhao, Y (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	lzhang2@unlnotes.unl.edu			National Institutes of Health [CA138213Z, CA108951, CA108951Z]; National Center for Research Resources Centers [RR15635]; NATIONAL CANCER INSTITUTE [R01CA108951] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from National Institutes of Health grants CA138213Z, CA108951, CA108951Z, and National Center for Research Resources Centers of Biomedical Research Excellence grant RR15635 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2003, CANCER RES, V63, P6424; BENBASSAT H, 1977, INT J CANCER, V19, P27, DOI 10.1002/ijc.2910190105; CALENDER A, 1987, P NATL ACAD SCI USA, V84, P8060, DOI 10.1073/pnas.84.22.8060; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; FUJITA T, 1979, J GEN VIROL, V45, P301, DOI 10.1099/0022-1317-45-2-301; GARNER JG, 1984, INFECT IMMUN, V43, P920, DOI 10.1128/IAI.43.3.920-924.1984; Geiger TR, 2006, J VIROL, V80, P11638, DOI 10.1128/JVI.01570-06; GIRES O, 1997, EMBO J, V16; HAVELL EA, 1972, ANTIMICROB AGENTS CH, V2, P476, DOI 10.1128/AAC.2.6.476; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu GD, 2006, EXPERT REV ANTICANC, V6, P775, DOI 10.1586/14737140.6.5.775; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P1447, DOI 10.1073/pnas.94.4.1447; KANDA K, 1992, MOL CELL BIOL, V12, P4930, DOI 10.1128/MCB.12.11.4930; KAYE KM, 1993, P NATL ACAD SCI USA, V90, P9150, DOI 10.1073/pnas.90.19.9150; KIEFF E, 1996, FIELDS VIROLOGY, V3, P2343; KIKUTA H, 1986, Hokkaido Journal of Medical Science, V61, P46; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; LIN JC, 1989, J INFECT DIS, V159, P248, DOI 10.1093/infdis/159.2.248; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Mamane Y, 2002, J INTERF CYTOK RES, V22, P135, DOI 10.1089/107999002753452746; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martin HJ, 2007, J VIROL, V81, P9748, DOI 10.1128/JVI.01122-07; MILLER WE, 1995, J VIROL, V69, P4390, DOI 10.1128/JVI.69.7.4390-4398.1995; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; NGUYEN H, 1995, ONCOGENE, V11, P537; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Nonkwelo C, 1996, J VIROL, V70, P623, DOI 10.1128/JVI.70.1.623-627.1996; Pagano JS, 1999, P ASSOC AM PHYSICIAN, V111, P573, DOI 10.1046/j.1525-1381.1999.t01-1-99220.x; RICKINSON AB, 1996, FIELDS VIROLOGY, V3, P2397; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Song L, 2008, EXCLI J, V7, P1; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; XU D, 2008, J VIROL; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2000, MOL BIOTECHNOL, V14, P73, DOI 10.1385/MB:14:1:73; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhang LW, 2001, SEMIN CANCER BIOL, V11, P445, DOI 10.1006/scbi.2001.0411; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 2001, J VIROL, V75, P341, DOI 10.1128/JVI.75.1.341-350.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000	62	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9459	10.1371/journal.pone.0009459	http://dx.doi.org/10.1371/journal.pone.0009459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209099	Green Published, gold			2022-12-27	WOS:000275197100004
J	De Majumdar, S; Sharma, D; Vashist, A; Kaur, K; Taneja, NK; Chauhan, S; Challu, VK; Ramanathan, VD; Balasangameshwara, V; Kumar, P; Tyagi, JS				De Majumdar, Shyamasree; Sharma, Deepak; Vashist, Atul; Kaur, Kohinoor; Taneja, Neetu Kumra; Chauhan, Santosh; Challu, Vijay K.; Ramanathan, V. D.; Balasangameshwara, V.; Kumar, Prahlad; Tyagi, Jaya Sivaswami			Co-Expression of DevR and DevR(N)-Aph Proteins Is Associated with Hypoxic Adaptation Defect and Virulence Attenuation of Mycobacterium tuberculosis	PLOS ONE			English	Article							RESPONSE REGULATOR; 2-COMPONENT SYSTEM; BINDING-SITES; GUINEA-PIG; CROSS-TALK; TRANSCRIPTION; IDENTIFICATION; EXPRESSION; GRANULOMAS; CLONING	Background: The DevR response regulator is implicated in both hypoxic adaptation and virulence of Mycobacterium tuberculosis (M. tb). DevR regulon genes are powerfully induced in vivo implicating them in bacterial adaptation to host control strategies. A better understanding of DevR function will illumine the way for new strategies to control and treat tuberculosis. Methodology/Principal Findings: Towards this objective, we used a combination of genetic, microbiological, biochemical, cell biological tools and a guinea pig virulence assay to compare the hypoxic adaptation and virulence properties of two novel M. tb strains, namely, a devR disruption mutant, Mut1, that expresses C-terminal truncated N-terminal domain of DevR (DevR(NTD)) as a fusion protein with AphI (DevR(N)-Kan), and its complemented strain, Comp1, that expresses intact DevR along with DevRN-Kan. Comp1 bacteria exhibit a defect in DevR-mediated phosphosignalling, hypoxic induction of HspX and also hypoxic survival. In addition, we find that Comp1 is attenuated in virulence in guinea pigs and shows decreased infectivity of THP-1 cells. While Mut1 bacilli are also defective in hypoxic adaptation and early growth in spleen, they exhibit an overall virulence comparable to that of wild-type bacteria. Conclusions/Significance: The hypoxic defect of Comp1 is associated to a defect in DevR expression level. The demonstrated repression of DevR function by DevR(N)-Kan suggests that such a knockdown approach could be useful for evaluating the activity of DevRS and other two-component signaling pathways. Further investigation is necessary to elucidate the mechanism underlying Comp1 attenuation.	[De Majumdar, Shyamasree; Sharma, Deepak; Vashist, Atul; Kaur, Kohinoor; Taneja, Neetu Kumra; Chauhan, Santosh; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Ramanathan, V. D.] TB Res Ctr, Dept Pathol, Chennai, Tamil Nadu, India; [Challu, Vijay K.; Balasangameshwara, V.; Kumar, Prahlad] Natl TB Inst, Bangalore, Karnataka, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	De Majumdar, S (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Chauhan, Santosh/K-3031-2019; Vashist, Atul/AAX-6219-2021; Kaur, Kohinoor/HEB-9125-2022	Chauhan, Santosh/0000-0001-9167-5107; Vashist, Atul/0000-0002-2843-1166; TANEJA, NEETU/0000-0002-2390-7647	CSIR; DBT, Government of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, Government of India(Department of Biotechnology (DBT) India)	D.M., D.S., N.K.T. and S.C. are each thankful to CSIR for a Senior Research Fellowship. K. K. is thankful to UGC for a Senior Research Fellowship and A.V. is thankful to DBT for a Junior Research Fellowship. Financial support from DBT, Government of India to J.S.T., V.K.C. and V.D.R. is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P359; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; KINGER AK, 1993, GENE, V131, P113, DOI 10.1016/0378-1119(93)90678-V; Lukey P T, 2001, Methods Mol Med, V54, P271, DOI 10.1385/1-59259-147-7:271; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; MITCHISON D, 1961, B WORLD HEALTH ORGAN, V25, P285; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Ramanathan VD, 1999, INDIAN J MED RES, V109, P212; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tyagi JS, 2004, CURR SCI INDIA, V86, P93; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205	32	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9448	10.1371/journal.pone.0009448	http://dx.doi.org/10.1371/journal.pone.0009448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195478	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000274997000014
J	Deregnaucourt, S				Deregnaucourt, Sebastien			Interspecific Hybridization as a Tool to Understand Vocal Divergence: The Example of Crowing in Quail (Genus Coturnix)	PLOS ONE			English	Article							DOVE STREPTOPELIA-CAPICOLA; JAPANESE-QUAIL; SEXUAL SELECTION; EUROPEAN QUAIL; HYBRID ZONE; C.-COTURNIX; SPECIES-DIFFERENCES; SONG SIMILARITY; CALLS; JAPONICA	Understanding the mechanisms that lead organisms to be separated into distinct species remains a challenge in evolutionary biology. Interspecific hybridization, which results from incomplete reproductive isolation, is a useful tool to investigate such mechanisms. In birds, interspecific hybridization is relatively frequent, despite the fact that closed species exhibit morphological and behavioural differences. Evolution of behaviour is difficult to investigate on a large timescale since it does not `fossilize'. Here I propose that calls of hybrid non-songbirds that develop without the influence of learning may help in understanding the gradual process that leads to vocal divergence during speciation. I recorded crows produced by the European quail (Coturnix c. coturnix), the domestic Japanese quail (Coturnix c. japonica) and their hybrids (F1, F2 and backcrosses). Most crowing patterns were intermediate to those of the parental species; some were similar to one or the other parental species, or not present in either parental species. I also observed vocal changes in hybrid crows during the breeding season and from one year to the other. This vocal variability resembles those observed during the ontogeny of the crow in quails. It is likely that similar mechanisms involved in vocal changes during ontogeny might have driven vocal divergence in the species of Palearctic quails. I suggest that hybrid crows might have resembled those produced by intermediary forms of quails during speciation.	[Deregnaucourt, Sebastien] Max Planck Inst Ornithol, Seewiesen, Germany; [Deregnaucourt, Sebastien] Univ Rennes 1, CNRS, UMR Ethol Evolut Ecol 6552, Rennes, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Deregnaucourt, S (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	seb@orn.mpg.de			Office National de la Chasse et de la Faune Sauvage [ONC 97/27]; Max Planck Society	Office National de la Chasse et de la Faune Sauvage; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Office National de la Chasse et de la Faune Sauvage (research convention ONC 97/27) and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1990, J EVOLUTION BIOL, V3, P375, DOI 10.1046/j.1420-9101.1990.3050375.x; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Aubin T, 2007, POLAR BIOL, V30, P1027, DOI 10.1007/s00300-007-0262-6; BAKER JA, 1987, CAN J ZOOL, V65, P1010, DOI 10.1139/z87-160; Balaban E, 1997, P NATL ACAD SCI USA, V94, P2001, DOI 10.1073/pnas.94.5.2001; Baptista Luis F., 1996, P39; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Becker P.H., 1982, P213; Beckers GJL, 2003, ANIM BEHAV, V65, P605, DOI 10.1006/anbe.2003.2080; Bloomer P, 1998, MOL PHYLOGENET EVOL, V9, P236, DOI 10.1006/mpev.1997.0469; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CARIOU M-L, 1969, Bulletin Biologique de la France et de la Belgique, V103, P323; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Ceugniet M, 1999, CR ACAD SCI III-VIE, V322, P887, DOI 10.1016/S0764-4469(00)86655-X; Collins SA, 1998, ETHOLOGY, V104, P977; de Kort SR, 2002, BEHAV ECOL SOCIOBIOL, V51, P378, DOI 10.1007/s00265-001-0449-8; de Kort SR, 2002, J AVIAN BIOL, V33, P150, DOI 10.1034/j.1600-048X.2002.330205.x; Delport W, 2004, AUK, V121, P565, DOI 10.1642/0004-8038(2004)121[0565:SOAARH]2.0.CO;2; Deregnaucourt S, 2005, IBIS, V147, P25, DOI 10.1111/j.1474-919x.2004.00313.x; Deregnaucourt S, 2003, ETHOLOGY, V109, P107, DOI 10.1046/j.1439-0310.2003.00854.x; Deregnaucourt S, 2002, ARDEA, V90, P15; Deregnaucourt S, 2001, BEHAV PROCESS, V56, P103, DOI 10.1016/S0376-6357(01)00188-7; Deregnaucourt S, 2009, P ROY SOC B-BIOL SCI, V276, P2153, DOI 10.1098/rspb.2009.0016; Dobzhansky T., 1951, COPEIA; Dowsett-Lemaire F, 1999, OSTRICH, V70, P123, DOI 10.1080/00306525.1999.9634526; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; EMLEN ST, 1972, BEHAVIOUR, V41, P130, DOI 10.1163/156853972X00248; Gee JM, 2005, BIOL J LINN SOC, V86, P253, DOI 10.1111/j.1095-8312.2005.00538.x; Goodson JL, 1997, CONDOR, V99, P990, DOI 10.2307/1370153; Grant BR, 2008, PHILOS T R SOC B, V363, P2821, DOI 10.1098/rstb.2008.0051; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; GROOTHUIS T, 1992, ANIM BEHAV, V43, P1, DOI 10.1016/S0003-3472(05)80067-3; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; Guyomarc'h JC, 1998, ETHOL ECOL EVOL, V10, P333, DOI 10.1080/08927014.1998.9522847; Guyomarch JC, 1996, CR ACAD SCI III-VIE, V319, P827; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; Haeckel E. H., 1866, GENERELLE MORPHOLOGI; KOLLAR EJ, 1980, SCIENCE, V207, P993, DOI 10.1126/science.7352302; Konishi M., 1969, P29; Lachlan RF, 2004, EVOLUTION, V58, P2049; LADE BI, 1964, NATURE, V202, P366, DOI 10.1038/202366a0; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; MCGRATH TA, 1972, NATURE, V237, P47, DOI 10.1038/237047a0; MEDICUS G, 1992, HUM DEV, V35, P1, DOI 10.1159/000277108; MILLER DB, 1978, Z TIERPSYCHOL, V47, P182; Miller E.H., 1982, P253; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; Mitsiadis TA, 2003, P NATL ACAD SCI USA, V100, P6541, DOI 10.1073/pnas.1137104100; MOREAU RE, 1968, ARDEA, V56, P209; Mousseau TA, 1998, EVOLUTION, V52, P1104, DOI [10.2307/2411240, 10.1111/j.1558-5646.1998.tb01837.x]; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Pfennig KS, 1998, P ROY SOC B-BIOL SCI, V265, P1743, DOI 10.1098/rspb.1998.0497; POTASH LM, 1972, PSYCHON SCI, V26, P252; Price TD, 2002, GENETICA, V116, P311, DOI 10.1023/A:1021248913179; Qvarnstrom A, 2006, J EVOLUTION BIOL, V19, P1202, DOI 10.1111/j.1420-9101.2006.01140.x; ROTELLA JJ, 1988, CONDOR, V90, P304, DOI 10.2307/1368558; RYAN MJ, 1995, SCIENCE, V269, P390, DOI 10.1126/science.269.5222.390; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; SACHS B. D., 1969, Horm. Behav., V1, P7, DOI 10.1016/0018-506X(69)90002-6; SCHLEIDT W M, 1973, Zeitschrift fuer Tierpsychologie, V33, P35; Secondi J, 2003, BIOL J LINN SOC, V80, P507, DOI 10.1046/j.1095-8312.2003.00248.x; Shaw KL, 2000, EVOLUTION, V54, P1303, DOI 10.1111/j.0014-3820.2000.tb00563.x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Slabbekoorn H, 1999, ETHOLOGY, V105, P377, DOI 10.1046/j.1439-0310.1999.00420.x; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Walcott C, 2006, ANIM BEHAV, V71, P673, DOI 10.1016/j.anbehav.2005.07.011; White C.M., 1994, NEW WORLD VULTURES G; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Zeigler HP, 2008, NEUROSCIENCE BIRDSON; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	79	5	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9451	10.1371/journal.pone.0009451	http://dx.doi.org/10.1371/journal.pone.0009451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195481	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997000016
J	Dyrda, A; Cytlak, U; Ciuraszkiewicz, A; Lipinska, A; Cueff, A; Bouyer, G; Egee, S; Bennekou, P; Lew, VL; Thomas, SLY				Dyrda, Agnieszka; Cytlak, Urszula; Ciuraszkiewicz, Anna; Lipinska, Agnieszka; Cueff, Anne; Bouyer, Guillaume; Egee, Stephane; Bennekou, Poul; Lew, Virgilio L.; Thomas, Serge L. Y.			Local Membrane Deformations Activate Ca2+-Dependent K+ and Anionic Currents in Intact Human Red Blood Cells	PLOS ONE			English	Article							HUMAN-ERYTHROCYTES; CATION PERMEABILITY; POTASSIUM-TRANSPORT; MECHANICAL-STRESS; ION-TRANSPORT; CHANNEL; ANEMIA; VOLUME; MODEL; PUMP	Background: The mechanical, rheological and shape properties of red blood cells are determined by their cortical cytoskeleton, evolutionarily optimized to provide the dynamic deformability required for flow through capillaries much narrower than the cell's diameter. The shear stress induced by such flow, as well as the local membrane deformations generated in certain pathological conditions, such as sickle cell anemia, have been shown to increase membrane permeability, based largely on experimentation with red cell suspensions. We attempted here the first measurements of membrane currents activated by a local and controlled membrane deformation in single red blood cells under on-cell patch clamp to define the nature of the stretch-activated currents. Methodology/Principal Findings: The cell-attached configuration of the patch-clamp technique was used to allow recordings of single channel activity in intact red blood cells. Gigaohm seal formation was obtained with and without membrane deformation. Deformation was induced by the application of a negative pressure pulse of 10 mmHg for less than 5 s. Currents were only detected when the membrane was seen domed under negative pressure within the patchpipette. K+ and Cl- currents were strictly dependent on the presence of Ca2+. The Ca2+-dependent currents were transient, with typical decay half-times of about 5-10 min, suggesting the spontaneous inactivation of a stretch-activated Ca2+ permeability (PCa). These results indicate that local membrane deformations can transiently activate a Ca2+ permeability pathway leading to increased [Ca2+](i), secondary activation of Ca2+-sensitive K+ channels (Gardos channel, IK1, KCa3.1), and hyperpolarization-induced anion currents. Conclusions/Significance: The stretch-activated transient PCa observed here under local membrane deformation is a likely contributor to the Ca2+-mediated effects observed during the normal aging process of red blood cells, and to the increased Ca2+ content of red cells in certain hereditary anemias such as thalassemia and sickle cell anemia.	[Dyrda, Agnieszka; Cytlak, Urszula; Ciuraszkiewicz, Anna; Lipinska, Agnieszka; Cueff, Anne; Bouyer, Guillaume; Egee, Stephane; Thomas, Serge L. Y.] Univ Paris 06, CNRS, UMR 7150, Roscoff, France; [Bennekou, Poul] Univ Copenhagen, Inst Biol, Copenhagen, Denmark; [Cytlak, Urszula; Ciuraszkiewicz, Anna] Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland; [Lew, Virgilio L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; Wroclaw University of Science & Technology; University of Cambridge	Dyrda, A (corresponding author), Univ Paris 06, CNRS, UMR 7150, Roscoff, France.	thomas@sb-roscoff.fr	Cytlak, Urszula/Y-2382-2019; Dyrda, Agnieszka/AAB-9420-2021	Cytlak, Urszula/0000-0002-2536-6012; Dyrda, Agnieszka/0000-0001-8796-2402; Bouyer, guillaume/0000-0002-5808-0539	CNRS; UPMC [UMR7150]	CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC	CNRS and UPMC fundings supported the work (UMR7150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ J, 1987, BIOCHIM BIOPHYS ACTA, V903, P543, DOI 10.1016/0005-2736(87)90062-9; Bouyer G, 2006, BLOOD CELL MOL DIS, V36, P248, DOI 10.1016/j.bcmd.2006.01.005; Bouyer G, 2007, P NATL ACAD SCI USA, V104, P11044, DOI 10.1073/pnas.0704582104; Brain MC, 2004, BLOOD CELL MOL DIS, V32, P349, DOI 10.1016/j.bcmd.2004.01.005; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1993, J BIOL CHEM, V268, P8760; CLARK MR, 1988, PHYSIOL REV, V68, P503, DOI 10.1152/physrev.1988.68.2.503; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Decherf G, 2007, BLOOD CELL MOL DIS, V39, P24, DOI 10.1016/j.bcmd.2007.02.014; Egee S, 2002, J PHYSIOL-LONDON, V542, P795, DOI 10.1113/jphysiol.2002.022970; GARDOS G, 1956, ACTA PHYSL, V4, P185; GRYGORCZYK R, 1983, CELL CALCIUM, V4, P499, DOI 10.1016/0143-4160(83)90025-8; GRYGORCZYK R, 1987, BIOCHIM BIOPHYS ACTA, V902, P159, DOI 10.1016/0005-2736(87)90291-4; HUNTER MJ, 1977, J PHYSIOL-LONDON, V268, P35, DOI 10.1113/jphysiol.1977.sp011845; JOHNSON RM, 1990, AM J PHYSIOL, V259, pC746, DOI 10.1152/ajpcell.1990.259.5.C746; JOHNSON RM, 1992, BIOCHIM BIOPHYS ACTA, V1107, P314, DOI 10.1016/0005-2736(92)90418-L; JOHNSON RM, 1994, BIOPHYS J, V67, P1876, DOI 10.1016/S0006-3495(94)80669-1; JOINER CH, 1993, AM J PHYSIOL, V264, pC251, DOI 10.1152/ajpcell.1993.264.2.C251; LARSEN FL, 1981, NATURE, V294, P667, DOI 10.1038/294667a0; Lew VL, 2007, TRENDS PARASITOL, V23, P481, DOI 10.1016/j.pt.2007.08.001; Lew VL, 2007, BLOOD, V110, P1334, DOI 10.1182/blood-2006-11-057232; LEW VL, 1986, J MEMBRANE BIOL, V92, P57, DOI 10.1007/BF01869016; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Lew VL, 2003, BLOOD, V102, P4206, DOI 10.1182/blood-2003-06-1787; Lew VL, 1997, J CLIN INVEST, V99, P2727, DOI 10.1172/JCI119462; LEW VL, 1976, NATURE, V263, P336, DOI 10.1038/263336a0; LEW VL, 1982, NATURE, V296, P742, DOI 10.1038/296742a0; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LUTZ HU, 1988, BLOOD CELLS, V14, P76; Mason MJ, 2005, BIOPHYS J, V88, P739, DOI 10.1529/biophysj.104.049866; ORTIZ OE, 1986, BLOOD, V67, P710; ORTIZ OE, 1990, J PHYSIOL-LONDON, V427, P211, DOI 10.1113/jphysiol.1990.sp018168; PLISHKER GA, 1992, J BIOL CHEM, V267, P21839; PORZIG H, 1975, J PHYSIOL-LONDON, V249, P27, DOI 10.1113/jphysiol.1975.sp011001; Romero PJ, 1997, CELL CALCIUM, V21, P353, DOI 10.1016/S0143-4160(97)90028-2; SIMONS TJB, 1976, J PHYSIOL-LONDON, V256, P227, DOI 10.1113/jphysiol.1976.sp011322; Tiffert T, 2001, CELL CALCIUM, V30, P337, DOI 10.1054/ceca.2001.0241; TOSTESON DC, 1955, J GEN PHYSIOL, V39, P31, DOI 10.1085/jgp.39.1.31; TOSTESON DC, 1952, J CLIN INVEST, V31, P406, DOI 10.1172/JCI102623; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542	40	53	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9447	10.1371/journal.pone.0009447	http://dx.doi.org/10.1371/journal.pone.0009447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195477	gold, Green Published			2022-12-27	WOS:000274997000013
J	Doucet, D; Badami, C; Palange, D; Bonitz, RP; Lu, Q; Xu, DZ; Kannan, KB; Colorado, I; Feinman, R; Deitch, EA				Doucet, Danielle; Badami, Chirag; Palange, David; Bonitz, R. Paul; Lu, Qi; Xu, Da-Zhong; Kannan, Kolenkode B.; Colorado, Iriana; Feinman, Rena; Deitch, Edwin A.			Estrogen Receptor Hormone Agonists Limit Trauma Hemorrhage Shock-Induced Gut and Lung Injury in Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SEX-HORMONES; BACTERIAL TRANSLOCATION; NEUTROPHIL ACTIVATION; HEMODYNAMIC-RESPONSE; MESENTERIC LYMPH; UP-REGULATION; BETA AGONIST; GENDER; DYSFUNCTION	Background: Acute lung injury (ALI) and the development of the multiple organ dysfunction syndrome (MODS) is a major cause of death in trauma patients. Earlier studies in trauma hemorrhagic shock (T/HS) have documented that splanchnic ischemia leading to gut inflammation and loss of barrier function is an initial triggering event that leads to gut-induced ARDS and MODS. Since sex hormones have been shown to modulate the response to T/HS and proestrous (PE) females are more resistant to T/HS-induced gut and distant organ injury, the goal of our study was to determine the contribution of estrogen receptor (ER)alpha and ER beta in modulating the protective response of female rats to T/HS-induced gut and lung injury. Methods/Principal Findings: The incidence of gut and lung injury was assessed in PE and ovariectomized (OVX) female rats subjected to T/HS or trauma sham shock (T/SS) as well as OVX rats that were administered estradiol (E2) or agonists for ER alpha or ER beta immediately prior to resuscitation. Marked gut and lung injury was observed in OVX rats subjected to T/HS as compared to PE rats or E2-treated OVX rats subjected to T/HS. Both ER alpha and ER beta agonists were equally effective in limiting T/HS-induced morphologic villous injury and bacterial translocation, whereas the ER beta agonist was more effective than the ER alpha agonist in limiting T/HS-induced lung injury as determined by histology, Evan's blue lung permeability, bronchoalevolar fluid/plasma protein ratio and myeloperoxidase levels. Similarly, treatment with either E2 or the ER beta agonist attenuated the induction of the intestinal iNOS response in OVX rats subjected to T/HS whereas the ER alpha agonist was only partially protective. Conclusions/Significance: Our study demonstrates that estrogen attenuates T/HS-induced gut and lung injury and that its protective effects are mediated by the activation of ER alpha, ER beta or both receptors.	[Doucet, Danielle; Badami, Chirag; Palange, David; Bonitz, R. Paul; Lu, Qi; Xu, Da-Zhong; Kannan, Kolenkode B.; Colorado, Iriana; Feinman, Rena; Deitch, Edwin A.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Doucet, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA.	edeitch@umdnj.edu		Xu, Dazhong/0000-0001-9264-3342	NIH [1P50GM069790, T32-GM069330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM069330, P50GM069790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants 1P50GM069790 (to EAD and RF) and T32-GM069330 (to DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2000, AM SURGEON, V66, P905; Ananthakrishnan P, 2005, SURGERY, V137, P56, DOI 10.1016/j.surg.2004.04.037; ANATHAKRISHNAN P, 2003, XX VS XY, V1, P108; Angele MK, 2000, SHOCK, V14, P81, DOI 10.1097/00024382-200014020-00001; BA ZF, 2003, AM J PHYSIOL-HEART C, V284; BAKER HJ, 1979, LAB RAT, V1, P54; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Caruso JM, 2003, J TRAUMA, V55, P531, DOI 10.1097/01.TA.0000025584.46870.95; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Deitch EA, 2004, SHOCK, V22, P221, DOI 10.1097/01.shk.0000133592.55400.83; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Deitch EA, 2008, J TRAUMA, V65, P566, DOI 10.1097/TA.0b013e31814b2c38; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; Deitch EA, 2006, AM J PHYSIOL-HEART C, V291, pH1456, DOI 10.1152/ajpheart.00694.2005; Dossett LA, 2008, SURG INFECT, V9, P41, DOI 10.1089/sur.2007.037; Doucet DR, 2010, J TRAUMA, V68, P35, DOI 10.1097/TA.0b013e3181bbbddb; Edwin A, 2006, J ORGAN DYSFUNCTION, V2, P70, DOI 10.1080/17471060600551772; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; HENDRICKSE CW, 1993, BRIT J SURG, V80, P636, DOI 10.1002/bjs.1800800531; Jarrar D, 2000, SURGERY, V128, P246, DOI 10.1067/msy.2000.107376; Kauser K, 1997, AM J PHYSIOL-HEART C, V273, pH506, DOI 10.1152/ajpheart.1997.273.1.H506; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Machiedo GW, 2004, J TRAUMA, V56, P837, DOI 10.1097/01.TA.0000058128.04007.90; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Proctor KG, 2008, AM J PHYSIOL-REG I, V294, pR1822, DOI 10.1152/ajpregu.90301.2008; Raju R, 2008, MOL MED, V14, P213, DOI 10.2119/2008-00001.Raju; Reilly PM, 2001, SHOCK, V15, P329, DOI 10.1097/00024382-200115050-00001; Salzman A L, 1995, New Horiz, V3, P33; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scheingraber S, 2005, SURG TODAY, V35, P846, DOI 10.1007/s00595-005-3044-1; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Sifri ZC, 2006, SHOCK, V25, P12, DOI 10.1097/01.shk.0000188708.97153.ce; Sifri ZC, 2007, CRIT CARE MED, V35, P864, DOI 10.1097/01.CCM.0000256839.50053.1D; Suzuki T, 2007, J APPL PHYSIOL, V102, P163, DOI 10.1152/japplphysiol.00964.2006; Suzuki Y, 2000, CRIT CARE MED, V28, P3692, DOI 10.1097/00003246-200011000-00026; Szabo C, 1995, New Horiz, V3, P2; THOMAS ML, 1993, ENDOCRINOLOGY, V132, P426, DOI 10.1210/en.132.1.426; Unno N, 1997, AM J PHYSIOL-GASTR L, V272, pG923, DOI 10.1152/ajpgi.1997.272.5.G923; Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010; Yu HP, 2006, AM J PHYSIOL-LUNG C, V290, pL1004, DOI 10.1152/ajplung.00504.2005; Yu HP, 2006, J MOL CELL CARDIOL, V40, P185, DOI 10.1016/j.yjmcc.2005.10.001; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596	46	50	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9421	10.1371/journal.pone.0009421	http://dx.doi.org/10.1371/journal.pone.0009421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195535	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300011
J	Wenzel, K; Wallukat, G; Qadri, F; Hubner, N; Schulz, H; Hummel, O; Herse, F; Heuser, A; Fischer, R; Heidecke, H; Luft, FC; Muller, DN; Dietz, R; Dechend, R				Wenzel, Katrin; Wallukat, Gerd; Qadri, Fatimunnisa; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Herse, Florian; Heuser, Arnd; Fischer, Robert; Heidecke, Harald; Luft, Friedrich C.; Muller, Dominik N.; Dietz, Rainer; Dechend, Ralf			alpha(1A)-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; SARCOPLASMIC-RETICULUM CA2+-ATPASE; IDIOPATHIC DILATED CARDIOMYOPATHY; SPONTANEOUSLY HYPERTENSIVE-RATS; ADENOVIRAL GENE-TRANSFER; ALPHA(1)-ADRENERGIC RECEPTOR; HEART-FAILURE; CARDIAC-HYPERTROPHY; EXPRESSION; COLLAGEN	Background: Agonistic autoantibodies to the alpha(1)-adrenergic receptor occur in nearly half of patients with refractory hypertension; however, their relevance is uncertain. Methods/Principal Findings: We immunized Lewis rats with the second extracellular-loop peptides of the human alpha(1A)-adrenergic receptor and maintained them for one year. alpha(1A)-adrenergic antibodies (alpha(1A)-AR-AB) were monitored with a neonatal cardiomyocyte contraction assay by ELISA, and by ERK1/2 phosphorylation in human alpha(1A)-adrenergic receptor transfected Chinese hamster ovary cells. The rats were followed with radiotelemetric blood pressure measurements and echocardiography. At 12 months, the left ventricles of immunized rats had greater wall thickness than control rats. The fractional shortening and dp/dt(max) demonstrated preserved systolic function. A decreased E/A ratio in immunized rats indicated a diastolic dysfunction. Invasive hemodynamics revealed increased left ventricular end-diastolic pressures and decreased dp/dt(min). Mean diameter of cardiomyocytes showed hypertrophy in immunized rats. Long-term blood pressure values and heart rates were not different. Genes encoding sarcomeric proteins, collagens, extracellular matrix proteins, calcium regulating proteins, and proteins of energy metabolism in immunized rat hearts were upregulated, compared to controls. Furthermore, fibrosis was present in immunized hearts, but not in control hearts. A subset of immunized and control rats was infused with angiotensin (Ang) II. The stressor raised blood pressure to a greater degree and led to more cardiac fibrosis in immunized, than in control rats. Conclusions/Significance: We show that alpha(1A)-AR-AB cause diastolic dysfunction independent of hypertension, and can increase the sensitivity to Ang II. We suggest that alpha(1A)-AR-AB could contribute to cardiovascular endorgan damage.	[Wenzel, Katrin; Qadri, Fatimunnisa; Herse, Florian; Fischer, Robert; Dietz, Rainer] Fac Med Charite, Berlin, Germany; [Wenzel, Katrin; Wallukat, Gerd; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Heuser, Arnd; Fischer, Robert; Luft, Friedrich C.; Muller, Dominik N.; Dechend, Ralf] Max Delbruck Ctr Mol Med, Berlin, Germany; [Wenzel, Katrin; Wallukat, Gerd; Hubner, Norbert; Schulz, Herbert; Hummel, Oliver; Heuser, Arnd; Fischer, Robert; Luft, Friedrich C.; Muller, Dominik N.; Dechend, Ralf] Expt & Clin Res Ctr, Berlin, Germany; [Heidecke, Harald] CellTrend, Luckenwalde, Germany; [Luft, Friedrich C.; Dechend, Ralf] Franz Volhard Clin, HELIOS Clin Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center	Wenzel, K (corresponding author), Fac Med Charite, Berlin, Germany.	katrin.wenzel@charite.de	Bader, Michael/K-2124-2013	Heuser, Arnd/0000-0002-3334-960X; Luft, Friedrich/0000-0002-8635-1199; Muller, Dominik N/0000-0003-3650-5644; Herse, Florian/0000-0002-9305-8134	Deutsche Forschungsgemeinschaft; Helmholtz Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Foundation(Helmholtz Association)	The Deutsche Forschungsgemeinschaft supported Ralf Dechend and Dominik N. Muller with grants in-aid. The Helmholtz Foundation also supported the studies. Dominik N. Muller is a Helmholtz Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bishop JE, 1998, MOL MED TODAY, V4, P69, DOI 10.1016/S1357-4310(97)01193-3; BROCKWAY BP, 1991, CLIN EXP HYPERTENS A, V13, P885, DOI 10.3109/10641969109042094; CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787; deBlois D, 1996, ARTERIOSCL THROM VAS, V16, P1122, DOI 10.1161/01.ATV.16.9.1122; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; GunjaSmith Z, 1996, AM J PATHOL, V148, P1639; Haase H, 1996, J MOL MED-JMM, V74, P99; HOLUBARSCH C, 1985, CIRC RES, V56, P78, DOI 10.1161/01.RES.56.1.78; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Liao YH, 2002, HYPERTENS RES, V25, P641; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Nakayama H, 2002, FASEB J, V16, P61, DOI 10.1096/fj.02-0474fje; PATEL MB, 1991, CIRCULATION, V84, P2091, DOI 10.1161/01.CIR.84.5.2091; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790; Sugiura S, 1998, CIRC RES, V82, P1029, DOI 10.1161/01.RES.82.10.1029; Tanoue A, 2002, LIFE SCI, V71, P2207, DOI 10.1016/S0024-3205(02)02012-X; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Verlohren S, 2009, HYPERTENSION, V54, P439, DOI 10.1161/HYPERTENSIONAHA.108.120253; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; WALLUKAT G, 1995, J HYPERTENS, V13, P1031, DOI 10.1097/00004872-199509000-00014; Wallukat G, 2003, MOL CELL BIOCHEM, V251, P67, DOI 10.1023/A:1025469515963; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; Wenzel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003742; Zhou ZH, 2005, CLIN IMMUNOL, V114, P164, DOI 10.1016/j.clim.2004.09.011	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9409	10.1371/journal.pone.0009409	http://dx.doi.org/10.1371/journal.pone.0009409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195525	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000274924200029
J	Bertolino, A; Taurisano, P; Pisciotta, NM; Blasi, G; Fazio, L; Romano, R; Gelao, B; Lo Bianco, L; Lozupone, M; Di Giorgio, A; Caforio, G; Sambataro, F; Niccoli-Asabella, A; Papp, A; Ursini, G; Sinibaldi, L; Popolizio, T; Sadee, W; Rubini, G				Bertolino, Alessandro; Taurisano, Paolo; Pisciotta, Nicola Marco; Blasi, Giuseppe; Fazio, Leonardo; Romano, Raffaella; Gelao, Barbara; Lo Bianco, Luciana; Lozupone, Madia; Di Giorgio, Annabella; Caforio, Grazia; Sambataro, Fabio; Niccoli-Asabella, Artor; Papp, Audrey; Ursini, Gianluca; Sinibaldi, Lorenzo; Popolizio, Teresa; Sadee, Wolfgang; Rubini, Giuseppe			Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory Performance	PLOS ONE			English	Article							DOPAMINE TRANSPORTER FUNCTION; VAL(108/158) MET GENOTYPE; RECEPTOR GENE; PARKINSONS-DISEASE; D-2 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; N-ACETYLASPARTATE; SPECT MEASUREMENT; CEREBRAL-CORTEX; FUNCTIONAL MRI	Background: Variation of the gene coding for D2 receptors (DRD2) has been associated with risk for schizophrenia and with working memory deficits. A functional intronic SNP (rs1076560) predicts relative expression of the two D2 receptors isoforms, D2S (mainly pre-synaptic) and D2L (mainly post-synaptic). However, the effect of functional genetic variation of DRD2 on striatal dopamine D2 signaling and on its correlation with prefrontal activity during working memory in humans is not known. Methods: Thirty-seven healthy subjects were genotyped for rs1076560 (G>T) and underwent SPECT with [I-123]IBZM (which binds primarily to post-synaptic D2 receptors) and with [I-123]FP-CIT (which binds to pre-synaptic dopamine transporters, whose activity and density is also regulated by pre-synaptic D2 receptors), as well as BOLD fMRI during N-Back working memory. Results: Subjects carrying the T allele (previously associated with reduced D2S expression) had striatal reductions of [I-123]IBZM and of [I-123]FP-CIT binding. DRD2 genotype also differentially predicted the correlation between striatal dopamine D2 signaling (as identified with factor analysis of the two radiotracers) and activity of the prefrontal cortex during working memory as measured with BOLD fMRI, which was positive in GG subjects and negative in GT. Conclusions: Our results demonstrate that this functional SNP within DRD2 predicts striatal binding of the two radiotracers to dopamine transporters and D2 receptors as well as the correlation between striatal D2 signaling with prefrontal cortex activity during performance of a working memory task. These data are consistent with the possibility that the balance of excitatory/inhibitory modulation of striatal neurons may also affect striatal outputs in relationship with prefrontal activity during working memory performance within the cortico-striatal-thalamic-cortical pathway.	[Bertolino, Alessandro; Taurisano, Paolo; Blasi, Giuseppe; Fazio, Leonardo; Romano, Raffaella; Gelao, Barbara; Lo Bianco, Luciana; Lozupone, Madia; Di Giorgio, Annabella; Caforio, Grazia; Ursini, Gianluca] Univ Bari, Dept Neurol & Psychiat Sci, Psychiat Neurosci Grp, Bari, Italy; [Bertolino, Alessandro; Fazio, Leonardo; Popolizio, Teresa] IRCCS Casa Sollievo Sofferenza, Dept Neuroradiol, San Giovanni Rotondo, Italy; [Pisciotta, Nicola Marco; Niccoli-Asabella, Artor; Rubini, Giuseppe] Univ Bari, Dept Internal Med & Publ Med, Nucl Med Unit, Bari, Italy; [Sambataro, Fabio] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; [Papp, Audrey; Sadee, Wolfgang] Ohio State Univ, Coll Med, Dept Pharmacol, Program Pharmacogenom, Columbus, OH 43210 USA; [Papp, Audrey; Sadee, Wolfgang] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA; [Ursini, Gianluca; Sinibaldi, Lorenzo] IRCCS CSS Mendel Inst, Rome, Italy; [Sinibaldi, Lorenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome	Bertolino, A (corresponding author), Univ Bari, Dept Neurol & Psychiat Sci, Psychiat Neurosci Grp, Bari, Italy.	a.bertolino@psichiat.uniba.it	Taurisano, Paolo/AID-5342-2022; Lozupone, Madia/F-7262-2018; Bertolino, Alessandro/O-6352-2016; Sambataro, Fabio/E-3426-2010; Blasi, Giuseppe/HHS-5404-2022; Ursini, Gianluca/AAA-8242-2019; Taurisano, Paolo/U-1828-2017; Sinibaldi, Lorenzo/HFZ-8860-2022; Fazio, Leonardo/J-4570-2012; Di Giorgio, Annabella/D-7353-2017; Di Giorgio, Annabella/AAS-1137-2020; Picchioni, Marco M/E-3300-2010; Di Giorgio, Annabella/AAI-5367-2020; Asabella, Artor Niccoli/M-1745-2015	Taurisano, Paolo/0000-0001-6140-9326; Lozupone, Madia/0000-0002-1674-9724; Bertolino, Alessandro/0000-0002-1251-1380; Sambataro, Fabio/0000-0003-2102-416X; Taurisano, Paolo/0000-0001-6140-9326; Sinibaldi, Lorenzo/0000-0002-1371-936X; Fazio, Leonardo/0000-0003-4000-974X; Di Giorgio, Annabella/0000-0001-7876-3495; Picchioni, Marco M/0000-0001-6681-147X; Di Giorgio, Annabella/0000-0001-7876-3495; Asabella, Artor Niccoli/0000-0002-1227-029X; Blasi, Giuseppe/0000-0003-0878-1131; Rubini, Giuseppe/0000-0003-1972-3308; Ursini, Gianluca/0000-0002-4733-5196	National Institutes of Health (NIH) [DA022199]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Part of this work was supported by a National Institutes of Health (NIH) grant DA022199 (W.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Bertolino A, 1999, BIOL PSYCHIAT, V45, P660, DOI 10.1016/S0006-3223(98)00380-1; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; Bertolino A, 2004, BIOL PSYCHIAT, V56, P190, DOI 10.1016/j.biopsych.2004.04.009; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Bertolino A, 2009, J NEUROSCI, V29, P1224, DOI 10.1523/JNEUROSCI.4858-08.2009; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Beukers RJ, 2009, EUR J NUCL MED MOL I, V36, P269, DOI 10.1007/s00259-008-0924-9; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Booij J, 2001, SYNAPSE, V39, P101, DOI 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.3.CO;2-T; Booij J, 1999, J NUCL MED, V40, P753; BRUCKE T, 1991, J CEREBR BLOOD F MET, V11, P220; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160, P709, DOI 10.1176/appi.ajp.160.4.709; Carlsson Arvid, 2006, Dialogues Clin Neurosci, V8, P137; Catafau AM, 2004, MOVEMENT DISORD, V19, P1175, DOI 10.1002/mds.20112; Catafau AM, 2008, SYNAPSE, V62, P62, DOI 10.1002/syn.20465; Centonze D, 2004, NEUROSCIENCE, V129, P157, DOI 10.1016/j.neuroscience.2004.07.043; Chen PS, 2005, PSYCHOL MED, V35, P197, DOI 10.1017/S0033291704003101; Curtis CE, 2004, J NEUROSCI, V24, P3944, DOI 10.1523/JNEUROSCI.5640-03.2004; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Frankle WG, 2004, PSYCHOPHARMACOLOGY, V175, P473, DOI 10.1007/s00213-004-1852-4; Glatt SJ, 2003, MOL PSYCHIATR, V8, P911, DOI 10.1038/sj.mp.4001321; GLATT SJ, 2008, MOL PSYCHIAT; Glickstein SB, 2002, J NEUROSCI, V22, P5619; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; GUO N, 2009, NEUROPSYCHOPHARMACOL; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hill T., 2006, STAT METHODS APPL CO; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; HIRVONEN MM, 2009, IN VIVO MOL IMAGING; Howes OD, 2009, ARCH GEN PSYCHIAT, V66, P13, DOI 10.1001/archgenpsychiatry.2008.514; Huttunen J, 2008, BIOL PSYCHIAT, V63, P114, DOI 10.1016/j.biopsych.2007.04.017; Ishikawa T, 1996, J NUCL MED, V37, P1760; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Jonsson EG, 1999, SCHIZOPHR RES, V40, P31, DOI 10.1016/S0920-9964(99)00033-X; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kegeles LS, 1999, SYNAPSE, V31, P302; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kimberg DY, 2001, HUM BRAIN MAPP, V12, P246, DOI 10.1002/1097-0193(200104)12:4<246::AID-HBM1019>3.0.CO;2-9; Kimmel HL, 2001, J PHARMACOL EXP THER, V298, P129; KUNG HF, 1990, J NUCL MED, V31, P573; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Laruelle M, 1994, NIDA Res Monogr, V138, P131; Laruelle M, 1997, NEUROPSYCHOPHARMACOL, V17, P162, DOI 10.1016/S0893-133X(97)00043-2; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LIDOW MS, 1989, P NATL ACAD SCI USA, V86, P6412, DOI 10.1073/pnas.86.16.6412; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Manoach DS, 2004, NEUROIMAGE, V21, P894, DOI 10.1016/j.neuroimage.2003.10.025; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Manoach DS, 2001, AM J PSYCHIAT, V158, P955, DOI 10.1176/appi.ajp.158.6.955; Mehta MA, 2003, NEUROIMAGE, V20, P1982, DOI 10.1016/j.neuroimage.2003.08.007; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; Meyer PT, 2008, NEUROIMAGE, V42, P548, DOI 10.1016/j.neuroimage.2008.05.023; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Meyer-Lindenberg A, 2008, NEUROIMAGE, V40, P655, DOI 10.1016/j.neuroimage.2007.11.058; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Nyberg L, 2009, NEUROIMAGE, V46, P1194, DOI 10.1016/j.neuroimage.2009.03.035; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; PARSONS LH, 1993, J NEUROCHEM, V60, P376, DOI 10.1111/j.1471-4159.1993.tb05864.x; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Rakshi JS, 1999, BRAIN, V122, P1637, DOI 10.1093/brain/122.9.1637; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Scheffel U, 1997, SYNAPSE, V25, P345, DOI 10.1002/(SICI)1098-2396(199704)25:4<345::AID-SYN5>3.3.CO;2-Z; Scherfler C, 2005, BRAIN, V128, P1605, DOI 10.1093/brain/awh485; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seibyl J, 2005, Q J NUCL MED MOL IM, V49, P215; SEIBYL JP, 1992, J NUCL MED, V33, P1964; Seidman LJ, 2006, SCHIZOPHR RES, V85, P58, DOI 10.1016/j.schres.2006.03.019; Sesack S R, 1998, Adv Pharmacol, V42, P171; Soret M, 2003, J NUCL MED, V44, P1184; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Tatsch K, 2002, EUR J NUCL MED MOL I, V29, pBP23; Tsuchida T, 2004, ANN NUCL MED, V18, P609, DOI 10.1007/BF02984583; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; VERHOEFF NPLG, 1993, J NUCL MED, V34, P2076; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P11, DOI 10.1016/0925-4927(96)02809-0; Volkow ND, 1998, AM J PSYCHIAT, V155, P344; Volkow ND, 1996, J NUCL MED, V37, P554; Watanabe K, 2009, J NEUROPHYSIOL, V101, P665, DOI 10.1152/jn.90806.2008; Wei XC, 2004, NEUROIMAGE, V21, P1000, DOI 10.1016/j.neuroimage.2003.10.039; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams GV, 2006, NEUROSCIENCE, V139, P263, DOI 10.1016/j.neuroscience.2005.09.028; Zhang Y, 2005, J BIOL CHEM, V280, P32618, DOI 10.1074/jbc.M504942200; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	103	70	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9348	10.1371/journal.pone.0009348	http://dx.doi.org/10.1371/journal.pone.0009348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179754	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923900014
J	Dubois, A; Raymond, O; Maene, M; Baudino, S; Langlade, NB; Boltz, V; Vergne, P; Bendahmane, M				Dubois, Annick; Raymond, Olivier; Maene, Marion; Baudino, Sylvie; Langlade, Nicolas B.; Boltz, Veronique; Vergne, Philippe; Bendahmane, Mohammed			Tinkering with the C-Function: A Molecular Frame for the Selection of Double Flowers in Cultivated Roses	PLOS ONE			English	Article							MADS-BOX GENES; EVOLUTION; PETAL; IDENTITY; DOMESTICATION; ASSOCIATION; CHIMERISM; MASAKO-C1; GENETICS	Background: Roses have been cultivated for centuries and a number of varieties have been selected based on flower traits such as petal form, color, and number. Wild-type roses have five petals (simple flowers), whereas high numbers of petals (double flowers) are typical attributes of most of the cultivated roses. Here, we investigated the molecular mechanisms that could have been selected to control petal number in roses. Methodology/Principal Findings: We have analyzed the expression of several candidate genes known to be involved in floral organ identity determination in roses from similar genetic backgrounds but exhibiting contrasting petal numbers per flower. We show that the rose ortholog of AGAMOUS (RhAG) is differentially expressed in double flowers as compared to simple flowers. In situ hybridization experiments confirm the differential expression of RhAG and demonstrate that in the double-flower roses, the expression domain of RhAG is restricted toward the center of the flower. Conversely, in simple-flower roses, RhAG expression domain is wider. We further show that the border of RhAG expression domain is labile, which allows the selection of rose flowers with increased petal number. Double-flower roses were selected independently in the two major regions for domestication, China and the peri-Mediterranean areas. Comparison of RhAG expression in the wildtype ancestors of cultivated roses and their descendants both in the European and Chinese lineages corroborates the correlation between the degree of restriction of RhAG expression domain and the number of petals. Our data suggests that a restriction of RhAG expression domain is the basis for selection of double flowers in both the Chinese and peri-Mediterranean centers of domestication. Conclusions/Significance: We demonstrate that a shift in RhAG expression domain boundary occurred in rose hybrids, causing double-flower phenotype. This molecular event was selected independently during rose domestication in Europe/Middle East and in China.	[Dubois, Annick; Raymond, Olivier; Maene, Marion; Boltz, Veronique; Vergne, Philippe; Bendahmane, Mohammed] Univ Lyon, Reprod & Dev Plantes, Lyon, France; [Baudino, Sylvie] Univ St Etienne, Lab Biotechnol Vegetales Appl Plantes Aromat & Me, St Etienne, France; [Langlade, Nicolas B.] INRA, Castanet Tolosan, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; INRAE	Dubois, A (corresponding author), Univ Lyon, Reprod & Dev Plantes, Lyon, France.	mohammed.bendahmane@ens-lyon.fr	Dubois, Annick/AAX-2219-2021; Langlade, Nicolas/C-6191-2008; Bendahmane, Mohammed/AAX-1296-2020; Raymond, Olivier/AAO-5868-2020	Dubois, Annick/0000-0002-3646-3811; Langlade, Nicolas/0000-0002-5651-1446; Bendahmane, Mohammed/0000-0003-1661-1060; Raymond, Olivier/0000-0002-9664-5377; Baudino, Sylvie/0000-0002-3367-172X	Biologie Vegetale Department of the French Institut National de la Recherche Agronomique; Region Rhone-Alpes/Cluster 9; Region Rhone-Alpes	Biologie Vegetale Department of the French Institut National de la Recherche Agronomique; Region Rhone-Alpes/Cluster 9(Region Auvergne-Rhone-Alpes); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was funded by the Biologie Vegetale Department of the French Institut National de la Recherche Agronomique and by funds from the Region Rhone-Alpes/Cluster 9. MM was supported by a PhD fellowship Prospective from Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergougnoux V, 2007, PLANTA, V226, P853, DOI 10.1007/s00425-007-0531-1; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Bowman J L, 1991, Symp Soc Exp Biol, V45, P89; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; CAIRNS T, 2000, MODERN ROSES, V11; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Cherri-Martin M, 2007, SCI HORTIC-AMSTERDAM, V113, P177, DOI 10.1016/j.scienta.2007.03.002; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Fernandez L, 2006, GENOME, V49, P721, DOI 10.1139/G06-034; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Gregory T.R., 2009, EVOLUTION, V2, P5, DOI [DOI 10.1007/S12052-008-0114-Z, 10.1007/s12052-008-0114-z]; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Hibino Y, 2006, PLANT SCI, V170, P778, DOI 10.1016/j.plantsci.2005.11.010; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kitahara K, 2004, PLANT SCI, V166, P1245, DOI 10.1016/j.plantsci.2003.12.040; Kitahara K, 2000, PLANT SCI, V151, P121, DOI 10.1016/S0168-9452(99)00206-X; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; KRUSSMANN G, 1981, COMPLETE BOOK ROSES, P436; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Li Wanlong, 2006, Functional & Integrative Genomics, V6, P300, DOI 10.1007/s10142-005-0015-y; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; Lu SH, 2007, EVOL DEV, V9, P92, DOI 10.1111/j.1525-142X.2006.00140.x; Ma N, 2008, PLANT PHYSIOL, V148, P894, DOI 10.1104/pp.108.120154; Martin M, 2001, THEOR APPL GENET, V102, P398, DOI 10.1007/s001220051660; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P144, DOI 10.1093/nar/gkn900; MIZUKAMI Y, 1995, PLANT MOL BIOL, V28, P767, DOI 10.1007/BF00042064; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Roeder AHK, 2001, DEV CELL, V1, P4, DOI 10.1016/S1534-5807(01)00013-2; Saedler H, 2001, ACTA BIOCHIM POL, V48, P351; Soltis DE, 2007, TRENDS PLANT SCI, V12, P358, DOI 10.1016/j.tplants.2007.06.012; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker AR, 2006, PLANT MOL BIOL, V62, P623, DOI 10.1007/s11103-006-9043-9; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435	41	69	86	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9288	10.1371/journal.pone.0009288	http://dx.doi.org/10.1371/journal.pone.0009288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174587	Green Published, gold			2022-12-27	WOS:000274654700018
J	Valensi-Kurtz, M; Lefler, S; Cohen, MA; Aharonowiz, M; Cohen-Kupiec, R; Sheinin, A; Ashery, U; Reubinoff, B; Weil, M				Valensi-Kurtz, Moran; Lefler, Sharon; Cohen, Malkiel A.; Aharonowiz, Michal; Cohen-Kupiec, Rachel; Sheinin, Anton; Ashery, Uri; Reubinoff, Benjamin; Weil, Miguel			Enriched Population of PNS Neurons Derived from Human Embryonic Stem Cells as a Platform for Studying Peripheral Neuropathies	PLOS ONE			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; NEURAL CREST CELLS; FAMILIAL DYSAUTONOMIA; IN-VITRO; DIRECTED DIFFERENTIATION; SYMPATHETIC NEURONS; CHOLINERGIC NEURONS; GENERATION; SPECIFICATION; PRECURSORS	Background: The absence of a suitable cellular model is a major obstacle for the study of peripheral neuropathies. Human embryonic stem cells hold the potential to be differentiated into peripheral neurons which makes them a suitable candidate for this purpose. However, so far the potential of hESC to differentiate into derivatives of the peripheral nervous system (PNS) was not investigated enough and in particular, the few trials conducted resulted in low yields of PNS neurons. Here we describe a novel hESC differentiation method to produce enriched populations of PNS mature neurons. By plating 8 weeks hESC derived neural progenitors (hESC-NPs) on laminin for two weeks in a defined medium, we demonstrate that over 70% of the resulting neurons express PNS markers and 30% of these cells are sensory neurons. Methods/Findings: Our method shows that the hNPs express neuronal crest lineage markers in a temporal manner, and by plating 8 weeks hESC-NPs into laminin coated dishes these hNPs were promoted to differentiate and give rise to homogeneous PNS neuronal populations, expressing several PNS lineage-specific markers. Importantly, these cultures produced functional neurons with electrophysiological activities typical of mature neurons. Moreover, supporting this physiological capacity implantation of 8 weeks old hESC-NPs into the neural tube of chick embryos also produced human neurons expressing specific PNS markers in vivo in just a few days. Having the enriched PNS differentiation system in hand, we show for the first time in human PNS neurons the expression of IKAP/hELP1 protein, where a splicing mutation on the gene encoding this protein causes the peripheral neuropathy Familial Dysautonomia. Conclusions/Significance: We conclude that this differentiation system to produce high numbers of human PNS neurons will be useful for studying PNS related neuropathies and for developing future drug screening applications for these diseases.	[Valensi-Kurtz, Moran; Lefler, Sharon; Cohen-Kupiec, Rachel; Weil, Miguel] Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Cohen, Malkiel A.; Aharonowiz, Michal; Reubinoff, Benjamin] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Sheinin, Anton; Ashery, Uri] Hadassah Univ Hosp, Dept Gynecol, IL-91120 Jerusalem, Israel	Tel Aviv University; Tel Aviv University; Hebrew University of Jerusalem	Valensi-Kurtz, M (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	miguelw@tauex.tau.ac.il	Cohen, Malkiel/AAE-1115-2020	Ashery, Uri/0000-0001-6338-7888; Reubinoff, Benjamin/0000-0003-0353-1299; Cohen, Malkiel/0000-0002-4187-691X	Familial Dysautonomia-Hope Foundation in the United States; Tel Aviv University Reccanati Fund	Familial Dysautonomia-Hope Foundation in the United States; Tel Aviv University Reccanati Fund	This work was supported by the Familial Dysautonomia-Hope Foundation (http://www.fdhope.org/) in the United States and by The Tel Aviv University Reccanati Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Arvidsson U, 1997, J COMP NEUROL, V378, P454; Baker CVH, 2002, DEV BIOL, V249, P219, DOI 10.1006/dbio.2002.0767; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; BROKHMAN I, 2007, DIFFERENTIATION; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Cohen M. A., 2007, CURR PROTOC CELL BIO; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Harris ML, 2007, DEV DYNAM, V236, P1, DOI 10.1002/dvdy.20919; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; JIANG X, 2008, STEM CELLS DEV; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Koblar SA, 1999, J NEUROSCI RES, V56, P518, DOI 10.1002/(SICI)1097-4547(19990601)56:5<518::AID-JNR7>3.0.CO;2-8; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Le Douarin NM, 1999, NEURAL CREST, V2; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Leyne M, 2003, AM J MED GENET A, V118A, P305, DOI 10.1002/ajmg.a.20052; MAAYAN C, 1987, CLIN GENET, V32, P106; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; RILEY CM, 1949, PEDIATRICS, V3, P468; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; SWEENEY TM, 1990, LAMININ POTENTIATES; Zeng X, 2007, NEUROSCIENCE, V145, P1348, DOI 10.1016/j.neuroscience.2006.09.017; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	40	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9290	10.1371/journal.pone.0009290	http://dx.doi.org/10.1371/journal.pone.0009290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174633	Green Submitted, gold, Green Published			2022-12-27	WOS:000274654700019
J	Savic, I; Berglund, H				Savic, Ivanka; Berglund, Hans			Androstenol - a Steroid Derived Odor Activates the Hypothalamus in Women	PLOS ONE			English	Article							PUTATIVE PHEROMONES; BRAIN ACTIVATION; 16-ANDROSTENES; EXPOSURE; HORMONE; HUMANS; SWEAT; MOOD	Background: Whether pheromone signaling exists in humans is still a matter of intense discussion. In the present study we tested if smelling of Androstenol, a steroid produced by the human body and reported to affect human behavior, may elicit cerebral activation. A further issue was to evaluate whether the pattern of activation resembles the pattern of common odors. Methodology: PET measurements of regional cerebral blood flow (rCBF) were conducted in 16 healthy heterosexual women during passive smelling of Androstenol, four ordinary odors (OO), and odorless air (the base line condition). Principal findings: Smelling Androstenol caused activation of a portion of the hypothalamus, which according to animal data mediates the pheromone triggered mating behavior. Smelling of OO, on the other hand, engaged only the classical olfactory regions (the piriform cortex, lateral amygdala, anterior insular and anterior cingulate cortex). Conclusions: The observed pattern of activation is very similar to the pattern previously detected with 4,16-androstadien-3-one in heterosexual females. It suggests that several compounds released by human body may activate cerebral networks involved in human reproduction.	[Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden; [Berglund, Hans] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Savic, I (corresponding author), Karolinska Inst, Stockholm Brain Inst, Dept Clin Neurosci, Stockholm, Sweden.	ivanka.savic-berglund@ki.se			Osher Pro Suecia Foundation; Swedish Research Council	Osher Pro Suecia Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Osher Pro Suecia Foundation and Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; Bensafi M, 2004, PSYCHONEUROENDOCRINO, V29, P1290, DOI 10.1016/j.psyneuen.2004.03.007; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; COWLEY JJ, 1991, J STEROID BIOCHEM, V39, P647, DOI 10.1016/0960-0760(91)90264-6; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Kaminski RM, 2005, EPILEPSIA, V46, P819, DOI 10.1111/j.1528-1167.2005.00705.x; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; McCluskey JJ, 2005, J AGR RESOUR ECON, V30, P1; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Savic I, 2001, NEURON, V31, P661, DOI 10.1016/S0896-6273(01)00390-7; Shinohara K, 2000, CHEM SENSES, V25, P465, DOI 10.1093/chemse/25.4.465; Sobel N, 1998, J NEUROSCI, V18, P8990; Sobel N, 1999, BRAIN, V122, P209, DOI 10.1093/brain/122.2.209; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	20	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e8651	10.1371/journal.pone.0008651	http://dx.doi.org/10.1371/journal.pone.0008651			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174662	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590600001
J	Katsuragawa, TH; Gil, LHS; Tada, MS; Silva, ADE; Costa, JDN; Araujo, MD; Escobar, AL; da Silva, LHP				Katsuragawa, Tony Hiroshi; Soares Gil, Luiz Herman; Tada, Mauro Shugiro; de Almeida e Silva, Alexandre; Neves Costa, Joana D'Arc; Araujo, Maisa da Silva; Escobar, Ana Lucia; Pereira da Silva, Luiz Hildebrando			The Dynamics of Transmission and Spatial Distribution of Malaria in Riverside Areas of Porto Velho, Rondonia, in the Amazon Region of Brazil	PLOS ONE			English	Article							COMPARATIVE SUSCEPTIBILITY; PLASMODIUM-FALCIPARUM; ASYMPTOMATIC CARRIERS; ANOPHELINE MOSQUITOS; HYPOENDEMIC MALARIA; HIGH PREVALENCE; ENDEMIC AREAS; URBAN; INFECTION; GAMBIAE	The study area in Rondonia was the site of extensive malaria epidemic outbreaks in the 19(th) and 20(th) centuries related to environmental impacts, with large immigration flows. The present work analyzes the transmission dynamics of malaria in these areas to propose measures for avoiding epidemic outbreaks due to the construction of two Hydroelectric Power Plants. A population based baseline demographic census and a malaria prevalence follow up were performed in two river side localities in the suburbs of Porto Velho city and in its rural vicinity. The quantification and nature of malaria parasites in clinical patients and asymptomatic parasite carriers were performed using microscopic and Real Time PCR methodologies. Anopheles densities and their seasonal variation were done by monthly captures for defining HBR (hourly biting rate) values. Main results: (i) malaria among residents show the riverside profile, with population at risk represented by children and young adults; (ii) asymptomatic vivax and falciparum malaria parasite carriers correspond to around 15% of adults living in the area; (iii) vivax malaria relapses were responsible for 30% of clinical cases; (iv) malaria risk for the residents was evaluated as 20-25% for vivax and 5-7% for falciparum malaria; (v) anopheline densities shown outdoors HBR values 5 to 10 fold higher than indoors and reach 10.000 bites/person/year; (vi) very high incidence observed in one of the surveyed localities was explained by a micro epidemic outbreak affecting visitors and temporary residents. Temporary residents living in tents or shacks are accessible to outdoors transmission. Seasonal fishermen were the main group at risk in the study and were responsible for a 2.6 fold increase in the malaria incidence in the locality. This situation illustrates the danger of extensive epidemic outbreaks when thousands of workers and secondary immigrant population will arrive attracted by opportunities opened by the Hydroelectric Power Plants constructions.	[Katsuragawa, Tony Hiroshi] Inst Pesquisas Patol Tropicais, Lab Epidemiol, Porto Velho, Rondonia, Brazil; [Soares Gil, Luiz Herman; de Almeida e Silva, Alexandre; Araujo, Maisa da Silva] Inst Pesquisas Patol Tropicais, Entomol Lab, Porto Velho, Rondonia, Brazil; [Neves Costa, Joana D'Arc; Pereira da Silva, Luiz Hildebrando] Inst Pesquisas Patol Tropicais, Mol Parasitol Lab, Porto Velho, Rondonia, Brazil; [Tada, Mauro Shugiro] Res Ctr Trop Med, Porto Velho, Rondonia, Brazil; [de Almeida e Silva, Alexandre] Fed Univ Rondonia, Dept Biol, Nucleo Ciencias & Tecnol, Porto Velho, Rondonia, Brazil; [Escobar, Ana Lucia] Fed Univ Rondonia, Dept Med, Nucleo Saude, Porto Velho, Rondonia, Brazil	Universidade Federal de Rondonia; Universidade Federal de Rondonia	Katsuragawa, TH (corresponding author), Inst Pesquisas Patol Tropicais, Lab Epidemiol, Porto Velho, Rondonia, Brazil.	hildebrando.pereira@yahoo.com.br	Silva, Alexandre A./A-6768-2008; Araujo, Maisa/AAJ-8827-2020; de Almeida e Silva, Alexandre/C-2597-2018; Costa, Joana D'Arc Neves/AAO-2140-2020	de Almeida e Silva, Alexandre/0000-0002-6500-0402; Neves Costa, Joana D'Arc/0000-0003-3675-742X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [410509/2006-0, 475097/2006]; Ministerio de Ciencia e Tecnologia, Brasil; Odebrecht Engenharia e Construcao	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio de Ciencia e Tecnologia, Brasil; Odebrecht Engenharia e Construcao	The present work was funded by contracts numbers 410509/2006-0 and 475097/2006 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Ministerio de Ciencia e Tecnologia, Brasil, and funds from Odebrecht Engenharia e Construcao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; CAMARGO L, THESIS U DADE SAO PA; Camargo LMA, 1999, ACTA TROP, V72, P1, DOI 10.1016/S0001-706X(98)00082-5; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS, P190; CONSTANTINI C, 1998, AM J TROP MED HYG, V58, P56; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Deane L., 1992, REV SOC BRAS MED TRO, V25, P12; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; FORATTINI OP, 2002, CULICIDOLOGIA MED, V2, P139; Gil LHS, 2003, J MED ENTOMOL, V40, P636, DOI 10.1603/0022-2585-40.5.636; Katsuragawa Tony Hiroshi, 2008, Estud. av., V22, P111, DOI 10.1590/S0103-40142008000300008; Klein T.A., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P13, DOI 10.1590/S0037-86821991000100003; KLEIN TA, 1991, AM J TROP MED HYG, V44, P598, DOI 10.4269/ajtmh.1991.44.598; KLEIN TA, 1991, AM J TROP MED HYG, V45, P463, DOI 10.4269/ajtmh.1991.45.463; KLEIN TA, 1990, J AM MOSQUITO CONTR, V6, P700; LOURENCODEOLIVEIRA R, 1989, MEM I OSWALDO CRUZ, V84, P501, DOI 10.1590/S0074-02761989000400008; LourencodeOliveira R, 1996, MEM I OSWALDO CRUZ, V91, P687, DOI 10.1590/S0074-02761996000600005; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; *MIN SAUD, 2008, GRUP TRAB CAPT MOSQ; Ministerio da Saude, 2006, AC CONTR MAL MAN PRO; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; SAWYER D R, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P342; Sawyer DR, 1988, FRONTIER MALARIA AMA; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Gil LHS, 2007, MEM I OSWALDO CRUZ, V102, P271, DOI 10.1590/S0074-02762007005000013; Tada MS, 2007, MEM I OSWALDO CRUZ, V102, P263, DOI 10.1590/S0074-02762007005000012; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; TADEI WP, 1988, REV I MED TROP, V30, P221, DOI 10.1590/S0036-46651988000300017; TADEI WP, 1988, C SOC BRASILEIRA MED, V24, P26; TADEI WP, 1986, ACTA AMAZON, V16, P151; Tadei WP, 1993, BASES CIENTIFICAS ES, P167; VILLALOBOSSALCE.JM, 2000, MEM I O CRUZ, V95, P139; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191	37	34	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9245	10.1371/journal.pone.0009245	http://dx.doi.org/10.1371/journal.pone.0009245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169070	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500023
J	Schirmer, A				Schirmer, Annett			Mark My Words: Tone of Voice Changes Affective Word Representations in Memory	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; EMOTIONAL PROSODY; DIRECTED SPEECH; RELEVANCE DETECTION; MEANINGLESS SPEECH; SEPARATING CONTENT; NEURAL RESPONSES; VISUAL-ATTENTION; HUMAN AMYGDALA; ANGER PROSODY	The present study explored the effect of speaker prosody on the representation of words in memory. To this end, participants were presented with a series of words and asked to remember the words for a subsequent recognition test. During study, words were presented auditorily with an emotional or neutral prosody, whereas during test, words were presented visually. Recognition performance was comparable for words studied with emotional and neutral prosody. However, subsequent valence ratings indicated that study prosody changed the affective representation of words in memory. Compared to words with neutral prosody, words with sad prosody were later rated as more negative and words with happy prosody were later rated as more positive. Interestingly, the participants' ability to remember study prosody failed to predict this effect, suggesting that changes in word valence were implicit and associated with initial word processing rather than word retrieval. Taken together these results identify a mechanism by which speakers can have sustained effects on listener attitudes towards word referents.	Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore	National University of Singapore	Schirmer, A (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	schirmer@nus.edu.sg	Schirmer, Annett/A-5257-2012	Schirmer, Annett/0000-0003-1474-2788	NUS [WBS R-581-000-066-101]	NUS(National University of Singapore)	Funding: This research was supported by a NUS young investigator award (WBS R-581-000-066-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Bach DR, 2008, CEREB CORTEX, V18, P145, DOI 10.1093/cercor/bhm040; Bachorowski JA, 2003, ANN NY ACAD SCI, V1000, P244, DOI 10.1196/annals.1280.012; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Brierley B, 2007, COGNITION EMOTION, V21, P495, DOI 10.1080/02699930600684963; Brosch T, 2008, COGNITION, V106, P1497, DOI 10.1016/j.cognition.2007.05.011; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Dewhurst SA, 2000, EUR J COGN PSYCHOL, V12, P541, DOI 10.1080/095414400750050222; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Ethofer T, 2006, NEUROREPORT, V17, P249, DOI 10.1097/01.wnr.0000199466.32036.5d; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friederici Angela D, 2004, Curr Neurol Neurosci Rep, V4, P466, DOI 10.1007/s11910-004-0070-0; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Grimshaw GM, 1998, BRAIN COGNITION, V36, P108, DOI 10.1006/brcg.1997.0949; Hawk ST, 2009, EMOTION, V9, P293, DOI 10.1037/a0015178; Ishii K, 2003, PSYCHOL SCI, V14, P39, DOI 10.1111/1467-9280.01416; Jackson MC, 2009, J EXP PSYCHOL HUMAN, V35, P363, DOI 10.1037/a0013895; KAPLAN PS, 1995, INFANT BEHAV DEV, V18, P209, DOI 10.1016/0163-6383(95)90050-0; Kensinger EA, 2007, CURR DIR PSYCHOL SCI, V16, P213, DOI 10.1111/j.1467-8721.2007.00506.x; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kitayama S, 1996, J EXP SOC PSYCHOL, V32, P289, DOI 10.1006/jesp.1996.0014; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Medford N, 2005, PSYCHIAT RES-NEUROIM, V138, P247, DOI 10.1016/j.pscychresns.2004.10.004; Mitchell RLC, 2006, EUR J NEUROSCI, V24, P3611, DOI 10.1111/j.1460-9568.2006.05231.x; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Morris JS, 1999, NEUROPSYCHOLOGIA, V37, P1155, DOI 10.1016/S0028-3932(99)00015-9; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Phelps EA, 1997, BRAIN COGNITION, V35, P85, DOI 10.1006/brcg.1997.0929; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pinker Steven, 1994, LANGUAGE INSTINCT MI; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schirmer A, 2008, NEUROIMAGE, V40, P1402, DOI 10.1016/j.neuroimage.2008.01.018; Schirmer A, 2007, BRAIN RES, V1176, P103, DOI 10.1016/j.brainres.2007.08.008; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Shimamura AP, 2009, PSYCHOL REV, V116, P1, DOI 10.1037/a0014500; Silva-Pereyra J, 2003, CLIN NEUROPHYSIOL, V114, P2469, DOI 10.1016/S1388-2457(03)00248-7; Sinaceur M, 2006, J EXP SOC PSYCHOL, V42, P314, DOI 10.1016/j.jesp.2005.05.002; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Trainor LJ, 2000, PSYCHOL SCI, V11, P188, DOI 10.1111/1467-9280.00240; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; Werker JF, 2007, COGNITION, V103, P147, DOI 10.1016/j.cognition.2006.03.006; Wiethoff S, 2008, NEUROIMAGE, V39, P885, DOI 10.1016/j.neuroimage.2007.09.028; Wiethoff S, 2009, NEUROREPORT, V20, P1356, DOI 10.1097/WNR.0b013e328330eb83; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; ZAHN GL, 1973, J EXP SOC PSYCHOL, V9, P320, DOI 10.1016/0022-1031(73)90069-3	64	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9080	10.1371/journal.pone.0009080	http://dx.doi.org/10.1371/journal.pone.0009080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554ZD	20169154	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474700001
J	Starck, CS; Sutherland-Smith, AJ				Starck, Carlene S.; Sutherland-Smith, Andrew J.			Cytotoxic Aggregation and Amyloid Formation by the Myostatin Precursor Protein	PLOS ONE			English	Article							INCLUSION-BODY MYOSITIS; ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; FIBRIL FORMATION; THIOFLAVIN-T; MYOBLAST PROLIFERATION; DEGENERATIVE DISEASES; MISFOLDING DISEASES; NEGATIVE REGULATOR; CRYSTAL-STRUCTURE	Myostatin, a negative regulator of muscle growth, has been implicated in sporadic inclusion body myositis (sIBM). sIBM is the most common age-related muscle-wastage disease with a pathogenesis similar to that of amyloid disorders such as Alzheimer's and Parkinson's diseases. Myostatin precursor protein (MstnPP) has been shown to associate with large molecular weight filamentous inclusions containing the Alzheimer's amyloid beta peptide in sIBM tissue, and MstnPP is upregulated following ER stress. The mechanism for how MstnPP contributes to disease pathogenesis is unknown. Here, we show for the first time that MstnPP is capable of forming amyloid fibrils in vitro. When MstnPP-containing Escherichia coli inclusion bodies are refolded and purified, a proportion of MstnPP spontaneously misfolds into amyloid-like aggregates as characterised by electron microscopy and binding of the amyloid-specific dye thioflavin T. When subjected to a slightly acidic pH and elevated temperature, the aggregates form straight and unbranched amyloid fibrils 15 nm in diameter and also exhibit higher order amyloid structures. Circular dichroism spectroscopy reveals that the amyloid fibrils are dominated by beta-sheet and that their formation occurs via a conformational change that occurs at a physiologically relevant temperature. Importantly, MstnPP aggregates and protofibrils have a negative effect on the viability of myoblasts. These novel results show that the myostatin precursor protein is capable of forming amyloid structures in vitro with implications for a role in sIBM pathogenesis.	[Starck, Carlene S.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Starck, CS (corresponding author), Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.	A.J.Sutherland-Smith@massey.ac.nz	Sutherland-Smith, Andrew/F-1813-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428	Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships; Massey University Research Fund; Palmerston North Medical Research Foundation	Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships; Massey University Research Fund; Palmerston North Medical Research Foundation	This work was funded by Tertiary Education Commission Top Achiever Doctoral and New Zealand Neuromuscular Alliance Henry Kelsey Scholarships to C.S.S. and grants from the Massey University Research Fund and the Palmerston North Medical Research Foundation to A.J.S.-S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/015005; Amthor H, 2006, DEV DYNAM, V235, P672, DOI 10.1002/dvdy.20680; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Askanas V, 2008, ACTA NEUROPATHOL, V116, P583, DOI 10.1007/s00401-008-0449-0; Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Bourhim M, 2007, J NEUROSCI METH, V160, P264, DOI 10.1016/j.jneumeth.2006.09.013; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calloni G, 2008, J AM CHEM SOC, V130, P13040, DOI 10.1021/ja8029224; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Funkenstein B, 2007, PROTEIN EXPRES PURIF, V54, P54, DOI 10.1016/j.pep.2007.02.002; Garlepp MJ, 2008, CURR OPIN RHEUMATOL, V20, P662, DOI 10.1097/BOR.0b013e328313644c; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goda S, 2000, PROTEIN SCI, V9, P369; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Jansen R, 2005, BIOPHYS J, V88, P1344, DOI 10.1529/biophysj.104.048843; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Jin HJ, 2004, PROTEIN EXPRES PURIF, V35, P1, DOI 10.1016/j.pep.2004.01.001; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Juarez J, 2009, BIOPHYS J, V96, P2353, DOI 10.1016/j.bpj.2008.12.3901; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Karpati G, 2009, ANN NEUROL, V65, P7, DOI 10.1002/ana.21622; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kumar S, 2007, J MOL BIOL, V367, P1186, DOI 10.1016/j.jmb.2007.01.039; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; McNally EM, 2004, NEW ENGL J MED, V350, P2642, DOI 10.1056/NEJMp048124; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Mittl PRE, 1996, PROTEIN SCI, V5, P1261, DOI 10.1002/pro.5560050705; Nogalska A, 2007, EXP NEUROL, V204, P610, DOI 10.1016/j.expneurol.2006.12.014; Paschen W, 2003, CELL CALCIUM, V34, P365, DOI 10.1016/S0143-4160(03)00139-8; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Reumers J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S9; Rezaei-Ghaleh N, 2009, BIOPOLYMERS, V91, P28, DOI 10.1002/bip.21079; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Svane ASP, 2008, BIOPHYS J, V95, P366, DOI 10.1529/biophysj.107.122895; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tobin JF, 2005, CURR OPIN PHARMACOL, V5, P328, DOI 10.1016/j.coph.2005.01.011; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Vattemi G, 2009, ACTA NEUROPATHOL, V117, P569, DOI 10.1007/s00401-009-0511-6; WAGNER K, 2002, ANN NEUROL, V52; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Wojcik S, 2007, NEUROPATH APPL NEURO, V33, P238, DOI 10.1111/j.1365-2990.2006.00821.x; Wojcik S, 2005, ACTA NEUROPATHOL, V110, P173, DOI 10.1007/s00401-005-1035-3; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; [No title captured]	82	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9170	10.1371/journal.pone.0009170	http://dx.doi.org/10.1371/journal.pone.0009170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161792	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442800016
J	Yuan, P; Kadara, H; Behrens, C; Tang, XM; Woods, D; Solis, LM; Huang, JT; Spinola, M; Dong, WL; Yin, GS; Fujimoto, J; Kim, E; Xie, Y; Girard, L; Moran, C; Hong, WK; Minna, JD; Wistuba, II				Yuan, Ping; Kadara, Humam; Behrens, Carmen; Tang, Ximing; Woods, Denise; Solis, Luisa M.; Huang, Jiaoti; Spinola, Monica; Dong, Wenli; Yin, Guosheng; Fujimoto, Junya; Kim, Edward; Xie, Yang; Girard, Luc; Moran, Cesar; Hong, Waun Ki; Minna, John D.; Wistuba, Ignacio I.			Sex Determining Region Y-Box 2 (SOX2) Is a Potential Cell-Lineage Gene Highly Expressed in the Pathogenesis of Squamous Cell Carcinomas of the Lung	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BRANCHING MORPHOGENESIS; STEM-CELLS; CANCER; ONCOGENE	Background: Non-small cell lung cancer (NSCLC) represents the majority (85%) of lung cancers and is comprised mainly of adenocarcinomas and squamous cell carcinomas (SCCs). The sequential pathogenesis of lung adenocarcinomas and SCCs occurs through dissimilar phases as the former tumors typically arise in the lung periphery whereas the latter normally arise near the central airway. Methodology/Principal Findings: We assessed the expression of SOX2, an embryonic stem cell transcriptional factor that also plays important roles in the proliferation of basal tracheal cells and whose expression is restricted to the main and central airways and bronchioles of the developing and adult mouse lung, in NSCLC by various methodologies. Here, we found that SOX2 mRNA levels, from various published datasets, were significantly elevated in lung SCCs compared to adenocarcinomas (all p < 0.001). Moreover, a previously characterized OCT4/SOX2/NANOG signature effectively separated lung SCCs from adenocarcinomas in two independent publicly available datasets which correlated with increased SOX2 mRNA in SCCs. Immunohistochemical analysis of various histological lung tissue specimens demonstrated marked nuclear SOX2 protein expression in all normal bronchial epithelia, alveolar bronchiolization structures and premalignant lesions in SCC development (hyperplasia, dysplasia and carcinoma in situ) and absence of expression in all normal alveoli and atypical adenomatous hyperplasias. Moreover, SOX2 protein expression was greatly higher in lung SCCs compared to adenocarcinomas following analyses in two independent large TMA sets (TMA set I, n = 287; TMA set II, n = 511 both p < 0.001). Furthermore, amplification of SOX2 DNA was detected in 20% of lung SCCs tested (n = 40) and in none of the adenocarcinomas (n = 17). Conclusions/Significance: Our findings highlight a cell-lineage gene expression pattern for the stem cell transcriptional factor SOX2 in the pathogenesis of lung SCCs and suggest a differential activation of stem cell-related pathways between squamous cell carcinomas and adenocarcinomas of the lung.	[Yuan, Ping; Woods, Denise; Solis, Luisa M.; Moran, Cesar; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Kadara, Humam; Behrens, Carmen; Tang, Ximing; Fujimoto, Junya; Kim, Edward; Hong, Waun Ki; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Dong, Wenli; Yin, Guosheng] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Spinola, Monica; Girard, Luc; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Biostat, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yuan, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	iiwistuba@mdanderson.org	Yin, Guosheng/D-3214-2009	Yin, Guosheng/0000-0003-3276-1392; Huang, Jiaoti/0000-0003-1195-1998	Department of Defense [W81XWH-04-1-0142, W81XWH-07-1-03060]; Specialized Program of Research Excellence in Lung Cancer [P50CA70907]; National Cancer Institute [CA-16672]; NATIONAL CANCER INSTITUTE [P50CA070907, P30CA016672] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Specialized Program of Research Excellence in Lung Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from the Department of Defense (W81XWH-04-1-0142 and W81XWH-07-1-03060 to W. K. H., J. D. M., I. I. W.) and by the Specialized Program of Research Excellence in Lung Cancer Grant P50CA70907 (J. D. M., I. I. W.) and Cancer Center Support Grant CA-16672 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Behrens C, 2008, CLIN CANCER RES, V14, P6014, DOI 10.1158/1078-0432.CCR-08-0167; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Simon R, 2007, CANCER INFORM, V3, P11; Tang XM, 2008, CANCER PREV RES, V1, P192, DOI 10.1158/1940-6207.CAPR-08-0032; Westra WH, 1996, CANCER RES, V56, P2224; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103	20	103	105	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9112	10.1371/journal.pone.0009112	http://dx.doi.org/10.1371/journal.pone.0009112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161759	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600010
J	Iwata, A; Morgan-Stevenson, V; Schwartz, B; Liu, L; Tupper, J; Zhu, XD; Harlan, J; Winn, R				Iwata, Akiko; Morgan-Stevenson, Vicki; Schwartz, Barbara; Liu, Li; Tupper, Joan; Zhu, Xiaodong; Harlan, John; Winn, Robert			Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage in Murine Models of Ischemia-Reperfusion Injury	PLOS ONE			English	Article							MEDIATED GENE-TRANSFER; BH4 DOMAIN; ANTIAPOPTOTIC PROTEIN; CEREBROSPINAL-FLUID; HEPATIC ISCHEMIA; CELL-DEATH; APOPTOSIS; EXPRESSION; SERUM; PEPTIDE	Background: Ischemia-reperfusion (I/R) injury contributes to organ dysfunction in a variety of clinical disorders, including myocardial infarction, stroke, organ transplantation, and hemorrhagic shock. Recent investigations have demonstrated that apoptosis as an important mechanism of cell death leading to organ dysfunction following I/R. Intracellular danger-associated molecular patterns (DAMPs) released during cell death can activate cytoprotective responses by engaging receptors of the innate immune system. Methodology/Principal Findings: Ischemia was induced in the mouse hind limb by tourniquet or in the heart by coronary artery ligation. Reperfusion injury of skeletal or cardiac muscle was markedly reduced by intraperitoneal or subcutaneous injection of recombinant human (rh)BCL2 protein or rhBCL2-related protein A1 (BCL2A1) (50 ng/g) given prior to ischemia or at the time of reperfusion. The cytoprotective activity of extracellular rhBCL2 or rhBCL2A1 protein was mapped to the BH4 domain, as treatment with a mutant BCL2 protein lacking the BH4 domain was not protective, whereas peptides derived from the BH4 domain of BCL2 or the BH4-like domain of BCL2A1 were. Protection by extracellular rhBCL2 or rhBCL2A1 was associated with a reduction in apoptosis in skeletal and cardiac muscle following I/R, concomitant with increased expression of endogenous mouse BCL2 (mBCL2) protein. Notably, treatment with rhBCL2A1 protein did not protect mice deficient in toll-like receptor-2 (TLR2) or the adaptor protein, myeloid differentiation factor-88 (MyD88). Conclusions/Significance: Treatment with cytokine-like doses of rhBCL2 or rhBCL2A1 protein or BH4-domain peptides reduces apoptosis and tissue injury following I/R by a TLR2-MyD88-dependent mechanism. These findings establish a novel extracellular cytoprotective activity of BCL2 BH4-domain proteins as potent cytoprotective DAMPs.	[Iwata, Akiko; Morgan-Stevenson, Vicki; Winn, Robert] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Schwartz, Barbara; Liu, Li; Tupper, Joan; Zhu, Xiaodong; Harlan, John] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Iwata, A (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	jharlan@u.washington.edu			Seredigm Corporation; National Institutes of Health [GM66197, GM42686, GM071398, HL72262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686, R01GM071398, R01GM066197] Funding Source: NIH RePORTER	Seredigm Corporation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: Seredigm Corporation and National Institutes of Health grants GM66197 (RW), GM42686 (RW), GM071398 (JH), and HL72262 (JH) supported this work. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aprahamian CJ, 2008, PEDIATR CRIT CARE ME, V9, P105, DOI 10.1097/01.PCC.0000288717.44702.C0; Arumugam TV, 2009, SHOCK, V32, P4, DOI 10.1097/SHK.0b013e318193e333; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bilbao G, 1999, ANN SURG, V230, P185, DOI 10.1097/00000658-199908000-00008; Brocheriou V, 2000, J GENE MED, V2, P326, DOI 10.1002/1521-2254(200009/10)2:5<326::AID-JGM133>3.0.CO;2-1; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Camlica H, 2008, AM J CLIN ONCOL-CANC, V31, P585, DOI 10.1097/COC.0b013e318174dbd2; Cantara S, 2004, J VASC RES, V41, P202, DOI 10.1159/000077408; Cao YJ, 2002, GENE THER, V9, P415, DOI 10.1038/sj.gt.3301676; Carter WO, 1998, J APPL PHYSIOL, V85, P1676, DOI 10.1152/jappl.1998.85.5.1676; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CHOI SS, 1995, ONCOGENE, V11, P1693; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Fathi NA, 2006, CLIN EXP IMMUNOL, V146, P339, DOI 10.1111/j.1365-2249.2006.03219.x; FERRERA R, 1993, J MOL CELL CARDIOL, V25, P1091, DOI 10.1006/jmcc.1993.1121; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Hua F, 2008, J NEUROIMMUNOL, V199, P75, DOI 10.1016/j.jneuroim.2008.05.009; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Iwata A, 2002, BLOOD, V100, P2077, DOI 10.1182/blood-2002-03-0752; Izuishi K, 2006, J IMMUNOL, V176, P7154, DOI 10.4049/jimmunol.176.12.7154; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Klune JR, 2008, J LEUKOCYTE BIOL, V83, P558, DOI 10.1189/jlb.0607406; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kyriakides C, 2000, J TRAUMA, V48, P32, DOI 10.1097/00005373-200001000-00006; Li CF, 2004, CARDIOVASC RES, V61, P538, DOI 10.1016/j.cardiores.2003.09.007; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; LIN EY, 1993, J IMMUNOL, V151, P1979; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Ono M, 2005, EUR J CARDIO-THORAC, V27, P117, DOI 10.1016/j.ejcts.2004.09.025; Oshiro T, 2002, J SURG RES, V103, P30, DOI 10.1006/jsre.2001.6313; Osman H G, 2007, Indian J Med Microbiol, V25, P323; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Protopsaltis J, 2007, MED PRIN PRACT, V16, P222, DOI 10.1159/000100394; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Sakai T, 1999, J INTERF CYTOK RES, V19, P999, DOI 10.1089/107999099313208; Selzner M, 2002, J HEPATOL, V36, P218, DOI 10.1016/S0168-8278(01)00259-8; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Sierra SS, 2009, EMBO J, V28, P2018, DOI 10.1038/emboj.2009.158; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sugioka R, 2003, ONCOGENE, V22, P8432, DOI 10.1038/sj.onc.1207180; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092	59	30	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9103	10.1371/journal.pone.0009103	http://dx.doi.org/10.1371/journal.pone.0009103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161703	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442500010
J	McDonald, RI; Forman, RTT; Kareiva, P				McDonald, Robert I.; Forman, Richard T. T.; Kareiva, Peter			Open Space Loss and Land Inequality in United States' Cities, 1990-2000	PLOS ONE			English	Article							PROTECTED AREAS; URBAN SPRAWL; SMART GROWTH; URBANIZATION; FUTURE; COVER	Urban growth reduces open space in and around cities, impacting biodiversity and ecosystem services. Using land-cover and population data, we examined land consumption and open space loss between 1990 and 2000 for all 274 metropolitan areas in the contiguous United States. Nationally, 1.4 million ha of open space was lost, and the amount lost in a given city was correlated with population growth (r(272) = 0.85, P < 0.001). In 2000, cities varied in per capita land consumption by an order of magnitude, from 459 m(2)/person in New York to 5393 m(2)/person in Grand Forks, ND. The per capita land consumption (m(2)/person) of most cities decreased on average over the decade from 1,564 to 1,454 m(2)/person, but there was substantial regional variation and some cities even increased. Cities with greater conservation funding or more reformminded zoning tended to decrease in per capita land consumption more than other cities. The majority of developed area in cities is in low-density neighborhoods housing a small proportion of urban residents, with Gini coefficients that quantify this developed land inequality averaging 0.63. Our results suggest conservation funding and reform-minded zoning decrease per capita open space loss.	[McDonald, Robert I.] Nature Conservancy, Worldwide Off, Arlington, VA USA; [Forman, Richard T. T.] Harvard Univ, Grad Sch Design, Cambridge, MA 02138 USA; [Kareiva, Peter] Nature Conservancy, Seattle Off, Seattle, WA USA	Nature Conservancy; Harvard University; Nature Conservancy	McDonald, RI (corresponding author), Nature Conservancy, Worldwide Off, 1815 N Lynn St, Arlington, VA USA.	rob_mcdonald@TNC.ORG		McDonald, Robert/0000-0002-7273-6549	Nature Conservancy; D. H. Smith Fellowship; Harvard University	Nature Conservancy; D. H. Smith Fellowship; Harvard University	The authors were financially supported by The Nature Conservancy (R. I. M., P. K.), the D. H. Smith Fellowship (R. I. M.) and Harvard University (R. T. T. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1976, LAND USE LAND COVER; [Anonymous], 2000, FED REG, V65, P82228; Brown DG, 2006, ECOL SOC, V11; Calthorpe P., 1993, NEXT AM METROPOLIS E; Danielsen KA, 1999, HOUS POLICY DEBATE, V10, P513; Duany A., 2000, SUBURBAN NATION RISE; Forman R.T.T, 2008, URBAN REGIONS ECOLOG; Fulton W., 2001, WHO SPRAWLS MOST GRO; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; Hansen AJ, 2007, ECOL APPL, V17, P974, DOI 10.1890/05-1098; Hobbs F, 2002, CENSR4 US CENS BUR; Irwin EG, 2007, P NATL ACAD SCI USA, V104, P20672, DOI 10.1073/pnas.0705527105; Jackson K., 1985, CRABGRASS FRONTIER; Kenworthy JR, 1999, TRANSPORT RES A-POL, V33, P691, DOI 10.1016/S0965-8564(99)00006-3; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; MacDonald K, 2005, APPL GEOGR, V25, P67, DOI 10.1016/j.apgeog.2004.07.001; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McDonald RI, 2008, FRONT ECOL ENVIRON, V6, P99, DOI 10.1890/070038; McDonald RI, 2006, BIOL INVASIONS, V8, P1049, DOI 10.1007/s10530-005-5227-5; Pendall Rolf, 2006, TRADITIONAL REFORMED; PISARSKI, 2006, COMMUTING AM, V3; Porter D., 2002, MAKING SMART GROWTH; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Talen Emily., 2005, NEW URBANISM AM PLAN; Theobald D.M., 2005, ECOL SOC, V10, P34, DOI [10.5751/ES-01390-100132, DOI 10.5751/ES-01390-100132]; Theobald DM, 2001, GEOGR REV, V91, P544, DOI 10.2307/3594740; Walker R, 2001, ECOL ECON, V37, P357, DOI 10.1016/S0921-8009(01)00178-1	29	48	49	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9509	10.1371/journal.pone.0009509	http://dx.doi.org/10.1371/journal.pone.0009509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209082	gold, Green Published, Green Submitted			2022-12-27	WOS:000275063400015
J	Latif, R; Michalek, K; Morshed, SA; Davies, TF				Latif, Rauf; Michalek, Krzysztof; Morshed, Syed Ahmed; Davies, Terry F.			A Tyrosine Residue on the TSH Receptor Stabilizes Multimer Formation	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED RECEPTORS; NEGATIVE COOPERATIVITY; STIMULATING-HORMONE; LIPID RAFTS; OLIGOMERIZATION; COMPLEX; ECTODOMAIN; AUTOANTIBODIES; DIMERIZATION	Background: The thyrotropin stimulating hormone receptor (TSHR) is a G protein coupled receptor (GPCR) with a large ectodomain. The ligand, TSH, acting via this receptor regulates thyroid growth and thyroid hormone production and secretion. The TSH receptor (TSHR) undergoes complex post -translational modifications including intramolecular cleavage and receptor multimerization. Since monomeric and multimeric receptors coexist in cells, understanding the functional role of just the TSHR multimers is difficult. Therefore, to help understand the physiological significance of receptor multimerization, it will be necessary to abrogate multimer formation, which requires identifying the ectodomain and endodomain interaction sites on the TSHR. Here, we have examined the contribution of the ectodomain to constitutive multimerization of the TSHR and determined the possible residue(s) that may be involved in this interaction. Methodology/Principal Findings: We studied ectodomain multimer formation by expressing the extracellular domain of the TSHR linked to a glycophosphotidyl (GPI) anchor in both stable and transient expression systems. Using co-immunoprecipitation and FRET of tagged receptors, we established that the TSH receptor ectodomain was capable of multimerization even when totally devoid of the transmembrane domain. Further, we studied the effect of two residues that likely made critical contact points in this interaction. We showed that a conserved tyrosine residue (Y116) on the convex surface of the LRR3 was a critical residue in ectodomain multimer formation since mutation of this residue to serine totally abrogated ectodomain multimers. This abrogation was not seen with the mutation of cysteine 176 on the inner side of the LRR5, demonstrating that inter-receptor disulfide bonding was not involved in ectodomain multimer formation. Additionally, the Y116 mutation in the intact wild type receptor enhanced receptor degradation. Conclusions/Significance: These data establish the TSH receptor ectodomain as one site of multimerization, independent of the transmembrane region, and that this interaction was primarily via a conserved tyrosine residue in LRR3.	[Latif, Rauf; Michalek, Krzysztof; Morshed, Syed Ahmed; Davies, Terry F.] Mt Sinai Sch Med, James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY 10029 USA; [Michalek, Krzysztof] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Dis, Poznan, Poland	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Poznan University of Medical Sciences	Latif, R (corresponding author), Mt Sinai Sch Med, James J Peters VA Med Ctr, Thyroid Res Unit, New York, NY 10029 USA.	rauf.latif@mssm.edu	latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020	Latif, Rauf/0000-0002-4226-3728	National Institutes of Health (NIH) [DK069713, DK052464]; VA Merit Award program; David Owen Segal Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052464, R01DK069713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award program; David Owen Segal Endowment; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) grants DK069713, DK052464, the VA Merit Award program (TFD) and the David Owen Segal Endowment (to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, J ENDOCRINOL, V195, P179, DOI 10.1677/JOE-07-0058; BDALLA S, 1999, J BIOL CHEM, V274, P26079; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Calebiro D, 2005, HUM MOL GENET, V14, P2991, DOI 10.1093/hmg/ddi329; Chazenbalk GD, 1997, ENDOCRINOLOGY, V138, P2893, DOI 10.1210/en.138.7.2893; Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Couet J, 1996, J BIOL CHEM, V271, P4545; Da Costa CR, 1998, J BIOL CHEM, V273, P11874, DOI 10.1074/jbc.273.19.11874; Davies T, 2002, J CLIN INVEST, V110, P161, DOI 10.1172/JCI200216234; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; DE MP, 1976, J SUPRAMOL STRUCT, V4, P241; Devi LA, 2000, TRENDS PHARMACOL SCI, V21, P324, DOI 10.1016/S0165-6147(00)01519-4; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fanelli F, 2007, MOL CELL ENDOCRINOL, V260, P59, DOI 10.1016/j.mce.2005.12.054; Filizola M, 2002, PROTEIN ENG, V15, P881, DOI 10.1093/protein/15.11.881; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; Kaezur V, 2007, J MOL RECOGNIT, V20, P392, DOI 10.1002/jmr.851; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; LATIF R, 2002, J BIOL CHEM; Lewandowicz AM, 2006, BRIT J PHARMACOL, V147, P422, DOI 10.1038/sj.bjp.0706624; MICAHALEK K, 2008, END SOC M; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Periasamy A, 2001, J BIOMED OPT, V6, P287, DOI 10.1117/1.1383063; Persani L, 2007, NAT CLIN PRACT ENDOC, V3, P180, DOI 10.1038/ncpendmet0401; Puett D, 2007, MOL CELL ENDOCRINOL, V260, P126, DOI 10.1016/j.mce.2006.05.009; Rapoport B, 1998, ENDOCR REV, V19, P673, DOI 10.1210/er.19.6.673; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; VAN DJ, 2006, MOL ENDOCRINOL, V20, P2247; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9449	10.1371/journal.pone.0009449	http://dx.doi.org/10.1371/journal.pone.0009449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195479	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997000015
J	Mitsuya, S; El-Shami, M; Sparkes, IA; Charlton, WL; Lousa, CD; Johnson, B; Baker, A				Mitsuya, Shiro; El-Shami, Mahmoud; Sparkes, Imogen A.; Charlton, Wayne L.; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison			Salt Stress Causes Peroxisome Proliferation, but Inducing Peroxisome Proliferation Does Not Improve NaCl Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; PLANT PEROXISOMES; MEMBRANE-PROTEIN; TOBACCO PLANTS; PEA-PLANTS; EXPRESSION; JASMONATE; DIVISION	The PEX11 family of peroxisome membrane proteins have been shown to be involved in regulation of peroxisome size and number in plant, animals, and yeast cells. We and others have previously suggested that peroxisome proliferation as a result of abiotic stress may be important in plant stress responses, and recently it was reported that several rice PEX11 genes were up regulated in response to abiotic stress. We sought to test the hypothesis that promoting peroxisome proliferation in Arabidopsis thaliana by over expression of one PEX11 family member, PEX11e, would give increased resistance to salt stress. We could demonstrate up regulation of PEX11e by salt stress and increased peroxisome number by both PEX11e over expression and salt stress, however our experiments failed to find a correlation between PEX11e over expression and increased peroxisome metabolic activity or resistance to salt stress. This suggests that although peroxisome proliferation may be a consequence of salt stress, it does not affect the ability of Arabidopsis plants to tolerate saline conditions.	[Mitsuya, Shiro; El-Shami, Mahmoud; Sparkes, Imogen A.; Charlton, Wayne L.; Lousa, Carine De Marcos; Johnson, Barbara; Baker, Alison] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Mitsuya, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	a.baker@leeds.ac.uk		De Marcos Lousa, Carine/0000-0002-5041-6261; Baker, Alison/0000-0003-2181-4057	Biotechnology and Biological Sciences Research Council (United Kingdom) [24/P13265]; Japan Society for Promotion of Science [20780011];  [JPA1811]; BBSRC [BB/D524875/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the Biotechnology and Biological Sciences Research Council (United Kingdom) (www.bbsrc.ac.uk), grant number 24/P13265, and Japan partnering award JPA1811. SM acknowledges the support of the grant 'KAKENHI (20780011)' from the Japan Society for Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 2006, TRENDS PLANT SCI, V11, P124, DOI 10.1016/j.tplants.2006.01.005; Brown LA, 2008, MOL MEMBR BIOL, V25, P363, DOI 10.1080/09687680802130583; Charlton WL, 2005, PLANT CELL ENVIRON, V28, P513, DOI 10.1111/j.1365-3040.2004.01293.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CORPAS FJ, 1993, J PLANT PHYSL, V141; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; DEFELIPE MR, 1988, J PLANT PHYSIOL, V132, P67, DOI 10.1016/S0176-1617(88)80185-8; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; Desai M, 2008, PLANT PHYSIOL, V146, P1117, DOI 10.1104/pp.107.113555; Dietrich D, 2009, MOL BIOL CELL, V20, P530, DOI 10.1091/mbc.E08-07-0745; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; FERREIRA RMB, 1989, J EXP BOT, V40, P1029, DOI 10.1093/jxb/40.9.1029; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HESS R, 1965, NATURE, V208, P856, DOI 10.1038/208856a0; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hu JP, 2007, J INTEGR PLANT BIOL, V49, P1112, DOI 10.1111/j.1672-9072.2007.00537.x; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Kishitani S, 2000, PLANT CELL ENVIRON, V23, P107, DOI 10.1046/j.1365-3040.2000.00527.x; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, MOL CELL BIOL, V22, P4358, DOI 10.1128/MCB.22.12.4358-4365.2002; Li XL, 2002, MOL CELL BIOL, V22, P8226, DOI 10.1128/MCB.22.23.8226-8240.2002; Li YJ, 2009, PLANT BREEDING, V128, P404, DOI 10.1111/j.1439-0523.2008.01593.x; Lingard MJ, 2008, PLANT CELL, V20, P1567, DOI 10.1105/tpc.107.057679; Lingard MJ, 2006, J CELL SCI, V119, P1961, DOI 10.1242/jcs.02904; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Mano S, 2004, PLANT J, V38, P487, DOI 10.1111/j.1365-313X.2004.02063.x; Marshall PA, 1996, J CELL BIOL, V135, P123, DOI 10.1083/jcb.135.1.123; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; McCarthy I, 2001, PLANT CELL ENVIRON, V24, P1065, DOI 10.1046/j.1365-3040.2001.00750.x; MORRE DJ, 1990, PROTOPLASMA, V155, P58, DOI 10.1007/BF01322615; Mullen RT, 2006, BBA-MOL CELL RES, V1763, P1655, DOI 10.1016/j.bbamcr.2006.09.011; NAMBARA E, 1992, PLANT J, V2, P435, DOI 10.1111/j.1365-313X.1992.00435.x; Nayidu NK, 2008, GENE, V412, P59, DOI 10.1016/j.gene.2008.01.006; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; Oksanen E, 2004, NEW PHYTOL, V161, P791, DOI 10.1111/j.1469-8137.2003.00981.x; Orth T, 2007, PLANT CELL, V19, P333, DOI 10.1105/tpc.106.045831; PALMA JM, 1987, PLANT PHYSIOL, V85, P570, DOI 10.1104/pp.85.2.570; PALMA JM, 1991, ARCH BIOCHEM BIOPHYS, V287, P68, DOI 10.1016/0003-9861(91)90389-Z; Rahim G, 2009, J EXP BOT, V60, P257, DOI 10.1093/jxb/ern283; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rouster J, 1997, PLANT J, V11, P513, DOI 10.1046/j.1365-313X.1997.11030513.x; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sparkes IA, 2005, PLANT PHYSIOL, V139, P690, DOI 10.1104/pp.105.065094; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tam YYC, 2003, MOL BIOL CELL, V14, P4089, DOI 10.1091/mbc.E03-03-0150; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thoms S, 2005, FEBS J, V272, P5169, DOI 10.1111/j.1742-4658.2005.04939.x; Tugal HB, 1999, PLANT PHYSIOL, V120, P309, DOI 10.1104/pp.120.1.309; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; Vizeacoumar FJ, 2004, MOL BIOL CELL, V15, P665, DOI 10.1091/mbc.E03-09-0681; Vizeacoumar FJ, 2003, J CELL BIOL, V161, P321, DOI 10.1083/jcb.200210130; Zhang XC, 2008, MOL PLANT, V1, P1036, DOI 10.1093/mp/ssn056; Zhang XC, 2009, PLANT J, V57, P146, DOI 10.1111/j.1365-313X.2008.03677.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	70	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9408	10.1371/journal.pone.0009408	http://dx.doi.org/10.1371/journal.pone.0009408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195524	Green Published, gold			2022-12-27	WOS:000274924200028
J	Miyamoto-Sato, E; Fujimori, S; Ishizaka, M; Hirai, N; Masuoka, K; Saito, R; Ozawa, Y; Hino, K; Washio, T; Tomita, M; Yamashita, T; Oshikubo, T; Akasaka, H; Sugiyama, J; Matsumoto, Y; Yanagawa, H				Miyamoto-Sato, Etsuko; Fujimori, Shigeo; Ishizaka, Masamichi; Hirai, Naoya; Masuoka, Kazuyo; Saito, Rintaro; Ozawa, Yosuke; Hino, Katsuya; Washio, Takanori; Tomita, Masaru; Yamashita, Tatsuhiro; Oshikubo, Tomohiro; Akasaka, Hidetoshi; Sugiyama, Jun; Matsumoto, Yasuo; Yanagawa, Hiroshi			A Comprehensive Resource of Interacting Protein Regions for Refining Human Transcription Factor Networks	PLOS ONE			English	Article							IN-VITRO SELECTION; FUNCTIONAL-ANALYSIS; INTRINSIC DISORDER; BINDING PROTEINS; INTERACTION MAP; HUB PROTEINS; C-ELEGANS; TGF-BETA; YEAST; COMPLEXES	Large-scale data sets of protein-protein interactions (PPIs) are a valuable resource for mapping and analysis of the topological and dynamic features of interactome networks. The currently available large-scale PPI data sets only contain information on interaction partners. The data presented in this study also include the sequences involved in the interactions (i.e., the interacting regions, IRs) suggested to correspond to functional and structural domains. Here we present the first large-scale IR data set obtained using mRNA display for 50 human transcription factors (TFs), including 12 transcription-related proteins. The core data set (966 IRs; 943 PPIs) displays a verification rate of 70%. Analysis of the IR data set revealed the existence of IRs that interact with multiple partners. Furthermore, these IRs were preferentially associated with intrinsic disorder. This finding supports the hypothesis that intrinsically disordered regions play a major role in the dynamics and diversity of TF networks through their ability to structurally adapt to and bind with multiple partners. Accordingly, this domain-based interaction resource represents an important step in refining protein interactions and networks at the domain level and in associating network analysis with biological structure and function.	[Miyamoto-Sato, Etsuko; Fujimori, Shigeo; Hirai, Naoya; Masuoka, Kazuyo; Hino, Katsuya; Yanagawa, Hiroshi] Keio Univ, Adv Res Ctr, Yokohama, Kanagawa 223, Japan; [Miyamoto-Sato, Etsuko; Ishizaka, Masamichi; Hino, Katsuya; Washio, Takanori; Yamashita, Tatsuhiro; Oshikubo, Tomohiro; Akasaka, Hidetoshi; Sugiyama, Jun; Matsumoto, Yasuo; Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Saito, Rintaro; Tomita, Masaru] Keio Univ, Dept Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Ozawa, Yosuke] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Yamashita, Tatsuhiro] Fujitsu Ltd, BioIT Business Dev Unit, Chiba, Japan; [Oshikubo, Tomohiro; Akasaka, Hidetoshi] Fujitsu Adv Engn Ltd, Solut & Serv Dept, Prod Solut Div, Prod Solut Business Unit, Tokyo, Japan; [Sugiyama, Jun] Invitrogen Japan KK, Haneda Labs, Custom Primer Prod Dept, Special Suite Team, Tokyo, Japan; [Matsumoto, Yasuo] QIAGEN KK, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; Fujitsu Ltd; Fujitsu Ltd	Miyamoto-Sato, E (corresponding author), Keio Univ, Adv Res Ctr, Yokohama, Kanagawa 223, Japan.	nekoneko@educ.cc.keio.ac.jp; hyana@bio.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding was received from the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There is no other funder in the study.	Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garza AS, 2009, LIFE SCI, V84, P189, DOI 10.1016/j.lfs.2008.12.002; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hakes L, 2008, NAT BIOTECHNOL, V26, P69, DOI 10.1038/nbt0108-69; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Miyamoto-Sato E, 2000, NUCLEIC ACIDS RES, V28, P1176, DOI 10.1093/nar/28.5.1176; Miyamoto-Sato E, 2006, J DRUG TARGET, V14, P505, DOI 10.1080/10611860600845017; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Park J, 2001, J MOL BIOL, V307, P929, DOI 10.1006/jmbi.2001.4526; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; UVERSKY VN, 2008, ANNU REV BIOPHYS, V215, P246; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	57	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9289	10.1371/journal.pone.0009289	http://dx.doi.org/10.1371/journal.pone.0009289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195357	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924200002
J	Gjuvsland, AB; Plahte, E; Adnoy, T; Omholt, SW				Gjuvsland, Arne B.; Plahte, Erik; Adnoy, Tormod; Omholt, Stig W.			Allele Interaction - Single Locus Genetics Meets Regulatory Biology	PLOS ONE			English	Article							DOSAGE COMPENSATION; MOLECULAR-BASIS; AUTOREGULATION; TRANSCRIPTION; EXPRESSION; NETWORKS; MODEL; ANEUPLOIDY; EFFICIENCY; STABILITY	Background: Since the dawn of genetics, additive and dominant gene action in diploids have been defined by comparison of heterozygote and homozygote phenotypes. However, these definitions provide little insight into the underlying intralocus allelic functional dependency and thus cannot serve directly as a mediator between genetics theory and regulatory biology, a link that is sorely needed. Methodology/Principal Findings: We provide such a link by distinguishing between positive, negative and zero allele interaction at the genotype level. First, these distinctions disclose that a biallelic locus can display 18 qualitatively different allele interaction sign motifs (triplets of +,- and 0). Second, we show that for a single locus, Mendelian dominance is not related to heterozygote allele interaction alone, but is actually a function of the degrees of allele interaction in all the three genotypes. Third, we demonstrate how the allele interaction in each genotype is directly quantifiable in gene regulatory models, and that there is a unique, one-to-one correspondence between the sign of autoregulatory feedback loops and the sign of the allele interactions. Conclusion/Significance: The concept of allele interaction refines single locus genetics substantially, and it provides a direct link between classical models of gene action and gene regulatory biology. Together with available empirical data, our results indicate that allele interaction can be exploited experimentally to identify and explain intricate intra- and inter-locus feedback relationships in eukaryotes.	[Gjuvsland, Arne B.; Plahte, Erik] Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway; [Adnoy, Tormod; Omholt, Stig W.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Gjuvsland, AB (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, Ctr Integrat Genet CIGENE, As, Norway.	stig.omholt@umb.no		Gjuvsland, Arne/0000-0002-4391-3411	National Program for Research in Functional Genomics in Norway (FUGE) [NFR151924/S10]; Norwegian eScience program (eVITA) [NFR178901/V30]	National Program for Research in Functional Genomics in Norway (FUGE); Norwegian eScience program (eVITA)	This study was supported by the National Program for Research in Functional Genomics in Norway (FUGE) (RCN grant no. NFR151924/S10) and by the Norwegian eScience program (eVITA) (RCN grant no. NFR178901/V30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman E, 1998, PROG NUCLEIC ACID RE, V60, P133, DOI 10.1016/S0079-6603(08)60892-2; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Blanchard EM, 1997, CIRC RES, V81, P1005; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; CABRERA CV, 1984, J MOL BIOL, V174, P85, DOI 10.1016/0022-2836(84)90366-8; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; CHEVERUD JM, 1995, GENETICS, V139, P1455; Davidson EH, 2006, REG GEN GEN REG; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-57; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-32; Gove P. B., 2002, WEBSTERS 3 NEW INT D; Guidi CJ, 2004, J BIOL CHEM, V279, P4180, DOI 10.1074/jbc.M312043200; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hoogendoorn B, 2003, HUM MOL GENET, V12, P2249, DOI 10.1093/hmg/ddg246; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Johnson NA, 2001, GENETICA, V112, P45, DOI 10.1023/A:1013371201773; KACSER H, 1981, GENETICS, V97, P639; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lynch M., 1998, GENETICS ANAL QUANTI; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Minamisawa S, 1999, J BIOL CHEM, V274, P10066, DOI 10.1074/jbc.274.15.10066; Omholt SW, 2000, GENETICS, V155, P969; OMHOLT SW, 1994, J THEOR BIOL, V168, P231, DOI 10.1006/jtbi.1994.1103; OMHOLT SW, 2006, BIOL DOMINANCE GEORG; Peccoud J, 2004, GENETICS, V166, P1715, DOI 10.1534/genetics.166.4.1715; Peng J, 2005, RNA, V11, P958, DOI 10.1261/rna.2020805; Prescott K, 2005, HUM GENET, V116, P486, DOI 10.1007/s00439-005-1274-3; Rajasingh H, 2008, GENETICS, V179, P1113, DOI 10.1534/genetics.108.087064; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Thomas R., 1990, BIOL FEEDBACK; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Trieu M, 2003, DEVELOPMENT, V130, P111, DOI 10.1242/dev.00194; Wang J, 1999, J MOL BIOL, V286, P315, DOI 10.1006/jmbi.1998.2489; Wang KLC, 1998, MOL CELL BIOL, V18, P4368, DOI 10.1128/MCB.18.7.4368; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; WARMKE J, 1992, J CELL BIOL, V119, P1523, DOI 10.1083/jcb.119.6.1523; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan Z, 2009, GENETICS, V182, P623, DOI 10.1534/genetics.109.103036	56	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9379	10.1371/journal.pone.0009379	http://dx.doi.org/10.1371/journal.pone.0009379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186347	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924000020
J	Shin, YJ; Nourani, M				Shin, Yong-Jun; Nourani, Mehrdad			Statecharts for Gene Network Modeling	PLOS ONE			English	Article							REGULATORY NETWORKS; FEEDFORWARD LOOP; SYNTHETIC BIOLOGY; INPUT FUNCTIONS; EXPRESSION; SYSTEMS; MOTIFS; LOGIC	State diagrams (stategraphs) are suitable for describing the behavior of dynamic systems. However, when they are used to model large and complex systems, determining the states and transitions among them can be overwhelming, due to their flat, unstratified structure. In this article, we present the use of statecharts as a novel way of modeling complex gene networks. Statecharts extend conventional state diagrams with features such as nested hierarchy, recursion, and concurrency. These features are commonly utilized in engineering for designing complex systems and can enable us to model complex gene networks in an efficient and systematic way. We modeled five key gene network motifs, simple regulation, autoregulation, feed-forward loop, single-input module, and dense overlapping regulon, using statecharts. Specifically, utilizing nested hierarchy and recursion, we were able to model a complex interlocked feed-forward loop network in a highly structured way, demonstrating the potential of our approach for modeling large and complex gene networks.	[Shin, Yong-Jun; Nourani, Mehrdad] Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Shin, YJ (corresponding author), Univ Texas Dallas, Dept Elect Engn, Richardson, TX 75083 USA.	yshin@utdallas.edu						Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Batt G, 2005, BIOINFORMATICS, V21, pI19, DOI 10.1093/bioinformatics/bti1048; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2008, COMPUTATIONAL MODELI; BROWN S, 2005, FUNDAMENTALS DIGITAL; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cuccato G, 2009, HEREDITY, V102, P527, DOI 10.1038/hdy.2009.18; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Endler L, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0035.focus; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Hetherington JPJ, 2006, J R SOC INTERFACE, V3, P319, DOI 10.1098/rsif.2005.0101; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; KOHANE IS, 2005, MICROARRAYS INTEGRAT; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Sahoo D, 2007, NUCLEIC ACIDS RES, V35, P3705, DOI 10.1093/nar/gkm284; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schilstra MJ, 2008, ARTIF LIFE, V14, P121, DOI 10.1162/artl.2008.14.1.121; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P1319, DOI 10.1093/bioinformatics/18.10.1319; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Smolen P, 2000, B MATH BIOL, V62, P247, DOI 10.1006/bulm.1999.0155; Steggles LJ, 2007, BIOINFORMATICS, V23, P336, DOI 10.1093/bioinformatics/btl596; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Wu FX, 2008, INT J DATA MIN BIOIN, V2, P1, DOI 10.1504/IJDMB.2008.016753; Yuh Chiou-Hwa, 2001, P73	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9376	10.1371/journal.pone.0009376	http://dx.doi.org/10.1371/journal.pone.0009376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186343	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924000017
J	D'Amato, M; Zucchelli, M; Seddighzadeh, M; Anedda, F; Lindblad, S; Kere, J; Alfredsson, L; Klareskog, L; Padyukov, L				D'Amato, Mauro; Zucchelli, Marco; Seddighzadeh, Maria; Anedda, Francesca; Lindblad, Staffan; Kere, Juha; Alfredsson, Lars; Klareskog, Lars; Padyukov, Leonid			Analysis of Neuropeptide S Receptor Gene (NPSR1) Polymorphism in Rheumatoid Arthritis	PLOS ONE			English	Article							ASSOCIATION; SUSCEPTIBILITY; POPULATION; DISEASE; LOCUS; 6Q23; RISK	Background: Polymorphism in the neuropeptide S receptor gene NPSR1 is associated with asthma and inflammatory bowel disease. NPSR1 is expressed in the brain, where it modulates anxiety and responses to stress, but also in other tissues and cell types including lymphocytes, the lungs, and the intestine, where it appears to be up-regulated in inflammation. We sought to determine whether genetic variability at the NPSR1 locus influences the susceptibility and clinical manifestation of rheumatoid arthritis (RA). Methodology/Principal Findings: From the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study, 1,888 rheumatoid arthritis patients and 888 controls were genotyped for 19 single-nucleotide polymorphisms (SNPs) spanning the entire NPSR1 gene and 220 KB of DNA on chromosome 7p14. The association between individual genetic markers and their haplotypic combinations, respectively, and diagnosis of RA, presence of autoantibodies to citrullinated proteins (ACPA), and disease activity score based on 28 joints (DAS28) was tested. There was no association between diagnosis of RA and NPSR1 variants. However, several associations of nominal significance were detected concerning susceptibility to ACPA-negative RA and disease activity measures (DAS28). Among these, the association of SNP rs324987 with ACPA-negative RA [(p = 0.004, OR = 0.674 (95% CI 0.512-0.888)] and that of SNP rs10263447 with DAS28 [p = 0.0002, OR = 0.380 (95% CI 0.227-0.635)] remained significant after correction for multiple comparisons. Conclusions/Significance: NPSR1 polymorphism may be relevant to RA susceptibility and its clinical manifestation. Specific alleles at the NPSR1 locus may represent common risk factors for chronic inflammatory diseases, including RA.	[D'Amato, Mauro; Zucchelli, Marco; Anedda, Francesca; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, S-10401 Stockholm, Sweden; [Seddighzadeh, Maria; Lindblad, Staffan; Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, S-10401 Stockholm, Sweden; [Anedda, Francesca] CNR, Inst Neurogenet & Neuropharmacol, Monserrato, Italy; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Consiglio Nazionale delle Ricerche (CNR); Karolinska Institutet	D'Amato, M (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-10401 Stockholm, Sweden.	leonid.padyukov@ki.se	D'Amato, Mauro/B-5050-2019; Alfredsson, Lars/AAC-9007-2019; D'Amato, Mauro/F-2450-2010; Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021; Padyukov, Leonid/A-4890-2009	D'Amato, Mauro/0000-0003-2743-5197; Alfredsson, Lars/0000-0003-1688-6697; D'Amato, Mauro/0000-0003-2743-5197; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Padyukov, Leonid/0000-0003-2950-5670; Klareskog, Lars/0000-0001-9601-6186	Swedish Medical Research Council; Swedish Rheumatism Foundation; AFA Insurance; National Institutes of Allergy and Infectious Diseases [AI067152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Rheumatism Foundation; AFA Insurance; National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Swedish Medical Research Council, the Swedish Rheumatism Foundation, AFA Insurance, and the National Institutes of Allergy and Infectious Diseases (AI067152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Feng Y, 2006, J ALLERGY CLIN IMMUN, V117, P612, DOI 10.1016/j.jaci.2005.11.045; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Pulkkinen V, 2006, HUM MOL GENET, V15, P1667, DOI 10.1093/hmg/ddl090; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Reinscheid Rainer K., 2008, V46, P145, DOI 10.1007/400_2007_051; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; van der Helm-van Mil AHM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2384; Vendelin J, 2006, HUM MOL GENET, V15, P2923, DOI 10.1093/hmg/ddl234; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302	19	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9315	10.1371/journal.pone.0009315	http://dx.doi.org/10.1371/journal.pone.0009315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179762	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900004
J	Pan, RK; Chatterjee, N; Sinha, S				Pan, Raj Kumar; Chatterjee, Nivedita; Sinha, Sitabhra			Mesoscopic Organization Reveals the Constraints Governing Caenorhabditis elegans Nervous System	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SMALL-WORLD; HIERARCHICAL ORGANIZATION; MODULAR ORGANIZATION; CONNECTIVITY; NETWORKS; INTEGRATION; NEMATODE; OPTIMIZATION; CENTRALITY	One of the biggest challenges in biology is to understand how activity at the cellular level of neurons, as a result of their mutual interactions, leads to the observed behavior of an organism responding to a variety of environmental stimuli. Investigating the intermediate or mesoscopic level of organization in the nervous system is a vital step towards understanding how the integration of micro-level dynamics results in macro-level functioning. The coordination of many different co-occurring processes at this level underlies the command and control of overall network activity. In this paper, we have considered the somatic nervous system of the nematode Caenorhabditis elegans, for which the entire neuronal connectivity diagram is known. We focus on the organization of the system into modules, i.e., neuronal groups having relatively higher connection density compared to that of the overall network. We show that this mesoscopic feature cannot be explained exclusively in terms of considerations such as, optimizing for resource constraints (viz., total wiring cost) and communication efficiency (i.e., network path length). Even including information about the genetic relatedness of the cells cannot account for the observed modular structure. Comparison with other complex networks designed for efficient transport (of signals or resources) implies that neuronal networks form a distinct class. This suggests that the principal function of the network, viz., processing of sensory information resulting in appropriate motor response, may be playing a vital role in determining the connection topology. Using modular spectral analysis we make explicit the intimate relation between function and structure in the nervous system. This is further brought out by identifying functionally critical neurons purely on the basis of patterns of intra-and inter-modular connections. Our study reveals how the design of the nervous system reflects several constraints, including its key functional role as a processor of information.	[Pan, Raj Kumar; Sinha, Sitabhra] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Chatterjee, Nivedita] Sankara Nethralaya, Vis Res Fdn, Madras, Tamil Nadu, India	Institute of Mathematical Sciences (IMSc) India	Pan, RK (corresponding author), Inst Math Sci, Madras 600113, Tamil Nadu, India.	sitabhra@imsc.res.in	Pan, Raj Kumar/B-4352-2010	Pan, Raj Kumar/0000-0001-9803-6332; Sinha, Sitabhra/0000-0002-3004-1079	Complex Systems Project (XI Plan); Department of Atomic Energy, Government of India	Complex Systems Project (XI Plan); Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was funded by the Complex Systems Project (XI Plan), Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2006, PHYSICA A, V367, P531, DOI 10.1016/j.physa.2005.12.013; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arenas A, 2008, LECT NOTES COMPUT SC, V5151, P9; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bany IA, 2003, J NEUROSCI, V23, P8060; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cancho RFI, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046119; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Costa LD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-16; Daniels SA, 2000, GENETICS, V156, P123; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; Ferrarini L, 2009, HUM BRAIN MAPP, V30, P2220, DOI 10.1002/hbm.20663; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.017101; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hobert O, 2005, SPECIFICATION NERVOU; HOFMAN MA, 1988, BRAIN BEHAV EVOLUT, V32, P17, DOI 10.1159/000116529; Horwitz B, 1995, NEUROREPORT, V6, P2287, DOI 10.1097/00001756-199511270-00005; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Itzkovitz S, 2008, P NATL ACAD SCI USA, V105, P9278, DOI 10.1073/pnas.0712207105; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kim BJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045101; Klemm K, 2005, P NATL ACAD SCI USA, V102, P18414, DOI 10.1073/pnas.0509132102; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Kuncheva LI, 2004, IEEE SYS MAN CYBERN, P1214; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Morris R., 2007, HIPPOCAMPUS BOOK; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045103; Pan RK, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/68006; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Perez-Escudero A, 2007, P NATL ACAD SCI USA, V104, P17180, DOI 10.1073/pnas.0703183104; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; RIDDLE DL, C ELEGANS, V2; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Sawin E. R., 1996, THESIS MIT CAMBRIDGE; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCANNELL JW, 1995, J NEUROSCI, V15, P1463; Schnabel R, 1997, SEMIN CELL DEV BIOL, V8, P341, DOI 10.1006/scdb.1997.0158; Schwarz AJ, 2008, MAGN RESON IMAGING, V26, P914, DOI 10.1016/j.mri.2008.01.048; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; SHEPHERD GM, SYNAPTIC ORG BRAIN; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wicks SR, 1996, J COMP PHYSIOL A, V179, P675, DOI 10.1007/BF00216131; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	85	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9240	10.1371/journal.pone.0009240	http://dx.doi.org/10.1371/journal.pone.0009240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179757	Green Submitted, Green Published, gold			2022-12-27	WOS:000274923900002
J	Snyder, BR; Chiu, AM; Prockop, DJ; Chan, AWS				Snyder, Brooke R.; Chiu, Andrew M.; Prockop, Darwin J.; Chan, Anthony W. S.			Human Multipotent Stromal Cells (MSCs) Increase Neurogenesis and Decrease Atrophy of the Striatum in a Transgenic Mouse Model for Huntington's Disease	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; STEM/PROGENITOR CELLS; SUBEPENDYMAL LAYER; ACID; TRANSPLANTATION; MICROSPHERES; PROGENITORS; NEURONS; REPAIR	Background: Implantation of human multipotent stromal cells from bone marrow (hMSCs) into the dentate gyrus of the hippocampus of mice was previously shown to stimulate proliferation, migration and neural differentiation of endogenous neural stem cells. We hypothesized that hMSCs would be beneficial in a mouse model of Huntington disease (HD) due to these neurogenic effects. Results: We implanted hMSCs into the striatum of transgenic mice (N171-82Q) that are a model for HD. The implanted hMSCs rapidly disappeared over 3 to 15 days. However, they increased proliferation and neural differentiation of endogenous neural stem cells for up to 30 days. They also increased neurotrophic signaling and decreased atrophy of the striatum in 3-month old HD mice implanted with hMSCs one month earlier. Conclusions: The results therefore suggested that neural implantation of hMSCs may be of benefit in HD but a number of parameters of dose, treatment schedule, and route of administration need to be optimized.	[Snyder, Brooke R.; Chiu, Andrew M.; Chan, Anthony W. S.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Snyder, Brooke R.; Prockop, Darwin J.] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70118 USA	Emory University; Tulane University	Snyder, BR (corresponding author), Yerkes Natl Primate Res Ctr, Atlanta, GA USA.	Prockop@medicine.tamhsc.edu; awchan@emory.edu			National Center for Research Resources (NCRR)/National Institutes of Health (NIH) [RR-00165, RR018827]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018827, P51RR000165] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Center for Research Resources (NCRR)/National Institutes of Health (NIH) grants RR-00165 and RR018827. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista CMC, 2006, J NEUROSCI, V26, P10452, DOI 10.1523/JNEUROSCI.2850-06.2006; Bjugstad KB, 2001, J INHERIT METAB DIS, V24, P631, DOI 10.1023/A:1012706908779; Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Curtis MA, 2005, NEUROSCIENCE, V132, P777, DOI 10.1016/j.neuroscience.2004.12.051; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dezawa M, 2008, MED MOL MORPHOL, V41, P14, DOI 10.1007/s00795-007-0389-0; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Emerich DF, 1998, CELL TRANSPLANT, V7, P213, DOI 10.1016/S0963-6897(97)00163-2; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gouhier C, 2000, NEUROSCI LETT, V288, P71, DOI 10.1016/S0304-3940(00)01172-1; Hardy SA, 2008, CURR STEM CELL RES T, V3, P43; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Joel D, 2001, MOVEMENT DISORD, V16, P407, DOI 10.1002/mds.1096; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lescaudron L, 2003, INT J NEUROSCI, V113, P945, DOI 10.1080/00207450390207759; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; MYERS RH, 1982, NEW ENGL J MED, V307, P561; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; OWEN M, 1988, CIBA F SYMP, V136, P42; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Tattersfield AS, 2004, NEUROSCIENCE, V127, P319, DOI 10.1016/j.neuroscience.2004.04.061; Vassos E, 2007, BIOL PSYCHIAT, V62, P1347, DOI 10.1016/j.biopsych.2006.12.016; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975	36	65	68	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9347	10.1371/journal.pone.0009347	http://dx.doi.org/10.1371/journal.pone.0009347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179764	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923900013
J	Nougairede, A; Ninove, L; Zandotti, C; de Lamballerie, X; Gazin, C; Drancourt, M; La Scola, B; Raoult, D; Charrel, RN				Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; de Lamballerie, Xavier; Gazin, Celine; Drancourt, Michel; La Scola, Bernard; Raoult, Didier; Charrel, Remi N.			Point of Care Strategy for Rapid Diagnosis of Novel A/H1N1 Influenza Virus	PLOS ONE			English	Article							INFECTIONS	Background: Within months of the emergence of the novel A/H1N1 pandemic influenza virus (nA/H1N1v), systematic screening for the surveillance of the pandemic was abandoned in France and in some other countries. At the end of June 2009, we implemented, for the public hospitals of Marseille, a Point Of Care (POC) strategy for rapid diagnosis of the novel A/H1N1 influenza virus, in order to maintain local surveillance and to evaluate locally the kinetics of the pandemic. Methodology/Principal Findings: Two POC laboratories, located in strategic places, were organized to receive and test samples 24 h/24. POC strategy consisted of receiving and processing naso-pharyngeal specimens in preparation for the rapid influenza diagnostic test (RIDT) and real-time RT-PCR assay (rtRT-PCR). This strategy had the theoretical capacity of processing up to 36 samples per 24 h. When the flow of samples was too high, the rtRT-PCR test was abandoned in the POC laboratories and transferred to the core virology laboratory. Confirmatory diagnosis was performed in the core virology laboratory twice a day using two distinct rtRT-PCR techniques that detect either influenza A virus or nA/N1N1v. Over a period of three months, 1974 samples were received in the POC laboratories, of which 111 were positive for nA/H1N1v. Specificity and sensitivity of RIDT were 100%, and 57.7% respectively. Positive results obtained using RIDT were transmitted to clinical practitioners in less than 2 hours. POC processed rtRT-PCR results were available within 7 hours, and rtRT-PCR confirmation within 24 hours. Conclusions/Significance: The POC strategy is of benefit, in all cases (with or without rtRT-PCR assay), because it provides continuous reception/processing of samples and reduction of the time to provide consolidated results to the clinical practitioners. We believe that implementation of the POC strategy for the largest number of suspect cases may improve the quality of patient care and our knowledge of the epidemiology of the pandemic.	[Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; de Lamballerie, Xavier; Gazin, Celine; Drancourt, Michel; La Scola, Bernard; Raoult, Didier; Charrel, Remi N.] Assistance Publ Hop Marseille, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; de Lamballerie, Xavier; Charrel, Remi N.] Univ Mediterranee, UMR Emergence Pathol Virales 190, Unite Virus Emergents, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; de Lamballerie, Xavier; Charrel, Remi N.] Inst Rech Dev, Marseille, France; [Drancourt, Michel; La Scola, Bernard; Raoult, Didier] Univ Mediterranee, Unite Rech Malad Infect & Trop Emergentes, UMR 6236, CNRS,Fac Med,IFR 48,IRD 3R198, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Nougairede, A (corresponding author), Assistance Publ Hop Marseille, Marseille, France.	remi.charrel@univmed.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital [228292]	AP-HM Public Hospital	This study was partly funded by AP-HM Public Hospital system and by the FP7 European project n<SUP>o</SUP>228292 European Virus Archive (EVA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgian working group on influenza A(H1N1), 2009, EUROSURVEILLANCE, V14; Enserink M, 2009, SCIENCE, V323, P700, DOI 10.1126/science.323.5915.700; Follin P, 2009, EUROSURVEILLANCE, V14; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; LEVYBRUHL D, 2009, EURO SURVEILL, V14; Lytras T, 2009, EUROSURVEILLANCE, V14, P6; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NINOVE L, 2009, VECTOR BORNE ZOONOTI; NINOVE L, 2009, CLIN MICROB IN PRESS; Raoult D, 2004, NAT REV MICROBIOL, V2, P151, DOI 10.1038/nrmicro820; Rizzo C, 2009, EURO SURVEILL, V14; *VS I, 2009, B EP GRIPP A H1N1 20; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; World Health Organization, 2009, COMMUNICATION	16	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9215	10.1371/journal.pone.0009215	http://dx.doi.org/10.1371/journal.pone.0009215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174646	gold, Green Submitted, Green Published			2022-12-27	WOS:000274590600007
J	Al Tanoury, Z; Schaffner-Reckinger, E; Halavatyi, A; Hoffmann, C; Moes, M; Hadzic, E; Catillon, M; Yatskou, M; Friederich, E				Al Tanoury, Ziad; Schaffner-Reckinger, Elisabeth; Halavatyi, Aliaksandr; Hoffmann, Celine; Moes, Michele; Hadzic, Ermin; Catillon, Marie; Yatskou, Mikalai; Friederich, Evelyne			Quantitative Kinetic Study of the Actin-Bundling Protein L-Plastin and of Its Impact on Actin Turn-Over	PLOS ONE			English	Article							FILAMENT CROSS-LINKING; KINASE-C ISOZYMES; F-ACTIN; HUMAN NEUTROPHILS; NEOPLASTIC-CELLS; PHORBOL ESTER; SMOOTH-MUSCLE; CANCER-CELLS; IN-VITRO; PHOSPHORYLATION	Background: Initially detected in leukocytes and cancer cells derived from solid tissues, L-plastin/fimbrin belongs to a large family of actin crosslinkers and is considered as a marker for many cancers. Phosphorylation of L-plastin on residue Ser5 increases its F-actin binding activity and is required for L-plastin-mediated cell invasion. Methodology/Principal Findings: To study the kinetics of L-plastin and the impact of L-plastin Ser5 phosphorylation on L-plastin dynamics and actin turn-over in live cells, simian Vero cells were transfected with GFP-coupled WT-L-plastin, Ser5 substitution variants (S5/A, S5/E) or actin and analyzed by fluorescence recovery after photobleaching (FRAP). FRAP data were explored by mathematical modeling to estimate steady-state reaction parameters. We demonstrate that in Vero cell focal adhesions L-plastin undergoes rapid cycles of association/dissociation following a two-binding-state model. Phosphorylation of L-plastin increased its association rates by two-fold, whereas dissociation rates were unaffected. Importantly, L-plastin affected actin turn-over by decreasing the actin dissociation rate by four-fold, increasing thereby the amount of F-actin in the focal adhesions, all these effects being promoted by Ser5 phosphorylation. In MCF-7 breast carcinoma cells, phorbol 12-myristate 13-acetate (PMA) treatment induced L-plastin translocation to de novo actin polymerization sites in ruffling membranes and spike-like structures and highly increased its Ser5 phosphorylation. Both inhibition studies and siRNA knock-down of PKC isozymes pointed to the involvement of the novel PKC-delta isozyme in the PMA-elicited signaling pathway leading to L-plastin Ser5 phosphorylation. Furthermore, the L-plastin contribution to actin dynamics regulation was substantiated by its association with a protein complex comprising cortactin, which is known to be involved in this process. Conclusions/Significance: Altogether these findings quantitatively demonstrate for the first time that L-plastin contributes to the fine-tuning of actin turn-over, an activity which is regulated by Ser5 phosphorylation promoting its high affinity binding to the cytoskeleton. In carcinoma cells, PKC-delta signaling pathways appear to link L-plastin phosphorylation to actin polymerization and invasion.	[Al Tanoury, Ziad; Schaffner-Reckinger, Elisabeth; Halavatyi, Aliaksandr; Moes, Michele; Hadzic, Ermin; Catillon, Marie; Yatskou, Mikalai; Friederich, Evelyne] Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Luxembourg, Luxembourg; [Hoffmann, Celine] Publ Res Ctr Hlth CRP Sante, Plant Mol Biol Lab, Strassen, Luxembourg	University of Luxembourg; Luxembourg Institute of Health	Al Tanoury, Z (corresponding author), Univ Luxembourg, Life Sci Res Unit, Lab Cytoskeleton & Cell Plast, Luxembourg, Luxembourg.	Evelyne.Friederich@uni.lu	Hoffmann, Céline/F-3741-2016	Hoffmann, Céline/0000-0002-7564-2329	Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg; Fonds National de la Recherche, Luxembourg; Human Frontier Science Program [RGP0058/2005]	Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg; Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); Human Frontier Science Program(Human Frontier Science Program)	Funding: Ziad Al Tanoury, Aliaksandr Halavatyi and Ermin Hadzic were supported by fellowships from the Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg, and from the Fonds National de la Recherche, Luxembourg. This work was supported by a grant of the Human Frontier Science Program (RGP0058/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; ARPIN M, 1994, J CELL BIOL, V127, P1995, DOI 10.1083/jcb.127.6.1995; Babb SG, 1997, CELL MOTIL CYTOSKEL, V37, P308; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DELANOTE V, 2009, FASEB J; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Friederich E, 1999, J BIOL CHEM, V274, P26751, DOI 10.1074/jbc.274.38.26751; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GOLDSTEIN D, 1985, CANCER RES, V45, P5643; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hiroyama M, 2005, J CELL PHYSIOL, V202, P608, DOI 10.1002/jcp.20156; Hofmann WA, 2006, J CELL BIOL, V172, P495, DOI 10.1083/jcb.200601095; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; JANJI B, 2009, J CELL MOL MED; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Jones SL, 1996, J BIOL CHEM, V271, P14623, DOI 10.1074/jbc.271.24.14623; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Klemke M, 2007, INT J CANCER, V120, P2590, DOI 10.1002/ijc.22589; Lacroix M, 2004, ONCOL REP, V12, P701; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapillonne A, 2000, ANTICANCER RES, V20, P3177; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lebart MC, 2004, BIOCHEMISTRY-US, V43, P2428, DOI 10.1021/bi030151p; Lee SO, 2008, BIOCHEM BIOPH RES CO, V366, P1019, DOI 10.1016/j.bbrc.2007.12.068; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; LIN CS, 1993, J BIOL CHEM, V268, P2793; LIN CS, 1993, J BIOL CHEM, V268, P2781; Lin CS, 1998, DNA CELL BIOL, V17, P1041, DOI 10.1089/dna.1998.17.1041; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; MESSIER JM, 1993, CELL MOTIL CYTOSKEL, V25, P223, DOI 10.1002/cm.970250303; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Paclet MH, 2004, BIOCHEM J, V377, P469, DOI 10.1042/BJ20031114; PARK TS, 1994, CANCER RES, V54, P1775; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; SHINOMIYA H, 1995, J IMMUNOL, V154, P3471; SHIROO M, 1990, Cytokine, V2, P13, DOI 10.1016/1043-4666(90)90038-U; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; TONEGUZZO F, 1986, MOL CELL BIOL, V6, P703, DOI 10.1128/MCB.6.2.703; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang J, 1999, J BIOL CHEM, V274, P24349, DOI 10.1074/jbc.274.34.24349; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Woodsome TP, 2001, J PHYSIOL-LONDON, V535, P553, DOI 10.1111/j.1469-7793.2001.t01-1-00553.x; Zhou LY, 1996, J INVEST DERMATOL, V107, P248, DOI 10.1111/1523-1747.ep12329733	59	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9210	10.1371/journal.pone.0009210	http://dx.doi.org/10.1371/journal.pone.0009210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169155	Green Published, gold			2022-12-27	WOS:000274474700008
J	Gupta, V; Gupta, RK; Khare, G; Salunke, DM; Surolia, A; Tyagi, AK				Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Salunke, Dinakar M.; Surolia, Avadhesha; Tyagi, Anil K.			Structural Ordering of Disordered Ligand-Binding Loops of Biotin Protein Ligase into Active Conformations as a Consequence of Dehydration	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURES; DIFFRACTION; CARBOXYLASE; SPECIFICITY; DOMAINS; CRYSTALLIZATION; BIOTINYLATION; DIMERIZATION; RESOLUTION	Mycobacterium tuberculosis (Mtb), a dreaded pathogen, has a unique cell envelope composed of high fatty acid content that plays a crucial role in its pathogenesis. Acetyl Coenzyme A Carboxylase (ACC), an important enzyme that catalyzes the first reaction of fatty acid biosynthesis, is biotinylated by biotin acetyl-CoA carboxylase ligase (BirA). The ligand-binding loops in all known apo BirAs to date are disordered and attain an ordered structure only after undergoing a conformational change upon ligand-binding. Here, we report that dehydration of Mtb-BirA crystals traps both the apo and active conformations in its asymmetric unit, and for the first time provides structural evidence of such transformation. Recombinant Mtb-BirA was crystallized at room temperature, and diffraction data was collected at 295 K as well as at 120 K. Transfer of crystals to paraffin and paratone-N oil (cryoprotectants) prior to flash-freezing induced lattice shrinkage and enhancement in the resolution of the X-ray diffraction data. Intriguingly, the crystal lattice rearrangement due to shrinkage in the dehydrated Mtb-BirA crystals ensued structural order of otherwise flexible ligand-binding loops L4 and L8 in apo BirA. In addition, crystal dehydration resulted in a shift of similar to 3.5 angstrom in the flexible loop L6, a proline-rich loop unique to Mtb complex as well as around the L11 region. The shift in loop L11 in the C-terminal domain on dehydration emulates the action responsible for the complex formation with its protein ligand biotin carboxyl carrier protein (BCCP) domain of ACCA3. This is contrary to the involvement of loop L14 observed in Pyrococcus horikoshii BirA-BCCP complex. Another interesting feature that emerges from this dehydrated structure is that the two subunits A and B, though related by a noncrystallographic twofold symmetry, assemble into an asymmetric dimer representing the ligand-bound and ligand-free states of the protein, respectively. In-depth analyses of the sequence and the structure also provide answers to the reported lower affinities of Mtb-BirA toward ATP and biotin substrates. This dehydrated crystal structure not only provides key leads to the understanding of the structure/function relationships in the protein in the absence of any ligand-bound structure, but also demonstrates the merit of dehydration of crystals as an inimitable technique to have a glance at proteins in action.	[Gupta, Vibha; Gupta, Rakesh K.; Khare, Garima; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Gupta, Rakesh K.] Univ Delhi, Dept Microbiol, New Delhi, India; [Salunke, Dinakar M.; Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Gupta, V (corresponding author), Univ Delhi, Dept Biochem, New Delhi, India.	aniltyagi@south.du.ac.in			Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	Funding: This work was supported by the financial grants received from the Department of Biotechnology, Government of India. G. K. is grateful to the Council of Scientific and Industrial Research, India, for a fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; Beckett D, 2009, J NUTR, V139, P167, DOI 10.3945/jn.108.095760; Bell JA, 1999, PROTEIN SCI, V8, P2033, DOI 10.1110/ps.8.10.2033; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; Daniel J, 2007, J BACTERIOL, V189, P911, DOI 10.1128/JB.01019-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gupta V, 2008, ACTA CRYSTALLOGR F, V64, P524, DOI 10.1107/S1744309108012475; Harata K, 2007, ACTA CRYSTALLOGR D, V63, P1016, DOI 10.1107/S0907444907031319; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Kuo A, 2003, J STRUCT BIOL, V141, P97, DOI 10.1016/S1047-8477(02)00633-0; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Kwon K, 2000, J MOL BIOL, V304, P821, DOI 10.1006/jmbi.2000.4249; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mukhopadhyay B, 2001, J BACTERIOL, V183, P3804, DOI 10.1128/JB.183.12.3804-3810.2001; Naganathan S, 2007, J MOL BIOL, V373, P96, DOI 10.1016/j.jmb.2007.07.020; Nagendra HG, 1998, PROTEINS, V32, P229, DOI 10.1002/(SICI)1097-0134(19980801)32:2<229::AID-PROT9>3.0.CO;2-F; Parrish NM, 2001, ANTIMICROB AGENTS CH, V45, P1143, DOI 10.1128/AAC.45.4.1143-1150.2001; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Purushothaman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002320; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; SALUNKE DM, 1985, ACTA CRYSTALLOGR B, V41, P431, DOI 10.1107/S0108768185002415; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Vijayalakshmi L, 2008, PROTEINS, V71, P241, DOI 10.1002/prot.21695; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Zhao HY, 2009, J MOL BIOL, V389, P336, DOI 10.1016/j.jmb.2009.04.009	36	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9222	10.1371/journal.pone.0009222	http://dx.doi.org/10.1371/journal.pone.0009222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169168	Green Published, gold			2022-12-27	WOS:000274474700016
J	Spanholtz, J; Tordoir, M; Eissens, D; Preijers, F; van der Meer, A; Joosten, I; Schaap, N; de Witte, TM; Dolstra, H				Spanholtz, Jan; Tordoir, Marleen; Eissens, Diana; Preijers, Frank; van der Meer, Arnold; Joosten, Irma; Schaap, Nicolaas; de Witte, Theo M.; Dolstra, Harry			High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy	PLOS ONE			English	Article							EX-VIVO EXPANSION; NK CELLS; IN-VIVO; BONE-MARROW; STEM-CELLS; TRANSPLANTATION; DIFFERENTIATION; PROGENITORS; MELANOMA; IDENTIFICATION	Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical grade protocols. We established an extremely efficient cytokine-based culture system for ex vivo expansion of NK cells from hematopoietic stem and progenitor cells from umbilical cord blood (UCB). Systematic refinement of this two-step system using a novel clinical grade medium resulted in a therapeutically applicable cell culture protocol. CD56(+)CD3(-) NK cell products could be routinely generated from freshly selected CD34(+) UCB cells with a mean expansion of > 15,000 fold and a nearly 100% purity. Moreover, our protocol has the capacity to produce more than 3-log NK cell expansion from frozen CD34(+) UCB cells. These ex vivo-generated cell products contain NK cell subsets differentially expressing NKG2A and killer immunoglobulin-like receptors. Furthermore, UCB-derived CD56(+) NK cells generated by our protocol uniformly express high levels of activating NKG2D and natural cytotoxicity receptors. Functional analysis showed that these ex vivo-generated NK cells efficiently target myeloid leukemia and melanoma tumor cell lines, and mediate cytolysis of primary leukemia cells at low NK-target ratios. Our culture system exemplifies a major breakthrough in producing pure NK cell products from limited numbers of CD34(+) cells for cancer immunotherapy.	[Spanholtz, Jan; Tordoir, Marleen; Preijers, Frank; de Witte, Theo M.; Dolstra, Harry] Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Schaap, Nicolaas; de Witte, Theo M.] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Lab Med Immunol,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Eissens, Diana] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol,Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Spanholtz, J (corresponding author), Radboud Univ Nijmegen, Hematol Lab, Dept Lab Med, Nijmegen Ctr Mol Life Sci,Med Ctr, NL-6525 ED Nijmegen, Netherlands.	h.dolstra@chl.umcn.nl	Preijers, Frank/L-4586-2015; van der Meer, Arnold/M-1693-2016; de Witte, T.J.M./L-4762-2015; Dolstra, H./L-4276-2015; Schaap, Nicolaas/L-4625-2015; Joosten, Irma/N-4418-2013	van der Meer, Arnold/0000-0001-8274-414X; Dolstra, H./0000-0002-3998-687X; Schaap, Nicolaas/0000-0001-7696-4752; Joosten, Irma/0000-0003-2950-4977; Spanholtz, Jan/0000-0001-7152-6956	Radboud University Nijmegen Medical Centre; Glycostem Therapeutics	Radboud University Nijmegen Medical Centre; Glycostem Therapeutics	Funding: This work was financially supported by the Radboud University Nijmegen Medical Centre and Glycostem Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arai S, 2008, CYTOTHERAPY, V10, P625, DOI 10.1080/14653240802301872; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Cooley S, 2007, BLOOD, V110, P578, DOI 10.1182/blood-2006-07-036228; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Iyengar R, 2003, CYTOTHERAPY, V5, P479, DOI 10.1080/14653240310003558; Kao IT, 2007, STEM CELLS DEV, V16, P1043, DOI 10.1089/scd.2007.0033; Klingemann HG, 2004, CYTOTHERAPY, V6, P15, DOI 10.1080/14653240310004548; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; LOTZOVA E, 1993, J IMMUNOL, V150, P5263; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; Meyer-Monard S, 2009, TRANSFUSION, V49, P362, DOI 10.1111/j.1537-2995.2008.01969.x; MILLER JS, 1992, BLOOD, V80, P2182; MILLER JS, 1994, BLOOD, V83, P2594; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Overes IM, 2008, BRIT J HAEMATOL, V141, P799, DOI 10.1111/j.1365-2141.2008.07125.x; Passweg JR, 2006, BEST PRACT RES CL HA, V19, P811, DOI 10.1016/j.beha.2006.06.004; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Perez SA, 2003, BLOOD, V101, P3444, DOI 10.1182/blood-2002-05-1501; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Punzel M, 1999, LEUKEMIA, V13, P1079, DOI 10.1038/sj.leu.2401432; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Shilling HG, 2003, BLOOD, V101, P3730, DOI 10.1182/blood-2002-08-2568; SIEGLER U, 2008, ASH ANN M, V112, P3893; Vitale C, 2008, INT IMMUNOL, V20, P565, DOI 10.1093/intimm/dxn014; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Yu Y, 2001, J IMMUNOL, V166, P1590, DOI 10.4049/jimmunol.166.3.1590	34	119	130	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9221	10.1371/journal.pone.0009221	http://dx.doi.org/10.1371/journal.pone.0009221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169160	Green Published, gold			2022-12-27	WOS:000274474700015
J	Davis, J; Metzger, JM				Davis, Jennifer; Metzger, Joseph M.			Combinatorial Effects of Double Cardiomyopathy Mutant Alleles in Rodent Myocytes: A Predictive Cellular Model of Myofilament Dysregulation in Disease	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; BINDING-PROTEIN-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; ADULT CARDIAC MYOCYTES; SKELETAL TROPONIN-I; THIN FILAMENT; GENE-TRANSFER; COOPERATIVE INTERACTIONS; MECHANICAL-PROPERTIES; TROPOMYOSIN MICE	Inherited cardiomyopathy (CM) represents a diverse group of cardiac muscle diseases that present with a broad spectrum of symptoms ranging from benign to highly malignant. Contributing to this genetic complexity and clinical heterogeneity is the emergence of a cohort of patients that are double or compound heterozygotes who have inherited two different CM mutant alleles in the same or different sarcomeric gene. These patients typically have early disease onset with worse clinical outcomes. Little experimental attention has been directed towards elucidating the physiologic basis of double CM mutations at the cellular-molecular level. Here, dual gene transfer to isolated adult rat cardiac myocytes was used to determine the primary effects of co-expressing two different CM-linked mutant proteins on intact cardiac myocyte contractile physiology. Dual expression of two CM mutants, that alone moderately increase myofilament activation, tropomyosin mutant A63V and cardiac troponin mutant R146G, were shown to additively slow myocyte relaxation beyond either mutant studied in isolation. These results were qualitatively similar to a combination of moderate and strong activating CM mutant alleles aTmA63V and cTnI R193H, which approached a functional threshold. Interestingly, a combination of a CM myofilament deactivating mutant, troponin C G159D, together with an activating mutant, cTnIR193H, produced a hybrid phenotype that blunted the strong activating phenotype of cTnIR193H alone. This is evidence of neutralizing effects of activating/deactivating mutant alleles in combination. Taken together, this combinatorial mutant allele functional analysis lends molecular insight into disease severity and forms the foundation for a predictive model to deconstruct the myriad of possible CM double mutations in presenting patients.	[Davis, Jennifer; Metzger, Joseph M.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Davis, J (corresponding author), Childrens Hosp, Med Ctr, Dept Mol Cardiovasc Biol, Cincinnati, OH 45229 USA.	metzgerj@umn.edu		DAVIS, JENNIFER/0000-0003-2380-1321	NIH; American Heart Association's Greater Midwest Predoctoral Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's Greater Midwest Predoctoral Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH and American Heart Association's Greater Midwest Predoctoral Fellowship. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; BRANDT PW, 1990, J MOL BIOL, V212, P473, DOI 10.1016/0022-2836(90)90326-H; Braunwald E, 2002, CIRCULATION, V106, P1312, DOI 10.1161/01.CIR.0000030314.11999.6A; Coutu P, 2005, AM J PHYSIOL-HEART C, V288, pH601, DOI 10.1152/ajpheart.00424.2004; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Davis J, 2008, PHYSIOL REV, V88, P1567, DOI 10.1152/physrev.00039.2007; Davis J, 2008, J MOL CELL CARDIOL, V44, P891, DOI 10.1016/j.yjmcc.2008.02.274; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Day S, 2006, ANN NY ACAD SCI, V1080, P437, DOI 10.1196/annals.1380.033; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; Doolan Alessandra, 2004, Heart Lung Circ, V13, P15, DOI 10.1016/j.hlc.2004.01.026; DWECK D, 2008, J BIOL CHEM; EATON BL, 1975, BIOCHEMISTRY-US, V14, P2718, DOI 10.1021/bi00683a025; Epstein ND, 1998, ADV EXP MED BIOL, V453, P105; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002; Frazier A, 2008, PEDIATR CARDIOL, V29, P846, DOI 10.1007/s00246-007-9177-9; Garcia-Castro M, 2005, INT J CARDIOL, V102, P501, DOI 10.1016/j.ijcard.2004.05.060; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P99, DOI 10.1023/B:MCBI.0000041852.42291.aa; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Herron TJ, 2007, CIRC RES, V100, P1182, DOI 10.1161/01.RES.0000264102.00706.4e; Hilario E, 2004, EUR J BIOCHEM, V271, P4132, DOI 10.1111/j.1432-1033.2004.04351.x; Ho CY, 2000, CIRCULATION, V102, P1950, DOI 10.1161/01.CIR.102.16.1950; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Kim SJ, 1999, AM J PHYSIOL-HEART C, V276, pH1780, DOI 10.1152/ajpheart.1999.276.5.H1780; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Lin TL, 2000, CARDIOLOGY, V93, P155, DOI 10.1159/000007020; Lindhout DA, 2005, BIOCHEMISTRY-US, V44, P14750, DOI 10.1021/bi051580l; Marian AJ, 2002, CURR OPIN CARDIOL, V17, P242, DOI 10.1097/00001573-200205000-00006; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MARTIN AF, 1981, J BIOL CHEM, V256, P964; McConnell BK, 1999, J CLIN INVEST, V104, P1771, DOI 10.1172/JCI7377C1; MEHEGAN JP, 1991, J BIOL CHEM, V266, P966; Metzger JM, 2003, J BIOL CHEM, V278, P13118, DOI 10.1074/jbc.M212601200; METZGER JM, 1995, BIOPHYS J, V68, P1430, DOI 10.1016/S0006-3495(95)80316-4; Michele DE, 1999, NAT MED, V5, P1413; Michele DE, 1999, J CELL BIOL, V145, P1483, DOI 10.1083/jcb.145.7.1483; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Michele DE, 2002, PHYSIOL GENOMICS, V9, P103, DOI 10.1152/physiolgenomics.00099.2001; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Mohiddin SA, 2003, GENET TEST, V7, P21, DOI 10.1089/109065703321560895; MOSS RL, 1992, CIRC RES, V70, P865, DOI 10.1161/01.RES.70.5.865; MOSS RL, 1986, J GEN PHYSIOL, V87, P761, DOI 10.1085/jgp.87.5.761; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; *NHLBI PROGR GEN A, GEN CARD DEV AD REM; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Preston LC, 2007, PFLUG ARCH EUR J PHY, V453, P771, DOI 10.1007/s00424-006-0161-7; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Richard P, 1999, J MED GENET, V36, P542; Richard P, 2000, J MOL CELL CARDIOL, V32, P1575, DOI 10.1006/jmcc.2000.1193; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Rust EM, 1998, MOL CELL BIOCHEM, V181, P143, DOI 10.1023/A:1006802719136; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Semsarian C, 2001, J MOL CELL CARDIOL, V33, P2055, DOI 10.1006/jmcc.2001.1466; Solaro RJ, 1996, J MOL CELL CARDIOL, V28, P217; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; Tsoutsman T, 2008, CIRCULATION, V117, P1820, DOI 10.1161/CIRCULATIONAHA.107.755777; Tsoutsman T, 2006, J MOL CELL CARDIOL, V41, P623, DOI 10.1016/j.yjmcc.2006.07.016; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Van Driest SL, 2002, CIRCULATION, V106, P3085, DOI 10.1161/01.CIR.0000042675.59901.14; Westfall MV, 1997, P NATL ACAD SCI USA, V94, P5444, DOI 10.1073/pnas.94.10.5444; Westfall MV, 2000, CIRC RES, V86, P470, DOI 10.1161/01.RES.86.4.470; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0; Westfall MV, 1997, METHOD CELL BIOL, V52, P307, DOI 10.1016/S0091-679X(08)60385-4; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	76	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9140	10.1371/journal.pone.0009140	http://dx.doi.org/10.1371/journal.pone.0009140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161772	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442700006
J	Martin, RA; Pfennig, DW				Martin, Ryan A.; Pfennig, David W.			Maternal Investment Influences Expression of Resource Polymorphism in Amphibians: Implications for the Evolution of Novel Resource-Use Phenotypes	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; CHARACTER DISPLACEMENT; EGG SIZE; OVUM SIZE; POPULATION DIVERGENCE; ADAPTIVE SIGNIFICANCE; TROPHIC POLYMORPHISM; FROG; POLYPHENISM; SALAMANDER	Maternal effects-where an individual's phenotype is influenced by the phenotype or environment of its mother-are taxonomically and ecologically widespread. Yet, their role in the origin of novel, complex traits remains unclear. Here we investigate the role of maternal effects in influencing the induction of a novel resource-use phenotype. Spadefoot toad tadpoles, Spea multiplicata, often deviate from their normal development and produce a morphologically distinctive carnivore-morph phenotype, which specializes on anostracan fairy shrimp. We evaluated whether maternal investment influences expression of this novel phenotype. We found that larger females invested in larger eggs, which, in turn, produced larger tadpoles. Such larger tadpoles are better able to capture the shrimp that induce carnivores. By influencing the expression of novel resource-use phenotypes, maternal effects may play a largely underappreciated role in the origins of novelty.	[Martin, Ryan A.; Pfennig, David W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Martin, RA (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	martinra@email.unc.edu	Martin, Ryan A/D-8945-2011; Martin, Ryan/AAF-1314-2019	Martin, Ryan/0000-0002-7448-5907	National Science Foundation [DEB-0640026]	National Science Foundation(National Science Foundation (NSF))	This work was funded by a National Science Foundation grant DEB-0640026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; Baldwin JM, 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Bernardo J, 1996, AM ZOOL, V36, P216; Bragg AN, 1965, GNOMES NIGHT SPADEFO; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; COLLINS JP, 1983, AM ZOOL, V23, P77; Frankino WA, 2001, EVOL ECOL RES, V3, P939; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gosner K. L., 1960, Herpetologica, V16, P183; GROSS MR, 1985, AM ZOOL, V25, P807; Hamilton W.D., 1979, P167; Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.2307/177041; JORGENSEN CB, 1982, J EXP ZOOL, V224, P437, DOI 10.1002/jez.1402240317; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kaplan RH, 2006, EVOLUTION, V60, P142; KAPLAN RH, 1979, COPEIA, P348; KAPLAN RH, 1987, OECOLOGIA, V71, P273, DOI 10.1007/BF00377295; KAPLAN RH, 1989, FUNCT ECOL, V3, P597, DOI 10.2307/2389574; KAPLAN RH, 1979, AM NAT, V113, P671, DOI 10.1086/283425; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Kaplan RH, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P244; King EG, 1997, J HERPETOL, V31, P299, DOI 10.2307/1565402; Ledon-Rettig CC, 2008, EVOL DEV, V10, P316, DOI 10.1111/j.1525-142X.2008.00240.x; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; LOEB MLG, 1994, FUNCT ECOL, V8, P151, DOI 10.2307/2389898; Loman J, 2002, J ZOOL, V257, P93, DOI 10.1017/S0952836902000687; MARET TJ, 1994, OECOLOGIA, V100, P279, DOI 10.1007/BF00316955; Martin RA, 2009, AM NAT, V174, P268, DOI 10.1086/600090; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2009, OECOLOGIA, V160, P601, DOI 10.1007/s00442-009-1319-8; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nishihara A, 1996, COPEIA, P478, DOI 10.2307/1446871; PARICHY DM, 1995, FUNCT ECOL, V9, P606, DOI 10.2307/2390151; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; PFENNIG D, 1990, OECOLOGIA, V85, P101, DOI 10.1007/BF00317349; Pfennig DW, 2007, EVOLUTION, V61, P257, DOI 10.1111/j.1558-5646.2007.00034.x; Pfennig DW, 2009, EVOLUTION, V63, P898, DOI 10.1111/j.1558-5646.2008.00544.x; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; Pfennig DW, 2000, EVOLUTION, V54, P1738; Pfennig DW, 2006, ECOLOGY, V87, P769, DOI 10.1890/05-0787; Pfennig DW, 1999, P ROY SOC B-BIOL SCI, V266, P57, DOI 10.1098/rspb.1999.0604; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig DW, 2002, EVOLUTION, V56, P1217; Pfennig DW, 1997, EVOLUTION, V51, P1993, DOI 10.1111/j.1558-5646.1997.tb05120.x; PFENNIG DW, 2009, PHILOS T B IN PRESS; Pfennig KS, 2005, EVOLUTION, V59, P2200; Pfenning DW, 2000, AM NAT, V155, P335, DOI 10.1086/303329; Plaistow SJ, 2006, AM NAT, V167, P206, DOI 10.1086/499380; POMEROY LV, 1981, THESIS U CALIFORNIA; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rasanen K, 2003, EVOLUTION, V57, P363, DOI 10.1554/0014-3820(2003)057[0363:GVIAST]2.0.CO;2; RASBAND WS, 1996, IMAGEJ; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Schmalhausen I. I., 1949, FACTORS OF EVOLUTION; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; Skulason S, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P70; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Storz BL, 2004, OECOLOGIA, V141, P402, DOI 10.1007/s00442-004-1672-6; Storz Brian L., 2007, TSW Development & Embryology, V2, P60; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; WAINWRIGHT PC, 1991, FUNCT ECOL, V5, P40, DOI 10.2307/2389554; WALLS SC, 1993, OECOLOGIA, V96, P162, DOI 10.1007/BF00317728; West-Eberhard Mary Jane, 2003, pi; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	73	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9117	10.1371/journal.pone.0009117	http://dx.doi.org/10.1371/journal.pone.0009117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161745	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442600015
J	Reinhard, J; Sinclair, M; Srinivasan, MV; Claudianos, C				Reinhard, Judith; Sinclair, Michael; Srinivasan, Mandyam V.; Claudianos, Charles			Honeybees Learn Odour Mixtures via a Selection of Key Odorants	PLOS ONE			English	Article							OILSEED RAPE VOLATILES; APIS-MELLIFERA L; ANTENNAL LOBE; BEHAVIORAL ASSAY; OLFACTORY CUES; MANDUCA-SEXTA; DISCRIMINATION; BEE; REPRESENTATIONS; RECOGNITION	Background: The honeybee has to detect, process and learn numerous complex odours from her natural environment on a daily basis. Most of these odours are floral scents, which are mixtures of dozens of different odorants. To date, it is still unclear how the bee brain unravels the complex information contained in scent mixtures. Methodology/Principal Findings: This study investigates learning of complex odour mixtures in honeybees using a simple olfactory conditioning procedure, the Proboscis-Extension-Reflex (PER) paradigm. Restrained honeybees were trained to three scent mixtures composed of 14 floral odorants each, and then tested with the individual odorants of each mixture. Bees did not respond to all odorants of a mixture equally: They responded well to a selection of key odorants, which were unique for each of the three scent mixtures. Bees showed less or very little response to the other odorants of the mixtures. The bees' response to mixtures composed of only the key odorants was as good as to the original mixtures of 14 odorants. A mixture composed of the other, non-key-odorants elicited a significantly lower response. Neither an odorant's volatility or molecular structure, nor learning efficiencies for individual odorants affected whether an odorant became a key odorant for a particular mixture. Odorant concentration had a positive effect, with odorants at high concentration likely to become key odorants. Conclusions/Significance: Our study suggests that the brain processes complex scent mixtures by predominantly learning information from selected key odorants. Our observations on key odorant learning lend significant support to previous work on olfactory learning and mixture processing in honeybees.	[Reinhard, Judith; Srinivasan, Mandyam V.; Claudianos, Charles] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Sinclair, Michael] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Srinivasan, Mandyam V.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Australian National University; University of Queensland	Reinhard, J (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	j.reinhard@uq.edu.au	Srinivasan, Mandyam V/G-5571-2010	Claudianos, Charles/0000-0002-9799-9572; Muthukumarasamy, Srinivasan/0000-0002-2948-6206	Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund [CBR3_45865_9W2003]	Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund	Funding: This work was supported by a grant from the Commonwealth Scientific and Industrial Research Organisation Food Futures Flagship Collaborative Research Fund (CBR3_45865_9W2003, http://www.csiro.au/org/FoodFuturesFlagship.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Brunke EJ, 1994, FLAVOUR FRAG J, V9, P59, DOI 10.1002/ffj.2730090205; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Dudareva N, 2006, BIOLOGY OF FLORAL SCENT, P55; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; FLANAGAN D, 1989, INT J INSECT MORPHOL, V18, P145, DOI 10.1016/0020-7322(89)90023-8; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HEISENBERG M, 2004, NATURE, V4, P266; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kelber C, 2006, J COMP NEUROL, V496, P395, DOI 10.1002/cne.20930; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Laloi D, 1999, J INSECT BEHAV, V12, P585, DOI 10.1023/A:1020919501871; Laloi D, 2000, J CHEM ECOL, V26, P2307, DOI 10.1023/A:1005522826673; Laska M, 1999, CHEM SENSES, V24, P263, DOI 10.1093/chemse/24.3.263; Laska M, 2001, BEHAV NEUROSCI, V115, P632, DOI 10.1037/0735-7044.115.3.632; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; LeMetayer M, 1997, CHEM SENSES, V22, P391, DOI 10.1093/chemse/22.4.391; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; PHAMDELEGUE MH, 1993, CHEM SENSES, V18, P483, DOI 10.1093/chemse/18.5.483; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Rao BRR, 2000, FLAVOUR FRAG J, V15, P105, DOI 10.1002/(SICI)1099-1026(200003/04)15:2&lt;105::AID-FFJ875&gt;3.0.CO;2-G; Reinhard J, 2009, CONTEMP TOP ENTOMOL, P165; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Smith BH, 1998, PHYSIOL BEHAV, V65, P397, DOI 10.1016/S0031-9384(98)00142-5; SMITH BH, 1994, J EXP BIOL, V195, P91; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; WADHAMS LJ, 1994, J CHEM ECOL, V20, P3221, DOI 10.1007/BF02033722; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; Wright GA, 2004, P ROY SOC B-BIOL SCI, V271, P147, DOI 10.1098/rspb.2003.2590	41	69	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9110	10.1371/journal.pone.0009110	http://dx.doi.org/10.1371/journal.pone.0009110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161714	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442500016
J	Repellin, CE; Tsimbouri, PM; Philbey, AW; Wilson, JB				Repellin, Claire E.; Tsimbouri, Penelope M.; Philbey, Adrian W.; Wilson, Joanna B.			Lymphoid Hyperplasia and Lymphoma in Transgenic Mice Expressing the Small Non-Coding RNA, EBER1 of Epstein-Barr Virus	PLOS ONE			English	Article							ENCODED SMALL RNAS; BURKITTS-LYMPHOMA; PROTEIN-KINASE; MALIGNANT-TRANSFORMATION; GROWTH TRANSFORMATION; (EBV)-ENCODED RNA; NUCLEAR ANTIGEN-1; INDUCED APOPTOSIS; MICRORNAS; CELLS	Background: Non-coding RNAs have critical functions in diverse biological processes, particularly in gene regulation. Viruses, like their host cells, employ such functional RNAs and the human cancer associated Epstein-Barr virus (EBV) is no exception. Nearly all EBV associated tumours express the EBV small, non-coding RNAs (EBERs) 1 and 2, however their role in viral pathogenesis remains largely obscure. Methodology/Principal Findings: To investigate the action of EBER1 in vivo, we produced ten transgenic mouse lines expressing EBER1 in the lymphoid compartment using the mouse immunoglobulin heavy chain intronic enhancer E mu. Mice of several of these E mu EBER1 lines developed lymphoid hyperplasia which in some cases proceeded to B cell malignancy. The hallmark of the transgenic phenotype is enlargement of the spleen and mesenteric lymph nodes and in some cases enlargement of the thymus, liver and peripheral lymph nodes. The tumours were found to be of B cell origin and showed clonal IgH rearrangements. In order to explore if EBER1 would cooperate with c-Myc (deregulated in Burkitt's lymphoma) to accelerate lymphomagenesis, a cross-breeding study was undertaken with EmEBER1 and E mu Myc mice. While no significant reduction in latency to lymphoma onset was observed in bi-transgenic mice, c-Myc induction was detected in some EmEBER1 single transgenic tumours, indicative of a functional cooperation. Conclusions/Significance: This study is the first to describe the in vivo expression of a polymerase III, non-coding viral gene and demonstrate its oncogenic potential. The data suggest that EBER1 plays an oncogenic role in EBV associated malignant disease.	[Repellin, Claire E.; Tsimbouri, Penelope M.; Wilson, Joanna B.] Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow, Lanark, Scotland; [Philbey, Adrian W.] Univ Glasgow, Sch Vet, Div Pathol Sci, Inst Comparat Med, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Repellin, CE (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Mol & Cellular Biol, Glasgow, Lanark, Scotland.	Joanna.Wilson@bio.gla.ac.uk	Wilson, Joanna B/B-4466-2009	Tsimbouri, Penelope/0000-0001-5124-7458	Wellcome Trust [065530, 078519]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: Wellcome Trust #065530 and #078519 (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ARRAND JR, 1982, J VIROL, V41, P376, DOI 10.1128/JVI.41.2.376-389.1982; ARRAND JR, 1989, J VIROL, V63, P983, DOI 10.1128/JVI.63.2.983-986.1989; Charalambous CT, 2007, CARCINOGENESIS, V28, P1839, DOI 10.1093/carcin/bgm055; Clemens MJ, 2006, INT J BIOCHEM CELL B, V38, P164, DOI 10.1016/j.biocel.2005.09.014; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; Eilebrecht Sebastian, 2008, BMC Res Notes, V1, P100, DOI 10.1186/1756-0500-1-100; Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; HOWE JG, 1989, CELL, V57, P825, DOI 10.1016/0092-8674(89)90797-6; HOWE JG, 1988, J VIROL, V62, P2790, DOI 10.1128/JVI.62.8.2790-2798.1988; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; JAT P, 1982, NUCLEIC ACIDS RES, V10, P3407, DOI 10.1093/nar/10.11.3407; KHAN G, 1992, J CLIN PATHOL, V45, P616, DOI 10.1136/jcp.45.7.616; Kitagawa N, 2000, EMBO J, V19, P6742, DOI 10.1093/emboj/19.24.6742; Komano J, 1999, J VIROL, V73, P9827, DOI 10.1128/JVI.73.12.9827-9831.1999; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Laing KG, 2002, VIROLOGY, V297, P253, DOI 10.1006/viro.2002.1354; LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805; Lu CC, 2004, J GEN VIROL, V85, P2755, DOI 10.1099/vir.0.80239-0; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Nanbo A, 2002, EMBO J, V21, P954, DOI 10.1093/emboj/21.5.954; Niller HH, 2003, MED SCI MONITOR, V9, pHY1; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; ROSA MD, 1981, MOL CELL BIOL, V1, P785, DOI 10.1128/MCB.1.9.785; Ruf IK, 2000, J VIROL, V74, P10223, DOI 10.1128/JVI.74.21.10223-10228.2000; Ruf IK, 2005, J VIROL, V79, P14562, DOI 10.1128/JVI.79.23.14562-14569.2005; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Stevenson D, 2005, CANCER RES, V65, P8826, DOI 10.1158/0008-5472.CAN-05-0591; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; WILSON JB, 1990, CELL, V61, P1315, DOI 10.1016/0092-8674(90)90695-B; Wu Y, 2007, J VIROL, V81, P11236, DOI 10.1128/JVI.00579-07; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yajima M, 2005, J VIROL, V79, P4298, DOI 10.1128/JVI.79.7.4298-4307.2005; Yamamoto N, 2000, FEBS LETT, V484, P153, DOI 10.1016/S0014-5793(00)02145-1; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	44	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9092	10.1371/journal.pone.0009092	http://dx.doi.org/10.1371/journal.pone.0009092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161707	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000274442500004
J	Busch, CR; DiRuggiero, J				Busch, Courtney R.; DiRuggiero, Jocelyne			MutS and MutL Are Dispensable for Maintenance of the Genomic Mutation Rate in the Halophilic Archaeon Halobacterium salinarum NRC-1	PLOS ONE			English	Article							DNA MISMATCH REPAIR; ESCHERICHIA-COLI MUTS; SP STRAIN NRC-1; LACI GENE; SULFOLOBUS-ACIDOCALDARIUS; PYROCOCCUS-FURIOSUS; URACIL RECOGNITION; FIDELITY; REPLICATION; POLYMERASES	Background: The genome of the halophilic archaeon Halobacterium salinarum NRC-1 encodes for homologs of MutS and MutL, which are key proteins of a DNA mismatch repair pathway conserved in Bacteria and Eukarya. Mismatch repair is essential for retaining the fidelity of genetic information and defects in this pathway result in the deleterious accumulation of mutations and in hereditary diseases in humans. Methodology/Principal Findings: We calculated the spontaneous genomic mutation rate of H. salinarum NRC-1 using fluctuation tests targeting genes of the uracil monophosphate biosynthesis pathway. We found that H. salinarum NRC-1 has a low incidence of mutation suggesting the presence of active mechanisms to control spontaneous mutations during replication. The spectrum of mutational changes found in H. salinarum NRC-1, and in other archaea, appears to be unique to this domain of life and might be a consequence of their adaption to extreme environmental conditions. In-frame targeted gene deletions of H. salinarum NRC-1 mismatch repair genes and phenotypic characterization of the mutants demonstrated that the mutS and mutL genes are not required for maintenance of the observed mutation rate. Conclusions/Significance: We established that H. salinarum NRC-1 mutS and mutL genes are redundant to an alternative system that limits spontaneous mutation in this organism. This finding leads to the puzzling question of what mechanism is responsible for maintenance of the low genomic mutation rates observed in the Archaea, which for the most part do not have MutS and MutL homologs.	[Busch, Courtney R.; DiRuggiero, Jocelyne] Univ Maryland, Dept Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Busch, CR (corresponding author), Univ Maryland, Dept Biol & Mol Genet, College Pk, MD 20742 USA.	jdiruggiero@jhu.edu			NASA [EXB04-0000-0055]; NSF [MCB-0425825]; AFOSR [FA95500710158]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by grants from NASA (EXB04-0000-0055), NSF (MCB-0425825), and AFOSR ((FA95500710158) to J.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bawa S, 1997, CANCER RES, V57, P2715; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Berkner S, 2008, EXTREMOPHILES, V12, P263, DOI 10.1007/s00792-007-0125-7; Bjornson KP, 2003, J BIOL CHEM, V278, P34667, DOI 10.1074/jbc.M305513200; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Chen LM, 2005, J BACTERIOL, V187, P4992, DOI 10.1128/JB.187.14.4992-4999.2005; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/bst0310699; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Engel MB, 2005, CELL BIOL INT, V29, P616, DOI 10.1016/j.cellbi.2005.03.024; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Grogan DW, 2000, TRENDS MICROBIOL, V8, P180, DOI 10.1016/S0966-842X(00)01729-7; Grogan DW, 2001, P NATL ACAD SCI USA, V98, P7928, DOI 10.1073/pnas.141113098; HALLIDAY JA, 1991, MUTAT RES, V250, P55, DOI 10.1016/0027-5107(91)90162-H; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs KL, 1997, J BACTERIOL, V179, P3298, DOI 10.1128/jb.179.10.3298-3303.1997; Kish A, 2008, J BACTERIOL, V190, P5210, DOI 10.1128/JB.00292-08; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; KUNKEL TA, 1992, J BIOL CHEM, V267, P18251; Lasken RS, 1996, J BIOL CHEM, V271, P17692, DOI 10.1074/jbc.271.30.17692; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; LUNDBERG KS, 1991, GENE, V108, P1, DOI 10.1016/0378-1119(91)90480-Y; Mackwan RR, 2008, GENETICS, V180, P17, DOI 10.1534/genetics.108.089086; Mackwan RR, 2007, GENETICS, V176, P697, DOI 10.1534/genetics.106.069666; Martin EL, 2000, CAN J MICROBIOL, V46, P180, DOI 10.1139/cjm-46-2-180; MATTILA P, 1991, NUCLEIC ACIDS RES, V19, P4967, DOI 10.1093/nar/19.18.4967; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SCHAAPER RM, 1991, GENETICS, V129, P317; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Vijayvargia R, 2002, CURR MICROBIOL, V44, P224, DOI 10.1007/s00284-001-0025-5; Wang GJ, 2004, J BACTERIOL, V186, P3187, DOI 10.1128/JB.186.10.3187-3194.2004; Whitehead K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100091; XIAO W, 1995, CARCINOGENESIS, V16, P1933, DOI 10.1093/carcin/16.8.1933; YANG H, 2002, J BIOL CHEM; Yang HJ, 2000, J BACTERIOL, V182, P1272, DOI 10.1128/JB.182.5.1272-1279.2000; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	57	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9045	10.1371/journal.pone.0009045	http://dx.doi.org/10.1371/journal.pone.0009045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140215	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474400004
J	Huang, HC; Jupiter, D; VanBuren, V				Huang, Hung-Chung; Jupiter, Daniel; VanBuren, Vincent			Classification of Genes and Putative Biomarker Identification Using Distribution Metrics on Expression Profiles	PLOS ONE			English	Article							ESSENTIAL FATTY-ACIDS; HEDGEHOG PATHWAY; CEREBROSPINAL-FLUID; AXON GUIDANCE; NCBI GEO; MECHANISMS; RECEPTORS; DEMENTIA; INFLAMMATION; ACTIVATION	Background: Identification of genes with switch-like properties will facilitate discovery of regulatory mechanisms that underlie these properties, and will provide knowledge for the appropriate application of Boolean networks in gene regulatory models. As switch-like behavior is likely associated with tissue-specific expression, these gene products are expected to be plausible candidates as tissue-specific biomarkers. Methodology/Principal Findings: In a systematic classification of genes and search for biomarkers, gene expression profiles (GEPs) of more than 16,000 genes from 2,145 mouse array samples were analyzed. Four distribution metrics (mean, standard deviation, kurtosis and skewness) were used to classify GEPs into four categories: predominantly-off, predominantly-on, graded (rheostatic), and switch-like genes. The arrays under study were also grouped and examined by tissue type. For example, arrays were categorized as 'brain group' and 'non-brain group'; the Kolmogorov-Smirnov distance and Pearson correlation coefficient were then used to compare GEPs between brain and non-brain for each gene. We were thus able to identify tissue-specific biomarker candidate genes. Conclusions/Significance: The methodology employed here may be used to facilitate disease-specific biomarker discovery.	[Huang, Hung-Chung; Jupiter, Daniel; VanBuren, Vincent] Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Huang, HC (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Syst Biol & Translat Med, Temple, TX USA.	vanburen@tamu.edu			Department of Systems Biology and Translational Medicine; Dean of the Texas A&M Health Science Center College of Medicine; AHA [SDG 0630263N]	Department of Systems Biology and Translational Medicine; Dean of the Texas A&M Health Science Center College of Medicine; AHA(American Heart Association)	This work was supported by start-up funds to VV from the Department of Systems Biology and Translational Medicine and the Dean of the Texas A&M Health Science Center College of Medicine. Identification of candidate biomarkers for heart (supplied in Table S3) was supported by AHA SDG 0630263N (PI: VV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akabas M H, 1990, Int Rev Neurobiol, V32, P241; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barginear MF, 2009, BREAST CANCER RES TR, V116, P239, DOI 10.1007/s10549-009-0423-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bernet A, 2008, EXPERT OPIN THER TAR, V12, P995, DOI [10.1517/14728222.12.8.995, 10.1517/14728222.12.8.995 ]; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; BISCOE TJ, 1990, AM J PHYSIOL, V258, pL271, DOI 10.1152/ajplung.1990.258.6.L271; Bolstad B, 2005, BIOINFORMATICS COMPU; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Bourque CW, 2007, EXP PHYSIOL, V92, P499, DOI 10.1113/expphysiol.2006.035634; Boyce JA, 2008, CURR MOL MED, V8, P335, DOI 10.2174/156652408785160989; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; CHAKRAVARTI IM, 1967, HDB METHODS APPL STA, V1, P160; Chen L, 2009, PROTEIN PEPTIDE LETT, V16, P467, DOI 10.2174/092986609788167851; Choolani M, 2009, EXPERT REV PROTEOMIC, V6, P87, DOI 10.1586/14789450.6.1.87; Cohen J., 2002, APPL MULTIPLE REGRES, P736; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; Cunnane SC, 1997, J LIPID RES, V38, P805; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Davies NWS, 2005, J NEUROL NEUROSUR PS, V76, P82, DOI 10.1136/jnnp.2004.045336; DESIMONE JA, 1993, CIBA F SYMP, V179, P218; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Badry AM, 2007, J HEPATOL, V47, P718, DOI 10.1016/j.jhep.2007.08.005; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-3; Ertel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-628; Frankfort SV, 2008, CURR CLIN PHARMACOL, V3, P123, DOI 10.2174/157488408784293723; Giles PJ, 2003, BIOINFORMATICS, V19, P2254, DOI 10.1093/bioinformatics/btg311; Graeber MB, 2009, EXP NEUROL, V216, P249, DOI 10.1016/j.expneurol.2008.12.017; Heidelberger R, 2007, J PHYSIOL-LONDON, V585, P663, DOI 10.1113/jphysiol.2007.137927; Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamjute P, 2009, J MATERN-FETAL NEO M, V22, P274, DOI 10.1080/14767050802211929; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Jupiter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001717; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kaznessis YN, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-47; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Killeen MT, 2008, DEV BIOL, V323, P143, DOI 10.1016/j.ydbio.2008.08.027; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kotake Shigeru, 2009, Clin Calcium, V19, P362; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Laterza OF, 2006, CLIN CHEM, V52, P1713, DOI 10.1373/clinchem.2006.070912; Lennon S, 2009, J CLIN ONCOL, V27, P1685, DOI 10.1200/JCO.2008.16.8351; Lewczuk P, 2008, PROTEOMICS, V8, P1292, DOI 10.1002/pmic.200700703; Lo R, 2009, CURR MED CHEM, V16, P1442, DOI 10.2174/092986709787909622; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma BY, 2009, P NATL ACAD SCI USA, V106, P6887, DOI 10.1073/pnas.0903024106; Mann F, 2004, INT J DEV BIOL, V48, P957, DOI 10.1387/ijdb.041899fm; Massoumi R, 2007, THESCIENTIFICWORLDJO, V7, P1413, DOI 10.1100/tsw.2007.200; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Medina V, 2009, CLIN TRANSL ONCOL, V11, P199, DOI 10.1007/s12094-009-0341-y; Meyers B, 2008, J FOOD SCI, V73, pR81, DOI 10.1111/j.1750-3841.2008.00832.x; Mody I, 2008, NEUROCHEM INT, V52, P60, DOI 10.1016/j.neuint.2007.07.010; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; NINFA AJ, 2004, SCI STKE, pPE20, DOI DOI 10.1126/STKE.2322004PE2; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rajendra S, 1997, PHARMACOL THERAPEUT, V73, P121, DOI 10.1016/S0163-7258(96)00163-5; Reid RC, 2005, CURR MED CHEM, V12, P3011, DOI 10.2174/092986705774462860; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schlitt T, 2006, PHILOS T R SOC B, V361, P483, DOI 10.1098/rstb.2005.1806; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Sheng T, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-29; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Simpson F, 2009, MECH DEVELOP, V126, P279, DOI 10.1016/j.mod.2009.01.007; Singer JH, 2007, J PHYSIOL-LONDON, V580, P23, DOI 10.1113/jphysiol.2006.125302; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sugita M, 2006, CELL MOL LIFE SCI, V63, P2000, DOI 10.1007/s00018-006-6100-0; Tang FR, 2009, CURR MED CHEM, V16, P2189, DOI 10.2174/092986709788612710; Van den Veyver IB, 2009, PRENATAL DIAG, V29, P29, DOI 10.1002/pd.2127; Veleiro AS, 2009, CURR MED CHEM, V16, P455, DOI 10.2174/092986709787315522; Wiltfang J, 2005, WORLD J BIOL PSYCHIA, V6, P69, DOI 10.1080/15622970510029786; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Yasuo T, 2008, BIOL PHARM BULL, V31, P1833, DOI 10.1248/bpb.31.1833; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	87	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9056	10.1371/journal.pone.0009056	http://dx.doi.org/10.1371/journal.pone.0009056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140228	Green Submitted, gold, Green Published			2022-12-27	WOS:000274474400014
J	Ruan, JH				Ruan, Jianhua			A Top-Performing Algorithm for the DREAM3 Gene Expression Prediction Challenge	PLOS ONE			English	Article							NETWORKS	A wealth of computational methods has been developed to address problems in systems biology, such as modeling gene expression. However, to objectively evaluate and compare such methods is notoriously difficult. The DREAM (Dialogue on Reverse Engineering Assessments and Methods) project is a community-wide effort to assess the relative strengths and weaknesses of different computational methods for a set of core problems in systems biology. This article presents a top-performing algorithm for one of the challenge problems in the third annual DREAM (DREAM3), namely the gene expression prediction challenge. In this challenge, participants are asked to predict the expression levels of a small set of genes in a yeast deletion strain, given the expression levels of all other genes in the same strain and complete gene expression data for several other yeast strains. I propose a simple k-nearest-neighbor (KNN) method to solve this problem. Despite its simplicity, this method works well for this challenge, sharing the "top performer'' honor with a much more sophisticated method. I also describe several alternative, simple strategies, including a modified KNN algorithm that further improves the performance of the standard KNN method. The success of these methods suggests that complex methods attempting to integrate multiple data sets do not necessarily lead to better performance than simple yet robust methods. Furthermore, none of these top-performing methods, including the one by a different team, are based on gene regulatory networks, which seems to suggest that accurately modeling gene expression using gene regulatory networks is unfortunately still a difficult task.	Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Ruan, JH (corresponding author), Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA.	jruan@cs.utsa.edu	Ruan, Jianhua/I-2529-2012	Ruan, Jianhua/0000-0002-5622-3137	University of Texas; National Institutes of Health [1SC3GM086305-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM086305] Funding Source: NIH RePORTER	University of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by a University of Texas at San Antonio Faculty Research Award and National Institutes of Health grant 1SC3GM086305-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brito MR, 1997, STAT PROBABIL LETT, V35, P33, DOI 10.1016/S0167-7152(96)00213-1; Burrage K, 2006, BRIEF BIOINFORM, V7, P390, DOI 10.1093/bib/bbl033; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Frazier Zach, 2009, V541, P535, DOI 10.1007/978-1-59745-243-4_23; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; Gustafsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009134; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Lilburn TG, 2006, BRIEF BIOINFORM, V7, P186, DOI 10.1093/bib/bbl005; Middendorf M, 2004, BIOINFORMATICS, V20, P232, DOI 10.1093/bioinformatics/bth923; Ruan JH, 2006, BIOINFORMATICS, V22, P332, DOI 10.1093/bioinformatics/bti792; Ruan JH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S8; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e8944	10.1371/journal.pone.0008944	http://dx.doi.org/10.1371/journal.pone.0008944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140212	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474400001
J	Harrington, LS; Moreno, L; Reed, A; Wort, SJ; Desvergne, B; Garland, C; Zhao, L; Mitchell, JA				Harrington, Louise S.; Moreno, Laura; Reed, Anna; Wort, Stephen J.; Desvergne, Beatrice; Garland, Christopher; Zhao, Lan; Mitchell, Jane A.			The PPAR beta/delta Agonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; PROSTACYCLIN; MODULATION; SURVIVAL; INFLAMMATION; ENDOTHELIUM; RECEPTORS; THERAPY; DISEASE; LIGAND	Background: Pulmonary vascular diseases are increasingly recognised as important clinical conditions. Pulmonary hypertension associated with a range of aetiologies is difficult to treat and associated with progressive morbidity and mortality. Current therapies for pulmonary hypertension include phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, or prostacyclin mimetics. However, none of these provide a cure and the clinical benefits of these drugs individually decline over time. There is, therefore, an urgent need to identify new treatment strategies for pulmonary hypertension. Methodology/Principal Findings: Here we show that the PPAR beta/delta agonist GW0742 induces vasorelaxation in systemic and pulmonary vessels. Using tissue from genetically modified mice, we show that the dilator effects of GW0742 are independent of the target receptor PPAR beta/delta or cell surface prostacyclin (IP) receptors. In aortic tissue, vascular relaxant effects of GW0742 were not associated with increases in cGMP, cAMP or hyperpolarisation, but were attributed to inhibition of RhoA activity. In a rat model of hypoxia-induced pulmonary hypertension, daily oral dosing of animals with GW0742 (30 mg/kg) for 3 weeks significantly reduced the associated right heart hypertrophy and right ventricular systolic pressure. GW0742 had no effect on vascular remodelling induced by hypoxia in this model. Conclusions/Significance: These observations are the first to show a therapeutic benefit of 'PPAR beta/delta' agonists in experimental pulmonary arterial hypertension and provide pre-clinical evidence to favour clinical trials in man.	[Harrington, Louise S.; Moreno, Laura; Reed, Anna; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England; [Wort, Stephen J.] Royal Brompton Hosp, NHLI, London SW3 6LY, England; [Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Garland, Christopher] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Zhao, Lan] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England	Imperial College London; Imperial College London; Royal Brompton Hospital; University of Lausanne; University of Oxford; Imperial College London	Harrington, LS (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, London, England.	j.a.mitchell@ic.ac.uk	Mackenzie, Louise/AAY-7585-2020; Reed, Anna/GQY-8730-2022; Mitchell, Jane A/A-1991-2009; Moreno, Laura/A-9433-2010; Desvergne, Beatrice/C-8892-2016	Mackenzie, Louise/0000-0003-4271-379X; Moreno, Laura/0000-0001-9028-2299; Desvergne, Beatrice/0000-0001-5483-288X	British Heart Foundation; Wellcome Trust	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the British Heart Foundation and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Ali FY, 2006, FASEB J, V20, P326, DOI 10.1096/fj.05-4395fje; Ali FY, 2009, ARTERIOSCL THROM VAS, V29, P706, DOI 10.1161/ATVBAHA.108.183160; Ali FY, 2006, AM J RESP CELL MOL, V34, P242, DOI 10.1165/rcmb.2005-0289OC; ALI FY, 2009, ARTERIOSCLER THROMB; Barst RJ, 2009, J AM COLL CARDIOL, V54, pS78, DOI 10.1016/j.jacc.2009.04.017; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Chen SJ, 1995, J APPL PHYSIOL, V79, P2122, DOI 10.1152/jappl.1995.79.6.2122; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Crossno JT, 2007, AM J PHYSIOL-LUNG C, V292, pL885, DOI 10.1152/ajplung.00258.2006; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Harrington LS, 2007, AM J PHYSIOL-HEART C, V293, pH1682, DOI 10.1152/ajpheart.00389.2007; Hart CM, 2008, J INVEST MED, V56, P518, DOI 10.2310/JIM.0b013e318165e921; Haskova Z, 2008, INFLAMM RES, V57, P314, DOI 10.1007/s00011-007-7157-4; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Matsuda Yasushi, 2005, Nihon Kokyuki Gakkai Zasshi, V43, P283; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Mitchell JA, 2008, EXP PHYSIOL, V93, P141, DOI 10.1113/expphysiol.2007.038588; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Weissmann N, 2009, AM J PHYSIOL-LUNG C, V297, pL658, DOI 10.1152/ajplung.00189.2009; Wise H, 2003, ACTA PHARMACOL SIN, V24, P625; Wort SJ, 2001, AM J RESP CELL MOL, V25, P104, DOI 10.1165/ajrcmb.25.1.4331; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	33	39	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9526	10.1371/journal.pone.0009526	http://dx.doi.org/10.1371/journal.pone.0009526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209098	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100011
J	Soscia, SJ; Kirby, JE; Washicosky, KJ; Tucker, SM; Ingelsson, M; Hyman, B; Burton, MA; Goldstein, LE; Duong, S; Tanzi, RE; Moir, RD				Soscia, Stephanie J.; Kirby, James E.; Washicosky, Kevin J.; Tucker, Stephanie M.; Ingelsson, Martin; Hyman, Bradley; Burton, Mark A.; Goldstein, Lee E.; Duong, Scott; Tanzi, Rudolph E.; Moir, Robert D.			The Alzheimer's Disease-Associated Amyloid beta-Protein Is an Antimicrobial Peptide	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PRECURSOR-LIKE PROTEIN; A-BETA; APOLIPOPROTEIN-E; INNATE IMMUNITY; ALAMAR-BLUE; CELL-DEATH; BRAIN; BACTERIAL; BINDING	Background: The amyloid beta-protein (A beta) is believed to be the key mediator of Alzheimer's disease (AD) pathology. A beta is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role. However, A beta has been shown to be a specific ligand for a number of different receptors and other molecules, transported by complex trafficking pathways, modulated in response to a variety of environmental stressors, and able to induce pro-inflammatory activities. Methodology/Principal Findings: Here, we provide data supporting an in vivo function for A beta as an antimicrobial peptide (AMP). Experiments used established in vitro assays to compare antimicrobial activities of A beta and LL-37, an archetypical human AMP. Findings reveal that A beta exerts antimicrobial activity against eight common and clinically relevant microorganisms with a potency equivalent to, and in some cases greater than, LL-37. Furthermore, we show that AD whole brain homogenates have significantly higher antimicrobial activity than aged matched non-AD samples and that AMP action correlates with tissue A beta levels. Consistent with A beta-mediated activity, the increased antimicrobial action was ablated by immunodepletion of AD brain homogenates with anti-A beta antibodies. Conclusions/Significance: Our findings suggest A beta is a hitherto unrecognized AMP that may normally function in the innate immune system. This finding stands in stark contrast to current models of A beta-mediated pathology and has important implications for ongoing and future AD treatment strategies.	[Soscia, Stephanie J.; Washicosky, Kevin J.; Tucker, Stephanie M.; Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA; [Soscia, Stephanie J.; Washicosky, Kevin J.; Tucker, Stephanie M.; Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Soscia, Stephanie J.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Kirby, James E.; Duong, Scott] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Hyman, Bradley; Tanzi, Rudolph E.; Moir, Robert D.] Harvard Univ, Sch Med, Boston, MA USA; [Burton, Mark A.; Goldstein, Lee E.] Boston Univ, Sch Med, Coll Engn, Mol Aging & Dev Lab,Photon Ctr, Boston, MA 02118 USA; [Burton, Mark A.; Goldstein, Lee E.] Boston Univ, Alzheimers Dis Ctr, Boston, MA 02118 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Uppsala University; Harvard University; Harvard Medical School; Boston University; Boston University	Soscia, SJ (corresponding author), Massachusetts Gen Hosp, Mass Gen Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA.	tanzi@helix.mgh.harvard.edu	Kirby, James/K-4438-2019; Moir, Robert D./M-7612-2017; Tanzi, Rudolph/AAE-9622-2019	Moir, Robert D./0000-0001-5431-3553; Tanzi, Rudolph/0000-0002-7032-1454; Goldstein, Lee/0000-0001-8419-9800	Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081990] Funding Source: NIH RePORTER	Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Cure Alzheimer's Disease Fund (http://www.curealzfund.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Ando Y, 2002, LAB INVEST, V82, P757, DOI 10.1097/01.LAB.0000017170.26718.89; Araki-Sasaki K, 2005, BRIT J OPHTHALMOL, V89, P684, DOI 10.1136/bjo.2004.056804; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Bergman P, 2005, J NEUROCHEM, V93, P1132, DOI 10.1111/j.1471-4159.2005.03081.x; Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bolintineanu D, 2010, PEPTIDES, V31, P1, DOI 10.1016/j.peptides.2009.11.010; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Chakrabarti A, 2007, NEUROL INDIA, V55, P191, DOI 10.4103/0028-3886.35679; Chauhan A, 2000, NEUROCHEM RES, V25, P423, DOI 10.1023/A:1007509608440; Chen Xi, 2006, Current Alzheimer Research, V3, P515, DOI 10.2174/156720506779025215; Chen YN, 2006, BIOCHEM BIOPH RES CO, V341, P1, DOI 10.1016/j.bbrc.2005.12.150; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chi EY, 2008, PROTEINS, V72, P1, DOI 10.1002/prot.21887; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Dennison SR, 2006, FEBS J, V273, P3792, DOI 10.1111/j.1742-4658.2006.05387.x; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Eckert GP, 2001, J NEURAL TRANSM, V108, P1051, DOI 10.1007/s007020170024; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Goumon Y, 1998, J BIOL CHEM, V273, P29847, DOI 10.1074/jbc.273.45.29847; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kee KH, 2008, ANN DIAGN PATHOL, V12, P235, DOI 10.1016/j.anndiagpath.2007.12.004; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Kobayashi N, 2008, BIOCONTROL SCI, V13, P49, DOI 10.4265/bio.13.49; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Kountouras J, 2006, NEUROLOGY, V66, P938, DOI 10.1212/01.wnl.0000203644.68059.5f; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Le YY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0003.2001; Lee M, 2002, BIOCHEM J, V366, P937, DOI 10.1042/BJ20020453; Leib SL, 1999, INFECT DIS CLIN N AM, V13, P527, DOI 10.1016/S0891-5520(05)70093-3; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Linke RP, 2005, J LAB CLIN MED, V145, P187, DOI 10.1016/j.lab.2005.02.002; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; McCafferty DG, 1999, CURR OPIN CHEM BIOL, V3, P672, DOI 10.1016/S1367-5931(99)00025-3; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; *NAT COMM CLIN LAB, M26A NCCLS; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Paris D, 1999, EXP NEUROL, V157, P211, DOI 10.1006/exnr.1999.7055; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Repp KK, 2007, MED MYCOL, V45, P603, DOI 10.1080/13693780701581458; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sal-Man N, 2002, BIOCHEMISTRY-US, V41, P11921, DOI 10.1021/bi0260482; Shiloh MU, 1997, INFECT IMMUN, V65, P3193, DOI 10.1128/IAI.65.8.3193-3198.1997; SHOOSHTARIZADEH P, 2009, REGULATORY IN PRESS; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Subasinghe S, 2003, J NEUROCHEM, V84, P471, DOI 10.1046/j.1471-4159.2003.01552.x; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Townsend KP, 2002, ANN NY ACAD SCI, V977, P65, DOI 10.1111/j.1749-6632.2002.tb04799.x; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Urosevic N, 2008, J ALZHEIMERS DIS, V13, P421; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; WASCO W, 1993, GENOMICS, V15, P237, DOI 10.1006/geno.1993.1047; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Youngsteadt E, 2008, SCIENCE, V320, P1577, DOI 10.1126/science.320.5883.1577a; Zaiou M, 2007, J MOL MED, V85, P317, DOI 10.1007/s00109-006-0143-4; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	85	701	718	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9505	10.1371/journal.pone.0009505	http://dx.doi.org/10.1371/journal.pone.0009505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209079	Green Published, gold			2022-12-27	WOS:000275063400012
J	Litvinova, EA; Goncharova, EP; Zaydman, AM; Zenkova, MA; Moshkin, MP				Litvinova, Ekaterina A.; Goncharova, Elena P.; Zaydman, Alla M.; Zenkova, Marina A.; Moshkin, Mikhail P.			Female Scent Signals Enhance the Resistance of Male Mice to Influenza	PLOS ONE			English	Article							AEROBIC PERFORMANCE; INNATE IMMUNITY; GAS-EXCHANGE; LUNG INJURY; TESTOSTERONE; INFLAMMATION; PNEUMONIA; MECHANICS; PROTECTS; MODEL	Background: The scent from receptive female mice functions as a signal, which stimulates male mice to search for potential mating partners. This searching behavior is coupled with infection risk due to sniffing both scent marks as well as nasal and anogenital areas of females, which harbor bacteria and viruses. Consideration of host evolution under unavoidable parasitic pressures, including helminthes, bacteria, viruses, etc., predicts adaptations that help protect hosts against the parasites associated with mating. Methods and Findings: We propose that the perception of female signals by BALB/c male mice leads to adaptive redistribution of the immune defense directed to protection against respiratory infection risks. Our results demonstrate migration of macrophages and neutrophils to the upper airways upon exposure to female odor stimuli, which results in an increased resistance of the males to experimental influenza virus infection. This moderate leukocyte intervention had no negative effect on the aerobic performance in male mice. Conclusions: Our data provide the first demonstration of the adaptive immunological response to female odor stimuli through induction of nonspecific immune responses in the upper respiratory tract.	[Litvinova, Ekaterina A.; Moshkin, Mikhail P.] Russian Acad Sci, Siberian Branch, Inst Systemat & Ecol Anim, Lab Physiol Adaptat Anim, Novosibirsk, Russia; [Goncharova, Elena P.; Zenkova, Marina A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Lab Nucle Acids Biochem, Novosibirsk, Russia; [Zaydman, Alla M.] Novosibirsk Inst Traumatol, Dept Histol, Novosibirsk, Russia; [Moshkin, Mikhail P.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Dept Anim Genet Resources, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk Research Institute of Traumatology & Orthopaedics; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Litvinova, EA (corresponding author), Russian Acad Sci, Siberian Branch, Inst Systemat & Ecol Anim, Lab Physiol Adaptat Anim, Novosibirsk, Russia.	mmp@bionet.nsc.ru	Goncharova, Elena P/G-5099-2013; Zenkova, Marina A/G-5088-2013; Zaydman, Alla/AAE-6100-2019; Litvinova, Ekaterina/ADP-2658-2022; Moshkin, Mikhail P./N-7620-2014; Zenkova, Marina A./H-4666-2014	Zenkova, Marina/0000-0003-4044-1049; Litvinova, Ekaterina/0000-0001-6398-7154	Russian Foundation for Basic Research [N 08-04-00406a]; Program of Interdisciplinary Studies of Siberian Branch [RAS N 15, 94]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Interdisciplinary Studies of Siberian Branch	This project was supported by the Russian Foundation for Basic Research N 08-04-00406a (www.rfbr.ru) and Program of Interdisciplinary Studies of Siberian Branch of RAS N 15, 94 (www.sbras.nsc.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstislavskaya TG, 2004, HORM BEHAV, V46, P544, DOI 10.1016/j.yhbeh.2004.05.010; Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Braude S, 1999, BEHAV ECOL, V10, P345, DOI 10.1093/beheco/10.3.345; BRONSON FH, 1979, Q REV BIOL, V54, P265, DOI 10.1086/411295; BRUGH M, 1994, HDB ZOONOSES VIRAL, P385; Clement CG, 2008, AM J RESP CRIT CARE, V177, P1322, DOI 10.1164/rccm.200607-1038OC; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Dugan HA, 2003, J CLIN PHARM THER, V28, P123, DOI 10.1046/j.1365-2710.2003.00471.x; HANLY P, 1987, LUNG, V165, P305, DOI 10.1007/BF02714447; Kemming GI, 2005, ANESTHESIOLOGY, V103, P585, DOI 10.1097/00000542-200509000-00022; Koyama S, 2000, PHYSIOL BEHAV, V71, P415, DOI 10.1016/S0031-9384(00)00361-9; Liles W C, 2001, Semin Respir Infect, V16, P11; LINDSTEDT SL, 1988, INT J SPORTS MED, V9, P210, DOI 10.1055/s-2007-1025008; Litvinova EA, 2009, ZH OBSHCH BIOL, V70, P46; Litvinova EA, 2009, INTEGR ZOOL, V4, P285, DOI 10.1111/j.1749-4877.2009.00162.x; MACRIDES F, 1975, SCIENCE, V189, P1104, DOI 10.1126/science.1162363; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mizgerd JP, 2003, AM J RESP CRIT CARE, V168, P810, DOI 10.1164/rccm.200303-412OC; Mizutani A, 2008, J APPL PHYSIOL, V105, P678, DOI 10.1152/japplphysiol.00232.2007; Okulewicz A., 2003, Polish Journal of Veterinary Sciences, V6, P51; REED LJ, 1938, AM J HYG, V27; Rezende EL, 2006, J EXP BIOL, V209, P115, DOI 10.1242/jeb.01883; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rojas M, 2005, AM J PHYSIOL-LUNG C, V288, pL333, DOI 10.1152/ajplung.00334.2004; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; Santuz P, 1997, EUR RESPIR J, V10, P1254, DOI 10.1183/09031936.97.10061254; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Tuvim MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004176; Vaahtovuo J, 2003, FEMS MICROBIOL ECOL, V44, P131, DOI 10.1016/S0168-6496(02)00460-9; Vandenbergh John G., 1994, P343; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Yao GH, 2003, INT IMMUNOPHARMACOL, V3, P1853, DOI 10.1016/j.intimp.2003.09.002	34	15	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9473	10.1371/journal.pone.0009473	http://dx.doi.org/10.1371/journal.pone.0009473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208997	Green Submitted, Green Published, gold			2022-12-27	WOS:000274997100019
J	Qin, WM; Shi, Y; Zhao, BT; Yao, CG; Jin, L; Ma, JX; Jin, YX				Qin, Wenming; Shi, Yi; Zhao, Botao; Yao, Chengguo; Jin, Li; Ma, Jiexian; Jin, Youxin			miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells	PLOS ONE			English	Article							FAS-ASSOCIATED FACTOR-1; PROSTATE-CANCER; MICRORNAS; EXPRESSION; REPRESSION; RECEPTOR; GENE	Background: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs at the post-transcriptional stage. Several studies have shown that miRNAs modulate gene expression in mammalian cells by base pairing to complementary sites in the 3'-untranslated region (3'-UTR) of the target mRNAs. Methodology/Principal Findings: In the present study, miR-24 was found to target fas associated factor 1(FAF1) by binding to its amino acid coding sequence (CDS) region, thereby regulating apoptosis in DU-145 cells. This result supports an augmented model whereby animal miRNAs can exercise their effects through binding to the CDS region of the target mRNA. Transfection of miR-24 antisense oligonucleotide (miR-24-ASO) also induced apoptosis in HGC-27, MGC-803 and HeLa cells. Conclusions/Significance: We found that miR-24 regulates apoptosis by targeting FAF1 in cancer cells. These findings suggest that miR-24 could be an effective drug target for treatment of hormone-insensitive prostate cancer or other types of cancers. Future work may further develop miR-24 for therapeutic applications in cancer biology.	[Qin, Wenming; Shi, Yi; Zhao, Botao; Yao, Chengguo; Ma, Jiexian; Jin, Youxin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai, Peoples R China; [Jin, Li] St Lukes Hosp, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Qin, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai, Peoples R China.	yxjin@sibs.ac.cn	Jackson, Benjamin L/C-4297-2012; Zhao, Botao/J-5201-2015		National Key Basic Research and Development Program [2005CB724602]; Programs from the Chinese Academy of Sciences [KSCX-2-SW-228, KSCX1-YW-R-64]	National Key Basic Research and Development Program(National Basic Research Program of China); Programs from the Chinese Academy of Sciences	This work was supported by the National Key Basic Research and Development Program (2005CB724602) and Programs from the Chinese Academy of Sciences (KSCX-2-SW-228 and KSCX1-YW-R-64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Axtell MJ, 2008, BBA-GENE REGUL MECH, V1779, P725, DOI 10.1016/j.bbagrm.2008.02.007; Barmoshe S, 2006, EXPERT OPIN PHARMACO, V7, P1685, DOI 10.1517/14656566.7.13.1685; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; CHU KT, 1995, P NATL ACAD SCI USA, V92, P11894, DOI 10.1073/pnas.92.25.11894; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; FORMAN J, 2008, P NATL ACAD SCI USA, V105, P6; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Ghosh A.K., 2009, CANC LETT; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1965, J PATHOL BACTERIOL, V90, P419, DOI 10.1002/path.1700900210; Ko HY, 2009, FEBS J, V276, P4854, DOI 10.1111/j.1742-4658.2009.07185.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; LEE KH, 2009, ONCOGENE; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Menges CW, 2009, CELL CYCLE, V8, P2528, DOI 10.4161/cc.8.16.9280; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; NAKANO H, 2009, INT J CANC; OLENA AF, J CELL PHYSL, V222, P540; Ploner A, 2009, RNA, V15, P1797, DOI 10.1261/rna.1740009; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rosa A, 2009, CELL CYCLE, V8, P3513, DOI 10.4161/cc.8.21.9847; Ryu SW, 2003, J BIOL CHEM, V278, P24003, DOI 10.1074/jbc.M302200200; Ryu SW, 2001, BIOCHEM BIOPH RES CO, V286, P1027, DOI 10.1006/bbrc.2001.5505; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; SUBRAMANIAN S, J CELL PHYSL; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Xiong Y, 2009, HEPATOLOGY; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	43	186	204	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9429	10.1371/journal.pone.0009429	http://dx.doi.org/10.1371/journal.pone.0009429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195546	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300017
J	Wang, F; Robbins, S; Guo, JT; Shen, WJ; Schultz, PG				Wang, Feng; Robbins, Scott; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.			Genetic Incorporation of Unnatural Amino Acids into Proteins in Mycobacterium tuberculosis	PLOS ONE			English	Article							CODE	New tools are needed to study the intracellular pathogen Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), to facilitate new drug discovery and vaccine development. We have developed methodology to genetically incorporate unnatural amino acids into proteins in Mycobacterium smegmatis, BCG and Mtb, grown both extracellularly in culture and inside host cells. Orthogonal mutant tRNA(Tyr)/tyrosyl-tRNA synthetase pairs derived from Methanococcus jannaschii and evolved in Escherichia coli incorporate a variety of unnatural amino acids (including photocrosslinking, chemically reactive, heavy atom containing, and immunogenic amino acids) into proteins in response to the amber nonsense codon. By taking advantage of the fidelity and suppression efficiency of the MjtRNA/pIpaRS pair in mycobacteria, we are also able to use p-iodophenylalanine to induce the expression of proteins in mycobacteria both extracellularly in culture and inside of mammalian host cells. This provides a new approach to regulate the expression of reporter genes or mycobacteria endogenous genes of interest. The establishment of the unnatural amino acid expression system in Mtb, an intracellular pathogen, should facilitate studies of TB biology and vaccine development.	[Wang, Feng; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wang, Feng; Guo, Jiantao; Shen, Weijun; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Robbins, Scott; Schultz, Peter G.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Novartis	Wang, F (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	schultz@scripps.edu	Guo, Jiantao/O-1776-2016	Guo, Jiantao/0000-0001-6983-9953; Shen, Weijun/0000-0001-8388-729X; Wang, Feng/0000-0003-2980-4646	NIH [R01GM62159]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH R01GM62159. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brustad E, 2008, ANGEW CHEM INT EDIT, V47, P8220, DOI 10.1002/anie.200803240; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Deiters A, 2003, J AM CHEM SOC, V125, P11782, DOI 10.1021/ja0370037; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gruenewald J, 2008, P NATL ACAD SCI USA, V105, P11276, DOI 10.1073/pnas.0804157105; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Lee HS, 2009, J AM CHEM SOC, V131, P2481, DOI 10.1021/ja808340b; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Vasanthakrishna M, 1997, MICROBIOL-SGM, V143, P3591, DOI 10.1099/00221287-143-11-3591; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Xie JM, 2007, ANGEW CHEM INT EDIT, V46, P9239, DOI 10.1002/anie.200703397	19	45	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9354	10.1371/journal.pone.0009354	http://dx.doi.org/10.1371/journal.pone.0009354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179771	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900018
J	Dumortier, A; Durham, AD; Di Piazza, M; Vauclair, S; Koch, U; Ferrand, G; Ferrero, I; Demehri, S; Song, LL; Farr, AG; Leonard, WJ; Kopan, R; Miele, L; Hohl, D; Finke, D; Radtke, F				Dumortier, Alexis; Durham, Andre-Dante; Di Piazza, Matteo; Vauclair, Sophie; Koch, Ute; Ferrand, Gisele; Ferrero, Isabel; Demehri, Shadmehr; Song, Lynda Li; Farr, Andrew G.; Leonard, Warren J.; Kopan, Raphael; Miele, Lucio; Hohl, Daniel; Finke, Daniela; Radtke, Freddy			Atopic Dermatitis-Like Disease and Associated Lethal Myeloproliferative Disorder Arise from Loss of Notch Signaling in the Murine Skin	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; HUMAN EPITHELIAL-CELLS; IGM(+) B-CELLS; T-CELL; MOUSE KERATINOCYTES; IN-VITRO; EXPRESSION; INFLAMMATION; GROWTH; MICE	Background: The Notch pathway is essential for proper epidermal differentiation during embryonic skin development. Moreover, skin specific loss of Notch signaling in the embryo results in skin barrier defects accompanied by a B-lymphoproliferative disease. However, much less is known about the consequences of loss of Notch signaling after birth. Methodology and Principal Findings: To study the function of Notch signaling in the skin of adult mice, we made use of a series of conditional gene targeted mice that allow inactivation of several components of the Notch signaling pathway specifically in the skin. We demonstrate that skin-specific inactivation of Notch1 and Notch2 simultaneously, or RBP-J, induces the development of a severe form of atopic dermatitis (AD), characterized by acanthosis, spongiosis and hyperkeratosis, as well as a massive dermal infiltration of eosinophils and mast cells. Likewise, patients suffering from AD, but not psoriasis or lichen planus, have a marked reduction of Notch receptor expression in the skin. Loss of Notch in keratinocytes induces the production of thymic stromal lymphopoietin (TSLP), a cytokine deeply implicated in the pathogenesis of AD. The AD-like associated inflammation is accompanied by a myeloproliferative disorder (MPD) characterized by an increase in immature myeloid populations in the bone marrow and spleen. Transplantation studies revealed that the MPD is cell non-autonomous and caused by dramatic microenvironmental alterations. Genetic studies demontrated that G-CSF mediates the MPD as well as changes in the bone marrow microenvironment leading to osteopenia. Significance: Our data demonstrate a critical role for Notch in repressing TSLP production in keratinocytes, thereby maintaining integrity of the skin and the hematopoietic system.	[Dumortier, Alexis; Durham, Andre-Dante; Di Piazza, Matteo; Vauclair, Sophie; Koch, Ute; Ferrand, Gisele; Radtke, Freddy] Ecole Polytech Fed Lausanne, SV, ISREC, CH-1015 Lausanne, Switzerland; [Ferrero, Isabel] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Demehri, Shadmehr; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Demehri, Shadmehr; Kopan, Raphael] Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA; [Song, Lynda Li; Miele, Lucio] Loyola Univ, Breast Canc Program, Cardinal Bernardin Canc Ctr, Chicago, IL 60611 USA; [Farr, Andrew G.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Farr, Andrew G.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Hohl, Daniel] CHU Vaudois, Dept Dermatol, Lausanne, Switzerland; [Finke, Daniela] Univ Basel, Ctr Biomed, Dept Clin & Biol Sci DKBW, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Ludwig Institute for Cancer Research; University of Lausanne; Washington University (WUSTL); Washington University (WUSTL); Loyola University Chicago; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Dumortier, A (corresponding author), Ecole Polytech Fed Lausanne, SV, ISREC, CH-1015 Lausanne, Switzerland.	Freddy.Radtke@epfl.ch	Kopan, Raphael/AFG-3275-2022; Demehri, Shadmehr/N-5732-2019; Hohl, Daniel M/N-7554-2016; Leonard, Warren/AAA-1397-2022; Radtke, Freddy/Q-3198-2017; Durham, Andre/AAC-1020-2019; Kopan, Raphael/AAF-1357-2022	Radtke, Freddy/0000-0003-4315-4045; Durham, Andre/0000-0002-5875-0301; Koch, Ute/0000-0001-7914-7061; Miele, Lucio/0000-0002-5853-7287; Kopan, Raphael/0000-0002-0350-2730	Swiss Cancer League [OCS-01560-08-2004]; Swiss National Science Foundation [FNS: 3236B0-111292 (ADD), PPOOA-68855 (DF)]; Eurosystems, Optistem; Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005409] Funding Source: NIH RePORTER	Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eurosystems, Optistem; Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by the Swiss Cancer League (OCS-01560-08-2004) and the Swiss National Science Foundation (FNS: 3236B0-111292 (ADD), and PPOOA-68855 (DF)), Eurosystems, Optistem, and the Division of Intramural Research, National Heart, Lung and Blood Institute, NIH (WJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Arellano FM, 2007, J INVEST DERMATOL, V127, P808, DOI 10.1038/sj.jid.5700622; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caruso R, 2009, NAT MED, V15, P1013, DOI 10.1038/nm.1995; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Eichenfield Lawrence F, 2003, J Am Acad Dermatol, V49, P1088, DOI 10.1016/S0190-9622(03)02539-8; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Guttman-Yassky E, 2008, J IMMUNOL, V181, P7420, DOI 10.4049/jimmunol.181.10.7420; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Levin SD, 1999, J IMMUNOL, V162, P677; Li M, 2005, P NATL ACAD SCI USA, V102, P14795, DOI 10.1073/pnas.0507385102; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Natalija Novak, 2003, J ALLERGY CLIN IMMUN, V112, pS128, DOI DOI 10.1016/j.jaci.2003.09.032; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Osborn MJ, 2004, BLOOD, V103, P843, DOI 10.1182/blood-2003-05-1557; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Sims JE, 2000, J EXP MED, V192, P671, DOI 10.1084/jem.192.5.671; Sinke JD, 2002, VET IMMUNOL IMMUNOP, V87, P351, DOI 10.1016/S0165-2427(02)00066-1; Soderberg KC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-51; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang H, 2006, BRIT J DERMATOL, V154, P205, DOI 10.1111/j.1365-2133.2005.07077.x; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang YW, 2004, CANCER CAUSE CONTROL, V15, P419, DOI 10.1023/B:CACO.0000027506.55846.5d; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	71	132	133	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9258	10.1371/journal.pone.0009258	http://dx.doi.org/10.1371/journal.pone.0009258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174635	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700010
J	Tobin, S; Bisson, N; Grondin, S				Tobin, Simon; Bisson, Nicolas; Grondin, Simon			An Ecological Approach to Prospective and Retrospective Timing of Long Durations: A Study Involving Gamers	PLOS ONE			English	Article							TIME PERCEPTION; BODY-TEMPERATURE; EVENT STRUCTURE; CLOCK DURATION; JUDGMENTS; ATTENTION; EXPECTANCIES; ADOLESCENTS; INFORMATION; PARADIGMS	To date, most studies comparing prospective and retrospective timing have failed to use long durations and tasks with a certain degree of ecological validity. The present study assessed the effect of the timing paradigm on playing video games in a "naturalistic environment'' (gaming centers). In addition, as it involved gamers, it provided an opportunity to examine the effect of gaming profile on time estimation. A total of 116 participants were asked to estimate prospectively or retrospectively a video game session lasting 12, 35 or 58 minutes. The results indicate that time is perceived as longer in the prospective paradigm than in the retrospective one, although the variability of estimates is the same. Moreover, the 12-minute session was perceived as longer, proportionally, than the 35- and 58-minute sessions. The study also revealed that the number of hours participants spent playing video games per week was a significant predictor of time estimates. To account for the main findings, the differences between prospective and retrospective timing are discussed in quantitative terms using a proposed theoretical framework, which states that both paradigms use the same cognitive processes, but in different proportions. Finally, the hypothesis that gamers play more because they underestimate time is also discussed.	[Tobin, Simon; Bisson, Nicolas; Grondin, Simon] Univ Laval, Quebec City, PQ, Canada	Laval University	Tobin, S (corresponding author), Univ Laval, Quebec City, PQ, Canada.	simon.tobin.1@ulaval.ca			Social Sciences and Humanities Research Council of Canada [CRSH-084927]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a research grant from the Social Sciences and Humanities Research Council of Canada (Conseil de recherches en sciences humaines du Canada) to Simon Grondin grant # CRSH-084927 http://www.sshrc.ca/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni-Babad D, 2003, J EXP PSYCHOL GEN, V132, P543, DOI 10.1037/0096-3445.132.4.543; Bakan P., 1955, PERCEPT MOTOR SKILL, V5, P147, DOI [10.2466/PMS.5..147-148, DOI 10.2466/PMS.5..147-148]; Bisson N, 2009, NEUROQUANTOLOGY, V7, P46, DOI 10.14704/nq.2009.7.1.206; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; BLOCK RA, 1980, ACTA PSYCHOL, V46, P81, DOI 10.1016/0001-6918(80)90001-3; BLOCK RA, 1992, NATO ADV SCI INST SE, V66, P141; Block RA, 2001, TIME MEMORY ISSUES P, P59; BOLTZ M, 1989, PERCEPT PSYCHOPHYS, V46, P409; BOLTZ M, 1992, NATO ADV SCI INST SE, V66, P153; Boltz MG, 1998, J EXP PSYCHOL HUMAN, V24, P1087, DOI 10.1037/0096-1523.24.4.1087; Boltz MG, 2005, PERCEPT PSYCHOPHYS, V67, P1362, DOI 10.3758/BF03193641; BOLTZ MG, 1995, PERCEPT PSYCHOPHYS, V57, P1080, DOI 10.3758/BF03205466; BOLTZ MG, 1993, MEM COGNITION, V21, P853, DOI 10.3758/BF03202753; Brown SW, 2008, PSYCHOLOGY OF TIME, P111, DOI 10.1016/B978-0-08046-977-5.00004-1; BROWN SW, 1985, PERCEPT PSYCHOPHYS, V38, P115, DOI 10.3758/BF03198848; Brown SW, 2002, J EXP PSYCHOL HUMAN, V28, P600, DOI 10.1037//0096-1523.28.3.600; BROWN SW, 1988, PERCEPTION, V17, P297, DOI 10.1068/p170297; BROWN SW, 1992, PERCEPTION, V21, P545, DOI 10.1068/p210545; Bueno Martuinez, 1990, ESTUDIOS PSICOLOGIA, V45, P109; Casini L, 1997, MEM COGNITION, V25, P812, DOI 10.3758/BF03211325; CASINI L, 1992, NATO ADV SCI INST SE, V66, P177; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; EISLER H, 1976, PSYCHOL BULL, V83, P1154, DOI 10.1037/0033-2909.83.6.1154; EISLER H, PSYCHOL TIME, P75; Graf P, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P1, DOI 10.1142/9789812707123_0001; Griffiths MD, 1998, PSYCHOL REP, V82, P475, DOI 10.2466/PR0.82.2.475-480; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2007, Q J EXP PSYCHOL, V60, P1303, DOI 10.1080/17470210600988976; Grondin S, 2008, PSYCHOLOGY OF TIME, P51, DOI 10.1016/B978-0-08046-977-5.00002-8; Gruber RP, 2003, HUM PSYCHOPHARM CLIN, V18, P351, DOI 10.1002/hup.501; Grusser SM, 2007, CYBERPSYCHOL BEHAV, V10, P290, DOI 10.1089/cpb.2006.9956; HANCOCK PA, 1993, J GEN PSYCHOL, V120, P197, DOI 10.1080/00221309.1993.9711144; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; KIKKAWA M, 1983, J CHILD DEV, V19, P14; Klapproth F, 2007, PERCEPT MOTOR SKILL, V104, P749, DOI 10.2466/PMS.104.3.749-757; Kurtz RM, 2003, INT J CLIN EXP HYP, V51, P400, DOI 10.1076/iceh.51.4.400.16412; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V34, P185, DOI 10.3758/BF03211347; MILLER GW, 1978, ACTA PSYCHOL, V42, P173, DOI 10.1016/0001-6918(78)90026-4; Predebon J, 1999, PERCEPT MOTOR SKILL, V88, P1251, DOI 10.2466/PMS.88.3.1251-1254; PREDEBON J, 1995, PERCEPT MOTOR SKILL, V80, P941, DOI 10.2466/pms.1995.80.3.941; Predebon J, 1996, ACTA PSYCHOL, V94, P41, DOI 10.1016/0001-6918(95)00044-5; Rau PLP, 2006, CYBERPSYCHOL BEHAV, V9, P396, DOI 10.1089/cpb.2006.9.396; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Thomas KE, 2008, ACTA PSYCHOL, V127, P24, DOI 10.1016/j.actpsy.2006.12.004; Tobin S, 2009, COMPUT HUM BEHAV, V25, P554, DOI 10.1016/j.chb.2008.12.002; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Wood RTA, 2007, CYBERPSYCHOL BEHAV, V10, P38, DOI 10.1089/cpb.2006.9994; Yarmey AD, 2000, APPL COGNITIVE PSYCH, V14, P45; ZAKAY D, 1993, PERCEPT PSYCHOPHYS, V54, P656, DOI 10.3758/BF03211789; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319; ZAKAY D, 1984, ACTA PSYCHOL, V57, P69, DOI 10.1016/0001-6918(84)90054-4; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; ZAKAY D, 1992, J EXP CHILD PSYCHOL, V54, P355, DOI 10.1016/0022-0965(92)90025-2	56	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9271	10.1371/journal.pone.0009271	http://dx.doi.org/10.1371/journal.pone.0009271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556KU	20174648	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590600024
J	Denecke, C; Bedi, DS; Ge, XP; Kim, IKE; Jurisch, A; Weiland, A; Habicht, A; Li, XC; Tullius, SG				Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Habicht, Antje; Li, Xian C.; Tullius, Stefan G.			Prolonged Graft Survival in Older Recipient Mice Is Determined by Impaired Effector T-Cell but Intact Regulatory T-Cell Responses	PLOS ONE			English	Article							AGE-RELATED-CHANGES; TRANSGENIC MODEL; IN-VIVO; ACTIVATION; REJECTION	Elderly organ transplant recipients represent a fast growing segment of patients on the waiting list. We examined age-dependent CD4(+) T-cell functions in a wild-type (WT) and a transgenic mouse transplant model and analyzed the suppressive function of old regulatory T-cells. We found that splenocytes of naive old B6 mice contained significantly higher frequencies of T-cells with an effector/memory phenotype (CD4(+)CD44(high)CD62L(low)). However, in-vitro proliferation (MLR) and IFN gamma-production (ELISPOT) were markedly reduced with increasing age. Likewise, skin graft rejection was significantly delayed in older recipients and fewer graft infiltrating CD4(+) T-cells were observed. Old CD4(+) T-cells demonstrated a significant impaired responsiveness as indicated by diminished proliferation and activation. In contrast, old alloantigen-specific CD4(+)CD25(+)FoxP3(+) T-cells demonstrated a dose-dependent well-preserved suppressor function. Next, we examined characteristics of 18-month old alloreactive T-cells in a transgenic adoptive transfer model. Adoptively transferred old T-cells proliferated significantly less in response to antigen. Skin graft rejection was significantly delayed in older recipients, and graft infiltrating cells were reduced. In summary, advanced recipient age was associated with delayed acute rejection and impaired CD4(+) T-cell function and proliferation while CD4(+)CD25(+)FoxP3(+) T-cells (Tregs) showed a well-preserved function.	[Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Tullius, Stefan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Transplant Surg, Boston, MA 02115 USA; [Denecke, Christian; Bedi, Damanpreet Singh; Ge, Xupeng; Kim, Irene Kyung-eun; Jurisch, Anke; Weiland, Anne; Tullius, Stefan G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Transplant Surg Res Lab, Boston, MA 02115 USA; [Habicht, Antje] Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA 02115 USA; [Habicht, Antje] Childrens Hosp, Boston, MA 02115 USA; [Li, Xian C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Res Ctr, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Denecke, C (corresponding author), Univ Hosp Berlin, Dept Gen Transplant & Visceral Surg, Charite, Berlin, Germany.	stullius@partners.org		Li, Xian Chang/0000-0002-5981-2762	Deutsche Forschungsgemeinschaft (DFG) [DE 1452/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	C. Denecke was supported by a Deutsche Forschungsgemeinschaft (DFG) Grant DE 1452/1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Elrefaei M, 2002, VIROLOGY, V299, P8, DOI 10.1006/viro.2002.1367; Fritsche L, 2003, AM J TRANSPLANT, V3, P1434, DOI 10.1046/j.1600-6135.2003.00251.x; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Habicht A, 2006, J IMMUNOL, V176, P36, DOI 10.4049/jimmunol.176.1.36; Haynes L, 1997, MECH AGEING DEV, V93, P95, DOI 10.1016/S0047-6374(96)01826-X; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Jassal S V, 1997, Geriatr Nephrol Urol, V7, P157, DOI 10.1023/A:1008246129084; Junt T, 2004, J IMMUNOL, V173, P6684, DOI 10.4049/jimmunol.173.11.6684; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891; Lufft V, 2000, TRANSPLANTATION, V69, P790; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P306, DOI 10.1097/00007890-200007270-00012; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Ming JK, 2003, J IMMUNOL, V170, P1556, DOI 10.4049/jimmunol.170.3.1556; Mu XY, 1999, J GERONTOL A-BIOL, V54, pB116, DOI 10.1093/gerona/54.3.B116; Pascher A, 2003, TRANSPLANTATION, V76, P1560, DOI 10.1097/01.TP.0000090161.79609.D3; ROSENBERG AS, 1994, EUR J IMMUNOL, V24, P1312, DOI 10.1002/eji.1830240611; Sandner SE, 2003, AM J TRANSPLANT, V3, P1242, DOI 10.1046/j.1600-6143.2003.00220.x; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Shen XH, 2009, CELL STEM CELL, V4, P1, DOI 10.1016/j.stem.2008.12.006; Sun YM, 2004, CELL MOL IMMUNOL, V1, P440; Tesar BM, 2009, AM J TRANSPLANT, V9, P54, DOI 10.1111/j.1600-6143.2008.02458.x; Uppaluri R, 2008, TRANSPLANTATION, V86, P137, DOI 10.1097/TP.0b013e31817b8e4b	24	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9232	10.1371/journal.pone.0009232	http://dx.doi.org/10.1371/journal.pone.0009232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169060	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500014
J	Chang, TC; Chen, YC; Yang, MH; Chen, CH; Hsing, EW; Ko, BS; Liou, JY; Wu, KK				Chang, Tzu-Ching; Chen, Yen-Chung; Yang, Ming-Hua; Chen, Chien-Hung; Hsing, En-Wei; Ko, Bor-Sheng; Liou, Jun-Yang; Wu, Kenneth K.			Rho Kinases Regulate the Renewal and Neural Differentiation of Embryonic Stem Cells in a Cell Plating Density-Dependent Manner	PLOS ONE			English	Article							SIGNALING PATHWAY; BETA-CATENIN; ROCK; PROTEINS; GTPASES; PHOSPHORYLATION; CYTOKINESIS; MAINTENANCE; COMMITMENT; INHIBITOR	Background: Rho kinases (ROCKs) mediate cell contraction, local adhesion, and cell motility, which are considered to be important in cell differentiation. We postulated that ROCKs are involved in controlling embryonic stem (ES) cell renewal and differentiation. Methodology/Principal Findings: CCE, a murine ES cell, was treated with Y-27632 for 48 to 96 hours and colony formation was evaluated. Y-27632 blocked CCE colony formation and induced CCE to grow as individual cells, regardless of the initial seeding cell density either at 10(4)/cm(2) ("high'' seeding density) or 2 x 10(3)/cm(2) ("low'' density). However, at high seeding density, Y-27632-treated cells exhibited reduction of alkaline phosphatase (AP) staining and Oct3/4 expression. They expressed SOX-1, nestin, and MAP2c, but not beta III-tubulin or NG-2. They did not express endoderm or mesoderm lineage markers. After removal of Y-27632, the cells failed to form colonies or regain undifferentiated state. Silencing of ROCK-1 or ROCK-2 with selective small interference RNA induced CCE morphological changes similar to Y-27632. Silencing of ROCK-1 or ROCK-2 individually was sufficient to cause reduction of AP and Oct3/4, and expression of SOX-1, nestin, and MAP2c; and combined silencing of both ROCKs did not augment the effects exerted by individual ROCK siRNA. Y-27632-treated CCE cells seeded at 2 x 10(3) or 6.6 x 10(3) cells/cm(2) did not lose renewal factors or express differentiation markers. Furthermore, they were able to form AP-positive colonies after removal of Y-27632 and reseeding. Similar to ROCK inhibition by Y-27632, silencing of ROCK-1 or ROCK-2 in cells seeded at 2 x 10(3)/cm(2) did not change renewal factors. Conclusions/Significance: We conclude that ROCKs promote ES cell colony formation, maintain them at undifferentiated state, and prevent them from neural differentiation at high seeding density. ROCK inhibition represents a new strategy for preparing large numbers of neural progenitor cells.	[Chang, Tzu-Ching; Chen, Yen-Chung; Yang, Ming-Hua; Chen, Chien-Hung; Hsing, En-Wei; Liou, Jun-Yang; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ko, Bor-Sheng; Wu, Kenneth K.] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Kenneth K.] Univ Texas Hlth Sci Ctr, Houston, TX USA	National Health Research Institutes - Taiwan; National Taiwan University; University of Texas System; University of Texas Health Science Center Houston	Chang, TC (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw	Liou, Jun-Yang/B-1065-2010; Wu, Kenneth Kun-Yu/B-1070-2010	KO, BOR-SHENG/0000-0002-7965-7579	National Science Council, Taiwan; National Health Research Institutes, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by a Stem Cell Flagship Center grant from the National Science Council, Taiwan, and intramural funding from the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Dietrich C, 2002, BIOCHEM BIOPH RES CO, V292, P195, DOI 10.1006/bbrc.2002.6625; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Liou JY, 2007, STEM CELLS, V25, P1096, DOI 10.1634/stemcells.2006-0505; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Pacary E, 2007, MOL CELL NEUROSCI, V35, P409, DOI 10.1016/j.mcn.2007.04.002; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Pelosi M, 2007, MOL CELL BIOL, V27, P6163, DOI 10.1128/MCB.01735-06; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249	30	26	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9187	10.1371/journal.pone.0009187	http://dx.doi.org/10.1371/journal.pone.0009187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169147	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474600008
J	Clarkson, BK; Gilbert, WV; Doudna, JA				Clarkson, Bryan K.; Gilbert, Wendy V.; Doudna, Jennifer A.			Functional Overlap between eIF4G Isoforms in Saccharomyces cerevisiae	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INITIATION-FACTOR EIF4G; RIBOSOMAL-RNA SYNTHESIS; FACTOR 4G EIF4G; MESSENGER-RNA; EUKARYOTIC TRANSLATION; PROTEIN-SYNTHESIS; HELICASE ACTIVITY; INTERNAL INITIATION; FEEDBACK-REGULATION	Initiation factor eIF4G is a key regulator of eukaryotic protein synthesis, recognizing proteins bound at both ends of an mRNA to help recruit messages to the small (40S) ribosomal subunit. Notably, the genomes of a wide variety of eukaryotes encode multiple distinct variants of eIF4G. We found that deletion of eIF4G1, but not eIF4G2, impairs growth and global translation initiation rates in budding yeast under standard laboratory conditions. Not all mRNAs are equally sensitive to loss of eIF4G1; genes that encode messages with longer poly(A) tails are preferentially affected. However, eIF4G1-deletion strains contain significantly lower levels of total eIF4G, relative to eIF4G2-delete or wild type strains. Homogenic strains, which encode two copies of either eIF4G1 or eIF4G2 under native promoter control, express a single isoform at levels similar to the total amount of eIF4G in a wild type cell and have a similar capacity to support normal translation initiation rates. Polysome microarray analysis of these strains and the wild type parent showed that translationally active mRNAs are similar. These results suggest that total eIF4G levels, but not isoform-specific functions, determine mRNA-specific translational efficiency.	[Clarkson, Bryan K.; Gilbert, Wendy V.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Clarkson, BK (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu		/0000-0003-2807-9657	NIH [K99]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM081399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a program grant from the NIH (JAD), a K99 award from the NIH (WVG) and an NIH training grant (BKC). JAD is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; [Anonymous], SACCHAROMYCES GENOME; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Bovee ML, 1998, VIROLOGY, V245, P241, DOI 10.1006/viro.1998.9172; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Coldwell MJ, 2006, MOL CELL BIOL, V26, P8448, DOI 10.1128/MCB.01248-06; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; Contreras V, 2008, CELL DEATH DIFFER, V15, P1232, DOI 10.1038/cdd.2008.46; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Dominguez D, 2001, BIOCHEM J, V355, P223, DOI 10.1042/0264-6021:3550223; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franklin-Dumont TM, 2007, DEVELOPMENT, V134, P2851, DOI 10.1242/dev.003517; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gentleman R, 2005, BIOINFORMATICS COMPU, p[xix, 473]; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guthrie C., 2002, GUIDE YEAST GENETICS; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hundsdoerfer P, 2005, P NATL ACAD SCI USA, V102, P13421, DOI 10.1073/pnas.0506536102; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kuhn KM, 2001, MOL CELL BIOL, V21, P916, DOI 10.1128/MCB.21.3.916-927.2001; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LANKER S, 1992, J BIOL CHEM, V267, P21167; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li L, 2005, EUKARYOT CELL, V4, P948, DOI 10.1128/EC.4.5.948-959.2005; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; MATHEWS M, 2007, TRANSLATIONAL CONTRO, pR10; MERRICK WC, 2000, CURRENT PROTOCOLS CE; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ng WL, 2003, J BACTERIOL, V185, P359, DOI 10.1128/JB.185.1.359-370.2003; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rasband W., 2006, IMAGEJ; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Searfoss AW, 2000, P NATL ACAD SCI USA, V97, P9133, DOI 10.1073/pnas.97.16.9133; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SPELLMAN PT, 1998, MOL BIOL CELL; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Tuteja Renu, 2009, Communicative & Integrative Biology, V2, P245; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; von der Haar T, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-87; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; YAMAGISHI M, 1987, J MOL BIOL, V198, P547, DOI 10.1016/0022-2836(87)90299-3; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	90	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9114	10.1371/journal.pone.0009114	http://dx.doi.org/10.1371/journal.pone.0009114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161741	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442600012
J	Zha, WB; Liang, G; Xiao, J; Studer, EJ; Hylemon, PB; Pandak, WM; Wang, GJ; Li, XK; Zhou, HP				Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Wang, Guangji; Li, Xiaokun; Zhou, Huiping			Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA STABILITY; INFECTED PATIENTS; NATURAL-PRODUCTS; IL-6 EXPRESSION; TNF-ALPHA; KINASE; TRISTETRAPROLIN; MEDICINE; ACTIVATE	Background: HIV protease inhibitor (PI)-induced inflammatory response plays an important role in HIV PI-associated dyslipidemia and cardiovascular complications. This study examined the effect of berberine, a traditional herb medicine, on HIV PI-induced inflammatory response and further investigated the underlying cellular/molecular mechanisms in macrophages. Methodology and Principal Findings: Cultured mouse J774A.1 macrophages and primary mouse macrophages were used in this study. The expression of TNF-alpha and IL-6 were detected by real-time RT-PCR and ELISA. Activations of ER stress and ERK signaling pathways were determined by Western blot analysis. Immunofluorescent staining was used to determine the intracellular localization of RNA binding protein HuR. RNA-pull down assay was used to determine the association of HuR with endogenous TNF-alpha and IL-6. Berberine significantly inhibited HIV PI-induced TNF-alpha and IL-6 expression by modulating ER stress signaling pathways and subsequent ERK activation, in turn preventing the accumulation of the RNA binding protein HuR in cytosol and inhibiting the binding of HuR to the 3'-UTRs of TNF-alpha and IL-6 in macrophages. Conclusions and Significance: Inhibition of ER stress represents a key mechanism by which berberine prevents HIV PI-induced inflammatory response. Our findings provide a new insight into the molecular mechanisms of berberine and show the potential application of berberine as a complimentary therapeutic agent for HIV infection.	[Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Virginia Commonwealth Univ, Dept Microbiol & Immunol & Internal Med Gastroent, Richmond, VA 23284 USA; [Zha, Weibin; Liang, Guang; Xiao, Jian; Studer, Elaine J.; Hylemon, Phillip B.; Pandak, William M., Jr.; Zhou, Huiping] Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Zha, Weibin] China Pharmaceut Univ, Nanjing 210009, Peoples R China; [Liang, Guang; Xiao, Jian; Wang, Guangji; Li, Xiaokun; Zhou, Huiping] Wenzhou Med Coll, Sch Pharm, Wenzhou, Peoples R China	Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; China Pharmaceutical University; Wenzhou Medical University	Zha, WB (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol & Internal Med Gastroent, Richmond, VA 23284 USA.	wangguangji01@gmail.com; hzhou@vcu.edu	Zhou, Huiping/H-6875-2019; Zhou, Huiping/J-3639-2015	Zhou, Huiping/0000-0002-0050-372X; 	NIH [R01AT004148, R21AI068432, R01AI057189, P01DK38030]; Wenzhou Medical College Key Project fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057189, R21AI068432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenzhou Medical College Key Project fund; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH Grants R01AT004148, R21AI068432, R01AI057189, and P01DK38030. A. D. William fund, and Wenzhou Medical College Key Project fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Asztalos BF, 2006, ATHEROSCLEROSIS, V184, P72, DOI 10.1016/j.atherosclerosis.2005.04.013; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen L, 2009, BIOCHEM PHARMACOL, V78, P70, DOI 10.1016/j.bcp.2009.03.022; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Clevenbergh P, 2003, HIV CLIN TRIALS, V4, P330, DOI 10.1310/8TXF-P814-8JPF-7TRY; Cohen Calvin J, 2005, AIDS Read, V15, P528; Cooper EL, 2005, EVID-BASED COMPL ALT, V2, P125, DOI 10.1093/ecam/neh094; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, pE955, DOI 10.1152/ajpendo.90599.2008; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim S, 2008, PHYTOMEDICINE, V15, P340, DOI 10.1016/j.phymed.2007.09.011; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lau CW, 2001, CARDIOVASC DRUG REV, V19, P234; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Lu JY, 2004, J BIOL CHEM, V279, P12974, DOI 10.1074/jbc.M310433200; Martinet W, 2004, Verh K Acad Geneeskd Belg, V66, P61; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Palmerini CA, 2008, J BIOCHEM MOL TOXIC, V22, P35, DOI 10.1002/jbt.20211; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; RASHEVA VI, 2009, APOPTOSIS; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Spector AA, 2006, ARTERIOSCL THROM VAS, V26, P7, DOI 10.1161/01.ATV.0000198749.28422.29; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou Huiping, 2007, Atherosclerosis, V195, pe134, DOI 10.1016/j.atherosclerosis.2007.04.008; Zhou HP, 2006, AM J PHYSIOL-GASTR L, V291, pG1071, DOI 10.1152/ajpgi.00182.2006; Zhu XZ, 2004, EUR J PHARMACOL, V500, P221, DOI 10.1016/j.ejphar.2004.07.027	36	54	59	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9069	10.1371/journal.pone.0009069	http://dx.doi.org/10.1371/journal.pone.0009069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161729	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442600004
J	Angeli, S; Shao, J; Diamond, MI				Angeli, Suzanne; Shao, Jieya; Diamond, Marc I.			F-Actin Binding Regions on the Androgen Receptor and Huntingtin Increase Aggregation and Alter Aggregate Characteristics	PLOS ONE			English	Article							BULBAR MUSCULAR-ATROPHY; POLYGLUTAMINE AGGREGATION; IN-VITRO; TOXICITY; PROTEINS; EXPRESSION; PROFILIN; CLEAVAGE; DISEASE; PHOSPHORYLATION	Protein aggregation is associated with neurodegeneration. Polyglutamine expansion diseases such as spinobulbar muscular atrophy and Huntington disease feature proteins that are destabilized by an expanded polyglutamine tract in their N-termini. It has previously been reported that intracellular aggregation of these target proteins, the androgen receptor (AR) and huntingtin (Htt), is modulated by actin-regulatory pathways. Sequences that flank the polyglutamine tract of AR and Htt might influence protein aggregation and toxicity through protein-protein interactions, but this has not been studied in detail. Here we have evaluated an N-terminal 127 amino acid fragment of AR and Htt exon 1. The first 50 amino acids of ARN127 and the first 14 amino acids of Htt exon 1 mediate binding to filamentous actin in vitro. Deletion of these actin-binding regions renders the polyglutamine-expanded forms of ARN127 and Htt exon 1 less aggregation-prone, and increases the SDS-solubility of aggregates that do form. These regions thus appear to alter the aggregation frequency and type of polyglutamine-induced aggregation. These findings highlight the importance of flanking sequences in determining the propensity of unstable proteins to misfold.	[Angeli, Suzanne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Shao, Jieya; Diamond, Marc I.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	University of California System; University of California San Francisco; Washington University (WUSTL)	Angeli, S (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	diamondm@neuro.wustl.edu		Angeli, Suzanne/0000-0002-6229-9648	NIH/NINDS [1 R01 NS50284, 5F31NS054604]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054604, R01NS050284] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Muscular Dystrophy Association: www.mda.org, NIH/NINDS: 1 R01 NS50284, NIH/NINDS: 5F31NS054604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; [Anonymous], CELL, V72, P971; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Burnett BG, 2008, NEUROBIOL DIS, V30, P365, DOI 10.1016/j.nbd.2008.02.007; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Diamond MI, 2000, P NATL ACAD SCI USA, V97, P657, DOI 10.1073/pnas.97.2.657; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; LI M, 2009, NEUROBIOL DIS; Li M, 2007, J BIOL CHEM, V282, P3157, DOI 10.1074/jbc.M609972200; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; THOMPSON LM, 2009, J CELL BIOL; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003	38	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9053	10.1371/journal.pone.0009053	http://dx.doi.org/10.1371/journal.pone.0009053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140226	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474400012
J	Weisser, H; Altmann, A; Sierra, S; Incardona, F; Struck, D; Sonnerborg, A; Kaiser, R; Zazzi, M; Tschochner, M; Walter, H; Lengauer, T				Weisser, Hendrik; Altmann, Andre; Sierra, Saleta; Incardona, Francesca; Struck, Daniel; Sonnerborg, Anders; Kaiser, Rolf; Zazzi, Maurizio; Tschochner, Monika; Walter, Hauke; Lengauer, Thomas			Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; TREATMENT FAILURE; INHIBITORS; PROTEASE; FITNESS; REGRESSION; MUTATION	Background: Replication capacity (RC) of specific HIV isolates is occasionally blamed for unexpected treatment responses. However, the role of viral RC in response to antiretroviral therapy is not yet fully understood. Materials and Methods: We developed a method for predicting RC from genotype using support vector machines (SVMs) trained on about 300 genotype-RC pairs. Next, we studied the impact of predicted viral RC (pRC) on the change of viral load (VL) and CD4(+) T-cell count (CD4) during the course of therapy on about 3,000 treatment change episodes (TCEs) extracted from the EuResist integrated database. Specifically, linear regression models using either treatment activity scores (TAS), the drug combination, or pRC or any combination of these covariates were trained to predict change in VL and CD4, respectively. Results: The SVM models achieved a Spearman correlation (rho) of 0.54 between measured RC and pRC. The prediction of change in VL (CD4) was best at 180 (360) days, reaching a correlation of rho = 0.45 (rho = 0.27). In general, pRC was inversely correlated to drug resistance at treatment start (on average rho = 20.38). Inclusion of pRC in the linear regression models significantly improved prediction of virological response to treatment based either on the drug combination or on the TAS (t-test; p-values range from 0.0247 to 4 10(-6)) but not for the model using both TAS and drug combination. For predicting the change in CD4 the improvement derived from inclusion of pRC was not significant. Conclusion: Viral RC could be predicted from genotype with moderate accuracy and could slightly improve prediction of virological treatment response. However, the observed improvement could simply be a consequence of the significant correlation between pRC and drug resistance.	[Weisser, Hendrik; Altmann, Andre; Lengauer, Thomas] Max Planck Inst Informat, Saarbrucken, Germany; [Sierra, Saleta; Kaiser, Rolf] Univ Cologne, Inst Virol, Cologne, Germany; [Incardona, Francesca] Informa SRL, Rome, Italy; [Struck, Daniel] CRP Sante, Retrovirol Lab, Strassen, Luxembourg; [Sonnerborg, Anders] Karolinska Inst, Div Infect Dis, Dept Med, Stockholm, Sweden; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Tschochner, Monika; Walter, Hauke] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany	Max Planck Society; University of Cologne; Luxembourg Institute of Health; Karolinska Institutet; University of Siena; University of Erlangen Nuremberg	Weisser, H (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	altmann@mpi-inf.mpg.de	Altmann, Andre/ABF-1675-2020; Sönnerborg, Anders/W-2011-2019; Zazzi, Maurizio/K-3422-2018	Altmann, Andre/0000-0002-9265-2393; Sönnerborg, Anders/0000-0001-8928-3374; Zazzi, Maurizio/0000-0002-0344-6281	EU [IST-2004-027173-STP]	EU(European Commission)	The work at Max Planck Institute for Informatics was supported by the EuResist project (EU grant IST-2004-027173-STP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2007, ANTIVIR THER, V12, P169; Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Balduin M, 2005, J CLIN VIROL, V34, P277, DOI 10.1016/j.jcv.2005.08.007; Beerenwinkel N, 2003, NUCLEIC ACIDS RES, V31, P3850, DOI 10.1093/nar/gkg575; Birkner MD, 2005, STAT APPL GENET MOL, V4; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; De Luca A, 2007, JAIDS-J ACQ IMM DEF, V45, P411, DOI 10.1097/QAI.0b013e318074f008; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; DIMITRIADOU E, 2007, E1071 MISC FUNCTIONS; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Grant P, 2009, CLIN INFECT DIS, V48, P680, DOI 10.1086/597008; Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269; Larder B, 2007, ANTIVIR THER, V12, P15; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Nijhuis M., 2009, V189, P299, DOI 10.1007/978-3-540-79086-0_11; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PERES Y, 2007, EUR J MED RES, P11; Perrin L, 1998, SCIENCE, V280, P1871, DOI 10.1126/science.280.5371.1871; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; Quinones-Mateu ME, 2002, DRUG RESIST UPDATE, V5, P224, DOI 10.1016/S1368-7646(02)00123-1; R Development Core Team, 2007, R LANG ENV STAT COMP; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Segal M.R., 2004, STAT APPL GENET MOL, V3; Segal M.R., 2004, STAT APPL GENET MOL, V3; Segal MR., 2004, STAT APPL GENET MOL, V3, P2, DOI [10.2202/1544-6115.1031, DOI 10.2202/1544-6115.1031]; Shafer RW, 2008, AIDS REV, V10, P67; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Vermeiren H, 2007, J VIROL METHODS, V145, P47, DOI 10.1016/j.jviromet.2007.05.009; Walter H, 1999, J CLIN VIROL, V13, P71, DOI 10.1016/S1386-6532(99)00010-4	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9044	10.1371/journal.pone.0009044	http://dx.doi.org/10.1371/journal.pone.0009044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140263	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200024
J	Xin, HQ; Li, Y; Shen, LH; Liu, XS; Wang, XL; Zhang, J; Pourabdollah-Nejad, S; Zhang, CL; Zhang, L; Jiang, H; Zhang, ZG; Chopp, M				Xin, Hongqi; Li, Yi; Shen, Li Hong; Liu, Xianshuang; Wang, Xinli; Zhang, Jing; Pourabdollah-Nejad, Siamak; Zhang, Chunling; Zhang, Li; Jiang, Hao; Zhang, Zheng Gang; Chopp, Michael			Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR PRODUCTION; ARTERY OCCLUSION MODEL; BONE-MARROW; FUNCTIONAL RECOVERY; AXONAL REGENERATION; REACTIVE ASTROCYTES; MATRIX-METALLOPROTEINASE	We demonstrate that tissue plasminogen activator (tPA) and its inhibitors contribute to neurite outgrowth in the central nervous system (CNS) after treatment of stroke with multipotent mesenchymal stromal cells (MSCs). In vivo, administration of MSCs to mice subjected to middle cerebral artery occlusion (MCAo) significantly increased activation of tPA and downregulated PAI-1 levels in the ischemic boundary zone (IBZ) compared with control PBS treated mice, concurrently with increases of myelinated axons and synaptophysin. In vitro, MSCs significantly increased tPA levels and concomitantly reduced plasminogen activator inhibitor 1 (PAI-1) expression in astrocytes under normal and oxygen and glucose deprivation (OGD) conditions. ELISA analysis of conditioned medium revealed that MSCs stimulated astrocytes to secrete tPA. When primary cortical neurons were cultured in the conditioned medium from MSC co-cultured astrocytes, these neurons exhibited a significant increase in neurite outgrowth compared to conditioned medium from astrocytes alone. Blockage of tPA with a neutralizing antibody or knock-down of tPA with siRNA significantly attenuated the effect of the conditioned medium on neurite outgrowth. Addition of recombinant human tPA into cortical neuronal cultures also substantially enhanced neurite outgrowth. Collectively, these in vivo and in vitro data suggest that the MSC mediated increased activation of tPA in astrocytes promotes neurite outgrowth after stroke.	[Xin, Hongqi; Li, Yi; Shen, Li Hong; Liu, Xianshuang; Wang, Xinli; Zhang, Jing; Pourabdollah-Nejad, Siamak; Zhang, Chunling; Zhang, Li; Jiang, Hao; Zhang, Zheng Gang; Chopp, Michael] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Xin, HQ (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.	chopp@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Xin, Hongqi/0000-0003-3172-416X; Nejad-Davarani, Siamak/0000-0002-2415-6689	National Institute of Neurological Disorders and Stroke (NINDS) [PO1 NS042345]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066041, P01NS042345] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/)grants PO1 NS042345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; An J, 2008, BLOOD, V112, P2787, DOI 10.1182/blood-2008-02-141630; Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Aoki C, 1998, PROG BRAIN RES, V118, P83; Barker PA, 2009, NAT NEUROSCI, V12, P105, DOI 10.1038/nn0209-105; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Braungart E, 2001, J INVEST DERMATOL, V116, P778, DOI 10.1046/j.1523-1747.2001.01310.x; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; CHOPP M, 2008, EUROPEAN NE IN PRESS; CHOPP M, 2006, ACUTE STROKE BENCH B, P473; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; CRUTCHER KA, 1986, CRIT REV NEUROBIOL, V2, P297; Cui X, 2008, NEUROSCIENCE, V156, P155, DOI 10.1016/j.neuroscience.2008.07.019; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; EDGAR D, 1985, J CELL SCI, P107; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fok-Seang J, 1998, EUR J NEUROSCI, V10, P2400, DOI 10.1046/j.1460-9568.1998.00251.x; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Gabriel C, 2002, FASEB J, V16, P277, DOI 10.1096/fj.02-0403fje; Gao Q, 2008, NEUROSCIENCE, V152, P646, DOI 10.1016/j.neuroscience.2007.10.069; Gravanis I, 2005, GLIA, V49, P177, DOI 10.1002/glia.20115; Hardy SA, 2008, CURR STEM CELL RES T, V3, P43; Hino H, 2001, NEUROSCI LETT, V297, P105, DOI 10.1016/S0304-3940(00)01679-7; Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Kahles T, 2005, VASC PHARMACOL, V43, P254, DOI 10.1016/j.vph.2005.07.008; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kucharewicz I, 2003, THROMB RES, V112, P1, DOI 10.1016/j.thromres.2003.10.011; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; LAWRENCE DA, 1990, J BIOL CHEM, V265, P20293; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lee SR, 2007, NEUROSCIENCE, V150, P50, DOI 10.1016/j.neuroscience.2007.06.029; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Lu WQ, 2002, DEVELOPMENT, V129, P2043; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Matsui Fumiko, 2004, Congenital Anomalies, V44, P181, DOI 10.1111/j.1741-4520.2004.00038.x; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Nolin WB, 2008, GLIA, V56, P177, DOI 10.1002/glia.20603; Oikawa K, 2000, XENOBIOTICA, V30, P993, DOI 10.1080/00498250050200140; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Peltonen S, 1996, THROMB RES, V82, P369, DOI 10.1016/0049-3848(96)00086-2; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Ribotta MG, 2004, ACTA NEUROCHIR SUPPL, V89, P87; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; SALTHOUSE TN, 1964, STAIN TECHNOL, V39, P123; Samson AL, 2008, J NEUROCHEM, V107, P1091, DOI 10.1111/j.1471-4159.2008.05687.x; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; SHICHINOHE H, 2009, NEUROPATHOLOGY; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Siao CJ, 2002, CELL MOL BIOL, V48, P151; SIDDIQUI S, 2009, GLIA; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; TOSHNIWAL PK, 1987, J NEUROL SCI, V80, P277, DOI 10.1016/0022-510X(87)90162-6; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/BST0300222; Tzarfaty-Majar V, 2001, J BIOL CHEM, V276, P28233, DOI 10.1074/jbc.M102585200; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Vivien D, 2000, J CEREBR BLOOD F MET, V20, P755, DOI 10.1097/00004647-200005000-00001; von Bohlen und Halbach O, 1998, J NEUROSCI METH, V81, P169, DOI 10.1016/S0165-0270(98)00026-0; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YF, 1997, EXP EYE RES, V65, P105, DOI 10.1006/exer.1997.0314; Wozniak W, 1993, Folia Morphol (Warsz), V52, P173; Wu YP, 2000, J CELL BIOL, V148, P1295, DOI 10.1083/jcb.148.6.1295; Xin HQ, 2006, J NEUROSCI RES, V83, P1485, DOI 10.1002/jnr.20834; Yamada K, 2008, BIOL PHARM BULL, V31, P1635, DOI 10.1248/bpb.31.1635; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Yepes M, 2004, THROMB HAEMOSTASIS, V91, P457, DOI 10.1160/TH03-12-0766; Yepes M, 2000, BLOOD, V96, P569; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang J, 2004, BRAIN RES, V1030, P19, DOI 10.1016/j.brainres.2004.09.061; Zhang N, 2005, J NEUROSCI, V25, P2761, DOI 10.1523/JNEUROSCI.3195-04.2005; Zhang Y, 2009, POLYM COMPOSITE, V30, P38, DOI 10.1002/pc.20526; Zheng S, 2008, MOL VIS, V14, P975	102	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9027	10.1371/journal.pone.0009027	http://dx.doi.org/10.1371/journal.pone.0009027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140248	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200013
J	Nichol, KL; Tummers, K; Hoyer-Leitzel, A; Marsh, J; Moynihan, M; McKelvey, S				Nichol, Kristin L.; Tummers, Kate; Hoyer-Leitzel, Alanna; Marsh, Jennifer; Moynihan, Matt; McKelvey, Steven			Modeling Seasonal Influenza Outbreak in a Closed College Campus: Impact of Pre-Season Vaccination, In-Season Vaccination and Holidays/Breaks	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; RESPIRATORY ILLNESSES; MIXING PATTERNS; SCHOOL CLOSURE; HAND HYGIENE; TRANSMISSION; HEALTH; SPREAD; ADULTS; SIMULATION	Background: College and university students experience substantial morbidity from influenza and influenza-like illness, and they can benefit substantially from vaccination. Public health authorities encourage vaccination not only before the influenza season but also into and even throughout the influenza season. We conducted the present study to assess the impact of various vaccination strategies including delayed (i.e., in-season) vaccination on influenza outbreaks on a college campus. Methods/Findings: We used a Susceptible R Infected R Recovered (SIR) framework for our mathematical models to simulate influenza epidemics in a closed, college campus. We included both students and faculty/staff in the model and derived values for the model parameters from the published literature. The values for key model parameters were varied to assess the impact on the outbreak of various pre-season and delayed vaccination rates; one-way sensitivity analyses were conducted to test the sensitivity of the model outputs to changes in selected parameter values. In the base case, with a pre-season vaccination rate of 20%, no delayed vaccination, and 1 student index case, the total attack rate (total percent infected, TAR) was 45%. With higher pre-season vaccination rates TARs were lower. Even if vaccinations were given 30 days after outbreak onset, TARs were still lower than the TAR of 69% in the absence of vaccination. Varying the proportions of vaccinations given pre-season versus delayed until after the onset of the outbreak gave intermediate TAR values. Base case outputs were sensitive to changes in infectious contact rates and infectious periods and a holiday/break schedule. Conclusion: Delayed vaccination and holidays/breaks can be important adjunctive measures to complement traditional pre-eason influenza vaccination for controlling and preventing influenza in a closed college campus.	[Nichol, Kristin L.] Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA; [Nichol, Kristin L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Tummers, Kate; Hoyer-Leitzel, Alanna; Marsh, Jennifer; Moynihan, Matt; McKelvey, Steven] St Olaf Coll, Dept Math Stat & Comp Sci, Northfield, MN 55057 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Saint Olaf College	Nichol, KL (corresponding author), Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA.	nicho014@umn.edu			Minneapolis Veterans Affairs Medical Center; St. Olaf College	Minneapolis Veterans Affairs Medical Center; St. Olaf College	This project was supported in part by the Minneapolis Veterans Affairs Medical Center and St. Olaf College. These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no external sources of funding for this project.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Allen L.J.S., 2010, INTRO STOCHASTIC PRO; American College Health Association, 2006, NAT COLL HLTH ASS RE; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; CDC, 2008, MMWR EARLY RELEASE, V57, P1; COUCH RB, 1993, ANN NY ACAD SCI, V685, P803, DOI 10.1111/j.1749-6632.1993.tb35946.x; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub2; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; LAYDE PM, 1980, J INFECT DIS, V142, P347, DOI 10.1093/infdis/142.3.347; LONGINI IM, 1984, INT J EPIDEMIOL, V13, P496, DOI 10.1093/ije/13.4.496; MOGABGAB WJ, 1968, AM REV RESPIR DIS, V98, P359; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nichol KL, 2006, VACCINE, V24, P6724, DOI 10.1016/j.vaccine.2006.05.033; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Nichol KL, 2008, ARCH PEDIAT ADOL MED, V162, P1113, DOI 10.1001/archpedi.162.12.1113; Orenstein WA, 2008, AM J MED, V121, pS22, DOI 10.1016/j.amjmed.2008.05.004; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Poland GA, 2008, AM J MED, V121, pS3, DOI 10.1016/j.amjmed.2008.05.002; PONS VG, 1980, AM J EPIDEMIOL, V111, P23, DOI 10.1093/oxfordjournals.aje.a112871; SOBAL J, 1982, PUBLIC HEALTH REP, V97, P66; TRUSCOTT J, 2009, PLOS CURR INFLU 1103; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009	38	37	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9548	10.1371/journal.pone.0009548	http://dx.doi.org/10.1371/journal.pone.0009548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209058	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100025
J	Jambou, R; Martinelli, A; Pinto, J; Gribaldo, S; Legrand, E; Niang, M; Kim, N; Pharath, L; Volnay, B; Ekala, MT; Bouchier, C; Fandeur, T; Berzosa, P; Benito, A; Ferreira, ID; Ferreira, C; Vieira, PP; Alecrim, MD; Mercereau-Puijalon, O; Cravo, P				Jambou, Ronan; Martinelli, Axel; Pinto, Joao; Gribaldo, Simonetta; Legrand, Eric; Niang, Makhtar; Kim, Nimol; Pharath, Lim; Volnay, Beatrice; Ekala, Marie Therese; Bouchier, Christiane; Fandeur, Thierry; Berzosa, Pedro; Benito, Agustin; Ferreira, Isabel Dinis; Ferreira, Cynthia; Vieira, Pedro Paulo; Alecrim, Maria das Gracas; Mercereau-Puijalon, Odile; Cravo, Pedro			Geographic Structuring of the Plasmodium falciparum Sarco(endo)plasmic Reticulum Ca2+ATPase (PfSERCA) Gene Diversity	PLOS ONE			English	Article							ARTEMISININ-RESISTANT MALARIA; CA2+ ATPASE; CHLOROQUINE-RESISTANCE; ARTESUNATE-MEFLOQUINE; COMBINATION THERAPY; S-GLUTATHIOLATION; POINT MUTATIONS; CA2+-ATPASE; SERCA; SEQUENCE	Artemisinin, a thapsigargin-like sesquiterpene has been shown to inhibit the Plasmodium falciparum sarco/endoplasmic reticulum calcium-ATPase PfSERCA. To collect baseline pfserca sequence information before field deployment of Artemisinin-based Combination therapies that may select mutant parasites, we conducted a sequence analysis of 100 isolates from multiple sites in Africa, Asia and South America. Coding sequence diversity was large, with 29 mutated codons, including 32 SNPs (average of one SNP/115 bp), of which 19 were novel mutations. Most SNP detected in this study were clustered within a region in the cytosolic head of the protein. The PfSERCA functional domains were very well conserved, with non synonymous mutations located outside the functional domains, except for the S769N mutation associated in French Guiana with elevated IC50 for artemether. The S769N mutation is located close to the hinge of the headpiece, which in other species modulates calcium affinity and in consequence efficacy of inhibitors, possibly linking calcium homeostasis to drug resistance. Genetic diversity was highest in Senegal, Brazil and French Guiana, and few mutations were identified in Asia. Population genetic analysis was conducted for a partial fragment of the gene encompassing nucleotide coordinates 87-2862 (unambiguous sequence available for 96 isolates). This supported a geographic clustering, with a separation between Old and New World samples and one dominant ancestral haplotype. Genetic drift alone cannot explain the observed polymorphism, suggesting that other evolutionary mechanisms are operating. One possible contributor could be the frequency of haemoglobinopathies that are associated with calcium dysregulation in the erythrocyte.	[Jambou, Ronan; Niang, Makhtar] Inst Pasteur, Dakar, Senegal; [Jambou, Ronan; Gribaldo, Simonetta; Ekala, Marie Therese; Bouchier, Christiane] Inst Pasteur, Paris, France; [Martinelli, Axel; Pinto, Joao; Ferreira, Isabel Dinis; Mercereau-Puijalon, Odile; Cravo, Pedro] Univ Nova Lisboa, UEI Malaria, UEI Biol Mol, Ctr Malaria & Outras Doencas Tropicais IHMT, Lisbon, Portugal; [Legrand, Eric; Volnay, Beatrice] Inst Pasteur, Cayenne, French Guiana; [Kim, Nimol; Pharath, Lim; Fandeur, Thierry] Inst Pasteur Cambodge, Phnom Penh, Cambodia; [Berzosa, Pedro; Benito, Agustin] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Ferreira, Cynthia; Vieira, Pedro Paulo; Alecrim, Maria das Gracas] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT)	Jambou, R (corresponding author), Inst Pasteur, BP 220, Dakar, Senegal.	rjambou@pasteur.fr	JAMBOU, RONAN/CAG-3718-2022; Cravo, Pedro/AET-0639-2022; Pinto, Joao/C-2208-2012; J., Pinto/H-6177-2019; gribaldo, simonetta/AAW-4377-2020; Cravo, Pedro VL/G-3532-2012; Mercereau-Puijalon, Odile/AAA-2242-2020	Cravo, Pedro/0000-0003-1675-4504; Pinto, Joao/0000-0001-8572-7708; J., Pinto/0000-0001-8572-7708; gribaldo, simonetta/0000-0002-7662-021X; Cravo, Pedro VL/0000-0003-1675-4504; Legrand, Eric/0000-0003-4725-0712; Berzosa, Pedro/0000-0002-8768-717X; Lim, Pharath/0000-0002-1012-2461; Benito, Agustin/0000-0001-8229-5540	Louis D. Foundation (Academie des Sciences, Paris, France); FSP-RAI programme (Ministere francais des Affaires etrangeres); European Commission [QLK2-CT20021-1503]; FAPEAM/CNPq; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)	Louis D. Foundation (Academie des Sciences, Paris, France); FSP-RAI programme (Ministere francais des Affaires etrangeres); European Commission(European CommissionEuropean Commission Joint Research Centre); FAPEAM/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET)	This study was supported by the Louis D. Foundation (Academie des Sciences, Paris, France), the FSP-RAI programme (Ministere francais des Affaires etrangeres), the European Commission (contract QLK2-CT20021-1503) ResMalChip project, the FAPEAM/CNPq. P. Berzosa was supported by the Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Christensen SB, 2009, ANTI-CANCER AGENT ME, V9, P276, DOI 10.2174/1871520610909030276; Cohen RA, 2006, TRENDS CARDIOVAS MED, V16, P109, DOI 10.1016/j.tcm.2006.02.001; Cojean S, 2006, EMERG INFECT DIS, V12, P1798, DOI 10.3201/eid1211.060903; CRANDALL KA, 1993, GENETICS, V134, P959; Dahlstrom S, 2008, INFECT GENET EVOL, V8, P340, DOI 10.1016/j.meegid.2008.02.002; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ekala MT, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-164; Ferreira ID, 2007, TROP MED INT HEALTH, V12, P353, DOI 10.1111/j.1365-3156.2006.01789.x; Foller M, 2008, IUBMB LIFE, V60, P661, DOI 10.1002/iub.106; FU YX, 1993, GENETICS, V133, P693; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Hebbel R P, 1981, Prog Clin Biol Res, V51, P321; HUDSON RR, 1992, GENETICS, V132, P583; Hunt P, 2004, MOL BIOCHEM PARASIT, V133, P27, DOI 10.1016/j.molbiopara.2003.08.010; Ibrahim ML, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-28; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Jung M, 2005, BIOORG MED CHEM LETT, V15, P2994, DOI 10.1016/j.bmcl.2005.04.041; KAWAZOE U, 2008, EXPT PARASITOLOGY, V118, P2; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KIMURA M, 1993, J CELL SCI, V104, P1129; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Legrand E, 2007, EMERG INFECT DIS, V13, P808, DOI 10.3201/eid1305.061442; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; Menegon M, 2008, PARASITOL INT, V57, P233, DOI 10.1016/j.parint.2007.12.004; MENTZER WC, 1983, BIOMEMBRANE, V11, P79; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2007, ANTIMICROB AGENTS CH, V51, P3816, DOI 10.1128/AAC.00582-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe K, 2004, J MOL EVOL, V59, P687, DOI 10.1007/s00239-004-2662-3; TEMPLETON AR, 1992, GENETICS, V132, P619; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; TOSHIHIKO T, 1992, J BIOL CHEM, V267, P14490; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2003, FEBS LETT, V555, P106, DOI 10.1016/S0014-5793(03)01086-X; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; World Health Organization, 2008, WORLD MAL REP; Wu SN, 2003, CURR MED CHEM, V10, P649, DOI 10.2174/0929867033457863; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Yu MH, 1999, ARCH BIOCHEM BIOPHYS, V362, P225, DOI 10.1006/abbi.1998.1049	67	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9424	10.1371/journal.pone.0009424	http://dx.doi.org/10.1371/journal.pone.0009424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195531	gold, Green Published			2022-12-27	WOS:000274924300012
J	Zuccolo, J; Bau, J; Childs, SJ; Goss, GG; Sensen, CW; Deans, JP				Zuccolo, Jonathan; Bau, Jeremy; Childs, Sarah J.; Goss, Greg G.; Sensen, Christoph W.; Deans, Julie P.			Phylogenetic Analysis of the MS4A and TMEM176 Gene Families	PLOS ONE			English	Article							EPSILON-RI-BETA; T-CELLS; CD20; PROTEIN; IDENTIFICATION; EXPRESSION; RITUXIMAB; CHANNEL; LOCALIZATION; LYMPHOCYTES	Background: The MS4A gene family in humans includes CD20 (MS4A1), FcRb (MS4A2), Htm4 (MS4A3), and at least 13 other syntenic genes encoding membrane proteins, most having characteristic tetraspanning topology. Expression of MS4A genes is variable in tissues throughout the body; however, several are limited to cells in the hematopoietic system where they have known roles in immune cell functions. Genes in the small TMEM176 group share significant sequence similarity with MS4A genes and there is evidence of immune function of at least one of the encoded proteins. In this study, we examined the evolutionary history of the MS4A/TMEM176 families as well as tissue expression of the phylogenetically earliest members, in order to investigate their possible origins in immune cells. Principal Findings: Orthologs of human MS4A genes were found only in mammals; however, MS4A gene homologs were found in most jawed vertebrates. TMEM176 genes were found only in mammals and bony fish. Several unusual MS4A genes having 2 or more tandem MS4A sequences were identified in the chicken (Gallus gallus) and early mammals ( opossum, Monodelphis domestica and platypus, Ornithorhyncus anatinus). A large number of highly conserved MS4A and TMEM176 genes was found in zebrafish ( Danio rerio). The most primitive organism identified to have MS4A genes was spiny dogfish ( Squalus acanthus). Tissue expression of MS4A genes in S. acanthias and D. rerio showed no evidence of expression restricted to the hematopoietic system. Conclusions/Significance: Our findings suggest that MS4A genes first appeared in cartilaginous fish with expression outside of the immune system, and have since diversified in many species into their modern forms with expression and function in both immune and nonimmune cells.	[Zuccolo, Jonathan; Bau, Jeremy; Childs, Sarah J.; Sensen, Christoph W.; Deans, Julie P.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Zuccolo, Jonathan; Bau, Jeremy; Deans, Julie P.] Univ Calgary, Fac Med, Immunol Res Grp, Inst Infect Immun & Inflammat, Calgary, AB, Canada; [Sensen, Christoph W.] Univ Calgary, Fac Med, Sun Ctr Excellence Visual Genom, Calgary, AB, Canada; [Goss, Greg G.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Goss, Greg G.] Bamfield Marine Sci Ctr, Bamfield, BC, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; Simon Fraser University	Zuccolo, J (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jdeans@ucalgary.ca	Sensen, Christoph W./C-1798-2013; Childs, Sarah/AAG-5111-2021; Goss, Greg G/A-2646-2014; Goss, Greg/D-2723-2015	Sensen, Christoph W./0000-0001-9604-8962; Goss, Greg/0000-0003-0786-8868; Bau, Jeremy/0000-0002-8264-0698; Childs, Sarah/0000-0003-2261-580X	Canadian Institutes of Health Research [15095]; Alberta Cancer Research Institute; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	Research was supported by operating grant no. 15095 from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). JZ is supported by a graduate studentship from the Alberta Cancer Research Institute. JB was supported by a summer studentship from the Alberta Heritage Foundation for Medical Research. SJC is a Senior Scholar of the Alberta Heritage Foundation for Medical Research and holds a Tier II Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker YT, 2006, TRANSPL INT, V19, P621, DOI 10.1111/j.1432-2277.2006.00345.x; BUBIEN JK, 1993, J CELL BIOL, V121, P1121, DOI 10.1083/jcb.121.5.1121; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Dombrowicz D, 1998, IMMUNITY, V8, P517, DOI 10.1016/S1074-7613(00)80556-7; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gopal AK, 1999, J LAB CLIN MED, V134, P445, DOI 10.1016/S0022-2143(99)90164-6; Howie D, 2009, J IMMUNOL, V183, P4197, DOI 10.4049/jimmunol.0901070; Hulett MD, 2001, BIOCHEM BIOPH RES CO, V280, P374, DOI 10.1006/bbrc.2000.4088; Ishibashi K, 2001, GENE, V264, P87, DOI 10.1016/S0378-1119(00)00598-9; Ju YK, 2003, J CELL PHYSIOL, V197, P53, DOI 10.1002/jcp.10347; KANZAKI M, 1995, J BIOL CHEM, V270, P13099, DOI 10.1074/jbc.270.22.13099; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Koslowski M, 2008, CANCER RES, V68, P3458, DOI 10.1158/0008-5472.CAN-07-5768; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HD, 2003, J BIOL CHEM, V278, P42427, DOI 10.1074/jbc.M308802200; Liang YH, 2001, GENOMICS, V72, P119, DOI 10.1006/geno.2000.6472; Liang YH, 2001, IMMUNOGENETICS, V53, P357, DOI 10.1007/s002510100339; Louvet C, 2005, AM J TRANSPLANT, V5, P2143, DOI 10.1111/j.1600-6143.2005.01007.x; Maeda Y, 2006, BRAIN RES, V1104, P18, DOI 10.1016/j.brainres.2006.05.068; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nicholas KB., 1997, GENEDOC TOOL EDITING; Pescovitz MD, 2006, AM J TRANSPLANT, V6, P859, DOI 10.1111/j.1600-6143.2006.01288.x; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Rastetter W, 2004, ANNU REV MED, V55, P477, DOI 10.1146/annurev.med.55.091902.104249; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SANDFORD AJ, 1995, EUR J HUM GENET, V3, P188; THISSE C, 1993, DEVELOPMENT, V119, P1203; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Westerfield M, 1993, ZEBRAFISH BOOK; Xiao YL, 2008, J IMMUNOL, V181, P1071, DOI 10.4049/jimmunol.181.2.1071; Xu H, 2006, BLOOD, V107, P2400, DOI 10.1182/blood-2005-08-3340	35	50	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9369	10.1371/journal.pone.0009369	http://dx.doi.org/10.1371/journal.pone.0009369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186339	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924000012
J	Bouzigues, C; Holcman, D; Dahan, M				Bouzigues, Cedric; Holcman, David; Dahan, Maxime			A Mechanism for the Polarity Formation of Chemoreceptors at the Growth Cone Membrane for Gradient Amplification during Directional Sensing	PLOS ONE			English	Article							CELL POLARITY; DICTYOSTELIUM-DISCOIDEUM; EUKARYOTIC CHEMOTAXIS; MOLECULAR GRADIENTS; GABA(A) RECEPTOR; GUIDANCE CUES; AXONS; DYNAMICS; PROTEIN; POLARIZATION	Accurate response to external directional signals is essential for many physiological functions such as chemotaxis or axonal guidance. It relies on the detection and amplification of gradients of chemical cues, which, in eukaryotic cells, involves the asymmetric relocalization of signaling molecules. How molecular events coordinate to induce a polarity at the cell level remains however poorly understood, particularly for nerve chemotaxis. Here, we propose a model, inspired by single-molecule experiments, for the membrane dynamics of GABA chemoreceptors in nerve growth cones (GCs) during directional sensing. In our model, transient interactions between the receptors and the microtubules, coupled to GABA-induced signaling, provide a positive-feedback loop that leads to redistribution of the receptors towards the gradient source. Using numerical simulations with parameters derived from experiments, we find that the kinetics of polarization and the steady-state polarized distribution of GABA receptors are in remarkable agreement with experimental observations. Furthermore, we make predictions on the properties of the GC seen as a sensing, amplification and filtering module. In particular, the growth cone acts as a low-pass filter with a time constant,10 minutes determined by the Brownian diffusion of chemoreceptors in the membrane. This filtering makes the gradient amplification resistent to rapid fluctuations of the external signals, a beneficial feature to enhance the accuracy of neuronal wiring. Since the model is based on minimal assumptions on the receptor/cytoskeleton interactions, its validity extends to polarity formation beyond the case of GABA gradient sensing. Altogether, it constitutes an original positive-feedback mechanism by which cells can dynamically adapt their internal organization to external signals.	[Bouzigues, Cedric] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,U696, F-7645 Palaiseau, France; [Holcman, David; Dahan, Maxime] Ecole Normale Super, Dept Biol, F-75231 Paris, France; [Dahan, Maxime] Univ Paris 06, CNRS, Ecole Normale Super, Lab Kastler Brossel,UMR 8552, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS)	Bouzigues, C (corresponding author), Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,U696, F-7645 Palaiseau, France.	cedric.bouzigues@polytechnique.edu	Holcman, David/L-9243-2013; Dahan, Maxime/F-1740-2010	holcman, david/0000-0001-9854-5014; Dahan, Maxime/0000-0002-4943-2491	Fondation pour la recherche medicale; Fondation Pierre-Gilles de Gennes	Fondation pour la recherche medicale(Fondation pour la Recherche Medicale); Fondation Pierre-Gilles de Gennes	Sources of funding: Fondation pour la recherche medicale (www.frm.org) - Fondation Pierre-Gilles de Gennes (www.fondation-pgg.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Bak M, 2003, DEVELOPMENT, V130, P4999, DOI 10.1242/dev.00713; BOUZIGUES C, 2007, BIOPHYSICAL J, V92; Bouzigues Cedric, 2007, Methods Mol Biol, V374, P81; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Bray D, 1998, ANNU REV BIOPH BIOM, V27, P59, DOI 10.1146/annurev.biophys.27.1.59; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; CARUNCHO HJ, 1995, NEUROSCIENCE, V67, P583, DOI 10.1016/0306-4522(95)00065-Q; Causin P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000479; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; de Keijzer S, 2008, J CELL SCI, V121, P1750, DOI 10.1242/jcs.030692; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; EDIDIN M, 1994, P NATL ACAD SCI USA, V91, P1378; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; FLYVBJERG H, 1994, PHYS REV LETT, V73, P2372, DOI 10.1103/PhysRevLett.73.2372; Franca-Koh J, 2004, PHYSIOLOGY, V19, P300, DOI 10.1152/physiol.00017.2004; Fukura H, 1996, J NEUROCHEM, V67, P1426; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Huberman AD, 2007, CURR OPIN NEUROBIOL, V17, P73, DOI 10.1016/j.conb.2007.01.005; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Karsenti E, 2006, NAT CELL BIOL, V8, P1204, DOI 10.1038/ncb1498; Kulkarni RP, 2007, P NATL ACAD SCI USA, V104, P1207, DOI 10.1073/pnas.0610142104; LEUNG KM, 2006, NAT NEUROSCI, V9, P1201; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lin AC, 2007, EMBO J, V26, P3729, DOI 10.1038/sj.emboj.7601808; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Meinhardt H, 1999, J CELL SCI, V112, P2867; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Morel M, 2009, LAB CHIP, V9, P1011, DOI 10.1039/b819090a; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Mortimer D, 2009, P NATL ACAD SCI USA, V106, P10296, DOI 10.1073/pnas.0900715106; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; POSTMA M, 2001, BIOPHYS J, V81, P612; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Singer A, 2006, J STAT PHYS, V122, P437, DOI 10.1007/s10955-005-8026-6; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Stepanova T, 2003, J NEUROSCI, V23, P2655; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Suter DM, 2004, CURR BIOL, V14, P1194, DOI 10.1016/j.cub.2004.06.049; Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	59	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9243	10.1371/journal.pone.0009243	http://dx.doi.org/10.1371/journal.pone.0009243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179770	Green Published, gold			2022-12-27	WOS:000274923900003
J	Sammons, MA; Antons, AK; Bendjennat, M; Udd, B; Krahe, R; Link, AJ				Sammons, Morgan A.; Antons, Amanda K.; Bendjennat, Mourad; Udd, Bjarne; Krahe, Ralf; Link, Andrew J.			ZNF9 Activation of IRES-Mediated Translation of the Human ODC mRNA Is Decreased in Myotonic Dystrophy Type 2	PLOS ONE			English	Article							EXPANDED-REPEAT TRANSCRIPTS; TRANS-ACTING FACTORS; MASS-SPECTROMETRY; T-CELLS; IN-VIVO; PROTEIN TRANSLATION; CUG REPEATS; LA PROTEIN; DM2; EXPRESSION	Myotonic dystrophy types 1 and 2 (DM1 and DM2) are forms of muscular dystrophy that share similar clinical and molecular manifestations, such as myotonia, muscle weakness, cardiac anomalies, cataracts, and the presence of defined RNA-containing foci in muscle nuclei. DM2 is caused by an expansion of the tetranucleotide CCTG repeat within the first intron of ZNF9, although the mechanism by which the expanded nucleotide repeat causes the debilitating symptoms of DM2 is unclear. Conflicting studies have led to two models for the mechanisms leading to the problems associated with DM2. First, a gain-of-function disease model hypothesizes that the repeat expansions in the transcribed RNA do not directly affect ZNF9 function. Instead repeat-containing RNAs are thought to sequester proteins in the nucleus, causing misregulation of normal cellular processes. In the alternative model, the repeat expansions impair ZNF9 function and lead to a decrease in the level of translation. Here we examine the normal in vivo function of ZNF9. We report that ZNF9 associates with actively translating ribosomes and functions as an activator of cap-independent translation of the human ODC mRNA. This activity is mediated by direct binding of ZNF9 to the internal ribosome entry site sequence (IRES) within the 5'UTR of ODC mRNA. ZNF9 can activate IRES-mediated translation of ODC within primary human myoblasts, and this activity is reduced in myoblasts derived from a DM2 patient. These data identify ZNF9 as a regulator of cap-independent translation and indicate that ZNF9 activity may contribute mechanistically to the myotonic dystrophy type 2 phenotype.	[Sammons, Morgan A.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Udd, Bjarne] Tampere Univ Hosp & Med Sch, Neuromuscular Res Unit, Tampere, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Krahe, Ralf] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Antons, Amanda K.; Bendjennat, Mourad; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA	Vanderbilt University; University of Helsinki; Tampere University; Tampere University Hospital; Vaasa Central Hospital; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University	Sammons, MA (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	andrew.link@vanderbilt.edu			National Institutes of Health (NIH) [AR055231, GM064779]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.L. was supported by National Institutes of Health (NIH) grants AR055231 and GM064779. M. A. S. was supported by National Institutes of Health (NIH) grant AR055231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, DEV BIOL, V295, P116, DOI 10.1016/j.ydbio.2006.03.012; Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2002, J CELL BIOL, V159, P419, DOI 10.1083/jcb.200206020; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Botta A, 2006, BBA-MOL BASIS DIS, V1762, P329, DOI 10.1016/j.bbadis.2005.11.004; Cardinali B, 2003, J BIOL CHEM, V278, P35145, DOI 10.1074/jbc.M300722200; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Chen W, 2007, J MOL BIOL, V368, P8, DOI 10.1016/j.jmb.2007.01.088; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; Crosio C, 2000, NUCLEIC ACIDS RES, V28, P2927, DOI 10.1093/nar/28.15.2927; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Pellizzoni L, 1998, J MOL BIOL, V281, P593, DOI 10.1006/jmbi.1998.1961; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ranum Laura P W, 2002, Curr Neurol Neurosci Rep, V2, P465, DOI 10.1007/s11910-002-0074-6; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; Sallinen R, 2004, NEUROMUSCULAR DISORD, V14, P274, DOI 10.1016/j.nmd.2004.01.002; Scheper GC, 2006, TRENDS MOL MED, V12, P159, DOI 10.1016/j.molmed.2006.02.006; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Sundrud MS, 2003, J IMMUNOL, V171, P3542, DOI 10.4049/jimmunol.171.7.3542; Udd B, 2006, Neuromuscul Disord, V16, P403, DOI 10.1016/j.nmd.2006.03.010; Vihola A, 2003, NEUROLOGY, V60, P1854, DOI 10.1212/01.WNL.0000065898.61358.09; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	51	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9301	10.1371/journal.pone.0009301	http://dx.doi.org/10.1371/journal.pone.0009301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174632	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700025
J	Amrouni, D; Gautier-Sauvigne, S; Meiller, A; Vincendeau, P; Bouteille, B; Buguet, A; Cespuglio, R				Amrouni, Donia; Gautier-Sauvigne, Sabine; Meiller, Anne; Vincendeau, Philippe; Bouteille, Bernard; Buguet, Alain; Cespuglio, Raymond			Cerebral and Peripheral Changes Occurring in Nitric Oxide (NO) Synthesis in a Rat Model of Sleeping Sickness: Identification of Brain iNOS Expressing Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SYNTHASE; IL-10; INFECTION; STATES	Background: The implication of nitric oxide (NO) in the development of human African trypanosomiasis (HAT) using an animal model, was examined. The manner by which the trypanocidal activity of NO is impaired in the periphery and in the brain of rats infected with Trypanosoma brucei brucei (T. b. brucei) was analyzed through: (i) the changes occurring in NO concentration in both peripheral (blood) and cerebral compartments; (ii) the activity of nNOS and iNOS enzymes; (iii) identification of the brain cell types in which the NO-pathways are particularly active during the time-course of the infection. Methodology/Principal Findings: NO concentration (direct measures by voltammetry) was determined in central (brain) and peripheral (blood) compartments in healthy and infected animals at various days post-infection: D5, D10, D16 and D22. Opposite changes were observed in the two compartments. NO production increased in the brain (hypothalamus) from D10 (+32%) to D16 (+71%), but decreased in the blood from D10 (222%) to D16 (246%) and D22 (260%). In parallel with NO measures, cerebral iNOS activity increased and peaked significantly at D16 (up to +700%). However, nNOS activity did not vary. Immunohistochemical staining confirmed iNOS activation in several brain regions, particularly in the hypothalamus. In peritoneal macrophages, iNOS activity decreased from D10 (283%) to D16 (265%) and D22 (274%) similarly to circulating NO. Conclusion/Significance: The NO changes observed in our rat model were dependent on iNOS activity in both peripheral and central compartments. In the periphery, the NO production decrease may reflect an arginase-mediated synthesis of polyamines necessary to trypanosome growth. In the brain, the increased NO concentration may result from an enhanced activity of iNOS present in neurons and glial cells. It may be regarded as a marker of deleterious inflammatory reactions.	[Amrouni, Donia; Gautier-Sauvigne, Sabine; Meiller, Anne; Buguet, Alain; Cespuglio, Raymond] Univ Lyon, Fac Med, EA Lab Free Rad Energy Substrates & Cerebral Phys, Lyon, France; [Vincendeau, Philippe] Univ Bordeaux 2, EA Lab Parasitol 3677, F-33076 Bordeaux, France; [Bouteille, Bernard] Univ Limoges, EA Lab Trop & Compared Neuroepidemiol 3174, Limoges, France; [Bouteille, Bernard] Fac Med Limoges, IFR GEIST 145, F-87025 Limoges, France	UDICE-French Research Universities; Universite de Bordeaux; Universite de Limoges	Amrouni, D (corresponding author), Univ Lyon, Fac Med, EA Lab Free Rad Energy Substrates & Cerebral Phys, Lyon, France.	cespuglio@univ-lyon1.fr	Buguet, Alain/W-1610-2019; Bouteille, Bernard/T-6519-2019; Bouteille, Bernard/M-4547-2018	Bouteille, Bernard/0000-0001-9661-0302; CESPUGLIO, Raymond/0000-0003-2246-8643; MEILLER, Anne/0000-0001-5546-3035	INSERM; Claude Bernard University Lyon 1	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Claude Bernard University Lyon 1	This work was supported by INSERM, Claude Bernard University Lyon 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Antoine-Moussiaux N, 2008, TRENDS PARASITOL, V24, P411, DOI 10.1016/j.pt.2008.05.010; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Buguet A, 1996, CR ACAD SCI III-VIE, V319, P201; Buguet A., 2002, ADAPTATION BIOL MED, V3, P222; Burlet S, 1997, NEUROSCI LETT, V226, P131, DOI 10.1016/S0304-3940(97)00247-4; CESPUGLIO R, 2004, J SLEEP RES S1, V13, P131; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chevrier C, 2005, ACTA TROP, V95, P33, DOI 10.1016/j.actatropica.2005.04.011; Clarencon D, 1999, INT J RADIAT BIOL, V75, P201, DOI 10.1080/095530099140654; Clement P, 2005, NEUROSCIENCE, V135, P347, DOI 10.1016/j.neuroscience.2005.05.064; Clement P, 2003, NEUROSCIENCE, V116, P863, DOI 10.1016/S0306-4522(02)00761-3; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Darsaud A, 2003, EXP BIOL MED, V228, P1355, DOI 10.1177/153537020322801114; Darsaud A, 2004, TROP MED INT HEALTH, V9, P83, DOI 10.1046/j.1365-3156.2003.01154.x; Dauvilliers Y, 2008, SLEEP, V31, P348, DOI 10.1093/sleep/31.3.348; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; Gautier-Sauvigne S, 2005, SLEEP MED REV, V9, P101, DOI 10.1016/j.smrv.2004.07.004; Girard M, 2000, PARASITE IMMUNOL, V22, P7, DOI 10.1046/j.1365-3024.2000.00264.x; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Keita M, 2000, EXP PARASITOL, V95, P19, DOI 10.1006/expr.2000.4505; Kennedy PGE, 2006, INT J PARASITOL, V36, P505, DOI 10.1016/j.ijpara.2006.01.012; Munder M, 1998, J IMMUNOL, V160, P5347; Ohno K, 2008, FRONT NEUROENDOCRIN, V29, P70, DOI 10.1016/j.yfrne.2007.08.001; OSWALD IP, 1994, COMP BIOCHEM PHYS C, V108, P11, DOI 10.1016/1367-8280(94)90083-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rhind SG, 1997, CLIN IMMUNOL IMMUNOP, V83, P185, DOI 10.1006/clin.1997.4350; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Rodgers J, 2009, J NEUROIMMUNOL, V211, P16, DOI 10.1016/j.jneuroim.2009.02.007; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Sternberg JM, 2005, J NEUROIMMUNOL, V167, P81, DOI 10.1016/j.jneuroim.2005.06.017; Taylor K, 1998, PARASITE IMMUNOL, V20, P421, DOI 10.1046/j.1365-3024.1998.00165.x; Vincendeau P, 2006, AN ACAD BRAS CIENC, V78, P645, DOI 10.1590/S0001-37652006000400004; Viswambharan H, 2003, INT J PARASITOL, V33, P1099, DOI 10.1016/S0020-7519(03)00180-2	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9211	10.1371/journal.pone.0009211	http://dx.doi.org/10.1371/journal.pone.0009211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169057	Green Published, gold			2022-12-27	WOS:000274590500004
J	Druzhinina, IS; Komon-Zelazowska, M; Atanasova, L; Seidl, V; Kubicek, CP				Druzhinina, Irina S.; Komon-Zelazowska, Monika; Atanasova, Lea; Seidl, Verena; Kubicek, Christian P.			Evolution and Ecophysiology of the Industrial Producer Hypocrea jecorina (Anamorph Trichoderma reesei) and a New Sympatric Agamospecies Related to It	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; REPRODUCTIVE ISOLATION; FUSARIUM-GRAMINEARUM; SPECIATION; PHOTOSTIMULATION; LONGIBRACHIATUM; STRATEGIES; DIVERSITY; CELLULASE; STRAINS	Background: Trichoderma reesei, a mitosporic green mould, was recognized during the WW II based on a single isolate from the Solomon Islands and since then used in industry for production of cellulases. It is believed to be an anamorph (asexual stage) of the common pantropical ascomycete Hypocrea jecorina. Methodology/Principal Findings: We combined molecular evolutionary analysis and multiple methods of phenotype profiling in order to reveal the genetic relationship of T. reesei to H. jecorina. The resulting data show that the isolates which were previously identified as H. jecorina by means of morphophysiology and ITS1 and 2 (rRNA gene cluster) barcode in fact comprise several species: i) H. jecorina/T. reesei sensu stricto which contains most of the teleomorphs (sexual stages) found on dead wood and the wild-type strain of T. reesei QM 6a; ii) T. parareesei nom. prov., which contains all strains isolated as anamorphs from soil; iii) and two other hypothetical new species for which only one or two isolates are available. In silico tests for recombination and in vitro mating experiments revealed a history of sexual reproduction for H. jecorina and confirmed clonality for T. parareesei nom. prov. Isolates of both species were consistently found worldwide in pantropical climatic zone. Ecophysiological comparison of H. jecorina and T. parareesei nom. prov. revealed striking differences in carbon source utilization, conidiation intensity, photosensitivity and mycoparasitism, thus suggesting adaptation to different ecological niches with the high opportunistic potential for T. parareesei nom. prov. Conclusions: Our data prove that T. reesei belongs to a holomorph H. jecorina and displays a history of worldwide gene flow. We also show that its nearest genetic neighbour - T. parareesei nom. prov., is a cryptic phylogenetic agamospecies which inhabits the same biogeographic zone. These two species thus provide a so far rare example of sympatric speciation within saprotrophic fungi, with divergent ecophysiological adaptations and reproductive strategies.	[Druzhinina, Irina S.; Komon-Zelazowska, Monika; Atanasova, Lea; Seidl, Verena; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1040 Vienna, Austria	Technische Universitat Wien	Druzhinina, IS (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Area Gene Technol & Appl Biochem, A-1040 Vienna, Austria.	druzhini@mail.zserv.tuwien.ac.at	Atanasova, Lea/AAK-4479-2021; Druzhinina, Irina S./AAK-7054-2021	Atanasova, Lea/0000-0002-1751-277X; Druzhinina, Irina S./0000-0003-2821-5268	Austrian Science Fund [P-19340-MOB, P17859-B06]	Austrian Science Fund(Austrian Science Fund (FWF))	This research has been supported by the Austrian Science Fund grants FWF (www.fwf.ac.at) P-19340-MOB to C. P. K. and P17859-B06 to I. S. D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BISBY G. R., 1939, TRANS BRIT MYCOL SOC, V23, P149; BISSETT J, 1984, CAN J BOT, V62, P924, DOI 10.1139/b84-131; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; DOSEFF AI, 1997, GENETICS, V147, P857; Druzhinina IS, 2008, MICROBIOL-SGM, V154, P3447, DOI 10.1099/mic.0.2008/021196-0; Druzhinina IS, 2006, APPL ENVIRON MICROB, V72, P2126, DOI 10.1128/AEM.72.3.2126-2133.2006; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; Friedl MA, 2008, APPL ENVIRON MICROB, V74, P245, DOI 10.1128/AEM.02068-07; Giraud T, 2008, FUNGAL GENET BIOL, V45, P791, DOI 10.1016/j.fgb.2008.02.001; Harman G. E., 1998, TRICHODERMA GLIOCLAD, V2, P393; HOYOSCARVAJAL L, 2009, FUNGAL GENE IN PRESS; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Komon-Zelazowska M, 2007, APPL ENVIRON MICROB, V73, P7415, DOI 10.1128/AEM.01059-07; KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; KUBICEK CP, 2009, BIOTECHNOL IN PRESS; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lieckfeldt E, 2000, MYCOLOGIA, V92, P374, DOI 10.2307/3761493; MANDELS M, 1985, BIOCHEM SOC T, V13, P414, DOI 10.1042/bst0130414; Nicholas KB., 1997, GENEDOC TOOL EDITING; NYLANDER JA, 1981, AWTY SYSTEM GRAPHICA, P581; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Posada D., 2003, CURRENT PROTOCOLS BI; REESE E. T., 1950, FARLOWIA, V4, P45; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; SAMUELS GJ, 1994, MYCOLOGIA, V86, P421, DOI 10.2307/3760575; Samuels GJ, 1998, STUD MYCOL, P1; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SEIDL V, 2009, P NATL ACAD IN PRESS; SIMMONS EG, 1977, IND MYC C, P618; SMITH JM, 1992, J MOL EVOL, V34, P126; Steenkamp ET, 2002, MYCOLOGIA, V94, P1032, DOI 10.2307/3761868; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	54	51	54	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9191	10.1371/journal.pone.0009191	http://dx.doi.org/10.1371/journal.pone.0009191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169200	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600012
J	Lonergan, KM; Chari, R; Coe, BP; Wilson, IM; Tsao, MS; Ng, RT; MacAulay, C; Lam, S; Lam, WL				Lonergan, Kim M.; Chari, Raj; Coe, Bradley P.; Wilson, Ian M.; Tsao, Ming-Sound; Ng, Raymond T.; MacAulay, Calum; Lam, Stephen; Lam, Wan L.			Transcriptome Profiles of Carcinoma-in-Situ and Invasive Non-Small Cell Lung Cancer as Revealed by SAGE	PLOS ONE			English	Article							PANCREATIC STELLATE CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; MICROFIBRILLAR PROTEINS MAGP-1; PROLINE-RICH PROTEIN; G HLA-G; BRONCHIAL EPITHELIUM; TARGETED THERAPIES; EPIDERMAL DIFFERENTIATION; CARDIAC-HYPERTROPHY; GENOMIC IMBALANCES	Background: Non-small cell lung cancer (NSCLC) presents as a progressive disease spanning precancerous, preinvasive, locally invasive, and metastatic lesions. Identification of biological pathways reflective of these progressive stages, and aberrantly expressed genes associated with these pathways, would conceivably enhance therapeutic approaches to this devastating disease. Methodology/Principal Findings: Through the construction and analysis of SAGE libraries, we have determined transcriptome profiles for preinvasive carcinoma-in-situ (CIS) and invasive squamous cell carcinoma (SCC) of the lung, and compared these with expression profiles generated from both bronchial epithelium, and precancerous metaplastic and dysplastic lesions using Ingenuity Pathway Analysis. Expression of genes associated with epidermal development, and loss of expression of genes associated with mucociliary biology, are predominant features of CIS, largely shared with precancerous lesions. Additionally, expression of genes associated with xenobiotic metabolism/detoxification is a notable feature of CIS, and is largely maintained in invasive cancer. Genes related to tissue fibrosis and acute phase immune response are characteristic of the invasive SCC phenotype. Moreover, the data presented here suggests that tissue remodeling/fibrosis is initiated at the early stages of CIS. Additionally, this study indicates that alteration in copy-number status represents a plausible mechanism for differential gene expression in CIS and invasive SCC. Conclusions/Significance: This study is the first report of large-scale expression profiling of CIS of the lung. Unbiased expression profiling of these preinvasive and invasive lesions provides a platform for further investigations into the molecular genetic events relevant to early stages of squamous NSCLC development. Additionally, up-regulated genes detected at extreme differences between CIS and invasive cancer may have potential to serve as biomarkers for early detection.	[Lonergan, Kim M.; Chari, Raj; Coe, Bradley P.; Wilson, Ian M.; Ng, Raymond T.; Lam, Wan L.] British Columbia Canc Res Ctr, Genet Unit, Vancouver, BC V5Z 1L3, Canada; [MacAulay, Calum; Lam, Stephen] British Columbia Canc Res Ctr, Imaging Unit, Vancouver, BC V5Z 1L3, Canada; [Tsao, Ming-Sound] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Ng, Raymond T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of British Columbia	Lonergan, KM (corresponding author), British Columbia Canc Res Ctr, Genet Unit, Vancouver, BC V5Z 1L3, Canada.	klonergan@bccrc.ca	Chari, Raj/G-3285-2019; Coe, Bradley/A-2878-2009; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; MacAulay, Calum/K-1795-2016; Chari, Rajagopal/B-6980-2008	Tsao, Ming Sound/0000-0002-9160-5405; MacAulay, Calum/0000-0003-4440-2792; Coe, Bradley/0000-0001-8471-4016	Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute; Canadian Cancer Society Research Institute [CCS 20485]; Canadian Institutes of Health Canada [MOP200113, MOP 86731]	Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute(Genome Canada); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from Genome Canada/Genome British Columbia, Canadian Cancer Society Research Institute (CCS#20485) and the Canadian Institutes of Health Canada (MOP200113 and MOP 86731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Atzori L, 2009, INT J BIOCHEM CELL B, V41, P1639, DOI 10.1016/j.biocel.2009.03.001; Auberger J, 2006, CURR CANCER DRUG TAR, V6, P271, DOI 10.2174/156800906777441780; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bazzi H, 2007, DEV DYNAM, V236, P961, DOI 10.1002/dvdy.21099; Beyer C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2598; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Bota S, 2001, AM J RESP CRIT CARE, V164, P1688, DOI 10.1164/ajrccm.164.9.2012147; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brodeur GM, 2009, CLIN CANCER RES, V15, P3244, DOI 10.1158/1078-0432.CCR-08-1815; Buys TPH, 2009, J THORAC ONCOL, V4, P227, DOI 10.1097/JTO.0b013e3181952678; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; Cascone T, 2007, CURR OPIN ONCOL, V19, P98, DOI 10.1097/CCO.0b013e328011beec; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Chari R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-422; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Cimmino F, 2009, ONCOGENE, V28, P2015, DOI 10.1038/onc.2009.70; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Deleeuw RJ, 2007, GASTROENTEROLOGY, V132, P1902, DOI 10.1053/j.gastro.2007.03.036; Di Maio M, 2005, J CELL PHYSIOL, V205, P355, DOI 10.1002/jcp.20402; Eferl R, 2008, P NATL ACAD SCI USA, V105, P10525, DOI 10.1073/pnas.0801414105; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Ermakov A, 2009, DEV DYNAM, V238, P581, DOI 10.1002/dvdy.21874; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Fraga CH, 1998, J UROLOGY, V159, P270, DOI 10.1016/S0022-5347(01)64080-1; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Garnis C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-50; Gazdar AF, 2004, CHEST, V125, p97S, DOI 10.1378/chest.125.5_suppl.97S-a; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Gresner P, 2007, LUNG CANCER, V57, P1, DOI 10.1016/j.lungcan.2007.02.002; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Hayashi T, 2008, AM J PHYSIOL-HEART C, V294, pH2197, DOI 10.1152/ajpheart.91496.2007; Hefler-Frischmuth K, 2009, EUR J OBSTET GYN R B, V147, P65, DOI 10.1016/j.ejogrb.2009.06.010; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Hirsch FR, 2003, LUNG CANCER, V41, pS29, DOI 10.1016/S0169-5002(03)00137-5; Hofmann HS, 2006, ONCOL REP, V16, P587; IE MS, 2007, HUM IMMUNOL, V68, P272; Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Isobe T, 2005, SEMIN ONCOL, V32, P315, DOI 10.1053/j.seminoncol.2005.02.016; Janne PA, 2006, CLIN CANCER RES, V12, p4416S, DOI 10.1158/1078-0432.CCR-06-0555; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jie G, 2007, INT J CLIN PRACT, V61, P1523, DOI 10.1111/j.1742-1241.2006.01033.x; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Khojasteh M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-274; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kong WY, 2003, J BIOL CHEM, V278, P22781, DOI 10.1074/jbc.M210488200; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuroishi S, 2009, RESPIROLOGY, V14, P828, DOI 10.1111/j.1440-1843.2009.01561.x; Lam S, 1998, CHEST, V113, P696, DOI 10.1378/chest.113.3.696; Lam S, 2000, CANCER-AM CANCER SOC, V89, P2468; Lee SH, 2003, BIOCHEM BIOPH RES CO, V303, P954, DOI 10.1016/S0006-291X(03)00448-0; Lee WH, 2005, J INVEST DERMATOL, V125, P995, DOI 10.1111/j.0022-202X.2005.23887.x; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Maione P, 2006, ONCOLOGIST, V11, P274, DOI 10.1634/theoncologist.11-3-274; Malik Manzoor A, 2009, J Gastrointest Cancer, V40, P26, DOI 10.1007/s12029-009-9072-0; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Mastracci TL, 2006, GENE CHROMOSOME CANC, V45, P1007, DOI 10.1002/gcc.20368; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Moffatt P, 2004, GENE, V334, P123, DOI 10.1016/j.gene.2004.03.010; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olson P, 2009, SCIENCE, V324, P1400, DOI 10.1126/science.1175940; Oomizu S, 2000, GENE, V256, P19, DOI 10.1016/S0378-1119(00)00357-7; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Paramio JM, 2001, J BIOL CHEM, V276, P44203, DOI 10.1074/jbc.M105650200; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Qiu XY, 2003, CANCER RES, V63, P6488; Quinn AM, 2008, CHEM RES TOXICOL, V21, P1086, DOI 10.1021/tx700345v; Reade CA, 2009, BIOL-TARGETS THER, V3, P215; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Segade F, 2002, J BIOL CHEM, V277, P11050, DOI 10.1074/jbc.M110347200; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Stawowy P, 2004, CARDIOVASC RES, V63, P87, DOI 10.1016/j.cardiores.2004.03.010; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Svensson S, 2003, CANCER RES, V63, P1737; Tanney A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-20; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Tsuchida S, 2004, J INVEST DERMATOL, V122, P1225, DOI 10.1111/j.0022-202X.2004.22511.x; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Venmans BJW, 2000, CHEST, V117, P1572, DOI 10.1378/chest.117.6.1572; Vermeer PD, 2006, AM J PHYSIOL-LUNG C, V291, pL175, DOI 10.1152/ajplung.00547.2005; Vijayachandra K, 2009, MOL CARCINOGEN, V48, P181, DOI 10.1002/mc.20472; Vokes Everett E, 2006, Oncology (Williston Park), V20, P15; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Watson SK, 2007, HUM GENET, V120, P795, DOI 10.1007/s00439-006-0251-9; Wei Q, 2008, P NATL ACAD SCI USA, V105, P19738, DOI 10.1073/pnas.0810676105; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Yagihara H, 2009, VET J, V180, P348, DOI 10.1016/j.tvjl.2008.01.006; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yie SM, 2007, AM J CLIN PATHOL, V128, P1002, DOI 10.1309/JNCW1QLDFB6AM9WE; Yie SM, 2007, LUNG CANCER, V58, P267, DOI 10.1016/j.lungcan.2007.06.011; Yie SM, 2007, ANN SURG ONCOL, V14, P2721, DOI 10.1245/s10434-007-9464-y; Yoneda K, 2009, INT J ONCOL, V35, P33, DOI 10.3892/ijo_00000310; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zang XP, 2009, ANTICANCER RES, V29, P3417; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	149	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9162	10.1371/journal.pone.0009162	http://dx.doi.org/10.1371/journal.pone.0009162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161782	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442800008
J	Wen, J; Ronn, T; Olsson, A; Yang, Z; Lu, B; Du, YP; Groop, L; Ling, C; Hu, RM				Wen, Jie; Ronn, Tina; Olsson, Anders; Yang, Zhen; Lu, Bin; Du, Yieping; Groop, Leif; Ling, Charlotte; Hu, Renming			Investigation of Type 2 Diabetes Risk Alleles Support CDKN2A/B, CDKAL1, and TCF7L2 As Susceptibility Genes in a Han Chinese Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FTO GENE; COMMON VARIANTS; FAT MASS; LOCI; REPLICATION; POLYMORPHISMS; IGF2BP2; OBESITY; HHEX	Background: Recent genome-wide association studies (GWASs) have reported several genetic variants to be reproducibly associated with type 2 diabetes. Additional variants have also been detected from a metaanalysis of three GWASs, performed in populations of European ancestry. In the present study, we evaluated the influence of 17 genetic variants from 15 candidate loci, identified in type 2 diabetes GWASs and the metaanalysis, in a Han Chinese cohort. Methodology/Principal Findings: Selected type 2 diabetes-associated genetic variants were genotyped in 1,165 type 2 diabetic patients and 1,136 normoglycemic control individuals of Southern Han Chinese ancestry. The OR for risk of developing type 2 diabetes was calculated using a logistic regression model adjusted for age, sex, and BMI. Genotype-phenotype associations were tested using a multivariate linear regression model. Genetic variants in CDKN2A/B, CDKAL1, TCF7L2, TCF2, MC4R, and PPARG showed a nominal association with type 2 diabetes (P <= 0.05), of whom the three first would stand correction for multiple testing: CDKN2A/B rs10811661, OR: 1.26 (1.12-1.43) P = 1.8* 10(-4); CDKAL1 rs10946398, OR: 1.23 (1.09-1.39); P = 7.1* 10(-4), and TCF7L2 rs7903146, OR: 1.61 (1.19-2.18) P = 2.3* 10(-3). Only nominal phenotype associations were observed, notably for rs8050136 in FTO and fasting plasma glucose (P = 0.002), postprandial plasma glucose (P = 0.002), and fasting C-peptide levels (P = 0.006) in the diabetic patients, and with BMI in controls (P = 0.033). Conclusions/Significance: We have identified significant association between variants in CDKN2A/B, CDKAL1 and TCF7L2, and type 2 diabetes in a Han Chinese cohort, indicating these genes as strong candidates conferring susceptibility to type 2 diabetes across different ethnicities.	[Wen, Jie; Yang, Zhen; Lu, Bin; Du, Yieping; Hu, Renming] Fudan Univ, Shanghai Med Coll, Dept Endocrinol, Shanghai 200433, Peoples R China; [Ronn, Tina; Olsson, Anders; Groop, Leif; Ling, Charlotte] Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden	Fudan University; Lund University	Wen, J (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Endocrinol, Shanghai 200433, Peoples R China.	Renminghu@Fudan.edu.cn	Ling, Charlotte/Q-2432-2015	Ling, Charlotte/0000-0003-0587-7154; Ronn, Tina/0000-0001-7622-800X	Swedish Research Council; Wallenberg foundation; Novo Nordisk; Bergvall; Pahlsson; Nilsson-Ehle; Tore Nilsson; Ake Wiberg; Soderbergs; Crafoord; Swedish Diabetes Association; National Science Foundation of China [30230380]; National Nature Science foundation of China [30670999, 30711120573, 3030770854]; National Key Basic Research and Development Program [2002 CB713703]; Key Project of Shanghai Commission for Science and Technology [04dz19504]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg foundation(European Commission); Novo Nordisk(Novo Nordisk); Bergvall; Pahlsson; Nilsson-Ehle; Tore Nilsson; Ake Wiberg; Soderbergs; Crafoord; Swedish Diabetes Association; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); Key Project of Shanghai Commission for Science and Technology	This study was supported by grants from the Swedish Research Council, the Wallenberg foundation, Novo Nordisk, Bergvall, Pahlsson, Nilsson-Ehle, Tore Nilsson, Ake Wiberg, Soderbergs, Crafoord, and the Swedish Diabetes Association. This study was also supported by research grants (to RH) from the Key Project of National Science Foundation of China (30230380), the National Nature Science foundation of China (30670999, 30711120573, 3030770854), the National Key Basic Research and Development Program (2002 CB713703), and the Key Project of Shanghai Commission for Science and Technology (04dz19504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chang YC, 2007, DIABETES, V56, P2631, DOI 10.2337/db07-0421; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Liu Y, 2008, DIABETOLOGIA, V51, P2134, DOI 10.1007/s00125-008-1141-6; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ng MCY, 2007, J CLIN ENDOCR METAB, V92, P3733, DOI 10.1210/jc.2007-0849; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ren Q, 2008, DIABETOLOGIA, V51, P1146, DOI 10.1007/s00125-008-1039-3; Ronn T., 2009, DIABETOLOGIA; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	37	103	109	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9153	10.1371/journal.pone.0009153	http://dx.doi.org/10.1371/journal.pone.0009153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161779	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442700017
J	Carr, KA; Janes, BK; Hanna, PC				Carr, Katherine A.; Janes, Brian K.; Hanna, Philip C.			Role of the gerP Operon in Germination and Outgrowth of Bacillus anthracis Spores	PLOS ONE			English	Article							GENOME SEQUENCE; IN-VITRO; SUBTILIS; PROTEINS; CEREUS; SPORULATION; ENDOSPORES; LOCALIZATION; SUPEROXIDE; RESISTANCE	Germination of Bacillus anthracis spores occurs when nutrients such as amino acids or purine nucleosides stimulate specific germinant receptors located in the spore inner membrane. The gerP(ABCDEF) operon has been suggested to play a role in facilitating the interaction between germinants and their receptors in spores of Bacillus subtilis and Bacillus cereus. B. anthracis mutants containing deletions in each of the six genes belonging to the orthologue of the gerP(ABCDEF) operon, or deletion of the entire operon, were tested for their ability to germinate. Deletion of the entire gerP operon resulted in a significant delay in germination in response to nutrient germinants. These spores eventually germinated to levels equivalent to wild-type, suggesting that an additional entry point for nutrient germinants may exist. Deletions of each individual gene resulted in a similar phenotype, with the exception of Delta gerPF, which showed no obvious defect. The removal of two additional gerPF-like orthologues was necessary to achieve the germination defect observed for the other mutants. Upon physical removal of the spore coat, the mutant lacking the full gerP operon no longer exhibited a germination defect, suggesting that the GerP proteins play a role in spore coat permeability. Additionally, each of the gerP mutants exhibited a severe defect in calcium-dipicolinic acid (Ca-DPA)-dependent germination, suggesting a role for the GerP proteins in this process. Collectively, these data implicate all GerP proteins in the early stages of spore germination.	[Carr, Katherine A.; Janes, Brian K.; Hanna, Philip C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Carr, KA (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pchanna@umich.edu			Health and Human Services [N266200400059C/N01-AI-40059]; Southeast Regional Centers of Excellence for Biodefense and Emerging Infections	Health and Human Services; Southeast Regional Centers of Excellence for Biodefense and Emerging Infections	This work was supported in part by Health and Human Services contract N266200400059C/N01-AI-40059 and by the Great Lakes and the Southeast Regional Centers of Excellence for Biodefense and Emerging Infections. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagyan I, 2002, J BACTERIOL, V184, P1219, DOI 10.1128/jb.184.4.1219-1224.2002; Baillie L, 2005, FEMS MICROBIOL LETT, V245, P33, DOI 10.1016/j.femsle.2005.02.016; Behravan J, 2000, J BACTERIOL, V182, P1987, DOI 10.1128/JB.182.7.1987-1994.2000; Bergman NH, 2007, APPL ENVIRON MICROB, V73, P846, DOI 10.1128/AEM.01686-06; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; BETTY JM, 1970, J APPL MICROBIOL, V33, P103; Bozue J, 2007, INFECT IMMUN, V75, P4498, DOI 10.1128/IAI.00434-07; Brahmbhatt TN, 2007, INFECT IMMUN, V75, P5233, DOI 10.1128/IAI.00660-07; BROWN WC, 1982, J BACTERIOL, V149, P969, DOI 10.1128/JB.149.3.969-976.1982; DANIEL JR, 2003, FEMS MICROBIOL LETT, V221, P103; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; GOULD GW, 1977, J APPL BACTERIOL, V42, P297, DOI 10.1111/j.1365-2672.1977.tb00697.x; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Ireland JAW, 2002, J BACTERIOL, V184, P1296, DOI 10.1128/JB.184.5.1296-1303.2002; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; JENKINSON HF, 1980, J BACTERIOL, V141, P793, DOI 10.1128/JB.141.2.793-805.1980; KIM HU, 1974, J APPL BACTERIOL, V37, P265, DOI 10.1111/j.1365-2672.1974.tb00438.x; Klobutcher LA, 2006, P NATL ACAD SCI USA, V103, P165, DOI 10.1073/pnas.0507121102; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; MCCORMIC.NG, 1965, J BACTERIOL, V89, P1180, DOI 10.1128/JB.89.5.1180-1185.1965; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Moir A, 2003, TRENDS MICROBIOL, V11, P452, DOI 10.1016/j.tim.2003.08.001; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Paidhungat M, 2001, J BACTERIOL, V183, P3982, DOI 10.1128/JB.183.13.3982-3990.2001; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Popham DL, 2002, CELL MOL LIFE SCI, V59, P426, DOI 10.1007/s00018-002-8435-5; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Setlow B, 2001, J BACTERIOL, V183, P4894, DOI 10.1128/JB.183.16.4894-4899.2001; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P313; Todd SJ, 2003, J BACTERIOL, V185, P3373, DOI 10.1128/JB.185.11.3373-3378.2003; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003	38	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9128	10.1371/journal.pone.0009128	http://dx.doi.org/10.1371/journal.pone.0009128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161744	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442600025
J	Gakhar, L; Bartlett, JA; Penterman, J; Mizrachi, D; Singh, PK; Mallampalli, RK; Ramaswamy, S; McCray, PB				Gakhar, Lokesh; Bartlett, Jennifer A.; Penterman, Jon; Mizrachi, Dario; Singh, Pradeep K.; Mallampalli, Rama K.; Ramaswamy, S.; McCray, Paul B., Jr.			PLUNC Is a Novel Airway Surfactant Protein with Anti-Biofilm Activity	PLOS ONE			English	Article							NASAL LAVAGE FLUID; IN-VITRO MODEL; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; PULMONARY SURFACTANT; LIQUID VOLUME; HORSE SWEAT; LUNG; LIPOPOLYSACCHARIDE; BIOSURFACTANTS	Background: The PLUNC (``Palate, lung, nasal epithelium clone'') protein is an abundant secretory product of epithelia present throughout the conducting airways of humans and other mammals, which is evolutionarily related to the lipid transfer/lipopolysaccharide binding protein (LT/LBP) family. Two members of this family - the bactericidal/permeability increasing protein (BPI) and the lipopolysaccharide binding protein (LBP) - are innate immune molecules with recognized roles in sensing and responding to Gram negative bacteria, leading many to propose that PLUNC may play a host defense role in the human airways. Methodology/Principal Findings: Based on its marked hydrophobicity, we hypothesized that PLUNC may be an airway surfactant. We found that purified recombinant human PLUNC greatly enhanced the ability of aqueous solutions to spread on a hydrophobic surface. Furthermore, we discovered that PLUNC significantly reduced surface tension at the air-liquid interface in aqueous solutions, indicating novel and biologically relevant surfactant properties. Of note, surface tensions achieved by adding PLUNC to solutions are very similar to measurements of the surface tension in tracheobronchial secretions from humans and animal models. Because surfactants of microbial origin can disperse matrix-encased bacterial clusters known as biofilms [1], we hypothesized that PLUNC may also have anti-biofilm activity. We found that, at a physiologically relevant concentration, PLUNC inhibited biofilm formation by the airway pathogen Pseudomonas aeruginosa in an in vitro model. Conclusions/Significance: Our data suggest that the PLUNC protein contributes to the surfactant properties of airway secretions, and that this activity may interfere with biofilm formation by an airway pathogen.	[Gakhar, Lokesh; Ramaswamy, S.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh; Ramaswamy, S.] Univ Iowa, Prot Crystallog Facil, Iowa City, IA 52242 USA; [Bartlett, Jennifer A.; McCray, Paul B., Jr.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Penterman, Jon; Singh, Pradeep K.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Penterman, Jon; Singh, Pradeep K.] Univ Washington, Dept Med, Seattle, WA USA; [Mizrachi, Dario] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mallampalli, Rama K.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa	Gakhar, L (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	paul-mccray@uiowa.edu	Gakhar, Lokesh/F-2113-2010; Gakhar, Lokesh/P-8356-2019; Subramanian, Ramaswamy/Q-8671-2019; Bartlett, Jennifer/AAH-4532-2020	Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; Subramanian, Ramaswamy/0000-0002-6709-190X; McCray, Paul/0000-0002-4067-577X	National Institutes of Health [P50 HL-61234, P01 HL-091842]; National Institute for Environmental Health Sciences Research Center [P30 ES05605]; NIH Ruth L. Kirschstein National Research Service Award [GM087635]; Cystic Fibrosis Foundation; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Environmental Health Sciences Research Center; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the National Institutes of Health (http://www.nih.gov/) grants NIH P50 HL-61234 and P01 HL-091842 (PBM), as well as the Roy J. Carver Charitable Trust (https://www.carvertrust.org) (PBM). In addition, this research was funded by the National Institute for Environmental Health Sciences Research Center (http://www.niehs.nih.gov), NIEHS/NIH P30 ES05605 (JAB). JP is supported by a NIH Ruth L. Kirschstein National Research Service Award (GM087635) (http://www.nih.gov/). PS is supported by grants from the National Institutes of Health (http://www.nih.gov/), the Cystic Fibrosis Foundation (http://www.cff.org/), and the Burroughs Wellcome Fund (http://www.bwfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; ALLEGRA L, 1985, EUR J RESPIR DIS S, V142, P71; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Banerjee R, 2000, J BIOMATER APPL, V14, P243, DOI 10.1106/9D4B-L6PP-7CTF-BY8G; Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; BEELEY JG, 1986, BIOCHEM J, V235, P645, DOI 10.1042/bj2350645; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernhard W, 1997, AM J RESP CELL MOL, V17, P41, DOI 10.1165/ajrcmb.17.1.2594; Bingle CD, 2004, INT J BIOCHEM CELL B, V36, P2144, DOI 10.1016/j.biocel.2004.05.002; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x; Botros HG, 2001, EUR J BIOCHEM, V268, P3126, DOI 10.1046/j.1432-1327.2001.02217.x; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; Geiser M, 2003, J APPL PHYSIOL, V94, P1793, DOI 10.1152/japplphysiol.00514.2002; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Ghafouri B, 2003, BIOCHEM SOC T, V31, P810, DOI 10.1042/BST0310810; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; GIL J, 1971, ANAT REC, V169, P185, DOI 10.1002/ar.1091690205; Hof VI, 1997, RESP PHYSIOL, V109, P81, DOI 10.1016/S0034-5687(97)84032-7; Irie Y, 2005, FEMS MICROBIOL LETT, V250, P237, DOI 10.1016/j.femsle.2005.07.012; KAKUTA Y, 1991, RESP PHYSIOL, V83, P313, DOI 10.1016/0034-5687(91)90050-S; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeClair EE, 2003, J DENT RES, V82, P944, DOI 10.1177/154405910308201202; Lindahl M, 2001, ELECTROPHORESIS, V22, P1795, DOI 10.1002/1522-2683(200105)22:9<1795::AID-ELPS1795>3.0.CO;2-J; McDonald RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005726; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole GA, 2005, NAT BIOTECHNOL, V23, P1378, DOI 10.1038/nbt1105-1378; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Possmayer F, 2001, COMP BIOCHEM PHYS A, V129, P209, DOI 10.1016/S1095-6433(01)00317-8; Rachana, 2004, COLLOID SURFACE B, V34, P95, DOI 10.1016/j.colsurfb.2003.12.001; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; Scheetz TE, 2004, PHYSIOL GENOMICS, V17, P69, DOI 10.1152/physiolgenomics.00188.2003; SCHURCH S, 1990, RESP PHYSIOL, V80, P17, DOI 10.1016/0034-5687(90)90003-H; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2000, AM J PHYSIOL-LUNG C, V279, pL799, DOI 10.1152/ajplung.2000.279.5.L799; Tarran R, 2001, J GEN PHYSIOL, V118, P223, DOI 10.1085/jgp.118.2.223; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; WEISS J, 1978, J BIOL CHEM, V253, P2664; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387	58	95	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9098	10.1371/journal.pone.0009098	http://dx.doi.org/10.1371/journal.pone.0009098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161732	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600006
J	Larsen, N; Vogensen, FK; van den Berg, FWJ; Nielsen, DS; Andreasen, AS; Pedersen, BK; Abu Al-Soud, W; Sorensen, SJ; Hansen, LH; Jakobsen, M				Larsen, Nadja; Vogensen, Finn K.; van den Berg, Frans W. J.; Nielsen, Dennis Sandris; Andreasen, Anne Sofie; Pedersen, Bente K.; Abu Al-Soud, Waleed; Sorensen, Soren J.; Hansen, Lars H.; Jakobsen, Mogens			Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults	PLOS ONE			English	Article							REAL-TIME PCR; LACTIC-ACID BACTERIA; RIBOSOMAL-RNA; WEIGHT-LOSS; ANTIBIOTIC-TREATMENT; FECAL MICROBIOTA; HUMAN FECES; OBESITY; LACTOBACILLUS; INFLAMMATION	Background: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. Methods and Findings: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). Conclusions: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.	[Larsen, Nadja; Vogensen, Finn K.; van den Berg, Frans W. J.; Nielsen, Dennis Sandris; Jakobsen, Mogens] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Andreasen, Anne Sofie; Pedersen, Bente K.] Rigshosp, Univ Hosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Andreasen, Anne Sofie; Pedersen, Bente K.] Rigshosp, Univ Hosp, CMRC, DK-2100 Copenhagen, Denmark; [Abu Al-Soud, Waleed; Sorensen, Soren J.; Hansen, Lars H.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Larsen, N (corresponding author), Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark.	nf@life.ku.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Nielsen, Dennis/A-9769-2015; Abu Al-Soud, Waleed/AAH-3477-2021; van den Berg, Frans W.J./N-2899-2014; Sørensen, Søren J/J-5015-2014; Vogensen, Finn/E-1245-2015; Abu Al-Soud, Waleed/K-4408-2014; Sørensen, Søren Johannes/N-2120-2019; Larsen, Nadja/F-2692-2015; Berg, Frans/ABB-5814-2021; Abu Al-Soud, Waleed/K-4408-2014	Pedersen, Bente Klarlund/0000-0001-6508-6288; Nielsen, Dennis/0000-0001-8121-1114; Abu Al-Soud, Waleed/0000-0002-1143-9233; van den Berg, Frans W.J./0000-0002-9170-9052; Sørensen, Søren J/0000-0001-6227-9906; Vogensen, Finn/0000-0003-2151-7802; Abu Al-Soud, Waleed/0000-0002-1143-9233; Sørensen, Søren Johannes/0000-0001-6227-9906; Larsen, Nadja/0000-0002-5899-4883; Abu Al-Soud, Waleed/0000-0002-1488-4826; Andreasen, Anne Sofie/0000-0002-8759-3405	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency [3304-FSE-06-0501-1]	Danish Ministry of Food, Agriculture and Fisheries; Danish Food Industry Agency	This study was supported by the Danish Ministry of Food, Agriculture and Fisheries, The Danish Food Industry Agency (J. nr. 3304-FSE-06-0501-1; www. dffe. dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock GH, 2001, CLIN EXP IMMUNOL, V123, P62, DOI 10.1046/j.1365-2249.2001.01370.x; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Cani PD, 2008, DIABETOLOGIA, V51, pS34; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dicksved J, 2007, APPL ENVIRON MICROB, V73, P2284, DOI 10.1128/AEM.02223-06; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nadal I, 2009, INT J OBESITY, V33, P758, DOI 10.1038/ijo.2008.260; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; Nielsen DS, 2003, APPL ENVIRON MICROB, V69, P7545, DOI 10.1128/AEM.69.12.7545-7548.2003; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Santacruz A, 2009, OBESITY, V17, P1906, DOI 10.1038/oby.2009.112; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; SCHWIERTZ A, 2009, OBESITY; Tilg H, 2009, GASTROENTEROLOGY, V136, P1476, DOI 10.1053/j.gastro.2009.03.030; Tsukumo DM, 2009, ARQ BRAS ENDOCRINOL, V53, P139, DOI 10.1590/S0004-27302009000200004; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	36	1769	1985	10	485	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9085	10.1371/journal.pone.0009085	http://dx.doi.org/10.1371/journal.pone.0009085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140211	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400021
J	Hodges, AP; Dai, DJ; Xiang, ZS; Woolf, P; Xi, CW; He, YQ				Hodges, Andrew P.; Dai, Dongjuan; Xiang, Zuoshuang; Woolf, Peter; Xi, Chuanwu; He, Yongqun			Bayesian Network Expansion Identifies New ROS and Biofilm Regulators	PLOS ONE			English	Article							ESCHERICHIA-COLI RESPONSE; OXIDATIVE-STRESS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; HYDROGEN-PEROXIDE; MICROARRAY DATA; SEED GENES; DATABASE; PROTEIN; CELLS	Signaling and regulatory pathways that guide gene expression have only been partially defined for most organisms. However, given the increasing number of microarray measurements, it may be possible to reconstruct such pathways and uncover missing connections directly from experimental data. Using a compendium of microarray gene expression data obtained from Escherichia coli, we constructed a series of Bayesian network models for the reactive oxygen species (ROS) pathway as defined by EcoCyc. A consensus Bayesian network model was generated using those networks sharing the top recovered score. This microarray-based network only partially agreed with the known ROS pathway curated from the literature and databases. A top network was then expanded to predict genes that could enhance the Bayesian network model using an algorithm we termed 'BN+1'. This expansion procedure predicted many stress-related genes (e. g., dusB and uspE), and their possible interactions with other ROS pathway genes. A term enrichment method discovered that biofilm-associated microarray data usually contained high expression levels of both uspE and gadX. The predicted involvement of gene uspE in the ROS pathway and interactions between uspE and gadX were confirmed experimentally using E. coli reporter strains. Genes gadX and uspE showed a feedback relationship in regulating each other's expression. Both genes were verified to regulate biofilm formation through gene knockout experiments. These data suggest that the BN+1 expansion method can faithfully uncover hidden or unknown genes for a selected pathway with significant biological roles. The presently reported BN+1 expansion method is a generalized approach applicable to the characterization and expansion of other biological pathways and living systems.	[Hodges, Andrew P.; Woolf, Peter; He, Yongqun] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Dai, Dongjuan; Xi, Chuanwu] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Xiang, Zuoshuang; He, Yongqun] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA; [Woolf, Peter] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Woolf, Peter] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [He, Yongqun] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hodges, AP (corresponding author), Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.	yongqunh@umich.edu		He, Yongqun/0000-0001-9189-9661; Xi, Chuanwu/0000-0002-7554-1915	National Institutes of Health (NIH) [U54-DA-021519, 5 T32 GM070449-04]; University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by National Institutes of Health (NIH) Grant U54-DA-021519. A. P. H. was also supported by a NIH Training Grant (5 T32 GM070449-04) and a 2008 Rackham Spring/Summer Research Grant at the University of Michigan. Additional support for A. P. H. was provided by the University of Michigan Bioinformatics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Battistoni A, 2000, INFECT IMMUN, V68, P30, DOI 10.1128/IAI.68.1.30-37.2000; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bidaut G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-99; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Djebbari A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-57; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gat-Viks I, 2007, GENOME RES, V17, P358, DOI 10.1101/gr.5750507; Hashimoto RF, 2004, BIOINFORMATICS, V20, P1241, DOI 10.1093/bioinformatics/bth074; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Junker LM, 2006, MICROBIOL-SGM, V152, P2233, DOI 10.1099/mic.0.28767-0; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Laval J, 1996, PATHOL BIOL, V44, P14; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Luke I, 2008, ARCH MICROBIOL, V190, P685, DOI 10.1007/s00203-008-0420-4; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Morett E, 1998, FEBS LETT, V433, P108, DOI 10.1016/S0014-5793(98)00888-6; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993; Patrauchan MA, 2007, MICROBIOL-SGM, V153, P3838, DOI 10.1099/mic.0.2007/010371-0; Pena JM, 2005, BIOINFORMATICS, V21, P224, DOI 10.1093/bioinformatics/bti1137; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Salgado H, 1999, NUCLEIC ACIDS RES, V27, P59, DOI 10.1093/nar/27.1.59; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2001, Bioinformatics, V17 Suppl 1, pS270; Tourancheau AB, 1999, PROTIST, V150, P137, DOI 10.1016/S1434-4610(99)70017-9; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Weinstein-Fischer D, 2000, MOL MICROBIOL, V35, P1413, DOI 10.1046/j.1365-2958.2000.01805.x; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; XIANG Z, 2007, BIOINFORMATICS; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	51	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9513	10.1371/journal.pone.0009513	http://dx.doi.org/10.1371/journal.pone.0009513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209085	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400018
J	Fritzsch, B; Dillard, M; Lavado, A; Harvey, NL; Jahan, I				Fritzsch, Bernd; Dillard, Miriam; Lavado, Alfonso; Harvey, Natasha L.; Jahan, Israt			Canal Cristae Growth and Fiber Extension to the Outer Hair Cells of the Mouse Ear Require Prox1 Activity	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; AUDITORY SENSORY EPITHELIUM; CELLULAR-DIFFERENTIATION; FATE DETERMINATION; ORGAN DEVELOPMENT; VERTEBRATE EAR; DROSOPHILA EYE; CYCLE EXIT; STEM-CELLS; NULL MICE	Background: The homeobox gene Prox1 is required for lens, retina, pancreas, liver, and lymphatic vasculature development and is expressed in inner ear supporting cells and neurons. Methodology/Principal Findings: We have investigated the role of Prox1 in the developing mouse ear taking advantage of available standard and conditional Prox1 mutant mouse strains using Tg(Pax2-Cre) and Tg(Nes-Cre). A severe reduction in the size of the canal cristae but not of other vestibular organs or the cochlea was identified in the E18.5 Prox1(Flox/Flox); Tg(Pax2-Cre) mutant ear. In these mutant embryos, hair cell differentiated; however, their distribution pattern was slightly disorganized in the cochlea where the growth of type II nerve fibers to outer hair cells along Prox1 expressing supporting cells was severely disrupted. In the case of Nestin-Cre, we found that newborn Prox1(Flox/Flox); Tg(Nestin-Cre) exhibit only a disorganized innervation of outer hair cells despite apparently normal cellular differentiation of the organ of Corti, suggesting a cell-autonomous function of Prox1 in neurons. Conclusions/Significance: These results identify a dual role of Prox1 during inner ear development; growth of the canal cristae and fiber guidance of Type II fibers along supporting cells in the cochlea.	[Fritzsch, Bernd; Jahan, Israt] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Dillard, Miriam; Lavado, Alfonso; Harvey, Natasha L.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	University of Iowa; St Jude Children's Research Hospital	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Harvey, Natasha/0000-0001-9839-8966; Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01-DC005590]; EPSCoR [EPS-0346476, CFD 47.076]; Carver Center for Imaging; Roy J. Carver Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Carver Center for Imaging; Roy J. Carver Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grant R01-DC005590 (to BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge the use of the confocal microscope facility of the NCCB, supported by EPSCoR EPS-0346476 (CFD 47.076) and the Carver Center for Imaging, supported by the Roy J. Carver Foundation.	Adam J, 1998, DEVELOPMENT, V125, P4645; Behan KJ, 2005, DEV GENES EVOL, V215, P423, DOI 10.1007/s00427-005-0490-0; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; Caldwell JC, 2002, J NEUROBIOL, V53, P172, DOI 10.1002/neu.10126; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Domingos PM, 2004, DEV BIOL, V273, P121, DOI 10.1016/j.ydbio.2004.05.026; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Fritzsch B, 2006, BRAIN RES, V1091, P151, DOI 10.1016/j.brainres.2006.02.078; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi T, 2001, MECH DEVELOP, V108, P13, DOI 10.1016/S0925-4773(01)00466-X; Hayashi T, 2007, DEV DYNAM, V236, P525, DOI 10.1002/dvdy.21026; Hidalgo A, 2004, CELL CYCLE, V3, P1118; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Jensen-Smith Heather, 2007, Immunol Invest, V36, P763, DOI 10.1080/08820130701706711; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; KELLEY MW, 2006, HAIR CELL DEV COMMIT; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matei VA, 2006, BRAIN RES BULL, V70, P33, DOI 10.1016/j.brainresbull.2005.11.007; Misra K, 2008, DEV DYNAM, V237, P393, DOI 10.1002/dvdy.21422; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morsli H, 1998, J NEUROSCI, V18, P3327; Nichols DH, 2008, CELL TISSUE RES, V334, P339, DOI 10.1007/s00441-008-0709-2; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; SRINIVASAN RS, 2007, GENES DEV IN PRESS; Stone JS, 2003, J COMP NEUROL, V460, P487, DOI 10.1002/cne.10662; von Bartheld CS, 2001, TRENDS NEUROSCI, V24, P504, DOI 10.1016/S0166-2236(00)01960-3; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021; WARD TS, 2007, MICROSC RES TECH; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Xiang MQ, 1998, DEVELOPMENT, V125, P3935	77	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9377	10.1371/journal.pone.0009377	http://dx.doi.org/10.1371/journal.pone.0009377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186345	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000274924000018
J	Piper, KE; Fernandez-Sampedro, M; Steckelberg, KE; Mandrekar, JN; Karau, MJ; Steckelberg, JM; Berbari, EF; Osmon, DR; Hanssen, AD; Lewallen, DG; Cofield, RH; Sperling, JW; Sanchez-Sotelo, J; Huddleston, PM; Dekutoski, MB; Yaszemski, M; Currier, B; Patel, R				Piper, Kerryl E.; Fernandez-Sampedro, Marta; Steckelberg, Kathryn E.; Mandrekar, Jayawant N.; Karau, Melissa J.; Steckelberg, James M.; Berbari, Elie F.; Osmon, Douglas R.; Hanssen, Arlen D.; Lewallen, David G.; Cofield, Robert H.; Sperling, John W.; Sanchez-Sotelo, Joaquin; Huddleston, Paul M.; Dekutoski, Mark B.; Yaszemski, Michael; Currier, Bradford; Patel, Robin			C-Reactive Protein, Erythrocyte Sedimentation Rate and Orthopedic Implant Infection	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; PERI-PROSTHETIC INFECTION; JOINT INFECTION; DIAGNOSIS; SURGERY; REPLACEMENT; SONICATION; VALUES; LEVEL	Background: C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) have been shown to be useful for diagnosis of prosthetic hip and knee infection. Little information is available on CRP and ESR in patients undergoing revision or resection of shoulder arthroplasties or spine implants. Methods/Results: We analyzed preoperative CRP and ESR in 636 subjects who underwent knee (n = 297), hip (n = 221) or shoulder (n = 64) arthroplasty, or spine implant (n = 54) removal. A standardized definition of orthopedic implant-associated infection was applied. Receiver operating curve analysis was used to determine ideal cutoff values for differentiating infected from non-infected cases. ESR was significantly different in subjects with aseptic failure infection of knee (median 11 and 53.5 mm/h, respectively, p = <0.0001) and hip (median 11 and 30 mm/h, respectively, p = <0.0001) arthroplasties and spine implants (median 10 and 48.5 mm/h, respectively, p = 0.0033), but not shoulder arthroplasties (median 10 and 9 mm/h, respectively, p = 0.9883). Optimized ESR cutoffs for knee, hip and shoulder arthroplasties and spine implants were 19, 13, 26, and 45 mm/h, respectively. Using these cutoffs, sensitivity and specificity to detect infection were 89 and 74% for knee, 82 and 60% for hip, and 32 and 93% for shoulder arthroplasties, and 57 and 90% for spine implants. CRP was significantly different in subjects with aseptic failure and infection of knee (median 4 and 51 mg/l, respectively, p < 0.0001), hip (median 3 and 18 mg/l, respectively, p < 0.0001), and shoulder (median 3 and 10 mg/l, respectively, p = 0.01) arthroplasties, and spine implants (median 3 and 20 mg/l, respectively, p = 0.0011). Optimized CRP cutoffs for knee, hip, and shoulder arthroplasties, and spine implants were 14.5, 10.3, 7, and 4.6 mg/l, respectively. Using these cutoffs, sensitivity and specificity to detect infection were 79 and 88% for knee, 74 and 79% for hip, and 63 and 73% for shoulder arthroplasties, and 79 and 68% for spine implants. Conclusion: CRP and ESR have poor sensitivity for the diagnosis of shoulder implant infection. A CRP of 4.6 mg/l had a sensitivity of 79 and a specificity of 68% to detect infection of spine implants.	[Piper, Kerryl E.; Fernandez-Sampedro, Marta; Steckelberg, Kathryn E.; Karau, Melissa J.; Steckelberg, James M.; Berbari, Elie F.; Osmon, Douglas R.; Patel, Robin] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA; [Mandrekar, Jayawant N.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Patel, Robin] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN USA; [Hanssen, Arlen D.; Lewallen, David G.; Cofield, Robert H.; Sperling, John W.; Sanchez-Sotelo, Joaquin; Huddleston, Paul M.; Dekutoski, Mark B.; Yaszemski, Michael; Currier, Bradford] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Piper, KE (corresponding author), Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Huddleston, Paul/ABI-6836-2020; Sanchez-Sotelo, Joaquin/AAJ-1248-2021	Huddleston, Paul/0000-0002-8665-3787; 				AALTO K, 1984, CLIN ORTHOP RELAT R, P118; Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005; Bare J, 2006, CLIN ORTHOP RELAT R, P40, DOI 10.1097/01.blo.0000218727.14097.d5; Bernard L, 2004, SCAND J INFECT DIS, V36, P410, DOI 10.1080/00365540410015240; Bilgen OF, 2001, J INT MED RES, V29, P7, DOI 10.1177/147323000102900102; Bottner F, 2007, J BONE JOINT SURG BR, V89B, P94, DOI 10.1302/0301-620X.89B1.17485; CHOUDHRY RR, 1992, J BONE JOINT SURG BR, V74, P523, DOI 10.1302/0301-620X.74B4.1624508; DELPOZO JL, 2009, NEW ENGL J MED, V361, P43; Feldman DS, 1995, J BONE JOINT SURG AM, V77A, P1807, DOI 10.2106/00004623-199512000-00003; Fink B, 2008, J BONE JOINT SURG BR, V90B, P874, DOI 10.1302/0301-620X.90B7.20417; Greidanus NV, 2007, J BONE JOINT SURG AM, V89A, P1409, DOI 10.2106/JBJS.D.02602; Hahn F, 2005, EUR SPINE J, V14, P783, DOI 10.1007/s00586-004-0854-6; JONSSON B, 1991, SPINE, V16, P1049; Kanafani ZA, 2009, CLIN INFECT DIS, V49, P1083, DOI 10.1086/605577; Kowalski TJ, 2007, AM J NEURORADIOL, V28, P693; Laiho K, 2001, ANN RHEUM DIS, V60, P275, DOI 10.1136/ard.60.3.275; LARSSON S, 1992, CLIN ORTHOP RELAT R, P237; LEVIN BR, 1991, TRENDS ECOL EVOL, V6, P237, DOI 10.1016/0169-5347(91)90067-8; Moreschini O, 2001, INT J TISSUE REACT, V23, P151; Muller Michael, 2008, J Orthop Surg Res, V3, P31, DOI 10.1186/1749-799X-3-31; Niskanen RO, 1996, J BONE JOINT SURG BR, V78B, P431, DOI 10.1302/0301-620X.78B3.0780431; Piper KE, 2009, J CLIN MICROBIOL, V47, P1878, DOI 10.1128/JCM.01686-08; SAMPEDRO MF, SPINE IN PRESS; Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255; SHIH LY, 1987, CLIN ORTHOP RELAT R, P238; Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Virolainen P, 2002, Scand J Surg, V91, P178; White J, 1998, J BONE JOINT SURG BR, V80B, P909, DOI 10.1302/0301-620X.80B5.8708	29	122	130	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9358	10.1371/journal.pone.0009358	http://dx.doi.org/10.1371/journal.pone.0009358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179760	Green Published, gold			2022-12-27	WOS:000274923900019
J	Zhang, H; Wang, P; Papangelopoulos, N; Xu, Y; Sette, A; Bourne, PE; Lund, O; Ponomarenko, J; Nielsen, M; Peters, B				Zhang, Hao; Wang, Peng; Papangelopoulos, Nikitas; Xu, Ying; Sette, Alessandro; Bourne, Philip E.; Lund, Ole; Ponomarenko, Julia; Nielsen, Morten; Peters, Bjoern			Limitations of Ab Initio Predictions of Peptide Binding to MHC Class II Molecules	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; STRUCTURAL PREDICTION; PROTEIN; COMPLEX; SEQUENCE; RECEPTOR; DYNAMICS; NETMHCPAN; POCKETS; SERVER	Successful predictions of peptide MHC binding typically require a large set of binding data for the specific MHC molecule that is examined. Structure based prediction methods promise to circumvent this requirement by evaluating the physical contacts a peptide can make with an MHC molecule based on the highly conserved 3D structure of peptide: MHC complexes. While several such methods have been described before, most are not publicly available and have not been independently tested for their performance. We here implemented and evaluated three prediction methods for MHC class II molecules: statistical potentials derived from the analysis of known protein structures; energetic evaluation of different peptide snapshots in a molecular dynamics simulation; and direct analysis of contacts made in known 3D structures of peptide: MHC complexes. These methods are ab initio in that they require structural data of the MHC molecule examined, but no specific peptide: MHC binding data. Moreover, these methods retain the ability to make predictions in a sufficiently short time scale to be useful in a real world application, such as screening a whole proteome for candidate binding peptides. A rigorous evaluation of each methods prediction performance showed that these are significantly better than random, but still substantially lower than the best performing sequence based class II prediction methods available. While the approaches presented here were developed independently, we have chosen to present our results together in order to support the notion that generating structure based predictions of peptide: MHC binding without using binding data is unlikely to give satisfactory results.	[Zhang, Hao; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Wang, Peng; Sette, Alessandro; Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Papangelopoulos, Nikitas; Bourne, Philip E.; Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, San Diego, CA 92103 USA; [Papangelopoulos, Nikitas; Bourne, Philip E.; Ponomarenko, Julia] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA	Technical University of Denmark; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Georgia; University of Georgia	Zhang, H (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	bpeters@liai.org	Ponomarenko, Julia/K-8105-2015; Nielsen, Morten/E-7754-2011; Sette, Alessandro/AFO-8916-2022; Bourne, Philip E/C-2073-2008; Lund, Ole/F-4437-2014; Nielsen, Morten/AAL-8700-2020	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Ponomarenko, Julia/0000-0002-1477-9444	National Institutes of Health [HHSN26620040006C, HHSN266200400083C, HHSN266200400025C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health contracts HHSN26620040006C, HHSN266200400083C and HHSN266200400025C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2004, METHODS, V34, P454, DOI 10.1016/j.ymeth.2004.06.008; ALTUVIA Y, 1995, J MOL BIOL, V249, P244, DOI 10.1006/jmbi.1995.0293; Altuvia Y, 1997, HUM IMMUNOL, V58, P1, DOI 10.1016/S0198-8859(97)00210-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordner AJ, 2006, PROTEINS, V63, P512, DOI 10.1002/prot.20831; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2006, PROTEINS, V63, P43, DOI 10.1002/prot.20870; Davies MN, 2003, MOL MED, V9, P220, DOI 10.2119/2003-00032.Sansom; Doytchinova IA, 2004, J IMMUNOL, V172, P7495, DOI 10.4049/jimmunol.172.12.7495; Fagerberg T, 2006, J MOL BIOL, V356, P521, DOI 10.1016/j.jmb.2005.11.059; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jojic N, 2006, BIOINFORMATICS, V22, pE227, DOI 10.1093/bioinformatics/btl255; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Moreira IS, 2007, J COMPUT CHEM, V28, P644, DOI 10.1002/jcc.20566; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; *RDC T, 2006, R LANG ENV STAT COMP; Richards MW, 2009, MOL CELL, V36, P560, DOI 10.1016/j.molcel.2009.09.038; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Schafroth HD, 2004, PROTEINS, V54, P534, DOI 10.1002/prot.10608; SIDNEY JS, 1998, MEASUREMENT MHC PEPT; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh SP, 2008, BIOINFORMATION, V3, P72, DOI 10.6026/97320630003072; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Zaitlen N, 2008, J COMPUT BIOL, V15, P927, DOI 10.1089/cmb.2007.0183; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	49	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9272	10.1371/journal.pone.0009272	http://dx.doi.org/10.1371/journal.pone.0009272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174654	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590600025
J	Bouamrani, A; Ramus, C; Gay, E; Pelletier, L; Cubizolles, M; Brugiere, S; Wion, D; Berger, F; Issartel, JP				Bouamrani, Ali; Ramus, Claire; Gay, Emmanuel; Pelletier, Laurent; Cubizolles, Myriam; Brugiere, Sabine; Wion, Didier; Berger, Francois; Issartel, Jean-Paul			Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; RHEUMATOID-ARTHRITIS; BRAIN-TUMORS; EXPRESSION; KINASE; CANCER; CELLS; CARCINOMA; CYTOSKELETON; PROSTATE	Background: Tissue invasion or tissue infiltration are clinical behaviors of a poor-prognosis subset of meningiomas. We carried out proteomic analyses of tissue extracts to discover new markers to accurately distinguish between infiltrative and noninfiltrative meningiomas. Methodology/Principal Findings: Protein lysates of 64 different tissue samples (including two brain-invasive and 32 infiltrative tumors) were submitted to SELDI-TOF mass spectrometric analysis. Mass profiles were used to build up both unsupervised and supervised hierarchical clustering. One marker was found at high levels in noninvasive and noninfiltrative tumors and appeared to be a discriminative marker for clustering infiltrative and/or invasive meningiomas versus noninvasive meningiomas in two distinct subsets. Sensitivity and specificity were 86.7% and 100%, respectively. This marker was purified and identified as a multiphosphorylated form of vimentin, a cytoskeletal protein expressed in meningiomas. Conclusions/Significance: Specific forms of vimentin can be surrogate molecular indicators of the invasive/infiltrative phenotype in tumors.	[Bouamrani, Ali; Ramus, Claire; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci, Grenoble, France; [Gay, Emmanuel] CHU Grenoble, Dept Neurosurg & Pathol, F-38043 Grenoble, France; [Cubizolles, Myriam] Ciphergen Inc, Fremont, CA USA; [Brugiere, Sabine] CEA, Grenoble, France; [Issartel, Jean-Paul] CNRS, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Bouamrani, A (corresponding author), Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci, Grenoble, France.	jean-paul.issartel@ujf-grenoble.fr	Cubizolles, Myriam/AAZ-7719-2021; ISSARTEL, Jean-Paul/B-8727-2014; Wion, Didier/M-7045-2018	Wion, Didier/0000-0001-7144-6470; Sabine, BRUGIERE/0000-0002-0757-0968	Region Rhne-Alpes; Ligue contre le Cancer; Lyon, Auvergne, Rhne-Alpes Canceropole; Institut National du Cancer	Region Rhne-Alpes; Ligue contre le Cancer(Ligue nationale contre le cancer); Lyon, Auvergne, Rhne-Alpes Canceropole; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from the Region Rhne-Alpes; the Ligue contre le Cancer; the Lyon, Auvergne, Rhne-Alpes Canceropole and the Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; ANDO S, 1991, BIOCHEM BIOPH RES CO, V175, P955, DOI 10.1016/0006-291X(91)91658-Y; Bang H, 2007, ARTHRITIS RHEUM-US, V56, P2503, DOI 10.1002/art.22817; BLACK PM, 1993, NEUROSURGERY, V32, P643, DOI 10.1227/00006123-199304000-00023; Bonam-Rani A, 2006, CLIN CHEM, V52, P2103, DOI 10.1373/clinchem.2006.070979; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; CHAMBERLAIN MC, 2004, CURR TREAT OPTION NE, V26, P297; Cheng TJ, 2003, J CELL BIOCHEM, V89, P589, DOI 10.1002/jcb.10511; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Chu YW, 1996, AM J PATHOL, V148, P63; Diamandis EP, 2003, CLIN CHEM, V49, P1272, DOI 10.1373/49.8.1272; DONHUIJSEN K, 1989, PATHOL RES PRACT, V184, P287, DOI 10.1016/S0344-0338(89)80088-3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gilles C, 1999, J CELL SCI, V112, P4615; HEATLEY M, 1995, J CLIN PATHOL, V48, P1031, DOI 10.1136/jcp.48.11.1031; Hong SH, 2006, BIOMARK INSIGHTS, V1, P175; HUANG TJ, 1994, J PROTEIN CHEM, V13, P517, DOI 10.1007/BF01901533; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li Zu-mao, 2008, Zhonghua Zhong Liu Za Zhi, V30, P408; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Nakamura Y, 2009, INT J CANCER, V124, P2512, DOI 10.1002/ijc.24229; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Perry A, 1999, CANCER, V85, P2046, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2046::AID-CNCR23>3.0.CO;2-M; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; RAYMOND WA, 1989, J PATHOL, V158, P107, DOI 10.1002/path.1711580205; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; SCHWECHHEIMER K, 1984, LAB INVEST, V51, P584; Seshadri R, 1996, INT J CANCER, V67, P353; Singh S, 2003, CANCER RES, V63, P2306; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Trog D, 2008, AMINO ACIDS, V34, P539, DOI 10.1007/s00726-007-0007-4; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Wiesner A, 2004, CURR PHARM BIOTECHNO, V5, P45, DOI 10.2174/1389201043489675; YANG HY, 1994, MOL CHEM NEUROPATHOL, V21, P155, DOI 10.1007/BF02815349; YUNG WKA, 1985, J NEURO-ONCOL, V3, P35; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	42	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9238	10.1371/journal.pone.0009238	http://dx.doi.org/10.1371/journal.pone.0009238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169076	Green Published, gold			2022-12-27	WOS:000274590500019
J	Xue, L; Chiang, L; He, B; Zhao, YY; Winoto, A				Xue, Ling; Chiang, Leslie; He, Bo; Zhao, You-Yang; Winoto, Astar			FoxM1, a Forkhead Transcription Factor Is a Master Cell Cycle Regulator for Mouse Mature T Cells but Not Double Positive Thymocytes	PLOS ONE			English	Article							BOX M1; NEGATIVE SELECTION; FACTOR TRIDENT; APOPTOSIS; MITOSIS; CANCER; PROLIFERATION; HOMEOSTASIS; PROGRESSION; INHIBITOR	FoxM1 is a forkhead box transcription factor and a known master regulator required for different phases of the cell cycle. In cell lines, FoxM1 deficient cells exhibit delayed S phase entry, aneuploidy, polyploidy and can't complete mitosis. In vivo, FoxM1 is expressed mostly in proliferating cells but is surprisingly also found in non-proliferating CD4(+)CD8(+) double positive thymocytes. Here, we addressed the role of FoxM1 in T cell development by generating and analyzing two different lines of T-cell specific FoxM1 deficient mice. As expected, FoxM1 is required for proliferation of early thymocytes and activated mature T cells. Defective expression of many cell cycle proteins was detected, including cyclin A, cyclin B1, cdc2, cdk2, p27 and the Rb family members p107 and p130 but surprisingly not survivin. Unexpectedly, loss of FoxM1 only affects a few cell cycle proteins in CD4(+)CD8(+) thymocytes and has little effect on their sensitivity to apoptosis and the subsequent steps of T cell differentiation. Thus, regulation of cell cycle genes by FoxM1 is stage-and context-dependent.	[Xue, Ling; Chiang, Leslie; He, Bo; Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Xue, Ling; Chiang, Leslie; He, Bo; Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xue, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	winoto@berkeley.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Korver W, 1997, IMMUNOBIOLOGY, V198, P157, DOI 10.1016/S0171-2985(97)80036-8; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; MYATT SS, 2007, NATUER REV CANC, V7; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pellicciari C, 1996, EXP CELL RES, V229, P370, DOI 10.1006/excr.1996.0382; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tait ED, 2009, NAT IMMUNOL, V10, P457, DOI 10.1038/ni0509-457; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	36	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9229	10.1371/journal.pone.0009229	http://dx.doi.org/10.1371/journal.pone.0009229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169079	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500011
J	Kadota, M; Yang, HH; Gomez, B; Sato, M; Clifford, RJ; Meerzaman, D; Dunn, BK; Wakefield, LM; Lee, MP				Kadota, Mitsutaka; Yang, Howard H.; Gomez, Bianca; Sato, Misako; Clifford, Robert J.; Meerzaman, Daoud; Dunn, Barbara K.; Wakefield, Lalage M.; Lee, Maxwell P.			Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-CELLS; EXPRESSION; MODEL; IMMORTALIZATION; SUPPRESSOR; RECEPTOR; PIK3CA	To gain insight into the role of genomic alterations in breast cancer progression, we conducted a comprehensive genetic characterization of a series of four cell lines derived from MCF10A. MCF10A is an immortalized mammary epithelial cell line (MEC); MCF10AT is a premalignant cell line generated from MCF10A by transformation with an activated HRAS gene; MCF10CA1h and MCF10CA1a, both derived from MCF10AT xenografts, form well-differentiated and poorly-differentiated malignant tumors in the xenograft models, respectively. We analyzed DNA copy number variation using the Affymetrix 500 K SNP arrays with the goal of identifying gene-specific amplification and deletion events. In addition to a previously noted deletion in the CDKN2A locus, our studies identified MYC amplification in all four cell lines. Additionally, we found intragenic deletions in several genes, including LRP1B in MCF10CA1h and MCF10CA1a, FHIT and CDH13 in MCF10CA1h, and RUNX1 in MCF10CA1a. We confirmed the deletion of RUNX1 in MCF10CA1a by DNA and RNA analyses, as well as the absence of the RUNX1 protein in that cell line. Furthermore, we found that RUNX1 expression was reduced in high-grade primary breast tumors compared to low/mid-grade tumors. Mutational analysis identified an activating PIK3CA mutation, H1047R, in MCF10CA1h and MCF10CA1a, which correlates with an increase of AKT1 phosphorylation at Ser473 and Thr308. Furthermore, we showed increased expression levels for genes located in the genomic regions with copy number gain. Thus, our genetic analyses have uncovered sequential molecular events that delineate breast tumor progression. These events include CDKN2A deletion and MYC amplification in immortalization, HRAS activation in transformation, PIK3CA activation in the formation of malignant tumors, and RUNX1 deletion associated with poorly-differentiated malignant tumors.	[Kadota, Mitsutaka; Yang, Howard H.; Gomez, Bianca; Clifford, Robert J.; Meerzaman, Daoud; Lee, Maxwell P.] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Sato, Misako; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Dunn, Barbara K.] NCI, Basic Prevent Sci Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kadota, M (corresponding author), NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	leemax@mail.nih.gov	Kadota, Mitsutaka/AAF-2652-2019; Wakefield, Lalage M/M-1963-2017	Kadota, Mitsutaka/0000-0002-1674-6697; Wakefield, Lalage M/0000-0003-4124-5250	NIH; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011253, ZIABC005785, ZIABC011250, ZIABC011252, ZIABC010986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This research was supported by the Intramural Research Program of the NIH and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Choong LY, 2007, MOL CANCER THER, V6, P2828, DOI 10.1158/1535-7163.MCT-06-0809; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; Dawson PJ, 1996, AM J PATHOL, V148, P313; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kim IY, 2009, CANCER LETT, V275, P227, DOI 10.1016/j.canlet.2008.10.013; Kim SH, 2009, INT J CANCER, V124, P2813, DOI 10.1002/ijc.24278; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Shekhar PVM, 1998, INT J ONCOL, V13, P907; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1990, CANCER RES, V50, P6075; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101	22	108	110	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9201	10.1371/journal.pone.0009201	http://dx.doi.org/10.1371/journal.pone.0009201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169162	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474700005
J	Hohm, T; Zitzler, E; Simon, R				Hohm, Tim; Zitzler, Eckart; Simon, Ruediger			A Dynamic Model for Stem Cell Homeostasis and Patterning in Arabidopsis Meristems	PLOS ONE			English	Article							SHOOT MERISTEM; GENE ENCODES; WUSCHEL; FATE; EXPRESSION; KINASE; LOOP	Plants maintain stem cells in their meristems as a source for new undifferentiated cells throughout their life. Meristems are small groups of cells that provide the microenvironment that allows stem cells to prosper. Homeostasis of a stem cell domain within a growing meristem is achieved by signalling between stem cells and surrounding cells. We have here simulated the origin and maintenance of a defined stem cell domain at the tip of Arabidopsis shoot meristems, based on the assumption that meristems are self-organizing systems. The model comprises two coupled feedback regulated genetic systems that control stem cell behaviour. Using a minimal set of spatial parameters, the mathematical model allows to predict the generation, shape and size of the stem cell domain, and the underlying organizing centre. We use the model to explore the parameter space that allows stem cell maintenance, and to simulate the consequences of mutations, gene misexpression and cell ablations.	[Hohm, Tim] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Hohm, Tim] Univ Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Hohm, Tim; Zitzler, Eckart] Comp Engn & Networks Lab, Zurich, Switzerland; [Simon, Ruediger] Univ Dusseldorf, Inst Genet, Dusseldorf, Germany	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Heinrich Heine University Dusseldorf	Hohm, T (corresponding author), Univ Lausanne, Dept Med Genet, Lausanne, Switzerland.	ruediger.simon@uni-duesseldorf.de	Hohm, Tim/D-8593-2015; Simon, Rudiger/T-6755-2018	Hohm, Tim/0000-0003-0935-9784; Simon, Rudiger/0000-0002-1317-7716	European Commission [5336]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Commission under the Marie Curie Research Training Network SY-STEM, Project 5336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Foster JA, 2001, NAT REV GENET, V2, P428, DOI 10.1038/35076523; Geier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003553; Gordon SP, 2007, DEVELOPMENT, V134, P3539, DOI 10.1242/dev.010298; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Han P, 2008, PLANT CELL, V20, P1482, DOI 10.1105/tpc.108.058867; Hohm T, 2007, LECT NOTES COMPUT SC, V4447, P102; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Jonsson H, 2003, SIGNALLING MULTICELL, P156; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kwon CS, 2005, GENE DEV, V19, P992, DOI 10.1101/gad.1276305; Laux T, 1996, DEVELOPMENT, V122, P87; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Muller R, 2006, PLANT CELL, V18, P1188, DOI 10.1105/tpc.105.040444; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Reddy GV, 2005, SCIENCE, V310, P663, DOI 10.1126/science.1116261; Reinhardt D, 2003, DEVELOPMENT, V130, P4073, DOI 10.1242/dev.00596; Ruuth SJ, 1995, J MATH BIOL, V34, P148, DOI 10.1007/BF00178771; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Tomlin CJ, 2007, NAT REV GENET, V8, P331, DOI 10.1038/nrg2098; TUCKER MR, 2008, DEVELOPMENT; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9189	10.1371/journal.pone.0009189	http://dx.doi.org/10.1371/journal.pone.0009189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169148	Green Published, gold			2022-12-27	WOS:000274474600010
J	Menke, SB; Booth, W; Dunn, RR; Schal, C; Vargo, EL; Silverman, J				Menke, Sean B.; Booth, Warren; Dunn, Robert R.; Schal, Coby; Vargo, Edward L.; Silverman, Jules			Is It Easy to Be Urban? Convergent Success in Urban Habitats among Lineages of a Widespread Native Ant	PLOS ONE			English	Article							ODOROUS HOUSE ANT; ARGENTINE ANTS; LINEPITHEMA-HUMILE; EVOLUTION; COMMUNITIES; INVASION; CONSERVATION; GENETICS; BIOLOGY; SUPERCOLONIES	The most rapidly expanding habitat globally is the urban habitat, yet the origin and life histories of the populations of native species that inhabit this habitat remain poorly understood. We use DNA barcoding of the COI gene in the widespread native pest ant Tapinoma sessile to test two hypotheses regarding the origin of urban populations and traits associated with their success. First, we determine if urban samples of T. sessile have a single origin from natural populations by looking at patterns of haplotype clustering fromacross their range. Second, we examine whether polygynous colony structure - a trait associated with invasion success - is correlated with urban environments, by studying the lineage dependence of colony structure. Our phylogenetic analysis of 49 samples identified four well supported geographic clades. Within clades, Kimura-2 parameter pairwise genetic distances revealed <2.3% variation; however, between clade genetic distances were 7.5-10.0%, suggesting the possibility of the presence of cryptic species. Our results indicate that T. sessile has successfully colonized urban environments multiple times. Additionally, polygynous colony structure is a highly plastic trait across habitat, clade, and haplotype. In short, T. sessile has colonized urban habitats repeatedly and appears to do so using life history strategies already present in more natural populations. Whether similar results hold for other species found in urban habitats has scarcely begun to be considered.	[Menke, Sean B.; Booth, Warren; Schal, Coby; Vargo, Edward L.; Silverman, Jules] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Menke, Sean B.; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Menke, Sean B.; Booth, Warren; Dunn, Robert R.; Schal, Coby; Vargo, Edward L.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Menke, SB (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	sean_menke@ncsu.edu	Vargo, Edward/D-1097-2010; Schal, Coby/A-8717-2010; Dunn, Robert/B-1360-2013	Vargo, Edward/0000-0002-8712-1248; Schal, Coby/0000-0001-7195-6358; Dunn, Robert/0000-0002-6030-4837	Pest Management Foundation; Blanton J. Whitmire endowment; Department of Energy (DOE) Program for Ecosystem Research (PER) [DE-FG02-08ER64510]; National Aeronautics and Space Administration (NASA) Biodiversity Grant	Pest Management Foundation; Blanton J. Whitmire endowment; Department of Energy (DOE) Program for Ecosystem Research (PER)(United States Department of Energy (DOE)); National Aeronautics and Space Administration (NASA) Biodiversity Grant(National Aeronautics & Space Administration (NASA))	This research was funded by the Pest Management Foundation (http://npmapestworld.org/PMFoundation/), the Blanton J. Whitmire endowment, Department of Energy (DOE) Program for Ecosystem Research (PER) DE-FG02-08ER64510 (http://per. ornl. gov/), and a National Aeronautics and Space Administration (NASA) Biodiversity Grant (http://www. nasa. gov/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce MS, 2008, J ECON ENTOMOL, V101, P1443, DOI 10.1603/0022-0493(2008)101[1443:MNVIIP]2.0.CO;2; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; BARBANI LE, 2003, FORAGING ACTIVITY FO; BRISTOW CM, 1984, J ANIM ECOL, V53, P715, DOI 10.2307/4654; Buczkowski G, 2006, INSECT SOC, V53, P282, DOI 10.1007/s00040-006-0870-0; Buczkowski G, 2008, ECOL ENTOMOL, V33, P780, DOI 10.1111/j.1365-2311.2008.01034.x; Chapman RE, 2001, ECOL LETT, V4, P650, DOI 10.1046/j.1461-0248.2001.00253.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Copren KA, 2005, MOL PHYLOGENET EVOL, V35, P689, DOI 10.1016/j.ympev.2005.03.002; Cremer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003838; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELLERS JH, 1987, ECOLOGY, V68, P1466, DOI 10.2307/1939230; FELLERS JH, 1989, OECOLOGIA, V78, P69, DOI 10.1007/BF00377199; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; FOUCAUD J, 2009, MOL ECOLOGY; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAMM CA, 2008, PHYLOGEOGRAPHY TAPIN; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedges S. A., 1998, FIELD GUIDE MANAGEME; HEDGES SA, 2000, COAST TO COAST; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; La Sorte FA, 2005, J BIOGEOGR, V32, P1151, DOI 10.1111/j.1365-2699.2005.01271.x; Landry B, 1999, ANN ENTOMOL SOC AM, V92, P40, DOI 10.1093/aesa/92.1.40; Lockwood JL, 2007, INVASION ECOLOGY; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Lundholm J. T., 2006, Urban Ecosystems, V9, P139, DOI 10.1007/s11252-006-8587-4; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McGowan KJ, 2001, AVIAN ECOLOGY CONSER, P332, DOI [10.1007/978-1-4615-1531-9_16, DOI 10.1007/978-1-4615-1531-9_16]; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Milford ER, 1999, SOUTHWEST NAT, V44, P278; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Novak SJ, 2007, P NATL ACAD SCI USA, V104, P3671, DOI 10.1073/pnas.0700224104; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ross KG, 1996, P NATL ACAD SCI USA, V93, P3021, DOI 10.1073/pnas.93.7.3021; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; SMALLWOOD J, 1982, INSECT SOC, V29, P138, DOI 10.1007/BF02228747; SMITH MA, 2005, RAPID ASSESSMENT ANT; SMITH MARION R., 1928, ANN ENT SOC AMER, V21, P307, DOI 10.1093/aesa/21.2.307; SMITH MR, 1965, HOUSE INFESTING ANTS; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; Thompson K, 2008, J ECOL, V96, P853, DOI 10.1111/j.1365-2745.2008.01383.x; Tschinkel WR, 2006, FIRE ANTS; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; Tsutsui ND, 2001, MOL ECOL, V10, P2151, DOI 10.1046/j.0962-1083.2001.01363.x; *UN, 2007, AFF UDOEAS; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Vogt JT, 2004, J ENTOMOL SCI, V39, P444, DOI 10.18474/0749-8004-39.3.444; Walters AC, 2005, AUSTRAL ECOL, V30, P395, DOI 10.1111/j.1442-9993.2005.01481.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	80	38	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9194	10.1371/journal.pone.0009194	http://dx.doi.org/10.1371/journal.pone.0009194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169204	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600014
J	Domenici, E; Wille, DR; Tozzi, F; Prokopenko, I; Miller, S; McKeown, A; Brittain, C; Rujescu, D; Giegling, I; Turck, CW; Holsboer, F; Bullmore, ET; Middleton, L; Merlo-Pich, E; Alexander, RC; Muglia, P				Domenici, Enrico; Wille, David R.; Tozzi, Federica; Prokopenko, Inga; Miller, Sam; McKeown, Astrid; Brittain, Claire; Rujescu, Dan; Giegling, Ina; Turck, Christoph W.; Holsboer, Florian; Bullmore, Edward T.; Middleton, Lefkos; Merlo-Pich, Emilio; Alexander, Robert C.; Muglia, Pierandrea			Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; EPIDERMAL-GROWTH-FACTOR; LONG-TERM POTENTIATION; MAJOR DEPRESSION; NEUROTROPHIC FACTOR; INSULIN-RESISTANCE; TREATMENT RESPONSE; MATRIX METALLOPROTEINASES; RECEPTOR ANTAGONIST; SERUM-LEVELS	Despite significant research efforts aimed at understanding the neurobiological underpinnings of psychiatric disorders, the diagnosis and the evaluation of treatment of these disorders are still based solely on relatively subjective assessment of symptoms. Therefore, biological markers which could improve the current classification of psychiatry disorders, and in perspective stratify patients on a biological basis into more homogeneous clinically distinct subgroups, are highly needed. In order to identify novel candidate biological markers for major depression and schizophrenia, we have applied a focused proteomic approach using plasma samples from a large case-control collection. Patients were diagnosed according to DSM criteria using structured interviews and a number of additional clinical variables and demographic information were assessed. Plasma samples from 245 depressed patients, 229 schizophrenic patients and 254 controls were submitted to multi analyte profiling allowing the evaluation of up to 79 proteins, including a series of cytokines, chemokines and neurotrophins previously suggested to be involved in the pathophysiology of depression and schizophrenia. Univariate data analysis showed more significant p-values than would be expected by chance and highlighted several proteins belonging to pathways or mechanisms previously suspected to be involved in the pathophysiology of major depression or schizophrenia, such as insulin and MMP-9 for depression, and BDNF, EGF and a number of chemokines for schizophrenia. Multivariate analysis was carried out to improve the differentiation of cases from controls and identify the most informative panel of markers. The results illustrate the potential of plasma biomarker profiling for psychiatric disorders, when conducted in large collections. The study highlighted a set of analytes as candidate biomarker signatures for depression and schizophrenia, warranting further investigation in independent collections.	[Domenici, Enrico; Merlo-Pich, Emilio; Alexander, Robert C.; Muglia, Pierandrea] GlaxoSmithKline R&D, Neurosci Ctr Excellence Drug Discovery, Verona, Italy; [Wille, David R.; Miller, Sam; Brittain, Claire] GlaxoSmithKline R&D, Discovery Stat Europe, Harlow, Essex, England; [Tozzi, Federica] GlaxoSmithKline R&D, Quantitat Sci, Verona, Italy; [Prokopenko, Inga] GlaxoSmithKline R&D, Div Genet, Drug Discovery, Verona, Italy; [McKeown, Astrid; Bullmore, Edward T.] Addenbrookes Hosp, GSK Clin Units, Cambridge, England; [Rujescu, Dan; Giegling, Ina] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Turck, Christoph W.; Holsboer, Florian] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Bullmore, Edward T.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Middleton, Lefkos] GlaxoSmithKline R&D, Div Genet, Drug Discovery, Greenford, Middx, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Munich; Max Planck Society; University of Cambridge; GlaxoSmithKline	Domenici, E (corresponding author), GlaxoSmithKline R&D, Neurosci Ctr Excellence Drug Discovery, Verona, Italy.	enrico.h.domenici@gsk.com	Bullmore, Ed/C-1706-2012; Rujescu, Dan/GRS-3875-2022; Giegling, Ina/ABA-3677-2021; Domenici, Enrico/K-8194-2016; Prokopenko, Inga/H-3241-2014; Tozzi, Federica/AAP-5462-2021; Muglia, Pierandrea/ABD-9235-2020; Prokopenko, Inga/AAU-9895-2020	Bullmore, Ed/0000-0002-8955-8283; Domenici, Enrico/0000-0001-7436-6919; Prokopenko, Inga/0000-0003-1624-7457; Tozzi, Federica/0000-0002-3536-2920; Muglia, Pierandrea/0000-0002-3973-8606; 	Max-Planck Institute; Ludwig-Maximilian University; GSK; Medical Research Council [G0001354, G0001354B] Funding Source: researchfish	Max-Planck Institute(Foundation CELLEX); Ludwig-Maximilian University; GSK(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Munich patients collection at Max-Planck Institute and the Ludwig-Maximilian University were funded by GSK. GSK supported the biomarker data collection and analysis and approved the publication of the results.	Alesci S, 2005, J CLIN ENDOCR METAB, V90, P2522, DOI 10.1210/jc.2004-1667; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; CONNOR TJ, 2004, HDB EXPT PHARM ANTID, V157, P117; Domenici Enrico, 2007, Expert Opin Med Diagn, V1, P235, DOI 10.1517/17530059.1.2.235; Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; GAMA CS, 2007, NEUROSCI LETT; Goncalves FM, 2009, CLIN CHIM ACTA, V403, P173, DOI 10.1016/j.cca.2009.02.013; Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x; Grillo RW, 2007, J PSYCHIAT RES, V41, P31, DOI 10.1016/j.jpsychires.2006.01.005; Hashimoto K, 2005, PSYCHIAT RES, V135, P257, DOI 10.1016/j.psychres.2003.11.006; Hestad KA, 2003, J ECT, V19, P183, DOI 10.1097/00124509-200312000-00002; Himmerich H, 2008, EUR PSYCHIAT, V23, P421, DOI 10.1016/j.eurpsy.2008.03.013; Himmerich H, 2006, EUR CYTOKINE NETW, V17, P196, DOI 10.1684/ecn.2006.0037; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Ikeda Y, 2008, SCHIZOPHR RES, V101, P58, DOI 10.1016/j.schres.2008.01.017; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Katon WJ, 2008, AM J MED, V121, P8, DOI 10.1016/j.amjmed.2008.09.008; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; Kubera M, 2000, POL J PHARMACOL, V52, P237; Lanquillon S, 2000, NEUROPSYCHOPHARMACOL, V22, P370, DOI 10.1016/S0893-133X(99)00134-7; Lee BH, 2009, NEUROPSYCHOBIOLOGY, V59, P51, DOI 10.1159/000205518; Lorenzl S, 2008, INT PSYCHOGERIATR, V20, P67, DOI 10.1017/S1041610207005790; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; MAES M, 1995, J AFFECT DISORDERS, V34, P301, DOI 10.1016/0165-0327(95)00028-L; MAES M, 1995, J AFFECT DISORDERS, V34, P61, DOI 10.1016/0165-0327(94)00106-J; Mikova O, 2001, EUR NEUROPSYCHOPHARM, V11, P203, DOI 10.1016/S0924-977X(01)00081-5; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Narita K, 2006, PROG NEURO-PSYCHOPH, V30, P1159, DOI 10.1016/j.pnpbp.2006.03.030; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Okamura F, 2000, METABOLISM, V49, P1255, DOI 10.1053/meta.2000.9515; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2003, NEUROSCI LETT, V351, P111, DOI 10.1016/j.neulet.2003.08.004; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Tashiro A, 1997, DIABETES CARE, V20, P1924, DOI 10.2337/diacare.20.12.1924; Teixeira AL, 2008, PROG NEURO-PSYCHOPH, V32, P710, DOI 10.1016/j.pnpbp.2007.11.019; Tuglu C, 2003, PSYCHOPHARMACOLOGY, V170, P429, DOI 10.1007/s00213-003-1566-z; Van den Oord EJCG, 2006, SCHIZOPHR RES, V82, P213, DOI 10.1016/j.schres.2005.09.002; VAN HF, 1996, PSYCHIAT RES, V65, P159; Weber B, 2000, EXP CLIN ENDOCR DIAB, V108, P187, DOI 10.1055/s-2000-7742; WINOKUR A, 1988, AM J PSYCHIAT, V145, P325; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095	55	255	274	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9166	10.1371/journal.pone.0009166	http://dx.doi.org/10.1371/journal.pone.0009166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161799	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800012
J	Quan, FS; Vunnava, A; Compans, RW; Kang, SM				Quan, Fu-Shi; Vunnava, Aswani; Compans, Richard W.; Kang, Sang-Moo			Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice	PLOS ONE			English	Article							IMMUNE-RESPONSES; HETEROSUBTYPIC IMMUNITY; IMMUNOGENICITY; IMMUNIZATION; INDUCTION; EMERGENCE; ANTIBODY; HUMANS	Background: The 2009 influenza pandemic and shortages in vaccine supplies worldwide underscore the need for new approaches to develop more effective vaccines. Methodology/Principal Findings: We generated influenza virus-like particles (VLPs) containing proteins derived from the A/California/04/2009 virus, and tested their efficacy as a vaccine in mice. A single intramuscular vaccination with VLPs provided complete protection against lethal challenge with the A/California/04/2009 virus and partial protection against A/PR/8/1934 virus, an antigenically distant human isolate. VLP vaccination induced predominant IgG2a antibody responses, high hemagglutination inhibition (HAI) titers, and recall IgG and IgA antibody responses. HAI titers after VLP vaccination were equivalent to those observed after live virus infection. VLP immune sera also showed HAI responses against diverse geographic pandemic isolates. Notably, a low dose of VLPs could provide protection against lethal infection. Conclusion/Significance: This study demonstrates that VLP vaccination provides highly effective protection against the 2009 pandemic influenza virus. The results indicate that VLPs can be developed into an effective vaccine, which can be rapidly produced and avoid the need to isolate high growth reassortants for egg-based production.	[Quan, Fu-Shi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Quan, FS (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rompan@emory.edu; skang2@emory.edu	Compans, Richard W/I-4087-2013; Quan, Fu-Shi/V-1826-2019	Compans, Richard W/0000-0003-2360-335X; 	National Institute of Allergy and Infectious Diseases [R01AI0680003, 3R01AI068003-04S1]; Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068003] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by Award Numbers R01AI0680003 (R.W.C.), 3R01AI068003-04S1 (R.W.C.) from the National Institute of Allergy and Infectious Diseases, and partially by the fund from the Georgia Research Alliance (S.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gluck R, 2000, J INFECT DIS, V181, P1129, DOI 10.1086/315337; Glueck R, 2001, ADV DRUG DELIVER REV, V51, P203, DOI 10.1016/S0169-409X(01)00174-0; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Itoh Y, 2009, NATURE; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SOLOVYOV A, 2009, EURO SURVEILL, V14; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	31	70	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9161	10.1371/journal.pone.0009161	http://dx.doi.org/10.1371/journal.pone.0009161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161790	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442800007
J	Straschewski, S; Warmer, M; Frascaroli, G; Hohenberg, H; Mertens, T; Winkler, M				Straschewski, Sarah; Warmer, Martin; Frascaroli, Giada; Hohenberg, Heinrich; Mertens, Thomas; Winkler, Michael			Human Cytomegaloviruses Expressing Yellow Fluorescent Fusion Proteins - Characterization and Use in Antiviral Screening	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; POTENT INHIBITORS; ESCHERICHIA-COLI; LATE TIMES; RECOMBINANT; GENE; TEGUMENT; REPLICATION; GROWTH	Recombinant viruses labelled with fluorescent proteins are useful tools in molecular virology with multiple applications (e.g., studies on intracellular trafficking, protein localization, or gene activity). We generated by homologous recombination three recombinant cytomegaloviruses carrying the enhanced yellow fluorescent protein (EYFP) fused with the viral proteins IE-2, ppUL32 (pp150), and ppUL83 (pp65). In growth kinetics, the three viruses behaved all like wild type, even at low multiplicity of infection (MOI). The expression of all three fusion proteins was detected, and their respective localizations were the same as for the unmodified proteins in wild-type virus-infected cells. We established the in vivo measurement of fluorescence intensity and used the recombinant viruses to measure inhibition of viral replication by neutralizing antibodies or antiviral substances. The use of these viruses in a pilot screen based on fluorescence intensity and high-content analysis identified cellular kinase inhibitors that block viral replication. In summary, these viruses with individually EYFP-tagged proteins will be useful to study antiviral substances and the dynamics of viral infection in cell culture.	[Straschewski, Sarah; Frascaroli, Giada; Mertens, Thomas; Winkler, Michael] Ulm Univ Hosp, Inst Virol, Ulm, Germany; [Winkler, Michael] Univ Klinikum Schleswig Holstein, Inst Infect Med, Kiel, Germany; [Warmer, Martin; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	Ulm University; University of Kiel; Schleswig Holstein University Hospital; Heinrich Pette Institute; University of Hamburg	Straschewski, S (corresponding author), Ulm Univ Hosp, Inst Virol, Ulm, Germany.	winkler@infmed.uni-kiel.de	Mertens, Thomas M/E-9826-2013	Mayer, Sarah/0000-0002-9667-1794; Winkler, Michael/0000-0002-6198-554X	Deutsche Forschungsgemeinschaft [WI 1725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (WI 1725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuCoin DP, 2006, J VIROL, V80, P8199, DOI 10.1128/JVI.00457-06; Baxter MK, 2001, J VIROL, V75, P6865, DOI 10.1128/JVI.75.15.6865-6873.2001; BEVILACQUA F, 1995, J GEN VIROL, V76, P1927, DOI 10.1099/0022-1317-76-8-1927; BILDER GE, 1991, AM J PHYSIOL, V260, pC721, DOI 10.1152/ajpcell.1991.260.4.C721; BOGNER E, 1992, ARCH VIROL, V126, P67, DOI 10.1007/BF01309685; Bresnahan WA, 1997, VIROLOGY, V231, P239, DOI 10.1006/viro.1997.8489; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; BRITT WJ, 1987, J GEN VIROL, V68, P1897, DOI 10.1099/0022-1317-68-7-1897; CHEE M, 1989, J VIROL, V63, P1345, DOI 10.1128/JVI.63.3.1345-1353.1989; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Chevillotte M, 2009, J VIROL, V83, P2480, DOI 10.1128/JVI.01818-08; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Dal Pozzo F, 2008, J VIROL METHODS, V151, P66, DOI 10.1016/j.jviromet.2008.03.025; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Frommolt P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-475; Goodrum FD, 2002, P NATL ACAD SCI USA, V99, P16255, DOI 10.1073/pnas.252630899; Heider JA, 2002, J VIROL, V76, P928, DOI 10.1128/JVI.76.2.928-932.2002; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Iwata M, 1999, BLOOD, V94, P572, DOI 10.1182/blood.V94.2.572.414k18_572_578; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kerman IA, 2003, J NEUROSCI, V23, P4657; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Meyer HH, 1997, J GEN VIROL, V78, P2621, DOI 10.1099/0022-1317-78-10-2621; Michel D, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P573; Mocarski E.S., 2001, FIELDS VIROLOGY, V4th Edn, P2629; Mocarski ES, 1996, P NATL ACAD SCI USA, V93, P11321, DOI 10.1073/pnas.93.21.11321; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; PASS RF, 2001, FIELDS VIROLOGY, P2675; Patterson G, 2001, J CELL SCI, V114, P837; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; PLACHTER B, 1992, J CLIN MICROBIOL, V30, P201, DOI 10.1128/JCM.30.1.201-206.1992; Potel C, 2002, J VIROL METHODS, V105, P13, DOI 10.1016/S0166-0934(02)00027-7; Pyner S, 2001, EXP PHYSIOL, V86, P695, DOI 10.1111/j.1469-445X.2001.tb00034.x; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Sanchez V, 2002, J VIROL, V76, P2973, DOI 10.1128/JVI.76.6.2973-2989.2002; Sanchez V, 2007, J VIROL, V81, P11730, DOI 10.1128/JVI.02760-06; Schierling K, 2005, J VIROL, V79, P3084, DOI 10.1128/JVI.79.5.3084-3096.2005; SCHMOLKE S, 1995, J VIROL, V69, P5959, DOI 10.1128/JVI.69.10.5959-5968.1995; SCHMOLKE S, 1995, J VIROL, V69, P1071, DOI 10.1128/JVI.69.2.1071-1078.1995; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; UTZ U, 1989, J VIROL, V63, P1995, DOI 10.1128/JVI.63.5.1995-2001.1989; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; WATHEN MW, 1982, J VIROL, V41, P462, DOI 10.1128/JVI.41.2.462-477.1982; White EA, 2004, J VIROL, V78, P1817, DOI 10.1128/JVI.78.4.1817-1830.2004; WINKLER M, 1994, J VIROL, V68, P3943, DOI 10.1128/JVI.68.6.3943-3954.1994; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; YURA Y, 1995, ARCH VIROL, V140, P1181, DOI 10.1007/BF01322745; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zimmermann A, 2000, ANTIVIR RES, V48, P49, DOI 10.1016/S0166-3542(00)00118-2	69	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9174	10.1371/journal.pone.0009174	http://dx.doi.org/10.1371/journal.pone.0009174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161802	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442800020
J	Talman, AM; Blagborough, AM; Sinden, RE				Talman, Arthur M.; Blagborough, Andrew M.; Sinden, Robert E.			A Plasmodium falciparum Strain Expressing GFP throughout the Parasite's Life-Cycle	PLOS ONE			English	Article							MALARIA PARASITES; PHYLOGENY	The human malaria parasite Plasmodium falciparum is responsible for the majority of malaria-related deaths. Tools allowing the study of the basic biology of P. falciparum throughout the life cycle are critical to the development of new strategies to target the parasite within both human and mosquito hosts. We here present 3D7HT-GFP, a strain of P. falciparum constitutively expressing the Green Fluorescent Protein (GFP) throughout the life cycle, which has retained its capacity to complete sporogonic development. The GFP expressing cassette was inserted in the Pf47 locus. Using this transgenic strain, parasite tracking and population dynamics studies in mosquito stages and exo-erythrocytic schizogony is greatly facilitated. The development of 3D7HT-GFP will permit a deeper understanding of the biology of parasite-host vector interactions, and facilitate the development of high-throughput malaria transmission assays and thus aid development of new intervention strategies against both parasite and mosquito.	[Talman, Arthur M.; Blagborough, Andrew M.; Sinden, Robert E.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	Imperial College London	Talman, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England.	arthur.talman@imperial.ac.uk	Talman, Arthur/GMW-9116-2022	Talman, Arthur/0000-0003-2584-3672	EU BioMalPar Network of Excellence; BBSRC; Wellcome Trust; EU-funded Marie Curie Action MalParTraining [MEST-CT-2005-020492]	EU BioMalPar Network of Excellence; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU-funded Marie Curie Action MalParTraining	This work was supported by research grants from the EU BioMalPar Network of Excellence, BBSRC and the Wellcome Trust for research funds. AMT is a recipient of support from the EU-funded Marie Curie Action MalParTraining (MEST-CT-2005-020492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANO P, 1990, ANNU REV MICROBIOL, V44, P429, DOI 10.1146/annurev.mi.44.100190.002241; Alavi Y, 2004, INT J PARASITOL, V34, P245, DOI 10.1016/j.ijpara.2003.05.001; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Dube A, 2009, TRENDS PARASITOL, V25, P432, DOI 10.1016/j.pt.2009.06.006; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Garnham PCC., 1966, MALARIA PARASITES OT; HOPPE HC, 1991, EXP PARASITOL, V72, P464, DOI 10.1016/0014-4894(91)90093-C; JANSE CJ, 1988, PARASITOLOGY, V96, P1, DOI 10.1017/S0031182000081609; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8	18	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9156	10.1371/journal.pone.0009156	http://dx.doi.org/10.1371/journal.pone.0009156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161781	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442700018
J	Lejeune, F; Audeoud, F; Marcus, L; Streri, A; Debillon, T; Gentaz, E				Lejeune, Fleur; Audeoud, Frederique; Marcus, Leila; Streri, Arlette; Debillon, Thierry; Gentaz, Edouard			The Manual Habituation and Discrimination of Shapes in Preterm Human Infants from 33 to 34+6 Post-Conceptional Age	PLOS ONE			English	Article							TEXTURE; RESPONSIVITY; PERCEPTION; PREMATURE; CARE	Background: Grasping at birth is well-known as a reflex in response to a stimulation of the palm of the hand. Recent studies revealed that this grasping was not only a pure reflex because human newborns are able to detect and to remember differences in shape features. The manual perception of shapes has not been investigated in preterm human infants. The aim of the present study was to investigate manual perception by preterm infants. Methodology/Principal Findings: We used a habituation/reaction to novelty procedure in twenty-four human preterm infants from 33 to 34+6 post-conceptional age. After habituation to an object (prism or cylinder) in one hand (left or right) in a habituation phase, babies were given either the same object or the other (novel) object in the same hand in a test phase. We observed that after successive presentations of the same object, a decrease of the holding time is observed for each preterm infant. Moreover, a significant increase of the holding time is obtained with the presentation of the novel object. Finally, the comparison between the current performance of preterm infants and those of full-term newborns showed that preterm babies only had a faster tactile habituation to a shape. Conclusion/Significance: For the first time, the results reveal that preterm infants from 33 to 34+6 GW can detect the specific features that differentiate prism and cylinder shapes by touch, and remember them. The results suggest that there is no qualitative, but only quantitative, difference between the perceptual abilities of preterm babies and those of full-term babies in perceiving shape manually.	[Lejeune, Fleur; Gentaz, Edouard] CNRS, Lab Psychol & NeuroCognit, UMR, Grenoble, France; [Lejeune, Fleur; Gentaz, Edouard] Univ Pierre Mendes France, Grenoble, France; [Audeoud, Frederique; Marcus, Leila; Debillon, Thierry] CHU Grenoble, Serv Neonatol, F-38043 Grenoble, France; [Streri, Arlette] Univ Paris 05, Paris, France; [Streri, Arlette] CNRS, Lab Psychol Percept, UMR, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Lejeune, F (corresponding author), CNRS, Lab Psychol & NeuroCognit, UMR, Grenoble, France.	Edouard.Gentaz@upmf-grenoble.fr	Debillon, Thierry/M-6929-2014					ALS H, 1994, JAMA-J AM MED ASSOC, V272, P853, DOI 10.1001/jama.272.11.853; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; BORNSTEIN MH, 1998, DEV SENSORY MOTOR CO, P301; Brazelton T. B., 1995, NEONATAL BEHAV ASSES; ERHARDT RP, 1974, AM J OCCUP THER, V28, P592; Fearon I, 2002, INFANCY, V3, P31, DOI 10.1207/S15327078IN0301_2; Gentaz E, 2009, MAIN TOUCHER CERVEAU; Hernandez-Reif Maria, 2001, Infant Behavior and Development, V24, P305, DOI 10.1016/S0163-6383(01)00081-9; Hooker D, 1938, P AM PHILOS SOC, V79, P597; Howell DC, 1998, METHODES STAT SCI HU; Humphery T, 1964, PROGR BRAIN RES, V4, P93, DOI [10.1016/s0079-6123(08)61273-x, DOI 10.1016/S0079-6123(08)61273-X, 10.1016/S0079-6123]; Humphrey T, 1970, Adv Child Dev Behav, V5, P1, DOI 10.1016/S0065-2407(08)60464-4; Johnston CC, 1996, PEDIATRICS, V98, P925; Kostovic I, 2006, SEMIN FETAL NEONAT M, V11, P415, DOI 10.1016/j.siny.2006.07.001; MCGRAW MB, 1935, NEUROMUSCULAR MATURA; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; Molina M, 2003, DEV PSYCHOBIOL, V42, P378, DOI 10.1002/dev.10111; Molina M, 1998, INFANT BEHAV DEV, V21, P659, DOI 10.1016/S0163-6383(98)90036-4; PIAZZA SD, 1997, ENFANT PREMATURE POI; ROCHAT P, 1987, INFANT BEHAV DEV, V10, P435, DOI 10.1016/0163-6383(87)90041-5; ROSE SA, 1980, CHILD DEV, V51, P416; ROSE SA, 1976, DEV PSYCHOL, V12, P311, DOI 10.1037/0012-1649.12.4.311; Sann C, 2008, NEUROPSYCHOLOGIA, V46, P698, DOI 10.1016/j.neuropsychologia.2007.09.014; Sann C, 2007, DEVELOPMENTAL SCI, V10, P399, DOI 10.1111/j.1467-7687.2007.00593.x; SIZUN J, 2005, RES EARLY DEV CARE P; Streri A, 2004, NEUROPSYCHOLOGIA, V42, P1365, DOI 10.1016/j.neuropsychologia.2004.02.012; Streri A, 2003, SOMATOSENS MOT RES, V20, P13, DOI 10.1080/0899022031000083799; Streri A, 2000, DEVELOPMENTAL SCI, V3, P319, DOI 10.1111/1467-7687.00126; TWITCHELL TE, 1965, NEUROPSYCHOLOGIA, V3, P247, DOI 10.1016/0028-3932(65)90027-8; [No title captured]	30	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9108	10.1371/journal.pone.0009108	http://dx.doi.org/10.1371/journal.pone.0009108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NV	20161731	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442600008
J	Vu, GTH; Dear, PH; Caligari, PDS; Wilkinson, MJ				Vu, Giang T. H.; Dear, Paul H.; Caligari, Peter D. S.; Wilkinson, Mike J.			BAC-HAPPY Mapping (BAP Mapping): A New and Efficient Protocol for Physical Mapping	PLOS ONE			English	Article							GENOME; MAP; SEQUENCE; PCR	Physical and linkage mapping underpin efforts to sequence and characterize the genomes of eukaryotic organisms by providing a skeleton framework for whole genome assembly. Hitherto, linkage and physical "contig" maps were generated independently prior to merging. Here, we develop a new and easy method, BAC HAPPY MAPPING (BAP mapping), that utilizes BAC library pools as a HAPPY mapping panel together with an Mbp-sized DNA panel to integrate the linkage and physical mapping efforts into one pipeline. Using Arabidopsis thaliana as an exemplar, a set of 40 Sequence Tagged Site (STS) markers spanning similar to 10% of chromosome 4 were simultaneously assembled onto a BAP map compiled using both a series of BAC pools each comprising 0.7x genome coverage and dilute (0.7x genome) samples of sheared genomic DNA. The resultant BAP map overcomes the need for polymorphic loci to separate genetic loci by recombination and allows physical mapping in segments of suppressed recombination that are difficult to analyze using traditional mapping techniques. Even virtual "BAC-HAPPY-mapping" to convert BAC landing data into BAC linkage contigs is possible.	[Vu, Giang T. H.; Wilkinson, Mike J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Dear, Paul H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Caligari, Peter D. S.] Sumatra Biosci, Singapore, Singapore; [Caligari, Peter D. S.] BioHybrids Int, Woodley, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); MRC Laboratory Molecular Biology	Vu, GTH (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	jjw@aber.ac.uk	Dear, Paul H/A-1162-2012; Caligari, Peter/B-1298-2008; Vu, Giang/D-7928-2016	Caligari, Peter/0000-0003-1223-7833; Vu, Giang/0000-0001-8394-9067; Wilkinson, Michael/0000-0002-9881-6993	Biohybrids International; Sumatra Biosciences; Medical Research Council [MC_U105131672] Funding Source: researchfish; MRC [MC_U105131672] Funding Source: UKRI	Biohybrids International; Sumatra Biosciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: Biohybrids International and Sumatra Biosciences funded this work. Other than the input of one author in the wording of the manuscript, and in providing materials and approving permission to publish freely, the sponsors had no direct role in the conception of the method (except to define the need), the study design, data collection, or analysis.	Cai WW, 2001, GENOME RES, V11, P1619, DOI 10.1101/gr.198101; DEAR PH, 1989, NUCLEIC ACIDS RES, V17, P6795, DOI 10.1093/nar/17.17.6795; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Konfortov BA, 2000, GENOME RES, V10, P1737, DOI 10.1101/gr.141700; Kunzel G, 2000, GENETICS, V154, P397; LEWIN HA, 2009, EVERY GENOME SEQUENC; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mueller LA, 2005, COMP FUNCT GENOM, V6, P153, DOI 10.1002/cfg.468; NEWELL WR, 1995, GENOMICS, V30, P59, DOI 10.1006/geno.1995.0009; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Piper MB, 1998, GENOME RES, V8, P1299, DOI 10.1101/gr.8.12.1299; Snelling WM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r165; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; Thangavelu M, 2003, PLANT BIOTECHNOL J, V1, P23, DOI 10.1046/j.1467-7652.2003.00001.x; Wiley G., 2009, CURR PROTOC HUM GENE; Xu JC, 1998, P NATL ACAD SCI USA, V95, P5661, DOI 10.1073/pnas.95.10.5661; YAOGUANG L, 1995, PLANT J, V7, P351; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-371; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	27	4	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9089	10.1371/journal.pone.0009089	http://dx.doi.org/10.1371/journal.pone.0009089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161702	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442500003
J	Dobbins, AC; Grossmann, JK				Dobbins, Allan C.; Grossmann, Jon K.			Asymmetries in Perception of 3D Orientation	PLOS ONE			English	Article							MONKEY CORTEX; NEURONS; GAZE; DISTANCE; SHAPE; ORGANIZATION; MODULATION; ANGLE	Visual scene interpretation depends on assumptions based on the statistical regularities of the world. People have some preference for seeing ambiguously oriented objects (Necker cubes) as if tilted down or viewed from above. This bias is a near certainty in the first instant (similar to 1 s) of viewing and declines over the course of many seconds. In addition, we found that there is modulation of perceived orientation that varies with position-for example objects on the left are more likely to be interpreted as viewed from the right. Therefore there is both a viewed-from-above prior and a scene position-dependent modulation of perceived 3-D orientation. These results are consistent with the idea that ambiguously oriented objects are initially assigned an orientation consistent with our experience of an asymmetric world in which objects most probably sit on surfaces below eye level.	[Dobbins, Allan C.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Vis Sci Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Dobbins, AC (corresponding author), Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.	adobbins@uab.edu			National Eye Institute [R01EY016874]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (grant R01EY016874) to A. C. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1958, AM J PSYCHOL, V71, P548, DOI 10.2307/1420250; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ATTNEAVE F, 1968, AM J PSYCHOL, V81, P447, DOI 10.2307/1420645; Bremmer F, 1997, J NEUROPHYSIOL, V77, P962, DOI 10.1152/jn.1997.77.2.962; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 2000, NEUROREPORT, V11, P1277, DOI 10.1097/00001756-200004270-00027; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; ENNS JT, 1990, SCIENCE, V247, P721, DOI 10.1126/science.2300824; ENNS JT, 1990, PSYCHOL SCI, V1, P323, DOI 10.1111/j.1467-9280.1990.tb00227.x; FREEMAN WT, 1994, NATURE, V368, P542, DOI 10.1038/368542a0; GALLETTI C, 1989, J NEUROSCI, V9, P1112; GALLETTI C, 1991, EUR J NEUROSCI, V3, P452, DOI 10.1111/j.1460-9568.1991.tb00832.x; KAUFFMAN L, 1975, SIGHT MIND; Kornmeier J, 2007, PSYCHOPHYSIOLOGY, V44, P552, DOI 10.1111/j.1469-8986.2007.00525.x; Lehky SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003492; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; NAKAYAMA K, 1992, SCIENCE, V257, P1357, DOI 10.1126/science.1529336; Nowicka A, 2000, EUR J NEUROSCI, V12, P751, DOI 10.1046/j.1460-9568.2000.00943.x; ORBACH J, 1963, Percept Mot Skills, V17, P571; PETERSON MA, 1991, J EXP PSYCHOL HUMAN, V17, P170, DOI 10.1037/0096-1523.17.1.170; RAMACHANDRAN VS, 1983, NATURE, V304, P529, DOI 10.1038/304529a0; RAMACHANDRAN VS, 1985, PERCEPTION, V14, P135, DOI 10.1068/p140135; RAMACHANDRAN VS, 1988, NATURE, V331, P163, DOI 10.1038/331163a0; Rensink RA, 2004, PERCEPTION, V33, P1339, DOI 10.1068/p5322; Rosenbluth D, 2002, NEURON, V33, P143, DOI 10.1016/S0896-6273(01)00559-1; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; SCOTTO MA, 1990, PERCEPT MOTOR SKILL, V70, P1059; Sun J, 1996, NATURE, V379, P165, DOI 10.1038/379165a0; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; Trotter Y, 1996, J NEUROPHYSIOL, V76, P2872, DOI 10.1152/jn.1996.76.5.2872; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066	33	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9553	10.1371/journal.pone.0009553	http://dx.doi.org/10.1371/journal.pone.0009553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	564EW	20209050	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100027
J	Goswami, A; Polly, PD				Goswami, Anjali; Polly, P. David			The Influence of Modularity on Cranial Morphological Disparity in Carnivora and Primates (Mammalia)	PLOS ONE			English	Article							QUANTITATIVE GENETICS; DEVELOPMENTAL INTEGRATION; VARIATION PATTERNS; GEOMETRIC SHAPE; SAKIS PITHECIA; EVOLUTION; PHYLOGENY; SAGUINUS; ONTOGENY; MODULES	Background: Although variation provides the raw material for natural selection and evolution, few empirical data exist about the factors controlling morphological variation. Because developmental constraints on variation are expected to act by influencing trait correlations, studies of modularity offer promising approaches that quantify and summarize patterns of trait relationships. Modules, highly-correlated and semi-autonomous sets of traits, are observed at many levels of biological organization, from genes to colonies. The evolutionary significance of modularity is considerable, with potential effects including constraining the variation of individual traits, circumventing pleiotropy and canalization, and facilitating the transformation of functional structures. Despite these important consequences, there has been little empirical study of how modularity influences morphological evolution on a macroevolutionary scale. Here, we conduct the first morphometric analysis of modularity and disparity in two clades of placental mammals, Primates and Carnivora, and test if trait integration within modules constrains or facilitates morphological evolution. Principal Findings: We used both randomization methods and direct comparisons of landmark variance to compare disparity in the six cranial modules identified in previous studies. The cranial base, a highly-integrated module, showed significantly low disparity in Primates and low landmark variance in both Primates and Carnivora. The vault, zygomatic-pterygoid and orbit modules, characterized by low trait integration, displayed significantly high disparity within Carnivora. 14 of 24 results from analyses of disparity show no significant relationship between module integration and morphological disparity. Of the ten significant or marginally significant results, eight support the hypothesis that integration within modules constrains morphological evolution in the placental skull. Only the molar module, a highly-integrated and functionally important module, showed significantly high disparity in Carnivora, in support of the facilitation hypothesis. Conclusions: This analysis of within-module disparity suggested that strong integration of traits had little influence on morphological evolution over large time scales. However, where significant results were found, the primary effect of strong integration of traits was to constrain morphological variation. Thus, within Primates and Carnivora, there was some support for the hypothesis that integration of traits within cranial modules limits morphological evolution, presumably by limiting the variation of individual traits.	[Goswami, Anjali] UCL, Dept Genet Evolut & Environm, London, England; [Goswami, Anjali] UCL, Dept Earth Sci, London, England; [Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	University of London; University College London; University of London; University College London; Indiana University System; Indiana University Bloomington	Goswami, A (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	a.goswami@ucl.ac.uk	Polly, P. David/ABC-6597-2020; Goswami, Anjali/B-3440-2010	Polly, P. David/0000-0001-7338-8526; 	U.S. National Science Foundation International Research Fellowship OISE [0502186]; U.S. National Science Foundation DDIG [0308765]; Field Museum Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History Collections Study Grant; University of California Samuel P. and Doris Welles Fund; University of Chicago Hinds Fund	U.S. National Science Foundation International Research Fellowship OISE; U.S. National Science Foundation DDIG(National Science Foundation (NSF)); Field Museum Women-in-Science Fellowship; Society of Vertebrate Paleontology Predoctoral Fellowship; American Museum of Natural History Collections Study Grant; University of California Samuel P. and Doris Welles Fund(University of California System); University of Chicago Hinds Fund	This study is based upon research supported by the U.S. National Science Foundation International Research Fellowship OISE #0502186 (to AG). Morphometric data was collected during AG's doctoral research, supported by U.S. National Science Foundation DDIG # 0308765, the Field Museum Women-in-Science Fellowship, the Society of Vertebrate Paleontology Predoctoral Fellowship, the American Museum of Natural History Collections Study Grant, the University of California Samuel P. and Doris Welles Fund, and the University of Chicago Hinds Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2000, AM J PHYS ANTHROPOL, V111, P489, DOI 10.1002/(SICI)1096-8644(200004)111:4<489::AID-AJPA5>3.0.CO;2-U; Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; ATCHLEY WR, 1991, BIOL REV, V66, P101, DOI 10.1111/j.1469-185X.1991.tb01138.x; Atchley WR, 1993, SKULL, V1, P207; Badyaev AV, 2005, AM NAT, V166, P382, DOI 10.1086/432559; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bruner E, 2008, AM J PHYS ANTHROPOL, V137, P30, DOI 10.1002/ajpa.20837; Calabretta R, 2000, ARTIF LIFE, V6, P69, DOI 10.1162/106454600568320; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; Cheverud JM, 2004, J EXP ZOOL PART B, V302B, P424, DOI 10.1002/jez.b.21008; CHEVERUD JM, 1988, AM J PHYS ANTHROPOL, V75, P195; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1989, EVOLUTION, V43, P1737, DOI 10.1111/j.1558-5646.1989.tb02623.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; Cheverud JM, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P132; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; CHEVERUD JM, 1983, EVOLUTION, V37, P895, DOI 10.1111/j.1558-5646.1983.tb05619.x; Eble GJ, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P253; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Gilbert BM, 1990, MAMMALIAN OSTEOLOGY; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Klaauw C. J. van der, 1948, Archives Neerlandaises de Zoologie, V9, P1; Klingenberg CP, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P213; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 1999, EVOLUTION, V53, P358, DOI [10.2307/2640773, 10.1111/j.1558-5646.1999.tb03772.x]; Klingenberg CP, 2001, EVOLUTION, V55, P2342; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2005, EVOLUTION, V59, P1128; Marroig G, 2004, AM J PHYS ANTHROPOL, V125, P266, DOI 10.1002/ajpa.10421; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Myers P., 2022, ANIMAL DIVERSITY WEB; Olson E. C., 1958, MORPHOLOGICAL INTEGR; OLSON EC, 1951, EVOLUTION, V5, P325, DOI 10.2307/2405677; Polly PD, 2001, BEYOND HETEROCHRONY, P305; Rohlf FJ, 1990, P MICH MORPH WORKSH, P227; Rose KD., 2005, RISE PLACENTAL MAMMA; Schlosser G, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P1; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Shubin NH, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P429; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; VERMEIJ GJ, 1973, SYST ZOOL, V22, P466, DOI 10.2307/2412953; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1995, LECT NOTES ARTIF INT, V929, P317; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; Zelditch ML, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P274; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	66	144	145	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9517	10.1371/journal.pone.0009517	http://dx.doi.org/10.1371/journal.pone.0009517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209089	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400022
J	Zahid, M; Velez-Fort, M; Papagiakoumou, E; Ventalon, C; Angulo, MC; Emiliani, V				Zahid, Morad; Velez-Fort, Mateo; Papagiakoumou, Eirini; Ventalon, Cathie; Angulo, Maria Cecilia; Emiliani, Valentina			Holographic Photolysis for Multiple Cell Stimulation in Mouse Hippocampal Slices	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; RAT BARREL CORTEX; ILLUMINATION MICROSCOPY; AMPA RECEPTORS; REMOTE-CONTROL; GLUTAMATE; SYNAPSES; PLASTICITY; LIGHT; ACTIVATION	Background: Advanced light microscopy offers sensitive and non-invasive means to image neural activity and to control signaling with photolysable molecules and, recently, light-gated channels. These approaches require precise and yet flexible light excitation patterns. For synchronous stimulation of subsets of cells, they also require large excitation areas with millisecond and micrometric resolution. We have recently developed a new method for such optical control using a phase holographic modulation of optical wave-fronts, which minimizes power loss, enables rapid switching between excitation patterns, and allows a true 3D sculpting of the excitation volumes. In previous studies we have used holographic photololysis to control glutamate uncaging on single neuronal cells. Here, we extend the use of holographic photolysis for the excitation of multiple neurons and of glial cells. Methods/Principal Findings: The system combines a liquid crystal device for holographic patterned photostimulation, high-resolution optical imaging, the HiLo microscopy, to define the stimulated regions and a conventional Ca2+ imaging system to detect neural activity. By means of electrophysiological recordings and calcium imaging in acute hippocampal slices, we show that the use of excitation patterns precisely tailored to the shape of multiple neuronal somata represents a very efficient way for the simultaneous excitation of a group of neurons. In addition, we demonstrate that fast shaped illumination patterns also induce reliable responses in single glial cells. Conclusions/Significance: We show that the main advantage of holographic illumination is that it allows for an efficient excitation of multiple cells with a spatiotemporal resolution unachievable with other existing approaches. Although this paper focuses on the photoactivation of caged molecules, our approach will surely prove very efficient for other probes, such as light-gated channels, genetically encoded photoactivatable proteins, photoactivatable fluorescent proteins, and voltage-sensitive dyes.	[Zahid, Morad; Papagiakoumou, Eirini; Ventalon, Cathie; Emiliani, Valentina] Univ Paris 05, INSERM, Wavefront Engn Microscopy Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France; [Velez-Fort, Mateo; Angulo, Maria Cecilia] Univ Paris 05, INSERM, Neuron Glia Interact Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Zahid, M (corresponding author), Univ Paris 05, INSERM, Wavefront Engn Microscopy Grp,U603, Neurophysiol & New Microscopies Lab,CNRS UMR 8154, Paris, France.	valentina.emiliani@parisdescartes.fr	Papagiakoumou, Eirini/B-1150-2017; Angulo, Maria Cecilia/B-8236-2014; Papagiakoumou, Eirini/ABC-7935-2021; PAPAGIAKOUMOU, Eirini/Q-4472-2019	Papagiakoumou, Eirini/0000-0002-7333-8796; Angulo, Maria Cecilia/0000-0002-0758-0496; PAPAGIAKOUMOU, Eirini/0000-0002-7333-8796; Ventalon, Cathie/0000-0001-8174-7840; Velez-Fort, Mateo/0000-0002-2640-4666; Emiliani, Valentina/0000-0003-2992-9510	Network of European Neuroscience Institutes (ENINET) [LSHM-CT-2005-19063]; European Science Fondation (ESF); "Centre National de la Recherche Scientifique'' (CNRS); European Commission [LSHM-CT-2007-037765]; "Agence Nationale de la Recherche'' (ANR); "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP)	Network of European Neuroscience Institutes (ENINET); European Science Fondation (ESF); "Centre National de la Recherche Scientifique'' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); "Agence Nationale de la Recherche'' (ANR)(French National Research Agency (ANR)); "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP)(Region Ile-de-France)	This work was supported by the Network of European Neuroscience Institutes (ENINET, contract number LSHM-CT-2005-19063), the European Science Fondation (ESF) and the "Centre National de la Recherche Scientifique'' (CNRS) through the European Young Investigator program (EURYI), the European Commission FP6 Specific Targeted Project "PHOTOLYSIS'' (contract number LSHM-CT-2007-037765). M. C. A. was supported by a young investigator grant from the "Agence Nationale de la Recherche'' (ANR). M.V.-F. was supported by fellowships from "Region Ile-de-France'' and "Ligue Francaise contre la Sclerose En Plaques'' (LFSEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Canepari M, 2001, J NEUROSCI METH, V112, P29, DOI 10.1016/S0165-0270(01)00451-4; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DiGregorio DA, 2007, J NEUROSCI, V27, P8344, DOI 10.1523/JNEUROSCI.2399-07.2007; FARAH N, 2007, C P IEEE ENG MED BIO, P6369; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Ge WP, 2006, SCIENCE, V312, P1533, DOI 10.1126/science.1124669; Golan L, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066004; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; HORNBECK LJ, 1983, IEEE T ELECTRON DEV, V30, P539, DOI 10.1109/T-ED.1983.21163; Judkewitz B, 2006, NEURON, V50, P180, DOI 10.1016/j.neuron.2006.04.011; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lutz C, 2008, NAT METHODS, V5, P821, DOI 10.1038/NMETH.1241; Matsuzaki M, 2008, J NEUROPHYSIOL, V99, P1535, DOI 10.1152/jn.01127.2007; Matthias K, 2003, J NEUROSCI, V23, P1750; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; MOHANTY SK, 2008, BIOPHYS J; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Nikolenko V, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.005.2008; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Oron D, 2005, OPT EXPRESS, V13, P1468, DOI 10.1364/OPEX.13.001468; Papagiakoumou E, 2008, OPT EXPRESS, V16, P22039, DOI 10.1364/OE.16.022039; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Polin M, 2005, OPT EXPRESS, V13, P5831, DOI 10.1364/OPEX.13.005831; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Santos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3130266; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; TANG CM, 2006, CURR PROTOC NEUROSCI, pCH6; Thompson SM, 2005, J NEUROSCI, V25, P10358, DOI 10.1523/JNEUROSCI.3515-05.2005; Trigo FF, 2009, J NEUROSCI METH, V180, P9, DOI 10.1016/j.jneumeth.2009.01.032; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Ventalon C, 2007, OPT LETT, V32, P1417, DOI 10.1364/OL.32.001417; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; WYROWSKI F, 1988, J OPT SOC AM A, V5, P1058, DOI 10.1364/JOSAA.5.001058; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	48	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9431	10.1371/journal.pone.0009431	http://dx.doi.org/10.1371/journal.pone.0009431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195547	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924300018
J	Brown, JW; McKnight, CJ				Brown, Jeffrey W.; McKnight, C. James			Molecular Model of the Microvillar Cytoskeleton and Organization of the Brush Border	PLOS ONE			English	Article							PARALLEL ACTIN BUNDLES; MYOSIN-I; F-ACTIN; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ELECTRON-MICROSCOPY; MEMBRANE SKELETON; BINDING PROTEIN; LIPID RAFTS; VILLIN	Background: Brush border microvilli are similar to 1-mu m long finger-like projections emanating from the apical surfaces of certain, specialized absorptive epithelial cells. A highly symmetric hexagonal array of thousands of these uniformly sized structures form the brush border, which in addition to aiding in nutrient absorption also defends the large surface area against pathogens. Here, we present a molecular model of the protein cytoskeleton responsible for this dramatic cellular morphology. Methodology/Principal Findings: The model is constructed from published crystallographic and microscopic structures reported by several groups over the last 30+ years. Our efforts resulted in a single, unique, self-consistent arrangement of actin, fimbrin, villin, brush border myosin (Myo1A), calmodulin, and brush border spectrin. The central actin core bundle that supports the microvillus is nearly saturated with fimbrin and villin cross-linkers and has a density similar to that found in protein crystals. The proposed model accounts for all major proteinaceous components, reproduces the experimentally determined stoichiometry, and is consistent with the size and morphology of the biological brush border membrane. Conclusions/Significance: The model presented here will serve as a structural framework to explain many of the dynamic cellular processes occurring over several time scales, such as protein diffusion, association, and turnover, lipid raft sorting, membrane deformation, cytoskeletal-membrane interactions, and even effacement of the brush border by invading pathogens. In addition, this model provides a structural basis for evaluating the equilibrium processes that result in the uniform size and structure of the highly dynamic microvilli.	[Brown, Jeffrey W.; McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Brown, JW (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	cjmck@bu.edu	Brown, Jeffrey Wade/ABA-7141-2021	Brown, Jeffrey Wade/0000-0002-3992-9613; McKnight, Christopher/0000-0002-3237-0896	Boston University Graduate Student Research Fellowship; National Institutes of Health (NIH) [GM62886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062886] Funding Source: NIH RePORTER	Boston University Graduate Student Research Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by a Boston University Graduate Student Research Fellowship to J.W.B. and National Institutes of Health (NIH) Grant GM62886 to C.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2005, BIOINFORMATICS, V21, P3677, DOI 10.1093/bioinformatics/bti602; [Anonymous], 2004, PERS VIS RAYTR VERS; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Borrego-Diaz E, 2006, J STRUCT BIOL, V155, P230, DOI 10.1016/j.jsb.2006.01.013; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; Coluccio LM, 1997, AM J PHYSIOL-CELL PH, V273, pC347, DOI 10.1152/ajpcell.1997.273.2.C347; CRAIG SW, 1980, CELL, V22, P739, DOI 10.1016/0092-8674(80)90550-4; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Danielsen EM, 2003, BBA-BIOMEMBRANES, V1617, P1, DOI 10.1016/j.bbamem.2003.09.005; DEROSIER DJ, 1980, NATURE, V287, P291, DOI 10.1038/287291a0; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; GLENNEY JR, 1982, CELL, V28, P843, DOI 10.1016/0092-8674(82)90063-0; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; GRANGER B, 1950, ANAT REC, V107, P423, DOI 10.1002/ar.1091070409; Hampton CM, 2008, STRUCTURE, V16, P1882, DOI 10.1016/j.str.2008.09.015; Hansen GH, 2001, J BIOL CHEM, V276, P32338, DOI 10.1074/jbc.M102667200; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HESTERBERG LK, 1983, J BIOL CHEM, V258, P359; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; HIROKAWA N, 1981, J CELL BIOL, V91, P399, DOI 10.1083/jcb.91.2.399; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Ilyin VA, 2004, PROTEIN SCI, V13, P1865, DOI 10.1110/ps.04672604; Jewett AI, 2003, BIOINFORMATICS, V19, P625, DOI 10.1093/bioinformatics/btg035; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Jontes JD, 1997, J MOL BIOL, V266, P331, DOI 10.1006/jmbi.1996.0777; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kleywegt G. J., UNPUB; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Kumar N, 2004, J BIOL CHEM, V279, P3096, DOI 10.1074/jbc.M308878200; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Lauwaet T, 2003, J BIOL CHEM, V278, P22650, DOI 10.1074/jbc.M300142200; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA P, 1983, NATURE, V301, P209, DOI 10.1038/301209a0; MATSUDAIRA PT, 1982, J CELL BIOL, V92, P657, DOI 10.1083/jcb.92.3.657; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; MATSUDAIRA PT, 1983, CIBA F SYMP, V95, P233; MATSUDAIRA PT, 1981, COLD SPRING HARB SYM, V46, P845; Mattoo S, 2008, DEV CELL, V14, P8, DOI 10.1016/j.devcel.2007.12.016; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; MCGOUGH AM, 1990, P NATL ACAD SCI USA, V87, P5208, DOI 10.1073/pnas.87.13.5208; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; MOOSEKER MS, 1980, J CELL BIOL, V87, P809, DOI 10.1083/jcb.87.3.809; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; MOOSEKER MS, 1989, J CELL BIOL, V109, P1153, DOI 10.1083/jcb.109.3.1153; MOOSEKER MS, 1982, J CELL BIOL, V95, P223, DOI 10.1083/jcb.95.1.223; NERMUT MV, 1981, EUR J CELL BIOL, V25, P265; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OHNO SI, 1992, J ANAT, V180, P315; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINDER JC, 1983, J CELL BIOL, V96, P768, DOI 10.1083/jcb.96.3.768; Pinson KI, 1998, DEV DYNAM, V211, P109, DOI 10.1002/(SICI)1097-0177(199801)211:1<109::AID-AJA10>3.0.CO;2-7; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Smirnov SL, 2007, BIOCHEMISTRY-US, V46, P7488, DOI 10.1021/bi700110v; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; URSITTI JA, 1991, CELL MOTIL CYTOSKEL, V19, P227, DOI 10.1002/cm.970190402; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	84	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9406	10.1371/journal.pone.0009406	http://dx.doi.org/10.1371/journal.pone.0009406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195380	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200026
J	Hohwy, J; Paton, B				Hohwy, Jakob; Paton, Bryan			Explaining Away the Body: Experiences of Supernaturally Caused Touch and Touch on Non-Hand Objects within the Rubber Hand Illusion	PLOS ONE			English	Article							PERIPERSONAL SPACE; BODILY SELF; OWNERSHIP; LIMB; PROPRIOCEPTION; REPRESENTATION; ARM	Background: In rubber hand illusions and full body illusions, touch sensations are projected to non-body objects such as rubber hands, dolls or virtual bodies. The robustness, limits and further perceptual consequences of such illusions are not yet fully explored or understood. A number of experiments are reported that test the limits of a variant of the rubber hand illusion. Methodology/Principal Findings: A variant of the rubber hand illusion is explored, in which the real and foreign hands are aligned in personal space. The presence of the illusion is ascertained with participants' scores and temperature changes of the real arm. This generates a basic illusion of touch projected to a foreign arm. Participants are presented with further, unusual visuotactile stimuli subsequent to onset of the basic illusion. Such further visuotactile stimulation is found to generate very unusual experiences of supernatural touch and touch on a non-hand object. The finding of touch on a non-hand object conflicts with prior findings, and to resolve this conflict a further hypothesis is successfully tested: that without prior onset of the basic illusion this unusual experience does not occur. Conclusions/Significance: A rubber hand illusion is found that can arise when the real and the foreign arm are aligned in personal space. This illusion persists through periods of no tactile stimulation and is strong enough to allow very unusual experiences of touch felt on a cardboard box and experiences of touch produced at a distance, as if by supernatural causation. These findings suggest that one's visual body image is explained away during experience of the illusion and they may be of further importance to understanding the role of experience in delusion formation. The findings of touch on non-hand objects may help reconcile conflicting results in this area of research. In addition, new evidence is provided that relates to the recently discovered psychologically induced temperature changes that occur during the illusion.	[Hohwy, Jakob; Paton, Bryan] Monash Univ, Philosophy Program, Clayton, Vic, Australia; [Paton, Bryan] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia	Monash University; Monash University	Hohwy, J (corresponding author), Monash Univ, Philosophy Program, Clayton, Vic, Australia.	Jakob.Hohwy@arts.monash.edu.au		Hohwy, Jakob/0000-0003-3906-3060	Australian Research Council [DP0984572]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council (www.arc.gov.au) Discovery Grant DP0984572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, CAUSALITY; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Coltheart M, 2007, Q J EXP PSYCHOL, V60, P1041, DOI 10.1080/17470210701338071; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Gregory R., 1998, EYE BRAIN, V5th; Hohwy J, 2005, MIND LANG, V20, P141, DOI 10.1111/j.0268-1064.2005.00280.x; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; MAHER BA, 1974, J INDIV PSYCHOL, V30, P98; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Metzinger T, 2009, EGO TUNNEL; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Press C, 2008, J COGNITIVE NEUROSCI, V20, P312, DOI 10.1162/jocn.2008.20022; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Schwabe L, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.017.2008; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006185; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; TSAKIRIS M, 2009, EXPT BRAIN IN PRESS	29	107	110	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9416	10.1371/journal.pone.0009416	http://dx.doi.org/10.1371/journal.pone.0009416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SX	20195378	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924200031
J	Hensen, U; Lange, OF; Grubmuller, H				Hensen, Ulf; Lange, Oliver F.; Grubmueller, Helmut			Estimating Absolute Configurational Entropies of Macromolecules: The Minimally Coupled Subspace Approach	PLOS ONE			English	Article							FREE-ENERGY; MOLECULAR-DYNAMICS; SIMULATION; EFFICIENT; WATER	We develop a general minimally coupled subspace approach (MCSA) to compute absolute entropies of macromolecules, such as proteins, from computer generated canonical ensembles. Our approach overcomes limitations of current estimates such as the quasi-harmonic approximation which neglects non-linear and higher-order correlations as well as multi-minima characteristics of protein energy landscapes. Here, Full Correlation Analysis, adaptive kernel density estimation, and mutual information expansions are combined and high accuracy is demonstrated for a number of test systems ranging from alkanes to a 14 residue peptide. We further computed the configurational entropy for the full 67-residue cofactor of the TATA box binding protein illustrating that MCSA yields improved results also for large macromolecular systems.	[Hensen, Ulf; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany; [Lange, Oliver F.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Max Planck Society; University of Washington; University of Washington Seattle	Hensen, U (corresponding author), Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany.	olange@u.washington.edu	Lange, Oliver/K-5749-2012; Lange, Oliver/G-1366-2010	Lange, Oliver/0000-0002-4018-7020; 	Deutsche Forschungsgemeinschaft [782]; Human Frontiers of Science Program; Volkswagen Foundation [I/80436]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontiers of Science Program(Human Frontier Science Program); Volkswagen Foundation(Volkswagen)	U. H. was supported by the Deutsche Forschungsgemeinschaft (research training group 782). O.F.L. was supported by the Human Frontiers of Science Program and by the Volkswagen Foundation, Grant I/80436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard P, 1997, PHYS REV E, V56, P4052, DOI 10.1103/PhysRevE.56.4052; Attard P, 1999, STAT PHYS EVE 21 CEN; BARANYAI A, 1989, PHYS REV A, V40, P3817, DOI 10.1103/PhysRevA.40.3817; Baron Riccardo, 2006, Trends in Physical Chemistry, V11, P87; Baron R, 2006, J PHYS CHEM B, V110, P8464, DOI 10.1021/jp055888y; Baron R, 2008, CHEMPHYSCHEM, V9, P983, DOI 10.1002/cphc.200700857; Bellman R., 1961, ADAPTIVE CONTROL PRO; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEVERIDGE DL, 1989, ANNU REV BIOPHYS BIO, V18, P431, DOI 10.1146/annurev.bb.18.060189.002243; Chang CE, 2005, J CHEM THEORY COMPUT, V1, P1017, DOI 10.1021/ct0500904; Chang CE, 2003, J PHYS CHEM B, V107, P1048, DOI 10.1021/jp027149c; Chang CEA, 2007, P NATL ACAD SCI USA, V104, P1534, DOI 10.1073/pnas.0610494104; Cheluvaraja S, 2004, P NATL ACAD SCI USA, V101, P9241, DOI 10.1073/pnas.0308201101; Cheluvaraja S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2208608; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; HENNIG M, 2007, THESIS U JENA; Hensen U, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011913; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2002, J CHEM PHYS, V116, P209, DOI 10.1063/1.1421362; Hnizdo V, 2008, J COMPUT CHEM, V29, P1605, DOI 10.1002/jcc.20919; Hnizdo V, 2007, J COMPUT CHEM, V28, P655, DOI 10.1002/jcc.20589; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KARPLUS M, 1981, MACROMOLECULES, V14, P325, DOI 10.1021/ma50003a019; Killian BJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2746329; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Kolossvary I, 1997, J PHYS CHEM A, V101, P9900, DOI 10.1021/jp972794i; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Meirovitch H, 2007, CURR OPIN STRUC BIOL, V17, P181, DOI 10.1016/j.sbi.2007.03.016; Minh DDL, 2005, BIOPHYS J, V89, pL25, DOI 10.1529/biophysj.105.069336; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Peter C, 2004, J CHEM PHYS, V120, P2652, DOI 10.1063/1.1636153; Reinhard F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2400220; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STRAATSMA TP, 1992, ANNU REV PHYS CHEM, V43, P407; Tyka MD, 2006, J PHYS CHEM B, V110, P17212, DOI 10.1021/jp060734j; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANGUNSTEREN WF, 1998, GROMOS FORCE FIELD, P1211	44	54	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9179	10.1371/journal.pone.0009179	http://dx.doi.org/10.1371/journal.pone.0009179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186277	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924000001
J	Guttridge, TL; Gruber, SH; Krause, J; Sims, DW				Guttridge, Tristan L.; Gruber, Samuel H.; Krause, Jens; Sims, David W.			Novel Acoustic Technology for Studying Free-Ranging Shark Social Behaviour by Recording Individuals' Interactions	PLOS ONE			English	Article							JUVENILE LEMON SHARKS; SCALLOPED HAMMERHEAD SHARK; SEXUAL SEGREGATION; NEGAPRION-BREVIROSTRIS; PATTERNS; CONSERVATION; STRATEGIES; PROXIMITY; NETWORKS; TRACKING	Group behaviours are widespread among fish but comparatively little is known about the interactions between free-ranging individuals and how these might change across different spatio-temporal scales. This is largely due to the difficulty of observing wild fish groups directly underwater over long enough time periods to quantify group structure and individual associations. Here we describe the use of a novel technology, an animal-borne acoustic proximity receiver that records close-spatial associations between free-ranging fish by detection of acoustic signals emitted from transmitters on other individuals. Validation trials, held within enclosures in the natural environment, on juvenile lemon sharks Negaprion brevirostris fitted with external receivers and transmitters, showed receivers logged interactions between individuals regularly when sharks were within 4 m (similar to 4 body lengths) of each other, but rarely when at 10 m distance. A field trial lasting 17 days with 5 juvenile lemon sharks implanted with proximity receivers showed one receiver successfully recorded association data, demonstrating this shark associated with 9 other juvenile lemon sharks on 128 occasions. This study describes the use of acoustic underwater proximity receivers to quantify interactions among wild sharks, setting the scene for new advances in understanding the social behaviours of marine animals.	[Guttridge, Tristan L.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Guttridge, Tristan L.; Gruber, Samuel H.] Bimini Biol Field Stn, S Bimini, Bahamas; [Gruber, Samuel H.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, Miami, FL 33149 USA; [Krause, Jens] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Sims, David W.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England; [Sims, David W.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Inst Marine, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Leeds; University of Miami; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Marine Biological Association United Kingdom; University of Plymouth	Guttridge, TL (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	tristanguttridge@gmail.com	Krause, Jens/C-2750-2011; Krause, Jens/J-4381-2013	Krause, Jens/0000-0002-1289-2857; Sims, David/0000-0002-0916-7363	Bimini Biological Field Station; Lacy Hoover; Earthwatch Institute; National Science Foundation [NSF-OCE 97-12793]; Department of Education, State of Florida [FLORIDA 8749703000001]; Leverhulme Trust; Engineering and Physical Sciences Research Council [GR/T11241/01(P)]; Natural Environment Research Council [NE/D011035/1]; Natural Environment Research Council; MBA Senior Research Fellowship; NERC [MBA010001] Funding Source: UKRI; Natural Environment Research Council [MBA010001] Funding Source: researchfish	Bimini Biological Field Station; Lacy Hoover; Earthwatch Institute; National Science Foundation(National Science Foundation (NSF)); Department of Education, State of Florida; Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MBA Senior Research Fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study would not have been possible without financial support from the Bimini Biological Field Station, Lacy Hoover, Earthwatch Institute, National Science Foundation (NSF-OCE 97-12793) and Department of Education, State of Florida (FLORIDA 8749703000001). T. L. G. was supported by a Leverhulme Trust study aboard studentship for postgraduate work. J.K. was funded by grants from the Engineering and Physical Sciences Research Council (GR/T11241/01(P)) and the Natural Environment Research Council (NE/D011035/1). D. W. S. was supported by the Natural Environment Research Council Oceans 2025 Strategic Research Programme (www.oceans2025.org) and by an MBA Senior Research Fellowship (www.mba.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Croft DP, 2004, P ROY SOC B-BIOL SCI, V271, pS516, DOI 10.1098/rsbl.2004.0206; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; FRANKS BR, 2007, THESIS DREXEL U US; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gleiss AC, 2009, FISH RES, V97, P11, DOI 10.1016/j.fishres.2008.12.012; GRUBER S H, 1982, Florida Scientist, V45, P46; GRUBER SH, 1988, B MAR SCI, V43, P61; GUTTRIDGE, 2009, THESIS U LEEDS UK; Guttridge TL, 2009, ANIM BEHAV, V78, P543, DOI 10.1016/j.anbehav.2009.06.009; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Hight BV, 2007, J EXP MAR BIOL ECOL, V352, P114, DOI 10.1016/j.jembe.2007.07.021; HOLLAND KN, 1992, AUST J MAR FRESH RES, V43, P61; HOLLAND KN, 2009, ENDANGER SPECIES RES, V10, P287, DOI DOI 10.3354/ESR00226; Ji WH, 2005, J APPL ECOL, V42, P595, DOI 10.1111/j.1365-2664.2005.01026.x; KLIMLEY AP, 1981, FISH B-NOAA, V79, P356; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Krause J, 2000, BIOL REV, V75, P477; Krause J., 2002, LIVING GROUPS; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MORRISSEY JF, 1993, COPEIA, P425; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; MYRBERG AA, 1974, COPEIA, P358; Parrish J., 1997, ANIMAL GROUPS 3 DIME; PITCHER TJ, 1993, LONDON BEHAV TELEOST, P363; Prange S, 2006, WILDLIFE SOC B, V34, P1333, DOI 10.2193/0091-7648(2006)34[1333:NRFTDO]2.0.CO;2; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Sims DW, 2003, J FISH BIOL, V63, P53, DOI 10.1111/j.1095-8649.2003.00207.x; Sims DW, 2001, MAR BIOL, V139, P1165; Sims DW, 2000, P ROY SOC B-BIOL SCI, V267, P1897, DOI 10.1098/rspb.2000.1227; SIMS DW, 2010, BIOL SHARKS THEIR RE, V2, P341; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Strier KB, 2002, BEHAVIOUR, V139, P315, DOI 10.1163/156853902760102690; Sundstrom LF, 2002, J FISH BIOL, V61, P834, DOI 10.1006/jfbi.2002.2058; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001	43	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9324	10.1371/journal.pone.0009324	http://dx.doi.org/10.1371/journal.pone.0009324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174465	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700022
J	Baluchg, F; Itti, L				Baluchg, Farhan; Itti, Laurent			Training Top-Down Attention Improves Performance on a Triple-Conjunction Search Task	PLOS ONE			English	Article							EYE-MOVEMENTS; POP-OUT; NEURAL MECHANISMS; DISCRIMINATION; EXPERTISE; SELECTION; MODEL; V1	Training has been shown to improve perceptual performance on limited sets of stimuli. However, whether training can generally improve top-down biasing of visual search in a target-nonspecific manner remains unknown. We trained subjects over ten days on a visual search task, challenging them with a novel target (top-down goal) on every trial, while bottom-up uncertainty (distribution of distractors) remained constant. We analyzed the changes in saccade statistics and visual behavior over the course of training by recording eye movements as subjects performed the task. Subjects became experts at this task, with twofold increased performance, decreased fixation duration, and stronger tendency to guide gaze toward items with color and spatial frequency (but not necessarily orientation) that resembled the target, suggesting improved general top-down biasing of search.	[Baluchg, Farhan; Itti, Laurent] Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA; [Itti, Laurent] Univ So Calif, Dept Comp Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Baluchg, F (corresponding author), Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90089 USA.	itti@usc.edu			National Geospatial-Intelligence Agency; Defense Advanced Research Projects Agency; National Science Foundation; Army Research Office	National Geospatial-Intelligence Agency; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Army Research Office	Supported by the National Geospatial-Intelligence Agency, the Defense Advanced Research Projects Agency, the National Science Foundation, and the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1996, VISION RES, V36, P3487, DOI 10.1016/0042-6989(96)00036-3; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Bellenkes AH, 1997, AVIAT SPACE ENVIR MD, V68, P569; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; COURTNEY AJ, 1986, PERCEPT PSYCHOPHYS, V40, P39, DOI 10.3758/BF03207592; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; ENGEL FL, 1971, VISION RES, V11, P563, DOI 10.1016/0042-6989(71)90077-0; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Farr M.J., 1988, NATURE EXPERTISE, P311; Ferrari V, 2008, Q J EXP PSYCHOL, V61, P1265, DOI 10.1080/17470210701503344; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Herzog MH, 1998, BIOL CYBERN, V78, P107, DOI 10.1007/s004220050418; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hooge ITC, 1999, VISION RES, V39, P1567, DOI 10.1016/S0042-6989(98)00213-2; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kellman PJ, 2009, PHYS LIFE REV, V6, P53, DOI 10.1016/j.plrev.2008.12.001; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LURIA SM, 1975, PERCEPT PSYCHOPHYS, V17, P303, DOI 10.3758/BF03203215; McCarley JS, 2004, PSYCHOL SCI, V15, P302, DOI 10.1111/j.0956-7976.2004.00673.x; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Motter BC, 1998, VISION RES, V38, P1805, DOI 10.1016/S0042-6989(97)00349-0; Navalpakkam V, 2006, J VISION, V6, P1180, DOI 10.1167/6.11.4; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; Phillips MH, 2008, VISION RES, V48, P926, DOI 10.1016/j.visres.2007.12.020; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Rutishauser U, 2007, J VISION, V7, DOI 10.1167/7.6.5; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schoups AA, 1996, P NATL ACAD SCI USA, V93, P7358, DOI 10.1073/pnas.93.14.7358; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SIRETEANU R, 1995, VISION RES, V35, P2037, DOI 10.1016/0042-6989(94)00295-W; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936; Zelinsky GJ, 1996, VISION RES, V36, P2177, DOI 10.1016/0042-6989(95)00300-2	49	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9127	10.1371/journal.pone.0009127	http://dx.doi.org/10.1371/journal.pone.0009127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557FJ	20174622	gold, Green Submitted, Green Published			2022-12-27	WOS:000274654700004
J	Bogdarina, I; Haase, A; Langley-Evans, S; Clark, AJL				Bogdarina, Irina; Haase, Andrea; Langley-Evans, Simon; Clark, Adrian J. L.			Glucocorticoid Effects on the Programming of AT1b Angiotensin Receptor Gene Methylation and Expression in the Rat	PLOS ONE			English	Article							LOW-PROTEIN DIET; ISCHEMIC-HEART-DISEASE; ADULT-BLOOD PRESSURE; PRENATAL EXPOSURE; DIFFERENTIAL EXPRESSION; EPIGENETIC MODIFICATION; INDUCED HYPERTENSION; LATER LIFE; FETAL; CONSEQUENCES	Adverse events in pregnancy may 'programme' offspring for the later development of cardiovascular disease and hypertension. Previously, using a rodent model of programmed hypertension we have demonstrated the role of the renin-angiotensin system in this process. More recently we showed that a maternal low protein diet resulted in undermethylation of the At1b angiotensin receptor promoter and the early overexpression of this gene in the adrenal of offspring. Here, we investigate the hypothesis that maternal glucocorticoid modulates this effect on fetal DNA methylation and gene expression. We investigated whether treatment of rat dams with the 11 beta-hydroxylase inhibitor metyrapone, could prevent the epigenetic and gene expression changes we observed. Offspring of mothers subjected to a low protein diet in pregnancy showed reduced adrenal Agtr1b methylation and increased adrenal gene expression as we observed previously. Treatment of mothers with metyrapone for the first 14 days of pregnancy reversed these changes and prevented the appearance of hypertension in the offspring at 4 weeks of age. As a control for non-specific effects of programmed hypertension we studied offspring of mothers treated with dexamethasone from day 15 of pregnancy and showed that, whilst they had raised blood pressure, they failed to show any evidence of Agtr1b methylation or increase in gene expression. We conclude that maternal glucocorticoid in early pregnancy may induce changes in methylation and expression of the Agtr1b gene as these are clearly reversed by an 11 beta-hydroxylase inhibitor. However in later pregnancy a converse effect with dexamethasone could not be demonstrated and this may reflect either an alternative mechanism of this glucocorticoid or a stage-specific influence.	[Bogdarina, Irina; Clark, Adrian J. L.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Endocrinol, London, England; [Haase, Andrea; Langley-Evans, Simon] Univ Nottingham, Div Nutr Sci, Loughborough, Leics, England	University of London; Queen Mary University London; University of Nottingham	Bogdarina, I (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Endocrinol, London, England.	a.j.clark@qmul.ac.uk	Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020	Langley-Evans, Simon C/0000-0002-1969-8416; 	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (http://www.bhf.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAM TZ, 1990, LIFE SCI, V47, P485, DOI 10.1016/0024-3205(90)90607-S; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bogdarina IG, 2009, J MOL ENDOCRINOL, V43, P73, DOI 10.1677/JME-09-0036; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; DLUHY RG, 1975, STEROID THERAPY, P1; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Gardner DS, 1997, HYPERTENSION, V30, P1525, DOI 10.1161/01.HYP.30.6.1525; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; GOLDBERG GR, 1994, NUTR REV, V52, P191, DOI 10.1111/j.1753-4887.1994.tb01420.x; GUO DF, 1994, BBA-GENE STRUCT EXPR, V1218, P91, DOI 10.1016/0167-4781(94)90105-8; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Johren O, 2003, HYPERTENSION, V41, P984, DOI 10.1161/01.HYP.0000062466.38314.B7; Kwong WY, 2000, DEVELOPMENT, V127, P4195; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; LangleyEvans SC, 1997, LIFE SCI, V60, P1213, DOI 10.1016/S0024-3205(96)00611-X; LangleyEvans SC, 1996, J NUTR BIOCHEM, V7, P173, DOI 10.1016/0955-2863(95)00197-2; Law CM, 2001, INT J EPIDEMIOL, V30, P52, DOI 10.1093/ije/30.1.52; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; McMullen S, 2004, BRIT J NUTR, V91, P133, DOI 10.1079/BJN20031029; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Pladys P, 2005, AM J PHYSIOL-REG I, V289, pR1580, DOI 10.1152/ajpregu.00031.2005; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sherman RC, 2000, CLIN SCI, V98, P269, DOI 10.1042/CS19990275; Sherman RC, 1998, CLIN SCI, V94, P373, DOI 10.1042/cs0940373; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Vasanthi D, 2008, J GENET GENOMICS, V35, P413, DOI 10.1016/S1673-8527(08)60059-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2005, AM J PHYSIOL-REG I, V289, pR955, DOI 10.1152/ajpregu.00455.2004; Woods LL, 2006, AM J PHYSIOL-REG I, V291, pR1069, DOI 10.1152/ajpregu.00753.2005; Zhang TY, 2004, ANN NY ACAD SCI, V1032, P85, DOI 10.1196/annals.1314.007	48	69	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9237	10.1371/journal.pone.0009237	http://dx.doi.org/10.1371/journal.pone.0009237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169056	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500018
J	Stucken, K; John, U; Cembella, A; Murillo, AA; Soto-Liebe, K; Fuentes-Valdes, JJ; Friedel, M; Plominsky, AM; Vasquez, M; Glockner, G				Stucken, Karina; John, Uwe; Cembella, Allan; Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Friedel, Maik; Plominsky, Alvaro M.; Vasquez, Monica; Gloeckner, Gernot			The Smallest Known Genomes of Multicellular and Toxic Cyanobacteria: Comparison, Minimal Gene Sets for Linked Traits and the Evolutionary Implications	PLOS ONE			English	Article							SP STRAIN PCC-7120; HETEROCYST PATTERN-FORMATION; FRESH-WATER CYANOBACTERIUM; ANABAENA SP PCC-7120; CYLINDROSPERMOPSIS-RACIBORSKII; 1ST REPORT; DIFFERENTIATION; SAXITOXIN; IDENTIFICATION; EXPRESSION	Cyanobacterial morphology is diverse, ranging from unicellular spheres or rods to multicellular structures such as colonies and filaments. Multicellular species represent an evolutionary strategy to differentiate and compartmentalize certain metabolic functions for reproduction and nitrogen (N-2) fixation into specialized cell types (e.g. akinetes, heterocysts and diazocytes). Only a few filamentous, differentiated cyanobacterial species, with genome sizes over 5 Mb, have been sequenced. We sequenced the genomes of two strains of closely related filamentous cyanobacterial species to yield further insights into the molecular basis of the traits of N-2 fixation, filament formation and cell differentiation. Cylindrospermopsis raciborskii CS-505 is a cylindrospermopsin-producing strain from Australia, whereas Raphidiopsis brookii D9 from Brazil synthesizes neurotoxins associated with paralytic shellfish poisoning (PSP). Despite their different morphology, toxin composition and disjunct geographical distribution, these strains form a monophyletic group. With genome sizes of approximately 3.9 (CS-505) and 3.2 (D9) Mb, these are the smallest genomes described for free-living filamentous cyanobacteria. We observed remarkable gene order conservation (synteny) between these genomes despite the difference in repetitive element content, which accounts for most of the genome size difference between them. We show here that the strains share a specific set of 2539 genes with >90% average nucleotide identity. The fact that the CS-505 and D9 genomes are small and streamlined compared to those of other filamentous cyanobacterial species and the lack of the ability for heterocyst formation in strain D9 allowed us to define a core set of genes responsible for each trait in filamentous species. We presume that in strain D9 the ability to form proper heterocysts was secondarily lost together with N2 fixation capacity. Further comparisons to all available cyanobacterial genomes covering almost the entire evolutionary branch revealed a common minimal gene set for each of these cyanobacterial traits.	[Stucken, Karina; John, Uwe; Cembella, Allan] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Plominsky, Alvaro M.; Vasquez, Monica] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Mol Genet & Microbiol, Santiago, Chile; [Stucken, Karina; Murillo, Alejandro A.; Soto-Liebe, Katia; Fuentes-Valdes, Juan J.; Plominsky, Alvaro M.; Vasquez, Monica] Millenium Nucleus EMBA, Santiago, Chile; [Friedel, Maik; Gloeckner, Gernot] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Gloeckner, Gernot] Univ Cologne, Inst Biochem 1, Cologne, Germany; [Gloeckner, Gernot] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Pontificia Universidad Catolica de Chile; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Stucken, K (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	mvasquez@bio.puc.cl; gloeckner@igb-berlin.de	Murillo, Alejandro A./AAY-5276-2020; Stucken, Karina/AAI-8343-2021; john, uwe/S-3009-2016; Glöckner, Gernot/A-7800-2010	Murillo, Alejandro A./0000-0003-3553-1330; Stucken, Karina/0000-0002-2783-4342; john, uwe/0000-0002-1297-4086; Glöckner, Gernot/0000-0002-9061-1061; Cembella, Allan/0000-0002-1297-2240; M. Plominsky, Alvaro/0000-0003-0816-8580	Fondecyt, Chile [1050433, 1080075]; Fondef, Chile [MR07I1005]; Millennium Nucleus [EMBA P04/007]; Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG; EU [GOCE CT-2004-511154]; Alfred Wegener Institute (Helmholtz Society)	Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondef, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDEF); Millennium Nucleus; Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG(German Research Foundation (DFG)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); EU(European Commission); Alfred Wegener Institute (Helmholtz Society)(Helmholtz Association)	Financial support for this work was provided by Grants from Chile (to M. V.): Fondecyt 1050433 and 1080075; Fondef MR07I1005; Millennium Nucleus EMBA P04/007; and Programa de Cooperacion Cientifica Internacional (PCCI) CONICYT/DFG between the P. Universidad Catolica de Chile and the Alfred Wegener Institute for Polar and Marine Research (Helmholtz Foundation). Additional operational support was obtained from the EU-project ESTTAL (GOCE CT-2004-511154) (to A. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author (K. S.) received a scholarship from the Alfred Wegener Institute (Helmholtz Society) under the MARCOPOLI program in Earth and Environment and is a member of the MarMic program administered from the MPI for Marine Microbiology.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Awai K, 2007, FEMS MICROBIOL LETT, V266, P98, DOI 10.1111/j.1574-6968.2006.00512.x; BOLHUIS H, 2009, ISME J; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Campbell EL, 2007, J BACTERIOL, V189, P5247, DOI 10.1128/JB.00360-07; Castro D, 2004, TOXICON, V44, P483, DOI 10.1016/j.toxicon.2004.06.005; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Des Marais DJ, 2000, SCIENCE, V289, P1703; Ehira S, 2003, DNA RES, V10, P97, DOI 10.1093/dnares/10.3.97; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Falconer IR, 2006, ENVIRON TOXICOL, V21, P299, DOI 10.1002/tox.20194; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gugger MF, 2004, INT J SYST EVOL MICR, V54, P349, DOI 10.1099/ijs.0.02744-0; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Huang G, 2005, J BACTERIOL, V187, P1114, DOI 10.1128/JB.187.3.1114-1123.2005; Jones KM, 2003, J BACTERIOL, V185, P2306, DOI 10.1128/JB.185.7.2306-2314.2003; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kellmann R, 2008, J MOL EVOL, V67, P526, DOI 10.1007/s00239-008-9169-2; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Khudyakov IY, 2004, P NATL ACAD SCI USA, V101, P16040, DOI 10.1073/pnas.0405572101; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X; LANDER E S, 1988, Genomics, V2, P231; Li RH, 2001, J PHYCOL, V37, P1121, DOI 10.1046/j.1529-8817.2001.01075.x; LIANG J, 1992, P NATL ACAD SCI USA, V89, P5655, DOI 10.1073/pnas.89.12.5655; Liu DA, 2002, J BACTERIOL, V184, P6873, DOI 10.1128/JB.184.24.6873-6881.2002; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Mihali TK, 2008, APPL ENVIRON MICROB, V74, P716, DOI 10.1128/AEM.01988-07; Miyagishima SY, 2005, MOL MICROBIOL, V56, P126, DOI 10.1111/j.1365-2958.2005.04548.x; Mohamed ZA, 2007, FEMS MICROBIOL ECOL, V59, P749, DOI 10.1111/j.1574-6941.2006.00226.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Namikoshi M, 2003, TOXICON, V42, P533, DOI 10.1016/S0041-0101(03)00233-2; Padisak J., 1997, ARCH HYDROBIOL, V4, P563; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Saker ML, 1999, J PHYCOL, V35, P599, DOI 10.1046/j.1529-8817.1999.3530599.x; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Stucken K, 2009, SYST APPL MICROBIOL, V32, P37, DOI 10.1016/j.syapm.2008.10.002; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Thiel T, 1997, J BACTERIOL, V179, P5222, DOI 10.1128/jb.179.16.5222-5225.1997; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Xu XD, 2001, J BACTERIOL, V183, P393, DOI 10.1128/JB.183.1.393-396.2001; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoshimura H, 2007, DNA RES, V14, P13, DOI 10.1093/dnares/dsm003; Yunes JS, 2009, J PHYCOL, V45, P585, DOI 10.1111/j.1529-8817.2009.00673.x; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhang JY, 2009, MICROBIOL-SGM, V155, P1418, DOI 10.1099/mic.0.027540-0; Zhang W, 2007, MOL MICROBIOL, V66, P1429, DOI 10.1111/j.1365-2958.2007.05997.x; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102	58	139	148	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9235	10.1371/journal.pone.0009235	http://dx.doi.org/10.1371/journal.pone.0009235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169071	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500017
J	Zhu, HP; Qian, H; Li, GP				Zhu, Huaiping; Qian, Hong; Li, Guangpu			Delayed Onset of Positive Feedback Activation of Rab5 by Rabex-5 and Rabaptin-5 in Endocytosis	PLOS ONE			English	Article							EXCHANGE FACTOR RABEX-5; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; DOMAIN; GTPASES; CELL	Background: Rabex-5 is a guanine nucleotide exchange factor (GEF) that specifically activates Rab5, i.e., converting Rab5-GDP to Rab5-GTP, through two distinct pathways to promote endosome fusion and endocytosis. The direct pathway involves a pool of membrane-associated Rabex-5 that targets to the membrane via an early endosomal targeting (EET) domain. The indirect pathway, on the other hand, involves a cytosolic pool of Rabex-5/Rabaptin-5 complex. The complex is recruited to the membrane via Rabaptin-5 binding to Rab5-GTP, suggesting a positive feedback mechanism. The relationship of these two pathways for Rab5 activation in the cell is unclear. Methodology/Principal Findings: We dissect the relative contribution of each pathway to Rab5 activation via mathematical modeling and kinetic analysis in the cell. These studies show that the indirect pathway constitutes a positive feedback loop for converting Rab5-GDP to Rab5-GTP on the endosomal membrane and allows sensitive regulation of endosome fusion activity by the levels of Rab5 and Rabex-5 in the cell. The onset of this positive feedback effect, however, contains a threshold, which requires above endogenous levels of Rab5 or Rabex-5 in the cell. We term this novel phenomenon "delayed response". The presence of the direct pathway reduces the delay by increasing the basal level of Rab5-GTP, thus facilitates the function of the Rabex-5/Rabaptin-5-mediated positive feedback loop. Conclusion: Our data support the mathematical model. With the model's guidance, the data reveal the affinity of Rabex-5/Rabaptin-5/Rab5-GTP interaction in the cell, which is quantitatively related to the Rabex-5 concentration for the onset of the indirect positive feedback pathway. The presence of the direct pathway and increased Rab5 concentration can reduce the Rabex-5 concentration required for the onset of the positive feedback loop. Thus the direct and indirect pathways cooperate in the regulation of early endosome fusion.	[Zhu, Huaiping; Li, Guangpu] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Washington; University of Washington Seattle	Zhu, HP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	guangpu-li@ouhsc.edu	Li, Guangpu/GRS-5397-2022		National Institutes of Health (NIH) [R01 GM074692]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074692] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health (NIH) grant R01 GM074692 (to GL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Goryachev AB, 2006, PLOS COMPUT BIOL, V2, P1511, DOI 10.1371/journal.pcbi.0020172; Hassler Christopher, 2005, Am J Cardiovasc Drugs, V5, P7, DOI 10.2165/00129784-200505010-00002; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; LI GP, 1994, J BIOL CHEM, V269, P14631; Li GP, 2001, BIOCHEM J, V355, P681, DOI 10.1042/bj3550681; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Tam SY, 2004, NAT IMMUNOL, V5, P844, DOI 10.1038/ni1093; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	20	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9226	10.1371/journal.pone.0009226	http://dx.doi.org/10.1371/journal.pone.0009226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169068	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590500008
J	Cerami, E; Demir, E; Schultz, N; Taylor, BS; Sander, C				Cerami, Ethan; Demir, Emek; Schultz, Nikolaus; Taylor, Barry S.; Sander, Chris			Automated Network Analysis Identifies Core Pathways in Glioblastoma	PLOS ONE			English	Article							INTEGRATED ANALYSIS; FUNCTIONAL MODULES; PROTEIN INTERACTIONS; PIKE-A; AMPLIFICATION; ORGANIZATION; TOPOLOGY; PATTERNS; REVEALS; GLIOMAS	Background: Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumor in humans and the first cancer with comprehensive genomic profiles mapped by The Cancer Genome Atlas (TCGA) project. A central challenge in large-scale genome projects, such as the TCGA GBM project, is the ability to distinguish cancer-causing "driver'' mutations from passively selected "passenger'' mutations. Principal Findings: In contrast to a purely frequency based approach to identifying driver mutations in cancer, we propose an automated network-based approach for identifying candidate oncogenic processes and driver genes. The approach is based on the hypothesis that cellular networks contain functional modules, and that tumors target specific modules critical to their growth. Key elements in the approach include combined analysis of sequence mutations and DNA copy number alterations; use of a unified molecular interaction network consisting of both protein-protein interactions and signaling pathways; and identification and statistical assessment of network modules, i.e. cohesive groups of genes of interest with a higher density of interactions within groups than between groups. Conclusions: We confirm and extend the observation that GBM alterations tend to occur within specific functional modules, in spite of considerable patient-to-patient variation, and that two of the largest modules involve signaling via p53, Rb, PI3K and receptor protein kinases. We also identify new candidate drivers in GBM, including AGAP2/CENTG1, a putative oncogene and an activator of the PI3K pathway; and, three additional significantly altered modules, including one involved in microtubule organization. To facilitate the application of our network-based approach to additional cancer types, we make the method freely available as part of a software tool called NetBox.	[Cerami, Ethan; Demir, Emek; Schultz, Nikolaus; Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Cerami, Ethan] Tri Inst Training Program Computat Biol & Med, New York, NY USA	Memorial Sloan Kettering Cancer Center	Cerami, E (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, 1275 York Ave, New York, NY 10021 USA.	gbm-network@cbio.mskcc.org	Schultz, Nikolaus/ABE-6347-2020; Sander, Chris/H-1452-2011	Sander, Chris/0000-0001-6059-6270; Schultz, Nikolaus/0000-0002-0131-4904; Demir, Emek/0000-0002-3663-7113	National Cancer Institute [1R21CA135870-01, U24CA126543]; National Human Genome Research Institute [1P41HG004118-01A1]; Tri-Institutional Training Program; NATIONAL CANCER INSTITUTE [U24CA126543, R21CA135870] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004118] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Tri-Institutional Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Support for this work was provided by National Cancer Institute grants (1R21CA135870-01, A Computational Platform for Analyzing and Visualizing Integrated TCGA Data in the Context of Biological Pathways; and U24CA126543, TCGA Cancer Genome Characterization Center). Support for Pathway Commons and BioPAX tools was provided by an National Human Genome Research Institute grant (1P41HG004118-01A1, Pathway Commons: Research Resource For Biological Pathways). Additional support was provided by the Tri-Institutional Training Program in Computational Biology and Medicine. The National Institutes of Health did have a role in the study design and data collection of the original TCGA GBM study, but it and other funders had no role in the network analysis presented here, decision to publish, or preparation of the manuscript.	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaschke C, 2001, COMP FUNCT GENOM, V2, P196, DOI 10.1002/cfg.91; Blom T, 2008, INT J CANCER, V123, P793, DOI 10.1002/ijc.23576; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costello JF, 1997, CANCER RES, V57, P1250; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; DEMIR E, 2009, PAXTOOLS LIB ACCESSI; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durek P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-100; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomes AL, 2007, CELL ONCOL, V29, P399; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HENSON JW, 1994, ANN NEUROL, V36, P714, DOI 10.1002/ana.410360505; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holopainen T, 2009, CANCER RES, V69, P4656, DOI 10.1158/0008-5472.CAN-08-4654; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; JAMES CD, 1988, CANCER RES, V48, P5546; *JUNG, 2009, JUNG JAV UN NETW GRA; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Loffler H, 2006, EXP CELL RES, V312, P2633, DOI 10.1016/j.yexcr.2006.06.008; Lu HC, 2006, BIOCHEM BIOPH RES CO, V345, P302, DOI 10.1016/j.bbrc.2006.04.088; Marks PW, 1998, J CELL SCI, V111, P2129; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mischel PS, 2003, BRAIN PATHOL, V13, P52; *MSKCC, 2009, SIF INT RUL; *MSKCC, 2009, CBIO CANC GEN DAT PO; *NCT, 2009, TCGA DAT PORT; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Reis RM, 2005, CELL ONCOL, V27, P319; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; TORKAMANI A, 2009, GENOME RES; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Yamada T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-130; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001	59	256	264	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e8918	10.1371/journal.pone.0008918	http://dx.doi.org/10.1371/journal.pone.0008918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169195	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474600001
J	Ying, HY; Shen, X; Park, B; Yue, BYJT				Ying, Hongyu; Shen, Xiang; Park, BumChan; Yue, Beatrice Y. J. T.			Posttranslational Modifications, Localization, and Protein Interactions of Optineurin, the Product of a Glaucoma Gene	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; ENHANCER-BLOCKING ACTIVITY; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK; MYOSIN-VI; IN-VITRO; INHIBITION; EXPRESSION; DISEASE	Background: Glaucoma is a major blinding disease. The most common form of this disease, primary open angle glaucoma (POAG), is genetically heterogeneous. One of the candidate genes, optineurin, is linked principally to normal tension glaucoma, a subtype of POAG. The present study was undertaken to illustrate the basic characteristics of optineurin. Methodology/Principal Findings: Lysates from rat retinal ganglion RGC5 cells were subjected to N- or O-deglycosylation or membrane protein extraction. The phosphorylation status was evaluated after immunoprecipitation. It was found that while phosphorylated, optineurin was neither N- nor O-glycosylated, and was by itself not a membrane protein. RGC5 and human retinal pigment epithelial cells were double stained with anti-optineurin and anti-GM130. The endogenous optineurin exhibited a diffuse, cytoplasmic distribution, but a population of the protein was associated with the Golgi apparatus. Turnover experiments showed that the endogenous optineurin was relatively short-lived, with a half-life of approximately 8 hours. Native blue gel electrophoresis revealed that the endogenous optineurin formed homohexamers. Optineurin also interacted with molecules including Rab8, myosin VI, and transferrin receptor to assemble into supermolecular complexes. When overexpressed, optineurin-green fluorescence protein (GFP) fusion protein formed punctate structures termed "foci'' in the perinuclear region. Treatment of nocadazole resulted in dispersion of the optineurin foci. In addition, tetracycline-regulated optineurin-GFPs expressing RGC5 stable cell lines were established for the first time. Conclusions/Significance: The present study provides new information regarding basic characteristics of optineurin that are important for future efforts in defining precisely how optineurin functions normally and how mutations may result in pathology. The inducible optineurin-GFP-expressing cell lines are also anticipated to facilitate in-depth studies of optineurin. Furthermore, the demonstrations that optineurin is an aggregation-prone protein and that the foci formation is microtubule-dependent bear similarities to features documented in neurodegenerative diseases, supporting a neurodegenerative paradigm for glaucoma.	[Ying, Hongyu; Shen, Xiang; Park, BumChan; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ying, HY (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA.	beatyue@uic.edu			National Eye Institute [EY018828, EY005628, EY003890, EY01792]; National Institutes of Health; American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants EY018828, EY005628, and EY003890 (to B.Y.J.T.Y.); by Core Grant EY01792 from the National Eye Institute, National Institutes of Health (www.nei.nih.gov; Bethesda, Maryland); and by a grant from the American Health Assistance Foundation (www.ahaf.org; Clarksburg, Maryland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; Chibalina MV, 2008, METHOD ENZYMOL, V438, P11, DOI 10.1016/S0076-6879(07)38002-6; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Franch HA, 2001, J BIOL CHEM, V276, P19126, DOI 10.1074/jbc.M101777200; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Gallagher PG, 2009, BLOOD, V113, P1547, DOI 10.1182/blood-2008-06-164954; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; HANAWA H, 2009, MOL THER; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; Hisanaga S, 2003, NEUROSIGNALS, V12, P221, DOI 10.1159/000074624; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Obazawa M, 2004, INVEST OPHTH VIS SCI, V45, P2652, DOI 10.1167/iovs.03-0572; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pradere JP, 2007, BBA-MOL CELL BIOL L, V1771, P93, DOI 10.1016/j.bbalip.2006.11.010; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; TAYLOR CR, 1994, HUM PATHOL, V25, P263, DOI 10.1016/0046-8177(94)90198-8; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Yang C, 2009, INVEST OPHTH VIS SCI, V50, P1290, DOI 10.1167/iovs.08-1920; Zhou B, 2004, FEBS LETT, V576, P401, DOI 10.1016/j.febslet.2004.09.039; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	55	47	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9168	10.1371/journal.pone.0009168	http://dx.doi.org/10.1371/journal.pone.0009168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161783	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442800014
J	Jee, MK; Kim, JH; Han, YM; Jung, SJ; Kang, KS; Kim, DW; Kang, SK				Jee, Min Ki; Kim, Ji Hoon; Han, Yong Man; Jung, Sung Jun; Kang, Kyung Sun; Kim, Dong Wook; Kang, Soo Kyung			DHP-Derivative and Low Oxygen Tension Effectively Induces Human Adipose Stromal Cell Reprogramming	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; RADIAL GLIA; STEM-CELL; CEREBRAL-ISCHEMIA; PLANT-CELLS; ADULT-RATS; DEDIFFERENTIATION; PLASTICITY; TRANSFORMATION; IMPROVEMENT	Background and Methods: In this study, we utilized a combination of low oxygen tension and a novel anti-oxidant, 4-(3,4-dihydroxy- phenyl)-derivative (DHP-d) to directly induce adipose tissue stromal cells (ATSC) to de-differentiate into more primitive stem cells. De-differentiated ATSCs was overexpress stemness genes, Rex-1, Oct-4, Sox-2, and Nanog. Additionally, demethylation of the regulatory regions of Rex-1, stemnesses, and HIF1 alpha and scavenging of reactive oxygen species were finally resulted in an improved stem cell behavior of de-differentiate ATSC (de-ATSC). Proliferation activity of ATSCs after dedifferentiation was induced by REX1, Oct4, and JAK/STAT3 directly or indirectly. De-ATSCs showed increased migration activity that mediated by P38/JUNK and ERK phosphorylation. Moreover, regenerative efficacy of de-ATSC engrafted spinal cord-injured rats and chemical-induced diabetes animals were significantly restored their functions. Conclusions/Significance: Our stem cell remodeling system may provide a good model which would provide insight into the molecular mechanisms underlying ATSC proliferation and transdifferentiation. Also, these multipotent stem cells can be harvested may provide us with a valuable reservoir of primitive and autologous stem cells for use in a broad spectrum of regenerative cell-based disease therapy.	[Jee, Min Ki; Kang, Soo Kyung] Seoul Natl Univ, Coll Vet Med, Dept Biotechnol, Seoul, South Korea; [Kim, Ji Hoon; Han, Yong Man] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kang, Kyung Sun] Seoul Natl Univ, Coll Vet Med, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea; [Kim, Dong Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Jung, Sung Jun] Han Yang Univ, Coll Med, Dept Physiol, Seoul, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Hanyang University	Jee, MK (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Biotechnol, Seoul, South Korea.	sookang@snu.ac.kr	Han, Yong-Mahn/C-1652-2011	Dong-Wook, Kim/0000-0002-5025-1532	21st Century Frontier/Stem Cell Research Committee [SC5110, SC5112]; Korean Science and Engineering Foundation; South Korean government [M10841000109-08N4100-10910]	21st Century Frontier/Stem Cell Research Committee; Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); South Korean government(Korean Government)	This work was supported by the 21st Century Frontier/Stem Cell Research Committee (SC5110, SC5112) and was also supported by a Korean Science and Engineering Foundation grant funded by the South Korean government (MOST, No. M10841000109-08N4100-10910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 2004, INT J RADIAT BIOL, V80, P483, DOI 10.1080/09553000410001725107; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Avivi Y, 2004, DEV DYNAM, V230, P12, DOI 10.1002/dvdy.20006; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Goodell MA, 2003, CURR OPIN HEMATOL, V10, P208, DOI 10.1097/00062752-200305000-00003; Grafi G, 2004, DEV BIOL, V268, P1, DOI 10.1016/j.ydbio.2003.12.027; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HATTEN ME, 1984, DEV BRAIN RES, V13, P309, DOI 10.1016/0165-3806(84)90166-4; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kim JH, 2008, STEM CELLS, V26, P2724, DOI 10.1634/stemcells.2008-0184; Lennmyr F, 2002, ACTA NEUROL SCAND, V106, P333, DOI 10.1034/j.1600-0404.2002.01313.x; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; PIXLEY SKR, 1984, DEV BRAIN RES, V15, P201, DOI 10.1016/0165-3806(84)90097-X; ROSEN GD, 1994, DEV BRAIN RES, V82, P127, DOI 10.1016/0165-3806(94)90155-4; ROSEN GD, 1992, J NEUROPATH EXP NEUR, V51, P601, DOI 10.1097/00005072-199211000-00005; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; TAKEBE I, 1971, NATURWISSENSCHAFTEN, V58, P318, DOI 10.1007/BF00624737; Valente P, 1998, PLANT SCI, V134, P207, DOI 10.1016/S0168-9452(98)00062-4; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200	32	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9026	10.1371/journal.pone.0009026	http://dx.doi.org/10.1371/journal.pone.0009026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161735	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442600001
J	de Barros, APDN; Takiya, CM; Garzoni, LR; Leal-Ferreira, ML; Dutra, HS; Chiarini, LB; Meirelles, MN; Borojevic, R; Rossi, MID				de Barros, Ana Paula D. N.; Takiya, Christina M.; Garzoni, Luciana R.; Leal-Ferreira, Mona Lisa; Dutra, Helio S.; Chiarini, Luciana B.; Meirelles, Maria Nazareth; Borojevic, Radovan; Rossi, Maria Isabel D.			Osteoblasts and Bone Marrow Mesenchymal Stromal Cells Control Hematopoietic Stem Cell Migration and Proliferation in 3D In Vitro Model	PLOS ONE			English	Article							PROGENITOR CELLS; NICHE; MICROENVIRONMENT; HYPOXIA; BLOOD; OSTEOPONTIN; MAINTENANCE; TRAFFICKING; COMPONENT; SYSTEM	Background: Migration, proliferation, and differentiation of hematopoietic stem cells (HSCs) are dependent upon a complex three-dimensional (3D) bone marrow microenvironment. Although osteoblasts control the HSC pool, the subendosteal niche is complex and its cellular composition and the role of each cell population in HSC fate have not been established. In vivo models are complex and involve subtle species-specific differences, while bidimensional cultures do not reflect the 3D tissue organization. The aim of this study was to investigate in vitro the role of human bone marrow-derived mesenchymal stromal cells (BMSC) and active osteoblasts in control of migration, lodgment, and proliferation of HSCs. Methodology/Principal Findings: A complex mixed multicellular spheroid in vitro model was developed with human BMSC, undifferentiated or induced for one week into osteoblasts. A clear limit between the two stromal cells was established, and deposition of extracellular matrix proteins fibronectin, collagens I and IV, laminin, and osteopontin was similar to the observed in vivo. Noninduced BMSC cultured as spheroid expressed higher levels of mRNA for the chemokine CXCL12, and the growth factors Wnt5a and Kit ligand. Cord blood and bone marrow CD34(+) cells moved in and out the spheroids, and some lodged at the interface of the two stromal cells. Myeloid colony-forming cells were maintained after seven days of coculture with mixed spheroids, and the frequency of cycling CD34(+) cells was decreased. Conclusions/Significance: Undifferentiated and one-week osteo-induced BMSC self-assembled in a 3D spheroid and formed a microenvironment that is informative for hematopoietic progenitor cells, allowing their lodgment and controlling their proliferation.	[de Barros, Ana Paula D. N.; Takiya, Christina M.; Dutra, Helio S.; Borojevic, Radovan; Rossi, Maria Isabel D.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil; [Garzoni, Luciana R.; Meirelles, Maria Nazareth] Inst Oswaldo Cruz, Dept Ultrastruct & Biol Celular, BR-20001 Rio De Janeiro, Brazil; [Leal-Ferreira, Mona Lisa; Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biofis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	de Barros, APDN (corresponding author), Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil.	idrossi@hucff.ufrj.br	Rossi, Maria Isabel D/J-4802-2012; Takiya, Christina/AAU-5959-2021; Borojevic, Radovan/V-8500-2019; Chiarini, Luciana B/J-3644-2015	Rossi, Maria Isabel D/0000-0003-3432-8453; Takiya, Christina/0000-0002-8019-628X; Borojevic, Radovan/0000-0002-2393-7280; 	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Pesquisa; Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior; Associacao e Programa de Biologia Celular Aplicada a Medicina	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Pesquisa; Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Associacao e Programa de Biologia Celular Aplicada a Medicina	Funding: This work was supported by grants of the Brazilian agencies Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Pesquisa, Coordenacao de Aperfeicaoamento de Pessoal de Nivel Superior, and Associacao e Programa de Biologia Celular Aplicada a Medicina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Andersen TL, 2009, AM J PATHOL, V174, P239, DOI 10.2353/ajpath.2009.080627; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Askenasy N, 2003, BRIT J HAEMATOL, V120, P505, DOI 10.1046/j.1365-2141.2003.04114.x; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bug G, 2002, J LEUKOCYTE BIOL, V72, P837; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; deCarvalho HF, 1996, HISTOCHEM CELL BIOL, V106, P587, DOI 10.1007/s004180050080; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Garzoni LR, 2009, EXP CELL RES, V315, P3406, DOI 10.1016/j.yexcr.2009.09.016; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Kalajzic Z, 2008, BONE, V43, P501, DOI 10.1016/j.bone.2008.04.023; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larsson J, 2008, CELL STEM CELL, V3, P221, DOI 10.1016/j.stem.2008.06.005; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Nilsson SK, 2006, EXP HEMATOL, V34, P123, DOI 10.1016/j.exphem.2005.08.006; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Remy-Martin JP, 1999, EXP HEMATOL, V27, P1782, DOI 10.1016/S0301-472X(99)00122-8; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Rossi MID, 2001, J IMMUNOL, V167, P3033, DOI 10.4049/jimmunol.167.6.3033; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; SKAWINA A, 1994, J ANAT, V185, P369; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; WEISS L, 1976, ANAT RECORD, V186, P161, DOI 10.1002/ar.1091860204; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	65	77	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9093	10.1371/journal.pone.0009093	http://dx.doi.org/10.1371/journal.pone.0009093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161704	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442500005
J	Layden, BT; Newman, M; Chen, F; Fisher, A; Lowe, WL				Layden, Brian T.; Newman, Marsha; Chen, Fei; Fisher, Amanda; Lowe, William L., Jr.			G Protein Coupled Receptors in Embryonic Stem Cells: A Role for Gs-Alpha Signaling	PLOS ONE			English	Article							SELF-RENEWAL; DIFFERENTIATION; GROWTH; PROLIFERATION; PROGENITORS; EXPRESSION; MEDICINE; BIOLOGY; MODELS	Background: Identification of receptor mediated signaling pathways in embryonic stem (ES) cells is needed to facilitate strategies for cell replacement using ES cells. One large receptor family, largely uninvestigated in ES cells, is G protein coupled receptors (GPCRs). An important role for these receptors in embryonic development has been described, but little is known about GPCR expression in ES cells. Methodology/Principal Findings: We have examined the expression profile of 343 different GPCRs in mouse ES cells demonstrating for the first time that a large number of GPCRs are expressed in undifferentiated and differentiating ES cells, and in many cases at high levels. To begin to define a role for GPCR signaling in ES cells, the impact of activating Gs-alpha, one of the major alpha subunits that couples to GPCRs, was investigated. Gs-alpha activation resulted in larger embryoid bodies (EBs), due, in part, to increased cell proliferation and prevented the time-related decline in expression of transcription factors important for maintaining ES cell pluripotency. Significance/Conclusions: These studies suggest that Gs-alpha signaling contributes to ES cell proliferation and pluripotency and provide a framework for further investigation of GPCRs in ES cells.	[Layden, Brian T.; Newman, Marsha; Chen, Fei; Fisher, Amanda; Lowe, William L., Jr.] Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Layden, BT (corresponding author), Northwestern Univ, Dept Med, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA.	wlowe@northwestern.edu			Butz Foundation; Northwestern Memorial Foundation	Butz Foundation; Northwestern Memorial Foundation	Funding: This work was supported by grants from the Butz Foundation and Northwestern Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G.B., 2009, NATURE; Anisimov SV, 2002, GENOMICS, V79, P169, DOI 10.1006/geno.2002.6687; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Matteson PG, 2008, P NATL ACAD SCI USA, V105, P2088, DOI 10.1073/pnas.0705657105; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; Okoye Ujunwa C, 2008, J Mol Signal, V3, P16, DOI 10.1186/1750-2187-3-16; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Trounson A, 2007, CURR OPIN BIOTECH, V18, P432, DOI 10.1016/j.copbio.2007.10.003; Wang X, 2008, J VIS EXP; Weinstein LS, 2007, PHARMACOL THERAPEUT, V115, P271, DOI 10.1016/j.pharmthera.2007.03.013; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9105	10.1371/journal.pone.0009105	http://dx.doi.org/10.1371/journal.pone.0009105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161705	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442500012
J	Sarrabayrouse, G; Pich, C; Moriez, R; Armand-Labit, V; Rochaix, P; Favre, G; Tilkin-Mariame, AF				Sarrabayrouse, Guillaume; Pich, Christine; Moriez, Raphael; Armand-Labit, Virginie; Rochaix, Philippe; Favre, Gilles; Tilkin-Mariame, Anne-Francoise			Melanoma Cells Treated with GGTI and IFN-gamma Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells	PLOS ONE			English	Article							GERANYLGERANYLTRANSFERASE-I; ANTITUMOR IMMUNITY; TUMOR-CELLS; EXPRESSION; CANCER; PEPTIDE; INHIBITION; IMMUNOTHERAPY; LYMPHOCYTES; INDUCTION	Background: Suboptimal activation of T lymphocytes by melanoma cells is often due to the defective expression of class I major histocompatibility antigens (MHC-I) and costimulatory molecules. We have previously shown that geranylgeranyl transferase inhibition (done with GGTI-298) stimulates anti-melanoma immune response through MHC-I and costimulatory molecule expression in the B16F10 murine model [1]. Methodology/Principal Findings: In this study, it is shown that vaccination with mIFN-gamma and GGTI-298 pretreated B16F10 cells induces a protection against untreated tumor growth and pulmonary metastases implantation. Furthermore, using a human melanoma model (LB1319-MEL), we demonstrated that in vitro treatment with hIFN-gamma and GGTI-298 led to the up regulation of MHC-I and a costimulatory molecule CD86 and down regulation of an inhibitory molecule PD-1L. Co-culture experiments with peripheral blood mononuclear cells (PBMC) revealed that modifications induced by hIFN-gamma and GGTI-298 on the selected melanoma cells, enables the stimulation of lymphocytes from HLA compatible healthy donors. Indeed, as compared with untreated melanoma cells, pretreatment with hIFN-gamma and GGTI-298 together rendered the melanoma cells more efficient at inducing the: i) activation of CD8 T lymphocytes (CD8+/CD69+); ii) proliferation of tumor-specific CD8 T cells (MelanA-MART1/TCR+); iii) secretion of hIFN-gamma; and iv) anti-melanoma specific cytotoxic cells. Conclusions/Significance: These data indicate that pharmacological treatment of melanoma cell lines with IFN-gamma and GGTI-298 stimulates their immunogenicity and could be a novel approach to produce tumor cells suitable for vaccination and for stimulation of anti-melanoma effector cells.	[Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Favre, Gilles; Tilkin-Mariame, Anne-Francoise] Fac Med Toulouse, INSERM, U563, Dept Innovat Therapeut & Oncol Mol,CPTP, F-31073 Toulouse, France; [Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Rochaix, Philippe; Favre, Gilles; Tilkin-Mariame, Anne-Francoise] Inst Claudius Regaud, Toulouse, France; [Sarrabayrouse, Guillaume; Pich, Christine; Armand-Labit, Virginie; Favre, Gilles] Univ Toulouse 3, F-31062 Toulouse, France; [Moriez, Raphael] INRA, Neurogastroenterol & Nutr Unit, F-31931 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE	Sarrabayrouse, G (corresponding author), Fac Med Toulouse, INSERM, U563, Dept Innovat Therapeut & Oncol Mol,CPTP, U317, F-31073 Toulouse, France.	tilkin.anne@claudiusregaud.fr	GLADIEFF, Laurence/O-5129-2014; FAVRE, Gilles/K-9189-2014; ARMAND-LABIT, Virginie/P-5807-2014; Rochaix, Philippe/O-4710-2014; Moriez, Raphael/M-1773-2014	GLADIEFF, Laurence/0000-0002-6980-9719; FAVRE, Gilles/0000-0002-2344-1883; ARMAND-LABIT, Virginie/0000-0003-4643-5344; Rochaix, Philippe/0000-0001-6238-1599; Pich-Bavastro, Christine/0000-0002-6526-749X; Moriez, Raphael/0000-0002-0569-2558	Institut National de la Sante et de la Recherche Medicale; La Ligue contre le Cancer, Region Midi Pyrenees; Institut Claudius Regaud	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue contre le Cancer, Region Midi Pyrenees(Region Occitanie); Institut Claudius Regaud	This work was supported by the "Institut National de la Sante et de la Recherche Medicale'' and by grants from "La Ligue contre le Cancer, Region Midi Pyrenees'' and from the "Institut Claudius Regaud''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2004, ANTICANCER RES, V24, P571; Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Benlalam H, 2007, CANCER IMMUNOL IMMUN, V56, P515, DOI 10.1007/s00262-006-0204-0; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Botella-Estrada R, 2005, EUR CYTOKINE NETW, V16, P47; Bredel M, 1998, NEUROSURGERY, V43, P124, DOI 10.1097/00006123-199807000-00081; Coral S, 2002, CLIN CANCER RES, V8, P2690; Cormary C, 2005, CANCER GENE THER, V12, P963, DOI 10.1038/sj.cgt.7700861; Cormary C, 2004, CANCER GENE THER, V11, P497, DOI 10.1038/sj.cgt.7700708; Coulie PG, 2001, P NATL ACAD SCI USA, V98, P10290, DOI 10.1073/pnas.161260098; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Godelaine D, 2003, J IMMUNOL, V171, P4893, DOI 10.4049/jimmunol.171.9.4893; HERSEY P, 1994, INT J CANCER, V58, P527, DOI 10.1002/ijc.2910580413; HORI Y, 1991, ONCOGENE, V6, P515; Kusama T, 2003, CLIN EXP METASTAS, V20, P561, DOI 10.1023/A:1025898316728; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Luo W, 2006, J IMMUNOL, V176, P6046, DOI 10.4049/jimmunol.176.10.6046; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Reinke S, 2005, AM J DERMATOPATH, V27, P401, DOI 10.1097/01.dad.0000180076.17932.ee; Sarrabayrouse G, 2007, NEOPLASIA, V9, P1078, DOI 10.1593/neo.07727; Seliger B, 2001, CANCER RES, V61, P1095; Shu S, 2006, CANCER METAST REV, V25, P233, DOI 10.1007/s10555-006-8503-7; Sojka DK, 2000, J IMMUNOL, V164, P6230, DOI 10.4049/jimmunol.164.12.6230; Tilkin-Mariame AF, 2005, FASEB J, V19, P1513, DOI 10.1096/fj.04-3482fje; YOKOYAMA WM, 1989, IMMUNOL REV, V109, P153, DOI 10.1111/j.1600-065X.1989.tb00024.x	27	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9043	10.1371/journal.pone.0009043	http://dx.doi.org/10.1371/journal.pone.0009043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140259	Green Published, gold			2022-12-27	WOS:000274474200023
J	Burman, JL; Hamlin, JNR; McPherson, PS				Burman, Jonathon L.; Hamlin, Jason N. R.; McPherson, Peter S.			Scyl1 Regulates Golgi Morphology	PLOS ONE			English	Article							RECESSIVE FORM; PROTEIN; COPI; DYNAMICS; GENE; CLONING; TRAFFICKING; TRANSPORT; SUBUNIT; ENCODES	Background: Membrane trafficking is a defining feature of eukaryotic cells, and is essential for the maintenance of organelle homeostasis and identity. We previously identified Scy1-like 1 (Scyl1), a member of the Scy1-like family of catalytically inactive protein kinases, as a high-affinity binding partner of COPI coats. COPI-coated vesicles control Golgi to endoplasmic reticulum trafficking and we observed that disruption of Scyl1 function leads to a decrease in trafficking of the KDEL receptor via the COPI pathway. We reasoned that if Scyl1 plays a major role in COPI trafficking its disruption could influence Golgi homeostasis. Methodology/Principal Findings: We performed Scyl1 knock down in cultured cells using previously established methods and observed an alteration in Golgi morphology. Both the surface area and volume of the Golgi is increased in Scyl1-depleted cells, but the continuity and polarity of the organelle is unperturbed. At the ultrastructural level we observe a decrease in the orderly structure of the Golgi with an increase in cisternal luminal width, while the number of Golgi cisternae remains unchanged. The golgin family of proteins forms a detergent resistant network that controls Golgi homeostasis. Disruption of this protein network by knock down of the golgin p115 disrupts the Golgi localization of Scyl1. Moreover, we find that Scyl1 interacts with 58K/formiminotransferase cyclodeaminase (FTCD), a protein that is tightly associated with the cis face of the Golgi. Conclusions/Significance: Our results place Scyl1 at an interface between the golgin network and COPI trafficking and demonstrate that Scyl1 is required for the maintenance of Golgi morphology. Coupled with the observation from others that Scyl1 is the gene product responsible for the neurodegenerative mouse model mdf, our results additionally implicate the regulation of COPI trafficking and Golgi homeostasis in neurodegeneration.	[Burman, Jonathon L.; Hamlin, Jason N. R.; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Burman, JL (corresponding author), Univ Washington, Dept Genome Sci, Genome Sci Ctr, Seattle, WA 98195 USA.	peter.mcpherson@mcgill.ca			Canadian Institutes of Health Research (CIHR) [t MOP 62684]; Great-West Life; London Life; Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute; ALS society	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Great-West Life; London Life; Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute; ALS society	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP 62684 awarded to PSM and a grant from the Great-West Life, London Life and Canada Life Experimental Therapeutics Fund at the Montreal Neurological Institute. JLB was supported by a studentship from the CIHR. JNRH holds a studentship from the ALS society. PSM holds the James McGill Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Dosari M, 2009, AM J MED GENET A, V149A, P2093, DOI 10.1002/ajmg.a.32996; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; BURMAN JL, 2009, UCSD NATURE MOL PAGE, DOI DOI 10.1038/MP.A003453.01; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Dejgaard SY, 2007, J HISTOCHEM CYTOCHEM, V55, P709, DOI 10.1369/jhc.6A7090.2007; Di YJ, 2003, J HUM GENET, V48, P315, DOI 10.1007/s10038-003-0031-5; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Elsner M, 2003, EMBO REP, V4, P1000, DOI 10.1038/sj.embor.embor942; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058; Hennies HC, 2008, NAT GENET, V40, P1410, DOI 10.1038/ng.252; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Hsu VW, 2009, NAT REV MOL CELL BIO, V10, P360, DOI 10.1038/nrm2663; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Liu SCH, 2000, BBA-GENE STRUCT EXPR, V1517, P148, DOI 10.1016/S0167-4781(00)00234-7; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Storrie B, 2000, TRENDS CELL BIOL, V10, P385, DOI 10.1016/S0962-8924(00)01818-3; STURGESS JM, 1972, J CELL BIOL, V55, P524, DOI 10.1083/jcb.55.2.524; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065	38	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9537	10.1371/journal.pone.0009537	http://dx.doi.org/10.1371/journal.pone.0009537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209057	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100017
J	Maunoury, N; Redondo-Nieto, M; Bourcy, M; Van de Velde, W; Alunni, B; Laporte, P; Durand, P; Agier, N; Marisa, L; Vaubert, D; Delacroix, H; Duc, G; Ratet, P; Aggerbeck, L; Kondorosi, E; Mergaert, P				Maunoury, Nicolas; Redondo-Nieto, Miguel; Bourcy, Marie; Van de Velde, Willem; Alunni, Benoit; Laporte, Philippe; Durand, Patricia; Agier, Nicolas; Marisa, Laetitia; Vaubert, Daniele; Delacroix, Herve; Duc, Gerard; Ratet, Pascal; Aggerbeck, Lawrence; Kondorosi, Eva; Mergaert, Peter			Differentiation of Symbiotic Cells and Endosymbionts in Medicago truncatula Nodulation Are Coupled to Two Transcriptome-Switches	PLOS ONE			English	Article							MITOTIC INHIBITOR CCS52; SINORHIZOBIUM-MELILOTI; NODULE DEVELOPMENT; NITROGEN-FIXATION; ALFALFA NODULES; GENE-EXPRESSION; PERIBACTEROID MEMBRANE; PLANT DEFENSE; ROOT-NODULES; LIPID-A	The legume plant Medicago truncatula establishes a symbiosis with the nitrogen-fixing bacterium Sinorhizobium meliloti which takes place in root nodules. The formation of nodules employs a complex developmental program involving organogenesis, specific cellular differentiation of the host cells and the endosymbiotic bacteria, called bacteroids, as well as the specific activation of a large number of plant genes. By using a collection of plant and bacterial mutants inducing nonfunctional, Fix 2 nodules, we studied the differentiation processes of the symbiotic partners together with the nodule transcriptome, with the aim of unravelling links between cell differentiation and transcriptome activation. Two waves of transcriptional reprogramming involving the repression and the massive induction of hundreds of genes were observed during wild-type nodule formation. The dominant features of this "nodule-specific transcriptome'' were the repression of plant defense-related genes, the transient activation of cell cycle and protein synthesis genes at the early stage of nodule development and the activation of the secretory pathway along with a large number of transmembrane and secretory proteins or peptides throughout organogenesis. The fifteen plant and bacterial mutants that were analyzed fell into four major categories. Members of the first category of mutants formed non-functional nodules although they had differentiated nodule cells and bacteroids. This group passed the two transcriptome switch-points similarly to the wild type. The second category, which formed nodules in which the plant cells were differentiated and infected but the bacteroids did not differentiate, passed the first transcriptome switch but not the second one. Nodules in the third category contained infection threads but were devoid of differentiated symbiotic cells and displayed a root-like transcriptome. Nodules in the fourth category were free of bacteria, devoid of differentiated symbiotic cells and also displayed a root-like transcriptome. A correlation thus exists between the differentiation of symbiotic nodule cells and the first wave of nodule specific gene activation and between differentiation of rhizobia to bacteroids and the second transcriptome wave in nodules. The differentiation of symbiotic cells and of bacteroids may therefore constitute signals for the execution of these transcriptome-switches.	[Maunoury, Nicolas; Redondo-Nieto, Miguel; Bourcy, Marie; Van de Velde, Willem; Alunni, Benoit; Laporte, Philippe; Durand, Patricia; Vaubert, Daniele; Ratet, Pascal; Kondorosi, Eva; Mergaert, Peter] CNRS, Unite Propre Rech 2355, Inst Sci Vegetal, Gif Sur Yvette, France; [Agier, Nicolas; Marisa, Laetitia; Delacroix, Herve; Aggerbeck, Lawrence] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Delacroix, Herve] Univ Paris 11, Orsay, France; [Duc, Gerard] INRA, Genet & Ecophysiol Legumineuses Graines, F-21034 Dijon, France; [Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Maunoury, N (corresponding author), INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	peter.mergaert@isv.cnrs-gif.fr	Redondo-Nieto, Miguel/A-6169-2011; Mergaert, Peter/M-1265-2019; Ratet, Pascal/GPP-3654-2022	Redondo-Nieto, Miguel/0000-0002-3361-520X; Mergaert, Peter/0000-0002-5919-7317; Ratet, Pascal/0000-0002-8621-1495; Kondorosi, Eva/0000-0002-4065-8515	Agence National de la Recherche [ANR-05-BLAN-0129-01]; IFR115 Genomes: Structure, Fonction et Evolution; Universite Paris Sud XI; CNRS; Institut Curie; French Ministry of Research; Spanish Ministerio de Educacion y Ciencia; Institut de Chimie des Substances Naturelles, CNRS	Agence National de la Recherche(French National Research Agency (ANR)); IFR115 Genomes: Structure, Fonction et Evolution; Universite Paris Sud XI; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Institut de Chimie des Substances Naturelles, CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grant N degrees ANR-05-BLAN-0129-01 from the Agence National de la Recherche to P. M. The GODMAP platform was funded by the IFR115 Genomes: Structure, Fonction et Evolution, the Universite Paris Sud XI (Plan Pluri-Formation "Plate-forme Puces-a-ADN 2006-2009''), the CNRS and the Institut Curie. N. M. and B. A. were the beneficiaries of PhD fellowships from the French Ministry of Research. M. R-N. was funded by the Spanish Ministerio de Educacion y Ciencia Progam Becas Postdoctorales. L. M. was supported by the Institut de Chimie des Substances Naturelles, CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus U, 2001, NEW PHYTOL, V151, P597, DOI 10.1046/j.0028-646x.2001.00214.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; BENABEN V, 1995, PLANT PHYSIOL, V107, P53, DOI 10.1104/pp.107.1.53; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BOIVIN C, 1990, PLANT CELL, V2, P1157, DOI 10.1105/tpc.2.12.1157; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Campbell GRO, 2002, P NATL ACAD SCI USA, V99, P3938, DOI 10.1073/pnas.062425699; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; COOK D, 1995, PLANT CELL, V7, P43, DOI 10.1105/tpc.7.1.43; Coque L, 2008, MOL PLANT MICROBE IN, V21, P404, DOI 10.1094/MPMI-21-4-0404; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; delaPena TC, 1997, PLANT J, V11, P407, DOI 10.1046/j.1365-313X.1997.11030407.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engler JD, 2001, METHODS, V23, P325, DOI 10.1006/meth.2000.1144; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Gonzalez-Sama A, 2006, MOL PLANT MICROBE IN, V19, P173, DOI 10.1094/MPMI-19-0173; Gyorgyey J, 2000, MOL PLANT MICROBE IN, V13, P62, DOI 10.1094/MPMI.2000.13.1.62; HIRSCH AM, 1983, J BACTERIOL, V155, P367, DOI 10.1128/JB.155.1.367-380.1983; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x; Kardailsky IV, 1996, PLANT PHYSIOL, V111, P49, DOI 10.1104/pp.111.1.49; Kevei Z, 2002, MOL PLANT MICROBE IN, V15, P922, DOI 10.1094/MPMI.2002.15.9.922; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; LEONG SA, 1985, NUCLEIC ACIDS RES, V13, P5965, DOI 10.1093/nar/13.16.5965; Limpens E, 2009, PLANT CELL, V21, P2811, DOI 10.1105/tpc.108.064410; Liu JQ, 2006, PLANT PHYSIOL, V141, P167, DOI 10.1104/pp.106.076711; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Mathis R, 1999, MOL PLANT MICROBE IN, V12, P544, DOI 10.1094/MPMI.1999.12.6.544; Maunoury N., 2008, V7, P153; McKhann HI, 1997, PLANT MOL BIOL, V34, P771, DOI 10.1023/A:1005899410389; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Mithofer A, 1996, PLANTA, V199, P270, DOI 10.1007/BF00196568; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Morandi D, 2005, MYCORRHIZA, V15, P283, DOI 10.1007/s00572-004-0331-4; Newton W.E., 1998, BIOL NITROGEN FIXATI, P317; Niehaus K, 1998, MOL PLANT MICROBE IN, V11, P906, DOI 10.1094/MPMI.1998.11.9.906; NIEHAUS K, 1993, PLANTA, V190, P415; NORRIS JH, 1988, PLANT PHYSIOL, V88, P321, DOI 10.1104/pp.88.2.321; Pellock BJ, 2000, J BACTERIOL, V182, P4310, DOI 10.1128/JB.182.15.4310-4318.2000; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rickman DS, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng109; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SAGAN M, 1995, PLANT SCI, V111, P63, DOI 10.1016/0168-9452(95)04229-N; Shi LF, 1997, PLANT CELL, V9, P1339, DOI 10.1105/tpc.9.8.1339; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; Timmers ACJ, 2000, MOL PLANT MICROBE IN, V13, P1204, DOI 10.1094/MPMI.2000.13.11.1204; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; VANDEVELDE W, 2010, SCIENCE IN PRESS; VANDEWIEL C, 1990, EMBO J, V9, P1; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma DPS, 1996, TRENDS MICROBIOL, V4, P364, DOI 10.1016/0966-842X(96)10053-6; Vernoud V, 1999, MOL PLANT MICROBE IN, V12, P604, DOI 10.1094/MPMI.1999.12.7.604; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; WANG D, 2010, SCIENCE IN PRESS; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Woo HH, 1999, PLANT CELL, V11, P2303, DOI 10.1105/tpc.11.12.2303	75	112	115	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9519	10.1371/journal.pone.0009519	http://dx.doi.org/10.1371/journal.pone.0009519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209049	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197100007
J	Kugelberg, E; Gollan, B; Farrance, C; Bratcher, H; Lucidarme, J; Ibarz-Pavon, AB; Maiden, MCJ; Borrow, R; Tang, CM				Kugelberg, Elisabeth; Gollan, Bridget; Farrance, Christopher; Bratcher, Holly; Lucidarme, Jay; Ibarz-Pavon, Ana Belen; Maiden, Martin C. J.; Borrow, Ray; Tang, Christoph M.			The Influence of IS 1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease	PLOS ONE			English	Article							C CONJUGATE VACCINE; NEISSERIA-MENINGITIDIS; SIALIC-ACID; EXPRESSION; BACTERIOPHAGE; TRANSCRIPTION; EPIDEMIOLOGY; EFFICACY; RECEPTOR; ENGLAND	Previously we have shown that insertion of IS1301 in the sia/ctr intergenic region (IGR) of serogroup C Neisseria meningitidis (MenC) isolates from Spain confers increased resistance against complement-mediated killing. Here we investigate the significance of IS1301 in the same location in N. meningitidis isolates from the UK. PCR and sequencing was used to screen a collection of more than 1500 meningococcal carriage and disease isolates from the UK for the presence of IS1301 in the IGR. IS1301 was not identified in the IGR among vaccine failure strains but was frequently found in serogroup B isolates (MenB) from clonal complex 269 (cc269). Almost all IS1301 insertions in cc269 were associated with novel polymorphisms, and did not change capsule expression or resistance to human complement. After excluding sequence types (STs) distant from the central genotype within cc269, there was no significant difference for the presence of IS1301 in the IGR of carriage isolates compared to disease isolates. Isolates with insertion of IS1301 in the IGR are not responsible for MenC disease in UK vaccine failures. Novel polymorphisms associated with IS1301 in the IGR of UK MenB isolates do not lead to the resistance phenotype seen for IS1301 in the IGR of MenC isolates.	[Kugelberg, Elisabeth; Gollan, Bridget; Farrance, Christopher; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London, England; [Bratcher, Holly; Ibarz-Pavon, Ana Belen; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Lucidarme, Jay; Borrow, Ray] Hlth Protect Agcy, Manchester Royal Infirm, Manchester, Lancs, England	Imperial College London; University of Oxford; Health Protection Agency; University of Manchester	Kugelberg, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London, England.	c.tang@imperial.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; Kugelberg, Elisabeth/0000-0002-8302-3595; Bratcher, Holly/0000-0002-7246-7772	EMBO Longterm Fellowship; MRC [G0601195]; Wellcome Trust [84369]; Medical Research Council [G0601195] Funding Source: researchfish	EMBO Longterm Fellowship(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	E. K. was the recipient of an EMBO Longterm Fellowship. Work in CMTs laboratory is supported by grants from the MRC (G0601195) and Wellcome Trust (84369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Diggle MA, 2005, J CLIN MICROBIOL, V43, P4649, DOI 10.1128/JCM.43.9.4649-4653.2005; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; Kugelberg E, 2008, VACCINE, V26, pI34, DOI 10.1016/j.vaccine.2008.11.059; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Swartley JS, 1996, J BACTERIOL, V178, P4052, DOI 10.1128/jb.178.14.4052-4059.1996; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; von Loewenich FD, 2001, INT J MED MICROBIOL, V291, P361, DOI 10.1078/1438-4221-00142; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9413	10.1371/journal.pone.0009413	http://dx.doi.org/10.1371/journal.pone.0009413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195528	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300005
J	Fuerer, C; Nusse, R				Fuerer, Christophe; Nusse, Roel			Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway	PLOS ONE			English	Article							PSEUDOTYPED RETROVIRAL VECTORS; HEMATOPOIETIC STEM-CELLS; CENTRAL POLYPURINE TRACT; VIVO GENE DELIVERY; HIGH-TITER; IN-VIVO; NONDIVIDING CELLS; TRANSDUCTION; ACTIVATION; CARCINOMA	Background: The Wnt signaling pathway plays key roles in development, adult tissue homeostasis and stem cell maintenance. Further understanding of the function of Wnt signaling in specific cell types could benefit from lentiviral vectors expressing reporters for the Wnt pathway or vectors interfering with signaling. Methodology/Principal Findings: We have developed a set of fluorescent and luminescent lentiviral vectors that report Wnt signaling activity and discriminate between negative and uninfected cells. These vectors possess a 7xTcf-eGFP or 7xTcf-FFluc ( Firefly Luciferase) reporter cassette followed by either an SV40-mCherry or SV40-Puro(R) ( puromycin N-acetyltransferase) selection cassette. We have also constructed a vector that allows drug-based selection of cells with activated Wnt signaling by placing Puro(R) under the control of the 7xTcf promoter. Lastly, we have expressed dominantnegative Tcf4 (dnTcf4) or constitutively active beta-catenin (beta-catenin(4A)) from the hEF1 alpha promoter in a SV40-Puro(R) or SV40-mCherry backbone to create vectors that inhibit or activate the Wnt signaling pathway. These vectors will be made available to the scientific community through Addgene. Conclusions: These novel lentiviruses are efficient tools to probe and manipulate Wnt signaling. The use of a selection cassette in Wnt-reporter viruses enables discriminating between uninfected and non-responsive cells, an important requirement for experiments where selection of clones is not possible. The use of a chemiluminescent readout enables quantification of signaling. Finally, selectable vectors can be used to either inhibit or activate the Wnt signaling pathway. Altogether, these vectors can probe and modulate the Wnt signaling pathway in experimental settings where persistence of the transgene or gene transfer cannot be accomplished by non-viral techniques.	[Fuerer, Christophe; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Fuerer, C (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu		Fuerer, Christophe/0000-0003-1717-6718	Howard Hughes Medical Institute; Swiss National Science Foundation [PA00A3-115379]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	These studies were supported by the Howard Hughes Medical Institute and by the Swiss National Science Foundation (grant PA00A3-115379 to C. Fuerer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fuerer C, 2010, DEV DYNAM, V239, P184, DOI 10.1002/dvdy.22067; Higashimoto T, 2007, GENE THER, V14, P1298, DOI 10.1038/sj.gt.3302979; Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sirven A, 2000, BLOOD, V96, P4103; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Trono D, 2002, LENTIVIRAL VECTORS; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wurtzer S, 2006, J VIROL, V80, P3679, DOI 10.1128/JVI.80.7.3679-3683.2006; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	30	195	196	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9370	10.1371/journal.pone.0009370	http://dx.doi.org/10.1371/journal.pone.0009370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186325	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924000013
J	Sun, X; Wang, X; Chen, TX; Li, TY; Cao, K; Lu, A; Chen, YX; Sun, DM; Luo, JH; Fan, JQ; Young, W; Ren, Y				Sun, Xin; Wang, Xi; Chen, Tianxiang; Li, Tianyi; Cao, Kai; Lu, Andrew; Chen, Yongxiong; Sun, Dongming; Luo, Jianhong; Fan, Jianqing; Young, Wise; Ren, Yi			Myelin Activates FAK/Akt/NF-kappa B Pathways and Provokes CR3-Dependent Inflammatory Response in Murine System	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; WALLERIAN DEGENERATION; MACROPHAGE RESPONSES; FUNCTIONAL RECOVERY; CYTOKINE SYNTHESIS; DOWN-REGULATION; PHAGOCYTOSIS; REGENERATION	Inflammatory response following central nervous system (CNS) injury contributes to progressive neuropathology and reduction in functional recovery. Axons are sensitive to mechanical injury and toxic inflammatory mediators, which may lead to demyelination. Although it is well documented that degenerated myelin triggers undesirable inflammatory responses in autoimmune diseases such as multiple sclerosis ( MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), there has been very little study of the direct inflammatory consequences of damaged myelin in spinal cord injury (SCI), i.e., there is no direct evidence to show that myelin debris from injured spinal cord can trigger undesirable inflammation in vitro and in vivo. Our data showed that myelin can initiate inflammatory responses in vivo, which is complement receptor 3 (CR3)-dependent via stimulating macrophages to express pro-inflammatory molecules and down-regulates expression of anti-inflammatory cytokines. Mechanism study revealed that myelin-increased cytokine expression is through activation of FAK/PI3K/Akt/NF-kappa B signaling pathways and CR3 contributes to myelin-induced PI3K/Akt/NF-kappa B activation and cytokine production. The myelin induced inflammatory response is myelin specific as sphingomyelin ( the major lipid of myelin) and myelin basic protein (MBP, one of the major proteins of myelin) are not able to activate NF-kappa B signaling pathway. In conclusion, our results demonstrate a crucial role of myelin as an endogenous inflammatory stimulus that induces pro-inflammatory responses and suggest that blocking myelin-CR3 interaction and enhancing myelin debris clearance may be effective interventions for treating SCI.	[Sun, Xin; Wang, Xi; Chen, Tianxiang; Li, Tianyi; Cao, Kai; Lu, Andrew; Chen, Yongxiong; Sun, Dongming; Young, Wise; Ren, Yi] Rutgers State Univ, Dept Cell Biol & Neurosci, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Sun, Xin; Luo, Jianhong] Zhejiang Univ, Sch Med, Inst Neurosci, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Jianqing] Princeton Univ, Stat Lab, Princeton, NJ 08544 USA	Rutgers State University New Brunswick; Zhejiang University; Princeton University	Sun, X (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.	ren@dls.rutgers.edu	Luo, jian/HGE-7331-2022; Fan, Jianqing/B-2115-2008		National Science Foundation [DMS-0714589]; National Institutes of Health (NIH) [R01-GM072611]; Joyce and Les Goodman scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072611] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joyce and Les Goodman scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (DMS-0714589), National Institutes of Health (NIH) (R01-GM072611) and Joyce and Les Goodman scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Campbell IL, 1998, NEUROIMMUNOMODULAT, V5, P126, DOI 10.1159/000026329; Chatzizacharias NA, 2008, TOXICOLOGY, V245, P1, DOI 10.1016/j.tox.2007.12.003; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fife BT, 2001, J IMMUNOL, V166, P7617, DOI 10.4049/jimmunol.166.12.7617; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; Halder RC, 2007, NEUROCHEM RES, V32, P257, DOI 10.1007/s11064-006-9145-4; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Harvey R Donald, 2007, Future Oncol, V3, P639, DOI 10.2217/14796694.3.6.639; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HENDRIKS JJ, 2008, J NEUROIMMUNOL; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Kanter JL, 2006, NAT MED, V12, P138, DOI 10.1038/nm1344; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Muller M, 2007, J IMMUNOL, V179, P2774, DOI 10.4049/jimmunol.179.5.2774; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pan JZ, 2002, J NEUROSCI RES, V68, P315, DOI 10.1002/jnr.10215; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Qian L, 2008, J IMMUNOL, V181, P660, DOI 10.4049/jimmunol.181.1.660; Reichert F, 1996, J NEUROIMMUNOL, V70, P153, DOI 10.1016/S0165-5728(96)00112-9; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Rubel C, 2003, EUR J IMMUNOL, V33, P1429, DOI 10.1002/eji.200323512; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Zhang H, 2003, INFLAMM RES, V52, P86, DOI 10.1007/s000110300006; [No title captured]	43	89	92	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9380	10.1371/journal.pone.0009380	http://dx.doi.org/10.1371/journal.pone.0009380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186338	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000021
J	Taylor, AH; Medina, FS; Holzhaider, JC; Hearne, LJ; Hunt, GR; Gray, RD				Taylor, Alex H.; Medina, Felipe S.; Holzhaider, Jennifer C.; Hearne, Lindsay J.; Hunt, Gavin R.; Gray, Russell D.			An Investigation into the Cognition Behind Spontaneous String Pulling in New Caledonian Crows	PLOS ONE			English	Article							BIRDS; PASSERIFORMES; MANUFACTURE; RAVENS; BRAIN; TOOLS	The ability of some bird species to pull up meat hung on a string is a famous example of spontaneous animal problem solving. The "insight'' hypothesis claims that this complex behaviour is based on cognitive abilities such as mental scenario building and imagination. An operant conditioning account, in contrast, would claim that this spontaneity is due to each action in string pulling being reinforced by the meat moving closer and remaining closer to the bird on the perch. We presented experienced and naive New Caledonian crows with a novel, visually restricted string-pulling problem that reduced the quality of visual feedback during string pulling. Experienced crows solved this problem with reduced efficiency and increased errors compared to their performance in standard string pulling. Naive crows either failed or solved the problem by trial and error learning. However, when visual feedback was available via a mirror mounted next to the apparatus, two naive crows were able to perform at the same level as the experienced group. Our results raise the possibility that spontaneous string pulling in New Caledonian crows may not be based on insight but on operant conditioning mediated by a perceptual-motor feedback cycle.	[Taylor, Alex H.; Medina, Felipe S.; Holzhaider, Jennifer C.; Hearne, Lindsay J.; Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Auckland	Taylor, AH (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	alexhtaylor@gmail.com; rd.gray@auckland.ac.nz	Gray, Russell/H-2078-2015; Taylor, Alex H/D-6428-2012	Gray, Russell/0000-0002-9858-0191; Taylor, Alex/0000-0003-3492-7667	Commonwealth Doctoral Scholarship; CONCICYT [26080006]; New Zealand Marsden Fund	Commonwealth Doctoral Scholarship; CONCICYT; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The work was supported by a Commonwealth Doctoral Scholarship (A.H.T.), CONCICYT 26080006 (F. M.) and a grant from the New Zealand Marsden Fund (G.R.H. and R.D.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN DR, 1962, AM J PSYCHOL, V75, P144, DOI 10.2307/1419554; DUCKER G, 1977, BEHAVIOUR, V62, P164, DOI 10.1163/156853977X00081; Emery Nathan J., 2004, P3; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Gibbs R., 2006, EMBODIMENT COGNITIVE; Hauser MD, 1997, COGNITION, V64, P285, DOI 10.1016/S0010-0277(97)00028-0; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Heinrich Bernd, 2000, P289; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; KIRSH D, 1994, COGNITIVE SCI, V18, P513, DOI 10.1207/s15516709cog1804_1; KOHLER W, 1959, AM PSYCHOL, V14, P727; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Perrins C., 1994, HDB BIRDS MIDDLE E N, V8; Piaget J., 1936, NAISSANCE INTELLIGEN; Plinius C., 1554, HIST MUNDI LIBRI 37, VXXXVII; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Seibt U, 2006, ETHOLOGY, V112, P493, DOI 10.1111/j.1439-0310.2005.01172.x; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor Alex, 2009, Communicative & Integrative Biology, V2, P311; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; VINCE M. A., 1961, BEHAVIOUR, V17, P103, DOI 10.1163/156853961X00033; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	29	81	81	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9345	10.1371/journal.pone.0009345	http://dx.doi.org/10.1371/journal.pone.0009345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SU	20179759	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923900011
J	Solovey, G; Dawson, SP				Solovey, Guillermo; Dawson, Silvina Ponce			Intra-Cluster Percolation of Calcium Signals	PLOS ONE			English	Article							INOSITOL TRISPHOSPHATE; IP3 RECEPTORS; CA2+ RELEASE; SINGLE; OSCILLATIONS; MODEL; PUFFS; MODULATION; DYNAMICS; BUFFERS	Calcium signals are involved in a large variety of physiological processes. Their versatility relies on the diversity of spatio-temporal behaviors that the calcium concentration can display. Calcium entry through inositol 1,4,5-trisphosphate (IP3) receptors (IP3R's) is a key component that participates in both local signals such as "puffs'' and in global waves. IP3R's are usually organized in clusters on the membrane of the endoplasmic reticulum and their spatial distribution has important effects on the resulting signal. Recent high resolution observations [1] of Ca2+ puffs offer a window to study intra-cluster organization. The experiments give the distribution of the number of IP3R's that open during each puff without much processing. Here we present a simple model with which we interpret the experimental distribution in terms of two stochastic processes: IP3 binding and unbinding and Ca2+-mediated inter-channel coupling. Depending on the parameters of the system, the distribution may be dominated by one or the other process. The transition between both extreme cases is similar to a percolation process. We show how, from an analysis of the experimental distribution, information can be obtained on the relative weight of the two processes. The largest distance over which Ca2+-mediated coupling acts and the density of IP3-bound IP3R's of the cluster can also be estimated. The approach allows us to infer properties of the interactions among the channels of the cluster from statistical information on their emergent collective behavior.	[Solovey, Guillermo; Dawson, Silvina Ponce] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires	Solovey, G (corresponding author), Rockefeller Univ, Phys Math Lab, 1230 York Ave, New York, NY 10021 USA.	gsolovey@df.uba.ar		Ponce Dawson, Silvina/0000-0001-6550-4267	Proyecto de Investigacion Cientifica y Tecnologica (PICT) [17-21001]; Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT]; Proyecto de Investigacion Plurianual (PIP) [112-200801-01612]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Proyecto de Investigacion Cientifica y Tecnologica (PICT)(ANPCyT); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Proyecto de Investigacion Plurianual (PIP); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Proyecto de Investigacion Cientifica y Tecnologica (PICT) 17-21001 granted by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, http://www.agencia.gov.ar/), and by Proyecto de Investigacion Plurianual (PIP) 112-200801-01612 granted by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) UBA (http://www.uba.ar/secyt/subsidios/index.php), Santa Fe Institute (http://www.santafe.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Bar M, 2000, PHYS REV LETT, V84, P5664, DOI 10.1103/PhysRevLett.84.5664; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; BRUNO L, 2009, CELL CALCIU IN PRESS; Bugrim AE, 1997, BIOPHYS J, V73, P2897, DOI 10.1016/S0006-3495(97)78318-8; Callamaras N, 1998, J PHYSIOL-LONDON, V509, P81, DOI 10.1111/j.1469-7793.1998.081bo.x; Dawson SP, 1999, P NATL ACAD SCI USA, V96, P6060, DOI 10.1073/pnas.96.11.6060; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Falcke M, 2003, BIOPHYS J, V84, P28, DOI 10.1016/S0006-3495(03)74830-9; Falcke M, 2003, BIOPHYS J, V84, P42, DOI 10.1016/S0006-3495(03)74831-0; Falcke M, 2009, CHAOS, V19, DOI 10.1063/1.3234259; Fraiman D, 2004, CELL CALCIUM, V35, P403, DOI 10.1016/j.ceca.2003.10.004; Fraiman D, 2006, BIOPHYS J, V90, P3897, DOI 10.1529/biophysj.105.075911; Parker I, 1996, J PHYSIOL-LONDON, V491, P663, DOI 10.1113/jphysiol.1996.sp021247; Pencea CS, 2000, PHYS REV E, V62, P8420, DOI 10.1103/PhysRevE.62.8420; Perc M, 2006, CHEM PHYS LETT, V421, P106, DOI 10.1016/j.cplett.2006.01.065; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shuai J W, 2002, Phys Rev Lett, V88, P068102; Shuai JW, 2008, BIOPHYS J, V95, P3738, DOI 10.1529/biophysj.108.137182; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; Shuai JW, 2006, BIOPHYS J, V91, P4033, DOI 10.1529/biophysj.106.088880; Shuai JW, 2003, P NATL ACAD SCI USA, V100, P506, DOI 10.1073/pnas.0236032100; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Sun XP, 1998, J PHYSIOL-LONDON, V509, P67, DOI 10.1111/j.1469-7793.1998.067bo.x; Swillens S, 1999, P NATL ACAD SCI USA, V96, P13750, DOI 10.1073/pnas.96.24.13750; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Timofeeva Y, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.062901; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538; Zeller S, 2009, BIOPHYS J, V97, P992, DOI 10.1016/j.bpj.2009.05.050	34	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8997	10.1371/journal.pone.0008997	http://dx.doi.org/10.1371/journal.pone.0008997			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174630	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700003
J	Gache, V; Waridel, P; Winter, C; Juhem, A; Schroeder, M; Shevchenko, A; Popov, AV				Gache, Vincent; Waridel, Patrice; Winter, Christof; Juhem, Aurelie; Schroeder, Michael; Shevchenko, Andrej; Popov, Andrei V.			Xenopus Meiotic Microtubule-Associated Interactome	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GENOME-WIDE ANALYSIS; MITOTIC SPINDLE; IN-VITRO; MASS-SPECTROMETRY; CELL-DIVISION; MOUSE OOCYTES; SUBCELLULAR-LOCALIZATION; INTERACTION NETWORK; BINDING PROTEINS	In metazoan oocytes the assembly of a microtubule-based spindle depends on the activity of a large number of accessory non-tubulin proteins, many of which remain unknown. In this work we isolated the microtubule-bound proteins from Xenopus eggs. Using mass spectrometry we identified 318 proteins, only 43 of which are known to bind microtubules. To integrate our results, we compiled for the first time a network of the meiotic microtubule-related interactome. The map reveals numerous interactions between spindle microtubules and the newly identified non-tubulin spindle components and highlights proteins absent from the mitotic spindle proteome. To validate newly identified spindle components, we expressed as GFP-fusions nine proteins identified by us and for first time demonstrated that Mgc68500, Loc398535, Nif3l1bp1/THOC7, LSM14A/RAP55A, TSGA14/CEP41, Mgc80361 and Mgc81475 are associated with spindles in egg extracts or in somatic cells. Furthermore, we showed that transfection of HeLa cells with siRNAs, corresponding to the human orthologue of Mgc81475 dramatically perturbs spindle formation in HeLa cells. These results show that our approach to the identification of the Xenopus microtubule-associated proteome yielded bona fide factors with a role in spindle assembly.	[Gache, Vincent; Juhem, Aurelie; Popov, Andrei V.] CEA Grenoble, INSERM, U366, DRDC CS, Grenoble, France; [Waridel, Patrice; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Winter, Christof; Schroeder, Michael] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Technische Universitat Dresden	Gache, V (corresponding author), Univ Paris 06, INSERM, Myol Grp, Inst Myol,UMR S 787, Paris, France.	andrei.popov@ujf-grenoble.fr	Schroeder, Michael/A-3040-2010; GACHE, vincent/L-1990-2019; Winter, Christof/A-1887-2011; Winter, Christof/AAF-1860-2020; GACHE, Vincent/M-9556-2015	GACHE, vincent/0000-0002-2928-791X; Winter, Christof/0000-0002-0253-9056; Winter, Christof/0000-0002-0253-9056; GACHE, Vincent/0000-0002-2928-791X	Inserm; French Research Ministry [BCM0210]; Bundesministerium fur Bildung und Forschung (BMBF) [PTJ-BIO/0313130]; National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS) [1R01GM070986-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070986] Funding Source: NIH RePORTER	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Research Ministry(Ministry of Research, France); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the group of A. P. was supported by the Avenir grant of Inserm, "Action Concertee Incitative'' (ACI) "Biologie cellulaire, moleculaire et structurale'' (BCMS) 2003 of the French Research Ministry (project BCM0210), equipment grant of the "La Ligue contre le Cancer'' (Comite de l'Isere), equipment grant "Emergence 2004'' of the Department de Rhone-Alpes and equipment grant of the "Association pour la Recherche sur le Cancer (project 7833). Work in Shevchenko lab was supported by grants PTJ-BIO/0313130 from Bundesministerium fur Bildung und Forschung (BMBF) and 1R01GM070986-01A1 from National Institute of Health, National Institute of General Medical Sciences (NIH NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Battaglia DE, 1996, HUM REPROD, V11, P2217; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; BONIFACINO JS, CURRENT PROTOCOLS CE; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Casaletto JB, 2005, J CELL BIOL, V169, P61, DOI 10.1083/jcb.200411056; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Castedo Maria, 2004, Journal de la Societe de Biologie, V198, P97; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cha BJ, 1999, J CELL SCI, V112, P4337; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Cukurcam S, 2004, MUTAT RES-GEN TOX EN, V564, P165, DOI 10.1016/j.mrgentox.2004.08.008; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Eichenmuller B, 2003, CELL MOTIL CYTOSKEL, V56, P225, DOI 10.1002/cm.10147; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Frank A, 2005, ANAL CHEM, V77, P964, DOI 10.1021/ac048788h; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; GACHE V, 2007, METHODS MOL MED MICR, P29; Gassmann R, 2005, CHROMOSOMA, V113, P385, DOI 10.1007/s00412-004-0326-0; Groen AC, 2004, CURR BIOL, V14, P1801, DOI 10.1016/j.cub.2004.10.002; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Mailhes JB, 2004, MUTAT RES-GEN TOX EN, V559, P153, DOI 10.1016/j.mrgentox.2004.01.001; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; MOREJOHN LC, 1994, PLANT CELL, V6, P1696, DOI 10.2307/3869900; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nicolaidis P, 1998, HUM REPROD, V13, P313, DOI 10.1093/humrep/13.2.313; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; RAFFERTY KA, 1969, BIOL AMPHIBIAN TUMOR, P52; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko Anna, 2003, Methods Mol Biol, V211, P221; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Simpson JC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-222; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; SLOBODA RD, 1975, P NATL ACAD SCI USA, V72, P177, DOI 10.1073/pnas.72.1.177; Spike CA, 2001, MOL CELL BIOL, V21, P4985, DOI 10.1128/MCB.21.15.4985-4995.2001; SUPRENANT KA, 1993, J CELL SCI, V104, P445; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang S, 2004, J BIOL CHEM, V279, P35958, DOI 10.1074/jbc.M313778200; Wang WH, 2006, FRONT BIOSCI-LANDMRK, V11, P620, DOI 10.2741/1822; Waridel P, 2007, PROTEOMICS, V7, P2318, DOI 10.1002/pmic.200700003; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; YOSHIDA S, 1994, MOL CELL BIOCHEM, V138, P39, DOI 10.1007/BF00928441; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	95	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9248	10.1371/journal.pone.0009248	http://dx.doi.org/10.1371/journal.pone.0009248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174651	Green Published, gold			2022-12-27	WOS:000274590600009
J	Chintagari, NR; Mishra, A; Su, LJ; Wang, Y; Ayalew, S; Hartson, SD; Liu, L				Chintagari, Narendranath Reddy; Mishra, Amarjit; Su, Lijing; Wang, Yang; Ayalew, Sahlu; Hartson, Steven D.; Liu, Lin			Vacuolar ATPase Regulates Surfactant Secretion in Rat Alveolar Type II Cells by Modulating Lamellar Body Calcium	PLOS ONE			English	Article							LUNG PHOSPHOLIPID-METABOLISM; LIPID RAFT MICRODOMAINS; RENAL TUBULAR-ACIDOSIS; H+-ATPASE; V-ATPASE; PROTEOMIC ANALYSIS; GRANULAR PNEUMOCYTES; EPITHELIAL-CELLS; INTRACELLULAR PH; PROTON PUMPS	Lung surfactant reduces surface tension and maintains the stability of alveoli. How surfactant is released from alveolar epithelial type II cells is not fully understood. Vacuolar ATPase (V-ATPase) is the enzyme responsible for pumping H(+) into lamellar bodies and is required for the processing of surfactant proteins and the packaging of surfactant lipids. However, its role in lung surfactant secretion is unknown. Proteomic analysis revealed that vacuolar ATPase (V-ATPase) dominated the alveolar type II cell lipid raft proteome. Western blotting confirmed the association of V-ATPase a1 and B1/2 subunits with lipid rafts and their enrichment in lamellar bodies. The dissipation of lamellar body pH gradient by Bafilomycin A1 (Baf A1), an inhibitor of V-ATPase, increased surfactant secretion. Baf A1-stimulated secretion was blocked by the intracellular Ca(2+) chelator, BAPTA-AM, the protein kinase C (PKC) inhibitor, staurosporine, and the Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), KN-62. Baf A1 induced Ca(2+) release from isolated lamellar bodies. Thapsigargin reduced the Baf A1-induced secretion, indicating cross-talk between lamellar body and endoplasmic reticulum Ca(2+) pools. Stimulation of type II cells with surfactant secretagogues dissipated the pH gradient across lamellar bodies and disassembled the V-ATPase complex, indicating the physiological relevance of the V-ATPase-mediated surfactant secretion. Finally, silencing of V-ATPase a1 and B2 subunits decreased stimulated surfactant secretion, indicating that these subunits were crucial for surfactant secretion. We conclude that V-ATPase regulates surfactant secretion via an increased Ca(2+) mobilization from lamellar bodies and endoplasmic reticulum, and the activation of PKC and CaMKII. Our finding revealed a previously unrealized role of V-ATPase in surfactant secretion.	[Chintagari, Narendranath Reddy; Mishra, Amarjit; Su, Lijing; Wang, Yang; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA; [Ayalew, Sahlu] Oklahoma State Univ, Dept Pathobiol, Stillwater, OK 74078 USA; [Hartson, Steven D.] Oklahoma State Univ, Dept Mol Biol & Biochem, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Chintagari, NR (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	Wang, Yang/G-4496-2014; MISHRA, AMARJIT/I-4928-2019; MISHRA, AMARJIT/D-7504-2016	Wang, Yang/0000-0002-2626-478X; MISHRA, AMARJIT/0000-0002-3777-0338; MISHRA, AMARJIT/0000-0002-3777-0338	NIH [R01 HL-052146, R01 HL-071628, R01 HL-083188]; Center for Veterinary Health Sciences, Oklahoma State University; American Heart Association [0810016Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071628, R01HL052146, R01HL083188] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Veterinary Health Sciences, Oklahoma State University; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH R01 HL-052146, R01 HL-071628 and R01 HL-083188 (LL) and a Student Seed Grant from Center for Veterinary Health Sciences, Oklahoma State University (NRC). YW was supported by a pre-doctoral fellowship from the American Heart Association (0810016Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonyo BO, 2004, BIOCHEMISTRY-US, V43, P3499, DOI 10.1021/bi036338y; Abonyo BO, 2003, AM J RESP CELL MOL, V29, P273, DOI 10.1165/rcmb.2002-0189OC; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; Berkane AA, 2007, BIOCHEM BIOPH RES CO, V355, P813, DOI 10.1016/j.bbrc.2007.02.037; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; CHANDER A, 1986, J BIOL CHEM, V261, P6126; CHANDER A, 1982, BIOCHEM J, V208, P651, DOI 10.1042/bj2080651; Chander A, 1996, BIOCHEM J, V318, P271, DOI 10.1042/bj3180271; CHANDER A, 1989, AM J PHYSIOL, V257, pL354, DOI 10.1152/ajplung.1989.257.6.L354; Chintagari NR, 2008, CELL RES, V18, P701, DOI 10.1038/cr.2008.55; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Christensen KA, 2002, J CELL SCI, V115, P599; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; ECKENHOFF RG, 1988, AM J PHYSIOL, V254, pC614, DOI 10.1152/ajpcell.1988.254.5.C614; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 1996, J LIPID RES, V37, P1057; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Galli T, 1996, J BIOL CHEM, V271, P2193, DOI 10.1074/jbc.271.4.2193; GOU D, 2004, ANNEXINS, V1, P31; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; HILDEBRAN JN, 1981, J APPL PHYSIOL, V51, P905, DOI 10.1152/jappl.1981.51.4.905; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; JONES PG, 1994, BIOCHEMISTRY-US, V33, P8180, DOI 10.1021/bi00193a003; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Li N, 2004, PROTEOMICS, V4, P3156, DOI 10.1002/pmic.200400832; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Liu L, 1999, J CELL BIOCHEM, V72, P103, DOI 10.1002/(SICI)1097-4644(19990101)72:1<103::AID-JCB11>3.0.CO;2-5; MacLellan DL, 2005, PROTEOMICS, V5, P4733, DOI 10.1002/pmic.200500044; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Morel N, 2001, J NEUROCHEM, V79, P485, DOI 10.1046/j.1471-4159.2001.00611.x; MYERS M, 1993, J BIOL CHEM, V268, P9184; Nguyen HTT, 2006, BIOCHEM BIOPH RES CO, V342, P236, DOI 10.1016/j.bbrc.2006.01.141; NICHOLAS TE, 1983, RESP PHYSIOL, V52, P69, DOI 10.1016/0034-5687(83)90137-8; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishiguchi M, 2003, NEUROCHEM INT, V42, P493, DOI 10.1016/S0197-0186(02)00139-0; NORDSTROM T, 1995, J BIOL CHEM, V270, P2203, DOI 10.1074/jbc.270.5.2203; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Razzaq TM, 2004, IMMUNOLOGY, V113, P413, DOI 10.1111/j.1365-2567.2004.01998.x; Salaun B, 2004, AM J PATHOL, V164, P861, DOI 10.1016/S0002-9440(10)63174-4; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sprenger Richard R, 2007, Methods Mol Biol, V357, P199; Strayer DS, 1999, BIOCHEM J, V344, P39, DOI 10.1042/0264-6021:3440039; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sundler R, 1997, ACTA PHYSIOL SCAND, V161, P553, DOI 10.1046/j.1365-201X.1997.00262.x; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wadsworth SJ, 1997, AM J PHYSIOL-LUNG C, V273, pL427, DOI 10.1152/ajplung.1997.273.2.L427; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Yamada H, 2001, DIABETES, V50, P1012, DOI 10.2337/diabetes.50.5.1012; Yanagida M, 2007, PROTEOMICS, V7, P2398, DOI 10.1002/pmic.200700056; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003	67	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9228	10.1371/journal.pone.0009228	http://dx.doi.org/10.1371/journal.pone.0009228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169059	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500010
J	Rinaudo, CD; Rosini, R; Galeotti, CL; Berti, F; Necchi, F; Reguzzi, V; Ghezzo, C; Telford, JL; Grandi, G; Maione, D				Rinaudo, Cira Daniela; Rosini, Roberto; Galeotti, Cesira L.; Berti, Francesco; Necchi, Francesca; Reguzzi, Valerio; Ghezzo, Claudia; Telford, John Laird; Grandi, Guido; Maione, Domenico			Specific Involvement of Pilus Type 2a in Biofilm Formation in Group B Streptococcus	PLOS ONE			English	Article							BACTERIAL BIOFILMS; CELL-ADHESION; AGALACTIAE; INFECTIONS; PYOGENES; IDENTIFICATION; COLONIZATION; PNEUMONIAE; PROTEINS; VACCINE	Streptococcus agalactiae is the primary colonizer of the anogenital mucosa of up to 30% of healthy women and can infect newborns during delivery and cause severe sepsis and meningitis. Persistent colonization usually involves the formation of biofilm and increasing evidences indicate that in pathogenic streptococci biofilm formation is mediated by pili. Recently, we have characterized pili distribution and conservation in 289 GBS clinical isolates and we have shown that GBS has three pilus types, 1, 2a and 2b encoded by three corresponding pilus islands, and that each strain carries one or two islands. Here we have investigated the capacity of these strains to form biofilms. We have found that most of the biofilm-formers carry pilus 2a, and using insertion and deletion mutants we have confirmed that pilus type 2a, but not pilus types 1 and 2b, confers biofilm-forming phenotype. We also show that deletion of the major ancillary protein of type 2a did not impair biofilm formation while the inactivation of the other ancillary protein and of the backbone protein completely abolished this phenotype. Furthermore, antibodies raised against pilus components inhibited bacterial adherence to solid surfaces, offering new strategies to prevent GBS infection by targeting bacteria during their initial attachment to host epithelial cells.	[Rinaudo, Cira Daniela; Rosini, Roberto; Galeotti, Cesira L.; Berti, Francesco; Necchi, Francesca; Reguzzi, Valerio; Ghezzo, Claudia; Telford, John Laird; Grandi, Guido; Maione, Domenico] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	Rinaudo, CD (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020	Grandi, Guido/0000-0001-9724-2185	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	Funding: This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Brodeur BR, 2000, INFECT IMMUN, V68, P5610, DOI 10.1128/IAI.68.10.5610-5618.2000; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Courtney HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004166; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Kaur H, 2009, MICROB PATHOGENESIS, V46, P321, DOI 10.1016/j.micpath.2009.04.004; Keefe GP, 1997, CAN VET J, V38, P429; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; MARRIE TJ, 1983, ARCH INTERN MED, V143, P1135, DOI 10.1001/archinte.143.6.1135; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Olson ME, 2002, CAN J VET RES, V66, P86; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; WESSELS MR, 1993, INFECT IMMUN, V61, P4760, DOI 10.1128/IAI.61.11.4760-4766.1993	43	81	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9216	10.1371/journal.pone.0009216	http://dx.doi.org/10.1371/journal.pone.0009216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169161	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474700010
J	Soubry, A; Staes, K; Parthoens, E; Noppen, S; Stove, C; Bogaert, P; van Hengel, J; van Roy, F				Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans			The Transcriptional Repressor Kaiso Localizes at the Mitotic Spindle and Is a Constituent of the Pericentriolar Material	PLOS ONE			English	Article							GAMMA-TUBULIN COMPLEXES; DNA-BINDING PROTEIN; P120 CATENIN; NUCLEAR-LOCALIZATION; CENTROSOMAL PROTEINS; MICROTUBULE-BINDING; MAMMALIAN-CELLS; PARTNER KAISO; P120(CTN); ORGANIZATION	Kaiso is a BTB/POZ zinc finger protein known as a transcriptional repressor. It was originally identified through its in vitro association with the Armadillo protein p120ctn. Subcellular localization of Kaiso in cell lines and in normal and cancerous human tissues revealed that its expression is not restricted to the nucleus. In the present study we monitored Kaiso's subcellular localization during the cell cycle and found the following: (1) during interphase, Kaiso is located not only in the nucleus, but also on microtubular structures, including the centrosome; (2) at metaphase, it is present at the centrosomes and on the spindle microtubules; (3) during telophase, it accumulates at the midbody. We found that Kaiso is a genuine PCM component that belongs to a pericentrin molecular complex. We analyzed the functions of different domains of Kaiso by visualizing the subcellular distribution of GFP-tagged Kaiso fragments throughout the cell cycle. Our results indicate that two domains are responsible for targeting Kaiso to the centrosomes and microtubules. The first domain, designated SA1 for spindle-associated domain 1, is located in the center of the Kaiso protein and localizes at the spindle microtubules and centrosomes; the second domain, SA2, is an evolutionarily conserved domain situated just before the zinc finger domain and might be responsible for localizing Kaiso towards the centrosomal region. Constructs containing both SA domains and Kaiso's aminoterminal BTB/POZ domain triggered the formation of abnormal centrosomes. We also observed that overexpression of longer or full-length Kaiso constructs led to mitotic cell arrest and frequent cell death. Knockdown of Kaiso accelerated cell proliferation. Our data reveal a new target for Kaiso at the centrosomes and spindle microtubules during mitosis. They also strongly imply that Kaiso's function as a transcriptional regulator might be linked to the control of the cell cycle and to cell proliferation in cancer.	[Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Soubry, Adelheid; Staes, Katrien; Parthoens, Eef; Noppen, Sam; Stove, Christophe; Bogaert, Pieter; van Hengel, Jolanda; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Soubry, A (corresponding author), Duke Univ, Dept Cell Biol, Durham, NC 27710 USA.	F.Vanroy@dmbr.VIB-UGent.be	Noppen, Sam/F-8681-2018; van Roy, Frans M/C-6123-2009; Stove, Christophe/B-6057-2008	Noppen, Sam/0000-0002-2831-5042; van Roy, Frans M/0000-0003-4358-1039; Stove, Christophe/0000-0001-7126-348X	Ghent University [BOF09/01M00709]; Belgian Federation against Cancer - Stichting tegen Kanker; Research Foundation Flanders (FWO)	Ghent University(Ghent University); Belgian Federation against Cancer - Stichting tegen Kanker; Research Foundation Flanders (FWO)(FWO)	Funding: This project was supported by a Special Research Grant (BOF: Bijzonder Onderzoeksfonds) from Ghent University (http://www.ugent.be/en/research/opportunities), a Ghent University Methusalem (BOF09/01M00709) grant (http://www.ugent.be/en/news/bulletin/methusalem.htm/), a research grant from the Belgian Federation against Cancer - Stichting tegen Kanker (http://www.kanker.be/), and a research grant from the Research Foundation Flanders (FWO; http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Caballero IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004315; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; DAI SD, 2009, LUNG CANC; Dai SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-178; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Defossez PA, 2005, J BIOL CHEM, V280, P43017, DOI 10.1074/jbc.M510802200; DELAVAL B, 2009, J CELL BIOL; Dionne MA, 1999, CELL MOTIL CYTOSKEL, V42, P189, DOI 10.1002/(SICI)1097-0169(1999)42:3<189::AID-CM3>3.0.CO;2-X; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Fant X, 2004, INT REV CYTOL, V238, P1, DOI 10.1016/S0074-7696(04)38001-0; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gunawardane RN, 2000, CURR TOP DEV BIOL, V49, P55; JULIAN M, 1993, J CELL SCI, V105, P145; Kantidze OL, 2009, CELL CYCLE, V8, P2303, DOI 10.4161/cc.8.14.8944; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Keryer G, 2003, MOL BIOL CELL, V14, P4260, DOI 10.1091/mbc.E02-11-0773; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Lopes EC, 2008, CANCER RES, V68, P7258, DOI 10.1158/0008-5472.CAN-08-0344; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; OEGEMA K, 1995, J CELL BIOL, V131, P1261, DOI 10.1083/jcb.131.5.1261; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Prokhortchouk A, 2006, MOL CELL BIOL, V26, P199, DOI 10.1128/MCB.26.1.199-208.2006; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; Ruzov A, 2009, DEVELOPMENT, V136, P723, DOI 10.1242/dev.025577; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Schatten H, 2008, HISTOCHEM CELL BIOL, V129, P667, DOI 10.1007/s00418-008-0427-6; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; TOBEY RA, 1972, EXP CELL RES, V75, P460, DOI 10.1016/0014-4827(72)90453-3; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; van Hengel J, 2007, BBA-MOL CELL RES, V1773, P78, DOI 10.1016/j.bbamcr.2006.08.033; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WHITFIELD WGF, 1995, J CELL SCI, V108, P3377; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang ZH, 1997, J CELL BIOL, V137, P657, DOI 10.1083/jcb.137.3.657; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhang R, 2004, EXP CELL RES, V294, P86, DOI 10.1016/j.yexcr.2003.11.015; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	68	21	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9203	10.1371/journal.pone.0009203	http://dx.doi.org/10.1371/journal.pone.0009203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169156	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474700006
J	Negi, VD; Nagarajan, AG; Chakravortty, D				Negi, Vidya Devi; Nagarajan, Arvindhan G.; Chakravortty, Dipshikha			A Safe Vaccine (DV-STM-07) against Salmonella Infection Prevents Abortion and Confers Protective Immunity to the Pregnant and New Born Mice	PLOS ONE			English	Article							AMNIOTIC-FLUID; POLYSACCHARIDE VACCINE; TYPHIMURIUM INFECTION; IFN-GAMMA; RESISTANCE; CYTOKINES; TYPHI; EXPRESSION; RESPONSES; TH1	Pregnancy is a transient immuno-compromised condition which has evolved to avoid the immune rejection of the fetus by the maternal immune system. The altered immune response of the pregnant female leads to increased susceptibility to invading pathogens, resulting in abortion and congenital defects of the fetus and a subnormal response to vaccination. Active vaccination during pregnancy may lead to abortion induced by heightened cell mediated immune response. In this study, we have administered the highly attenuated vaccine strain delta pmrG-HM-D (DV-STM-07) in female mice before the onset of pregnancy and followed the immune reaction against challenge with virulent S. Typhimurium in pregnant mice. Here we demonstrate that DV-STM-07 vaccine gives protection against Salmonella in pregnant mice and also prevents Salmonella induced abortion. This protection is conferred by directing the immune response towards Th2 activation and Th1 suppression. The low Th1 response prevents abortion. The use of live attenuated vaccine just before pregnancy carries the risk of transmission to the fetus. We have shown that this vaccine is safe as the vaccine strain is quickly eliminated from the mother and is not transmitted to the fetus. This vaccine also confers immunity to the new born mice of vaccinated mothers. Since there is no evidence of the vaccine candidate reaching the new born mice, we hypothesize that it may be due to trans-colostral transfer of protective anti-Salmonella antibodies. These results suggest that our vaccine DV-STM-07 can be very useful in preventing abortion in the pregnant individuals and confer immunity to the new born. Since there are no such vaccine candidates which can be given to the new born and to the pregnant women, this vaccine holds a very bright future to combat Salmonella induced pregnancy loss.	[Negi, Vidya Devi] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Dept Microbiol & Cell Biol, Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Negi, VD (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	chakravortty, dipshikha/A-9492-2009; Chakravortty, Dipshikha/AAI-4448-2020; Negi, Vidya Devi/AAY-6756-2021	Negi, Vidya Devi/0000-0001-6835-556X; Chakravortty, Dipshikha/0000-0002-7838-5145	ICMR (Center for Advanced Study in Molecular Medicine); DST (FIST); UGC; Director of Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology [DBT 197, DBT 172]; Council of Scientific and Industrial Research (CSIR)	ICMR (Center for Advanced Study in Molecular Medicine)(Indian Council of Medical Research (ICMR)); DST (FIST)(Department of Science & Technology (India)); UGC(University Grants Commission, India); Director of Indian Institute of Science, Bangalore, India; Department of Biotechnology; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. The authors would also like to thank the Central Animal Facility (CAF) for providing the mice. This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172) to D. C. V. D. N. acknowledges the Council of Scientific and Industrial Research (CSIR) for fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Arya SC, 1999, VACCINE, V17, P1015; Arya SC, 1997, VACCINE, V15, P244, DOI 10.1016/S0264-410X(96)00168-5; Ashkar AA, 1999, BIOL REPROD, V61, P493, DOI 10.1095/biolreprod61.2.493; AWADALLA SG, 1985, OBSTET GYNECOL, V65, pS30; Bennett W A, 1997, Early Pregnancy, V3, P190; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Clark RG, 2007, NEW ZEAL VET J, V55, P356, DOI 10.1080/00480169.2007.36794; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; DALAKER K, 1988, ACTA OBSTET GYN SCAN, V67, P185, DOI 10.3109/00016348809004197; Daniel Y, 1998, AM J REPROD IMMUNOL, V39, P376; Dietz HH, 2006, CAN VET J, V47, P1201; Dubinsky V, 2008, AM J REPROD IMMUNOL, V60, P197, DOI 10.1111/j.1600-0897.2008.00614.x; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; GORHAM JR, 1949, AM J VET RES, V10, P183; HASHIMOTO Y, 1991, FEMS MICROBIOL LETT, V90, P53, DOI 10.1016/0378-1097(91)90645-Q; HILL JA, 1995, JAMA-J AM MED ASSOC, V273, P1933, DOI 10.1001/jama.273.24.1933; HINTON M, 1973, J HYG-CAMBRIDGE, V71, P459, DOI 10.1017/S0022172400046441; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; Kaaja RJ, 2005, JAMA-J AM MED ASSOC, V294, P2751, DOI 10.1001/jama.294.21.2751; KENT ASH, 1994, J REPROD FERTIL, V100, P81; KILLAR LM, 1985, INFECT IMMUN, V47, P605, DOI 10.1128/IAI.47.3.605-612.1985; Krishnan L, 1996, J IMMUNOL, V156, P644; LUFT BJ, 1982, INFECT IMMUN, V38, P1164, DOI 10.1128/IAI.38.3.1164-1171.1982; Luque I, 2009, VET MICROBIOL, V134, P396, DOI 10.1016/j.vetmic.2008.08.015; Madic J, 1997, EQUINE VET J, V29, P230, DOI 10.1111/j.2042-3306.1997.tb01674.x; MASTROENI PSC, 2000, J IMMUNOL, V15, P1648; MENON R, 1995, AM J OBSTET GYNECOL, V172, P493, DOI 10.1016/0002-9378(95)90562-6; Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648; Mizuno Y, 2003, CLIN EXP IMMUNOL, V131, P111, DOI 10.1046/j.1365-2249.2003.02060.x; Mukkur TKS, 1998, COMP IMMUNOL MICROB, V21, P327, DOI 10.1016/S0147-9571(97)00021-0; Nahum R, 2004, HUM REPROD, V19, P715, DOI 10.1093/humrep/deh099; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Negi VD, 2007, VACCINE, V25, P5315, DOI 10.1016/j.vaccine.2007.05.015; Orsi NA, 2007, J REPROD IMMUNOL, V75, P97, DOI 10.1016/j.jri.2007.03.002; Pejcic-Karapetrovic B, 2007, J IMMUNOL, V179, P6088, DOI 10.4049/jimmunol.179.9.6088; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; ROBBINS JD, 1984, J INFECT DIS, V150, P436, DOI 10.1093/infdis/150.3.436; SALERNOGONCALVE.RP, 2002, J IMMUNOL, V169; SALERNOGONCALVE.RW, 2003, J IMMUNOL; Salzman NH, 2003, INFECT IMMUN, V71, P1109, DOI 10.1128/IAI.71.3.1109-1115.2003; SILVER RM, 1993, AM J OBSTET GYNECOL, V169, P1101, DOI 10.1016/0002-9378(93)90263-I; Sin JI, 1998, EUR J IMMUNOL, V28, P3530, DOI 10.1002/(SICI)1521-4141(199811)28:11<3530::AID-IMMU3530>3.0.CO;2-C; STOCKER BAD, 1982, DEV BIOLOGICALS, V53, P47; THOMAS GW, 1993, IMMUNOL TODAY, V14, P353; Veith GL, 1999, GYNECOL OBSTET INVES, V48, P163, DOI 10.1159/000010165; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	49	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9139	10.1371/journal.pone.0009139	http://dx.doi.org/10.1371/journal.pone.0009139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161765	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442700005
J	Jimenez, RH; Lee, JS; Francesconi, M; Castellani, G; Neretti, N; Sanders, JA; Sedivy, J; Gruppuso, PA				Jimenez, Rosa H.; Lee, Ju-Seog; Francesconi, Mirko; Castellani, Gastone; Neretti, Nicola; Sanders, Jennifer A.; Sedivy, John; Gruppuso, Philip A.			Regulation of Gene Expression in Hepatic Cells by the Mammalian Target of Rapamycin (mTOR)	PLOS ONE			English	Article							C-MYC; IMMUNOGLOBULIN ENHANCER; RAT-LIVER; GROWTH; TOR; TRANSCRIPTION; NUTRIENT; CYCLE; IDENTIFICATION; COMPLEXES	Background: We investigated mTOR regulation of gene expression by studying rapamycin effect in two hepatic cell lines, the non-tumorigenic WB-F344 cells and the tumorigenic WB311 cells. The latter are resistant to the growth inhibitory effects of rapamycin, thus providing us with an opportunity to study the gene expression effects of rapamycin without confounding effects on cell proliferation. Methodology/Principal Findings: The hepatic cells were exposed to rapamycin for 24 hr. Microarray analysis on total RNA preparations identified genes that were affected by rapamycin in both cell lines and, therefore, modulated independent of growth arrest. Further studies showed that the promoter regions of these genes included E-box-containing transcription factor binding sites at higher than expected rates. Based on this, we tested the hypothesis that c-Myc is involved in regulation of gene expression by mTOR by comparing genes altered by rapamycin in the hepatic cells and by c-Myc induction in fibroblasts engineered to express c-myc in an inducible manner. Results showed enrichment for c-Myc targets among rapamycin sensitive genes in both hepatic cell lines. However, microarray analyses on wild type and c-myc null fibroblasts showed similar rapamycin effect, with the set of rapamycin-sensitive genes being enriched for c-Myc targets in both cases. Conclusions/Significance: There is considerable overlap in the regulation of gene expression by mTOR and c-Myc. However, regulation of gene expression through mTOR is c-Myc-independent and cannot be attributed to the involvement of specific transcription factors regulated by the rapamycin-sensitive mTOR Complex 1.	[Jimenez, Rosa H.; Sanders, Jennifer A.; Gruppuso, Philip A.] Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Francesconi, Mirko; Castellani, Gastone] Univ Bologna, Interdepartmental Ctr L Galvani, Bologna, Italy; [Neretti, Nicola] Brown Univ, Inst Brain & Neural Syst, Providence, RI 02912 USA; [Neretti, Nicola; Sedivy, John] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Neretti, Nicola; Sedivy, John] Brown Univ, Ctr Genom & Prote, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Bologna; Brown University; Brown University; Brown University	Gruppuso, PA (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Philip_Gruppuso@brown.edu	Lee, Ju-Seog/X-1786-2018; francesconi, mirko/O-8080-2015; Castellani, Gastone c/L-3333-2017	Lee, Ju-Seog/0000-0002-5666-9753; francesconi, mirko/0000-0002-8702-0877; Castellani, Gastone c/0000-0003-4892-925X; Sanders, Jennifer/0000-0002-4714-5114; Neretti, Nicola/0000-0002-9552-1663	National Research Service Award (NRSA) [F31HD041893]; National Institutes of Health [R01HD024455, R01HD035831]; Ministry of Science and Technology in Korea [1R01AG035328, K25AG028753, P20RR017695]; National Institute of Nuclear Physics (INFN); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035831, F31HD041893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG028753, R01AG035328] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology in Korea(Ministry of Science & Technology (MOST), Republic of Korea); National Institute of Nuclear Physics (INFN)(Istituto Nazionale di Fisica Nucleare (INFN)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.H.J. is supported by National Research Service Award (NRSA) grant F31HD041893. Additional support was provided by National Institutes of Health grants R01HD024455 and R01HD035831 (to P. G.), 1R01AG035328 (to J. S.), K25AG028753 (to N. N.) and P20RR017695 to J. A. S. J.-S. Lee is supported by FG-4-2 of the 21C Frontier Functional Human Genome Project from the Ministry of Science and Technology in Korea. G. Castellani is supported by grants from the National Institute of Nuclear Physics (INFN) in support of the SHEILA and EXCALIBUR projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001; James MJ, 2004, J BIOL CHEM, V279, P8911, DOI 10.1074/jbc.M307735200; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; LEE LW, 1989, AM J PATHOL, V135, P63; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Morrish F, 2008, CELL CYCLE, V7, P1054, DOI 10.4161/cc.7.8.5739; Murooka TT, 2009, BIOCHEM BIOPH RES CO, V387, P381, DOI 10.1016/j.bbrc.2009.07.035; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; PROUTY SM, 1993, ONCOGENE, V8, P899; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ravitz MJ, 2007, CANCER RES, V67, P11209, DOI 10.1158/0008-5472.CAN-06-4351; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sanders JA, 2006, AM J PHYSIOL-GASTR L, V290, pG145, DOI 10.1152/ajpgi.00545.2004; Schmidt EV, 2009, CELL CYCLE, V8, P1344, DOI 10.4161/cc.8.9.8215; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Veerla S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-384; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102	45	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9084	10.1371/journal.pone.0009084	http://dx.doi.org/10.1371/journal.pone.0009084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140209	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400020
J	Leliveld, LMC; Scheumann, M; Zimmermann, E				Leliveld, Lisette M. C.; Scheumann, Marina; Zimmermann, Elke			Effects of Caller Characteristics on Auditory Laterality in an Early Primate (Microcebus murinus)	PLOS ONE			English	Article							HEMISPHERIC-SPECIALIZATION; CONSPECIFIC VOCALIZATIONS; ORIENTING ASYMMETRIES; JAPANESE MACAQUES; NEURAL LATERALIZATION; SOCIAL RECOGNITION; RHESUS-MONKEYS; ADVANTAGE; CORTEX; DISCRIMINATION	Background: Auditory laterality is suggested to be characterized by a left hemisphere dominance for the processing of conspecific communication. Nevertheless, there are indications that auditory laterality can also be affected by communicative significance, emotional valence and social recognition. Methodology/Principal Findings: In order to gain insight into the effects of caller characteristics on auditory laterality in the early primate brain, 17 gray mouse lemurs were tested in a head turn paradigm. The head turn paradigm was established to examine potential functional hemispheric asymmetries on the behavioral level. Subjects were presented with playbacks of two conspecific call types (tsak calls and trill calls) from senders differing in familiarity (unfamiliar vs. familiar) and sex (same sex vs. other sex). Based on the head turn direction towards these calls, evidence was found for a right ear/left hemisphere dominance for the processing of calls of the other sex (Binomial test: p = 0.021, N = 10). Familiarity had no effect on the orientation biases. Conclusions/Significance: The findings in this study support the growing consensus that auditory laterality is not only determined by the acoustic processing of conspecific communication, but also by other factors like the sex of the sender.	[Leliveld, Lisette M. C.; Scheumann, Marina; Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Leliveld, Lisette M. C.; Zimmermann, Elke] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Leliveld, LMC (corresponding author), Univ Vet Med Hannover, Inst Zool, Hannover, Germany.	Lisette.Maria.Charlotte.Leliveld@tiho-hannover.de		Leliveld, Lisette/0000-0002-1299-0748; Scheumann, Marina/0000-0002-4091-9500	European Commission [MEST-CT-2005-021014]; German Research Foundation [FOR 499, GK 289]	European Commission(European CommissionEuropean Commission Joint Research Centre); German Research Foundation(German Research Foundation (DFG))	This work was supported by the European Commission, Community's Sixth Framework Programme, Marie Curie Fellowship for Early Stage Research Training under contract no. MEST-CT-2005-021014, and by the German Research Foundation (DFG; FOR 499 and GK 289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2002, NEUROPSYCHOLOGIA, V40, P2242, DOI 10.1016/S0028-3932(02)00107-0; Basile M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006295; Basile M, 2009, ANIM COGN, V12, P611, DOI 10.1007/s10071-009-0220-5; BEECHER MD, 1979, BRAIN BEHAV EVOLUT, V16, P443, DOI 10.1159/000121881; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Bethmann A, 2007, BRAIN RES, V1133, P145, DOI 10.1016/j.brainres.2006.11.057; Bisazza A, 1998, BEHAV BRAIN RES, V91, P157, DOI 10.1016/S0166-4328(97)00114-9; Boye M, 2005, EUR J NEUROSCI, V21, P1727, DOI 10.1111/j.1460-9568.2005.04005.x; Brudzynski SM, 2009, HDB MAMMALIAN VOCALI, P215; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1372, DOI 10.1073/pnas.89.4.1372; Deng C, 2002, ANIM BEHAV, V63, P697, DOI 10.1006/anbe.2001.1942; EcklundFlores L, 1996, DEV PSYCHOBIOL, V29, P205, DOI 10.1002/(SICI)1098-2302(199604)29:3<205::AID-DEV2>3.0.CO;2-V; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; George I, 2004, BEHAV NEUROSCI, V118, P597, DOI 10.1037/0735-7044.118.3.597; Ghazanfar AA, 1999, TRENDS COGN SCI, V3, P377, DOI 10.1016/S1364-6613(99)01379-0; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Gil-da-Costa R, 2006, P ROY SOC B-BIOL SCI, V273, P2313, DOI 10.1098/rspb.2006.3580; Hauser MD, 1998, ANIM BEHAV, V56, P41, DOI 10.1006/anbe.1998.0738; HAUSER MD, 1994, P NATL ACAD SCI USA, V91, P3946, DOI 10.1073/pnas.91.9.3946; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; LANDIS T, 1982, NEUROPSYCHOLOGIA, V20, P501, DOI 10.1016/0028-3932(82)90049-5; LELIVELD LMC, ACOUSTIC CORRE UNPUB; Lonsdorf EV, 2005, P NATL ACAD SCI USA, V102, P12634, DOI 10.1073/pnas.0505806102; MARTIN RD, 1972, BEHAV ECOLOGY NOCTUR, P43; Palleroni A, 2003, SCIENCE, V299, P1195, DOI 10.1126/science.1078813; Peirce JW, 2000, NEUROPSYCHOLOGIA, V38, P475, DOI 10.1016/S0028-3932(99)00088-3; PETERSEN MR, 1984, BEHAV NEUROSCI, V98, P779, DOI 10.1037/0735-7044.98.5.779; PETERSEN MR, 1978, SCIENCE, V202, P324, DOI 10.1126/science.99817; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Pulvermuller F, 2001, NEUROIMAGE, V14, P607, DOI 10.1006/nimg.2001.0864; Rukstalis M, 2005, HORM BEHAV, V47, P1, DOI 10.1016/j.yhbeh.2004.09.004; Scheumann M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-3; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Sproul C, 2006, ANIM BEHAV, V72, P1379, DOI 10.1016/j.anbehav.2006.04.006; Teufel C, 2007, ANIM BEHAV, V73, P249, DOI 10.1016/j.anbehav.2006.04.011; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1; VANLANCKER D, 1987, NEUROPSYCHOLOGIA, V25, P829, DOI 10.1016/0028-3932(87)90120-5; Ventolini N, 2005, ANIM BEHAV, V69, P1077, DOI 10.1016/j.anbehav.2004.09.003; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Wrogemann D, 2001, INT J PRIMATOL, V22, P91, DOI 10.1023/A:1026418132281; Yasin I, 2007, NEUROPSYCHOLOGIA, V45, P2718, DOI 10.1016/j.neuropsychologia.2007.04.009; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zucca P, 2008, CORTEX, V44, P13, DOI 10.1016/j.cortex.2006.01.002	45	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9031	10.1371/journal.pone.0009031	http://dx.doi.org/10.1371/journal.pone.0009031			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140257	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200017
J	Wanders, AJ; Brouwer, IA; Siebelink, E; Katan, MB				Wanders, Anne J.; Brouwer, Ingeborg A.; Siebelink, Els; Katan, Martijn B.			Effect of a High Intake of Conjugated Linoleic Acid on Lipoprotein Levels in Healthy Human Subjects	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; CORONARY HEART-DISEASE; MIDDLE-AGED MEN; BODY-COMPOSITION; CARDIOVASCULAR-DISEASE; LIPID-METABOLISM; HDL CHOLESTEROL; BLOOD-LIPIDS; HIGH-DENSITY; SUPPLEMENTATION	Background: Trans fatty acids are produced either by industrial hydrogenation or by biohydrogenation in the rumens of cows and sheep. Industrial trans fatty acids lower high-density lipoprotein (HDL) cholesterol, raise low-density lipoprotein (LDL) cholesterol, and increase the risk of coronary heart disease. The effects of trans fatty acids from ruminants are less clear. We investigated the effect on blood lipids of cis-9, trans-11 conjugated linoleic acid (CLA), a trans fatty acid largely restricted to ruminant fats. Methodology/Principal Findings: Sixty-one healthy women and men were sequentially fed each of three diets for three weeks, in random order, for a total of nine weeks. Diets were identical except for 7% of energy (approximately 20 g/day), which was provided either by oleic acid, by industrial trans fatty acids, or by a mixture of 80% cis-9, trans-11 and 20% trans-10, cis-12 CLA. After the oleic acid diet, mean (+/- SD) serum LDL cholesterol was 2.68 +/- 0.62 mmol/L compared to 3.00 +/- 0.66 mmol/L after industrial trans fatty acids (p < 0.001), and 2.92 +/- 0.70 mmol/L after CLA (p < 0.001). Compared to oleic acid, HDL-cholesterol was 0.05 +/- 0.12 mmol/L lower after industrial trans fatty acids (p = 0.001) and 0.06 +/- 0.10 mmol/L lower after CLA (p < 0.001). The total-to-HDL cholesterol ratio was 11.6% higher after industrial trans fatty acids (p < 0.001) and 10.0% higher after CLA (p < 0.001) relative to the oleic acid diet. Conclusions/Significance: High intakes of an 80:20 mixture of cis-9, trans-11 and trans-10, cis-12 CLA raise the total to HDL cholesterol ratio in healthy volunteers. The effect of CLA may be somewhat less than that of industrial trans fatty acids.	[Wanders, Anne J.; Brouwer, Ingeborg A.; Katan, Martijn B.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Wanders, Anne J.; Brouwer, Ingeborg A.; Katan, Martijn B.] Vrije Univ Amsterdam, EMGO Inst Hlth Care Res, Amsterdam, Netherlands; [Wanders, Anne J.; Brouwer, Ingeborg A.; Siebelink, Els] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research	Wanders, AJ (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	Ingeborg.Brouwer@falw.vu.nl	Katan, Martijn/ABB-6613-2021	Brouwer, Ingeborg/0000-0002-8762-382X	Netherlands Heart Foundation [2006B176]; Foundation for Nutrition and Health Research; Royal Netherlands Academy of Arts and Sciences	Netherlands Heart Foundation(Netherlands Heart Foundation); Foundation for Nutrition and Health Research; Royal Netherlands Academy of Arts and Sciences	This study was supported by the Netherlands Heart Foundation ( grant # 2006B176), the Foundation for Nutrition and Health Research, and the Royal Netherlands Academy of Arts and Sciences. The Conjugated Linoleic Acid oil was sponsored by Lipid Nutrition, and the margarine hardstock was sponsored by Unilever Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbones-Mainar JM, 2006, ATHEROSCLEROSIS, V189, P318, DOI 10.1016/j.atherosclerosis.2006.01.015; ASCHERIO A, 1994, CIRCULATION, V89, P94, DOI 10.1161/01.CIR.89.1.94; Benito P, 2001, LIPIDS, V36, P229, DOI 10.1007/s11745-001-0712-x; Berven G, 2000, EUR J LIPID SCI TECH, V102, P455, DOI 10.1002/1438-9312(200008)102:7<455::AID-EJLT455>3.3.CO;2-M; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; BRUSSAARD JH, 1982, ATHEROSCLEROSIS, V42, P205, DOI 10.1016/0021-9150(82)90151-4; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; de Roos NM, 2001, ARTERIOSCL THROM VAS, V21, P1233, DOI 10.1161/hq0701.092161; Desroches S, 2005, AM J CLIN NUTR, V82, P309, DOI 10.1093/ajcn/82.2.309; Elgersma A, 2006, ANIM FEED SCI TECH, V131, P207, DOI 10.1016/j.anifeedsci.2006.06.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fritsche J, 1998, Z LEBENSM UNTERS F A, V206, P77, DOI 10.1007/s002170050218; Gaullier JM, 2007, BRIT J NUTR, V97, P550, DOI 10.1017/S0007114507381324; GLATZ JFC, 1989, AM J CLIN NUTR, V49, P269, DOI 10.1093/ajcn/49.2.269; HIEMSTRA G, 2005, NED TTIJDSCHR DIETI, V60, P88; Iwata Toshio, 2007, J Oleo Sci, V56, P517; Laloux L, 2007, EUR J LIPID SCI TECH, V109, P918, DOI 10.1002/ejlt.200600278; Lambert EV, 2007, BRIT J NUTR, V97, P1001, DOI 10.1017/S0007114507172822; LeDoux M, 2007, LIPIDS, V42, P135, DOI 10.1007/s11745-007-3023-y; Lock AL, 2004, LIPIDS, V39, P1197, DOI 10.1007/s11745-004-1348-6; MENSINK RP, 1987, LANCET, V1, P122, DOI 10.1016/S0140-6736(87)91965-9; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Mitchell PL, 2008, BIOCHEM CELL BIOL, V86, P293, DOI [10.1139/O08-070, 10.1139/o08-070]; Mitchikpe ECS, 2008, J FOOD COMPOS ANAL, V21, P17, DOI 10.1016/j.jfca.2007.06.006; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Naumann E, 2006, ATHEROSCLEROSIS, V188, P167, DOI 10.1016/j.atherosclerosis.2005.10.019; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Oomen CM, 2001, LANCET, V357, P746, DOI 10.1016/S0140-6736(00)04166-0; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; Riserus U, 2001, INT J OBESITY, V25, P1129, DOI 10.1038/sj.ijo.0801659; Salas-Salvado J, 2006, CRIT REV FOOD SCI, V46, P479, DOI 10.1080/10408390600723953; Smedman A, 2001, LIPIDS, V36, P773, DOI 10.1007/s11745-001-0784-7; Steck SE, 2007, J NUTR, V137, P1188, DOI 10.1093/jn/137.5.1188; Tricon S, 2006, AM J CLIN NUTR, V83, P744, DOI 10.1093/ajcn/83.4.744; Tricon S, 2004, AM J CLIN NUTR, V80, P614; Turpeinen AM, 2002, AM J CLIN NUTR, V76, P504, DOI 10.1093/ajcn/76.3.504; Urgert R, 1997, ANNU REV NUTR, V17, P305, DOI 10.1146/annurev.nutr.17.1.305; WANDERS AJ, 2009, FOOD CHEM T IN PRESS; Weggemans RM, 1999, EUR J CLIN INVEST, V29, P827; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; WOLFINGER R, 1993, COMMUN STAT-SIMUL C, V22, P1079, DOI 10.1080/03610919308813143	45	56	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9000	10.1371/journal.pone.0009000	http://dx.doi.org/10.1371/journal.pone.0009000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140250	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200004
J	Losina, E; Bassett, IV; Giddy, J; Chetty, S; Regan, S; Walensky, RP; Ross, D; Scott, CA; Uhler, LM; Katz, JN; Holst, H; Freedberg, KA				Losina, Elena; Bassett, Ingrid V.; Giddy, Janet; Chetty, Senica; Regan, Susan; Walensky, Rochelle P.; Ross, Douglas; Scott, Callie A.; Uhler, Lauren M.; Katz, Jeffrey N.; Holst, Helga; Freedberg, Kenneth A.			The "ART" of Linkage: Pre-Treatment Loss to Care after HIV Diagnosis at Two PEPFAR Sites in Durban, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; OUTCOMES; MORTALITY; PROGRAM; DISTRICT; SERVICE; MALAWI; KENYA	Background: Although loss to follow-up after antiretroviral therapy (ART) initiation is increasingly recognized, little is known about pre-treatment losses to care (PTLC) after an initial positive HIV test. Our objective was to determine PTLC in newly identified HIV-infected individuals in South Africa. Methodology/Principal Findings: We assembled the South African Test, Identify and Link (STIAL) Cohort of persons presenting for HIV testing at two sites offering HIV and CD4 count testing and HIV care in Durban, South Africa. We defined PTLC as failure to have a CD4 count within 8 weeks of HIV diagnosis. We performed multivariate analysis to identify factors associated with PTLC. From November 2006 to May 2007, of 712 persons who underwent HIV testing and received their test result, 454 (64%) were HIV-positive. Of those, 206 (45%) had PTLC. Infected patients were significantly more likely to have PTLC if they lived >= 10 kilometers from the testing center (RR = 1.37; 95% CI: 1.11-1.71), had a history of tuberculosis treatment (RR = 1.26; 95% CI: 1.00-1.58), or were referred for testing by a health care provider rather than self-referred (RR = 1.61; 95% CI: 1.22-2.13). Patients with one, two or three of these risks for PTLC were 1.88, 2.50 and 3.84 times more likely to have PTLC compared to those with no risk factors. Conclusions/Significance: Nearly half of HIV-infected persons at two high prevalence sites in Durban, South Africa, failed to have CD4 counts following HIV diagnosis. These high rates of pre-treatment loss to care highlight the urgent need to improve rates of linkage to HIV care after an initial positive HIV test.	[Losina, Elena; Bassett, Ingrid V.; Regan, Susan; Walensky, Rochelle P.; Scott, Callie A.; Uhler, Lauren M.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bassett, Ingrid V.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Losina, Elena; Bassett, Ingrid V.; Regan, Susan; Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Walensky, Rochelle P.; Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Walensky, Rochelle P.; Katz, Jeffrey N.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Giddy, Janet; Chetty, Senica; Holst, Helga] McCord Hosp, Dept Med, Durban, South Africa; [Ross, Douglas] St Marys Hosp, Dept Med, Durban, South Africa	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Losina, E (corresponding author), Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA.	elosina@partners.org	Bassett, Ingrid V./ABI-7674-2020	Bassett, Ingrid V./0000-0001-6920-6080; Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X; Regan, Susan/0000-0003-0940-2017	US National Institute of Allergy and Infectious Diseases [R01 AI058736, K24 AI062476, K23 AI068458]; Harvard University Center for AIDS Research [P30 AI42851]; National Institutes of Health [K24 AR 02123]; Doris Duke Charitable Foundation; Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K24AI062476, K23AI068458, P30AI060354, P30AI042851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002123] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard University Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Harvard University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the US National Institute of Allergy and Infectious Diseases (R01 AI058736, K24 AI062476, K23 AI068458), the Harvard University Center for AIDS Research P30 AI42851, National Institutes of Health K24 AR 02123, the Doris Duke Charitable Foundation (Clinical Scientist Development Award), and the Harvard University Program on AIDS (HUPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; *DEP HLTH, 2007, HIV AIDS STI STRAT P, P2007; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Krebs DW, 2008, AIDS CARE, V20, P311, DOI 10.1080/09540120701594776; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; MICEK MA, 2009, J ACQUIR IMMUNE DEFI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *UNAIDS WHO, 2007, AIDS EP UPD; *WHO UNAIDS UN, 2007, UN ACC SCAL PRIOR HI; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Bank, 2009, WORLD DEV IND DAT; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	19	152	157	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9538	10.1371/journal.pone.0009538	http://dx.doi.org/10.1371/journal.pone.0009538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209059	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100018
J	Gruaz, L; Delucinge-Vivier, C; Descombes, P; Dayer, JM; Burger, D				Gruaz, Lyssia; Delucinge-Vivier, Celine; Descombes, Patrick; Dayer, Jean-Michel; Burger, Danielle			Blockade of T Cell Contact-Activation of Human Monocytes by High-Density Lipoproteins Reveals a New Pattern of Cytokine and Inflammatory Genes	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; DIFFERENTIAL REGULATION; RHEUMATOID-ARTHRITIS; TISSUE-INHIBITOR; DENDRITIC CELLS; TH17 CELLS; LYMPHOCYTES; INDUCE; INTERLEUKIN-1-BETA	Background: Cellular contact with stimulated T cells is a potent inducer of cytokine production in human monocytes and is likely to play a substantial part in chronic/sterile inflammatory diseases. High-density lipoproteins (HDL) specifically inhibit the production of pro-inflammatory cytokines induced by T cell contact. Methodology/Principal Findings: To further elucidate the pro-inflammatory functions of cellular contact with stimulated T cells and its inhibition by HDL, we carried out multiplex and microarray analyses. Multiplex analysis of monocyte supernatant revealed that 12 out of 27 cytokines were induced upon contact with stimulated T cells, which cytokines included IL-1Ra, G-CSF, GM-CSF, IFN gamma, CCL2, CCL5, TNF, IL-1 beta, IL-6, IL-8, CCL3, and CCL4, but only the latter six were inhibited by HDL. Microarray analysis showed that 437 out of 54,675 probe sets were enhanced in monocytes activated by contact with stimulated T cells, 164 probe sets (i.e., 38%) being inhibited by HDL. These results were validated by qPCR. Interestingly, the cytokines induced by T cell contact in monocytes comprised IL-1 beta, IL-6 but not IL-12, suggesting that this mechanism might favor TH17 polarization, which emphasizes the relevance of this mechanism to chronic inflammatory diseases and highlights the contrast with acute inflammatory conditions that usually involve lipopolysaccharides (LPS). In addition, the expression of miR-155 and production of prostaglandin E(2)-both involved in inflammatory response-were triggered by T cell contact and inhibited in the presence of HDL. Conclusions/Significance: These results leave no doubt as to the pro-inflammatory nature of T cell contact-activation of human monocytes and the anti-inflammatory functions of HDL.	[Gruaz, Lyssia; Burger, Danielle] Univ Geneva, Dept Internal Med, Hans Wilsdorf Lab, Div Immunol & Allergy,Inflammat & Allergy Res Grp, Geneva, Switzerland; [Gruaz, Lyssia; Dayer, Jean-Michel; Burger, Danielle] Univ Geneva, Fac Med, Geneva, Switzerland; [Delucinge-Vivier, Celine; Descombes, Patrick] Univ Geneva, Natl Ctr Competence Res Frontiers Genet, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Gruaz, L (corresponding author), Univ Geneva, Dept Internal Med, Hans Wilsdorf Lab, Div Immunol & Allergy,Inflammat & Allergy Res Grp, Geneva, Switzerland.	danielle.Burger@hcuge.ch	Burger, Danielle/A-1996-2008		Swiss National Science Foundation [320000-116259]; Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Multiple Sclerosis; Hans Wilsdorf Foundation	This work was supported by grants from the Swiss National Science Foundation (#320000-116259), the Swiss Society for Multiple Sclerosis, and the Hans Wilsdorf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Beutler B, 2007, IMMUNOL REV, V220, P113, DOI 10.1111/j.1600-065X.2007.00577.x; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brennan FM, 2002, ARTHRITIS RHEUM, V46, P31, DOI 10.1002/1529-0131(200201)46:1<31::AID-ART10029>3.0.CO;2-5; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Burger D, 2000, EUR CYTOKINE NETW, V11, P346; Burger D, 1998, ARTHRITIS RHEUM, V41, P1748, DOI 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.3.CO;2-V; Burger D, 2003, RHEUMATOLOGY, V42, P89, DOI 10.1093/rheumatology/keg038; BURGER D, 2007, CONT TARGETED THERAP, P85; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chizzolini C, 1997, EUR J IMMUNOL, V27, P171, DOI 10.1002/eji.1830270125; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Deage V, 1998, EUR CYTOKINE NETW, V9, P663; Dinarello CA, 2007, ARTHRITIS RHEUM-US, V56, P2817, DOI 10.1002/art.22841; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Foey A, 2002, ARTHRITIS RES, V4, P64, DOI 10.1186/ar385; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; MALEFYT RD, 1991, J EXP MED, V174, P1209; Malefyt RW., 2000, CYTOKINE REFERENCE, P165; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Molnarfi N, 2008, MOL IMMUNOL, V45, P3419, DOI 10.1016/j.molimm.2008.04.001; Molnarfi N, 2007, J IMMUNOL, V178, P446, DOI 10.4049/jimmunol.178.1.446; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Scanu A, 2008, J LEUKOCYTE BIOL, V83, P921, DOI 10.1189/jlb.0807551; Sebbag M, 1997, EUR J IMMUNOL, V27, P624, DOI 10.1002/eji.1830270308; VEY E, 1992, J IMMUNOL, V149, P2040; Vey E, 1997, CYTOKINE, V9, P480, DOI 10.1006/cyto.1997.0191; Vey E, 1996, EUR J IMMUNOL, V26, P2404, DOI 10.1002/eji.1830261021	36	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9418	10.1371/journal.pone.0009418	http://dx.doi.org/10.1371/journal.pone.0009418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195532	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924300008
J	Ben-Shahar, Y; Lu, B; Collier, DM; Snyder, PM; Schnizler, M; Welsh, MJ				Ben-Shahar, Yehuda; Lu, Beika; Collier, Daniel M.; Snyder, Peter M.; Schnizler, Mikael; Welsh, Michael J.			The Drosophila Gene CheB42a Is a Novel Modifier of Deg/ENaC Channel Function	PLOS ONE			English	Article							PHEROMONE PERCEPTION; ION CHANNELS; PROTEIN; SUBUNIT; NEURONS; TOUCH; ORGANIZATION; CONTRIBUTES; EXPRESSION; COURTSHIP	Degenerin/epithelial Na+ channels (DEG/ENaC) represent a diverse family of voltage-insensitive cation channels whose functions include Na+ transport across epithelia, mechanosensation, nociception, salt sensing, modification of neurotransmission, and detecting the neurotransmitter FMRFamide. We previously showed that the Drosophila melanogaster Deg/ENaC gene lounge lizard (llz) is co-transcribed in an operon-like locus with another gene of unknown function, CheB42a. Because operons often encode proteins in the same biochemical or physiological pathway, we hypothesized that CHEB42A and LLZ might function together. Consistent with this hypothesis, we found both genes expressed in cells previously implicated in sensory functions during male courtship. Furthermore, when coexpressed, LLZ coprecipitated with CHEB42A, suggesting that the two proteins form a complex. Although LLZ expressed either alone or with CHEB42A did not generate ion channel currents, CHEB42A increased current amplitude of another DEG/ENaC protein whose ligand (protons) is known, acid-sensing ion channel 1a (ASIC1a). We also found that CHEB42A was cleaved to generate a secreted protein, suggesting that CHEB42A may play an important role in the extracellular space. These data suggest that CHEB42A is a modulatory subunit for sensory-related Deg/ENaC signaling. These results are consistent with operon-like transcription of CheB42a and llz and explain the similar contributions of these genes to courtship behavior.	[Ben-Shahar, Yehuda; Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Collier, Daniel M.; Snyder, Peter M.; Schnizler, Mikael; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Collier, Daniel M.; Snyder, Peter M.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Ben-Shahar, Yehuda; Lu, Beika] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Washington University (WUSTL)	Ben-Shahar, Y (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	michael-welsh@uiowa.edu	Collier, Daniel/GVU-0199-2022	Welsh, Michael/0000-0002-1646-6206	National Heart, Lung and Blood Institute; Cystic Fibrosis Foundation [R458-CR02, ENGLH9850]; National Institutes of Diabetes and Digestive and Kidney Diseases [DK54759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010244] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The University of Iowa In Vitro Models and Cell Culture Core is supported in part by the National Heart, Lung and Blood Institute, the Cystic Fibrosis Foundation (R458-CR02 and ENGLH9850), and the National Institutes of Diabetes and Digestive and Kidney Diseases (DK54759)]. Y.B.S. was an Associate and M.J.W. is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Ben-Shahar Y, 2007, P NATL ACAD SCI USA, V104, P222, DOI 10.1073/pnas.0609683104; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Heusser K, 2005, CURR OPIN NEUROBIOL, V15, P364, DOI 10.1016/j.conb.2005.04.001; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Lawrence JG, 2002, CELL, V110, P407, DOI 10.1016/S0092-8674(02)00900-5; LIN H, 2005, P NATL ACAD SCI US; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Matsunami H, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-220; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sakaguchi M, 1997, CURR OPIN BIOTECH, V8, P595, DOI 10.1016/S0958-1669(97)80035-3; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shimada Y, 2003, J LIPID RES, V44, P342, DOI 10.1194/jlr.M200234-JLR200; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Starostina E, 2009, J BIOL CHEM, V284, P585, DOI 10.1074/jbc.M806474200; SWICK AG, 1992, P NATL ACAD SCI USA, V89, P1812, DOI 10.1073/pnas.89.5.1812; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang Y, 2008, EMBO J, V27, P2388, DOI 10.1038/emboj.2008.161; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	44	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9395	10.1371/journal.pone.0009395	http://dx.doi.org/10.1371/journal.pone.0009395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195381	Green Published, gold			2022-12-27	WOS:000274924200017
J	Farooq, U; Majeed, M; Bhatti, JA; Khan, JS; Razzak, JA; Khan, MM				Farooq, Umar; Majeed, Mudassir; Bhatti, Junaid Ahmad; Khan, Jahangir Sarwar; Razzak, Junaid Abdul; Khan, Muhammad Mussadiq			Differences in Reporting of Violence and Deliberate Self Harm Related Injuries to Health and Police Authorities, Rawalpindi, Pakistan	PLOS ONE			English	Article							DOMESTIC VIOLENCE; PREVENTION; KARACHI; IMPACT	Background: The aim of study was to assess differences in reporting of violence and deliberate self harm (DSH) related injuries to police and emergency department (ED) in an urban town of Pakistan. Methods/Principal Findings: Study setting was Rawalpindi city of 1.6 million inhabitants. Incidences of violence and DSH related injuries and deaths were estimated from record linkage of police and ED data. These were then compared to reported figures in both datasets. All persons reporting violence and DSH related injury to the police station, the public hospital's ED, or both in Rawalpindi city from July 1, 2007 to June 30, 2008 were included. In Rawalpindi city, 1 016 intentional injury victims reported to police whereas 3 012 reported to ED. Comparing violence related fatality estimates (N = 56, 95% CI: 46-64), police reported 75.0% and ED reported 42.8% of them. Comparing violence related injury estimates (N = 7 990, 95% CI: 7 322-8 565), police reported 12.1% and ED reported 33.2% of them. Comparing DSH related fatality estimates (N = 17, 95% CI: 4-30), police reported 17.7% and ED reported 47.1% of them. Comparing DSH related injury estimates (N = 809, 95% CI: 101-1 516), police reported 0.5% and ED reported 39.9% of them. Conclusion: In Rawalpindi city, police records were more likely to be complete for violence related deaths as compared to injuries due to same mechanism. As compared to ED, police reported DSH related injuries and deaths far less than those due to other types of violence.	[Farooq, Umar; Majeed, Mudassir; Khan, Jahangir Sarwar; Khan, Muhammad Mussadiq] Holy Family Hosp, Dept Surg, Surg Unit 1, Rawalpindi, Pakistan; [Bhatti, Junaid Ahmad] Univ Bordeaux 2, INSERM, U897, Equipe Prevent & Prise Charge Traumatismes, F-33076 Bordeaux, France; [Razzak, Junaid Abdul] Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Aga Khan University	Farooq, U (corresponding author), Holy Family Hosp, Dept Surg, Surg Unit 1, Rawalpindi, Pakistan.	dr_umar_farooq@yahoo.com; junaid.bhatti@yahoo.com	Bhatti, Junaid/C-7289-2011; Razzak, Junaid/ABE-3549-2020	Razzak, Junaid/0000-0003-0735-9094	Government of Punjab, Pakistan	Government of Punjab, Pakistan	The injury surveillance study was funded by the Government of Punjab, Pakistan. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Tazeen Saeed, 2007, JPMA Journal of the Pakistan Medical Association, V57, P27; Chotani HA, 2002, INJ PREV, V8, P57, DOI 10.1136/ip.8.1.57; Comstock RD, 2005, INJURY PREV, V11, P58, DOI 10.1136/ip.2004.007567; Dahlberg Linda L, 2005, Int J Inj Contr Saf Promot, V12, P93, DOI 10.1080/15660970500086239; *FED BUR STAT, 2008, PAK SOC LIV STAND ME; Fikree FF, 1999, INT J GYNECOL OBSTET, V65, P195, DOI 10.1016/S0020-7292(99)00035-1; Ghaffar A, 2001, HEALTH POLICY PLANN, V16, P322, DOI 10.1093/heapol/16.3.322; Ghaffar A, 1999, HEALTH POLICY PLANN, V14, P11, DOI 10.1093/heapol/14.1.11; *GOV PAK, 1997, QIS DIYAT ORD; Government of Punjab, 2005, PUNJ DEV STAT 2005; Hadi S, 2003, J Clin Forensic Med, V10, P179, DOI 10.1016/S1353-1131(03)00074-9; HAQ IU, 2007, RAWALPINDI MITIGATIO; Hassan Qudsia, 2005, J Ayub Med Coll Abbottabad, V17, P78; Holder Y., 2001, INJURY SURVEILLANCE; Houry D, 1999, ANN EMERG MED, V34, P715, DOI 10.1016/S0196-0644(99)70096-X; Hussain Zahid, 2006, J Ayub Med Coll Abbottabad, V18, P44; Hyder AA, 2009, J SCI MED SPORT, V12, P422, DOI 10.1016/j.jsams.2008.12.630; Karmaliani R, 2008, ACTA OBSTET GYN SCAN, V87, P1194, DOI 10.1080/00016340802460263; Khan M M, 2000, Crisis, V21, P31, DOI 10.1027//0227-5910.21.1.31; Khan M.M., 1998, CRISIS, V19, P172, DOI [DOI 10.1027/0227-5910.19.4.172, 10.1027/0227-5910.19.4.172]; Khan Murad M, 2007, J Pak Med Assoc, V57, P478; Krug EG, 1997, AM J PREV MED, V13, P459, DOI 10.1016/S0749-3797(18)30142-9; Krug G. E., 2002, WORLD REPORT VIOLENC; KRUGER J, 1998, PUBLIC HLTH APPROACH, P399; Matzopoulos R, 2008, INT J INJ CONTROL SA, V15, P177, DOI 10.1080/17457300802396487; MCCARTY DJ, 1993, INT J EPIDEMIOL, V22, P559, DOI 10.1093/ije/22.3.559; Moosa M, 2006, SUICIDE LIFE-THREAT, V36, P76, DOI 10.1521/suli.2006.36.1.76; Nishtar S, 2005, AM J PREV MED, V29, P102, DOI 10.1016/j.amepre.2005.07.034; Pridemore WA, 2003, SOC SCI MED, V57, P1343, DOI 10.1016/S0277-9536(02)00509-9; Razzak JA, 1998, INT J EPIDEMIOL, V27, P866, DOI 10.1093/ije/27.5.866; Shah Mian Mujahid, 2008, J Ayub Med Coll Abbottabad, V20, P102; Shahid M, 2008, INT J INJ CONTROL SA, V15, P233, DOI 10.1080/17457300802149811; SUDDLE MS, 2007, POLICE EXECUTIVE REL; World Health Organization, 2000, WORLD HLTH REP 2000; ZAHOORI N, 2002, INJ CONTROL SAF PROM, P255	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9373	10.1371/journal.pone.0009373	http://dx.doi.org/10.1371/journal.pone.0009373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SV	20186326	Green Published, gold			2022-12-27	WOS:000274924000015
J	Kao, HT; Buka, SL; Kelsey, KT; Gruber, DF; Porton, B				Kao, Hung-Teh; Buka, Stephen L.; Kelsey, Karl T.; Gruber, David F.; Porton, Barbara			The Correlation between Rates of Cancer and Autism: An Exploratory Ecological Investigation	PLOS ONE			English	Article							SPECTRUM DISORDER; EDUCATION DATA; PREVALENCE; STATES; TESTS; RISK; LOCI; AGE	Background: Autism is associated with high rates of genomic aberrations, including chromosomal rearrangements and de novo copy-number variations. These observations are reminiscent of cancer, a disease where genomic rearrangements also play a role. We undertook a correlative epidemiological study to explore the possibility that shared risk factors might exist for autism and specific types of cancer. Methodology/Principal Findings: To determine if significant correlations exist between the prevalence of autism and the incidence of cancer, we obtained and analyzed state-wide data reported by age and gender throughout the United States. Autism data were obtained from the U. S. Department of Education via the Individuals with Disabilities Education Act ( IDEA) (2000-2007, reported annually by age group) and cancer incidence data were obtained from the Centers for Disease Control and Prevention (CDC) (1999-2005). IDEA data were further subdivided depending on the method used to diagnose autism (DSM IV or the Code of Federal Regulations, using strict or expanded criteria). Spearman rank correlations were calculated for all possible pairwise combinations of annual autism rates and the incidence of specific cancers. Following this, Bonferroni's correction was applied to significance values. Two independent methods for determining an overall combined p-value based on dependent correlations were obtained for each set of calculations. High correlations were found between autism rates and the incidence of in situ breast cancer (p <= 10(-10), modified inverse chi square, n = 16) using data from states that adhere strictly to the Code of Federal Regulations for diagnosing autism. By contrast, few significant correlations were observed between autism prevalence and the incidence of 23 other female and 22 male cancers. Conclusions: These findings suggest that there may be an association between autism and specific forms of cancer.	[Kao, Hung-Teh; Gruber, David F.; Porton, Barbara] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Buka, Stephen L.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Gruber, David F.] CUNY, Dept Nat Sci, Baruch Coll, New York, NY 10021 USA; [Gruber, David F.] CUNY, Grad Ctr, New York, NY 10021 USA	Brown University; Brown University; City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System	Kao, HT (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA.	Hung-Teh_Kao@brown.edu	Buka, Stephen/H-7335-2014; Kelsey, Karl T/I-1252-2014	Buka, Stephen/0000-0002-8578-9308; 	NIH [NS047209, CA121147, CA100679, CA078609, CA126939, MH070898]; Stanley Medical Research Institute; NATIONAL CANCER INSTITUTE [R01CA126939, R01CA100679, R01CA078609, R01CA121147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the NIH NS047209 (H.-T.K); CA121147, CA100679, CA078609 and CA126939 (K.T.K.); MH070898 (B.P.) and the Stanley Medical Research Institute (S.L.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; [Anonymous], 1932, STAT METHODS RES WOR; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; Gernsbacher MA, 2005, CURR DIR PSYCHOL SCI, V14, P55, DOI 10.1111/j.0963-7214.2005.00334.x; Laidler JR, 2005, PEDIATRICS, V116, pE120, DOI 10.1542/peds.2004-2341; MACFARLANE JR, 2009, J CHILD FAM STUD; Mandell DS, 2005, ARCH PEDIAT ADOL MED, V159, P266, DOI 10.1001/archpedi.159.3.266; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Newschaffer CJ, 2005, PEDIATRICS, V115, pE277, DOI 10.1542/peds.2004-1958; Newschaffer CJ, 2003, PUBLIC HEALTH REP, V118, P393, DOI 10.1093/phr/118.5.393; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shattuck PT, 2006, PEDIATRICS, V117, P1438, DOI 10.1542/peds.2005-2911; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9372	10.1371/journal.pone.0009372	http://dx.doi.org/10.1371/journal.pone.0009372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SV	20186340	Green Published, gold			2022-12-27	WOS:000274924000014
J	Kistner, O; Crowe, BA; Wodal, W; Kerschbaum, A; Savidis-Dacho, H; Sabarth, N; Falkner, FG; Mayerhofer, I; Mundt, W; Reiter, M; Grillberger, L; Tauer, C; Graninger, M; Sachslehner, A; Schwendinger, M; Bruhl, P; Kreil, TR; Ehrlich, HJ; Barrett, PN				Kistner, Otfried; Crowe, Brian A.; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Sabarth, Nicolas; Falkner, Falko G.; Mayerhofer, Ines; Mundt, Wolfgang; Reiter, Manfred; Grillberger, Leopold; Tauer, Christa; Graninger, Michael; Sachslehner, Alois; Schwendinger, Michael; Bruehl, Peter; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel			A Whole Virus Pandemic Influenza H1N1 Vaccine Is Highly Immunogenic and Protective in Active Immunization and Passive Protection Mouse Models	PLOS ONE			English	Article							CELL-CULTURE; H5N1 VACCINE; MICE; INFECTION; RESPONSES; TRIAL; TRANSMISSION; PATHOGENESIS; ANTIBODIES; FERRETS	The recent emergence and rapid spread of a novel swine-derived H1N1 influenza virus has resulted in the first influenza pandemic of this century. Monovalent vaccines have undergone preclinical and clinical development prior to initiation of mass immunization campaigns. We have carried out a series of immunogenicity and protection studies following active immunization of mice, which indicate that a whole virus, nonadjuvanted vaccine is immunogenic at low doses and protects against live virus challenge. The immunogenicity in this model was comparable to that of a whole virus H5N1 vaccine, which had previously been demonstrated to induce high levels of seroprotection in clinical studies. The efficacy of the H1N1 pandemic vaccine in protecting against live virus challenge was also seen to be equivalent to that of the H5N1 vaccine. The protective efficacy of the H1N1 vaccine was also confirmed using a severe combined immunodeficient ( SCID) mouse model. It was demonstrated that mouse and guinea pig immune sera elicited following active H1N1 vaccination resulted in 100% protection of SCID mice following passive transfer of immune sera and lethal challenge. The immune responses to a whole virus pandemic H1N1 and a split seasonal H1N1 vaccine were also compared in this study. It was demonstrated that the whole virus vaccine induced a balanced Th-1 and Th-2 response in mice, whereas the split vaccine induced mainly a Th-2 response and only minimal levels of Th-1 responses. These data supported the initiation of clinical studies with the same low doses of whole virus vaccine that had previously been demonstrated to be immunogenic in clinical studies with a whole virus H5N1 vaccine.	[Kistner, Otfried; Crowe, Brian A.; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Sabarth, Nicolas; Falkner, Falko G.; Mayerhofer, Ines; Mundt, Wolfgang; Reiter, Manfred; Grillberger, Leopold; Tauer, Christa; Graninger, Michael; Sachslehner, Alois; Schwendinger, Michael; Bruehl, Peter; Kreil, Thomas R.; Ehrlich, Hartmut J.; Barrett, P. Noel] Baxter BioSci, Global Res & Dev, Vienna, Austria		Kistner, O (corresponding author), Baxter BioSci, Global Res & Dev, Vienna, Austria.	noel_barrett@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter Bioscience	Baxter Bioscience	This study was funded by Baxter Bioscience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	AICHINGER G, 2009, 3 INT C INFL VACC WO; Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; DORMITZER PR, 2009, PLOS CURR INFLUENZA; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; GASPARINI R, 2009, INT J CLIN IN PRESS; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Gupta M, 2001, J VIROL, V75, P4649, DOI 10.1128/JVI.75.10.4649-4654.2001; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HOWARD MK, 2008, BIOL CHEM; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kistner O, 1998, VACCINE, V16, P960, DOI 10.1016/S0264-410X(97)00301-0; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; LIANG XF, 2009, LANCET, V375, P49; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; ROMAN F, 2009, VACCINE IN PRESS; SCHERLE PA, 1992, J IMMUNOL, V148, P212; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; VAJO Z, 2009, LANCET, V375, P56; *WHO, 2010, PAND HINI 2009 UPD 8; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	32	39	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9349	10.1371/journal.pone.0009349	http://dx.doi.org/10.1371/journal.pone.0009349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186321	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000005
J	Banning, C; Votteler, J; Hoffmann, D; Koppensteiner, H; Warmer, M; Reimer, R; Kirchhoff, F; Schubert, U; Hauber, J; Schindler, M				Banning, Carina; Votteler, Joerg; Hoffmann, Dirk; Koppensteiner, Herwig; Warmer, Martin; Reimer, Rudolph; Kirchhoff, Frank; Schubert, Ulrich; Hauber, Joachim; Schindler, Michael			A Flow Cytometry-Based FRET Assay to Identify and Analyse Protein-Protein Interactions in Living Cells	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; VIRUS TYPE-1 NEF; VPU PROTEIN; FLUORESCENT PROTEIN; DOWN-MODULATION; HIV-1 VPU; ACTIVATION; DEGRADATION; EXPRESSION; BINDS	Background: Forsters resonance energy transfer (FRET) microscopy is widely used for the analysis of protein interactions in intact cells. However, FRET microscopy is technically challenging and does not allow assessing interactions in large cell numbers. To overcome these limitations we developed a flow cytometry-based FRET assay and analysed interactions of human and simian immunodeficiency virus (HIV and SIV) Nef and Vpu proteins with cellular factors, as well as HIV Rev multimer-formation. Results: Amongst others, we characterize the interaction of Vpu with CD317 (also termed Bst-2 or tetherin), a host restriction factor that inhibits HIV release from infected cells and demonstrate that the direct binding of both is mediated by the Vpu membrane-spanning region. Furthermore, we adapted our assay to allow the identification of novel protein interaction partners in a high-throughput format. Conclusion: The presented combination of FRET and FACS offers the precious possibility to discover and define protein interactions in living cells and is expected to contribute to the identification of novel therapeutic targets for treatment of human diseases.	[Banning, Carina; Hoffmann, Dirk; Koppensteiner, Herwig; Warmer, Martin; Reimer, Rudolph; Hauber, Joachim; Schindler, Michael] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Votteler, Joerg; Schubert, Ulrich] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany; [Kirchhoff, Frank] Univ Ulm, Inst Virol, Ulm, Germany	Heinrich Pette Institute; University of Hamburg; University of Erlangen Nuremberg; Ulm University	Banning, C (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-2000 Hamburg, Germany.	michael.schindler@hpi.uni-hamburg.de	Schindler, Michael/C-1647-2015; Kirchhoff, Frank/O-8367-2018	Schindler, Michael/0000-0001-8989-5813; Kirchhoff, Frank/0000-0002-7052-2360	Deutsche Forschungsgemeinschaft (DFG); EU; NIH [R01, AI067057]; DFG [HA2580/2-2, SCHI1073/2-1]; Stiftung fuer neurovirale Erkrankungen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067057] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Stiftung fuer neurovirale Erkrankungen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	F.K. is supported by the Deutsche Forschungsgemeinschaft (DFG), the EU and NIH R01 grant AI067057. J. H. is supported by the DFG grant HA2580/2-2. This work was funded by grants to M.S. from the DFG (SCHI1073/2-1) and the Stiftung fuer neurovirale Erkrankungen (NVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Binette Julie, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P297, DOI 10.2174/1568008043339695; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; D'haeseleer P, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P216; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; DOUGLAS JL, 2009, J VIROL; DUBE M, 2009, J VIROL; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Kirchhoff F, 2008, CELL MOL LIFE SCI, V65, P2621, DOI 10.1007/s00018-008-8094-2; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Schaefer TM, 2002, VIROLOGY, V302, P106, DOI 10.1006/viro.2002.1628; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; SIEGEL RM, 2000, SCI STKE, pPL1; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Thomas SL, 1998, J VIROL, V72, P2935, DOI 10.1128/JVI.72.4.2935-2944.1998; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103	40	112	114	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9344	10.1371/journal.pone.0009344	http://dx.doi.org/10.1371/journal.pone.0009344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179761	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923900010
J	Smith, ER; Cai, KQ; Smedberg, JL; Ribeiro, MM; Rula, ME; Slater, C; Godwin, AK; Xu, XX				Smith, Elizabeth R.; Cai, Kathy Qi; Smedberg, Jennifer L.; Ribeiro, Melina M.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.; Xu, Xiang-Xi			Nuclear Entry of Activated MAPK Is Restricted in Primary Ovarian and Mammary Epithelial Cells	PLOS ONE			English	Article							DEVELOPING DROSOPHILA EYE; SURFACE EPITHELIUM; PROTEIN-KINASE; GENE-EXPRESSION; TRANSLOCATION; TRANSPORT; GROWTH; PHOSPHORYLATION; IMPORT; ERK2	Background: The MAPK/ERK1/2 serine kinases are primary mediators of the Ras mitogenic signaling pathway. Phosphorylation by MEK activates MAPK/ERK in the cytoplasm, and phospho-ERK is thought to enter the nucleus readily to modulate transcription. Principal Findings: Here, however, we observe that in primary cultures of breast and ovarian epithelial cells, phosphorylation and activation of ERK1/2 are disassociated from nuclear translocalization and transcription of downstream targets, such as c-Fos, suggesting that nuclear translocation is limited in primary cells. Accordingly, in import assays in vitro, primary cells showed a lower import activity for ERK1/2 than cancer cells, in which activated MAPK readily translocated into the nucleus and activated c-Fos expression. Primary cells express lower levels of nuclear pore complex proteins and the nuclear transport factors, importin B1 and importin 7, which may explain the limiting ERK1/2 import found in primary cells. Additionally, reduction in expression of nucleoporin 153 by siRNA targeting reduced ERK1/2 nuclear activity in cancer cells. Conclusion: ERK1/2 activation is dissociated from nuclear entry, which is a rate limiting step in primary cells and in vivo, and the restriction of nuclear entry is disrupted in transformed cells by the increased expression of nuclear pores and/or nuclear transport factors.	[Smith, Elizabeth R.; Ribeiro, Melina M.; Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Smith, Elizabeth R.; Ribeiro, Melina M.; Xu, Xiang-Xi] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Cai, Kathy Qi; Smedberg, Jennifer L.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Ovarian Canc Program, Philadelphia, PA 19111 USA; [Cai, Kathy Qi; Smedberg, Jennifer L.; Rula, Malgorzata E.; Slater, Carolyn; Godwin, Andrew K.] Fox Chase Canc Ctr, Dept Med Oncol, Tumor Cell Biol Program, Philadelphia, PA 19111 USA	University of Miami; University of Miami; Fox Chase Cancer Center; Fox Chase Cancer Center	Smith, ER (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	esmith@med.miami.edu			National Cancer Institute [R01CA099471, R01CA79716, R01CA75389]; Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept [W81XWH-07-1-0303]; NATIONAL CANCER INSTITUTE [R01CA075389, R01CA099471, R01CA079716] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grants R01CA099471, R01CA79716, and R01CA75389 (to X-XX). E. R. S. received support from the Marsha Rivkin Ovarian Cancer Research Center and DOD Ovarian Concept W81XWH-07-1-0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, EMBO J, V18, P5347, DOI 10.1093/emboj/18.19.5347; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; BERCHUCK A, 1991, AM J OBSTET GYNECOL, V164, P669, DOI 10.1016/S0002-9378(11)80044-X; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cai KQ, 2007, MOL CARCINOGEN, V46, P130, DOI 10.1002/mc.20273; Capo-Chichi CD, 2002, CANCER-AM CANCER SOC, V95, P1802, DOI 10.1002/cncr.10870; Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6; FELDHERR CM, 1991, J CELL BIOL, V115, P933, DOI 10.1083/jcb.115.4.933; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Gaytan M, 2005, REPRODUCTION, V129, P311, DOI 10.1530/rep.1.00401; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GILLET JY, 1980, BIOL OVARY, P86; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KRUK PA, 1990, LAB INVEST, V63, P132; Kumar JP, 2003, DEVELOPMENT, V130, P3703, DOI 10.1242/dev.00556; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; Lyman SK, 2001, J CELL BIOL, V154, P17, DOI 10.1083/jcb.200106071; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; MARAIS R, 1993, CELL, V65, P663; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; Martinez N, 1999, CANCER RES, V59, P5408; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Ranganathan A, 2006, J BIOL CHEM, V281, P15645, DOI 10.1074/jbc.M513866200; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; SIEMENS CH, 1988, J CELL PHYSIOL, V134, P347, DOI 10.1002/jcp.1041340305; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; SOULE HD, 1986, IN VITRO CELL DEV B, V22, P6, DOI 10.1007/BF02623435; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tresini M, 2001, EXP CELL RES, V269, P287, DOI 10.1006/excr.2001.5334; Vrailas AD, 2006, DEVELOPMENT, V133, P1485, DOI 10.1242/dev.02334; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Yazicioglu MN, 2007, J BIOL CHEM, V282, P28759, DOI 10.1074/jbc.M703460200	55	32	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9295	10.1371/journal.pone.0009295	http://dx.doi.org/10.1371/journal.pone.0009295			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174585	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700022
J	Rato, S; Maia, S; Brito, PM; Resende, L; Pereira, CF; Moita, C; Freitas, RP; Moniz-Pereira, J; Hacohen, N; Moita, LF; Goncalves, J				Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moita, Catarina; Freitas, Rui P.; Moniz-Pereira, Jose; Hacohen, Nir; Moita, Luis Ferreira; Goncalves, Joao			Novel HIV-1 Knockdown Targets Identified by an Enriched Kinases/Phosphatases shRNA Library Using a Long-Term Iterative Screen in Jurkat T-Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LENTIVIRAL VECTORS; DRUGGABLE GENOME; HUMAN HOMOLOG; TAT PROTEIN; EED; REPLICATION; KINASES; DRUG; VPR	HIV-1 is a complex retrovirus that uses host machinery to promote its replication. Understanding cellular proteins involved in the multistep process of HIV-1 infection may result in the discovery of more adapted and effective therapeutic targets. Kinases and phosphatases are a druggable class of proteins critically involved in regulation of signal pathways of eukaryotic cells. Here, we focused on the discovery of kinases and phosphatases that are essential for HIV-1 replication but dispensable for cell viability. We performed an iterative screen in Jurkat T-cells with a short-hairpin-RNA (shRNA) library highly enriched for human kinases and phosphatases. We identified 14 new proteins essential for HIV-1 replication that do not affect cell viability. These proteins are described to be involved in MAPK, JNK and ERK pathways, vesicular traffic and DNA repair. Moreover, we show that the proteins under study are important in an early step of HIV-1 infection before viral integration, whereas some of them affect viral transcription/translation. This study brings new insights for the complex interplay of HIV1/host cell and opens new possibilities for antiviral strategies.	[Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moniz-Pereira, Jose; Goncalves, Joao] Univ Lisbon, Fac Farm, URIA Ctr Patogenese Mol, P-1699 Lisbon, Portugal; [Rato, Sylvie; Maia, Sara; Brito, Paula M.; Resende, Leonor; Pereira, Carina F.; Moita, Catarina; Freitas, Rui P.; Moita, Luis Ferreira; Goncalves, Joao] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Rheumatol Allergy & Immunol, Charlestown, MA USA; [Hacohen, Nir] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Hacohen, Nir] MIT, Cambridge, MA 02139 USA	Universidade de Lisboa; Universidade de Lisboa; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Rato, S (corresponding author), Univ Lisbon, Fac Farm, URIA Ctr Patogenese Mol, P-1699 Lisbon, Portugal.	joao.goncalves@ff.ul.pt	Moita, Luis F./L-1296-2013; iMed.ULisboa, M2B/B-5277-2014; Moita, Luis/HCI-2793-2022; Brito, Paula/H-3693-2013; Maia, Sara/B-2513-2013; Goncalves, Joao/B-2013-2008	Moita, Luis F./0000-0003-0707-315X; iMed.ULisboa, M2B/0000-0002-1245-3715; Moita, Luis/0000-0003-0707-315X; Brito, Paula/0000-0002-0105-6968; Maia, Sara/0000-0001-8638-0566; Goncalves, Joao/0000-0002-1245-3715; /0000-0002-8779-2017; Ferreira Moita, Catarina/0000-0002-9910-2343; Rato, Sylvie/0000-0002-0204-0335	Fundacao para Ciencia e Tecnologia [PTDC/SAU-MII/65346/2006, PTDC/SAU-MII/69280/2006, PTDC/SAU-MII/78333/2006]	Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para Ciencia e Tecnologia (PTDC/SAU-MII/65346/2006, PTDC/SAU-MII/69280/2006 and PTDC/SAU-MII/78333/2006)(www.fct.mctes.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bristow CL, 2003, BLOOD, V102, P4479, DOI 10.1182/blood-2003-05-1635; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Dayton AI, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-15; Devroe E, 2005, VIROLOGY, V331, P181, DOI 10.1016/j.virol.2004.10.023; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Goff SP, 2008, CELL, V135, P417, DOI 10.1016/j.cell.2008.10.007; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hui B, 2006, J NEUROCHEM, V97, P334, DOI 10.1111/j.1471-4159.2006.03698.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Kok KH, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-78; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Mischiati C, 1999, AIDS, V13, P1637, DOI 10.1097/00002030-199909100-00006; Mishra S, 2007, J BIOL CHEM, V282, P4288, DOI 10.1074/jbc.M608307200; Muthumani K, 2005, CELL DEATH DIFFER, V12, P962, DOI 10.1038/sj.cdd.4401583; Nekhai S, 2007, CURR HIV RES, V5, P3, DOI 10.2174/157016207779316279; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; Rakotobe D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-37; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Schafer EA, 2006, ANTIVIR RES, V72, P224, DOI 10.1016/j.antiviral.2006.06.008; Stevenson M, 2008, SCI AM, V299, P78, DOI 10.1038/scientificamerican1108-78; Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; van Hoffen A, 2003, TOXICOLOGY, V193, P79, DOI 10.1016/j.tox.2003.06.001; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Witte V, 2004, MOL CELL, V13, P179, DOI 10.1016/S1097-2765(04)00004-8; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	47	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9276	10.1371/journal.pone.0009276	http://dx.doi.org/10.1371/journal.pone.0009276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174665	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590600029
J	Huijgen, R; Kindt, I; Verhoeven, SBJ; Sijbrands, EJG; Vissers, MN; Kastelein, JJP; Hutten, BA				Huijgen, Roeland; Kindt, Iris; Verhoeven, Sjoerd B. J.; Sijbrands, Eric J. G.; Vissers, Maud N.; Kastelein, John J. P.; Hutten, Barbara A.			Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal	PLOS ONE			English	Article							RANDOMIZED-TRIALS; EFFICACY; STATINS; METAANALYSIS; NETHERLANDS; MUTATIONS; SAFETY; RISK	Background: The risk of premature cardiovascular disease in patients with familial hypercholesterolemia (FH) can be profoundly reduced by cholesterol-lowering therapy, and current guidelines for FH advocate ambitious low-density lipoprotein cholesterol (LDL-C) goals. In the present study, we determined whether these goals are reflected in current clinical practice once FH has been diagnosed. Methodology/Principal Findings: In 2008, we sent questionnaires to all subjects (aged 18-65 years) who were molecularly diagnosed with FH in the year 2006 through the screening program in the Netherlands. Of these 1062 subjects, 781 completed the questionnaire (46% males; mean age: 42 +/- 12 years; mean LDL-C at molecular diagnosis (baseline): 4.1 +/- 1.3 mmol/L). The number of persons that used cholesterol-lowering therapy increased from 397 (51%) at baseline to 636 (81%) after diagnosis. Mean treated LDL-C levels decreased significantly to 3.2 +/- 1.1 mmol/L two years after diagnosis. Only 22% achieved the LDL-C target level of <= 2.5 mmol/L. Conclusions/Significance: The proportion of patients using cholesterol-lowering medication was significantly increased after FH diagnosis through genetic cascade screening. The attained LDL-C levels were lower than those reported in previous surveys on medication use in FH, which could reflect the effect of more stringent lipid target levels. However, only a minority of the medication users reached the LDL-C target.	[Huijgen, Roeland; Verhoeven, Sjoerd B. J.; Vissers, Maud N.; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kindt, Iris] Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands; [Sijbrands, Eric J. G.] Erasmus MC, Dept Cardiovasc Genet, Rotterdam, Netherlands; [Sijbrands, Eric J. G.] Erasmus MC, Dept Pharmacol Vasc & Metab Dis, Rotterdam, Netherlands; [Hutten, Barbara A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Huijgen, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.huijgen@amc.uva.nl	Kastelein, John/AAF-7950-2020; Sijbrands, Eric/A-1065-2009	Sijbrands, Eric/0000-0001-8857-7389	AstraZeneca; Pfizer; Roche; Novartis; Merck; Merck-Schering-Plough; Isis; Genzyme; Sanofi-Aventis; Ministry of Health of the Dutch Government	AstraZeneca(AstraZeneca); Pfizer(Pfizer); Roche(Roche Holding); Novartis(Novartis); Merck(Merck & Company); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Isis; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi-Aventis(Sanofi-Aventis); Ministry of Health of the Dutch Government	Funding: J.J.P.K. received grant support from AstraZeneca, Pfizer, Roche, Novartis, Merck, Merck-Schering-Plough, Isis, Genzyme, and Sanofi-Aventis; lecture fees from AstraZeneca, GlaxoSmithKline, Pfizer, Novartis, Merck-Schering-Plough, Roche, Isis, and Boehringer Ingelheim; and consulting fees from AstraZeneca, Abbott, Pfizer, Isis, Genzyme, Roche, Novartis, Merck, Merck-Schering-Plough, and Sanofi-Aventis. The FH screening program itself is financed by the Ministry of Health of the Dutch Government. Although no specific additional funding was required for the author's survey, the authors state that the funders of the screening program had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abifadel M, 2009, HUM MUTAT, V30, pE682, DOI 10.1002/humu.21002; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Fouchier Sigrid W, 2004, Semin Vasc Med, V4, P259, DOI 10.1055/s-2004-861493; Fouchier SW, 2005, HUM MUTAT, V26, P550, DOI 10.1002/humu.20256; Fouchier SW, 2009, ATHEROSCLEROSIS SUPP, V10, pP870; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; GOTTO AM, 1984, CIRCULATION, V69, pA1065; Hadfield SG, 2008, ANN CLIN BIOCHEM, V45, P199, DOI 10.1258/acb.2007.007078; HUIJGEN R, 2009, ATHEROSCLEROSIS SUPP, V10, pP841; Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Leren TP, 2008, COMMUNITY GENET, V11, P26, DOI 10.1159/000111637; Neil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; PIJLMAN AH, 2009, ATHEROSCLER IN PRESS; Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085; SLACK J, 1969, LANCET, V2, P1380; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Souverein OW, 2007, EUR HEART J, V28, P299, DOI 10.1093/eurheartj/ehl366; Umans-Eckenhausen MAW, 2003, ARCH INTERN MED, V163, P65, DOI 10.1001/archinte.163.1.65; Umans-Eckenhausen MAW, 2002, CIRCULATION, V106, P3031, DOI 10.1161/01.CIR.0000041253.61683.08; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; van der Graaf A, 2008, ANN INTERN MED, V148, P712, DOI 10.7326/0003-4819-148-9-200805060-00022; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Walma E P, 2006, Ned Tijdschr Geneeskd, V150, P18; Wierzbicki AS, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1095	27	100	104	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9220	10.1371/journal.pone.0009220	http://dx.doi.org/10.1371/journal.pone.0009220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169164	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474700014
J	van Woesik, R; Shiroma, K; Koksal, S				van Woesik, Robert; Shiroma, Kazuyo; Koksal, Semen			Phenotypic Variance Predicts Symbiont Population Densities in Corals: A Modeling Approach	PLOS ONE			English	Article							GREAT-BARRIER-REEF; PHOTOCHEMICAL EFFICIENCY; LANDSCAPE ECOLOGY; DIURNAL CHANGES; PHOTOSYSTEM-II; CLIMATE-CHANGE; ZOOXANTHELLAE; DIVERSITY; EVOLUTION; PATTERNS	Background: We test whether the phenotypic variance of symbionts (Symbiodinium) in corals is closely related with the capacity of corals to acclimatize to increasing seawater temperatures. Moreover, we assess whether more specialist symbionts will increase within coral hosts under ocean warming. The present study is only applicable to those corals that naturally have the capacity to support more than one type of Symbiodinium within the lifetime of a colony; for example, Montastraea annularis and Montastraea faveolata. Methodology/Principal Findings: The population dynamics of competing Symbiodinium symbiont populations were projected through time in coral hosts using a novel, discrete time optimal-resource model. Models were run for two Atlantic Ocean localities. Four symbiont populations, with different environmental optima and phenotypic variances, were modeled to grow, divide, and compete in the corals under seasonal fluctuations in solar insolation and seawater temperature. Elevated seawater temperatures were input into the model 1.5 degrees C above the seasonal summer average, and the symbiont population response was observed for each location. The models showed dynamic fluctuations in Symbiodinium populations densities within corals. Population density predictions for Lee Stocking Island, the Bahamas, where temperatures were relatively homogenous throughout the year, showed a dominance of both type 2, with high phenotypic variance, and type 1, a high-temperature and high-insolation specialist. Whereas the densities of Symbiodinium types 3 and 4, a high-temperature, low-insolation specialist, and a high-temperature, low-insolation generalist, remained consistently low. Predictions for Key Largo, Florida, where environmental conditions were more seasonally variable, showed the coexistence of generalists (types 2 and 4) and low densities of specialists (types 1 and 3). When elevated temperatures were input into the model, population densities in corals at Lee Stocking Island showed an emergence of high-temperature specialists. However, even under high temperatures, corals in the Florida Keys were dominated by generalists. Conclusions/Significance: Predictions at higher seawater temperatures showed endogenous shuffling and an emergence of the high-temperature Symbiodinium specialists, even though their phenotypic variance was low. The model shows that sustaining these "hidden'' specialists becomes advantageous under thermal stress conditions, and shuffling symbionts may increase the corals' capacity to acclimatize but not adapt to climatechange-induced ocean warming.	[van Woesik, Robert; Shiroma, Kazuyo] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Koksal, Semen] Florida Inst Technol, Dept Math Sci, Melbourne, FL 32901 USA	Florida Institute of Technology; Florida Institute of Technology	van Woesik, R (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	rvw@fit.edu			Okinawa International Exchange & Human Resources Development Foundation; World Bank; Global Environmental Facility; Coral Bleaching; Local Environmental Responses working group	Okinawa International Exchange & Human Resources Development Foundation; World Bank(The World Bank India); Global Environmental Facility; Coral Bleaching; Local Environmental Responses working group	Funding for study to KS was provided by the Okinawa International Exchange & Human Resources Development Foundation. This research was supported in part by the World Bank and the Global Environmental Facility through the Coral Reef Targeted Research and Capacity Building for Management program, Coral Bleaching and Local Environmental Responses working group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Berkelmans R, 2002, MAR ECOL PROG SER, V229, P73, DOI 10.3354/meps229073; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 1999, CORAL REEFS, V18, P99; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Day T, 2008, AM NAT, V171, pE72, DOI 10.1086/524956; Dunn SR, 2002, J EXP MAR BIOL ECOL, V272, P29, DOI 10.1016/S0022-0981(02)00036-9; Fagoonee I, 1999, SCIENCE, V283, P843, DOI 10.1126/science.283.5403.843; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fitt WK, 2001, MAR BIOL, V139, P507; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; GLYNN PW, 1991, TRENDS ECOL EVOL, V6, P175, DOI 10.1016/0169-5347(91)90208-F; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hubbell S.P., 2001, MG POP BIOL, V32; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Hutchinson GE, 1941, AM NAT, V75, P406, DOI 10.1086/280983; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; McClanahan T, 2002, AMBIO, V31, P543, DOI 10.1639/0044-7447(2002)031[0543:EOTCME]2.0.CO;2; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Pillay RM, 2005, SYMBIOSIS, V38, P209; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2004, J PHYCOL, V40, P395, DOI 10.1111/j.1529-8817.2004.03186.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stimson J, 1997, J EXP MAR BIOL ECOL, V214, P35, DOI 10.1016/S0022-0981(96)02753-0; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Taylor DL, 1974, SYMBIOSIS SEA, P245; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006262; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; van Woesik R, 2006, ECOL LETT, V9, P390, DOI 10.1111/j.1461-0248.2006.00886.x; van Woesik R., 2002, Comments on Theoretical Biology, V7, P201, DOI 10.1080/08948550214054; VANWOESIK R, 2006, COASTAL ESTUARINE ST, V61, P129; Wagner D, 2008, B MAR SCI, V83, P553; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4; Warner ME, 2006, LIMNOL OCEANOGR, V51, P1887, DOI 10.4319/lo.2006.51.4.1887; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 2002, MAR BIOL, V141, P31, DOI 10.1007/s00227-002-0807-8	66	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9185	10.1371/journal.pone.0009185	http://dx.doi.org/10.1371/journal.pone.0009185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169202	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474600006
J	De Kroon, MLA; Renders, CM; Van Wouwe, JP; Van Buuren, S; Hirasing, RA				De Kroon, Marlou L. A.; Renders, Carry M.; Van Wouwe, Jacobus P.; Van Buuren, Stef; Hirasing, Remy A.			The Terneuzen Birth Cohort: BMI Changes between 2 and 6 Years Correlate Strongest with Adult Overweight	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT-GAIN; CHILDHOOD GROWTH; YOUNG ADULTHOOD; OBESITY; CHILDREN; INFANT; SIZE; ADOLESCENCE; AGE	Background: Complications of overweight amplify with age, and irreversible damage already exists in young persons. Identifying the most sensitive age interval(s) for adult overweight is relevant for primary prevention. The aim of the study was to assess the relative contribution of body mass index (BMI) changes between 0 and 18 years to adult overweight, and to identify the earliest critical growth period. Methods and Findings: Data from 762 subjects in the Terneuzen Birth Cohort with an average of 21 growth measurements per subject from birth until 18 years were used. The main outcome measure was the BMI standard deviation score (SDS) at young adulthood. For each subject BMI SDS was fitted by a piecewise linear model at eight different ages and correlated to adult BMI SDS. The age intervals in between are considered critical according to three criteria, tested by respectively Students' t-tests, multiple linear regression analyses and Pearson's correlation tests. In the age intervals 4 months(m) -1 year(y), 2-6 y, 6-10 y and 10-18 y the BMI SDS change differs between adults with and without overweight (P <= 0.001). The age intervals 2-6 y and 10-18 y also meet the second criterion, implying that the BMI change during this period has a predictive value for adult BMI SDS in addition to BMI SDS at the end of the period. The largest rise in correlation between estimated BMI SDS and measured adult BMI SDS occurs during the period 2-6 y (from 0.36 to 0.63), which results in a high sensitivity (0.6) and specificity (0.8) by the age of 6 y. Conclusions/Significance: The age interval from 2 y to 6 y is the earliest and most critical growth period for adult overweight. Therefore, primary prevention of adult overweight seems most likely to be successful if targeted at this specific age interval. By identifying those with an upwards centile crossing between 2 and 6 years, the development towards adult overweight might be reversed.	[De Kroon, Marlou L. A.; Renders, Carry M.; Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Van Wouwe, Jacobus P.; Van Buuren, Stef] TNO Qual Life Prevent & Hlth Care, Netherlands Org Appl Sci Res, Leiden, Netherlands; [Van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, Fac Social Sci, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Utrecht University	De Kroon, MLA (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.	ml.dekroon@vumc.nl	de Kroon, Marlou MLA/M-4040-2014; Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; van Buuren, Stef/0000-0003-1098-2119; de Kroon, Marlou/0000-0003-1730-4994; Renders, Carry/0000-0001-6688-1312	Health Research and Development Council of the Netherlands [2100.0092]; Municipal Health Services of Terneuzen (GGD Zeeland)	Health Research and Development Council of the Netherlands; Municipal Health Services of Terneuzen (GGD Zeeland)	This study received a grant from the Health Research and Development Council of the Netherlands (ZONMw Grants no. 2100.0092). The funders had no role in study desigh, data collection and analysis, decision to publish or preparation of the manuscript.; We gratefully thank all participants for their time, the assistants for their contribution in the field work, the laboratory of the Community Hospital in the city of Terneuzen, especially Ruud Muusze, PhD, the Municipal Health Services of Terneuzen (GGD Zeeland) for support and cooperation, and Guus A. de Jonge, PhD, professor emeritus, for laying the foundations of this study in 1977-1986.	Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Blair NJ, 2007, ARCH DIS CHILD, V92, P866, DOI 10.1136/adc.2007.116855; Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760; Cole T J, 2004, BMC Pediatr, V4, P6; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; DEKROON ML, 2008, EUR J PUBLIC HEALTH, V6, P656; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Euser AM, 2005, AM J CLIN NUTR, V81, P480; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Freedman DS, 2009, ARCH PEDIAT ADOL MED, V163, P805, DOI 10.1001/archpediatrics.2009.104; Jones HE, 2009, STAT MED, V28, P1645, DOI 10.1002/sim.3583; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Kvaavik E, 2003, ARCH PEDIAT ADOL MED, V157, P1212, DOI 10.1001/archpedi.157.12.1212; Lagstrom H, 2008, PEDIATRICS, V122, pE876, DOI 10.1542/peds.2007-2354; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MARTORELL R, 1995, J NUTR, V125, pS1127, DOI 10.1093/jn/125.suppl_4.1127S; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Scholtens S, 2007, AM J EPIDEMIOL, V165, P919, DOI 10.1093/aje/kwk083; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Snijders T, 1999, MULTILEVEL ANAL; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Vogels N, 2006, AM J CLIN NUTR, V84, P717, DOI 10.1093/ajcn/84.4.717; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; WHITAKER RC, 1998, PEDIATRICS, V101, P1	34	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9155	10.1371/journal.pone.0009155	http://dx.doi.org/10.1371/journal.pone.0009155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161800	Green Published, gold			2022-12-27	WOS:000274442800003
J	Gordienko, R; Ohno, H; Singh, VK; Jia, ZC; Ripmeester, JA; Walker, VK				Gordienko, Raimond; Ohno, Hiroshi; Singh, Vinay K.; Jia, Zongchao; Ripmeester, John A.; Walker, Virginia K.			Towards a Green Hydrate Inhibitor: Imaging Antifreeze Proteins on Clathrates	PLOS ONE			English	Article							KINETIC INHIBITORS; GAS; GROWTH; CRYSTAL; MELT	The formation of hydrate plugs in oil and gas pipelines is a serious industrial problem and recently there has been an increased interest in the use of alternative hydrate inhibitors as substitutes for thermodynamic inhibitors like methanol. We show here that antifreeze proteins (AFPs) possess the ability to modify structure II (sII) tetrahydrofuran (THF) hydrate crystal morphologies by adhering to the hydrate surface and inhibiting growth in a similar fashion to the kinetic inhibitor poly-N-vinylpyrrolidone (PVP). The effects of AFPs on the formation and growth rate of high-pressure sII gas mix hydrate demonstrated that AFPs are superior hydrate inhibitors compared to PVP. These results indicate that AFPs may be suitable for the study of new inhibitor systems and represent an important step towards the development of biologically-based hydrate inhibitors.	[Gordienko, Raimond; Ohno, Hiroshi; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Singh, Vinay K.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Ohno, Hiroshi; Ripmeester, John A.] Natl Res Council Canada, Mat Struct & Funct Grp, Ottawa, ON, Canada	Queens University - Canada; Queens University - Canada; National Research Council Canada	Gordienko, R (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	walkervk@queensu.ca	Ripmeester, John A/G-1950-2011		Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic and Discovery grants: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RPP- PP/SNG-SRS_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; CHAKRABARTTY A, 1991, EUR J BIOCHEM, V202, P1057, DOI 10.1111/j.1432-1033.1991.tb16470.x; Davies SR, 2006, AICHE J, V52, P4016, DOI 10.1002/aic.11005; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; GORDON MS, 1962, BIOL BULL, V122, P52, DOI 10.2307/1539321; Huo Z, 2001, CHEM ENG SCI, V56, P4979, DOI 10.1016/S0009-2509(01)00188-9; Kennedy J.L., 1993, OIL GAS PIPELINE FUN; Knight CA, 2002, PHILOS MAG A, V82, P1609, DOI 10.1080/01418610210128159; Koh CA, 2002, FLUID PHASE EQUILIBR, V194, P143, DOI 10.1016/S0378-3812(01)00660-4; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Larsen R, 1998, FLUID PHASE EQUILIBR, V150, P353, DOI 10.1016/S0378-3812(98)00335-5; Lederhos JP, 1996, CHEM ENG SCI, V51, P1221, DOI 10.1016/0009-2509(95)00370-3; Lee JD, 2005, CHEM ENG SCI, V60, P5323, DOI 10.1016/j.ces.2005.05.023; Makogon TY, 1997, J CRYST GROWTH, V179, P258, DOI 10.1016/S0022-0248(97)00118-8; MATERER N, 1995, J PHYS CHEM-US, V99, P6267, DOI 10.1021/j100017a002; MEHTA A, 2006, ANN NY ACAD SCI, V912, P366; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Pudney PDA, 2003, ARCH BIOCHEM BIOPHYS, V410, P238, DOI 10.1016/S0003-9861(02)00697-5; Scotter AJ, 2006, CRYOBIOLOGY, V53, P229, DOI 10.1016/j.cryobiol.2006.06.006; Seo YT, 2005, ENVIRON SCI TECHNOL, V39, P2315, DOI 10.1021/es049269z; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Smith J.M., 2001, INTRO CHEM ENG THERM; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; Zeng H, 2006, J AM CHEM SOC, V128, P2844, DOI 10.1021/ja0548182; Zeng H, 2003, CAN J PHYS, V81, P17, DOI 10.1139/P03-001; Zeng H., 2007, ANGEW CHEM, V119, P5498; Zeng H, 2006, AICHE J, V52, P3304, DOI 10.1002/aic.10929	27	74	77	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e8953	10.1371/journal.pone.0008953	http://dx.doi.org/10.1371/journal.pone.0008953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161789	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800001
J	Nemolato, S; Cabras, T; Cau, F; Fanari, MU; Fanni, D; Manconi, B; Messana, I; Castagnola, M; Faa, G				Nemolato, Sonia; Cabras, Tiziana; Cau, Flaviana; Fanari, Mattia Umberto; Fanni, Daniela; Manconi, Barbara; Messana, Irene; Castagnola, Massimo; Faa, Gavino			Different Thymosin Beta 4 Immunoreactivity in Foetal and Adult Gastrointestinal Tract	PLOS ONE			English	Article							ACTIN; CELLS; EXPRESSION; INSIGHTS; BIOLOGY; SWITCH	Background: Thymosin beta 4 (T beta(4)) is a member of beta-thymosins, a family of peptides that play essential roles in many cellular functions. A recent study from our group suggested a role for T beta(4) in the development of human salivary glands. The aim of this study was to analyze the expression of T beta(4) in the human gut during development, and in the adult. Methodology/Principal Findings: Immunolocalization of T beta(4) was studied in autoptic samples of tongue, oesophagus, stomach, ileum, colon, liver and pancreas obtained from two human foetuses and two adults. T beta(4) appeared unevenly distributed, with marked differences between foetuses and adults. In the stomach, superficial epithelium was positive in foetuses and negative in adults. Ileal enterocytes were strongly positive in the adult and weakly positive in the foetuses. An increase in reactivity for T beta(4) was observed in superficial colon epithelium of adults as compared with the foetuses. Striking differences were found between foetal and adult liver: the former showed a very low reactivity for T beta(4) while in the adult we observed a strong reactivity in the vast majority of the hepatocytes. A peculiar pattern was found in the pancreas, with the strongest reactivity observed in foetal and adult islet cells. Significance: Our data show a strong expression of T beta(4) in the human gut and in endocrine pancreas during development. The observed differential expression of T beta(4) suggests specific roles of the peptide in the gut of foetuses and adults. The observed heterogeneity of T beta(4) expression in the foetal life, ranging from a very rare detection in liver cells up to a diffuse reactivity in endocrine pancreas, should be taken into account when the role of T beta(4) in the development of human embryo is assessed. Future studies are needed to shed light on the link between T beta(4) and organogenesis.	[Nemolato, Sonia; Cau, Flaviana; Fanari, Mattia Umberto; Fanni, Daniela; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy; [Cabras, Tiziana; Manconi, Barbara; Messana, Irene] Univ Cagliari, Dipartimento Sci Applicate Biosistemi, Cagliari, Italy; [Castagnola, Massimo] Univ Cattolica, Ist Biochim & Biochim Clin, Rome, Italy; [Castagnola, Massimo] Int ISI, Ist Sci, Ist Chim Riconoscimento Mol, CNR, Rome, Italy	University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Nemolato, S (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy.	gavinofaa@gmail.com	Cabras, Tiziana/AAF-6231-2020; Castagnola, Massimo/AAM-6355-2021; Messana, Irene/L-2478-2019; Castagnola, Massimo/AAB-2825-2019; Fanni, Daniela/ABD-9643-2020; Fanni, Daniela/N-5669-2016	Messana, Irene/0000-0002-1436-6105; Castagnola, Massimo/0000-0002-0959-7259; Fanni, Daniela/0000-0003-2797-8343; Fanni, Daniela/0000-0003-2797-8343; cau, flaviana/0000-0001-6205-4555; Faa, Gavino/0000-0002-6129-0975	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy(Fondazione Banco di Sardegna)	The authors acknowledge the financial support of Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet D, 1996, EXP HEMATOL, V24, P776; De La Cruz EM, 2001, SCIENCE, V293, P616, DOI 10.1126/science.1063558; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Girardi M, 2003, IMMUNOLOGY, V109, P1, DOI 10.1046/j.1365-2567.2003.01616.x; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; GomezMarquez J, 1996, BBA-GENE STRUCT EXPR, V1306, P187, DOI 10.1016/0167-4781(96)00003-6; Hertzog M, 2004, CELL, V117, P611, DOI 10.1016/S0092-8674(04)00403-9; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Kupatt C, 2005, FASEB J, V19, P1576, DOI 10.1096/fj.04-3282fje; Lee SJ, 2008, FEBS LETT, V582, P2161, DOI 10.1016/j.febslet.2008.03.058; LIN SC, 1990, J MOL NEUROSCI, V2, P35, DOI 10.1007/BF02896924; LOW TLK, 1979, J BIOL CHEM, V254, P981; Moon HS, 2006, EXP CELL RES, V312, P3425, DOI 10.1016/j.yexcr.2006.07.021; Nemolato S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005109; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Safer D, 1997, BIOCHEMISTRY-US, V36, P5806, DOI 10.1021/bi970185v; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2002, MECH DEVELOP, V119, pS65, DOI 10.1016/S0925-4773(03)00093-5; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Stossel TP, 2006, J CELL SCI, V119, P3261, DOI 10.1242/jcs.02994; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Sun W, 2007, ANN NY ACAD SCI, V1112, P210, DOI 10.1196/annals.1415.013; von Kodpolitsch Y, 2004, Z KARDIOL, V93, P929, DOI 10.1007/s00392-004-0152-7; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Young JD, 1999, NAT MED, V5, P1424	28	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9111	10.1371/journal.pone.0009111	http://dx.doi.org/10.1371/journal.pone.0009111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161756	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442600009
J	Cropley, JE; Suter, CM; Beckman, KB; Martin, DIK				Cropley, Jennifer E.; Suter, Catherine M.; Beckman, Kenneth B.; Martin, David I. K.			CpG Methylation of a Silent Controlling Element in the Murine A(vy) Allele Is Incomplete and Unresponsive to Methyl Donor Supplementation	PLOS ONE			English	Article							AGOUTI GENE-EXPRESSION; DNA METHYLATION; EPIGENETIC INHERITANCE; TRANSPOSABLE ELEMENTS; MOLECULAR-BASIS; COAT COLOR; MLH1; RETROTRANSPOSONS; PHENOTYPE; MUTATION	Background: The viable yellow allele of agouti (A(vy)) is remarkable for its unstable and partially heritable epigenetic state, which produces wide variation in phenotypes of isogenic mice. In the A(vy) allele an inserted intracisternal A particle (IAP) acts as a controlling element which deregulates expression of agouti by transcription from the LTR of the IAP; the phenotypic state has been linked to CpG methylation of the LTR. Phenotypic variation between A(vy) mice indicates that the epigenetic state of the IAP is unstable in the germline. Principal Findings: We have made a detailed examination of somatic methylation of the IAP using bisulphite allelic sequencing, and find that the promoter is incompletely methylated even when it is transcriptionally silent. In utero exposure to supplementary methyl donors, which alters the spectrum of A(vy) phenotypes, does not increase the density of CpG methylation in the silent LTR. Conclusions: Our findings suggest that, contrary to previous supposition, methyl donor supplementation acts through an indirect mechanism to silence A(vy). The incomplete cytosine methylation we observe at the somatically silent A(vy) allele may reflect its unstable germline state, and the influence of epigenetic modifications underlying CpG methylation.	[Cropley, Jennifer E.; Suter, Catherine M.; Martin, David I. K.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Suter, Catherine M.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Cropley, Jennifer E.; Suter, Catherine M.; Beckman, Kenneth B.; Martin, David I. K.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Cropley, JE (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	dimartin@chori.org		Cropley, Jennifer/0000-0001-6078-2604	NCI [CA115768-01]; NATIONAL CANCER INSTITUTE [R01CA115768] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA115768-01 to DM, and by a grant from the Australian Research council to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argeson AC, 1996, GENETICS, V142, P557; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Clark SJ, 2002, METHODS, V27, P99, DOI 10.1016/S1046-2023(02)00059-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cooney CA, 2002, J NUTR, V132, p2393S; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; FINCHAM JRS, 1974, ANNU REV GENET, V8, P15, DOI 10.1146/annurev.ge.08.120174.000311; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; GALBRAITH DB, 1974, J HERED, V65, P137, DOI 10.1093/oxfordjournals.jhered.a108484; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Gazzoli I, 2002, CANCER RES, V62, P3925; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; PERRY WL, 1994, BIOESSAYS, V16, P705, DOI 10.1002/bies.950161002; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WOLFF GL, 1978, GENETICS, V88, P529; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	39	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9055	10.1371/journal.pone.0009055	http://dx.doi.org/10.1371/journal.pone.0009055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140227	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474400013
J	Pellegrini, M; Di Siena, S; Claps, G; Di Cesare, S; Dolci, S; Rossi, P; Geremia, R; Grimaldi, P				Pellegrini, Manuela; Di Siena, Sara; Claps, Giuseppina; Di Cesare, Silvia; Dolci, Susanna; Rossi, Pellegrino; Geremia, Raffaele; Grimaldi, Paola			Microgravity Promotes Differentiation and Meiotic Entry of Postnatal Mouse Male Germ Cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; C-KIT; SPERMATOGONIA; SPERMATOGENESIS; PROLIFERATION; SPERMATOCYTES; ACTIVATION; EXPRESSION; OOGENESIS; AKT	A critical step of spermatogenesis is the entry of mitotic spermatogonia into meiosis. Progresses on these topics are hampered by the lack of an in vitro culture system allowing mouse spermatogonia differentiation and entry into meiosis. Previous studies have shown that mouse pachytene spermatocytes cultured in simulated microgravity (SM) undergo a spontaneous meiotic progression. Here we report that mouse mitotic spermatogonia cultured under SM with a rotary cell culture system (RCCS) enter into meiosis in the absence of any added exogenous factor or contact with somatic cells. We found that isolated Kit-positive spermatogonia under the RCCS condition enter into the prophase of the first meiotic division (leptotene stage), as monitored by chromosomal organization of the synaptonemal complex 3 protein (Scp3) and up-regulation of several promeiotic genes. SM was found to activate the phosphatidyl inositol 3 kinase (PI3K) pathway and to induce in Kit-positive spermatogonia the last round of DNA replication, typical of the preleptotene stage. A PI3K inhibitor abolished Scp3 induction and meiotic entry stimulated by RCCS conditions. A positive effect of SM on germ cell differentiation was also observed in undifferentiated (Kit-negative) spermatogonia, in which RCCS conditions stimulate the expression of Kit and Stra8. In conclusion, SM is an artificial environmental condition which promotes postnatal male germ cell differentiation and might provide a tool to study the molecular mechanisms underlying the switch from mitosis to meiosis in mammals.	[Pellegrini, Manuela; Di Siena, Sara; Claps, Giuseppina; Di Cesare, Silvia; Dolci, Susanna; Rossi, Pellegrino; Geremia, Raffaele; Grimaldi, Paola] Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Rome, Italy	University of Rome Tor Vergata	Pellegrini, M (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Rome, Italy.	grimaldi@uniroma2.it	Rossi, Pellegrino/AAA-7072-2019; Pellegrini, manuela/AAC-1423-2022; dolci, susanna/B-8363-2013; Grimaldi, Paola/AAW-8721-2020; GRIMALDI, PAOLA/AAJ-7920-2020; DI CESARE, SILVIA/AAB-5754-2020; Claps, Giuseppina/G-6180-2018	dolci, susanna/0000-0002-6864-3673; GRIMALDI, PAOLA/0000-0001-6724-7604; DI CESARE, SILVIA/0000-0002-9912-7997; ROSSI, PELLEGRINO/0000-0003-4796-327X; GEREMIA, Raffaele/0000-0001-9056-6603; pellegrini, manuela/0000-0001-6387-5187; Claps, Giuseppina/0000-0002-3064-0063	Italian Ministry of University [200788TPYE_002]; Agenzia Spaziale Italiana (ASI)	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Ministry of University (Grant Prin 2007 200788TPYE_002) and Agenzia Spaziale Italiana (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Boehrs Jessica, 2008, J Prosthodont, V17, P517, DOI 10.1111/j.1532-849X.2008.00330.x; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chiarini-Garcia H, 2002, REPRODUCTION, V123, P567, DOI 10.1530/reprod/123.4.567; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Di Agostino S, 2004, REPRODUCTION, V128, P25, DOI 10.1530/rep.1.00184; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371; Lolicato F, 2008, DEV BIOL, V313, P725, DOI 10.1016/j.ydbio.2007.11.011; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Mark M, 2008, J CELL SCI, V121, P3233, DOI 10.1242/jcs.035071; Morbidelli L, 2005, BIOCHEM BIOPH RES CO, V334, P491, DOI 10.1016/j.bbrc.2005.06.124; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Ollinger R, 2005, MOL BIOL CELL, V16, P212; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Ricci G, 2008, J ENDOCRINOL INVEST, V31, P229, DOI 10.1007/BF03345595; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Rossi P, 2008, GENE EXPR PATTERNS, V8, P58, DOI 10.1016/j.modgep.2007.10.007; Sanford GL, 2002, IN VITRO CELL DEV-AN, V38, P493; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; SORRENTINO V, 1991, ONCOGENE, V6, P149; Tamma R, 2009, FASEB J, V23, P2549, DOI 10.1096/fj.08-127951; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	30	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9064	10.1371/journal.pone.0009064	http://dx.doi.org/10.1371/journal.pone.0009064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140225	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474400019
J	Boniolo, G; D'Agostino, M; Di Fiore, PP				Boniolo, Giovanni; D'Agostino, Marcello; Di Fiore, Pier Paolo			Zsyntax: A Formal Language for Molecular Biology with Projected Applications in Text Mining and Biological Prediction	PLOS ONE			English	Article							MINIMUM INFORMATION; NETWORKS; P53; SYSTEMS; AXIOMATIZATION; REPRESENTATION; GENETICS; NUMB	We propose a formal language that allows for transposing biological information precisely and rigorously into machine-readable information. This language, which we call Zsyntax (where Z stands for the Greek word zeta omega eta, life), is grounded on a particular type of non-classical logic, and it can be used to write algorithms and computer programs. We present it as a first step towards a comprehensive formal language for molecular biology in which any biological process can be written and analyzed as a sort of logical "deduction''. Moreover, we illustrate the potential value of this language, both in the field of text mining and in that of biological prediction.	[Boniolo, Giovanni; Di Fiore, Pier Paolo] IFOM, Ist FIRC Oncol Mol, Milan, Italy; [Boniolo, Giovanni; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy; [D'Agostino, Marcello] Univ Ferrara, Dipartimento Sci Umane, I-44100 Ferrara, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Ferrara; IRCCS European Institute of Oncology (IEO)	Boniolo, G (corresponding author), IFOM, Ist FIRC Oncol Mol, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it	D'Agostino, Marcello/T-8565-2019; Boniolo, Giovanni/N-1603-2015; Di Fiore, Pier Paolo/K-2130-2012	D'Agostino, Marcello/0000-0002-3832-4487; Boniolo, Giovanni/0000-0003-1968-4249; Di Fiore, Pier Paolo/0000-0002-2252-0950	AIRC (Italian Association for Cancer Research); European Community; Monzino Foundation; Ferrari Foundation; Cariplo Foundation; Italian Ministry of University and Research	AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Monzino Foundation; Ferrari Foundation; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Work in the laboratory of PPDF is supported by grants from AIRC (Italian Association for Cancer Research), the European Community, the Monzino Foundation, the Ferrari Foundation and the Cariplo Foundation. Work by GB and MD'A was supported by the Italian Ministry of University and Research (PRIN 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, PHYS REV LETT, V84, P5660, DOI 10.1103/PhysRevLett.84.5660; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Baader F., 2003, DESCRIPTION LOGIC HD; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruck Jozsef, 2006, Genome Inform, V17, P208; Calzone L, 2006, BIOINFORMATICS, V22, P1805, DOI 10.1093/bioinformatics/btl172; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Conzelmann H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-34; DAgostino M., 1999, HDB TABLEAU METHODS; Danos V, 2004, THEOR COMPUT SCI, V325, P69, DOI 10.1016/j.tcs.2004.03.065; Dosen K., 1993, SUBSTRUCTURAL LOGICS; FAGES F, 2008, SFM, P5016; Fontana W, 2008, ACM SIGPLAN NOTICES, V43, P1, DOI 10.1145/1328897.1328439; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gabbay D.M., 1996, LABELLED DEDUCTIVE S; GABBAY DM, 1994, WHAT IS LOGICAL SYST; GIRARD JY, 1987, THEOR COMPUT SCI, V50, P1, DOI 10.1016/0304-3975(87)90045-4; JUVEN T, 1993, ONCOGENE, V8, P3411; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; KOSCHORRECK M, 2008, BMC SYST BIOL, V2; Luciano JS, 2005, DRUG DISCOV TODAY, V10, P937, DOI 10.1016/S1359-6446(05)03501-4; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Murray JD, 2003, MATH BIOL, V3; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Priami C, 2001, INFORM PROCESS LETT, V80, P25, DOI 10.1016/S0020-0190(01)00214-9; Regev A, 2004, NAT COMPUT SER, P219; Regev A, 2001, Pac Symp Biocomput, P459; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; RIZZOTTI M, 1986, J THEOR BIOL, V118, P61, DOI 10.1016/S0022-5193(86)80008-X; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; Sakaguchi K, 2000, J BIOL CHEM, V275, P9278, DOI 10.1074/jbc.275.13.9278; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; TENNANT N, 1990, NATURAL LOGIC; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Woodger J.H., 1937, AXIOMATIC METHOD BIO; ZANARDO A, 1986, J THEOR BIOL, V118, P145, DOI 10.1016/S0022-5193(86)80130-8	43	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9511	10.1371/journal.pone.0009511	http://dx.doi.org/10.1371/journal.pone.0009511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209084	gold, Green Published, Green Submitted			2022-12-27	WOS:000275063400017
J	Biessmann, H; Andronopoulou, E; Biessmann, MR; Douris, V; Dimitratos, SD; Eliopoulos, E; Guerin, PM; Iatrou, K; Justice, RW; Krober, T; Marinotti, O; Tsitoura, P; Woods, DF; Walter, MF				Biessmann, Harald; Andronopoulou, Evi; Biessmann, Max R.; Douris, Vassilis; Dimitratos, Spiros D.; Eliopoulos, Elias; Guerin, Patrick M.; Iatrou, Kostas; Justice, Robin W.; Kroeber, Thomas; Marinotti, Osvaldo; Tsitoura, Panagiota; Woods, Daniel F.; Walter, Marika F.			The Anopheles gambiae Odorant Binding Protein 1 (AgamOBP1) Mediates Indole Recognition in the Antennae of Female Mosquitoes	PLOS ONE			English	Article							PHEROMONE-BINDING; OVIPOSITION ATTRACTANTS; CULEX-QUINQUEFASCIATUS; SEXUAL ATTRACTION; MALARIA MOSQUITO; CRYSTAL-STRUCTURE; SILKWORM MOTH; IDENTIFICATION; EXPRESSION; RESPONSES	Haematophagous insects are frequently carriers of parasitic diseases, including malaria. The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa and is thus responsible for thousands of deaths daily. Although the role of olfaction in A. gambiae host detection has been demonstrated, little is known about the combinations of ligands and odorant binding proteins (OBPs) that can produce specific odor-related responses in vivo. We identified a ligand, indole, for an A. gambiae odorant binding protein, AgamOBP1, modeled the interaction in silico and confirmed the interaction using biochemical assays. RNAi-mediated gene silencing coupled with electrophysiological analyses confirmed that AgamOBP1 binds indole in A. gambiae and that the antennal receptor cells do not respond to indole in the absence of AgamOBP1. This case represents the first documented instance of a specific A. gambiae OBP-ligand pairing combination, demonstrates the significance of OBPs in odor recognition, and can be expanded to the identification of other ligands for OBPs of Anopheles and other medically important insects.	[Biessmann, Harald; Biessmann, Max R.; Marinotti, Osvaldo; Walter, Marika F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Ctr Dev Biol, Irvine, CA 92717 USA; [Andronopoulou, Evi; Douris, Vassilis; Iatrou, Kostas; Tsitoura, Panagiota] Natl Ctr Sci Res Demokritos, Inst Biol, Insect Mol Genet & Biotechnol Grp, Athens, Greece; [Dimitratos, Spiros D.; Justice, Robin W.; Woods, Daniel F.] Inscent Inc, Irvine, CA USA; [Eliopoulos, Elias] Agr Univ Athens, Dept Agr Biotechnol, Athens, Greece; [Guerin, Patrick M.; Kroeber, Thomas] Univ Neuchatel, Fac Sci, Inst Biol, CH-2000 Neuchatel, Switzerland; [Justice, Robin W.] Claremont Coll, Joint Sci Dept, Claremont, CA USA; [Justice, Robin W.] Claremont Mckenna Coll, Claremont, CA 91711 USA; [Justice, Robin W.] Pitzer Coll, Claremont, CA 91711 USA; [Justice, Robin W.] Scripps Coll, Claremont, CA 91711 USA	University of California System; University of California Irvine; National Centre of Scientific Research "Demokritos"; Agricultural University of Athens; University of Neuchatel; Claremont Colleges; Claremont Graduate School; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Pitzer College; Claremont Colleges; Scripps College		mfwalter@uci.edu	Douris, Vassilis/AAG-9423-2020	Douris, Vassilis/0000-0003-4608-7482; Eliopoulos, Elias/0000-0002-0919-0571; KROBER, Thomas/0000-0001-6798-4946; Marinotti, Osvaldo/0000-0002-7173-7160	General Secretariat of Science and Technology; Greek Ministry of Development [GRUSA 052]; National Institute of Health [2R01AI051485-06A1, R56AI051485]; Director's Initiative Fund; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); European Community's Seventh Framework Programme [FP7/2007-2013, FP7-222927]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051485, R56AI051485] Funding Source: NIH RePORTER	General Secretariat of Science and Technology; Greek Ministry of Development; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Initiative Fund; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR); European Community's Seventh Framework Programme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the General Secretariat of Science and Technology, Greek Ministry of Development to K. I. (grant number GRUSA 052); the National Institute of Health (NIAID grant 2R01AI051485-06A1 to H. B. and grant R56AI051485 to H. B. and M. F. W.); the Director's Initiative Fund, UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) to P. M. G.; the European Community's Seventh Framework Programme (FP7/2007-2013 to K. I., P. M. G., E. E. and D. F. W. under grant agreement FP7-222927). The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham EG, 2005, INSECT MOL BIOL, V14, P271, DOI 10.1111/j.1365-2583.2004.00557.x; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Andronopoulou E, 2006, INSECT MOL BIOL, V15, P797, DOI 10.1111/j.1365-2583.2006.00685.x; ARN H, 1975, Z NATURFORSCH C, V30, P722; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; BLACKWELL A, 1993, PHYSIOL ENTOMOL, V18, P343, DOI 10.1111/j.1365-3032.1993.tb00607.x; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Costantini C, 2001, MED VET ENTOMOL, V15, P259, DOI 10.1046/j.0269-283x.2001.00297.x; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; Dekker T, 2001, J MED ENTOMOL, V38, P868, DOI 10.1603/0022-2585-38.6.868; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Fujita Y, 2005, BIOORG MED CHEM LETT, V15, P4317, DOI 10.1016/j.bmcl.2005.06.047; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HAYES RO, 1953, J ECON ENTOMOL, V46, P624, DOI 10.1093/jee/46.4.624; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Justice RW, 2003, BIOESSAYS, V25, P1011, DOI 10.1002/bies.10331; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Klusak V, 2003, CHEM BIOL, V10, P331, DOI 10.1016/S1074-5521(03)00074-7; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Matsui M, 2007, EUR NEUROL, V57, P57, DOI 10.1159/000097120; Meijerink J, 1999, J INSECT PHYSIOL, V45, P365, DOI 10.1016/S0022-1910(98)00135-8; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Meijerink J, 2000, J CHEM ECOL, V26, P1367, DOI 10.1023/A:1005475422978; MILLAR JG, 1992, J AM MOSQUITO CONTR, V8, P11; Mohl Claudia, 2002, Invertebrate Neuroscience, V4, P165, DOI 10.1007/s10158-002-0018-5; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; MORDUE AJ, 1992, EXPERIENTIA, V48, P1109, DOI 10.1007/BF01947999; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; van den Broek IVF, 1999, J INSECT PHYSIOL, V45, P1001, DOI 10.1016/S0022-1910(99)00081-5; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	52	162	173	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9471	10.1371/journal.pone.0009471	http://dx.doi.org/10.1371/journal.pone.0009471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208991	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997100017
J	Adli, M; Merkhofer, E; Cogswell, P; Baldwin, AS				Adli, Mazhar; Merkhofer, Evan; Cogswell, Patricia; Baldwin, Albert S.			IKK alpha and IKK beta Each Function to Regulate NF-kappa B Activation in the TNF-Induced/Canonical Pathway	PLOS ONE			English	Article							SEVERE LIVER DEGENERATION; KINASE COMPLEX; MICE LACKING; GENE-EXPRESSION; DEFICIENT MICE; PHOSPHORYLATION; INHIBITION; SUBUNIT; TRANSCRIPTION; APOPTOSIS	Background: Activation of the transcription factor NF-kappa B by cytokines is rapid, mediated through the activation of the IKK complex with subsequent phosphorylation and degradation of the inhibitory I kappa B proteins. The IKK complex is comprised of two catalytic subunits, IKK alpha and IKK beta, and a regulatory protein known as NEMO. Using cells from mice that are genetically deficient in IKK beta or IKK alpha, or using a kinase inactive mutant of IKK beta, it has been proposed that IKK beta is critical for TNF-induced I kappa B phosphorylation/degradation through the canonical pathway while IKK alpha has been shown to be involved in the non-canonical pathway for NF-kappa B activation. These conclusions have led to a focus on development of IKK beta inhibitors for potential use in inflammatory disorders and cancer. Methodology: Analysis of NF-kappa B activation in response to TNF in MEFs reveals that IKK beta is essential for efficient phosphorylation and subsequent degradation of I kappa B alpha, yet IKK alpha contributes to the NF-kappa B activation response in these cells as measured via DNA binding assays. In HeLa cells, both IKK alpha and IKK beta contribute to I kappa B alpha phosphorylation and NF-kappa B activation. A kinase inactive mutant of IKK beta, which has been used as evidence for the critical importance of IKK beta in TNF-induced signaling, blocks activation of NF-kappa B induced by IKK alpha, even in cells that are deficient in IKK beta. Conclusions: These results demonstrate the importance of IKK alpha in canonical NF-kappa B activation, downstream of cytokine treatment of cells. The experiments suggest that IKK alpha will be a therapeutic target in inflammatory disorders.	[Adli, Mazhar; Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Merkhofer, Evan; Baldwin, Albert S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Adli, Mazhar; Merkhofer, Evan; Cogswell, Patricia; Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Adli, M (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	abaldwin@med.unc.edu			National Institutes of Health (NIH) [AI35098, CA75080]; Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA075080, R01CA073756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waxman Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI35098 and CA75080, and by support from the Waxman Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yamamoto Y, 2000, MOL CELL BIOL, V20, P3655, DOI 10.1128/MCB.20.10.3655-3666.2000; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	33	80	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9428	10.1371/journal.pone.0009428	http://dx.doi.org/10.1371/journal.pone.0009428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195534	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924300016
J	Safran, RJ; McGraw, KJ; Wilkins, MR; Hubbard, JK; Marling, J				Safran, Rebecca J.; McGraw, Kevin J.; Wilkins, Matthew R.; Hubbard, Joanna K.; Marling, Julie			Positive Carotenoid Balance Correlates with Greater Reproductive Performance in a Wild Bird	PLOS ONE			English	Article							HISTORY TRADE-OFFS; MALE BARN SWALLOWS; OXIDATIVE STRESS; IMMUNE FUNCTION; DIETARY ANTIOXIDANTS; HIRUNDO-RUSTICA; SITE SELECTION; EGG-PRODUCTION; ZEBRA FINCHES; PLUMAGE COLOR	Background: Carotenoids can confer somatic and reproductive benefits, but most evidence is from captive animal experimentation or single time-point sampling. Another perhaps more informative means by which to assess physiological contributions to animal performance is by tracking an individual's ability to increase or sustain carotenoids or other health-related molecules over time, as these are likely to be temporally variable. Methodology/Principal Findings: In a field study of North American barn swallows (Hirundo rustica erythrogaster), we analyzed within-individual changes in carotenoid concentrations by repeatedly sampling the carotenoid profiles of individuals over the course of the breeding season. Our results demonstrate that carotenoid concentrations of individuals are temporally dynamic and that season-long balance of these molecules, rather than single time-point samples, predict reproductive performance. This was true even when controlling for two important variables associated with reproductive outcomes: (1) timing of breeding and (2) sexually selected plumage coloration, which is itself positively correlated with and concomitantly changes with circulating carotenoid concentrations. Conclusions/Significance: While reproduction itself is purported to impose health stress on organisms, these data suggest that free-ranging, high-quality individuals can mitigate such costs, by one or several genetic, environmental (diet), or physiological mechanisms. Moreover, the temporal variations in both health-linked physiological measures and morphological traits we uncover here merit further examination in other species, especially when goals include the estimation of signal information content or the costs of trait expression.	[Safran, Rebecca J.; Wilkins, Matthew R.; Hubbard, Joanna K.; Marling, Julie] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	University of Colorado System; University of Colorado Boulder; Arizona State University; Arizona State University-Tempe	Safran, RJ (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	Rebecca.Safran@colorado.edu	Hubbard, Joanna K./H-5206-2019	Hubbard, Joanna K./0000-0002-7234-8001; Wilkins, Matthew/0000-0002-3162-6749				Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Ardia DR, 2005, J ANIM ECOL, V74, P517, DOI 10.1111/j.1365-2656.2005.00950.x; Bertrand S, 2006, OECOLOGIA, V147, P576, DOI 10.1007/s00442-005-0317-8; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Hasegawa Masaru, 2008, Ornithological Science, V7, P117, DOI 10.2326/1347-0558-7.2.117; Horak P, 2007, AM NAT, V170, P625, DOI 10.1086/521232; Hughes DA, 2001, NUTRITION, V17, P823, DOI 10.1016/S0899-9007(01)00638-4; Krinsky NI, 2001, NUTRITION, V17, P815, DOI 10.1016/S0899-9007(01)00651-7; Maguire SE, 2010, J AVIAN BIOL, V41, P74, DOI 10.1111/j.1600-048X.2009.04806.x; McGraw KJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P1991, DOI 10.1007/s00265-008-0622-4; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; McGraw KJ, 2003, AM NAT, V162, P704, DOI 10.1086/378904; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Ninni P, 2004, OIKOS, V105, P55, DOI 10.1111/j.0030-1299.2004.12516.x; Pike TW, 2007, P ROY SOC B-BIOL SCI, V274, P1591, DOI 10.1098/rspb.2007.0317; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Safran RJ, 2008, CURR BIOL, V18, pR461, DOI 10.1016/j.cub.2008.03.031; Safran RJ, 2008, BEHAV ECOL SOCIOBIOL, V62, P427, DOI 10.1007/s00265-007-0470-7; Safran RJ, 2006, CAN J ZOOL, V84, P1533, DOI 10.1139/Z06-176; Safran RJ, 2005, SCIENCE, V309, P2210, DOI 10.1126/science.1115090; Safran RJ, 2004, AM NAT, V164, P121, DOI 10.1086/422198; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Saino N, 1999, AM NAT, V154, P441, DOI 10.1086/303246; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Wang Y, 2001, EXP GERONTOL, V36, P1349, DOI 10.1016/S0531-5565(01)00095-X; Wiersma P, 2004, P ROY SOC B-BIOL SCI, V271, pS360, DOI 10.1098/rsbl.2004.0171	31	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9420	10.1371/journal.pone.0009420	http://dx.doi.org/10.1371/journal.pone.0009420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195540	gold, Green Published			2022-12-27	WOS:000274924300010
J	Chen, XJ; Larson, CS; West, J; Zhang, XM; Kaufman, DB				Chen, Xiaojuan; Larson, Courtney S.; West, Jason; Zhang, Xiaomin; Kaufman, Dixon B.			In Vivo Detection of Extrapancreatic Insulin Gene Expression in Diabetic Mice by Bioluminescence Imaging	PLOS ONE			English	Article							OVAL CELL ACTIVATION; LIVER; TRANSDIFFERENTIATION; DIFFERENTIATION; ELEMENTS; ISLETS; PDX-1	Background: Extrapancreatic tissues such as liver may serve as potential sources of tissue for generating insulin-producing cells. The dynamics of insulin gene promoter activity in extrapancreatic tissues may be monitored in vivo by bioluminescence-imaging (BLI) of transgenic mice Tg(RIP-luc) expressing the firefly luciferase (luc) under a rat-insulin gene promoter (RIP). Methods: The Tg(RIP-luc) mice were made diabetic by a single injection of the pancreatic beta-cell toxin streptozotocin. Control mice were treated with saline. Mice were subject to serum glucose measurement and bioluminescence imaging daily. On day eight of the treatment, mice were sacrificed and tissues harvested for quantitative luciferase activity measurement, luciferase protein cellular localization, and insulin gene expression analysis. Results: Streptozotocin-induced diabetic Tg(RIP-luc) mice demonstrated a dramatic decline in the BLI signal intensity in the pancreas and a concomitant progressive increase in the signal intensity in the liver. An average of 5.7 fold increase in the liver signal intensity was detected in the mice that were exposed to hyperglycemia for 8 days. Ex vivo quantitative assays demonstrated a 34-fold induction of the enzyme activity in the liver of streptozotocin-treated mice compared to that of the buffer-treated controls. Luciferase-positive cells with oval-cell-like morphology were detected by immunohistochemistry in the liver samples of diabetic mice, but not in that of non-treated control transgenic mice. Gene expression analyses of liver RNA confirmed an elevated expression of insulin genes in the liver tissue exposed to hyperglycemia. Conclusions: BLI is a sensitive method for monitoring insulin gene expression in extrapancreatic tissues in vivo. The BLI system may be used for in vivo screening of biological events or pharmacologic activators that have the potential of stimulating the generation of extrapancreatic insulin-producing cells.	[Chen, Xiaojuan; Larson, Courtney S.; West, Jason; Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA; [Chen, Xiaojuan; Zhang, Xiaomin; Kaufman, Dixon B.] Northwestern Univ, Feinberg Sch Med, Comprehens Transplantat Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chen, XJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA.	x-chen@northwestern.edu	Kaufman, Dixon B/E-4524-2016		National Institutes of Health [DK063565]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK063565 (D. B. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Xiaojuan, 2004, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V4, P301, DOI 10.2174/1568013043357365; Chen XJ, 2006, TRANSPLANTATION, V81, P1421, DOI 10.1097/01.tp.0000206109.71181.bf; Contag CH, 2002, J MAGN RESON IMAGING, V16, P378, DOI 10.1002/jmri.10178; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Kim S, 2007, LAB INVEST, V87, P702, DOI 10.1038/labinvest.3700561; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Porat Shay, 2007, Curr Diab Rep, V7, P304, DOI 10.1007/s11892-007-0049-8; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Vorobeychik M, 2008, J MOL HISTOL, V39, P463, DOI 10.1007/s10735-008-9185-y; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012	21	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9397	10.1371/journal.pone.0009397	http://dx.doi.org/10.1371/journal.pone.0009397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195523	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924200019
J	Zammar, GR; Shah, J; Ferreira, APB; Cofiel, L; Lyles, KW; Pietrobon, R				Zammar, Guilherme Roberto; Shah, Jatin; Bonilauri Ferreira, Ana Paula; Cofiel, Luciana; Lyles, Kenneth W.; Pietrobon, Ricardo			Qualitative Analysis of the Interdisciplinary Interaction between Data Analysis Specialists and Novice Clinical Researchers	PLOS ONE			English	Article							MEDICAL-RESEARCH; STATISTICIAN	Background: The inherent complexity of statistical methods and clinical phenomena compel researchers with diverse domains of expertise to work in interdisciplinary teams, where none of them have a complete knowledge in their counterpart's field. As a result, knowledge exchange may often be characterized by miscommunication leading to misinterpretation, ultimately resulting in errors in research and even clinical practice. Though communication has a central role in interdisciplinary collaboration and since miscommunication can have a negative impact on research processes, to the best of our knowledge, no study has yet explored how data analysis specialists and clinical researchers communicate over time. Methods/Principal Findings: We conducted qualitative analysis of encounters between clinical researchers and data analysis specialists (epidemiologist, clinical epidemiologist, and data mining specialist). These encounters were recorded and systematically analyzed using a grounded theory methodology for extraction of emerging themes, followed by data triangulation and analysis of negative cases for validation. A policy analysis was then performed using a system dynamics methodology looking for potential interventions to improve this process. Four major emerging themes were found. Definitions using lay language were frequently employed as a way to bridge the language gap between the specialties. Thought experiments presented a series of "what if'' situations that helped clarify how the method or information from the other field would behave, if exposed to alternative situations, ultimately aiding in explaining their main objective. Metaphors and analogies were used to translate concepts across fields, from the unfamiliar to the familiar. Prolepsis was used to anticipate study outcomes, thus helping specialists understand the current context based on an understanding of their final goal. Conclusion/Significance: The communication between clinical researchers and data analysis specialists presents multiple challenges that can lead to errors.	[Zammar, Guilherme Roberto] PUCPR, Curitiba, Parana, Brazil; [Shah, Jatin; Pietrobon, Ricardo] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Shah, Jatin; Bonilauri Ferreira, Ana Paula; Cofiel, Luciana; Pietrobon, Ricardo] Duke Univ, Res Res Grp, Durham, NC USA; [Bonilauri Ferreira, Ana Paula] Univille Univ, Dept Dent, Joinville, Brazil; [Cofiel, Luciana] Univ Sao Paulo, Dept Psychiat, BR-05508 Sao Paulo, Brazil; [Lyles, Kenneth W.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Pietrobon, Ricardo] Duke Univ, Dept Surg, Durham, NC USA	Pontificia Universidade Catolica do Parana; National University of Singapore; Duke University; Universidade da Regiao de Joinville; Universidade de Sao Paulo; Duke University; Duke University	Zammar, GR (corresponding author), PUCPR, Curitiba, Parana, Brazil.	rpietro@duke.edu	Shah, Jatin/B-6039-2011	Shah, Jatin/0000-0002-2457-491X; Pietrobon, Ricardo/0000-0003-2996-2193				ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2817, DOI 10.1001/jama.287.21.2817; ALTMAN DG, 1991, PRACTICAL STAT MED R, V282, P1; Anapolitanos DA., 1991, THOUGHT EXPT SCI PHI, P87; [Anonymous], 2000, BUSINESS DYNAMICS; Berman Nancy, 2007, V404, P489, DOI 10.1007/978-1-59745-530-5_23; Bossel H., 2007, SYSTEMS MODELS COMPL; Bowman AW, 2007, ASTA-ADV STAT ANAL, V91, P361, DOI 10.1007/s10182-007-0039-9; BROWN JR, 1996, THOUGHT EXPT SUBSTAN; Buderer NMF, 1999, AM J EMERG MED, V17, P692, DOI 10.1016/S0735-6757(99)90162-6; DAVIDSON D, 1978, CRIT INQUIRY, V5, P31, DOI 10.1086/447971; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; GOLDSTEIN H, 1961, PUBLIC HEALTH REP, V76, P43, DOI 10.2307/4591058; GWYN R, 2002, COMMUNICATING HLTH I; JOLLIFFE F, 2000, LEARNING EXPERIENCE, P355; Martin M. A., 2003, J STAT ED, V11; Pietrobon Ricardo, 2004, BMC Med Res Methodol, V4, P29, DOI 10.1186/1471-2288-4-29; Ploeg J., 1999, EVID BASED NURS, V2, P36, DOI [10.1136/ebn.2.2.36, DOI 10.1136/EBN.2.2.36]; Reich SM, 2006, AM J COMMUN PSYCHOL, V38, P51, DOI 10.1007/s10464-006-9064-1; SALTER L, 1997, OUTSIDE LINES; Shah J, 2009, ACAD MED, V84, P511, DOI 10.1097/ACM.0b013e31819a8c3c; Sprent P, 2003, SWISS MED WKLY, V133, P522; Strasak AM, 2007, AM STAT, V61, P47, DOI 10.1198/000313007X170242; Strauss A., 1998, BASICS QUALITATIVE R; Svensson E., 2001, TRAINING RES USE STA, P23; TONGEREN GWV, 1997, METAPHORS MED TEXTS; ZAMMAR GR, 2009, QUALITATIVE AN UNPUB	27	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9400	10.1371/journal.pone.0009400	http://dx.doi.org/10.1371/journal.pone.0009400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195374	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200022
J	Prill, RJ; Marbach, D; Saez-Rodriguez, J; Sorger, PK; Alexopoulos, LG; Xue, XW; Clarke, ND; Altan-Bonnet, G; Stolovitzky, G				Prill, Robert J.; Marbach, Daniel; Saez-Rodriguez, Julio; Sorger, Peter K.; Alexopoulos, Leonidas G.; Xue, Xiaowei; Clarke, Neil D.; Altan-Bonnet, Gregoire; Stolovitzky, Gustavo			Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges	PLOS ONE			English	Article							REGULATORY NETWORKS; BENCHMARKING; EXPRESSION; INFERENCE; YEAST	Background: Systems biology has embraced computational modeling in response to the quantitative nature and increasing scale of contemporary data sets. The onslaught of data is accelerating as molecular profiling technology evolves. The Dialogue for Reverse Engineering Assessments and Methods ( DREAM) is a community effort to catalyze discussion about the design, application, and assessment of systems biology models through annual reverse-engineering challenges. Methodology and Principal Findings: We describe our assessments of the four challenges associated with the third DREAM conference which came to be known as the DREAM3 challenges: signaling cascade identification, signaling response prediction, gene expression prediction, and the DREAM3 in silico network challenge. The challenges, based on anonymized data sets, tested participants in network inference and prediction of measurements. Forty teams submitted 413 predicted networks and measurement test sets. Overall, a handful of best-performer teams were identified, while a majority of teams made predictions that were equivalent to random. Counter-intuitively, combining the predictions of multiple teams ( including the weaker teams) can in some cases improve predictive power beyond that of any single method. Conclusions: DREAM provides valuable feedback to practitioners of systems biology modeling. Lessons learned from the predictions of the community provide much-needed context for interpreting claims of efficacy of algorithms described in the scientific literature.	[Prill, Robert J.; Stolovitzky, Gustavo] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Marbach, Daniel] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, Lausanne, Switzerland; [Saez-Rodriguez, Julio; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Saez-Rodriguez, Julio; Sorger, Peter K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alexopoulos, Leonidas G.] Natl Tech Univ Athens, Dept Mech Engn, Athens, Greece; [Xue, Xiaowei; Clarke, Neil D.] Genome Inst Singapore, Singapore, Singapore; [Altan-Bonnet, Gregoire] Mem Sloan Kettering Canc Ctr, Program Computat Biol & Immunol, New York, NY 10021 USA	International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); National Technical University of Athens; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Memorial Sloan Kettering Cancer Center	Prill, RJ (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	gustavo@us.ibm.com	Clarke, Neil/D-9613-2014; Alexopoulos, Leonidas/AAN-1148-2021; Saez-Rodriguez, Julio/H-7114-2019	Saez-Rodriguez, Julio/0000-0002-8552-8976; Altan-Bonnet, Gregoire/0000-0002-7283-3162; Sorger, Peter/0000-0002-3364-1838; Alexopoulos, Leonidas G/0000-0003-0425-166X	National Institutes of Health (NIH) Roadmap Initiative [P50-GM68762, U54-CA11296, AI083408]; Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet); IBM Computational Biology Center; Marie Curie [MIRG-CT-2007-46531]; National Science Foundation (NSF) [0848030]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet); IBM Computational Biology Center(International Business Machines (IBM)); Marie Curie(European Commission); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G. S. and R. P. acknowledge support of the National Institutes of Health (NIH) Roadmap Initiative, the Columbia University Center for Multiscale Analysis Genomic and Cellular Networks (MAGNet), and the IBM Computational Biology Center. L. A. acknowledges funding from the Marie Curie MIRG-CT-2007-46531 grant. J.R. acknowledges funding from NIH P50-GM68762 and U54-CA11296 grants. G.A.-B. acknowledges funding from a National Science Foundation (NSF) grant 0848030 and NIH grant AI083408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS L, 2009, NETWORKS RE IN PRESS; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; BOURQUE G, PLOS ONE UNPUB; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Camacho D, 2007, ANN NY ACAD SCI, V1115, P73, DOI 10.1196/annals.1407.006; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; David LA, 2007, ANN NY ACAD SCI, V1115, P90, DOI 10.1196/annals.1407.009; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; GUEX N, PLOS ONE IN PRESS; GUSTAFSSON M, PLOS ONE IN PRESS; Hache H, 2009, BIOINFORMATICS, V25, P1205, DOI 10.1093/bioinformatics/btp115; Haynes BC, 2009, BIOINFORMATICS, V25, P801, DOI 10.1093/bioinformatics/btp068; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JIANHUA R, PLOS BIOL UNPUB; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; MADAR A, PLOS ONE UNPUB; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Moult J, 2006, PHILOS T R SOC B, V361, P453, DOI 10.1098/rstb.2005.1810; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; YIP K, PLOS ONE IN PRESS; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; 2009, DREAM	33	292	295	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9202	10.1371/journal.pone.0009202	http://dx.doi.org/10.1371/journal.pone.0009202			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186320	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924000002
J	Nguyen, JT; Hoopes, JD; Le, MH; Smee, DF; Patick, AK; Faix, DJ; Blair, PJ; de Jong, MD; Prichard, MN; Went, GT				Nguyen, Jack T.; Hoopes, Justin D.; Le, Minh H.; Smee, Donald F.; Patick, Amy K.; Faix, Dennis J.; Blair, Patrick J.; de Jong, Menno D.; Prichard, Mark N.; Went, Gregory T.			Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro	PLOS ONE			English	Article							CELL-CULTURE; HEMAGGLUTININ; INFECTIONS; SURVEILLANCE; MECHANISM; THERAPY	The rapid emergence and subsequent spread of the novel 2009 Influenza A/H1N1 virus (2009 H1N1) has prompted the World Health Organization to declare the first pandemic of the 21(st) century, highlighting the threat of influenza to public health and healthcare systems. Widespread resistance to both classes of influenza antivirals (adamantanes and neuraminidase inhibitors) occurs in both pandemic and seasonal viruses, rendering these drugs to be of marginal utility in the treatment modality. Worldwide, virtually all 2009 H1N1 and seasonal H3N2 strains are resistant to the adamantanes (rimantadine and amantadine), and the majority of seasonal H1N1 strains are resistant to oseltamivir, the most widely prescribed neuraminidase inhibitor (NAI). To address the need for more effective therapy, we evaluated the in vitro activity of a triple combination antiviral drug (TCAD) regimen composed of drugs with different mechanisms of action against drug-resistant seasonal and 2009 H1N1 influenza viruses. Amantadine, ribavirin, and oseltamivir, alone and in combination, were tested against amantadine-and oseltamivir-resistant influenza A viruses using an in vitro infection model in MDCK cells. Our data show that the triple combination was highly synergistic against drug-resistant viruses, and the synergy of the triple combination was significantly greater than the synergy of any double combination tested (P < 0.05), including the combination of two NAIs. Surprisingly, amantadine and oseltamivir contributed to the antiviral activity of the TCAD regimen against amantadine-and oseltamivir-resistant viruses, respectively, at concentrations where they had no activity as single agents, and at concentrations that were clinically achievable. Our data demonstrate that the TCAD regimen composed of amantadine, ribavirin, and oseltamivir is highly synergistic against resistant viruses, including 2009 H1N1. The TCAD regimen overcomes baseline drug resistance to both classes of approved influenza antivirals, and thus may represent a highly active antiviral therapy for seasonal and pandemic influenza.	[Nguyen, Jack T.; Le, Minh H.; Patick, Amy K.; Went, Gregory T.] Adamas Pharmaceut Inc, Emeryville, CA USA; [Hoopes, Justin D.; Smee, Donald F.] Utah State Univ, Logan, UT 84322 USA; [Faix, Dennis J.; Blair, Patrick J.] USN, Hlth Res Ctr, San Diego, CA 92152 USA; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Prichard, Mark N.] Univ Alabama Birmingham, Birmingham, AL USA	Utah System of Higher Education; Utah State University; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); University of Amsterdam; Academic Medical Center Amsterdam; University of Alabama System; University of Alabama Birmingham	Nguyen, JT (corresponding author), Adamas Pharmaceut Inc, Emeryville, CA USA.	jnguyen@adamaspharma.com; gwent@adamaspharma.com		Prichard, Mark/0000-0002-2720-6661	Adamas Pharmaceuticals	Adamas Pharmaceuticals	Funding for this study was provided by Adamas Pharmaceuticals. Authors from Adamas Pharmaceuticals participated in the design of the studies, analysis of the data, and preparing the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Adinolfi LE, 2003, GUT, V52, P701, DOI 10.1136/gut.52.5.701; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; BROWNE MJ, 1979, ANTIMICROB AGENTS CH, V15, P747, DOI 10.1128/AAC.15.6.747; Cameron CE, 2001, CURR OPIN INFECT DIS, V14, P757, DOI 10.1097/00001432-200112000-00015; *CDC, 2009, FLUVIEW 2009 2010 IN; *CDC, 2008, FLUVIEW 2008 2009 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Chan M, 2009, SWINE INFLUENZA; Chan M., 2009, WORLD NOW START 2009; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; DANIELS RS, 1985, CELL, V40, P431, DOI 10.1016/0092-8674(85)90157-6; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; *END PHARM INC, 2007, SYMM PACK INS; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V18, P536, DOI 10.1128/AAC.18.4.536; HAYDEN FG, 1984, ANTIMICROB AGENTS CH, V25, P53, DOI 10.1128/AAC.25.1.53; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; JOHNSON CE, 2009, DETERMINATION PUBLIC; MADREN LK, 1995, ANTIVIR CHEM CHEMOTH, V6, P109, DOI 10.1177/095632029500600205; Masihi KN, 2007, J CHEMOTHERAPY, V19, P295, DOI 10.1179/joc.2007.19.3.295; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Nguyen JT, 2009, ANTIMICROB AGENTS CH, V53, P4115, DOI 10.1128/AAC.00476-09; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; PRICHARD MN, 1993, ANTIMICROB AGENTS CH, V37, P540, DOI 10.1128/AAC.37.3.540; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; *ROCH LAB INC, 2008, TAM PACK INS; *SCHER CORP, 2008, REB OFF FDA INF; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Smee DF, 2002, CHEMOTHERAPY, V48, P88, DOI 10.1159/000057668; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Smee DF, 2009, ANTIMICROB AGENTS CH, V53, P2120, DOI 10.1128/AAC.01012-08; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525	40	124	135	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9332	10.1371/journal.pone.0009332	http://dx.doi.org/10.1371/journal.pone.0009332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179772	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923900006
J	Mishto, M; Bellavista, E; Ligorio, C; Textoris-Taube, K; Santoro, A; Giordano, M; D'Alfonso, S; Listi, F; Nacmias, B; Cellini, E; Leone, M; Grimaldi, LME; Fenoglio, C; Esposito, F; Martinelli-Boneschi, F; Galimberti, D; Scarpini, E; Seifert, U; Amato, MP; Caruso, C; Foschini, MP; Kloetzel, PM; Franceschi, C				Mishto, Michele; Bellavista, Elena; Ligorio, Claudia; Textoris-Taube, Kathrin; Santoro, Aurelia; Giordano, Mara; D'Alfonso, Sandra; Listi, Florinda; Nacmias, Benedetta; Cellini, Elena; Leone, Maurizio; Grimaldi, Luigi M. E.; Fenoglio, Chiara; Esposito, Federica; Martinelli-Boneschi, Filippo; Galimberti, Daniela; Scarpini, Elio; Seifert, Ulrike; Amato, Maria Pia; Caruso, Calogero; Foschini, Maria P.; Kloetzel, Peter M.; Franceschi, Claudio			Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; CD8(+) T-CELLS; BLOOD-BRAIN-BARRIER; INTERFERON-GAMMA; ENDOTHELIAL-CELLS; IN-VITRO; PROTEASOME; POLYMORPHISM; INDUCTION; RESPONSES	Background: Albeit several studies pointed out the pivotal role that CD4+T cells have in Multiple Sclerosis, the CD8+ T cells involvement in the pathology is still in its early phases of investigation. Proteasome degradation is the key step in the production of MHC class I-restricted epitopes and therefore its activity could be an important element in the activation and regulation of autoreactive CD8+ T cells in Multiple Sclerosis. Methodology/Principal Findings: Immunoproteasomes and PA28-alpha beta regulator are present in MS affected brain area and accumulated in plaques. They are expressed in cell types supposed to be involved in MS development such as neurons, endothelial cells, oligodendrocytes, macrophages/macroglia and lymphocytes. Furthermore, in a genetic study on 1262 Italian MS cases and 845 controls we observed that HLA-A*02+ female subjects carrying the immunoproteasome LMP2 codon 60HH variant have a reduced risk to develop MS. Accordingly, immunoproteasomes carrying the LMP2 60H allele produce in vitro a lower amount of the HLA-A*0201 restricted immunodominant epitope MBP111-119. Conclusion/Significance: The immunoproteasome LMP2 60HH variant reduces the risk to develop MS amongst Italian HLA-A*02+ females. We propose that such an effect is mediated by the altered proteasome-dependent production of a specific MBP epitope presented on the MHC class I. Our observations thereby support the hypothesis of an involvement of immunoproteasome in the MS pathogenesis.	[Mishto, Michele; Santoro, Aurelia; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Mishto, Michele; Bellavista, Elena; Santoro, Aurelia; Franceschi, Claudio] Interdept Ctr Studies Biophys Bioinformat & Bioco, Bologna, Italy; [Mishto, Michele; Textoris-Taube, Kathrin; Seifert, Ulrike; Kloetzel, Peter M.] Fac Med Charite, Inst Biochem, Berlin, Germany; [Ligorio, Claudia; Foschini, Maria P.] Univ Bologna, Dept Hematol & Oncol, Sect Anat Pathol, Bologna, Italy; [Ligorio, Claudia; Foschini, Maria P.] Bellaria Hosp, Bologna, Italy; [Giordano, Mara; D'Alfonso, Sandra] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Giordano, Mara; D'Alfonso, Sandra] Univ Piemonte Orientale, IRCAD, Novara, Italy; [Listi, Florinda; Caruso, Calogero] Univ Palermo, Dept Biopathol & Biomed Methodol, Palermo, Italy; [Nacmias, Benedetta; Cellini, Elena; Amato, Maria Pia] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; [Leone, Maurizio] Osped Maggiore La Carita, Neurol Clin, Novara, Italy; [Grimaldi, Luigi M. E.] Ist San Raffaele G Giglio Cefalu, UO Neurol Fdn, Cefalu, PA, Italy; [Fenoglio, Chiara; Galimberti, Daniela; Scarpini, Elio] Univ Milan, Dept Neurol Sci, IRCCS Fdn, Osped Maggiore Policlin, Milan, Italy; [Esposito, Federica; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Esposito, Federica; Martinelli-Boneschi, Filippo] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy	University of Bologna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bologna; AUSL di Bologna; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Palermo; University of Florence; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Mishto, M (corresponding author), Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.	michele.mishto@charite.de	Leone, Maurizio A./J-4130-2016; Boneschi, Filippo Martinelli/H-8592-2012; Amato, Maria Pia/AAC-5940-2022; amato, Maria Pia/AAL-5998-2020; D'Alfonso, Sandra/K-7295-2014; Franceschi, Claudio/L-4484-2017; Esposito, Federica/K-6537-2016; mishto, michele/A-5592-2010; Cellini, Elena/J-4031-2018; GIORDANO, Mara/AAB-1379-2019; Nacmias, Benedetta/J-5084-2018; Galimberti, Daniela/N-7209-2019; Grimaldi, Luigi/L-2614-2019; Scarpini, Elio/K-6547-2016; Foschini, Maria P./A-6306-2016	Leone, Maurizio A./0000-0002-6339-5738; amato, Maria Pia/0000-0003-3325-3760; D'Alfonso, Sandra/0000-0002-3983-9925; Franceschi, Claudio/0000-0001-9841-6386; Esposito, Federica/0000-0003-2550-0805; mishto, michele/0000-0003-3042-2792; Cellini, Elena/0000-0001-7597-940X; GIORDANO, Mara/0000-0001-6686-4600; Nacmias, Benedetta/0000-0001-9338-9040; Galimberti, Daniela/0000-0002-9284-5953; Scarpini, Elio/0000-0002-6395-2119; Rapa, Anna/0000-0002-5523-5224; Foschini, Maria P./0000-0001-7079-7260; Santoro, Aurelia/0000-0002-7187-1116; martinelli boneschi, filippo/0000-0002-9955-1368	Italian Ministry of Health; European Commission [FP6]; Fondazione Italiana Sclerosi Multipla (FISM) [2003/R26]; BioPharmaNet [2002/R/40, 2005/R/10, 2008/R/11]; University of Bologna (FRO); Regione Piemonte; Sonderforschungsbereich [SFB-507, SFB-421]; Neurocure; A. V. Humboldt PostDoc fellowship;  [TR43]	Italian Ministry of Health(Ministry of Health, Italy); European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); BioPharmaNet; University of Bologna (FRO); Regione Piemonte(Regione Piemonte); Sonderforschungsbereich(German Research Foundation (DFG)); Neurocure; A. V. Humboldt PostDoc fellowship(Alexander von Humboldt Foundation); 	This work was financed in part by the grant Giovani Ricercatori 2007 from Italian Ministry of Health to MM, DG and FMB, by a grant from the European Commission Integrated Project PROTEOMAGE (FP6) to CF, by the finalized projects of Fondazione Italiana Sclerosi Multipla (FISM) cod. 2003/R26 and BioPharmaNet to CF and 2002/R/40 and 2005/R/10, 2008/R/11 (Genoa) to SD'A, by the University of Bologna (FRO) to MPF, by the Regione Piemonte (Ricerca Sanitaria Finalizzata Project and Ricerca Sanitaria Applicata-CIPE Project) to SD'A, by Associazione Amici del Centro Dino Ferrari and IRCCS Ospedale Maggiore Policlinico, Milano to DG and by the grants Sonderforschungsbereich (SFB-507, SFB-421) to PMK and US, the grants TR43 and Neurocure to PMK. MM benefited from the A. V. Humboldt PostDoc fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERGAMASCHI L, 2009, GENES IMMUN; BOURDOULOUS S, 1995, EUR J IMMUNOL, V25, P1176, DOI 10.1002/eji.1830250507; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; El-Etr M, 2005, J NEUROL SCI, V233, P49, DOI 10.1016/j.jns.2005.03.004; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fugger L, 2009, NAT REV IMMUNOL; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217; Kraemer U, 2007, GENES IMMUN, V8, P513, DOI 10.1038/sj.gene.6364404; KUCKELKORN U, 1995, EUR J IMMUNOL, V25, P2605, DOI 10.1002/eji.1830250930; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; LEWONTIN RC, 1988, THEOR POPUL BIOL, V34, P177, DOI 10.1016/0040-5809(88)90041-X; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Macagno A, 1999, EUR J IMMUNOL, V29, P4037, DOI 10.1002/(SICI)1521-4141(199912)29:12<4037::AID-IMMU4037>3.0.CO;2-T; Maksymowych WP, 2000, J RHEUMATOL, V27, P183; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meuth SG, 2008, J NEUROL, V255, P93, DOI 10.1007/s00415-008-6017-7; Mishto M, 2006, BIOL CHEM, V387, P417, DOI 10.1515/BC.2006.056; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8; Mishto M, 2002, EXP GERONTOL, V37, P301, DOI 10.1016/S0531-5565(01)00196-6; MISHTO M, 2009, UBIQUITIN PROTEASOME; Mishto M, 2008, J MOL BIOL, V377, P1607, DOI 10.1016/j.jmb.2008.01.086; Moldovan IR, 2008, J NEUROIMMUNOL, V193, P161, DOI 10.1016/j.jneuroim.2007.10.010; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Papenfuss Tracey L, 2007, ScientificWorldJournal, V7, P112; Pastorino R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006526; Pelfrey CM, 2005, J NEUROIMMUNOL, V167, P190, DOI 10.1016/j.jneuroim.2005.06.014; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; Perchellet A, 2008, P NATL ACAD SCI USA, V105, P14040, DOI 10.1073/pnas.0804970105; RISAU W, 1990, J CELL BIOL, V110, P1757, DOI 10.1083/jcb.110.5.1757; Silva AM, 2009, MULT SCLER, V15, P771, DOI 10.1177/1352458509104588; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Textoris-Taube K, 2007, J BIOL CHEM, V282, P12749, DOI 10.1074/jbc.M611644200; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; Valmori D, 1998, J IMMUNOL, V160, P1750; Vargas-Alarcon G, 2004, HUM IMMUNOL, V65, P1437, DOI 10.1016/j.humimm.2004.09.007; Wehenkel M, 2008, MOL BIOSYST, V4, P280, DOI 10.1039/b716221a; WILCOX CE, 1989, IMMUNOLOGY, V67, P435; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120	52	51	57	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9287	10.1371/journal.pone.0009287	http://dx.doi.org/10.1371/journal.pone.0009287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174631	gold, Green Published			2022-12-27	WOS:000274654700017
J	Sahini, L; Tempczyk-Russell, A; Agarwal, R				Sahini, Leepakshi; Tempczyk-Russell, Anna; Agarwal, Ritu			Large-Scale Sequence Analysis of Hemagglutinin of Influenza A Virus Identifies Conserved Regions Suitable for Targeting an Anti-Viral Response	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; MEMBRANE GLYCOPROTEIN; ANTIGENIC STRUCTURE; IMMUNE RECOGNITION; STRUCTURAL BASIS; SURFACE REGIONS; PROTEIN; ANTIBODIES; SUBTYPES; H5	Background: Influenza A viral surface protein, hemagglutinin, is the major target of neutralizing antibody response and hence a main constituent of all vaccine formulations. But due to its marked evolutionary variability, vaccines have to be reformulated so as to include the hemagglutinin protein from the emerging new viral strain. With the constant fear of a pandemic, there is critical need for the development of anti-viral strategies that can provide wider protection against any Influenza A pathogen. An anti-viral approach that is directed against the conserved regions of the hemaggutinin protein has a potential to protect against any current and new Influenza A virus and provide a solution to this ever-present threat to public health. Methodology/Principal Findings: Influenza A human hemagglutinin protein sequences available in the NCBI database, corresponding to H1, H2, H3 and H5 subtypes, were used to identify highly invariable regions of the protein. Nine such regions were identified and analyzed for structural properties like surface exposure, hydrophilicity and residue type to evaluate their suitability for targeting an anti-peptide antibody/anti-viral response. Conclusion/Significance: This study has identified nine conserved regions in the hemagglutinin protein, five of which have the structural characteristics suitable for an anti-viral/anti-peptide response. This is a critical step in the design of efficient anti-peptide antibodies as novel anti-viral agents against any Influenza A pathogen. In addition, these anti-peptide antibodies will provide broadly cross-reactive immunological reagents and aid the rapid development of vaccines against new and emerging Influenza A strains.	[Sahini, Leepakshi; Agarwal, Ritu] ChimericBio Inc, Dept Proc & Analyt Biochem, Long Isl City, NY USA; [Tempczyk-Russell, Anna] Accelrys Inc, Dept Computat Biol & Chem, San Diego, CA USA	BIOVIA	Sahini, L (corresponding author), ChimericBio Inc, Dept Proc & Analyt Biochem, Long Isl City, NY USA.	agarwalr@chimericbio.com			Chimericbio Incorporated	Chimericbio Incorporated	This work was supported by Chimericbio Incorporated, and software expertise was provided by Accelrys Incorporated as a collaborative effort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0; MULLER GM, 1982, P NATL ACAD SCI-BIOL, V79, P569, DOI 10.1073/pnas.79.2.569; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Palese P, 2004, NAT MED, V10, pS82, DOI 10.1038/nm1141; Rohm C, 1996, VIROLOGY, V217, P508, DOI 10.1006/viro.1996.0145; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; SCHMITZ HE, 1983, IMMUNOL COMMUN, V12, P161, DOI 10.3109/08820138309066866; Smirnov YA, 1999, ACTA VIROL, V43, P237; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; VANREGENMORTEL MHV, 1992, STRUCTURE ANTIGENS, P277; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	37	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9268	10.1371/journal.pone.0009268	http://dx.doi.org/10.1371/journal.pone.0009268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174650	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590600021
J	Gong, S; Blundell, TL				Gong, Sungsam; Blundell, Tom L.			Structural and Functional Restraints on the Occurrence of Single Amino Acid Variations in Human Proteins	PLOS ONE			English	Article							PHYTANOYL-COA HYDROXYLASE; NUCLEOTIDE POLYMORPHISMS; STABILITY CHANGES; MOLECULAR-BASIS; GENOME SEQUENCE; REFSUM-DISEASE; PREDICTION; MUTATIONS; DATABASE; CONSTRAINTS	Human genetic variation is the incarnation of diverse evolutionary history, which reflects both selectively advantageous and selectively neutral change. In this study, we catalogue structural and functional features of proteins that restrain genetic variation leading to single amino acid substitutions. Our variation dataset is divided into three categories: i) Mendelian disease-related variants, ii) neutral polymorphisms and iii) cancer somatic mutations. We characterize structural environments of the amino acid variants by the following properties: i) side-chain solvent accessibility, ii) main-chain secondary structure, and iii) hydrogen bonds from a side chain to a main chain or other side chains. To address functional restraints, amino acid substitutions in proteins are examined to see whether they are located at functionally important sites involved in protein-protein interactions, protein-ligand interactions or catalytic activity of enzymes. We also measure the likelihood of amino acid substitutions and the degree of residue conservation where variants occur. We show that various types of variants are under different degrees of structural and functional restraints, which affect their occurrence in human proteome.	[Gong, Sungsam; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Biocomp Grp, Cambridge CB2 1QW, England	University of Cambridge	Gong, S (corresponding author), Univ Cambridge, Dept Biochem, Biocomp Grp, Tennis Court Rd, Cambridge CB2 1QW, England.	tom@cryst.bioc.cam.ac.uk	Gong, Sungsam/AAW-6501-2020	Gong, Sungsam/0000-0001-5796-4423	Wellcome Trust [GR079281RR]	Wellcome Trust(Wellcome TrustEuropean Commission)	TLB acknowledges support from the Wellcome Trust (GR079281RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bao L, 2006, FEBS LETT, V580, P1231, DOI 10.1016/j.febslet.2006.01.035; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Dayhoff MO, 1968, ATLAS PROTEIN SEQUEN, P33; Deane CM, 1999, PROTEIN ENG, V12, P1025, DOI 10.1093/protein/12.12.1025; DEHOUCK Y, 2009, BIOINFORMATICS; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gong SS, 2009, BIOCHEM SOC T, V37, P727, DOI 10.1042/BST0370727; Gong S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000179; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; HUBBARD TJP, 1987, PROTEIN ENG, V1, P159, DOI 10.1093/protein/1.3.159; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jansen GA, 2000, HUM MOL GENET, V9, P1195, DOI 10.1093/hmg/9.8.1195; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Jansen GA, 1999, ADV EXP MED BIOL, V466, P371; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Lee S, 2009, BIOINFORMATICS, V25, P1976, DOI 10.1093/bioinformatics/btp300; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masso M, 2008, BIOINFORMATICS, V24, P2002, DOI 10.1093/bioinformatics/btn353; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OVERINGTON J, 1990, P ROY SOC B-BIOL SCI, V241, P132, DOI 10.1098/rspb.1990.0077; OVERINGTON J, 1992, PROTEIN SCI, V1, P216; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Steward RE, 2003, TRENDS GENET, V19, P505, DOI 10.1016/S0168-9525(03)00195-1; Sunyaev S, 1999, J MOL MED-JMM, V77, P754, DOI 10.1007/s001099900059; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; TALAVERA D, 2009, PROTEINS; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Worth CL, 2009, NAT REV MOL CELL BIO, V10, P709, DOI 10.1038/nrm2762; Worth CL, 2009, PROTEINS, V75, P413, DOI 10.1002/prot.22248; Yip YL, 2008, HUM MUTAT, V29, P361, DOI 10.1002/humu.20671; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020	57	32	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9186	10.1371/journal.pone.0009186	http://dx.doi.org/10.1371/journal.pone.0009186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169194	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474600007
J	Ma, HX; Zheng, L; Liu, YB; Zhao, CY; Harrison, TJ; Ma, YY; Sun, SH; Zhang, JG; Wang, YC				Ma, Hongxia; Zheng, Lin; Liu, Yunbo; Zhao, Chenyan; Harrison, Tim J.; Ma, Yuyuan; Sun, Shuhua; Zhang, Jingang; Wang, Youchun			Experimental Infection of Rabbits with Rabbit and Genotypes 1 and 4 Hepatitis E Viruses	PLOS ONE			English	Article							RT-PCR ASSAY; SWINE; HEV; SEQUENCE; PIGS; PREVALENCE; DEER; PATHOGENESIS; CHINA; TRANSMISSION	Background: A recent study provided evidence that farmed rabbits in China harbor a novel hepatitis E virus (HEV) genotype. Although the rabbit HEV isolate had 77-79% nucleotide identity to the mammalian HEV genotypes 1 to 4, their genomic organization is very similar. Since rabbits are used widely experimentally, including as models of infection, we investigated whether they constitute an appropriate animal model for human HEV infection. Methods: Forty-two SPF rabbits were divided randomly into eleven groups and inoculated with six different isolates of rabbit HEV, two different doses of a second-passage rabbit HEV, and with genotype 1 and 4 HEV. Sera and feces were collected weekly after inoculation. HEV antigen, RNA, antibody and alanine aminotransferase in sera and HEV RNA in feces were detected. The liver samples were collected during necropsy subject to histopathological examination. Findings: Rabbits inoculated with rabbit HEV became infected with HEV, with viremia, fecal virus shedding and high serum levels of viral antigens, and developed hepatitis, with elevation of the liver enzyme, ALT. The severity of disease corresponded to the infectious dose (genome equivalents), with the most severe hepatic disease caused by strain GDC54-18. However, only two of nine rabbits infected with HEV genotype 4, and none infected with genotype 1, developed hepatitis although six of nine rabbits inoculated with the genotype 1 HEV and in all rabbits inoculated with the genotype 4 HEV seroconverted to be positive for anti-HEV IgG antibody by 14 weeks post-inoculation. Conclusions: These data indicate that rabbits are an appropriate model for rabbit HEV infection but are not likely to be useful for the study of human HEV. The rabbit HEV infection of rabbits may provide an appropriate parallel animal model to study HEV pathogenesis.	[Ma, Hongxia; Zhao, Chenyan; Wang, Youchun] Natl Inst Control Pharmaceut & Biol Prod, Dept Cellular Biol, Beijing, Peoples R China; [Zheng, Lin; Ma, Yuyuan; Zhang, Jingang] Acad Mil Med Sci, Inst Transfus Med, Natl Ctr Biomed Anal, Lab Viral Detect, Beijing, Peoples R China; [Liu, Yunbo; Sun, Shuhua] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100037, Peoples R China; [Liu, Yunbo; Sun, Shuhua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Hongxia] Henan Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Harrison, Tim J.] UCL, Sch Med, Div Med, London W1N 8AA, England	National Institute of Food & Drug Control - China; Academy of Military Medical Sciences - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of London; University College London; UCL Medical School	Ma, HX (corresponding author), Natl Inst Control Pharmaceut & Biol Prod, Dept Cellular Biol, Beijing, Peoples R China.	wychun3@yahoo.com	Harrison, Tim J/C-6550-2009		Ministry of Science and Technology, China [2006AA02Z453]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by the 863 project (grant: 2006AA02Z453) from the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 1997, Trop Gastroenterol, V18, P49; Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376; Arankalle VA, 2001, J VIRAL HEPATITIS, V8, P223, DOI 10.1046/j.1365-2893.2001.00290.x; Billam P, 2005, J VIROL, V79, P3429, DOI 10.1128/JVI.79.6.3429-3437.2005; Bouwknegt M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-7; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Emerson SU, 2001, P NATL ACAD SCI USA, V98, P15270, DOI 10.1073/pnas.251555098; Favorov MO, 2000, J INFECT DIS, V181, P449, DOI 10.1086/315273; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Halbur PG, 2001, J CLIN MICROBIOL, V39, P918, DOI 10.1128/JCM.39.3.918-923.2001; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang WJ, 2008, J MED VIROL, V80, P824, DOI 10.1002/jmv.21140; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Kasorndorkbua C, 2002, J VIROL METHODS, V101, P71, DOI 10.1016/S0166-0934(01)00420-7; Panda SK, 2007, REV MED VIROL, V17, P151, DOI 10.1002/rmv.522; Lee YH, 2009, VET J, V179, P417, DOI 10.1016/j.tvjl.2007.10.028; Li WG, 2009, J MED VIROL, V81, P1591, DOI 10.1002/jmv.21573; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; MA H, 2009, ARCH VIROL; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng XJ, 1998, ARCH VIROL, V143, P1405, DOI 10.1007/s007050050384; Meng XJ, 1998, J VIROL, V72, P9714, DOI 10.1128/JVI.72.12.9714-9721.1998; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Nakamura M, 2006, HEPATOL RES, V34, P137, DOI 10.1016/j.hepres.2005.10.010; Purcell R H, 2001, ILAR J, V42, P161; Saad MD, 2007, INFECT GENET EVOL, V7, P368, DOI 10.1016/j.meegid.2006.07.007; Sonoda H, 2004, J CLIN MICROBIOL, V42, P5371, DOI 10.1128/JCM.42.11.5371-5374.2004; Takahashi K, 2004, VIROLOGY, V330, P501, DOI 10.1016/j.virol.2004.10.006; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Tei S, 2004, J MED VIROL, V74, P67, DOI 10.1002/jmv.20147; TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Wang YC, 2002, J MED VIROL, V67, P516, DOI 10.1002/jmv.10131; Williams TPE, 2001, J CLIN MICROBIOL, V39, P3040, DOI 10.1128/JCM.39.9.3040-3046.2001; Worm HC, 2002, MICROBES INFECT, V4, P657, DOI 10.1016/S1286-4579(02)01584-8; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhao CY, 2009, J GASTROENTEROL, V44, P139, DOI 10.1007/s00535-008-2281-7	42	77	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9160	10.1371/journal.pone.0009160	http://dx.doi.org/10.1371/journal.pone.0009160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161794	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800006
J	Crossett, A; Lauter, N; Love, TM				Crossett, Andrew; Lauter, Nick; Love, Tanzy M.			An Empirical Method for Establishing Positional Confidence Intervals Tailored for Composite Interval Mapping of QTL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC DISSECTION; MAIZE; MAP; ARCHITECTURE; LOCATION; GENOMICS; LINKAGE	Background: Improved genetic resolution and availability of sequenced genomes have made positional cloning of moderate-effect QTL realistic in several systems, emphasizing the need for precise and accurate derivation of positional confidence intervals (CIs) for QTL. Support interval (SI) methods based on the shape of the QTL likelihood curve have proven adequate for standard interval mapping, but have not been shown to be appropriate for use with composite interval mapping (CIM), which is one of the most commonly used QTL mapping methods. Results: Based on a non-parametric confidence interval (NPCI) method designed for use with the Haley-Knott regression method for mapping QTL, a CIM-specific method (CIM-NPCI) was developed to appropriately account for the selection of background markers during analysis of bootstrap-resampled data sets. Coverage probabilities and interval widths resulting from use of the NPCI, SI, and CIM-NPCI methods were compared in a series of simulations analyzed via CIM, wherein four genetic effects were simulated in chromosomal regions with distinct marker densities while heritability was fixed at 0.6 for a population of 200 isolines. CIM-NPCIs consistently capture the simulated QTL across these conditions while slightly narrower SIs and NPCIs fail at unacceptably high rates, especially in genomic regions where marker density is high, which is increasingly common for real studies. The effects of a known CIM bias toward locating QTL peaks at markers were also investigated for each marker density case. Evaluation of sub-simulations that varied according to the positions of simulated effects relative to the nearest markers showed that the CIM-NPCI method overcomes this bias, offering an explanation for the improved coverage probabilities when marker densities are high. Conclusions: Extensive simulation studies herein demonstrate that the QTL confidence interval methods typically used to positionally evaluate CIM results can be dramatically improved by accounting for the procedural complexity of CIM via an empirical approach, CIM-NPCI. Confidence intervals are a critical measure of QTL utility, but have received inadequate treatment due to a perception that QTL mapping is not sufficiently precise for procedural improvements to matter. Technological advances will continue to challenge this assumption, creating even more need for the current improvement to be refined.	[Crossett, Andrew; Love, Tanzy M.] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Lauter, Nick] Iowa State Univ, Dept Plant Pathol, Ames, IA USA; [Lauter, Nick] Iowa State Univ, Dept Agron, Ames, IA USA; [Lauter, Nick] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA	Carnegie Mellon University; Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Crossett, A (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	Tanzy_Love@urmc.rochester.edu	Love, Tanzy M T/F-3954-2010	Love, Tanzy M T/0000-0002-7154-0229	Department of Statistics at Carnegie Mellon University [3625-21000049- 00D]; National Science Foundation [DMS-0240019]; National Institutes of Health [T32 ES007271]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007271] Funding Source: NIH RePORTER	Department of Statistics at Carnegie Mellon University; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Department of Statistics at Carnegie Mellon University, by the USDA Agricultural Research Service (CRIS# 3625-21000049- 00D), by the National Science Foundation (DMS-0240019), and by the National Institutes of Health (T32 ES007271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Basten C. J., 2003, QTL CARTOGRAPHER VER; Chen LS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r219; DARVASI A, 1993, GENETICS, V134, P943; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Dupuis J, 1999, GENETICS, V151, P373; Fu Y, 2006, GENETICS, V174, P1671, DOI 10.1534/genetics.106.060376; Hussain T, 2007, J PLANT REGIST, V1, P81, DOI 10.3198/jpr2005.11.0414crs; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jookim J, 2002, GENET RES, V79, P259, DOI 10.1017/S001667230200561X; LANDER ES, 1989, GENETICS, V121, P185; Lauter N, 2008, PLANT GENOME-US, V1, P99, DOI 10.3835/plantgenome2008.06.0385; Lebreton CM, 1998, GENETICS, V148, P525; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Luo ZW, 2007, GENETICS, V176, P789, DOI 10.1534/genetics.106.067843; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MANGIN B, 1994, GENETICS, V138, P1301; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Visscher PM, 1996, GENETICS, V143, P1013; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9039	10.1371/journal.pone.0009039	http://dx.doi.org/10.1371/journal.pone.0009039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161743	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442600003
J	Gupta, S; Chakraborti, D; Sengupta, A; Basu, D; Das, S				Gupta, Sumanti; Chakraborti, Dipankar; Sengupta, Anindita; Basu, Debabrata; Das, Sampa			Primary Metabolism of Chickpea Is the Initial Target of Wound Inducing Early Sensed Fusarium oxysporum f. sp ciceri Race I	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; PLANT-PATHOGENIC FUNGI; SALICYLIC-ACID; CALLOSE DEPOSITION; DEFENSE RESPONSES; METHYL JASMONATE; SUCROSE SYNTHASE; GENE-EXPRESSION; PROTEIN-KINASE; ARIETINUM L.	Background: Biotrophic interaction between host and pathogen induces generation of reactive oxygen species that leads to programmed cell death of the host tissue specifically encompassing the site of infection conferring resistance to the host. However, in the present study, biotrophic relationship between Fusarium oxysporum and chickpea provided some novel insights into the classical concepts of defense signaling and disease perception where ROS (reactive oxygen species) generation followed by hypersensitive responses determined the magnitude of susceptibility or resistant potentiality of the host. Methodology/Principal Findings: Microscopic observations detected wound mediated in planta pathogenic establishment and its gradual progression within the host vascular tissue. cDNA-AFLP showed differential expression of many defense responsive elements. Real time expression profiling also validated the early recognition of the wound inducing pathogen by the host. The interplay between fungus and host activated changes in primary metabolism, which generated defense signals in the form of sugar molecules for combating pathogenic encounter. Conclusions/Significance: The present study showed the limitations of hypersensitive response mediated resistance, especially when foreign encounters involved the food production as well as the translocation machinery of the host. It was also predicted from the obtained results that hypersensitivity and active species generation failed to impart host defense in compatible interaction between chickpea and Fusarium. On the contrary, the defense related gene(s) played a critical role in conferring natural resistance to the resistant host. Thus, this study suggests that natural selection is the decisive factor for selecting and segregating out the suitable type of defense mechanism to be undertaken by the host without disturbing its normal metabolism, which could deviate from the known classical defense mechanisms.	[Gupta, Sumanti; Chakraborti, Dipankar; Sengupta, Anindita; Das, Sampa] Bose Inst, Plant Mol & Cellular Genet Sect, Kolkata, India; [Basu, Debabrata] Bose Inst, Dept Bot, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Gupta, S (corresponding author), Bose Inst, Plant Mol & Cellular Genet Sect, Kolkata, India.	sampa@bic.boseinst.ernet.in			Council of Scientific and Industrial Research [10-2(5) 2003(1)-EU. 11]; Bose Institute, Department of Science and Technology, Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute, Department of Science and Technology, Government of India(Department of Science & Technology (India))	SG is thankful to the Council of Scientific and Industrial Research for providing financial assistance (F. No. 10-2(5) 2003(1)-EU. 11). AS is thankful to the Department of Biotechnology, Government of India for financial assistance. SD and DB are supported by funds from the Bose Institute, Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI T, 1997, PLANT PHYSIOL, V115, P1288; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aoki T, 2000, J PLANT RES, V113, P475, DOI 10.1007/PL00013958; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ashraf N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-415; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; BAKER CJ, 1995, ANNU REV PHYTOPATHOL, V33, P299, DOI 10.1146/annurev.py.33.090195.001503; Chakraborti D, 2006, AFR J BIOTECHNOL, V5, P585; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chen H, 2004, J BIOL CHEM, V279, P45998, DOI 10.1074/jbc.M407151200; Cho SH, 2004, PHYSIOL MOL PLANT P, V64, P57, DOI 10.1016/j.pmpp.2004.07.003; Choi KY, 2003, GENE, V311, P13, DOI 10.1016/S0378-1119(03)00561-4; COHEN Y, 1989, PHYSIOL MOL PLANT P, V34, P27, DOI 10.1016/0885-5765(89)90014-3; Dakora FD, 1996, PHYSIOL MOL PLANT P, V49, P1, DOI 10.1006/pmpp.1996.0035; Debarry M, 2005, PLANT SCI, V168, P1171, DOI 10.1016/j.plantsci.2004.12.016; DIA Z, 1996, PLANT MOL BIOL, V32, P1055; DIETZ KJ, 1995, PLANT J, V8, P521, DOI 10.1046/j.1365-313X.1995.8040521.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Flandez-Galvez H, 2003, THEOR APPL GENET, V106, P1447, DOI 10.1007/s00122-003-1199-y; Ghose K, 2008, MOL PLANT PATHOL, V9, P763, DOI [10.1111/j.1364-3703.2008.00497.x, 10.1111/J.1364-3703.2008.00497.X]; Giri AP, 1998, PLANT PATHOL, V47, P693, DOI 10.1046/j.1365-3059.1998.00299.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; GORDON AJ, 1997, PLANT PHYSIOL, V120, P867; GRIFFITHS HM, 2003, PLANT PHYSIOL, V131, P419; Gupta S, 2009, PHYTOPATHOLOGY, V99, P1245, DOI 10.1094/PHYTO-99-11-1245; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Ibraheem O, 2008, AFR J BIOTECHNOL, V7, P4850; Jimenez-Gasco MM, 2004, INT MICROBIOL, V7, P95; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; JUAN A, 2000, PHYTOPATHOLOGY, V90, P1269; KISTLER HC, 1984, J GEN MICROBIOL, V130, P2605; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; Lee A, 2002, BIOCHEMISTRY-US, V41, P8886, DOI 10.1021/bi020183x; Lee MH, 2007, PLANT BIOTECHNOL-NAR, V24, P209, DOI 10.5511/plantbiotechnology.24.209; Li HY, 2008, J EXP BOT, V59, P3997, DOI 10.1093/jxb/ern241; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Machenaud J, 2007, B INSECTOL, V60, P219; Martinez M, 2003, MOL PLANT MICROBE IN, V16, P876, DOI 10.1094/MPMI.2003.16.10.876; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; MELNTOSH KB, 2005, GENOME, V48, P443; Mendgen K, 2002, TRENDS PLANT SCI, V7, P352, DOI 10.1016/S1360-1385(02)02297-5; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Morimoto S, 1998, J BIOL CHEM, V273, P12606, DOI 10.1074/jbc.273.20.12606; Nimbalkar SB, 2006, PHYSIOL MOL PLANT P, V68, P176, DOI 10.1016/j.pmpp.2006.10.003; O'Connell RJ, 2006, NEW PHYTOL, V171, P699, DOI 10.1111/j.1469-8137.2006.01829.x; Ohta H, 1997, PHYSIOL PLANTARUM, V100, P647, DOI 10.1034/j.1399-3054.1997.1000328.x; Padmanaban S, 2004, PLANT PHYSIOL, V134, P1514, DOI 10.1104/pp.103.034025; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Ronning CM, 2003, PLANT PHYSIOL, V131, P419, DOI 10.1104/pp.013581; Ryan CA, 2002, PLANT CELL, V14, pS251, DOI 10.1105/tpc.010484; Saikia R, 2006, CURR SCI INDIA, V91, P1543; Schaller A, 1999, PLANT CELL, V11, P263, DOI 10.1105/tpc.11.2.263; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Senthilkumar P, 2005, CURR SCI INDIA, V89, P1386; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Soares-Costa A, 2002, BIOCHEM BIOPH RES CO, V296, P1194, DOI 10.1016/S0006-291X(02)02046-6; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; Sparla F, 2006, PLANT PHYSIOL, V141, P840, DOI 10.1104/pp.106.079186; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; STANGHELLINI ME, 1993, PHYTOPATHOLOGY, V83, P1498, DOI 10.1094/Phyto-83-1498; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Takahashi H, 2006, J PHYTOPATHOL, V154, P156, DOI 10.1111/j.1439-0434.2006.01076.x; Thoungchaleun V, 2008, PLANT PATHOLOGY J, V24, P112, DOI 10.5423/PPJ.2008.24.2.112; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; *UN FAO, 1994, FAO PROD YB; Viehweger K, 2006, PLANT CELL, V18, P1510, DOI 10.1105/tpc.105.035121; Voegele RT, 2001, P NATL ACAD SCI USA, V98, P8133, DOI 10.1073/pnas.131186798; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wu JW, 2000, COMP BIOCHEM PHYS C, V127, P209, DOI 10.1016/S0742-8413(00)00145-6; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	90	42	45	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9030	10.1371/journal.pone.0009030	http://dx.doi.org/10.1371/journal.pone.0009030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140256	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474200016
J	Esue, O; Rupprecht, L; Sun, SX; Wirtz, D				Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis			Dynamics of the Bacterial Intermediate Filament Crescentin In Vitro and In Vivo	PLOS ONE			English	Article							BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; ESCHERICHIA-COLI; CELL-DIVISION; ALPHA-ACTININ; MECHANICAL-PROPERTIES; LIVING CELLS; VIMENTIN; NETWORKS; PROTEIN	Background: Crescentin, the recently discovered bacterial intermediate filament protein, organizes into an extended filamentous structure that spans the length of the bacterium Caulobacter crescentus and plays a critical role in defining its curvature. The mechanism by which crescentin mediates cell curvature and whether crescentin filamentous structures are dynamic and/or polar are not fully understood. Methodology/Principal Findings: Using light microscopy, electron microscopy and quantitative rheology, we investigated the mechanics and dynamics of crescentin structures. Live-cell microscopy reveals that crescentin forms structures in vivo that undergo slow remodeling. The exchange of subunits between these structures and a pool of unassembled subunits is slow during the life cycle of the cell however; in vitro assembly and gelation of C. crescentus crescentin structures are rapid. Moreover, crescentin forms filamentous structures that are elastic, solid-like, and, like other intermediate filaments, can recover a significant portion of their network elasticity after shear. The assembly efficiency of crescentin is largely unaffected by monovalent cations (K+, Na+), but is enhanced by divalent cations (Mg2+, Ca2+), suggesting that the assembly kinetics and micromechanics of crescentin depend on the valence of the ions present in solution. Conclusions/Significance: These results indicate that crescentin forms filamentous structures that are elastic, labile, and stiff, and that their low dissociation rate from established structures controls the slow remodeling of crescentin in C. crescentus.	[Esue, Osigwe] Genentech Inc, Dept Pharmaceut Dev, San Francisco, CA USA; [Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Esue, Osigwe; Rupprecht, Laura; Sun, Sean X.; Wirtz, Denis] Johns Hopkins Univ, Phys Sci Oncol Ctr, Baltimore, MD USA; [Rupprecht, Laura] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Sun, Sean X.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins University; Boston University; Johns Hopkins University	Esue, O (corresponding author), Genentech Inc, Dept Pharmaceut Dev, San Francisco, CA USA.	esue.osigwe@gene.com	Sun, Sean/M-7208-2019; Sun, Sean X/C-6755-2009; Wirtz, Denis/A-3257-2010	Sun, Sean/0000-0002-9077-7088; Sun, Sean X/0000-0002-9077-7088; Rupprecht, Laura/0000-0002-7012-3116	National Institutes of Health [GM075305, U54CA143868]; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Genentech and grants from the National Institutes of Health (GM075305 and U54CA143868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x; BENBASAT JA, 1984, BIOCHEMISTRY-US, V23, P3609, DOI 10.1021/bi00311a007; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bretschneider T, 2002, J MUSCLE RES CELL M, V23, P639, DOI 10.1023/A:1024455023518; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; CARY RB, 1994, J CELL SCI, V107, P1609; Charbon G, 2009, GENE DEV, V23, P1131, DOI 10.1101/gad.1795509; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Daniels BR, 2009, J CELL BIOL, V184, P473, DOI 10.1083/jcb.200809077; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; ECKELT A, 1992, EUR J CELL BIOL, V58, P319; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Garcia-Verdugo I, 2008, BIOCHEMISTRY-US, V47, P5127, DOI 10.1021/bi800070u; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 1998, Subcell Biochem, V31, P319; HOFMANN I, 1991, EUR J CELL BIOL, V56, P328; Jaiswal R, 2009, J BIOCHEM, V146, P733, DOI 10.1093/jb/mvp120; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; Kim JS, 2009, BIOPHYS J, V96, pL47, DOI 10.1016/j.bpj.2009.02.010; KUCHIBHATLA A, 2009, LANGMUIR; Li Xiu-zhen, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P132; Lowe J, 1999, EMBO J, V18, P2364, DOI 10.1093/emboj/18.9.2364; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; MANNING GS, 1977, BIOPHYS CHEM, V7, P189, DOI 10.1016/0301-4622(77)87021-X; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MILLER RK, 1991, J CELL BIOL, V113, P843, DOI 10.1083/jcb.113.4.843; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2005, CURR OPIN CELL BIOL, V17, P75, DOI 10.1016/j.ceb.2004.11.002; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; NAKAMURA Y, 1991, GLIA, V4, P101, DOI 10.1002/glia.440040112; NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4; Norlen L, 2007, EXP CELL RES, V313, P2217, DOI 10.1016/j.yexcr.2007.03.037; POINDEXTER JS, 1984, ARCH MICROBIOL, V138, P140, DOI 10.1007/BF00413014; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P3692, DOI 10.1073/pnas.78.6.3692; Strelkov SV, 2004, METHOD CELL BIOL, V78, P25; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; TRONCOSO JC, 1990, J STRUCT BIOL, V103, P2, DOI 10.1016/1047-8477(90)90080-V; Tseng Y, 2001, BIOPHYS J, V81, P1643, DOI 10.1016/S0006-3495(01)75818-3; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; VIKSTROM KL, 1992, J CELL BIOL, V118, P121, DOI 10.1083/jcb.118.1.121; WACHI M, 1989, J BACTERIOL, V171, P3123, DOI 10.1128/jb.171.6.3123-3127.1989; WADSWORTH P, 1986, J CELL BIOL, V102, P1032, DOI 10.1083/jcb.102.3.1032; Watanabe Y, 2004, CELL STRUCT FUNCT, V29, P67, DOI 10.1247/csf.29.67; Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004; WILSON RW, 1980, BIOPHYS J, V30, P317, DOI 10.1016/S0006-3495(80)85097-1; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050	69	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8855	10.1371/journal.pone.0008855	http://dx.doi.org/10.1371/journal.pone.0008855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20140233	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300007
J	Cohn, B; Manque, P; Lara, AM; Serrano, M; Sheth, N; Buck, G				Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Sheth, Nihar; Buck, Gregory			Putative cis-Regulatory Elements Associated with Heat Shock Genes Activated During Excystation of Cryptosporidium parvum	PLOS ONE			English	Article							IDENTIFICATION; INFECTION; PROTEINS; SEQUENCE; OOCYSTS; GENOME; EXPRESSION; RISK	Background: Cryptosporidiosis is a ubiquitous infectious disease, caused by the protozoan parasites Cryptosporidium hominis and C. parvum, leading to acute, persistent and chronic diarrhea worldwide. Although the complications of this disease can be serious, even fatal, in immunocompromised patients of any age, they have also been found to lead to long term effects, including growth inhibition and impaired cognitive development, in infected immunocompetent children. The Cryptosporidium life cycle alternates between a dormant stage, the oocyst, and a highly replicative phase that includes both asexual vegetative stages as well as sexual stages, implying fine genetic regulatory mechanisms. The parasite is extremely difficult to study because it cannot be cultured in vitro and animal models are equally challenging. The recent publication of the genome sequence of C. hominis and C. parvum has, however, significantly advanced our understanding of the biology and pathogenesis of this parasite. Methodology/Principal Findings: Herein, our goal was to identify cis-regulatory elements associated with heat shock response in Cryptosporidium using a combination of in silico and real time RT-PCR strategies. Analysis with Gibbs-Sampling algorithms of upstream non-translated regions of twelve genes annotated as heat shock proteins in the Cryptosporidium genome identified a highly conserved over-represented sequence motif in eleven of them. RT-PCR analyses, described herein and also by others, show that these eleven genes bearing the putative element are induced concurrent with excystation of parasite oocysts via heat shock. Conclusions/Significance: Our analyses suggest that occurrences of a motif identified in the upstream regions of the Cryptosporidium heat shock genes represent parts of the transcriptional apparatus and function as stress response elements that activate expression of these genes during excystation, and possibly at other stages in the life cycle of the parasite. Since heat shock and excystation represent a critical step in the development of the infectious sporozoite form of Cryptosporidium, these results provide important insight into the pathogenicity of the parasite.	[Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Buck, Gregory] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Cohn, Benjamin; Manque, Patricio; Lara, Ana M.; Serrano, Myrna; Sheth, Nihar; Buck, Gregory] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Cohn, B (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	gabuck@vcu.edu		manque, patricio/0000-0002-6606-0896	NSF [EEC-0234101]; NIH-NIAID [U34 AI57168, 1R01 AI55347.]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055347, U54AI057168] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from NSF EEC-0234101, NIH-NIAID U34 AI57168, and NIH-NIAID 1R01 AI55347. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; Gophna U, 2003, INT J MED MICROBIOL, V292, P453, DOI 10.1078/1438-4221-00230; Guerrant RL, 1997, EMERG INFECT DIS, V3, P51, DOI 10.3201/eid0301.970106; Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5; Heikkila JJ, 2007, BIOTECHNOL ADV, V25, P385, DOI 10.1016/j.biotechadv.2007.03.003; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hunter PR, 2002, CLIN MICROBIOL REV, V15, P145, DOI 10.1128/CMR.15.1.145-154.2002; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MACKENZIE WR, 1995, CLIN INFECT DIS, V21, P57, DOI 10.1093/clinids/21.1.57; Militello KT, 2004, MOL BIOCHEM PARASIT, V134, P75, DOI 10.1016/j.molbiopara.2003.11.004; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Mullapudi N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-13; Navin TR, 1999, J ACQ IMMUN DEF SYND, V20, P154, DOI 10.1097/00042560-199902010-00007; REDUKER DW, 1985, J PARASITOL, V71, P112, DOI 10.2307/3281988; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; Thompson RCA, 2005, ADV PARASIT, V59, P77, DOI 10.1016/S0065-308X(05)59002-X; VANDERPLOEG LHT, 1985, SCIENCE, V228, P1443, DOI 10.1126/science.4012301; WAGNERWIENING C, 1995, APPL ENVIRON MICROB, V61, P4514, DOI 10.1128/AEM.61.12.4514-4516.1995; Widmer G, 2007, PARASITOLOGY, V134, P1583, DOI 10.1017/S0031182007002922; Wolska-Kusnierz B, 2007, J PEDIATR GASTR NUTR, V45, P458, DOI 10.1097/MPG.0b013e318054b09b; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	31	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9512	10.1371/journal.pone.0009512	http://dx.doi.org/10.1371/journal.pone.0009512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209102	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100006
J	Lefevre, T; Gouagna, LC; Dabire, KR; Elguero, E; Fontenille, D; Renaud, F; Costantini, C; Thomas, F				Lefevre, Thierry; Gouagna, Louis-Clement; Dabire, Kounbobr Roch; Elguero, Eric; Fontenille, Didier; Renaud, Francois; Costantini, Carlo; Thomas, Frederic			Beer Consumption Increases Human Attractiveness to Malaria Mosquitoes	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; DIFFERENTIAL ATTRACTIVENESS; PREGNANT-WOMEN; HOST SELECTION; ALCOHOL; DIPTERA; CULICIDAE; BEHAVIOR; ETHANOL; S.S.	Background: Malaria and alcohol consumption both represent major public health problems. Alcohol consumption is rising in developing countries and, as efforts to manage malaria are expanded, understanding the links between malaria and alcohol consumption becomes crucial. Our aim was to ascertain the effect of beer consumption on human attractiveness to malaria mosquitoes in semi field conditions in Burkina Faso. Methodology/Principal Findings: We used a Y tube-olfactometer designed to take advantage of the whole body odour (breath and skin emanations) as a stimulus to gauge human attractiveness to Anopheles gambiae (the primary African malaria vector) before and after volunteers consumed either beer (n = 25 volunteers and a total of 2500 mosquitoes tested) or water (n = 18 volunteers and a total of 1800 mosquitoes). Water consumption had no effect on human attractiveness to An. gambiae mosquitoes, but beer consumption increased volunteer attractiveness. Body odours of volunteers who consumed beer increased mosquito activation (proportion of mosquitoes engaging in take-off and up-wind flight) and orientation (proportion of mosquitoes flying towards volunteers' odours). The level of exhaled carbon dioxide and body temperature had no effect on human attractiveness to mosquitoes. Despite individual volunteer variation, beer consumption consistently increased attractiveness to mosquitoes. Conclusions/Significance: These results suggest that beer consumption is a risk factor for malaria and needs to be integrated into public health policies for the design of control measures.	[Lefevre, Thierry; Elguero, Eric; Renaud, Francois; Thomas, Frederic] CNRS, UMR IRD 2724, Montpellier, France; [Gouagna, Louis-Clement; Fontenille, Didier; Costantini, Carlo] IRD UR 016, Montpellier, France; [Gouagna, Louis-Clement; Dabire, Kounbobr Roch] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Dabire, Kounbobr Roch] Ctr Muraz, Lab Parasitol & Entomol Med, Bobo Dioulasso, Burkina Faso; [Costantini, Carlo] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Thomas, Frederic] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Centre Muraz; Universite de Montreal	Lefevre, T (corresponding author), CNRS, UMR IRD 2724, Montpellier, France.	telefev@emory.edu	Costantini, Carlo/F-3470-2012; FONTENILLE, didier/G-4091-2013; Lefèvre, Thierry/E-2157-2011; Dabire, Roch Kounbobr/ABF-3525-2020; Elguero, Eric/J-3014-2012	Costantini, Carlo/0000-0003-1016-129X; Lefèvre, Thierry/0000-0002-9736-6142; FONTENILLE, didier/0000-0002-0544-3885; Gouagna, Louis Clement/0000-0003-0957-4484; THOMAS, Frederic/0000-0003-2238-1978	French National Research Agency (ANR) [FI-071215-01-01]	French National Research Agency (ANR)(French National Research Agency (ANR))	The study was supported by the French National Research Agency (ANR) number FI-071215-01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2006, J APPL PHYSIOL, V100, P649, DOI 10.1152/japplphysiol.00927.2005; Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; Besansky NJ, 2004, TRENDS PARASITOL, V20, P249, DOI 10.1016/j.pt.2004.03.007; Brady J, 1997, ANN TROP MED PARASIT, V91, pS121, DOI 10.1080/00034989761436; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; BURKOT TR, 1988, PARASITOL TODAY, V4, P156, DOI 10.1016/0169-4758(88)90151-2; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209; Crawley M.J., 2007, R BOOK; CURTIS CF, 1987, MED VET ENTOMOL, V1, P109, DOI 10.1111/j.1365-2915.1987.tb00331.x; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Dekker T, 2001, PHYSIOL ENTOMOL, V26, P124, DOI 10.1046/j.1365-3032.2001.00225.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Havlicek J, 2008, CHEM SIGNAL, V11, P199, DOI 10.1007/978-0-387-73945-8_19; Havlicek J, 2006, CHEM SENSES, V31, P747, DOI 10.1093/chemse/bjl017; Himeidan YE, 2004, ANN TROP MED PARASIT, V98, P631, DOI 10.1179/000349804225021307; Kelly DW, 2001, TRENDS PARASITOL, V17, P578, DOI 10.1016/S1471-4922(01)02116-X; KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lefevre T, 2009, TROP MED INT HEALTH, V14, P228, DOI 10.1111/j.1365-3156.2009.02206.x; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Lenochova P, 2008, CHEM SIGNAL, V11, P189, DOI 10.1007/978-0-387-73945-8_18; Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Macdonald G, 1957, EPIDEMIOLOGY CONTROL; Mukabana Wolfgang R., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-17; Mukabana WR, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-1; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Odunfa S. A., 1985, Microbiology of fermented foods. Vol. 2., P155; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Roberts SC, 2005, CHEM SENSES, V30, P651, DOI 10.1093/chemse/bji058; Ross R., 1911, PREVENTION MALARIA; Sawadogo-Lingani H, 2007, J APPL MICROBIOL, V103, P765, DOI 10.1111/j.1365-2672.2007.03306.x; Shirai Y, 2002, J AM MOSQUITO CONTR, V18, P91; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Takken W, 1997, ANN TROP MED PARASIT, V91, pS119, DOI 10.1080/00034989761427; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; WHO, 2004, GLOB STAT REP ALC; WILKINSON PK, 1980, ALCOHOL CLIN EXP RES, V4, P6, DOI 10.1111/j.1530-0277.1980.tb04785.x; World Health Organization, 2008, WORLD MAL REP	49	41	42	0	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9546	10.1371/journal.pone.0009546	http://dx.doi.org/10.1371/journal.pone.0009546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209056	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100024
J	Francischetti, IMB; Kotsyfakis, M; Andersen, JF; Lukszo, J				Francischetti, Ivo M. B.; Kotsyfakis, Michalis; Andersen, John F.; Lukszo, Jan			Cyr61/CCN1 Displays High-Affinity Binding to the Somatomedin B (1-44) Domain of Vitronectin	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; UROKINASE RECEPTOR; EXTRACELLULAR-MATRIX; CELL-ADHESION; INTEGRIN ALPHA-V-BETA-3; SALIVARY-GLAND; CCN FAMILY; EXPRESSION; PROTEINS; GROWTH	Background: Cyr61 is a member of the CCN (Cyr61, connective tissue growth, NOV) family of extracellular-associated (matricellular) proteins that present four distinct functional modules, namely insulin-like growth factor binding protein (IGFBP), von Willebrand factor type C (vWF), thrombospondin type 1 (TSP), and C-terminal growth factor cysteine knot (CT) domain. While heparin sulphate proteoglycans reportedly mediate the interaction of Cyr61 with the matrix and cell surface, the role of other extracellular associated proteins has not been revealed. Methods and Findings: In this report, surface plasmon resonance (SPR) experiments and solid-phase binding assays demonstrate that recombinant Cyr61 interacts with immobilized monomeric or multimeric vitronectin (VTNC) with K-D in the nanomolar range. Notably, the binding site for Cyr61 was identified as the somatomedin B domain (SMTB (1-44)) of VTNC, which mediates its interaction with PAI-1, uPAR, and integrin alpha v beta 3. Accordingly, PAI-1 outcompetes Cyr61 for binding to immobilized SMTB (1-44), and Cyr61 attenuates uPAR-mediated U937 adhesion to VTNC. In contrast, isothermal titration calorimetry shows that Cyr61 does not display high-affinity binding for SMTB (1-44) in solution. Nevertheless, competitive ELISA revealed that multimeric VTNC, heat-modified monomeric VTNC, or SMTB (1-44) at high concentrations attenuate Cyr61 binding to immobilized VTNC, while monomeric VTNC was ineffective. Therefore, immobilization of VTNC exposes cryptic epitopes that recognize Cyr61 with high affinity, as reported for a number of antibodies, beta-endorphin, and other molecules. Conclusions: The finding that Cyr61 interacts with the SMTB (1-44) domain suggests that VTNC represent a point of anchorage for CCN family members to the matrix. Results are discussed in the context of the role of CCN and VTNC in matrix biology and angiogenesis.	[Francischetti, Ivo M. B.; Andersen, John F.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, Res Technol Branch,NIH, Bethesda, MD 20892 USA; [Lukszo, Jan] NIAID, Peptide Synth & Anal Lab, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Kotsyfakis, Michalis] Natl Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Ceske Budejovice, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Francischetti, IMB (corresponding author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, Res Technol Branch,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ifrancischetti@niaid.nih.gov	Kotsyfakis, Michail/G-9525-2014	Kotsyfakis, Michail/0000-0002-7526-1876	NIH/NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Intramural Research Program - NIH/NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Bafetti LM, 1998, J BIOL CHEM, V273, P143, DOI 10.1074/jbc.273.1.143; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Carreiras F, 1996, GYNECOL ONCOL, V62, P260, DOI 10.1006/gyno.1996.0225; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Chavakis T, 1998, BLOOD, V91, P2305, DOI 10.1182/blood.V91.7.2305.2305_2305_2312; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Desnoyers L, 2001, J BIOL CHEM, V276, P47599, DOI 10.1074/jbc.M108339200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; HILDEBRAND A, 1989, J BIOL CHEM, V264, P15429; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; JASKIEWICZ K, 1993, ANTICANCER RES, V13, P2229; Kamikubo Y, 2006, BIOCHEMISTRY-US, V45, P3297, DOI 10.1021/bi052278f; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002; KOST C, 1992, J BIOL CHEM, V267, P12098; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mayasundari A, 2004, J BIOL CHEM, V279, P29359, DOI 10.1074/jbc.M401279200; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nam T, 2002, ENDOCRINOLOGY, V143, P30, DOI 10.1210/en.143.1.30; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; O'Kelly J, 2008, INT J ONCOL, V33, P59; Okumura Y, 2002, J BIOL CHEM, V277, P9395, DOI 10.1074/jbc.M111225200; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Schar CR, 2008, J BIOL CHEM, V283, P28487, DOI 10.1074/jbc.M804257200; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; SEIFFERT D, 1995, FEBS LETT, V368, P155, DOI 10.1016/0014-5793(95)00630-R; SEIFFERT D, 1994, J BIOL CHEM, V269, P2659; Seiffert D, 1997, HISTOL HISTOPATHOL, V12, P787; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WEI Y, 1994, J BIOL CHEM, V269, P32380; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YANG GP, 1991, CELL GROWTH DIFFER, V2, P351; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	55	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9356	10.1371/journal.pone.0009356	http://dx.doi.org/10.1371/journal.pone.0009356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195466	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997000003
J	Torri, A; Beretta, O; Ranghetti, A; Granucci, F; Ricciardi-Castagnoli, P; Foti, M				Torri, Anna; Beretta, Ottavio; Ranghetti, Anna; Granucci, Francesca; Ricciardi-Castagnoli, Paola; Foti, Maria			Gene Expression Profiles Identify Inflammatory Signatures in Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BREAST-CANCER; 1,25-DIHYDROXYVITAMIN D-3; MICROARRAY DATA; IL-1 RECEPTOR; RANDOM FOREST; IFN-ALPHA; CLASSIFICATION; INNATE; IDENTIFICATION	Dendritic cells (DCs) constitute a heterogeneous group of antigen-presenting leukocytes important in activation of both innate and adaptive immunity. We studied the gene expression patterns of DCs incubated with reagents inducing their activation or inhibition. Total RNA was isolated from DCs and gene expression profiling was performed with oligonucleotide microarrays. Using a supervised learning algorithm based on Random Forest, we generated a molecular signature of inflammation from a training set of 77 samples. We then validated this molecular signature in a testing set of 38 samples. Supervised analysis identified a set of 44 genes that distinguished very accurately between inflammatory and non inflammatory samples. The diagnostic performance of the signature genes was assessed against an independent set of samples, by qRT-PCR. Our findings suggest that the gene expression signature of DCs can provide a molecular classification for use in the selection of anti-inflammatory or adjuvant molecules with specific effects on DC activity.	[Torri, Anna; Ranghetti, Anna; Granucci, Francesca; Foti, Maria] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; [Beretta, Ottavio; Ricciardi-Castagnoli, Paola] Singapore Immunol Network, Singapore, Singapore	University of Milano-Bicocca; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Torri, A (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.	maria.foti@unimib.it	Foti, Maria/AAB-9961-2022; Castagnoli, Paola/E-8288-2010; Ranghetti, Anna/AAO-2867-2020; GRANUCCI, Francesca/K-6150-2019	granucci, francesca/0000-0002-7046-4914; FOTI, MARIA/0000-0002-4481-1900	European Commission; Italian Ministry of Education and Research [PRIN-COFIN 20077NFBH8_003]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the grants from European Commission 6th Framework Program (AIDS-CoVAC), the Italian Ministry of Education and Research PRIN-COFIN 20077NFBH8_003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Aebischer T, 2005, EUR J IMMUNOL, V35, P476, DOI 10.1002/eji.200425674; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Foti M, 2006, E SCHERING RES FDN W, V56, P61; Foti M, 2004, TRENDS IMMUNOL, V25, P650, DOI 10.1016/j.it.2004.10.007; Foti Maria, 2007, Methods Mol Biol, V380, P215; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang WY, 2008, STAT APPL GENET MOL, V7; Ju XS, 2004, IMMUNOBIOLOGY, V209, P155, DOI 10.1016/j.imbio.2004.02.005; Kong J, 2006, J IMMUNOL, V176, P3780, DOI 10.4049/jimmunol.176.6.3780; LACEY DL, 1993, J CLIN INVEST, V91, P1731, DOI 10.1172/JCI116383; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Luft T, 2002, INT IMMUNOL, V14, P367, DOI 10.1093/intimm/14.4.367; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mathieu C, 2006, CLIN NEPHROL, V66, P275; McIlroy D, 2005, J LEUKOCYTE BIOL, V78, P794, DOI 10.1189/jlb.0105029; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pavelka N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-203; Peng YX, 2006, CANCER INFORM, V2, P301; PIRAMI L, 1991, P NATL ACAD SCI USA, V88, P7543, DOI 10.1073/pnas.88.17.7543; PREHN JL, 1989, TRANSPL P, V21, P90; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ritter M, 2005, BIOCHEM BIOPH RES CO, V334, P254, DOI 10.1016/j.bbrc.2005.06.084; Schoeters E, 2006, TOXICOL APPL PHARM, V216, P131, DOI 10.1016/j.taap.2006.04.009; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Svane IM, 2006, SCAND J IMMUNOL, V63, P217, DOI 10.1111/j.1365-3083.2006.01728.x; SYMMANS WF, 1995, HUM PATHOL, V26, P210, DOI 10.1016/0046-8177(95)90039-X; Trottein F, 2004, J IMMUNOL, V172, P3011, DOI 10.4049/jimmunol.172.5.3011; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yamagata T, 2006, IMMUNOL REV, V210, P52, DOI 10.1111/j.0105-2896.2006.00371.x; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S22; Zaslona Z, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-2; ZHANG WW, 1994, CANCER GENE THER, V1, P5; Zhong WX, 2009, CELL MOL BIOL LETT, V14, P587, DOI 10.2478/s11658-009-0023-3; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	62	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9404	10.1371/journal.pone.0009404	http://dx.doi.org/10.1371/journal.pone.0009404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195376	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924200024
J	Bulchand, S; Menon, SD; George, SE; Chia, W				Bulchand, Sarada; Menon, Sree Devi; George, Simi Elizabeth; Chia, William			The Intracellular Domain of Dumbfounded Affects Myoblast Fusion Efficiency and Interacts with Rolling Pebbles and Loner	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MUSCLE DEVELOPMENT; IMMUNOGLOBULIN SUPERFAMILY; FOUNDER CELL; BLOWN-FUSE; D-TITIN; PROTEIN; MYOGENESIS; GENE; MEMBRANE	Drosophila body wall muscles are multinucleated syncytia formed by successive fusions between a founder myoblast and several fusion competent myoblasts. Initial fusion gives rise to a bi/trinucleate precursor followed by more fusion cycles forming a mature muscle. This process requires the functions of various molecules including the transmembrane myoblast attractants Dumbfounded (Duf) and its paralogue Roughest (Rst), a scaffold protein Rolling pebbles (Rols) and a guanine nucleotide exchange factor Loner. Fusion completely fails in a duf, rst mutant, and is blocked at the bi/trinucleate stage in rols and loner single mutants. We analysed the transmembrane and intracellular domains of Duf, by mutating conserved putative signaling sites and serially deleting the intracellular domain. These were tested for their ability to translocate and interact with Rols and Loner and to rescue the fusion defect in duf, rst mutant embryos. Studying combinations of double mutants, further tested the function of Rols, Loner and other fusion molecules. Here we show that serial truncations of the Duf intracellular domain successively compromise its function to translocate and interact with Rols and Loner in addition to affecting myoblast fusion efficiency in embryos. Putative phosphorylation sites function additively while the extreme C terminus including a PDZ binding domain is dispensable for its function. We also show that fusion is completely blocked in a rols, loner double mutant and is compromised in other double mutants. These results suggest an additive function of the intracellular domain of Duf and an early function of Rols and Loner which is independent of Duf.	[Bulchand, Sarada; Menon, Sree Devi; George, Simi Elizabeth; Chia, William] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore	National University of Singapore	Bulchand, S (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore.	sbulchand@gmail.com			Temasek Lifesciences Laboratory; Singapore Millenium Foundation	Temasek Lifesciences Laboratory; Singapore Millenium Foundation	Temasek Lifesciences Laboratory. Singapore Millenium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 2003, INT REV CYTOL, V225, P33, DOI 10.1016/S0074-7696(05)25002-7; Artero RD, 2001, DEVELOPMENT, V128, P4251; BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Beckett K, 2007, DEV BIOL, V309, P113, DOI 10.1016/j.ydbio.2007.06.024; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Bour BA, 2000, GENE DEV, V14, P1498; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P167; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Chen EH, 2001, DEV CELL, V1, P705, DOI 10.1016/S1534-5807(01)00084-3; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Cohen SM., 1993, DEV DROSOPHILA MELAN; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Kocherlakota KS, 2008, GENETICS, V178, P1371, DOI 10.1534/genetics.107.083808; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Menon SD, 2005, J CELL BIOL, V169, P909, DOI 10.1083/jcb.200501126; Menon SD, 2001, DEV CELL, V1, P691, DOI 10.1016/S1534-5807(01)00075-2; Radhakrishna H, 1999, J CELL SCI, V112, P855; Rau A, 2001, DEVELOPMENT, V128, P5061; Richardson B, 2008, BIOESSAYS, V30, P423, DOI 10.1002/bies.20756; Richardson BE, 2007, DEVELOPMENT, V134, P4357, DOI 10.1242/dev.010678; Richardson Brian E., 2008, V475, P263, DOI 10.1007/978-1-59745-250-2_15; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; Strunkelnberg M, 2003, J MOL EVOL, V56, P187, DOI 10.1007/s00239-002-2393-2; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Taylor MV, 1998, CURR BIOL, V8, pR356, DOI 10.1016/S0960-9822(98)70221-0; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Ungermann C, 2005, J CELL SCI, V118, P3819, DOI 10.1242/jcs.02561; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhang Y, 2000, J CELL SCI, V113, P3103	49	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9374	10.1371/journal.pone.0009374	http://dx.doi.org/10.1371/journal.pone.0009374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186342	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000016
J	Gonzalvez, F; Pariselli, F; Jalmar, O; Dupaigne, P; Sureau, F; Dellinger, M; Hendrickson, EA; Bernard, S; Petit, PX				Gonzalvez, Francois; Pariselli, Fabrizio; Jalmar, Olivier; Dupaigne, Pauline; Sureau, Franck; Dellinger, Marc; Hendrickson, Eric A.; Bernard, Sophie; Petit, Patrice X.			Mechanistic Issues of the Interaction of the Hairpin-Forming Domain of tBid with Mitochondrial Cardiolipin	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; BCL-2 FAMILY; RAT-LIVER; X-RAY; BAX; MEMBRANE; DEATH; PATHWAY; PROTEIN	Background: The pro-apoptotic effector Bid induces mitochondrial apoptosis in synergy with Bax and Bak. In response to death receptors activation, Bid is cleaved by caspase-8 into its active form, tBid (truncated Bid), which then translocates to the mitochondria to trigger cytochrome c release and subsequent apoptosis. Accumulating evidence now indicate that the binding of tBid initiates an ordered sequences of events that prime mitochondria from the action of Bax and Bak: (1) tBid interacts with mitochondria via a specific binding to cardiolipin (CL) and immediately disturbs mitochondrial structure and function idependently of its BH3 domain; (2) Then, tBid activates through its BH3 domain Bax and/or Bak and induces their subsequent oligomerization in mitochondrial membranes. To date, the underlying mechanism responsible for targeting tBid to mitochondria and disrupting mitochondrial bioenergetics has yet be elucidated. Principal Findings: The present study investigates the mechanism by which tBid interacts with mitochondria issued from mouse hepatocytes and perturbs mitochondrial function. We show here that the helix alpha H6 is responsible for targeting tBid to mitochondrial CL and disrupting mitochondrial bioenergetics. In particular, alpha H6 interacts with mitochondria through electrostatic interactions involving the lysines 157 and 158 and induces an inhibition of state-3 respiration and an uncoupling of state-4 respiration. These changes may represent a key event that primes mitochondria for the action of Bax and Bak. In addition, we also demonstrate that tBid required its helix alpha H6 to efficiently induce cytochrome c release and apoptosis. Conclusions: Our findings provide new insights into the mechanism of action of tBid, and particularly emphasize the importance of the interaction of the helix alpha H6 with CL for both mitochondrial targeting and pro-apoptotic activity of tBid. These support the notion that tBid acts as a bifunctional molecule: first, it binds to mitochondrial CL via its helix alpha H6 and destabilizes mitochondrial structure and function, and then it promotes through its BH3 domain the activation and oligomerization of Bax and/or Bak, leading to cytochrome c release and execution of apoptosis. Our findings also imply an active role of the membrane in modulating the interactions between Bcl-2 proteins that has so far been underestimated.	[Gonzalvez, Francois; Pariselli, Fabrizio; Jalmar, Olivier; Petit, Patrice X.] Univ Paris 05, INSERM, UMR8104, Inst Cochin,CNRS,U567, Paris, France; [Dupaigne, Pauline] Univ Paris 05, CNRS, UPR2228, Paris, France; [Sureau, Franck] Univ Paris 08, Univ Paris 06, CNRS, UMR7033,BioMoCeti,GENOPOLE Campus 1, Evry, France; [Dellinger, Marc] Museum Natl Hist Nat, USM Biol Fonct Protozoaires 504, F-75231 Paris, France; [Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Bernard, Sophie] Univ Paris 05, IFR 95, CNRS, UPR 2228, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Genopole; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-VIII; Museum National d'Histoire Naturelle (MNHN); University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gonzalvez, F (corresponding author), Univ Paris 05, INSERM, UMR8104, Inst Cochin,CNRS,U567, Paris, France.	patrice.petit@inserm.fr	Petit, Patrice X./A-3692-2009; Dupaigne, Pauline/C-6873-2019; Petit, patrice/AAF-6774-2020	Petit, Patrice X./0000-0002-5038-9101; Dupaigne, Pauline/0000-0001-7033-4055	Centre national de la Recherche Scientifique (CNRS); Association de recherche contre le Cancer [4493]; AFM [11557/2005, 13313/2008]	Centre national de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association de recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); AFM(Association Francaise contre les Myopathies)	This work was supported by grants from the Centre national de la Recherche Scientifique (CNRS), Association de recherche contre le Cancer (ARC 4493 to PXP) and AFM 11557/2005 and 13313/2008 to PXP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ahmad KA, 2004, CANCER RES, V64, P7867, DOI 10.1158/0008-5472.CAN-04-0648; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DELACOSTE A, 1998, AM J PHYSIOL, V59, P5017; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Esposti MD, 2002, BBA-BIOENERGETICS, V1553, P331, DOI 10.1016/S0005-2728(02)00187-1; Etienne F, 2008, CHEM PHYS LIPIDS, V152, P13, DOI 10.1016/j.chemphyslip.2007.12.002; Gabriel B, 2003, EXP CELL RES, V289, P195, DOI 10.1016/S0014-4827(03)00255-6; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Kim TH, 2004, MOL BIOL CELL, V15, P3061, DOI 10.1091/mbc.E03-12-0864; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacronique V, 1996, NAT MED, V2, P80, DOI 10.1038/nm0196-80; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu J, 2004, APOPTOSIS, V9, P533, DOI 10.1023/B:APPT.0000038034.16230.ea; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	39	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9342	10.1371/journal.pone.0009342	http://dx.doi.org/10.1371/journal.pone.0009342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179769	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923900009
J	Guo, G; Cai, TJ; Guo, R; Wang, HY; Harris, KM				Guo, Guang; Cai, Tianji; Guo, Rui; Wang, Hongyu; Harris, Kathleen Mullan			The Dopamine Transporter Gene, a Spectrum of Most Common Risky Behaviors, and the Legal Status of the Behaviors	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; NONINVASIVE METHOD; SMOKING-BEHAVIOR; VARIABLE NUMBER; YOUTH ACCESS; DAT1; POLYMORPHISMS; AVAILABILITY; ALCOHOL	This study tests the specific hypothesis that the 9R/9R genotype in the VNTR of the dopamine transporter gene (DAT1) exerts a general protective effect against a spectrum of risky behaviors in comparison to the 10R/9R and 10R/10R genotypes, drawing on three-time repeated measures of risky behaviors in adolescence and young adulthood on about 822 non-Hispanic white males from the Add Health study. Our data have established two empirical findings. The first is a protective main effect in the DAT1 gene against risky behaviors. The second finding is that the protective effect varies over age, with the effect prominent at ages when a behavior is illegal and the effect largely vanished at ages when the behavior becomes legal or more socially tolerated. Both the protective main effect and the gene-lifecourse interaction effect are replicated across a spectrum of most common risky behaviors: delinquency, variety of sexual partners, binge drinking, drinking quantity, smoking quantity, smoking frequency, marijuana use, cocaine use, other illegal drug use, and seatbelt non-wearing. We also compared individuals with the protective genotype and individuals without it in terms of age, physical maturity, verbal IQ, GPA, received popularity, sent popularity, church attendance, two biological parents, and parental education. These comparisons indicate that the protective effect of DAT1*9R/9R cannot be explained away by these background characteristics. Our work demonstrates how legal/social contexts can enhance or reduce a genetic effect on risky behaviors.	[Guo, Guang; Cai, Tianji; Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Guo, Guang; Harris, Kathleen Mullan] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Guo, Guang; Harris, Kathleen Mullan] Univ N Carolina, Caroline Populat Ctr, Chapel Hill, NC USA; [Guo, Rui] N Carolina Cent Univ, Sch Lib & Informat Sci, Durham, NC 27707 USA; [Wang, Hongyu] Univ Macau, Dept Sociol, Taipa, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina Central University; University of Macau	Guo, G (corresponding author), Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA.	guang_guo@unc.edu	Cai, Tianji/R-8697-2019	Cai, Tianji/0000-0002-8962-2660	National Institute of Child Health and Human Development [P01-HD31921]; National Institutes of Health (NIH) [P01-HD31921, R03 HD042490-02, R03 HD053385-01]; NSF [SES-0210389]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD042490, R03HD053385] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris, and funded by a grant P01-HD31921 from the National Institute of Child Health and Human Development, with cooperative funding from 17 other agencies (www.cpc. unc.edu/addhealth/contract. html). The authors gratefully acknowledge support from National Institutes of Health (NIH): P01-HD31921 to Add Health, R03 HD042490-02 to Guang Guo, R03 HD053385-01 to Guang Guo; and support from NSF, SES-0210389 to Guang Guo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, HEALTH POLICY, V75, P74, DOI 10.1016/j.healthpol.2005.02.004; Ahmad S, 2007, HEALTH POLICY, V80, P378, DOI 10.1016/j.healthpol.2006.04.001; BANNON MJ, 1995, CAN J PHYSIOL PHARM, V73, P866, DOI 10.1139/y95-119; Barkley RA, 2006, AM J MED GENET B, V141B, P487, DOI 10.1002/ajmg.b.30326; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; Bressan RA, 2005, ACTA PSYCHIAT SCAND, V111, P14, DOI 10.1111/j.1600-0447.2005.00540.x; Chen CK, 2003, MOL PSYCHIATR, V8, P393, DOI 10.1038/sj.mp.4001238; Cheuk DKL, 2006, AM J MED GENET B, V141B, P123, DOI 10.1002/ajmg.b.30280; COOK EH, 1995, AM J HUM GENET, V56, P993; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Curran S, 2001, MOL PSYCHIATR, V6, P425, DOI 10.1038/sj.mp.4000914; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; DOUCETTESTAMM LA, 1995, GENET EPIDEMIOL, V12, P303, DOI 10.1002/gepi.1370120307; Feng Y, 2005, AM J MED GENET B, V139B, P1, DOI 10.1002/ajmg.b.30190; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freeman B, 1997, BEHAV GENET, V27, P251, DOI 10.1023/A:1025614231190; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Goode E., 2008, DRUGS AM SOC; Gottfredson M.R., 1990, GEN THEORY CRIME; Guo G, 2008, AM SOCIOL REV, V73, P543, DOI 10.1177/000312240807300402; Guo G, 2007, EUR J HUM GENET, V15, P279, DOI 10.1038/sj.ejhg.5201763; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Harris K.M., 2003, NATL LONGITUDINAL ST; Heinz A, 2000, NEUROPSYCHOPHARMACOL, V22, P133, DOI 10.1016/S0893-133X(99)00099-8; Hirschi T., 1969, CAUSE OF DELINQUENCY; Jacobsen LK, 2000, AM J PSYCHIAT, V157, P1700, DOI 10.1176/appi.ajp.157.10.1700; JOHNSTON LD, 2003, NIH PUB; Kalivas P. W, 2002, NEUROPSYCHOPHARMACOL; LENCH N, 1988, LANCET, V1, P1356; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LUBIN B, 1984, AM PSYCHOL, V39, P451, DOI 10.1037/0003-066X.39.4.451; Lynch DR, 2003, MOVEMENT DISORD, V18, P804, DOI 10.1002/mds.10430; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P553, DOI 10.1016/S0893-133X(00)00216-5; MAXSON S, HDB BEHAV G IN PRESS; MEULENBELT I, 1995, AM J HUM GENET, V57, P1252; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; MOONEY LA, 1992, DEVIANT BEHAV, V13, P59, DOI 10.1080/01639625.1992.9967898; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; RICE JA, 1967, AM J MENT DEF, V71, P602; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Sander T, 1997, AM J MED GENET, V74, P483, DOI 10.1002/(SICI)1096-8628(19970919)74:5<483::AID-AJMG5>3.0.CO;2-P; Schmidt LG, 1998, AM J PSYCHIAT, V155, P474, DOI 10.1176/ajp.155.4.474; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sieminska A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-92; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Thornberry T. P., 2000, CRIMINAL JUSTICE, V4, P33, DOI DOI 10.2307/1141583; Timberlake DS, 2006, HEALTH PSYCHOL, V25, P190, DOI 10.1037/0278-6133.25.2.190; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van Dyck CH, 2005, J NUCL MED, V46, P745; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	58	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9352	10.1371/journal.pone.0009352	http://dx.doi.org/10.1371/journal.pone.0009352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179766	Green Published, gold			2022-12-27	WOS:000274923900016
J	Axmacher, N; Gossen, A; Elger, CE; Fell, J				Axmacher, Nikolai; Gossen, Anna; Elger, Christian E.; Fell, Juergen			Graded Effects of Social Conformity on Recognition Memory	PLOS ONE			English	Article							COLLABORATIVE INHIBITION; TASK	Previous studies have shown that the opinion of confederates in a group influences recognition memory, but inconsistent results have been obtained concerning the question of whether recognition of items as old and new are affected similarly, possibly because only one or two confederates are present during the recognition phase. Here, we present data from a study where recognition of novel faces was tested in the presence of four confederates. In a long version of this experiment, recognition of items as old and new was similarly affected by group responses. However, in the short version, recognition of old items depended proportionally on the number of correct group responses, while rejection of new items only decreased significantly when all confederates gave an incorrect response. These findings indicate that differential effects of social conformity on recognition of items as old and new occur in situations with an intermediate level of group pressure.	[Axmacher, Nikolai; Gossen, Anna; Elger, Christian E.; Fell, Juergen] Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany	University of Bonn	Axmacher, N (corresponding author), Univ Bonn, Dept Epileptol, D-5300 Bonn, Germany.	nikolai.axmacher@ukb.uni-bonn.de		Axmacher, Nikolai/0000-0002-0475-6492	Volkswagen Stiftung [I/79878]	Volkswagen Stiftung(Volkswagen)	The work was supported by the Volkswagen Stiftung, grant I/79878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrow K., 1963, SOCIAL CHOICE INDIVI; Baron RS, 1996, J PERS SOC PSYCHOL, V71, P915, DOI 10.1037/0022-3514.71.5.915; Berns GS, 2005, BIOL PSYCHIAT, V58, P245, DOI 10.1016/j.biopsych.2005.04.012; Bond R, 1996, PSYCHOL BULL, V119, P111, DOI 10.1037/0033-2909.119.1.111; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Elizabeth F., 1996, EYEWITNESS TESTIMONY; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Levine J M, 1999, Pers Soc Psychol Rev, V3, P358, DOI 10.1207/s15327957pspr0304_5; Reysen MB, 2007, MEM COGNITION, V35, P59, DOI 10.3758/BF03195942; Reysen MB, 2005, MEMORY, V13, P87, DOI 10.1080/09658210344000602; Roediger HL, 2001, PSYCHON B REV, V8, P365, DOI 10.3758/BF03196174; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Schneider DM, 1996, PSYCHON B REV, V3, P481, DOI 10.3758/BF03214550; Walther E, 2002, APPL COGNITIVE PSYCH, V16, P793, DOI 10.1002/acp.828; Weldon MS, 2000, J EXP PSYCHOL LEARN, V26, P1568, DOI 10.1037/0278-7393.26.6.1568; Weldon MS, 1997, J EXP PSYCHOL LEARN, V23, P1160, DOI 10.1037/0278-7393.23.5.1160; Wells GL, 2003, ANNU REV PSYCHOL, V54, P277, DOI 10.1146/annurev.psych.54.101601.145028; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x; Wright DB, 2000, BRIT J PSYCHOL, V91, P189, DOI 10.1348/000712600161781; Wright DB, 2005, J EXP PSYCHOL-APPL, V11, P200, DOI 10.1037/1076-898X.11.3.200; Wright DB, 2004, PSYCHON B REV, V11, P1080, DOI 10.3758/BF03196740; Wright DB, 1996, APPL COGNITIVE PSYCH, V10, P75; Yates F. A., 1966, THE ART OF MEMORY; [No title captured]	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9270	10.1371/journal.pone.0009270	http://dx.doi.org/10.1371/journal.pone.0009270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556KU	20174641	Green Published, gold			2022-12-27	WOS:000274590600023
J	Edwards, CJ; Magee, DA; Park, SDE; McGettigan, PA; Lohan, AJ; Murphy, A; Finlay, EK; Shapiro, B; Chamberlain, AT; Richards, MB; Bradley, DG; Loftus, BJ; MacHugh, DE				Edwards, Ceiridwen J.; Magee, David A.; Park, Stephen D. E.; McGettigan, Paul A.; Lohan, Amanda J.; Murphy, Alison; Finlay, Emma K.; Shapiro, Beth; Chamberlain, Andrew T.; Richards, Martin B.; Bradley, Daniel G.; Loftus, Brendan J.; MacHugh, David E.			A Complete Mitochondrial Genome Sequence from a Mesolithic Wild Aurochs (Bos primigenius)	PLOS ONE			English	Article							EUROPEAN CATTLE; TAURINE CATTLE; DNA ANALYSIS; ANCIENT; EXTINCT; ORIGIN; HYBRIDIZATION; DOMESTICATION; AMPLIFICATION; DIVERSITY	Background: The derivation of domestic cattle from the extinct wild aurochs (Bos primigenius) has been well-documented by archaeological and genetic studies. Genetic studies point towards the Neolithic Near East as the centre of origin for Bos taurus, with some lines of evidence suggesting possible, albeit rare, genetic contributions from locally domesticated wild aurochsen across Eurasia. Inferences from these investigations have been based largely on the analysis of partial mitochondrial DNA sequences generated from modern animals, with limited sequence data from ancient aurochsen samples. Recent developments in DNA sequencing technologies, however, are affording new opportunities for the examination of genetic material retrieved from extinct species, providing new insight into their evolutionary history. Here we present DNA sequence analysis of the first complete mitochondrial genome (16,338 base pairs) from an archaeologically-verified and exceptionally-well preserved aurochs bone sample. Methodology: DNA extracts were generated from an aurochs humerus bone sample recovered from a cave site located in Derbyshire, England and radiocarbon-dated to 6,738668 calibrated years before present. These extracts were prepared for both Sanger and next generation DNA sequencing technologies (Illumina Genome Analyzer). In total, 289.9 megabases (22.48%) of the post-filtered DNA sequences generated using the Illumina Genome Analyzer from this sample mapped with confidence to the bovine genome. A consensus B. primigenius mitochondrial genome sequence was constructed and was analysed alongside all available complete bovine mitochondrial genome sequences. Conclusions: For all nucleotide positions where both Sanger and Illumina Genome Analyzer sequencing methods gave high-confidence calls, no discrepancies were observed. Sequence analysis reveals evidence of heteroplasmy in this sample and places this mitochondrial genome sequence securely within a previously identified aurochsen haplogroup (haplogroup P), thus providing novel insights into pre-domestic patterns of variation. The high proportion of authentic, endogenous aurochs DNA preserved in this sample bodes well for future efforts to determine the complete genome sequence of a wild ancestor of domestic cattle.	[Edwards, Ceiridwen J.; Finlay, Emma K.; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Magee, David A.; Park, Stephen D. E.; McGettigan, Paul A.; MacHugh, David E.] Univ Coll Dublin, Anim Genom Lab, Sch Agr Food Sci & Vet Med, Coll Life Sci, Dublin 2, Ireland; [Lohan, Amanda J.; Murphy, Alison; Loftus, Brendan J.; MacHugh, David E.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Shapiro, Beth] Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; [Chamberlain, Andrew T.] Univ Sheffield, Dept Archaeol, Sheffield, S Yorkshire, England; [Richards, Martin B.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds, W Yorkshire, England	Trinity College Dublin; University College Dublin; University College Dublin; University of Oxford; University of Sheffield; University of Leeds	Edwards, CJ (corresponding author), Univ Oxford, Res Lab Archaeol, Oxford, England.	david.machugh@ucd.ie	Edwards, Ceiridwen/F-8855-2010; Bradley, Daniel G/A-3240-2012; Chamberlain, Andrew T/F-2118-2018	Edwards, Ceiridwen/0000-0001-9126-1377; Finlay, Emma/0000-0003-0621-2744; McGettigan, Paul/0000-0001-5815-8394; Lohan, Amanda/0000-0002-3574-7572; Bradley, Daniel G/0000-0001-7335-7092; Shapiro, Beth/0000-0002-2733-7776; loftus, brendan/0000-0001-8871-8356; MacHugh, David/0000-0002-8112-4704; RICHARDS, MARTIN/0000-0003-3118-0967	Science Foundation Ireland [SFI/01/F.1/B028, 08/IN.l/B2038]; Research Stimulus Grant from the Department of Agriculture, Fisheries and Food [RSF 06 406]; Science Foundation Ireland Research Professorship [05/RP1/908/EC07]; Science Foundation Ireland Research Frontiers Programme [05/RF/MAT031]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Research Stimulus Grant from the Department of Agriculture, Fisheries and Food; Science Foundation Ireland Research Professorship(Science Foundation Ireland); Science Foundation Ireland Research Frontiers Programme(Science Foundation Ireland)	This work was supported by Principal Investigator Grants from Science Foundation Ireland (project numbers: SFI/01/F.1/B028; 08/IN.l/B2038) and a Research Stimulus Grant from the Department of Agriculture, Fisheries and Food (project number: RSF 06 406). B. J. L. is supported by a Science Foundation Ireland Research Professorship (grant number: 05/RP1/908/EC07). C. J. E. was supported by a Science Foundation Ireland Research Frontiers Programme (project number: 05/RF/MAT031). Science Foundation Ireland (SFI) website: http://www.sfi.ie. Department of Agriculture, Fisheries and Food (DAFF) website:http://www.agriculture.gov.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Baig M, 2005, CURR SCI INDIA, V89, P38; Bailey JF, 1996, P ROY SOC B-BIOL SCI, V263, P1467, DOI 10.1098/rspb.1996.0214; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bradley DG, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P317; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brown A, 2007, ANTIQUITY, V81, P1042, DOI 10.1017/S0003598X00096101; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; Clark AG, 2008, CELL, V134, P388, DOI 10.1016/j.cell.2008.07.026; CLUTTONBROCK J, 1989, WALKING LARDER PATTE, P368; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert MTP, 2008, P NATL ACAD SCI USA, V105, P8327, DOI 10.1073/pnas.0802315105; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Helmer Daniel, 2005, P86; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Irwin JA, 2009, J MOL EVOL, V68, P516, DOI 10.1007/s00239-009-9227-4; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; KRAUSE J, 2009, CURR BIOL; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lin CS, 1999, GENE, V236, P107, DOI 10.1016/S0378-1119(99)00247-4; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Macaulay V.A., 1998, CRED CREDIBLE REGION; MacHugh DE, 1999, PHILOS T ROY SOC B, V354, P99, DOI 10.1098/rstb.1999.0363; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; Magee DA, 2002, J HERED, V93, P429, DOI 10.1093/jhered/93.6.429; Magee DA, 2007, VERTEBR PALEOBIOL PA, P385, DOI 10.1007/1-4020-5562-5_17; Mannen H, 2004, MOL PHYLOGENET EVOL, V32, P539, DOI 10.1016/j.ympev.2004.01.010; Mason I.L., 1984, EVOLUTION DOMESTICAT, P452; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; POINAR HN, 2006, DNA SCI, V311, P392; Ramirez O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005670; Rogaev EI, 2006, PLOS BIOL, V4, P403, DOI 10.1371/journal.pbio.0040073; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Smith CI, 2001, NATURE, V410, P771, DOI 10.1038/35071177; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	67	56	59	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9255	10.1371/journal.pone.0009255	http://dx.doi.org/10.1371/journal.pone.0009255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174668	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000274590600012
J	Ben-Zvi, I; Aranow, C; Mackay, M; Stanevsky, A; Kamen, DL; Marinescu, LM; Collins, CE; Gilkeson, GS; Diamond, B; Hardin, JA				Ben-Zvi, Ilan; Aranow, Cynthia; Mackay, Meggan; Stanevsky, Anfisa; Kamen, Diane L.; Marinescu, L. Manuela; Collins, Christopher E.; Gilkeson, Gary S.; Diamond, Betty; Hardin, John A.			The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							INDUCIBLE GENE-EXPRESSION; INTERFERON-ALPHA ACTIVITY; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; IFN-ALPHA; RHEUMATOID-ARTHRITIS; MICROARRAY ANALYSIS; AUTOIMMUNE-DISEASE; D-RECEPTOR	Background: Excessive activity of dendritic cells (DCs) is postulated as a central disease mechanism in Systemic Lupus Erythematosus (SLE). Vitamin D is known to reduce responsiveness of healthy donor DCs to the stimulatory effects of Type I IFN. As vitamin D deficiency is reportedly common in SLE, we hypothesized that vitamin D might play a regulatory role in the IFN alpha amplification loop in SLE. Our goals were to investigate the relationship between vitamin D levels and disease activity in SLE patients and to investigate the effects of vitamin D on DC activation and expression of IFN alpha-regulated genes in vitro. Methodology/Principal Findings: In this study, 25-OH vitamin D (25-D) levels were measured in 198 consecutively recruited SLE patients. Respectively, 29.3% and 11.8% of African American and Hispanic SLE patient had 25-D levels <10 ng/ml. The degree of vitamin D deficiency correlated inversely with disease activity; R = -.234, p = .002. In 19 SLE patients stratified by 25-D levels, there were no differences between circulating DC number and phenotype. Monocyte-derived DCs (MDDCs) of SLE patients were normally responsive to the regulatory effects of vitamin D in vitro as evidenced by decreased activation in response to LPS stimulation in the presence of 1,25-D. Additionally, vitamin D conditioning reduced expression of IFN alpha-regulated genes by healthy donor and SLE MDDCs in response to factors in activating SLE plasma. Conclusions/Significance: We report on severe 25-D deficiency in a substantial percentage of SLE patients tested and demonstrate an inverse correlation with disease activity. Our results suggest that vitamin D supplementation will contribute to restoring immune homeostasis in SLE patients through its inhibitory effects on DC maturation and activation. We are encouraged to support the importance of adequate vitamin D supplementation and the need for a clinical trial to assess whether vitamin D supplementation affects IFN alpha activity in vivo and, most importantly, improves clinical outcome.	[Ben-Zvi, Ilan; Aranow, Cynthia; Mackay, Meggan; Stanevsky, Anfisa; Diamond, Betty] Feinstein Inst Med Res, Div Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Marinescu, L. Manuela; Hardin, John A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kamen, Diane L.; Gilkeson, Gary S.] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA; [Collins, Christopher E.; Gilkeson, Gary S.] Ralph H Johnson Vet Adm Med Ctr, Dept Med, Charleston, SC USA; [Hardin, John A.] NIAID, NIH, Washington, DC USA	Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ben-Zvi, I (corresponding author), Feinstein Inst Med Res, Div Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	johnhardin@arthritis.org	Ben-Zvi, Ilan/ABE-7114-2021	Ben-Zvi, Ilan/0000-0002-9160-3098; Collins, Christopher/0000-0002-3136-7767	National Institutes of Health [P60 AR049459, RR01070, AR052364]; National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence; Autoimmunity Centers of Excellence; American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; NIAMS; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882, M01RR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR052364, P60AR049459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Autoimmunity Centers of Excellence; American College of Rheumatology Research and Education Foundation; Alliance for Lupus Research; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the National Institutes of Health to GSG (P60 AR049459) and DLK (General Clinical Research Center grant #RR01070); by grants from the National Institutes of Health (National Institute of Allergy and Infectious Disease) and the Autoimmunity Centers of Excellence to BD, MM, CA, and JAH; by an American College of Rheumatology Research and Education Foundation award to DLK; and by a grant from the Alliance for Lupus Research to JAH. Additional support for DLK: K23 Award from NIAMS: NIH K23 AR052364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE J, 1990, J NUTR SCI VITAMINOL, V36, P21, DOI 10.3177/jnsv.36.21; Andjelkovic Z, 1999, CLIN EXP RHEUMATOL, V17, P453; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Becker A, 2001, Z RHEUMATOL, V60, P352, DOI 10.1007/s003930170035; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Borba VZC, 2009, OSTEOPOROSIS INT, V20, P427, DOI 10.1007/s00198-008-0676-1; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Carvalho JF, 2007, ANN NY ACAD SCI, V1109, P550, DOI 10.1196/annals.1398.061; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; Crow MK, 2003, AUTOIMMUNITY, V36, P481, DOI 10.1080/08916930310001625952; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; Dong XY, 2005, P NATL ACAD SCI USA, V102, P16007, DOI 10.1073/pnas.0506516102; Dusso AS, 1997, J CLIN ENDOCR METAB, V82, P2222, DOI 10.1210/jc.82.7.2222; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gaal J, 2009, ACTA DERM-VENEREOL, V89, P140, DOI 10.2340/00015555-0555; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gill MA, 2002, HUM IMMUNOL, V63, P1172, DOI 10.1016/S0198-8859(02)00756-5; Gregori S, 2001, J IMMUNOL, V167, P1945, DOI 10.4049/jimmunol.167.4.1945; Griffin MD, 2004, J STEROID BIOCHEM, V89-90, P443, DOI 10.1016/j.jsbmb.2004.03.039; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; Hardin JA, 2003, J EXP MED, V197, P681, DOI 10.1084/jem.20030130; Hewison M, 2004, MOL CELL ENDOCRINOL, V215, P31, DOI 10.1016/j.mce.2003.11.017; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Huisman AM, 2001, J RHEUMATOL, V28, P2535; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kamen DL, 2006, AUTOIMMUN REV, V5, P114, DOI 10.1016/j.autrev.2005.05.009; KAMEN DL, 2005, ARTHRITIS RHEUM, V48; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kariuki SN, 2009, J IMMUNOL, V182, P34, DOI 10.4049/jimmunol.182.1.34; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; KOIZUMI T, 1985, INT ARCH ALLER A IMM, V77, P396, DOI 10.1159/000233815; Koller M, 2004, INT IMMUNOL, V16, P1595, DOI 10.1093/intimm/dxh160; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Mahon BD, 2003, J NEUROIMMUNOL, V134, P128, DOI 10.1016/S0165-5728(02)00396-X; Merlino LA, 2004, ARTHRITIS RHEUM-US, V50, P72, DOI 10.1002/art.11434; MULLER K, 1995, CLIN RHEUMATOL, V14, P397, DOI 10.1007/BF02207671; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Niewold TB, 2007, GENES IMMUN, V8, P492, DOI 10.1038/sj.gene.6364408; Niewold TB, 2005, CLIN RHEUMATOL, V24, P178, DOI 10.1007/s10067-004-1024-2; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; OREGAN S, 1979, ACTA PAEDIATR SCAND, V68, P109, DOI 10.1111/j.1651-2227.1979.tb04969.x; Overbergh L, 2000, DIABETES, V49, P1301, DOI 10.2337/diabetes.49.8.1301; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Platzer B, 2004, BLOOD, V104, P3655, DOI 10.1182/blood-2004-02-0412; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Ruiz-Irastorza G, 2008, RHEUMATOLOGY, V47, P920, DOI 10.1093/rheumatology/ken121; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Scheinecker C, 2001, ARTHRITIS RHEUM, V44, P856, DOI 10.1002/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A; Shoenfeld N, 2009, NAT CLIN PRACT RHEUM, V5, P99, DOI 10.1038/ncprheum0989; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Thudi A, 2008, AM J MED SCI, V335, P99, DOI 10.1097/MAJ.0b013e318134eeb6; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; ZADSHIR A, 2005, ETHN DIS S5, V15, DOI DOI 10.1136/JMG.2004.024083	66	110	121	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9193	10.1371/journal.pone.0009193	http://dx.doi.org/10.1371/journal.pone.0009193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169063	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500003
J	Merendino, AM; Bucchieri, F; Campanella, C; Marciano, V; Ribbene, A; David, S; Zummo, G; Burgio, G; Corona, DFV; de Macario, EC; Macario, AJL; Cappello, F				Merendino, Anna M.; Bucchieri, Fabio; Campanella, Claudia; Marciano, Vito; Ribbene, Anna; David, Sabrina; Zummo, Giovanni; Burgio, Giosalba; Corona, Davide F. V.; de Macario, Everly Conway; Macario, Alberto J. L.; Cappello, Francesco			Hsp60 Is Actively Secreted by Human Tumor Cells	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STRESS-PROTEINS; EPITHELIAL-CELLS; K562 CELLS; T-CELLS; EXOSOMES; HEAT-SHOCK-PROTEIN-60; EXPRESSION; PATHWAY; SURFACE	Background: Hsp60, a Group I mitochondrial chaperonin, is classically considered an intracellular chaperone with residence in the mitochondria; nonetheless, in the last few years it has been found extracellularly as well as in the cell membrane. Important questions remain pertaining to extracellular Hsp60 such as how generalized is its occurrence outside cells, what are its extracellular functions and the translocation mechanisms that transport the chaperone outside of the cell. These questions are particularly relevant for cancer biology since it is believed that extracellular chaperones, like Hsp70, may play an active role in tumor growth and dissemination. Methodology/Principal Findings: Since cancer cells may undergo necrosis and apoptosis, it could be possible that extracellular Hsps are chiefly the result of cell destruction but not the product of an active, physiological process. In this work, we studied three tumor cells lines and found that they all release Hsp60 into the culture media by an active mechanism independently of cell death. Biochemical analyses of one of the cell lines revealed that Hsp60 secretion was significantly reduced, by inhibitors of exosomes and lipid rafts. Conclusions/Significance: Our data suggest that Hsp60 release is the result of an active secretion mechanism and, since extracellular release of the chaperone was demonstrated in all tumor cell lines investigated, our observations most likely reflect a general physiological phenomenon, occurring in many tumors.	[Merendino, Anna M.; Bucchieri, Fabio; Campanella, Claudia; Marciano, Vito; Ribbene, Anna; David, Sabrina; Zummo, Giovanni; Cappello, Francesco] Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Univ Palermo, Dipartimento Biol Cellulare & Sviluppo, Palermo, Italy; [Burgio, Giosalba; Corona, Davide F. V.] Dulbecco Telethon Inst, Palermo, Italy; [de Macario, Everly Conway; Macario, Alberto J. L.] Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; [Cappello, Francesco] Ist EuroMEditerraneo Sci & Tecnol, Palermo, Italy	University of Palermo; University of Palermo; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University System of Maryland; University of Maryland Baltimore	Merendino, AM (corresponding author), Univ Palermo, Dipartimento Biomed Sperimentale & Neurosci Clin, Palermo, Italy.	francapp@hotmail.com	Bucchieri, Fabio/F-8877-2012; Corona, Davide F.V./H-8467-2012; Cappello, Francesco/F-9153-2012	BUCCHIERI, Fabio/0000-0002-0209-8668; Cappello, Francesco/0000-0001-9288-1148; DAVID, Sabrina/0000-0003-4106-6826	MIUR; Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST); Federazione Italiana Ricerca Cancro (FIRC); Fondazione Telethon; Armenise-Harvard Foundation; Associazione Italiana Ricerca Cancro (AIRC); Fondo per gli investimenti per la Ricerca di Base (FIRB)	MIUR(Ministry of Education, Universities and Research (MIUR)); Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST); Federazione Italiana Ricerca Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione TelethonEuropean Commission); Armenise-Harvard Foundation; Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondo per gli investimenti per la Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR))	This work was supported by funds from MIUR ex-60% (F. C., S. D. and G. Z.), Istituto EuroMEditerraneo di Scienza e Tecnologia (IEMEST) (F. C.), Federazione Italiana Ricerca Cancro (FIRC) fellowship (G. B.), and Fondazione Telethon, Armenise-Harvard Foundation, Associazione Italiana Ricerca Cancro (AIRC) and Fondo per gli investimenti per la Ricerca di Base (FIRB) (D. F. V. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Campanella C, 2008, EUR J HISTOCHEM, V52, P221; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Cappello F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000552; Chen WL, 2006, EUR J IMMUNOL, V36, P1598, DOI 10.1002/eji.200535501; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Merendino AM, 2006, AM J RESP CELL MOL, V35, P155, DOI 10.1165/rcmb.2005-0433OC; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schiera G, 2007, J CELL MOL MED, V11, P1384, DOI 10.1111/j.1582-4934.2007.00100.x; Shamaei-Tousi A, 2007, CELL STRESS CHAPERON, V12, P384, DOI 10.1379/CSC-300.1; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I	30	125	129	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9247	10.1371/journal.pone.0009247	http://dx.doi.org/10.1371/journal.pone.0009247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169074	Green Submitted, Green Published, gold			2022-12-27	WOS:000274590500025
J	Wang, SM; Lu, B; Girman, S; Duan, J; McFarland, T; Zhang, QS; Grompe, M; Adamus, G; Appukuttan, B; Lund, R				Wang, Shaomei; Lu, Bin; Girman, Sergei; Duan, Jie; McFarland, Trevor; Zhang, Qing-shuo; Grompe, Markus; Adamus, Grazyna; Appukuttan, Binoy; Lund, Raymond			Non-Invasive Stem Cell Therapy in a Rat Model for Retinal Degeneration and Vascular Pathology	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; RCS RAT; SUBRETINAL TRANSPLANTATION; PHOTORECEPTOR DEGENERATION; PROMOTING MIGRATION; VISUAL FUNCTION; ANIMAL-MODELS; GENE-TRANSFER; CONE VISION; RESCUE	Background: Retinitis pigmentosa (RP) is characterized by progressive night blindness, visual field loss, altered vascular permeability and loss of central vision. Currently there is no effective treatment available except gene replacement therapy has shown promise in a few patients with specific gene defects. There is an urgent need to develop therapies that offer generic neuro- and vascular-protective effects with non-invasive intervention. Here we explored the potential of systemic administration of pluripotent bone marrow-derived mesenchymal stem cells (MSCs) to rescue vision and associated vascular pathology in the Royal College Surgeons (RCS) rat, a well-established animal model for RP. Methodology/Principal Findings: Animals received syngeneic MSCs (1 x 10(6) cells) by tail vein at an age before major photoreceptor loss. Principal results: both rod and cone photoreceptors were preserved (5-6 cells thick) at the time when control animal has a single layer of photoreceptors remained; Visual function was significantly preserved compared with controls as determined by visual acuity and luminance threshold recording from the superior colliculus; The number of pathological vascular complexes (abnormal vessels associated with migrating pigment epithelium cells) and area of vascular leakage that would ordinarily develop were dramatically reduced; Semi-quantitative RT-PCR analysis indicated there was upregulation of growth factors and immunohistochemistry revealed that there was an increase in neurotrophic factors within eyes of animals that received MSCs. Conclusions/Significance: These results underscore the potential application of MSCs in treating retinal degeneration. The advantages of this non-invasive cell-based therapy are: cells are easily isolated and can be expanded in large quantity for autologous graft; hypoimmunogenic nature as allogeneic donors; less controversial in nature than other stem cells; can be readministered with minor discomfort. Therefore, MSCs may prove to be the ideal cell source for auto-cell therapy for retinal degeneration and other ocular vascular diseases.	[Wang, Shaomei; Lu, Bin; Girman, Sergei; Duan, Jie; McFarland, Trevor; Adamus, Grazyna; Appukuttan, Binoy; Lund, Raymond] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Zhang, Qing-shuo; Grompe, Markus] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Wang, SM (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	wangsha@ohsu.edu		Grompe, Markus/0000-0002-6616-4345; Zhang, Qing-shuo/0000-0002-4407-6053	Foundation Fighting Blindness, Research Prevent Blindness; Lincy Foundation; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER	Foundation Fighting Blindness, Research Prevent Blindness; Lincy Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This work was supported by grants of Foundation Fighting Blindness, Research Prevent Blindness and Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Arnhold S, 2006, INVEST OPHTH VIS SCI, V47, P4121, DOI 10.1167/iovs.04-1501; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cayouette M, 1998, J NEUROSCI, V18, P9282; CHAITIN MH, 1983, INVEST OPHTH VIS SCI, V24, P812; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; Fukuda Keiichi, 2003, Hum Cell, V16, P83, DOI 10.1111/j.1749-0774.2003.tb00138.x; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Girman S, 2005, VISION RES, V45, P343, DOI 10.1016/j.visres.2004.08.023; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; LI ZY, 1995, OPHTHALMOLOGY, V102, P805, DOI 10.1016/S0161-6420(95)30953-0; LU B, 2009, STEM CELLS; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; MacDonald IM, 2007, CAN J OPHTHALMOL, V42, P399, DOI 10.3129/i07-039; MILAM AH, 1995, RETINAL PATHOLOGY RE; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Sasahara M, 2008, AM J PATHOL, V172, P1693, DOI 10.2353/ajpath.2008.080024; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771; Smith TC, 2007, AUST FAM PHYSICIAN, V36, P359; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Steinberg Roy H., 1994, Current Opinion in Neurobiology, V4, P515, DOI 10.1016/0959-4388(94)90052-3; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wang SM, 2005, INVEST OPHTH VIS SCI, V46, P2552, DOI 10.1167/iovs.05-0279; Wang SM, 2005, J COMP NEUROL, V491, P400, DOI 10.1002/cne.20695; Williams DS, 2008, VISION RES, V48, P433, DOI 10.1016/j.visres.2007.08.015; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475	57	102	110	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9200	10.1371/journal.pone.0009200	http://dx.doi.org/10.1371/journal.pone.0009200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169166	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474700004
J	Wood, NI; Carta, V; Milde, S; Skillings, EA; McAllister, CJ; Ang, YLM; Duguid, A; Wijesuriya, N; Afzal, SM; Fernandes, JX; Leong, TW; Morton, J				Wood, Nigel I.; Carta, Valentina; Milde, Stefan; Skillings, Elizabeth A.; McAllister, Catherine J.; Ang, Y. L. Mabel; Duguid, Alasdair; Wijesuriya, Nadeev; Afzal, Samira Mohd; Fernandes, Joe X.; Leong, T. W.; Morton, Jennifer			Responses to Environmental Enrichment Differ with Sex and Genotype in a Transgenic Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; MICE; BEHAVIOR; STRESS; GENE; SURVIVAL; DEFICITS; CONSEQUENCES; HIPPOCAMPAL; EXPRESSION	Background: Environmental enrichment (EE) in laboratory animals improves neurological function and motor/cognitive performance, and is proposed as a strategy for treating neurodegenerative diseases. EE has been investigated in the R6/2 mouse model of Huntington's disease (HD), where increased social interaction, sensory stimulation, exploration, and physical activity improved survival. We have also shown previously that HD patients and R6/2 mice have disrupted circadian rhythms, treatment of which may improve cognition, general health, and survival. Methodology/Principal Findings: We examined the effects of EE on the behavioral phenotype and circadian activity of R6/2 mice. Our mice are typically housed in an "enriched'' environment, so the EE that the mice received was in addition to these enhanced housing conditions. Mice were either kept in their home cages or exposed daily to the EE (a large playground box containing running wheels and other toys). The "home cage'' and "playground'' groups were subdivided into "handling'' (stimulated throughout the experimental period) and "no-handling'' groups. All mice were assessed for survival, body weight, and cognitive performance in the Morris water maze (MWM). Mice in the playground groups were more active throughout the enrichment period than home cage mice. Furthermore, R6/2 mice in the EE/no-handling groups had better survival than those in the home cage/no-handling groups. Sex differences were seen in response to EE. Handling was detrimental to R6/2 female mice, but EE increased the body weight of male R6/2 and WT mice in the handling group. EE combined with handling significantly improved MWM performance in female, but not male, R6/2 mice. Conclusions/Significance: We show that even when mice are living in an enriched home cage, further EE had beneficial effects. However, the improvements in cognition and survival vary with sex and genotype. These results indicate that EE may improve the quality of life of HD patients, but we suggest that EE as a therapy should be tailored to individuals.	[Wood, Nigel I.; Carta, Valentina; Milde, Stefan; Skillings, Elizabeth A.; McAllister, Catherine J.; Ang, Y. L. Mabel; Duguid, Alasdair; Wijesuriya, Nadeev; Afzal, Samira Mohd; Fernandes, Joe X.; Leong, T. W.; Morton, Jennifer] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Wood, NI (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	niw20@cam.ac.uk	Longo, Kenneth A/A-5631-2010	Leong, Tian Weng/0000-0001-6090-7163; McAllister, Catherine/0000-0001-6147-6449	CHDI Foundation	CHDI Foundation	This work was supported by grants to AJM from CHDI Foundation (www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Baudic S, 2006, DEMENT GERIATR COGN, V21, P316, DOI 10.1159/000091523; Bode FJ, 2009, BEHAV BRAIN RES, V205, P175, DOI 10.1016/j.bbr.2009.06.031; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buchanan JB, 2008, PSYCHONEUROENDOCRINO, V33, P755, DOI 10.1016/j.psyneuen.2008.02.013; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Cummings J L, 1995, Adv Neurol, V65, P179; Dorner JL, 2007, BEHAV BRAIN RES, V178, P90, DOI 10.1016/j.bbr.2006.12.004; Ferrer I, 2000, BRAIN RES, V866, P257, DOI 10.1016/S0006-8993(00)02237-X; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Kim JJ, 2007, P NATL ACAD SCI USA, V104, P18297, DOI 10.1073/pnas.0708644104; Kitraki E, 2004, ANN NY ACAD SCI, V1018, P323, DOI 10.1196/annals.1296.039; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Orr AL, 2008, J BIOL CHEM, V283, P16027, DOI 10.1074/jbc.M710606200; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Pallier PN, 2009, BRAIN RES, V1279, P90, DOI 10.1016/j.brainres.2009.03.072; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Sullivan F R, 2001, J Neurosci Nurs, V33, P136; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; Wood NI, 2008, BRAIN RES BULL, V76, P70, DOI 10.1016/j.brainresbull.2007.12.007; Wood NI, 2007, NEUROBIOL DIS, V25, P342, DOI 10.1016/j.nbd.2006.09.015; Zinzi P, 2007, CLIN REHABIL, V21, P603, DOI 10.1177/0269215507075495; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	39	72	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9077	10.1371/journal.pone.0009077	http://dx.doi.org/10.1371/journal.pone.0009077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20174443	Green Submitted, gold, Green Published			2022-12-27	WOS:000274474600002
J	Pandey, AK; Munjal, N; Datta, M				Pandey, Amit K.; Munjal, Neha; Datta, Malabika			Gene Expression Profiling and Network Analysis Reveals Lipid and Steroid Metabolism to Be the Most Favored by TNF alpha in HepG2 Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SQUALENE EPOXIDASE INHIBITOR; FACTOR-KAPPA-B; TRANSCRIPTION FACTOR; C/EBP-ALPHA; LIVER-REGENERATION; ADIPOSE-TISSUE; RECEPTOR; CHOLESTEROL; MICE	Background: The proinflammatory cytokine, TNF alpha, is a crucial mediator of the pathogenesis of several diseases, more so in cases involving the liver wherein it is critical in maintaining liver homeostasis since it is a major determiner of hepatocyte life and death. Gene expression profiling serves as an appropriate strategy to unravel the underlying signatures to envisage such varied responses and considering this, gene transcription profiling was examined in control and TNF alpha treated HepG2 cells. Methods and Findings: Microarray experiments between control and TNF alpha treated HepG2 cells indicated that TNF alpha could significantly alter the expression profiling of 140 genes; among those up-regulated, several GO (Gene Ontology) terms related to lipid and fat metabolism were significantly (p < 0.01) overrepresented indicating a global preference of fat metabolism within the hepatocyte and those within the down-regulated dataset included genes involved in several aspects of the immune response like immunoglobulin receptor activity and IgE binding thereby indicating a compromise in the immune defense mechanism(s). Conserved transcription factor binding sites were identified in identically clustered genes within a common GO term and SREBP-1 and FOXJ2 depicted increased occupation of their respective binding elements in the presence of TNF alpha. The interacting network of "lipid metabolism, small molecule biochemistry'' was derived to be significantly overrepresented that correlated well with the top canonical pathway of "biosynthesis of steroids''. Conclusions: TNF alpha alters the transcriptome profiling within HepG2 cells with an interesting catalog of genes being affected and those involved in lipid and steroid metabolism to be the most favored. This study represents a composite analysis of the effects of TNF alpha in HepG2 cells that encompasses the altered transcriptome profiling, the functional analysis of the up- and down- regulated genes and the identification of conserved transcription factor binding sites. These could possibly determine TNF alpha mediated alterations mainly the phenotypes of hepatic steatosis and fatty liver associated with several hepatic pathological states.	[Pandey, Amit K.; Munjal, Neha; Datta, Malabika] Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Pandey, AK (corresponding author), Inst Genom & Integrat Biol, Council Sci & Ind Res, Delhi, India.	mdatta@igib.res.in	Pandey, Amit Kumar/AAY-2887-2020	Pandey, Amit Kumar/0000-0002-8886-1694	Department of Science and Technology, New Delhi, India [SR/FT/L-21/2005]; Council of Scientific and Industrial Research, New Delhi, India [NWP0036]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, New Delhi, India (SR/FT/L-21/2005). N.M. and A. K. P. are thankful to the Task Force Project (NWP0036) from the Council of Scientific and Industrial Research, New Delhi, India for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Akobeng AK, 2008, ARCH DIS CHILD, V93, P787, DOI 10.1136/adc.2007.128751; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Berry M, 2007, CURR OPIN PHARMACOL, V7, P279, DOI 10.1016/j.coph.2007.03.001; Brenner D, 1998, J GASTROEN HEPATOL, V13, pS93; Cigana C, 2007, ANTIMICROB AGENTS CH, V51, P975, DOI 10.1128/AAC.01142-06; de Wit H, 1998, LEUKEMIA, V12, P363, DOI 10.1038/sj.leu.2400950; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Endo M, 2007, EXP BIOL MED, V232, P614; FEINGOLD KR, 1989, ENDOCRINOLOGY, V125, P267, DOI 10.1210/endo-125-1-267; FEINGOLD KR, 1988, BIOCHEM BIOPH RES CO, V153, P576, DOI 10.1016/S0006-291X(88)81134-3; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; Gomez-Ferreria MA, 2003, J MOL BIOL, V329, P631, DOI 10.1016/S0022-2836(03)00524-2; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Heyninck K, 2003, BIOCHEM PHARMACOL, V66, P1409, DOI 10.1016/S0006-2952(03)00491-X; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ishii KJ, 2008, CURR OPIN IMMUNOL, V20, P524, DOI 10.1016/j.coi.2008.07.002; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kallinowski B, 1998, CLIN EXP IMMUNOL, V111, P269; Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538; Katso RMT, 2000, CLIN CANCER RES, V6, P3271; KIMURA T, 1994, SCIENCE, V264, P1921, DOI 10.1126/science.8009222; Kudo M, 2004, ENDOCRINOLOGY, V145, P4948, DOI 10.1210/en.2004-0180; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Le Jossic-Corcos C, 2005, BIOCHEM J, V385, P787, DOI 10.1042/BJ20040933; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Li Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-21; Liu XY, 2005, J INTERF CYTOK RES, V25, P617, DOI 10.1089/jir.2005.25.617; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Matzno S, 1997, J LIPID RES, V38, P1639; Mavri-Damelin Demetra, 2007, Int J Biochem Cell Biol, V39, P555, DOI 10.1016/j.biocel.2006.10.007; McClain CJ, 2004, AM J PHYSIOL-GASTR L, V287, pG497, DOI 10.1152/ajpgi.00171.2004; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MEMON RA, 1993, ENDOCRINOLOGY, V132, P2246, DOI 10.1210/en.132.5.2246; Mulcahy B, 1996, AM J HUM GENET, V59, P676; MUTO Y, 1988, LANCET, V2, P72; Nee LE, 2004, KIDNEY INT, V66, P1376, DOI 10.1111/j.1523-1755.2004.00900.x; Nelson DR, 1997, DIGEST DIS SCI, V42, P2487, DOI 10.1023/A:1018804426724; Oberkofler H, 2002, BBA-GENE STRUCT EXPR, V1575, P75, DOI 10.1016/S0167-4781(02)00279-8; Overdier DG, 1997, J BIOL CHEM, V272, P13725, DOI 10.1074/jbc.272.21.13725; Pantelidis P, 2001, AM J RESP CRIT CARE, V163, P1432, DOI 10.1164/ajrccm.163.6.2006064; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Pedersen TA, 2007, EMBO J, V26, P1081, DOI 10.1038/sj.emboj.7601563; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; Qin BL, 2008, AM J PHYSIOL-GASTR L, V294, pG1120, DOI 10.1152/ajpgi.00407.2007; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Roderfeld M, 2006, LIVER INT, V26, P579, DOI 10.1111/j.1478-3231.2006.01271.x; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Sasaki M, 2000, MEDIAT INFLAMM, V9, P155, DOI 10.1080/09629350020002895; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; SATOH T, 1990, J LIPID RES, V31, P2095; Sharma S, 2006, AM J RESP CELL MOL, V35, P488, DOI 10.1165/rcmb.2006-0084OC; SHERON N, 1991, J HEPATOL, V12, P241, DOI 10.1016/0168-8278(91)90945-8; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shiraga T, 2005, EXP CELL RES, V308, P41, DOI 10.1016/j.yexcr.2005.04.008; STEPHENS JM, 1992, J BIOL CHEM, V267, P13580; Sutherland JP, 2004, METAB SYNDR RELAT D, V2, P82, DOI 10.1089/met.2004.2.82; Tacer KF, 2007, PHYSIOL GENOMICS, V31, P216, DOI 10.1152/physiolgenomics.00264.2006; Teng L, 2008, DEVELOPMENT, V135, P1615, DOI 10.1242/dev.012179; Vock C, 2007, BBA-GEN SUBJECTS, V1770, P1283, DOI 10.1016/j.bbagen.2007.07.001; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Yap YL, 2005, NUCLEIC ACIDS RES, V33, P409, DOI 10.1093/nar/gki188; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287	80	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9063	10.1371/journal.pone.0009063	http://dx.doi.org/10.1371/journal.pone.0009063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140224	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474400018
J	Serduc, R; Brauer-Krisch, E; Siegbahn, EA; Bouchet, A; Pouyatos, B; Carron, R; Pannetier, N; Renaud, L; Berruyer, G; Nemoz, C; Brochard, T; Remy, C; Barbier, EL; Bravin, A; Le Duc, G; Depaulis, A; Esteve, F; Laissue, JA				Serduc, Raphael; Braeuer-Krisch, Elke; Siegbahn, Erik A.; Bouchet, Audrey; Pouyatos, Benoit; Carron, Romain; Pannetier, Nicolas; Renaud, Luc; Berruyer, Gilles; Nemoz, Christian; Brochard, Thierry; Remy, Chantal; Barbier, Emmanuel L.; Bravin, Alberto; Le Duc, Geraldine; Depaulis, Antoine; Esteve, Francois; Laissue, Jean A.			High-Precision Radiosurgical Dose Delivery by Interlaced Microbeam Arrays of High-Flux Low-Energy Synchrotron X-Rays	PLOS ONE			English	Article							HUMAN-BRAIN MOTION; GAMMA-KNIFE RADIOSURGERY; RADIATION-THERAPY; CEREBROSPINAL-FLUID; STEREOTACTIC RADIOSURGERY; MICROPLANAR BEAMS; MOUSE-BRAIN; IN-VIVO; CHEMOTHERAPY; TUMORS	Microbeam Radiation Therapy (MRT) is a preclinical form of radiosurgery dedicated to brain tumor treatment. It uses micrometer-wide synchrotron-generated X-ray beams on the basis of spatial beam fractionation. Due to the radioresistance of normal brain vasculature to MRT, a continuous blood supply can be maintained which would in part explain the surprising tolerance of normal tissues to very high radiation doses (hundreds of Gy). Based on this well described normal tissue sparing effect of microplanar beams, we developed a new irradiation geometry which allows the delivery of a high uniform dose deposition at a given brain target whereas surrounding normal tissues are irradiated by well tolerated parallel microbeams only. Normal rat brains were exposed to 4 focally interlaced arrays of 10 microplanar beams (52 mu m wide, spaced 200 mu m on-center, 50 to 350 keV in energy range), targeted from 4 different ports, with a peak entrance dose of 200Gy each, to deliver an homogenous dose to a target volume of 7 mm(3) in the caudate nucleus. Magnetic resonance imaging follow-up of rats showed a highly localized increase in blood vessel permeability, starting 1 week after irradiation. Contrast agent diffusion was confined to the target volume and was still observed 1 month after irradiation, along with histopathological changes, including damaged blood vessels. No changes in vessel permeability were detected in the normal brain tissue surrounding the target. The interlacing radiation-induced reduction of spontaneous seizures of epileptic rats illustrated the potential pre-clinical applications of this new irradiation geometry. Finally, Monte Carlo simulations performed on a human-sized head phantom suggested that synchrotron photons can be used for human radiosurgical applications. Our data show that interlaced microbeam irradiation allows a high homogeneous dose deposition in a brain target and leads to a confined tissue necrosis while sparing surrounding tissues. The use of synchrotron-generated X-rays enables delivery of high doses for destruction of small focal regions in human brains, with sharper dose fall-offs than those described in any other conventional radiation therapy.	[Serduc, Raphael; Renaud, Luc] Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France; [Serduc, Raphael; Renaud, Luc] CNRS, CerCo, Toulouse, France; [Serduc, Raphael; Braeuer-Krisch, Elke; Bouchet, Audrey; Berruyer, Gilles; Nemoz, Christian; Brochard, Thierry; Bravin, Alberto; Le Duc, Geraldine] ESRF, Grenoble, France; [Siegbahn, Erik A.] Dept Med Phys, Stockholm, Sweden; [Pouyatos, Benoit; Pannetier, Nicolas; Remy, Chantal; Barbier, Emmanuel L.; Depaulis, Antoine; Esteve, Francois] INSERM, U836, Grenoble, France; [Pouyatos, Benoit; Pannetier, Nicolas; Remy, Chantal; Barbier, Emmanuel L.; Depaulis, Antoine; Esteve, Francois] Univ Grenoble 1, Inst Neurosci, UMR S836, Grenoble, France; [Carron, Romain] CHU Grenoble, Dept Neurosurg, F-38043 Grenoble, France; [Laissue, Jean A.] Univ Bern, Inst Pathol, Bern, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Bern	Serduc, R (corresponding author), Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France.	raph.serduc@gmail.com	Remy, Chantal/L-9459-2014; Bravin, Alberto/R-8633-2016; Audrey, Bouchet/AAR-5929-2021; Serduc, Raphael/D-6398-2017; Barbier, Emmanuel/E-6302-2011; Bravin, Alberto/AAN-6114-2020; Depaulis, Antoine/B-6098-2012; CARRON, Romain/D-5003-2014; bravin, alberto/B-4911-2008; Brauer-Krisch, Elke/O-6026-2017	Bravin, Alberto/0000-0001-6868-2755; Audrey, Bouchet/0000-0001-7228-8830; Serduc, Raphael/0000-0003-3294-8544; Barbier, Emmanuel/0000-0002-4952-1240; Bravin, Alberto/0000-0001-6868-2755; Depaulis, Antoine/0000-0001-6543-6700; Brauer-Krisch, Elke/0000-0003-4587-1160; Pannetier, Nicolas/0000-0002-0744-5155; Pouyatos, Benoit/0000-0001-6828-1257; Siegbahn, Albert/0000-0002-1491-487X	European Synchrotron Radiation Facility; Agence Nationale de la Recherche [ANR-06-BLAN-023803]	European Synchrotron Radiation Facility; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the European Synchrotron Radiation Facility and by a grant from Agence Nationale de la Recherche (ANR-06-BLAN-023803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett GH, 2007, J NEUROSURG, V106, P1, DOI 10.3171/jns.2007.106.1.1; Bartolomei F, 2008, NEUROLOGY, V70, P1658, DOI 10.1212/01.wnl.0000294326.05118.d8; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Brauer-Krisch E, 2005, NUCL INSTRUM METH A, V548, P69, DOI 10.1016/j.nima.2005.03.068; Curtis H J, 1967, Radiat Res Suppl, V7, P250, DOI 10.2307/3583718; Curtis H J, 1967, Radiat Res Suppl, V7, P258, DOI 10.2307/3583719; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Dilmanian F A, 2003, Cardiovasc Radiat Med, V4, P139, DOI 10.1016/S1522-1865(03)00180-X; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2006, P NATL ACAD SCI USA, V103, P9709, DOI 10.1073/pnas.0603567103; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; ENZMANN DR, 1992, RADIOLOGY, V185, P653, DOI 10.1148/radiology.185.3.1438741; FEINBERG DA, 1992, RADIOLOGY, V185, P630, DOI 10.1148/radiology.185.3.1438734; FEINBERG DA, 1987, RADIOLOGY, V163, P793, DOI 10.1148/radiology.163.3.3575734; Fuss M, 2000, INT J RADIAT ONCOL, V48, P53, DOI 10.1016/S0360-3016(00)00590-3; Kondziolka D., 2008, NEUROSURGERY S2, V62, P719; Kondziolka D, 2008, NEUROSURGERY, V62, P707, DOI [10.1227/01.NEU.0000296953.45771.66, 10.1227/01.neu.0000316275.12962.0e]; LAISSUE J, 2003, PRECLINICAL MICROBEA; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; LAISSUE JA, 2001, WEANLING PIGLET CERE, P65; LEKSELL L, 1951, ACTA CHIR SCAND, V102, P316; Levegrun S, 2004, INT J RADIAT ONCOL, V59, P796, DOI 10.1016/j.ijrobp.2003.11.033; Lonardi S, 2005, CANCER TREAT REV, V31, P79, DOI 10.1016/j.ctrv.2004.12.005; Ohye C, 2009, PROG NEUROL SURG, V22, P170, DOI 10.1159/000163416; Pattany PM, 2002, AM J NEURORADIOL, V23, P225; Pena LA, 2000, CANCER RES, V60, P321; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Pollock BE, 1998, NEUROSURGERY, V42, P1239, DOI 10.1097/00006123-199806000-00020; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Qin DX, 2001, INT J RADIAT ONCOL, V51, P959, DOI 10.1016/S0360-3016(01)01735-7; Regis J, 2008, NEUROCHIRURGIE, V54, P320, DOI 10.1016/j.neuchi.2008.02.016; REIDY MA, 1981, LAB INVEST, V44, P301; Renier M, 2002, NUCL INSTRUM METH A, V479, P656, DOI 10.1016/S0168-9002(01)00905-6; Salvat F., 2019, WORK P; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; SERDUC R, 2009, PHYS MED BI IN PRESS; SERDUC R, 2006, THESIS U J FOURIER G; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Serizawa T, 2009, INT J CLIN ONCOL, V14, P289, DOI 10.1007/s10147-009-0910-7; Serizawa T, 2008, J NEUROSURG, V109, P118, DOI 10.3171/JNS/2008/109/12/S18; Siegbahn EA, 2006, MED PHYS, V33, P3248, DOI 10.1118/1.2229422; Siegbahn EA, 2009, MED PHYS, V36, P1128, DOI 10.1118/1.3081934; Sims E, 1999, CLIN ONCOL-UK, V11, P303, DOI 10.1053/clon.1999.9073; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1994, METHOD MICROBEAM RAD; Soellinger M, 2007, J MAGN RESON IMAGING, V25, P709, DOI 10.1002/jmri.20882; St George EJ, 2002, J NEUROSURG, V97, P631; Strik C, 2002, J MAGN RESON IMAGING, V15, P251, DOI 10.1002/jmri.10084; Sundgren PC, 2006, MAGN RESON IMAGING, V24, P1131, DOI 10.1016/j.mri.2006.07.008; Thomlinson W, 2000, CELL MOL BIOL, V46, P1053; van Vulpen M, 2002, ONCOL REP, V9, P683; ZEMAN W, 1961, RADIAT RES, V15, P496, DOI 10.2307/3571293	54	74	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9028	10.1371/journal.pone.0009028	http://dx.doi.org/10.1371/journal.pone.0009028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140254	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200014
J	Hubert, MA; Sherritt, SL; Bachurski, CJ; Handwerger, S				Hubert, Michael A.; Sherritt, Susan L.; Bachurski, Cindy J.; Handwerger, Stuart			Involvement of Transcription Factor NR2F2 in Human Trophoblast Differentiation	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; LACTOGEN GENE-EXPRESSION; RETINOIC ACID; IN-VITRO; ACTIVATOR PROTEIN-2; HORMONE-SECRETION; BETA-CATENIN; RXR-ALPHA; RECEPTOR; PLACENTA	Background: During the in vitro differentiation of human villous cytotrophoblast (CTB) cells to a syncytiotrophoblast (STB) phenotype, mRNA levels for the nuclear hormone receptor NR2F2 (ARP-1, COUP-TFII) increase rapidly, reaching a peak at day 1 of differentiation that is 8.8-fold greater than that in undifferentiated CTB cells. To examine whether NR2F2 is involved in the regulation of villous CTB cell differentiation, studies were performed to determine whether NR2F2 regulates the expression of TFAP2A (AP-2 alpha), a transcription factor that is critical for the terminal differentiation of these cells to a STB phenotype. Methodology/Primary Findings: Overexpression of NR2F2 in primary cultures of human CTB cells and JEG-3 human choriocarcinoma cells induced dose-dependent increases in TFAP2A promoter activity. Conversely, siRNA mediated silencing of the NR2F2 gene in villous CTB undergoing spontaneous differentiation blocked the induction of the mRNAs for TFAP2A and several STB cell specific marker genes, including human placental lactogen (hPL), pregnancy specific glycoprotein 1 (PSG1) and corticotropin releasing hormone (CRH) by 51-59%. The induction of TFAP2A promoter activity by NR2F2 was potentiated by the nuclear hormone receptors retinoic acid receptor alpha (RARA) and retinoid X receptor alpha (RXRA). Conclusions/Significance: Taken together, these results strongly suggest that NR2F2 is involved in villous CTB cell differentiation and that NR2F2 acts, at least in part, by directly activating TFAP2A gene expression and by potentiating the transactivation of TFAP2A by RARA and RXRA.	[Hubert, Michael A.; Sherritt, Susan L.; Bachurski, Cindy J.; Handwerger, Stuart] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Hubert, Michael A.; Sherritt, Susan L.; Handwerger, Stuart] Childrens Hosp Med Ctr, Div Endocrinol, Cincinnati, OH USA; [Bachurski, Cindy J.] Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Hubert, MA (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA.	stuart.handwerger@cchmc.org		Bachurski, Cindy/0000-0002-3118-0636	National Institutes of Health (NIH) [HD-07447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007447] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD007447, R56HD007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	National Institutes of Health (NIH) HD-07447 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P105, DOI 10.1152/physiolgenomics.2001.6.2.105; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheng YH, 2004, PHYSIOL GENOMICS, V18, P99, DOI 10.1152/physiolgenomics.00181.2003; Cheng YH, 2002, MOL CELL ENDOCRINOL, V191, P127, DOI 10.1016/S0303-7207(02)00081-3; GARCIALLORET MI, 1994, EXP CELL RES, V214, P46, DOI 10.1006/excr.1994.1232; Getsios S, 2001, MOL REPROD DEV, V59, P168, DOI 10.1002/mrd.1019; Getsios S, 2000, J REPROD FERTIL, V119, P59, DOI 10.1530/reprod/119.1.59; GHERSA P, 1994, GENE, V151, P331, DOI 10.1016/0378-1119(94)90681-5; Guibourdenche J, 1998, J CLIN ENDOCR METAB, V83, P1384, DOI 10.1210/jc.83.4.1384; HUPPERTZ B, 2006, MICRON; Iwanaga K, 2003, FEBS LETT, V552, P120, DOI 10.1016/S0014-5793(03)00897-4; Johnson W, 1997, J BIOL CHEM, V272, P15405, DOI 10.1074/jbc.272.24.15405; Kang S, 2003, J BIOL CHEM, V278, P30478, DOI 10.1074/jbc.M304201200; KATO Y, 1991, ENDOCRINOLOGY, V128, P401, DOI 10.1210/endo-128-1-401; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KOJIMA K, 1995, HUM REPROD, V10, P1907, DOI 10.1093/oxfordjournals.humrep.a136205; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Lazennec G, 1997, MOL CELL BIOL, V17, P5053, DOI 10.1128/MCB.17.9.5053; Lee K, 2006, J STEROID BIOCHEM, V102, P41, DOI 10.1016/j.jsbmb.2006.09.006; LUSCHER B, 1989, GENE DEV, V3, P1507, DOI 10.1101/gad.3.10.1507; MALIK S, 1995, NUCLEIC ACIDS RES, V23, P1536, DOI 10.1093/nar/23.9.1536; Maruo T, 1995, Early Pregnancy, V1, P54; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Matsuo H, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P23; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; NAAR EM, 1991, BIOL REPROD, V45, P178, DOI 10.1095/biolreprod45.1.178; Peng Chun, 2003, J Obstet Gynaecol Can, V25, P834; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; PIAO YS, 1995, MOL ENDOCRINOL, V9, P1633, DOI 10.1210/me.9.12.1633; Power SC, 1996, MOL CELL BIOL, V16, P778; Richardson BD, 2000, MOL CELL ENDOCRINOL, V160, P183, DOI 10.1016/S0303-7207(99)00209-9; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; SHI QJ, 1993, ENDOCRINOLOGY, V132, P1387, DOI 10.1210/en.132.3.1387; Stephanou A, 1996, J MOL ENDOCRINOL, V16, P221, DOI 10.1677/jme.0.0160221; STRAUSS JF, 1992, PLACENTA, V13, P389, DOI 10.1016/0143-4004(92)90047-W; Stroobandt D, 2000, IEEE CIRCUITS SYSTEM, V11, P4; Suzuki T, 2000, MOL CELL ENDOCRINOL, V164, P69, DOI 10.1016/S0303-7207(00)00242-2; WADA N, 1993, J BIOL CHEM, V268, P14003; Wang Q, 2004, CANCER LETT, V214, P81, DOI 10.1016/j.canlet.2004.03.032; WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380; YAMADA K, 1995, J BIOL CHEM, V270, P25064, DOI 10.1074/jbc.270.42.25064; Yamamoto E, 2005, MOL HUM REPROD, V11, P825, DOI 10.1093/molehr/gah239; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	44	22	23	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9417	10.1371/journal.pone.0009417	http://dx.doi.org/10.1371/journal.pone.0009417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195529	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924300007
J	Kourmpetis, YAI; van Dijk, ADJ; Bink, MCAM; van Ham, RCHJ; ter Braak, CJF				Kourmpetis, Yiannis A. I.; van Dijk, Aalt D. J.; Bink, Marco C. A. M.; van Ham, Roeland C. H. J.; ter Braak, Cajo J. F.			Bayesian Markov Random Field Analysis for Protein Function Prediction Based on Network Data	PLOS ONE			English	Article							GENE; ALGORITHM; INTEGRATION; QUEST; MODEL	Inference of protein functions is one of the most important aims of modern biology. To fully exploit the large volumes of genomic data typically produced in modern-day genomic experiments, automated computational methods for protein function prediction are urgently needed. Established methods use sequence or structure similarity to infer functions but those types of data do not suffice to determine the biological context in which proteins act. Current high-throughput biological experiments produce large amounts of data on the interactions between proteins. Such data can be used to infer interaction networks and to predict the biological process that the protein is involved in. Here, we develop a probabilistic approach for protein function prediction using network data, such as protein-protein interaction measurements. We take a Bayesian approach to an existing Markov Random Field method by performing simultaneous estimation of the model parameters and prediction of protein functions. We use an adaptive Markov Chain Monte Carlo algorithm that leads to more accurate parameter estimates and consequently to improved prediction performance compared to the standard Markov Random Fields method. We tested our method using a high quality S. cereviciae validation network with 1622 proteins against 90 Gene Ontology terms of different levels of abstraction. Compared to three other protein function prediction methods, our approach shows very good prediction performance. Our method can be directly applied to protein-protein interaction or coexpression networks, but also can be extended to use multiple data sources. We apply our method to physical protein interaction data from S. cerevisiae and provide novel predictions, using 340 Gene Ontology terms, for 1170 unannotated proteins and we evaluate the predictions using the available literature.	[Kourmpetis, Yiannis A. I.; Bink, Marco C. A. M.; ter Braak, Cajo J. F.] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [van Dijk, Aalt D. J.; van Ham, Roeland C. H. J.] Plant Res Int, Appl Bioinformat, Wageningen, Netherlands; [van Ham, Roeland C. H. J.] Wageningen Univ, Lab Bioinformat, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kourmpetis, YAI (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	cajo.terbraak@wur.nl	Braak, Cajo J. F. ter/G-7006-2011	Braak, Cajo J. F. ter/0000-0002-0414-8745; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Bioinformatics Centre (NBIC); BSIK; EU [FOOD-CT-2006-016214]	Netherlands Bioinformatics Centre (NBIC); BSIK(Ministry of Economic Affairs, Netherlands); EU(European Commission)	This work is part of the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by a BSIK grant through the Netherlands Genomics Initiative (NGI). CtB and RvH kindly acknowledge financial support from the EU 6th FP project EU-SOL (FOOD-CT-2006-016214). ADJvD kindly acknowledges the Netherlands Organization for Scientific Research (NWO, VENI Grant 863.08.027). Funder's URL: http://www.nbic.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2002, DIFFUSION KERNELS GR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barutcuoglu Z, 2006, BIOINFORMATICS, V22, P830, DOI 10.1093/bioinformatics/btk048; BESAG J, 1986, J R STAT SOC B, V48, P259; CASTILLO LP, 2008, GENOME BIOL S1, V9, pS2, DOI DOI 10.1186/GB-2008-9-S1-S2; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Deng MH, 2004, J COMPUT BIOL, V11, P463, DOI 10.1089/1066527041410346; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Federovitch CM, 2008, MOL BIOL CELL, V19, P4506, DOI 10.1091/mbc.E07-11-1188; Ferre S, 2006, J COMPUT BIOL, V13, P719, DOI 10.1089/cmb.2006.13.719; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kosmidis I., 2007, BRGLM BIAS REDUCTION; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lee H, 2006, OMICS, V10, P40, DOI 10.1089/omi.2006.10.40; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; LI S, 1995, MARKOV RANDOM FIELD; MacKay D. J. C., 2002, INFORM THEORY INFERE; McCullagh P., 1989, GEN LINEAR MODELS; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nariai N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000337; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Ter Braak CJF, 2006, STAT COMPUT, V16, P239, DOI 10.1007/s11222-006-8769-1; ter Braak CJF, 2008, STAT COMPUT, V18, P435, DOI 10.1007/s11222-008-9104-9; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Vethantham V, 2007, MOL CELL BIOL, V27, P8848, DOI 10.1128/MCB.01186-07; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129	42	68	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9293	10.1371/journal.pone.0009293	http://dx.doi.org/10.1371/journal.pone.0009293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195360	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200003
J	Braun, E; Geurten, B; Egelhaaf, M				Braun, Elke; Geurten, Bart; Egelhaaf, Martin			Identifying Prototypical Components in Behaviour Using Clustering Algorithms	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; OPTIC FLOW; BLOWFLY FLIGHT; PRIMITIVES; DROSOPHILA; MOVEMENT; CLASSIFICATION; VALIDATION; PHENOTYPES; DYNAMICS	Quantitative analysis of animal behaviour is a requirement to understand the task solving strategies of animals and the underlying control mechanisms. The identification of repeatedly occurring behavioural components is thereby a key element of a structured quantitative description. However, the complexity of most behaviours makes the identification of such behavioural components a challenging problem. We propose an automatic and objective approach for determining and evaluating prototypical behavioural components. Behavioural prototypes are identified using clustering algorithms and finally evaluated with respect to their ability to represent the whole behavioural data set. The prototypes allow for a meaningful segmentation of behavioural sequences. We applied our clustering approach to identify prototypical movements of the head of blowflies during cruising flight. The results confirm the previously established saccadic gaze strategy by the set of prototypes being divided into either predominantly translational or rotational movements, respectively. The prototypes reveal additional details about the saccadic and intersaccadic flight sections that could not be unravelled so far. Successful application of the proposed approach to behavioural data shows its ability to automatically identify prototypical behavioural components within a large and noisy database and to evaluate these with respect to their quality and stability. Hence, this approach might be applied to a broad range of behavioural and neural data obtained from different animals and in different contexts.	[Braun, Elke; Geurten, Bart; Egelhaaf, Martin] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, Bielefeld, Germany	University of Bielefeld	Braun, E (corresponding author), Univ Bielefeld, Ctr Excellence Cognit Interact Technol, Bielefeld, Germany.	elke.braun@uni-bielefeld.de	Geurten, Bart/I-2037-2019; Egelhaaf, Martin/A-9824-2010	Geurten, Bart/0000-0002-1816-3241; Egelhaaf, Martin/0000-0002-9336-4270	Deutsche Forschungsgemeinschaft (DFG); Studienstiftung des deutschen Volkes	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) and by a PhD grant of the Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; Bobick AF, 1998, PROC CVPR IEEE, P196, DOI 10.1109/CVPR.1998.698609; Boeddeker N, 2005, J EXP BIOL, V208, P1563, DOI 10.1242/jeb.01558; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; COGGINS JM, 1985, PATTERN RECOGN LETT, V3, P195, DOI 10.1016/0167-8655(85)90053-4; Del Vecchio D, 2003, AUTOMATICA, V39, P2085, DOI 10.1016/S0005-1098(03)00250-4; DUDA RO, 2001, PATTERN CLASSIFICATI, pR20; Dudoit S, 2002, GENOME BIOL, V3; Everitt B., 2001, CLUSTER ANAL, pviii; FENTRESS JC, 1973, NATURE, V244, P52, DOI 10.1038/244052a0; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Fod A, 2002, AUTON ROBOT, V12, P39, DOI 10.1023/A:1013254724861; FUKUNAGA K, 1990, INTRO STAT PATTERN R, pR13; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Geng W, 2003, GENETICS, V165, P1117; Ghahramani Z, 2000, NATURE, V407, P682, DOI 10.1038/35037690; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hardle W. K., 2003, APPL MULTIVARIATE ST; Hoshi K, 2006, J NEUROSCI METH, V157, P355, DOI 10.1016/j.jneumeth.2006.05.002; JAIN AK, 1988, ALGORITHMS CLUSTERIN, pR14; JAMBU M, 1983, CLUSTER ANAL DATA AN, pR24; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kern R, 2005, PLOS BIOL, V3, P1130, DOI 10.1371/journal.pbio.0030171; Lange T, 2004, NEURAL COMPUT, V16, P1299, DOI 10.1162/089976604773717621; LEHNER PN, 1998, HDB ETHOLOGICAL METH, pR19; Levine E, 2001, NEURAL COMPUT, V13, P2573, DOI 10.1162/089976601753196030; Lindemann JP, 2003, VISION RES, V43, P779, DOI 10.1016/S0042-6989(03)00039-7; MARTIN P, 2002, MEASURING BEHAV, pR16; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; NIEMANN H, 1990, SPRINGER SERIES INFO, V4, pR14; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Panuccio A., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P734; POMPLUN M, 2001, IRIS02410 U SO CAL I; SARASWATI S, J NEUROBIOLOGY, V58; Schack T., 2004, J SPORT EXERCISE PSY, V2, P403, DOI [10.1080/1612197x.2004.9671753, DOI 10.1080/1612197X.2004.9671753, 10.1080/1612197X.2004.9671753]; Schilstra C, 1998, J NEUROSCI METH, V83, P125, DOI 10.1016/S0165-0270(98)00069-7; Schilstra C, 1999, J EXP BIOL, V202, P1481; Smyth P, 2000, STAT COMPUT, V10, P63, DOI 10.1023/A:1008940618127; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Suster ML, 2004, GENES BRAIN BEHAV, V3, P273, DOI 10.1111/j.1601-183X.2004.00082.x; Thurau C, 2004, LECT NOTES COMPUT SC, V3175, P179; Van Hateren JH, 1999, J EXP BIOL, V202, P1491; WEST DB, 2001, INTRO GRAPH THEORY, pR19	46	51	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9361	10.1371/journal.pone.0009361	http://dx.doi.org/10.1371/journal.pone.0009361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179763	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900021
J	Rohan, LC; Moncla, BJ; Ayudhya, RPKN; Cost, M; Huang, Y; Gai, F; Billitto, N; Lynam, JD; Pryke, K; Graebing, P; Hopkins, N; Rooney, JF; Friend, D; Dezzutti, CS				Rohan, Lisa C.; Moncla, Bernard J.; Ayudhya, Ratiya Pamela Kunjara Na; Cost, Marilyn; Huang, Yunda; Gai, Fang; Billitto, Nicole; Lynam, J. D.; Pryke, Kara; Graebing, Phillip; Hopkins, Nicole; Rooney, James F.; Friend, David; Dezzutti, Charlene S.			In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide	PLOS ONE			English	Article							NONOXYNOL-9 VAGINAL GEL; PLACEBO-CONTROLLED TRIAL; FEMALE SEX WORKERS; TOPICAL MICROBICIDES; NEISSERIA-GONORRHOEAE; RECTAL TRANSMISSION; EXPLANT CULTURE; CLINICAL-TRIALS; SOUTH-AFRICA; DOUBLE-BLIND	Background: Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 infection but has no published data regarding pre-clinical testing using in vitro and ex vivo models. To validate our findings with on-going clinical trial results, we evaluated topical tenofovir gel for safety and efficacy. We also modeled systemic application of tenofovir for efficacy. Methods and Findings: Formulation assessment of tenofovir gel included osmolality, viscosity, in vitro release, and permeability testing. Safety was evaluated by measuring the effect on the viability of vaginal flora, PBMCs, epithelial cells, and ectocervical and colorectal explant tissues. For efficacy testing, PBMCs were cultured with tenofovir or vehicle control gels and HIV-1 representing subtypes A, B, and C. Additionally, polarized ectocervical and colorectal explant cultures were treated apically with either gel. Tenofovir was added basolaterally to simulate systemic application. All tissues were challenged with HIV-1 applied apically. Infection was assessed by measuring p24 by ELISA on collected supernatants and immunohistochemistry for ectocervical explants. Formulation testing showed the tenofovir and vehicle control gels were >10 times isosmolar. Permeability through ectocervical tissue was variable but in all cases the receptor compartment drug concentration reached levels that inhibit HIV-1 infection in vitro. The gels were non-toxic toward vaginal flora, PBMCs, or epithelial cells. A transient reduction in epithelial monolayer integrity and epithelial fracture for ectocervical and colorectal explants was noted and likely due to the hyperosmolar nature of the formulation. Tenofovir gel prevented HIV-1 infection of PBMCs regardless of HIV-1 subtype. Topical and systemic tenofovir were effective at preventing HIV-1 infection of explant cultures. Conclusions: These studies provide a mechanism for pre-clinical prediction of safety and efficacy of formulated microbicides. Tenofovir was effective against HIV-1 infection in our algorithm. These data support the use of tenofovir for pre-exposure prophylaxis.	[Rohan, Lisa C.; Moncla, Bernard J.; Ayudhya, Ratiya Pamela Kunjara Na; Cost, Marilyn; Billitto, Nicole; Lynam, J. D.; Pryke, Kara; Graebing, Phillip; Hopkins, Nicole; Dezzutti, Charlene S.] Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Huang, Yunda; Gai, Fang] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Friend, David] CONRAD, Arlington, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Fred Hutchinson Cancer Center; Gilead Sciences	Rohan, LC (corresponding author), Univ Pittsburgh, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	cdezzutti@mwri.magee.edu		Huang, Yunda/0000-0003-1546-6172; Dezzutti, Charlene/0000-0001-5902-5841	National Institute of Allergy and Infectious Diseases [U01 AI068633]; National Institute of Child Health and Development; National Institute of Mental Health; United States National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Microbicide Trials Network funded by the National Institute of Allergy and Infectious Diseases (U01 AI068633), the National Institute of Child Health and Development, and the National Institute of Mental Health, all of the United States National Institutes of Health. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ANTON P, 2009, STRONG SUPPRESSION H; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; AYUDHYA RPK, KEYST S PREV HIV AID; Beer BE, 2006, ANTIMICROB AGENTS CH, V50, P713, DOI 10.1128/AAC.50.2.713-723.2006; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Cosentino LA, 2003, J CLIN MICROBIOL, V41, P3592, DOI 10.1128/JCM.41.8.3592-3596.2003; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Fletcher PS, 2006, AIDS, V20, P1237, DOI 10.1097/01.aids.0000232230.96134.80; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gray Ronald H, 2008, Curr Infect Dis Rep, V10, P121, DOI 10.1007/s11908-008-0022-y; Greig FE, 2003, AIDS BEHAV, V7, P195, DOI 10.1023/A:1023954526639; Harwood B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.020; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Hillier SL, 2008, SAFETY ACCEPTABILITY; JENNINGS R, 1993, J ANTIMICROB CHEMOTH, V32, P71, DOI 10.1093/jac/32.1.71; Kalichman SC, 1998, J WOMENS HEALTH, V7, P371, DOI 10.1089/jwh.1998.7.371; KARIM SA, 2009, SAFETY EFFECTIVENESS; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; MALKOVSKY M, 1988, LANCET, V1, P645; Martin HL, 1997, SEX TRANSM DIS, V24, P279, DOI 10.1097/00007435-199705000-00008; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Microbicides Development Programme, 2009, HIV PREV GEL PRO 200; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; Moncla BJ, 2008, ANTIMICROB AGENTS CH, V52, P1577, DOI 10.1128/AAC.01023-07; Moncla BJ, 2005, SEX TRANSM DIS, V32, P491, DOI 10.1097/01.olq.0000170444.13666.e9; MONCLA BJ, 1991, J CLIN MICROBIOL, V29, P1955, DOI 10.1128/JCM.29.9.1955-1958.1991; Moszynski P, 2007, BRIT MED J, V334, P276, DOI 10.1136/bmj.39118.473356.DB; NIRUTHISARD S, 1992, LANCET, V339, P1371, DOI 10.1016/0140-6736(92)91195-E; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; Olmsted SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-79; Palmer S, 2001, AIDS RES HUM RETROV, V17, P1167, DOI 10.1089/088922201316912772; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Phillips DM, 2004, CONTRACEPTION, V70, P107, DOI 10.1016/j.contraception.2004.04.008; Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Tabet SR, 1999, SEX TRANSM DIS, V26, P564, DOI 10.1097/00007435-199911000-00005; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Tuyama ACG, 2006, J INFECT DIS, V194, P795, DOI 10.1086/506948; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Van Damme L, 2000, AIDS, V14, P85, DOI 10.1097/00002030-200001070-00010; Van Damme L, 1998, AIDS, V12, P433, DOI 10.1097/00002030-199804000-00013; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957	55	154	159	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9310	10.1371/journal.pone.0009310	http://dx.doi.org/10.1371/journal.pone.0009310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174579	Green Accepted, Green Published, gold			2022-12-27	WOS:000274923700014
J	Gao, XL; Wang, SH; Fan, YJ; Bai, H; Yang, J; Yang, X				Gao, Xiaoling; Wang, Shuhe; Fan, Yijun; Bai, Hong; Yang, Jie; Yang, Xi			CD8(+) DC, but Not CD8(-)DC, Isolated from BCG-Infected Mice Reduces Pathological Reactions Induced by Mycobacterial Challenge Infection	PLOS ONE			English	Article							DENDRITIC CELL SUBSETS; REGULATORY T-CELLS; IN-VIVO; TUBERCULOSIS INFECTION; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; CD8-ALPHA(+); SPLEEN; SUBPOPULATION; MACROPHAGES	Background: Tuberculosis is a mycobacterial infection causing worldwide public health problems but the available vaccine is far from ideal. Type-1 T cell immunity has been shown to be critical for host defence against tuberculosis infection, but the role of dendritic cell (DC) subsets in pathogenesis of mycobacterial infection remains unclear. Methodology/Principal Findings: We examined the effectiveness of dendritic cell (DC) subsets in BCG-infected mice in generating immune responses beneficial for pathogen clearance and reduction of pathological reactions in the tissues following challenge infection. Our data showed that only the adoptive transfer of the subset of CD8 alpha(+) DC isolated from infected mice (iCD8(+) DC) generated significant protection, demonstrated by less mycobacterial growth and pathological changes in the lung and liver tissues in iCD8(+) DC recipients than sham-treated control mice. The adoptive transfer of the CD8 alpha-DC from the infected mice (iCD8(-) DC) not only failed to reduce bacterial growth, but enhanced inflammation characterized by diffuse heavy cellular infiltration. Notably, iCD8(-)DC produced significantly higher levels of IL-10 than iCD8(+) DC and promoted more Th2 cytokine responses in in vitro DC-T cell co-culture and in vivo adoptive transfer experiments. Conclusions/Significance: The data indicate that in vivo BCG-primed CD8(+)DC is the dominant DC subset in inducing protective immunity especially for reducing pathological reactions in infected tissues. The finding has implications for the rational improvement of the prophylactic and therapeutic approaches for controlling tuberculosis infection and related diseases.	[Gao, Xiaoling; Wang, Shuhe; Fan, Yijun; Bai, Hong; Yang, Jie; Yang, Xi] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada; [Bai, Hong; Yang, Xi] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China	University of Manitoba; Tianjin Medical University	Gao, XL (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Infect & Immun, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca	Gao, xiao ling/GQI-2790-2022	Yang, Xi/0000-0002-8831-7488	Canadian Institutes of Health Research (CIHR) [MT16480]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to X. Y. (MT16480). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SS, 1999, J IMMUNOL, V163, P3890; Bajana S, 2007, IMMUNOLOGY, V122, P381, DOI 10.1111/j.1365-2567.2007.02650.x; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; Britton WJ, 2003, IMMUNOL CELL BIOL, V81, P34, DOI 10.1046/j.0818-9641.2002.01143.x; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gonzalez-Juarrero M, 2002, CELL IMMUNOL, V220, P13, DOI 10.1016/S0008-8749(03)00010-8; Grohmann U, 2003, J IMMUNOL, V171, P2581, DOI 10.4049/jimmunol.171.5.2581; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamijo R, 1994, Hokkaido Igaku Zasshi, V69, P1332; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Mahnke K, 2005, CURR TOP MICROBIOL, V293, P133, DOI 10.1007/3-540-27702-1_7; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Maldonado-Lopez R, 2001, J IMMUNOL, V167, P4345, DOI 10.4049/jimmunol.167.8.4345; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mitchison DA, 2005, EUR RESPIR J, V25, P376, DOI 10.1183/09031936.05.00075704; North RJ, 1998, CLIN EXP IMMUNOL, V113, P55, DOI 10.1046/j.1365-2249.1998.00636.x; Orme IA, 2005, MICROBES INFECT, V7, P905, DOI 10.1016/j.micinf.2005.03.008; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Pulendran B, 1997, J IMMUNOL, V159, P2222; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Walls T, 2007, ARCH DIS CHILD, V92, P726, DOI 10.1136/adc.2006.102889; World Health Organization, 2004, TB HIV CLIN MAN, V2nd	39	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9281	10.1371/journal.pone.0009281	http://dx.doi.org/10.1371/journal.pone.0009281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174628	Green Submitted, Green Published, gold			2022-12-27	WOS:000274654700015
J	Sverrisdottir, YB; Jansson, LM; Hagg, U; Gan, LM				Sverrisdottir, Yrsa Bergmann; Jansson, Linda Marie; Hagg, Ulrika; Gan, Li-Ming			Muscle Sympathetic Nerve Activity Is Related to a Surrogate Marker of Endothelial Function in Healthy Individuals	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE; HEART-FAILURE; NORADRENALINE SPILLOVER; ESSENTIAL-HYPERTENSION; VASCULAR-TONE; EXERCISE; HUMANS; REST	Background: Evidence from animal studies indicates the importance of an interaction between the sympathetic nervous system and the endothelium for cardiovascular regulation. However the interaction between these two systems remains largely unexplored in humans. The aim of this study was to investigate whether directly recorded sympathetic vasoconstrictor outflow is related to a surrogate marker of endothelial function in healthy individuals. Methods and Results: In 10 healthy normotensive subjects (3 f/7 m), (age 37+/-11 yrs), (BMI 24+/-3 kg/m(2)) direct recordings of sympathetic action potentials to the muscle vascular bed (MSNA) were performed and endothelial function estimated with the Reactive Hyperaemia-Peripheral Arterial Tonometry (RH-PAT) technique. Blood samples were taken and time spent on leisure-time physical activities was estimated. In all subjects the rate between resting flow and the maximum flow, the Reactive Hyperemic index (RH-PAT index), was within the normal range (1,9 -3,3) and MSNA was as expected for age and gender (13-44 burst/minute). RH-PAT index was inversely related to MSNA (r = -0.8, p = 0.005). RH-PAT index and MSNA were reciprocally related to time (h/week) spent on physical activity (p = 0.005 and p = 0.006 respectively) and platelet concentration (PLT) (p = 0.02 and p = 0.004 respectively). Conclusions: Our results show that sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy normotensive individuals, indicating that sympathetic outflow may be modulated by changes in endothelial function. In this study time spent on physical activity is identified as a predictor of sympathetic nerve activity and endothelial function in a group of healthy individuals. The results are of importance in understanding mechanisms underlying sympathetic activation in conditions associated with endothelial dysfunction and emphasise the importance of a daily exercise routine for maintenance of cardiovascular health.	[Sverrisdottir, Yrsa Bergmann; Jansson, Linda Marie; Hagg, Ulrika; Gan, Li-Ming] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Sverrisdottir, YB (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	yrsa.sverrisdottir@neuro.gu.se			Swedish Medical Research Council [15105-01A]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study was supported by grants from the Swedish Medical Research Council (Project No. 15105-01A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger R H, 1999, J Endocrinol Invest, V22, P75; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Bonetti PO, 2003, J AM COLL CARDIOL, V41, P1761, DOI 10.1016/S0735-1097(03)00329-2; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Elherik K, 2002, CLIN SCI, V102, P547, DOI 10.1042/CS20010278; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; Fagius J, 1993, Clin Auton Res, V3, P201; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Forte P, 1998, HYPERTENSION, V32, P730, DOI 10.1161/01.HYP.32.4.730; Fraga R, 2007, EUR J HEART FAIL, V9, P630, DOI 10.1016/j.ejheart.2007.03.003; Franzoni F, 2004, CLIN SCI, V106, P329, DOI 10.1042/CS20030229; Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Gao L, 2007, CIRCULATION, V115, P3095, DOI 10.1161/CIRCULATIONAHA.106.677989; GRASSI G, 1994, HYPERTENSION, V23, P294, DOI 10.1161/01.HYP.23.3.294; Hagg U, 2005, AM J PHYSIOL-HEART C, V289, pH1627, DOI 10.1152/ajpheart.00135.2005; Haller MJ, 2007, PEDIATR DIABETES, V8, P193, DOI 10.1111/j.1399-5448.2007.00246.x; Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702; HARADA S, 1993, CIRC RES, V72, P511, DOI 10.1161/01.RES.72.3.511; Hedblad B, 2001, CIRCULATION, V103, P1721, DOI 10.1161/01.CIR.103.13.1721; Hijmering ML, 2002, J AM COLL CARDIOL, V39, P683, DOI 10.1016/S0735-1097(01)01786-7; KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2; Kingwell BA, 2000, FASEB J, V14, P1685, DOI 10.1096/fj.99-0896rev; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KUBO SH, 1991, CIRCULATION, V84, P1589, DOI 10.1161/01.CIR.84.4.1589; Lowenstein L, 2007, EUR J OBSTET GYN R B, V134, P208, DOI 10.1016/j.ejogrb.2007.02.011; Marsh SA, 2005, INT J CARDIOL, V99, P165, DOI 10.1016/j.ijcard.2004.02.005; MORRIS JN, 1980, LANCET, V2, P1207; NG AV, 1993, HYPERTENSION, V21, P498, DOI 10.1161/01.HYP.21.4.498; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Otto ME, 2004, CIRCULATION, V109, P2507, DOI 10.1161/01.CIR.0000128207.26863.C4; Owlya R, 1997, CIRCULATION, V96, P3897; Panza JA, 1997, CLIN CARDIOL, V20, P26; PARATI G, 1989, HYPERTENSION, V13, P647, DOI 10.1161/01.HYP.13.6.647; Ray CA, 1998, MED SCI SPORT EXER, V30, P387, DOI 10.1097/00005768-199803000-00008; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sartori C, 2005, PHARMACOL THERAPEUT, V106, P209, DOI 10.1016/j.pharmthera.2004.11.009; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Sverrisdottir YB, 2003, J HYPERTENS, V21, P1905, DOI 10.1097/01.hjh.0000084757.37215.55; Sverrisdottir YB, 1998, J CLIN ENDOCR METAB, V83, P1881, DOI 10.1210/jc.83.6.1881; Sverrisdottir YB, 2001, J HYPERTENS, V19, P2019, DOI 10.1097/00004872-200111000-00012; SVERRISDOTTIR YB, 2008, AM J PHYSIOL-ENDOC M; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; VALLBO AB, 1979, PHYSIOL REV, V59, P919, DOI 10.1152/physrev.1979.59.4.919; Wallin BG, 2007, MUSCLE NERVE, V36, P595, DOI 10.1002/mus.20831; Wallin BG, 1996, J PHYSIOL-LONDON, V491, P881, DOI 10.1113/jphysiol.1996.sp021265; WALLIN BG, 1992, J PHYSIOL-LONDON, V453, P45, DOI 10.1113/jphysiol.1992.sp019217; ZANZINGER J, 1994, CIRC RES, V75, P1073, DOI 10.1161/01.RES.75.6.1073; Zoppini G, 2007, DIABETIC MED, V24, P370, DOI 10.1111/j.1464-5491.2007.02076.x	52	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9257	10.1371/journal.pone.0009257	http://dx.doi.org/10.1371/journal.pone.0009257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174639	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600014
J	Daniau, AL; d'Errico, F; Goni, MFS				Daniau, Anne-Laure; d'Errico, Francesco; Goni, Maria Fernanda Sanchez			Testing the Hypothesis of Fire Use for Ecosystem Management by Neanderthal and Upper Palaeolithic Modern Human Populations	PLOS ONE			English	Article							SCALE CLIMATIC VARIABILITY; MODERN HUMAN ORIGINS; PLANKTONIC-FORAMINIFERA; HUMAN OCCUPATIONS; ORGANIC-MATTER; FOREST-FIRES; BLACK CARBON; HUMAN IMPACT; ARNHEM-LAND; 000 YR	Background: It has been proposed that a greater control and more extensive use of fire was one of the behavioral innovations that emerged in Africa among early Modern Humans, favouring their spread throughout the world and determining their eventual evolutionary success. We would expect, if extensive fire use for ecosystem management were a component of the modern human technical and cognitive package, as suggested for Australia, to find major disturbances in the natural biomass burning variability associated with the colonisation of Europe by Modern Humans. Methodology/Principal Findings: Analyses of microcharcoal preserved in two deep-sea cores located off Iberia and France were used to reconstruct changes in biomass burning between 70 and 10 kyr cal BP. Results indicate that fire regime follows the Dansgaard-Oeschger climatic variability and its impacts on fuel load. No major disturbance in natural fire regime variability is observed at the time of the arrival of Modern Humans in Europe or during the remainder of the Upper Palaeolithic (40-10 kyr cal BP). Conclusions/Significance: Results indicate that either Neanderthals and Modern humans did not influence fire regime or that, if they did, their respective influence was comparable at a regional scale, and not as pronounced as that observed in the biomass burning history of Southeast Asia.	[Daniau, Anne-Laure; Goni, Maria Fernanda Sanchez] Univ Bordeaux 1, EPHE, CNRS, EPOC,UMR5805, F-33405 Talence, France; [Daniau, Anne-Laure; d'Errico, Francesco] Univ Bordeaux 1, CNRS, UMR5199, PACEA, F-33405 Talence, France; [d'Errico, Francesco] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand	Daniau, AL (corresponding author), Univ Bordeaux 1, EPHE, CNRS, EPOC,UMR5805, F-33405 Talence, France.	al.daniau@bristol.ac.uk	DANIAU, Anne-Laure/O-2379-2017; Goñi, Maria Fernanda Sanchez/R-3699-2019	DANIAU, Anne-Laure/0000-0002-1621-3911; Goñi, Maria Fernanda Sanchez/0000-0001-8238-7488	RESOLuTION (ESF-Eurocores-Euroclimate); OMLL (ESF-Eurocores); ARTEMIS programmes [20040206003N]	RESOLuTION (ESF-Eurocores-Euroclimate)(European Science Foundation (ESF)); OMLL (ESF-Eurocores); ARTEMIS programmes	The work of A.-L. Daniau was funded by a BDI-CNRS- Region Aquitaine fellowship. This study was supported by the RESOLuTION (ESF-Eurocores-Euroclimate), the OMLL (ESF-Eurocores) and ARTEMIS programmes, Region Aquitaine project 20040206003N and the Universite Bordeaux1 BQR/RAMSEMAR (Reconnaissance Automatique des Micro-objets contenus dans les SEdiments MARins)/project 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson MK, 1999, HUM ECOL, V27, P79, DOI 10.1023/A:1018757317568; [Anonymous], 1994, PALYNOLOGY SEDIMENTA; [Anonymous], 1977, PREHISTOIRE FEU; [Anonymous], 1994, SEDIMENTATION ORGANI, DOI DOI 10.1017/CBO9780511524875.018; [Anonymous], 1994, SEDIMENTATION ORGANI; Baena Preysler J., 2005, MONOGRAFIAS MUSEO NA, V20, P461; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bard E, 2004, QUATERNARY RES, V61, P204, DOI 10.1016/j.yqres.2003.11.006; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Beaufort L, 2003, MAR GEOL, V201, P53, DOI 10.1016/S0025-3227(03)00208-1; Bird RB, 2008, P NATL ACAD SCI USA, V105, P14796, DOI 10.1073/pnas.0804757105; Bocquet-Appel JP, 2005, J ARCHAEOL SCI, V32, P1656, DOI 10.1016/j.jas.2005.05.006; BON F, 2006, DEFINITION AURIGNACI, P133; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bos JAA, 2003, VEG HIST ARCHAEOBOT, V12, P19, DOI 10.1007/s00334-003-0006-7; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Bowman DMJS, 2004, J BIOGEOGR, V31, P207, DOI 10.1046/j.0305-0270.2003.00997.x; BRADSHAW RHW, 1997, SEDIMENT RECORDS BIO, P341; BRAIN CK, 1988, NATURE, V336, P464, DOI 10.1038/336464a0; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; BURROWS ND, 2006, BUSHF C 2006 LIF FIR, P1; Caldararo N, 2002, SCI TOTAL ENVIRON, V292, P141, DOI 10.1016/S0048-9697(01)01067-1; Carcaillet C, 2001, J ECOL, V89, P930, DOI 10.1111/j.1365-2745.2001.00614.x; Carcaillet C, 1998, J ECOL, V86, P384, DOI 10.1046/j.1365-2745.1998.00267.x; Carmona-Moreno C, 2005, GLOBAL CHANGE BIOL, V11, P1537, DOI 10.1111/j.1365-2486.2005.01003.x; Cayre O, 1999, PALEOCEANOGRAPHY, V14, P384, DOI 10.1029/1998PA900027; Chmura GL, 1999, PALAEOGEOGR PALAEOCL, V149, P257, DOI 10.1016/S0031-0182(98)00205-3; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Clark JD, 1985, AFR ARCHAEOL REV, V3, P3, DOI DOI 10.1007/BF01117453; Clark JS, 1996, HOLOCENE, V6, P129, DOI 10.1177/095968369600600201; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Daniau AL, 2007, QUATERNARY SCI REV, V26, P1369, DOI 10.1016/j.quascirev.2007.02.005; Daniau AL, 2009, QUATERNARY RES, V71, P385, DOI 10.1016/j.yqres.2009.01.007; Delcourt HR, 1997, CONSERV BIOL, V11, P1010, DOI 10.1046/j.1523-1739.1997.96338.x; Dodson JR, 2005, AUSTRAL ECOL, V30, P592, DOI 10.1111/j.1442-9993.2005.01490.x; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Goni MFS, 2000, QUATERNARY RES, V54, P394, DOI 10.1006/qres.2000.2176; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Gravina B, 2005, NATURE, V438, P51, DOI 10.1038/nature04006; GRIFFIN JJ, 1975, LIMNOL OCEANOGR, V20, P456, DOI 10.4319/lo.1975.20.3.0456; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Hill R, 2003, HUM ECOL, V31, P27, DOI 10.1023/A:1022830123349; Hockaday WC, 2006, ORG GEOCHEM, V37, P501, DOI 10.1016/j.orggeochem.2005.11.003; HOOGHIEMSTRA H, 1992, REV PALAEOBOT PALYNO, V74, P1, DOI 10.1016/0034-6667(92)90137-6; Hu F. S., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P829, DOI 10.1007/s11027-005-9015-4; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hunt CO, 2007, J ARCHAEOL SCI, V34, P1953, DOI 10.1016/j.jas.2007.02.023; JAMES SR, 1989, CURR ANTHROPOL, V30, P1, DOI 10.1086/203705; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; JONES TP, 1997, SEDIMENT RECORDS BIO, P9; Jouanneau JM, 1998, PROG OCEANOGR, V42, P233, DOI 10.1016/S0079-6611(98)00036-6; Jouanneau JM, 1999, DEEP-SEA RES PT II, V46, P2205, DOI 10.1016/S0967-0645(99)00060-0; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Kershaw A. P., 2002, Flammable Australia: the fire regimes and biodiversity of a continent, punknown; Kershaw P, 2003, FRESHWATER BIOL, V48, P1274, DOI 10.1046/j.1365-2427.2003.01085.x; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; Lezine AM, 1997, GEOLOGY, V25, P119, DOI 10.1130/0091-7613(1997)025<0119:EACITE>2.3.CO;2; MAGRI D, 1994, REV PALAEOBOT PALYNO, V81, P313, DOI 10.1016/0034-6667(94)90115-5; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Marshall AG, 2006, J QUATERNARY SCI, V21, P789, DOI 10.1002/jqs.1063; Mason SLR, 2000, PALAEOGEOGR PALAEOCL, V164, P139, DOI 10.1016/S0031-0182(00)00181-4; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Meignen L, 2000, EXEMPLE PROCHE ORIEN, V26, P9; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Meyn A, 2007, PROG PHYS GEOG, V31, P287, DOI 10.1177/0309133307079365; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Millspaugh SH, 2000, GEOLOGY, V28, P211, DOI 10.1130/0091-7613(2000)28<211:VIFFAC>2.0.CO;2; MORENO E, 2000, PROPRIETES MAGNETIQU; Movius HL, 1950, SOUTHWEST J ANTHROP, V6, P139, DOI 10.1086/soutjanth.6.2.3628638; Nichols GJ, 2000, PALAEOGEOGR PALAEOCL, V164, P43, DOI 10.1016/S0031-0182(00)00174-7; Pailler D, 2002, PALAEOGEOGR PALAEOCL, V181, P431, DOI 10.1016/S0031-0182(01)00444-8; Palmer TY., 1975, FIRE TECHNOL, V11, P111, DOI [10.1007/BF02589941, DOI 10.1007/BF02589941]; Pereira MG, 2005, AGR FOREST METEOROL, V129, P11, DOI 10.1016/j.agrformet.2004.12.007; Perez B, 2003, FOREST ECOL MANAG, V182, P273, DOI 10.1016/S0378-1127(03)00069-0; Polunin O., 1985, GUIDE VEGETATION BRI, P320; Quenea K, 2006, ORG GEOCHEM, V37, P1185, DOI 10.1016/j.orggeochem.2006.05.010; RussellSmith J, 1997, HUM ECOL, V25, P159, DOI 10.1023/A:1021970021670; Sanchez-Goni MF, 2006, QUATERNAIRE, V17, P3; Sanchezgoni MF, 2002, CLIM DYNAM, V19, P95, DOI 10.1007/s00382-001-0212-x; Sepulchre P, 2007, EARTH PLANET SC LETT, V258, P283, DOI 10.1016/j.epsl.2007.03.041; Shackleton NJ, 2004, QUATERNARY SCI REV, V23, P1513, DOI 10.1016/j.quascirev.2004.03.006; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; SHACKLETON NJ, 2000, IGBP PAGES WORLD DAT; Simmons IG, 1996, J ARCHAEOL SCI, V23, P193, DOI 10.1006/jasc.1996.0017; Singh G., 1981, FIRE AUSTR BIOTA, P23; Smith E. F., 1972, Proceedings, Annual Tall Timbers Fire Ecology Conference, P9; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; Stevenson J, 2005, QUATERNARY RES, V64, P372, DOI 10.1016/j.yqres.2005.08.011; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Teichmuller M., 1982, 1982 COAL PETROLOGY, P5; THERYPARISOT I, 1998, EC COMBUSTIBLE PALEO; Thevenon F, 2004, PALAEOGEOGR PALAEOCL, V213, P83, DOI 10.1016/j.palaeo.2004.07.003; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Thouveny N, 2000, EARTH PLANET SC LETT, V180, P61, DOI 10.1016/S0012-821X(00)00155-2; TOSCANO LGV, 1990, PALEOLITHIQUE MOYEN, P169; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Vallverdu J, 2005, J HUM EVOL, V48, P157, DOI 10.1016/j.jhevol.2004.10.004; Vaquero M., 2006, NEANDERTHALS MODERN, P419; Verardo DJ, 1997, LIMNOL OCEANOGR, V42, P192, DOI 10.4319/lo.1997.42.1.0192; WALSH PM, 1997, FUEL EN ABSTR, V38, P172; Whitlock C, 2004, DEV QUA SCI, V1, P479; Whitlock C, 1996, HOLOCENE, V6, P7, DOI 10.1177/095968369600600102; Whitlock Cathy, 2001, Biology and Environment, V101B, P65; WILLIAMS GW, 2002, WILDERNESS POLITICAL; WYNN T, 2004, J HUMAN EVOLUTION, V46; WYNN T, 2003, FARMING, V2, P1; Wynn T, 2008, AM SCI, V96, P44, DOI 10.1511/2008.69.44; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; ZILHAO J, 2006, J W MEDITERRANEAN PR, V1, P7; Zilhao J, 2003, TRABALHOS ARQUEOLOGI, P313, DOI DOI 10.1007/S10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	119	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9157	10.1371/journal.pone.0009157	http://dx.doi.org/10.1371/journal.pone.0009157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NX	20161786	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442800004
J	Niino, Y; Hotta, K; Oka, K				Niino, Yusuke; Hotta, Kohji; Oka, Kotaro			Blue Fluorescent cGMP Sensor for Multiparameter Fluorescence Imaging	PLOS ONE			English	Article							CYCLIC-AMP; PROTEIN; FRET; BIOSENSORS; EVENTS; CELLS; PAIRS; CAMP; CA2+	Cyclic GMP (cGMP) regulates many physiological processes by cooperating with the other signaling molecules such as cyclic AMP (cAMP) and Ca(2+). Genetically encoded sensors for cGMP have been developed based on fluorescence resonance energy transfer (FRET) between fluorescent proteins. However, to analyze the dynamic relationship among these second messengers, combined use of existing sensors in a single cell is inadequate because of the significant spectral overlaps. A single wavelength indicator is an effective alternative to avoid this problem, but color variants of a single fluorescent protein-based biosensor are limited. In this study, to construct a new color fluorescent sensor, we converted the FRET-based sensor into a single wavelength indicator using a dark FRET acceptor. We developed a blue fluorescent cGMP biosensor, which is spectrally compatible with a FRET-based cAMP sensor using cyan and yellow fluorescent proteins (CFP/YFP). We cotransfected them and loaded a red fluorescent probe for Ca(2+) into cells, and accomplished triple-parameter fluorescence imaging of these cyclic nucleotides and Ca(2+), confirming the applicability of this combination to individually monitor their dynamics in a single cell. This blue fluorescent sensor and the approach using this FRET pair would be useful for multiparameter fluorescence imaging to understand complex signal transduction networks.	[Niino, Yusuke; Hotta, Kohji; Oka, Kotaro] Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan	Keio University	Niino, Y (corresponding author), Keio Univ, Ctr Biosci & Informat, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	niino@bpni.bio.keio.ac.jp; oka@bio.keio.ac.jp	Oka, Kotaro/C-4918-2014; Hotta, Kohji/D-1162-2014	Hotta, Kohji/0000-0003-4614-7473	Japan Ministry of Education, Culture, Sports, Science and Technology [21300112]; Nakatani Foundation of Electronic Measuring Technology Advancement; The Naito Foundation	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatani Foundation of Electronic Measuring Technology Advancement; The Naito Foundation	This work was supported in part by Grants-in-Aid for Scientific Research 21300112 from the Japan Ministry of Education, Culture, Sports, Science and Technology, by Nakatani Foundation of Electronic Measuring Technology Advancement and by The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Canossa M, 2002, P NATL ACAD SCI USA, V99, P3282, DOI 10.1073/pnas.042504299; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; GATTI G, 1988, BIOCHEM J, V255, P753, DOI 10.1042/bj2550753; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Niino Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006036; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Schultz C, 2005, CHEMBIOCHEM, V6, P1323, DOI 10.1002/cbic.200500012; Souslova EA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P683, DOI 10.1134/S0006297907070012; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501	24	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9164	10.1371/journal.pone.0009164	http://dx.doi.org/10.1371/journal.pone.0009164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161796	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442800010
J	Zughaier, S; Karna, P; Stephens, D; Aneja, R				Zughaier, Susu; Karna, Prasanthi; Stephens, David; Aneja, Ritu			Potent Anti-Inflammatory Activity of Novel Microtubule-Modulating Brominated Noscapine Analogs	PLOS ONE			English	Article							CANCER-CELLS; UNDERGO APOPTOSIS; IMMUNE-RESPONSES; PERTURB MITOSIS; BREAST-CANCER; AUTOPHAGY; AGENT; MACROPHAGES; BINDING; INNATE	Noscapine, a plant-derived, non-toxic, over-the-counter antitussive alkaloid has tubulin-binding properties. Based upon the structural resemblance of noscapine to colchicine, a tubulin-binding anti-inflammatory drug, noscapine and its semisynthetic brominated analogs were examined for in vitro anti-inflammatory activity. Brominated noscapine analogs were found to inhibit cytokine and chemokine release from macrophage cell lines but did not affect cell viability. Brominated noscapine analogs demonstrated anti-inflammatory properties in both TLR- and non-TLR induced in vitro innate immune pathway inflammation models, mimicking septic and sterile infection respectively. In addition, electron microscopy and immunoblotting data indicated that these analogs induced robust autophagy in human macrophages. This study is the first report to identify brominated noscapines as innate immune pathway anti-inflammatory molecules.	[Zughaier, Susu; Stephens, David] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Karna, Prasanthi; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA	Emory University; University System of Georgia; Georgia State University	Zughaier, S (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA.	szughai@emory.edu; raneja@gsu.edu	Zughaier, Susu/GLQ-9288-2022; Zughaier, Susu/N-3185-2019	Zughaier, Susu/0000-0001-7487-8770	Department of Defense [PC073104]; National Cancer Institute [K99 CA131489]; NIH [R01 AI033517]; NATIONAL CANCER INSTITUTE [K99CA131489, R00CA131489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033517] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to RA from the Department of Defense (PC073104), and National Cancer Institute (K99 CA131489); and to DS from NIH (R01 AI033517). SZ, DS and RA acknowledge financial support from Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja R, 2006, CANCER RES, V66, P3782, DOI 10.1158/0008-5472.CAN-05-2962; Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; ANEJA R, 2009, INT J CANC; Aneja R, 2008, CANCER RES, V68, P1495, DOI 10.1158/0008-5472.CAN-07-1874; Aneja R, 2007, MOL CANCER THER, V6, P2891, DOI 10.1158/1535-7163.MCT-07-0359; Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; AZAD MB, 2008, ANTIOXID REDOX SIGNA; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; DING AH, 1990, J EXP MED, V171, P715, DOI 10.1084/jem.171.3.715; Heidemann S, 2006, BLOOD, V107, P2216, DOI 10.1182/blood-2005-12-5142; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Jayaprakash Vikram, 2007, N Z Med J, V120, pU2402; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Landen JW, 2002, CANCER RES, V62, P4109; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Oh SH, 2008, AUTOPHAGY, V4, P1009, DOI 10.4161/auto.6886; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PRISE KM, 1986, BIOCHIM BIOPHYS ACTA, V887, P13, DOI 10.1016/0167-4889(86)90116-3; ROWINSKY E K, 1991, Current Opinion in Oncology, V3, P1060, DOI 10.1097/00001622-199112000-00015; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2005, CANCER CHEMOTH PHARM, V55, P461, DOI 10.1007/s00280-004-0903-1; Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200; Zughaier SM, 2005, CELL MICROBIOL, V7, P1251, DOI 10.1111/j.1462-5822.2005.00549.x; Zughaier SM, 2005, INFECT IMMUN, V73, P2940, DOI 10.1128/IAI.73.5.2940-2950.2005; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	36	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9165	10.1371/journal.pone.0009165	http://dx.doi.org/10.1371/journal.pone.0009165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161797	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800011
J	Erridge, C; Duncan, SH; Bereswill, S; Heimesaat, MM				Erridge, Clett; Duncan, Sylvia H.; Bereswill, Stefan; Heimesaat, Markus M.			The Induction of Colitis and Ileitis in Mice Is Associated with Marked Increases in Intestinal Concentrations of Stimulants of TLRs 2, 4, and 5	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; ESCHERICHIA-COLI; IMMUNE-RESPONSE; BACTERIAL FLAGELLIN; MUCOSAL FLORA; CPG MOTIFS; LIPOPOLYSACCHARIDE; LIGANDS	Background: Inflammatory bowel diseases (IBDs) appear to be modulated by the interaction of pathogen-associated molecular patterns (PAMPs) derived from intestinal bacteria with their respective innate immune receptors, including Toll-like receptors (TLRs). We aimed to establish if intestinal concentrations of proinflammatory bacterial ligands of TLR2, TLR4, or TLR5 may be altered in murine IBD models, and to characterize which of the major bacterial groups may contribute to each signal. Methodology/Principal Findings: PAMPs specific for TLR2 (lipopeptide equivalents), TLR4 (lipopolysaccharide equivalents), and TLR5 (flagellin equivalents) in human and murine fecal and intestinal samples were quantified using HEK-293 cells transfected with respective TLRs and calibrated with defined standard PAMPs. The induction of colitis in mice by dextran-sodium-sulphate treatment significantly increased colonic lipopeptide (fourfold) and LPS equivalent (550-fold) concentrations, while flagellin equivalent concentrations remained similar. The induction of ileitis by oral infection with Toxoplasma gondii dramatically increased ileal concentrations of lipopeptide (370-fold), LPS (3,300-fold), and flagellin equivalents (38-fold), all P < 0.01. Analysis of representative strains of the major bacterial groups of the human intestine revealed that enterobacterial species are likely to be more significant contributors of soluble TLR2 and TLR4 stimulants to the intestinal milieu than Bacteroides species or Gram-positive Firmicutes. Conclusions/Significance: We conclude that the induction of colitis or ileitis in mice is associated with significant disease-specific alterations to the PAMP profile of the gut microbiota.	[Erridge, Clett] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Duncan, Sylvia H.] Rowett Inst Nutr & Hlth, Microbial Ecol Grp, Aberdeen, Scotland; [Bereswill, Stefan; Heimesaat, Markus M.] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany	University of Leicester; University of Aberdeen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Erridge, C (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	ce55@le.ac.uk		Duncan, Sylvia/0000-0002-4903-0978; Heimesaat, Markus/0000-0001-6399-651X; Erridge, Clett/0000-0003-2978-346X	Leicester University College of Medicine Fellowship; Scottish Government Rural and Environment Research and Analysis Directorate; German Research Foundation [DFG; SFB633, TP A7, DFG; SFB633, TP B6]	Leicester University College of Medicine Fellowship; Scottish Government Rural and Environment Research and Analysis Directorate; German Research Foundation(German Research Foundation (DFG))	This study was supported by a Leicester University College of Medicine Fellowship awarded to CE. The Rowett Institute receives financial support from the Scottish Government Rural and Environment Research and Analysis Directorate. S. B. and M. M. H. were supported by grants from the German Research Foundation (DFG; SFB633, TP A7 and DFG; SFB633, TP B6, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; DELAHOOKE D, 1996, INFECT IMMUN, V63, P840; Dionne S, 2003, CLIN EXP IMMUNOL, V133, P108, DOI 10.1046/j.1365-2249.2003.02191.x; Erridge C, 2008, EUR J CLIN INVEST, V38, P713, DOI 10.1111/j.1365-2362.2008.02010.x; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; Erridge C, 2007, ATHEROSCLEROSIS, V193, P77, DOI 10.1016/j.atherosclerosis.2006.08.032; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HOTTA T, 1986, RES EXP MED, V186, P61, DOI 10.1007/BF01851834; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Lange S, 1996, APMIS, V104, P823, DOI 10.1111/j.1699-0463.1996.tb04948.x; Levin A, 2008, WORLD J GASTROENTERO, V14, P5149, DOI 10.3748/wjg.14.5149; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061; Obermeier F, 2002, EUR J IMMUNOL, V32, P2084, DOI 10.1002/1521-4141(200207)32:7<2084::AID-IMMU2084>3.0.CO;2-Q; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345	39	94	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9125	10.1371/journal.pone.0009125	http://dx.doi.org/10.1371/journal.pone.0009125			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161736	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442600023
J	Kocher, SD; Ayroles, JF; Stone, EA; Grozinger, CM				Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.			Individual Variation in Pheromone Response Correlates with Reproductive Traits and Brain Gene Expression in Worker Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA L.; DIVISION-OF-LABOR; QUEEN MANDIBULAR PHEROMONE; SOCIAL-BEHAVIOR; OVARY DEVELOPMENT; JUVENILE-HORMONE; COLONIES; DIVERSITY; CASTE; GENOMICS	Background: Variation in individual behavior within social groups can affect the fitness of the group as well as the individual, and can be caused by a combination of genetic and environmental factors. However, the molecular factors associated with individual variation in social behavior remain relatively unexplored. We used honey bees (Apis mellifera) as a model to examine differences in socially-regulated behavior among individual workers, and used transcriptional profiling to determine if specific gene expression patterns are associated with these individual differences. In honey bees, the reproductive queen produces a pheromonal signal that regulates many aspects of worker behavior and physiology and maintains colony organization. Methodology/Principal Findings: Here, we demonstrate that there is substantial natural variation in individual worker attraction to queen pheromone (QMP). Furthermore, worker attraction is negatively correlated with ovariole number-a trait associated with reproductive potential in workers. We identified transcriptional differences in the adult brain associated with individual worker attraction to QMP, and identified hundreds of transcripts that are organized into statistically-correlated gene networks and associated with this response. Conclusions/Significance: Our studies demonstrate that there is substantial variation in worker attraction to QMP among individuals, and that this variation is linked with specific differences in physiology and brain gene expression patterns. This variation in individual response thresholds may reveal underlying variation in queen-worker reproductive conflict, and may mediate colony function and productivity by creating variation in individual task performance.	[Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Stone, Eric A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Grozinger, Christina M.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Kocher, Sarah D.; Ayroles, Julien F.; Stone, Eric A.; Grozinger, Christina M.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kocher, SD (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	skocher@gmail.com; cmgrozinger@psu.edu	Stone, Eric/Q-7840-2016	Stone, Eric/0000-0002-2725-4209	National Institutes of Health Training; North Carolina State University; National Science Foundation CAREER [0746338]	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina State University; National Science Foundation CAREER(National Science Foundation (NSF))	This work is supported by a National Institutes of Health Training Grant and a Sigma XI Grant in Aid of Research to SDK, funding from North Carolina State University to CMG, and a National Science Foundation CAREER grant (IOS 0746338) to CMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MH, 2003, BEHAV ECOL SOCIOBIOL, V54, P555, DOI 10.1007/s00265-003-0666-4; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Bloch Guy, 2002, P195; BLUM MS, 1978, J APICULT RES, V17, P218, DOI 10.1080/00218839.1978.11099929; Calis JNM, 2002, APIDOLOGIE, V33, P193, DOI 10.1051/apido:2002009; Carde R.T., 1984, P355; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Evans JD, 2001, GENOME BIOL, V2; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Grozinger CM, 2007, J COMP PHYSIOL A, V193, P461, DOI 10.1007/s00359-006-0202-x; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hunt GJ, 1998, GENETICS, V148, P1203; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kocher SD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-232; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Martin CG, 2004, BEHAV ECOL SOCIOBIOL, V56, P42, DOI 10.1007/s00265-004-0755-z; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; Moritz RFA, 2002, INSECT SOC, V49, P86, DOI 10.1007/s00040-002-8284-0; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Oldroyd BP, 2008, TRENDS ECOL EVOL, V23, P59, DOI 10.1016/j.tree.2007.10.012; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; PAGE RE, 1988, BEHAV ECOL SOCIOBIOL, V23, P117, DOI 10.1007/BF00299895; PAGE RE, 1994, BEHAV ECOL SOCIOBIOL, V35, P99, DOI 10.1007/BF00171499; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pankiw T, 1997, CAN ENTOMOL, V129, P679, DOI 10.4039/Ent129679-4; Pankiw T, 2000, NATURWISSENSCHAFTEN, V87, P487, DOI 10.1007/s001140050764; PANKIW T, 1994, J INSECT BEHAV, V7, P1, DOI 10.1007/BF01989823; PHAMDELEGUE MH, 1993, APIDOLOGIE, V24, P267, DOI 10.1051/apido:19930307; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; PICKETT JA, 1980, J CHEM ECOL, V6, P1561; Renn SCP, 2008, J EXP BIOL, V211, P3041, DOI 10.1242/jeb.018242; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Robinson GE, 2002, GENES BRAIN BEHAV, V1, P197, DOI 10.1034/j.1601-183X.2002.10401.x; ROBINSON GE, 1990, BEHAV ECOL SOCIOBIOL, V26, P315, DOI 10.1007/BF00171096; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Winston M. L. L., 1991, BIOL HONEY BEE; WIRTZ P, 1972, INDUCTION CASTE DIFF, P517; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	72	40	40	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9116	10.1371/journal.pone.0009116	http://dx.doi.org/10.1371/journal.pone.0009116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161742	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442600014
J	Smaers, JB; Schleicher, A; Zilles, K; Vinicius, L				Smaers, Jeroen Bert; Schleicher, Axel; Zilles, Karl; Vinicius, Lucio			Frontal White Matter Volume Is Associated with Brain Enlargement and Higher Structural Connectivity in Anthropoid Primates	PLOS ONE			English	Article							BASAL-GANGLIA; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; SOCIAL BRAIN; GREAT APES; EVOLUTION; HUMANS; ORGANIZATION; PROJECTIONS; PATTERNS	Previous research has indicated the importance of the frontal lobe and its `executive' connections to other brain structures as crucial in explaining primate neocortical adaptations. However, a representative sample of volumetric measurements of frontal connective tissue (white matter) has not been available. In this study, we present new volumetric measurements of white and grey matter in the frontal and non-frontal neocortical lobes from 18 anthropoid species. We analyze this data in the context of existing theories of neocortex, frontal lobe and white versus grey matter hyperscaling. Results indicate that the `universal scaling law' of neocortical white to grey matter applies separately for frontal and non-frontal lobes; that hyperscaling of both neocortex and frontal lobe to rest of brain is mainly due to frontal white matter; and that changes in frontal (but not non-frontal) white matter volume are associated with changes in rest of brain and basal ganglia, a group of subcortical nuclei functionally linked to `executive control'. Results suggest a central role for frontal white matter in explaining neocortex and frontal lobe hyperscaling, brain size variation and higher neural structural connectivity in anthropoids.	[Smaers, Jeroen Bert; Vinicius, Lucio] Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England; [Schleicher, Axel; Zilles, Karl] Univ Dusseldorf, Cecile & Oskar Vogt Inst Brain Res, Dusseldorf, Germany	University of Cambridge; Heinrich Heine University Dusseldorf	Smaers, JB (corresponding author), Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 3DZ, England.	jbs32@cam.ac.uk	Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019	Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175; Smaers, Jeroen/0000-0003-1741-9839	Cambridge European Trust; Leverhulme Trust	Cambridge European Trust; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Cambridge European Trust and the Leverhulme Trust. JBS is partly funded by the Cambridge European Trust: http://www.admin.cam.ac.uk/univ/gsprospectus/funding/overseas/. LVC is funded by the Leverhulme Trust: http://www.leverhulme.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Allman J.M., 1999, EVOLVING BRAINS; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Cavalieri B, 1635, GEOMETRIA INDIVISIBI; CHKLOVSKII D, 2000, ADV NEURAL INFORM PR; Doyon J, 1997, BRAIN COGNITION, V34, P218, DOI 10.1006/brcg.1997.0899; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITZPATRICK KA, 1982, J COMP NEUROL, V204, P296, DOI 10.1002/cne.902040308; FOGASSI L, 1994, BEHAV BRAIN RES, V60, P91, DOI 10.1016/0166-4328(94)90067-1; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; GOLDMAN PS, 1977, J COMP NEUROL, V171, P369, DOI 10.1002/cne.901710305; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P419, DOI 10.1016/S0166-2236(84)80146-0; Grey L.J., 1994, BRODMANNS LOCALIZATI; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; Hollerman JR, 2000, PROG BRAIN RES, V126, P193; Howard C, 1998, UNBIASED STEREOLOGY; Joffe TH, 1997, P ROY SOC B-BIOL SCI, V264, P1303, DOI 10.1098/rspb.1997.0180; JOHNSON TN, 1968, EXP NEUROL, V21, P20, DOI 10.1016/0014-4886(68)90030-7; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Kolb B, 1996, FUNDAMENTALS HUMAN N; MacLeod CE, 2003, J HUM EVOL, V44, P401, DOI 10.1016/S0047-2484(03)00028-9; Martins E. P., 2004, COMPARE VERSION 4 6B; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Middleton FA, 2001, FRONTAL-SUBCORTICAL CIRCUITS IN PSYCHIATRIC AND NEUROLOGICAL DISORDERS, P44; Middleton FA, 2002, CEREB CORTEX, V12, P926, DOI 10.1093/cercor/12.9.926; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Rivara CB, 2003, ANAT REC PART A, V270A, P137, DOI 10.1002/ar.a.10015; Sanides F., 1967, Journal fuer Hirnforschung, V9, P225; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; SCHULTZ W, 1992, EXP BRAIN RES, V91, P363; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2002, NAT NEUROSCI, V5, P272, DOI 10.1038/nn814; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Sherwood CC, 2005, NAT NEUROSCI, V8, P537, DOI 10.1038/nn0505-537; Sherwood CC, 2004, BRAIN BEHAV EVOLUT, V63, P61, DOI 10.1159/000075672; Sherwood CC, 2003, BRAIN BEHAV EVOLUT, V61, P28, DOI 10.1159/000068879; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SMITH RJ, 2002, INT J PRIMATOL, V23; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H., 1980, BRAIN COMMON MARMOSE; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; WEINBERGER DR, 1993, J NEUROPSYCH CLIN N, V5, P241; Whiting BA, 2003, J HUM EVOL, V44, P3, DOI 10.1016/S0047-2484(02)00162-8; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; ZILLES K, 1982, MICROSC ACTA, V86, P339	61	58	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9123	10.1371/journal.pone.0009123	http://dx.doi.org/10.1371/journal.pone.0009123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161758	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600021
J	Tillo, D; Kaplan, N; Moore, IK; Fondufe-Mittendorf, Y; Gossett, AJ; Field, Y; Lieb, JD; Widom, J; Segal, E; Hughes, TR				Tillo, Desiree; Kaplan, Noam; Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Gossett, Andrea J.; Field, Yair; Lieb, Jason D.; Widom, Jonathan; Segal, Eran; Hughes, Timothy R.			High Nucleosome Occupancy Is Encoded at Human Regulatory Sequences	PLOS ONE			English	Article							CHIP-SEQ DATA; HIGH-RESOLUTION; HUMAN GENOME; BINDING-SITES; TRANSCRIPTION FACTOR; DNA-SEQUENCE; CPG ISLANDS; CHROMATIN; ORGANIZATION; PROMOTERS	Active eukaryotic regulatory sites are characterized by open chromatin, and yeast promoters and transcription factor binding sites (TFBSs) typically have low intrinsic nucleosome occupancy. Here, we show that in contrast to yeast, DNA at human promoters, enhancers, and TFBSs generally encodes high intrinsic nucleosome occupancy. In most cases we examined, these elements also have high experimentally measured nucleosome occupancy in vivo. These regions typically have high G+C content, which correlates positively with intrinsic nucleosome occupancy, and are depleted for nucleosome-excluding poly-A sequences. We propose that high nucleosome preference is directly encoded at regulatory sequences in the human genome to restrict access to regulatory information that will ultimately be utilized in only a subset of differentiated cells.	[Tillo, Desiree; Hughes, Timothy R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kaplan, Noam; Field, Yair; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Moore, Irene K.; Fondufe-Mittendorf, Yvonne; Widom, Jonathan] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [Gossett, Andrea J.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of Toronto; Weizmann Institute of Science; Northwestern University; University of North Carolina; University of North Carolina Chapel Hill	Tillo, D (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	t.hughes@utoronto.ca	Segal, Eran/AAF-4855-2019; Kaplan, Noam/A-3544-2011; Kaplan, Noam/K-4383-2019	Kaplan, Noam/0000-0001-9940-1987; Kaplan, Noam/0000-0001-9940-1987; Gossett, Andrea/0000-0002-9471-3970; Segal, Eran/0000-0002-6859-1164; Lieb, Jason/0000-0001-7601-8061	Alexander Graham Bell Canada; Canadian Institutes of Health Research (CIHR) [MOP-86705]; Genome Canada; Howard Hughes Medical Institute; Canadian Institute for Advanced Research	Alexander Graham Bell Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	D.T. holds an Alexander Graham Bell Canada Graduate Scholarship (http://www.nserc-crsng.gc.ca/). This work was supported by a Canadian Institutes of Health Research (CIHR) Operating Grant MOP-86705 to T. R. H. and C. Nislow (http://www.cihr-irsc.gc.ca/e/193.html), by Genome Canada through the Ontario Genomics Institute and the Ontario Research Fund, the Howard Hughes Medical Institute, and the Canadian Institute for Advanced Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Di Filippo M, 2008, GENE, V419, P62, DOI 10.1016/j.gene.2008.02.012; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LOHR D, 1979, P NATL ACAD SCI USA, V76, P6326, DOI 10.1073/pnas.76.12.6326; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; LUTTER LC, 1989, METHOD ENZYMOL, V170, P264; MIRNY L, 2009, NUCLEOSOME MEDIATED; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Perry RP, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-15; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rozenberg JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-67; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Segal MR, 2008, STAT APPL GENET MOL, V7; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Steger DJ, 1997, EMBO J, V16, P2463, DOI 10.1093/emboj/16.9.2463; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Voss TC, 2008, BBA-MOL CELL RES, V1783, P2044, DOI 10.1016/j.bbamcr.2008.06.022; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136	40	136	137	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9129	10.1371/journal.pone.0009129	http://dx.doi.org/10.1371/journal.pone.0009129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161746	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442600026
J	Tomonaga, M; Imura, T				Tomonaga, Masaki; Imura, Tomoko			Visual Search for Human Gaze Direction by a Chimpanzee (Pan troglodytes)	PLOS ONE			English	Article							EXPERIMENTER-GIVEN CUES; SUPERIOR TEMPORAL SULCUS; OBJECT-CHOICE TASKS; EYE CONTACT; INFANT CHIMPANZEES; SPECIES FOLLOW; FACES; PERCEPTION; ATTENTION; MONKEYS	Background: Humans detect faces with direct gazes among those with averted gazes more efficiently than they detect faces with averted gazes among those with direct gazes. We examined whether this "stare-in-the-crowd" effect occurs in chimpanzees (Pan troglodytes), whose eye morphology differs from that of humans (i.e., low-contrast eyes, dark sclera). Methodology/Principal Findings: An adult female chimpanzee was trained to search for an odd-item target (front view of a human face) among distractors that differed from the target only with respect to the direction of the eye gaze. During visual-search testing, she performed more efficiently when the target was a direct-gaze face than when it was an averted-gaze face. This direct-gaze superiority was maintained when the faces were inverted and when parts of the face were scrambled. Subsequent tests revealed that gaze perception in the chimpanzee was controlled by the contrast between iris and sclera, as in humans, but that the chimpanzee attended only to the position of the iris in the eye, irrespective of head direction. Conclusion/Significance: These results suggest that the chimpanzee can discriminate among human gaze directions and are more sensitive to direct gazes. However, limitations in the perception of human gaze by the chimpanzee are suggested by her inability to completely transfer her performance to faces showing a three-quarter view.	[Tomonaga, Masaki; Imura, Tomoko] Kyoto Univ, Primate Res Inst, Aichi, Japan	Kyoto University	Tomonaga, M (corresponding author), Kyoto Univ, Primate Res Inst, Aichi, Japan.	tomonaga@pri.kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [12002009, 13610086, 16002001, 16300084, 19300091, 20002001]; MEXT [A14, D10]; global COE [A06, D07]	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan Society for the Promotion of Science (JSPS) (12002009, 13610086, 16002001, 16300084, 19300091, 20002001); and by MEXT Grants-in-Aid for the 21st Century COE Programs (A14 and D10) and global COE Programs (A06 and D07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; Anderson JR, 1999, FOLIA PRIMATOL, V70, P17, DOI 10.1159/000021670; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; ANSTIS SM, 1969, AM J PSYCHOL, V82, P474, DOI 10.2307/1420441; Bard KA, 2005, DEV PSYCHOL, V41, P616, DOI 10.1037/0012-1649.41.4.616; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Brown V, 1997, PERCEPTION, V26, P1555, DOI 10.1068/p261555; CAMPBELL R, 1990, NEUROPSYCHOLOGIA, V28, P1123, DOI 10.1016/0028-3932(90)90050-X; CLINE MG, 1967, AM J PSYCHOL, V80, P41, DOI 10.2307/1420539; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; EACOTT MJ, 1993, NEUROPSYCHOLOGIA, V31, P609, DOI 10.1016/0028-3932(93)90055-5; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; Ferrari PF, 2000, P NATL ACAD SCI USA, V97, P13997, DOI 10.1073/pnas.250241197; GIBSON JJ, 1963, AM J PSYCHOL, V76, P386, DOI 10.2307/1419779; Goodall J., 1986, CHIMPANZEES GOMBE PA; HEYWOOD CA, 1992, PHILOS T ROY SOC B, V335, P31, DOI 10.1098/rstb.1992.0004; IDANI G, 1995, PRIMATES, V36, P377, DOI 10.1007/BF02382860; Itakura S, 1998, J COMP PSYCHOL, V112, P119, DOI 10.1037/0735-7036.112.2.119; Itakura S, 1996, JPN PSYCHOL RES, V38, P174, DOI 10.1111/j.1468-5884.1996.tb00022.x; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Kaplan G, 2002, INT J PRIMATOL, V23, P501, DOI 10.1023/A:1014913532057; KEATING CF, 1993, J COMP PSYCHOL, V107, P131, DOI 10.1037/0735-7036.107.2.131; Kirk RE, 1995, EXPT DESIGN; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Kobayashi H, 1997, NATURE, V387, P767, DOI 10.1038/42842; Matsuno T, 2006, BEHAV BRAIN RES, V172, P219, DOI 10.1016/j.bbr.2006.05.004; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2001, PSYCHOLOGIA, V44, P24; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Nakato E, 2009, INFANT BEHAV DEV, V32, P422, DOI 10.1016/j.infbeh.2009.07.006; NOTHDURFT HC, 1993, PERCEPTION, V22, P1287, DOI 10.1068/p221287; Okamoto S, 2002, ANIM COGN, V5, P107, DOI 10.1007/s10071-002-0133-z; Okamoto S, 2004, JPN PSYCHOL RES, V46, P236, DOI 10.1111/j.1468-5584.2004.00255.x; Okamoto-Barth S, 2008, DEVELOPMENTAL SCI, V11, P98, DOI 10.1111/j.1467-7687.2007.00658.x; Povinelli DJ, 1996, PSYCHOL SCI, V7, P129, DOI 10.1111/j.1467-9280.1996.tb00345.x; Ricciardelli P, 2000, COGNITION, V77, pB1, DOI 10.1016/S0010-0277(00)00092-5; Sato N, 2001, J COMP PSYCHOL, V115, P115, DOI 10.1037/0735-7036.115.2.115; Senju A, 2003, COGNITION, V89, pB43, DOI 10.1016/S0010-0277(03)00081-7; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Tomonaga M, 1999, PRIMATES, V40, P417, DOI 10.1007/BF02557579; TOMONAGA M, 1993, PERCEPT MOTOR SKILL, V76, P1287, DOI 10.2466/pms.1993.76.3c.1287; Tomonaga M., 1998, ANIM COGN, V1, P25, DOI [10.1007/s100710050004, DOI 10.1007/S100710050004]; Tomonaga M, 2007, J COMP PSYCHOL, V121, P156, DOI 10.1037/0735-7036.121.2.156; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; Tomonaga M, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-14; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; Wilson HR, 2000, VISION RES, V40, P459, DOI 10.1016/S0042-6989(99)00195-9; Wollaston W.H., 1824, PHILOS T R SOC LOND, V114, P247; YAMAGIWA J, 1992, PRIMATES, V33, P523, DOI 10.1007/BF02381153	60	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9131	10.1371/journal.pone.0009131	http://dx.doi.org/10.1371/journal.pone.0009131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NV	20161750	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442600028
J	Osada, M; Jardine, L; Misir, R; Andl, T; Millar, SE; Pezzano, M				Osada, Masako; Jardine, Logan; Misir, Ruth; Andl, Thomas; Millar, Sarah E.; Pezzano, Mark			DKK1 Mediated Inhibition of Wnt Signaling in Postnatal Mice Leads to Loss of TEC Progenitors and Thymic Degeneration	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; MEDULLARY EPITHELIAL-CELLS; BETA-CATENIN; SELF-RENEWAL; THYMOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; SMALL-INTESTINE; EXPRESSION; P63; DIFFERENTIATION	Background: Thymic epithelial cell (TEC) microenvironments are essential for the recruitment of T cell precursors from the bone marrow, as well as the subsequent expansion and selection of thymocytes resulting in a mature self-tolerant T cell repertoire. The molecular mechanisms, which control both the initial development and subsequent maintenance of these critical microenvironments, are poorly defined. Wnt signaling has been shown to be important to the development of several epithelial tissues and organs. Regulation of Wnt signaling has also been shown to impact both early thymocyte and thymic epithelial development. However, early blocks in thymic organogenesis or death of the mice have prevented analysis of a role of canonical Wnt signaling in the maintenance of TECs in the postnatal thymus. Methodology/Principal Findings: Here we demonstrate that tetracycline-regulated expression of the canonical Wnt inhibitor DKK1 in TECs localized in both the cortex and medulla of adult mice, results in rapid thymic degeneration characterized by a loss of Delta NP63(+) Foxn1(+) and Aire(+) TECs, loss of K5K8DP TECs thought to represent or contain an immature TEC progenitor, decreased TEC proliferation and the development of cystic structures, similar to an aged thymus. Removal of DKK1 from DKK1-involuted mice results in full recovery, suggesting that canonical Wnt signaling is required for the differentiation or proliferation of TEC populations needed for maintenance of properly organized adult thymic epithelial microenvironments. Conclusions/Significance: Taken together, the results of this study demonstrate that canonical Wnt signaling within TECs is required for the maintenance of epithelial microenvironments in the postnatal thymus, possibly through effects on TEC progenitor/stem cell populations. Downstream targets of Wnt signaling, which are responsible for maintenance of these TEC progenitors may provide useful targets for therapies aimed at counteracting age associated thymic involution or the premature thymic degeneration associated with cancer therapy and bone marrow transplants.	[Osada, Masako; Jardine, Logan; Misir, Ruth; Pezzano, Mark] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Andl, Thomas] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Millar, Sarah E.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Millar, Sarah E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	City University of New York (CUNY) System; City College of New York (CUNY); Vanderbilt University; University of Pennsylvania; University of Pennsylvania	Osada, M (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	mpezzano@sci.ccny.cuny.edu		Andl, Thomas/0000-0002-5555-468X; Millar, Sarah/0000-0001-8792-6890	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [1SC1AI081527]; NIH/NCI [1U56 CA96299, U54 1U54CA137788-01, PSCREG-39-1051, RO1-AR47709, RO1-DE015342, RO1-HD053829]; National Center for Research Resources Research Centers in Minority Institutions [G12RR03060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053829] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA137788, U54CA132378, U56CA096299] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI104994, SC1AI081527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR047709, R01AR047709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015342] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding: This work was supported by grants from National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) 1SC1AI081527 NIH/NCI 1U56 CA96299, NIH/NCI U54 1U54CA137788-01 and PSCREG-39-1051 to M. P. and RO1-AR47709, RO1-DE015342, RO1-HD053829 to S. E. M. Infrastructure support for core facilities and technical staff was provided by a grant to The City College of New York from the National Center for Research Resources Research Centers in Minority Institutions program grant # G12RR03060. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Aw D, 2008, AGING CELL, V7, P158, DOI 10.1111/j.1474-9726.2007.00365.x; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; BARCLAY AN, 1981, J EXP MED, V153, P1666, DOI 10.1084/jem.153.6.1666; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Candi E, 2007, P NATL ACAD SCI USA, V104, P11999, DOI 10.1073/pnas.0703458104; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Dotto J, 2007, AM J CLIN PATHOL, V127, P415, DOI 10.1309/2GAYKPDDM85P2VEW; FERRICK DA, 1989, CELL, V57, P483, DOI 10.1016/0092-8674(89)90923-9; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Flores KG, 1999, J CLIN INVEST, V104, P1031, DOI 10.1172/JCI7558; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Gillard GO, 2007, J IMMUNOL, V178, P3007, DOI 10.4049/jimmunol.178.5.3007; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Grotewold L, 2002, INT J DEV BIOL, V46, P943; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Hattori N, 1996, J EXP MED, V184, P1137, DOI 10.1084/jem.184.3.1137; Hattori N, 1996, J EXP MED, V184, P1901, DOI 10.1084/jem.184.5.1901; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; HIROKAWA K, 1994, IMMUNOL LETT, V40, P269, DOI 10.1016/0165-2478(94)00065-4; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Irifune T, 2004, ARCH HISTOL CYTOL, V67, P149, DOI 10.1679/aohc.67.149; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itoi M, 2007, INT IMMUNOL, V19, P953, DOI 10.1093/intimm/dxm060; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Kikuchi T, 2004, INT IMMUNOL, V16, P831, DOI 10.1093/intimm/dxh087; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Kwack MH, 2008, J INVEST DERMATOL, V128, P262, DOI 10.1038/sj.jid.5700999; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Millar JBA, 2002, GENOME BIOL, V3; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mulroy T, 2003, INT IMMUNOL, V15, P1485, DOI 10.1093/intimm/dxg146; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Osada M, 2006, CLIN DEV IMMUNOL, V13, P299, DOI 10.1080/17402520600935097; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schilham MW, 1998, J IMMUNOL, V161, P3984; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; SHORES EW, 1991, EUR J IMMUNOL, V21, P1657, DOI 10.1002/eji.1830210711; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Takeoka Y, 1996, INT ARCH ALLERGY IMM, V111, P5, DOI 10.1159/000237337; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; UTSUYAMA M, 1995, MECH AGEING DEV, V81, P107, DOI 10.1016/0047-6374(95)01589-R; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	93	47	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9062	10.1371/journal.pone.0009062	http://dx.doi.org/10.1371/journal.pone.0009062			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161711	Green Published, gold			2022-12-27	WOS:000274442500002
J	Kim, MS; Chang, XF; LeBron, C; Nagpal, JK; Lee, J; Huang, YP; Yamashita, K; Trink, B; Ratovitski, EA; Sidransky, D				Kim, Myoung Sook; Chang, Xiaofei; LeBron, Cynthia; Nagpal, Jatin K.; Lee, Juna; Huang, Yiping; Yamashita, Keishi; Trink, Barry; Ratovitski, Edward A.; Sidransky, David			Neurofilament Heavy Polypeptide Regulates the Akt-beta-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; GROWTH-FACTOR; CANCER-CELLS; C-MYC; PROMOTER HYPERMETHYLATION; MITOCHONDRIAL BIOGENESIS; BIOENERGETIC SIGNATURE; NEOPLASTIC PROGRESSION; PROGNOSTIC MARKER; SIGNALING PATHWAY	Aerobic glycolysis and mitochondrial dysfunction are common features of aggressive cancer growth. We observed promoter methylation and loss of expression in neurofilament heavy polypeptide (NEFH) in a significant proportion of primary esophageal squamous cell carcinoma (ESCC) samples that were of a high tumor grade and advanced stage. RNA interference-mediated knockdown of NEFH accelerated ESCC cell growth in culture and increased tumorigenicity in vivo, whereas forced expression of NEFH significantly inhibited cell growth and colony formation. Loss of NEFH caused upregulation of pyruvate kinase-M2 type and down-regulation of pyruvate dehydrogenase, via activation of the Akt/beta-catenin pathway, resulting in enhanced aerobic glycolysis and mitochondrial dysfunction. The acceleration of glycolysis and mitochondrial dysfunction in NEFH-knockdown cells was suppressed in the absence of beta-catenin expression, and was decreased by the treatment of 2-Deoxyglucose, a glycolytic inhibitor, or API-2, an Akt inhibitor. Loss of NEFH activates the Akt/beta-catenin pathway and increases glycolysis and mitochondrial dysfunction. Cancer cells with methylated NEFH can be targeted for destruction with specific inhibitors of deregulated downstream pathways.	[Kim, Myoung Sook; Chang, Xiaofei; LeBron, Cynthia; Nagpal, Jatin K.; Lee, Juna; Trink, Barry; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA; [Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Yamashita, Keishi] Kitasato Univ Hosp, Dept Surg, Kanagawa, Japan	Johns Hopkins University; Johns Hopkins University; Kitasato University	Kim, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA.	dsidrans@jhmi.edu			National Cancer Institute [U01-CA84986]; Oncomethylome Sciences; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oncomethylome Sciences; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (U01-CA84986), Oncomethylome Sciences, and the Flight Attendant Medical Research Institute (Myoung S. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 1998, ADV CANCER RES, V72, P141; Bobos M, 2006, AM J DERMATOPATH, V28, P99, DOI 10.1097/01.dad.0000183701.67366.c7; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Deng YZ, 2007, J BIOL CHEM, V282, P36571, DOI 10.1074/jbc.M704141200; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Fujita M, 2000, CANCER RES, V60, P6683; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GOSEKI N, 1992, CANCER, V69, P1088; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Ishiguro H, 2000, JPN J CANCER RES, V91, P597, DOI 10.1111/j.1349-7006.2000.tb00987.x; KATO J, 1993, GENE DEV, V7, P331; Kawasoe T, 2000, CANCER RES, V60, P3354; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kazakov DV, 2009, AM J DERMATOPATH, V31, P248, DOI 10.1097/DAD.0b013e318198922a; Kihara C, 2000, JPN J CANCER RES, V91, P190, DOI 10.1111/j.1349-7006.2000.tb00931.x; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kimura Y, 1999, INT J CANCER, V84, P174, DOI 10.1002/(SICI)1097-0215(19990420)84:2<174::AID-IJC14>3.0.CO;2-E; Kuroki T, 2003, CANCER RES, V63, P3724; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu SH, 2006, MOL CELL PROTEOMICS, V5, P1019, DOI 10.1074/mcp.M500299-MCP200; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Mena H, 2001, CANCER, V91, P136, DOI 10.1002/1097-0142(20010101)91:1<136::AID-CNCR18>3.3.CO;2-F; Miettinen M, 2001, AM J SURG PATHOL, V25, P846, DOI 10.1097/00000478-200107000-00002; Mizushima T, 2002, CANCER RES, V62, P277; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; PENG H, 2009, CHIN J CANC, V28, P38; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Polakis P, 1999, ADV EXP MED BIOL, V470, P23; Ren Y, 2005, CLIN CANCER RES, V11, P6190, DOI 10.1158/1078-0432.CCR-04-2553; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Roth MJ, 2005, GENE CHROMOSOME CANC, V44, P423, DOI 10.1002/gcc.20251; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; RUTTLEDGE MH, 1993, NEUROLOGY, V43, P1753, DOI 10.1212/WNL.43.9.1753; SAINIO M, 1995, NEUROLOGY, V45, P1314, DOI 10.1212/WNL.45.7.1314; Sakanaka C, 2002, J BIOCHEM, V132, P697, DOI 10.1093/oxfordjournals.jbchem.a003276; Schleicher RL, 1997, CANCER RES, V57, P3532; SEGAL A, 1994, PATHOLOGY, V26, P439, DOI 10.1080/00313029400169162; Stoner GD, 2001, CARCINOGENESIS, V22, P1737, DOI 10.1093/carcin/22.11.1737; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Szebenyi G, 2002, J NEUROSCI RES, V68, P185, DOI 10.1002/jnr.10212; Tanaka Y, 2000, AM J SURG PATHOL, V24, P1295, DOI 10.1097/00000478-200009000-00015; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wang LD, 2003, WORLD J GASTROENTERO, V9, P1156, DOI 10.3748/wjg.v9.i6.1156; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; *WHO, 1997, WORLD HLTH REP; Wu G, 2006, BIOCHEMISTRY-US, V45, P5319, DOI 10.1021/bi0601149; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Xing EP, 1999, CLIN CANCER RES, V5, P1231; Yan S, 2008, CANCER LETT, V271, P85, DOI 10.1016/j.canlet.2008.05.035; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; You H, 2005, J NEURO-ONCOL, V74, P1, DOI 10.1007/s11060-004-2354-2; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zhang G, 2005, PATHOL INT, V55, P310, DOI 10.1111/j.1440-1827.2005.01840.x; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang L, 2003, CARCINOGENESIS, V24, P1039, DOI 10.1093/carcin/bgg062; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	71	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9003	10.1371/journal.pone.0009003	http://dx.doi.org/10.1371/journal.pone.0009003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140245	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200005
J	Khanna, S; Biswas, S; Shang, YL; Collard, E; Azad, A; Kauh, C; Bhasker, V; Gordillo, GM; Sen, CK; Roy, S				Khanna, Savita; Biswas, Sabyasachi; Shang, Yingli; Collard, Eric; Azad, Ali; Kauh, Courtney; Bhasker, Vineet; Gordillo, Gayle M.; Sen, Chandan K.; Roy, Sashwati			Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice	PLOS ONE			English	Article							APOPTOTIC CELLS; CARDIAC FIBROBLASTS; RECEPTOR-ACTIVITY; BETA-CELLS; FAS LIGAND; KEY ROLE; MOUSE; MODEL; MECHANISMS; EXPRESSION	Background: Chronic inflammation is a characteristic feature of diabetic cutaneous wounds. We sought to delineate novel mechanisms involved in the impairment of resolution of inflammation in diabetic cutaneous wounds. At the wound-site, efficient dead cell clearance (efferocytosis) is a pre-requisite for the timely resolution of inflammation and successful healing. Methodology/Principal Findings: Macrophages isolated from wounds of diabetic mice showed significant impairment in efferocytosis. Impaired efferocytosis was associated with significantly higher burden of apoptotic cells in wound tissue as well as higher expression of pro-inflammatory and lower expression of anti-inflammatory cytokines. Observations related to apoptotic cell load at the wound site in mice were validated in the wound tissue of diabetic and non-diabetic patients. Forced Fas ligand driven elevation of apoptotic cell burden at the wound site augmented pro-inflammatory and attenuated anti-inflammatory cytokine response. Furthermore, successful efferocytosis switched wound macrophages from pro-inflammatory to an anti-inflammatory mode. Conclusions/Significance: Taken together, this study presents first evidence demonstrating that diabetic wounds suffer from dysfunctional macrophage efferocytosis resulting in increased apoptotic cell burden at the wound site. This burden, in turn, prolongs the inflammatory phase and complicates wound healing.	[Khanna, Savita; Biswas, Sabyasachi; Shang, Yingli; Collard, Eric; Azad, Ali; Kauh, Courtney; Bhasker, Vineet; Gordillo, Gayle M.; Sen, Chandan K.; Roy, Sashwati] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg,Comprehens Wound Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Khanna, S (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Dept Surg,Comprehens Wound Ctr, Columbus, OH 43210 USA.	sashwati.roy@osumc.edu	Khanna, Savita/E-3378-2011; Roy, sashwati/E-3990-2011; Gordillo, Gayle M/E-3136-2011; Sen, Chandan K/A-8762-2013		National Institutes of Health (NIH) [DK076566, GM077185]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) RO1 award DK076566 to SR, and in part by GM077185 to CKS (http:// www2. niddk. nih. gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1984, J IMMUNOL, V133, P1307; ALBINA JE, 1988, AM J PHYSIOL, V254, pE459, DOI 10.1152/ajpendo.1988.254.4.E459; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bouma G, 2005, EUR J IMMUNOL, V35, P225, DOI 10.1002/eji.200425513; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; COHEN JJ, 1991, ADV IMMUNOL, V50, P55; Cooper L, 2005, GENOME BIOL, V6; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Depraetere V, 2000, NAT CELL BIOL, V2, pE104, DOI 10.1038/35014098; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Devitt A., 2004, METH MOL B, V282, P207; Efron DT, 2003, METH MOLEC MED, V78, P83; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; ERWIG LP, 2007, CELL DEATH DIFFER; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gittes C, 2000, J PEDIATR SURG, V35, P872; GLASS EJ, 1987, DIABETOLOGIA, V30, P228, DOI 10.1007/BF00270420; GLASS EJ, 1986, CLIN EXP IMMUNOL, V65, P614; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; KHANNA S, 2007, J BIOL CHEM     0614; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; Lundberg JE, 1998, ARCH DERMATOL RES, V290, P669, DOI 10.1007/s004030050371; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; Maree AFM, 2005, J THEOR BIOL, V233, P533, DOI 10.1016/j.jtbi.2004.10.030; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Matalka KZ, 2005, NEUROENDOCRINOL LETT, V26, P231; MATSUE H, 1995, ARCH DERMATOL RES, V287, P315, DOI 10.1007/BF01105085; Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35, DOI 10.1002/jlb.65.1.35; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Brien BA, 2002, CELL DEATH DIFFER, V9, P457, DOI 10.1038/sj.cdd.4400973; Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809; Pierce GF, 2001, AM J PATHOL, V159, P399, DOI 10.1016/S0002-9440(10)61709-9; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; ROY S, 2008, PHYSL GENOMICS; Roy S, 2007, MOL BIOL CELL, V18, P4837, DOI 10.1091/mbc.E07-03-0270; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill John, 2000, Kidney and Blood Pressure Research, V23, P173; Schaffer MR, 2004, J SURG RES, V122, P43, DOI 10.1016/j.jss.2004.05.009; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sudo Chiaki, 2007, Lab Hematol, V13, P108; Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4; Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023; Underwood RA, 2001, J HISTOCHEM CYTOCHEM, V49, P1285, DOI 10.1177/002215540104901011; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; WHEAT LJ, 1980, DIABETES CARE, V3, P187, DOI 10.2337/diacare.3.1.187; ZHANG Z, 2009, FASEB J	81	396	407	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9539	10.1371/journal.pone.0009539	http://dx.doi.org/10.1371/journal.pone.0009539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209061	Green Submitted, gold, Green Published			2022-12-27	WOS:000275197100019
J	Guerreiro, RJ; Beck, J; Gibbs, JR; Santana, I; Rossor, MN; Schott, JM; Nalls, MA; Ribeiro, H; Santiago, B; Fox, NC; Oliveira, C; Collinge, J; Mead, S; Singleton, A; Hardy, J				Guerreiro, Rita J.; Beck, John; Gibbs, J. Raphael; Santana, Isabel; Rossor, Martin N.; Schott, Jonathan M.; Nalls, Michael A.; Ribeiro, Helena; Santiago, Beatriz; Fox, Nick C.; Oliveira, Catarina; Collinge, John; Mead, Simon; Singleton, Andrew; Hardy, John			Genetic Variability in CLU and Its Association with Alzheimer's Disease	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-J; AMYLOID-BETA; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; SENILE PLAQUES; CLUSTERIN GENE; BRAIN; EXPRESSION	Background: Recently, two large genome wide association studies in Alzheimer disease (AD) have identified variants in three different genes (CLU, PICALM and CR1) as being associated with the risk of developing AD. The strongest association was reported for an intronic single nucleotide polymorphism (SNP) in CLU. Methodology/Principal Findings: To further characterize this association we have sequenced the coding region of this gene in a total of 495 AD cases and 330 healthy controls. A total of twenty-four variants were found in both cases and controls. For the changes found in more than one individual, the genotypic frequencies were compared between cases and controls. Coding variants were found in both groups (including a nonsense mutation in a healthy subject), indicating that the pathogenicity of variants found in this gene must be carefully evaluated. We found no common coding variant associated with disease. In order to determine if common variants at the CLU locus effect expression of nearby (cis) mRNA transcripts, an expression quantitative loci (eQTL) analysis was performed. No significant eQTL associations were observed for the SNPs previously associated with AD. Conclusions/Significance: We conclude that common coding variability at this locus does not explain the association, and that there is no large effect of common genetic variability on expression in brain tissue. We surmise that the most likely mechanism underpinning the association is either small effects of genetic variability on resting gene expression, or effects on damage induced expression of the protein.	[Guerreiro, Rita J.; Gibbs, J. Raphael; Nalls, Michael A.; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Guerreiro, Rita J.; Ribeiro, Helena; Oliveira, Catarina] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Beck, John; Collinge, John; Mead, Simon] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London, England; [Gibbs, J. Raphael; Hardy, John] Reta Lila Weston Inst, London, England; [Gibbs, J. Raphael; Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Gibbs, J. Raphael; Hardy, John] Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Santana, Isabel; Ribeiro, Helena; Santiago, Beatriz; Oliveira, Catarina] Coimbra Univ Hosp, Neurol Serv, Coimbra, Portugal; [Rossor, Martin N.; Schott, Jonathan M.; Fox, Nick C.] UCL, Inst Neurol, Dementia Res Ctr, London, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade de Coimbra; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of London; University College London	Guerreiro, RJ (corresponding author), NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	Singleta@mail.nih.gov	Mead, Simon/E-9414-2011; Fox, Nick C/AAE-1849-2021; Fox, Nick C/B-1319-2009; Hardy, John/C-2451-2009; Schott, Jonathan M/A-9065-2011; Singleton, Andrew B/C-3010-2009; Guerreiro, Rita J L/A-1327-2011; Gibbs, J. Raphael/A-3984-2010; Rossor, Martin/C-1598-2008; Oliveira, Catarina R./F-3685-2010	Mead, Simon/0000-0002-4326-1468; Fox, Nick C/0000-0002-6660-657X; Fox, Nick C/0000-0002-6660-657X; Hardy, John/0000-0002-3122-0423; Schott, Jonathan M/0000-0003-2059-024X; Gibbs, J. Raphael/0000-0002-6985-0658; Guerreiro, Rita/0000-0001-5879-3486; Rossor, Martin/0000-0001-8215-3120; Oliveira, Catarina/0000-0001-6942-4328; Santana, Isabel/0000-0002-8114-9434	Intramural Research Program of the National Institute on Aging; National Institutes of Health, Department of Health and Human Services [Z01 AG000950-06]; MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/29647/2006, PIC/IC/83206/2007]; UK cohort; Department of Health National Institute for Health Research Biomedical Research Centres; MRC; HEFCE/NHS Senior lecturership; NATIONAL INSTITUTE ON AGING [ZIAAG000950, Z01AG000950] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PG2010-1] Funding Source: researchfish; Medical Research Council [G0601846, G0701075, MC_U123160651, MC_U123192748] Funding Source: researchfish; MRC [G0701075, G0601846, MC_U123192748, MC_U123160651] Funding Source: UKRI	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK cohort; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HEFCE/NHS Senior lecturership(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services, project number Z01 AG000950-06; MRC Prion Unit and Fundacao para a Ciencia e Tecnologia, Portugal [grant SFRH/BD/29647/2006 and project PIC/IC/83206/2007]. The UK Medical Research Council funded the analysis of the UK cohort. Some of this work was done at University College London Hospitals/University College London which received a proportion of funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. The Dementia Research Centre in the Department of Neurodegenerative Disease, UCL is an Alzheimer Research Trust Coordinating Centre. NCF is funded by the MRC; JMS is in receipt of a HEFCE/NHS Senior lecturership and JH of a MRC Returning Scientist Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; DANIK M, 1993, J COMP NEUROL, V334, P209, DOI 10.1002/cne.903340205; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Falush D, 2003, GENETICS, V164, P1567; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; GUERREIRO RJ, 2008, NEUROBIOL A IN PRESS; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; JENNE DE, 1992, TRENDS BIOCHEM SCI, V17, P154, DOI 10.1016/0968-0004(92)90325-4; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; KIDA E, 1995, BRAIN RES, V685, P211, DOI 10.1016/0006-8993(95)00482-6; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCGEER PL, 1992, BRAIN RES, V579, P337, DOI 10.1016/0006-8993(92)90071-G; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; Miwa Y, 2005, BIOCHEM BIOPH RES CO, V331, P1587, DOI 10.1016/j.bbrc.2005.04.069; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nestlerode CS, 1999, HUM BIOL, V71, P197; ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rogaeva E, 2002, NEUROMOL MED, V2, P1, DOI 10.1385/NMM:2:1:01; Ross OA, 2007, MECH AGEING DEV, V128, P378, DOI 10.1016/j.mad.2007.04.002; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; Takamaru Yuji, 1994, Hokkaido Journal of Medical Science, V69, P191; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tycko B, 1996, HUM GENET, V98, P430, DOI 10.1007/s004390050234; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; WONG P, 1993, J BIOL CHEM, V268, P5021; WORKMAN C, 2002, GENOME BIOL, V0003; Zlokovic BV, 1996, LIFE SCI, V59, P1483, DOI 10.1016/0024-3205(96)00310-4	36	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9510	10.1371/journal.pone.0009510	http://dx.doi.org/10.1371/journal.pone.0009510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209083	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400016
J	Vo, ATT; van Duijkeren, E; Gaastra, W; Fluit, AC				Vo, An T. T.; van Duijkeren, Engeline; Gaastra, Wim; Fluit, Ad C.			Antimicrobial Resistance, Class 1 Integrons, and Genomic Island 1 in Salmonella Isolates from Vietnam	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; ENTERICA SEROTYPE TYPHIMURIUM; MULTIDRUG-RESISTANCE; QUINOLONE RESISTANCE; SEROVAR TYPHIMURIUM; GENE CASSETTES; HUMANS; MECHANISMS; MUTATIONS; ANIMALS	Background: The objective was to investigate the phenotypic and genotypic resistance and the horizontal transfer of resistance determinants from Salmonella isolates from humans and animals in Vietnam. Methodology/Principal Findings: The susceptibility of 297 epidemiologically unrelated non-typhoid Salmonella isolates was investigated by disk diffusion assay. The isolates were screened for the presence of class 1 integrons and Salmonella genomic island 1 by PCR. The potential for the transfer of resistance determinants was investigated by conjugation experiments. Resistance to gentamicin, kanamycin, chloramphenicol, streptomycin, trimethoprim, ampicillin, nalidixic acid, sulphonamides, and tetracycline was found in 13 to 50% of the isolates. Nine distinct integron types were detected in 28% of the isolates belonging to 11 Salmonella serovars including S. Tallahassee. Gene cassettes identified were aadA1, aadA2, aadA5, bla(PSE-1), bla(OXA-30), dfrA1, dfrA12, dfrA17, and sat, as well as open reading frames with unknown functions. Most integrons were located on conjugative plasmids, which can transfer their antimicrobial resistance determinants to Escherichia coli or Salmonella Enteritidis, or with Salmonella Genomic Island 1 or its variants. The resistance gene cluster in serovar Emek identified by PCR mapping and nucleotide sequencing contained SGI1-J3 which is integrated in SGI1 at another position than the majority of SGI1. This is the second report on the insertion of SGI1 at this position. High-level resistance to fluoroquinolones was found in 3 multiresistant S. Typhimurium isolates and was associated with mutations in the gyrA gene leading to the amino acid changes Ser83Phe and Asp87Asn. Conclusions: Resistance was common among Vietnamese Salmonella isolates from different sources. Legislation to enforce a more prudent use of antibiotics in both human and veterinary medicine should be implemented by the authorities in Vietnam.	[Vo, An T. T.; van Duijkeren, Engeline; Gaastra, Wim] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Vo, An T. T.] Nong Lam Univ, Fac Anim Husb & Vet Med, Ho Chi Minh City, Vietnam	Utrecht University; Utrecht University; Utrecht University Medical Center; Nong Lam University	Vo, ATT (corresponding author), Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands.	e.vanduijkeren@uu.nl			Vietnamese government [322]	Vietnamese government	This study was supported by a grant from the Vietnamese government in the Project 322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeed YM, 2008, ANTIMICROB AGENTS CH, V52, P2428, DOI 10.1128/AAC.00084-08; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Clinical and Laboratory Standards Institute (CLSI), 2004, M100S14 CLSI; DINH TT, 2003, J VET SCI TECH, V10, P50; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2009, ANTIMICROB AGENTS CH, V53, P824, DOI 10.1128/AAC.01015-08; Ebner P, 2004, J ANTIMICROB CHEMOTH, V53, P1004, DOI 10.1093/jac/dkh192; Edrington TS, 2004, MICROB DRUG RESIST, V10, P51, DOI 10.1089/107662904323047808; Esaki H, 2004, J ANTIMICROB CHEMOTH, V53, P266, DOI 10.1093/jac/dkh081; *FAO, 2003, JOINTAO OIE WHO EXP; Fisher IST, 2005, EPIDEMIOL INFECT, V133, P1, DOI 10.1017/S095026880400305X; Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398; Gales AC, 2001, J CLIN MICROBIOL, V39, P183, DOI 10.1128/JCM.39.1.183-190.2001; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; GUINEE PAM, 1974, ZBL BAKT-INT J MED M, V226, P194; HALL RM, 1994, J BACTERIOL, V176, P6286, DOI 10.1128/jb.176.20.6286-6294.1994; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Huang TM, 2004, VET MICROBIOL, V100, P247, DOI 10.1016/j.vetmic.2004.03.003; Isenbarger DW, 2002, EMERG INFECT DIS, V8, P175; Kwon HJ, 2002, VET MICROBIOL, V89, P303, DOI 10.1016/S0378-1135(02)00257-2; Leverstein-van Hall MA, 2003, J INFECT DIS, V187, P251, DOI 10.1086/345880; Leverstein-van Hall MA, 2002, J CLIN MICROBIOL, V40, P3038, DOI 10.1128/JCM.40.8.3038-3040.2002; Leverstein-van Hall MA, 2002, J INFECT DIS, V186, P49, DOI 10.1086/341078; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Levings RS, 2008, ANTIMICROB AGENTS CH, V52, P2529, DOI 10.1128/AAC.00189-08; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Meunier D, 2002, EMERG INFECT DIS, V8, P430; Miko A, 2005, J ANTIMICROB CHEMOTH, V56, P1025, DOI 10.1093/jac/dki365; *NAT COMM CLIN LAB, 2001, M31A2 NCCLS; O'Mahony R, 2005, FOODBORNE PATHOG DIS, V2, P274, DOI 10.1089/fpd.2005.2.274; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Randall LP, 2004, J ANTIMICROB CHEMOTH, V53, P208, DOI 10.1093/jac/dkh070; Ruiz J, 1997, J MED MICROBIOL, V46, P623, DOI 10.1099/00222615-46-7-623; Threlfall E J, 2003, Euro Surveill, V8, P41; Vo ATT, 2006, INT J ANTIMICROB AG, V28, P172, DOI 10.1016/j.ijantimicag.2006.05.027; Vo ATT, 2006, VET MICROBIOL, V113, P153, DOI 10.1016/j.vetmic.2005.10.034; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Yang SJ, 2002, VET MICROBIOL, V86, P295, DOI 10.1016/S0378-1135(02)00009-3; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500; Zhao S, 2005, FOODBORNE PATHOG DIS, V2, P169, DOI 10.1089/fpd.2005.2.169	45	69	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9440	10.1371/journal.pone.0009440	http://dx.doi.org/10.1371/journal.pone.0009440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195474	Green Published, gold, Green Submitted			2022-12-27	WOS:000274997000009
J	de Groot, NS; Ventura, S				de Groot, Natalia S.; Ventura, Salvador			Protein Aggregation Profile of the Bacterial Cytosol	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; CODON ADAPTATION INDEX; BOVINE SERUM-ALBUMIN; ESCHERICHIA-COLI; INCLUSION-BODIES; SUBCELLULAR-LOCALIZATION; GLOBULAR-PROTEINS; EXPRESSION LEVELS; BETA-AGGREGATION; GENE-EXPRESSION	Background: Protein misfolding is usually deleterious for the cell, either as a consequence of the loss of protein function or the buildup of insoluble and toxic aggregates. The aggregation behavior of a given polypeptide is strongly influenced by the intrinsic properties encoded in its sequence. This has allowed the development of effective computational methods to predict protein aggregation propensity. Methodology/Principal Findings: Here, we use the AGGRESCAN algorithm to approximate the aggregation profile of an experimental cytosolic Escherichia coli proteome. The analysis indicates that the aggregation propensity of bacterial proteins is associated with their length, conformation, location, function, and abundance. The data are consistent with the predictions of other algorithms on different theoretical proteomes. Conclusions/Significance: Overall, the study suggests that the avoidance of protein aggregation in functional environments acts as a strong evolutionary constraint on polypeptide sequences in both prokaryotic and eukaryotic organisms.	[de Groot, Natalia S.; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Ventura, S (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	salvador.ventura@uab.es	Ventura, Salvador/AAY-3170-2021; de Groot, Natalia Sanchez/AFN-2768-2022; de Groot, Natalia Sanchez/J-8212-2014; Ventura, Salvador/C-7021-2008	Ventura, Salvador/0000-0002-9652-6351; de Groot, Natalia Sanchez/0000-0002-0492-5532; de Groot, Natalia Sanchez/0000-0002-0492-5532; Ventura, Salvador/0000-0002-9652-6351	Ministerio de Ciencia y Innovacion (Spain) [BIO2007-68046-C02-02]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) [2009-SGR-760]; Ministerio de Ciencia y Innovacion (Spain)	Ministerio de Ciencia y Innovacion (Spain); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Ciencia y Innovacion (Spain)	This work was supported by grants BIO2007-68046-C02-02 from Ministerio de Ciencia y Innovacion (Spain) and 2009-SGR-760 from Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya). NSdG was beneficiary of a Formacion del Personal Investigador fellowship awarded by the Ministerio de Ciencia y Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bolon DN, 2001, BIOCHEMISTRY-US, V40, P10047, DOI 10.1021/bi010427y; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Chen YW, 2008, MOL BIOL EVOL, V25, P1530, DOI 10.1093/molbev/msn122; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; de Groot NS, 2006, J BIOTECHNOL, V125, P110, DOI 10.1016/j.jbiotec.2006.02.026; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Ellis RJ, 2000, TRENDS BIOCHEM SCI, V25, P210, DOI 10.1016/S0968-0004(00)01576-0; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Irback A, 2000, BIOPHYS J, V79, P2252, DOI 10.1016/S0006-3495(00)76472-1; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Kajander T, 2000, STRUCTURE, V8, P1203, DOI 10.1016/S0969-2126(00)00520-7; Kiraga J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-163; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu Y, 2004, BIOCHEM BIOPH RES CO, V316, P795, DOI 10.1016/j.bbrc.2004.02.125; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Monsellier E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000199; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; Quijano FAR, 2006, BIOCHEMISTRY-US, V45, P4638, DOI 10.1021/bi052226q; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Saiki M, 2006, BIOCHEM BIOPH RES CO, V343, P1262, DOI 10.1016/j.bbrc.2006.03.089; de Groot NS, 2007, BIOPHYS J, V92, P1732, DOI 10.1529/biophysj.106.096677; de Groot NS, 2006, FEBS LETT, V580, P6471, DOI 10.1016/j.febslet.2006.10.071; Sandelin E, 2004, BIOPHYS J, V86, P23, DOI 10.1016/S0006-3495(04)74080-1; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Seo MJ, 2009, PROTEIN SCI, V18, P259, DOI 10.1002/pro.31; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; Shirota M, 2008, PROTEIN SCI, V17, P1596, DOI 10.1110/ps.035592.108; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Tartaglia GG, 2005, PROTEIN SCI, V14, P2735, DOI 10.1110/ps.051473805; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2007, PROTEINS, V68, P273, DOI 10.1002/prot.21427; Tartaglia GG, 2007, TRENDS BIOCHEM SCI, V32, P204, DOI 10.1016/j.tibs.2007.03.005; Tartaglia GG, 2009, MOL BIOSYST, V5, P1873, DOI 10.1039/b913099n; Tartaglia GG, 2009, J MOL BIOL, V388, P381, DOI 10.1016/j.jmb.2009.03.002; TELLER DC, 1976, NATURE, V260, P729, DOI 10.1038/260729a0; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Vendruscolo M, 2007, NATURE, V449, P555, DOI 10.1038/449555a; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Vetri V, 2007, EUR BIOPHYS J BIOPHY, V36, P717, DOI 10.1007/s00249-007-0196-5; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; WASMER C, 2009, ANGEW CHEM IN PRESS; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zibaee S, 2007, PROTEIN SCI, V16, P906, DOI 10.1110/ps.062624507	83	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9383	10.1371/journal.pone.0009383	http://dx.doi.org/10.1371/journal.pone.0009383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195530	Green Published, gold			2022-12-27	WOS:000274924300001
J	Iwata, T; Schultz, D; Hicks, J; Hubbard, GK; Mutton, LN; Lotan, TL; Bethel, C; Lotz, MT; Yegnasubramanian, S; Nelson, WG; Dang, CV; Xu, MM; Anele, U; Koh, CM; Bieberich, CJ; De Marzo, AM				Iwata, Tsuyoshi; Schultz, Denise; Hicks, Jessica; Hubbard, Gretchen K.; Mutton, Laura N.; Lotan, Tamara L.; Bethel, Carlise; Lotz, Matthew T.; Yegnasubramanian, Srinivasan; Nelson, William G.; Dang, Chi V.; Xu, MengMeng; Anele, Uzoma; Koh, Cheryl M.; Bieberich, Charles J.; De Marzo, Angelo M.			MYC Overexpression Induces Prostatic Intraepithelial Neoplasia and Loss of Nkx3.1 in Mouse Luminal Epithelial Cells	PLOS ONE			English	Article							PROLIFERATIVE INFLAMMATORY ATROPHY; GENETICALLY-ENGINEERED MICE; IN-SITU HYBRIDIZATION; HOMEOBOX GENE NKX3.1; C-MYC; STEM-CELL; HIGH-GRADE; TRANSGENIC ADENOCARCINOMA; NEUROENDOCRINE CARCINOMA; CHROMOSOMAL-ANOMALIES	Lo-MYC and Hi-MYC mice develop prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma as a result of MYC overexpression in the mouse prostate[1]. However, prior studies have not determined precisely when, and in which cell types, MYC is induced. Using immunohistochemistry (IHC) to localize MYC expression in Lo-MYC transgenic mice, we show that morphological and molecular alterations characteristic of high grade PIN arise in luminal epithelial cells as soon as MYC overexpression is detected. These changes include increased nuclear and nucleolar size and large scale chromatin remodeling. Mouse PIN cells retained a columnar architecture and abundant cytoplasm and appeared as either a single layer of neoplastic cells or as pseudo-stratified/multilayered structures with open glandular lumina-features highly analogous to human high grade PIN. Also using IHC, we show that the onset of MYC overexpression and PIN development coincided precisely with decreased expression of the homeodomain transcription factor and tumor suppressor, Nkx3.1. Virtually all normal appearing prostate luminal cells expressed high levels of Nkx3.1, but all cells expressing MYC in PIN lesions showed marked reductions in Nkx3.1, implicating MYC as a key factor that represses Nkx3.1 in PIN lesions. To determine the effects of less pronounced overexpression of MYC we generated a new line of mice expressing MYC in the prostate under the transcriptional control of the mouse Nkx3.1 control region. These "`Super-Lo-MYC'' mice also developed PIN, albeit a less aggressive form. We also identified a histologically defined intermediate step in the progression of mouse PIN into invasive adenocarcinoma. These lesions are characterized by a loss of cell polarity, multi-layering, and cribriform formation, and by a "`paradoxical'' increase in Nkx3.1 protein. Similar histopathological changes occurred in Hi-MYC mice, albeit with accelerated kinetics. Our results using IHC provide novel insights that support the contention that MYC overexpression is sufficient to transform prostate luminal epithelial cells into PIN cells in vivo. We also identified a novel histopathologically identifiable intermediate step prior to invasion that should facilitate studies of molecular pathway alterations occurring during early progression of prostatic adenocarcinomas.	[Iwata, Tsuyoshi; Schultz, Denise; Hicks, Jessica; Lotan, Tamara L.; Bethel, Carlise; Lotz, Matthew T.; Nelson, William G.; Dang, Chi V.; Xu, MengMeng; Anele, Uzoma; Koh, Cheryl M.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Lotan, Tamara L.; Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Lotan, Tamara L.; Yegnasubramanian, Srinivasan; Nelson, William G.; Dang, Chi V.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bethel, Carlise; Yegnasubramanian, Srinivasan; Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Nelson, William G.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Brady Urol Res Inst, Baltimore, MD USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Hematol & Med, Baltimore, MD USA; [Hubbard, Gretchen K.; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore County	Iwata, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ademarz@jhmi.edu	Dang, Chi/Y-3375-2019; Anele, Uzoma/Q-9855-2019	Anele, Uzoma/0000-0002-3509-7856; Lotan, Tamara/0000-0002-0494-9067; Bieberich, Charles/0000-0002-9208-5077; Dang, Chi/0000-0002-4031-2522	Patrick C. Walsh Prostate Cancer Research Fund; NIH/NCI SPORE [P50 CA58236]; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22791489] Funding Source: KAKEN	Patrick C. Walsh Prostate Cancer Research Fund; NIH/NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Patrick C. Walsh Prostate Cancer Research Fund, NIH/NCI SPORE No. P50 CA58236 (Pathology Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Allam CK, 1996, MODERN PATHOL, V9, P742; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Barclay WW, 2008, STEM CELLS, V26, P600, DOI 10.1634/stemcells.2007-0309; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; BONKHOFF H, 1994, HUM PATHOL, V25, P42, DOI 10.1016/0046-8177(94)90169-4; BONKHOFF H, 1994, PROSTATE, V24, P114, DOI 10.1002/pros.2990240303; Bostwick DG, 1996, PROSTATE, V29, P117; Bowen C, 2000, CANCER RES, V60, P6111; Bradshaw MS, 1995, NUCLEIC ACIDS RES, V23, P4850, DOI 10.1093/nar/23.23.4850; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Chuang AY, 2007, AM J SURG PATHOL, V31, P1246, DOI 10.1097/PAS.0b013e31802f5d33; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; De Marzo AM, 1998, J UROLOGY, V160, P2381, DOI 10.1016/S0022-5347(01)62196-7; De Marzo AM, 1998, AM J PATHOL, V153, P911, DOI 10.1016/S0002-9440(10)65632-5; De Marzo AM, 2007, J UROLOGY, V177, P373, DOI 10.1016/S0022-5347(18)31345-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Egevad L, 2006, MODERN PATHOL, V19, P180, DOI 10.1038/modpathol.3800522; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Elo JP, 2001, ANN MED, V33, P130, DOI 10.3109/07853890109002068; EPSTEIN JI, 2004, BLADDER BIOPSY INTER; Epstein JI, 2009, VIRCHOWS ARCH, V454, P1, DOI 10.1007/s00428-008-0707-5; FLEMING WH, 1986, CANCER RES, V46, P1535; Freie BW, 2008, CANCER CELL, V14, P425, DOI 10.1016/j.ccr.2008.11.008; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gingrich JR, 1996, CANCER RES, V56, P4096; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gonzalgo ML, 2003, J UROLOGY, V170, P2444, DOI 10.1097/01.ju.0000085381.20139.b6; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huss WJ, 2007, NEOPLASIA, V9, P938, DOI 10.1593/neo.07562; Jenkins RB, 1997, CANCER RES, V57, P524; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Korkmaz CG, 2004, J UROLOGY, V172, P1134, DOI 10.1097/01.ju.0000136526.78535.b8; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Masumori N, 2001, CANCER RES, V61, P2239; MCNEAL JE, 1995, PROSTATE, V27, P258, DOI 10.1002/pros.2990270505; MCNEAL JE, 1988, AM J CLIN PATHOL, V90, P23, DOI 10.1093/ajcp/90.1.23; Meeker AK, 2002, CANCER RES, V62, P6405; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Qian JQ, 1997, MODERN PATHOL, V10, P1113; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; SONG H, 2009, ONCOGENE; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Williams K, 2005, PROSTATE, V63, P369, DOI 10.1002/pros.20200; Xu LL, 2000, J UROLOGY, V163, P972, DOI 10.1016/S0022-5347(05)67867-6; Yan Y, 1997, PROSTATE, V32, P129; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang XJ, 2000, PROSTATE, V43, P278	86	89	90	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9427	10.1371/journal.pone.0009427	http://dx.doi.org/10.1371/journal.pone.0009427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195545	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300015
J	Yam, AY; Gao, CM; Wang, XM; Wu, P; Peretz, D				Yam, Alice Y.; Gao, Carol Man; Wang, Xuemei; Wu, Ping; Peretz, David			The Octarepeat Region of the Prion Protein Is Conformationally Altered in PrPSc	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; REPEAT INSERTIONAL MUTATION; SCRAPIE PRION; N-TERMINUS; GENE; FEATURES; DOMAIN; AGGREGATION; COEXISTENCE; ASSAY	Background: Prion diseases are fatal neurodegenerative disorders characterized by misfolding and aggregation of the normal prion protein PrPC. Little is known about the details of the structural rearrangement of physiological PrPC into a still-elusive disease-associated conformation termed PrPSc. Increasing evidence suggests that the amino-terminal octapeptide sequences of PrP (huPrP, residues 59-89), though not essential, play a role in modulating prion replication and disease presentation. Methodology/Principal Findings: Here, we report that trypsin digestion of PrPSc from variant and sporadic human CJD results in a disease-specific trypsin-resistant PrPSc fragment including amino acids similar to 49-231, thus preserving important epitopes such as the octapeptide domain for biochemical examination. Our immunodetection analyses reveal that several epitopes buried in this region of PrPSc are exposed in PrPC. Conclusions/Significance: We conclude that the octapeptide region undergoes a previously unrecognized conformational transition in the formation of PrPSc. This phenomenon may be relevant to the mechanism by which the amino terminus of PrPC participates in PrPSc conversion, and may also be exploited for diagnostic purposes.	[Yam, Alice Y.; Gao, Carol Man; Wang, Xuemei; Wu, Ping; Peretz, David] Novartis Vaccines & Diagnost Inc, Res & Dev, Emeryville, CA USA	Novartis	Yam, AY (corresponding author), Novartis Vaccines & Diagnost Inc, Res & Dev, Emeryville, CA USA.	alice.yam@novartis.com	Wang, Xuemei/GXF-3702-2022		Novartis Vaccines & Diagnostics, Inc	Novartis Vaccines & Diagnostics, Inc	This work was funded by Novartis Vaccines & Diagnostics, Inc. The authors are or were employed by the funder and, as such, the funders played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Campbell TA, 1996, NEUROLOGY, V46, P761, DOI 10.1212/WNL.46.3.761; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Cooper JK, 2007, VOX SANG, V92, P302, DOI 10.1111/j.1423-0410.2007.00904.x; Dong JJ, 2007, J BIOL CHEM, V282, P34204, DOI 10.1074/jbc.M704952200; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Frankenfield KN, 2005, PROTEIN SCI, V14, P2154, DOI 10.1110/ps.051434005; Leclerc E, 2001, EMBO J, V20, P1547, DOI 10.1093/emboj/20.7.1547; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Minor P, 2004, J GEN VIROL, V85, P1777, DOI 10.1099/vir.0.79959-0; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Pietrini V, 2003, NEUROLOGY, V61, P1288, DOI 10.1212/01.WNL.0000092017.74772.CA; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossi G, 2000, NEUROLOGY, V55, P405, DOI 10.1212/WNL.55.3.405; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Yanagihara C, 2002, J NEUROL NEUROSUR PS, V72, P788, DOI 10.1136/jnnp.72.6.788; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	34	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9316	10.1371/journal.pone.0009316	http://dx.doi.org/10.1371/journal.pone.0009316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195363	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924200004
J	Yang, HH; Hu, N; Wang, CY; Ding, T; Dunn, BK; Goldstein, AM; Taylor, PR; Lee, MP				Yang, Howard H.; Hu, Nan; Wang, Chaoyu; Ding, Ti; Dunn, Barbara K.; Goldstein, Alisa M.; Taylor, Philip R.; Lee, Maxwell P.			Influence of Genetic Background and Tissue Types on Global DNA Methylation Patterns	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DROSOPHILA-TRITHORAX; ESOPHAGEAL CANCER; FAMILY-HISTORY; HYPERMETHYLATION; TRANSLOCATIONS; WIDE	Recent studies have shown a genetic influence on gene expression variation, chromatin, and DNA methylation. However, the effects of genetic background and tissue types on DNA methylation at the genome-wide level have not been characterized extensively. To study the effect of genetic background and tissue types on global DNA methylation, we performed DNA methylation analysis using the Affymetrix 500K SNP array on tumor, adjacent normal tissue, and blood DNA from 30 patients with esophageal squamous cell carcinoma (ESCC). The use of multiple tissues from 30 individuals allowed us to evaluate variation of DNA methylation states across tissues and individuals. Our results demonstrate that blood and esophageal tissues shared similar DNA methylation patterns within the same individual, suggesting an influence of genetic background on DNA methylation. Furthermore, we showed that tissue types are important contributors of DNA methylation states.	[Yang, Howard H.; Lee, Maxwell P.] NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Hu, Nan; Wang, Chaoyu; Goldstein, Alisa M.; Taylor, Philip R.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ding, Ti] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Dunn, Barbara K.] NCI, Basic Prevent Sci Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yang, HH (corresponding author), NCI, Lab Populat Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	ptaylor@mail.nih.gov; leemax@mail.nih.gov			Intramural Research Program of the National Institutes of Health; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011253, ZIABC011250, ZIABC010986] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2; BIBIKOVA M, 2006, GENOME RES; Bird A, 2004, COLD SPRING HARB SYM, V69, P113, DOI 10.1101/sqb.2004.69.113; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HERMAN JG, 1995, CANCER RES, V55, P4525; Hu N, 1999, CLIN CANCER RES, V5, P3476; HU N, 1991, EUR J CANCER, V27, P1336, DOI 10.1016/0277-5379(91)90116-U; Hu N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-299; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sanchez-Cespedes M, 2000, CANCER RES, V60, P892; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	32	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9355	10.1371/journal.pone.0009355	http://dx.doi.org/10.1371/journal.pone.0009355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186319	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924000006
J	Schrack, JA; Simonsick, EM; Ferrucci, L				Schrack, Jennifer A.; Simonsick, Eleanor M.; Ferrucci, Luigi			Comparison of the Cosmed K4b(2) Portable Metabolic System in Measuring Steady-State Walking Energy Expenditure	PLOS ONE			English	Article							OVERGROUND WALKING; ACCURACY; AGREEMENT; TREADMILL	Background and Aims: Recent introduction of the Cosmed K4b(2) portable metabolic analyzer allows measurement of oxygen consumption outside of a laboratory setting in more typical clinical or household environments and thus may be used to obtain information on the metabolic costs of specific daily life activities. The purpose of this study was to assess the accuracy of the Cosmed K4b(2) portable metabolic analyzer against a traditional, stationary gas exchange system (the Medgraphics D-Series) during steady-state, submaximal walking exercise. Methods: Nineteen men and women (9 women, 10 men) with an average age of 39.8 years (+/- 13.8) completed two 400 meter walk tests using the two systems at a constant, self-selected pace on a treadmill. Average oxygen consumption (VO2) and carbon dioxide production (VCO2) from each walk were compared. Results: Intraclass Correlation Coefficient (ICC) and Pearson correlation coefficients between the two systems for weight indexed VO2 (ml/kg/min), total VO2 (ml/min), and VCO2 (ml/min) ranged from 0.93 to 0.97. Comparison of the average values obtained using the Cosmed K4b(2) and Medgraphics systems using paired t-tests indicate no significant difference for VO2 (ml/kg/min) overall (p = 0.25), or when stratified by sex (p = 0.21 women, p = 0.69 men). The mean difference between analyzers was - 0.296 ml/kg/min (+/- 0.26). Results were not significantly different for VO2 (ml/min) or VCO2 (ml/min) within the study population (p = 0.16 and p = 0.08, respectively), or when stratified by sex (VO2: p = 0.51 women, p = 0.16 men; VCO2: p =.11 women, p = 0.53 men). Conclusion: The Cosmed K4b(2) portable metabolic analyzer provides measures of VO2 and VCO2 during steady-state, submaximal exercise similar to a traditional, stationary gas exchange system.	[Schrack, Jennifer A.; Simonsick, Eleanor M.; Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; [Schrack, Jennifer A.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Aging & Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Schrack, JA (corresponding author), NIA, Longitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA.	schrackja@mail.nih.gov	Simonsick, Eleanor/W-6864-2019; Schrack, Jennifer/AAJ-1772-2021	Schrack, Jennifer/0000-0001-9244-9267	National Institutes of Health (NIH); National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000015, ZIAAG000964] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging. The funder(s) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Doyon KH, 2001, CAN J APPL PHYSIOL, V26, P1, DOI 10.1139/h01-001; Duffield R, 2004, J SCI MED SPORT, V7, P11, DOI 10.1016/S1440-2440(04)80039-2; Evans WJ, 2007, AM J PHYS MED REHAB, V86, pS29, DOI 10.1097/PHM.0b013e31802ba53c; LaBreche J. M., 2001, CAN J APPL PHYSIOL, V26, P492; Marsh AP, 2006, MED SCI SPORT EXER, V38, P1157, DOI 10.1249/01.mss.0000222844.81638.35; Matarese LE, 1997, J AM DIET ASSOC, V97, pS154, DOI 10.1016/S0002-8223(97)00754-2; McArdle W., 2014, EXERCISE PHYSL ENERG, P253; McClave SA, 2003, JPEN-PARENTER ENTER, V27, P16, DOI 10.1177/014860710302700116; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; McNaughton LR, 2005, J SPORT MED PHYS FIT, V45, P315; Parvataneni L, 2009, CLIN BIOMECH, V24, P95, DOI 10.1016/j.clinbiomech.2008.07.002; Pinnington HC, 2001, J SCI MED SPORT, V4, P324, DOI 10.1016/S1440-2440(01)80041-4; Prieur F, 1998, MED SCI SPORT EXER, V30, P958, DOI 10.1097/00005768-199806000-00028; Reeves MM, 2004, J APPL PHYSIOL, V97, P130, DOI 10.1152/japplphysiol.01212.2003; Scott CB, 1998, INT J SPORTS MED, V19, P277, DOI 10.1055/s-2007-971918; Simonsick EM, 2001, J AM GERIATR SOC, V49, P1544, DOI 10.1046/j.1532-5415.2001.4911247.x; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	18	61	62	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9292	10.1371/journal.pone.0009292	http://dx.doi.org/10.1371/journal.pone.0009292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174583	Green Published, Green Submitted, gold			2022-12-27	WOS:000274654700020
J	Spinner, JL; Seo, KS; O'Loughlin, JL; Cundiff, JA; Minnich, SA; Bohach, GA; Kobayashi, SD				Spinner, Justin L.; Seo, Keun Seok; O'Loughlin, Jason L.; Cundiff, Jennifer A.; Minnich, Scott A.; Bohach, Gregory A.; Kobayashi, Scott D.			Neutrophils Are Resistant to Yersinia YopJ/P-Induced Apoptosis and Are Protected from ROS-Mediated Cell Death by the Type III Secretion System	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; UNDERGO APOPTOSIS; IMMUNE CELLS; ENTEROCOLITICA; MACROPHAGES; PESTIS; VIRULENCE; YOPP; ACTIVATION; CYTOTOXICITY	Background: The human innate immune system relies on the coordinated activity of macrophages and polymorphonuclear leukocytes (neutrophils or PMNs) for defense against bacterial pathogens. Yersinia spp. subvert the innate immune response to cause disease in humans. In particular, the Yersinia outer protein YopJ (Y. pestis and Y. pseudotuberculosis) and YopP (Y. enterocolitica) rapidly induce apoptosis in murine macrophages and dendritic cells. However, the effects of Yersinia Yop J/P on neutrophil fate are not clearly defined. Methodology/Principal Findings: In this study, we utilized wild-type and mutant strains of Yersinia to test the contribution of YopJ and YopP on induction of apoptosis in human monocyte-derived macrophages (HMDM) and neutrophils. Whereas YopJ and YopP similarly induced apoptosis in HMDMs, interaction of human neutrophils with virulence plasmid-containing Yersinia did not result in PMN caspase activation, release of LDH, or loss of membrane integrity greater than PMN controls. In contrast, interaction of human PMNs with the virulence plasmid-deficient Y. pestis strain KIM6 resulted in increased surface exposure of phosphatidylserine (PS) and cell death. PMN reactive oxygen species (ROS) production was inhibited in a virulence plasmid-dependent but YopJ/YopP-independent manner. Following phagocytic interaction with Y. pestis strain KIM6, inhibition of PMN ROS production with diphenyleneiodonium chloride resulted in a reduction of PMN cell death similar to that induced by the virulence plasmid-containing strain Y. pestis KIM5. Conclusions: Our findings showed that Yersinia YopJ and/or YopP did not induce pronounced apoptosis in human neutrophils. Furthermore, robust PMN ROS production in response to virulence plasmid-deficient Yersinia was associated with increased PMN cell death, suggesting that Yersinia inhibition of PMN ROS production plays a role in evasion of the human innate immune response in part by limiting PMN apoptosis.	[Spinner, Justin L.; Seo, Keun Seok; O'Loughlin, Jason L.; Cundiff, Jennifer A.; Minnich, Scott A.; Bohach, Gregory A.; Kobayashi, Scott D.] Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA	Idaho; University of Idaho	Spinner, JL (corresponding author), Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83843 USA.	kobayashis@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; Seo, Keun Seok/0000-0001-9280-9680	NIH [1K22AI6274, P20RR015587, P20RR016454]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454, P20RR015587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this research was provided by NIH awards 1K22AI6274 and P20RR015587 to S. D. Kobayashi, and P20RR016454 to S. A. Minnich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fadeel B, 1998, BLOOD, V92, P4808, DOI 10.1182/blood.V92.12.4808.424k01_4808_4818; GOGUEN JD, 1986, INFECT IMMUN, V51, P788, DOI 10.1128/IAI.51.3.788-794.1986; Grobner S, 2007, APOPTOSIS, V12, P1813, DOI 10.1007/s10495-007-0100-x; Grobner S, 2006, APOPTOSIS, V11, P1959, DOI 10.1007/s10495-006-0189-3; Hampton MB, 2002, J LEUKOCYTE BIOL, V71, P775; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196, DOI 10.1002/jlb.65.2.196; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; NAUSEEF WM, 2005, BASIC PRINCIPLES DIA, P93; O'Loughlin JL, 2010, INFECT IMMUN, V78, P773, DOI 10.1128/IAI.00718-09; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996; Ruckdeschel K, 1997, INFECT IMMUN, V65, P4813, DOI 10.1128/IAI.65.11.4813-4821.1997; Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SEO KS, 2009, J LEUKOCYTE BIOL, V85, P1; Shao F, 2008, CURR OPIN MICROBIOL, V11, P21, DOI 10.1016/j.mib.2008.01.005; Spinner JL, 2008, INFECT IMMUN, V76, P3754, DOI 10.1128/IAI.00385-08; van den Berg JM, 2001, J LEUKOCYTE BIOL, V69, P467; Watson RWG, 1996, J IMMUNOL, V156, P3986; Wilkie RP, 2007, INFECT IMMUN, V75, P3256, DOI 10.1128/IAI.01984-06; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	44	40	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9279	10.1371/journal.pone.0009279	http://dx.doi.org/10.1371/journal.pone.0009279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174624	Green Submitted, Green Published, gold			2022-12-27	WOS:000274654700013
J	Datiko, DG; Lindtjorn, B				Datiko, Daniel G.; Lindtjorn, Bernt			Cost and Cost-Effectiveness of Smear-Positive Tuberculosis Treatment by Health Extension Workers in Southern Ethiopia: A Community Randomized Trial	PLOS ONE			English	Article							CARE FACILITY INVOLVEMENT; SUB-SAHARAN AFRICA; MACHAKOS DISTRICT; DECENTRALIZATION; LILONGWE	by HEWs in the health posts and general health workers at health facility were compared along a community-randomized trial. Costs were analysed from societal perspective in 2007 in US $ using standard methods. We prospectively enrolled smear positive patients, and calculated cost-effectiveness as the cost per patient successfully treated. The total cost for each successfully treated smear-positive patient was higher in health facility ($ 158.9) compared with community ($ 61.7). Community-based treatment reduced the total, patient and caregiver cost by 61.2%, 68.1% and 79.8%, respectively. Involving HEWs added a total cost of $ 8.80 (14.3% of total cost) on health service per patient treated in the community. Conclusions/Significance: Community-based treatment by HEWs costs only 39% of what treatment by general health workers costs for similar outcomes. Involving HEWs in TB treatment is a cost effective treatment alternative to the health service, to the patients and the family. There is an economic and public health reason to consider involving HEWs in TB treatment in Ethiopia. However, community-based treatment requires initial investment to start its implementation, training and supervision.	[Datiko, Daniel G.; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Datiko, Daniel G.] Nationalities & Peoples Reg State Hlth Bur, Hawassa, Ethiopia	University of Bergen	Datiko, DG (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	danieljohn42@yahoo.com	Datiko, Daniel/AAE-7019-2020; Lindtjorn, Bernt/K-9465-2018; Datiko, Daniel G./AAE-6856-2020	Datiko, Daniel/0000-0002-8556-3069; Lindtjorn, Bernt/0000-0002-6267-6984; 	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Datiko DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-266; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; DONNER A, 2000, DES AN CLUST RAND TR; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; *FED MIN HLTH ETH, 2007, HLTH HLTH REL IND; Federal Ministry of Health Ethiopia, 2008, TUB LEPR TB HIV PREV; Federal Ministry of Health of Ethiopia, 2005, ESS HLTH SERV PACK E; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Kangangi JK, 2003, INT J TUBERC LUNG D, V7, pS5; Maher D, 2005, TROP MED INT HEALTH, V10, P734, DOI 10.1111/j.1365-3156.2005.01456.x; Maher D, 1997, INT J TUBERC LUNG D, V1, P276; Mangura B, 2002, INT J TUBERC LUNG D, V6, P654; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P663; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Nyirenda TE, 2003, INT J TUBERC LUNG D, V7, pS21; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Okello D, 2003, INT J TUBERC LUNG D, V7, pS72; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; Singh AA, 2004, INT J TUBERC LUNG D, V8, P800; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; Wandwalo Eliud, 2005, Cost Eff Resour Alloc, V3, P6, DOI 10.1186/1478-7547-3-6; *WHO, 2003, COMM TB CAR PRACT PO; World Health Organisation, 2003, MAK CHOIC HLTH WHO G; World Health Organisation, 2008, GLOB TUB CONTR SURV, P1; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166	29	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9158	10.1371/journal.pone.0009158	http://dx.doi.org/10.1371/journal.pone.0009158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174642	Green Published, gold			2022-12-27	WOS:000274590600003
J	Herrera, EA; Verkerk, MM; Derks, JB; Giussani, DA				Herrera, Emilio A.; Verkerk, Misha M.; Derks, Jan B.; Giussani, Dino A.			Antioxidant Treatment Alters Peripheral Vascular Dysfunction Induced by Postnatal Glucocorticoid Therapy in Rats	PLOS ONE			English	Article							INDUCED HYPERTENSION; ENDOCRINE RESPONSES; LUNG-DISEASE; DEXAMETHASONE; MECHANISMS; VASORELAXATION; PROLIFERATION; BAROREFLEX; EXPRESSION; SYNTHASE	Background: Postnatal glucocorticoid therapy in premature infants diminishes chronic lung disease, but it also increases the risk of hypertension in adulthood. Since glucocorticoid excess leads to overproduction of free radicals and endothelial dysfunction, this study tested the hypothesis that adverse effects on cardiovascular function of postnatal glucocorticoids are secondary to oxidative stress. Therefore, combined postnatal treatment of glucocorticoids with antioxidants may diminish unwanted effects. Methodology/Principal Findings: Male rat pups received a course of dexamethasone (Dex), or Dex with vitamins C and E (DexCE), on postnatal days 1-6 (P1-6). Controls received vehicle (Ctrl) or vehicle with vitamins (CtrlCE). At P21, femoral vascular reactivity was determined via wire myography. Dex, but not DexCE or CtrlCE, increased mortality relative to Ctrl (81.3 versus 96.9 versus 90.6 versus 100% survival, respectively; P< 0.05). Constrictor responses to phenylephrine (PE) and thromboxane were enhanced in Dex relative to Ctrl (84.7+/-4.8 versus 67.5+/-5.7 and 132.7+/-4.9 versus 107.0+/-4.9% Kmax, respectively; P<0.05); effects that were diminished in DexCE (58.3+/-7.5 and 121.1+/-4.3% Kmax, respectively; P<0.05). Endothelium-dependent dilatation was depressed in Dex relative to Ctrl (115.3+/-11.9 versus 216.9+/-18.9, AUC; P<0.05); however, this effect was not restored in DexCE (68.3+/-8.3, AUC). Relative to Ctrl, CtrlCE alone diminished PE-induced constriction (43.4+/-3.7% Kmax) and the endothelium-dependent dilatation (74.7+/-8.7 AUC; P<0.05). Conclusions/Significance: Treatment of newborn rats with dexamethasone has detrimental effects on survival and peripheral vasoconstrictor function. Coadministration of dexamethasone with antioxidant vitamins improves survival and partially restores vascular dysfunction. Antioxidant vitamins alone affect peripheral vascular function.	[Herrera, Emilio A.; Verkerk, Misha M.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Derks, Jan B.] Univ Med Ctr Utrecht, Dept Perinatol, Utrecht, Netherlands	University of Cambridge; Utrecht University; Utrecht University Medical Center	Herrera, EA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	Herrera, Emilio A/H-5992-2018	Herrera, Emilio A/0000-0002-6342-085X; Giussani, Dino/0000-0002-1308-1204	British Heart Foundation [PMAG/148]; Biotechnology and Biological Sciences Research Council [PMAG/095]	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the British Heart Foundation (PMAG/148) and the Biotechnology and Biological Sciences Research Council (PMAG/095). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER AR, 2009, NEONATOLOGY IN PRESS; Bal MP, 2005, PEDIATR RES, V58, P46, DOI 10.1203/01.PDR.0000163617.01673.9A; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; BENEDIKTSSON R, 1993, LANCET, V341, P339, DOI 10.1016/0140-6736(93)90138-7; Bennet L, 1999, BRIT J OBSTET GYNAEC, V106, P331, DOI 10.1111/j.1471-0528.1999.tb08270.x; Bensky AS, 1996, PEDIATRICS, V97, P818; BERK BC, 1988, J CELL PHYSIOL, V137, P391, DOI 10.1002/jcp.1041370302; BIAN XP, 1993, TERATOLOGY, V47, P109, DOI 10.1002/tera.1420470203; Carr AC, 2000, CIRC RES, V87, P349, DOI 10.1161/01.RES.87.5.349; Carvajal JA, 2000, J CELL PHYSIOL, V184, P409, DOI 10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.3.CO;2-B; Chen Y, 2004, NITRIC OXIDE-BIOL CH, V11, P121; de Vries WB, 2006, BASIC RES CARDIOL, V101, P36, DOI 10.1007/s00395-005-0557-0; De Vries WB, 2002, PEDIATR RES, V52, P900, DOI 10.1203/01.PDR.0000036281.74804.27; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gunnett CA, 2001, ARTERIOSCL THROM VAS, V21, P1281, DOI 10.1161/hq0801.093509; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; HANDA M, 1984, HYPERTENSION, V6, P236, DOI 10.1161/01.HYP.6.2_Pt_1.236; HAYASHI T, 1991, AM J PHYSIOL, V261, pC106, DOI 10.1152/ajpcell.1991.261.1.C106; He J, 2004, AM J PHYSIOL-REG I, V287, pR198, DOI 10.1152/ajpregu.00349.2003; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jellyman JK, 2005, J PHYSIOL-LONDON, V567, P673, DOI 10.1113/jphysiol.2005.089805; Katusic ZS, 1996, FREE RADICAL BIO MED, V20, P443, DOI 10.1016/0891-5849(96)02116-8; Molnar J, 2003, J PHYSIOL-LONDON, V547, P61, DOI 10.1113/jphysiol.2002.032565; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Oncu M, 2002, HUM EXP TOXICOL, V21, P223, DOI 10.1191/0960327102ht225oa; PIRPIRIS M, 1992, HYPERTENSION, V19, P567, DOI 10.1161/01.HYP.19.6.567; Porter JP, 2000, AM J PHYSIOL-REG I, V279, pR1386, DOI 10.1152/ajpregu.2000.279.4.R1386; Roghair RD, 2005, AM J PHYSIOL-REG I, V288, pR46, DOI 10.1152/ajpregu.00165.2004; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; SAKAUE M, 1991, J CLIN INVEST, V88, P385, DOI 10.1172/JCI115315; Schafer SC, 2005, AM J PHYSIOL-HEART C, V288, pH436, DOI 10.1152/ajpheart.00587.2004; Segar JL, 2006, AM J PHYSIOL-REG I, V291, pR481, DOI 10.1152/ajpregu.00677.2005; Simmons WW, 1996, J BIOL CHEM, V271, P23928, DOI 10.1074/jbc.271.39.23928; Stark AR, 2001, NEW ENGL J MED, V344, P95, DOI 10.1056/NEJM200101113440203; Suzuki T, 2003, MICROSC RES TECHNIQ, V60, P76, DOI 10.1002/jemt.10246; TANGALAKIS K, 1992, EXP PHYSIOL, V77, P709, DOI 10.1113/expphysiol.1992.sp003637; THIBEAULT DW, 1993, PEDIATR PULM, V16, P81, DOI 10.1002/ppul.1950160202; TSENG YT, 1995, EUR J PHARM-MOLEC PH, V289, P353, DOI 10.1016/0922-4106(95)90113-2; VILLA AE, 1994, J CLIN INVEST, V93, P1243, DOI 10.1172/JCI117078; Wallerath T, 1999, P NATL ACAD SCI USA, V96, P13357, DOI 10.1073/pnas.96.23.13357; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; WHITWORTH JA, 1995, STEROIDS, V60, P76, DOI 10.1016/0039-128X(94)00033-9; Wise GE, 2001, CLIN ANAT, V14, P204, DOI 10.1002/ca.1034; Yamashita T, 2000, HYPERTENSION, V36, P97, DOI 10.1161/01.HYP.36.1.97; Yang Shumei, 2004, Current Vascular Pharmacology, V2, P1, DOI 10.2174/1570161043476483; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200	49	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9250	10.1371/journal.pone.0009250	http://dx.doi.org/10.1371/journal.pone.0009250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174656	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590600010
J	Dere, R; Wilson, PD; Sandford, RN; Walker, CL				Dere, Ruhee; Wilson, Patricia D.; Sandford, Richard N.; Walker, Cheryl Lyn			Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR	PLOS ONE			English	Article							SLOWS DISEASE PROGRESSION; KIDNEY-DISEASE; GENE-PRODUCT; C-JUN; MEMBRANE LOCALIZATION; CELL-GROWTH; PATHOGENESIS; PROTEIN; KINASE; PHOSPHORYLATION	Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited renal disorder caused by defects in the PKD1 or PKD2 genes. ADPKD is associated with significant morbidity, and is a major underlying cause of end-stage renal failure (ESRF). Commonly, treatment options are limited to the management of hypertension, cardiovascular risk factors, dialysis, and transplantation when ESRF develops, although several new pharmacotherapies, including rapamycin, have shown early promise in animal and human studies. Evidence implicates polycystin-1 (PC-1), the gene product of the PKD1 gene, in regulation of the mTOR pathway. Here we demonstrate a mechanism by which the intracellular, carboxy-terminal tail of polycystin-1 (CP1) regulates mTOR signaling by altering the subcellular localization of the tuberous sclerosis complex 2 (TSC2) tumor suppressor, a gatekeeper for mTOR activity. Phosphorylation of TSC2 at S939 by AKT causes partitioning of TSC2 away from the membrane, its GAP target Rheb, and its activating partner TSC1 to the cytosol via 14-3-3 protein binding. We found that TSC2 and a C-terminal polycystin-1 peptide (CP1) directly interact and that a membrane-tethered CP1 protects TSC2 from AKT phosphorylation at S939, retaining TSC2 at the membrane to inhibit the mTOR pathway. CP1 decreased binding of 14-3-3 proteins to TSC2 and increased the interaction between TSC2 and its activating partner TSC1. Interestingly, while membrane tethering of CP1 was required to activate TSC2 and repress mTOR, the ability of CP1 to inhibit mTOR signaling did not require primary cilia and was independent of AMPK activation. These data identify a unique mechanism for modulation of TSC2 repression of mTOR signaling via membrane retention of this tumor suppressor, and identify PC-1 as a regulator of this downstream component of the PI3K signaling cascade.	[Dere, Ruhee; Walker, Cheryl Lyn] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA; [Wilson, Patricia D.] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Sandford, Richard N.] Univ Cambridge, Dept Med Genet, Cambridge, England	University of Texas System; UTMD Anderson Cancer Center; Medical College of Wisconsin; University of Cambridge	Dere, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA.	cwalker@wotan.mdacc.tmc.edu	Wilson, Patricia/AAW-8481-2021	Wilson, Patricia/0000-0003-0902-188X	Polycystic Kidney Disease (PKD) Foundation [157b2f]; David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health (NIH) [DK062345]; National Institute of Health Research Cambridge Biomedical Research Center; National Institute for Environmental Health Sciences (NIEHS) Center [ES007784]; PKD/TSC Collaborative Research Initiative; NATIONAL CANCER INSTITUTE [R01CA143811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK062345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Polycystic Kidney Disease (PKD) Foundation; David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Research Cambridge Biomedical Research Center(National Institute for Health Research (NIHR)); National Institute for Environmental Health Sciences (NIEHS) Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PKD/TSC Collaborative Research Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by post-doctoral fellowships awarded to R. D. by the Polycystic Kidney Disease (PKD) Foundation (157b2f) and the David H. Koch Center for Applied Research of Genitourinary Cancers, a National Institutes of Health (NIH) grant (DK062345) awarded to P. D. W., a National Institute of Health Research Cambridge Biomedical Research Center awarded to R.N.S., a National Institute for Environmental Health Sciences (NIEHS) Centfer Grant (ES007784), and a PKD/TSC Collaborative Research Initiative grant (from the PKD foundation and the Tuberous Sclerosis (TS) Alliance) awarded to C. L. W., R.N.S. and P.D.W.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER A, 2010, ATM SIGNALS IN PRESS; Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Bonnet CS, 2009, HUM MOL GENET, V18, P2166, DOI 10.1093/hmg/ddp149; Braun WE, 2009, CLEV CLIN J MED, V76, P97, DOI 10.3949/ccjm.76a.gr001; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495; Deane JA, 2007, NEPHROLOGY, V12, P559, DOI 10.1111/j.1440-1797.2007.00869.x; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fischer DC, 2009, NEPHROL DIAL TRANSPL, V24, P1819, DOI 10.1093/ndt/gfn744; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; Guay-Woodford LM, 2003, AM J PHYSIOL-RENAL, V285, pF1034, DOI 10.1152/ajprenal.00195.2003; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hooper KM, 2003, CLIN SCI, V104, P217, DOI 10.1042/CS20020239; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kleymenova E, 2001, MOL CELL, V7, P823, DOI 10.1016/S1097-2765(01)00226-X; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Le NH, 2005, J AM SOC NEPHROL, V16, P2724, DOI 10.1681/ASN.2004110913; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Meijer E, 2008, J NEPHROL, V21, P133; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NEAME SJ, 1992, EMBO J, V11, P4733, DOI 10.1002/j.1460-2075.1992.tb05578.x; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; Pollizzi K, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-38; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra Andreas L, 2007, BMC Nephrol, V8, P13, DOI 10.1186/1471-2369-8-13; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Sutters M, 2006, NEPHRON EXP NEPHROL, V103, pE149, DOI 10.1159/000093216; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Weston BS, 2003, FEBS LETT, V538, P8, DOI 10.1016/S0014-5793(03)00130-3; Wilson PD, 2007, ANNU REV PATHOL-MECH, V2, P341, DOI 10.1146/annurev.pathol.2.010506.091850; Wilson PD, 2008, CURR TOP DEV BIOL, V84, P311, DOI 10.1016/S0070-2153(08)00606-6; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, INT J BIOCHEM CELL B, V36, P1868, DOI 10.1016/j.biocel.2004.03.012; Wu M, 2007, KIDNEY BLOOD PRESS R, V30, P253, DOI 10.1159/000104818; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	56	74	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9239	10.1371/journal.pone.0009239	http://dx.doi.org/10.1371/journal.pone.0009239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169078	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590500020
J	Coppe, JP; Patil, CK; Rodier, F; Krtolica, A; Beausejour, CM; Parrinello, S; Hodgson, JG; Chin, KE; Desprez, PY; Campisi, J				Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Krtolica, Ana; Beausejour, Christian M.; Parrinello, Simona; Hodgson, J. Graeme; Chin, Koei; Desprez, Pierre-Yves; Campisi, Judith			A Human-Like Senescence-Associated Secretory Phenotype Is Conserved in Mouse Cells Dependent on Physiological Oxygen	PLOS ONE			English	Article							CELLULAR SENESCENCE; DNA-DAMAGE; GENE-EXPRESSION; REPLICATIVE SENESCENCE; TRIGGERS SENESCENCE; HUMAN FIBROBLASTS; GROWTH-FACTOR; IN-VIVO; CANCER; IMMORTALIZATION	Cellular senescence irreversibly arrests cell proliferation in response to oncogenic stimuli. Human cells develop a senescence-associated secretory phenotype (SASP), which increases the secretion of cytokines and other factors that alter the behavior of neighboring cells. We show here that "senescent'' mouse fibroblasts, which arrested growth after repeated passage under standard culture conditions (20% oxygen), do not express a human-like SASP, and differ from similarly cultured human cells in other respects. However, when cultured in physiological (3%) oxygen and induced to senesce by radiation, mouse cells more closely resemble human cells, including expression of a robust SASP. We describe two new aspects of the human and mouse SASPs. First, cells from both species upregulated the expression and secretion of several matrix metalloproteinases, which comprise a conserved genomic cluster. Second, for both species, the ability to promote the growth of premalignant epithelial cells was due primarily to the conserved SASP factor CXCL-1/KC/GRO-alpha. Further, mouse fibroblasts made senescent in 3%, but not 20%, oxygen promoted epithelial tumorigenesis in mouse xenographs. Our findings underscore critical mouse-human differences in oxygen sensitivity, identify conditions to use mouse cells to model human cellular senescence, and reveal novel conserved features of the SASP.	[Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Krtolica, Ana; Parrinello, Simona; Desprez, Pierre-Yves; Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Coppe, Jean-Philippe; Patil, Christopher K.; Rodier, Francis; Desprez, Pierre-Yves; Campisi, Judith] Buck Inst Age Res, Novato, CA USA; [Beausejour, Christian M.] Univ Montreal, CHU Ste Justine, Ctr Rech, Montreal, PQ, Canada; [Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Hodgson, J. Graeme; Chin, Koei] Univ Calif San Francisco, Dept Lab Med, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging; Universite de Montreal; Universite de Montreal; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; California Pacific Medical Center; California Pacific Medical Center Research Institute	Coppe, JP (corresponding author), Dynam Throughput Inc, Berkeley, CA USA.	jcampisi@buckinstitute.org		Rodier, Francis/0000-0003-2523-309X	National Institutes of Health [AG09909, AG017242, CA126540, AG000266, AG0025708]; Larry L. Hillblom Foundation; California Breast Cancer Research Program [8KB-0100]; US Department of Energy [DE-AC03-76SF00098]; NATIONAL CANCER INSTITUTE [U54CA126540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG009909, P01AG017242, R01AG009909, P30AG025708, R37AG009909, T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; California Breast Cancer Research Program; US Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (research grants AG09909, AG017242 and CA126540 to JC; training grant AG000266; center grant AG0025708), Larry L. Hillblom Foundation (to CKP), California Breast Cancer Research Program (8KB-0100 to AK) and the US Department of Energy under contract DE-AC03-76SF00098 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beliveau A, 2007, P NATL ACAD SCI USA, V104, P4431, DOI 10.1073/pnas.0700260104; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; HORNSBY PJ, 2003, SCI AGING KNOWLEDGE, pPE21; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Krtolica A, 2002, CYTOMETRY, V49, P73, DOI 10.1002/cyto.10149; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Martin JA, 2003, J BONE JOINT SURG AM, V85A, P106, DOI 10.2106/00004623-200300002-00014; Mason DX, 2004, ONCOGENE, V23, P9238, DOI 10.1038/sj.onc.1208172; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	54	280	289	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9188	10.1371/journal.pone.0009188	http://dx.doi.org/10.1371/journal.pone.0009188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169192	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474600009
J	Hecht, MM; Nitz, N; Araujo, PF; Sousa, AO; Rosa, AD; Gomes, DA; Leonardecz, E; Teixeira, ARL				Hecht, Mariana M.; Nitz, Nadjar; Araujo, Perla F.; Sousa, Alessandro O.; Rosa, Ana de Cassia; Gomes, Dawidson A.; Leonardecz, Eduardo; Teixeira, Antonio R. L.			Inheritance of DNA Transferred from American Trypanosomes to Human Hosts	PLOS ONE			English	Article							CHAGAS-DISEASE; GENE-EXPRESSION; CRUZI; EVOLUTION; AMPLIFICATION; GENOME; SEQUENCES; PCR; IDENTIFICATION; MINICIRCLES	Interspecies DNA transfer is a major biological process leading to the accumulation of mutations inherited by sexual reproduction among eukaryotes. Lateral DNA transfer events and their inheritance has been challenging to document. In this study we modified a thermal asymmetric interlaced PCR by using additional targeted primers, along with Southern blots, fluorescence techniques, and bioinformatics, to identify lateral DNA transfer events from parasite to host. Instances of naturally occurring human infections by Trypanosoma cruzi are documented, where mitochondrial minicircles integrated mainly into retrotransposable LINE-1 of various chromosomes. The founders of five families show minicircle integrations that were transferred vertically to their progeny. Microhomology end-joining of 6 to 22 AC-rich nucleotide repeats in the minicircles and host DNA mediates foreign DNA integration. Heterogeneous minicircle sequences were distributed randomly among families, with diversity increasing due to subsequent rearrangement of inserted fragments. Mosaic recombination and hitchhiking on retrotransposition events to different loci were more prevalent in germ line as compared to somatic cells. Potential new genes, pseudogenes, and knockouts were identified. A pathway of minicircle integration and maintenance in the host genome is suggested. Thus, infection by T. cruzi has the unexpected consequence of increasing human genetic diversity, and Chagas disease may be a fortuitous share of negative selection. This demonstration of contemporary transfer of eukaryotic DNA to the human genome and its subsequent inheritance by descendants introduces a significant change in the scientific concept of evolutionary biology and medicine.	[Hecht, Mariana M.; Nitz, Nadjar; Araujo, Perla F.; Sousa, Alessandro O.; Rosa, Ana de Cassia; Leonardecz, Eduardo; Teixeira, Antonio R. L.] Univ Brasilia, Fac Med, Chagas Dis Multidisciplinary Res Lab, Brasilia, DF, Brazil; [Gomes, Dawidson A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil	Universidade de Brasilia; Universidade Federal de Minas Gerais	Hecht, MM (corresponding author), Univ Brasilia, Fac Med, Chagas Dis Multidisciplinary Res Lab, Brasilia, DF, Brazil.	ateixeir@unb.br	de Araújo, Nadjar Nitz Silva Lociks/O-4052-2019; Sousa, Alessandro/F-2983-2012; Nitz, Nadjar/J-5794-2014; Gomes, Dawidson Assis/O-1372-2013; Leonardecz, Eduardo/E-9164-2012	de Araújo, Nadjar Nitz Silva Lociks/0000-0001-7820-0027; Nitz, Nadjar/0000-0001-7820-0027; Gomes, Dawidson Assis/0000-0001-7714-991X; Leonardecz, Eduardo/0000-0002-4654-5159	National Research Council for Scientific and Technological Development; CNPq/MCT; Financiadora de Estudos e Projetos; FINEP, Brazil	National Research Council for Scientific and Technological Development; CNPq/MCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); FINEP, Brazil(Financiadora de Inovacao e Pesquisa (Finep))	This work received financial support from the National Research Council for Scientific and Technological Development, CNPq/MCT, and by Financiadora de Estudos e Projetos, FINEP, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrews NW, 2002, J CELL BIOL, V158, P389, DOI 10.1083/jcb.200205110; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Bohne A, 2008, CHROMOSOME RES, V16, P203, DOI 10.1007/s10577-007-1202-6; Carter KL, 2000, MOL ECOL, V9, P2149, DOI 10.1046/j.1365-294X.2000.01114.x; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; CRANE MSJ, 1979, J PROTOZOOL, V26, P599, DOI 10.1111/j.1550-7408.1979.tb04203.x; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Fantaccione S, 2008, GENOMICS, V91, P178, DOI 10.1016/j.ygeno.2007.10.008; Fassot C, 2008, J HYPERTENS, V26, P747, DOI 10.1097/HJH.0b013e3282f4b3d0; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; Hazkani-Covo E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000237; Hines JC, 2008, NUCLEIC ACIDS RES, V36, P444, DOI 10.1093/nar/gkm1061; Januszyk K, 2007, J BIOL CHEM, V282, P24893, DOI 10.1074/jbc.M702023200; JONES DH, 1992, NUCLEIC ACIDS RES, V20, P595, DOI 10.1093/nar/20.3.595; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kirchhoff LV, 1996, J CLIN MICROBIOL, V34, P1171, DOI 10.1128/JCM.34.5.1171-1175.1996; Klein J, 2007, ANNU REV GENET, V41, P281, DOI 10.1146/annurev.genet.41.110306.130137; KRESS Y, 1975, NATURE, V257, P394, DOI 10.1038/257394a0; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Kynast RG, 2004, P NATL ACAD SCI USA, V101, P9921, DOI 10.1073/pnas.0403421101; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; Le Rouzic A, 2007, P NATL ACAD SCI USA, V104, P19375, DOI 10.1073/pnas.0705238104; Liu YN, 2007, MOL MICROBIOL, V64, P676, DOI 10.1111/j.1365-2958.2007.05686.x; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; LIU YG, 1998, GENOMICS, V25, P175; Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; MAZARS GR, 1991, NUCLEIC ACIDS RES, V19, P4783, DOI 10.1093/nar/19.17.4783; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; MOSER DR, 1989, J CLIN MICROBIOL, V27, P1477, DOI 10.1128/JCM.27.7.1477-1482.1989; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; Musova Z, 2006, BIOCHEM BIOPH RES CO, V347, P145, DOI 10.1016/j.bbrc.2006.06.071; Nonacs P, 2007, J EVOLUTION BIOL, V20, P2253, DOI 10.1111/j.1420-9101.2007.01418.x; O'Malley MA, 2005, STUD HIST PHI PART C, V36, P183, DOI 10.1016/j.shpsc.2004.12.002; OCHMAN H, 1988, GENETICS, V120, P621; Ogiwara I, 1999, MOL BIOL EVOL, V16, P1238, DOI 10.1093/oxfordjournals.molbev.a026214; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Rogers K, 2007, J BIOL CHEM, V282, P29073, DOI 10.1074/jbc.M704551200; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; Rudi K, 1999, BIOTECHNIQUES, V27, P1170, DOI 10.2144/99276st03; Sambrook J., 2001, MOL CLONING LAB MANU; Simoes-Barbosa A, 1999, MEM I OSWALDO CRUZ, V94, P249, DOI 10.1590/S0074-02761999000700041; Simoes-Barbosa A, 2006, MEM I OSWALDO CRUZ, V101, P833, DOI 10.1590/S0074-02762006000800003; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Song MZ, 2007, GENE, V390, P206, DOI 10.1016/j.gene.2006.09.033; Stanhope MJ, 2001, NATURE, V411, P940, DOI 10.1038/35082058; Sturm Nancy R., 2009, P63; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Teixeira ARL, 2006, POSTGRAD MED J, V82, P788, DOI 10.1136/pgmj.2006.047357; Teixeira A.R.L., 1991, Revista da Sociedade Brasileira de Medicina Tropical, V24, P55, DOI 10.1590/S0037-86821991000100010; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Teixeira Antonio R. L., 2009, P104; TEIXEIRA ARL, 1986, AM J PATHOL, V124, P363; TEIXEIRA ARL, 1983, AM J TROP MED HYG, V32, P258, DOI 10.4269/ajtmh.1983.32.258; TEIXEIRA ARL, 1990, AM J TROP MED HYG, V43, P146, DOI 10.4269/ajtmh.1990.43.146; Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115; TEIXEIRA ARL, 1994, MUTAT RES, V305, P197, DOI 10.1016/0027-5107(94)90240-2; Thomas S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-133; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Vanhamme L, 2008, CURR DRUG TARGETS, V9, P979, DOI 10.2174/138945008786786064; Virreira M, 2003, AM J TROP MED HYG, V68, P574, DOI 10.4269/ajtmh.2003.68.574; World Health Organization, 2002, 2 WHO, P1; Ziegler A, 2002, AM J REPROD IMMUNOL, V48, P34, DOI 10.1034/j.1600-0897.2002.01097.x	78	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9181	10.1371/journal.pone.0009181	http://dx.doi.org/10.1371/journal.pone.0009181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169193	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600004
J	Sawasdidoln, C; Taweechaisupapong, S; Sermswan, RW; Tattawasart, U; Tungpradabkul, S; Wongratanacheewin, S				Sawasdidoln, Chakrit; Taweechaisupapong, Suwimol; Sermswan, Rasana W.; Tattawasart, Unchalee; Tungpradabkul, Sumalee; Wongratanacheewin, Surasakdi			Growing Burkholderia pseudomallei in Biofilm Stimulating Conditions Significantly Induces Antimicrobial Resistance	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; PSEUDOMONAS-AERUGINOSA BIOFILMS; BETA-LACTAM ANTIBIOTICS; IN-VITRO; PERMEABILITY BARRIERS; POLYACRYLAMIDE GELS; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY; MELIOIDOSIS; VIRULENCE	Background: Burkholderia pseudomallei, a Gram-negative bacterium that causes melioidosis, was reported to produce biofilm. As the disease causes high relapse rate when compared to other bacterial infections, it therefore might be due to the reactivation of the biofilm forming bacteria which also provided resistance to antimicrobial agents. However, the mechanism on how biofilm can provide tolerance to antimicrobials is still unclear. Methodology/Principal Findings: The change in resistance of B. pseudomallei to doxycycline, ceftazidime, imipenem, and trimethoprim/sulfamethoxazole during biofilm formation were measured as minimum biofilm elimination concentration (MBEC) in 50 soil and clinical isolates and also in capsule, flagellin, LPS and biofilm mutants. Almost all planktonic isolates were susceptible to all agents studied. In contrast, when they were grown in the condition that induced biofilm formation, they were markedly resistant to all antimicrobial agents even though the amount of biofilm production was not the same. The capsule and O-side chains of LPS mutants had no effect on biofilm formation whereas the flagellin-defective mutant markedly reduced in biofilm production. No alteration of LPS profiles was observed when susceptible form was changed to resistance. The higher amount of N-acyl homoserine lactones (AHLs) was detected in the high biofilm-producing isolates. Interestingly, the biofilm mutant which produced a very low amount of biofilm and was sensitive to antimicrobial agents significantly resisted those agents when grown in biofilm inducing condition. Conclusions/Significance: The possible drug resistance mechanism of biofilm mutants and other isolates is not by having biofilm but rather from some factors that up-regulated when biofilm formation genes were stimulated. The understanding of genes related to this situation may lead us to prevent B. pseudomallei biofilms leading to the relapse of melioidosis.	[Sawasdidoln, Chakrit; Taweechaisupapong, Suwimol; Sermswan, Rasana W.; Tattawasart, Unchalee; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Sawasdidoln, Chakrit; Tattawasart, Unchalee; Wongratanacheewin, Surasakdi] Khon Kaen Univ, Dept Microbiol, Khon Kaen, Thailand; [Sermswan, Rasana W.] Khon Kaen Univ, Dept Biochem, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol] Khon Kaen Univ, Dept Oral Diag, Khon Kaen, Thailand; [Tungpradabkul, Sumalee] Mahidol Univ, Dept Biochem, Bangkok 10700, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University	Sawasdidoln, C (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.	sura_wng@kku.ac.th	Wongratanacheewin, Surasakdi/F-7324-2010; Taweechaisupapong, suwimol/F-6759-2010	Wongratanacheewin, Surasakdi/0000-0003-2921-2536; 	Commission on Higher Education (CHE)(CHE-RG), Thailand	Commission on Higher Education (CHE)(CHE-RG), Thailand(Office of Higher Education Commission (OHEC))	This study received financial supports from The Commission on Higher Education (CHE)(CHE-RG), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Bagge N, 2000, APMIS, V108, P589, DOI 10.1034/j.1600-0463.2000.d01-102.x; Banemann A, 1998, INFECT IMMUN, V66, P5607, DOI 10.1128/IAI.66.12.5607-5612.1998; Byers JT, 2002, J BACTERIOL, V184, P1163, DOI 10.1128/jb.184.4.1163-1171.2002; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DEBEER D, 1994, BIOTECHNOL BIOENG, V43, P1131, DOI 10.1002/bit.260431118; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Driffield K, 2008, J ANTIMICROB CHEMOTH, V61, P1053, DOI 10.1093/jac/dkn044; Farnaud S, 2004, FEMS MICROBIOL LETT, V233, P193, DOI 10.1016/j.femsle.2004.01.039; FLEMING MP, 1972, BMJ-BRIT MED J, V1, P726, DOI 10.1136/bmj.1.5802.726; Gilbert P, 1997, Adv Dent Res, V11, P160; GIWERCMAN B, 1991, ANTIMICROB AGENTS CH, V35, P1008, DOI 10.1128/AAC.35.5.1008; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Ishida H, 1998, ANTIMICROB AGENTS CH, V42, P1641, DOI 10.1128/AAC.42.7.1641; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM J, 1980, INFECT IMMUN, V28, P546; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; NIKAIDO H, 1985, PHARMACOL THERAPEUT, V27, P197, DOI 10.1016/0163-7258(85)90069-5; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Olson ME, 2002, CAN J VET RES, V66, P86; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; RUSSELL AD, 1986, J HOSP INFECT, V8, P47, DOI 10.1016/0195-6701(86)90104-0; Skurnik M, 1999, MOL MICROBIOL, V31, P1443, DOI 10.1046/j.1365-2958.1999.01285.x; Song Y, 2005, J BACTERIOL, V187, P785, DOI 10.1128/JB.187.2.785-790.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tanaka G, 1999, CHEMOTHERAPY, V45, P28, DOI 10.1159/000007162; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Tomlin KL, 2005, APPL ENVIRON MICROB, V71, P5208, DOI 10.1128/AEM.71.9.5208-5218.2005; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Ulrich RL, 2004, J MED MICROBIOL, V53, P1053, DOI 10.1099/jmm.0.45661-0; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Vorachit M, 1995, J TROP MED HYG, V98, P379; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445	45	63	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9196	10.1371/journal.pone.0009196	http://dx.doi.org/10.1371/journal.pone.0009196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169199	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474600016
J	Tang, ED; Wang, CY				Tang, Eric D.; Wang, Cun-Yu			TRAF5 Is a Downstream Target of MAVS in Antiviral Innate Immune Signaling	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRANDED-RNA; RIG-I; IKK-EPSILON; ACTIVATION; RESPONSES; ADAPTER; RECOGNITION; PROTEIN; IRF3	The recognition of nucleic acids by the innate immune system during viral infection results in the production of type I interferons and the activation of antiviral immune responses. The RNA helicases RIG-I and MDA-5 recognize distinct types of cytosolic RNA species and signal through the mitochondrial protein MAVS to stimulate the phosphorylation and activation of the transcription factors IRF3 and IRF7, thereby inducing type I interferon expression. Alternatively, the activation of NF-kappa B leads to proinflammatory cytokine production. The function of MAVS is dependent on both its C-terminal transmembrane (TM) domain and N-terminal caspase recruitment domain (CARD). The TM domain mediates MAVS dimerization in response to viral RNA, allowing the CARD to bind to and activate the downstream effector TRAF3. Notably, dimerization of the MAVS CARD alone is sufficient to activate IRF3, IRF7, and NF-kappa B. However, TRAF3-deficient cells display only a partial reduction in interferon production in response to RNA virus infection and are not defective in NF-kappa B activation. Here we find that the related ubiquitin ligase TRAF5 is a downstream target of MAVS that mediates both IRF3 and NF-kappa B activation. The TM domain of MAVS allows it to dimerize and thereby associate with TRAF5 and induce its ubiquitination in a CARD-dependent manner. Also, NEMO is recruited to the dimerized MAVS CARD domain in a TRAF3 and TRAF5-dependent manner. Thus, our findings reveal a possible function for TRAF5 in mediating the activation of IRF3 and NF-kappa B downstream of MAVS through the recruitment of NEMO. TRAF5 may be a key molecule in the innate response against viral infection.	[Tang, Eric D.; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Mol Signalling Lab, Div Oral Biol & Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Tang, ED (corresponding author), Univ Calif Los Angeles, Sch Dent, Mol Signalling Lab, Div Oral Biol & Med, Los Angeles, CA 90024 USA.	cwang@dentistry.ucla.edu			National Institutes of Health [DE13848, DE15964]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE015964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE13848 and DE15964 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui XF, 2004, BIOCHEM CELL BIOL, V82, P401, DOI 10.1139/O04-041; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; MacCorkle RA, 1998, P NATL ACAD SCI USA, V95, P3655, DOI 10.1073/pnas.95.7.3655; Nakano H, 1996, J BIOL CHEM, V271, P14661, DOI 10.1074/jbc.271.25.14661; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tang ED, 2003, J BIOL CHEM, V278, P38566, DOI 10.1074/jbc.M304374200; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	41	62	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9172	10.1371/journal.pone.0009172	http://dx.doi.org/10.1371/journal.pone.0009172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161788	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800018
J	Tao, YG; Xi, SC; Briones, V; Muegge, K				Tao, Yongguang; Xi, Sichuan; Briones, Victorino; Muegge, Kathrin			Lsh Mediated RNA Polymerase II Stalling at HoxC6 and HoxC8 Involves DNA Methylation	PLOS ONE			English	Article							DE-NOVO METHYLATION; TRANSCRIPTIONAL ELONGATION; CHROMATIN-STRUCTURE; HUMAN GENOME; CPG ISLAND; GENE; CELLS; NUCLEOSOMES; EXPRESSION; PROMOTERS	DNA cytosine methylation is an important epigenetic mechanism that is involved in transcriptional silencing of developmental genes. Several molecular pathways have been described that interfere with Pol II initiation, but at individual genes the molecular mechanism of repression remains uncertain. Here, we study the molecular mechanism of transcriptional regulation at Hox genes in dependence of the epigenetic regulator Lsh that controls CpG methylation at selected Hox genes. Wild type cells show a nucleosomal deprived region around the transcriptional start site at methylated Hox genes and mediate gene silencing via Pol II stalling. Hypomethylation in Lsh-/- cells is associated with efficient transcriptional elongation and splicing, in part mediated by the chromodomain protein Chd1. Dynamic modulation of DNA methylation in Lsh-/- and wild type cells demonstrates that catalytically active DNA methyltransferase activity is required for Pol II stalling. Taken together, the data suggests that DNA methylation can be compatible with Pol II binding at selected genes and Pol II stalling can act as alternate mechanism to explain transcriptional silencing associated with DNA methylation.	[Tao, Yongguang; Xi, Sichuan; Briones, Victorino; Muegge, Kathrin] NCI, Lab Canc Prevent, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Tao, YG (corresponding author), NCI, Lab Canc Prevent, SAIC Frederick, Frederick, MD 21701 USA.	muegge@ncifcrf.gov			National Cancer Institute; National Institutes of Health [HHSN261200800001E]; Intramural Research Program of NIH; National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010014] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported by the Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Fan T, 2005, DEVELOPMENT, V132, P635, DOI 10.1242/dev.01612; Fan T, 2003, CANCER RES, V63, P4677; Fan T, 2008, EPIGENETICS-US, V3, P134, DOI 10.4161/epi.3.3.6252; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hsieh CL, 1999, MOL CELL BIOL, V19, P8211; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Juan AH, 2006, ANN NY ACAD SCI, V1068, P87, DOI 10.1196/annals.1346.046; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Strathdee G, 2007, CARCINOGENESIS, V28, P299, DOI 10.1093/carcin/bgl133; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wu XD, 2008, NUCLEIC ACIDS RES, V36, P3590, DOI 10.1093/nar/gkn243; XI S, 2009, STEM CELLS; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Yan QS, 2003, MOL CELL BIOL, V23, P8416, DOI 10.1128/MCB.23.23.8416-8428.2003; Yan QS, 2003, EMBO J, V22, P5154, DOI 10.1093/emboj/cdg493; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhu HM, 2006, EMBO J, V25, P335, DOI 10.1038/sj.emboj.7600925	60	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9163	10.1371/journal.pone.0009163	http://dx.doi.org/10.1371/journal.pone.0009163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161795	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442800009
J	Beck, L; Leroy, C; Beck-Cormier, S; Forand, A; Salaun, C; Paris, N; Bernier, A; Urena-Torres, P; Prie, D; Ollero, M; Coulombel, L; Friedlander, G				Beck, Laurent; Leroy, Christine; Beck-Cormier, Sarah; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Coulombel, Laure; Friedlander, Gerard			The Phosphate Transporter PiT1 (Slc20a1) Revealed As a New Essential Gene for Mouse Liver Development	PLOS ONE			English	Article							APE LEUKEMIA-VIRUS; EMBRYONIC LETHALITY; RETROVIRUS RECEPTOR; CELLULAR RECEPTOR; MESSENGER-RNA; MICE LACKING; FETAL LIVER; EXPRESSION; COTRANSPORTER; GROWTH	Background: PiT1 (or SLC20a1) encodes a widely expressed plasma membrane protein functioning as a high-affinity Na+-phosphate (Pi) cotransporter. As such, PiT1 is often considered as a ubiquitous supplier of Pi for cellular needs regardless of the lack of experimental data. Although the importance of PiT1 in mineralizing processes have been demonstrated in vitro in osteoblasts, chondrocytes and vascular smooth muscle cells, in vivo evidence is missing. Methodology/Principal Findings: To determine the in vivo function of PiT1, we generated an allelic series of PiT1 mutations in mice by combination of wild-type, hypomorphic and null PiT1 alleles expressing from 100% to 0% of PiT1. In this report we show that complete deletion of PiT1 results in embryonic lethality at E12.5. PiT1-deficient embryos display severely hypoplastic fetal livers and subsequent reduced hematopoiesis resulting in embryonic death from anemia. We show that the anemia is not due to placental, yolk sac or vascular defects and that hematopoietic progenitors have no cell-autonomous defects in proliferation and differentiation. In contrast, mutant fetal livers display decreased proliferation and massive apoptosis. Animals carrying two copies of hypomorphic PiT1 alleles (resulting in 15% PiT1 expression comparing to wild-type animals) survive at birth but are growth-retarded and anemic. The combination of both hypomorphic and null alleles in heterozygous compounds results in late embryonic lethality (E14.5-E16.5) with phenotypic features intermediate between null and hypomorphic mice. In the three mouse lines generated we could not evidence defects in early skeleton formation. Conclusion/Significance: This work is the first to illustrate a specific in vivo role for PiT1 by uncovering it as being a critical gene for normal developmental liver growth.	[Beck, Laurent; Leroy, Christine; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Friedlander, Gerard] INSERM, U845, Ctr Rech Croissance & Signalisat, Paris, France; [Beck, Laurent; Leroy, Christine; Forand, Anne; Salauen, Christine; Paris, Nadine; Bernier, Adeline; Urena-Torres, Pablo; Prie, Dominique; Ollero, Mario; Friedlander, Gerard] Univ Paris 05, Fac Med, Paris, France; [Beck-Cormier, Sarah] Inst Pasteur, Unite Genet Fonct Souris, Paris, France; [Beck-Cormier, Sarah] CNRS, URA2578, Unite Genet Fonct Souris, Paris, France; [Coulombel, Laure] INSERM, U935, Villejuif, France; [Coulombel, Laure] Hop Paul Brousse, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Beck, L (corresponding author), INSERM, U845, Ctr Rech Croissance & Signalisat, Paris, France.	laurent.beck@inserm.fr	Beck-Cormier, Sarah/P-3091-2014; Ollero, Mario/AAJ-3545-2020; BECK, Laurent/P-2952-2014; Ollero, Mario/Q-6147-2018	Beck-Cormier, Sarah/0000-0001-5258-1933; BECK, Laurent/0000-0002-6730-2762; Salaun, Christine/0000-0003-3002-6810; Forand, Anne/0000-0003-4970-2372; Friedlander, Gerard/0000-0002-6854-4261; Ollero, Mario/0000-0003-3590-706X; Bernier, Adeline/0000-0003-3023-429X	INSERM; CNRS; Institut Pasteur; Paris Descartes University; Association Laboratoire de Recherches Physiologiques; ANR (Agence Nationale pour la Recherche)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Paris Descartes University; Association Laboratoire de Recherches Physiologiques; ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR))	This study was supported by grants from INSERM, CNRS, Institut Pasteur, Paris Descartes University, Association Laboratoire de Recherches Physiologiques and ANR (Agence Nationale pour la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2000, J BIOL CHEM, V275, P11880, DOI 10.1074/jbc.275.16.11880; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Breitwieser W, 2007, GENE DEV, V21, P2069, DOI 10.1101/gad.430207; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Festing MH, 2009, GENESIS, V47, P858, DOI 10.1002/dvg.20577; Frei P, 2005, AM J PHYSIOL-GASTR L, V288, pG771, DOI 10.1152/ajpgi.00272.2004; Ganiatsas S, 1998, P NATL ACAD SCI USA, V95, P6881, DOI 10.1073/pnas.95.12.6881; Giachelli CM, 2009, KIDNEY INT, V75, P890, DOI 10.1038/ki.2008.644; GOHEEN SC, 1982, LIPIDS, V17, P594, DOI 10.1007/BF02535364; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Isern J, 2008, P NATL ACAD SCI USA, V105, P6662, DOI 10.1073/pnas.0802032105; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Nielsen LB, 2001, BONE, V28, P160, DOI 10.1016/S8756-3282(00)00418-X; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Ollero M, 2006, METABOLISM, V55, P1192, DOI 10.1016/j.metabol.2006.05.002; Palmer G, 2000, ENDOCRINOLOGY, V141, P2236, DOI 10.1210/en.141.6.2236; Palmer G, 1997, ENDOCRINOLOGY, V138, P5202, DOI 10.1210/en.138.12.5202; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Suzuki A, 2001, BONE, V28, P589, DOI 10.1016/S8756-3282(01)00459-8; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Villa-Bellosta R, 2007, ARTERIOSCL THROM VAS, V27, P1030, DOI 10.1161/ATVBAHA.106.132266; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Vincent F, 2009, CANCER RES, V69, P2853, DOI 10.1158/0008-5472.CAN-08-2484; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; Wang DS, 2001, J BIOL CHEM, V276, P33995, DOI 10.1074/jbc.M007757200; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	52	79	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9148	10.1371/journal.pone.0009148	http://dx.doi.org/10.1371/journal.pone.0009148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161774	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442700012
J	Becquart, P; Wauquier, N; Mahlakoiv, T; Nkoghe, D; Padilla, C; Souris, M; Ollomo, B; Gonzalez, JP; De Lamballerie, X; Kazanji, M; Leroy, EM				Becquart, Pierre; Wauquier, Nadia; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Padilla, Cindy; Souris, Marc; Ollomo, Benjamin; Gonzalez, Jean-Paul; De Lamballerie, Xavier; Kazanji, Mirdad; Leroy, Eric M.			High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; ANTIBODY PREVALENCE; NONHUMAN-PRIMATES; VIRUS-INFECTION; IGG ANTIBODIES; MEMORY; RESPONSES; PROTECTION; SMALLPOX; OUTBREAK	To better understand Zaire ebolavirus (ZEBOV) circulation and transmission to humans, we conducted a large serological survey of rural populations in Gabon, a country characterized by both epidemic and non epidemic regions. The survey lasted three years and covered 4,349 individuals from 220 randomly selected villages, representing 10.7% of all villages in Gabon. Using a sensitive and specific ELISA method, we found a ZEBOV-specific IgG seroprevalence of 15.3% overall, the highest ever reported. The seroprevalence rate was significantly higher in forested areas (19.4%) than in other ecosystems, namely grassland (12.4%), savannah (10.5%), and lakeland (2.7%). No other risk factors for seropositivity were found. The specificity of anti-ZEBOV IgG was confirmed by Western blot in 138 individuals, and CD8 T cells from seven IgG+ individuals were shown to produce IFN-gamma after ZEBOV stimulation. Together, these findings show that a large fraction of the human population living in forested areas of Gabon has both humoral and cellular immunity to ZEBOV. In the absence of identified risk factors, the high prevalence of "immune'' persons suggests a common source of human exposure such as fruits contaminated by bat saliva. These findings provide significant new insights into ZEBOV circulation and human exposure, and raise important questions as to the human pathogenicity of ZEBOV and the existence of natural protective immunization.	[Becquart, Pierre; Wauquier, Nadia; Mahlakoiv, Tanel; Nkoghe, Dieudonne; Padilla, Cindy; Ollomo, Benjamin; Gonzalez, Jean-Paul; Kazanji, Mirdad; Leroy, Eric M.] Ctr Int Rech Med Franceville, Unite Malad Virales Emergentes, Franceville, Gabon; [Becquart, Pierre; Souris, Marc; De Lamballerie, Xavier; Leroy, Eric M.] Univ Aix Marseille 2, Emergence Pathol Virales UMR190, Marseille, France; [Becquart, Pierre; Souris, Marc; De Lamballerie, Xavier; Leroy, Eric M.] Inst Rech Dev, Marseille, France; [Souris, Marc] Mahidol Univ Salaya, Nakhonpathon, Thailand	UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Mahidol University	Becquart, P (corresponding author), Ctr Int Rech Med Franceville, Unite Malad Virales Emergentes, BP 769, Franceville, Gabon.	eric.leroy@ird.fr	Gonzalez, J-P/C-3077-2013; Becquart, Pierre/GLT-0845-2022; LEROY, Eric M/I-4347-2016; SOURIS, Marc/K-2506-2016	Gonzalez, J-P/0000-0003-3063-1770; LEROY, Eric M/0000-0003-0022-0890; SOURIS, Marc/0000-0002-2933-3488; Mahlakoiv, Tanel/0000-0001-9059-0486; Wauquier, Nadia/0000-0002-2874-7574; Becquart, Pierre/0000-0002-0980-1678	Agence Nationale pour la Recherche [ANR-06-MIME-022-01]; Ministere des Affaires Etrangeres de la France [2002005700]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere des Affaires Etrangeres de la France	This work was funded by a grant from Agence Nationale pour la Recherche (# ANR-06-MIME-022-01) and a Fonds de Solidarite Prioritaire grant from the Ministere des Affaires Etrangeres de la France (# 2002005700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; [Anonymous], 2005, SURVEYOFCLUSTERINGAL, V16, DOI [DOI 10.1086/503836, 10.1109/TNN.2005, DOI 10.1109/TNN.2005]; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; BOUREE P, 1983, AM J TROP MED HYG, V32, P1465, DOI 10.4269/ajtmh.1983.32.1465; Brehm MA, 2004, CELL MICROBIOL, V6, P411, DOI 10.1111/j.1462-5822.2004.00390.x; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Busico KM, 1999, J INFECT DIS, V179, pS102, DOI 10.1086/514309; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P73; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Combadiere B, 2004, J EXP MED, V199, P1585, DOI 10.1084/jem.20032083; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Feldmann H, 2007, FIELDS VIROLOGY, P1409; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2; GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8; Gourley TS, 2004, SEMIN IMMUNOL, V16, P323, DOI 10.1016/j.smim.2004.08.013; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heffernan RT, 2005, J INFECT DIS, V191, P964, DOI 10.1086/427994; IVANOFF B, 1982, T ROY SOC TROP MED H, V76, P719, DOI 10.1016/0035-9203(82)90089-X; JAHRLING PB, 1990, LANCET, V335, P502, DOI 10.1016/0140-6736(90)90737-P; JOHNSON BK, 1986, LANCET, V1, P1160; JOHNSON ED, 1993, T ROY SOC TROP MED H, V87, P536, DOI 10.1016/0035-9203(93)90077-4; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; KINGDOM J, 1984, E AFRICAN MAMMALS; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; LED J, 2004, GRANDS ENSEMBLES VEG; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MOE JB, 1981, J CLIN MICROBIOL, V13, P791, DOI 10.1128/JCM.13.4.791-793.1981; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Wilson JA, 2001, J VIROL, V75, P2660, DOI 10.1128/JVI.75.6.2660-2664.2001; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; [No title captured]	58	107	112	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9126	10.1371/journal.pone.0009126	http://dx.doi.org/10.1371/journal.pone.0009126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161740	gold, Green Published			2022-12-27	WOS:000274442600024
J	Bentley, P; Peck, G; Smeeth, L; Whittaker, J; Sharma, P				Bentley, Paul; Peck, George; Smeeth, Liam; Whittaker, John; Sharma, Pankaj			Causal Relationship of Susceptibility Genes to Ischemic Stroke: Comparison to Ischemic Heart Disease and Biochemical Determinants	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; RISK; METAANALYSIS; POLYMORPHISM; ASSOCIATION; PLASMA	Interrelationships between genetic and biochemical factors underlying ischemic stroke and ischemic heart disease are poorly understood. We: 1) undertook the most comprehensive meta-analysis of genetic polymorphisms in ischemic stroke to date; 2) compared genetic determinants of ischemic stroke with those of ischemic heart disease, and 3) compared effect sizes of gene-stroke associations with those predicted from independent biochemical data using a mendelian randomization strategy. Electronic databases were searched up to January 2009. We identified: 1) 187 ischemic stroke studies (37,481 cases; 95,322 controls) interrogating 43 polymorphisms in 29 genes; 2) 13 meta-analyses testing equivalent polymorphisms in ischemic heart disease; and 3) for the top five gene-stroke associations, 146 studies (65,703 subjects) describing equivalent gene-biochemical relationships, and 28 studies (46,928 subjects) describing biochemical-stroke relationships. Meta-analyses demonstrated positive associations with ischemic stroke for factor V Leiden Gln506, ACE I/D, MTHFR C677T, prothrombin G20210A, PAI-1 5G allele and glycoprotein IIIa Leu33Pro polymorphisms (ORs: 1.11-1.60). Most genetic associations show congruent levels of risk comparing ischemic stroke with ischemic heart disease, but three genes-glycoprotein IIIa, PAI-1 and angiotensinogen-show significant dissociations. The magnitudes of stroke risk observed for factor V Leiden, ACE, MTHFR and prothrombin, but not PAI-1, polymorphisms, are consistent with risks associated with equivalent changes in activated protein C resistance, ACE activity, homocysteine, prothrombin, and PAI-1 levels, respectively. Our results demonstrate causal relationships for four of the most robust genes associated with stroke while also showing that PAI-1 4G/5G polymorphism influences cardiovascular risk via a mechanism not simply related to plasma levels of PAI-1 (or tPA) alone.	[Bentley, Paul; Peck, George; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Imperial Coll Cerebrovasc Res Unit, London, England; [Smeeth, Liam; Whittaker, John] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Bentley, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Imperial Coll Cerebrovasc Res Unit, London, England.	p.bentley@imperial.ac.uk	Whittaker, John C/B-8609-2012; sharma, pankaj/HGE-4423-2022; Smeeth, Liam/X-5862-2018	Whittaker, John C/0000-0002-3529-2379; Bentley, Paul/0000-0001-8036-7010; Smeeth, Liam/0000-0002-9168-6022	Dept. of Health (UK); Wellcome Trust	Dept. of Health (UK); Wellcome Trust(Wellcome TrustEuropean Commission)	PB & PS are supported by Senior Clinical Fellowships from Dept. of Health (UK). LS is supported by a Senior Clinical Fellowship from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; Arason GJ, 2007, CLIN EXP IMMUNOL, V149, P132, DOI 10.1111/j.1365-2249.2007.03391.x; Ariyaratnam R, 2007, PLOS MED, V4, P728, DOI 10.1371/journal.pmed.0040131; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Attia John, 2007, J Stroke Cerebrovasc Dis, V16, P173, DOI 10.1016/j.jstrokecerebrovasdis.2007.03.002; Brenner D, 2005, ANN NEUROL, V58, P131, DOI 10.1002/ana.20537; Casas JP, 2004, CIRCULATION, V109, P1359, DOI 10.1161/01.CIR.0000121357.76910.A3; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellervik C, 2007, HEPATOLOGY, V46, P1071, DOI 10.1002/hep.21885; Fisher M, 2008, AM J THER, V15, P137, DOI 10.1097/MJT.0b013e31816a61bb; HAMSTEN A, 1987, LANCET, V2, P3; Henry M, 1998, ARTERIOSCL THROM VAS, V18, P84, DOI 10.1161/01.ATV.18.1.84; Hoekstra T, 2003, STROKE, V34, P2822, DOI 10.1161/01.STR.0000098004.26252.EB; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Jood K, 2005, STROKE, V36, P2077, DOI 10.1161/01.STR.0000183617.54752.69; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; Karvanen J, 2009, GENET EPIDEMIOL, V33, P237, DOI 10.1002/gepi.20374; Kingwell B, 2007, CLIN EXP PHARMACOL P, V34, P652, DOI 10.1111/j.1440-1681.2007.04655.x; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Matarin M, 2007, LANCET NEUROL, V6, P414, DOI 10.1016/S1474-4422(07)70081-9; Ntzani EE, 2007, AM J EPIDEMIOL, V165, P973, DOI 10.1093/aje/kwk085; Peck G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003691; Rao R, 2009, EUR NEUROL, V61, P76, DOI 10.1159/000177939; Sie MPS, 2006, ARTERIOSCL THROM VAS, V26, P212, DOI 10.1161/01.ATV.0000194099.65024.17; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tsantes AE, 2007, BLOOD COAGUL FIBRIN, V18, P497, DOI 10.1097/MBC.0b013e3281ec4eee; Voko Z, 2007, THROMB HAEMOSTASIS, V97, P458, DOI 10.1160/TH06-11-0676; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; Xu MQ, 2007, CIRCULATION, V116, P1356, DOI 10.1161/CIRCULATIONAHA.107.728857; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Ye Z, 2006, LANCET, V367, P651, DOI 10.1016/S0140-6736(06)68263-9; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	43	62	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9136	10.1371/journal.pone.0009136	http://dx.doi.org/10.1371/journal.pone.0009136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161734	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442600032
J	Collombet, JM; Elias, M; Gotthard, G; Four, E; Renault, F; Joffre, A; Baubichon, D; Rochu, D; Chabriere, E				Collombet, Jean-Marc; Elias, Mikael; Gotthard, Guillaume; Four, Elise; Renault, Frederique; Joffre, Aurelie; Baubichon, Dominique; Rochu, Daniel; Chabriere, Eric			Eukaryotic DING Proteins Are Endogenous: An Immunohistological Study in Mouse Tissues	PLOS ONE			English	Article							ST-JOHNS-WORT; HUMAN PARAOXONASE; HIV-1 EXPRESSION; T-CELLS; SEQUENCE; P27(SJ); CRYSTALLIZATION; DISCOVERY; MICE; HPBP	Background: DING proteins encompass an intriguing protein family first characterized by their conserved N-terminal sequences. Some of these proteins seem to have key roles in various human diseases, e. g., rheumatoid arthritis, atherosclerosis, HIV suppression. Although this protein family seems to be ubiquitous in eukaryotes, their genes are consistently lacking from genomic databases. Such a lack has considerably hampered functional studies and has fostered therefore the hypothesis that DING proteins isolated from eukaryotes were in fact prokaryotic contaminants. Principal Findings: In the framework of our study, we have performed a comprehensive immunological detection of DING proteins in mice. We demonstrate that DING proteins are present in all tissues tested as isoforms of various molecular weights (MWs). Their intracellular localization is tissue-dependant, being exclusively nuclear in neurons, but cytoplasmic and nuclear in other tissues. We also provide evidence that germ-free mouse plasma contains as much DING protein as wildtype. Significance: Hence, data herein provide a valuable basis for future investigations aimed at eukaryotic DING proteins, revealing that these proteins seem ubiquitous in mouse tissue. Our results strongly suggest that mouse DING proteins are endogenous. Moreover, the determination in this study of the precise cellular localization of DING proteins constitute a precious evidence to understand their molecular involvements in their related human diseases.	[Collombet, Jean-Marc; Four, Elise; Renault, Frederique; Baubichon, Dominique; Rochu, Daniel] Ctr Rech, Serv Sante Armees, Dept Toxicol, Inst Rech Biomed Armees, La Tronche, France; [Elias, Mikael; Gotthard, Guillaume; Chabriere, Eric] Aix Marseille Univ, CNRS, Marseille, France; [Joffre, Aurelie] Ctr Rech, Serv Sante Armees, Serv Microscopie & Imagerie Med, Inst Rech Biomed Armees, La Tronche, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Collombet, JM (corresponding author), Ctr Rech, Serv Sante Armees, Dept Toxicol, Inst Rech Biomed Armees, La Tronche, France.	eric.chabriere@afmb.univ-mrs.fr	Elias, Mikael/C-8484-2011; Elias, Mikael/AAH-9385-2021	Elias, Mikael/0000-0003-0406-7539; Elias, Mikael/0000-0003-0406-7539	Delegation Generale pour l'Armement [010807/03-10]; C.N.R.S.D.R.; German Bundesministerium der Verteidigung [M/SABX/8A001]; F.E.B.S.	Delegation Generale pour l'Armement; C.N.R.S.D.R.; German Bundesministerium der Verteidigung; F.E.B.S.	Funding: This research was supported by grants to E.C. by Delegation Generale pour l'Armement (CO n degrees 010807/03-10) and by the C.N.R.S.D.R. is under contract with the German Bundesministerium der Verteidigung (M/SABX/8A001). M. E. is a post-doctoral fellow supported by the F.E.B.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 2002, BBA-MOL BASIS DIS, V1586, P254, DOI 10.1016/S0925-4439(01)00104-1; Ahn S, 2007, FEBS LETT, V581, P3455, DOI 10.1016/j.febslet.2007.06.050; Belenky M, 2003, J NUTR, V133, p2497S, DOI 10.1093/jn/133.7.2497S; Berna A, 2002, FEBS LETT, V524, P6, DOI 10.1016/S0014-5793(02)03053-3; BERNA A, 2009, CELL MOL LIFE SCI; Berna A, 2008, INT J BIOCHEM CELL B, V40, P170, DOI 10.1016/j.biocel.2007.02.004; Berna A, 2009, BIOESSAYS, V31, P570, DOI 10.1002/bies.200800174; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Collombet JM, 2005, TOXICOLOGY, V208, P319, DOI 10.1016/j.tox.2004.11.036; Contreras-Martel C, 2006, ACTA CRYSTALLOGR F, V62, P67, DOI 10.1107/S1744309105041461; Darbinian N, 2008, ANTIVIR RES, V79, P136, DOI 10.1016/j.antiviral.2007.11.006; Darbinian N, 2009, J CELL BIOCHEM, V107, P400, DOI 10.1002/jcb.22135; Darbinian-Sarkissian N, 2006, GENE THER, V13, P288, DOI 10.1038/sj.gt.3302649; Diemer H, 2008, PROTEINS, V71, P1708, DOI 10.1002/prot.21866; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fokine A, 2003, ACTA CRYSTALLOGR D, V59, P2083, DOI 10.1107/S0907444903017682; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; HAIN N, 1990, RHEUMATOL INT, V10, P203, DOI 10.1007/BF02274834; Hain NAK, 1996, J IMMUNOL, V157, P1773; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kumar V, 2004, AM J PHYSIOL-RENAL, V287, pF373, DOI 10.1152/ajprenal.00418.2003; Lesner A, 2005, J IMMUNOL, V175, P2548, DOI 10.4049/jimmunol.175.4.2548; LESNER A, 2009, BIOCH BIOPHYS RES CO; Lewis AP, 2005, FEMS MICROBIOL LETT, V252, P215, DOI 10.1016/j.femsle.2005.08.047; Liebschner D, 2009, J AM CHEM SOC, V131, P7879, DOI 10.1021/ja901900y; Lillie R. D., 1976, HISTOPATHOLOGIC TECH, P208; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Moniot S, 2007, ACTA CRYSTALLOGR F, V63, P590, DOI 10.1107/S1744309107028102; Morales R., 2007, ANNALES PHARMACEUTIQUES FRANCAISES, V65, P98, DOI 10.1016/S0003-4509(07)90023-1; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; Mukerjee R, 2008, MOL IMMUNOL, V45, P4028, DOI 10.1016/j.molimm.2008.06.001; PANTAZAKI AA, 2007, DING PHOSPHATASE THE; Perera T, 2008, PHYTOCHEMISTRY, V69, P865, DOI 10.1016/j.phytochem.2007.10.001; Renault F, 2006, J CHROMATOGR B, V836, P15, DOI 10.1016/j.jchromb.2006.03.029; Riah O, 2000, CELL MOL NEUROBIOL, V20, P653, DOI 10.1023/A:1007094623775; Rochu D, 2007, BIOCHEM SOC T, V35, P1616, DOI 10.1042/BST0351616; ROCHU D, 2008, STABILISATION ACTIVE, P171; ROCHU D, 2007, TOXICOLOGY, V142; Scott K, 2005, BBA-MOL CELL RES, V1744, P234, DOI 10.1016/j.bbamcr.2005.02.003; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; STREIT WJ, 1990, J HISTOCHEM CYTOCHEM, V38, P1683, DOI 10.1177/38.11.2212623	41	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9099	10.1371/journal.pone.0009099	http://dx.doi.org/10.1371/journal.pone.0009099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161715	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442500008
J	Lin, E; Kiniboro, B; Gray, L; Dobbie, S; Robinson, L; Laumaea, A; Schopflin, S; Stanisic, D; Betuela, I; Blood-Zikursh, M; Siba, P; Felger, I; Schofield, L; Zimmerman, P; Mueller, I				Lin, Enmoore; Kiniboro, Benson; Gray, Laurie; Dobbie, Stuart; Robinson, Leanne; Laumaea, Annemarie; Schoepflin, Sonja; Stanisic, Danielle; Betuela, Inoni; Blood-Zikursh, Melinda; Siba, Peter; Felger, Ingrid; Schofield, Louis; Zimmerman, Peter; Mueller, Ivo			Differential Patterns of Infection and Disease with P. falciparum and P. vivax in Young Papua New Guinean Children	PLOS ONE			English	Article							DUFFY-BINDING-PROTEIN; EAST SEPIK PROVINCE; PLASMODIUM-VIVAX; RETROSPECTIVE EXAMINATION; ANTIGENIC VARIATION; ACQUIRED-IMMUNITY; MALARIA PARASITES; CLINICAL IMMUNITY; KAREN POPULATION; SURFACE-ANTIGENS	Background: Where P. vivax and P. falciparum occur in the same population, the peak burden of P. vivax infection and illness is often concentrated in younger age groups. Experiences from malaria therapy patients indicate that immunity is acquired faster to P. vivax than to P. falciparum challenge. There is however little prospective data on the comparative risk of infection and disease from both species in young children living in co-endemic areas. Methodology/Principal Findings: A cohort of 264 Papua New Guinean children aged 1-3 years (at enrolment) were actively followed-up for Plasmodium infection and febrile illness for 16 months. Infection status was determined by light microscopy and PCR every 8 weeks and at each febrile episode. A generalised estimating equation (GEE) approach was used to analyse both prevalence of infection and incidence of clinical episodes. A more pronounced rise in prevalence of P. falciparum compared to P. vivax infection was evident with increasing age. Although the overall incidence of clinical episodes was comparable (P. falciparum: 2.56, P. vivax 2.46 episodes / child / yr), P. falciparum and P. vivax infectious episodes showed strong but opposing age trends: P. falciparum incidence increased until the age of 30 months with little change thereafter, but incidence of P. vivax decreased significantly with age throughout the entire age range. For P. falciparum, both prevalence and incidence of P. falciparum showed marked seasonality, whereas only P. vivax incidence but not prevalence decreased in the dry season. Conclusions/Significance: Under high, perennial exposure, children in PNG begin acquiring significant clinical immunity, characterized by an increasing ability to control parasite densities below the pyrogenic threshold to P. vivax, but not to P. falciparum, in the 2(nd) and 3(rd) year of life. The ability to relapse from long-lasting liver-stages restricts the seasonal variation in prevalence of P. vivax infections.	[Lin, Enmoore; Kiniboro, Benson; Dobbie, Stuart; Laumaea, Annemarie; Stanisic, Danielle; Betuela, Inoni; Siba, Peter; Mueller, Ivo] PNG Inst Med Res, Madang, Papua N Guinea; [Gray, Laurie; Blood-Zikursh, Melinda; Zimmerman, Peter] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Robinson, Leanne; Stanisic, Danielle; Schofield, Louis] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Robinson, Leanne] Univ Melbourne, Dept Med Biol, Melbourne, Australia; [Schoepflin, Sonja; Felger, Ingrid] Swiss Trop Inst, CH-4002 Basel, Switzerland	PNG Institute Of Medical Research; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne; University of Basel; Swiss Tropical & Public Health Institute	Lin, E (corresponding author), PNG Inst Med Res, Madang, Papua N Guinea.	ivomueller@fastmail.fm	Mueller, Ivo/C-7251-2013; Laumaea, Annemarie/AGC-1405-2022	Mueller, Ivo/0000-0001-6554-6889; Stanisic, Danielle/0000-0003-3908-7468; Lin, Enmoore/0000-0002-8584-7627; Laumaea, Annemarie/0000-0002-4934-597X; Felger, Ingrid/0000-0003-1255-2606; Zimmerman, Peter/0000-0002-5349-4513	National Institutes of Health [AI063135, AI-46919, TW007872]; Swiss National Science Foundation [31003A-112196]; Australian Agency for International Development (AusAID); National Health and Medical Research Council [516735]; FOGARTY INTERNATIONAL CENTER [R01TW007872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI063135, R01AI046919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funding from National Institutes of Health (AI063135, AI-46919, and TW007872), the Swiss National Science Foundation (grant no. 31003A-112196), the Australian Agency for International Development (AusAID) and the National Health and Medical Research Council (Grant no. 516735). LS is an International Research Scholar of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Arevalo-Herrera M, 2001, MOL IMMUNOL, V38, P443, DOI 10.1016/S0161-5890(01)00080-3; BALFOUR M. C., 1935, American Journal of Tropical Medicine, V15, P301; Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y; Bockarie MJ, 1996, T ROY SOC TROP MED H, V90, P23, DOI 10.1016/S0035-9203(96)90465-4; Bockarie MJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-15; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Ciuca M., 1934, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V27, P619, DOI 10.1016/S0035-9203(34)90111-5; Cole-Tobian JL, 2002, J INFECT DIS, V186, P531, DOI 10.1086/341776; Collins WE, 2004, AM J TROP MED HYG, V70, P642, DOI 10.4269/ajtmh.2004.70.642; Collins WE, 2004, AM J TROP MED HYG, V70, P638, DOI 10.4269/ajtmh.2004.70.638; Collins WE, 1999, AM J TROP MED HYG, V61, P20, DOI 10.4269/tropmed.1999.61-020; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; EARLE W. C., 1939, Puerto Rico Journal of Public Health and Tropical Medicine, V15, P3; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; GUNEWARDENA DM, 1994, MEM I OSWALDO CRUZ, V89, P63, DOI 10.1590/S0074-02761994000600015; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Karunajeewa HA, 2008, NEW ENGL J MED, V359, P2545, DOI 10.1056/NEJMoa0804915; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; LUXEMBURGER C, 1994, T ROY SOC TROP MED H, V88, P155, DOI 10.1016/0035-9203(94)90273-9; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; McNamara DT, 2004, J CLIN MICROBIOL, V42, P2403, DOI 10.1128/JCM.42.6.2403-2410.2004; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mueller Ivo, 2009, Malar J, V8, P41, DOI 10.1186/1475-2875-8-41; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; MULLER I, MALAR J IN PRESS; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Smith T, 2001, T ROY SOC TROP MED H, V95, P1, DOI 10.1016/S0035-9203(01)90314-1; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Vestergaard LS, 2008, INFECT IMMUN, V76, P2706, DOI 10.1128/IAI.01401-06; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	50	107	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9047	10.1371/journal.pone.0009047	http://dx.doi.org/10.1371/journal.pone.0009047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140220	Green Published, Green Accepted, gold			2022-12-27	WOS:000274474400006
J	Turcan, S; Slonim, DK; Vetter, DE				Turcan, Sevin; Slonim, Donna K.; Vetter, Douglas E.			Lack of nAChR Activity Depresses Cochlear Maturation and Up-Regulates GABA System Components: Temporal Profiling of Gene Expression in alpha 9 Null Mice	PLOS ONE			English	Article							INNER HAIR-CELLS; NICOTINIC CHOLINERGIC-RECEPTOR; UBIQUITIN PROTEASOME SYSTEM; SUPERIOR OLIVARY COMPLEX; POTASSIUM CHANNELS; SYNAPTIC GROWTH; GUINEA-PIG; OLIVOCOCHLEAR PROJECTIONS; CHRONIC DEEFFERENTATION; ACETYLCHOLINE-RECEPTOR	Background: It has previously been shown that deletion of chrna9, the gene encoding the alpha 9 nicotinic acetylcholine receptor (nAChR) subunit, results in abnormal synaptic terminal structure. Additionally, all nAChR-mediated cochlear activity is lost, as characterized by a failure of the descending efferent system to suppress cochlear responses to sound. In an effort to characterize the molecular mechanisms underlying the structural and functional consequences following loss of alpha 9 subunit expression, we performed whole-transcriptome gene expression analyses on cochleae of wild type and alpha 9 knockout (alpha 9(-/-)) mice during postnatal days spanning critical periods of synapse formation and maturation. Principal Findings: Data revealed that loss of alpha 9 receptor subunit expression leads to an up-regulation of genes involved in synaptic transmission and ion channel activity. Unexpectedly, loss of alpha 9 receptor subunit expression also resulted in an increased expression of genes encoding GABA receptor subunits and the GABA synthetic enzyme, glutamic acid decarboxylase. These data suggest the existence of a previously unrecognized association between the nicotinic cholinergic and GABAergic systems in the cochlea. Computational analyses have highlighted differential expression of several gene sets upon loss of nicotinic cholinergic activity in the cochlea. Time-series analysis of whole transcriptome patterns, represented as self-organizing maps, revealed a disparate pattern of gene expression between alpha 9(-/-) and wild type cochleae at the onset of hearing (P13), with knockout samples resembling immature postnatal ages. Conclusions: We have taken a systems biology approach to provide insight into molecular programs influenced by the loss of nicotinic receptor-based cholinergic activity in the cochlea and to identify candidate genes that may be involved in nicotinic cholinergic synapse formation, stabilization or function within the inner ear. Additionally, our data indicate a change in the GABAergic system upon loss of alpha 9 nicotinic receptor subunit within the cochlea.	[Turcan, Sevin] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Slonim, Donna K.] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Turcan, Sevin; Vetter, Douglas E.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Turcan, S (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	douglas.vetter@tufts.edu	Vetter, Douglas E./O-8150-2019; Turcan, Sevin/AAF-1095-2019	Turcan, Sevin/0000-0002-0885-5607; Slonim, Donna/0000-0003-3357-437X; Vetter, Douglas/0000-0003-4580-3491	National Institutes of Health (NIH) [R01DC006258, R01HD058880, P30NS047243]; Tufts Center for Neuroscience Research (CNR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006258] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research (CNR)(Consiglio Nazionale delle Ricerche (CNR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) awards R01DC006258 (D. E. V.), R01HD058880 (D. K. S.), and P30NS047243 (to The Tufts Center for Neuroscience Research (CNR), which supports the CNR Genomics Core and Confocal Imaging Core). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Aleman IT, 2005, ADV EXP MED BIOL, V567, P243; Alonso G, 1997, NEUROSCIENCE, V77, P617; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barnes CM, 2005, P NATL ACAD SCI USA, V102, P19097, DOI 10.1073/pnas.0509579102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brors D, 2003, J COMP NEUROL, V462, P90, DOI 10.1002/cne.10707; Burgess BJ, 1997, HEARING RES, V108, P74, DOI 10.1016/S0378-5955(97)00040-3; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Chou JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-272; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duzhyy D, 2005, J BIOL CHEM, V280, P15165, DOI 10.1074/jbc.M500111200; Eichler GS, 2003, BIOINFORMATICS, V19, P2321, DOI 10.1093/bioinformatics/btg307; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Fechner FP, 1998, J COMP NEUROL, V400, P299, DOI 10.1002/(SICI)1096-9861(19981026)400:3<299::AID-CNE1>3.0.CO;2-3; Fuchs PA, 1996, CURR OPIN NEUROBIOL, V6, P514, DOI 10.1016/S0959-4388(96)80058-4; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Goold CP, 2007, NEURON, V56, P109, DOI 10.1016/j.neuron.2007.08.006; Goutman JD, 2005, J PHYSIOL-LONDON, V566, P49, DOI 10.1113/jphysiol.2005.087460; GUINAN JJ, 1984, J COMP NEUROL, V226, P21, DOI 10.1002/cne.902260103; GUINAN JJ, 1983, J COMP NEUROL, V221, P358, DOI 10.1002/cne.902210310; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Howard MA, 2003, HEARING RES, V178, P118, DOI 10.1016/S0378-5955(03)00068-6; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Katz E, 2000, HEARING RES, V141, P117, DOI 10.1016/S0378-5955(99)00214-2; Katz E, 2004, J NEUROSCI, V24, P7814, DOI 10.1523/JNEUROSCI.2102-04.2004; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Lee KH, 2005, LARYNGOSCOPE, V115, P1021, DOI 10.1097/01.MLG.0000162650.75806.A1; Liu Z, 2007, BIOCHEM PHARMACOL, V74, P1112, DOI 10.1016/j.bcp.2007.05.022; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Maison SF, 2006, J NEUROSCI, V26, P10315, DOI 10.1523/JNEUROSCI.2395-06.2006; Maison SF, 2009, JARO-J ASSOC RES OTO, V10, P50, DOI 10.1007/s10162-008-0138-7; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Matsunobu T, 2001, J NEUROSCI RES, V63, P252, DOI 10.1002/1097-4547(20010201)63:3<252::AID-JNR1018>3.0.CO;2-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MURTHY V, 2009, DEV NEUROBI IN PRESS; Murthy V, 2009, DEV NEUROBIOL, V69, P931, DOI 10.1002/dneu.20753; Murthy V, 2009, MOL CELL NEUROSCI, V40, P39, DOI 10.1016/j.mcn.2008.08.011; Nero D, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-59; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Plazas PV, 2005, J NEUROSCI, V25, P10905, DOI 10.1523/JNEUROSCI.3805-05.2005; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; RAJAN R, 1988, BRAIN RES, V459, P241, DOI 10.1016/0006-8993(88)90640-3; Ramsey MM, 2005, J NEUROPHYSIOL, V94, P247, DOI 10.1152/jn.00768.2004; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; ROTH B, 1992, ANAT EMBRYOL, V185, P571, DOI 10.1007/BF00185616; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Simmons DD, 1996, DEV BRAIN RES, V95, P213; Smyth G.K., 2004, STAT APPL GENET MOL; Sokolowski BHA, 2004, J NEUROSCI, V24, P6265, DOI 10.1523/JNEUROSCI.1291-04.2004; Song WJ, 1998, J NEUROSCI, V18, P3124; SRETAVAN DW, 1986, J NEUROSCI, V6, P990; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Torres-Aleman I, 1999, HORM METAB RES, V31, P114, DOI 10.1055/s-2007-978707; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Walsh EJ, 1998, J NEUROSCI, V18, P3859; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1; Yuhas WA, 1999, J COMP PHYSIOL A, V185, P455, DOI 10.1007/s003590050406; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4; Zheng XY, 1997, HEARING RES, V107, P147, DOI 10.1016/S0378-5955(97)00031-2	89	16	16	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9058	10.1371/journal.pone.0009058	http://dx.doi.org/10.1371/journal.pone.0009058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140217	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474400016
J	Merceron, G; Escarguel, G; Angibault, JM; Verheyden-Tixier, H				Merceron, Gildas; Escarguel, Gilles; Angibault, Jean-Marc; Verheyden-Tixier, Helene			Can Dental Microwear Textures Record Inter-Individual Dietary Variations?	PLOS ONE			English	Article							DEER CAPREOLUS-CAPREOLUS; TOOTH MICROWEAR; ENAMEL; HABITAT; PATTERN; ERROR; CAVE	Background: Dental microwear analyses are commonly used to deduce the diet of extinct mammals. Conventional methods rely on the user identifying features within a 2D image. However, recent interdisciplinary research has lead to the development of an advanced methodology that is free of observer error, based on the automated quantification of 3D surfaces by combining confocal microscopy with scale-sensitive fractal analysis. This method has already proved to be very efficient in detecting dietary differences between species. Focusing on a finer, intra-specific scale of analysis, the aim of this study is to test this method's ability to track such differences between individuals from a single population. Methodology/Principal Findings: For the purposes of this study, the 3D molar microwear of 78 individuals from a well-known population of extant roe deer (Capreolus caprelous) is quantified. Multivariate statistical analyses indicate significant seasonal and sexual differences in individual dental microwear design. These are probably the consequence of seasonal variations in fruit, seed and leaf availability, as well as differences in feeding preference between males and females due to distinct energy requirements during periods of rutting, gestation or giving birth. Nevertheless, further investigations using two-block Partial Least-Squares analysis show no strong relationship between individual stomach contents and microwear texture. This is an expected result, assuming that stomach contents are composed of food items ingested during the last few hours whereas dental microwear texture records the physical properties of items eaten over periods of days or weeks. Conclusions/Significance: Microwear 3D scale-sensitive fractal analysis does detect differences in diet ranging from the inter-feeding styles scale to the intra-population between-season and between-sex scales. It is therefore a possible tool, to be used with caution, in the further exploration of the feeding biology and ecology of extinct mammals.	[Merceron, Gildas; Escarguel, Gilles] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Angibault, Jean-Marc; Verheyden-Tixier, Helene] INRA, Lab Comportement & Ecol Faune Sauvage, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE	Merceron, G (corresponding author), Univ Lyon 1, CNRS, UMR 5125, Campus La Doua, F-69622 Villeurbanne, France.	gildas.merceron@univ-lyon1.fr	Escarguel, Gilles/C-3297-2011; Merceron, Gildas/C-8648-2012	Merceron, Gildas/0000-0001-5777-7126; Escarguel, Gilles/0000-0003-0985-6369	Singer-Polignac Foundation, Paris France; Fyssen Foundation, Paris, France	Singer-Polignac Foundation, Paris France; Fyssen Foundation, Paris, France	The Singer-Polignac Foundation (http://www.singer-polignac.org/; Paris, France) and the Fyssen Foundation ( http://www.fondation-fyssen.org/; Paris, France) funded this study through postdoctoral fellowships to G. M.. These two funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2003, STAT ANAL COMPOSITIO; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; CHAYES F, 1960, J GEOPHYS RES, V65, P4185, DOI 10.1029/JZ065i012p04185; CIBIEN C, 1989, ACTA THERIOL, V34, P111, DOI 10.4098/AT.arch.89-7; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cornelis J, 1999, J ZOOL, V248, P195, DOI 10.1111/j.1469-7998.1999.tb01196.x; COVERT HH, 1981, AM J PHYS ANTHROPOL, V55, P331, DOI 10.1002/ajpa.1330550307; Cransac N, 2001, MAMMALIA, V65, P1, DOI 10.1515/mamm.2001.65.1.1; Duncan P, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P91; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Grine FE, 2002, SCANNING, V24, P144, DOI 10.1002/sca.4950240307; Janis C.M., 1990, P241; Legendre P., 2012, NUMERICAL ECOLOGY; Linnell JDC, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P11; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; MAILLARD D, 1987, Gibier Faune Sauvage, V4, P1; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Merceron G, 2004, SMALL RUMINANT RES, V53, P125, DOI [10.1016/j.smallrumres.2003.10.002, 10.1016/j.smallrumers.2003.10.002]; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Morellet N, 1999, FOREST ECOL MANAG, V123, P11, DOI 10.1016/S0378-1127(99)00007-9; Oleffe P., 1993, Gibier Faune Sauvage, V10, P303; Ozbek M, 2009, J VET MED SCI, V71, P1273, DOI 10.1292/jvms.001273; Peigne S, 2009, P NATL ACAD SCI USA, V106, P15390, DOI 10.1073/pnas.0907373106; Porto IM, 2009, ARCH ORAL BIOL, V54, P313, DOI 10.1016/j.archoralbio.2009.01.007; Rivals Florent, 2007, Journal of Mammalian Evolution, V14, P182, DOI 10.1007/s10914-007-9044-8; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; SANDFORD RF, 1993, MATH GEOL, V25, P59, DOI DOI 10.1007/BF00890676; Schubert BW, 2006, PALAEOGEOGR PALAEOCL, V241, P301, DOI 10.1016/j.palaeo.2006.04.004; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sokal RR, 1998, BIOMETRY PRINCIPLES; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P391, DOI 10.1002/ajpa.1330800312; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Tixier H, 1997, J ZOOL, V242, P229, DOI 10.1111/j.1469-7998.1997.tb05799.x; Tixier H, 1996, REV ECOL-TERRE VIE, V51, P3; TIXIER H, 1996, DETERMINANTS ONTOGEN; Ungar P.S., 2008, TECHNIQUE APPL DENT, P389, DOI DOI 10.1017/CBO9780511542442.017; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar Peter S., 2007, Journal of Mammalian Evolution, V14, P163, DOI 10.1007/s10914-007-9050-x; VINCENT JP, 1994, MAMMALIA, V58, P293, DOI 10.1515/mamm.1994.58.2.293; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WALKER ARP, 1983, J TROP MED HYG, V86, P201	49	109	110	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9542	10.1371/journal.pone.0009542	http://dx.doi.org/10.1371/journal.pone.0009542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209051	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197100021
J	Albin, KC; Simons, CT				Albin, Kelly C.; Simons, Christopher T.			Psychophysical Evaluation of a Sanshool Derivative (Alkylamide) and the Elucidation of Mechanisms Subserving Tingle	PLOS ONE			English	Article							STIMULUS-INDUCED RECOVERY; ORAL CHEMICAL IRRITANTS; ROOT GANGLION NEURONS; CROSS-DESENSITIZATION; SELF-DESENSITIZATION; TRIGEMINAL CAUDALIS; CAPSAICIN SENSITIZATION; POTASSIUM CHANNELS; SENSORY NEURONS; SALT STIMULI	Previous studies investigated the neural and molecular underpinnings of the tingle sensation evoked by sanshool and other natural or synthetic alkylamides. Currently, we sought to characterize the psychophysical properties associated with administration of these compounds. Like other chemesthetic stimuli, the synthetic tingle analog isobutylalkylamide (IBA) evoked a sensation that was temporally dynamic. Repeated IBA application at short (30 sec) interstimulus intervals (ISI) resulted in a tingle sensation that increased across trials. Application at longer ISIs (similar to 30 min) resulted in a sensation of decreased intensity consistent with self-desensitization. Prior treatment with the TRPV1 or TRPA1 agonists, capsaicin and mustard oil did not cross-desensitize the tingle sensation evoked by IBA suggesting that neither TRPV1 nor TRPA1 participate in the transduction mechanism sub-serving tingle. When evaluated over 30-min time period, lingual IBA evoked a sensation that was described initially as tingling and pungent but after approximately 15 min, as a cooling sensation. Further, we found that the sensation evoked by lingual IBA was potentiated by simultaneous application of cold (0 degrees C) and cool (21 degrees C) thermal stimuli but was unaffected by warm (33 degrees C) and hot (41 degrees C) temperatures. Finally, to test the hypothesis that the tingling sensation is subserved by the activation of mechanosensitve fibers, we evaluated lingual tactile thresholds in the presence and absence of lingual IBA. The presence of IBA significantly raised lingual tactile thresholds, whereas capsaicin did not, identifying a role for mechanosensitive fibers in conveying the tingle sensation evoked by sanshool-like compounds. Collectively, these results show that lingual alkylamide evokes a complex sensation that is temporally dynamic and consistent with in vitro and in vivo experiments suggesting these compounds activate mechanosensitve neurons via blockade of KCNK two-pore potassium channels to induce the novel tingling sensation.	[Albin, Kelly C.; Simons, Christopher T.] Givaudan Flavors Corp, Cincinnati, OH USA; [Albin, Kelly C.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	Givaudan SA; University of California System; University of California San Diego	Albin, KC (corresponding author), Givaudan Flavors Corp, Cincinnati, OH USA.	christopher.simons@givaudan.com	Simons, Christopher/B-3036-2013		Givaudan Flavors Corporation	Givaudan Flavors Corporation	Funding for this work came from Givaudan Flavors Corporation. The authors are paid employees of Givaudan Flavors Corp., and they participated in study design, data collection, decision to publish and preparation of the manuscript.	Albin KC, 2008, CHEM SENSES, V33, P3, DOI 10.1093/chemse/bjm056; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; BROWN J, 1974, BRIT J PSYCHOL, V65, P13, DOI 10.1111/j.2044-8295.1974.tb02766.x; Bryant BP, 1999, BRAIN RES, V842, P452, DOI 10.1016/S0006-8993(99)01878-8; Carstens E, 2002, FOOD QUAL PREFER, V13, P431, DOI 10.1016/S0950-3293(01)00067-2; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; CLARK CC, 1994, CHEM SENSES, V19, P583, DOI 10.1093/chemse/19.6.583; Cliff MA, 1996, PHYSIOL BEHAV, V59, P487, DOI 10.1016/0031-9384(95)02089-6; Dessirier JM, 1997, CHEM SENSES, V22, P483, DOI 10.1093/chemse/22.5.483; Dessirier JM, 2001, PHYSIOL BEHAV, V72, P317, DOI 10.1016/S0031-9384(00)00412-1; Dessirier JM, 2000, CHEM SENSES, V25, P769, DOI 10.1093/chemse/25.6.769; Dessirier JM, 2000, J NEUROPHYSIOL, V84, P1851, DOI 10.1152/jn.2000.84.4.1851; Galopin CC, 2004, ACS SYM SER, V867, P139; GREEN BG, 1989, NEUROSCI LETT, V107, P173, DOI 10.1016/0304-3940(89)90812-4; GREEN BG, 1991, PHYSIOL BEHAV, V49, P501, DOI 10.1016/0031-9384(91)90271-O; Green BG, 2005, CHEM SENSES, V30, pI201, DOI 10.1093/chemse/bjh184; GREEN BG, 1985, PHYSIOL BEHAV, V35, P427, DOI 10.1016/0031-9384(85)90319-1; GREEN BG, 1986, CHEM SENSES, V11, P371, DOI 10.1093/chemse/11.3.371; GREEN BG, 1988, PERCEPT PSYCHOPHYS, V44, P108, DOI 10.3758/BF03208702; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KARRER T, 1991, PHYSIOL BEHAV, V49, P757, DOI 10.1016/0031-9384(91)90315-F; Kauppila T, 1998, BRAIN RES, V797, P361, DOI 10.1016/S0006-8993(98)00431-4; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; Koo JY, 2007, EUR J NEUROSCI, V26, P1139, DOI 10.1111/j.1460-9568.2007.05743.x; Lawless H. T., 1988, SENSORY EVALUATION F; LAWLESS HT, 1988, PERCEPT PSYCHOPHYS, V43, P72, DOI 10.3758/BF03208975; Lenfant F, 2009, APPETITE, V52, P659, DOI 10.1016/j.appet.2009.03.003; Liu L, 1996, AM J PHYSIOL-CELL PH, V270, pC1807, DOI 10.1152/ajpcell.1996.270.6.C1807; Liu L, 1996, J NEUROPHYSIOL, V75, P1503, DOI 10.1152/jn.1996.75.4.1503; Liu L, 2000, PHYSIOL BEHAV, V69, P177, DOI 10.1016/S0031-9384(00)00200-6; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; OMAHONY M, 1992, J SENS STUD, V7, P147; Pineau N, 2009, FOOD QUAL PREFER, V20, P450, DOI 10.1016/j.foodqual.2009.04.005; Prescott J, 1996, PHYSIOL BEHAV, V60, P617, DOI [10.1016/S0031-9384(96)80039-4, 10.1016/0031-9384(96)00064-9]; Prescott J, 1996, PHYSIOL BEHAV, V60, P1473, DOI 10.1016/S0031-9384(96)00248-X; RAJA SN, 1988, ANESTHESIOLOGY, V68, P571, DOI 10.1097/00000542-198804000-00016; Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6; RAVINDRAN PN, 2004, HDB HERBS SPICES, V2, P53; Riera CE, 2009, BRIT J PHARMACOL, V157, P1398, DOI 10.1111/j.1476-5381.2009.00307.x; Sawyer CM, 2009, J NEUROPHYSIOL, V101, P1742, DOI 10.1152/jn.91311.2008; Shin WJ, 2003, ANESTH ANALG, V96, P1340, DOI 10.1213/01.ANE.0000055365.31940.0A; Simons CT, 2004, PAIN, V110, P64, DOI 10.1016/j.pain.2004.03.009; Simons CT, 2003, CHEM SENSES, V28, P459, DOI 10.1093/chemse/28.6.459; Simons CT, 1999, J NEUROSCI, V19, P8134; SIMONS CT, 2008, AM CHEM SOC S SERIES, V979; STEVENS DA, 1987, PHYSIOL BEHAV, V39, P63, DOI 10.1016/0031-9384(87)90344-1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sudo S, 2003, BRAIN RES, V969, P237, DOI 10.1016/S0006-8993(03)02341-2; Sudo S, 2002, PAIN, V98, P277, DOI 10.1016/S0304-3959(02)00025-8; Sugai E, 2005, BIOSCI BIOTECH BIOCH, V69, P1951, DOI 10.1271/bbb.69.1951; Willis WD, 2009, EXP BRAIN RES, V196, P5, DOI 10.1007/s00221-009-1760-2; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006	60	36	41	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9520	10.1371/journal.pone.0009520	http://dx.doi.org/10.1371/journal.pone.0009520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209090	gold, Green Submitted, Green Published			2022-12-27	WOS:000275063400024
J	Bath, ML				Bath, Mary L.			Inhibition of In Vitro Fertilizing Capacity of Cryopreserved Mouse Sperm by Factors Released by Damaged Sperm, and Stimulation by Glutathione	PLOS ONE			English	Article							ZONA-PELLUCIDA; SPERMATOZOA; SULFHYDRYL; OOCYTES; ABILITY; CELLS; SEMEN; MICE	Background: In vitro fertilization (IVF) of eggs by frozen and thawed C57BL/6J mouse sperm is inhibited by dead sperm and enhanced by preincubation of the sperm in calcium-free medium. In other species, the presence of sperm killed by freezing and thawing has been associated with the generation of hydrogen peroxide. Methodology/Principal Findings: The proportion of eggs fertilized by cryopreserved C57BL/6J mouse sperm was increased significantly by increasing the volume of fertilization medium in which sperm and eggs were coincubated. Enhanced fertilization occurred even though the concentration of potentially fertile sperm was decreased fivefold. This suggested that if a putative soluble factor was inhibiting fertilization, dilution of that factor, but not the sperm, should increase the fertilization rate. This was achieved by coincubation of the gametes in cell culture inserts (Transwells (R)) that during incubation were transferred progressively to wells containing fresh fertilization medium. Fertilization rates using inserts were high (66.6 +/- 2.4% versus 27.3% +/- 2.8% in wells alone). On the assumption that the soluble factor could be H(2)O(2), reduced glutathione was added to the fertilization medium. This enhanced fertilization rate significantly (76.6% +/- 2.0% versus 21.2% +/- 1.9%), while addition of oxidized glutathione did not (82.7% +/- 6.5% with reduced glutathione; 44.5 +/- 8.8% with oxidized glutathione; 47.8% +/- 12.1% with no glutathione). Positive effects of reduced glutathione on IVF were also seen with frozen 129S1, FVB, and C3H sperm, and sperm from two lines of genetically modified C57BL/6J mice. Conclusions/Significance: IVF in cell culture inserts and addition of glutathione to fertilization medium significantly increased the proportion of eggs fertilized by cryopreserved mouse sperm from four inbred strains, suggesting that reactive oxygen species generated during fertilization inhibit fertilization. The modified IVF techniques developed here enhance the feasibility and efficiency of using cryopreserved sperm from genetically modified lines of inbred mice.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Genet Canc, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute	Bath, ML (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Mol Genet Canc, Parkville, Vic 3050, Australia.	bath@wehi.edu.au			Australian National Health and Medical Research Council [461221]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was carried out under Australian National Health and Medical Research Council Program grant #461221 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JL, 2000, J ANDROL, V21, P1; Ball BA, 2001, AM J VET RES, V62, P508, DOI 10.2460/ajvr.2001.62.508; Bath ML, 2003, BIOL REPROD, V68, P19, DOI 10.1095/biolreprod.102.007344; de Lamirande E, 1998, FREE RADICAL BIO MED, V25, P803, DOI 10.1016/S0891-5849(98)00156-7; De Lamirande E, 2003, FREE RADICAL BIO MED, V35, P1271, DOI 10.1016/S0891-5849(03)00501-X; Fan ZQ, 2009, LAB ANIM-UK, V43, P72, DOI 10.1258/la.2008.008029; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; GORDON JW, 1986, J EXP ZOOL, V239, P347, DOI 10.1002/jez.1402390306; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kim IH, 1999, THERIOGENOLOGY, V52, P537, DOI 10.1016/S0093-691X(99)00150-8; Kito S, 2005, ZYGOTE, V13, P145, DOI 10.1017/S0967199405003205; Lane M, 2004, LAB GUIDE MAMMALIAN, P24; Liu L, 2009, J AM ASSOC LAB ANIM, V48, P39; Luberda Zofia, 2005, Reprod Biol, V5, P5; Nakagata N, 1997, BIOL REPROD, V57, P1050, DOI 10.1095/biolreprod57.5.1050; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; Nishizono H, 2004, BIOL REPROD, V71, P973, DOI 10.1095/biolreprod.103.024422; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; SHANNON P, 1972, J DAIRY SCI, V55, P614, DOI 10.3168/jds.S0022-0302(72)85544-9; Smith DP, 2005, ONCOGENE, V24, P3544, DOI 10.1038/sj.onc.1208399; Suzuki-Migishima R, 2009, J REPROD DEVELOP, V55, P386, DOI 10.1262/jrd.20163; Taguma K, 2009, EXP ANIM TOKYO, V58, P395, DOI 10.1538/expanim.58.395; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Talevi R, 2007, BIOL REPROD, V76, P728, DOI 10.1095/biolreprod.106.056028; VASUDEVAN K, 2009, TRANSGENIC RES; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	27	42	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9387	10.1371/journal.pone.0009387	http://dx.doi.org/10.1371/journal.pone.0009387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195370	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200014
J	Blanco-Aparicio, C; Canamero, M; Cecilia, Y; Pequeno, B; Renner, O; Ferrer, I; Carnero, A				Blanco-Aparicio, Carmen; Canamero, Marta; Cecilia, Yolanda; Pequeno, Belen; Renner, Oliver; Ferrer, Irene; Carnero, Amancio			Exploring the Gain of Function Contribution of AKT to Mammary Tumorigenesis in Mouse Models	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; PROTEIN-KINASE-B; BREAST-CANCER; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; MOLECULAR CHARACTERIZATION; MEMBRANE LOCALIZATION; GERMLINE MUTATIONS; ORAL EPITHELIUM; HIGH-FREQUENCY	Elevated expression of AKT has been noted in a significant percentage of primary human breast cancers, mainly as a consequence of the PTEN/PI3K pathway deregulation. To investigate the mechanistic basis of the AKT gain of function-dependent mechanisms of breast tumorigenesis, we explored the phenotype induced by activated AKT transgenes in a quantitative manner. We generated several transgenic mice lines expressing different levels of constitutively active AKT in the mammary gland. We thoroughly analyzed the preneoplastic and neoplastic mammary lesions of these mice and correlated the process of tumorigenesis to AKT levels. Finally, we analyzed the impact that a possible senescent checkpoint might have in the tumor promotion inhibition observed, crossing these lines to mammary specific p53(R172H) mutant expression, and to p27 knock-out mice. We analyzed the benign, premalignant and malignant lesions extensively by pathology and at molecular level analysing the expression of proteins involved in the PI3K/AKT pathway and in cellular senescence. Our findings revealed an increased preneoplastic phenotype depending upon AKT signaling which was not altered by p27 or p53 loss. However, p53 inactivation by R172H point mutation combined with myrAKT transgenic expression significantly increased the percentage and size of mammary carcinoma observed, but was not sufficient to promote full penetrance of the tumorigenic phenotype. Molecular analysis suggest that tumors from double myrAKT; p53(R172H) mice result from acceleration of initiated p53(R172H) tumors and not from bypass of AKT-induced oncogenic senescence. Our work suggests that tumors are not the consequence of the bypass of senescence in MIN. We also show that AKT-induced oncogenic senescence is dependent of pRb but not of p53. Finally, our work also suggests that the cooperation observed between mutant p53 and activated AKT is due to AKT-induced acceleration of mutant p53-induced tumors. Finally, our work shows that levels of activated AKT are not essential in the induction of benign or premalignant tumors, or in the cooperation of AKT with other tumorigenic signal such as mutant p53, once AKT pathway is activated, the relative level of activity seems not to determine the phenotype.	[Blanco-Aparicio, Carmen; Pequeno, Belen; Renner, Oliver; Ferrer, Irene; Carnero, Amancio] Spanish Natl Canc Res Ctr, Expt Therapeut Programme, Madrid, Spain; [Canamero, Marta; Cecilia, Yolanda] Spanish Natl Canc Res Ctr, Biotechnol Programme, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blanco-Aparicio, C (corresponding author), Spanish Natl Canc Res Ctr, Expt Therapeut Programme, Madrid, Spain.	acarnero@ibis-sevilla.es	Ferrer, Irene/C-9418-2015; Renner, Oliver/M-7002-2015; IBIS, CANCER/P-3323-2015; Blanco-Aparicio, Carmen/I-3162-2015; /AAI-3238-2021	Ferrer, Irene/0000-0002-2748-2607; Renner, Oliver/0000-0002-4046-0517; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Carnero, Amancio/0000-0003-4357-3979	Spanish Ministry of Science and Innovation [SAF2009-08605]; Consejeria de Salud, Junta de Andalucia [PI-0142]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Science and Innovation (SAF2009-08605) and Consejeria de Salud, Junta de Andalucia (PI-0142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Beaty MW, 2005, INT J SURG PATHOL, V13, P9, DOI 10.1177/106689690501300102; Berns EMJJ, 2000, CANCER RES, V60, P2155; Bisogna M, 2001, CANCER GENET CYTOGEN, V125, P131, DOI 10.1016/S0165-4608(00)00367-8; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P584, DOI 10.1093/carcin/bgl190; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Butt S, 2009, EJSO-EUR J SURG ONC, V35, P702, DOI 10.1016/j.ejso.2008.03.017; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CARNERO A, 2009, CURRENT PHARM DESIGN, V17, P1435; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Cowell JK, 2005, CANCER GENET CYTOGEN, V163, P23, DOI 10.1016/j.cancergencyto.2005.04.019; D'Amico M, 2003, CANCER RES, V63, P3395; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; DUMITRESCU RG, 2009, J CELL MOL MED; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Gorgoulis VG, 1998, MOL MED, V4, P807, DOI 10.1007/BF03401773; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hui R, 2000, CLIN CANCER RES, V6, P2777; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Iwakuma T, 2007, ONCOGENE, V26, P2177, DOI 10.1038/sj.onc.1210278; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Li G, 2002, DEVELOPMENT, V129, P4159; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Marchio C, 2008, J PATHOL, V216, P399, DOI 10.1002/path.2423; Maroulakou IG, 2008, J CELL PHYSIOL, V217, P468, DOI 10.1002/jcp.21518; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Moral M, 2009, IN VIVO, V23, P653; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Okano Jun-ichi, 2003, Methods Mol Biol, V222, P131; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Renner O, 2008, CLIN TRANSL ONCOL, V10, P618, DOI 10.1007/s12094-008-0262-1; Renner O, 2008, CANCER RES, V68, P9643, DOI 10.1158/0008-5472.CAN-08-1539; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Ruiz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003230; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schade B, 2009, J BIOL CHEM, V284, P19018, DOI 10.1074/jbc.M109.018937; Schrager CA, 1998, HUM PATHOL, V29, P47, DOI 10.1016/S0046-8177(98)90389-6; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WRIGHT RW, 1981, J ANIM SCI, V52, P115, DOI 10.2527/jas1981.521115x; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012	73	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9305	10.1371/journal.pone.0009305	http://dx.doi.org/10.1371/journal.pone.0009305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174572	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700011
J	Chen, L; Shi, WL; Li, H; Sun, XL; Fan, XL; LeSage, G; Li, H; Li, Y; Zhang, Y; Zhang, XM; Zhang, Y; Yin, DL				Chen, Lin; Shi, Wanliang; Li, Hui; Sun, Xiuli; Fan, Xionglin; LeSage, Gene; Li, Hui; Li, Yi; Zhang, Yi; Zhang, Xiumei; Zhang, Ying; Yin, Deling			Critical Role of Toll-Like Receptor 9 in Morphine and Mycobacterium tuberculosis-Induced Apoptosis in Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INNATE IMMUNITY; CELL APOPTOSIS; INFECTION; TLR2; EXPRESSION; REGULATIONS; RECOGNITION; PROTEINS; FAMILY	Background: Although it is established that opioid and Mycobacterium tuberculosis are both public health problems, the mechanisms by which they affect lung functions remain elusive. Methodology/Principal Findings: We report here that mice subjected to chronic morphine administration and M. tuberculosis infection exhibited significant apoptosis in the lung in wild type mice as demonstrated by the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling assay. Morphine and M. tuberculosis significantly induced the expression of Toll-like receptor 9 (TLR9), a key mediator of innate immunity and inflammation. Interestingly, deficiency in TLR9 significantly inhibited the morphine and M. tuberculosis induced apoptosis in the lung. In addition, chronic morphine treatment and M. tuberculosis infection enhanced the levels of cytokines (TNF-alpha, IL-1 beta, and IL-6) in wild type mice, but not in TLR9 knockout (KO) mice. The bacterial load was much lower in TLR9 KO mice compared with that in wild type mice following morphine and M. tuberculosis treatment. Morphine alone did not alter the bacterial load in either wild type or TLR9 KO mice. Moreover, administration of morphine and M. tuberculosis decreased the levels of phosphorylation of Akt and GSK3 beta in the wild type mice, but not in TLR9 KO mice, suggesting an involvement of Akt/GSK3 beta in morphine and M. tuberculosis-mediated TLR9 signaling. Furthermore, administration of morphine and M. tuberculosis caused a dramatic decrease in Bcl-2 level but increase in Bax level in wild type mice, but not in TLR9 KO mice, indicating a role of Bcl-2 family in TLR9-mediated apoptosis in the lung following morphine and M. tuberculosis administration. Conclusions/Significance: These data reveal a role for TLR9 in the immune response to opioids during M. tuberculosis infection.	[Chen, Lin; Li, Hui; Sun, Xiuli; LeSage, Gene; Li, Yi; Zhang, Yi; Yin, Deling] E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA; [Chen, Lin; Zhang, Xiumei] Shandong Univ, Sch Med, Dept Pharmacol, Jinan 250100, Peoples R China; [Shi, Wanliang; Fan, Xionglin; Li, Hui; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Sun, Xiuli] Peking Univ, Peoples Hosp, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	East Tennessee State University; Shandong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Peking University	Chen, L (corresponding author), E Tennessee State Univ, Coll Med, Dept Internal Med, Johnson City, TN 37614 USA.	zhangxiumei@yahoo.com; yzhang@jhsph.edu; yin@etsu.edu	Fan, Xionglin/E-2747-2015	Fan, Xionglin/0000-0001-9754-372X	National Institutes of Health [DA020120-03A1]; East Tennessee State University Research Development Committee; Changjiang Scholars Program;  [AI44063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA020120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); East Tennessee State University Research Development Committee; Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grant DA020120-03A1 and East Tennessee State University Research Development Committee grant to D. Yin. Y. Zhang was supported by AI44063 and Changjiang Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Boronat MA, 2001, BRIT J PHARMACOL, V134, P1263, DOI 10.1038/sj.bjp.0704364; Chen L, 2009, BIOORGAN MED CHEM, V17, P4378, DOI 10.1016/j.bmc.2009.05.029; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Durante AJ, 1998, ADDICTION, V93, P1393, DOI 10.1046/j.1360-0443.1998.939139310.x; Gan L, 2006, IMMUNOL RES, V35, P295, DOI 10.1385/IR:35:3:295; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Li Y, 2009, BIOCHEM BIOPH RES CO, V378, P857, DOI 10.1016/j.bbrc.2008.12.001; Lin X, 2009, FEBS J, V276, P2022, DOI 10.1111/j.1742-4658.2009.06938.x; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; MACGREGOR RR, 1994, CLIN INFECT DIS, V19, P1100, DOI 10.1093/clinids/19.6.1100; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MEDZHITOV R, 1997, NATURE, V388, P397; Moorman J, 2009, BBA-MOL CELL RES, V1793, P1366, DOI 10.1016/j.bbamcr.2009.05.007; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Singh RP, 2008, LIFE SCI, V82, P308, DOI 10.1016/j.lfs.2007.11.024; Wang J, 2008, ARCH IMMUNOL THER EX, V56, P299, DOI 10.1007/s00005-008-0035-0; Wang JH, 2008, J IMMUNOL, V180, P3594, DOI 10.4049/jimmunol.180.5.3594; Yin DL, 2006, J NEUROIMMUNOL, V174, P101, DOI 10.1016/j.jneuroim.2006.02.001; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612; Yin DL, 1999, J IMMUNOL, V163, P4328; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423	35	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9205	10.1371/journal.pone.0009205	http://dx.doi.org/10.1371/journal.pone.0009205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174568	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923700001
J	Stevenson, IH; Kording, KP				Stevenson, Ian H.; Koerding, Konrad P.			On the Similarity of Functional Connectivity between Neurons Estimated across Timescales	PLOS ONE			English	Article							GRANGER CAUSALITY; FIELD POTENTIALS; VISUAL-CORTEX; MOTOR CORTEX; FIRING RATE; TELL US; MODELS; FMRI; BRAIN; NETWORK	A central objective in neuroscience is to understand how neurons interact. Such functional interactions have been estimated using signals recorded with different techniques and, consequently, different temporal resolutions. For example, spike data often have sub-millisecond resolution while some imaging techniques may have a resolution of many seconds. Here we use multi-electrode spike recordings to ask how similar functional connectivity inferred from slower timescale signals is to the one inferred from fast timescale signals. We find that functional connectivity is relatively robust to low-pass filtering-dropping by about 10% when low pass filtering at 10 hz and about 50% when low pass filtering down to about 1 Hz-and that estimates are robust to high levels of additive noise. Moreover, there is a weak correlation for physiological filters such as hemodynamic or Ca2+ impulse responses and filters based on local field potentials. We address the origin of these correlations using simulation techniques and find evidence that the similarity between functional connectivity estimated across timescales is due to processes that do not depend on fast pair-wise interactions alone. Rather, it appears that connectivity on multiple timescales or common-input related to stimuli or movement drives the observed correlations. Despite this qualification, our results suggest that techniques with intermediate temporal resolution may yield good estimates of the functional connections between individual neurons.	[Stevenson, Ian H.; Koerding, Konrad P.] Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Koerding, Konrad P.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine	Stevenson, IH (corresponding author), Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	i-stevenson@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Chicago Community Trust; National Institutes of Health [T32 AG020418]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020418] Funding Source: NIH RePORTER	Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Chicago Community Trust. IHS was supported by National Institutes of Health T32 AG020418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTIAS H, 1997, ADV NEURAL INFORM PR, V9; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; BROWN EN, 2002, TIME RESCALING THEOR, P325; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Chen CC, 2008, NEUROIMAGE, V41, P1293, DOI 10.1016/j.neuroimage.2008.03.026; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Ding M, 2006, QBIO0608035 ARXIV; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2005, ANNU REV PSYCHOL, V56, P57, DOI 10.1146/annurev.psych.56.091103.070311; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Guo SX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000087; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hatsopoulos N, 2004, J NEUROPHYSIOL, V92, P1165, DOI 10.1152/jn.01245.2003; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hoover JE, 1999, J NEUROSCI, V19, P1446; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kulkarni JE, 2007, NETWORK-COMP NEURAL, V18, P375, DOI 10.1080/09548980701625173; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Kwan AC, 2008, J NEUROPHYSIOL, V100, P2977, DOI 10.1152/jn.91037.2008; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pillow J. W., 2007, BAYESIAN BRAIN PROBA, P53, DOI [DOI 10.7551/MITPRESS/9780262042383.003.0003, 10.7551/mitpress/9780262042383.003.0003]; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; REICH DS, 2001, INDEPENDENT REDUNDAN, P2566; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; SMETTERS D, 1999, ENZYMOL, V2, P215; Stephan KE, 2004, CURR OPIN NEUROBIOL, V14, P629, DOI 10.1016/j.conb.2004.08.006; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Stevenson IH, 2008, CURR OPIN NEUROBIOL, V18, P582, DOI 10.1016/j.conb.2008.11.005; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VOGELSTEIN J, 2008, BIOPHYS J IN PRESS; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	55	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9206	10.1371/journal.pone.0009206	http://dx.doi.org/10.1371/journal.pone.0009206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174620	gold, Green Submitted, Green Published			2022-12-27	WOS:000274654700007
J	Kotelnikova, E; Ivanikova, N; Kalinin, A; Yuryev, A; Daraselia, N				Kotelnikova, Ekaterina; Ivanikova, Natalia; Kalinin, Andrey; Yuryev, Anton; Daraselia, Nikolai			Atlas of Signaling for Interpretation of Microarray Experiments	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; GENE-EXPRESSION; CELL-TYPE; PATHWAYS; MODULATION; APOPTOSIS; NETWORKS; GAMMA; MICE	Microarray-based expression profiling of living systems is a quick and inexpensive method to obtain insights into the nature of various diseases and phenotypes. A typical microarray profile can yield hundreds or even thousands of differentially expressed genes and finding biologically plausible themes or regulatory mechanisms underlying these changes is a nontrivial and daunting task. We describe a novel approach for systems-level interpretation of microarray expression data using a manually constructed "overview'' pathway depicting the main cellular signaling channels (Atlas of Signaling). Currently, the developed pathway focuses on signal transduction from surface receptors to transcription factors and further transcriptional regulation of cellular "workhorse'' proteins. We show how the constructed Atlas of Signaling in combination with an enrichment analysis algorithm allows quick identification and visualization of the main signaling cascades and cellular processes affected in a gene expression profiling experiment. We validate our approach using several publicly available gene expression datasets.	[Kotelnikova, Ekaterina; Ivanikova, Natalia; Kalinin, Andrey; Yuryev, Anton; Daraselia, Nikolai] Ariadne Genom Inc, Rockville, MD USA		Kotelnikova, E (corresponding author), Ariadne Genom Inc, Rockville, MD USA.	nikolai@ariadnegenomics.com	Ivanikova, Natalia/M-9003-2013; Kotelnikova, Elena/N-8496-2013	Kotelnikova, Ekaterina/0000-0002-8026-078X; Yuryev, Anton/0000-0003-1021-4849; Kalinin, Andrei/0000-0002-6059-4344				Daraselia N, 2004, BIOINFORMATICS, V20, P604, DOI 10.1093/bioinformatics/btg452; DARASELIA N, 2004, DAT MIN TEXT MIN BIO; Duan RS, 2006, EXP NEUROL, V202, P373, DOI 10.1016/j.expneurol.2006.06.013; Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5; Kirwan RP, 2005, GLIA, V52, P309, DOI 10.1002/glia.20247; Lee J, 2001, J BIOL CHEM, V276, P32956, DOI 10.1074/jbc.M104700200; Levi G, 1998, BIOCHIMIE, V80, P899, DOI 10.1016/S0300-9084(00)88886-0; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; OHMORI Y, 1993, AM J PATHOL, V142, P861; Panayiotidis MI, 2006, ACTA PHYSIOL, V187, P205, DOI 10.1111/j.1748-1716.2006.01562.x; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Sivachenko AY, 2007, J BIOINF COMPUT BIOL, V5, P429, DOI 10.1142/S0219720007002795; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takagi K, 2005, J IMMUNOL, V174, P1801, DOI 10.4049/jimmunol.174.4.1801; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wajant H, 2004, PROG MOLEC, V34, P47; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Xu Q, 2000, J BIOL CHEM, V275, P31770, DOI 10.1074/jbc.M002796200; Yuryev A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-171	22	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9256	10.1371/journal.pone.0009256	http://dx.doi.org/10.1371/journal.pone.0009256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174649	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590600013
J	Park, CJ; Bart, R; Chern, M; Canlas, PE; Bai, W; Ronald, PC				Park, Chang-Jin; Bart, Rebecca; Chern, Mawsheng; Canlas, Patrick E.; Bai, Wei; Ronald, Pamela C.			Overexpression of the Endoplasmic Reticulum Chaperone BiP3 Regulates XA21-Mediated Innate Immunity in Rice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TOLL-LIKE RECEPTORS; ORYZAE PV. ORYZAE; QUALITY-CONTROL; DISEASE RESISTANCE; NEGATIVE REGULATOR; STRESS; PERCEPTION; DOMAIN; GENE	Recognition of pathogen-associated molecular patterns by pattern recognition receptors (PRRs) activates the innate immune response. Although PRR-mediated signaling events are critical to the survival of plants and animals, secretion and localization of PRRs have not yet been clearly elucidated. Here we report the in vivo interaction of the endoplasmic reticulum (ER) chaperone BiP3 with the rice XA21 PRR, which confers resistance to the Gram negative bacterium, Xanthomonas oryzae pv. oryzae (Xoo). We show that XA21 is glycosylated and is primarily localized to the ER and also to the plasma membrane (PM). In BiP3-overexpressing rice plants, XA21-mediated immunity is compromised, XA21 stability is significantly decreased, and XA21 proteolytic cleavage is inhibited. BiP3 overexpression does not affect the general rice defense response, cell death or brassinolide-induced responses. These results indicate that BiP3 regulates XA21 protein stability and processing and that this regulation is critical for resistance to Xoo.	[Park, Chang-Jin; Bart, Rebecca; Chern, Mawsheng; Canlas, Patrick E.; Bai, Wei; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Park, CJ (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Park, Chang-Jin/AAX-1867-2021; Ronald, Pamela/AAK-7664-2020; Bart, Rebecca S/M-2838-2013	Park, Chang-Jin/0000-0002-2586-8856; Bart, Rebecca/0000-0003-1378-3481	NIH [GM55962]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER; Direct For Biological Sciences [0943352] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NIH GM55962 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Andaya CB, 2003, PHYSIOL MOL PLANT P, V62, P203, DOI 10.1016/S0885-5765(03)00060-2; Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Cai B, 1998, J CELL PHYSIOL, V177, P282, DOI 10.1002/(SICI)1097-4652(199811)177:2<282::AID-JCP10>3.0.CO;2-C; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Ditt RF, 2006, MOL PLANT MICROBE IN, V19, P665, DOI 10.1094/MPMI-19-0665; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; HONG Z, 2008, PLANT CELL; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; LEE SW, 2009, SCIENCE IN PRESS; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; LI J, 2009, P NATL ACAD SCI US; Liu G, 2006, MUTAT RES-FUND MOL M, V596, P12, DOI 10.1016/j.mrfmmm.2005.10.015; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mimura N, 2007, CELL DEATH DIFFER, V14, P1475, DOI 10.1038/sj.cdd.4402151; Min MK, 2007, PLANT PHYSIOL, V143, P1601, DOI 10.1104/pp.106.095091; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ponciano G, 2006, PHYSIOL MOL PLANT P, V69, P131, DOI 10.1016/j.pmpp.2007.03.002; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang XM, 2007, PFLUG ARCH EUR J PHY, V454, P143, DOI 10.1007/s00424-006-0179-x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	60	90	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9262	10.1371/journal.pone.0009262	http://dx.doi.org/10.1371/journal.pone.0009262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174657	Green Published, gold			2022-12-27	WOS:000274590600017
J	Hone, DWE; Tischlinger, H; Xu, X; Zhang, FC				Hone, David W. E.; Tischlinger, Helmut; Xu, Xing; Zhang, Fucheng			The Extent of the Preserved Feathers on the Four-Winged Dinosaur Microraptor gui under Ultraviolet Light	PLOS ONE			English	Article							CHINA; EVOLUTION; BIRDS	Background: The holotype of the theropod non-avian dinosaur Microraptor gui from the Early Cretaceous of China shows extensive preservation of feathers in a halo around the body and with flight feathers associated with both the fore and hindlimbs. It has been questioned as to whether or not the feathers did extend into the halo to reach the body, or had disassociated and moved before preservation. This taxon has important implications for the origin of flight in birds and the possibility of a four-winged gliding phase. Methodology/Principal Findings: Examination of the specimen under ultraviolet light reveals that these feathers actually reach the body of the animal and were not disassociated from the bones. Instead they may have been chemically altered by the body tissues of the animal meaning that they did not carbonise close into the animal or more likely were covered by other decaying tissue, though evidence of their presence remains. Conclusions/Significance: These UV images show that the feathers preserved on the slab are genuinely associated with the skeleton and that their arrangement and orientation is likely correct. The methods used here to reveal hidden features of the specimen may be applicable to other specimens from the fossil beds of Liaoning that produced Microraptor.	[Hone, David W. E.; Xu, Xing; Zhang, Fucheng] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Hone, DWE (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824	Chinese Academy of Sciences [202102]; Ministry of Science and Technology [2006CB806400]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Funding: This work was supported by a grant from the Chinese Academy of Sciences (http://english.cas.cn/) Number 202102 and the Ministry of Science and Technology 2006CB806400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE CW, 1915, ZOOLOGICA, V2, P38; Bennett SC, 2007, PALAEONTOL Z, V81, P376, DOI 10.1007/BF02990250; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P1576, DOI 10.1073/pnas.0609975104; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Davis PG, 1998, PALAIOS, V13, P3, DOI 10.2307/3515277; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; GILL FB, 2003, ORNITHOLOGY; Gohlich UB, 2006, ARCHAEOPTERYX, V24, P1; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 2009, NATURWISSENSCHAFTEN, V96, P423, DOI 10.1007/s00114-008-0488-3; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; LUCAS AM, 1972, AGR HDB, V362, P340; Padian K, 2005, NATURE, V438, pE3, DOI 10.1038/nature04354; Padian K, 2003, BIOSCIENCE, V53, P450; Schafer W., 1972, ECOLOGY PALAEOECOLOG; Tischlinger H., 2005, ZITTELIANA B, V26, P26; Tischlinger Helmut, 2002, Archaeopteryx, V20, P21; Tischlinger Helmut, 2004, Archaeopteryx, V22, P17; Tischlinger Helmut, 2005, Archaeopteryx, V23, P33; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Wellnhofer P., 2009, ARCHAEOPTERYX ICON E, P208; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; XU X, 2009, P NAT ACAD, V106; Xu X, 2006, INTEGR ZOOL, V1, P4, DOI 10.1111/j.1749-4877.2006.00004.x; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; YALDEN DW, 1985, BEGINNINGS BIRDS, P91; Zhang FC, 2001, CHINESE SCI BULL, V46, P945, DOI 10.1007/BF02900473; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhou ZH, 2002, NATURE, V420, P285, DOI 10.1038/420285a; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111; Zhou Zhong-He, 2006, Vertebrata Palasiatica, V44, P74; Zhou ZY, 2002, P SOC PHOTO-OPT INS, V4928, P160, DOI 10.1117/12.483166	39	42	43	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9223	10.1371/journal.pone.0009223	http://dx.doi.org/10.1371/journal.pone.0009223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169153	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474700017
J	Koirala, S; Corfas, G				Koirala, Samir; Corfas, Gabriel			Identification of Novel Glial Genes by Single-Cell Transcriptional Profiling of Bergmann Glial Cells from Mouse Cerebellum	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; STEM-CELLS; SYNAPSE FORMATION; EXPRESSION PATTERNS; PURKINJE NEURONS; RADIAL MIGRATION; RAT CEREBELLUM; NERVOUS-SYSTEM; D-SERINE; BRAIN	Bergmann glial cells play critical roles in the structure and function of the cerebellum. During development, their radial processes serve as guides for migrating granule neurons and their terminal endfeet tile to form the glia limitans. As the cerebellum matures, Bergmann glia perform important roles in synaptic transmission and synapse maintenance, while continuing to serve as essential structural elements. Despite growing evidence of the diverse functions of Bergmann glia, the molecular mechanisms that mediate these functions have remained largely unknown. As a step toward identifying the molecular repertoire underlying Bergmann glial function, here we examine global gene expression in individual Bergmann glia from developing (P6) and mature (P30) mouse cerebellum. When we select for developmentally regulated genes, we find that transcription factors and ribosomal genes are particularly enriched at P6 relative to P30; whereas synapse associated molecules are enriched at P30 relative to P6. We also analyze genes expressed at high levels at both ages. In all these categories, we find genes that were not previously known to be expressed in glial cells, and discuss novel functions some of these genes may potentially play in Bergmann glia. We also show that Bergmann glia, even in the adult, express a large set of genes thought to be specific to stem cells, suggesting that Bergmann glia may retain neural precursor potential as has been proposed. Finally, we highlight several genes that in the cerebellum are expressed in Bergmann glia but not astrocytes, and may therefore serve as new, specific markers for Bergmann glia.	[Koirala, Samir; Corfas, Gabriel] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA; [Koirala, Samir; Corfas, Gabriel] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Corfas, Gabriel] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Koirala, S (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA.	gabriel.corfas@childrens.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS35884]; National Institutes of Health (NIH) Mental Retardation Research Center [P30-HD 18655]; Fundamental Neurobiology National Institutes of Health (NIH) [T32 NS007484-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R01NS035884] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH) Mental Retardation Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundamental Neurobiology National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS35884 (to G. C.), National Institutes of Health (NIH) Mental Retardation Research Center grant P30-HD 18655 (to G. C.), and a Fundamental Neurobiology National Institutes of Health (NIH) training grant T32 NS007484-06 (to S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2007, MED HYPOTHESES, V69, P341, DOI 10.1016/j.mehy.2007.01.006; Altman J, 1997, DEV CEREBELLAR SYSTE; Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagri A, 2002, ADV EXP MED BIOL, V515, P13; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Belvindrah R, 2006, MOL CELL NEUROSCI, V33, P109, DOI 10.1016/j.mcn.2006.06.013; Bermingham JR, 2006, NAT NEUROSCI, V9, P76, DOI 10.1038/nn1598; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Bordey A, 2003, J NEUROPHYSIOL, V89, P979, DOI 10.1152/jn.00904.2002; Brockhaus J, 2002, J PHYSIOL-LONDON, V545, P581, DOI 10.1113/jphysiol.2002.028423; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Cui W, 2001, GLIA, V34, P272, DOI 10.1002/glia.1061; CUNNINGHAM NS, 1995, GROWTH FACTORS, V12, P99, DOI 10.3109/08977199509028956; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dolter KE, 2001, BIOTECHNIQUES, V30, P1358, DOI 10.2144/01306pf01; Dulac C, 1998, CURR TOP DEV BIOL, V36, P245; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eichele G, 1997, TRENDS GENET, V13, P343, DOI 10.1016/S0168-9525(97)01218-3; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAUSMANN B, 1985, J COMP NEUROL, V241, P50, DOI 10.1002/cne.902410105; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; JORGENSEN JR, 2009, J MOL NEUROSCI; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Lippman JJ, 2008, GLIA, V56, P1463, DOI 10.1002/glia.20712; Lopez-Bayghen E, 2007, NEURON GLIA BIOL, V3, P155, DOI 10.1017/S1740925X0700066X; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; MAGER WH, 1988, BIOCHIM BIOPHYS ACTA, V949, P1, DOI 10.1016/0167-4781(88)90048-6; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; Mustafa AK, 2004, NEURON GLIA BIOL, V1, P275, DOI 10.1017/S1740925X05000141; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nishino J, 2004, EMBO J, V23, P1998, DOI 10.1038/sj.emboj.7600202; Ottersen OP, 1997, PROG BRAIN RES, V114, P97; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Park WJ, 2008, NEUROSCI LETT, V444, P240, DOI 10.1016/j.neulet.2008.08.044; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Roubelakis MG, 2007, J CELL BIOCHEM, V102, P955, DOI 10.1002/jcb.21334; SASSOON D, 1993, METHOD ENZYMOL, V225, P384; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schoch S, 2006, EMBO J, V25, P5852, DOI 10.1038/sj.emboj.7601425; Schousboe A, 1997, GLIA, V21, P99; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; SIEVERS J, 1986, ANAT EMBRYOL, V175, P91, DOI 10.1007/BF00315459; SIEVERS J, 1981, J COMP NEUROL, V203, P751, DOI 10.1002/cne.902030412; SOTELO C, 1994, J NEUROSCI, V14, P124; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; TEICHBERG VI, 1991, FASEB J, V5, P3086, DOI 10.1096/fasebj.5.15.1660422; THIERRYMIEG D, 2006, GENOME BIOL S1, V7, pS1211; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tournell CE, 2006, NEUROSCIENCE, V141, P1327, DOI 10.1016/j.neuroscience.2006.05.004; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; TUSHINSKI RJ, 1982, J CELL PHYSIOL, V112, P128, DOI 10.1002/jcp.1041120119; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Weller M, 2006, DEV NEUROSCI-BASEL, V28, P70, DOI 10.1159/000090754; Yamada K, 2000, J COMP NEUROL, V418, P106; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x; Zhao RB, 1999, DEV BIOL, V212, P68, DOI 10.1006/dbio.1999.9326; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	92	61	61	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9198	10.1371/journal.pone.0009198	http://dx.doi.org/10.1371/journal.pone.0009198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169146	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600018
J	Rioux, JB; Philippe, N; Pereira, S; Pignol, D; Wu, LF; Ginet, N				Rioux, Jean-Baptiste; Philippe, Nadege; Pereira, Sandrine; Pignol, David; Wu, Long-Fei; Ginet, Nicolas			A Second Actin-Like MamK Protein in Magnetospirillum magneticum AMB-1 Encoded Outside the Genomic Magnetosome Island	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; GRYPHISWALDENSE; SEQUENCE; BIOMINERALIZATION; COMPLEX; REGION; DOMAIN	Magnetotactic bacteria are able to swim navigating along geomagnetic field lines. They synthesize ferromagnetic nanocrystals that are embedded in cytoplasmic membrane invaginations forming magnetosomes. Regularly aligned in the cytoplasm along cytoskeleton filaments, the magnetosome chain effectively forms a compass needle bestowing on bacteria their magnetotactic behaviour. A large genomic island, conserved among magnetotactic bacteria, contains the genes potentially involved in magnetosome formation. One of the genes, mamK has been described as encoding a prokaryotic actin-like protein which when it polymerizes forms in the cytoplasm filamentous structures that provide the scaffold for magnetosome alignment. Here, we have identified a series of genes highly similar to the mam genes in the genome of Magnetospirillum magneticum AMB-1. The newly annotated genes are clustered in a genomic islet distinct and distant from the known magnetosome genomic island and most probably acquired by lateral gene transfer rather than duplication. We focused on a mamK-like gene whose product shares 54.5% identity with the actin-like MamK. Filament bundles of polymerized MamK-like protein were observed in vitro with electron microscopy and in vivo in E. coli cells expressing MamK-like-Venus fusions by fluorescence microscopy. In addition, we demonstrate that mamK-like is transcribed in AMB-1 wild-type and DmamK mutant cells and that the actin-like filamentous structures observed in the DmamK strain are probably MamK-like polymers. Thus MamK-like is a new member of the prokaryotic actin-like family. This is the first evidence of a functional mam gene encoded outside the magnetosome genomic island.	[Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] CEA, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] CNRS, UMR Biol Vegetale & Microbiol Environm 6191, St Paul Les Durance, France; [Rioux, Jean-Baptiste; Pignol, David; Ginet, Nicolas] Aix Marseille Univ, St Paul Les Durance, France; [Philippe, Nadege; Wu, Long-Fei] CNRS, UPR 9043, Chim Bacterienne Lab, Marseille, France; [Pereira, Sandrine] Inst Radioprotect & Surete Nucl, Lab Radiotoxicol & Ecotoxicol, St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Rioux, JB (corresponding author), CEA, Inst Biol Environm & Biotechnol, Lab Bioenerget Cellulaire, St Paul Les Durance, France.	nicolas.ginet@cea.fr	Ginet, Nicolas/AEB-2370-2022	Philippe, Nadege/0000-0001-9154-0341; PIGNOL, David/0000-0002-8070-0319; Ginet, Nicolas/0000-0002-5544-4376	Le Commissariat a l'Energie Atomique; Le Centre National de la Recherche Scientifique; Aix-Marseille II Universite; Institut de Radioprotection et de Surete Nucleaire	Le Commissariat a l'Energie Atomique(French Atomic Energy Commission); Le Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille II Universite; Institut de Radioprotection et de Surete Nucleaire	This work was supported by Le Commissariat a l'Energie Atomique (http://www.cea.fr), Le Centre National de la Recherche Scientifique (http://www.cnrs.fr), Aix-Marseille II Universite (http://www.univmed.fr) and Institut de Radioprotection et de Surete Nucleaire (http://www.irsn.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; ARAKAKI A, 2009, J COLLOID INTERFACE; Bates PA, 1999, PROTEINS, P47; Bazylinski D.A., 2006, MAGNETOSOMES MAGNETO, P37; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P3, DOI 10.1007/s00343-009-0003-5; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P6, DOI 10.1007/s00343-009-0006-2; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Frankel RB, 2006, TRENDS MICROBIOL, V14, P329, DOI 10.1016/j.tim.2006.06.004; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Jogler C, 2009, APPL ENVIRON MICROB, V75, P3972, DOI 10.1128/AEM.02701-08; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Scheffel A, 2007, J BACTERIOL, V189, P6437, DOI 10.1128/JB.00421-07; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X	41	61	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9151	10.1371/journal.pone.0009151	http://dx.doi.org/10.1371/journal.pone.0009151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161777	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442700015
J	Moreno-Torres, A; Rosset-Llobet, J; Pujol, J; Fabregas, S; Gonzalez-de-Suso, JM				Moreno-Torres, Angel; Rosset-Llobet, Jaume; Pujol, Jesus; Fabregas, Silvia; Gonzalez-de-Suso, Jose-Manuel			Work-Related Pain in Extrinsic Finger Extensor Musculature of Instrumentalists Is Associated with Intracellular pH Compartmentation during Exercise	PLOS ONE			English	Article							REPETITIVE STRAIN INJURY; WRIST FLEXOR MUSCLES; OVERUSE SYNDROME; P-31-NMR SPECTROSCOPY; SKELETAL-MUSCLE; FIBER TYPES; UPPER-LIMB; MUSICIANS; METABOLISM; PATHOPHYSIOLOGY	Background: Although non-specific pain in the upper limb muscles of workers engaged in mild repetitive tasks is a common occupational health problem, much is unknown about the associated structural and biochemical changes. In this study, we compared the muscle energy metabolism of the extrinsic finger extensor musculature in instrumentalists suffering from work-related pain with that of healthy control instrumentalists using non-invasive phosphorus magnetic resonance spectroscopy (P-31-MRS). We hypothesize that the affected muscles will show alterations related with an impaired energy metabolism. Methodology/Principal Findings: We studied 19 volunteer instrumentalists (11 subjects with work-related pain affecting the extrinsic finger extensor musculature and 8 healthy controls). We used P-31-MRS to find deviations from the expected metabolic response to exercise in phosphocreatine (PCr), inorganic phosphate (Pi), Pi/PCr ratio and intracellular pH kinetics. We observed a reduced finger extensor exercise tolerance in instrumentalists with myalgia, an intracellular pH compartmentation in the form of neutral and acid compartments, as detected by Pi peak splitting in P-31-MRS spectra, predominantly in myalgic muscles, and a strong association of this pattern with the condition. Conclusions/Significance: Work-related pain in the finger extrinsic extensor muscles is associated with intracellular pH compartmentation during exercise, non-invasively detectable by P-31-MRS and consistent with the simultaneous energy production by oxidative metabolism and glycolysis. We speculate that a deficit in energy production by oxidative pathways may exist in the affected muscles. Two possible explanations for this would be the partial and/or local reduction of blood supply and the reduction of the muscle oxidative capacity itself.	[Moreno-Torres, Angel] Ctr Diagnost Pedralbes, Res Dept, Esplugas de Llobregat, Spain; [Moreno-Torres, Angel] CIBER BBN, Esplugas de Llobregat, Spain; [Rosset-Llobet, Jaume; Fabregas, Silvia] Inst Fisiol & Med Art, Terrassa, Spain; [Pujol, Jesus] Inst Alta Tecnol, Ctr Radiol Comp CRC Corp Sanitaria, Barcelona, Spain; [Pujol, Jesus] CIBER BBN, Barcelona, Spain; [Gonzalez-de-Suso, Jose-Manuel] Real Soc Futbol SAD, Sports Med Dept, Donostia San Sebastian, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Moreno-Torres, A (corresponding author), Ctr Diagnost Pedralbes, Res Dept, Esplugas de Llobregat, Spain.	amoreno@cetir.es						ACHTEN E, 1990, J APPL PHYSIOL, V68, P644, DOI 10.1152/jappl.1990.68.2.644; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Bejjani FJ, 1996, ARCH PHYS MED REHAB, V77, P406, DOI 10.1016/S0003-9993(96)90093-3; BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523; Brunnekreef JJ, 2006, CLIN PHYSIOL FUNCT I, V26, P178, DOI 10.1111/j.1475-097X.2006.00671.x; CHANCE B, 1985, P NATL ACAD SCI USA, V82, P8384, DOI 10.1073/pnas.82.24.8384; Chance B, 2006, NMR BIOMED, V19, P904, DOI 10.1002/nbm.1109; DENNETT X, 1988, LANCET, V1, P905; DENNETT X, 1999, MED ARTS, V30, P17; FRY HJH, 1986, MED PROBL PERFORM AR, V1, P51; FRY HJH, 1986, MED J AUSTRALIA, V144, P182, DOI 10.5694/j.1326-5377.1986.tb128353.x; FRY HJH, 1987, BRIT J IND MED, V44, P35; Hagg GM, 2000, EUR J APPL PHYSIOL, V83, P159, DOI 10.1007/s004210000274; HEFFNER RR, 1978, J NEUROL SCI, V38, P295, DOI 10.1016/0022-510X(78)90137-5; HINTZ CS, 1980, AM J PHYSIOL, V239, pC58, DOI 10.1152/ajpcell.1980.239.3.C58; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; LEXELL J, 1993, CELL TISSUE RES, V273, P357, DOI 10.1007/BF00312838; MACLAREN DPM, 1989, EXERCISE SPORT SCI R, V17, P29; MIZUNO M, 1994, AM J PHYSIOL, V267, pR408, DOI 10.1152/ajpregu.1994.267.2.R408; MIZUNO M, 1994, J APPL PHYSIOL, V76, P531, DOI 10.1152/jappl.1994.76.2.531; MIZUNO M, 1990, ACTA PHYSIOL SCAND, V139, P611, DOI 10.1111/j.1748-1716.1990.tb08967.x; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; PARK JH, 1987, P NATL ACAD SCI USA, V84, P8976, DOI 10.1073/pnas.84.24.8976; Pritchard MH, 2005, RHEUMATOLOGY, V44, P1442, DOI 10.1093/rheumatology/kei037; Pritchard MH, 1999, RHEUMATOLOGY, V38, P636, DOI 10.1093/rheumatology/38.7.636; Raymer GH, 2009, J APPL PHYSIOL, V106, P1198, DOI 10.1152/japplphysiol.90925.2008; Sluiter JK, 2001, SCAND J WORK ENV HEA, V27, P1; STONE WE, 1983, MED J AUSTRALIA, V2, P616, DOI 10.5694/j.1326-5377.1983.tb122723.x; Taylor D J, 1983, Mol Biol Med, V1, P77; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; White JW, 2003, HAND CLIN, V19, P331, DOI 10.1016/S0749-0712(03)00006-4; Winspur I, 2003, HAND CLIN, V19, P325, DOI 10.1016/S0749-0712(02)00124-5; Yoshida T, 1997, EUR J APPL PHYSIOL O, V75, P200, DOI 10.1007/s004210050148	34	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9091	10.1371/journal.pone.0009091	http://dx.doi.org/10.1371/journal.pone.0009091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161738	Green Published, gold			2022-12-27	WOS:000274442600005
J	Navaroli, DM; Melikian, HE				Navaroli, Deanna M.; Melikian, Haley E.			Insertion of Tetracysteine Motifs into Dopamine Transporter Extracellular Domains	PLOS ONE			English	Article							NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; TRANSMEMBRANE SEGMENT; FUNCTIONAL REGULATION; COCAINE ANALOGS; CROSS-LINKING; TRAFFICKING; INTERNALIZATION; ENDOCYTOSIS; PROTEINS	The neuronal dopamine transporter (DAT) is a major determinant of extracellular dopamine (DA) levels and is the primary target for a variety of addictive and therapeutic psychoactive drugs. DAT is acutely regulated by protein kinase C (PKC) activation and amphetamine exposure, both of which modulate DAT surface expression by endocytic trafficking. In order to use live imaging approaches to study DAT endocytosis, methods are needed to exclusively label the DAT surface pool. The use of membrane impermeant, sulfonated biarsenic dyes holds potential as one such approach, and requires introduction of an extracellular tetracysteine motif (tetraCys; CCPGCC) to facilitate dye binding. In the current study, we took advantage of intrinsic proline-glycine (Pro-Gly) dipeptides encoded in predicted DAT extracellular domains to introduce tetraCys motifs into DAT extracellular loops 2, 3, and 4. [(3)H]DA uptake studies, surface biotinylation and fluorescence microscopy in PC12 cells indicate that tetraCys insertion into the DAT second extracellular loop results in a functional transporter that maintains PKC-mediated downregulation. Introduction of tetraCys into extracellular loops 3 and 4 yielded DATs with severely compromised function that failed to mature and traffic to the cell surface. This is the first demonstration of successful introduction of a tetracysteine motif into a DAT extracellular domain, and may hold promise for use of biarsenic dyes in live DAT imaging studies.	[Navaroli, Deanna M.; Melikian, Haley E.] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA; [Melikian, Haley E.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Navaroli, DM (corresponding author), Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA.	haley.melikian@umassmed.edu	Melikian, Haley/S-8301-2016	Melikian, Haley/0000-0002-9694-5556	National Institutes of Health [DA15169]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institutes of Health grant # DA15169 to H. E. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Adams SR, 2008, NAT PROTOC, V3, P1527, DOI 10.1038/nprot.2008.144; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; ANJAN KB, 2007, CHEMBIOCHEM, V8, P1642; Beckman ML, 1998, J MEMBRANE BIOL, V164, P1; Blakely RD, 2001, J NEUROSCI, V21, P8319, DOI 10.1523/JNEUROSCI.21-21-08319.2001; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Machleidt T, 2007, METH MOL B, V356, P209; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Orun O, 2009, ACTA BIOL HUNG, V60, P15, DOI 10.1556/ABiol.60.2009.1.2; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Zahniser NR, 2004, NEUROPHARMACOLOGY, V47, P80, DOI 10.1016/j.neuropharm.2004.07.010; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9113	10.1371/journal.pone.0009113	http://dx.doi.org/10.1371/journal.pone.0009113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161733	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442600011
J	Shoemaker, LD; Orozco, NM; Geschwind, DH; Whitelegge, JP; Faull, KF; Kornblum, HI				Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.			Identification of Differentially Expressed Proteins in Murine Embryonic and Postnatal Cortical Neural Progenitors	PLOS ONE			English	Article							REPULSIVE GUIDANCE MOLECULE; STEM-CELLS; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; MULTIPLE ROLES; TUBE CLOSURE; ADULT-MOUSE; NEOGENIN; RGM; GROWTH	Background: The central nervous system (CNS) develops from a heterogeneous pool of neural stem and progenitor cells (NSPC), the underlying differences among which are poorly understood. The study of NSPC would be greatly facilitated by the identification of additional proteins that mediate their function and that would distinguish amongst different progenitor populations. Methodology/Principal Findings: To identify membrane and membrane-associated proteins expressed by NSPC, we used a proteomics approach to profile NSPC cultured as neurospheres (NS) isolated from the murine cortex during a period of neurogenesis (embryonic day 11.5, E11.5), as compared to NSPC isolated at a peak of gliogenesis (postnatal day 1, P0) and to differentiated E11.5 NS. 54 proteins were identified with high expression in E11.5 NS, including the TrkC receptor, several heterotrimeric G proteins, and the Neogenin receptor. 24 proteins were identified with similar expression in E11.5 and P0 NS over differentiated E11.5 NS, and 13 proteins were identified with high expression specifically in P0 NS compared to E11.5 NS. To illustrate the potential relevance of these identified proteins to neural stem cell biology, the function of Neogenin was further studied. Using Fluorescence Activated Cell Sorting (FACS) analysis, expression of Neogenin was associated with a self-renewing population present in both E11.5 and adult subventricular zone (SVZ) NS but not in P0 NS. E11.5 NS expressed a putative Neogenin ligand, RGMa, and underwent apoptosis when exposed to a ligand-blocking antibody. Conclusions/Significance: There are fundamental differences between the continuously self-renewing and more limited progenitors of the developing cortex. We identified a subset of differentially expressed proteins that serve not only as a set of functionally important proteins, but as a useful set of markers for the subsequent analysis of NSPC. Neogenin is associated with the continuously self-renewing and neurogenic cells present in E11.5 cortical and adult SVZ NS, and the Neogenin/RGMa receptor/ligand pair may regulate cell survival during development.	[Shoemaker, Lorelei D.; Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Neuropsychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Shoemaker, Lorelei D.; Orozco, Nicholas M.; Geschwind, Daniel H.; Whitelegge, Julian P.; Faull, Kym F.; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shoemaker, LD (corresponding author), Stanford Med Sch, Dept Neurosurg, Stanford, CA USA.	harley@ucla.edu		Shoemaker, Lorelei/0000-0002-2208-0537	National Institute of Mental Health [68649, 65756]; National Institutes of Health Shared Instrument [S10 RR16793: 010, S10 RR15952: 01]; University of California Los Angeles Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015952, S10RR016793] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Shared Instrument(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles Graduate Division; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by National Institute of Mental Health grants 68649 and 65756 (to HIK), National Institutes of Health Shared Instrument Grant award S10 RR16793: 010 and S10 RR15952: 01 (to KFF), and by University of California Los Angeles Graduate Division (to LDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova N, 2005, DEV BIOL, V283, P269, DOI 10.1016/j.ydbio.2005.03.040; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Costa MR, 2009, CEREB CORTEX, V19, pI135, DOI 10.1093/cercor/bhp046; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; Desai AR, 2000, DEVELOPMENT, V127, P2863; EASTERDAY MC, 2003, DEV BIOL IN PRESS; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fitzgerald DP, 2007, GENE EXPR PATTERNS, V7, P784, DOI 10.1016/j.modgep.2007.05.004; Fuja TJ, 2004, J NEUROSCI RES, V75, P782, DOI 10.1002/jnr.10874; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Henion PD, 1995, DEV BIOL, V172, P602, DOI 10.1006/dbio.1995.8054; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Keeling SL, 1997, ONCOGENE, V15, P691, DOI 10.1038/sj.onc.1201225; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Maurer MH, 2007, J PROTEOME RES, V6, P1198, DOI 10.1021/pr0605825; Maurer MH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-7; Maurer MH, 2004, NEUROCHEM RES, V29, P1129, DOI 10.1023/B:NERE.0000023600.25994.11; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Salim K, 2007, STEM CELLS DEV, V16, P143, DOI 10.1089/scd.2006.00100; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Seaberg RM, 2005, DEV BIOL, V278, P71, DOI 10.1016/j.ydbio.2004.10.017; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shin GJ, 2008, J MOL HISTOL, V39, P105, DOI 10.1007/s10735-007-9138-x; Skalnikova H, 2007, PROTEOMICS, V7, P1825, DOI 10.1002/pmic.200600867; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Willaime-Morawek S, 2006, J CELL BIOL, V175, P159, DOI 10.1083/jcb.200604123; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	55	6	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9121	10.1371/journal.pone.0009121	http://dx.doi.org/10.1371/journal.pone.0009121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161753	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600019
J	Wan, XY; Ji, W; Mei, X; Zhou, JG; Liu, JX; Fang, CC; Xiao, WH				Wan, Xiaoyang; Ji, Wei; Mei, Xue; Zhou, Jiangang; Liu, Jing-xia; Fang, Chengchi; Xiao, Wuhan			Negative Feedback Regulation of Wnt4 Signaling by EAF1 and EAF2/U19	PLOS ONE			English	Article							EXTENSION MOVEMENTS; ELL; EXPRESSION; CONVERGENCE; ACTIVATION; PROSTATE; PROTEIN; GENE	Previous studies indicated that EAF (ELL-associated factor) family members, EAF1 and EAF2/U19, play a role in cancer and embryogenesis. For example, EAF2/U19 may serve as a tumor suppressor in prostate cancer. At the same time, EAF2/U19 is a downstream factor in the non-canonical Wnt4 signaling pathway required for eye development in Xenopus laevis, and along with EAF1, contributes to convergence and extension movements in zebrafish embryos through Wnt maintenance. Here, we used zebrafish embryos and mammalian cells to show that both EAF1 and EAF2/U19 were up-regulated by Wnt4 (Wnt4a). Furthermore, we found that EAF1 and EAF2/U19 suppressed Wnt4 expression by directly binding to the Wnt4 promoter as seen in chromatin immunoprecipitation assays. These findings indicate that an auto-regulatory negative feedback loop occurs between Wnt4 and the EAF family, which is conserved between zebrafish and mammalian. The rescue experiments in zebrafish embryos showed that early embryonic development required the maintenance of the appropriate levels of Wnt4a through the feedback loop. Others have demonstrated that the tumor suppressors p63, p73 and WT1 positively regulate Wnt4 expression while p21 has the opposite effect, suggesting that maintenance of appropriate Wnt4 expression may also be critical for adult tissue homeostasis and prevention against tumor initiation. Thus, the autoregulatory negative feedback loop that controls expression of Wnt4 and EAF proteins may play an important role in both embryonic development and tumor suppression. Our findings provide the first convincing line of evidence that EAF and Wnt4 form an auto-regulatory negative feedback loop in vivo.	[Wan, Xiaoyang; Ji, Wei; Mei, Xue; Zhou, Jiangang; Liu, Jing-xia; Fang, Chengchi; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022	Wan, Xiaoyang/0000-0002-8871-2015	NSFC [30671037, 30971667, 30700440, 20890113]; National Transgene Project [2009ZX08010-021B];  [2010CB126306];  [2007CB815705];  [2004CB117404]	NSFC(National Natural Science Foundation of China (NSFC)); National Transgene Project; ; ; 	WX is supported by 973 grant 2010CB126306, 2007CB815705, 2004CB117404, NSFC grant 30671037, 30971667 and National Transgene Project 2009ZX08010-021B. JL is supported by NSFC grant (Youth Foundation) 30700440 and NSFC grant 20890113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jordan BK, 2003, P NATL ACAD SCI USA, V100, P10866, DOI 10.1073/pnas.1834480100; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Liu AP, 2000, MECH DEVELOP, V91, P409, DOI 10.1016/S0925-4773(99)00308-1; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Osada M, 2006, BIOCHEM BIOPH RES CO, V339, P1120, DOI 10.1016/j.bbrc.2005.11.118; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Sim EUH, 2002, ONCOGENE, V21, P2948, DOI 10.1038/sj.onc.1205373; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2006, PROSTATE, V66, P1, DOI 10.1002/pros.20309; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595	24	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9118	10.1371/journal.pone.0009118	http://dx.doi.org/10.1371/journal.pone.0009118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161747	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600016
J	Kunzli, N; Jerrett, M; Garcia-Esteban, R; Basagana, X; Beckermann, B; Gilliland, F; Medina, M; Peters, J; Hodis, HN; Mack, WJ				Kuenzli, Nino; Jerrett, Michael; Garcia-Esteban, Raquel; Basagana, Xavier; Beckermann, Bernardo; Gilliland, Frank; Medina, Merce; Peters, John; Hodis, Howard N.; Mack, Wendy J.			Ambient Air Pollution and the Progression of Atherosclerosis in Adults	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RANDOMIZED CONTROLLED-TRIAL; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; HORMONE-THERAPY; CAROTID-ARTERY; LOS-ANGELES; EXPOSURE; PREVENTION; EVENTS	Background: Cross-sectional studies suggest an association between exposure to ambient air pollution and atherosclerosis. We investigated the association between outdoor air quality and progression of subclinical atherosclerosis (common carotid artery intima-media thickness, CIMT). Methodology/Principal Findings: We examined data from five double-blind randomized trials that assessed effects of various treatments on the change in CIMT. The trials were conducted in the Los Angeles area. Spatial models and land-use data were used to estimate the home outdoor mean concentration of particulate matter up to 2.5 micrometer in diameter (PM2.5), and to classify residence by proximity to traffic-related pollution (within 100 m of highways). PM2.5 and traffic proximity were positively associated with CIMT progression. Adjusted coefficients were larger than crude associations, not sensitive to modelling specifications, and statistically significant for highway proximity while of borderline significance for PM2.5 (P = 0.08). Annual CIMT progression among those living within 100 m of a highway was accelerated (5.5 micrometers/yr [95% CI: 0.13-10.79; p = 0.04]) or more than twice the population mean progression. For PM2.5, coefficients were positive as well, reaching statistical significance in the socially disadvantaged; in subjects reporting lipid lowering treatment at baseline; among participants receiving on-trial treatments; and among the pool of four out of the five trials. Conclusion: Consistent with cross-sectional findings and animal studies, this is the first study to report an association between exposure to air pollution and the progression of atherosclerosis - indicated with CIMT change - in humans. Ostensibly, our results suggest that air pollution may contribute to the acceleration of cardiovascular disease development the main causes of morbidity and mortality in many countries. However, the heterogeneity of the volunteering populations across the five trials, the limited sample size within trials and other relevant subgroups, and the fact that some key findings reached statistical significance in subgroups rather than the sample precludes generalizations to the general population.	[Kuenzli, Nino] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Kuenzli, Nino; Garcia-Esteban, Raquel; Basagana, Xavier; Medina, Merce] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Jerrett, Michael; Beckermann, Bernardo] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Gilliland, Frank; Peters, John; Mack, Wendy J.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Hodis, Howard N.] Univ So Calif, Dept Med, Atherosclerosis Res Unit, Los Angeles, CA 90089 USA	University of Basel; Swiss Tropical & Public Health Institute; Pompeu Fabra University; University of California System; University of California Berkeley; University of Southern California; University of Southern California	Kunzli, N (corresponding author), Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland.	Nino.Kuenzli@unibas.ch	Jerrett, Michael/CAA-2482-2022; Basagaña, Xavier/C-3901-2017; Kuenzli, Nino/F-7195-2014	Basagaña, Xavier/0000-0002-8457-1489; Kuenzli, Nino/0000-0001-8360-080X; Garcia, Raquel/0000-0002-5663-6388	NIH National Institute on Aging [R01AG-13860, R01AG-17160, R01AG-18798]; National Health Lung and Blood Institute [U01HL-49298]; Office of Dietary Supplements; Office of Research on Minority Health; National Institute of Environmental Health Sciences [5 P30 ES07048]; Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva [JCI-2007-47-767]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL049298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013860, R01AG018798, R01AG017160] Funding Source: NIH RePORTER	NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Health Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research on Minority Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain(ICREA); Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The main author and data analyst (RG) had full access to the data and takes responsibility for the integrity of the data and the accuracy of the data analysis. NIH National Institute on Aging (grants R01AG-13860 (VEAPS); R01AG-17160 (BVAIT); R01AG-18798 (EPAT); National Health Lung and Blood Institute (U01HL-49298) (WELL-HART); Office of Dietary Supplements (VEAPS, BVAIT) and Office of Research on Minority Health (WELL-HART); National Institute of Environmental Health Sciences (5 P30 ES07048); Parke-Davis Pharmaceutical Research (TART); Wright Foundation; Hastings Foundation; Health Effects Institute; Catalan Institute for Research and Advanced studies (ICREA), Barcelona, Spain; Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Ministry of Science and Innovation Program Juan de la Cierva (JCI-2007-47-767).	ABE KC, 2009, ENV RES; Allen RW, 2009, EPIDEMIOLOGY, V20, P254, DOI 10.1097/EDE.0b013e31819644cc; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Bailey T, 1995, INTERACTIVE SPATIAL; Beelen R, 2009, OCCUP ENVIRON MED, V66, P243, DOI 10.1136/oem.2008.042358; BLANKENHORN DH, 1994, ARTERIOSCLER THROMB, V14, P177, DOI 10.1161/01.ATV.14.2.177; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Chambless LE, 2002, AM J EPIDEMIOL, V155, P38, DOI 10.1093/aje/155.1.38; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Health Effects Institute, 2009, 17 HEI; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2003, NEW ENGL J MED, V349, P535, DOI 10.1056/NEJMoa030830; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hodis HN, 1999, CURR PRACT MED, V2, P171; Hodis HN, 2008, CLIN OBSTET GYNECOL, V51, P564, DOI 10.1097/GRF.0b013e318181de86; Hodis HN, 2006, DIABETES CARE, V29, P1545, DOI 10.2337/dc05-2462; Hodis Howard N, 2008, Cleve Clin J Med, V75 Suppl 4, pS3; Hodis HN, 2009, STROKE, V40, P730, DOI 10.1161/STROKEAHA.108.526798; Hoek G, 2001, J EXPO ANAL ENV EPID, V11, P459, DOI 10.1038/sj.jea.7500189; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Jerrett M, 2009, ENVIRON HEALTH PERSP, V117, P772, DOI 10.1289/ehp.11533; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kunzli N, 2005, SWISS MED WKLY, V135, P697; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; RUBIN DB, 1996, J AM STAT ASSOC, V91, P473, DOI DOI 10.2307/2291635; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Sharman JE, 2002, ARCH ENVIRON HEALTH, V57, P536, DOI 10.1080/00039890209602085; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yanez ND, 1998, STAT MED, V17, P2597, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2597::AID-SIM940>3.0.CO;2-G; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842	42	188	192	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9096	10.1371/journal.pone.0009096	http://dx.doi.org/10.1371/journal.pone.0009096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161713	Green Published, gold			2022-12-27	WOS:000274442500007
J	Fujikawa, K; Iwata, T; Inoue, K; Akahori, M; Kadotani, H; Fukaya, M; Watanabe, M; Chang, Q; Barnett, EM; Swat, W				Fujikawa, Keiko; Iwata, Takeshi; Inoue, Kaoru; Akahori, Masakazu; Kadotani, Hanako; Fukaya, Masahiro; Watanabe, Masahiko; Chang, Qing; Barnett, Edward M.; Swat, Wojciech			VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR DYNAMICS; TRABECULAR MESHWORK; INTRAOCULAR-PRESSURE; JAPANESE PATIENTS; LOXL1 VARIANTS; IRIS ATROPHY; OUTFLOW; PROTEIN	Background: Glaucoma is a leading cause of blindness worldwide. Nonetheless, the mechanism of its pathogenesis has not been well-elucidated, particularly at the molecular level, because of insufficient availability of experimental genetic animal models. Methodology/Principal Findings: Here we demonstrate that deficiency of Vav2 and Vav3, guanine nucleotides exchange factors for Rho guanosine triphosphatases, leads to an ocular phenotype similar to human glaucoma. Vav2/Vav3-deficient mice, and to a lesser degree Vav2-deficient mice, show early onset of iridocorneal angle changes and elevated intraocular pressure, with subsequent selective loss of retinal ganglion cells and optic nerve head cupping, which are the hallmarks of glaucoma. The expression of Vav2 and Vav3 tissues was demonstrated in the iridocorneal angle and retina in both mouse and human eyes. In addition, a genome-wide association study screening glaucoma susceptibility loci using single nucleotide polymorphisms analysis identified VAV2 and VAV3 as candidates for associated genes in Japanese open-angle glaucoma patients. Conclusions/Significance: Vav2/Vav3-deficient mice should serve not only as a useful murine model of spontaneous glaucoma, but may also provide a valuable tool in understanding of the pathogenesis of glaucoma in humans, particularly the determinants of altered aqueous outflow and subsequent elevated intraocular pressure.	[Fujikawa, Keiko; Kadotani, Hanako] Hokkaido Univ, Grad Sch Med, Dept Pathol & Immunol, Sapporo, Hokkaido, Japan; [Iwata, Takeshi; Akahori, Masakazu] Natl Hosp Org, Tokyo Med Ctr, Natl Inst Sensory Organs, Tokyo, Japan; [Fujikawa, Keiko; Inoue, Kaoru] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Chang, Qing; Barnett, Edward M.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Fujikawa, Keiko; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Hokkaido University; Hokkaido University; Hokkaido University; Washington University (WUSTL); Washington University (WUSTL)	Fujikawa, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Pathol & Immunol, Sapporo, Hokkaido, Japan.	fujikawa@med.hokudai.ac.jp	Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012	Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science and Technology in Japan	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work described in this report was funded in parts by a grant from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara M, 2003, INVEST OPHTH VIS SCI, V44, P5168, DOI 10.1167/iovs.03-0504; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; BILL A, 1972, ACTA OPHTHALMOL, V50, P295; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Cella M, 2004, J EXP MED, V200, P817, DOI 10.1084/jem.20031847; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Diskin S, 2009, GLYCOBIOLOGY, V19, P29, DOI 10.1093/glycob/cwn100; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Filla MS, 2006, INVEST OPHTH VIS SCI, V47, P1956, DOI 10.1167/iovs.05-0626; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Funayama T, 2006, INVEST OPHTH VIS SCI, V47, P5368, DOI 10.1167/iovs.06-0196; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inagaki Y, 2006, MOL VIS, V12, P673; Ishikawa K, 2005, MOL VIS, V11, P431; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kumar A, 2007, MOL VIS, V13, P667; Liu YT, 2008, INVEST OPHTH VIS SCI, V49, P3465, DOI 10.1167/iovs.08-1850; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Narooie-Nejad M, 2009, HUM MOL GENET, V18, P3969, DOI 10.1093/hmg/ddp338; NEUFELD AH, 1979, SURV OPHTHALMOL, V23, P363, DOI 10.1016/0039-6257(79)90229-7; Pang IH, 2007, J GLAUCOMA, V16, P483, DOI 10.1097/IJG.0b013e3181405d4f; Peterson JA, 2005, J BIOL CHEM, V280, P6915, DOI 10.1074/jbc.M406625200; Pfeiffer N, 1997, SURV OPHTHALMOL, V42, P137, DOI 10.1016/S0039-6257(97)00053-2; Rao PV, 2008, INVEST OPHTH VIS SCI, V49, P2464, DOI 10.1167/iovs.07-1639; Riteau B, 2003, J EXP MED, V198, P469, DOI 10.1084/jem.20021995; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shibuya E, 2008, INVEST OPHTH VIS SCI, V49, P4453, DOI 10.1167/iovs.07-1575; Sud A, 2008, MOL VIS, V14, P1319; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Tanito M, 2008, MOL VIS, V14, P1898; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Tybulewicz VLJ, 2003, IMMUNOL REV, V192, P42, DOI 10.1034/j.1600-065X.2003.00032.x; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weinreb RN, 2002, SURV OPHTHALMOL, V47, pS53, DOI 10.1016/S0039-6257(02)00306-5; WIEDERHOLT M, 1995, EXP EYE RES, V61, P223, DOI 10.1016/S0014-4835(05)80042-9; Wolf C, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-91	49	39	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9050	10.1371/journal.pone.0009050	http://dx.doi.org/10.1371/journal.pone.0009050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140222	Green Published, gold			2022-12-27	WOS:000274474400009
J	Dechmann, DKN; Kranstauber, B; Gibbs, D; Wikelski, M				Dechmann, Dina K. N.; Kranstauber, Bart; Gibbs, David; Wikelski, Martin			Group Hunting-A Reason for Sociality in Molossid Bats?	PLOS ONE			English	Article							ECHOLOCATION; CALLS; EVOLUTION	Many bat species live in groups, some of them in highly complex social systems, but the reasons for sociality in bats remain largely unresolved. Increased foraging efficiency through passive information transfer in species foraging for ephemeral insects has been postulated as a reason for group formation of male bats in the temperate zones. We hypothesized that benefits from group hunting might also entice tropical bats of both sexes to live in groups. Here we investigate whether Molossus molossus, a small insectivorous bat in Panama, hunts in groups. We use a phased antenna array setup to reduce error in telemetry bearings. Our results confirmed that simultaneously radiotracked individuals from the same colony foraged together significantly more than expected by chance. Our data are consistent with the hypothesis that many bats are social because of information transfer between foraging group members. We suggest this reason for sociality to be more widespread than currently assumed. Furthermore, benefits from group hunting may also have contributed to the evolution of group living in other animals specialized on ephemeral food sources.	[Dechmann, Dina K. N.; Wikelski, Martin] Univ Konstanz, Chair Ornithol, Constance, Germany; [Dechmann, Dina K. N.; Kranstauber, Bart; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Gibbs, David; Wikelski, Martin] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Konstanz; Max Planck Society; Princeton University	Dechmann, DKN (corresponding author), Univ Konstanz, Chair Ornithol, Constance, Germany.	ddechmann@orn.mpg.de		Dechmann, Dina/0000-0003-0043-8267; Kranstauber, Bart/0000-0001-8303-780X	Princeton University; Max Planck Institute of Ornithology in Radolfzell, Germany	Princeton University(Princeton University); Max Planck Institute of Ornithology in Radolfzell, Germany	This study was conducted during a student course with students from Princeton University and the University of Konstanz ( see acknowledgments) and carried out with very little funding. Funding was received from Princeton University and the Max Planck Institute of Ornithology in Radolfzell, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; BALCOMBE JP, 1988, ETHOLOGY, V79, P158, DOI 10.1111/j.1439-0310.1988.tb00708.x; BARCLAY RMR, 1982, BEHAV ECOL SOCIOBIOL, V10, P271, DOI 10.1007/BF00302816; Beauchamp G, 2001, EVOL ECOL RES, V3, P703; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Cochran WW, 2001, WILDLIFE SOC B, V29, P594; DECHMANN DKN, 2009, P ROY SOC LOND B BIO, P2721; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fernandez-Juricic E, 2004, TRENDS ECOL EVOL, V19, P25, DOI 10.1016/j.tree.2003.10.003; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; GIRALDEAU LA, 2005, BEHAV ECOLOGY, V16, P352; Jones G, 2003, BAT ECOLOGY, P301; Kenward R.E., 2000, MANUAL WILDLIFE RADI; Leigh JEG, 1999, TROPICAL FOREST ECOL; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lourenco SI, 2007, J ZOOL, V273, P161, DOI 10.1111/j.1469-7998.2007.00322.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; R Core Team, 2020, R LANG ENV STAT COMP; RACEY PA, 1987, ENERGY COSTS PREGNAN, P107; Ratcliffe JM, 2005, BIOL LETTERS, V1, P72, DOI 10.1098/rsbl.2004.0252; SAFI K, 2009, EVOLUTIONARY ECOLOGY; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; von Frisch K, 1969, DANCE LANGUAGE ORIEN; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILKINSON GS, 1988, ETHOL SOCIOBIOL, V9, P85, DOI 10.1016/0162-3095(88)90015-5; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557; Windsor D.M, 1990, SMITHSON CONTRIB EAR, V29, P1, DOI [10.5479/SI.00810274.29.1, DOI 10.5479/SI.00810274.29.1]	32	61	63	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9012	10.1371/journal.pone.0009012	http://dx.doi.org/10.1371/journal.pone.0009012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140247	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474200009
J	Elstgeest, LE; Martens, SE; Lopriore, E; Walther, FJ; te Pas, AB				Elstgeest, Liset E.; Martens, Shirley E.; Lopriore, Enrico; Walther, Frans J.; te Pas, Arjan B.			Does Parenteral Nutrition Influence Electrolyte and Fluid Balance in Preterm Infants in the First Days after Birth?	PLOS ONE			English	Article							POSTNATAL SODIUM SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; PATENT DUCTUS-ARTERIOSUS; GESTATIONAL-AGE; WEIGHT INFANTS; BODY-COMPOSITION; ASSOCIATION	Background: New national guidelines recommend more restricted fluid intake and early initiation of total parenteral nutrition (TPN) in very preterm infants. The aim was study the effect of these guidelines on serum sodium and potassium levels and fluid balance in the first three days after birth. Methods: Two cohorts of infants <28 weeks gestational age, born at the Leiden University Medical Center in the Netherlands, were compared retrospectively before (2002-2004, late-TPN) and after (2006-2007, early-TPN) introduction of the new Dutch guideline. Outcome measures were serum sodium and potassium levels, diuresis, and changes in body weight in the first three postnatal days. Results: In the first three postnatal days no differences between late-TPN (N = 70) and early-TPN cohort (N = 73) in mean (SD) serum sodium (141.1 (3.8) vs 141.0 (3.7) mmol/l) or potassium (4.3 (0.5) vs 4.3 (0.5) mmol/l) were found, but in the early-TPN cohort diuresis (4.5 (1.6) vs 3.2 (1.4) ml/kg/h) and loss of body weight were decreased (26.0% (7.7) vs 20.8% (8.0)). Conclusions: Initiation of TPN immediately after birth and restricted fluid intake in very preterm infants do not seem to influence serum sodium and potassium levels in first three postnatal days. Further research is needed to see if a decreased diuresis and loss of body weight in the first days is the result of a delayed postnatal adaptation or better energy balance.	[Elstgeest, Liset E.; Martens, Shirley E.; Lopriore, Enrico; Walther, Frans J.; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Elstgeest, LE (corresponding author), Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.	a.b.te_pas@lumc.nl	Lopriore, Enrico/ABE-3576-2021; pas, arjan te/AAA-9019-2020	Lopriore, Enrico/0000-0002-3513-5066; pas, arjan te/0000-0001-7831-8797; Walther, Frans/0000-0003-1931-159X				Aggarwal Rajiv, 2001, Indian Journal of Pediatrics, V68, P1139, DOI 10.1007/BF02722931; Bell EF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000503.pub2; BELL EF, 1979, LANCET, V2, P90; BELL EF, 1980, NEW ENGL J MED, V302, P598, DOI 10.1056/NEJM198003133021103; Bhatia J, 2006, J PERINATOL, V26, pS19, DOI 10.1038/sj.jp.7211466; Braake FWJT, 2007, SEMIN FETAL NEONAT M, V12, P11, DOI 10.1016/j.siny.2006.10.002; COCKBURN F, 1993, LANCET, V342, P193; COSTARINO AT, 1992, J PEDIATR-US, V120, P99, DOI 10.1016/S0022-3476(05)80611-0; DELL KM, 2006, FANAROFF MARTINS NEO, P695; Gawlowski Z, 2006, J PAEDIATR CHILD H, V42, P771, DOI 10.1111/j.1440-1754.2006.00975.x; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF19, DOI 10.1136/fn.82.1.F19; Hartnoll G, 2000, ARCH DIS CHILD-FETAL, V82, pF24, DOI 10.1136/fn.82.1.F24; Hartnoll G, 2001, ARCH DIS CHILD-FETAL, V85, pF29, DOI 10.1136/fn.85.1.F29; HEIMLER R, 1993, J PEDIATR-US, V122, P110, DOI 10.1016/S0022-3476(05)83502-4; KOOLEN AMP, 2004, WERKBOEK ENTERALE PA, P17; LORENZ JM, 1982, J PEDIATR-US, V101, P423, DOI 10.1016/S0022-3476(82)80078-4; Lorenz JM, 1997, J PEDIATR-US, V131, P81, DOI 10.1016/S0022-3476(97)70128-8; Mildenberger E, 2002, EUR J PEDIATR, V161, P415, DOI 10.1007/s00431-002-0986-9; Modi N, 2004, ARCH DIS CHILD-FETAL, V89, P108, DOI 10.1136/adc.2001.004275; MODI N, 1993, ARCH DIS CHILD-FETAL, V69, P87, DOI 10.1136/adc.69.1_Spec_No.87; Oh W, 2005, J PEDIATR-US, V147, P786, DOI 10.1016/j.jpeds.2005.06.039; Omar SA, 2000, PEDIATRICS, V106, P561, DOI 10.1542/peds.106.3.561; Poindexter BB, 2006, J PEDIATR-US, V148, P300, DOI 10.1016/j.jpeds.2005.10.038; POINDEXTER BB, 2006, FANAROFF MARTINS NEO, P679; PUTHOFF TD, 2004, NEWBORN INFANT NURS, V4, P98; SHAFFER SG, 1989, J PEDIATR-US, V115, P285, DOI 10.1016/S0022-3476(89)80087-3; STEVENSON JG, 1977, J PEDIATR-US, V90, P257, DOI 10.1016/S0022-3476(77)80645-8; Tang W, 1997, ARCH DIS CHILD-FETAL, V77, pF28, DOI 10.1136/fn.77.1.F28; Van den Akker CHP, 2006, PEDIATR RES, V59, P732, DOI 10.1203/01.pdr.0000214990.86879.26; VANMARTER LJ, 1990, J PEDIATR-US, V116, P942; Wadhawan R, 2007, J PERINATOL, V27, P359, DOI 10.1038/sj.jp.7211751	31	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9033	10.1371/journal.pone.0009033	http://dx.doi.org/10.1371/journal.pone.0009033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140260	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474200019
J	Atencio, CA; Schreiner, CE				Atencio, Craig A.; Schreiner, Christoph E.			Columnar Connectivity and Laminar Processing in Cat Primary Auditory Cortex	PLOS ONE			English	Article							RAT BARREL CORTEX; RECEPTIVE-FIELD PROPERTIES; THALAMOCORTICAL SYSTEM; IN-VITRO; SYNAPTIC CONNECTIONS; CORTICAL-NEURONS; CEREBRAL-CORTEX; NEURAL ACTIVITY; INTRACELLULAR-RECORDINGS; SPECTRAL INTEGRATION	Background: Radial intra- and interlaminar connections form a basic microcircuit in primary auditory cortex (AI) that extracts acoustic information and distributes it to cortical and subcortical networks. Though the structure of this microcircuit is known, we do not know how the functional connectivity between layers relates to laminar processing. Methodology/Principal Findings: We studied the relationships between functional connectivity and receptive field properties in this columnar microcircuit by simultaneously recording from single neurons in cat AI in response to broadband dynamic moving ripple stimuli. We used spectrotemporal receptive fields (STRFs) to estimate the relationship between receptive field parameters and the functional connectivity between pairs of neurons. Interlaminar connectivity obtained through cross-covariance analysis reflected a consistent pattern of information flow from thalamic input layers to cortical output layers. Connection strength and STRF similarity were greatest for intralaminar neuron pairs and in supragranular layers and weaker for interlaminar projections. Interlaminar connection strength co-varied with several STRF parameters: feature selectivity, phase locking to the stimulus envelope, best temporal modulation frequency, and best spectral modulation frequency. Connectivity properties and receptive field relationships differed for vertical and horizontal connections. Conclusions/Significance: Thus, the mode of local processing in supragranular layers differs from that in infragranular layers. Therefore, specific connectivity patterns in the auditory cortex shape the flow of information and constrain how spectrotemporal processing transformations progress in the canonical columnar auditory microcircuit.	[Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif Berkeley, Berkeley Bioengn Grad Grp, Berkeley, CA 94720 USA; [Atencio, Craig A.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, Coleman Mem Lab, San Francisco, CA 94143 USA; [Atencio, Craig A.; Schreiner, Christoph E.] WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atencio, CA (corresponding author), Univ Calif Berkeley, Berkeley Bioengn Grad Grp, Berkeley, CA 94720 USA.	craig@phy.ucsf.edu		Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health [DC02260, MH077970]; Coleman Memorial Fund; Hearing Research, Inc. (San Francisco, California); NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coleman Memorial Fund; Hearing Research, Inc. (San Francisco, California); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health (DC02260, MH077970; www.nih.gov), the Coleman Memorial Fund, and Hearing Research, Inc. (San Francisco, California). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; ATENCIO CA, 2009, P NATL ACAD IN PRESS; ATENCIO CA, 2009, J NEUROPHYS IN PRESS; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Barbour DL, 2008, J NEUROSCI, V28, P11174, DOI 10.1523/JNEUROSCI.2093-08.2008; Brillinger DR, 1979, SELECTA STAT CANADIA, VV, P1; Brosch M, 1999, EUR J NEUROSCI, V11, P3517, DOI 10.1046/j.1460-9568.1999.00770.x; Bruno RM, 2002, J NEUROSCI, V22, P10966; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CODE RA, 1986, HEARING RES, V23, P205, DOI 10.1016/0378-5955(86)90110-3; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; EGGERMONT JJ, 1991, J NEUROPHYSIOL, V66, P1549, DOI 10.1152/jn.1991.66.5.1549; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2121, DOI 10.1097/00001756-199511000-00006; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708, DOI 10.1152/jn.2000.83.5.2708; EGGERMONT JJ, 1994, J NEUROPHYSIOL, V71, P246, DOI 10.1152/jn.1994.71.1.246; EGGERMONT JJ, 1995, NEUROREPORT, V6, P2125, DOI 10.1097/00001756-199511000-00007; Eggermont JJ, 1996, EXP BRAIN RES, V110, P379; EGGERMONT JJ, 1992, J NEUROPHYSIOL, V68, P1216, DOI 10.1152/jn.1992.68.4.1216; Eggermont JJ, 2006, J NEUROPHYSIOL, V96, P746, DOI 10.1152/jn.00059.2006; EPPING WJM, 1987, J NEUROPHYSIOL, V57, P1464, DOI 10.1152/jn.1987.57.5.1464; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Halliday D.M., 1999, TIME FREQUENCY DOMAI, P503, DOI DOI 10.1007/978-3-642-58552-4_18; Hefri BJ, 2003, JARO-J ASSOC RES OTO, V4, P106, DOI 10.1007/s10162-002-3012-z; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; IMIG TJ, 1981, J COMP NEUROL, V203, P1, DOI 10.1002/cne.902030102; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kubota M, 1997, NEUROSCI LETT, V237, P77, DOI 10.1016/S0304-3940(97)00806-9; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Linden JF, 2003, CEREB CORTEX, V13, P83, DOI 10.1093/cercor/13.1.83; Martinez LM, 2001, NEURON, V32, P515, DOI 10.1016/S0896-6273(01)00489-5; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; Mendelson JR, 1997, J COMP PHYSIOL A, V181, P615, DOI 10.1007/s003590050145; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Miller LM, 2001, J NEUROSCI, V21, P8136, DOI 10.1523/JNEUROSCI.21-20-08136.2001; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; MITANI A, 1985, J COMP NEUROL, V235, P430, DOI 10.1002/cne.902350403; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; OJIMA H, 1992, CEREB CORTEX, V2, P197, DOI 10.1093/cercor/2.3.197; Ojima H, 1991, CEREB CORTEX, V1, P80, DOI 10.1093/cercor/1.1.80; PHILLIPS DP, 1981, J NEUROPHYSIOL, V45, P48, DOI 10.1152/jn.1981.45.1.48; Read HL, 2001, P NATL ACAD SCI USA, V98, P8042, DOI 10.1073/pnas.131591898; ROCKEL AJ, 1980, BRAIN, V103, P221, DOI 10.1093/brain/103.2.221; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schofield BR, 2006, JARO-J ASSOC RES OTO, V7, P95, DOI 10.1007/s10162-005-0025-4; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; SZENTAGOTHAI J, 1975, BRAIN RES, V95, P475, DOI 10.1016/0006-8993(75)90122-5; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; VOIGT HF, 1990, J NEUROPHYSIOL, V64, P1590, DOI 10.1152/jn.1990.64.5.1590; VOLKOV IO, 1989, NEUROPHYSIOLOGY+, V21, P432; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Winer J.A., 1992, Springer Handbook of Auditory Research, V1, P222; WINER JA, 1984, J COMP NEUROL, V224, P535, DOI 10.1002/cne.902240405; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Winer JA, 2001, J COMP NEUROL, V434, P379, DOI 10.1002/cne.1183; WINGUTH SD, 1986, J COMP NEUROL, V248, P36, DOI 10.1002/cne.902480104; Wise KD, 2005, IEEE ENG MED BIOL, V24, P22, DOI 10.1109/MEMB.2005.1511497; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZHANG M, 2005, EXP BRAIN RES, P1; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003	86	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9521	10.1371/journal.pone.0009521	http://dx.doi.org/10.1371/journal.pone.0009521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209092	Green Published, gold			2022-12-27	WOS:000275063400025
J	Hur, C; Hayeck, TJ; Yeh, JM; Richards, EB; Spechler, SJ; Gazelle, GS; Kong, CY				Hur, Chin; Hayeck, Tristan J.; Yeh, Jennifer M.; Richards, Ethan B.; Spechler, Stuart J.; Gazelle, G. Scott; Kong, Chung Yin			Development, Calibration, and Validation of a US White Male Population-Based Simulation Model of Esophageal Adenocarcinoma	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BARRETTS-ESOPHAGUS; GASTRIC CARDIA; CLINICAL SPECTRUM; UNITED-STATES; CANCER-RISK; PREVALENCE; SYMPTOMS; SURVEILLANCE; TRENDS	Background: The incidence of esophageal adenocarcinoma (EAC) has risen rapidly in the U. S. and western world. The aim of the study was to begin the investigation of this rapid rise by developing, calibrating, and validating a mathematical disease simulation model of EAC using available epidemiologic data. Methods: The model represents the natural history of EAC, including the essential biologic health states from normal mucosa to detected cancer. Progression rates between health states were estimated via calibration, which identified distinct parameter sets producing model outputs that fit epidemiologic data; specifically, the prevalence of pre-cancerous lesions and EAC cancer incidence from the published literature and Surveillance, Epidemiology, and End Results (SEER) data. As an illustrative example of a clinical and policy application, the calibrated and validated model retrospectively analyzed the potential benefit of an aspirin chemoprevention program. Results: Model outcomes approximated calibration targets; results of the model's fit and validation are presented. Approximately 7,000 cases of EAC could have been prevented over a 30-year period if all white males started aspirin chemoprevention at age 40 in 1965. Conclusions: The model serves as the foundation for future analyses to determine a cost-effective screening and management strategy to prevent EAC morbidity and mortality.	[Hur, Chin; Hayeck, Tristan J.; Gazelle, G. Scott; Kong, Chung Yin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Hur, Chin; Hayeck, Tristan J.; Richards, Ethan B.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Hur, Chin; Gazelle, G. Scott; Kong, Chung Yin] Harvard Univ, Sch Med, Boston, MA USA; [Yeh, Jennifer M.; Gazelle, G. Scott] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Spechler, Stuart J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hur, C (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.	chur@mgh-ita.org		Hur, Chin/0000-0002-2819-7576	NIH/NCI [CA107060, CA133141]; NATIONAL CANCER INSTITUTE [K07CA107060, K25CA133141, K07CA143044] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: NIH/NCI Grant CA107060 (C. H.) and NIH/NCI Grant CA133141 (C. Y. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 2008, J NATL CANC I; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; Chak A, 2006, CANCER-AM CANCER SOC, V107, P2160, DOI 10.1002/cncr.22245; Chiocca JC, 2005, ALIMENT PHARM THER, V22, P331, DOI 10.1111/j.1365-2036.2005.02565.x; Clark G W, 1997, J Gastrointest Surg, V1, P113; COLLEN MJ, 1995, AM J GASTROENTEROL, V90, P1053; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2007, CLIN GASTROENTEROL H, V5, P17, DOI 10.1016/j.cgh.2006.09.016; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P1692, DOI 10.1053/j.gastro.2004.03.077; Gerson LB, 2004, CLIN GASTROENTEROL H, V2, P868, DOI 10.1016/S1542-3565(04)00394-5; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Goldie SJ, 2006, VACCINE S3, V24; GUANREI Y, 1988, ENDOSCOPY, V20, P95, DOI 10.1055/s-2007-1018145; Hur C, 2004, J NATL CANCER I, V96, P316, DOI 10.1093/jnci/djh039; HUR C, 2007, ADV EVIDENCE BASED A; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; ISOLAURI J, 1995, ANN MED, V27, P67, DOI 10.3109/07853899509031939; Jankowski J, 2004, JNCI-J NATL CANCER I, V96, P885, DOI 10.1093/jnci/djh171; Jeon J, 2006, CANCER CAUSE CONTROL, V17, P971, DOI 10.1007/s10552-006-0037-3; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; MENKEPLUYMERS MBE, 1993, CANCER, V72, P1155, DOI 10.1002/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Pera M, 2003, WORLD J SURG, V27, P999, DOI 10.1007/s00268-003-7052-2; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; RIES LAG, 2008, SEER 1975 2005 SEER; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P1259; Terry P, 2000, NUTR CANCER, V38, P186, DOI 10.1207/S15327914NC382_7; Valle C, 1999, DIGEST DIS SCI, V44, P1848, DOI 10.1023/A:1018846807296; Westhoff B, 2005, GASTROINTEST ENDOSC, V61, P226, DOI 10.1016/S0016-5107(04)02589-1; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212; ZHENG TZ, 1994, CANCER, V74, P1556, DOI 10.1002/1097-0142(19940901)74:5<1556::AID-CNCR2820740511>3.0.CO;2-0	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9483	10.1371/journal.pone.0009483	http://dx.doi.org/10.1371/journal.pone.0009483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208996	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997100022
J	Rodriguez-Garcia, M; Climent, N; Oliva, H; Casanova, V; Franco, R; Leon, A; Gatell, JM; Garcia, F; Gallart, T				Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Casanova, Victor; Franco, Rafael; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa			Increased alpha-Defensins 1-3 Production by Dendritic Cells in HIV-Infected Individuals Is Associated with Slower Disease Progression	PLOS ONE			English	Article							COPY NUMBER VARIATION; ANTIRETROVIRAL THERAPY; BETA-DEFENSIN; ANTIMICROBIAL DEFENSINS; UNINFECTED INDIVIDUALS; ANTIGEN PRESENTATION; INNATE IMMUNITY; PLASMA-LEVELS; HOST-DEFENSE; T-CELLS	Background: Defensins are natural endogenous antimicrobial peptides with potent anti-HIV activity and immunomodulatory effects. We recently demonstrated that immature dendritic cells (DC) produce alpha-defensins1-3 and that alpha-defensins1- 3 modulate DC generation and maturation. Since DC-HIV interaction plays a critical role during the first steps of HIV infection, we investigated the possible impact of alpha-defensins1-3 production by DC on disease progression. Methodology/Principal Findings: Monocyte-derived DC (MDDC) were analyzed comparatively in healthy controls (HC) and HIV-infected patients, including untreated "elite'' and "viremic'' controllers, untreated viremic non-controllers and antiretroviral-treated patients. We found that production of alpha-defensins1-3 was significantly increased in MDDC from HIV-infected patients versus HC, and this increase was mainly due to that observed in controllers, while in non-controllers the increase was not statistically significant (controllers vs. HC, p<0.005; controllers vs. non-controllers p<0.05). Secreted alpha-defensins1-3 by immature MDDC positively correlated with CD4 T cell counts in controllers, but not in non-controllers. Moreover, independently of their clinical classification, HIV-infected patients with higher alpha-defensins1-3 secretion by immature MDDC showed slower disease progression, measured as no decrease in the number of CD4+ T-cells below 350 cell/mm(3), lower increase of plasma viral load and no initiation of treatment over time. Plasma alpha-defensins1-3 levels lacked any relationship with immunologic and virologic parameters. Conclusions/Significance: High production of alpha-defensins1-3 by immature DCs appears as a host protective factor against progression of HIV-1infection, suggesting potential diagnostic, therapeutic and preventive implications. This protective effect may arise from the activity of alpha-defensins1-3 to damage the virions prior and/or after their internalization by immature DC, and hence favoring a more efficient viral processing and presentation to HIV-specific CD4+ T cells, without or with a minor rate of transmission of infectious HIV-1 virions.	[Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain; [Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa] IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Rodriguez-Garcia, Marta; Climent, Nuria; Oliva, Harold; Leon, Agathe; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Casanova, Victor; Franco, Rafael] Univ Barcelona, Sch Med, Hosp Clin Barcelona, Barcelona, Spain; [Casanova, Victor; Franco, Rafael] Dept Biochem & Mol Biol, Barcelona, Spain; [Franco, Rafael] Univ Barcelona, Fac Biol, Barcelona, Spain; [Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, E-31080 Pamplona, Spain; [Leon, Agathe; Gatell, Jose M.; Garcia, Felipe] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Navarra; University of Barcelona; Hospital Clinic de Barcelona	Rodriguez-Garcia, M (corresponding author), Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA.	TGALLART@clinic.ub.es	Climent, Núria/AAF-8161-2021; Franco, Rafael/C-3694-2015; Gatell, Jose M/ABC-3607-2020; , Felipe/F-4242-2014; Leon, Agathe/K-9851-2015	Climent, Núria/0000-0002-0791-656X; Franco, Rafael/0000-0003-2549-4919; , Felipe/0000-0001-7658-5832; Leon, Agathe/0000-0002-1198-5090; Casanova, Victor/0000-0002-4917-260X	Spanish Ministry of Health [FIS2003-1200, FIS2006-1259]; Spanish Ministry of Education and Science [SAF2005-05566, FIPSE36536-2005]; Foundation for the Investigation and Prevention of AIDS in Spain; Ministry of Health [ISCIII-RETIC RD06/006]; "Prof. Maximo Soriano Foundation'';  [FIPSE36750]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Education and Science(Spanish Government); Foundation for the Investigation and Prevention of AIDS in Spain; Ministry of Health; "Prof. Maximo Soriano Foundation''; 	This study was mainly supported by Research Grants FIS2003-1200 and FIS2006-1259 (T. G.) from the Spanish Ministry of Health. Additional support was also received from the research grants SAF2005-05566 (J.M.G.) from the Spanish Ministry of Education and Science, FIPSE36536-2005 (T. G.), the Foundation for the Investigation and Prevention of AIDS in Spain, ISCIII-RETIC RD06/006 from the Spanish Cooperative Network of AIDS Research Groups from the Ministry of Health (J.M.G., F. G., T. G.), and FIPSE36750 (R. F.). "Prof. Maximo Soriano Foundation'' contributed in the financial support of the PhD studies of H. A. This Foundation honors the memory of Maximo Soriano, a full Professor of Medicine of the Faculty of Medicine of the University of Barcelona. It is totally academic and aimed to promote biomedical and clinical research in the field of infectious diseases. M. R-G. is the recipient of a research award "Emili Letang'' (Hospital Clinic, Barcelona). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Ballantyne C, 2007, EUR J CARDIOV PREV R, V14, P3; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baroncelli S, 2008, JAIDS-J ACQ IMM DEF, V47, P647, DOI 10.1097/QAI.0b013e31815f3c4c; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chang TL, 2004, AIDS REV, V6, P161; Chang TLY, 2003, J VIROL, V77, P6777, DOI 10.1128/JVI.77.12.6777-6784.2003; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Folkvord JM, 2006, JAIDS-J ACQ IMM DEF, V42, P529, DOI 10.1097/01.qai.0000225010.68815.1b; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1987, INFECT IMMUN, V55, P568, DOI 10.1128/IAI.55.3.568-571.1987; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia F, 2005, J INFECT DIS, V191, P1680, DOI 10.1086/429340; Garcia F, 2001, AIDS, V15, P131, DOI 10.1097/00002030-200101050-00023; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guo CJ, 2004, AIDS, V18, P1217, DOI 10.1097/00002030-200405210-00020; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Larsson M, 2003, CURR TOP MICROBIOL, V276, P261; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Milanese M, 2009, JAIDS-J ACQ IMM DEF, V50, P331, DOI 10.1097/QAI.0b013e3181945f39; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Okazaki T, 2007, J OBSTET GYNAECOL RE, V33, P645, DOI 10.1111/j.1447-0756.2007.00626.x; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Rinaldo CR, 2009, J INTERN MED, V265, P138, DOI 10.1111/j.1365-2796.2008.02047.x; Rodriguez-Garcia M, 2007, J LEUKOCYTE BIOL, V82, P1143, DOI 10.1189/jlb.0507295; Rodriguez-Garcia M, 2009, CLIN IMMUNOL, V131, P374, DOI 10.1016/j.clim.2009.01.012; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Trabattoni D, 2004, JAIDS-J ACQ IMM DEF, V35, P455, DOI 10.1097/00126334-200404150-00003; Vaschetto R, 2007, J LEUKOCYTE BIOL, V81, P1022, DOI 10.1189/jlb.0706435; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463; ZHANG LY, 2002, J PLANT, V1, P2	61	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9436	10.1371/journal.pone.0009436	http://dx.doi.org/10.1371/journal.pone.0009436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195543	gold, Green Submitted, Green Published			2022-12-27	WOS:000274924300021
J	Bonomi, HR; Marchesini, MI; Klinke, S; Ugalde, JE; Zylberman, V; Ugalde, RA; Comerci, DJ; Goldbaum, FA				Ruy Bonomi, Hernan; Ines Marchesini, Maria; Klinke, Sebastian; Ugalde, Juan E.; Zylberman, Vanesa; Ugalde, Rodolfo A.; Comerci, Diego J.; Alberto Goldbaum, Fernando			An Atypical Riboflavin Pathway Is Essential for Brucella abortus Virulence	PLOS ONE			English	Article							LUMAZINE SYNTHASE; ACTINOBACILLUS-PLEUROPNEUMONIAE; TRANSPOSON MUTAGENESIS; ENDOPLASMIC-RETICULUM; RHODOCOCCUS-EQUI; BIOSYNTHESIS; RIBOSWITCHES; ADAPTATION; MACROPHAGE; MECHANISM	Brucellosis is a worldwide zoonosis that affects livestock and humans and is caused by closely related Brucella spp., which are adapted to intracellular life within cells of a large variety of mammals. Brucella can be considered a furtive pathogen that infects professional and non-professional phagocytes. In these cells Brucella survives in a replicative niche, which is characterized for having a very low oxygen tension and being deprived from nutrients such as amino acids and vitamins. Among these vitamins, we have focused on riboflavin (vitamin B2). Flavin metabolism has been barely implicated in bacterial virulence. We have recently described that Brucella and other Rhizobiales bear an atypical riboflavin metabolic pathway. In the present work we analyze the role of the flavin metabolism on Brucella virulence. Mutants on the two lumazine synthases (LS) isoenzymes RibH1 and RibH2 and a double RibH mutant were generated. These mutants and different complemented strains were tested for viability and virulence in cells and in mice. In this fashion we have established that at least one LS must be present for B. abortus survival and that RibH2 and not RibH1 is essential for intracellular survival due to its LS activity in vivo. In summary, we show that riboflavin biosynthesis is essential for Brucella survival inside cells or in mice. These results highlight the potential use of flavin biosynthetic pathway enzymes as targets for the chemotherapy of brucellosis.	[Ruy Bonomi, Hernan; Klinke, Sebastian; Zylberman, Vanesa; Alberto Goldbaum, Fernando] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Ines Marchesini, Maria; Ugalde, Juan E.; Ugalde, Rodolfo A.; Comerci, Diego J.] Univ Nacl Gen San Martin, CONICET, Inst Invest Biotecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bonomi, HR (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina.	fgoldbaum@leloir.org.ar	Klinke, Sebastián/N-6174-2018; Bonomi, Hernán Ruy/D-8826-2019	Klinke, Sebastián/0000-0002-8777-0870; Bonomi, Hernán Ruy/0000-0002-1550-6181; Marchesini, Ines/0000-0002-8540-2337; Goldbaum, Fernando/0000-0001-6235-3002; Comerci, Diego J./0000-0003-1949-4226	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2004 21193, PICT2005 38272, PICT2006 651]; National Institutes of Health [NIAID-NIH-RO1AI078891-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078891] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from the Howard Hughes Medical Institute to Dr. Fernando A. Goldbaum. Part of the work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (project PICT2004 21193, PICT2005 38272 & PICT2006 651) and from the National Institutes of Health (grant NIAID-NIH-RO1AI078891-01). http://www.hhmi.org/; http://www.conicet.gov.ar/; http://www.agencia.mincyt.gov.ar/; http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; Al Dahouk S, 2008, PROTEOMICS, V8, P3862, DOI 10.1002/pmic.200800026; Ashour J, 2003, J BACTERIOL, V185, P2644, DOI 10.1128/JB.185.8.2644-2652.2003; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Fischer M, 2005, NAT PROD REP, V22, P324, DOI 10.1039/b210142b; Fischer M, 2008, ARCH BIOCHEM BIOPHYS, V474, P252, DOI 10.1016/j.abb.2008.02.008; Fuller TE, 1996, INFECT IMMUN, V64, P4659, DOI 10.1128/IAI.64.11.4659-4664.1996; Fuller TE, 2000, VACCINE, V18, P2867, DOI 10.1016/S0264-410X(00)00076-1; GARCIARAMIREZ JJ, 1995, J BIOL CHEM, V270, P23801, DOI 10.1074/jbc.270.40.23801; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; GOLDBAUM FA, 1993, J CLIN MICROBIOL, V31, P2141, DOI 10.1128/JCM.31.8.2141-2145.1993; Imlay JA, 2002, ADV MICROB PHYSIOL, V46, P111, DOI 10.1016/S0065-2911(02)46003-1; de Bagues MPJ, 2007, INFECT IMMUN, V75, P531, DOI 10.1128/IAI.01185-06; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Klinke S, 2005, J MOL BIOL, V353, P124, DOI 10.1016/j.jmb.2005.08.017; Klinke S, 2007, J MOL BIOL, V373, P664, DOI 10.1016/j.jmb.2007.08.021; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Larnontagne J, 2009, J PROTEOME RES, V8, P1594, DOI 10.1021/pr800978p; Lopez AM, 2008, VACCINE, V26, P998, DOI 10.1016/j.vaccine.2007.10.069; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Starr T, 2008, TRAFFIC, V9, P678, DOI 10.1111/j.1600-0854.2008.00718.x; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Viadas C, 2009, MICROB PATHOGENESIS, V47, P189, DOI 10.1016/j.micpath.2009.06.002; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200; Zylberman V, 2006, J BACTERIOL, V188, P6135, DOI 10.1128/JB.00207-06	35	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9435	10.1371/journal.pone.0009435	http://dx.doi.org/10.1371/journal.pone.0009435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195542	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924300020
J	Geraci, G; D'Elia, I; del Gaudio, R; Di Giaimo, R				Geraci, Giuseppe; D'Elia, Ida; del Gaudio, Rosanna; Di Giaimo, Rossella			Evidence of Genetic Instability in Tumors and Normal Nearby Tissues	PLOS ONE			English	Article							AQUATICUS DNA-POLYMERASE; HPRT MUTATIONS; MEL CELLS; MULTIPLE MUTATIONS; MUTATOR PHENOTYPE; HUMAN CANCERS; STEM-CELLS; IN-VIVO; GENOME; DIFFERENTIATION	Background: Comprehensive analyses have recently been performed on many human cancer tissues, leading to the identification of a number of mutated genes but providing no information on the variety of mutations present in each of them. This information is of interest to understand the possible origin of gene mutations that cause tumors. Methodology/Principal Findings: We have analyzed the sequence heterogeneity of the transcripts of the human HPRT and G6PD single copy genes that are not considered tumor markers. Analyses have been performed on different colon cancers and on the nearby histologically normal tissues of two male patients. Several copies of each cDNA, which were produced by cloning the RT-PCR-amplified fragments of the specific mRNA, have been sequenced. Similar analyses have been performed on blood samples of two ostensibly healthy males as reference controls. The sequence heterogeneity of the HPRT and G6PD genes was also determined on DNA from tumor tissues. The employed analytical approach revealed the presence of low-frequency mutations not detectable by other procedures. The results show that genetic heterogeneity is detectable in HPRT and G6PD transcripts in both tumors and nearby healthy tissues of the two studied colon tumors. Similar frequencies of mutations are observed in patient genomic DNA, indicating that mutations have a somatic origin. HPRT transcripts show genetic heterogeneity also in healthy individuals, in agreement with previous results on human T-cells, while G6PD transcript heterogeneity is a characteristic of the patient tissues. Interestingly, data on TP53 show little, if any, heterogeneity in the same tissues. Conclusions/Significance: These findings show that genetic heterogeneity is a peculiarity not only of cancer cells but also of the normal tissue where a tumor arises.	[Geraci, Giuseppe; D'Elia, Ida; del Gaudio, Rosanna; Di Giaimo, Rossella] Univ Naples Federico 2, Dept Biol Sci, Naples, Italy; [Geraci, Giuseppe] Ceinge Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate	Geraci, G (corresponding author), Univ Naples Federico 2, Dept Biol Sci, Naples, Italy.	digiaimo@unina.it	del GAUDIO, ROSANNA/C-9240-2014; Di Giaimo, Rossella/A-3521-2014	del GAUDIO, ROSANNA/0000-0003-1208-6270; Di Giaimo, Rossella/0000-0003-3604-3697	Department of Biological Sciences, University of Naples Federico II	Department of Biological Sciences, University of Naples Federico II	This work was supported by research fundings of the Department of Biological Sciences, University of Naples Federico II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini RJ, 1998, MUTAT RES-FUND MOL M, V400, P381, DOI 10.1016/S0027-5107(98)00063-3; Albertini RJ, 2001, MUTAT RES-REV MUTAT, V489, P1, DOI 10.1016/S1383-5742(01)00064-3; Allegretta M, 2005, ENVIRON MOL MUTAGEN, V45, P326, DOI 10.1002/em.20120; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; COLEMAN WB, 1995, CLIN CHEM, V41, P644; Ferrari R, 2009, NAT REV GENET, V10, P290, DOI 10.1038/nrg2539; Foresti M, 1997, MUTAT RES-FUND MOL M, V374, P269, DOI 10.1016/S0027-5107(96)00242-4; FORESTI M, 1993, MUTAT RES, V294, P69, DOI 10.1016/0921-8777(93)90059-P; FORESTI M, 1992, MUTAT RES, V265, P195, DOI 10.1016/0027-5107(92)90048-7; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Grant BW, 1999, MUTAT RES-FUND MOL M, V431, P183, DOI 10.1016/S0027-5107(99)00161-X; Green P, 2003, NAT GENET, V33, P514, DOI 10.1038/ng1103; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; HESS ST, 1994, J MOL BIOL, V236, P1022, DOI 10.1016/0022-2836(94)90009-4; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Jackson AL, 1998, SEMIN CANCER BIOL, V8, P421, DOI 10.1006/scbi.1998.0113; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; Loeb LA, 2001, CANCER RES, V61, P3230; Majewski J, 2003, AM J HUM GENET, V73, P688, DOI 10.1086/378134; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; MOHANDAS T, 1984, AM J HUM GENET, V36, P916; Nicklas JA, 2006, ENVIRON MOL MUTAGEN, V47, P212, DOI 10.1002/em.20187; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wilson VL, 2000, CANCER RES, V60, P1830; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	31	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9343	10.1371/journal.pone.0009343	http://dx.doi.org/10.1371/journal.pone.0009343			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186333	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924000004
J	Shima-Sano, T; Yamada, R; Sekita, K; Hankins, RW; Hori, H; Seto, H; Sudo, K; Kondo, M; Kawahara, K; Tsukahara, Y; Inaba, N; Kato, S; Imai, M				Shima-Sano, Takako; Yamada, Rika; Sekita, Kazuyo; Hankins, Raleigh W.; Hori, Hiromasa; Seto, Hiroshi; Sudo, Koji; Kondo, Makiko; Kawahara, Kazuo; Tsukahara, Yuki; Inaba, Noriyuki; Kato, Shingo; Imai, Mitsunobu			A Human Immunodeficiency Virus Screening Algorithm to Address the High Rate of False-Positive Results in Pregnant Women in Japan	PLOS ONE			English	Article							COMBINED P24 ANTIGEN; ANTIBODY-ASSAYS; HIV; SPECIFICITY; INFECTION; TESTS	Background: Prenatal human immunodeficiency virus (HIV) testing is essential for the prevention of mother-to-child transmission. However, false-positive results of screening testing are a concern as they may cause unnecessary emotional stress to pregnant women waiting for confirmatory test results. In regions with an extremely low prevalence, the positive predictive values of screening are unacceptably low rate. Here, we propose a HIV screening algorithm consisting of serial two fourth-generation enzyme immunoassays to reduce the number of false-positive screening results. Methodology/Principal Findings: When 6461 pregnant women presenting to two maternity hospitals located in the Tokyo metropolitan area of Japan from September, 2004 to January, 2006 were tested using Enzygnost HIV Integral as a first screening test, 27 showed positive reactions. When these positive reaction samples were tested using VIDAS HIV DUO Quick as a second screening test, only one of them had a positive reaction, and the remaining 26 were nonreactive. Confirmatory Western blots and nucleic acid amplification test also showed that one was positive and the remaining 26 were negative; the subject who was positive with the confirmatory tests was identical to the subject who was positive with the second screening test. Thus, by adding the second screening test, the false-positive rate was improved from 0.4% to 0%, and the positive predictive value from 3.7% to 100%, compared with the single screening test. Conclusion: By applying our serial screening algorithm to HIV testing in maternity hospitals, many uninfected pregnant women would not need to receive confirmatory tests and be subjected to emotional turmoil while waiting for their confirmatory test results. This algorithm would be suitable for HIV testing of pregnant women living in low prevalence regions such as Japan.	[Shima-Sano, Takako; Sudo, Koji; Kondo, Makiko; Imai, Mitsunobu] Kanagawa Prefectural Inst Publ Hlth, Div Microbiol, Kanagawa, Japan; [Shima-Sano, Takako; Kawahara, Kazuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Hlth Care Management & Planning, Tokyo, Japan; [Yamada, Rika] Ishikawa Prefectural Cent Hosp, Dept Obstet & Gynecol, Ctr Womens & Childrens Hlth, Kanazawa, Ishikawa, Japan; [Sekita, Kazuyo; Hankins, Raleigh W.] Hlth Sci Res Inst Inc, Kanagawa, Japan; [Hori, Hiromasa] Hori Matern Hosp, Kanagawa, Japan; [Seto, Hiroshi] Seto Hosp, Saitama, Japan; [Tsukahara, Yuki] Natl Ctr Child Hlth & Dev, Div Obstet, Tokyo, Japan; [Inaba, Noriyuki] Dokkyo Med Univ, Dept Obstet & Gynecol, Mibu, Tochigi, Japan; [Sudo, Koji; Kato, Shingo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Ishikawa Prefectural Central Hospital; National Center for Child Health & Development - Japan; Dokkyo Medical University; Keio University	Shima-Sano, T (corresponding author), Kanagawa Prefectural Inst Publ Hlth, Div Microbiol, Kanagawa, Japan.	sano.ipn@pref.kanagawa.jp			National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission; Ministry of Health, Labour, and Welfare of Japan; Health Science Research Institute	National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Health Science Research Institute	This study was supported in part by grants-in-aid for the National Cooperative Study Group on HIV Infected Pregnant Women and Mother-to-child Transmission, and the Study Group on the improvement of HIV Testing and Counseling Services from the Ministry of Health, Labour, and Welfare of Japan. This was also supported by Health Science Research Institute, Incorporated, due to employment of two authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou R, 2005, ANN INTERN MED, V143, P38, DOI 10.7326/0003-4819-143-1-200507050-00009; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5; Guinn D, 2007, JAMA-J AM MED ASSOC, V297, P947, DOI 10.1001/jama.297.9.947-a; Joint United Nations Programme on HIV/AIDS & World Health Organization, 2008, EP FACT SHEET HIV AI; Ly TD, 2004, J VIROL METHODS, V122, P185, DOI 10.1016/j.jviromet.2004.08.018; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Magee LA, 1999, CAN MED ASSOC J, V160, P1285; *MIN HLTH LAB WELF, 2007, GUID PREV MOTH TO CH; *MIN HLTH LAB WELF, 2007, HIV TEST PREGN WOM N; *MIN HLTH LAB WELF, 2007, ANN RES REP COOP STU; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; *NAT I INF DIS JAP, 2008, IASR, V29, P145; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; Saville RD, 2001, J CLIN MICROBIOL, V39, P2518, DOI 10.1128/JCM.39.7.2518-2524.2001; TAMASHIRO H, 1993, LANCET, V342, P87, DOI 10.1016/0140-6736(93)91289-X; Weber B, 2002, J CLIN MICROBIOL, V40, P1420, DOI 10.1128/JCM.40.4.1420-1426.2002; Weber B, 2002, J CLIN MICROBIOL, V40, P1938, DOI 10.1128/JCM.40.6.1938-1946.2002; YAMADA R, 2008, NIHON SEIKANSENSYO G, V81, P562; Zacharias Nikolaos M, 2004, J Perinatol, V24, P743, DOI 10.1038/sj.jp.7211184	20	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9382	10.1371/journal.pone.0009382	http://dx.doi.org/10.1371/journal.pone.0009382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186348	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000022
J	Ferencko, L; Rotman, B				Ferencko, Linda; Rotman, Boris			Constructing Fluorogenic Bacillus Spores (F-Spores) via Hydrophobic Decoration of Coat Proteins	PLOS ONE			English	Article							GERMINATION; SUBTILIS	Background: Bacterial spores are protected by a coat consisting of about 60 different proteins assembled as a biochemically complex structure with intriguing morphological and mechanical properties. Historically, the coat has been considered a static structure providing rigidity and mainly acting as a sieve to exclude exogenous large toxic molecules, such as lytic enzymes. Over recent years, however, new information about the coat's architecture and function have emerged from experiments using innovative tools such as automated scanning microscopy, and high resolution atomic force microscopy. Principal Findings: Using thin-section electron microscopy, we found that the coat of Bacillus spores has topologically specific proteins forming a layer that is identifiable because it spontaneously becomes decorated with hydrophobic fluorogenic probes from the milieu. Moreover, spores with decorated coat proteins (termed F-spores) have the unexpected attribute of responding to external germination signals by generating intense fluorescence. Fluorescence data from diverse experimental designs, including F-spores constructed from five different Bacilli species, indicated that the fluorogenic ability of F-spores is under control of a putative germination-dependent mechanism. Conclusions: This work uncovers a novel attribute of spore-coat proteins that we exploited to decorate a specific layer imparting germination-dependent fluorogenicity to F-spores. We expect that F-spores will provide a model system to gain new insights into structure/function dynamics of spore-coat proteins.	[Ferencko, Linda; Rotman, Boris] BCR Diagnost, Jamestown, RI USA; [Rotman, Boris] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA	Brown University	Ferencko, L (corresponding author), BCR Diagnost, Jamestown, RI USA.	b_rotman@brown.edu			National Institutes of Health [HL070360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL070360, R43HL070360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health Grant HL070360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chada VGR, 2003, J BACTERIOL, V185, P6255, DOI 10.1128/JB.185.21.6255-6261.2003; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; DOYLE RJ, 1984, CURR MICROBIOL, V10, P329, DOI 10.1007/BF01626560; Driks A, 2003, P NATL ACAD SCI USA, V100, P3007, DOI 10.1073/pnas.0730807100; Driks A, 1999, MICROBIOL MOL BIOL R, V63, P1; Ferencko L, 2004, BIOCHEM BIOPH RES CO, V319, P854, DOI 10.1016/j.bbrc.2004.05.062; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; HACHISUKA YOETSU, 1955, JOUR BACT, V69, P399; Haugland R.P., 2005, INVITROGEN MOL PROBE, V10th; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Jagtap P, 2006, PROTEOMICS, V6, P5199, DOI 10.1002/pmic.200600314; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Lavis LD, 2008, ACS CHEM BIOL, V3, P203, DOI 10.1021/cb800065s; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Magge A, 2009, J APPL MICROBIOL, V106, P814, DOI 10.1111/j.1365-2672.2008.04048.x; Moir A, 2006, J APPL MICROBIOL, V101, P526, DOI 10.1111/j.1365-2672.2006.02885.x; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2001, J BACTERIOL, V183, P4886, DOI 10.1128/JB.183.16.4886-4893.2001; Paidhungat M, 2000, J BACTERIOL, V182, P2513, DOI 10.1128/JB.182.9.2513-2519.2000; Piggot P, 2002, BACILLUS SUBTILIS IT, P483; Plomp M, 2007, P NATL ACAD SCI USA, V104, P9644, DOI 10.1073/pnas.0610626104; Ricca Ezio, 2003, J Nanobiotechnology, V1, P6, DOI 10.1186/1477-3155-1-6; ROBINOW CF, 1953, J BACTERIOL, V66, P300, DOI 10.1128/JB.66.3.300-311.1953; ROTMAN B, 1963, P NATL ACAD SCI USA, V50, P1; ROTMAN B, 1966, P NATL ACAD SCI USA, V55, P134, DOI 10.1073/pnas.55.1.134; ROTMAN B, 1995, CELL VISION, V2, P145; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; SETLOW P, 1969, J BACTERIOL, V100, P1155, DOI 10.1128/JB.100.3.1155-1160.1969; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Wang R, 2007, LANGMUIR, V23, P10230, DOI 10.1021/la701788d; Westphal AJ, 2003, P NATL ACAD SCI USA, V100, P3461, DOI 10.1073/pnas.232710999; WIENCEK KM, 1990, APPL ENVIRON MICROB, V56, P2600, DOI 10.1128/AEM.56.9.2600-2605.1990; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; ZHANG J, 1993, J BACTERIOL, V175, P3757, DOI 10.1128/JB.175.12.3757-3766.1993	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9283	10.1371/journal.pone.0009283	http://dx.doi.org/10.1371/journal.pone.0009283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174569	Green Submitted, gold, Green Published			2022-12-27	WOS:000274923700004
J	Radhika, V; Kost, C; Boland, W; Heil, M				Radhika, Venkatesan; Kost, Christian; Boland, Wilhelm; Heil, Martin			The Role of Jasmonates in Floral Nectar Secretion	PLOS ONE			English	Article							BEAN PHASEOLUS-LUNATUS; BRASSICA-NAPUS L; ARABIDOPSIS-THALIANA; MACARANGA-TANARIUS; PLANT-RESPONSES; WOUND RESPONSE; ACID TREATMENT; GENE ENCODES; INDUCTION; DEFENSE	Plants produce nectar in their flowers as a reward for their pollinators and most of our crops depend on insect pollination, but little is known on the physiological control of nectar secretion. Jasmonates are well-known for their effects on senescence, the development and opening of flowers and on plant defences such as extrafloral nectar. Their role in floral nectar secretion has, however, not been explored so far. We investigated whether jasmonates have an influence on floral nectar secretion in oil-seed rape, Brassica napus. The floral tissues of this plant produced jasmonic acid (JA) endogenously, and JA concentrations peaked shortly before nectar secretion was highest. Exogenous application of JA to flowers induced nectar secretion, which was suppressed by treatment with phenidone, an inhibitor of JA synthesis. This effect could be reversed by additional application of JA. Jasmonoyl-isoleucine and its structural mimic coronalon also increased nectar secretion. Herbivory or addition of JA to the leaves did not have an effect on floral nectar secretion, demonstrating a functional separation of systemic defence signalling from reproductive nectar secretion. Jasmonates, which have been intensively studied in the context of herbivore defences and flower development, have a profound effect on floral nectar secretion and, thus, pollination efficiency in B. napus. Our results link floral nectar secretion to jasmonate signalling and thereby integrate the floral nectar secretion into the complex network of oxylipid-mediated developmental processes of plants.	[Radhika, Venkatesan; Kost, Christian; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Heil, Martin] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico	Max Planck Society; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Radhika, V (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	mheil@ira.cinvestav.mx	Heil, Martin/I-1797-2012; Heil, Martin/AAC-2730-2022; Kost, Christian/N-1553-2014	Kost, Christian/0000-0002-7870-7343; Heil, Martin/0000-0001-8036-8697	Max Planck Society; International Max Planck Research School (IMPRS); CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico)	Max Planck Society(Max Planck Society); International Max Planck Research School (IMPRS); CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support came from the Max Planck Society, the International Max Planck Research School (IMPRS) and CONACYT (Consejo Nacional de Ciencia y Tecnologi-a de Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHTOVA JTP, 1994, BIOL PLANTARUM, V36, P317, DOI 10.1007/BF02921108; Baker H.G., 1983, P117; BARENDSE GWM, 1985, BIOL PLANTARUM, V27, P408, DOI 10.1007/BF02879889; Bruinsma M, 2008, ENTOMOL EXP APPL, V128, P109, DOI 10.1111/j.1570-7458.2008.00695.x; Bruinsma M, 2010, OECOLOGIA, V162, P393, DOI 10.1007/s00442-009-1459-x; Castellanos MC, 2002, AM J BOT, V89, P111, DOI 10.3732/ajb.89.1.111; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; CUCUROU C, 1991, BIOCHEMISTRY-US, V30, P8964, DOI 10.1021/bi00101a008; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Devoto A, 2003, ANN BOT-LONDON, V92, P329, DOI 10.1093/aob/mcg151; EISIKOWITCH D, 1981, J AGR SCI, V96, P321, DOI 10.1017/S0021859600066107; Farkas A., 2007, EUR J PLANT SCI BIOT, V1, P125; Fischer E., 2006, Braz. J. Biol., V66, P747, DOI 10.1590/S1519-69842006000400019; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Hause B, 2000, PLANT J, V24, P113, DOI 10.1046/j.1365-313x.2000.00861.x; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2000, FUNCT ECOL, V14, P749, DOI 10.1046/j.1365-2435.2000.00480.x; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Higginson AD, 2006, ECOL ENTOMOL, V31, P269, DOI 10.1111/j.1365-2311.2006.00789.x; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Izaguirre MM, 2006, P NATL ACAD SCI USA, V103, P7170, DOI 10.1073/pnas.0509805103; KEVAN PG, 1990, EUPHYTICA, V45, P39; Krajncic B, 2006, PLANT PHYSIOL BIOCH, V44, P752, DOI 10.1016/j.plaphy.2006.10.029; Krumm T, 1995, FEBS LETT, V377, P523, DOI 10.1016/0014-5793(95)01398-9; Maciejewska BD, 2004, PLANT GROWTH REGUL, V43, P1, DOI 10.1023/B:GROW.0000038241.00771.bd; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Nepi M, 2001, INT J PLANT SCI, V162, P353, DOI 10.1086/319581; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Pak HS, 2009, PLANTA, V231, P79, DOI 10.1007/s00425-009-1029-9; Pierre J, 1999, PLANT BREEDING, V118, P471, DOI 10.1046/j.1439-0523.1999.00421.x; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Sanders PM, 2000, PLANT CELL, V12, P1041, DOI 10.1105/tpc.12.7.1041; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Schulze B, 2006, ANAL BIOCHEM, V348, P269, DOI 10.1016/j.ab.2005.10.021; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 2006, J PLANT PHYSIOL, V163, P297, DOI 10.1016/j.jplph.2005.10.014; WEILER EW, 1994, FEBS LETT, V345, P9, DOI 10.1016/0014-5793(94)00411-0; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; [No title captured]	51	57	57	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9265	10.1371/journal.pone.0009265	http://dx.doi.org/10.1371/journal.pone.0009265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174464	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923700002
J	Yu, H; Yuan, Q; Ge, SX; Wang, HY; Zhang, YL; Chen, QR; Zhang, J; Chen, PJ; Xia, NS				Yu, Hai; Yuan, Quan; Ge, Sheng-Xiang; Wang, Hurng-Yi; Zhang, Ya-Li; Chen, Qing-Rui; Zhang, Jun; Chen, Pei-Jer; Xia, Ning-Shao			Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype "I''	PLOS ONE			English	Article							SURFACE-ANTIGEN; MOUSE MODEL; VIRAL-DNA; STRAINS; SUBTYPE; GENOMES	A novel hepatitis B virus (HBV) strain (W29) was isolated from serum samples in the northwest of China. Phylogenetic and distance analyses indicate that this strain is grouped with a series of distinct strains discovered in Vietnam and Laos that have been proposed to be a new genotype I. TreeOrderScan and GroupScan methods were used to study the intergenotype recombination of this special group. Recombination plots and tree maps of W29 and these putative genotype I strains exhibit distinct characteristics that are unexpected in typical genotype C strains of HBV. The amino acids of P gene, S gene, X gene, and C gene of all genotypes (including subtypes) were compared, and eight unique sites were found in genotype I. In vitro and in vivo experiments were also conducted to determine phenotypic characteristics between W29 and other representative strains of different genotypes obtained from China. Secretion of HBsAg in Huh7 cells is uniformly abundant among genotypes A, B, C, and I (W29), but not genotype D. HBeAg secretion is low in genotype I (W29), whose level is close to genotype A and much lower than genotypes B, C, and D. Results from the acute hydrodynamic injection mouse model also exhibit a similar pattern. From an overview of the results, the viral markers of W29 (I1) in Huh7 cells and mice had a more similar level to genotype A than genotype C, although the latter was closer to W29 in distance analysis. All evidence suggests that W29, together with other related strains found in Vietnam and Laos, should be classified into a new genotype.	[Yu, Hai; Yuan, Quan; Ge, Sheng-Xiang; Zhang, Ya-Li; Chen, Qing-Rui; Zhang, Jun; Xia, Ning-Shao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Wang, Hurng-Yi; Chen, Pei-Jer] Natl Taiwan Univ & Hosp, Grad Inst Clin Med, Taipei, Taiwan	Xiamen University; National Taiwan University; National Taiwan University Hospital	Yu, H (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	zhangj@xmu.edu.cn	Xia, NS/G-4647-2010; Zhang, Jun/G-4598-2010; Ge, Shengxiang/Q-2256-2019	Zhang, Jun/0000-0002-6601-9180; Ge, Shengxiang/0000-0002-7165-3004; WANG, HURNG-YI/0000-0003-1708-8734; yuan, quan/0000-0001-5487-561X; Chen, Pei-Jer/0000-0001-8316-3785; Xia, Ningshao/0000-0003-0179-5266	National Scientific and Technological Major Project [2008ZX10002-012]; Excellent Youth Foundation of Fujian Province [2009J06020]	National Scientific and Technological Major Project; Excellent Youth Foundation of Fujian Province	This work was supported by a grant from the National Scientific and Technological Major Project (2008ZX10002-012), and a grant from the Excellent Youth Foundation of Fujian Province (2009J06020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS G, 1987, P NATL ACAD SCI USA, V84, P4641, DOI 10.1073/pnas.84.13.4641; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Colson P, 2009, J CLIN VIROL, V45, P165, DOI 10.1016/j.jcv.2009.03.007; GERBER MA, 1988, LAB INVEST, V59, P173; GUNTHER S, 1995, J VIROL, V69, P5437; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Schaefer S, 2005, J VIRAL HEPATITIS, V12, P111, DOI 10.1111/j.1365-2893.2005.00584.x; Schaefer S, 2009, INTERVIROLOGY, V52, P323, DOI 10.1159/000242353; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Sugiyama M, 2006, HEPATOLOGY, V44, P915, DOI 10.1002/hep.21345; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599	26	103	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9297	10.1371/journal.pone.0009297	http://dx.doi.org/10.1371/journal.pone.0009297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174575	Green Submitted, Green Published, gold			2022-12-27	WOS:000274923700008
J	Ben Hamida-Rebai, M; Robert, CH				Ben Hamida-Rebai, Meriam; Robert, Charles H.			A Computational Study of a Recreated G Protein-GEF Reaction Intermediate Competent for Nucleotide Exchange: Fate of the Mg Ion	PLOS ONE			English	Article							ELONGATION-FACTOR TU; MOLECULAR-DYNAMICS; ADP-RIBOSYLATION; SEC7 DOMAINS; FREE-ENERGY; CONFORMATIONAL STATES; ARF ACTIVATION; ATOMIC RADII; BREFELDIN-A; FACTOR ARNO	Small G-proteins of the superfamily Ras function as molecular switches, interacting with different cellular partners according to their activation state. G-protein activation involves the dissociation of bound GDP and its replacement by GTP, in an exchange reaction that is accelerated and regulated in the cell by guanine-nucleotide exchange factors (GEFs). Large conformational changes accompany the exchange reaction, and our understanding of the mechanism is correspondingly incomplete. However, much knowledge has been derived from structural studies of blocked or inactive mutant GEFs, which presumably closely represent intermediates in the exchange reaction and yet which are by design incompetent for carrying out the nucleotide exchange reaction. In this study we have used comparative modelling to recreate an exchange-competent form of a late, pre-GDP-ejection intermediate species in Arf1, a well-characterized small G-protein. We extensively characterized three distinct models of this intermediate using molecular dynamics simulations, allowing us to address ambiguities related to the mutant structural studies. We observed in particular the unfavorable nature of Mg2+ associated forms of the complex and the establishment of closer Arf1-GEF contacts in its absence. The results of this study shed light on GEF-mediated activation of this small G protein and on predicting the fate of the Mg ion at a critical point in the exchange reaction. The structural models themselves furnish additional targets for interfacial inhibitor design, a promising direction for exploring potentially druggable targets with high biological specificity.	[Ben Hamida-Rebai, Meriam; Robert, Charles H.] Univ Paris 11, CNRS, IBBMC, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ben Hamida-Rebai, M (corresponding author), Univ Paris 11, CNRS, IBBMC, F-91405 Orsay, France.	robert@ibpc.fr		Robert, Charles/0000-0003-0337-1504	French Centre Nationale de la Recherche Scientifique (CNRS); French Ministry of Education; IDRIS facility of the CNRS; Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN	French Centre Nationale de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Education; IDRIS facility of the CNRS; Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN	Funding for this study was provided by the French Centre Nationale de la Recherche Scientifique (CNRS) and the French Ministry of Education. Computational resources were provided by the IDRIS facility of the CNRS and by the Universite Paris Sud 11 (Orsay) Pluriformation Project DEMAIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov A, 2008, BIOCHEMISTRY-US, V47, P13594, DOI 10.1021/bi801726q; Alto NM, 2008, CELL MICROBIOL, V10, P566, DOI 10.1111/j.1462-5822.2007.01110.x; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; Banavali NK, 2002, J PHYS CHEM B, V106, P11026, DOI 10.1021/jp025852v; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carlson HA, 1999, J MED CHEM, V42, P109, DOI 10.1021/jm980351c; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cavalli A, 2001, PROTEINS, V45, P478, DOI 10.1002/prot.10013; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Grubmuller H., 1996, SOLVATE 1 0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; KAHN RA, 1984, J BIOL CHEM, V259, P6228; Kremer W, 2004, J BIOL CHEM, V279, P17004, DOI 10.1074/jbc.M312780200; Liao JC, 2004, EUR BIOPHYS J BIOPHY, V33, P29, DOI 10.1007/s00249-003-0339-2; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Mayaan E, 2007, J COMPUT CHEM, V28, P495, DOI 10.1002/jcc.20474; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Mori K, 2005, J AM CHEM SOC, V127, P15127, DOI 10.1021/ja0467972; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nina M, 1999, BIOPHYS CHEM, V78, P89, DOI 10.1016/S0301-4622(98)00236-1; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Peng YY, 2005, J MOL GRAPH MODEL, V24, P72, DOI 10.1016/j.jmgm.2005.06.002; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Robert CH, 2004, J MOL BIOL, V337, P969, DOI 10.1016/j.jmb.2004.01.052; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schimmoller F, 1997, CURR BIOL, V7, pR235, DOI 10.1016/S0960-9822(06)00109-6; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wong S, 2009, J CHEM THEORY COMPUT, V5, P422, DOI 10.1021/ct8003707; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zeeh JC, 2008, METHOD ENZYMOL, V438, P41, DOI 10.1016/S0076-6879(07)38004-X	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9142	10.1371/journal.pone.0009142	http://dx.doi.org/10.1371/journal.pone.0009142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174625	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700005
J	Schwartz, JH; Houghton, F; Macchiarelli, R; Bondioli, L				Schwartz, Jeffrey H.; Houghton, Frank; Macchiarelli, Roberto; Bondioli, Luca			Skeletal Remains from Punic Carthage Do Not Support Systematic Sacrifice of Infants	PLOS ONE			English	Article							NEONATAL LINE; TEETH; ENAMEL; MICROSCOPY	Two types of cemeteries occur at Punic Carthage and other Carthaginian settlements: one centrally situated housing the remains of older children through adults, and another at the periphery of the settlement (the "Tophet'') yielding small urns containing the cremated skeletal remains of very young animals and humans, sometimes comingled. Although the absence of the youngest humans at the primary cemeteries is unusual and worthy of discussion, debate has focused on the significance of Tophets, especially at Carthage, as burial grounds for the young. One interpretation, based on two supposed eye-witness reports of large-scale Carthaginian infant sacrifice [Kleitarchos (3(rd) c. BCE) and Diodorus Siculus (1(st) c. BCE)], a particular translation of inscriptions on some burial monuments, and the argument that if the animals had been sacrificed so too were the humans, is that Tophets represent burial grounds reserved for sacrificial victims. An alternative hypothesis acknowledges that while the Carthaginians may have occasionally sacrificed humans, as did their contemporaries, the extreme youth of Tophet individuals suggests these cemeteries were not only for the sacrificed, but also for the very young, however they died. Here we present the first rigorous analysis of the largest sample of cremated human skeletal remains (348 burial urns, N = 540 individuals) from the Carthaginian Tophet based on tooth formation, enamel histology, cranial and postcranial metrics, and the potential effects of heat-induced bone shrinkage. Most of the sample fell within the period prenatal to 5-to-6 postnatal months, with a significant presence of prenates. Rather than indicating sacrifice as the agent of death, this age distribution is consistent with modern-day data on perinatal mortality, which at Carthage would also have been exacerbated by numerous diseases common in other major cities, such as Rome and Pompeii. Our diverse approaches to analyzing the cremated human remains from Carthage strongly support the conclusion that Tophets were cemeteries for those who died shortly before or after birth, regardless of the cause.	[Schwartz, Jeffrey H.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA; [Houghton, Frank] Vet Res Fdn, Pittsburgh, PA USA; [Macchiarelli, Roberto] Museum Natl Hist Nat, CNRS, Dept Prehist, UMR 7194, Paris, France; [Bondioli, Luca] Museo Nazl Preistor Etnograf L Pigorini, Sez Antropol, Rome, Italy; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Poitiers, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers	Schwartz, JH (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA.	jhs@pitt.edu		Bondlioli, Luca/0000-0002-8511-7667	American Philosophical Society; National Endowment for the Humanities; American Schools of Oriental Research; University of Pittsburgh; British excavations at Carthage	American Philosophical Society; National Endowment for the Humanities; American Schools of Oriental Research; University of Pittsburgh(University of Pittsburgh); British excavations at Carthage	American Philosophical Society (http://www.amphilsoc.org/), National Endowment for the Humanities ( http://www.neh.gov/), American Schools of Oriental Research (http://www.asor.org/), University of Pittsburgh (http://www.pitt.edu), British excavations at Carthage (n.a.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These grants were for travel to do field research and preliminary analysis. The > 25 years research that culminated in this manuscript was accomplished by personal investment of finances and time.	Agelarakis A.P., 1998, E MEDITERRANEAN CYPR, P217; Baby R., 1954, HOPEWELL CREMATION P; Bartoloni P, 2006, DARWIN QUADERNI, V1, P68; BEHRMAN RE, 1997, NEONATAL PERINATAL M, P3; BENICHOU-SAFAR H., 1981, RIV STUDI FENICI, V5, P5; Bondioli L, 1999, AM J PHYS ANTHROPOL, P94; BONDIOLI L, 1999, UN ERUZIONE VESUVIAN, P67; Brown S., 1991, LATE CARTHAGINIAN CH; Buikstra J.E., 1989, BONE MODIFICATION, P247; Caropreso S, 2000, J MICROSC-OXFORD, V199, P244, DOI 10.1046/j.1365-2818.2000.00731.x; Chalmers J., 1980, TOPICS PERINATAL MED; CONTE S, 2007, CHILD SACRIFICE CHIL, P4; Durfee R. B., 1987, TOPICS PERINATAL MED; ELI I, 1989, Pediatric Dentistry, V11, P220; FANTAR MH, 2007, CHILD SACRIFICE CHIL, P2; Fazekas I. G. Y., 1979, FORENSIC FETAL OSTEO; FEDELE F., 1988, RIV STUDI FENICI, V16, P29; FitzGerald C, 2006, AM J PHYS ANTHROPOL, V130, P179, DOI 10.1002/ajpa.20275; GATTO E, 2003, PLACE CREMATION TRAI; Gejvall N.-G., 1969, SCI ARCHAEOLOGY, P468; GEJVALL NG, 1963, SCI ARCHAEOL, P379; Harden D., 1963, PHOENICIANS; HILLSON S, 1996, DENT ANTHR; Jaya D S, 1995, Indian Pediatr, V32, P1183; KRONFELD R, 1939, J AM DENT ASSOC, V16, P18; Lancel S., 1995, CARTHAGE HIST; LEVINE RS, 1979, EARLY HUM DEV, V3, P211, DOI 10.1016/0378-3782(79)90009-4; Macchiarelli R, 2006, INT J OSTEOARCHAEOL, V16, P328, DOI 10.1002/oa.828; MACCHIARELLI R, 1996, ATT MEM SOC MAGN GRE, V3, P101; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; McKinley J, 1994, ANGLOSAXON CEMETER 8; McKinley JI, 1989, BAR BRIT SERIES, V211, P65; MOSCA PG, 1975, CHILD SACRIFICE CANA; MOSCATI S., 1987, QUADERNI ACCADEMIA N, V261, P4; MOSCATI S, 1965, WORLD PHOENICIANS; MULLER M, 1938, BONN VERH INT K GER; Novotny, 1971, P ANTHR C DED A HRDL, P561; POINTEK J, 1976, ACHAEOLOGIA POLSKI, V21, P254; RANGGARD L, 1994, SCAND J DENT RES, V102, P254; RICHARD J, 1961, ETUDE MEDICOLEGALE U; Rossi P. F., 1999, OSTEODENTAL BIOL PEO; Rushton M. A., 1939, BRIT DENT J, V67, P1; SCHUTKOWSKI H, 1993, AM J PHYS ANTHROPOL, V90, P199, DOI 10.1002/ajpa.1330900206; Schwartz J.H., 2007, SKELETON KEYS INTRO; Schwartz J. H., 1989, TERRA, V28, P16; SCHWARTZ JH, 1993, WHAT BONES TELL US; Scobie Alex, 1986, KLIO, V68, P399; SEOW WK, 1986, AUST DENT J, V31, P23, DOI 10.1111/j.1834-7819.1986.tb02979.x; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; SIMONETTI A, 1983, RIV STUDI FENICI, V11, P91; SKINNER M, 1993, J FORENSIC SCI, V38, P1383; Skinner M., 1992, J PALEOPATHOL, V2, P41; Smith P, 2005, J ARCHAEOL SCI, V32, P83, DOI 10.1016/j.jas.2004.06.008; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Stager Lawrence E., 1984, BIBLICAL ARCHAEOLOGY, V10, P31; STAGER LE, 2007, CHILD SACRIFICE YES, P2; SUSINI A, 2003, ETUDE CARACTERISTIQU; TAYLOR CM, 1987, CURRENT OBSTET GYNEC, P161; Teivens A, 1996, FORENSIC SCI INT, V81, P175, DOI 10.1016/S0379-0738(96)01982-2; THURMAN MD, 1981, N AM ARCHAEOL, V2, P1980; WEBER DF, 1971, AM J ANAT, V132, P375, DOI 10.1002/aja.1001320307; WHITTAKER DK, 1978, ARCH ORAL BIOL, V23, P45, DOI 10.1016/0003-9969(78)90052-3	63	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9177	10.1371/journal.pone.0009177	http://dx.doi.org/10.1371/journal.pone.0009177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556KU	20174667	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590600004
J	Kujjo, LL; Laine, T; Pereira, RJG; Kagawa, W; Kurumizaka, H; Yokoyama, S; Perez, GI				Kujjo, Loro L.; Laine, Tiina; Pereira, Ricardo J. G.; Kagawa, Wataru; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki; Perez, Gloria I.			Enhancing Survival of Mouse Oocytes Following Chemotherapy or Aging by Targeting Bax and Rad51	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; GENE-EXPRESSION; DNA-DAMAGE; GERM-CELLS; AGED MICE; IN-VITRO; C-ABL; APOPTOSIS; DEATH; OVEREXPRESSION	Background: Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombination-dependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results: Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.	[Kujjo, Loro L.; Pereira, Ricardo J. G.; Perez, Gloria I.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Laine, Tiina] Univ Helsinki, Childrens Hosp, Program Dev & Reprod Biol, Helsinki, Finland; [Kagawa, Wataru; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Tokyo, Japan; [Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan	Michigan State University; University of Helsinki; Waseda University; RIKEN	Kujjo, LL (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	perezg@msu.edu	Perez, Gloria I/GMX-1286-2022; Pereira, Ricardo/C-7200-2012; Yokoyama, Shigeyuki/N-6911-2015	Pereira, Ricardo/0000-0003-3908-1007; Yokoyama, Shigeyuki/0000-0003-3133-7338; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kagawa, Wataru/0000-0002-8801-6589	Department of Physiology at Michigan State University [05-IRGP-400 MSU]	Department of Physiology at Michigan State University	This work was supported by 05-IRGP-400 MSU and the Department of Physiology at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Fujino Y, 1996, HUM REPROD, V11, P1480; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Henning W, 2003, TOXICOLOGY, V193, P91, DOI 10.1016/S0300-483X(03)00291-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jurisicova A, 2006, CELL DEATH DIFFER, V13, P1466, DOI 10.1038/sj.cdd.4401819; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Matikainen T, 2001, ENDOCRINOLOGY, V142, P2468, DOI 10.1210/en.142.6.2468; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615; Miyagawa K, 2008, CANCER SCI, V99, P187, DOI 10.1111/j.1349-7006.2007.00644.x; Morita Y, 1999, MOL ENDOCRINOL, V13, P841, DOI 10.1210/me.13.6.841; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Perez GI, 1997, HUM REPROD, V12, P2781, DOI 10.1093/humrep/12.12.2781; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1999, MOL HUM REPROD, V5, P414, DOI 10.1093/molehr/5.5.414; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Perez GI, 2007, P NATL ACAD SCI USA, V104, P5229, DOI 10.1073/pnas.0608557104; Tarin JJ, 2001, BIOL REPROD, V65, P141, DOI 10.1095/biolreprod65.1.141; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tatone C, 2006, BIOL REPROD, V74, P395, DOI 10.1095/biolreprod.105.046169; Wu L, 2008, BIOESSAYS, V30, P291, DOI 10.1002/bies.20735; Yuan SSF, 2003, MUTAT RES-FUND MOL M, V525, P85, DOI 10.1016/S0027-5107(03)00009-5; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799	34	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9204	10.1371/journal.pone.0009204	http://dx.doi.org/10.1371/journal.pone.0009204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169201	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600019
J	Yang, JW; Xu, J; Chen, XY; Zhang, YX; Jiang, XC; Guo, XK; Zhao, GP				Yang, Junwei; Xu, Jing; Chen, Xiaoying; Zhang, Yixuan; Jiang, Xucheng; Guo, Xiaokui; Zhao, Guoping			Decrease of Plasma Platelet-Activating Factor Acetylhydrolase Activity in Lipopolysaccharide Induced Mongolian Gerbil Sepsis Model	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ANIMAL-MODELS; EXPRESSION; LEPTOSPIROSIS; MULTICENTER; MORTALITY; MICE	Platelet-activating factor (PAF) plays an important role in the pathogenesis of sepsis, and the level of plasma PAF acetylhydrolase (pPAF-AH), which inactivates PAF, decreases in sepsis patients except for the sepsis caused by severe leptospirosis. Usually, increase of pPAF-AH activity was observed in lipopolysaccharide (LPS)-induced Syrian hamster and rat sepsis models, while contradictory effects were reported for mouse model in different studies. Here, we demonstrated the in vivo effects of LPS upon the change of pPAF-AH activity in C57BL/6 mice and Mongolian gerbils. After LPS-treatment, the clinical manifestations of Mongolian gerbil model were apparently similar to that of C57BL/6 mouse sepsis model. The pPAF-AH activity increased in C57BL/6 mice after LPS induction, but decreased in Mongolian gerbils, which was similar to that of the human sepsis. It thus suggests that among the LPS-induced rodent sepsis models, only Mongolian gerbil could be used for the study of pPAF-AH related to the pathogenesis of human sepsis. Proper application of this model might enable people to clarify the underline mechanism accounted for the contradictory results between the phase II and phase III clinical trials for the administration of recombinant human pPAF-AH in the sepsis therapy.	[Yang, Junwei; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Yang, Junwei; Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Xu, Jing] Shanghai Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Jing; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China; [Xu, Jing; Jiang, Xucheng; Guo, Xiaokui] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200030, Peoples R China; [Chen, Xiaoying; Zhang, Yixuan] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Lab Synthet Biol, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, JW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	gpzhao@sibs.ac.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [30830002, 30970077, 30900051, 30970125, 30770111, 30770820]; National Key Program for Infectious Diseases of China [2008ZX10004-002, 2008ZX10004-009, 2009ZX10004-712]; Shanghai Leading Academic Discipline [T0206]; Shanghai Natural Science Foundation of China [062R14056]; Shanghai Municipal Education Commission and Shanghai Education Development Foundation [2007CGB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC))	This work was supported in part by grants from the National Natural Science Foundation of China (No. 30830002, 30970077, 30900051, 30970125, 30770111 and 30770820), the National Key Program for Infectious Diseases of China (No. 2008ZX10004-002, 2008ZX10004-009 and 2009ZX10004-712), and Shanghai Leading Academic Discipline Project (T0206), Shanghai Natural Science Foundation of China (No. 062R14056), Shanghai Municipal Education Commission and Shanghai Education Development Foundation ("Chen Guang'' project, 2007CGB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cao Y, 1998, J BIOL CHEM, V273, P4012, DOI 10.1074/jbc.273.7.4012; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; Fink MP, 2008, KIDNEY INT, V74, P991, DOI 10.1038/ki.2008.442; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Howard KM, 2000, J BIOL CHEM, V275, P19891, DOI 10.1074/jbc.M001462200; Howard KM, 1997, J BIOL CHEM, V272, P27543, DOI 10.1074/jbc.272.44.27543; Jeong YI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006503; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Memon RA, 1999, AM J PHYSIOL-REG I, V277, pR94, DOI 10.1152/ajpregu.1999.277.1.R94; Metzler M, 1999, CRIT CARE MED, V27, pA85, DOI 10.1097/00003246-199901001-00201; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Partrick DA, 1997, SHOCK, V7, P170, DOI 10.1097/00024382-199703000-00003; Schuster DP, 2003, CRIT CARE MED, V31, P1612, DOI 10.1097/01.CCM.0000063267.79824.DB; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; Svetlov SI, 1999, HEPATOLOGY, V30, P128, DOI 10.1002/hep.510300122; Yang JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004181; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9190	10.1371/journal.pone.0009190	http://dx.doi.org/10.1371/journal.pone.0009190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169191	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474600011
J	Naumann, U; Cameroni, E; Pruenster, M; Mahabaleshwar, H; Raz, E; Zerwes, HG; Rot, A; Thelen, M				Naumann, Ulrike; Cameroni, Elisabetta; Pruenster, Monika; Mahabaleshwar, Harsha; Raz, Erez; Zerwes, Hans-Guenter; Rot, Antal; Thelen, Marcus			CXCR7 Functions as a Scavenger for CXCL12 and CXCL11	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; CELL-MIGRATION; ENDOTHELIAL-CELLS; ACTIVATION; LIGAND; SDF-1; RDC1; INTERNALIZATION; LYMPHOPOIESIS; HEMATOPOIESIS	Background: CXCR7 (RDC1), the recently discovered second receptor for CXCL12, is phylogenetically closely related to chemokine receptors, but fails to couple to G-proteins and to induce typical chemokine receptor mediated cellular responses. The function of CXCR7 is controversial. Some studies suggest a signaling activity in mammalian cells and zebrafish embryos, while others indicate a decoy activity in fish. Here we investigated the two propositions in human tissues. Methodology/Principal Findings: We provide evidence and mechanistic insight that CXCR7 acts as specific scavenger for CXCL12 and CXCL11 mediating effective ligand internalization and targeting of the chemokine cargo for degradation. Consistently, CXCR7 continuously cycles between the plasma membrane and intracellular compartments in the absence and presence of ligand, both in mammalian cells and in zebrafish. In accordance with the proposed activity as a scavenger receptor CXCR7-dependent chemokine degradation does not become saturated with increasing ligand concentrations. Active CXCL12 sequestration by CXCR7 is demonstrated in adult mouse heart valves and human umbilical vein endothelium. Conclusions/Significance: The finding that CXCR7 specifically scavenges CXCL12 suggests a critical function of the receptor in modulating the activity of the ubiquitously expressed CXCR4 in development and tumor formation. Scavenger activity of CXCR7 might also be important for the fine tuning of the mobility of hematopoietic cells in the bone marrow and lymphoid organs.	[Naumann, Ulrike; Cameroni, Elisabetta; Thelen, Marcus] Biomed Res Inst, Bellinzona, Switzerland; [Pruenster, Monika] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Mahabaleshwar, Harsha; Raz, Erez] Univ Munster, Inst Cell Biol, Munster, Germany; [Zerwes, Hans-Guenter] Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland; [Rot, Antal] Univ Birmingham, MRC, Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England	Universita della Svizzera Italiana; University of Munich; University of Munster; Novartis; University of Birmingham	Naumann, U (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	marcus.thelen@irb.unisi.ch	Pruenster, Monika/AAV-4694-2020	Rot, Antal/0000-0002-9730-6166	Helmut Horten Foundation; Swiss National Science Foundation; European Community Framework Program 6-Network of Excellence [LSHG-CT-2003-502935]; Novartis Foundation; Roche Research Foundation; MRC [G0802838] Funding Source: UKRI; Medical Research Council [G0802838] Funding Source: researchfish	Helmut Horten Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community Framework Program 6-Network of Excellence; Novartis Foundation(Novartis); Roche Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Helmut Horten Foundation, the Swiss National Science Foundation (M.T.), and the European Community Framework Program 6-Network of Excellence Grant LSHG-CT-2003-502935. E.C. was supported by the Novartis Foundation and the Roche Research Foundation, and the Fondazione Ticinese per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Cubedo N, 2009, MOL CELL NEUROSCI, V40, P474, DOI 10.1016/j.mcn.2009.01.003; Damaj BB, 1996, FASEB J, V10, P1426, DOI 10.1096/fasebj.10.12.8903513; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; De CE, 1994, ANTIMICROB AGENTS CH, V38, P668; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; FAGHIHI SM, 1982, J CELL SCI, V57, P115; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nibbs RJB, 2009, METHOD ENZYMOL, V460, P245, DOI 10.1016/S0076-6879(09)05212-4; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Proost P, 1998, FEBS LETT, V432, P73, DOI 10.1016/S0014-5793(98)00830-8; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rot A, 2005, CYTOKINE GROWTH F R, V16, P687, DOI 10.1016/j.cytogfr.2005.05.011; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Schultze-Lutter F, 2007, CLIN NEUROPSYCHIATR, V4, P11; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; SUN YX, 2008, CLIN EXP METASTASIS; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Wolff B, 1997, ANAL BIOCHEM, V244, P33, DOI 10.1006/abio.1996.9881; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	56	343	354	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9175	10.1371/journal.pone.0009175	http://dx.doi.org/10.1371/journal.pone.0009175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161793	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442800021
J	Tourino, C; Zimmer, A; Valverde, O				Tourino, Clara; Zimmer, Andreas; Valverde, Olga			THC Prevents MDMA Neurotoxicity in Mice	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; CORE BODY-TEMPERATURE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SUBSTITUTED AMPHETAMINES; CLINICAL-PHARMACOLOGY; CANNABINOID RECEPTOR; AMBIENT-TEMPERATURE; ACUTE HYPERTHERMIA; CB2 RECEPTORS; RAT-BRAIN	The majority of MDMA (ecstasy) recreational users also consume cannabis. Despite the rewarding effects that both drugs have, they induce several opposite pharmacological responses. MDMA causes hyperthermia, oxidative stress and neuronal damage, especially at warm ambient temperature. However, THC, the main psychoactive compound of cannabis, produces hypothermic, anti-inflammatory and antioxidant effects. Therefore, THC may have a neuroprotective effect against MDMAinduced neurotoxicity. Mice receiving a neurotoxic regimen of MDMA (20 mg/kg64) were pretreated with THC (3 mg/kg 64) at room (21 degrees C) and at warm (26 degrees C) temperature, and body temperature, striatal glial activation and DA terminal loss were assessed. To find out the mechanisms by which THC may prevent MDMA hyperthermia and neurotoxicity, the same procedure was carried out in animals pretreated with the CB1 receptor antagonist AM251 and the CB2 receptor antagonist AM630, as well as in CB1, CB2 and CB1/CB2 deficient mice. THC prevented A-induced-hyperthermia and glial activation in animals housed at both room and warm temperature. Surprisingly, MDMA-induced DA terminal loss was only observed in animals housed at warm but not at room temperature, and this neurotoxic effect was reversed by THC administration. However, THC did not prevent MDMA-induced hyperthermia, glial activation, and DA terminal loss in animals treated with the CB1 receptor antagonist AM251, neither in CB1 and CB1/CB2 knockout mice. On the other hand, THC prevented MDMA-induced hyperthermia and DA terminal loss, but only partially suppressed glial activation in animals treated with the CB2 cannabinoid antagonist and in CB2 knockout animals. Our results indicate that THC protects against MDMA neurotoxicity, and suggest that these neuroprotective actions are primarily mediated by the reduction of hyperthermia through the activation of CB1 receptor, although CB2 receptors may also contribute to attenuate neuroinflammation in this process.	[Tourino, Clara; Valverde, Olga] Univ Pompeu Fabra, GRNC, Dept Ciencies Expt & Salut, Barcelona, Spain; [Zimmer, Andreas] Univ Bonn, Dept Mol Psychiat, Bonn, Germany	Pompeu Fabra University; University of Bonn	Tourino, C (corresponding author), Univ Pompeu Fabra, GRNC, Dept Ciencies Expt & Salut, Barcelona, Spain.	clara.tourino@upf.edu; olga.valverde@upf.edu	Zimmer, Andreas/B-8357-2009; Valverde, Olga/D-8654-2012	Valverde, Olga/0000-0003-2264-7852	Spanish Ministry of Science and Innovation [SAF2007/60249]; Spanish Ministry of Health [RD06/0001/1001]; Department of Education and Universities from Generalitat de Catalunya; Social European Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Department of Education and Universities from Generalitat de Catalunya; Social European Fund(European Social Fund (ESF))	This work was supported by the Spanish Ministry of Science and Innovation (SAF2007/60249), the Spanish Ministry of Health (PNSD and RD06/0001/1001) to OV. CT was funded with a fellowship supported by the Department of Education and Universities from Generalitat de Catalunya and by the Social European Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Colado MI, 1997, BRIT J PHARMACOL, V121, P889, DOI 10.1038/sj.bjp.0701213; Daumann J, 2003, NEUROREPORT, V14, P1983, DOI 10.1097/00001756-200310270-00021; Di Forti M, 2007, CURR OPIN PSYCHIATR, V20, P228; Dissing-Olesen L, 2007, NEUROSCIENCE, V149, P112, DOI 10.1016/j.neuroscience.2007.06.037; FORMUKONG EA, 1988, INFLAMMATION, V12, P361, DOI 10.1007/BF00915771; Goni-Allo B, 2008, PSYCHOPHARMACOLOGY, V197, P263, DOI 10.1007/s00213-007-1027-1; Green AR, 2004, EUR J PHARMACOL, V500, P3, DOI 10.1016/j.ejphar.2004.07.006; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GREEN AR, 1995, PSYCHOPHARMACOLOGY, V119, P247, DOI 10.1007/BF02246288; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HEWITT KE, 1994, NEUROPHARMACOLOGY, V33, P1589, DOI 10.1016/0028-3908(94)90134-1; Indlekofer F, 2009, J PSYCHOPHARMACOL, V23, P495, DOI 10.1177/0269881108091076; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Karlsen SN, 2008, BASIC CLIN PHARMACOL, V102, P15, DOI 10.1111/j.1742-7843.2007.00159.x; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; LOGAN BJ, 1988, EUR J PHARMACOL, V152, P227, DOI 10.1016/0014-2999(88)90717-0; Malberg JE, 1998, J NEUROSCI, V18, P5086; Milani RM, 2005, HUM PSYCHOPHARM CLIN, V20, P249, DOI 10.1002/hup.684; Morley KC, 2004, NEUROPHARMACOLOGY, V46, P954, DOI 10.1016/j.neuropharm.2004.01.002; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; O'Shea E, 2001, NEUROPHARMACOLOGY, V40, P65, DOI 10.1016/S0028-3908(00)00106-4; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; OCALLAGHAN JP, 1994, J PHARMACOL EXP THER, V270, P741; Orio L, 2004, J NEUROCHEM, V89, P1445, DOI 10.1111/j.1471-4159.2004.02443.x; Parrott AC, 2007, J NEURAL TRANSM, V114, P959, DOI 10.1007/s00702-007-0715-7; Parrott AC, 2004, J PSYCHOPHARMACOL, V18, pA7, DOI 10.1177/0269881104047286; Racz I, 2008, J NEUROSCI, V28, P12125, DOI 10.1523/JNEUROSCI.3400-08.2008; Rawls SM, 2002, J PHARMACOL EXP THER, V301, P963, DOI 10.1124/jpet.301.3.963; Robledo P, 2007, PSYCHOPHARMACOLOGY, V195, P255, DOI 10.1007/s00213-007-0879-8; Sarne Y, 2005, CNS NEUROL DISORD-DR, V4, P677, DOI 10.2174/156800705774933005; SCHMIDT CJ, 1987, J PHARMACOL EXP THER, V240, P1; Strote J, 2002, J ADOLESCENT HEALTH, V30, P64, DOI 10.1016/S1054-139X(01)00315-9; Thomas DM, 2004, NEUROSCI LETT, V367, P349, DOI 10.1016/j.neulet.2004.06.065; Tourino C, 2008, BIOL PSYCHIAT, V63, P1030, DOI 10.1016/j.biopsych.2007.09.003; Tourino C, 2007, PSYCHOPHARMACOLOGY, V193, P75, DOI 10.1007/s00213-007-0772-5; Winstock AR, 2001, DRUG ALCOHOL DEPEN, V64, P9, DOI 10.1016/S0376-8716(00)00215-5; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	42	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9143	10.1371/journal.pone.0009143	http://dx.doi.org/10.1371/journal.pone.0009143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20174577	Green Published, gold			2022-12-27	WOS:000274442700019
J	Chen, L; Wei, Y; Wang, XQ; He, RQ				Chen, Lan; Wei, Yan; Wang, Xueqing; He, Rongqiao			Ribosylation Rapidly Induces alpha-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; PROTEIN AGGREGATION; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; NONENZYMATIC GLYCATION; OXIDATIVE STRESS; CROSS-LINKING; LEWY BODIES; TAU-PROTEIN; IN-VITRO; STATE	Background: Alpha synuclein (alpha-Syn) is the main component of Lewy bodies which are associated with several neurodegenerative diseases such as Parkinson's disease. While the glycation with D-glucose that results in alpha-Syn misfold and aggregation has been studied, the effects of glycation with D-ribose on alpha-Syn have not been investigated. Methodology/Principal Findings: Here, we show that ribosylation induces alpha-Syn misfolding and generates advanced glycation end products (AGEs) which form protein molten globules with high cytotoxcity. Results from native- and SDS-PAGE showed that D-ribose reacted rapidly with alpha-Syn, leading to dimerization and polymerization. Trypsin digestion and sequencing analysis revealed that during ribosylation the lysinyl residues (K-58, K-60, K-80, K-96, K-97 and K-102) in the C-terminal region reacted more quickly with D-ribose than those of the N-terminal region. Using Western blotting, AGEs resulting from the glycation of alpha-Syn were observed within 24 h in the presence of D-ribose, but were not observed in the presence of D-glucose. Changes in fluorescence at 410 nm demonstrated again that AGEs were formed during early ribosylation. Changes in the secondary structure of ribosylated alpha-Syn were not clearly detected by CD spectrometry in studies on protein conformation. However, intrinsic fluorescence at 310 nm decreased markedly in the presence of D-ribose. Observations with atomic force microscopy showed that the surface morphology of glycated alpha-Syn looked like globular aggregates. thioflavin T (ThT) fluorescence increased during alpha-Syn incubation regardless of ribosylation. As incubation time increased, ribosylation of alpha-Syn resulted in a blue-shift (similar to 100 nm) in the fluorescence of ANS. The light scattering intensity of ribosylated alpha-Syn was not markedly different from native alpha-Syn, suggesting that ribosylated alpha-Syn is present as molten protein globules. Ribosylated products had a high cytotoxicity to SH-SY5Y cells, leading to LDH release and increase in the levels of reactive oxygen species (ROS). Conclusions/Significance: alpha-Syn is rapidly glycated in the presence of D-ribose generating molten globule-like aggregations which cause cell oxidative stress and result in high cytotoxicity.	[Chen, Lan; Wei, Yan; Wang, Xueqing; He, Rongqiao] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [He, Rongqiao] Chinese Acad Sci, Inst Psychol, Lab Mental Hlth, Beijing 100080, Peoples R China; [Wei, Yan; He, Rongqiao] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	herq@sun5.ibp.ac.cn			973-project [2006CB500703, 2010CB912303]; CAS [KSCX2-YW-R-119, KSCX2-YW-R-256]; NSFC [30621004]	973-project(National Basic Research Program of China); CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This project was supported by the following grants: 973-project-2006CB500703, 2010CB912303, CAS-KSCX2-YW-R-119, KSCX2-YW-R-256 and NSFC-30621004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1985, CLIN CHEM, V31, P1550; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Ceru S, 2008, FEBS LETT, V582, P203, DOI 10.1016/j.febslet.2007.12.002; Chen L, 2009, CELL MOL LIFE SCI, V66, P2559, DOI 10.1007/s00018-009-0058-7; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Coussons PJ, 1997, FREE RADICAL BIO MED, V22, P1217, DOI 10.1016/S0891-5849(96)00557-6; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Ferrer E, 2005, J AGR FOOD CHEM, V53, P4911, DOI 10.1021/jf0403585; Fink AL, 1998, FOLD DES, V3, P19, DOI 10.1016/S1359-0278(98)00005-4; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GARLICK RL, 1983, J CLIN INVEST, V71, P1062, DOI 10.1172/JCI110856; Hasegawa Y, 2002, THROMB RES, V107, P319, DOI 10.1016/S0049-3848(02)00348-1; HE RQ, 1995, BIOCHEM J, V309, P133, DOI 10.1042/bj3090133; HE RQ, 1995, BBA-PROTEIN STRUCT M, V1253, P47, DOI 10.1016/0167-4838(95)00145-K; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Iwatsubo T, 1996, AM J PATHOL, V148, P1517; Iwatsubo T, 2007, NEUROPATHOLOGY, V27, P474, DOI 10.1111/j.1440-1789.2007.00785.x; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Ko LW, 1999, BRAIN RES, V830, P301, DOI 10.1016/S0006-8993(99)01415-8; Koga K, 2002, INT J CLIN PHARM RES, V22, P13; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; LEGRAND C, 1992, J BIOTECHNOL, V25, P231, DOI 10.1016/0168-1656(92)90158-6; Liu XM, 2007, J DAIRY SCI, V90, P24, DOI 10.3168/jds.S0022-0302(07)72605-X; Mak W., 2005, Hong Kong Medical Journal, V11, P457; Matiacevich SB, 2006, FOOD CHEM, V95, P423, DOI 10.1016/j.foodchem.2005.01.027; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mayo L, 2007, CELL DEATH DIFFER, V14, P183, DOI 10.1038/sj.cdd.4401989; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Mendez DL, 2005, ARCH BIOCHEM BIOPHYS, V444, P92, DOI 10.1016/j.abb.2005.10.019; Moreaux V, 1997, J AGR FOOD CHEM, V45, P1905, DOI 10.1021/jf9605005; MOSCA A, 1987, CLIN CHEM, V33, P1141; Munch G, 2003, BIOCHEM SOC T, V31, P1397; Munch G, 2000, J CHEM NEUROANAT, V20, P253, DOI 10.1016/S0891-0618(00)00096-X; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Necula M, 2004, J BIOL CHEM, V279, P49694, DOI 10.1074/jbc.M405527200; Nie Chun Lai, 2007, BMC Neurosci, V8, P9, DOI 10.1186/1471-2202-8-9; Nie CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000629; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Pande VS, 1998, P NATL ACAD SCI USA, V95, P1490, DOI 10.1073/pnas.95.4.1490; PLIML W, 1992, LANCET, V340, P507, DOI 10.1016/0140-6736(92)91709-H; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; RACHER AJ, 1990, CYTOTECHNOLOGY, V3, P301, DOI 10.1007/BF00365494; REIM DF, 1994, ANAL BIOCHEM, V216, P213, DOI 10.1006/abio.1994.1027; Sandal M, 2008, PLOS BIOL, V6, P99, DOI 10.1371/journal.pbio.0060006; Sanghera N, 2008, BBA-PROTEINS PROTEOM, V1784, P873, DOI 10.1016/j.bbapap.2008.02.017; Sattarahmady N, 2007, BBA-GEN SUBJECTS, V1770, P933, DOI 10.1016/j.bbagen.2007.02.001; SCOTT ML, 1982, NUTR CHICKEN, P100; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SEUFFER R, 1977, J CLIN CHEM CLIN BIO, V15, P663; Shaikh S, 2008, J NEUROSCI RES, V86, P2071, DOI 10.1002/jnr.21644; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Sheng ZL, 2008, PROG BIOCHEM BIOPHYS, V35, P1202; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J CELL BIOL, V169, P331, DOI 10.1083/jcb.200410041; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; SYROVY I, 1994, J BIOCHEM BIOPH METH, V28, P115, DOI 10.1016/0165-022X(94)90025-6; Tabner BJ, 2005, BIOCHEM SOC T, V33, P1082, DOI 10.1042/BST0331082; TSOU CL, 1988, BIOCHEMISTRY-US, V27, P1809, DOI 10.1021/bi00406a001; Wei Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-10; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Xu YJ, 2002, CLIN CHIM ACTA, V325, P127, DOI 10.1016/S0009-8981(02)00277-2; Xu Zhong, 2005, Chin J Traumatol, V8, P179; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787	75	87	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9052	10.1371/journal.pone.0009052	http://dx.doi.org/10.1371/journal.pone.0009052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140223	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474400011
J	Flower, K; Hellen, E; Newport, MJ; Jones, S; Sinclair, AJ				Flower, Kirsty; Hellen, Elizabeth; Newport, Melanie J.; Jones, Susan; Sinclair, Alison J.			Evaluation of a Prediction Protocol to Identify Potential Targets of Epigenetic Reprogramming by the Cancer Associated Epstein Barr Virus	PLOS ONE			English	Article							LYTIC TRANSACTIVATOR ZTA; LATENT MEMBRANE-PROTEIN; DNA-BINDING SPECIFICITY; CYCLE ACTIVATOR ZTA; DIMERIZATION DOMAIN; BURKITTS-LYMPHOMA; NUCLEAR ANTIGEN-2; LEUCINE ZIPPER; SWITCH PROTEIN; EARLY PROMOTER	Background: Epstein Barr virus (EBV) infects the majority of the human population, causing fatal diseases in a small proportion in conjunction with environmental factors. Following primary infection, EBV remains latent in the memory B cell population for life. Recurrent reactivation of the virus occurs, probably due to activation of the memory B-lymphocytes, resulting in viral replication and re-infection of B-lymphocytes. Methylation of the viral DNA at CpG motifs leads to silencing of viral gene expression during latency. Zta, the key viral protein that mediates the latency/reactivation balance, interacts with methylated DNA. Zta is a transcription factor for both viral and host genes. A sub-set of its DNA binding sites (ZREs) contains a CpG motif, which is recognised in its methylated form. Detailed analysis of the promoter of the viral gene BRLF1 revealed that interaction with a methylated CpG ZRE (RpZRE3) is key to overturning the epigenetic silencing of the gene. Methodology and Principal Findings: Here we question whether we can use this information to identify which host genes contain promoters with similar response elements. A computational search of human gene promoters identified 274 targets containing the 7-nucleotide RpZRE3 core element. DNA binding analysis of Zta with 17 of these targets revealed that the flanking context of the core element does not have a profound effect on the ability of Zta to interact with the methylated sites. A second juxtaposed ZRE was observed for one promoter. Zta was able to interact with this site, although co-occupancy with the RpZRE3 core element was not observed. Conclusions/Significance: This research demonstrates 274 human promoters have the potential to be regulated by Zta to overturn epigenetic silencing of gene expression during viral reactivation from latency.	[Flower, Kirsty; Jones, Susan; Sinclair, Alison J.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Hellen, Elizabeth; Newport, Melanie J.] Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of Sussex; University of Brighton; University of Sussex	Flower, K (corresponding author), Univ Sussex, Sch Life Sci, Brighton, E Sussex, England.	a.j.sinclair@sussex.ac.uk	Hellen, Elizabeth/C-1046-2013	Newport, Melanie/0000-0002-8946-7525; Sinclair, Alison/0000-0001-8510-8691; Flower, Kirsty/0000-0002-5473-1197; Montague-Hellen, Beth/0000-0003-0946-1842	University of Sussex; Brighton and Sussex Medical School; Medical Research Council [G0400735] Funding Source: researchfish; MRC [G0400735] Funding Source: UKRI	University of Sussex; Brighton and Sussex Medical School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by studentships from the University of Sussex and the Brighton and Sussex Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; Bhende PM, 2005, J VIROL, V79, P7338, DOI 10.1128/JVI.79.12.7338-7348.2005; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; ERNBERG I, 1989, J GEN VIROL, V70, P2989, DOI 10.1099/0022-1317-70-11-2989; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; FLEMINGTON E, 1990, J VIROL, V64, P1227, DOI 10.1128/JVI.64.3.1227-1232.1990; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Heather J, 2009, J GEN VIROL, V90, P1450, DOI 10.1099/vir.0.007922-0; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Israel BF, 2003, ONCOGENE, V22, P5122, DOI 10.1038/sj.onc.1206548; Jones RJ, 2007, J BIOL CHEM, V282, P8317, DOI 10.1074/jbc.M608667200; Karlsson QH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000005; Karlsson QH, 2008, BIOCHEM SOC T, V36, P637, DOI 10.1042/BST0360637; KOUZARIDES T, 1991, ONCOGENE, V6, P195; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Li D, 2009, J IMMUNOL, V182, P1799, DOI 10.4049/jimmunol.0802686; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LIEBERMAN PM, 1990, J VIROL, V64, P2560, DOI 10.1128/JVI.64.6.2560-2568.1990; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; MASUCCI MG, 1989, J VIROL, V63, P3135, DOI 10.1128/JVI.63.7.3135-3141.1989; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER G, 1989, YALE J BIOL MED, V62, P205; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; MURRAY PG, 2001, EXPERT REV MOL MED, P1; Niller HH, 2009, SEMIN CANCER BIOL, V19, P158, DOI 10.1016/j.semcancer.2009.02.012; QUINLIVAN EB, 1993, NUCLEIC ACIDS RES, V21, P1999, DOI 10.1093/nar/21.8.1999; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schelcher C, 2005, J VIROL, V79, P13822, DOI 10.1128/JVI.79.21.13822-13828.2005; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SINCLAIR AJ, 1991, J VIROL, V65, P2237, DOI 10.1128/JVI.65.5.2237-2244.1991; Sinclair AJ, 2006, TRENDS MICROBIOL, V14, P289, DOI 10.1016/j.tim.2006.05.003; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; Talbot SJ, 2004, EUR J CANCER, V40, P1998, DOI 10.1016/j.ejca.2003.11.039; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; TAYLOR N, 1991, J VIROL, V65, P4033, DOI 10.1128/JVI.65.8.4033-4041.1991; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsai SC, 2009, BLOOD, V114, P109, DOI 10.1182/blood-2008-12-193375; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zetterberg H, 2002, J GEN VIROL, V83, P2007, DOI 10.1099/0022-1317-83-8-2007	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9443	10.1371/journal.pone.0009443	http://dx.doi.org/10.1371/journal.pone.0009443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195470	gold, Green Accepted, Green Published			2022-12-27	WOS:000274997000012
J	Vergu, E; Busson, H; Ezanno, P				Vergu, Elisabeta; Busson, Henri; Ezanno, Pauline			Impact of the Infection Period Distribution on the Epidemic Spread in a Metapopulation Model	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; REALISTIC DISTRIBUTIONS; SPATIAL SPREAD; PERSISTENCE; DISEASE; DYNAMICS; SYNCHRONY	Epidemic models usually rely on the assumption of exponentially distributed sojourn times in infectious states. This is sometimes an acceptable approximation, but it is generally not realistic and it may influence the epidemic dynamics as it has already been shown in one population. Here, we explore the consequences of choosing constant or gamma-distributed infectious periods in a metapopulation context. For two coupled populations, we show that the probability of generating no secondary infections is the largest for most parameter values if the infectious period follows an exponential distribution, and we identify special cases where, inversely, the infection is more prone to extinction in early phases for constant infection durations. The impact of the infection duration distribution on the epidemic dynamics of many connected populations is studied by simulation and sensitivity analysis, taking into account the potential interactions with other factors. The analysis based on the average nonextinct epidemic trajectories shows that their sensitivity to the assumption on the infectious period distribution mostly depends on R-0, the mean infection duration and the network structure. This study shows that the effect of assuming exponential distribution for infection periods instead of more realistic distributions varies with respect to the output of interest and to other factors. Ultimately it highlights the risk of misleading recommendations based on modelling results when models including exponential infection durations are used for practical purposes.	[Vergu, Elisabeta; Busson, Henri] INRA, Math & Informat Appl UR341, Jouy En Josas, France; [Busson, Henri; Ezanno, Pauline] INRA, Bioagress Epidemiol & Anal Risques UMR1300, F-44026 Nantes, France; [Busson, Henri; Ezanno, Pauline] ENVN, Bioagress Epidemiol & Anal Risques UMR1300, Nantes, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Vergu, E (corresponding author), INRA, Math & Informat Appl UR341, Jouy En Josas, France.	elisabeta.vergu@jouy.inra.fr	Ezanno, Pauline/A-4699-2009	Ezanno, Pauline/0000-0002-0034-8950	ANR (French National Research Agency [ANR-05-PADD-014]	ANR (French National Research Agency(French National Research Agency (ANR))	This work was carried out with the financial support of the ANR (French National Research Agency, http://www.agence-nationale-recherche.fr) under the Programme Agriculture et Developpement Durable, project ANR-05-PADD-014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FP, 2007, METHOD INFORM MED, V46, P19; ARINO J., 2003, MATH POPUL STUD, V10, P175, DOI DOI 10.1080/08898480306720; Balenghien T, 2004, ACTA BIOTHEOR, V52, P365, DOI 10.1023/B:ACBI.0000046603.79561.70; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Feng ZL, 2007, B MATH BIOL, V69, P1511, DOI 10.1007/s11538-006-9174-9; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Fulford GR, 2002, THEOR POPUL BIOL, V61, P15, DOI 10.1006/tpbi.2001.1553; Hsieh YH, 2007, B MATH BIOL, V69, P1355, DOI 10.1007/s11538-006-9169-6; JESSE M, 2008, J THEOR BIOL; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1998, MATH BIOSCI, V147, P207, DOI 10.1016/S0025-5564(97)00101-6; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; MALICE MP, 1989, IMA J MATH APPL MED, V6, P233; Mccormack Robert K., 2007, Journal of Biological Dynamics, V1, P63, DOI 10.1080/17513750601032711; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Roberts MG, 2007, J MATH BIOL, V55, P803, DOI 10.1007/s00285-007-0112-8; Saltelli A., 2008, GLOBAL SENSITIVITY A; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; TAKACS L, 1957, ACTA MATH ACAD SCI H, V8, P169, DOI [10.1007/BF02025241, DOI 10.1007/BF02025241]; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Yan P, 2008, J THEOR BIOL, V251, P238, DOI 10.1016/j.jtbi.2007.11.027	30	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9371	10.1371/journal.pone.0009371	http://dx.doi.org/10.1371/journal.pone.0009371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195473	Green Published, gold			2022-12-27	WOS:000274997000006
J	Saijo, N; Gomi, H				Saijo, Naoki; Gomi, Hiroaki			Multiple Motor Learning Strategies in Visuomotor Rotation	PLOS ONE			English	Article							REACHING MOVEMENTS; FEEDBACK-CONTROL; VISUAL INFORMATION; INTERNAL-MODELS; PURKINJE-CELLS; ADAPTATION; CEREBELLUM; ERROR; TRANSFORMATIONS; PROPRIOCEPTION	Background: When exposed to a continuous directional discrepancy between movements of a visible hand cursor and the actual hand (visuomotor rotation), subjects adapt their reaching movements so that the cursor is brought to the target. Abrupt removal of the discrepancy after training induces reaching error in the direction opposite to the original discrepancy, which is called an aftereffect. Previous studies have shown that training with gradually increasing visuomotor rotation results in a larger aftereffect than with a suddenly increasing one. Although the aftereffect difference implies a difference in the learning process, it is still unclear whether the learned visuomotor transformations are qualitatively different between the training conditions. Methodology/Principal Findings: We examined the qualitative changes in the visuomotor transformation after the learning of the sudden and gradual visuomotor rotations. The learning of the sudden rotation led to a significant increase of the reaction time for arm movement initiation and then the reaching error decreased, indicating that the learning is associated with an increase of computational load in motor preparation (planning). In contrast, the learning of the gradual rotation did not change the reaction time but resulted in an increase of the gain of feedback control, suggesting that the online adjustment of the reaching contributes to the learning of the gradual rotation. When the online cursor feedback was eliminated during the learning of the gradual rotation, the reaction time increased, indicating that additional computations are involved in the learning of the gradual rotation. Conclusions/Significance: The results suggest that the change in the motor planning and online feedback adjustment of the movement are involved in the learning of the visuomotor rotation. The contributions of those computations to the learning are flexibly modulated according to the visual environment. Such multiple learning strategies would be required for reaching adaptation within a short training period.	[Saijo, Naoki; Gomi, Hiroaki] NTT Corp, NTT, Commun Sci Labs, Kanagawa, Japan; [Gomi, Hiroaki] Japan Sci & Technol Agcy, ERATO, Shimojo Implicit Brain Funct Project, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Saijo, N (corresponding author), NTT Corp, NTT, Commun Sci Labs, Kanagawa, Japan.	naokis@idea.brl.ntt.co.jp	Gomi, Hiroaki/C-5269-2013; Gomi, Hiroaki/AEL-2645-2022	Gomi, Hiroaki/0000-0003-3541-2251	Nippon Telegraph and Telephone Co	Nippon Telegraph and Telephone Co	The authors received annual research funding from Nippon Telegraph and Telephone Co. Funder employees carried out study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; GEORGOPOULOS AP, 1987, EXP BRAIN RES, V65, P361; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Gomi H, 1998, J NEUROPHYSIOL, V80, P818, DOI 10.1152/jn.1998.80.2.818; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GOMI H, 1992, BIOL CYBERN, V68, P105, DOI 10.1007/BF00201432; GOMI H, 1993, NEURAL NETWORKS, V6, P933, DOI 10.1016/S0893-6080(09)80004-X; GOMI H, 2008, CURR OPIN NEUROBIOL; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310, DOI 10.1152/jn.1999.82.5.2310; IMAMIZU H, 1995, J EXP PSYCHOL HUMAN, V21, P1174, DOI 10.1037/0096-1523.21.5.1174; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Sabes PN, 2000, CURR OPIN NEUROBIOL, V10, P740, DOI 10.1016/S0959-4388(00)00149-5; SAIJO N, 2009, IEICE T INF SYST, V92, P552; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Schaal S., 2002, HDB BRAIN THEORY NEU, P983; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Vetter P, 1999, J NEUROPHYSIOL, V81, P935, DOI 10.1152/jn.1999.81.2.935; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Yamamoto K, 2007, J NEUROPHYSIOL, V97, P1588, DOI 10.1152/jn.00206.2006; Yamamoto K, 2006, J NEUROPHYSIOL, V96, P2797, DOI 10.1152/jn.00209.2006	36	59	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9399	10.1371/journal.pone.0009399	http://dx.doi.org/10.1371/journal.pone.0009399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SX	20195373	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200021
J	Mahan, CS; Walusimbi, M; Johnson, DF; Lancioni, C; Charlebois, E; Baseke, J; Chervenak, KA; Mugerwa, RD; Havlir, DV; Mayanja-Kizza, H; Whalen, CC; Boom, WH				Mahan, C. Scott; Walusimbi, Maria; Johnson, Denise F.; Lancioni, Christina; Charlebois, Edwin; Baseke, Joyce; Chervenak, Keith A.; Mugerwa, Roy D.; Havlir, Diane V.; Mayanja-Kizza, Harriet; Whalen, Christopher C.; Boom, W. Henry		Uganda-Case Western Res Collaborat	Tuberculosis Treatment in HIV Infected Ugandans with CD4 Counts > 350 Cells/mm(3) Reduces Immune Activation with No Effect on HIV Load or CD4 Count	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL-ACTIVATION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; SEROLOGIC MARKERS; ADULTS; PATHOGENESIS; REPLICATION; THERAPY	Background: Both HIV and TB cause a state of heightened immune activation. Immune activation in HIV is associated with progression to AIDS. Prior studies, focusing on persons with advanced HIV, have shown no decline in markers of cellular activation in response to TB therapy alone. Methodology: This prospective cohort study, composed of participants within a larger phase 3 open-label randomized controlled clinical trial, measured the impact of TB treatment on immune activation in persons with non-advanced HIV infection (CD>350 cells/mm(3)) and pulmonary TB. HIV load, CD4 count, and markers of immune activation (CD38 and HLADR on CD4 and CD8 T cells) were measured prior to starting, during, and for 6 months after completion of standard 6 month anti-tuberculosis (TB) therapy in 38 HIV infected Ugandans with smear and culture confirmed pulmonary TB. Results: Expression of CD38, and co-expression of CD38 and HLA-DR, on CD8 cells declined significantly within 3 months of starting standard TB therapy in the absence of anti-retroviral therapy, and remained suppressed for 6 months after completion of therapy. In contrast, HIV load and CD4 count remained unchanged throughout the study period. Conclusion: TB therapy leads to measurable decreases in immune activation in persons with HIV/TB co-infection and CD4 counts.350 cells/mm(3).	[Mahan, C. Scott; Johnson, Denise F.; Lancioni, Christina; Chervenak, Keith A.; Boom, W. Henry] Case Western Reserve Univ, Sch Med, TB Res Unit, Cleveland, OH 44106 USA; [Mahan, C. Scott] Metrohlth Med Ctr, Div Infect Dis, Dept Med, Cleveland, OH USA; [Walusimbi, Maria; Baseke, Joyce; Mugerwa, Roy D.; Mayanja-Kizza, Harriet] Makerere Univ, Sch Med, Mulago Hosp, Uganda CWRU Res Collaborat, Kampala, Uganda; [Charlebois, Edwin; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Whalen, Christopher C.] Univ Georgia, Dept Epidemiol & Biostat, Coll Publ Hlth, Athens, GA USA; [Boom, W. Henry] Univ Hosp, Case Med Ctr, Cleveland, OH USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Makerere University; Mulago National Referral Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Georgia; University of Georgia; Case Western Reserve University; University Hospitals of Cleveland	Mahan, CS (corresponding author), Case Western Reserve Univ, Sch Med, TB Res Unit, Cleveland, OH 44106 USA.	csmahan@gmail.com	Mayanja-Kizza, Harriet/AAM-5372-2020	Mayanja-Kizza, Harriet/0000-0002-9297-6208; Lancioni, Christina/0000-0002-0821-1211	Trial: Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis [NCT0007847]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051219, N01AI095383, P30AI036219] Funding Source: NIH RePORTER	Trial: Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was Trial: Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis. Registry #: NCT0007847	Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Goletti D, 1996, J IMMUNOL, V157, P1271; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hertoghe T, 2000, CLIN EXP IMMUNOL, V122, P350, DOI 10.1046/j.1365-2249.2000.01385.x; Jones BE, 1997, CLIN INFECT DIS, V24, P988, DOI 10.1093/clinids/24.5.988; Kalou M, 2005, J MED VIROL, V75, P202, DOI 10.1002/jmv.20257; Lawn SD, 1999, AIDS, V13, P2231, DOI 10.1097/00002030-199911120-00005; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Morris L, 2003, J INFECT DIS, V187, P1967, DOI 10.1086/375346; Srikantiah P, 2008, JAIDS-J ACQ IMM DEF, V49, P458, DOI 10.1097/QAI.0b013e31817e9fb4; Sulkowski MS, 1998, J INFECT DIS, V178, P1642, DOI 10.1086/314491; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Villacian JS, 2005, J INFECTION, V51, P408, DOI 10.1016/j.jinf.2004.11.011; Whalen CC, 2000, AIDS, V14, P1219, DOI 10.1097/00002030-200006160-00020	16	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9138	10.1371/journal.pone.0009138	http://dx.doi.org/10.1371/journal.pone.0009138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179751	Green Submitted, Green Published, gold			2022-12-27	WOS:000274923900001
J	Douglas, DN; Kawahara, T; Sis, B; Bond, D; Fischer, KP; Tyrrell, DLJ; Lewis, JT; Kneteman, NM				Douglas, Donna N.; Kawahara, Toshiyasu; Sis, Banu; Bond, David; Fischer, Karl P.; Tyrrell, D. Lorne J.; Lewis, Jamie T.; Kneteman, Norman M.			Therapeutic Efficacy of Human Hepatocyte Transplantation in a SCID/uPA Mouse Model with Inducible Liver Disease	PLOS ONE			English	Article							THYMIDINE KINASE GENE; SIMPLEX-VIRUS TYPE-1; EXPERIMENTAL BRAIN-TUMORS; HSV-TK EXPRESSION; IN-VITRO; TRANSGENIC MICE; GAP-JUNCTIONS; CLINICAL-IMPLICATIONS; NONSENSE MUTATION; CATALYTIC SUBUNIT	Background: Severe Combined Immune Deficient (SCID)/Urokinase-type Plasminogen Activator (uPA) mice undergo liver failure and are useful hosts for the propagation of transplanted human hepatocytes (HH) which must compete with recipient-derived hepatocytes for replacement of the diseased liver parenchyma. While partial replacement by HH has proven useful for studies with Hepatitis C virus, complete replacement of SCID/uPA mouse liver by HH has never been achieved and limits the broader application of these mice for other areas of biomedical research. The herpes simplex virus type-1 thymidine kinase (HSVtk)/ganciclovir (GCV) system is a powerful tool for cell-specific ablation in transgenic animals. The aim of this study was to selectively eliminate murine-derived parenchymal liver cells from humanized SCID/uPA mouse liver in order to achieve mice with completely humanized liver parenchyma. Thus, we reproduced the HSVtk (vTK)/GCV system of hepatic failure in SCID/uPA mice. Methodology/Principal Findings: In vitro experiments demonstrated efficient killing of vTK expressing hepatoma cells after GCV treatment. For in vivo experiments, expression of vTK was targeted to the livers of FVB/N and SCID/uPA mice. Hepatic sensitivity to GCV was first established in FVB/N mice since these mice do not undergo liver failure inherent to SCID/uPA mice. Hepatic vTK expression was found to be an integral component of GCV-induced pathologic and biochemical alterations and caused death due to liver dysfunction in vTK transgenic FVB/N and non-transplanted SCID/uPA mice. In SCID/uPA mice with humanized liver, vTK/GCV caused death despite extensive replacement of the mouse liver parenchyma with HH (ranging from 32-87%). Surprisingly, vTK/GCV-dependent apoptosis and mitochondrial aberrations were also localized to bystander vTK-negative HH. Conclusions/Significance: Extensive replacement of mouse liver parenchyma by HH does not provide a secure therapeutic advantage against vTK/GCV-induced cytotoxicity targeted to residual mouse hepatocytes. Functional support by engrafted HH may be secured by strategies aimed at limiting this bystander effect.	[Douglas, Donna N.; Kawahara, Toshiyasu; Tyrrell, D. Lorne J.; Lewis, Jamie T.; Kneteman, Norman M.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Bond, David; Fischer, Karl P.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Sis, Banu] Univ Alberta Hosp, Dept Lab Med & Pathol, Edmonton, AB T6G 2R7, Canada; [Tyrrell, D. Lorne J.; Kneteman, Norman M.] KMT Hepatech Inc, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Douglas, DN (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	donnad@ualberta.ca		Sis, Banu/0000-0001-9215-2535	Canadian Institutes of Health Research [G019000018]; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by Canadian Institutes of Health Research Grant # G019000018 and Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; ALSHAWI R, 1991, MOL CELL BIOL, V11, P4207, DOI 10.1128/MCB.11.8.4207; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Asklund T, 2003, EXP CELL RES, V284, P185, DOI 10.1016/S0014-4827(02)00052-6; BARBA D, 1994, P NATL ACAD SCI USA, V91, P4348, DOI 10.1073/pnas.91.10.4348; BARRY M, 1990, PHARMACOL THERAPEUT, V48, P71, DOI 10.1016/0163-7258(90)90019-X; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; BI WL, 1993, HUM GENE THER, V4, P725, DOI 10.1089/hum.1993.4.6-725; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; Brand T, 1997, MECH DEVELOP, V64, P53, DOI 10.1016/S0925-4773(97)00044-0; Braun KM, 2000, NAT MED, V6, P320; BRAUN RE, 1990, BIOL REPROD, V43, P684, DOI 10.1095/biolreprod43.4.684; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Dilber MS, 1997, CANCER RES, V57, P1523; ELLISON AR, 1995, MOL REPROD DEV, V41, P425, DOI 10.1002/mrd.1080410405; Elshami AA, 1996, GENE THER, V3, P85; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fausto N, 2001, LIVER TRANSPLANT, V7, P835, DOI 10.1053/jlts.2001.27865; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1993, CANCER RES, V53, P5274; Freeman SM, 1996, SEMIN ONCOL, V23, P31; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Hamel W, 1996, CANCER RES, V56, P2697; HUTTNER KM, 1993, BIOL REPROD, V49, P251, DOI 10.1095/biolreprod49.2.251; Izquierdo M, 1996, GENE THER, V3, P491; KANEKO Y, 1995, CANCER LETT, V96, P105, DOI 10.1016/0304-3835(95)03919-N; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; Kneteman NM, 2006, HEPATOLOGY, V43, P1346, DOI 10.1002/hep.21209; LEE WM, 1995, NEW ENGL J MED, V333, P1118, DOI 10.1056/NEJM199510263331706; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Meuleman P, 2003, BIOCHEM BIOPH RES CO, V308, P375, DOI 10.1016/S0006-291X(03)01388-3; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Myronovych A, 2008, J HEPATOL, V49, P363, DOI 10.1016/j.jhep.2008.04.019; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; OLDFIELD EH, 1993, HUM GENE THER, V4, P39, DOI 10.1089/hum.1993.4.1-39; PARK BK, 1981, CLIN PHARMACOKINET, V6, P1, DOI 10.2165/00003088-198106010-00001; RAM Z, 1993, CANCER RES, V53, P83; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; Rodrigues A D, 1997, Adv Pharmacol, V43, P65, DOI 10.1016/S1054-3589(08)60202-1; Rodrigues AD, 2002, CURR DRUG METAB, V3, P289, DOI 10.2174/1389200023337522; RODRIGUES AD, 1994, ANAL BIOCHEM, V219, P309, DOI 10.1006/abio.1994.1271; RODRIGUES AD, 1994, BIOCHEM PHARMACOL, V48, P197; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SANDGREN EP, 1992, P NATL ACAD SCI USA, V89, P11523, DOI 10.1073/pnas.89.23.11523; SHIOTA G, 1995, RES COMMUN MOL PATH, V89, P259; Sterman DH, 1998, HEMATOL ONCOL CLIN N, V12, P553, DOI 10.1016/S0889-8588(05)70008-3; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Thust R, 2000, MUTAGENESIS, V15, P177, DOI 10.1093/mutage/15.2.177; van der Eb MM, 1998, GENE THER, V5, P451, DOI 10.1038/sj.gt.3300637; van der Eb MM, 2003, J GENE MED, V5, P1018, DOI 10.1002/jgm.450; Wallace H, 1996, ONCOGENE, V13, P55; Zhang Y, 2005, FEBS J, V272, P2207, DOI 10.1111/j.1742-4658.2005.04644.x	59	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9209	10.1371/journal.pone.0009209	http://dx.doi.org/10.1371/journal.pone.0009209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174638	Green Published, Green Submitted, gold			2022-12-27	WOS:000274654700008
J	Suzuki, K; Okada, K; Wakuda, T; Shinmura, C; Kameno, Y; Iwata, K; Takahashi, T; Suda, S; Matsuzaki, H; Iwata, Y; Hashimoto, K; Mori, N				Suzuki, Katsuaki; Okada, Kyoko; Wakuda, Tomoyasu; Shinmura, Chie; Kameno, Yosuke; Iwata, Keiko; Takahashi, Taro; Suda, Shiro; Matsuzaki, Hideo; Iwata, Yasuhide; Hashimoto, Kenji; Mori, Norio			Destruction of Dopaminergic Neurons in the Midbrain by 6-Hydroxydopamine Decreases Hippocampal Cell Proliferation in Rats: Reversal by Fluoxetine	PLOS ONE			English	Article							PARKINSONS-DISEASE; ANTIDEPRESSANT TREATMENT; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; STIMULATION PROMOTES; OPEN-LABEL; DEPRESSION; SYMPTOMS; PROJECTIONS; MANAGEMENT	Background: Non-motor symptoms (e. g., depression, anxiety, and cognitive deficits) in patients with Parkinson disease (PD) precede the onset of the motor symptoms. Although these symptoms do not respond to pharmacological dopamine replacement therapy, their precise pathological mechanisms are currently unclear. The present study was undertaken to examine whether the unilateral 6-hydroxydopamine (6-OHDA) lesion to the substantia nigra pars compacta (SNc), which represents a model of long-term dopaminergic neurotoxicity, could affect cell proliferation in the adult rat brain. Furthermore, we examined the effects of the selective serotonin reuptake inhibitor (SSRI) fluoxetine and the selective noradrenaline reuptake inhibitor maprotiline on the reduction in cell proliferation in the subgranular zone (SGZ) by the unilateral 6-OHDA lesion. Methodology/Principal Findings: A single unilateral injection of 6-OHDA into the rat SNc resulted in an almost complete loss of tyrosine hydroxylase (TH) immunoreactivity in the striatum and SNc, as well as in reductions of TH-positive cells and fibers in the ventral tegmental area (VTA). On the other hand, an injection of vehicle alone showed no overt change in TH immunoreactivity. A unilateral 6-OHDA lesion to SNc significantly decreased cell proliferation in the SGZ ipsilateral to the 6-OHDA lesion, but not in the contralateral SGZ or the subventricular zone (SVZ), of rats. Furthermore, subchronic (14 days) administration of fluoxetine (5 mg/kg/day), but not maprotiline significantly attenuated the reduction in cell proliferation in the SGZ by unilateral 6-OHDA lesion. Conclusions/Significance: The present study suggests that cell proliferation in the SGZ of the dentate gyrus might be, in part, under dopaminergic control by SNc and VTA, and that subchronic administration of fluoxetine reversed the reduction in cell proliferation in the SGZ by 6-OHDA. Therefore, SSRIs such as fluoxetine might be potential therapeutic drugs for non-motor symptoms as well as motor symptoms in patients with PD, which might be associated with the reduction in cell proliferation in the SGZ.	[Suzuki, Katsuaki; Iwata, Keiko; Takahashi, Taro; Suda, Shiro] Hamamatsu Univ Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4312102, Japan; [Okada, Kyoko; Wakuda, Tomoyasu; Shinmura, Chie; Kameno, Yosuke; Iwata, Yasuhide; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4312102, Japan; [Matsuzaki, Hideo] Osaka Univ, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Grad Sch Med, Suita, Osaka, Japan; [Hashimoto, Kenji] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Chiba University	Suzuki, K (corresponding author), Hamamatsu Univ Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4312102, Japan.	k-suzuki@hama-med.ac.jp; hashimoto@faculty.chiba-u.jp	MATSUZAKI, HIDEO/AAE-5246-2020; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Wakuda, Tomoyasu/0000-0002-1924-8167; Hashimoto, Kenji/0000-0002-8892-0439; Suzuki, Katsuaki/0000-0003-0446-3355	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19209039, 19591347]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to Drs. N. Mori (# 19209039) and T. Wakuda (# 19591347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMALRIC M, 1993, PROG BRAIN RES, V99, P209; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Beauquis J, 2006, EUR J NEUROSCI, V23, P1539, DOI 10.1111/j.1460-9568.2006.04691.x; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Brandstadter D, 2003, ADV NEUROL, V91, P371; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Coronas V, 2004, J NEUROCHEM, V91, P1292, DOI 10.1111/j.1471-4159.2004.02823.x; Dell'Agnello G, 2001, CLIN NEUROPHARMACOL, V24, P221, DOI 10.1097/00002826-200107000-00005; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; EHRINGER H, 1960, KLIN WOCHENSCHR, V38, P1236, DOI 10.1007/BF01485901; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; GREENFIELD JG, 1953, J NEUROL NEUROSUR PS, V16, P213, DOI 10.1136/jnnp.16.4.213; Grote HE, 2005, EUR J NEUROSCI, V22, P2081, DOI 10.1111/j.1460-9568.2005.04365.x; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hiramoto T, 2007, NEUROREPORT, V18, P659, DOI 10.1097/WNR.0b013e3280bef9d3; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Ishihara L, 2006, ACTA NEUROL SCAND, V113, P211, DOI 10.1111/j.1600-0404.2006.00579.x; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Lemke MR, 2008, EUR J NEUROL, V15, P21, DOI 10.1111/j.1468-1331.2008.02058.x; Loughlin S.E., 1985, RAT NERVOUS SYSTEM H, V2, P79; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Oertel WH, 2001, ADV NEUROL, V86, P373; Perera TD, 2008, NEUROSCIENTIST, V14, P326, DOI 10.1177/1073858408317242; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2004, BIOL PSYCHIAT, V56, P137, DOI 10.1016/j.biopsych.2004.04.012; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Schrag A, 2006, J NEUROL SCI, V248, P151, DOI 10.1016/j.jns.2006.05.030; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Vajda FJE, 2005, J CLIN NEUROSCI, V12, P739, DOI 10.1016/j.jocn.2005.03.008; Wakuda T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003648; Weintraub D, 2008, AM J MANAG CARE, V14, pS59; Weintraub D, 2008, AM J MANAG CARE, V14, pS40; Weintraub D, 2006, J NEUROPSYCH CLIN N, V18, P377, DOI 10.1176/appi.neuropsych.18.3.377; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	45	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9260	10.1371/journal.pone.0009260	http://dx.doi.org/10.1371/journal.pone.0009260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174647	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600015
J	Nilsson, M; Possnert, G; Edlund, H; Budowle, B; Kjellstrom, A; Allen, M				Nilsson, Martina; Possnert, Goran; Edlund, Hanna; Budowle, Bruce; Kjellstrom, Anna; Allen, Marie			Analysis of the Putative Remains of a European Patron Saint-St. Birgitta	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; ANCIENT DNA; MISCODING LESIONS; POSTMORTEM DAMAGE; GENETIC ANALYSES; RADIOCARBON; SEQUENCE; BONES	Saint Birgitta (Saint Bridget of Sweden) lived between 1303 and 1373 and was designated one of Europe's six patron saints by the Pope in 1999. According to legend, the skulls of St. Birgitta and her daughter Katarina are maintained in a relic shrine in Vadstena abbey, mid Sweden. The origin of the two skulls was assessed first by analysis of mitochondrial DNA (mtDNA) to confirm a maternal relationship. The results of this analysis displayed several differences between the two individuals, thus supporting an interpretation of the two skulls not being individuals that are maternally related. Because the efficiency of PCR amplification and quantity of DNA suggested a different amount of degradation and possibly a very different age for each of the skulls, an orthogonal procedure, radiocarbon dating, was performed. The radiocarbon dating results suggest an age difference of at least 200 years and neither of the dating results coincides with the period St. Birgitta or her daughter Katarina lived. The relic, thought to originate from St. Birgitta, has an age corresponding to the 13(th) century (1215-1270 cal AD, 2 sigma confidence), which is older than expected. Thus, the two different analyses are consistent in questioning the authenticity of either of the human skulls maintained in the Vadstena relic shrine being that of St. Birgitta. Of course there are limitations when interpreting the data of any ancient biological materials and these must be considered for a final decision on the authenticity of the remains.	[Nilsson, Martina; Edlund, Hanna; Allen, Marie] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Nilsson, Martina] Reg Criminal Invest Dept, Forens Unit, Stockholm, Sweden; [Possnert, Goran] Uppsala Univ, Dept Engn Sci, Angstrom Lab, Uppsala, Sweden; [Budowle, Bruce] FBI Lab, Quantico, VA USA; [Budowle, Bruce] Univ N Texas Hlth Sci Ctr, Dept Forens & Investigat Genet, Ft Worth, TX USA; [Kjellstrom, Anna] Stockholm Univ, Dept Archaeol & Class Studies, Wallenberg Lab, S-10691 Stockholm, Sweden	Uppsala University; Uppsala University; University of North Texas System; University of North Texas Health Science Center; Stockholm University	Nilsson, M (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	marie.allen@genpat.uu.se	Kjellström, Anna/C-4343-2016	Kjellström, Anna/0000-0001-8964-3771	Kjell and Marta Beijer Foundation; Goran Gustafsson Foundation; Carl Tryggers Foundation; Marcus Borgstroms Foundation; Sven and Dagmar Salen Foundation	Kjell and Marta Beijer Foundation; Goran Gustafsson Foundation; Carl Tryggers Foundation; Marcus Borgstroms Foundation; Sven and Dagmar Salen Foundation	This work was supported by the Kjell and Marta Beijer Foundation, Goran Gustafsson Foundation, Carl Tryggers Foundation, Marcus Borgstroms Foundation and Sven and Dagmar Salen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson H, 2002, BIOTECHNIQUES, V33, P402, DOI 10.2144/02332rr07; Andreasson H, 2007, FORENSIC SCI INT-GEN, V1, P35, DOI 10.1016/j.fsigen.2006.10.002; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bar W, 2000, INT J LEGAL MED, V113, P193, DOI 10.1007/s004140000149; Bayliss A, 2004, J ARCHAEOL SCI, V31, P563, DOI 10.1016/j.jas.2003.10.004; Budowle B, 1999, FORENSIC SCI INT, V103, P23, DOI 10.1016/S0379-0738(99)00042-0; BYGDEN A, 1954, HELIGA BIRGITTAS REL; CASAS MJ, 2006, AM J PHYS ANTHR; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Czarnetzki A, 2003, LANCET, V362, P408, DOI 10.1016/S0140-6736(03)14044-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Jehaes E, 1998, EUR J HUM GENET, V6, P383, DOI 10.1038/sj.ejhg.5200227; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Keyser-Tracqui Christine, 2005, V297, P253; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Landtblom AM, 2004, SEIZURE-EUR J EPILEP, V13, P161, DOI 10.1016/S1059-1311(03)00160-2; LANTING JN, 1998, J IRISH ARCHAEOLOGY, V9, P151; Liden K, 1994, FORNVANNEN FORNVANNE, V89, P13; LIDEN K, 1995, J ANTHR ARCHAEOLOGY, V14; Montiel R, 2001, HUM BIOL, V73, P689, DOI 10.1353/hub.2001.0069; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Stone AC, 2001, J FORENSIC SCI, V46, P173; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; SWGDAM, 2003, FORENSIC SCI COMMUNI, V5; TAYLOR RE, 1983, RADIOCARBON, V25, P647, DOI 10.1017/S003382220000597X; Vernesi C, 2001, P NATL ACAD SCI USA, V98, P13460, DOI 10.1073/pnas.211540498	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e8986	10.1371/journal.pone.0008986	http://dx.doi.org/10.1371/journal.pone.0008986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169108	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500001
J	Shehadeh, LA; Yu, K; Wang, LY; Guevara, A; Singer, C; Vance, J; Papapetropoulos, S				Shehadeh, Lina A.; Yu, Kristine; Wang, Liyong; Guevara, Alexandra; Singer, Carlos; Vance, Jeffery; Papapetropoulos, Spyridon			SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION; SUBSTANTIA-NIGRA; AXON GUIDANCE; FRONTOTEMPORAL DEMENTIA; GLUTAMATE TRANSPORTER; ALZHEIMERS-DISEASE; IN-VITRO; RNA; PROTEINS	Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms. Methodology/Principal Findings: We performed extensive analysis on 3 PD microarray experiments available through GEO and found that the RNA splicing gene SRRM2 (or SRm300), sereine/arginine repetitive matrix 2, was the only gene differentially upregulated among all the three PD experiments. SRRM2 expression was not changed in the blood of other neurological diseased patients versus the healthy controls. Using real-time PCR, we report that the shorter transcript of SRRM2 was 1.7 fold (p = 0.008) upregulated in the substantia nigra of PDs vs controls while the longer transcript was 0.4 downregulated in both the substantia nigra (p = 0.03) and amygdala (p = 0.003). To validate our results and test for the possibility of alternative splicing in PD, we performed independent microarray scans, using Affymetrix Exon_ST1 arrays, from peripheral blood of 28 individuals (17 PDs and 11 Ctrls) and found a significant upregulation of the upstream (5') exons of SRRM2 and a downregulation of the downstream exons, causing a total of 0.7 fold down regulation (p = 0.04) of the long isoform. In addition, we report novel information about hundreds of genes with significant alternative splicing (differential exonic expression) in PD blood versus controls. Conclusions/Significance: The consistent dysregulation of the RNA splicing factor SRRM2 in two different PD neuronal sources and in PD blood but not in blood of other neurologically diseased patients makes SRRM2 a strong candidate gene for PD and draws attention to the role of RNA splicing in the disease.	[Shehadeh, Lina A.] Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL 33152 USA; [Yu, Kristine; Wang, Liyong; Vance, Jeffery] Univ Miami, Dept Human Genet, Leonard M Miller Sch Med, Miami, FL USA; [Guevara, Alexandra; Singer, Carlos; Papapetropoulos, Spyridon] Univ Miami, Dept Neurol, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami	Shehadeh, LA (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Leonard M Miller Sch Med, Miami, FL 33152 USA.	lshehadeh@med.miami.edu	Singer, Carlos/AAI-6643-2020; Pinheiro, Maísa/E-7424-2012	Vance, Jeffery/0000-0003-3815-8199	University of Miami Miller School of Medicine; National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS); Morris K. Udall Parkinson Disease Research Center of Excellence (JV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL083673] Funding Source: NIH RePORTER	University of Miami Miller School of Medicine; National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Morris K. Udall Parkinson Disease Research Center of Excellence (JV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was partly supported by an intramural Scientific Awards Committee (SAC) grant from the University of Miami Miller School of Medicine (SP and LAS) and a National Institutes of Health National Institute of Neurological Disorders and Stroke (NIH/NINDS) Morris K. Udall Parkinson Disease Research Center of Excellence (JV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, BRAIN RES, V699, P297, DOI 10.1016/0006-8993(95)00922-D; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Chisa JL, 2007, GENETICS, V175, P1079, DOI 10.1534/genetics.106.066183; D'Agata V, 2004, NEUROCHEM RES, V29, P1715, DOI 10.1023/B:NERE.0000035807.25370.5e; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dubey D, 2008, HUM MOL GENET, V17, P3010, DOI 10.1093/hmg/ddn199; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; Gloor GB, 2000, GENETICS, V155, P1821; Greene JG, 2008, NEUROSCIENCE, V152, P198, DOI 10.1016/j.neuroscience.2007.11.029; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lesnick TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001449; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Lynch KW, 2001, J BIOL CHEM, V276, P24341, DOI 10.1074/jbc.M102175200; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Papapetropoulos S, 2007, FUTUR NEUROL, V2, P29, DOI 10.2217/14796708.2.1.29; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Potashkin JA, 2007, BRAIN RES, V1182, P1, DOI 10.1016/j.brainres.2007.08.080; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tan EK, 2005, NEUROGENETICS, V6, P179, DOI 10.1007/s10048-005-0001-5; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59	38	66	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9104	10.1371/journal.pone.0009104	http://dx.doi.org/10.1371/journal.pone.0009104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161708	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442500011
J	Kugler, JM; Lem, C; Lasko, P				Kugler, Jan-Michael; Lem, Christopher; Lasko, Paul			Reduced cul-5 Activity Causes Aberrant Follicular Morphogenesis and Germ Cell Loss in Drosophila Oogenesis	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; OOCYTE DIFFERENTIATION; NEUROGENIC GENES; CYST FORMATION; EGG CHAMBER; UBIQUITIN; FATE; LOCALIZATION; POLARITY; FUSOME	Drosophila oogenesis is especially well suited for studying stem cell biology, cellular differentiation, and morphogenesis. The small modifier protein ubiquitin regulates many cellular pathways. Ubiquitin is conjugated to target proteins by a diverse class of enzymes called ubiquitin E3 ligases. Here we characterize the requirement of Cul-5, a key component of a subgroup of Cullin-RING-type ubiquitin E3 ligases, in Drosophila oogenesis. We find that reduced cul-5 activity causes the formation of aberrant follicles that are characterized by excess germ cells. We show that germ line cells overproliferate in cul-5 mutant females, causing the formation of abnormally large germ line cysts. Also, the follicular epithelium that normally encapsulates single germ line cysts develops aberrantly in cul-5 mutant, leading to defects in cyst formation. We additionally found that Cul-5 is required for germ cell maintenance, as germ cells are depleted in a substantial fraction of cul-5 mutant ovaries. All of these cul-5 phenotypes are strongly enhanced by reduced activity of gustavus (gus), which encodes a substrate receptor of Cul-5-based ubiquitin E3 ligases. Taken together, our results implicate Cul-5/Gus ubiquitin E3 ligases in ovarian tissue morphogenesis, germ cell proliferation and maintenance of the ovarian germ cell population.	[Kugler, Jan-Michael; Lem, Christopher; Lasko, Paul] McGill Univ, Dept Biol, Dev Biol Res Initiat, Montreal, PQ H3A 1B1, Canada; [Lasko, Paul] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada	McGill University; McGill University	Kugler, JM (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	Paul.Lasko@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501	National Institute of Child Health and Development (NICHD) [R01-HD036631]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036631] Funding Source: NIH RePORTER	National Institute of Child Health and Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant R01-HD036631 from the National Institute of Child Health and Development (NICHD) to P. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115; Barry Michele, 2006, Sci STKE, V2006, ppe21; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bolivar J, 2006, DEV DYNAM, V235, P2969, DOI 10.1002/dvdy.20967; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Feng L, 2007, GENE DEV, V21, P2717, DOI 10.1101/gad.1604207; Fichelson Pierre, 2007, Prog Mol Subcell Biol, V45, P97; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; GOODE S, 1992, DEVELOPMENT, V116, P177; Goode S, 1996, DEVELOPMENT, V122, P3863; Goode S, 1996, DEV BIOL, V178, P35, DOI 10.1006/dbio.1996.0196; Grammont M, 2001, DEVELOPMENT, V128, P2243; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hawkins NC, 1996, DEVELOPMENT, V122, P281; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Jackson SM, 1997, DEVELOPMENT, V124, P3663; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Laszlo GS, 2009, CURR BIOL, V19, P157, DOI 10.1016/j.cub.2008.12.007; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Narbonne-Reveau K, 2009, MOL BIOL CELL, V20, P1960, DOI 10.1091/mbc.E08-09-0916; Ohlmeyer JT, 2003, DEVELOPMENT, V130, P6339, DOI 10.1242/dev.00855; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Reynolds PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002918; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rubsam R, 1998, MECH DEVELOP, V72, P131, DOI 10.1016/S0925-4773(98)00023-9; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; Spradling Allan C., 1993, P1; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Torres IL, 2003, DEV CELL, V5, P547, DOI 10.1016/S1534-5807(03)00272-7; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004	45	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9048	10.1371/journal.pone.0009048	http://dx.doi.org/10.1371/journal.pone.0009048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140218	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474400007
J	Altmann, DR; Korte, W; Maeder, MT; Fehr, T; Haager, P; Rickli, H; Kleger, GR; Rodriguez, R; Ammann, P				Altmann, David R.; Korte, Wolfgang; Maeder, Micha T.; Fehr, Thomas; Haager, Philipp; Rickli, Hans; Kleger, Gian-Reto; Rodriguez, Regulo; Ammann, Peter			Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis	PLOS ONE			English	Article							PLATELET; THROMBOELASTOGRAPHY; THROMBELASTOGRAPHY; HYPERCOAGULABILITY; DYSFUNCTION; ACTIVATION; DEPRESSION; RELEASE; RISK	Background: Elevated cardiac troponin I (cTnI) is frequently observed in patients with severe sepsis and septic shock. However, the mechanisms underlying cTnI release in these patients are still unknown. To date no data regarding coagulation disturbances as a possible mechanism for cTnI release during sepsis are available. Methodology/Principal Findings: Consecutive patients with systemic inflammatory response syndrome (SIRS), sepsis or septic shock without evidence of an acute coronary syndrome were analyzed. Coagulation parameters (clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF), alpha-angle) were assessed in native whole blood samples, and using specific activators to evaluate the extrinsic and intrinsic as well as the fibrin component of the coagulation pathway with the use of rotational thrombelastometry (ROTEM). Thirty-eight patients were included and 22 (58%) were cTnI-positive. Baseline characteristics between TnI-positive and -negative patients were similar. The CT, CFT, MCF and the a-angle were similar between the groups with trends towards shorter CT in the extrinsic and fibrin activation. Conclusions/Significance: We found no differences in coagulation parameters analyzed with rotational thrombelastometry between cTnI-positive and -negative patients with SIRS, severe sepsis, and septic shock. These findings suggest that pathophysiological mechanisms other than thrombus-associated myocardial damage might play a major role, including reversible myocardial membrane leakage and/or cytokine mediated apoptosis in these patients.	[Altmann, David R.; Haager, Philipp; Rickli, Hans; Ammann, Peter] Kantonsspital St Gallen, Div Cardiol, St Gallen, Switzerland; [Korte, Wolfgang] Kantonsspital St Gallen, Inst Clin Chem & Hematol, St Gallen, Switzerland; [Maeder, Micha T.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Fehr, Thomas] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Kleger, Gian-Reto] Kantonsspital St Gallen, Dept Internal Med, Intens Care Unit, St Gallen, Switzerland; [Rodriguez, Regulo] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland	Kantonsspital St. Gallen; Kantonsspital St. Gallen; Baker Heart and Diabetes Institute; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; Kantonsspital St. Gallen	Altmann, DR (corresponding author), Kantonsspital St Gallen, Div Cardiol, St Gallen, Switzerland.	peter.ammann@kssg.ch			Pentapharm GmbH	Pentapharm GmbH	There was no funding for this work. The rotational thrombelastometry (ROTEM) analysis was sponsored by Pentapharm GmbH. The sponsor had no role in the study design, data acquisition or analysis.	*AM COLL CHEST PHY, CRIT CARE MED, V20, P864; Ammann P, 2001, INTENS CARE MED, V27, P965, DOI 10.1007/s001340100920; Ammann P, 2003, J AM COLL CARDIOL, V41, P2004, DOI 10.1016/S0735-1097(03)00421-2; Bonz AW, 2002, J AM COLL CARDIOL, V40, P662, DOI 10.1016/S0735-1097(02)02014-4; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; Coakley M, 2006, J CARDIOTHOR VASC AN, V20, P548, DOI 10.1053/j.jvca.2006.01.016; Cuisset T, 2007, THROMB HAEMOSTASIS, V97, P282, DOI 10.1160/TH06-07-0362; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gonano C, 2006, CRIT CARE, V10, DOI 10.1186/cc5098; Kaufmann CR, 1997, J TRAUMA, V42, P716, DOI 10.1097/00005373-199704000-00023; Kumar A, 1996, J EXP MED, V183, P949, DOI 10.1084/jem.183.3.949; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Luddington RJ, 2005, CLIN LAB HAEMATOL, V27, P81, DOI 10.1111/j.1365-2257.2005.00681.x; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mahla E, 2001, ANESTH ANALG, V92, P572, DOI 10.1097/00000539-200103000-00004; MAZEIKA PK, 1992, J AM COLL CARDIOL, V19, P1203, DOI 10.1016/0735-1097(92)90325-H; McCrath DJ, 2005, ANESTH ANALG, V100, P1576, DOI 10.1213/01.ANE.0000155290.86795.12; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Poulsen LH, 2006, SCAND J CLIN LAB INV, V66, P329, DOI 10.1080/00365510600672783; Ray MJ, 2005, INT J CARDIOL, V101, P249, DOI 10.1016/j.ijcard.2004.03.033; Reinhofer M, 2008, BLOOD COAGUL FIBRIN, V19, P212, DOI 10.1097/MBC.0b013e3282f3f9d4; Rinder CS, 2002, ANESTHESIOLOGY, V97, P1118, DOI 10.1097/00000542-200211000-00013; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; ver Elst KM, 2000, CLIN CHEM, V46, P650; Wu AHB, 2001, INTENS CARE MED, V27, P959, DOI 10.1007/s001340100970; ZUCKERMAN L, 1981, THROMB HAEMOSTASIS, V46, P752	28	49	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9017	10.1371/journal.pone.0009017	http://dx.doi.org/10.1371/journal.pone.0009017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140242	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474200011
J	Juhlin, CC; Kiss, NB; Villablanca, A; Haglund, F; Nordenstrom, J; Hoog, A; Larsson, C				Juhlin, C. Christofer; Kiss, Nimrod B.; Villablanca, Andrea; Haglund, Felix; Nordenstrom, Jorgen; Hoog, Anders; Larsson, Catharina			Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; DNA METHYLATION; ABERRANT METHYLATION; MALIGNANT BEHAVIOR; GENE PROMOTER; HUMAN PAF1; CYCLIN D1; MEN1 GENE; RAR-BETA; C-MYC	Background: Parathyroid adenomas constitute the most common entity in primary hyperparathyroidism, and although recent advances have been made regarding the underlying genetic cause of these lesions, very little data on epigenetic alterations in this tumour type exists. In this study, we have determined the levels of promoter methylation regarding the four tumour suppressor genes APC, RASSF1A, p16(INK4A) and RAR-beta in parathyroid adenomas. In addition, the levels of global methylation were assessed by analyzing LINE-1 repeats. Methodology/Principal Findings: The sample collection consisted of 55 parathyroid tumours with known HRPT2 and/or MEN1 genotypes. Using Pyrosequencing analysis, we demonstrate APC promoter 1A and RASSF1A promoter hypermethylation in the majority of parathyroid tumours (71% and 98%, respectively). Using TaqMan qRT-PCR, all tumours analyzed displayed lower RASSF1A mRNA expression and higher levels of total APC mRNA than normal parathyroid, the latter of which was largely conferred by augmented APC 1B transcription levels. Hypermethylation of p16(INK4A) was demonstrated in a single adenoma, whereas RAR-b hypermethylation was not observed in any sample. Moreover, based on LINE-1 analyses, parathyroid tumours exhibited global methylation levels within the range of non-neoplastic parathyroid tissues. Conclusions/Significance: The results demonstrate that APC and RASSF1A promoter hypermethylation are common events in parathyroid tumours. While RASSF1A mRNA levels were found downregulated in all tumours investigated, APC gene expression was retained through APC 1B mRNA levels. These findings suggest the involvement of the Ras signaling pathway in parathyroid tumorigenesis. Additionally, in contrast to most other human cancers, parathyroid tumours were not characterized by global hypomethylation, as parathyroid tumours exhibited LINE-1 methylation levels similar to that of normal parathyroid tissues.	[Juhlin, C. Christofer; Kiss, Nimrod B.; Villablanca, Andrea; Haglund, Felix; Nordenstrom, Jorgen; Larsson, Catharina] Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Juhlin, C. Christofer; Hoog, Anders] Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Juhlin, CC (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden.	christofer.juhlin@ki.se	Juhlin, Carl Christofer/C-1125-2016	Juhlin, Carl Christofer/0000-0002-5945-9081	Swedish Cancer Foundation; Cancer Society in Stockholm; Gustav V. Jubilee Foundation; Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council; Stockholm County Council; Karolinska Institutet	Swedish Cancer Foundation; Cancer Society in Stockholm; Gustav V. Jubilee Foundation; Goran Gustavsson Foundation for Research in Natural Sciences and Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The study was financially supported by the Swedish Cancer Foundation, the Cancer Society in Stockholm, the Gustav V. Jubilee Foundation, the Goran Gustavsson Foundation for Research in Natural Sciences and Medicine, the Swedish Research Council, the Stockholm County Council, and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Bjorklund P, 2007, J CLIN ENDOCR METAB, V92, P338, DOI 10.1210/jc.2006-1197; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Chen J, 2005, CARCINOGENESIS, V26, P37, DOI 10.1093/carcin/bgh280; DELELLIS RA, 2004, WHO CLASSIFICATION T, P124; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Esteller M, 2000, CANCER RES, V60, P4366; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Farnebo F, 1998, J CLIN ENDOCR METAB, V83, P2627, DOI 10.1210/jc.83.8.2627; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fischer JR, 2006, LUNG CANCER, V54, P109, DOI 10.1016/j.lungcan.2006.06.017; Geli J, 2008, CLIN CANCER RES, V14, P2551, DOI 10.1158/1078-0432.CCR-07-1867; Geli J, 2007, ENDOCR-RELAT CANCER, V14, P125, DOI 10.1677/ERC-06-0031; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; He ML, 2009, PROSTATE, V69, P1643, DOI 10.1002/pros.21013; Hsi ED, 1996, J CLIN ENDOCR METAB, V81, P1736, DOI 10.1210/jc.81.5.1736; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Juhlin C, 2006, ENDOCR-RELAT CANCER, V13, P509, DOI 10.1677/erc.1.01058; Juhlin CC, 2007, ENDOCR-RELAT CANCER, V14, P501, DOI 10.1677/ERC-07-0021; Juhlin CC, 2009, INT J ONCOL, V34, P481, DOI 10.3892/ijo_00000173; Kiss NB, 2008, ENDOCR-RELAT CANCER, V15, P609, DOI 10.1677/ERC-07-0285; Lee JJ, 2008, INT J ONCOL, V33, P861, DOI 10.3892/ijo_00000074; Lemmens I, 1997, GENOMICS, V44, P94, DOI 10.1006/geno.1997.4872; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; MIKI Y, 1992, CANCER RES, V52, P643; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mould AW, 2009, INT J CANCER, V124, P1122, DOI 10.1002/ijc.24057; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Romermann D, 2008, LEUKEMIA, V22, P1954, DOI 10.1038/leu.2008.76; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Segditsas S, 2008, EXP MOL PATHOL, V85, P201, DOI 10.1016/j.yexmp.2008.09.006; Shen WJ, 2008, WORLD J GASTROENTERO, V14, P595, DOI 10.3748/wjg.14.595; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Tahara H, 1996, J CLIN ENDOCR METAB, V81, P3663, DOI 10.1210/jc.81.10.3663; Tominaga Y, 1999, KIDNEY INT, V55, P1375, DOI 10.1046/j.1523-1755.1999.00396.x; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; ZEKI K, 1994, J CLIN ENDOCR METAB, V79, P1317, DOI 10.1210/jc.79.5.1317; Zysman M, 2002, CANCER RES, V62, P3663	46	46	49	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9472	10.1371/journal.pone.0009472	http://dx.doi.org/10.1371/journal.pone.0009472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208994	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997100018
J	Brown, DE; McCoy, MW; Pilonieta, MC; Nix, RN; Detweiler, CS				Brown, Diane E.; McCoy, Melissa W.; Pilonieta, M. Carolina; Nix, Rebecca N.; Detweiler, Corrella S.			Chronic Murine Typhoid Fever Is a Natural Model of Secondary Hemophagocytic Lymphohistiocytosis	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM; MALIGNANT HISTIOCYTOSIS; IRON-DEFICIENCY; MUTANT MICE; IN-VIVO; INFECTION; MACROPHAGES; DIAGNOSIS; SPECTRUM; GENES	Hemophagocytic lymphohistiocytosis (HLH) is a hyper-inflammatory clinical syndrome associated with neoplastic disorders especially lymphoma, autoimmune conditions, and infectious agents including bacteria, viruses, protozoa and fungi. In both human and veterinary medicine, hemophagocytic histiocytic disorders are clinically important and frequently fatal. HLH in humans can be a primary (familial, autosomal recessive) or secondary (acquired) condition, with both types generally precipitated by an infectious agent. Previously, no mouse model for secondary HLH has been reported. Using Salmonella enterica serotype Typhimurium by oral gavage to mimic naturally-occurring infection in Sv129S6 mice, we characterized the clinical, hematologic and morphologic host responses to disease thereby describing an animal model with the clinicopathologic features of secondary HLH as set forth by the Histiocyte Society: fever, splenomegaly, cytopenias (anemia, thrombocytopenia), hemophagocytosis in bone marrow and spleen, hyperferritinemia, and hypofibrinogenemia. Disease severity correlates with high splenic and hepatic bacterial load, and we show disease course can be monitored and tracked in live animals. Whereby secondary HLH is known to occur in human patients with typhoid fever and other infectious diseases, our characterization of a viable natural disease model of secondary HLH offers an important means to elucidate pathogenesis of poorly understood mechanisms of secondary HLH and investigation of novel therapies. We characterize previously unreported secondary HLH in a chronic mouse model of typhoid fever, and novel changes in hematology including decreased tissue ferric iron storage that differs from classically described anemia of chronic disease. Our studies demonstrate S. Typhimurium infection of mice is a natural infectious disease model of secondary HLH that may have utility for elucidating disease pathogenesis and developing novel therapies.	[Brown, Diane E.; McCoy, Melissa W.; Pilonieta, M. Carolina; Nix, Rebecca N.; Detweiler, Corrella S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Brown, Diane E.] Univ Colorado, Museum Nat Hist, Paleontol Sect, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Brown, DE (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	diane.brown@colorado.edu; corrella.detweiler@colorado.edu	DETWEILER, CORRELLA S/ABG-2625-2021	DETWEILER, CORRELLA S/0000-0002-7783-0876	National Institutes of Health [AI076682, AI072492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076682, R01AI072492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants AI076682 and AI072492 (C. S. D.) from the National Institutes of Health (www3.niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka RS, 2002, BLOOD, V100, P1465, DOI 10.1182/blood-2001-11-0037; Allen CE, 2008, PEDIATR BLOOD CANCER, V50, P1227, DOI 10.1002/pbc.21423; Anderson G, 2005, J CLIN PATHOL, V58, P1305, DOI 10.1136/jcp.2005.027045; BESSMAN D, 1978, JAMA-J AM MED ASSOC, V239, P2475, DOI 10.1001/jama.239.23.2475; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; BROWN DE, 1994, AM J PATHOL, V144, P1412; Burkhard MJ, 2001, VET CLIN PATH, V30, P76, DOI 10.1111/j.1939-165X.2001.tb00262.x; Car BD, 2001, VET PATHOL, V38, P20, DOI 10.1354/vp.38-1-20; Castillo L, 2009, PEDIATR CRIT CARE ME, V10, P387, DOI 10.1097/PCC.0b013e3181a1ae08; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; Creput C, 2008, INTENS CARE MED, V34, P1177, DOI 10.1007/s00134-008-1111-y; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; ESUMI N, 1988, CANCER, V61, P2071, DOI 10.1002/1097-0142(19880515)61:10<2071::AID-CNCR2820611023>3.0.CO;2-6; Everds N.E., 2007, MOUSE BIOMEDICAL RES, V3, P133; FAVARA BE, 1992, SEMIN DIAGN PATHOL, V9, P63; FEINGOLD KR, 1994, ARTERIOSCLER THROMB, V14, P1866, DOI 10.1161/01.ATV.14.11.1866; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Friedrichs KR, 2008, VET CLIN PATH, V37, P121, DOI 10.1111/j.1939-165X.2008.00005.x; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1993, ACTA PAEDIATR, V82, P369, DOI 10.1111/j.1651-2227.1993.tb12699.x; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P675, DOI 10.1111/j.1651-2227.1991.tb11928.x; HORMAECHE CE, 1985, J INFECT DIS, V152, P1050, DOI 10.1093/infdis/152.5.1050; Horne A, 2008, BRIT J HAEMATOL, V140, P327, DOI 10.1111/j.1365-2141.2007.06922.x; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kirino Y, 2005, ARTHRITIS RES THER, V7, pR616, DOI 10.1186/ar1721; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Nahum E, 2000, Pediatr Crit Care Med, V1, P51, DOI 10.1097/00130478-200007000-00010; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; NAUCIEL C, 1988, INFECT IMMUN, V56, P2407, DOI 10.1128/IAI.56.9.2407-2411.1988; Nawabi P, 2008, MOL MICROBIOL, V68, P173, DOI 10.1111/j.1365-2958.2008.06142.x; NEWLANDS CE, 1994, J AM VET MED ASSOC, V205, P849; Nix RN, 2007, PLOS PATHOG, V3, P1982, DOI 10.1371/journal.ppat.0030193; Ohgami RS, 2005, BLOOD, V106, P3625, DOI 10.1182/blood-2005-01-0379; Percy DH, 2007, PATHOLOGY LAB RODENT, P3; Prophet E. B., 1992, LAB METHODS HISTOTEC; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Roy MF, 2007, J EXP MED, V204, P2949, DOI 10.1084/jem.20062606; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schaer DJ, 2006, EUR J HAEMATOL, V77, P432, DOI 10.1111/j.1600-0609.2006.00730.x; Schmid JP, 2008, EUR J IMMUNOL, V38, P3219, DOI 10.1002/eji.200838488; Shin Bo-Moon, 1994, Journal of Korean Medical Science, V9, P57; Singh ZN, 2005, CLIN LAB HAEMATOL, V27, P312, DOI 10.1111/j.1365-2257.2005.00717.x; SMITH BP, 1984, AM J VET RES, V45, P59; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Spangler WL, 1999, VET PATHOL, V36, P583, DOI 10.1354/vp.36-6-583; SPENCER DC, 1988, J INFECTION, V16, P153, DOI 10.1016/S0163-4453(88)93972-2; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Veerakul Gavivann, 2002, Journal of the Medical Association of Thailand, V85, pS530; Weiss DJ, 2007, JAVMA-J AM VET MED A, V230, P697, DOI 10.2460/javma.230.5.697; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006; Wickham ME, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-65	62	42	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9441	10.1371/journal.pone.0009441	http://dx.doi.org/10.1371/journal.pone.0009441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195482	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000010
J	Perin, L; Sedrakyan, S; Giuliani, S; Da Sacco, S; Carraro, G; Shiri, L; Lemley, KV; Rosol, M; Wu, S; Atala, A; Warburton, D; De Filippo, RE				Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Atala, Anthony; Warburton, David; De Filippo, Roger E.			Protective Effect of Human Amniotic Fluid Stem Cells in an Immunodeficient Mouse Model of Acute Tubular Necrosis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; T-CELLS; REPAIR; DIFFERENTIATION; PROLIFERATION; INFLAMMATION; PROTEIN; IL-10	Acute Tubular Necrosis (ATN) causes severe damage to the kidney epithelial tubular cells and is often associated with severe renal dysfunction. Stem-cell based therapies may provide alternative approaches to treating of ATN. We have previously shown that clonal c-kit(pos) stem cells, derived from human amniotic fluid (hAFSC) can be induced to a renal fate in an ex-vivo system. Herein, we show for the first time the successful therapeutic application of hAFSC in a mouse model with glycerol-induced rhabdomyolysis and ATN. When injected into the damaged kidney, luciferase-labeled hAFSC can be tracked using bioluminescence. Moreover, we show that hAFSC provide a protective effect, ameliorating ATN in the acute injury phase as reflected by decreased creatinine and BUN blood levels and by a decrease in the number of damaged tubules and apoptosis therein, as well as by promoting proliferation of tubular epithelial cells. We show significant immunomodulatory effects of hAFSC, over the course of ATN. We therefore speculate that AFSC could represent a novel source of stem cells that may function to modulate the kidney immune milieu in renal failure caused by ATN.	[Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Warburton, David; De Filippo, Roger E.] Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA; [Perin, Laura; Sedrakyan, Sargis; Giuliani, Stefano; Da Sacco, Stefano; Carraro, Gianni; Shiri, Liron; Lemley, Kevin V.; Rosol, Michael; Wu, Sam; Warburton, David; De Filippo, Roger E.] Univ So Calif, Keck Sch Med, Inst Urol, Los Angeles, CA 90033 USA; [Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Children's Hospital Los Angeles; University of Southern California; Wake Forest University	Perin, L (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, Dev Biol & Regenerat Med Program, Los Angeles, CA 90027 USA.	redefilippo@chla.usc.edu	Warburton, David/AAD-5709-2020; Da Sacco, Stefano/G-6346-2011	Da Sacco, Stefano/0000-0001-9654-6822; Giuliani, Stefano/0000-0002-4555-3093; Atala, Anthony/0000-0001-8186-2160; Carraro, Gianni/0000-0003-0824-7692	California Institute Regenerative Medicine (CIRM); American Urology Association (AUA); GOFARR; Pasadena Guild of Childrens Hospital Los Angeles	California Institute Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American Urology Association (AUA); GOFARR; Pasadena Guild of Childrens Hospital Los Angeles	Funding was receive from the California Institute Regenerative Medicine (CIRM), American Urology Association (AUA), GOFARR, and The Pasadena Guild of Childrens Hospital Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonventre JV, 2003, SEMIN NEPHROL, V23, P439, DOI 10.1016/S0270-9295(03)00115-3; Carraro G, 2008, STEM CELLS, V26, P2902, DOI 10.1634/stemcells.2008-0090; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; de Haan G, 2000, BRIT J HAEMATOL, V110, P638, DOI 10.1046/j.1365-2141.2000.02252.x; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Herrera MB, 2004, INT J MOL MED, V14, P1035; HULI J, 1987, J EXP MED, V165, P157, DOI 10.1084/jem.165.1.157; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; LIN F, 2007, PEDIAT NEPHROL; LIU CL, 1995, J INTERF CYTOK RES, V15, P985, DOI 10.1089/jir.1995.15.985; MALISZEWSKI CR, 1988, MOL IMMUNOL, V25, P843, DOI 10.1016/0161-5890(88)90120-4; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; *NAT KIDN UR DIS I, KIDN UR DIS STAT US; Perin L, 2007, CELL PROLIFERAT, V40, P936, DOI 10.1111/j.1365-2184.2007.00478.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Schwabe M, 1996, CELL IMMUNOL, V168, P117, DOI 10.1006/cimm.1996.0056; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Wang XL, 2003, BLOOD, V102, P3478, DOI 10.1182/blood-2003-05-1432; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; 1989, IMMUNODEFICIENT RODE	29	123	134	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9357	10.1371/journal.pone.0009357	http://dx.doi.org/10.1371/journal.pone.0009357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195358	Green Accepted, gold, Green Published			2022-12-27	WOS:000274924200010
J	Ingerslev, HC; Ossum, CG; Lindenstrom, T; Nielsen, ME				Ingerslev, Hans-Christian; Ossum, Carlo Gunnar; Lindenstrom, Thomas; Nielsen, Michael Engelbrecht			Fibroblasts Express Immune Relevant Genes and Are Important Sentinel Cells during Tissue Damage in Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR; HUMAN GINGIVAL FIBROBLASTS; SALMON SALMO-SALAR; ATLANTIC SALMON; TELEOST FISH; IFN-GAMMA; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MX1 PROMOTER; RESPONSES	Fibroblasts have shown to be an immune competent cell type in mammals. However, little is known about the immunological functions of this cell-type in lower vertebrates. A rainbow trout hypodermal fibroblast cell-line (RTHDF) was shown to be responsive to PAMPs and DAMPs after stimulation with LPS from E. coli, supernatant and debris from sonicated RTHDF cells. LPS was overall the strongest inducer of IL-1 beta, IL-8, IL-10, TLR-3 and TLR-9. IL-1 beta and IL-8 were already highly up regulated after 1 hour of LPS stimulation. Supernatant stimuli significantly increased the expression of IL-1 beta, TLR-3 and TLR-9, whereas the debris stimuli only increased expression of IL-1 beta. Consequently, an in vivo experiment was further set up. By mechanically damaging the muscle tissue of rainbow trout, it was shown that fibroblasts in the muscle tissue of rainbow trout contribute to electing a highly local inflammatory response following tissue injury. The damaged muscle tissue showed a strong increase in the expression of the immune genes IL-1 beta, IL-8 and TGF-beta already 4 hours post injury at the site of injury while the expression in non-damaged muscle tissue was not influenced. A weaker, but significant response was also seen for TLR-9 and TLR-22. Rainbow trout fibroblasts were found to be highly immune competent with a significant ability to express cytokines and immune receptors. Thus fish fibroblasts are believed to contribute significantly to local inflammatory reactions in concert with the traditional immune cells.	[Ingerslev, Hans-Christian; Nielsen, Michael Engelbrecht] DTU Food, Natl Food Inst, Div Seafood Res, Sect Aquat Prot Biochem, Lyngby, Denmark; [Ossum, Carlo Gunnar] Univ Copenhagen, August Krogh Inst, Dept Biochem, DK-2100 Copenhagen, Denmark; [Lindenstrom, Thomas] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen; Statens Serum Institut	Ingerslev, HC (corresponding author), DTU Food, Natl Food Inst, Div Seafood Res, Sect Aquat Prot Biochem, Lyngby, Denmark.	hci@aqua.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019; Lindenstrøm, Thomas/ABE-4203-2020; Ingerslev, Hans-Christian/AAP-6079-2020	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Lindenstrøm, Thomas/0000-0002-7162-8124; Ingerslev, Hans-Christian/0000-0002-9761-7474	Directorate for Food, Fisheries and Agri Business [3310-06-00116]; Strategic Research Council [2101-08-0017]	Directorate for Food, Fisheries and Agri Business; Strategic Research Council	This work was supported by The Directorate for Food, Fisheries and Agri Business Grant 3310-06-00116 and the Strategic Research Council grant 2101-08-0017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019; Alberts B., 1989, MOL BIOL CELL; Alberts B, 2008, MOL BIOL CELL; Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Campo GM, 2006, MOL CELL BIOCHEM, V292, P169, DOI 10.1007/s11010-006-9230-7; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Collet B, 2004, DEV COMP IMMUNOL, V28, P793, DOI 10.1016/j.dci.2003.12.005; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Dziarski R, 2000, J ENDOTOXIN RES, V6, P401, DOI 10.1179/096805100101532243; Ganassin RC, 1998, FISH SHELLFISH IMMUN, V8, P457, DOI 10.1006/fsim.1998.0153; Ganassin RC, 1996, FISH SHELLFISH IMMUN, V6, P17, DOI 10.1006/fsim.1996.0003; Gonzalez SF, 2007, DEV COMP IMMUNOL, V31, P244, DOI 10.1016/j.dci.2006.06.010; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; HORDVIK I, 1993, IMMUNOGENETICS, V37, P437, DOI 10.1007/BF00222467; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V142, P285, DOI 10.1111/j.1365-2249.2005.02912.x; Iliev DB, 2007, MOL IMMUNOL, V44, P1803, DOI 10.1016/j.molimm.2006.07.297; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Kaiser P, 2004, DEV COMP IMMUNOL, V28, P375, DOI 10.1016/j.dci.2003.09.004; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kumagai Y, 2008, ADV DRUG DELIVER REV, V60, P795, DOI 10.1016/j.addr.2007.12.004; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Chunguang, 1999, Methods in Cell Science, V21, P39, DOI 10.1023/A:1009824303498; Magor BG, 2001, DEV COMP IMMUNOL, V25, P651, DOI 10.1016/S0145-305X(01)00029-5; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; MURPHY KP, 2008, JANCWAYS IMMUNOBIOLO, pR21; Nemoto E, 2000, J IMMUNOL, V165, P5807, DOI 10.4049/jimmunol.165.10.5807; Nielsen AR, 2007, APPL PHYSIOL NUTR ME, V32, P833, DOI 10.1139/H07-054; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ohtani M, 2008, IMMUNOGENETICS, V60, P383, DOI 10.1007/s00251-008-0299-x; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Ossum CG, 2004, J FISH BIOL, V64, P1103, DOI 10.1111/j.1095-8649.2004.0378.x; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Rebl A, 2007, DEV COMP IMMUNOL, V31, P499, DOI 10.1016/j.dci.2006.08.007; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Ruiz C, 2007, J BONE MINER METAB, V25, P286, DOI 10.1007/s00774-007-0767-7; Sangrador-Vegas A, 2002, CYTOKINE, V17, P66, DOI 10.1006/cyto.2001.0991; Secombes C. J., 1996, The fish immune system: organism, pathogen, and environment, P63; Secombes CJ, 1999, FISH SHELLFISH IMMUN, V9, P335, DOI 10.1006/fsim.1998.0193; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; SHAN X, 2009, COLLOIDS SURF B; Skaleric U, 2000, EUR J ORAL SCI, V108, P130, DOI 10.1034/j.1600-0722.2000.90771.x; Skjaeveland I, 2008, DEV COMP IMMUNOL, V32, P603, DOI 10.1016/j.dci.2007.10.011; Smith RS, 1997, AM J PATHOL, V151, P317; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Sugawara S, 1998, INFECT IMMUN, V66, P3043, DOI 10.1128/IAI.66.7.3043-3049.1998; Takeuchi O, 2001, INT IMMUNOPHARMACOL, V1, P625, DOI 10.1016/S1567-5769(01)00010-8; TROBRIDGE GD, 1995, J INTERF CYTOK RES, V15, P691, DOI 10.1089/jir.1995.15.691; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; Wang TH, 2002, BBA-GENE STRUCT EXPR, V1575, P108, DOI 10.1016/S0167-4781(02)00235-X; Wang TH, 2008, J IMMUNOL, V181, P3310, DOI 10.4049/jimmunol.181.5.3310; WARR GW, 1995, DEV COMP IMMUNOL, V19, P1, DOI 10.1016/0145-305X(94)00052-H; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; Yoshiura Y, 2003, IMMUNOGENETICS, V55, P296, DOI 10.1007/s00251-003-0582-9; Zhang DC, 2005, J BIOCHEM MOL BIOL, V38, P571; Zhang Wensheng, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P697; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2004, EUR J BIOCHEM, V271, P1913, DOI 10.1111/j.1432-1033.2004.04101.x; Zou J, 1999, CYTOKINE, V11, P552, DOI 10.1006/cyto.1998.0470	74	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9304	10.1371/journal.pone.0009304	http://dx.doi.org/10.1371/journal.pone.0009304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174584	Green Submitted, Green Published, gold			2022-12-27	WOS:000274654700026
J	Pereira, JP; Cyster, JG; Xu, Y				Pereira, Joao Pedro; Cyster, Jason G.; Xu, Ying			A Role for S1P and S1P1 in Immature-B Cell Egress from Mouse Bone Marrow	PLOS ONE			English	Article							ANTI-IGM ANTIBODY; SPHINGOSINE-1-PHOSPHATE RECEPTOR; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; INVIVO PERFUSION; LOCALIZATION; TRAFFICKING; 2-ARACHIDONOYLGLYCEROL; ACTIVATION; PRECURSORS	B lymphocyte egress from secondary lymphoid organs requires sphingosine-1-phosphate (S1P) and S1P receptor-1 (S1P1). However, whether S1P contributes to immature-B cell egress from the bone marrow (BM) has not been fully assessed. Here we report that in S1P- and S1P1-conditionally deficient mice, the number of immature-B cells in the BM parenchyma increased, while it decreased in the blood. Moreover, a slower rate of bromodeoxyuridine incorporation suggested immature-B cells spent longer in the BM of mice in which S1P1-S1P signaling was genetically or pharmacologically impaired. Transgenic expression of S1P1 in developing B cells was sufficient to mobilize pro- and pre-B cells from the BM. We conclude that the S1P1-S1P pathway contributes to egress of immature-B cells from BM, and that this mechanism is partially redundant with other undefined pathways.	[Pereira, Joao Pedro; Cyster, Jason G.; Xu, Ying] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Pereira, JP (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	Joao.Pereira@ucsf.edu; Jason.Cyster@ucsf.edu		Pereira, Joao/0000-0002-5694-4938	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Donati C, 2007, STEM CELLS, V25, P1713, DOI 10.1634/stemcells.2006-0725; DONOVAN EE, 2009, EUR J IMMUNOL; Girkontaite I, 2004, J EXP MED, V200, P1491, DOI 10.1084/jem.20041483; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Halin C, 2005, BLOOD, V106, P1314, DOI 10.1182/blood-2004-09-3687; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; KIMURA Y, 2000, PHYS LOW DIMENS SEMI, V1, P1; Kohno T, 2002, FASEB J, V16, P983, DOI 10.1096/fj.01-0809com; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; OSMOND DG, 1984, AM J ANAT, V170, P349, DOI 10.1002/aja.1001700310; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pelanda R, 2002, GENESIS, V32, P154, DOI 10.1002/gene.10070; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; Sugiura T, 1998, BIOCHEM BIOPH RES CO, V243, P838, DOI 10.1006/bbrc.1998.8187; TAVASSOLI M, 1983, BONE MARROW STRUCTUR, pR12; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523	33	72	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9277	10.1371/journal.pone.0009277	http://dx.doi.org/10.1371/journal.pone.0009277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174580	gold, Green Published, Green Submitted			2022-12-27	WOS:000274654700012
J	Zhou, Y; Murthy, JN; Zeng, DW; Belardinelli, L; Blackburn, MR				Zhou, Yang; Murthy, Jayasimha N.; Zeng, Dewan; Belardinelli, Luiz; Blackburn, Michael R.			Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							DEAMINASE-DEFICIENT MICE; MAST-CELLS; INDUCED BRONCHOCONSTRICTION; AIRWAY INFLAMMATION; ASTHMATIC SUBJECTS; RECEPTOR AGONISTS; GENE-EXPRESSION; CYSTIC-FIBROSIS; A(2B) RECEPTORS; A(1) RECEPTOR	Background: Adenosine is generated in response to cellular stress and damage and is elevated in the lungs of patients with chronic lung disease. Adenosine signaling through its cell surface receptors serves as an amplifier of chronic lung disorders, suggesting adenosine-based therapeutics may be beneficial in the treatment of lung diseases such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Previous studies in mouse models of chronic lung disease demonstrate that the key components of adenosine metabolism and signaling are altered. Changes include an up-regulation of CD73, the major enzyme of adenosine production and down-regulation of adenosine deaminase (ADA), the major enzyme for adenosine metabolism. In addition, adenosine receptors are elevated. Methodology/Principal Findings: The focus of this study was to utilize tissues from patients with COPD or IPF to examine whether changes in purinergic metabolism and signaling occur in human disease. Results demonstrate that the levels of CD73 and A2BR are elevated in surgical lung biopsies from severe COPD and IPF patients. Immunolocalization assays revealed abundant expression of CD73 and the A2BR in alternatively activated macrophages in both COPD and IPF samples. In addition, mediators that are regulated by the A2BR, such as IL-6, IL-8 and osteopontin were elevated in these samples and activation of the A2BR on cells isolated from the airways of COPD and IPF patients was shown to directly induce the production of these mediators. Conclusions/Significance: These findings suggest that components of adenosine metabolism and signaling are altered in a manner that promotes adenosine production and signaling in the lungs of patients with COPD and IPF, and provide proof of concept information that these disorders may benefit from adenosine-based therapeutics. Furthermore, this study provides the first evidence that A2BR signaling can promote the production of inflammatory and fibrotic mediators in patients with these disorders.	[Zhou, Yang; Blackburn, Michael R.] Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Murthy, Jayasimha N.] Univ Texas Houston Med Sch, Div Pulm Crit Care & Sleep Med, Houston, TX USA; [Zhou, Yang; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Zeng, Dewan; Belardinelli, Luiz] Gilead Sci Inc, Palo Alto, CA USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Gilead Sciences	Zhou, Y (corresponding author), Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	ZHou, Yang/D-3320-2012	Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health (NIH) [HL095401, HL70952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095401, R01HL070952] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant numbers HL095401 and HL70952 to M. R. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI S, 1994, J PHARMACOL EXP THER, V268, P1328; BERKVENS TM, 1988, NUCLEIC ACIDS RES, V16, P3255, DOI 10.1093/nar/16.8.3255; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Brown RA, 2008, EUR RESPIR J, V31, P311, DOI 10.1183/09031936.00003707; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; CUSHLEY MJ, 1983, BRIT J CLIN PHARMACO, V15, P161, DOI 10.1111/j.1365-2125.1983.tb01481.x; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; FEOKTISTOV I, 1995, J CLIN INVEST, V96, P1979, DOI 10.1172/JCI118245; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huszar E, 2002, EUR RESPIR J, V20, P1393, DOI 10.1183/09031936.02.00005002; JOHNSON HG, 1985, BRIT J PHARMACOL, V86, P63, DOI 10.1111/j.1476-5381.1985.tb09435.x; Li Y, 2006, AM J RESP CELL MOL, V34, P600, DOI 10.1165/rcmb.2005-0421OC; Lupher ML, 2006, ADV IMMUNOL, V89, P245, DOI 10.1016/S0065-2776(05)89006-6; Ma B, 2006, J CLIN INVEST, V116, P1274, DOI 10.1172/JCI26372; MANN JS, 1986, CLIN SCI, V70, P461, DOI 10.1042/cs0700461; MANN JS, 1986, J APPL PHYSIOL, V61, P1667, DOI 10.1152/jappl.1986.61.5.1667; MARQUARDT DL, 1978, J IMMUNOL, V120, P871; Mohsenin A, 2007, FASEB J, V21, P1026, DOI 10.1096/fj.06-7301com; OOSTERHOFF Y, 1993, AM REV RESPIR DIS, V147, P553, DOI 10.1164/ajrccm/147.3.553; Picher M, 2004, J BIOL CHEM, V279, P20234, DOI 10.1074/jbc.M400305200; Roman J, 2006, AM J PHYSIOL-LUNG C, V290, pL317, DOI 10.1152/ajplung.00118.2005; Ryzhov S, 2004, J IMMUNOL, V172, P7726, DOI 10.4049/jimmunol.172.12.7726; Ryzhov S, 2008, J IMMUNOL, V180, P7212, DOI 10.4049/jimmunol.180.11.7212; Ryzhov S, 2008, J PHARMACOL EXP THER, V324, P694, DOI 10.1124/jpet.107.131540; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Vizi E, 2002, J ALLERGY CLIN IMMUN, V109, P446, DOI 10.1067/mai.2002.121955; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Walker BAM, 1997, AM J RESP CELL MOL, V16, P531, DOI 10.1165/ajrcmb.16.5.9160835; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; ZAYNAGETDINOV R, 2009, AM J RESP CELL MOL B; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhong HY, 2004, AM J RESP CELL MOL, V30, P118, DOI 10.1165/rcmb.2003-0118OC; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003	51	89	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9224	10.1371/journal.pone.0009224	http://dx.doi.org/10.1371/journal.pone.0009224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169073	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500006
J	Estes, LJ; Lloyd, LE; Teti, M; Raja, S; Bowleg, L; Allgood, KL; Glick, N				Estes, Larissa J.; Lloyd, Linda E.; Teti, Michelle; Raja, Sheela; Bowleg, Lisa; Allgood, Kristi L.; Glick, Nancy			Perceptions of Audio Computer-Assisted Self-Interviewing (ACASI) among Women in an HIV-Positive Prevention Program	PLOS ONE			English	Article							HEALTH; INTERVENTION; PEOPLE; STIGMA	Background: Audio Computer-Assisted Self Interviewing (ACASI) has improved the reliability and accuracy of self-reported HIV health and risk behavior data, yet few studies account for how participants experience the data collection process. Methodology/Principal Findings: This exploratory qualitative analysis aimed to better understand the experience and implications of using ACASI among HIV-positive women participating in sexual risk reduction interventions in Chicago (n = 12) and Philadelphia (n = 18). Strategies of Grounded Theory were used to explore participants' ACASI experiences. Conclusion/Significance: Key themes we identified included themes that could be attributed to the ACASI and other methods of data collection (e. g., paper-based self-administered questionnaire or face-to-face interviews). The key themes were usability; privacy and honesty; socially desirable responses and avoiding judgment; and unintentional discomfort resulting from recalling risky behavior using the ACASI. Despite both positive and negative findings about the ACASI experience, we conclude that ACASI is in general an appropriate method for collecting sensitive data about HIV/AIDS risk behaviors among HIV-positive women because it seemed to ensure privacy in the study population allowing for more honest responses, minimize socially desirable responses, and help participants avoid actual or perceived judgment.	[Estes, Larissa J.; Lloyd, Linda E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Teti, Michelle; Bowleg, Lisa] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Raja, Sheela] Univ Illinois, Coll Dent, Chicago, IL USA; [Allgood, Kristi L.; Glick, Nancy] Sinai Hlth Syst, Sinai Urban Hlth Inst, Chicago, IL USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Drexel University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Estes, LJ (corresponding author), Univ Texas Houston, Sch Publ Hlth, Houston, TX 77030 USA.	Larissa.J.Estes@uth.tmc.edu		Bowleg, Lisa/0000-0003-4677-8195; Teti, Michelle/0000-0002-3943-3810; , Sheela/0000-0001-5297-362X; Estes, Larissa/0000-0002-0601-2681; Allgood, Kristi/0000-0002-5056-3069	U.S. Department of Health and Human Services [03048]; Health Resources and Services Administration (HRSA); National Significance (SPNS) Program	U.S. Department of Health and Human Services; Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Significance (SPNS) Program	This research is supported by grant number 03048 from the U.S. Department of Health and Human Services, Health Resources and Services Administration (HRSA) Special Projects of National Significance (SPNS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript's contents are solely the responsibility of the authors and do not represent the official view of HRSA or the SPNS program.	ALMEIDA L, 2006, J CLIN PHARM, V46, P1077; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bowleg L, 2004, PSYCHOL WOMEN QUART, V28, P70, DOI 10.1111/j.1471-6402.2004.00124.x; Brewer NT, 2004, MED CARE, V42, P875, DOI 10.1097/01.mlr.0000135817.31355.6b; Bunting SM, 1996, ADV NURS SCI, V19, P64, DOI 10.1097/00012272-199612000-00008; Burt RS, 2005, BROKERAGE CLOSURE IN; Denzin N., 2018, SAGE HDB QUALITATIVE, V5th, DOI DOI 10.4135/9781849208550.N1; Edwards SL, 2007, AM J EPIDEMIOL, V165, P1336, DOI 10.1093/aje/kwm019; Eide P, 2008, NURS ETHICS, V15, P199, DOI 10.1177/0969733007086018; ELLIOTT DM, 1995, J TRAUMA STRESS, V8, P629, DOI 10.1007/BF02102892; Evans M, 2002, J MED ETHICS, V28, P41, DOI 10.1136/jme.28.1.41; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Green J., 2018, QUALITATIVE METHODS, VFourth; Griffin MG, 2003, J TRAUMA STRESS, V16, P221, DOI 10.1023/A:1023735821900; Guba EG., 1994, HDB QUALITATIVE RES, P105; Jacomb PA, 1999, SOC PSYCH PSYCH EPID, V34, P80, DOI 10.1007/s001270050115; Jones R, 2003, WESTERN J NURS RES, V25, P349, DOI 10.1177/0193945902250423; Kahn DL, 1999, QUAL HEALTH RES, V9, P119, DOI 10.1177/104973299129121631; Kim JH, 2008, IEEJ T ELECTR ELECTR, V3, P255, DOI 10.1002/tee.20264; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Kvale S., 2008, INTERVIEWS LEARNING; Kvale S, 1996, INTERVIEWS INTRO QUA; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Malitz FE, 2007, AIDS BEHAV, V11, pS1, DOI 10.1007/s10461-007-9252-5; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Minnis AM, 2007, CONTRACEPTION, V75, P59, DOI 10.1016/j.contraception.2006.07.002; Newman PA, 2008, J HEALTH CARE POOR U, V19, P829, DOI 10.1353/hpu.0.0043; NIMH Multisite HIV STD Prevent Tri, 2008, JAIDS-J ACQ IMM DEF, V49, pS52, DOI 10.1097/QAI.0b013e318184481a; Nunkoosing K, 2005, QUAL HEALTH RES, V15, P698, DOI 10.1177/1049732304273903; Pluhar E, 2007, J ASSOC NURSE AIDS C, V18, P51, DOI 10.1016/j.jana.2007.05.002; Raja S, 2007, AIDS BEHAV, V11, pS127, DOI 10.1007/s10461-007-9226-7; Sandelowski M, 2006, QUAL HEALTH RES, V16, P1350, DOI 10.1177/1049732306294274; Schneider S.J., 2000, J OFFICIAL STAT STOC, V16, P255; TETI M, 2009, MIXED METHODS EVALUA; Teti M, 2007, AIDS BEHAV, V11, pS106, DOI 10.1007/s10461-007-9275-y; *U CA SAN FRANC, 2008, ENH PREV POS EV CTR; van de Wijgert J, 2000, INT J EPIDEMIOL, V29, P885, DOI 10.1093/ije/29.5.885; Walker EA, 1997, GEN HOSP PSYCHIAT, V19, P403, DOI 10.1016/S0163-8343(97)00061-3; Waruru Anthony K, 2005, BMC Med Inform Decis Mak, V5, P24, DOI 10.1186/1472-6947-5-24; Wu Y, 2007, J SCHOOL HEALTH, V77, P23, DOI 10.1111/j.1746-1561.2007.00158.x	40	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9149	10.1371/journal.pone.0009149	http://dx.doi.org/10.1371/journal.pone.0009149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NW	20161771	Green Published, gold			2022-12-27	WOS:000274442700013
J	Dong, HJ; Zhang, YP; Dai, ZJ; Li, Y				Dong, Hongjun; Zhang, Yanping; Dai, Zongjie; Li, Yin			Engineering Clostridium Strain to Accept Unmethylated DNA	PLOS ONE			English	Article							INTRON TARGETRON VECTOR; ESCHERICHIA-COLI; GENETIC-TRANSFORMATION; TRANSFER EFFICIENCY; RESTRICTION; INACTIVATION; METHYLTRANSFERASE; DISRUPTION; OVEREXPRESSION; CYANOBACTERIUM	It is difficult to genetically manipulate the medically and biotechnologically important genus Clostridium due to the existence of the restriction and modification (RM) systems. We identified and engineered the RM system of a model clostridial species, C. acetobutylicum, with the aim to allow the host to accept the unmethylated DNA efficiently. A gene CAC1502 putatively encoding the type II restriction endonuclease Cac8241 was identified from the genome of C. acetobutylicum DSM1731, and disrupted using the ClosTron system based on group II intron insertion. The resulting strain SMB009 lost the type II restriction endonuclease activity, and can be transformed with unmethylated DNA as efficiently as with methylated DNA. The strategy reported here makes it easy to genetically modify the clostridial species using unmethylated DNA, which will help to advance the understanding of the clostridial physiology from the molecular level.	[Dong, Hongjun; Zhang, Yanping; Dai, Zongjie; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Dong, Hongjun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Dai, Zongjie] Univ Sci & Technol China, Dept Biochem & Mol Biol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dong, HJ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Li, Yin/C-6644-2009; Zhang, Yanping/C-7114-2009	Li, Yin/0000-0003-0995-3070; 	National High Technology Research and Development Program of China [2006AA02Z237]; National Basic Research Program of China [2007CB707803]; Knowledge Innovation Program of CAS [KSCXZ-YW-G-007]; Hundreds Talents Program of the Chinese Academy of Sciences	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Knowledge Innovation Program of CAS(Knowledge Innovation Program of the Chinese Academy of Sciences); Hundreds Talents Program of the Chinese Academy of Sciences	This work was supported by the National High Technology Research and Development Program of China (863 Project, # 2006AA02Z237), National Basic Research Program of China (973 Project, # 2007CB707803), Knowledge Innovation Program of CAS (# KSCXZ-YW-G-007), and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEDDOUG H, 1989, FEMS MICROBIOL LETT, V65, P323, DOI 10.1016/0378-1097(89)90239-5; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Bayliss CD, 2006, NUCLEIC ACIDS RES, V34, P4046, DOI 10.1093/nar/gkl568; Berndt C, 2003, MICROBIOL-SGM, V149, P895, DOI 10.1099/mic.0.26033-0; Brenner J., 2005, PROBACTERIA A, P27; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Durre P., 2005, HDB CLOSTRIDIA; Edwards RA, 1999, BIOTECHNIQUES, V26, P892, DOI 10.2144/99265st02; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; Green EM, 1998, BIOTECHNOL BIOENG, V58, P215, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<215::AID-BIT14>3.3.CO;2-I; Green EM, 1996, MICROBIOL-SGM, V142, P2079, DOI 10.1099/13500872-142-8-2079; Green EM, 1996, APPL BIOCHEM BIOTECH, V57-8, P213, DOI 10.1007/BF02941702; Harris LM, 2002, J BACTERIOL, V184, P3586, DOI 10.1128/JB.184.13.3586-3597.2002; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Hillmann F, 2009, J BACTERIOL, V191, P6082, DOI 10.1128/JB.00351-09; HIRSCH A, 1954, J DAIRY RES, V21, P101, DOI 10.1017/S0022029900007196; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kennedy CL, 2005, MOL MICROBIOL, V57, P1357, DOI 10.1111/j.1365-2958.2005.04774.x; LEE SY, 1992, ANN NY ACAD SCI, V665, P39, DOI 10.1111/j.1749-6632.1992.tb42572.x; Lewis TA, 1996, APPL ENVIRON MICROB, V62, P4669, DOI 10.1128/AEM.62.12.4669-4674.1996; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; MERMELSTEIN LD, 1993, APPL ENVIRON MICROB, V59, P1077, DOI 10.1128/AEM.59.4.1077-1081.1993; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Minton NP, 1989, INTRO PHYSL BIOCH GE, P27; MOSER DP, 1993, ARCH MICROBIOL, V160, P229; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Nikolajewa S, 2005, NUCLEIC ACIDS RES, V33, P2726, DOI 10.1093/nar/gki575; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ohshima H, 2002, J BACTERIOL, V184, P381, DOI 10.1128/JB.184.2.381-389.2002; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; Sambrook J., 2001, MOL CLONING LAB MANU; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; TRANBETCKE A, 1986, GENE, V42, P89, DOI 10.1016/0378-1119(86)90153-8; Tummala SB, 2003, J BACTERIOL, V185, P3644, DOI 10.1128/JB.185.12.3644-3653.2003; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248	48	60	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9038	10.1371/journal.pone.0009038	http://dx.doi.org/10.1371/journal.pone.0009038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161730	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442600002
J	Du, QS; Huang, RB; Wang, SQ; Chou, KC				Du, Qi-Shi; Huang, Ri-Bo; Wang, Shu-Qing; Chou, Kuo-Chen			Designing Inhibitors of M2 Proton Channel against H1N1 Swine Influenza Virus	PLOS ONE			English	Article							A VIRUS; ION-CHANNEL; RESISTANCE; MECHANISM; PROTEIN; SURVEILLANCE; COMBINATION; PREDICTION	Background: M2 proton channel of H1N1 influenza A virus is the target protein of anti-flu drugs amantadine and rimantadine. However, the two once powerful adamantane-based drugs lost their 90% bioactivity because of mutations of virus in recent twenty years. The NMR structure of the M2 channel protein determined by Schnell and Chou ( Nature, 2008, 451, 591-595) may help people to solve the drug-resistant problem and develop more powerful new drugs against H1N1 influenza virus. Methodology: Docking calculation is performed to build the complex structure between receptor M2 proton channel and ligands, including existing drugs amantadine and rimantadine, and two newly designed inhibitors. The computer-aided drug design methods are used to calculate the binding free energies, with the computational biology techniques to analyze the interactions between M2 proton channel and adamantine-based inhibitors. Conclusions: 1) The NMR structure of M2 proton channel provides a reliable structural basis for rational drug design against influenza virus. 2) The channel gating mechanism and the inhibiting mechanism of M2 proton channel, revealed by the NMR structure of M2 proton channel, provides the new ideas for channel inhibitor design. 3) The newly designed adamantane-based inhibitors based on the modeled structure of H1N1-M2 proton channel have two pharmacophore groups, which act like a "barrel hoop'', holding two adjacent helices of the H1N1-M2 tetramer through the two pharmacophore groups outside the channel. 4) The inhibitors with such binding mechanism may overcome the drug resistance problem of influenza A virus to the adamantane-based drugs.	[Du, Qi-Shi; Huang, Ri-Bo] Guangxi Acad Sci, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Huang, Ri-Bo] Guangxi Univ, Coll Life Sci & Tech, Nanning 530004, Guangxi, Peoples R China; [Wang, Shu-Qing] Tianjin Med Univ, Sch Pharmaceut Sci, Tianjin, Peoples R China; [Du, Qi-Shi; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Guangxi University; Tianjin Medical University	Du, QS (corresponding author), Guangxi Acad Sci, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009		National High-tech Research and Development Program ('863') of China [2006AA020103]; Chinese National Science Foundation (NSFC) [30970562]	National High-tech Research and Development Program ('863') of China(National High Technology Research and Development Program of China); Chinese National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National High-tech Research and Development Program ('863') of China under the project 2006AA020103, and by the Chinese National Science Foundation (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton GS, 2007, J STRUCT BIOL, V157, P570, DOI 10.1016/j.jsb.2006.10.020; Borman S, 2008, CHEM ENG NEWS, V86, P53, DOI 10.1021/cen-v086n006.p053; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Chou KC, 2004, J PROTEOME RES, V3, P1284, DOI 10.1021/pr049849v; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V319, P433, DOI 10.1016/j.bbrc.2004.05.016; Chou KC, 1997, FEBS LETT, V419, P49, DOI 10.1016/S0014-5793(97)01246-5; Clariana J, 2000, TETRAHEDRON-ASYMMETR, V11, P4549, DOI 10.1016/S0957-4166(00)00428-6; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Du QS, 2009, J THEOR BIOL, V259, P159, DOI 10.1016/j.jtbi.2009.03.003; Hay A.J., 1992, SEMIN VIROL, V3, P21, DOI DOI 10.1016/J.BMC.2015.06.030; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Kolocouris A, 1999, BIOORG MED CHEM LETT, V9, P3465, DOI 10.1016/S0960-894X(99)00631-9; Kolocouris N, 2007, BIOORG MED CHEM LETT, V17, P4358, DOI 10.1016/j.bmcl.2007.04.108; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Li H, 2004, PROTEINS, V55, P689, DOI 10.1002/prot.20032; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MORTON CC, 2008, HARVARD FOCUS NEWS; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Stamatiou G, 2001, BIOORG MED CHEM LETT, V11, P2137, DOI 10.1016/S0960-894X(01)00388-2; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Takeuchi H, 2003, FEBS LETT, V552, P35, DOI 10.1016/S0014-5793(03)00781-6; Tataridis D, 2007, BIOORG MED CHEM LETT, V17, P692, DOI 10.1016/j.bmcl.2006.10.092; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Turner JV, 2004, PHARM RES-DORDR, V21, P68, DOI 10.1023/B:PHAM.0000012154.09631.26; Wei H, 2009, MED CHEM, V5, P305, DOI 10.2174/157340609788681430	35	97	98	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9388	10.1371/journal.pone.0009388	http://dx.doi.org/10.1371/journal.pone.0009388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186344	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000024
J	Kim, JB; Urban, K; Cochran, E; Lee, S; Ang, A; Rice, B; Bata, A; Campbell, K; Coffee, R; Gorodinsky, A; Lu, Z; Zhou, H; Kishimoto, TK; Lassota, P				Kim, Jae-Beom; Urban, Konnie; Cochran, Edward; Lee, Steve; Ang, Angel; Rice, Bradley; Bata, Adam; Campbell, Kenneth; Coffee, Richard; Gorodinsky, Alex; Lu, Zhan; Zhou, He; Kishimoto, Takashi Kei; Lassota, Peter			Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo	PLOS ONE			English	Article							MOUSE MODEL; STEM-CELLS; PROSTATE-CANCER; BREAST-CANCER; TUMOR-GROWTH; UBIQUITIN-C; EXPRESSION; METASTASIS; VECTOR; PROLIFERATION	Early detection of tumors can significantly improve the outcome of tumor treatment. One of the most frequently asked questions in cancer imaging is how many cells can be detected non-invasively in a live animal. Although many factors limit such detection, increasing the light emission from cells is one of the most effective ways of overcoming these limitations. Here, we describe development and utilization of a lentiviral vector containing enhanced firefly luciferase (luc2) gene. The resulting single cell clones of the mouse mammary gland tumor (4T1-luc2) showed stable light emission in the range of 10,000 photons/sec/cell. In some cases individual 4T1-luc2 cells inserted under the skin of a nu/nu mouse could be detected non-invasively using a cooled CCD camera in some cases. In addition, we showed that only few cells are needed to develop tumors in these mice and tumor progression can be monitored right after the cells are implanted. Significantly higher luciferase activity in these cells allowed us to detect micrometastases in both, syngeneic Balb/c and nu/nu mice.	[Kim, Jae-Beom; Urban, Konnie; Lee, Steve; Ang, Angel; Rice, Bradley; Lassota, Peter] Caliper Life Sci Inc, Alameda, CA USA; [Bata, Adam; Campbell, Kenneth; Coffee, Richard; Gorodinsky, Alex; Lu, Zhan] Caliper Life Sci Inc, Cranbury, NJ USA; [Cochran, Edward; Zhou, He; Kishimoto, Takashi Kei] Momenta Pharmaceut Inc, Cambridge, MA USA		Kim, JB (corresponding author), Caliper Life Sci Inc, Alameda, CA USA.	jae.kim@caliperls.com; peter.lassota@caliperls.com			Caliper Life Sciences and Momenta Pharmaceuticals	Caliper Life Sciences and Momenta Pharmaceuticals	This work was funded internally at Caliper Life Sciences and Momenta Pharmaceuticals. The funders provided reagents, research space, and resources for this study. However, authors are solely involved in study design, data collection and analyses, or preparation of the manuscript. Caliper Life Sciences and Momenta Biopharma agreed to publish these data in a scientific journal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2008, J CANCER RES CLIN, V134, P137, DOI 10.1007/s00432-007-0260-7; Brakenhielm E, 2007, INT J CANCER, V121, P2153, DOI 10.1002/ijc.22900; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fomicheva EV, 2008, MOL THER, V16, P1594, DOI 10.1038/mt.2008.136; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Hirsch FR, 2001, CLIN CANCER RES, V7, P5; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Iyer M, 2004, MOL THER, V10, P545, DOI 10.1016/j.ymthe.2004.06.118; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; *PROM, 2007, PGL4 LUC REP VECT PR; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Ray S, 2008, MOL THER, V16, P1848, DOI 10.1038/mt.2008.180; Roda A, 2003, ANAL BIOANAL CHEM, V377, P826, DOI 10.1007/s00216-003-2096-6; Scatena CD, 2004, PROSTATE, V59, P292, DOI 10.1002/pros.20003; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Song H, 2008, CLIN CANCER RES, V14, P6116, DOI 10.1158/1078-0432.CCR-07-4672; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; VAUPEL P, 1989, CANCER RES, V49, P6449; Zhang GJ, 2004, NAT MED, V10, P643, DOI 10.1038/nm1047; Zheng M, 2006, ONCOLOGY-BASEL, V70, P418, DOI 10.1159/000098954; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	31	119	125	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9364	10.1371/journal.pone.0009364	http://dx.doi.org/10.1371/journal.pone.0009364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186331	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000008
J	Yu, YB; Dosanjh, L; Lao, LX; Tan, M; Shim, BS; Luo, Y				Yu, Young-Beob; Dosanjh, Laura; Lao, Lixing; Tan, Ming; Shim, Bum Sang; Luo, Yuan			Cinnamomum cassia Bark in Two Herbal Formulas Increases Life Span in Caenorhabditis elegans via Insulin Signaling and Stress Response Pathways	PLOS ONE			English	Article							BILOBA EXTRACT EGB-761; JUZEN-TAIHO-TO; POSTPRANDIAL BLOOD-GLUCOSE; EXPRESSION; MEDICINE; RESISTANCE; MICE; BEHAVIORS; TOLERANCE; INGESTION	Background: Proving the efficacy and corresponding mode of action of herbal supplements is a difficult challenge for evidence-based herbal therapy. A major hurdle is the complexity of herbal preparations, many of which combine multiple herbs, particularly when the combination is assumed to be vitally important to the effectiveness of the herbal therapy. This issue may be addressed through the use of contemporary methodology and validated animal models. Methods and Principal Findings: In this study, two commonly used traditional herbal formulas, Shi Quan Da Bu Tang (SQDB) and Huo Luo Xiao Ling Dan (HLXL) were evaluated using a survival assay and oxidative stress biomarkers in a well-established C. elegans model of aging. HLXL is an eleven herb formula modified from a top-selling traditional herbal formula for the treatment of arthritic joint pain. SQDB consists of ten herbs often used for fatigue and energy, particularly in the aged. We demonstrate here that SQDB significantly extend life span in a C. elegans model of aging. Among all individual herbs tested, two herbs Cinnamomum cassia bark (Chinese pharmaceutical name: Cinnamomi Cortex, CIN) and Panax ginseng root (Chinese pharmaceutical name: Ginseng Radix, GS) significantly extended life span in C. elegans. CIN in both SQDB and HLXL formula extended life span via modulation of multiple longevity assurance genes, including genes involved in insulin signaling and stress response pathways. All the life-span-extending herbs (SQDB, CIN and GS) also attenuated levels of H2O2 and enhanced small heat shock protein expression. Furthermore, the life span-extending herbs significantly delayed human amyloid beta (A beta)-induced toxicity in transgenic C. elegans expressing human A beta. Conclusion/Significance: These results validate an invertebrate model for rapid, systematic evaluation of commonly used Chinese herbal formulations and may provide insight for designing future evidence-based herbal therapy(s).	[Yu, Young-Beob; Dosanjh, Laura; Luo, Yuan] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Lao, Lixing; Luo, Yuan] Univ Maryland, Sch Med, Ctr Integrat Med, Baltimore, MD 21201 USA; [Tan, Ming] Univ Maryland, Sch Med, Div Biostat, Baltimore, MD 21201 USA; [Yu, Young-Beob] Korea Inst Oriental Med, Brain Dis Res Ctr, Taejon, South Korea; [Yu, Young-Beob] Nambu Univ, Dept Med Plant Resources, Kwangju, South Korea; [Shim, Bum Sang] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Korea Institute of Oriental Medicine (KIOM); Nambu University; Kyung Hee University	Yu, YB (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	yluo@rx.umaryland.edu	Shim, Bum-sang/AAH-9081-2020; Lao, Lixing/I-7979-2013; Lao, Lixing/P-9107-2019	Lao, Lixing/0000-0003-0198-9714; Yu, Young-Bob/0000-0001-7785-5988	NIH [AT001928]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	NIH AT001928 http://nccam.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin KA, 2009, INT J CLIN EXP MED, V2, P254; Antebi A, 2007, NATURE, V447, P536, DOI 10.1038/447536a; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blumenthal M, 2000, HERBAL MED; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Brown MK, 2006, PHARMACOL BIOCHEM BE, V85, P620, DOI 10.1016/j.pbb.2006.10.017; Brown MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-62; BURNS JJ, 2009, TOXICOLOGY      1007; Cao ZM, 2007, J GERONTOL A-BIOL, V62, P1337, DOI 10.1093/gerona/62.12.1337; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038; DOSANJH LE, 2009, J ALZHEIMERS DI 1105; Dragland S, 2003, J NUTR, V133, P1286; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; DUDONNE S, 2009, J AGR FOOD CHEM; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hasani-Ranjbar Shirin, 2009, Inflammation & Allergy Drug Targets, V8, P2; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hlebowicz J, 2007, AM J CLIN NUTR, V85, P1552, DOI 10.1093/ajcn/85.6.1552; Hlebowicz J, 2009, AM J CLIN NUTR, V89, P815, DOI 10.3945/ajcn.2008.26807; HU Y, 2009, IMMUNOPHARMACOL IMMU; Jitomir J, 2009, J MED FOOD, V12, P467, DOI 10.1089/jmf.2008.0128; Kamiyama H, 2005, BIOL PHARM BULL, V28, P2111, DOI 10.1248/bpb.28.2111; Kato M, 2007, WORLD J GASTROENTERO, V13, P2289, DOI 10.3748/wjg.v13.i16.2289; Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059; Kirkham S, 2009, DIABETES OBES METAB, V11, P1100, DOI 10.1111/j.1463-1326.2009.01094.x; Kogure T, 2005, PHYTOMEDICINE, V12, P327, DOI 10.1016/j.phymed.2004.05.002; Kwon HK, 2009, CANCER LETT, V278, P174, DOI 10.1016/j.canlet.2009.01.015; Lao LX, 2006, AM J CHINESE MED, V34, P833, DOI 10.1142/S0192415X06004326; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Luo Y., 2003, Current Topics in Nutraceutical Research, V1, P49; Luo Y, 2004, REDOX REP, V9, P65, DOI 10.1179/135100004225004733; Mettler S, 2009, NUTR RES, V29, P723, DOI 10.1016/j.nutres.2009.10.002; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Qin B, 2009, HORM METAB RES, V41, P516, DOI 10.1055/s-0029-1202813; QIN B, 2009, HORM METAB RES; Qin BL, 2003, DIABETES RES CLIN PR, V62, P139, DOI 10.1016/S0168-8227(03)00173-6; Qin BL, 2009, J NUTR BIOCHEM, V20, P901, DOI 10.1016/j.jnutbio.2008.08.005; Rajaiah R, 2009, J ETHNOPHARMACOL, V123, P40, DOI 10.1016/j.jep.2009.02.032; Riedlinger JE, 2001, ANN PHARMACOTHER, V35, P228, DOI 10.1345/aph.10122; Satoh H, 2002, J ALTERN COMPLEM MED, V8, P107, DOI 10.1089/107555302317371370; SMITH JV, 2003, J ALZ DIS, V4; Solomon TPJ, 2007, DIABETES OBES METAB, V9, P895, DOI 10.1111/j.1463-1326.2006.00694.x; Solomon TPJ, 2009, EUR J APPL PHYSIOL, V105, P969, DOI 10.1007/s00421-009-0986-9; Srivastava D, 2008, BIOGERONTOLOGY, V9, P309, DOI 10.1007/s10522-008-9139-5; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Tagami K, 2004, BIOL PHARM BULL, V27, P156, DOI 10.1248/bpb.27.156; Tsuchiya M, 2008, INT J CANCER, V123, P2503, DOI 10.1002/ijc.23828; Tsunemi A, 2005, NEUROCHEM RES, V30, P75, DOI 10.1007/s11064-004-9688-1; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wilson Mark A., 2008, BMC Pharmacology, V8, P15, DOI 10.1186/1471-2210-8-15; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; WU Y, 2008, NEUROBIOL AGING, V10, P1016; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Wu ZX, 2002, CELL MOL BIOL, V48, P725; Yang M, 2010, J ETHNOPHARMACOL, V127, P264, DOI 10.1016/j.jep.2009.11.010; YAO CJ, 2009, EVID BASED COMP 1123; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zee-Cheng Robert K.-Y, 1992, Methods and Findings in Experimental and Clinical Pharmacology, V14, P725; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041; Zhang RX, 2009, J ETHNOPHARMACOL, V121, P366, DOI 10.1016/j.jep.2008.11.018	74	50	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9339	10.1371/journal.pone.0009339	http://dx.doi.org/10.1371/journal.pone.0009339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179756	Green Submitted, Green Published, gold			2022-12-27	WOS:000274923900008
J	Buffin, E; Gho, M				Buffin, Eulalie; Gho, Michel			Laser Microdissection of Sensory Organ Precursor Cells of Drosophila Microchaetes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; EXPRESSION; GENES; TRANSFORMATION; SPECIFICATION; SENSELESS; PROTEINS; DIVISION	Background: In Drosophila, each external sensory organ originates from the division of a unique precursor cell (the sensory organ precursor cell or SOP). Each SOP is specified from a cluster of equivalent cells, called a proneural cluster, all of them competent to become SOP. Although, it is well known how SOP cells are selected from proneural clusters, little is known about the downstream genes that are regulated during SOP fate specification. Methodology/Principal Findings: In order to better understand the mechanism involved in the specification of these precursor cells, we combined laser microdissection, toisolate SOP cells, with transcriptome analysis, to study their RNA profile. Using this procedure, we found that genes that exhibit a 2-fold or greater expression in SOPs versus epithelial cells were mainly associated with Gene Ontology (GO) terms related with cell fate determination and sensory organ specification. Furthermore, we found that several genes such as pebbled/hindsight, scabrous, miranda, senseless, or cut, known to be expressed in SOP cells by independent procedures, are particularly detected in laser microdissected SOP cells rather than in epithelial cells. Conclusions/Significance: These results confirm the feasibility and the specificity of our laser microdissection based procedure. We anticipate that this analysis will give new insight into the selection and specification of neural precursor cells.	[Buffin, Eulalie; Gho, Michel] Univ Paris 06, UMR 7622, Paris, France; [Buffin, Eulalie; Gho, Michel] CNRS, UMR 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Buffin, E (corresponding author), Univ Paris 06, UMR 7622, Paris, France.	Michel.Gho@snv.jussieu.fr		Buffin, Eulalie/0000-0002-0471-7258	ARC [3291]; CNRS; UPMC	ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC	This work was supported by ARC (Grant 3291, www.arc.asso.fr), CNRS (www.cnrs.fr) and UPMC (www.UPMC.fr). E. B. was supported by a CNRS postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelilah-Seyfried S, 2000, GENETICS, V155, P733; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Erickson Heidi S., 2008, V424, P433, DOI 10.1007/978-1-60327-064-9_34; Fichelson P, 2004, DEV BIOL, V276, P367, DOI 10.1016/j.ydbio.2004.08.043; Gho M, 1999, DEVELOPMENT, V126, P3573; Inbal A, 2003, DEVELOPMENT, V130, P2467, DOI 10.1242/dev.00475; Jafar-Nejad H, 2003, GENE DEV, V17, P2966, DOI 10.1101/gad.1122403; Li YX, 2003, DEVELOPMENT, V130, P2819, DOI 10.1242/dev.00495; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Miller AC, 2008, DEVELOPMENT, V135, P707, DOI 10.1242/dev.016386; Miller SW, 2009, DEV BIOL, V329, P386, DOI 10.1016/j.ydbio.2009.02.009; Mollinari C, 2002, BIOL CELL, V94, P1, DOI 10.1016/S0248-4900(02)01181-4; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pi H, 2007, J BIOMED SCI, V14, P467, DOI 10.1007/s11373-007-9156-4; Pi HW, 2001, DEVELOPMENT, V128, P2699; Pickup AT, 2009, DEVELOPMENT, V136, P975, DOI 10.1242/dev.027318; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Sawamoto K, 1996, NEUROSCI RES, V26, P205, DOI 10.1016/S0168-0102(96)01110-8; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; Yamada T, 2003, DEVELOPMENT, V130, P4085, DOI 10.1242/dev.00624; Yeh E, 2000, EMBO J, V19, P4827, DOI 10.1093/emboj/19.17.4827	30	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9285	10.1371/journal.pone.0009285	http://dx.doi.org/10.1371/journal.pone.0009285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174573	Green Submitted, gold, Green Published			2022-12-27	WOS:000274923700006
J	Kranczioch, C; Mathews, S; Dean, P; Sterr, A				Kranczioch, Cornelia; Mathews, Simon; Dean, Philip; Sterr, Annette			Task Complexity Differentially Affects Executed and Imagined Movement Preparation: Evidence from Movement-Related Potentials	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; MOTOR PREPARATION; IMAGERY; HUMANS	Background: The neural simulation theory predicts similarity for the neural mechanisms subserving overt (motor execution) and covert (movement imagination) actions. Here we tested this prediction for movement preparation, a key characteristic of motor cognition. Methodology/Principal Findings: High-density electroencephalogram (EEG) was recorded during covert and overt actions. Movement preparation was studied with a motor priming paradigm, which varied task complexity and amount of advance information. Participants performed simple or complex sequential finger movements either overtly or covertly. Advance information was either fully predictive or partially predictive. Stimulus-locked event-related potential (ERP) data showed the typical pattern of foreperiod activation for overt and covert movements. The foreperiod contingent negative variation (CNV) differed between simple and complex movements only in the execution task. ERP topographies differed between execution and imagination only when advance information was fully predictive. Conclusions/Significance: Results suggest a differential contribution of the movement preparation network to action imagination and execution. Overt and covert actions seem to involve similar though not identical mechanisms, where overt actions engage a more fine-grained modulation of covert preparatory states.	[Kranczioch, Cornelia] Univ Hosp Jena, Dept Neurol, Jena, Germany; [Kranczioch, Cornelia] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Oldenburg, Germany; [Mathews, Simon; Dean, Philip; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Kranczioch, Cornelia] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	Friedrich Schiller University of Jena; Carl von Ossietzky Universitat Oldenburg; University of Surrey; University of Portsmouth	Kranczioch, C (corresponding author), Univ Hosp Jena, Dept Neurol, Jena, Germany.	a.sterr@surrey.ac.uk		Dean, Philip/0000-0002-2362-513X; Sterr, Annette/0000-0003-4490-985X	Economic and Social Research Council; Medical Research Council [61501]; MRC [G0200128] Funding Source: UKRI; Medical Research Council [G0200128] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SM was supported by a PhD studentship from the Economic and Social Research Council (www.ESRC.ac.uk). The study was funded by the Medical Research Council (www.MRC.ac.uk; reference 61501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCKER KBE, 1994, ELECTROEN CLIN NEURO, V91, P275, DOI 10.1016/0013-4694(94)90191-0; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Caldara R, 2004, EXP BRAIN RES, V159, P389, DOI 10.1007/s00221-004-2101-0; Carrillo-de-la-Pena MT, 2008, BRAIN RES, V1226, P134, DOI 10.1016/j.brainres.2008.05.089; Cui RQ, 2000, CLIN NEUROPHYSIOL, V111, P1847, DOI 10.1016/S1388-2457(00)00388-6; Cunnington R, 1996, EXP BRAIN RES, V111, P429; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jentzsch I, 2004, PSYCHOPHYSIOLOGY, V41, P231, DOI 10.1111/j.1469-8986.2004.00155.x; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kranczioch C, 2009, HUM BRAIN MAPP, V30, P3275, DOI 10.1002/hbm.20748; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; LAMARCHE M, 1995, ELECTROEN CLIN NEURO, V95, P268, DOI 10.1016/0013-4694(95)00117-H; Leuthold H, 2002, BIOL PSYCHOL, V60, P173, DOI 10.1016/S0301-0511(02)00032-7; Leuthold H, 2001, COGNITIVE BRAIN RES, V12, P207, DOI 10.1016/S0926-6410(01)00052-0; Mathews S, 2006, CLIN NEUROPHYSIOL, V117, P2675, DOI 10.1016/j.clinph.2006.08.001; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Praamstra P, 1999, COGNITIVE BRAIN RES, V8, P77, DOI 10.1016/S0926-6410(99)00008-7; Praeg E, 2006, BRAIN TOPOGR, V19, P61, DOI 10.1007/s10548-006-0013-y; ROSENBAUM DA, 1982, ACTA PSYCHOL, V51, P223, DOI 10.1016/0001-6918(82)90036-1; Schroter H, 2009, PSYCHOPHYSIOLOGY, V46, P388, DOI 10.1111/j.1469-8986.2008.00772.x; Ulrich R, 1998, PSYCHOPHYSIOLOGY, V35, P721, DOI 10.1111/1469-8986.3560721; Wild-Wall N, 2003, PSYCHOPHYSIOLOGY, V40, P7, DOI 10.1111/1469-8986.00002; Wilding EL, 2006, BIOL PSYCHOL, V72, P325, DOI 10.1016/j.biopsycho.2005.12.002	29	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9284	10.1371/journal.pone.0009284	http://dx.doi.org/10.1371/journal.pone.0009284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SS	20174567	Green Published, gold			2022-12-27	WOS:000274923700005
J	Leoni, AL; Gavillet, B; Rougier, JS; Marionneau, C; Probst, V; Le Scouarnec, S; Schott, JJ; Demolombe, S; Bruneval, P; Huang, CLH; Colledge, WH; Grace, AA; Le Marec, H; Wilde, AA; Mohler, PJ; Escande, D; Abriel, H; Charpentier, F				Leoni, Anne-Laure; Gavillet, Bruno; Rougier, Jean-Sebastien; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Bruneval, Patrick; Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.; Le Marec, Herve; Wilde, Arthur A.; Mohler, Peter J.; Escande, Denis; Abriel, Hugues; Charpentier, Flavien			Variable Na(v)1.5 Protein Expression from the Wild-Type Allele Correlates with the Penetrance of Cardiac Conduction Disease in the Scn5a(+/-) Mouse Model	PLOS ONE			English	Article							BRUGADA-SYNDROME; SODIUM-CHANNEL; TARGETED DISRUPTION; MUTATION; ANKYRIN; HEART; PHENOTYPE; GENE; MICE; CARDIOMYOCYTES	Background: Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na+ channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a mouse model with heterozygous targeted disruption of Scn5a (Scn5a(+/-) mice) and compared our results to those obtained in patients with loss-of-function mutations in SCN5A. Methodology/Principal Findings: Based on ECG, 10-week-old Scn5a(+/-) mice were divided into 2 subgroups, one displaying severe ventricular conduction defects (QRS interval>18 ms) and one a mild phenotype (QRS <= 18 ms; QRS in wild-type littermates: 10-18 ms). Phenotypic difference persisted with aging. At 10 weeks, the Na+ channel blocker ajmaline prolonged QRS interval similarly in both groups of Scn5a(+/-) mice. In contrast, in old mice (>53 weeks), ajmaline effect was larger in the severely affected subgroup. These data matched the clinical observations on patients with SCN5A loss-of-function mutations with either severe or mild conduction defects. Ventricular tachycardia developed in 5/10 old severely affected Scn5a(+/-) mice but not in mildly affected ones. Correspondingly, symptomatic SCN5A-mutated Brugada patients had more severe conduction defects than asymptomatic patients. Old severely affected Scn5a(+/-) mice but not mildly affected ones showed extensive cardiac fibrosis. Mildly affected Scn5a(+/-) mice had similar Na(v)1.5 mRNA but higher Na(v)1.5 protein expression, and moderately larger I-Na current than severely affected Scn5a(+/-) mice. As a consequence, action potential upstroke velocity was more decreased in severely affected Scn5a(+/-) mice than in mildly affected ones. Conclusions: Scn5a(+/-) mice show similar phenotypic heterogeneity as SCN5A-mutated patients. In Scn5a(+/-) mice, phenotype severity correlates with wild-type Na(v)1.5 protein expression.	[Leoni, Anne-Laure; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] INSERM, UMR915, Inst Thorax, Nantes, France; [Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Charpentier, Flavien] CNRS, ERL3147, Nantes, France; [Leoni, Anne-Laure; Marionneau, Celine; Probst, Vincent; Le Scouarnec, Solena; Schott, Jean-Jacques; Demolombe, Sophie; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] Univ Nantes, Nantes, France; [Probst, Vincent; Schott, Jean-Jacques; Le Marec, Herve; Escande, Denis; Charpentier, Flavien] CHU Nantes, Inst Thorax, F-44035 Nantes 01, France; [Rougier, Jean-Sebastien; Abriel, Hugues] Univ Bern, Dept Clin Res, Bern, Switzerland; [Bruneval, Patrick] Univ Paris 05, INSERM, U652, Paris, France; [Wilde, Arthur A.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.] Univ Cambridge, Dept Biochem, Sect Cardiovasc Biol, Cambridge CB2 1QW, England; [Huang, Christopher L. H.; Colledge, William H.; Grace, Andrew A.] Univ Cambridge, Dept Physiol, Cambridge CB2 1QW, England; [Mohler, Peter J.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Gavillet, Bruno] Univ Lausanne, Dept Pharmacol & Toxicol, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Nantes Universite; CHU de Nantes; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; University of Cambridge; University of Iowa; University of Lausanne	Leoni, AL (corresponding author), INSERM, UMR915, Inst Thorax, Nantes, France.	flavien.charpentier@nantes.inserm.fr	Le Marec, Hervé/D-2718-2015; Schott, jean-Jacques/F-8842-2013; Charpentier, Flavien/D-3586-2015; Marionneau, Céline/D-4011-2015; Abriel, Hugues/B-9800-2009; Le Scouarnec, Solena/D-3547-2015; Colledge, William/X-4976-2019; Rougier, Jean-Sébastien/AAX-5038-2021	Le Marec, Hervé/0000-0002-8288-8693; Schott, jean-Jacques/0000-0002-9578-9475; Charpentier, Flavien/0000-0002-5057-0998; Marionneau, Céline/0000-0003-0962-9756; Abriel, Hugues/0000-0003-0465-5138; Le Scouarnec, Solena/0000-0003-3444-2125; Colledge, William/0000-0002-9603-4429; ROUGIER, Jean-Sebastien/0000-0002-8710-0260	Agence Nationale de la Recherche, Paris, France [ANR-05-PCOD-037-01, ANR-05-MRAR-028]; Fondation Leducq, Paris, France; Netherlands Heart Foundation, Den Haag, The Netherlands [2003/B195]; National Institutes of Health, Bethesda, Maryland, United States of America (NIH) [R01 HL083422]; Swiss National Science Foundation, Bern, Switzerland [310000-120707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422] Funding Source: NIH RePORTER	Agence Nationale de la Recherche, Paris, France(French National Research Agency (ANR)); Fondation Leducq, Paris, France(Leducq Foundation); Netherlands Heart Foundation, Den Haag, The Netherlands(Netherlands Heart FoundationNetherlands Government); National Institutes of Health, Bethesda, Maryland, United States of America (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation, Bern, Switzerland(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Agence Nationale de la Recherche, Paris, France (ANR-05-PCOD-037-01 for FC; ANR-05-MRAR-028 for JJS and DE), the Fondation Leducq, Paris, France (DE, JJS, AAW), the Netherlands Heart Foundation, Den Haag, The Netherlands (2003/B195 for AAW), the National Institutes of Health, Bethesda, Maryland, United States of America (NIH R01 HL083422 for PJM) and the Swiss National Science Foundation, Bern, Switzerland (310000-120707 for HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2005, TRENDS CARDIOVAS MED, V15, P35, DOI 10.1016/j.tcm.2005.01.001; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Balasubramaniam R, 2003, J PHYSIOL-LONDON, V552, P535, DOI 10.1113/jphysiol.2003.048249; Bezzina CR, 2003, CIRC RES, V92, P159, DOI 10.1161/01.RES.0000052672.97759.36; Boixel C, 2006, AM J PHYSIOL-HEART C, V290, pH2257, DOI 10.1152/ajpheart.01060.2005; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chauhan VS, 2000, CIRC RES, V86, P441, DOI 10.1161/01.RES.86.4.441; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chesler EJ, 2002, NAT NEUROSCI, V5, P1101, DOI 10.1038/nn1102-1101; Clancy CE, 2002, J CLIN INVEST, V110, P1075, DOI 10.1172/JCI200216945; Cohen SA, 1996, CIRCULATION, V94, P3083, DOI 10.1161/01.CIR.94.12.3083; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Herfst LJ, 2004, J MOL CELL CARDIOL, V36, P185, DOI 10.1016/j.yjmcc.2003.11.014; Junttila MJ, 2008, J CARDIOVASC ELECTR, V19, P380, DOI 10.1111/j.1540-8167.2007.01050.x; Kaab S, 2005, CARDIOVASC RES, V67, P397, DOI 10.1016/j.cardiores.2005.04.005; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Probst V, 2006, J CARDIOVASC ELECTR, V17, P270, DOI 10.1111/j.1540-8167.2006.00349.x; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Tan HL, 2003, CARDIOVASC RES, V57, P961, DOI 10.1016/S0008-6363(02)00714-9; Tukkie R, 2004, CIRCULATION, V109, P1272, DOI 10.1161/01.CIR.0000118467.53182.D1; van Veen TAB, 2005, CIRCULATION, V112, P1927, DOI 10.1161/CIRCULATIONAHA.105.539072; van Veen TAB, 2006, ADV CARDIOL, V42, P18, DOI 10.1159/000092560	33	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9298	10.1371/journal.pone.0009298	http://dx.doi.org/10.1371/journal.pone.0009298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174578	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700009
J	Cotter, CR; Nguyen, ML; Yount, JS; Lopez, CB; Blaho, JA; Moran, TM				Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.			The Virion Host Shut-Off (vhs) Protein Blocks a TLR-Independent Pathway of Herpes Simplex Virus Type 1 Recognition in Human and Mouse Dendritic Cells	PLOS ONE			English	Article							LATENCY-ASSOCIATED TRANSCRIPT; WILD-TYPE; ADAPTIVE IMMUNITY; RNA DEGRADATION; GLYCOPROTEIN-D; INFECTION; GENE; APOPTOSIS; INTERFERON; ACTIVATION	Molecular pathways underlying the activation of dendritic cells (DCs) in response to Herpes Simplex Virus type 1 (HSV-1) are poorly understood. Removal of the HSV virion host shut-off (vhs) protein relieves a block to DC activation observed during wild-type infection. In this study, we utilized a potent DC stimulatory HSV-1 recombinant virus lacking vhs as a tool to investigate the mechanisms involved in the activation of DCs by HSV-1. We report that the release of pro-inflammatory cytokines by conventional DC (cDC) during HSV-1 infection is triggered by both virus replication-dependent and replication-independent pathways. Interestingly, while vhs is capable of inhibiting the release of cytokines during infection of human and mouse cDCs, the secretion of cytokines by plasmacytoid DC (pDC) is not affected by vhs. These data prompted us to postulate that infection of cDCs by HSV triggers a TLR independent pathway for cDC activation that is susceptible to blockage by the vhs protein. Using cDCs isolated from mice deficient in both the TLR adaptor protein MyD88 and TLR3, we show that HSV-1 and the vhs-deleted virus can activate cDCs independently of TLR signaling. In addition, virion-associated vhs fails to block cDC activation in response to treatment with TLR agonists, but it efficiently blocked cDC activation triggered by the paramyxoviruses Sendai Virus (SeV) and Newcastle Disease Virus (NDV). This block to SeV- and NDV induced activation of cDC resulted in elevated SeV and NDV viral gene expression indicating that infection with HSV-1 enhances the cell's susceptibility to other pathogens through the action of vhs. Our results demonstrate for the first time that a viral protein contained in the tegument of HSV-1 can block the induction of DC activation by TLR-independent pathways of viral recognition.	[Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Cotter, Christopher R.; Nguyen, Marie L.; Yount, Jacob S.; Lopez, Carolina B.; Blaho, John A.; Moran, Thomas M.] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Nguyen, Marie L.] Des Moines Univ, Dept Microbiol & Immunol, Des Moines, IA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cotter, CR (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	thomas.moran@mssm.edu	Lopez, Carolina/A-8887-2008; Yount, Jacob/F-9905-2014	Lopez, Carolina/0000-0002-7669-6572; Yount, Jacob/0000-0002-6128-4575	United States Public Health Service National Institutes of Health [AI48582, AI38873, AI07647, CA88796, R21AI077007, RO1AI041111]; National Institute of Allergy and Infectious Disease; NATIONAL CANCER INSTITUTE [T32CA088796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038873, R21AI038873, R01AI041111, R21AI077007, R01AI038873, R01AI048582] Funding Source: NIH RePORTER	United States Public Health Service National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AI48582 and AI38873 to John A. Blaho provided by United States Public Health Service National Institutes of Health; AI07647 to Christopher R. Cotter provided by United States Public Health Service National Institutes of Health; AI07647 and CA88796 to Marie L. Nyugen provided by United States Public Health Service National Institutes of Health; and R21AI077007 and RO1AI041111 to Thomas M. Moran provided by National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Aubert M, 1999, J VIROL, V73, P10359, DOI 10.1128/JVI.73.12.10359-10370.1999; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Bettahi I, 2007, INVEST OPHTH VIS SCI, V48, P4643, DOI 10.1167/iovs.07-0356; Caselli E, 2003, INTERVIROLOGY, V46, P141, DOI 10.1159/000071454; Caselli E, 2005, BLOOD, V106, P2790, DOI 10.1182/blood-2005-04-1390; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Esclatine A, 2004, P NATL ACAD SCI USA, V101, P18165, DOI 10.1073/pnas.0408272102; Esclatine A, 2004, P NATL ACAD SCI USA, V101, P3603, DOI 10.1073/pnas.0400354101; Everly DN, 1997, J VIROL, V71, P7157, DOI 10.1128/JVI.71.10.7157-7166.1997; Everly DN, 2002, J VIROL, V76, P8560, DOI 10.1128/JVI.76.17.8560-8571.2002; FENWICK ML, 1984, J GEN VIROL, V65, P1225, DOI 10.1099/0022-1317-65-7-1225; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Geiss BJ, 2000, J VIROL, V74, P11137, DOI 10.1128/JVI.74.23.11137-11144.2000; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Jin L, 2005, J VIROL, V79, P12286, DOI 10.1128/JVI.79.19.12286-12295.2005; Kruse M, 2000, J VIROL, V74, P7127, DOI 10.1128/JVI.74.15.7127-7136.2000; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; KWONG AD, 1988, J VIROL, V62, P912, DOI 10.1128/JVI.62.3.912-921.1988; Lee GE, 2003, J VIROL, V77, P2038, DOI 10.1128/JVI.77.3.2038-2045.2003; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Lopez CB, 2004, J IMMUNOL, V173, P6882, DOI 10.4049/jimmunol.173.11.6882; Lopez CB, 2003, J INFECT DIS, V187, P1126, DOI 10.1086/368381; Martinez EH, 2001, REV MED VIROL, V11, P253, DOI 10.1002/rmv.323; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Mikloska Z, 2001, J VIROL, V75, P5958, DOI 10.1128/JVI.75.13.5958-5964.2001; Miles DH, 2004, CURR EYE RES, V29, P79, DOI 10.1080/02713680490504669; Nguyen ML, 2005, VIROLOGY, V336, P274, DOI 10.1016/j.virol.2005.03.026; Nichol P F, 1994, Neurobiol Dis, V1, P83, DOI 10.1006/nbdi.1994.0011; NIEMIALTOWSKI MG, 1992, J IMMUNOL, V149, P3035; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Peri P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-140; Perng GC, 2002, J VIROL, V76, P1224, DOI 10.1128/JVI.76.3.1224-1235.2002; Pollara G, 2004, J IMMUNOL, V173, P4108, DOI 10.4049/jimmunol.173.6.4108; Pollara G, 2003, J INFECT DIS, V187, P165, DOI 10.1086/367675; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; Rasmussen SB, 2009, J GEN VIROL, V90, P74, DOI 10.1099/vir.0.005389-0; READ GS, 1983, J VIROL, V46, P498, DOI 10.1128/JVI.46.2.498-512.1983; READ GS, 1993, J VIROL, V67, P7149, DOI 10.1128/JVI.67.12.7149-7160.1993; Reske A, 2008, J IMMUNOL, V180, P7525, DOI 10.4049/jimmunol.180.11.7525; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabri F, 2006, J NEUROIMMUNOL, V171, P171, DOI 10.1016/j.jneuroim.2005.10.003; Salio M, 1999, EUR J IMMUNOL, V29, P3245, DOI 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.3.CO;2-O; Samady L, 2003, J VIROL, V77, P3768, DOI 10.1128/JVI.77.6.3768-3776.2003; Sanfilippo CM, 2004, J VIROL, V78, P224, DOI 10.1128/JVI.78.1.224-239.2004; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; SCHEK N, 1985, J VIROL, V55, P601, DOI 10.1128/JVI.55.3.601-610.1985; Schillinger JA, 2004, SEX TRANSM DIS, V31, P753, DOI 10.1097/01.olq.0000145852.43262.c3; SMIBERT CA, 1990, J VIROL, V64, P3882, DOI 10.1128/JVI.64.8.3882-3894.1990; SMIBERT CA, 1994, J VIROL, V68, P2339, DOI 10.1128/JVI.68.4.2339-2346.1994; Strand SS, 2004, J VIROL, V78, P13562, DOI 10.1128/JVI.78.24.13562-13572.2004; Strand SS, 2004, J VIROL, V78, P8400, DOI 10.1128/jvi.78.15.8400-8403.2004; Strelow L, 1997, VIROLOGY, V231, P28, DOI 10.1006/viro.1997.8497; STRELOW LI, 1995, J VIROL, V69, P6779, DOI 10.1128/JVI.69.11.6779-6786.1995; STROM T, 1987, J VIROL, V61, P2198, DOI 10.1128/JVI.61.7.2198-2207.1987; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Westra DF, 2000, J GEN VIROL, V81, P2011, DOI 10.1099/0022-1317-81-8-2011; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411; Zheng XD, 2001, INVEST OPHTH VIS SCI, V42, P120	69	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8684	10.1371/journal.pone.0008684	http://dx.doi.org/10.1371/journal.pone.0008684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174621	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700001
J	Freeman, R; Dennis, T; Landers, T; Thompson, D; Bell, E; Walker, M; Guilford, T				Freeman, Robin; Dennis, Todd; Landers, Todd; Thompson, David; Bell, Elizabeth; Walker, Mike; Guilford, Tim			Black Petrels (Procellaria parkinsoni) Patrol the Ocean Shelf-Break: GPS Tracking of a Vulnerable Procellariiform Seabird	PLOS ONE			English	Article							FORAGING BEHAVIOR; POSITIONAL ENTROPY; PELAGIC SEABIRD; CAPE GANNETS; ALBATROSSES; SYSTEM; MIGRATION; PENGUINS; PACIFIC; ECOLOGY	Background: Determining the foraging movements of pelagic seabirds is fundamental for their conservation. However, the vulnerability and elusive lifestyles of these animals have made them notoriously difficult to study. Recent developments in satellite telemetry have enabled tracking of smaller seabirds during foraging excursions. Methodology/Principal Findings: Here, we report the first successful precision tracking of a c. 700 g seabird, the vulnerable Black Petrel, Procellaria parkinsoni, foraging at sea during the breeding season, using miniature GPS-logging technology. Employing a combination of high-resolution fixes and low-power duty-cycles, we present data from nine individual foraging excursions tracked during the chick-rearing period in February 2006. Conclusions/Significance: We provide a snapshot of the species' foraging range and behaviour in relation to detailed underlying bathymetry off the coast of New Zealand, finding a significant relationship between foraging movements and regions of the shelf-break. We also highlight the potential of more sophisticated analyses to identify behavioural phenomena from position data alone.	[Freeman, Robin] Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England; [Freeman, Robin; Guilford, Tim] Univ Oxford, Dept Zool, Anim Behav Res Grp, Oxford OX1 3PS, England; [Dennis, Todd; Landers, Todd; Walker, Mike] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Landers, Todd] Auckland War Mem Museum, Auckland, New Zealand; [Thompson, David] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand; [Bell, Elizabeth] Wildlife Management Int Ltd, Rapaura, Blenheim, New Zealand	Microsoft; University of Oxford; University of Auckland; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Freeman, R (corresponding author), Microsoft Res, Computat Ecol & Environm Sci, Cambridge, England.	robin.freeman@microsoft.com	Thompson, David R/E-2431-2018	Thompson, David R/0000-0001-8518-6307; Walker, Michael/0000-0001-9631-9128	Engineering and Physical Sciences Research Council [GR/S58119/01]; Microsoft Research; Merton College, Oxford	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Microsoft Research(Microsoft); Merton College, Oxford	Financial support was kindly provided by the Engineering and Physical Sciences Research Council ( grant number: GR/S58119/01, http://www.epsrc.ac.uk), Microsoft Research (http://research.microsoft.com) and Merton College, Oxford (http://www.merton.ox.ac.uk). The corresponding author is currently employed at Microsoft Research as a post-doctoral researcher, but aside from this none of these funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACAP, 2006, AGR CONS ALB PETR; Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Baduini Cheryl L., 2003, Marine Ornithology, V31, P101; BELL E, 2005, 200304 DEP CONS; BirdLife International, 2004, TRACK OC WAND GLOB D; Bishop C. M, 2006, PATTERN RECOGNITION; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2004, J THEOR BIOL, V227, P25, DOI 10.1016/j.jtbi.2003.07.003; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; HUNTER C, 2001, DEP CONSERVATION INT, V2; Hyrenbach KD, 2006, FISH OCEANOGR, V15, P95, DOI 10.1111/j.1365-2419.2005.00350.x; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; Nevitt GA, 2000, BIOL BULL-US, V198, P245, DOI 10.2307/1542527; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; PITMAN RL, 1992, CONDOR, V94, P825, DOI 10.2307/1369280; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Steiner I, 2000, PHYSIOL BEHAV, V71, P589, DOI 10.1016/S0031-9384(00)00409-1; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; [No title captured]	28	38	39	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9236	10.1371/journal.pone.0009236	http://dx.doi.org/10.1371/journal.pone.0009236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174652	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600008
J	Kubo, Y; Takeuchi, T; Okano, K; Okano, T				Kubo, Yoko; Takeuchi, Takahiro; Okano, Keiko; Okano, Toshiyuki			Cryptochrome Genes Are Highly Expressed in the Ovary of the African Clawed Frog, Xenopus tropicalis	PLOS ONE			English	Article							CIRCADIAN CLOCK; LIGHT; DROSOPHILA; CRY1; ZEBRAFISH; GENETICS; EMBRYOS; RHYTHMS; FAMILY	Cryptochromes (CRYs) are flavoproteins sharing high homology with photolyases. Some of them have function(s) including transcription regulation in the circadian clock oscillation, blue-light photoreception for resetting the clock phase, and light-dependent magnetoreception. Vertebrates retain multiple sets of CRY or CRY-related genes, but their functions are yet unclear especially in the lower vertebrates. Although CRYs and the other circadian clock components have been extensively studied in the higher vertebrates such as mice, only a few model species have been studied in the lower vertebrates. In this study, we identified two CRYs, XtCRY1 and XtCRY2 in Xenopus tropicalis, an excellent experimental model species. Examination of tissue specificity of their mRNA expression by real-time PCR analysis revealed that both the XtCRYs showed extremely high mRNA expression levels in the ovary. The mRNA levels in the ovary were about 28-fold (XtCry1) and 48-fold (XtCry2) higher than levels in the next abundant tissues, the retina and kidney, respectively. For the functional analysis of the XtCRYs, we cloned circadian positive regulator XtCLOCK and XtBMAL1, and found circadian enhancer E-box in the upstream of XtPer1 gene. XtCLOCK and XtBMAL1 exhibited strong transactivation from the XtPer1 E-box element, and both the XtCRYs inhibited the XtCLOCK: XtBMAL1-mediated transactivation, thereby suggesting this element to drive the circadian transcription. These results revealed a conserved main feedback loop in the X. tropicalis circadian clockwork and imply a possible physiological importance of CRYs in the ovarian functions such as synthesis of steroid hormones and/or control of estrus cycles via the transcription regulation.	[Kubo, Yoko; Takeuchi, Takahiro; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan	Waseda University; Japan Science & Technology Agency (JST)	Kubo, Y (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the High-Tech Research Center Project for Private Universities: matching fund subsidy from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Besharse JC, 2004, EUR J NEUROSCI, V20, P167, DOI 10.1111/j.1460-9568.2004.03479.x; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Green CB, 2003, J NEUROENDOCRINOL, V15, P350, DOI 10.1046/j.1365-2826.2003.00999.x; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hirayama J, 2003, J BIOL CHEM, V278, P35620, DOI 10.1074/jbc.M305028200; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Johnsen S, 2007, J EXP BIOL, V210, P3171, DOI 10.1242/jeb.007567; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; LEUCHT T, 1990, J EXP BIOL, V148, P325; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Zhu HS, 2001, CURR BIOL, V11, P1945, DOI 10.1016/S0960-9822(01)00601-7	22	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9273	10.1371/journal.pone.0009273	http://dx.doi.org/10.1371/journal.pone.0009273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174658	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590600026
J	Selig, ER; Bruno, JF				Selig, Elizabeth R.; Bruno, John F.			A Global Analysis of the Effectiveness of Marine Protected Areas in Preventing Coral Loss	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; PHASE-SHIFTS; RESERVE; FISH; RESILIENCE; FISHERIES; IMPACTS; SCALE; CONSERVATION	Background: A variety of human activities have led to the recent global decline of reef-building corals [1,2]. The ecological, social, and economic value of coral reefs has made them an international conservation priority [2,3]. The success of Marine Protected Areas (MPAs) in restoring fish populations [4] has led to optimism that they could also benefit corals by indirectly reducing threats like overfishing, which cause coral degradation and mortality [2,5]. However, the general efficacy of MPAs in increasing coral reef resilience has never been tested. Methodology/Principal Findings: We compiled a global database of 8534 live coral cover surveys from 1969-2006 to compare annual changes in coral cover inside 310 MPAs to unprotected areas. We found that on average, coral cover within MPAs remained constant, while coral cover on unprotected reefs declined. Although the short-term differences between unprotected and protected reefs are modest, they could be significant over the long-term if the effects are temporally consistent. Our results also suggest that older MPAs were generally more effective in preventing coral loss. Initially, coral cover continued to decrease after MPA establishment. Several years later, however, rates of coral cover decline slowed and then stabilized so that further losses stopped. Conclusions/Significance: These findings suggest that MPAs can be a useful tool not only for fisheries management, but also for maintaining coral cover. Furthermore, the benefits of MPAs appear to increase with the number of years since MPA establishment. Given the time needed to maximize MPA benefits, there should be increased emphasis on implementing new MPAs and strengthening the enforcement of existing MPAs.	[Selig, Elizabeth R.] Univ N Carolina, Curriculum Ecol, Chapel Hill, NC USA; [Selig, Elizabeth R.; Bruno, John F.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Selig, ER (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, Arlington, VA USA.	e.selig@conservation.org			EPA STAR; UNC Dissertation Completion Fellowship; NSF [OCE-0326705]	EPA STAR(United States Environmental Protection Agency); UNC Dissertation Completion Fellowship; NSF(National Science Foundation (NSF))	This research was supported through an EPA STAR and UNC Dissertation Completion Fellowship to E. R. S. and NSF # OCE-0326705 to J. F. B.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Airame S, 2003, ECOL APPL, V13, pS170; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Ault JS, 2005, B MAR SCI, V76, P595; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Edgar GJ, 2004, ENVIRON CONSERV, V31, P212, DOI 10.1017/S0376892904001584; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edmunds PJ, 1996, MAR ECOL PROG SER, V143, P165, DOI 10.3354/meps143165; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Halpern BS, 2003, ECOL APPL, V13, pS117; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jameson SC, 2002, MAR POLLUT BULL, V44, P1177, DOI 10.1016/S0025-326X(02)00258-8; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones PJS, 2001, REV FISH BIOL FISHER, V11, P197, DOI 10.1023/A:1020327007975; Keller BD, 2005, OCEAN COAST MANAGE, V48, P869, DOI 10.1016/j.ocecoaman.2005.03.008; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kramer KL, 2007, MAR ECOL PROG SER, V349, P111, DOI 10.3354/meps07083; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maliao RJ, 2004, FISH RES, V66, P343, DOI 10.1016/s0165-7836(03)00181-4; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2001, CORAL REEFS, V19, P367, DOI 10.1007/s003380000131; McClanahan TR, 1999, CORAL REEFS, V18, P321, DOI 10.1007/s003380050205; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; OSENBERG CW, 1994, ECOL APPL, V4, P16, DOI 10.2307/1942111; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Roberts CM, 2000, B MAR SCI, V66, P581; SEBENS KP, 1994, AM ZOOL, V34, P115; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092	50	223	227	5	205	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9278	10.1371/journal.pone.0009278	http://dx.doi.org/10.1371/journal.pone.0009278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174644	gold, Green Published			2022-12-27	WOS:000274590600030
J	Lucas, G; Du, J; Romeas, T; Mnie-Filali, O; Haddjeri, N; Pineyro, G; Debonnel, G				Lucas, Guillaume; Du, Jenny; Romeas, Thomas; Mnie-Filali, Ouissame; Haddjeri, Nasser; Pineyro, Graciela; Debonnel, Guy			Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin(4) Receptor Agonists in the Rat	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; POSTSYNAPTIC 5-HT1A RECEPTORS; ELECTROPHYSIOLOGICAL EVIDENCE; NEURONAL-ACTIVITY; TONIC ACTIVATION; IN-VITRO; DEPRESSION; BINDING; CITALOPRAM; PINDOLOL	Background: We have recently reported that serotonin(4) (5-HT4) receptor agonists have a promising potential as fast-acting antidepressants. Here, we assess the extent to which this property may be optimized by the concomitant use of conventional antidepressants. Methodology/Principal Findings: We found that, in acute conditions, the 5-HT4 agonist prucalopride was able to counteract the inhibitory effect of the selective serotonin reuptake inhibitors (SSRI) fluvoxamine and citalopram on 5-HT neuron impulse flow, in Dorsal Raphe Nucleus (DRN) cells selected for their high (>1.8 Hz) basal discharge. The co-administration of both prucalopride and RS 67333 with citalopram for 3 days elicited an enhancement of DRN 5-HT neuron average firing rate, very similar to what was observed with either 5-HT4 agonist alone. At the postsynaptic level, this translated into the manifestation of a tonus on hippocampal postsynaptic 5-HT1A receptors, that was two to three times stronger when the 5-HT4 agonist was combined with citalopram. Similarly, co-administration of citalopram synergistically potentiated the enhancing effect of RS 67333 on CREB protein phosphorylation within the hippocampus. Finally, in the Forced Swimming Test, the combination of RS 67333 with various SSRIs (fluvoxamine, citalopram and fluoxetine) was more effective to reduce time of immobility than the separate administration of each compound. Conclusions/Significance: These findings strongly suggest that the adjunction of an SSRI to a 5-HT4 agonist may help to optimize the fast-acting antidepressant efficacy of the latter.	[Lucas, Guillaume; Du, Jenny; Romeas, Thomas; Mnie-Filali, Ouissame; Pineyro, Graciela] Univ Montreal, Dept Psychiat, Ctr Rech Fernand Seguin, Montreal, PQ H3C 3J7, Canada; [Mnie-Filali, Ouissame; Haddjeri, Nasser] Univ Lyon 1, CNRS, EAC 3006, ISPB,Fac Pharm, F-69365 Lyon, France; [Debonnel, Guy] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; McGill University	Lucas, G (corresponding author), Univ Montreal, Dept Psychiat, Ctr Rech Fernand Seguin, Montreal, PQ H3C 3J7, Canada.	guillaume.lucas@gmail.com	Lucas, Guillaume/N-6993-2017; Haddjeri, Nasser/M-6377-2014; Romeas, Thomas/S-6034-2019	Lucas, Guillaume/0000-0003-0647-9756; Haddjeri, Nasser/0000-0002-2161-2204; Romeas, Thomas/0000-0002-3298-5719; Pineyro, Graciela/0000-0001-9709-651X	Instituts de Recherche en Sant du Canada (IRSC/CIHR); Wyeth Ayerst Canada	Instituts de Recherche en Sant du Canada (IRSC/CIHR)(Canadian Institutes of Health Research (CIHR)); Wyeth Ayerst Canada	This work was supported by grants from the Instituts de Recherche en Sant du Canada (IRSC/CIHR). GL was a fellowship recipient from Wyeth Ayerst Canada in partnership with the IRSC/CIHR during the accomplishment of a part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, ESSAYS NEUROCHEMISTR, P1; Arborelius L, 1999, EUR J PHARMACOL, V382, P133, DOI 10.1016/S0014-2999(99)00592-0; Artigas F, 2006, CURR DRUG TARGETS, V7, P139, DOI 10.2174/138945006775515446; ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248; Artigas Francesc, 2002, Psychopharmacol Bull, V36 Suppl 2, P123; Beique JC, 2000, NEUROPSYCHOPHARMACOL, V23, P294; Besson A, 2000, EUR NEUROPSYCHOPHARM, V10, P177, DOI 10.1016/S0924-977X(00)00069-9; Blier P, 1999, NEUROPSYCHOPHARMACOL, V21, pS91, DOI 10.1016/S0893-133X(99)00036-6; Blier P, 2001, J CLIN PSYCHIAT, V62, P7; BLIER P, 1994, TRENDS PHARMACOL SCI, V15, P220, DOI 10.1016/0165-6147(94)90315-8; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Briejer MR, 2001, EUR J PHARMACOL, V423, P71, DOI 10.1016/S0014-2999(01)01087-1; CHAPUT Y, 1986, N-S ARCH PHARMACOL, V333, P342, DOI 10.1007/BF00500007; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Duman RS, 2007, NEURON, V55, P679, DOI 10.1016/j.neuron.2007.08.011; Duman RS, 1998, BIOL PSYCHIAT, V44, P324, DOI 10.1016/S0006-3223(98)00031-6; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; Fujita M, 2000, BIOL PSYCHIAT, V48, P801, DOI 10.1016/S0006-3223(00)00960-4; Furukawa TA, 2007, CAN J PSYCHIAT, V52, P545, DOI 10.1177/070674370705200902; Haddjeri N, 1998, J NEUROSCI, V18, P10150; Haddjeri N, 2004, NEUROPSYCHOPHARMACOL, V29, P1800, DOI 10.1038/sj.npp.1300489; Hajos M, 1999, BRIT J PHARMACOL, V126, P1741, DOI 10.1038/sj.bjp.0702510; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kapur S, 1996, AM J PSYCHIAT, V153, P466; Lengyel K, 2008, NEUROPHARMACOLOGY, V55, P63, DOI 10.1016/j.neuropharm.2008.04.014; Lucas G, 2005, BIOL PSYCHIAT, V57, P918, DOI 10.1016/j.biopsych.2004.12.023; Lucas G, 2002, EUR J NEUROSCI, V16, P817, DOI 10.1046/j.1460-9568.2002.02150.x; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Lucas Guillaume, 2008, Expert Rev Neurother, V8, P1, DOI 10.1586/14737175.8.1.1; Lucas G, 2008, INT J NEUROPSYCHOPH, V11, P485, DOI 10.1017/S1461145708008547; Martin-Ruiz R, 2001, NEUROPHARMACOLOGY, V41, P72, DOI 10.1016/S0028-3908(01)00050-8; Martinez D, 2001, NEUROPSYCHOPHARMACOL, V24, P209, DOI 10.1016/S0893-133X(00)00187-1; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Nibuya M, 1996, J NEUROSCI, V16, P2365; Pineyro G, 2001, MOL PHARMACOL, V60, P816; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Sanchez C, 1999, CELL MOL NEUROBIOL, V19, P467, DOI 10.1023/A:1006986824213; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shelton RC, 2008, ACTA PSYCHIAT SCAND, V117, P253, DOI 10.1111/j.1600-0447.2007.01130.x; Sprouse J, 2001, SYNAPSE, V41, P49, DOI 10.1002/syn.1059; Thase ME, 2002, J CLIN PSYCHIAT, V63, P95, DOI 10.4088/JCP.v63n0202; Thome J, 2000, J NEUROSCI, V20, P4030; Tiraboschi E, 2004, NEUROPSYCHOPHARMACOL, V29, P1831, DOI 10.1038/sj.npp.1300488; Trivedi Madhukar H, 2003, Ann Clin Psychiatry, V15, P59; Wong EHF, 2000, BIOL PSYCHIAT, V47, P818, DOI 10.1016/S0006-3223(99)00291-7	46	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9253	10.1371/journal.pone.0009253	http://dx.doi.org/10.1371/journal.pone.0009253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169084	Green Submitted, gold, Green Published			2022-12-27	WOS:000274590500028
J	Alexiou, P; Maragkakis, M; Papadopoulos, GL; Simmosis, VA; Zhang, L; Hatzigeorgiou, AG				Alexiou, Panagiotis; Maragkakis, Manolis; Papadopoulos, Giorgio L.; Simmosis, Victor A.; Zhang, Lin; Hatzigeorgiou, Artemis G.			The DIANA-mirExTra Web Server: From Gene Expression Data to MicroRNA Function	PLOS ONE			English	Article							KEGG	Background: High-throughput gene expression experiments are widely used to identify the role of genes involved in biological conditions of interest. MicroRNAs (miRNA) are regulatory molecules that have been functionally associated with several developmental programs and their deregulation with diverse diseases including cancer. Methodology/Principal Findings: Although miRNA expression levels may not be routinely measured in high-throughput experiments, a possible involvement of miRNAs in the deregulation of gene expression can be computationally predicted and quantified through analysis of overrepresented motifs in the deregulated genes 3' untranslated region (3'UTR) sequences. Here, we introduce a user-friendly web-server, DIANA-mirExTra (www.microrna.gr/mirextra) that allows the comparison of frequencies of miRNA associated motifs between sets of genes that can lead to the identification of miRNAs responsible for the deregulation of large numbers of genes. To this end, we have investigated different approaches and measures, and have practically implemented them on experimental data. Conclusions/Significance: On several datasets of miRNA overexpression and repression experiments, our proposed approaches have successfully identified the deregulated miRNA. Beyond the prediction of miRNAs responsible for the deregulation of transcripts, the web-server provides extensive links to DIANA-mirPath, a functional analysis tool incorporating miRNA targets in biological pathways. Additionally, in case information about miRNA expression changes is provided, the results can be filtered to display the analysis for miRNAs of interest only.	[Alexiou, Panagiotis; Maragkakis, Manolis; Papadopoulos, Giorgio L.; Simmosis, Victor A.; Hatzigeorgiou, Artemis G.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece; [Alexiou, Panagiotis] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece; [Maragkakis, Manolis] Univ Halle Wittenberg, Inst Comp Sci, Halle, Germany; [Zhang, Lin] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA	Alexander Fleming Biomedical Sciences Research Center; Aristotle University of Thessaloniki; Martin Luther University Halle Wittenberg; University of Pennsylvania	Alexiou, P (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Oncol, Varkiza, Greece.	hatzigeorgiou@fleming.gr	Alexiou, Panagiotis/ABB-6698-2020; Maragkakis, Emmanouil/F-5427-2010; Hatzigeorgiou, Artemis/Z-1976-2019; Maragkakis, Manolis/AAN-3407-2020; ALEXIOU, PANAGIOTIS/C-8906-2011; Zhang, Lin/K-8478-2012	Alexiou, Panagiotis/0000-0003-3437-7482; Maragkakis, Emmanouil/0000-0002-3158-1763; Maragkakis, Manolis/0000-0002-3158-1763; ALEXIOU, PANAGIOTIS/0000-0003-3437-7482; Papadopoulos, Giorgio Lucio/0000-0003-0199-0256	General Secretary Research and Technology, Greece	General Secretary Research and Technology, Greece	Aristeia Award from General Secretary Research and Technology, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Elkon R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000189; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolchik Donna, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s17; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; SELBACH M, 2008, NATURE; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Zhang JJ, 2009, J CHEM CRYSTALLOGR, V39, P1, DOI 10.1007/s10870-008-9423-x; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	22	68	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9171	10.1371/journal.pone.0009171	http://dx.doi.org/10.1371/journal.pone.0009171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161787	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442800017
J	Mengshol, JA; Golden-Mason, L; Arikawa, T; Smith, M; Niki, T; McWilliams, R; Randall, JA; McMahan, R; Zimmerman, MA; Rangachari, M; Dobrinskikh, E; Busson, P; Polyak, SJ; Hirashima, M; Rosen, HR				Mengshol, John A.; Golden-Mason, Lucy; Arikawa, Tomohiro; Smith, Maxwell; Niki, Toshiro; McWilliams, Ryan; Randall, Jessica A.; McMahan, Rachel; Zimmerman, Michael A.; Rangachari, Manu; Dobrinskikh, Evgenia; Busson, Pierre; Polyak, Stephen J.; Hirashima, Mitsuomi; Rosen, Hugo R.			A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection	PLOS ONE			English	Article							VIRUS-INFECTION; LIVER-INJURY; HEPATOCELLULAR-CARCINOMA; GLYCAN INTERACTIONS; CD127 EXPRESSION; HCV INFECTION; LYMPHOCYTES; TOLERANCE; TIM-3; APOPTOSIS	Approximately 200 million people throughout the world are infected with hepatitis C virus (HCV). One of the most striking features of HCV infection is its high propensity to establish persistence (similar to 70-80%) and progressive liver injury. Galectins are evolutionarily conserved glycan-binding proteins with diverse roles in innate and adaptive immune responses. Here, we demonstrate that galectin-9, the natural ligand for the T cell immunoglobulin domain and mucin domain protein 3 (Tim-3), circulates at very high levels in the serum and its hepatic expression (particularly on Kupffer cells) is significantly increased in patients with chronic HCV as compared to normal controls. Galectin-9 production from monocytes and macrophages is induced by IFN-gamma, which has been shown to be elevated in chronic HCV infection. In turn, galectin-9 induces proinflammatory cytokines in liver-derived and peripheral mononuclear cells; galectin-9 also induces anti-inflammatory cytokines from peripheral but not hepatic mononuclear cells. Galectin-9 results in expansion of CD4(+) CD25(+) FoxP3(+) CD127(low) regulatory T cells, contraction of CD4+ effector T cells, and apoptosis of HCV-specific CTLs. In conclusion, galectin-9 production by Kupffer cells links the innate and adaptive immune response, providing a potential novel immunotherapeutic target in this common viral infection.	[Mengshol, John A.; Golden-Mason, Lucy; McWilliams, Ryan; Randall, Jessica A.; McMahan, Rachel; Dobrinskikh, Evgenia; Rosen, Hugo R.] Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Mengshol, John A.; Rosen, Hugo R.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Sch Med, Div Clin Immunol, Denver, CO USA; [Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hosp, Denver, CO USA; [Smith, Maxwell] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA; [Arikawa, Tomohiro; Hirashima, Mitsuomi] Kagawa Med Univ, Dept Immunol & Immunopathol, Kagawa, Japan; [Niki, Toshiro] GalPharma, Kagawa, Japan; [Zimmerman, Michael A.] Univ Colorado, Sch Med, Div Transplant Surg, Aurora, CO USA; [Rangachari, Manu] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Busson, Pierre] Inst Cancerol Gustave Roussy, Villejuif, France; [Polyak, Stephen J.] Univ Washington, Div Lab Med, Seattle, WA 98195 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Kagawa University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UNICANCER; Gustave Roussy; University of Washington; University of Washington Seattle	Mengshol, JA (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA.	Hugo.Rosen@ucdenver.edu	Mengshol, John/ABG-2751-2021; Polyak, Stephen/B-5743-2011	Golden-Mason, Lucy/0000-0002-2087-4405; Golden-Mason, Lucy/0000-0003-3347-4192; Busson, Pierre/0000-0003-1027-3400	National Institutes of Health (NIH) [RO1 DK060590, U19 A 1066328-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060590] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by National Institutes of Health (NIH) grants RO1 DK060590 and U19 A 1066328-01 (HCV center grant) to HRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Niki from Galpharma provided antibodies.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Calne RY, 2000, IMMUNOL REV, V174, P280, DOI 10.1034/j.1600-0528.2002.017419.x; Chagan-Yasutan H, 2009, TOHOKU J EXP MED, V218, P285, DOI 10.1620/tjem.218.285; Dai SY, 2005, J IMMUNOL, V175, P2974, DOI 10.4049/jimmunol.175.5.2974; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keating R, 2007, J IMMUNOL, V178, P2737, DOI 10.4049/jimmunol.178.5.2737; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mengshol JA, 2007, NAT CLIN PRACT GASTR, V4, P622, DOI 10.1038/ncpgasthep0961; Napoli J, 1996, HEPATOLOGY, V24, P759; Neuman MG, 2002, CYTOKINE, V17, P108, DOI 10.1006/cyto.2001.0997; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Racanelli V, 2007, CLIN IMMUNOL, V124, P5, DOI 10.1016/j.clim.2007.04.009; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rehermann B, 1999, J VIRAL HEPATITIS, V6, P31, DOI 10.1046/j.1365-2893.1999.00008.x; Rosen HR, 2008, GASTROENTEROLOGY, V134, P1789, DOI 10.1053/j.gastro.2008.02.062; Sato M, 2002, GLYCOBIOLOGY, V12, P191, DOI 10.1093/glycob/12.3.191; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tu Z, 2007, CLIN EXP IMMUNOL, V149, P186, DOI 10.1111/j.1365-2249.2007.03415.x; Tu Z, 2008, J EXP MED, V205, P233, DOI 10.1084/jem.20072195; Unitt E, 2005, HEPATOLOGY, V41, P722, DOI 10.1002/hep.20644; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054; Wang F, 2009, IMMUNOBIOLOGY, V214, P342, DOI 10.1016/j.imbio.2008.10.007; Yoshida H, 2001, NEUROREPORT, V12, P3755, DOI 10.1097/00001756-200112040-00030; Zhang JL, 2009, COMPUT OPER RES, V36, P823, DOI 10.1016/j.cor.2007.11.001; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; 2004, WKLY EPIDEMIOL REC, V79, P314	52	148	157	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9504	10.1371/journal.pone.0009504	http://dx.doi.org/10.1371/journal.pone.0009504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209097	Green Submitted, Green Published, gold			2022-12-27	WOS:000275197100005
J	Silvestre, DC; Gil, GA; Tomasini, N; Bussolino, DF; Caputto, BL				Silvestre, David C.; Gil, German A.; Tomasini, Nicolas; Bussolino, Daniela F.; Caputto, Beatriz L.			Growth of Peripheral and Central Nervous System Tumors Is Supported by Cytoplasmic c-Fos in Humans and Mice	PLOS ONE			English	Article							PHOSPHOLIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; PC12 CELLS; NEUROFIBROMATOSIS 1; MOUSE MODELS; GENE; LIGHT; NF1; COMPLEX; RETINA	Background: We have previously shown that the transcription factor c-Fos is also capable of associating to endoplasmic reticulum membranes (ER) and activating phospholipid synthesis. Herein we examined phospholipid synthesis status in brain tumors from human patients and from NPcis mice, an animal model of the human disease Neurofibromatosis Type 1 (NF1). Principal Findings: In human samples, c-Fos expression was at the limit of detection in non-pathological specimens, but was abundantly expressed associated to ER membranes in tumor cells. This was also observed in CNS of adult tumor-bearing NPcis mice but not in NPcis fos(-/-) KO mice. A glioblastoma multiforme and a malignant PNS tumor from a NF1 patient (MPNST) showed a 2-and 4-fold c-Fos-dependent phospholipid synthesis activation, respectively. MPNST samples also showed increased cell proliferation rates and abundant c-Fos expression. Conclusions: Results highlight a role of cytoplasmic c-Fos as an activator of phospholipid synthesis in events demanding high rates of membrane biogenesis as occurs for the exacerbated growth of tumors cells. They also disclose this protein as a potential target for controlling tumor growth in the nervous system.	[Silvestre, David C.; Gil, German A.; Tomasini, Nicolas; Bussolino, Daniela F.; Caputto, Beatriz L.] Univ Nacl Cordoba, CIQUIBIC, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	National University of Cordoba	Silvestre, DC (corresponding author), CEA, DSV iRCM SCSR, Lab RadioPathol, Fontenay Aux Roses, France.	bcaputto@dqb.fcq.unc.edu.ar	GIL, GERMAN A./T-3018-2019	GIL, GERMAN A./0000-0001-6714-2693	James S. McDonnell Foundation, Argentina; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET), Argentina; SeCyT, Argentina; Universidad Nacional de Cordoba, Argentina	James S. McDonnell Foundation, Argentina; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET), Argentina; SeCyT, Argentina(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba, Argentina	This work was supported by the James S. McDonnell Foundation (www. jsmf. org), the Ministerio de Ciencia, Tecnologia e Innovacion Productiva (FONCyT and CONICET) (www. agencia. gov. ar and www. conicet. gov. ar) and SeCyT, Universidad Nacional de Cordoba, Argentina (www. secyt. unc. edu. ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; CAMMER W, 1989, GLIA, V2, P223, DOI 10.1002/glia.440020403; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Costa RM, 2003, TRENDS MOL MED, V9, P19, DOI 10.1016/S1471-4914(02)00008-4; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Ferner RE, 2002, CANCER RES, V62, P1573; Fleischmann A, 2000, GENE DEV, V14, P2695, DOI 10.1101/gad.187900; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guha A, 1996, ONCOGENE, V12, P507; GUIDO ME, 1990, J NEUROCHEM, V55, P1855, DOI 10.1111/j.1471-4159.1990.tb05768.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Scerbo MJ, 2009, J NEUROSCI RES, V87, P2273, DOI 10.1002/jnr.22048; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Penner MR, 2002, DEV BRAIN RES, V135, P71, DOI 10.1016/S0165-3806(02)00308-5; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Serra E, 1997, AM J HUM GENET, V61, P512, DOI 10.1086/515504; Silvestre DC, 2009, J NEUROSCI RES, V87, P857, DOI 10.1002/jnr.21915; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Wang Z, 2006, TOXICOL APPL PHARM, V214, P263, DOI 10.1016/j.taap.2005.12.014; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	37	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9544	10.1371/journal.pone.0009544	http://dx.doi.org/10.1371/journal.pone.0009544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209053	Green Published, Green Submitted, gold			2022-12-27	WOS:000275197100023
J	Zi, ZK; Liebermeister, W; Klipp, E				Zi, Zhike; Liebermeister, Wolfram; Klipp, Edda			A Quantitative Study of the Hog1 MAPK Response to Fluctuating Osmotic Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MARKUP LANGUAGE SBML; YEAST OSMOREGULATION; PARAMETER-ESTIMATION; KINASE; PATHWAY; CELLS; SIZE; ACCUMULATION; ADAPTATION	Background: Yeast cells live in a highly fluctuating environment with respect to temperature, nutrients, and especially osmolarity. The Hog1 mitogen-activated protein kinase (MAPK) pathway is crucial for the adaption of yeast cells to external osmotic changes. Methodology/Principal Findings: To better understand the osmo-adaption mechanism in the budding yeast Saccharomyces cerevisiae, we have developed a mathematical model and quantitatively investigated the Hog1 response to osmotic stress. The model agrees well with various experimental data for the Hog1 response to different types of osmotic changes. Kinetic analyses of the model indicate that budding yeast cells have evolved to protect themselves economically: while they show almost no response to fast pulse-like changes of osmolarity, they respond periodically and are well-adapted to osmotic changes with a certain frequency. To quantify the signal transduction efficiency of the osmo-adaption network, we introduced a measure of the signal response gain, which is defined as the ratio of output change integral to input (signal) change integral. Model simulations indicate that the Hog1 response gain shows bell-shaped response curves with respect to the duration of a single osmotic pulse and to the frequency of periodic square osmotic pulses, while for up-staircase (ramp) osmotic changes, the gain depends on the slope. Conclusions/Significance: The model analyses suggest that budding yeast cells have selectively evolved to be optimized to some specific types of osmotic changes. In addition, our work implies that the signaling output can be dynamically controlled by fine-tuning the signal input profiles.	[Zi, Zhike] Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany; [Zi, Zhike] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Freiburg, Germany; [Liebermeister, Wolfram; Klipp, Edda] Humboldt Univ, Inst Biol, Berlin, Germany	University of Freiburg; University of Freiburg; Humboldt University of Berlin	Zi, ZK (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies Bioss, Freiburg, Germany.	zhike.zi@bioss.uni-freiburg.de; edda.klipp@rz.hu-berlin.de	Liebermeister, Wolfram/AAC-7326-2020; Zi, Zhike/B-4185-2012; Zi, Zhike/I-2756-2019	Liebermeister, Wolfram/0000-0002-2568-2381; Zi, Zhike/0000-0002-7601-915X	German Federal and State Governments [(EXC 294,]; European Commission [201142]	German Federal and State Governments; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294, Z. Z.) and the European Commission within the seventh Framework Programme, theme 1 Health (UNICELLSYS project, grant agreement no.: 201142, E. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsa-Canto E, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-26; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Elston TC, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.142pe47; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hao N, 2007, CURR BIOL, V17, P659, DOI 10.1016/j.cub.2007.02.044; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jacoby T, 1997, J BIOL CHEM, V272, P17749, DOI 10.1074/jbc.272.28.17749; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Krantz M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.36; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mattison CP, 2000, GENE DEV, V14, P1229; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Tamaki H, 2005, GENES CELLS, V10, P193, DOI 10.1111/j.1365-2443.2005.00828.x; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Zi Z, 2006, BIOINFORMATICS, V22, P2704, DOI 10.1093/bioinformatics/btl443; Zi ZK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-342	30	46	47	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9522	10.1371/journal.pone.0009522	http://dx.doi.org/10.1371/journal.pone.0009522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209100	gold, Green Submitted, Green Published			2022-12-27	WOS:000275197100008
J	Denapaite, D; Bruckner, R; Nuhn, M; Reichmann, P; Henrich, B; Maurer, P; Schahle, Y; Selbmann, P; Zimmermann, W; Wambutt, R; Hakenbeck, R				Denapaite, Dalia; Brueckner, Reinhold; Nuhn, Michael; Reichmann, Peter; Henrich, Bernhard; Maurer, Patrick; Schaehle, Yvonne; Selbmann, Peter; Zimmermann, Wolfgang; Wambutt, Rolf; Hakenbeck, Regine			The Genome of Streptococcus mitis B6-What Is a Commensal?	PLOS ONE			English	Article							ARGININE TRANSLOCATION SYSTEM; SURFACE GLYCOPROTEINS GSPB; STAPHYLOCOCCUS-AUREUS; MOSAIC CHROMOSOMES; INSERTION-SEQUENCE; ALLELIC VARIATION; BINDING PROTEINS; SIGNAL PEPTIDES; S-MITIS; PNEUMONIAE	Streptococcus mitis is the closest relative of the major human pathogen S. pneumoniae. The 2,15 Mb sequence of the Streptococcus mitis B6 chromosome, an unusually high-level beta-lactam resistant and multiple antibiotic resistant strain, has now been determined to encode 2100 genes. The accessory genome is estimated to represent over 40%, including 75 mostly novel transposases and IS, the prophage phi B6 and another seven phage related regions. Tetracycline resistance mediated by Tn5801, and an unusual and large gene cluster containing three aminoglycoside resistance determinants have not been described in other Streptococcus spp. Comparative genomic analyses including hybridization experiments on a S. mitis B6 specific microarray reveal that individual S. mitis strains are almost as distantly related to the B6 strain as S. pneumoniae. Both species share a core of over 900 genes. Most proteins described as pneumococcal virulence factors are present in S. mitis B6, but the three choline binding proteins PcpA, PspA and PspC, and three gene clusters containing the hyaluronidase gene, ply and lytA, and the capsular genes are absent in S. mitis B6 and other S. mitis as well and confirm their importance for the pathogenetic potential of S. pneumoniae. Despite the close relatedness between the two species, the S. mitis B6 genome reveals a striking X-alignment when compared with S. pneumoniae.	[Denapaite, Dalia; Brueckner, Reinhold; Reichmann, Peter; Henrich, Bernhard; Maurer, Patrick; Schaehle, Yvonne; Hakenbeck, Regine] Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany; [Nuhn, Michael; Reichmann, Peter; Maurer, Patrick; Hakenbeck, Regine] Univ Kaiserslautern, Nano Bio Ctr, Kaiserslautern, Germany; [Selbmann, Peter; Zimmermann, Wolfgang; Wambutt, Rolf] AGOWA Genom, Berlin, Germany	University of Kaiserslautern; University of Kaiserslautern	Denapaite, D (corresponding author), Univ Kaiserslautern, Dept Microbiol, Kaiserslautern, Germany.	hakenb@rhrk.uni-kl.de	Denapaite, Dalia/E-2657-2018	Denapaite, Dalia/0000-0002-0700-3437; Nuhn, Michael/0000-0001-9753-7995	Bundesministerium fur Bildung und Forschung (BMBF) [PTJ-BIO/0313134, 0313801 1]; EU [LSHM-CT-2003-503413]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]; AGOWA company; Stiftung Rheinland Pfalz fur Innovation [15202-386261/580]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); Network of Excellence EuroPathoGenomics; AGOWA company; Stiftung Rheinland Pfalz fur Innovation	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF No. PTJ-BIO/0313134) and 0313801 1, the EU (Pneumococcal Resistance Epidemicity and Virulence, An International Study [PREVIS], LSHM-CT-2003-503413 and the Network of Excellence EuroPathoGenomics, LSHB-CT-2005-512061), the AGOWA company, and the Stiftung Rheinland Pfalz fur Innovation 15202-386261/580. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; BOURGAULT AM, 1979, J INFECT DIS, V140, P316, DOI 10.1093/infdis/140.3.316; BRANDENBURG RO, 1983, J AM COLL CARDIOL, V1, P280, DOI 10.1016/S0735-1097(83)80029-1; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; CAMPBELL AM, 1992, J BACTERIOL, V174, P7495, DOI 10.1128/JB.174.23.7495-7499.1992; Cerda P, 2007, INT MICROBIOL, V10, P57, DOI 10.2436/20.1501.01.8; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Culebras Esther, 1999, Frontiers in Bioscience, V4, pD1, DOI 10.2741/culebras; Dagerhamn J, 2008, J CLIN MICROBIOL, V46, P863, DOI 10.1128/JCM.01438-07; Dai LX, 2003, NUCLEIC ACIDS RES, V31, P424, DOI 10.1093/nar/gkg049; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DIAZ E, 1992, J BACTERIOL, V174, P5516; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Eisen JA, 2000, GENOME BIOL, V1; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; Fatholahzadeh B, 2009, INT J ANTIMICROB AG, V33, P264, DOI 10.1016/j.ijantimicag.2008.09.018; Ferrandiz MJ, 2005, ANTIMICROB AGENTS CH, V49, P2237, DOI 10.1128/AAC.49.6.2237-2245.2005; Franz CMAP, 2000, MICROBIOL-SGM, V146, P621, DOI 10.1099/00221287-146-3-621; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; HAMMERSCHMIDT S, 2007, MOL BIOL STREPTOCOCC, P141; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HENRICHSEN J, 1995, J CLIN MICROBIOL, V33, P2759, DOI 10.1128/JCM.33.10.2759-2762.1995; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hoskins J, 1999, J BACTERIOL, V181, P6552, DOI 10.1128/JB.181.20.6552-6555.1999; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jefferies J, 2007, J BACTERIOL, V189, P627, DOI 10.1128/JB.01092-06; Kearns AM, 2000, J CLIN MICROBIOL, V38, P1309, DOI 10.1128/JCM.38.3.1309-1310.2000; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Konig A, 1998, MICROB DRUG RESIST, V4, P45, DOI 10.1089/mdr.1998.4.45; Krauss J, 1997, ANTIMICROB AGENTS CH, V41, P936, DOI 10.1128/AAC.41.5.936; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Le Bourgeois P, 2007, PLOS GENET, V3, P1190, DOI 10.1371/journal.pgen.0030117; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; LOCK RA, 1992, MICROB PATHOGENESIS, V12, P137, DOI 10.1016/0882-4010(92)90116-6; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lux T, 2007, J BACTERIOL, V189, P7741, DOI 10.1128/JB.00474-07; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; MITCHELL TJ, 2007, MOL BIOL STREPTOCOCC, P205; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Morrison DA, 2007, J BACTERIOL, V189, P6497, DOI 10.1128/JB.00687-07; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Pagliero E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-19; Paik J, 1999, J BACTERIOL, V181, P3852, DOI 10.1128/JB.181.12.3852-3856.1999; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Reichmann P, 2002, J MOL MICROB BIOTECH, V4, P101; Reichmann P, 2000, FEMS MICROBIOL LETT, V190, P231, DOI 10.1016/S0378-1097(00)00340-2; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Romero P, 2004, J BACTERIOL, V186, P8229, DOI 10.1128/JB.186.24.8229-8239.2004; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SanchezBeato AR, 1997, J BACTERIOL, V179, P2459, DOI 10.1128/jb.179.7.2459-2463.1997; Schneeberger PM, 1996, INFECTION, V24, P29, DOI 10.1007/BF01780647; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Smith AM, 2005, ANTIMICROB AGENTS CH, V49, P2002, DOI 10.1128/AAC.49.5.2002-2007.2005; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Sutcliffe IC, 2004, ANTON LEEUW INT J G, V85, P305; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; VANDERMEER JTM, 1991, EUR J CLIN MICROBIOL, V10, P728; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Whatmore AM, 1999, INFECT IMMUN, V67, P4551, DOI 10.1128/IAI.67.9.4551-4556.1999; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yadegar A, 2009, MICROB DRUG RESIST, V15, P109, DOI 10.1089/mdr.2009.0897; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014; Zysk G, 2001, INFECT IMMUN, V69, P845, DOI 10.1128/IAI.69.2.845-852.2001	103	89	94	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9426	10.1371/journal.pone.0009426	http://dx.doi.org/10.1371/journal.pone.0009426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195536	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924300014
J	van Cleef, BA; Verkade, EJM; Wulf, MW; Buiting, AG; Voss, A; Huijsdens, XW; van Pelt, W; Mulders, MN; Kluytmans, JA				van Cleef, Brigitte A.; Verkade, Erwin J. M.; Wulf, Mireille W.; Buiting, Anton G.; Voss, Andreas; Huijsdens, Xander W.; van Pelt, Wilfrid; Mulders, Mick N.; Kluytmans, Jan A.			Prevalence of Livestock-Associated MRSA in Communities with High Pig-Densities in The Netherlands	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; HUMANS; ORIGIN; CC398	Background: Recently, livestock-associated methicillin-resistant Staphylococcus aureus CC398 has been discovered in animals, livestock farmers and retail meat. This cross-sectional study aimed to determine the spread to persons not in direct contact with livestock in areas with a high density of pig farms. Methodology/Principal Findings: With a random mailing in 3 selected municipalities in the Netherlands, adult persons were asked to fill in a questionnaire and to take a nose swab. In total, complete information was obtained on 583 persons. Of the 534 persons without livestock-contact, one was positive for MRSA (0.2%; 95% confidence interval, <0.01-1.2). Of the 49 persons who did indicate to be working at or living on a livestock farm, 13 were positive for MRSA (26.5%; 95% confidence interval, 16.1-40.4). All spa-types belonged to CC398. Conclusions/Significance: Livestock-associated MRSA has a high prevalence in people with direct contact with animals. At this moment it has not spread from the farms into the community.	[van Cleef, Brigitte A.; Huijsdens, Xander W.; van Pelt, Wilfrid; Mulders, Mick N.] RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [van Cleef, Brigitte A.; Kluytmans, Jan A.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van Cleef, Brigitte A.; Voss, Andreas] 7th Framework Programme, EU HEALTH Project PILGRIM, Nijmegen, Netherlands; [Verkade, Erwin J. M.; Kluytmans, Jan A.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Wulf, Mireille W.] Catharina Hosp, Veldhoven, Netherlands; [Wulf, Mireille W.] PAMM Lab Med Microbiol, Veldhoven, Netherlands; [Verkade, Erwin J. M.; Buiting, Anton G.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Control, Nijmegen, Netherlands; [Voss, Andreas] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Amphia Hospital; Catharina Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Canisius-Wilhelmina Hospital; Radboud University Nijmegen	van Cleef, BA (corresponding author), RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	brigitte.van.cleef@rivm.nl	Voss, A./H-8111-2014		EU	EU(European Commission)	This study was supported by the EU-HEALTH project PILGRIM of the 7th Framework Programme (www.fp7-pilgrim.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CBS, CBS STAT NETH ANN CO; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; DOLEE K, 2008, ARCH PHARM RES, V31, P1016; DONKER GSE, 2008, HUISARTS WETENSCHAP, V51; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Fanoy E, 2009, EUROSURVEILLANCE, V14; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P380, DOI 10.1086/596045; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lin J, 2009, J FOOD PROTECT, V72, P608, DOI 10.4315/0362-028X-72.3.608; *MUN HLTH SERV GGD, BEING LIV HLTH AMST; Pereira V, 2009, FOOD MICROBIOL, V26, P278, DOI 10.1016/j.fm.2008.12.008; Pu SH, 2009, APPL ENVIRON MICROB, V75, P265, DOI 10.1128/AEM.01110-08; Robicsek A, 2008, J CLIN MICROBIOL, V46, P588, DOI 10.1128/JCM.01746-07; *SWAB, SWAB NETHMAP 2008 CO; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Klis FRM, 2009, NETH J MED, V67, P301; van Griethuysen A, 1999, J CLIN MICROBIOL, V37, P2789, DOI 10.1128/JCM.37.9.2789-2792.1999; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; VIET AL, 2002, RISK FACTORS HLTH NE; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wassenberg M W M, 2008, Ned Tijdschr Geneeskd, V152, P2681; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MW, 2008, EURO SURVEILL, V13; 2009, EFSA SCI REPORT, V301, P1	37	98	99	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9385	10.1371/journal.pone.0009385	http://dx.doi.org/10.1371/journal.pone.0009385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195538	Green Submitted, Green Published, gold			2022-12-27	WOS:000274924300002
J	Kulkarni, MA; Desrochers, RE; Kerr, JT				Kulkarni, Manisha A.; Desrochers, Rachelle E.; Kerr, Jeremy T.			High Resolution Niche Models of Malaria Vectors in Northern Tanzania: A New Capacity to Predict Malaria Risk?	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-GAMBIAE COMPLEX; DIHYDROFOLATE-REDUCTASE; USAMBARA MOUNTAINS; TRANSMISSION RISK; SAMPLE-SIZE; AFRICA; CULICIDAE; DIPTERA; AREA	Background: Malaria transmission rates in Africa can vary dramatically over the space of a few kilometres. This spatial heterogeneity reflects variation in vector mosquito habitat and presents an important obstacle to the efficient allocation of malaria control resources. Malaria control is further complicated by combinations of vector species that respond differently to control interventions. Recent modelling innovations make it possible to predict vector distributions and extrapolate malaria risk continentally, but these risk mapping efforts have not yet bridged the spatial gap to guide on-the-ground control efforts. Methodology/Principal Findings: We used Maximum Entropy with purpose-built, high resolution land cover data and other environmental factors to model the spatial distributions of the three dominant malaria vector species in a 94,000 km(2) region of east Africa. Remotely sensed land cover was necessary in each vector's niche model. Seasonality of precipitation and maximum annual temperature also contributed to niche models for Anopheles arabiensis and An. funestus s.l. (AUC 0.989 and 0.991, respectively), but cold season precipitation and elevation were important for An. gambiae s.s. (AUC 0.997). Although these niche models appear highly accurate, the critical test is whether they improve predictions of malaria prevalence in human populations. Vector habitat within 1.5 km of community-based malaria prevalence measurements interacts with elevation to substantially improve predictions of Plasmodium falciparum prevalence in children. The inclusion of the mechanistic link between malaria prevalence and vector habitat greatly improves the precision and accuracy of prevalence predictions (r(2) = 0.83 including vector habitat, or r(2) = 0.50 without vector habitat). Predictions including vector habitat are unbiased (observations vs. model predictions of prevalence: slope = 1.02). Using this model, we generate a high resolution map of predicted malaria prevalence throughout the study region. Conclusions/Significance: The interaction between mosquito niche space and microclimate along elevational gradients indicates worrisome potential for climate and land use changes to exacerbate malaria resurgence in the east African highlands. Nevertheless, it is possible to direct interventions precisely to ameliorate potential impacts.	[Kulkarni, Manisha A.; Desrochers, Rachelle E.; Kerr, Jeremy T.] Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON, Canada	University of Ottawa	Kulkarni, MA (corresponding author), Univ Ottawa, Dept Biol, Canadian Facil Ecoinformat Res, Ottawa, ON, Canada.	manisha.kulkarni@uottawa.ca		Kulkarni, Manisha/0000-0002-5084-4960; Desrochers, Rachelle/0000-0001-5169-3853	Ontario Ministry of Research Innovation; NSERC	Ontario Ministry of Research Innovation(Ministry of Research and Innovation, Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a postdoctoral fellowship to MAK from the Ontario Ministry of Research & Innovation (www.mri.gov.on.ca) and a NSERC (www.nserc.gc.ca) grant to JTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifrangis M, 2003, AM J TROP MED HYG, V69, P601, DOI 10.4269/ajtmh.2003.69.601; [Anonymous], 2008, WORLD MAL REP 2008; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bayoh MN, 2004, MED VET ENTOMOL, V18, P174, DOI 10.1111/j.0269-283X.2004.00495.x; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Chandramohan D, 2001, B WORLD HEALTH ORGAN, V79, P375; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-40; COLUZZI M, 1984, B WORLD HEALTH ORGAN, V62, P107; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Ellman R, 1998, ANN TROP MED PARASIT, V92, P741, DOI 10.1080/00034989858989; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; *FAO, 2004, AFR PROJ; Gillies M, 1987, ANOPHELINAE AFRICA S; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hendrickx G, 2001, B ENTOMOL RES, V91, P333, DOI 10.1079/BER2001103; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kristan M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-231; Kuhn KG, 2002, J MED ENTOMOL, V39, P621, DOI 10.1603/0022-2585-39.4.621; KULKARNI MA, 2006, THESIS MCGILL U MONT; Kweka EJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-59; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lindsay SW, 2004, PHYSIOL ENTOMOL, V29, P204, DOI 10.1111/j.0307-6962.2004.00405.x; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MNZAVA AEP, 1986, ACTA TROP, V43, P277; MNZAVA AEP, 1995, MED VET ENTOMOL, V9, P316, DOI 10.1111/j.1365-2915.1995.tb00140.x; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; MUTUKU FM, 2009, INT J HEALTH GEOGR, V8, pE19; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Pearce RJ, 2003, ANTIMICROB AGENTS CH, V47, P1347, DOI 10.1128/AAC.47.4.1347-1354.2003; Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; *PMI, 2009, PRES MAL IN 3 ANN RE; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; ROGERS DJ, 1991, NATURE, V351, P739, DOI 10.1038/351739a0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Takken W, 1998, B ENTOMOL RES, V88, P561, DOI 10.1017/S0007485300026080; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Temu EA, 1998, T ROY SOC TROP MED H, V92, P152, DOI 10.1016/S0035-9203(98)90724-6; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	61	60	60	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9396	10.1371/journal.pone.0009396	http://dx.doi.org/10.1371/journal.pone.0009396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195366	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924200018
J	Krebiehl, G; Ruckerbauer, S; Burbulla, LF; Kieper, N; Maurer, B; Waak, J; Wolburg, H; Gizatullina, Z; Gellerich, FN; Woitalla, D; Riess, O; Kahle, PJ; Proikas-Cezanne, T; Kruger, R				Krebiehl, Guido; Ruckerbauer, Sabine; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Wolburg, Hartwig; Gizatullina, Zemfira; Gellerich, Frank N.; Woitalla, Dirk; Riess, Olaf; Kahle, Philipp J.; Proikas-Cezanne, Tassula; Krueger, Rejko			Reduced Basal Autophagy and Impaired Mitochondrial Dynamics Due to Loss of Parkinson's Disease-Associated Protein DJ-1	PLOS ONE			English	Article							CYSTEINE-SULFINIC ACID; ENERGETIC DEPRESSION; FUSION; DEGRADATION; MUTATIONS; PATHOLOGY; FISSION; MUSCLE; PINK1; GENE	Background: Mitochondrial dysfunction and degradation takes a central role in current paradigms of neurodegeneration in Parkinson's disease (PD). Loss of DJ-1 function is a rare cause of familial PD. Although a critical role of DJ-1 in oxidative stress response and mitochondrial function has been recognized, the effects on mitochondrial dynamics and downstream consequences remain to be determined. Methodology/Principal Findings: Using DJ-1 loss of function cellular models from knockout ( KO) mice and human carriers of the E64D mutation in the DJ-1 gene we define a novel role of DJ-1 in the integrity of both cellular organelles, mitochondria and lysosomes. We show that loss of DJ-1 caused impaired mitochondrial respiration, increased intramitochondrial reactive oxygen species, reduced mitochondrial membrane potential and characteristic alterations of mitochondrial shape as shown by quantitative morphology. Importantly, ultrastructural imaging and subsequent detailed lysosomal activity analyses revealed reduced basal autophagic degradation and the accumulation of defective mitochondria in DJ-1 KO cells, that was linked with decreased levels of phospho-activated ERK2. Conclusions/Significance: We show that loss of DJ-1 leads to impaired autophagy and accumulation of dysfunctional mitochondria that under physiological conditions would be compensated via lysosomal clearance. Our study provides evidence for a critical role of DJ-1 in mitochondrial homeostasis by connecting basal autophagy and mitochondrial integrity in Parkinson's disease.	[Ruckerbauer, Sabine; Proikas-Cezanne, Tassula] Univ Tubingen, Interfac Inst Cell Biol, Autophagy Lab, Tubingen, Germany; [Krebiehl, Guido; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Kahle, Philipp J.; Krueger, Rejko] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Krebiehl, Guido; Burbulla, Lena F.; Kieper, Nicole; Maurer, Brigitte; Waak, Jens; Kahle, Philipp J.; Krueger, Rejko] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Burbulla, Lena F.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Gizatullina, Zemfira] Otto VonGuericke Univ Magdegurg, Dept Neurol, D-39016 Magdeburg, Germany; [Gellerich, Frank N.] KeyNeurotek Pharmaceut AG, ZENIT, Magdeburg, Germany; [Woitalla, Dirk] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany; [Riess, Olaf] Univ Tubingen, Dept Med Genet, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Otto von Guericke University; Ruhr University Bochum; Eberhard Karls University of Tubingen	Proikas-Cezanne, T (corresponding author), Univ Tubingen, Interfac Inst Cell Biol, Autophagy Lab, Tubingen, Germany.	tassula.proikas-cezanne@uni-tuebingen.de; rejko.krueger@uni-tuebingen.de	Predoi, Daniela/C-4294-2011	Predoi, Daniela/0000-0003-3024-6290; Proikas-Cezanne, Prof. Dr. Tassula/0000-0001-6934-132X; Krueger, Rejko/0000-0003-4258-6241	German Research Council [KR2119/3-1, SFB773]; Federal Ministry for Education and Research [BMBF] [Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134]; Faculty of Medicine, University of Tubingen [1709-0-0]; Federal Ministry for Education and Research [BMBF]; Landesstiftung Baden Wuerttemberg	German Research Council(German Research Foundation (DFG)); Federal Ministry for Education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Faculty of Medicine, University of Tubingen; Federal Ministry for Education and Research [BMBF](Federal Ministry of Education & Research (BMBF)); Landesstiftung Baden Wuerttemberg	This work was supported by grants from the German Research Council [DFG, KR2119/3-1]; the Federal Ministry for Education and Research [BMBF, NGFNplus; 01GS08134]; and the Faculty of Medicine, University of Tubingen [Fortuene 1709-0-0] to RK; and grants of the Federal Ministry for Education and Research [BMBF, BioProfile]; Landesstiftung Baden Wuerttemberg; and the German Research Council [SFB773] to TPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cataldo AM, 1996, J NEUROPATH EXP NEUR, V55, P704, DOI 10.1097/00005072-199606000-00004; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cookson MR, 2003, NEURON, V37, P7, DOI 10.1016/S0896-6273(02)01166-2; DAGDA RK, 2009, MITOCHONDRION; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; FARRE JC, 2009, CURR OPIN CELL BIOL; Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gonzalez-Polo RA, 2009, J NEUROCHEM, V109, P889, DOI 10.1111/j.1471-4159.2009.06020.x; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hering R, 2004, HUM MUTAT, V24, P321, DOI 10.1002/humu.20089; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; JUNN E, 2008, J NEUROSCI RES; KANKI T, 2008, J BIOL CHEM; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Klein C, 2007, CURR OPIN NEUROL, V20, P453, DOI 10.1097/WCO.0b013e3281e6692b; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; KUZNETSOV AV, 2009, J CELL MOL MED; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Schapira AHV, 2005, J NEUROL NEUROSUR PS, V76, P1472, DOI 10.1136/jnnp.2004.035980; Schapira AHV, 2008, NEUROCHEM RES, V33, P2502, DOI 10.1007/s11064-008-9855-x; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Seppet E, 2009, INT J MOL SCI, V10, P2252, DOI 10.3390/ijms10052252; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; Stephenson LM, 2009, AUTOPHAGY, V5, P625, DOI 10.4161/auto.5.5.8133; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; THOMAS KJ, 2008, PARKINSONISM ASS PTE; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	67	263	279	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9367	10.1371/journal.pone.0009367	http://dx.doi.org/10.1371/journal.pone.0009367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186336	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000010
J	Shina, MC; Muller, R; Blau-Wasser, R; Glockner, G; Schleicher, M; Eichinger, L; Noegel, AA; Kolanus, W				Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Schleicher, Michael; Eichinger, Ludwig; Noegel, Angelika A.; Kolanus, Waldemar			A Cytohesin Homolog in Dictyostelium Amoebae	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CELL-ADHESION MOLECULE; ACTIN-BINDING; FACTOR ARNO; PROTEIN; ARF; DISCOIDEUM; FAMILY; SYSTEM; MORPHOGENESIS	Background: Dictyostelium, an amoeboid motile cell, harbors several paralogous Sec7 genes that encode members of three distinct subfamilies of the Sec7 superfamily of Guanine nucleotide exchange factors. Among them are proteins of the GBF/BIG family present in all eukaryotes. The third subfamily represented with three members in D. discoideum is the cytohesin family that has been thought to be metazoan specific. Cytohesins are characterized by a Sec7 PH tandem domain and have roles in cell adhesion and migration. Principal Findings: Dictyostelium SecG exhibits highest homologies to the cytohesins. It harbors at its amino terminus several ankyrin repeats that are followed by the Sec7 PH tandem domain. Mutants lacking SecG show reduced cell-substratum adhesion whereas cell-cell adhesion that is important for development is not affected. Accordingly, multicellular development proceeds normally in the mutant. During chemotaxis secG 2 cells elongate and migrate in a directed fashion towards cAMP, however speed is moderately reduced. Significance: The data indicate that SecG is a relevant factor for cell-substrate adhesion and reveal the basic function of a cytohesin in a lower eukaryote.	[Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Ctr Mol Med Cologne, Fac Med, Ctr Biochem, Cologne, Germany; [Shina, Maria Christina; Mueller, Rolf; Blau-Wasser, Rosemarie; Gloeckner, Gernot; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Gloeckner, Gernot] Fritz Lipmann Inst eV, Leibniz Inst Age Res, Jena, Germany; [Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Kolanus, Waldemar] Univ Bonn, LIMES Inst, Lab Mol Immunol, D-5300 Bonn, Germany	University of Cologne; University of Cologne; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munich; University of Munich; University of Bonn	Shina, MC (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Fac Med, Ctr Biochem, Cologne, Germany.	noegel@uni-koeln.de; wkolanus@uni-bonn.de	Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117				Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bloomfield G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r75; Bozzaro S, 1995, EXPERIENTIA, V51, P1175, DOI 10.1007/BF01944735; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Bukahrova T, 2005, J CELL SCI, V118, P4295, DOI 10.1242/jcs.02557; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; GERISCH G, 1981, J CELL SCI, V52, P1; Gillingham AK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000842; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Jeon TJ, 2009, DEV BIOL, V328, P210, DOI 10.1016/j.ydbio.2009.01.016; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Knuth M, 2004, J CELL SCI, V117, P5013, DOI 10.1242/jcs.01366; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kolanus W, 2007, IMMUNOL REV, V218, P102, DOI 10.1111/j.1600-065X.2007.00542.x; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; MULLER K, 1979, EUR J BIOCHEM, V99, P419, DOI 10.1111/j.1432-1033.1979.tb13271.x; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Parkinson K, 2009, J CELL SCI, V122, P335, DOI 10.1242/jcs.036822; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Quast T, 2009, BLOOD, V113, P5801, DOI 10.1182/blood-2008-08-176123; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schreiner T, 2002, EUKARYOT CELL, V1, P906, DOI 10.1128/EC.1.6.906-914.2002; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Thomason PA, 2006, PLASMID, V56, P145, DOI 10.1016/j.plasmid.2006.04.001; WEINER OH, 1993, J CELL BIOL, V123, P23, DOI 10.1083/jcb.123.1.23; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; WITKE W, 1992, CELL, V68, P53, DOI 10.1016/0092-8674(92)90205-Q; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wong E, 2002, DEVELOPMENT, V129, P3839; Wong EFS, 1996, J BIOL CHEM, V271, P16399, DOI 10.1074/jbc.271.27.16399	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9378	10.1371/journal.pone.0009378	http://dx.doi.org/10.1371/journal.pone.0009378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186335	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000019
J	Haubner, BJ; Neely, GG; Voelkl, JGJ; Damilano, F; Kuba, K; Imai, Y; Komnenovic, V; Mayr, A; Pachinger, O; Hirsch, E; Penninger, JM; Metzler, B				Haubner, Bernhard J.; Neely, G. Gregory; Voelkl, Jakob G. J.; Damilano, Federico; Kuba, Keiji; Imai, Yumiko; Komnenovic, Vukoslav; Mayr, Agnes; Pachinger, Otmar; Hirsch, Emilio; Penninger, Josef M.; Metzler, Bernhard			PI3K gamma Protects from Myocardial Ischemia and Reperfusion Injury through a Kinase-Independent Pathway	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; HEART-FAILURE; PRESSURE-OVERLOAD; INFARCTION; MICE; INFLAMMATION; INHIBITION; ACTIVATION; PI3K-DELTA; REGULATOR	Background: PI3K gamma functions in the immune compartment to promote inflammation in response to G-protein-coupled receptor (GPCR) agonists and PI3K gamma also acts within the heart itself both as a negative regulator of cardiac contractility and as a pro-survival factor. Thus, PI3K gamma has the potential to both promote and limit M I/R injury. Methodology/Principal Findings: Complete PI3K gamma(-/-) mutant mice, catalytically inactive PI3K gamma(KD/KD) (KD) knock-in mice, and control wild type (WT) mice were subjected to in vivo myocardial ischemia and reperfusion (M I/R) injury. Additionally, bone-marrow chimeric mice were constructed to elucidate the contribution of the inflammatory response to cardiac damage. PI3K gamma(-/-) mice exhibited a significantly increased infarction size following reperfusion. Mechanistically, PI3K gamma is required for activation of the Reperfusion Injury Salvage Kinase (RISK) pathway (AKT/ERK1/2) and regulates phospholamban phosphorylation in the acute injury response. Using bone marrow chimeras, the cardioprotective role of PI3K gamma was mapped to non-haematopoietic cells. Importantly, this massive increase in M I/R injury in PI3K gamma(-/-) mice was rescued in PI3K gamma kinase-dead (PI3K gamma(KD/KD)) knock-in mice. However, PI3K gamma(KD/KD) mice exhibited a cardiac injury similar to wild type animals, suggesting that specific blockade of PI3K gamma catalytic activity has no beneficial effects. Conclusions/Significance: Our data show that PI3K gamma is cardioprotective during M I/R injury independent of its catalytic kinase activity and that loss of PI3K gamma function in the hematopoietic compartment does not affect disease outcome. Thus, clinical development of specific PI3K gamma blockers should proceed with caution.	[Haubner, Bernhard J.; Voelkl, Jakob G. J.; Mayr, Agnes; Pachinger, Otmar; Metzler, Bernhard] Innsbruck Med Univ, Dept Internal Med Cardiol 3, Innsbruck, Austria; [Neely, G. Gregory; Kuba, Keiji; Imai, Yumiko; Komnenovic, Vukoslav; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Damilano, Federico; Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy	Medical University of Innsbruck; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Turin	Haubner, BJ (corresponding author), Innsbruck Med Univ, Dept Internal Med Cardiol 3, Innsbruck, Austria.	josef.penninger@oeaw.ac.at	Neely, Greg/AAB-4642-2020; Voelkl, Jakob/T-4298-2019; Imai, Yumiko/GXW-1144-2022; Hirsch, Emilio/F-4848-2013; neely, graham/A-6511-2011; Penninger, Josef M/I-6860-2013	Neely, Greg/0000-0002-1957-9732; Hirsch, Emilio/0000-0002-9073-6024; Penninger, Josef M/0000-0002-8194-3777; Metzler, Bernhard/0000-0002-5240-2453; , Agnes Mayr/0000-0001-9363-873X	EU; Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol	EU(European Commission); Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol	Supported by grants from IMBA and EuGeneHeart (EU grant) to J M.P. and from the Osterreichische Kardiologische Gesellschaft and Medizinischer Forschungsfond Tirol to B. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Ban K, 2008, CIRC RES, V103, P643, DOI 10.1161/CIRCRESAHA.108.175018; BRODDE OE, 1992, J HEART LUNG TRANSPL, V11, pS164; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cross HR, 2003, AM J PHYSIOL-HEART C, V284, pH683, DOI 10.1152/ajpheart.00567.2002; Curcio A, 2006, AM J PHYSIOL-HEART C, V291, pH1754, DOI 10.1152/ajpheart.01199.2005; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Doukas J, 2007, BIOCHEM SOC T, V35, P204, DOI 10.1042/BST0350204; FISHER TC, 1994, THROMB RES, V74, pS21, DOI 10.1016/S0049-3848(10)80004-0; GRISWOLD DE, 1988, J PHARMACOL METHOD, V20, P225, DOI 10.1016/0160-5402(88)90065-4; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kerfant BG, 2007, CIRC RES, V101, P400, DOI 10.1161/CIRCRESAHA.107.156422; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; Metzler B, 2001, CARDIOVASC RES, V49, P399, DOI 10.1016/S0008-6363(00)00261-3; MUSIOLIK J, 2009, CARDIOVASC RES; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Skyschally A, 2009, CIRC RES, V104, P15, DOI 10.1161/CIRCRESAHA.108.186429; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1	31	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9350	10.1371/journal.pone.0009350	http://dx.doi.org/10.1371/journal.pone.0009350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179753	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923900015
J	Azzari, C; Moriondo, M; Indolfi, G; Cortimiglia, M; Canessa, C; Becciolini, L; Lippi, F; de Martino, M; Resti, M				Azzari, Chiara; Moriondo, Maria; Indolfi, Giuseppe; Cortimiglia, Martina; Canessa, Clementina; Becciolini, Laura; Lippi, Francesca; de Martino, Maurizio; Resti, Massimo			Realtime PCR Is More Sensitive than Multiplex PCR for Diagnosis and Serotyping in Children with Culture Negative Pneumococcal Invasive Disease	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TIME PCR; CAPSULAR SEROTYPES; SURVEILLANCE; IDENTIFICATION; MENINGITIS; VACCINE; SAMPLES	Background: Pneumococcal serotyping is usually performed by Quellung reaction, considered the gold standard test. However the method cannot be used on culture-negative samples. Molecular methods can be a useful alternative. The aim of the study was to evaluate the use of Multiplex-sequential-PCR (MS-PCR) or Realtime-PCR on blood samples for diagnosis and serotyping of invasive pneumococcal disease (IPD) in a pediatric clinical setting. Methodology/Principal Findings: Sensitivity and specificity of MS-PCR and Realtime-PCR have been evaluated both on 46 well characterized pneumococcal isolates and on 67 clinical samples from children with culture-negative IPD. No difference in sensitivity and specificity between MS-PCR and Realtime PCR was found when the methods were used on isolates: both methods could type 100% isolates and the results were always consistent with culture-based methods. On the contrary, when used on clinical samples 43/67 (64.2%) were typeable by MS-PCR and 61/67 (91.0%) by Realtime-PCR (p = 0.0004, K Cohen 0.3, McNemar's p<0.001). Non-typeability by MS-PCR was associated in 18/20 cases (90.0%) with low bacterial load. The difference between the two methods was present both when they were used on normally sterile fluids (respectively 31/33 (93.9%) typeable samples for Realtime-PCR and 24/33 (72.7%) for MS-PCR, p = 0.047, 95% CL 0.03-0.98; K Cohen 0.3; McNemar's p = 0.0016) and when they were used on nasopharyngeal swabs (respectively 30/34 (88.2%) typeable samples for Realtime-PCR and 19/34 (55.9%) for MS-PCR, p = 0.007, 95% CL 0.04-0.66); the presence of multiple pneumococcal serotypes in nasopharyngeal swabs was found more frequently by Realtime PCR (19/30; 63.3%) than by Multiplex-sequential PCR (3/19; 15.8%; p = 0.003; 95% CL 1.87-39.97). Conclusions/Significance: In conclusion, both MS-PCR and Realtime PCR can be used for pneumococcal serotyping of most serotypes/serogroups directly on clinical samples from culture-negative patients but Realtime-PCR appears more sensitive.	[Azzari, Chiara] Anna Meyer Childrens Hosp, Dept Pediat, Florence, Italy; Univ Florence, Florence, Italy	University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Florence	Azzari, C (corresponding author), Anna Meyer Childrens Hosp, Dept Pediat, Florence, Italy.	c.azzari@meyer.it	Moriondo, Maria/AAB-7883-2019; Cortimiglia, Martina/AAA-2753-2019; Resti, Massimo/AAB-8756-2019; Azzari, Chiara/AAB-8584-2019; Indolfi, Giuseppe/AAK-5548-2020; Lippi, francesca/AAB-8952-2019	Moriondo, Maria/0000-0001-9653-8371; Resti, Massimo/0000-0001-6350-1361; Azzari, Chiara/0000-0001-7236-1655; Indolfi, Giuseppe/0000-0003-3830-9823; Lippi, francesca/0000-0003-2533-1802; Cortimiglia, Martina/0000-0002-3175-947X	Italian Department of Health; Italian Center for Disease Control and Prevention [117-19.01.07-6728]	Italian Department of Health; Italian Center for Disease Control and Prevention	The research has been partially supported by the Italian Department of Health; Italian Center for Disease Control and Prevention (grant 117-19.01.07-#6728 to C. A.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2001, MICROBIOL IMMUNOL, V45, P159, DOI 10.1111/j.1348-0421.2001.tb01284.x; Azzari C, 2008, J MED MICROBIOL, V57, P1205, DOI 10.1099/jmm.0.2008/000935-0; Azzari C, 2008, CLIN INFECT DIS, V47, P997, DOI 10.1086/591967; Bridy-Pappas AE, 2005, PHARMACOTHERAPY, V25, P1193, DOI 10.1592/phco.2005.25.9.1193; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; BUTLER JC, 1995, J INFECT DIS, V171, P885, DOI 10.1093/infdis/171.4.885; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Charalambous BM, 2008, J CLIN MICROBIOL, V46, P2467, DOI 10.1128/JCM.00838-08; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Dagan R, 1998, J CLIN MICROBIOL, V36, P669, DOI 10.1128/JCM.36.3.669-673.1998; FINLAND M, 1977, J CLIN MICROBIOL, V5, P154; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HEIDELBERGER M, 1983, INFECT IMMUN, V41, P1234, DOI 10.1128/IAI.41.3.1234-1244.1983; Henrichsen J, 1999, AM J MED, V107, P50, DOI 10.1016/S0002-9343(99)00100-X; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; ISAACMAN DJ, 2009, INT J INFECT DI 0821; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; KUMAR A, 1985, DIAGN MICR INFEC DIS, V3, P509, DOI 10.1016/S0732-8893(85)80007-9; Lalitha MK, 1999, J CLIN MICROBIOL, V37, P263, DOI 10.1128/JCM.37.1.263-265.1999; Lallemand F, 2000, J CLIN MICROBIOL, V38, P1404, DOI 10.1128/JCM.38.4.1404-1408.2000; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Martell M, 1999, J CLIN MICROBIOL, V37, P327, DOI 10.1128/JCM.37.2.327-332.1999; Murdoch DR, 2003, J CLIN MICROBIOL, V41, P63, DOI 10.1128/JCM.41.1.63-66.2003; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J CLIN MICROBIOL, V43, P4820, DOI 10.1128/JCM.43.9.4820-4822.2005; Pimenta FC, 2009, J CLIN MICROBIOL, V47, P2353, DOI 10.1128/JCM.00704-09; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Resti M, 2009, CLIN THER, V31, P1266, DOI 10.1016/j.clinthera.2009.06.010; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Tarallo L, 2006, VACCINE, V24, P6938, DOI 10.1016/j.vaccine.2006.05.012; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; Vestrheim DF, 2008, J CLIN MICROBIOL, V46, P2508, DOI 10.1128/JCM.02296-07; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93	39	94	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9282	10.1371/journal.pone.0009282	http://dx.doi.org/10.1371/journal.pone.0009282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174571	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923700003
J	Cao, PX; Yuan, YY; Pehek, EA; Moise, AR; Huang, Y; Palczewski, K; Feng, ZY				Cao, Pengxiu; Yuan, Yiyuan; Pehek, Elizabeth A.; Moise, Alex R.; Huang, Ying; Palczewski, Krzysztof; Feng, Zhaoyang			Alpha-Synuclein Disrupted Dopamine Homeostasis Leads to Dopaminergic Neuron Degeneration in Caenorhabditis elegans	PLOS ONE			English	Article							PARKINSONS-DISEASE; C-ELEGANS; DROSOPHILA MODEL; NEURITE OUTGROWTH; GENE; NEUROTOXICITY; PATHOGENESIS; MECHANISMS; STORAGE; PHOSPHORYLATION	Disruption of dopamine homeostasis may lead to dopaminergic neuron degeneration, a proposed explanation for the specific vulnerability of dopaminergic neurons in Parkinson's disease. While expression of human alpha-synuclein in C. elegans results in dopaminergic neuron degeneration, the effects of alpha-synuclein on dopamine homeostasis and its contribution to dopaminergic neuron degeneration in C. elegans have not been reported. Here, we examined the effects of alpha-synuclein overexpression on worm dopamine homeostasis. We found that alpha-synuclein expression results in upregulation of dopamine synthesis and content, and redistribution of dopaminergic synaptic vesicles, which significantly contribute to dopaminergic neuron degeneration. These results provide in vivo evidence supporting a critical role for dopamine homeostasis in supporting dopaminergic neuron integrity.	[Cao, Pengxiu; Yuan, Yiyuan; Moise, Alex R.; Huang, Ying; Palczewski, Krzysztof; Feng, Zhaoyang] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Pehek, Elizabeth A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Dept Vet Affairs, Cleveland, OH USA; [Feng, Zhaoyang] Xi An Jiao Tong Univ, Coll Med, Dept Physiol, Xian 710049, Shaanxi, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Xi'an Jiaotong University	Cao, PX (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.	john.feng@case.edu	Cao, Pengxiu/I-5378-2012; AR, Moise/P-2474-2019; Moise, Alexander R/C-9498-2009	AR, Moise/0000-0003-2307-6035; Moise, Alexander R/0000-0003-2307-6035; CAO, PENGXIU/0000-0002-5900-5645	Mt. Sinai Healthcare Foundation; Department of Veterans Affairs	Mt. Sinai Healthcare Foundation; Department of Veterans Affairs(US Department of Veterans Affairs)	This work is partially supported by Mt. Sinai Healthcare Scholarship from Mt. Sinai Healthcare Foundation (www.mtsinaifoundation.org/) to ZF and a MERIT Review grant of the Department of Veterans Affairs (www.research.va.gov/) to EAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Caudle WM, 2008, TRENDS NEUROSCI, V31, P303, DOI 10.1016/j.tins.2008.02.010; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; Duerr Janet S, 2006, WormBook, P1; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hobert O, 1999, DEVELOPMENT, V126, P1547; HSU AL, 2008, NEUROBIOL AGING; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; Kuwahara T, 2006, J BIOL CHEM, V281, P334, DOI 10.1074/jbc.M504860200; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lints R, 1999, DEVELOPMENT, V126, P5819; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park SS, 2007, EUR J NEUROSCI, V26, P3104, DOI 10.1111/j.1460-9568.2007.05929.x; Park SS, 2006, EUR J NEUROSCI, V23, P2908, DOI 10.1111/j.1460-9568.2006.04844.x; Pezzella A, 1997, J MED CHEM, V40, P2211, DOI 10.1021/jm970099t; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Spencer JPE, 1998, J NEUROCHEM, V71, P2112; Stiernagle Theresa, 2006, WormBook, P1; Sze JY, 2002, DEVELOPMENT, V129, P3901; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088	49	31	31	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9312	10.1371/journal.pone.0009312	http://dx.doi.org/10.1371/journal.pone.0009312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174477	Green Published, gold			2022-12-27	WOS:000274923700016
J	Crews, L; Spencer, B; Desplats, P; Patrick, C; Paulino, A; Rockenstein, E; Hansen, L; Adame, A; Galasko, D; Masliah, E				Crews, Leslie; Spencer, Brian; Desplats, Paula; Patrick, Christina; Paulino, Amy; Rockenstein, Edward; Hansen, Lawrence; Adame, Anthony; Galasko, Douglas; Masliah, Eliezer			Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of alpha-Synucleinopathy	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; AGGREGATE-PRONE PROTEINS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE; FRONTOTEMPORAL DEMENTIA; NEURONAL EXPRESSION; GAUCHER-DISEASE	Background: Lewy body disease is a heterogeneous group of neurodegenerative disorders characterized by alpha-synuclein accumulation that includes dementia with Lewy bodies (DLB) and Parkinson's Disease (PD). Recent evidence suggests that impairment of lysosomal pathways (i.e. autophagy) involved in alpha-synuclein clearance might play an important role. For this reason, we sought to examine the expression levels of members of the autophagy pathway in brains of patients with DLB and Alzheimer's Disease (AD) and in alpha-synuclein transgenic mice. Methodology/Principal Findings: By immunoblot analysis, compared to controls and AD, in DLB cases levels of mTor were elevated and Atg7 were reduced. Levels of other components of the autophagy pathway such as Atg5, Atg10, Atg12 and Beclin-1 were not different in DLB compared to controls. In DLB brains, mTor was more abundant in neurons displaying alpha-synuclein accumulation. These neurons also showed abnormal expression of lysosomal markers such as LC3, and ultrastructural analysis revealed the presence of abundant and abnormal autophagosomes. Similar alterations were observed in the brains of alpha-synuclein transgenic mice. Intra-cerebral infusion of rapamycin, an inhibitor of mTor, or injection of a lentiviral vector expressing Atg7 resulted in reduced accumulation of alpha-synuclein in transgenic mice and amelioration of associated neurodegenerative alterations. Conclusions/Significance: This study supports the notion that defects in the autophagy pathway and more specifically in mTor and Atg7 are associated with neurodegeneration in DLB cases and alpha-synuclein transgenic models and supports the possibility that modulators of the autophagy pathway might have potential therapeutic effects.	[Crews, Leslie; Hansen, Lawrence; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Spencer, Brian; Desplats, Paula; Patrick, Christina; Paulino, Amy; Rockenstein, Edward; Hansen, Lawrence; Adame, Anthony; Galasko, Douglas; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Crews, L (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	emasliah@UCSD.edu	Crews, Leslie/B-7584-2014; Desplats, Paula/AFW-5030-2022	Crews, Leslie/0000-0003-0704-0067; Desplats, Paula/0000-0002-4758-4280	NIH [AG18440, AG5131]; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, R37AG018440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG18440 and AG5131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Braak H, 2000, J NEUROL, V247, P3; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; HANSEN L, 1998, JNEUROLNEUROSURGPSYC; HANSEN L, 1997, J NEURAL TRANSM, V51, P111; HANSEN LA, 1991, NEUROSCI LETT, V129, P269, DOI 10.1016/0304-3940(91)90478-C; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 2003, J NEUROCHEM, V85, P1468, DOI 10.1046/j.1471-4159.2003.01791.x; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Janvin CC, 2006, MOVEMENT DISORD, V21, P337, DOI 10.1002/mds.20726; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jellinger KA, 2006, ACTA NEUROPATHOL, V112, P253, DOI 10.1007/s00401-006-0088-2; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P969, DOI 10.1001/archneur.55.7.969; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marr RA, 2003, J NEUROSCI, V23, P1992; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2003, NEUROLOGY, V61, P206, DOI 10.1212/01.WNL.0000073987.79060.4B; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; Nakajima T, 2005, BRAIN RES, V1040, P73, DOI 10.1016/j.brainres.2005.01.099; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P323, DOI 10.1093/jnen/63.4.323; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; van Kats JP, 2001, J HYPERTENS, V19, P583, DOI 10.1097/00004872-200103001-00010; Varkonyi J, 2003, AM J MED GENET A, V116A, P348, DOI 10.1002/ajmg.a.10028; Veinbergs I, 2001, EXP NEUROL, V170, P15, DOI 10.1006/exnr.2001.7684; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	89	267	280	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9313	10.1371/journal.pone.0009313	http://dx.doi.org/10.1371/journal.pone.0009313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174468	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700017
J	Calmettes, G; Deschodt-Arsac, V; Gouspillou, G; Miraux, S; Muller, B; Franconi, JM; Thiaudiere, E; Diolez, P				Calmettes, Guillaume; Deschodt-Arsac, Veronique; Gouspillou, Gilles; Miraux, Sylvain; Muller, Bernard; Franconi, Jean-Michel; Thiaudiere, Eric; Diolez, Philippe			Improved Energy Supply Regulation in Chronic Hypoxic Mouse Counteracts Hypoxia-Induced Altered Cardiac Energetics	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; METABOLIC-CONTROL ANALYSIS; MODULAR CONTROL ANALYSIS; FAILING HEART; TIME-COURSE; RAT-HEART; ADAPTATION; ATP; PERFORMANCE; MYOCARDIUM	Background: Hypoxic states of the cardiovacular system are undoubtedly associated with the most frequent diseases of modern time. Therefore, understanding hypoxic resistance encountered after physiological adaptation such as chronic hypoxia, is crucial to better deal with hypoxic insult. In this study, we examine the role of energetic modifications induced by chronic hypoxia (CH) in the higher tolerance to oxygen deprivation. Methodology/Principal Findings: Swiss mice were exposed to a simulated altitude of 5500 m in a barochamber for 21 days. Isolated perfused hearts were used to study the effects of a decreased oxygen concentration in the perfusate on contractile performance (RPP) and phosphocreatine (PCr) concentration (assessed by P-31-NMR), and to describe the integrated changes in cardiac energetics regulation by using Modular Control Analysis (MoCA). Oxygen reduction induced a concomitant decrease in RPP (-46%) and in [PCr] (-23%) in Control hearts while CH hearts energetics was unchanged. MoCA demonstrated that this adaptation to hypoxia is the direct consequence of the higher responsiveness (elasticity) of ATP production of CH hearts compared with Controls (-1.88 +/- 0.38 vs -0.89 +/- 0.41, p < 0.01) measured under low oxygen perfusion. This higher elasticity induces an improved response of energy supply to cellular energy demand. The result is the conservation of a healthy control pattern of contraction in CH hearts, whereas Control hearts are severely controlled by energy supply. C Conclusions/Significance: As suggested by the present study, the mechanisms responsible for this increase in elasticity and the consequent improved ability of CH heart metabolism to respond to oxygen deprivation could participate to limit the damages induced by hypoxia.	[Calmettes, Guillaume; Deschodt-Arsac, Veronique; Gouspillou, Gilles; Miraux, Sylvain; Franconi, Jean-Michel; Thiaudiere, Eric; Diolez, Philippe] Univ Bordeaux 2, CNRS, UMR 5536, Lab Resonance Magnet Syst Biol, F-33076 Bordeaux, France; [Muller, Bernard] Univ Bordeaux 2, INSERM, U885, Pharmacol Lab, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Calmettes, G (corresponding author), Univ Bordeaux 2, CNRS, UMR 5536, Lab Resonance Magnet Syst Biol, F-33076 Bordeaux, France.	guillaume.calmettes@rmsb.u-bordeaux2.fr; philippe.diolez@rmsb.u-bordeaux2.fr	Miraux, Sylvain/AAF-1023-2019; Calmettes, Guillaume/A-6916-2010	Gouspillou, Gilles/0000-0002-8543-3619; Diolez, Philippe/0000-0002-7548-2070; Miraux, Sylvain/0000-0002-3642-2390; Thiaudiere, Eric/0000-0002-9993-4035; Deschodt-Arsac, Veronique/0000-0002-9244-9862	"Centre National de la Recherche Scientifique, France''; "Region Aquitaine, France''; "Universite Bordeaux 2''	"Centre National de la Recherche Scientifique, France''(Centre National de la Recherche Scientifique (CNRS)); "Region Aquitaine, France''(Region Nouvelle-Aquitaine); "Universite Bordeaux 2''	This work was supported by the "Centre National de la Recherche Scientifique, France'', the "Region Aquitaine, France'', and the "Universite Bordeaux 2''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsac LM, 2008, BIOCHEM J, V414, P391, DOI 10.1042/BJ20080280; Asemu G, 2000, PHYSIOL RES, V49, P597; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; BEUSTE C, 2009, BIOCHEM J; BITTL JA, 1987, CIRC RES, V60, P871, DOI 10.1161/01.RES.60.6.871; Brand MD, 1997, J EXP BIOL, V200, P193; Calmettes G, 2008, AM J PHYSIOL-REG I, V295, pR1891, DOI 10.1152/ajpregu.90548.2008; Corbucci G G, 2005, Minerva Anestesiol, V71, P727; Diolez P, 2007, AM J PHYSIOL-REG I, V293, pR13, DOI 10.1152/ajpregu.00189.2006; Dos Santos P, 2000, J MOL CELL CARDIOL, V32, P1703, DOI 10.1006/jmcc.2000.1207; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Gibbs JSR, 2007, ADV EXP MED BIOL, V618, P13; Ingwall JS, 2006, CURR HYPERTENS REP, V8, P457, DOI 10.1007/s11906-006-0023-x; Itoh A, 2009, ACTA MED OKAYAMA, V63, P87; Kolar F, 2004, PHYSIOL RES, V53, pS3; Korzeniewski B, 2008, BIOCHEM J, V413, P343, DOI 10.1042/BJ20080162; McFalls EO, 2006, J MOL CELL CARDIOL, V41, P980, DOI 10.1016/j.yjmcc.2006.07.008; MEERSON FZ, 1973, AM J CARDIOL, V31, P30, DOI 10.1016/0002-9149(73)90806-0; Merati G, 1996, AM J PHYSIOL-HEART C, V271, pH2300, DOI 10.1152/ajpheart.1996.271.6.H2300; Miraux S, 2009, MAGN RESON MED, V62, P1099, DOI 10.1002/mrm.22139; Morris-Thurgood J A, 2000, Heart Fail Rev, V5, P307, DOI 10.1023/A:1026555012135; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Neckar J, 2002, CARDIOVASC RES, V55, P567, DOI 10.1016/S0008-6363(02)00456-X; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Pei JM, 2003, AM J PHYSIOL-CELL PH, V285, pC1420, DOI 10.1152/ajpcell.00534.2002; POIZAT C, 1994, BASIC RES CARDIOL, V89, P535, DOI 10.1007/BF00794953; Reboul C, 2005, J APPL PHYSIOL, V98, P83, DOI 10.1152/japplphysiol.00214.2004; Rossi A, 1996, CARDIOVASC RES, V31, P163, DOI 10.1016/S0008-6363(95)00183-2; SAMAJA M, 1994, J APPL PHYSIOL, V77, P2530, DOI 10.1152/jappl.1994.77.6.2530; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; TAJIMA M, 1994, CARDIOVASC RES, V28, P312, DOI 10.1093/cvr/28.3.312; Vogt AM, 2002, J BIOL CHEM, V277, P24411, DOI 10.1074/jbc.M201138200; Weiss JN, 2006, J LIPID RES, V47, P2355, DOI 10.1194/jlr.R600023-JLR200; Weiss JN, 2003, FASEB J, V17, P1, DOI 10.1096/fj.02-0408rev	38	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9306	10.1371/journal.pone.0009306	http://dx.doi.org/10.1371/journal.pone.0009306			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174637	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700027
J	Krishnamoorthy, J; Yu, VCK; Mok, YK				Krishnamoorthy, Janarthanan; Yu, Victor C. K.; Mok, Yu-Keung			Auto-FACE: An NMR Based Binding Site Mapping Program for Fast Chemical Exchange Protein-Ligand Systems	PLOS ONE			English	Article							NUCLEAR MAGNETIC RESONANCE; AQUEOUS-SOLUTION; THERMODYNAMICAL ANALYSIS; SHIFT PERTURBATIONS; COMPLETE RELAXATION; GENETIC ALGORITHM; ESCHERICHIA-COLI; DRUG DISCOVERY; AB-INITIO; DYNAMICS	Background: Nuclear Magnetic Resonance (NMR) spectroscopy offers a variety of experiments to study protein-ligand interactions at atomic resolution. Among these experiments, N-15 Heteronuclear Single Quantum Correlation (HSQC) experiment is simple, less time consuming and highly informative in mapping the binding site of the ligand. The interpretation of N-15 HSQC becomes ambiguous when the chemical shift perturbations are caused by non-specific interactions like allosteric changes and local structural rearrangement. Under such cases, detailed chemical exchange analysis based on chemical shift perturbation will assist in locating the binding site accurately. Methodology/Principal Findings: We have automated the mapping of binding sites for fast chemical exchange systems using information obtained from N-15 HSQC spectra of protein serially titrated with ligand of increasing concentrations. The automated program Auto-FACE (Auto-FAst Chemical Exchange analyzer) determines the parameters, e. g. rate of change of perturbation, binding equilibrium constant and magnitude of chemical shift perturbation to map the binding site residues. Interestingly, the rate of change of perturbation at lower ligand concentration is highly sensitive in differentiating the binding site residues from the non-binding site residues. To validate this program, the interaction between the protein hBcl(XL) and the ligand BH3I-1 was studied. Residues in the hydrophobic BH3 binding groove of hBcl(XL) were easily identified to be crucial for interaction with BH3I-1 from other residues that also exhibited perturbation. The geometrically averaged equilibrium constant (3.0 x 10(4)) calculated for the residues present at the identified binding site is consistent with the values obtained by other techniques like isothermal calorimetry and fluorescence polarization assays (12:8 x 10(4)). Adjacent to the primary site, an additional binding site was identified which had an affinity of 3.8 times weaker than the former one. Further NMR based model fitting for individual residues suggest single site model for residues present at these binding sites and two site model for residues present between these sites. This implies that chemical shift perturbation can represent the local binding event much more accurately than the global binding event. Conclusion/Significance: Detail NMR chemical shift perturbation analysis enabled binding site residues to be distinguished from non-binding site residues for accurate mapping of interaction site in complex fast exchange system between small molecule and protein. The methodology is automated and implemented in a program called "Auto-FACE'',which also allowed quantitative information of each interaction site and elucidation of binding mechanism.	[Krishnamoorthy, Janarthanan; Mok, Yu-Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yu, Victor C. K.] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Krishnamoorthy, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsmokh@nus.edu.sg	Yu, Victor/A-7899-2015; Mok, Yu Keung/H-8019-2012	Yu, Victor/0000-0003-3270-4734; Mok, Yu Keung/0000-0002-2829-4878; Krishnamoorthy, Janarthanan/0000-0002-9931-8187	A*Star Biomedical Research Council of Singapore [04/1/21/19/320]	A*Star Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the A*Star Biomedical Research Council of Singapore, 04/1/21/19/320, to Y.K.M and V.C.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Bain AD, 1996, CAN J CHEM, V74, P819, DOI 10.1139/v96-090; Bain AD, 2003, PROG NUCL MAG RES SP, V43, P63, DOI 10.1016/j.pnmrs.2003.08.001; Bain AD, 1998, BIOCHEM CELL BIOL, V76, P171, DOI 10.1139/bcb-76-2-3-171; BAIN AD, 2002, MEXICO 3 1 MCMASTER; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Berghella AM, 1998, CANCER BIOTHER RADIO, V13, P225, DOI 10.1089/cbr.1998.13.225; BINSCH G, 1969, J AM CHEM SOC, V91, P1304, DOI 10.1021/ja01034a007; BOWDEN AEC, 1977, J BIOCH, V165, P55; Carlomagno T, 2005, ANNU REV BIOPH BIOM, V34, P245, DOI 10.1146/annurev.biophys.34.040204.144419; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DALLAKYAN S, MGLTOOLS 1 5 2; Davies DB, 2000, J BIOMOL STRUCT DYN, V17, P887, DOI 10.1080/07391102.2000.10506577; Davies DB, 1996, J CHEM SOC FARADAY T, V92, P3545, DOI 10.1039/ft9969203545; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FERRIN T, CHIMERA 1 3 2577; Goddard P. E., 1903, U CALIFORNIA PUBLICA, V1, P1; Gorecki A, 2009, INT J BIOL MACROMOL, V44, P262, DOI 10.1016/j.ijbiomac.2008.12.015; GUTOWSKY HS, 1956, J CHEM PHYS, V25, P1228, DOI 10.1063/1.1743184; Harding S. E., 2001, PROTEIN LIGAND INTER; Huang C Y, 1979, Methods Enzymol, V63, P54; Huang ZW, 2000, ONCOGENE, V19, P6627, DOI 10.1038/sj.onc.1204087; Jayalakshmi V, 2004, J MAGN RESON, V168, P36, DOI 10.1016/j.jmr.2004.01.017; Jayalakshmi V, 2002, J MAGN RESON, V155, P106, DOI 10.1006/jmre.2001.2499; JOHNSON CS, 1965, ADV MAGN RESON, V1, P33; Keeler J., 2010, UNDERSTANDING NMR SP, V2; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Kovrigin EL, 2006, J MAGN RESON, V180, P93, DOI 10.1016/j.jmr.2006.01.010; Kovrigin EL, 2006, J AM CHEM SOC, V128, P7724, DOI 10.1021/ja061435a; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Le HB, 1996, J PHYS CHEM-US, V100, P16423, DOI 10.1021/jp9606164; Lugovskoy AA, 2002, J AM CHEM SOC, V124, P1234, DOI 10.1021/ja011239y; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; McCoy MA, 2002, J AM CHEM SOC, V124, P11758, DOI 10.1021/ja026166c; McCoy MA, 2002, J AM CHEM SOC, V124, P2104, DOI 10.1021/ja017242z; MERRITT E, GNUPLOT 4 2 4; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Moseley HNB, 1997, BIOCHEMISTRY-US, V36, P5293, DOI 10.1021/bi970242k; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; OSAPAY K, 1991, J AM CHEM SOC, V113, P9436, DOI 10.1021/ja00025a002; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Roberts GCK, 2000, DRUG DISCOV TODAY, V5, P230, DOI 10.1016/S1359-6446(00)01479-3; Segel H, 1975, ENZYME KINETICS; Sharma Y, 2002, J AM CHEM SOC, V124, P327, DOI 10.1021/ja016859d; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; TJELVAR SG, 2008, J MOL BIOL, V384, P1002; van Dongen M, 2002, DRUG DISCOV TODAY, V7, P471, DOI 10.1016/S1359-6446(02)02233-X; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; Veselkov AN, 2004, J MOL STRUCT, V701, P31, DOI 10.1016/j.molstruc.2004.05.014; Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023; NMRPIPE 9	53	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e8943	10.1371/journal.pone.0008943	http://dx.doi.org/10.1371/journal.pone.0008943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174626	gold, Green Submitted, Green Published			2022-12-27	WOS:000274654700002
J	Latawiec, D; Herrera, F; Bek, A; Losasso, V; Candotti, M; Benetti, F; Carlino, E; Kranjc, A; Lazzarino, M; Gustincich, S; Carloni, P; Legname, G				Latawiec, Diane; Herrera, Fernando; Bek, Alpan; Losasso, Valeria; Candotti, Michela; Benetti, Federico; Carlino, Elvio; Kranjc, Agata; Lazzarino, Marco; Gustincich, Stefano; Carloni, Paolo; Legname, Giuseppe			Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs	PLOS ONE			English	Article							PARKINSONS-DISEASE; MOLECULAR-DYNAMICS; LEWY BODIES; INHIBITION; BINDING; FIBRILLIZATION; PATHOGENESIS; FIBRILLATION; OLIGOMERIZATION; CATECHOLS	The action of dopamine on the aggregation of the unstructured alpha-synuclein (alpha-syn) protein may be linked to the pathogenesis of Parkinson's disease. Dopamine and its oxidation derivatives may inhibit alpha-syn aggregation by non-covalent binding. Exploiting this fact, we applied an integrated computational and experimental approach to find alternative ligands that might modulate the fibrillization of alpha-syn. Ligands structurally and electrostatically similar to dopamine were screened from an established library. Five analogs were selected for in vitro experimentation from the similarity ranked list of analogs. Molecular dynamics simulations showed they were, like dopamine, binding non-covalently to alpha-syn and, although much weaker than dopamine, they shared some of its binding properties. In vitro fibrillization assays were performed on these five dopamine analogs. Consistent with our predictions, analyses by atomic force and transmission electron microscopy revealed that all of the selected ligands affected the aggregation process, albeit to a varying and lesser extent than dopamine, used as the control ligand. The in silico/in vitro approach presented here emerges as a possible strategy for identifying ligands interfering with such a complex process as the fibrillization of an unstructured protein.	[Latawiec, Diane; Benetti, Federico; Gustincich, Stefano; Legname, Giuseppe] Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Neurobiol, Trieste, Italy; [Herrera, Fernando; Losasso, Valeria; Candotti, Michela; Kranjc, Agata; Carloni, Paolo] Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Stat & Biol Phys, Trieste, Italy; [Latawiec, Diane; Herrera, Fernando; Candotti, Michela; Benetti, Federico; Kranjc, Agata; Gustincich, Stefano; Carloni, Paolo; Legname, Giuseppe] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Bek, Alpan; Lazzarino, Marco] Ctr Mol Biomed CBM Scrl, Consorzio Ctr Biomed Mol, Trieste, Italy; [Carlino, Elvio; Lazzarino, Marco] TASC INFM Natl Lab, Trieste, Italy; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; Elettra Sincrotrone Trieste	Latawiec, D (corresponding author), Scuola Int Super Studi Avanzati, Scuola Int Super Studi Avanzati, Dept Neurobiol, Trieste, Italy.	carloni@sissa.it; legname@sissa.it	Carlino, Elvio/C-3607-2015; Legname, Giuseppe/C-1723-2012; Bek, Alpan/A-4847-2010; Lazzarino, Marco/AAC-3446-2022; Carloni, Paolo/H-8736-2013	Carlino, Elvio/0000-0003-0285-7297; Legname, Giuseppe/0000-0003-0716-4393; Bek, Alpan/0000-0002-0190-7945; Lazzarino, Marco/0000-0003-1077-6569; Herrera, Fernando E./0000-0002-8595-3382; Benetti, Federico/0000-0001-6491-4715; Gustincich, Stefano/0000-0002-2749-2514	Italian Institute of Technology; FP6; Bio-Nano European Infrastructure (BINASP) [SSA 011936]	Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); FP6(European Commission); Bio-Nano European Infrastructure (BINASP)	This work was supported by grants from the Italian Institute of Technology to PC and GL and by FP6, Bio-Nano European Infrastructure (BINASP) - SSA 011936 grant to AB and ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; Goedert M, 2001, CLIN CHEM LAB MED, V39, P308, DOI 10.1515/CCLM.2001.047; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lewy F., 1912, HDB NEUROLOGIE; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muchmore SW, 2006, CHEM BIOL DRUG DES, V67, P174, DOI 10.1111/j.1747-0285.2006.00341.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stratmann R.E., 2001, GAUSSIAN 98 REVISION; Tanimoto T.T., 1957, NOV, V17, P1957; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; von Grotthuss M, 2004, COMB CHEM HIGH T SCR, V7, P757; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wright JA, 2008, J NEUROSCI RES, V86, P496, DOI 10.1002/jnr.21461; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	47	36	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9234	10.1371/journal.pone.0009234	http://dx.doi.org/10.1371/journal.pone.0009234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169066	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500016
J	Ghosh, HS; McBurney, M; Robbins, PD				Ghosh, Hiyaa Singhee; McBurney, Michael; Robbins, Paul D.			SIRT1 Negatively Regulates the Mammalian Target of Rapamycin	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DOWN-REGULATION; CELL-GROWTH; MTOR; TOXICITY; DISEASE; MICE; NAD	The IGF/mTOR pathway, which is modulated by nutrients, growth factors, energy status and cellular stress regulates aging in various organisms. SIRT1 is a NAD+ dependent deacetylase that is known to regulate caloric restriction mediated longevity in model organisms, and has also been linked to the insulin/IGF signaling pathway. Here we investigated the potential regulation of mTOR signaling by SIRT1 in response to nutrients and cellular stress. We demonstrate that SIRT1 deficiency results in elevated mTOR signaling, which is not abolished by stress conditions. The SIRT1 activator resveratrol reduces, whereas SIRT1 inhibitor nicotinamide enhances mTOR activity in a SIRT1 dependent manner. Furthermore, we demonstrate that SIRT1 interacts with TSC2, a component of the mTOR inhibitory-complex upstream to mTORC1, and regulates mTOR signaling in a TSC2 dependent manner. These results demonstrate that SIRT1 negatively regulates mTOR signaling potentially through the TSC1/2 complex.	[Ghosh, Hiyaa Singhee; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [McBurney, Michael] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Med & Biochem, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Microbiol, Ottawa, ON, Canada; [McBurney, Michael] Univ Ottawa, Dept Immunol, Ottawa, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Ghosh, HS (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	probb@pitt.edu			Department of Defense (DOD) [17-03-1-0488, 17-03-0412]	Department of Defense (DOD)(United States Department of Defense)	Funding: This work was supported in part by Department of Defense (DOD) grants 17-03-1-0488 and 17-03-0412 to P. D. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Bedalov A, 2004, SCIENCE, V305, P954, DOI 10.1126/science.1102497; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Demidenko ZN, 2009, CELL CYCLE, V8, P1901, DOI 10.4161/cc.8.12.8810; GHOSH HS, 2007, BIOCH J; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; LEE IH, 2008, P NATL ACAD SCI US; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Narala SR, 2008, MOL BIOL CELL; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; 2009, AGING, V1, P511	43	276	290	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9199	10.1371/journal.pone.0009199	http://dx.doi.org/10.1371/journal.pone.0009199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169165	Green Published, Green Accepted, gold			2022-12-27	WOS:000274474700003
J	Joubert, BR; Franceschini, N; Mwapasa, V; North, KE; Meshnick, SR				Joubert, Bonnie R.; Franceschini, Nora; Mwapasa, Victor; North, Kari E.; Meshnick, Steven R.			Regulation of CCR5 Expression in Human Placenta: Insights from a Study of Mother-to-Child Transmission of HIV in Malawi	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR 5; CELL-SURFACE; HEPARAN-SULFATE; PROMOTER POLYMORPHISM; DISEASE PROGRESSION; ENDOTHELIAL-CELLS; GENE; PROTEOGLYCANS; INFECTION	Background: Human promoter polymorphisms in the chemokine co-receptor 5 gene (CCR5) have been noted for association with mother-to-child transmission of HIV (HIV MTCT) as well as reduced receptor expression in vitro, but have not been clearly associated with CCR5 expression in vivo. Placental expression of CCR5 may be influenced by such polymorphisms as well as other in vivo regulatory factors. Methodology/Principal Findings: We evaluated the associations between infant CCR5 polymorphisms, measures of maternal infection, and placental expression of CCR5 among mother-infant pairs in Blantyre, Malawi. RNA was extracted from placental tissue and used in multiplex real-time PCR to quantify gene expression. Through linear regression, we observed that CCR5-2554T (beta = -0.67, 95% CI = -1.23, -0.11) and -2132T (beta = -0.75, 95% CI = -0.131, -0.18) were significantly associated with reduced placental expression of CCR5. An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18). Among HIV infected mothers, an incremental increase in maternal HIV viral load was also associated with higher CCR5 expression (beta = 0.76, 95% CI = 0.12, 1.39). Maternal HIV status had no overall effect (beta = 0.072, 95% CI = -0.57, -0.72). Higher CCR5 expression was observed for mothers with malaria but was not statistically significant (beta = 0.37, 95% CI = -0.43, 1.18). Conclusions/Significance: These results provide in vivo evidence for genetic and environmental factors involved in the regulation of CCR5 expression in the placenta. Our findings also suggest that the measurement of placental expression of CCR5 alone is not an adequate indicator of the risk of mother-to-child transmission of HIV.	[Joubert, Bonnie R.; Franceschini, Nora; North, Kari E.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Mwapasa, Victor] Univ Malawi, Coll Med, Blantyre, Malawi; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill	Joubert, BR (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	joubert.bonnie@epa.gov		Joubert, Bonnie/0000-0001-7952-1180; Mwapasa, Victor/0000-0002-2748-8902	Centers for Disease Control and Prevention Dissertation [PAR 07-231]; NIH [T32 AI007419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007419] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention Dissertation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This research was supported by the Centers for Disease Control and Prevention Dissertation Award (PAR 07-231, 2008) and the NIH Virology Training Grant (T32 AI007419, 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REP GLOB AIDS EP 200; Argyris EG, 2003, J VIROL, V77, P12140, DOI 10.1128/JVI.77.22.12140-12151.2003; Behbahani H, 2000, AM J PATHOL, V157, P1811, DOI 10.1016/S0002-9440(10)64819-5; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; BRUSE S, 2006, MULTIPLEX LIGASE DET; Burns JC, 2005, J INFECT DIS, V192, P344, DOI 10.1086/430953; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Clegg AO, 2000, AIDS, V14, P103, DOI 10.1097/00002030-200001280-00004; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fernandez Elias J., 2001, Antiviral Chemistry and Chemotherapy, V12, P43; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; Gatignol A, 2000, Adv Pharmacol, V48, P209; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Knudsen TB, 2001, J MED VIROL, V65, P441, DOI 10.1002/jmv.2054.abs; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; MAIONE TE, 1991, CANCER RES, V51, P2077; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mondor I, 1998, J VIROL, V72, P3623, DOI 10.1128/JVI.72.5.3623-3634.1998; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838; RAZI N, 1995, J BIOL CHEM, V270, P11267, DOI 10.1074/jbc.270.19.11267; Rothman K., 1998, MODERN EPIDEMIOLOGY; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Samson M, 1996, BIOCHEMISTRY-US, V35, P3362, DOI 10.1021/bi952950g; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Slimani H, 2003, GLYCOBIOLOGY, V13, P623, DOI 10.1093/glycob/cwg083; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Ugolini S, 1999, TRENDS MICROBIOL, V7, P144, DOI 10.1016/S0966-842X(99)01474-2; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	46	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9212	10.1371/journal.pone.0009212	http://dx.doi.org/10.1371/journal.pone.0009212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169157	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474700009
J	Sheldon, IM; Rycroft, AN; Dogan, B; Craven, M; Bromfield, JJ; Chandler, A; Roberts, MH; Price, SB; Gilbert, RO; Simpson, KW				Sheldon, I. Martin; Rycroft, Andrew N.; Dogan, Belgin; Craven, Melanie; Bromfield, John J.; Chandler, Alyssa; Roberts, Mark H.; Price, Sian B.; Gilbert, Robert O.; Simpson, Kenneth W.			Specific Strains of Escherichia coli Are Pathogenic for the Endometrium of Cattle and Cause Pelvic Inflammatory Disease in Cattle and Mice	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; URINARY-TRACT; BACTERIAL-CONTAMINATION; GENOTYPIC DIVERSITY; VIRULENCE FACTORS; CROHNS-DISEASE; STROMAL CELLS; DAIRY-COWS; INNATE	Background: Escherichia coli are widespread in the environment and pathogenic strains cause diseases of mucosal surfaces including the female genital tract. Pelvic inflammatory disease (PID; metritis) or endometritis affects similar to 40% of cattle after parturition. We tested the expectation that multiple genetically diverse E. coli from the environment opportunistically contaminate the uterine lumen after parturition to establish PID. Methodology/Principal Findings: Distinct clonal groups of E. coli were identified by Random Amplification of Polymorphic DNA (RAPD) and Multilocus sequence typing (MLST) from animals with uterine disease and these differed from known diarrhoeic or extra-intestinal pathogenic E. coli. The endometrial pathogenic E. coli (EnPEC) were more adherent and invasive for endometrial epithelial and stromal cells, compared with E. coli isolated from the uterus of clinically unaffected animals. The endometrial epithelial and stromal cells produced more prostaglandin E-2 and interleukin-8 in response to lipopolysaccharide (LPS) purified from EnPEC compared with non-pathogenic E. coli. The EnPEC or their LPS also caused PID when infused into the uterus of mice with accumulation of neutrophils and macrophages in the endometrium. Infusion of EnPEC was only associated with bacterial invasion of the endometrium and myometrium. Despite their ability to invade cultured cells, elicit host cell responses and establish PID, EnPEC lacked sixteen genes commonly associated with adhesion and invasion by enteric or extraintestinal pathogenic E. coli, though the ferric yersiniabactin uptake gene (fyuA) was present in PID-associated EnPEC. Endometrial epithelial or stromal cells from wild type but not Toll-like receptor 4 (TLR4) null mice secreted prostaglandin E-2 and chemokine (C-X-C motif) ligand 1 (CXCL1) in response to LPS from EnPEC, highlighting the key role of LPS in PID. Conclusions/Significance: The implication arising from the discovery of EnPEC is that development of treatments or vaccines for PID should focus specifically on EnPEC and not other strains of E. coli.	[Sheldon, I. Martin; Bromfield, John J.; Roberts, Mark H.] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales; [Rycroft, Andrew N.; Price, Sian B.] Univ London Royal Vet Coll, Hatfield, Herts, England; [Dogan, Belgin; Craven, Melanie; Chandler, Alyssa; Gilbert, Robert O.; Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Swansea University; University of London; University of London Royal Veterinary College; Cornell University	Sheldon, IM (corresponding author), Swansea Univ, Sch Med, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	I.M.Sheldon@swansea.ac.uk	Bromfield, John/A-8830-2014; Sheldon, I Martin/E-1567-2013; Gilbert, Robert/J-9107-2012	Bromfield, John/0000-0001-5438-2137; Sheldon, I Martin/0000-0001-7902-5558; Gilbert, Robert/0000-0002-1528-243X	Biotechnology and Biological Sciences Research Council Research Development Fellowship [BB/D02028X/1]; Biotechnology and Biological Sciences Research Council [S19795, BB/D02028X/1, BB/D02028X/2] Funding Source: researchfish; BBSRC [BB/D02028X/1, BB/D02028X/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council Research Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/)Research Development Fellowship (BB/D02028X/1 to I. M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe CM, 2008, FEMS IMMUNOL MED MIC, V52, P397, DOI 10.1111/j.1574-695X.2008.00388.x; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrow GI, 1993, COWAN STEEL IS MANUA, V3rd; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Bettelheim KA, 2005, J APPL MICROBIOL, V98, P699, DOI 10.1111/j.1365-2672.2004.02501.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Deb Kaushik, 2005, Infect Dis Obstet Gynecol, V13, P125, DOI 10.1080/10647440500147885; Deb Kaushik, 2004, Archives of Gynecology and Obstetrics, V270, P133, DOI 10.1007/s00404-004-0623-0; DebRoy Chitrita, 2001, Animal Health Research Reviews, V2, P129; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dohmen MJW, 2000, THERIOGENOLOGY, V54, P1019, DOI 10.1016/S0093-691X(00)00410-6; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; FORTIER MA, 1988, J REPROD FERTIL, V83, P239, DOI 10.1530/jrf.0.0830239; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Houser BA, 2008, FOODBORNE PATHOG DIS, V5, P41, DOI 10.1089/fpd.2007.0036; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; KIM JJ, 1995, J REPROD FERTIL, V103, P239; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lewis Gregory S, 2003, Reprod Biol Endocrinol, V1, P117; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; *NCCLS, NCCLS PERF STAND ANT; POYSER NL, 1987, J REPROD FERTIL, V81, P269, DOI 10.1530/jrf.0.0810269; Rinaldi M, 2008, VET IMMUNOL IMMUNOP, V126, P199, DOI 10.1016/j.vetimm.2008.07.001; Ross JDC, 2002, SEX TRANSM INFECT, V78, P18, DOI 10.1136/sti.78.1.18; Runciman DJ, 2009, AUST VET J, V87, P369, DOI 10.1111/j.1751-0813.2009.00469.x; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Silva E, 2009, J DAIRY SCI, V92, P6000, DOI 10.3168/jds.2009-2358; Son I, 2009, FOODBORNE PATHOG DIS, V6, P837, DOI 10.1089/fpd.2008.0201; Torres AG, 2005, INFECT IMMUN, V73, P18, DOI 10.1128/IAI.73.1.18-29.2005; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2005, AM J REPROD IMMUNOL, V53, P65, DOI 10.1111/j.1600-0897.2004.00248.x; Wira CR, 2004, IMMUNOLOGY, V111, P13, DOI 10.1111/j.1365-2567.2004.01796.x; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Zerbe H, 2003, THERIOGENOLOGY, V60, P209, DOI 10.1016/S0093-691X(02)01376-6	50	199	207	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9192	10.1371/journal.pone.0009192	http://dx.doi.org/10.1371/journal.pone.0009192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169203	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474600013
J	Morine, KJ; Bish, LT; Pendrak, K; Sleeper, MM; Barton, ER; Sweeney, HL				Morine, Kevin J.; Bish, Lawrence T.; Pendrak, Klara; Sleeper, Meg M.; Barton, Elisabeth R.; Sweeney, H. Lee			Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; DUCHENNE MUSCULAR-DYSTROPHY; BETA SUPERFAMILY MEMBER; MDX MICE; DEFICIENT CARDIOMYOPATHY; MURINE MODEL; EXPRESSION; GROWTH; MOUSE; PROPEPTIDE	Background: Myostatin inhibition is a promising therapeutic strategy to maintain muscle mass in a variety of disorders, including the muscular dystrophies, cachexia, and sarcopenia. Previously described approaches to blocking myostatin signaling include injection delivery of inhibitory propeptide domain or neutralizing antibodies. Methodology/Principal Findings: Here we describe a unique method of myostatin inhibition utilizing recombinant adeno-associated virus to overexpress a secretable dominant negative myostatin exclusively in the liver of mice. Systemic myostatin inhibition led to increased skeletal muscle mass and strength in control C57 Bl/6 mice and in the dystrophin-deficient mdx model of Duchenne muscular dystrophy. The mdx soleus, a mouse muscle more representative of human fiber type composition, demonstrated the most profound improvement in force production and a shift toward faster myosin-heavy chain isoforms. Unexpectedly, the 11-month-old mdx diaphragm was not rescued by long-term myostatin inhibition. Further, mdx mice treated for 11 months exhibited cardiac hypertrophy and impaired function in an inhibitor dose-dependent manner. Conclusions/Significance: Liver-targeted gene transfer of a myostatin inhibitor is a valuable tool for preclinical investigation of myostatin blockade and provides novel insights into the long-term effects and shortcomings of myostatin inhibition on striated muscle.	[Morine, Kevin J.; Bish, Lawrence T.; Pendrak, Klara; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Sleeper, Meg M.] Univ Penn, Sch Vet Med, Cardiol Sect, Philadelphia, PA 19104 USA; [Barton, Elisabeth R.] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Morine, KJ (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	km446@drexel.edu	Sweeney, H Lee/F-1862-2010		Wellstone Muscular Dystrophy Cooperative Center [U54-AR052646]	Wellstone Muscular Dystrophy Cooperative Center	This work was supported by a Wellstone Muscular Dystrophy Cooperative Center Grant (U54-AR052646) to H.L.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Artaza JN, 2007, J ENDOCRINOL, V194, P63, DOI 10.1677/JOE-07-0072; Bartoli M, 2007, GENE THER, V14, P733, DOI 10.1038/sj.gt.3302928; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; BISH LT, 2008, HUM GENE THER; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Earnshaw JC, 2002, HISTOCHEM CELL BIOL, V118, P19, DOI 10.1007/s00418-002-0428-9; Forbes D, 2006, J CELL PHYSIOL, V206, P264, DOI 10.1002/jcp.20477; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Garg RR, 1999, MOL CELL ENDOCRINOL, V153, P169, DOI 10.1016/S0303-7207(99)00044-1; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Harding TC, 2004, GENE THER, V11, P204, DOI 10.1038/sj.gt.3302142; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Huang ZQ, 2007, CELL SIGNAL, V19, P2286, DOI 10.1016/j.cellsig.2007.07.002; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lee SJ, 2007, TRENDS GENET, V23, P475, DOI 10.1016/j.tig.2007.08.008; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li ZF, 2005, AM J PATHOL, V166, P491, DOI 10.1016/S0002-9440(10)62271-7; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; MARSHALL PA, 1989, MUSCLE NERVE, V12, P528, DOI 10.1002/mus.880120703; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Pacak Christina A, 2008, Genet Vaccines Ther, V6, P14, DOI 10.1186/1479-0556-6-14; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Philip B, 2005, CELL SIGNAL, V17, P365, DOI 10.1016/j.cellsig.2004.08.003; Qiao CP, 2008, HUM GENE THER, V19, P241, DOI 10.1089/hum.2007.159; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Salerno MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1031, DOI 10.1152/ajpcell.00492.2003; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Silcocks PB, 1997, HEART, V78, P237, DOI 10.1136/hrt.78.3.237; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Van Erp C, 2006, MUSCLE NERVE, V34, P327, DOI 10.1002/mus.20590; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wagner KR, 2002, ANN NEUROL, V52, P832, DOI 10.1002/ana.10385; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200	62	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9176	10.1371/journal.pone.0009176	http://dx.doi.org/10.1371/journal.pone.0009176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161803	Green Published, gold			2022-12-27	WOS:000274442800022
J	Huang, HY; Wu, Q				Huang, Haiyan; Wu, Qiang			Cloning and Comparative Analyses of the Zebrafish Ugt Repertoire Reveal Its Evolutionary Diversity	PLOS ONE			English	Article							HUMAN UDP-GLUCURONOSYLTRANSFERASES; RADIATION-INACTIVATION ANALYSIS; PROTEIN-COUPLED RECEPTORS; GENOMIC ORGANIZATION; PROTOCADHERIN GENES; 1ST EXONS; DUPLICATION; BILIRUBIN; FAMILY; LOCUS	UDP-glucuronosyl transferases (Ugts) are a supergene family of phase II drug-metabolizing enzymes that catalyze the conjugation of numerous hydrophobic small molecules with the UDP-glucuronic acid, converting them into hydrophilic molecules. Here, we report the identification and cloning of the complete zebrafish Ugt gene repertoire. We found that the zebrafish genome contains 45 Ugt genes that can be divided into three families: Ugt1, Ugt2, and Ugt5. Both Ugt1 and Ugt2 have two unlinked clusters: a and b. The Ugt1a, Ugt1b, Ugt2a, and Ugt2b clusters each contain variable and constant regions, similar to that of the protocadherin (Pcdh), immunoglobulin (Ig), and T-cell receptor (Tcr) clusters. Cloning the full-length coding sequences confirmed that each of the variable exons is separately spliced to the set of constant exons within each zebrafish Ugt cluster. Comparative analyses showed that both a and b clusters of the zebrafish Ugt1 and Ugt2 genes have orthologs in other teleosts, suggesting that they may be resulted from the "fish-specific" whole-genome duplication event. The Ugt5 genes are a novel family of Ugt genes that exist in teleosts and amphibians. Their entire open reading frames are encoded by single large exons. The zebrafish Ugt1, Ugt2, and Ugt5 genes can generate additional transcript diversity through alternative splicing. Based on phylogenetic analyses, we propose that the ancestral tetrapod and teleost Ugt1 clusters contained multiple Ugt1 paralogs. After speciation, these ancestral Ugt1 clusters underwent lineage-specific gene loss and duplication. The ancestral vertebrate Ugt2 cluster also underwent lineage-specific duplication. The intronless Ugt5 open reading frames may be derived from retrotransposition followed by gene duplication. They have been expanded dramatically in teleosts and have become the most abundant Ugt family in these lineages. These findings have interesting implications regarding the molecular evolution of genes with diversified variable exons in vertebrates.	[Huang, Haiyan; Wu, Qiang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Huang, Haiyan; Wu, Qiang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China.	qwu123@gmail.com	Wu, Qiang/A-6751-2009	Wu, Qiang/0000-0003-3841-3591	Ministry of Science and Technology of China; National Natural Science Foundation of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China and National Natural Science Foundation of China. Qiang Wu is a Pujiang Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; EMI Y, 1995, J BIOCHEM, V117, P392, DOI 10.1093/jb/117.2.392; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Girard H, 2007, PHARMACOGENET GENOM, V17, P1077, DOI 10.1097/FPC.0b013e3282f1f118; GSCHAIDMEIER H, 1994, BIOCHEM PHARMACOL, V48, P1545, DOI 10.1016/0006-2952(94)90198-8; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Innocenti F, 2004, J CLIN ONCOL, V22, P1382, DOI 10.1200/JCO.2004.07.173; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Leaver MJ, 2007, AQUAT TOXICOL, V84, P356, DOI 10.1016/j.aquatox.2007.06.015; Levesque E, 2007, HEPATOLOGY, V45, P128, DOI 10.1002/hep.21464; Li C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-69; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Owens IS, 2005, METHOD ENZYMOL, V400, P1, DOI 10.1016/S0076-6879(05)00001-7; PETERS WHM, 1984, J BIOL CHEM, V259, P1701; Riedy M, 2000, PHARMACOGENETICS, V10, P251, DOI 10.1097/00008571-200004000-00006; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian B, 2007, GENOME RES, V17, P156, DOI 10.1101/gr.5532707; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tukey RH, 2001, MOL PHARMACOL, V59, P405, DOI 10.1124/mol.59.3.405; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yu WP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-49; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	35	25	31	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9144	10.1371/journal.pone.0009144	http://dx.doi.org/10.1371/journal.pone.0009144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161780	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442700008
J	Tracht, SM; Del Valle, SY; Hyman, JM				Tracht, Samantha M.; Del Valle, Sara Y.; Hyman, James M.			Mathematical Modeling of the Effectiveness of Facemasks in Reducing the Spread of Novel Influenza A (H1N1)	PLOS ONE			English	Article							FACEPIECE RESPIRATORS; PERFORMANCE; TRANSMISSION	On June 11, 2009, the World Health Organization declared the outbreak of novel influenza A (H1N1) a pandemic. With limited supplies of antivirals and vaccines, countries and individuals are looking at other ways to reduce the spread of pandemic (H1N1) 2009, particularly options that are cost effective and relatively easy to implement. Recent experiences with the 2003 SARS and 2009 H1N1 epidemics have shown that people are willing to wear facemasks to protect themselves against infection; however, little research has been done to quantify the impact of using facemasks in reducing the spread of disease. We construct and analyze a mathematical model for a population in which some people wear facemasks during the pandemic and quantify impact of these masks on the spread of influenza. To estimate the parameter values used for the effectiveness of facemasks, we used available data from studies on N95 respirators and surgical facemasks. The results show that if N95 respirators are only 20% effective in reducing susceptibility and infectivity, only 10% of the population would have to wear them to reduce the number of influenza A (H1N1) cases by 20%. We can conclude from our model that, if worn properly, facemasks are an effective intervention strategy in reducing the spread of pandemic (H1N1) 2009.	[Tracht, Samantha M.; Del Valle, Sara Y.] Los Alamos Natl Lab, Decis Applicat Div, Energy & Infrastruct Anal Grp, Los Alamos, NM USA; [Tracht, Samantha M.] Capital Univ, Dept Math Comp Sci & Phys, Columbus, OH USA; [Hyman, James M.] Los Alamos Natl Lab, Div Theoret, Math Modeling & Anal Grp, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Capital University; United States Department of Energy (DOE); Los Alamos National Laboratory	Tracht, SM (corresponding author), Los Alamos Natl Lab, Decis Applicat Div, Energy & Infrastruct Anal Grp, Los Alamos, NM USA.	samantha.tracht@gmail.com	Hyman, James M/AAF-7389-2020; Del Valle, Sara/AAG-5148-2021	Hyman, James M/0000-0001-5247-5794; Del Valle, Sara/0000-0002-0159-1952	Los Alamos National Security, LLC (LANS) [DE-AC52-06NA25396]; U.S. Department of Energy (DOE)	Los Alamos National Security, LLC (LANS); U.S. Department of Energy (DOE)(United States Department of Energy (DOE))	This research was prepared by Los Alamos National Security, LLC (LANS) under Contract DE-AC52-06NA25396 with the U.S. Department of Energy (DOE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO A, 2008, 48 ANN INT C ANT AG; [Anonymous], INTERIM RECOMMENDATI; [Anonymous], 2009, MORBIDITY MORTALITY, V58, P467; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Balazy A, 2006, ANN OCCUP HYG, V50, P259, DOI 10.1093/annhyg/mei058; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; CHOWELL G, 2006, TRANSMISSION CONTROL; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Eninger RM, 2008, ANN OCCUP HYG, V52, P385, DOI 10.1093/annhyg/men019; FRASER EA, 2009, SCI EXPRESS, V324, P1557; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Lee SA, 2008, ANN OCCUP HYG, V52, P177, DOI 10.1093/annhyg/men005; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; LO JYC, 2005, EMERGING INFECT DIS, V11; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MCSHANE L, 2009, DAILY NEWS; Nishiura H, 2009, EUROSURVEILLANCE, V14; PASTEUR S, 2007, DO THEY MAKE INFLUEN; STROUD PD, 2006, EPISIMS LOS ANGELES; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; TANG JW, 2009, J ROYAL SOC INTERFAC; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; 2009, GLOBAL ALERT RESPONS; 2009, QUESTIONS ANSWERS RE; 2009, MORBIDITY MORTALITY, V58, P431; 2009, H1N1 FLU; 2009, TEMP SENSOR NEWS; HHS PANDEMIC INFLUEN; 2009, INTERIM GUIDANCE CLI; 2009, NOVEL H1N1 FLU SITUA	35	97	99	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9018	10.1371/journal.pone.0009018	http://dx.doi.org/10.1371/journal.pone.0009018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161764	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442700002
J	Matsuo, R; Kobayashi, S; Murakami, J; Ito, E				Matsuo, Ryota; Kobayashi, Suguru; Murakami, Jun; Ito, Etsuro			Spontaneous Recovery of the Injured Higher Olfactory Center in the Terrestrial Slug Limax	PLOS ONE			English	Article							ADULT NEUROGENESIS; STEM-CELLS; NEURAL PROGENITORS; BULBECTOMIZED RATS; TRAVELING-WAVES; IN-VITRO; MOLLUSK; REGENERATION; PROCEREBRUM; SNAIL	Background: Of all organs and tissues in adult mammals, the brain shows the most limited regeneration and recovery after injury. This is one reason why treating neurological damage such as ischemic injury after stroke presents such a challenge. Here we report a novel mode of regeneration which the slug's cognitive center, the procerebrum, shows after surgical lesioning in the adult. It is well known that the land slug Limax possesses the capacity to demonstrate conditioned food aversion. This learning ability critically depends on the procerebrum, which is the higher olfactory center in the brain of the terrestrial mollusk. Principal Findings: In the present study, after a 1-month recovery period post-surgical lesioning of the procerebrum we investigated whether the brain of the slug shows recovery from damage. We found that learning ability, local field potential oscillation, and the number of cells in the procerebrum (PC) all recovered spontaneously within 1 month of bilateral lesioning of the PC. Moreover, neurogenesis was enhanced in the lesioned PC. However, memory acquired before the surgery could not be retrieved 1 month after surgery although the procerebrum had recovered from injury by this time, consistent with the notion that the procerebrum is the storage site of odor-aversion memory, or deeply involved in the memory recall process. Significance: Our findings are the first to demonstrate that a brain region responsible for the associative memory of an adult organism can spontaneously reconstitute itself, and can recover its function following injury.	[Matsuo, Ryota; Kobayashi, Suguru; Murakami, Jun; Ito, Etsuro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan	Tokushima Bunri University	Matsuo, R (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Kagawa, Japan.	matsuor@kph.bunri-u.ac.jp	Kobayashi, Suguru/AAN-9001-2021		Ministry of Education, Culture, Sports, Science, and Technology [17790054]; Japan Society for the Promotion of Science [19370030, 21657022]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study was partly supported by Grants-in-Aid for KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology (No. 17790054 to RM, http://www.mext.go.jp/) and from the Japan Society for the Promotion of Science (No. 19370030 and 21657022 to EI, http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS TW, 1988, TRENDS NEUROSCI, V11, P128, DOI 10.1016/0166-2236(88)90137-3; Agata K, 2008, PHILOS T R SOC B, V363, P2071, DOI 10.1098/rstb.2008.2260; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BUTLER AB, 1984, NEUROSCI LETT, V48, P247, DOI 10.1016/0304-3940(84)90046-6; Chabaud P, 2000, CHEM SENSES, V25, P561, DOI 10.1093/chemse/25.5.561; CHASE R, 1993, MICROSC RES TECHNIQ, V24, P214, DOI 10.1002/jemt.1070240303; CHASE R, 1989, J COMP NEUROL, V283, P143, DOI 10.1002/cne.902830112; CHASE R, 1983, J NEUROBIOL, V14, P43, DOI 10.1002/neu.480140106; Chase R, 2000, MICROSC RES TECHNIQ, V49, P511, DOI 10.1002/1097-0029(20000615)49:6<511::AID-JEMT2>3.0.CO;2-L; EAKIN RM, 1973, J EXP ZOOL, V184, P81, DOI 10.1002/jez.1401840107; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GELPERIN A, 1975, SCIENCE, V189, P567, DOI 10.1126/science.1145215; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Gelperin A, 1999, J EXP BIOL, V202, P1855; Gheusi G, 2007, CHEM SENSES, V32, P397, DOI 10.1093/chemse/bjm012; GRAZIADEI PPC, 1978, P NATL ACAD SCI USA, V75, P5230, DOI 10.1073/pnas.75.10.5230; Inoue T, 2004, J NEUROPHYSIOL, V91, P372, DOI 10.1152/jn.00247.2003; Inoue T, 2006, J NEUROPHYSIOL, V95, P3898, DOI 10.1152/jn.00853.2005; Kasai Y, 2006, LEARN MEMORY, V13, P482, DOI 10.1101/lm.257606; Kawahara S, 1997, J EXP BIOL, V200, P1851; Kennard MA, 1942, ARCH NEURO PSYCHIATR, V48, P227, DOI 10.1001/archneurpsyc.1942.02290080073002; Kimura T, 1998, LEARN MEMORY, V4, P376, DOI 10.1101/lm.4.5.376; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402, DOI 10.1152/jn.1994.72.3.1402; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Levenson J, 2000, J COMP NEUROL, V423, P121, DOI 10.1002/1096-9861(20000717)423:1<121::AID-CNE10>3.0.CO;2-E; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Matsuo R, 2008, ACTA BIOL HUNG, V59, P73, DOI 10.1556/ABiol.59.2008.Suppl.11; Matsuo R, 2002, NEUROSCI LETT, V334, P201, DOI 10.1016/S0304-3940(02)01089-3; MATSUO R, 2009, NEUROBIOL L IN PRESS; Matsuo R, 2009, J NEUROSCI RES, V87, P3011, DOI 10.1002/jnr.22130; Matsuo R, 2009, BIOCHEM BIOPH RES CO, V386, P724, DOI 10.1016/j.bbrc.2009.06.112; MEREDITH M, 1983, SCIENCE, V222, P1254, DOI 10.1126/science.6648533; MOFFETT SB, 1995, PROG NEUROBIOL, V46, P289, DOI 10.1016/0301-0082(95)00007-I; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nakaya T, 2001, GENES CELLS, V6, P43, DOI 10.1046/j.1365-2443.2001.00397.x; Ravel N, 2003, EUR J NEUROSCI, V17, P350, DOI 10.1046/j.1460-9568.2003.02445.x; SAHLEY C, 1981, P NATL ACAD SCI-BIOL, V78, P640, DOI 10.1073/pnas.78.1.640; Shimozono S, 2001, BRAIN RES, V921, P98, DOI 10.1016/S0006-8993(01)03096-7; Shirahata T, 2006, LEARN MEMORY, V13, P267, DOI 10.1101/lm.133906; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; SNYDER KA, 1990, COMP BIOCHEM PHYS A, V96, P407, DOI 10.1016/0300-9629(90)90104-Z; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Watanabe S, 2003, J NEUROSCI, V23, P2932; Watanabe S, 2008, LEARN MEMORY, V15, P633, DOI 10.1101/lm920908; WRIGHT JW, 1982, SCIENCE, V216, P322, DOI 10.1126/science.7063891; Yamagishi M, 2008, J EXP BIOL, V211, P1841, DOI 10.1242/jeb.018028; Zakharov IS, 1998, J NEUROBIOL, V35, P271, DOI 10.1002/(SICI)1097-4695(19980605)35:3<271::AID-NEU4>3.0.CO;2-W; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9054	10.1371/journal.pone.0009054	http://dx.doi.org/10.1371/journal.pone.0009054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20161701	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442500001
J	Zhao, JS; Deng, YH; Manno, D; Hawari, J				Zhao, Jian-Shen; Deng, Yinghai; Manno, Dominic; Hawari, Jalal			Shewanella spp. Genomic Evolution for a Cold Marine Lifestyle and In-Situ Explosive Biodegradation	PLOS ONE			English	Article							OUTER-MEMBRANE CYTOCHROMES; AMINO-ACID-RESIDUES; CENTRAL BALTIC SEA; C-TYPE CYTOCHROME; SP-NOV.; SP. NOV.; ONEIDENSIS MR-1; HEXAHYDRO-1,3,5-TRINITRO-1,3,5-TRIAZINE RDX; EXTRACELLULAR RESPIRATION; LOCAL FLEXIBILITY	Shewanella halifaxensis and Shewanella sediminis were among a few aquatic gamma-proteobacteria that were psychrophiles and the first anaerobic bacteria that degraded hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX). Although many mesophilic or psychrophilic strains of Shewanella and gamma-proteobacteria were sequenced for their genomes, the genomic evolution pathways for temperature adaptation were poorly understood. On the other hand, the genes responsible for anaerobic RDX mineralization pathways remain unknown. To determine the unique genomic properties of bacteria responsible for both cold-adaptation and RDX degradation, the genomes of S. halifaxensis and S. sediminis were sequenced and compared with 108 other gamma-proteobacteria including Shewanella that differ in temperature and Na(+) requirements, as well as RDX degradation capability. Results showed that for coping with marine environments their genomes had extensively exchanged with deep sea bacterial genomes. Many genes for Na(+)-dependent nutrient transporters were recruited to use the high Na(+) content as an energy source. For coping with low temperatures, these two strains as well as other psychrophilic strains of Shewanella and gamma-proteobacteria were found to decrease their genome G+C content and proteome alanine, proline and arginine content (p-value < 0.01) to increase protein structural flexibility. Compared to poorer RDX-degrading strains, S. halifaxensis and S. sediminis have more number of genes for cytochromes and other enzymes related to RDX metabolic pathways. Experimentally, one cytochrome was found induced in S. halifaxensis by RDX when the chemical was the sole terminal electron acceptor. The isolated protein degraded RDX by mono-denitration and was identified as a multiheme 52 kDa cytochrome using a proteomic approach. The present analyses provided the first insight into divergent genomic evolution of bacterial strains for adaptation to the specific cold marine conditions and to the degradation of the pollutant RDX. The present study also provided the first evidence for the involvement of a specific c-type cytochrome in anaerobic RDX metabolism.	[Zhao, Jian-Shen; Deng, Yinghai; Manno, Dominic; Hawari, Jalal] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Zhao, JS (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.	jianszhao@yahoo.ca; jalal.hawari@nrc.ca			University of California; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Office of Naval Research [N000140610251]; Defense Research and Development Canada, Canada; US SERDP [ER1609];  [Zhao 0180 051115]	University of California(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Office of Naval Research(Office of Naval Research); Defense Research and Development Canada, Canada; US SERDP; 	Funding: Genome sequencing and annotation were performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The user agreement number is Zhao 0180 051115 for Dr. Jian-Shen Zhao as a principal collaborator. Financial support was also received from the Office of Naval Research (grant N000140610251) and Defense Research and Development Canada, Canada, and US SERDP (project ER1609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGAWAMATSUSHITA M, 1992, INT J SYST BACTERIOL, V42, P621, DOI 10.1099/00207713-42-4-621; Beddington J., 2005, MUNITIONS DUMPED SEA; Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Brettar I, 2002, INT J SYST EVOL MICR, V52, P2211, DOI 10.1099/00207713-52-6-2211; Brettar I, 2001, MICROB ECOL, V42, P295, DOI 10.1007/s00248-001-0011-2; BRYANT C, 1991, J BIOL CHEM, V266, P4119; Crocker FH, 2006, APPL MICROBIOL BIOT, V73, P274, DOI 10.1007/s00253-006-0588-y; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darrach MR, 1998, ENVIRON SCI TECHNOL, V32, P1354, DOI 10.1021/es970992h; DEMING JW, 1988, SYST APPL MICROBIOL, V10, P152, DOI 10.1016/S0723-2020(88)80030-4; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; GAUTHIER G, 1995, INT J SYST BACTERIOL, V45, P755, DOI 10.1099/00207713-45-4-755; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gianese G, 2001, PROTEIN ENG, V14, P141, DOI 10.1093/protein/14.3.141; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Hartshorne RS, 2007, J BIOL INORG CHEM, V12, P1083, DOI 10.1007/s00775-007-0278-y; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Jackson RG, 2007, P NATL ACAD SCI USA, V104, P16822, DOI 10.1073/pnas.0705110104; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Keigwin LD, 2003, CLIM DYNAM, V21, P53, DOI 10.1007/s00382-003-0316-6; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kitts CL, 2000, CAN J MICROBIOL, V46, P278, DOI 10.1139/cjm-46-3-278; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon MJ, 2006, APPL ENVIRON MICROB, V72, P5933, DOI 10.1128/AEM.00660-06; LAUSSERMAIR E, 1989, J BIOL CHEM, V264, P14710; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Leonardo MR, 1999, INT J SYST BACTERIOL, V49, P1341, DOI 10.1099/00207713-49-4-1341; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Makemson JC, 1997, INT J SYST BACTERIOL, V47, P1034, DOI 10.1099/00207713-47-4-1034; MAKEMSON JC, 1979, APPL ENVIRON MICROB, V38, P178, DOI 10.1128/AEM.38.1.178-180.1979; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Myers CR, 2004, LETT APPL MICROBIOL, V39, P466, DOI 10.1111/j.1472-765X.2004.01611.x; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; NEALSON KH, 2005, PROKARYOTES HDB BIOL, V6, P1133; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nogi Y, 1998, EXTREMOPHILES, V2, P1, DOI 10.1007/s007920050036; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PFENNIG N, 1971, International Journal of Systematic Bacteriology, V21, P19; PICARDAL FW, 1993, APPL ENVIRON MICROB, V59, P3763, DOI 10.1128/AEM.59.11.3763-3770.1993; Robidoux PY, 2000, ENVIRON TOXICOL CHEM, V19, P1764, DOI [10.1002/etc.5620190709, 10.1897/1551-5028(2000)019&lt;1764:CTOECI&gt;2.3.CO;2]; ROSEMOND ZA, 1998, TOXICOLOGICAL PROFIL; ROSENBERG IM, 1996, PROTEIN ANAL PURIFIC; Schleheck D, 2004, INT J SYST EVOL MICR, V54, P1489, DOI 10.1099/ijs.0.03020-0; Shi L, 2008, J BACTERIOL, V190, P5512, DOI 10.1128/JB.00514-08; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; *USEPA, 2000, EPA505R0001 OFF SOL; Venkateswaran K, 1998, INT J SYST BACTERIOL, V48, P965, DOI 10.1099/00207713-48-3-965; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; WATANABE K, 1991, J BIOL CHEM, V266, P24287; Wiebe CA, 2001, BIOCHEM J, V357, P1, DOI 10.1042/0264-6021:3570001; Williams RE, 2004, APPL ENVIRON MICROB, V70, P3566, DOI 10.1128/AEM.70.6.3566-3574.2004; Xiong YJ, 2006, J AM CHEM SOC, V128, P13978, DOI 10.1021/ja063526d; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yang H, 2009, J APPL MICROBIOL, V107, P1799, DOI 10.1111/j.1365-2672.2009.04366.x; Zhao JS, 2008, MICROBIOL-SGM, V154, P1026, DOI 10.1099/mic.0.2007/013409-0; Zhao JS, 2006, INT J SYST EVOL MICR, V56, P205, DOI 10.1099/ijs.0.63829-0; Zhao JS, 2005, INT J SYST EVOL MICR, V55, P1511, DOI 10.1099/ijs.0.63604-0; Zhao JS, 2004, FEMS MICROBIOL ECOL, V49, P349, DOI 10.1016/j.femsec.2004.04.008; Zhu GP, 1999, PROTEIN ENG, V12, P635, DOI 10.1093/protein/12.8.635	71	44	46	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2010	5	2							e9109	10.1371/journal.pone.0009109	http://dx.doi.org/10.1371/journal.pone.0009109			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NU	20174598	Green Published, gold, Green Accepted			2022-12-27	WOS:000274442500015
J	Cervera, A; Planas, AM; Justicia, C; Urra, X; Jensenius, JC; Torres, F; Lozano, F; Chamorro, A				Cervera, Alvaro; Planas, Anna M.; Justicia, Carles; Urra, Xabier; Jensenius, Jens C.; Torres, Ferran; Lozano, Francisco; Chamorro, Angel			Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; COMPLEMENT ACTIVATION; SERINE PROTEASES; BRAIN; PATHWAY; INFECTION; CELLS	Background: The complement system is a major effector of innate immunity that has been involved in stroke brain damage. Complement activation occurs through the classical, alternative and lectin pathways. The latter is initiated by mannosebinding lectin (MBL) and MBL-associated serine proteases (MASPs). Here we investigated whether the lectin pathway contributes to stroke outcome in mice and humans. Methodology/Principal Findings: Focal cerebral ischemia/reperfusion in MBL-null mice induced smaller infarctions, better functional outcome, and diminished C3 deposition and neutrophil infiltration than in wild-type mice. Accordingly, reconstitution of MBL-null mice with recombinant human MBL (rhMBL) enhanced brain damage. In order to investigate the clinical relevance of these experimental observations, a study of MBL2 and MASP-2 gene polymorphism rendering the lectin pathway dysfunctional was performed in 135 stroke patients. In logistic regression adjusted for age, gender and initial stroke severity, unfavourable outcome at 3 months was associated with MBL-sufficient genotype (OR 10.85, p = 0.008) and circulating MBL levels (OR 1.29, p = 0.04). Individuals carrying MBL-low genotypes (17.8%) had lower C3, C4, and CRP levels, and the proinflammatory cytokine profile was attenuated versus MBL-sufficient genotypes. Conclusions/Significance: In conclusion, genetically defined MBL-deficiency is associated with a better outcome after acute stroke in mice and humans.	[Cervera, Alvaro; Urra, Xabier; Chamorro, Angel] Univ Barcelona, Sch Med, Comprehens Stroke Ctr, IDIBAPS,Hosp Clin, Barcelona, Spain; [Planas, Anna M.; Justicia, Carles] CSIC, Dept Brain Ischemia & Neurodegenerat, IIBB, IDIBAPS, Barcelona, Spain; [Jensenius, Jens C.] Univ Aarhus, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Torres, Ferran] Univ Barcelona, Sch Med, Clin Pharmacol Unit, IDIBAPS,Hosp Clin, Barcelona, Spain; [Torres, Ferran; Lozano, Francisco] Univ Barcelona, Sch Med, Dept Cellular Biol Immunol & Neurosci, Barcelona, Spain; [Lozano, Francisco] IDIBAPS, Hosp Clin, Dept Immunol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Aarhus University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Cervera, A (corresponding author), Univ Barcelona, Sch Med, Comprehens Stroke Ctr, IDIBAPS,Hosp Clin, Barcelona, Spain.	Flozano@clinic.ub.es; achamorro@ub.edu	Justicia, Carles/H-7762-2015; Urra, Xabier/B-7637-2019; Torres, Ferran/D-1296-2011; LOZANO, FRANCISCO/AAB-7888-2019; Planas, Anna M/J-5991-2014; Lozano-Soto, Francisco/AAB-7930-2019	Justicia, Carles/0000-0003-0969-6158; Urra, Xabier/0000-0002-4763-5252; Torres, Ferran/0000-0002-7355-7913; LOZANO, FRANCISCO/0000-0003-1119-4368; Planas, Anna M/0000-0002-6147-1880; Lozano-Soto, Francisco/0000-0003-3714-2304	European Community [FP7/2007-2013]; Spanish Ministry of Education and Science [SAF200804515- CO2-01]; Fundacio n Melchor Colet; Spanish Network for the Research in Infectious Diseases [RD06/0008/1013]	European Community(European Commission); Spanish Ministry of Education and Science(Spanish Government); Fundacio n Melchor Colet; Spanish Network for the Research in Infectious Diseases	Financed in part by the European Community (FP7/2007-2013; grant agreement nu 201024), the Spanish Ministry of Education and Science (SAF200804515- CO2-01 to AMP), the non-profitable foundation 'Fundacio n Melchor Colet' to A. Ch., and the Spanish Network for the Research in Infectious Diseases (REIPI, RD06/0008/1013) to F. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Cervera and X. Urra are recipients of grants from the Spanish Institute of Health Carlos III.	Atkinson C, 2006, J IMMUNOL, V177, P7266, DOI 10.4049/jimmunol.177.10.7266; CARROLL MC, 2005, ADV IMMUNOL, V86, P37; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; Chaka W, 1997, J IMMUNOL, V159, P2979; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; CLARK WM, 1997, NEUROL RES, V19, P642; Cowell RM, 2003, J NEUROSCI, V23, P9459; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; GESUETE R, 2009, ANN NEUROL IN PRESS; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Justicia  C., 2006, J CEREB BLOOD FLOW M, V26, P321; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; Lozano F, 2005, TISSUE ANTIGENS, V66, P131, DOI 10.1111/j.1399-0039.2005.00436.x; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Moller-Kristensen M, 2005, SCAND J IMMUNOL, V61, P426, DOI 10.1111/j.1365-3083.2005.01591.x; Moller-Kristensen M, 2003, J IMMUNOL METHODS, V282, P159, DOI 10.1016/j.jim.2003.08.012; Mullighan CG, 2002, BLOOD, V99, P3524, DOI 10.1182/blood.V99.10.3524; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Planas AM, 2009, NAT MED, V15, P138, DOI 10.1038/nm0209-138; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; Shiratsuchi A, 2008, IMMUNOLOGY, V124, P575, DOI 10.1111/j.1365-2567.2008.02811.x; Sorensen R, 2005, SPRINGER SEMIN IMMUN, V27, P299, DOI 10.1007/s00281-005-0006-z; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Thiel S, 2002, IMMUNOBIOLOGY, V205, P446, DOI 10.1078/0171-2985-00145; Turner M W, 2000, Rev Immunogenet, V2, P305; Urra X, 2009, J CEREBR BLOOD F MET, V29, P994, DOI 10.1038/jcbfm.2009.25; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56	43	115	118	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8433	10.1371/journal.pone.0008433	http://dx.doi.org/10.1371/journal.pone.0008433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140243	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200001
J	Miotto, O; Heiny, AT; Albrecht, R; Garcia-Sastre, A; Tan, TW; August, JT; Brusic, V				Miotto, Olivo; Heiny, A. T.; Albrecht, Randy; Garcia-Sastre, Adolfo; Tan, Tin Wee; August, J. Thomas; Brusic, Vladimir			Complete-Proteome Mapping of Human Influenza A Adaptive Mutations: Implications for Human Transmissibility of Zoonotic Strains	PLOS ONE			English	Article							HOST-RANGE RESTRICTION; NUCLEAR EXPORT SIGNAL; AVIAN INFLUENZA; NS1 PROTEIN; VIRUS NUCLEOPROTEIN; POLYMERASE PROTEINS; PANDEMIC INFLUENZA; SEQUENCE-ANALYSIS; CRYSTAL-STRUCTURE; HIGH VIRULENCE	Background: There is widespread concern that H5N1 avian influenza A viruses will emerge as a pandemic threat, if they become capable of human-to-human (H2H) transmission. Avian strains lack this capability, which suggests that it requires important adaptive mutations. We performed a large-scale comparative analysis of proteins from avian and human strains, to produce a catalogue of mutations associated with H2H transmissibility, and to detect their presence in avian isolates. Methodology/Principal Findings: We constructed a dataset of influenza A protein sequences from 92,343 public database records. Human and avian sequence subsets were compared, using a method based on mutual information, to identify characteristic sites where human isolates present conserved mutations. The resulting catalogue comprises 68 characteristic sites in eight internal proteins. Subtype variability prevented the identification of adaptive mutations in the hemagglutinin and neuraminidase proteins. The high number of sites in the ribonucleoprotein complex suggests interdependence between mutations in multiple proteins. Characteristic sites are often clustered within known functional regions, suggesting their functional roles in cellular processes. By isolating and concatenating characteristic site residues, we defined adaptation signatures, which summarize the adaptive potential of specific isolates. Most adaptive mutations emerged within three decades after the 1918 pandemic, and have remained remarkably stable thereafter. Two lineages with stable internal protein constellations have circulated among humans without reassorting. On the contrary, H5N1 avian and swine viruses reassort frequently, causing both gains and losses of adaptive mutations. Conclusions: Human host adaptation appears to be complex and systemic, involving nearly all influenza proteins. Adaptation signatures suggest that the ability of H5N1 strains to infect humans is related to the presence of an unusually high number of adaptive mutations. However, these mutations appear unstable, suggesting low pandemic potential of H5N1 in its current form. In addition, adaptation signatures indicate that pandemic H1N1/09 strain possesses multiple human-transmissibility mutations, though not an unusually high number with respect to swine strains that infected humans in the past. Adaptation signatures provide a novel tool for identifying zoonotic strains with the potential to infect humans.	[Miotto, Olivo] Univ Oxford, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Heiny, A. T.; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Albrecht, Randy; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Emerging Pathogens Inst, New York, NY USA; [August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Brusic, Vladimir] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; National University of Singapore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute	Miotto, O (corresponding author), Univ Oxford, Ctr Genom & Global Hlth, Oxford, England.	olivo.miotto@ndm.ox.ac.uk	Miotto, Olivo/AAE-7124-2019; Tan, Tin Wee/B-8963-2009; Brusic, Vladimir/B-1478-2008; Albrecht, Randy A./H-5119-2019	Miotto, Olivo/0000-0001-8060-6771; Tan, Tin Wee/0000-0002-4062-2854; Brusic, Vladimir/0000-0003-0523-5266; Albrecht, Randy A./0000-0003-4008-503X; Garcia-Sastre, Adolfo/0000-0002-6551-1827	Medical Research Council, United Kingdom; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America [5 U19 AI56541, HHSN2662-00400085C, HHSN2662-00700010C]; EC [FP6-2004-IST-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge support by the Medical Research Council, United Kingdom; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, United States of America, under Grant No. 5 U19 AI56541 and Contract Nos. HHSN2662-00400085C and HHSN2662-00700010C. VB acknowledges support in part by the ImmunoGrid project, under EC contract FP6-2004-IST-4, NO 028069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; BAEZ M, 1981, VIROLOGY, V113, P397, DOI 10.1016/0042-6822(81)90166-5; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; BUCKLERWHITE AJ, 1986, J VIROL, V57, P697, DOI 10.1128/JVI.57.2.697-700.1986; BUONAGURIO DA, 1986, SCIENCE, V232, P980, DOI 10.1126/science.2939560; Capua I, 2002, ACTA TROP, V83, P1, DOI 10.1016/S0001-706X(02)00050-5; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Hui EKW, 2003, J VIROL, V77, P7078, DOI 10.1128/JVI.77.12.7078-7092.2003; Iwatsuki-Horimoto K, 2004, J VIROL, V78, P10149, DOI 10.1128/JVI.78.18.10149-10155.2004; JONES IM, 1986, EMBO J, V5, P2371, DOI 10.1002/j.1460-2075.1986.tb04506.x; Jung TE, 2006, J GEN VIROL, V87, P679, DOI 10.1099/vir.0.81453-0; KENDAL AP, 1978, VIROLOGY, V89, P632, DOI 10.1016/0042-6822(78)90207-6; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; PEIRIS JS, 2009, EUR J IMMUNOL; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Qian XY, 1995, RNA, V1, P948; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHOLTISSEK C, 1983, VIROLOGY, V129, P521, DOI 10.1016/0042-6822(83)90194-0; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Taubenberger JK, 2009, REV SCI TECH OIE, V28, P187, DOI 10.20506/rst.28.1.1879; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Webby RJ, 2004, VIRUS RES, V103, P67, DOI 10.1016/j.virusres.2004.02.015; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017	66	60	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9025	10.1371/journal.pone.0009025	http://dx.doi.org/10.1371/journal.pone.0009025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140252	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474200012
J	Nalbantoglu, U; Sayood, K; Dempsey, MP; Iwen, PC; Francesconi, SC; Barabote, RD; Xie, G; Brettin, TS; Hinrichs, SH; Fey, PD				Nalbantoglu, Ufuk; Sayood, Khalid; Dempsey, Michael P.; Iwen, Peter C.; Francesconi, Stephen C.; Barabote, Ravi D.; Xie, Gary; Brettin, Thomas S.; Hinrichs, Steven H.; Fey, Paul D.			Large Direct Repeats Flank Genomic Rearrangements between a New Clinical Isolate of Francisella tularensis subsp tularensis A1 and Schu S4	PLOS ONE			English	Article							UNITED-STATES; POPULATION-STRUCTURE; MOLECULAR ANALYSIS; IDENTIFICATION; TULAREMIA; SEQUENCE; STRAIN	Francisella tularensis subspecies tularensis consists of two separate populations A1 and A2. This report describes the complete genome sequence of NE061598, an F. tularensis subspecies tularensis A1 isolated in 1998 from a human with clinical disease in Nebraska, United States of America. The genome sequence was compared to Schu S4, an F. tularensis subspecies tularensis A1a strain originally isolated in Ohio in 1941. It was determined that there were 25 nucleotide polymorphisms (22 SNPs and 3 indels) between Schu S4 and NE061598; two of these polymorphisms were in potential virulence loci. Pulsed-field gel electrophoresis analysis demonstrated that NE061598 was an A1a genotype. Other differences included repeat sequences (n = 11 separate loci), four of which were contained in coding sequences, and an inversion and rearrangement probably mediated by insertion sequences and the previously identified direct repeats I, II, and III. Five new variable-number tandem repeats were identified; three of these five were unique in NE061598 compared to Schu S4. Importantly, there was no gene loss or gain identified between NE061598 and Schu S4. Interpretation of these data suggests there is significant sequence conservation and chromosomal synteny within the A1 population. Further studies are needed to determine the biological properties driving the selective pressure that maintains the chromosomal structure of this monomorphic pathogen.	[Nalbantoglu, Ufuk; Sayood, Khalid] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA; [Iwen, Peter C.; Hinrichs, Steven H.; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Barabote, Ravi D.; Xie, Gary] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Barabote, Ravi D.; Xie, Gary] DOE Joint Genome Inst, Walnut Creek, CA USA; [Dempsey, Michael P.] Armed Forces Inst Pathol, Div Microbiol, Washington, DC 20306 USA; [Francesconi, Stephen C.] USN, Med Res Ctr, Silver Spring, MD USA; [Brettin, Thomas S.] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Medical Center; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); United States Department of Defense; United States Department of Defense; United States Navy; United States Department of Energy (DOE); Oak Ridge National Laboratory	Nalbantoglu, U (corresponding author), Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.	pfey@unmc.edu	Barabote, Ravi/B-8727-2011; Dempsey, Michael/GSM-7774-2022; Nalbantoglu, Ozkan Ufuk/AAK-5238-2021; Nalbantoglu, Ufuk/AAA-8033-2022; Barabote, Ravi/C-1299-2017	Nalbantoglu, Ozkan Ufuk/0000-0002-2278-7786; Barabote, Ravi/0000-0002-0403-246X; xie, gary/0000-0002-9176-924X	Department of Defense, Defense Advanced Research Program Agency [W911NF0510275]	Department of Defense, Defense Advanced Research Program Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by a grant from the Department of Defense, Defense Advanced Research Program Agency ( award W911NF0510275) to S. H. H. The opinions expressed in this manuscript are the private views of the authors and are not the official views of the Armed Forces Institute of Pathology, the Department of the Army, the United States Air Force, or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; Farlow J, 2005, EMERG INFECT DIS, V11, P1835, DOI 10.3201/eid1112.050728; Fey PD, 2007, AM J CLIN PATHOL, V128, P926, DOI 10.1309/JN3NTHK4VVWKJT4A; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lin YC, 2006, NUCLEIC ACIDS RES, V34, pW696, DOI 10.1093/nar/gkl169; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; VOGLER AJ, 2009, J BACTERIOL	18	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9007	10.1371/journal.pone.0009007	http://dx.doi.org/10.1371/journal.pone.0009007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140244	Green Submitted, Green Published, gold			2022-12-27	WOS:000274474200008
J	Luu, P; Geyer, A; Fidopiastis, C; Campbell, G; Wheeler, T; Cohn, J; Tucker, DM				Luu, Phan; Geyer, Alexandra; Fidopiastis, Cali; Campbell, Gwendolyn; Wheeler, Tracey; Cohn, Joseph; Tucker, Don M.			Reentrant Processing in Intuitive Perception	PLOS ONE			English	Article							TOP-DOWN FACILITATION; GAMMA-BAND RESPONSE; ORBITOFRONTAL CORTEX; GLOBAL FEATURES; ATTENTION; EEG; NEUROSCIENCE; RECOGNITION; MECHANISMS; DISCOVERY	The process of perception requires not only the brain's receipt of sensory data but also the meaningful organization of that data in relation to the perceptual experience held in memory. Although it typically results in a conscious percept, the process of perception is not fully conscious. Research on the neural substrates of human visual perception has suggested that regions of limbic cortex, including the medial orbital frontal cortex (mOFC), may contribute to intuitive judgments about perceptual events, such as guessing whether an object might be present in a briefly presented fragmented drawing. Examining dense array measures of cortical electrical activity during a modified Waterloo Gestalt Closure Task, results show, as expected, that activity in medial orbital frontal electrical responses ( about 250 ms) was associated with intuitive judgments. Activity in the right temporal-parietal-occipital (TPO) region was found to predict mOFC (, 150 ms) activity and, in turn, was subsequently influenced by the mOFC at a later time (similar to 300 ms). The initial perception of gist or meaning of a visual stimulus in limbic networks may thus yield reentrant input to the visual areas to influence continued development of the percept. Before perception is completed, the initial representation of gist may support intuitive judgments about the ongoing perceptual process.	[Luu, Phan; Tucker, Don M.] Elect Geodes Inc, Eugene, OR USA; [Geyer, Alexandra] Aptima Inc, Woburn, MA USA; [Fidopiastis, Cali] Univ Cent Florida, Inst Simulat & Training, Orlando, FL 32816 USA; [Campbell, Gwendolyn] USN, Air Warfare Ctr, Training Syst Div, Orlando, FL USA; [Wheeler, Tracey] Syst Planning Corp, Arlington, VA USA; [Cohn, Joseph] Def Adv Res Projects Agcy, Def Sci Off, Arlington, VA USA	State University System of Florida; University of Central Florida; United States Department of Defense; United States Navy; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA)	Luu, P (corresponding author), Elect Geodes Inc, Eugene, OR USA.	pluu@egi.com			Defense Advance Research Projects Agency (DARPA)	Defense Advance Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was funded by the Defense Advance Research Projects Agency (DARPA). Several authors on this manuscript are also employees of a commercial EEG company. Like efforts of all authors on this project, their efforts reflect financial support from DARPA. DARPA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; [Anonymous], 1993, NEUROBIOLOGY CINGULA; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BOWERS KS, 1990, COGNITIVE PSYCHOL, V22, P72, DOI 10.1016/0010-0285(90)90004-N; BROWN JW, 1994, DEV PSYCHOPATHOL, V6, P551, DOI 10.1017/S0954579400004685; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Luu P, 2009, BRAIN RES, V1247, P100, DOI 10.1016/j.brainres.2008.09.084; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Pandya D. N., 1988, COMP PRIMATE BIOL, V4, P39; Robertson LC, 2000, CURR DIR PSYCHOL SCI, V9, P59, DOI 10.1111/1467-8721.00061; Rolls ET, 1999, J NEUROSCI, V19, P1532; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; SNODGRASS JG, 1987, BEHAV RES METH INSTR, V19, P270, DOI 10.3758/BF03203798; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tucker DM, 2007, COGNITIVE THER RES, V31, P189, DOI 10.1007/s10608-006-9115-9; Volz KG, 2008, COGN AFFECT BEHAV NE, V8, P318, DOI 10.3758/CABN.8.3.318; Volz KG, 2006, J COGNITIVE NEUROSCI, V18, P2077, DOI 10.1162/jocn.2006.18.12.2077; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; WARD LM, 1982, J EXP PSYCHOL HUMAN, V8, P562, DOI 10.1037/0096-1523.8.4.562; Werner H., 1957, COMP PSYCHOL MENTAL; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zaehle T, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.008.2009	31	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9523	10.1371/journal.pone.0009523	http://dx.doi.org/10.1371/journal.pone.0009523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	564EW	20209101	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100009
J	Klett, D; Cahoreau, C; Villeret, M; Combarnous, Y				Klett, Daniele; Cahoreau, Claire; Villeret, Melanie; Combarnous, Yves			Effect of Pharmaceutical Potential Endocrine Disruptor Compounds on Protein Disulfide Isomerase Reductase Activity Using Di-Eosin-Oxidized-Glutathion	PLOS ONE			English	Article							HORMONE-BINDING; ENDOPLASMIC-RETICULUM; RISK-ASSESSMENT; BISPHENOL-A; INHIBITION; CHEMICALS; DISEASE; BACITRACIN; EVOLUTION; ESTROGENS	Background: Protein Disulfide Isomerase (PDI) in the endoplasmic reticulum of all cells catalyzes the rearrangement of disulfide bridges during folding of membrane and secreted proteins. As PDI is also known to bind various molecules including hormones such as estradiol and thyroxin, we considered the hypothesis that adverse effects of endocrine-disrupter compounds (EDC) could be mediated through their interaction with PDI leading to defects in membrane or secreted proteins. Methodology/Principal Findings: Taking advantage of the recent description of the fluorescence self quenched substrate di-eosin-oxidized-glutathion (DiE-GSSG), we determined kinetically the effects of various potential pharmaceutical EDCs on the in-vitro reductase activity of bovine liver PDI by measuring the fluorescence of the reaction product (E-GSH). Our data show that estrogens (ethynylestradiol and bisphenol-A) as well as indomethacin exert an inhibition whereas medroxyprogesteroneacetate and nortestosterone exert a potentiation of bovine PDI reductase activity. Conclusions: The present data indicate that the tested EDCs could not only affect endocrine target cells through nuclear receptors as previously shown, but could also affect these and all other cells by positively or negatively affecting PDI activity. The substrate DiE-GSSG has been demonstrated to be a convenient substrate to measure PDI reductase activity in the presence of various potential EDCs. It will certainely be usefull for the screening of potential effect of all kinds of chemicals on PDI reductase activity.	[Klett, Daniele; Cahoreau, Claire; Villeret, Melanie; Combarnous, Yves] CNRS, INRA, Unit Physiol Reprod & Comportements, Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE	Klett, D (corresponding author), CNRS, INRA, Unit Physiol Reprod & Comportements, Nouzilly, France.	combarno@tours.inra.fr	Combarnous, Yves/K-4161-2019	Combarnous, Yves/0000-0002-0574-2025	European Community [2004-513953]	European Community(European Commission)	This work was supported by European Community contract # 2004-513953 Food & Fertility - Pharmaceutical Products in the Environment (2004-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL BA, 1993, J VIROL, V67, P5496, DOI 10.1128/JVI.67.9.5496-5501.1993; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fu XM, 2009, J STEROID BIOCHEM, V115, P20, DOI 10.1016/j.jsbmb.2009.02.008; Gilbert H F, 1991, Protein Expr Purif, V2, P194, DOI 10.1016/1046-5928(91)90071-P; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guthapfel R, 1996, EUR J BIOCHEM, V242, P315, DOI 10.1111/j.1432-1033.1996.0315r.x; Hashimoto S, 2008, J BIOCHEM, V144, P335, DOI 10.1093/jb/mvn075; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Jacobs MN, 2004, TOXICOLOGY, V205, P43, DOI 10.1016/j.tox.2004.06.036; Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.1289/ehp.96104s4715; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Klappa P, 1998, EUR J BIOCHEM, V254, P63, DOI 10.1046/j.1432-1327.1998.2540063.x; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Pendurthi UR, 2008, THROMB RES, V122, pS14, DOI 10.1016/S0049-3848(08)70012-4; PIERSMA AHP, 2005, PRIORITIZATION LIST; Primm TP, 2001, J BIOL CHEM, V276, P281, DOI 10.1074/jbc.M007670200; Raturi A, 2005, BIOCHEM J, V391, P351, DOI 10.1042/BJ20050770; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; ROTH RA, 1981, BIOCHEM BIOPH RES CO, V98, P431, DOI 10.1016/0006-291X(81)90858-5; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Toppari J, 2008, SEX DEV, V2, P260, DOI 10.1159/000152042; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; van Meeuwen JA, 2007, TOXICOL LETT, V170, P165, DOI 10.1016/j.toxlet.2007.03.003; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vosges M, 2008, REPROD TOXICOL, V25, P161, DOI 10.1016/j.reprotox.2007.12.002; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n	29	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9507	10.1371/journal.pone.0009507	http://dx.doi.org/10.1371/journal.pone.0009507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209080	Green Submitted, Green Published, gold			2022-12-27	WOS:000275063400013
J	Storr, M; Emmerdinger, D; Diegelmann, J; Pfennig, S; Ochsenkuhn, T; Goke, B; Lohse, P; Brand, S				Storr, Martin; Emmerdinger, Dominik; Diegelmann, Julia; Pfennig, Simone; Ochsenkuehn, Thomas; Goeke, Burkhard; Lohse, Peter; Brand, Stephan			The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; WORKING PARTY; CB1; GENE; ASSOCIATION; PROTECTS; CARD15; LIVER; RISK; CLASSIFICATION	Background: Recent evidence suggests a crucial role of the endocannabinoid system, including the cannabinoid 1 receptor (CNR1), in intestinal inflammation. We therefore investigated the influence of the CNR1 1359 G/A (p.Thr453Thr; rs1049353) single nucleotide polymorphism (SNP) on disease susceptibility and phenotype in patients with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Genomic DNA from 579 phenotypically well-characterized individuals was analyzed for the CNR1 1359 G/A SNP. Amongst these were 166 patients with UC, 216 patients with CD, and 197 healthy controls. Results: Compared to healthy controls, subjects A/A homozygous for the CNR1 1359 G/A SNP had a reduced risk to develop UC (p = 0.01, OR 0.30, 95% CI 0.12-0.78). The polymorphism did not modulate CD susceptibility, but carriers of the minor A allele had a lower body mass index than G/G wildtype carriers (p = 0.0005). In addition, homozygous carriers of the G allele were more likely to develop CD before 40 years of age (p = 5.9x10(-7)) than carriers of the A allele. Conclusion: The CNR1 p.Thr453Thr polymorphism appears to modulate UC susceptibility and the CD phenotype. The endocannabinoid system may influence the manifestation of inflammatory bowel diseases, suggesting endocannabinoids as potential target for future therapies.	[Storr, Martin] Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB, Canada; [Emmerdinger, Dominik; Diegelmann, Julia; Pfennig, Simone; Ochsenkuehn, Thomas; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, Munich, Germany	University of Calgary; University of Munich; University of Munich	Storr, M (corresponding author), Univ Calgary, Div Gastroenterol, Dept Med, Calgary, AB, Canada.	mstorr@ucalgary.ca	Storr, Martin/A-6329-2011		Deutsche Forschungsgemeinschaft [DFG STO645/2-2, BR 1912/5-1]; Crohn's and Colitis Foundation of Canada (CCFC); University of Calgary [URGC-1011592]; University of Munich (Promotionsstipendium); Else Kraner-Fresenius-Stiftung [P50/05/EKMS05/62]; Ludwig-Maximilians University Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Crohn's and Colitis Foundation of Canada (CCFC); University of Calgary; University of Munich (Promotionsstipendium); Else Kraner-Fresenius-Stiftung; Ludwig-Maximilians University Munich	M. Storr is supported by grants from the Deutsche Forschungsgemeinschaft (DFG STO645/2-2), the Crohn's and Colitis Foundation of Canada (CCFC), and a grant from the University of Calgary (URGC-1011592). J. Diegelmann received a grant from the University of Munich (Promotionsstipendium). S. Brand is supported by grants from the DFG (BR 1912/5-1), the Else Kraner-Fresenius-Stiftung (Else Kraner Fresenius Memorial Stipendium 2005; P50/05/EKMS05/62), by the Ludwig-Demling Grant 2007 from DCCV e. V., and grants from the Ludwig-Maximilians University Munich (Excellence Initiative - Investment Fund 2008 and FaFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti R, 2002, FUND INFORM, V51, P1; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brand S, 2005, INFLAMM BOWEL DIS, V11, P645, DOI 10.1097/01.MIB.0000168372.94907.d2; Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; De Jager PL, 2007, GENES IMMUN, V8, P387, DOI 10.1038/sj.gene.6364398; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Carlo G, 2003, EXPERT OPIN INV DRUG, V12, P39, DOI 10.1517/eoid.12.1.39.21246; Gadzicki D, 1999, MOL CELL PROBE, V13, P321, DOI 10.1006/mcpr.1999.0249; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Gazzerro P, 2007, INT J OBESITY, V31, P908, DOI 10.1038/sj.ijo.0803510; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2009, AM J GASTROENTEROL, V104, P665, DOI 10.1038/ajg.2008.65; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Grinspoon L, 1999, FORSCH KOMPLEMENTMED, V6, P40, DOI 10.1159/000057156; GRINSPOON L, 1995, JAMA-J AM MED ASSOC, V273, P1875, DOI 10.1001/jama.273.23.1875; HILEY CR, 2009, J CARDIOVASC PHARM; HOEHE MR, 1991, NEW BIOL, V3, P880; Horne AW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003969; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Izzo AA, 2008, GUT, V57, P1140, DOI 10.1136/gut.2008.148791; Jin WZ, 1999, J NEUROSCI, V19, P3773; Kimball ES, 2006, AM J PHYSIOL-GASTR L, V291, pG364, DOI 10.1152/ajpgi.00407.2005; King AL, 2000, ANN HUM GENET, V64, P479, DOI 10.1046/j.1469-1809.2000.6460479.x; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Leroy S, 2001, AM J MED GENET, V105, P749, DOI 10.1002/ajmg.10038; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mayer EA, 2002, GASTROENTEROLOGY, V122, P2032, DOI 10.1053/gast.2002.33584; Sarzani R, 2009, METABOLISM, V58, P361, DOI 10.1016/j.metabol.2008.10.009; Scheen AJ, 2009, CURR PROTEIN PEPT SC, V10, P56, DOI 10.2174/138920309787315149; Schmidt LG, 2002, DRUG ALCOHOL DEPEN, V65, P221, DOI 10.1016/S0376-8716(01)00164-8; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Sibaev A, 2006, J MOL MED, V84, P513, DOI 10.1007/s00109-006-0040-x; Siegfried Z, 2004, AM J MED GENET B, V125B, P126, DOI 10.1002/ajmg.b.20089; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Storr M, 2006, Z GASTROENTEROL, V44, P185, DOI 10.1055/s-2005-858931; Storr M, 2009, ALIMENT PHARM THER, V29, P542, DOI 10.1111/j.1365-2036.2008.03910.x; Storr MA, 2008, NEUROGASTROENT MOTIL, V20, P857, DOI 10.1111/j.1365-2982.2008.01175.x; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029	46	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9453	10.1371/journal.pone.0009453	http://dx.doi.org/10.1371/journal.pone.0009453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195480	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000017
J	Tio, M; Tan, KH; Lee, W; Wang, TT; Udolph, G				Tio, Murni; Tan, Kian Hwa; Lee, Wendy; Wang, Ting Ting; Udolph, Gerald			Roles of db-cAMP, IBMX and RA in Aspects of Neural Differentiation of Cord Blood Derived Mesenchymal-Like Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; MARROW STROMAL CELLS; TYROSINE-HYDROXYLASE ISOFORMS; INTRACELLULAR CYCLIC-AMP; C6 GLIOMA-CELLS; PROTEIN-KINASE; NERVOUS-SYSTEM; SH-SY5Y CELLS; PHOSPHORYLATION; NEURONS	Mesenchymal stem cells (MSCs) have multilineage differentiation potential which includes cell lineages of the central nervous system; hence MSCs might be useful in the treatment of neurodegenerative diseases such as Parkinson's disease. Although mesenchymal stem cells have been shown to differentiate into the neural lineage, there is still little knowledge about the underlying mechanisms of differentiation particularly towards specialized neurons such as dopaminergic neurons. Here, we show that MSCs derived from human umbilical cord blood (MSChUCBs) are capable of expressing tyrosine hydroxylase (TH) and Nurr1, markers typically associated with DA neurons. We also found differential phosphorylation of TH isoforms indicating the presence of post-translational mechanisms possibly activating and modifying TH in MSChUCB. Furthermore, functional dissection of components in the differentiation medium revealed that dibutyryl-cAMP (db-cAMP), 3-isobutyl-1-methylxanthine (IBMX) and retinoic acid (RA) are involved in the regulation of Nurr1 and Neurofilament-L expression as well as in the differential phosphorylation of TH. We also demonstrate a possible inhibitory role of the protein kinase A signaling pathway in the phosphorylation of specific TH isoforms.	[Tio, Murni; Tan, Kian Hwa; Lee, Wendy; Wang, Ting Ting; Udolph, Gerald] Inst Med Biol, Inst Biomed Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Tio, M (corresponding author), Inst Med Biol, Inst Biomed Sci, Singapore, Singapore.	gerald.udolph@imb.a-star.edu.sg	wang, tingting/AAK-2640-2020		Biomedical Research Council (BMRC), Singapore; Institute of Medical Biology (IMB), Singapore	Biomedical Research Council (BMRC), Singapore(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology (IMB), Singapore	Funding was received from the Biomedical Research Council (BMRC), Singapore, and the Institute of Medical Biology (IMB), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio J, 1998, J BIOL CHEM, V273, P10196, DOI 10.1074/jbc.273.17.10196; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Cheah TB, 1999, J NEUROSCI METH, V87, P167, DOI 10.1016/S0165-0270(99)00002-3; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Fallahi-Sichani M, 2007, CELL BIOL INT, V31, P299, DOI 10.1016/j.cellbi.2006.11.011; Fraser John K, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS33, DOI 10.1038/ncpcardio0444; Ghosh P, 1997, CELL BIOL INT, V21, P551, DOI 10.1006/cbir.1997.0193; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Greschat S, 2008, STEM CELLS DEV, V17, P221, DOI 10.1089/scd.2007.0118; Iacovitti L, 2001, BRAIN RES, V912, P99, DOI 10.1016/S0006-8993(01)02723-8; Imamura K, 2006, J NEUROSCI RES, V84, P1376, DOI 10.1002/jnr.21021; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; LEBOURDELLES B, 1991, J BIOL CHEM, V266, P17124; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; LEWIS DA, 1993, NEUROSCIENCE, V54, P477, DOI 10.1016/0306-4522(93)90267-J; Lindgren N, 2001, EUR J NEUROSCI, V13, P773, DOI 10.1046/j.0953-816x.2000.01443.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moore KD, 1996, MOL CHEM NEUROPATHOL, V29, P107, DOI 10.1007/BF02814996; MORGENROTH VH, 1975, J BIOL CHEM, V250, P1946; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; OMALLEY KL, 1987, BIOCHEMISTRY-US, V26, P6910, DOI 10.1021/bi00396a007; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Pansky A, 2007, CLIN LAB, V53, P81; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; SHARMA SK, 1987, J NEUROSCI RES, V17, P135, DOI 10.1002/jnr.490170207; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Takahashi T, 1997, J NEURAL TRANSM, V104, P59, DOI 10.1007/BF01271294; Talens-Visconti R, 2007, TOXICOL IN VITRO, V21, P324, DOI 10.1016/j.tiv.2006.08.009; Wang TT, 2007, BIOCHEM BIOPH RES CO, V357, P1021, DOI 10.1016/j.bbrc.2007.04.046; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	42	53	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9398	10.1371/journal.pone.0009398	http://dx.doi.org/10.1371/journal.pone.0009398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195526	Green Published, gold, Green Submitted			2022-12-27	WOS:000274924200020
J	Vendruscolo, LF; Gueye, AB; Darnaudery, M; Ahmed, SH; Cador, M				Vendruscolo, Leandro F.; Gueye, Aliou B.; Darnaudery, Muriel; Ahmed, Serge H.; Cador, Martine			Sugar Overconsumption during Adolescence Selectively Alters Motivation and Reward Function in Adult Rats	PLOS ONE			English	Article							DRUG-ADDICTION; COCAINE; FOOD; DOPAMINE; INTERMITTENT; SENSITIVITY; CONSUMPTION; ESCALATION; BEHAVIORS; BEVERAGES	Background: There has been a dramatic escalation in sugar intake in the last few decades, most strikingly observed in the adolescent population. Sugar overconsumption has been associated with several adverse health consequences, including obesity and diabetes. Very little is known, however, about the impact of sugar overconsumption on mental health in general, and on reward-related behavioral disorders in particular. This study examined in rats the effects of unlimited access to sucrose during adolescence on the motivation for natural and pharmacological rewards in adulthood. Methodology/Principal Findings: Adolescent rats had free access to 5% sucrose or water from postnatal day 30 to 46. The control group had access to water only. In adulthood, rats were tested for self-administration of saccharin (sweet), maltodextrin (non-sweet), and cocaine (a potent drug of abuse) using fixed-and progressive-ratio schedules, and a concentration-response curve for each substance. Adult rats, exposed or not exposed to sucrose, were tested for saccharin self-administration later in life to verify the specificity of adolescence for the sugar effects. Sugar overconsumption during adolescence, but not during adulthood, reduced the subsequent motivation for saccharin and maltodextrin, but not cocaine. This selective decrease in motivation is more likely due to changes in brain reward processing than changes in gustatory perception. Conclusions/Significance: Sugar overconsumption induces a developmental stage-specific chronic depression in reward processing that may contribute to an increase in the vulnerability to reward-related psychiatric disorders.	[Vendruscolo, Leandro F.; Gueye, Aliou B.; Ahmed, Serge H.; Cador, Martine] Univ Bordeaux, CNRS, UMR5227, Bordeaux, France; [Darnaudery, Muriel] Univ Bordeaux, CNRS, UMR5226, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Vendruscolo, LF (corresponding author), Univ Bordeaux, CNRS, UMR5227, Bordeaux, France.	vendruscolo@hotmail.com	Kauk, Rachel C/H-3622-2012; AHMED, Serge H/D-5236-2014; LE MOINE, Catherine/E-2671-2014	DARNAUDERY, Muriel/0000-0003-0209-3880; Ahmed, Serge/0000-0002-1225-9234	Fondation Fyssen, France; Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT), France [0901]; CNRS; University of Lille 1; University Bordeaux 2; Conseil regional d'aquitaine; IREB (Institut de Recherche sur les Boissons)	Fondation Fyssen, France; Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT), France; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lille 1; University Bordeaux 2; Conseil regional d'aquitaine(Region Nouvelle-Aquitaine); IREB (Institut de Recherche sur les Boissons)	LFV received financial support from Fondation Fyssen, France. ABG received financial support from Mission Interministerielle de la Lutte contre les Drogues et la Toxicomanie (MILDT #0901), France. SHA and MC were financially supported by CNRS and MD by University of Lille 1. Research was supported by CNRS, University Bordeaux 2, Conseil regional d'aquitaine, MILDT, IREB (Institut de Recherche sur les Boissons). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2005, PSYCHOPHARMACOLOGY, V180, P473, DOI 10.1007/s00213-005-2180-z; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Barbano MF, 2007, PSYCHOPHARMACOLOGY, V191, P497, DOI 10.1007/s00213-006-0521-1; Baunez C, 2005, NAT NEUROSCI, V8, P484, DOI 10.1038/nn1429; Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Colantuoni C, 2002, OBES RES, V10, P478, DOI 10.1038/oby.2002.66; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Davis CA, 2009, OBESITY, V17, P1220, DOI 10.1038/oby.2009.52; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; Diergaarde L, 2009, BEHAV NEUROSCI, V123, P794, DOI 10.1037/a0016504; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Drewnowski A, 2007, NUTR BULL, V32, P52, DOI 10.1111/j.1467-3010.2007.00604.x; Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9; Frazier CRM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003221; Goeders JE, 2009, PHARMACOL BIOCHEM BE, V93, P67, DOI 10.1016/j.pbb.2009.04.008; Grimm JW, 2007, PSYCHOPHARMACOLOGY, V194, P537, DOI 10.1007/s00213-007-0868-y; Guthrie JF, 2000, J AM DIET ASSOC, V100, P43, DOI 10.1016/S0002-8223(00)00018-3; Hayward MD, 2002, J NEUROSCI, V22, P8251; Iniguez SD, 2009, NEUROPSYCHOPHARMACOL, V34, P1609, DOI 10.1038/npp.2008.220; JACOBSON MF, 2005, LIQUID CANDY SOFT DR; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Le Merrer J, 2006, J NEUROSCI, V26, P7163, DOI 10.1523/JNEUROSCI.5345-05.2006; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Mintz S W, 1979, Marx Perspect, V2, P56; Moore SC, 2009, BRIT J PSYCHIAT, V195, P366, DOI 10.1192/bjp.bp.108.061820; Mormede P, 2004, ALCOHOL ALCOHOLISM, V39, P183, DOI 10.1093/alcalc/agh037; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179; Realini N, 2009, PHARMACOL RES, V60, P132, DOI 10.1016/j.phrs.2009.03.006; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Smith RF, 2003, NEUROTOXICOL TERATOL, V25, P291, DOI 10.1016/S0892-0362(02)00349-5; Spangler R, 2004, MOL BRAIN RES, V124, P134, DOI 10.1016/j.molbrainres.2004.02.013; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stafford D, 1998, PSYCHOPHARMACOLOGY, V139, P169, DOI 10.1007/s002130050702; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Torrey EF, 2001, INVISIBLE PLAGUE RIS; Vendruscolo LF, 2008, BEHAV PHARMACOL, V19, P21, DOI 10.1097/FBP.0b013e3282f3cfbe; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; White AA, 2004, J NUTR EDUC BEHAV, V36, P266, DOI 10.1016/S1499-4046(06)60390-4; WHO, 2003, DIET NUTR PREVENTION, V916; WURTMAN JJ, 1979, SCIENCE, V205, P321, DOI 10.1126/science.451607; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	49	73	73	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9296	10.1371/journal.pone.0009296	http://dx.doi.org/10.1371/journal.pone.0009296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SS	20174565	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700007
J	Kawaguchi, C; Isojima, Y; Shintani, N; Hatanaka, M; Guo, XH; Okumura, N; Nagai, K; Hashimoto, H; Baba, A				Kawaguchi, Chihiro; Isojima, Yasushi; Shintani, Norihito; Hatanaka, Michiyoshi; Guo, Xiaohong; Okumura, Nobuaki; Nagai, Katsuya; Hashimoto, Hitoshi; Baba, Akemichi			PACAP-Deficient Mice Exhibit Light Parameter-Dependent Abnormalities on Nonvisual Photoreception and Early Activity Onset	PLOS ONE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; INDUCED PHASE-SHIFT; GANGLION-CELLS; CIRCADIAN-RHYTHM; MASKING RESPONSES; MELANOPSIN; LACKING; CLOCK; IRRADIANCE; PEPTIDE	Background: The photopigment melanopsin has been suggested to act as a dominant photoreceptor in nonvisual photoreception including resetting of the circadian clock (entrainment), direct tuning or masking of vital status (activity, sleep/wake cycles, etc.), and the pupillary light reflex (PLR). Pituitary adenylate cyclase-activating polypeptide (PACAP) is exclusively coexpressed with melanopsin in a small subset of retinal ganglion cells and is predicted to be involved extensively in these responses; however, there were inconsistencies in the previous reports, and its functional role has not been well understood. Methodology/Principal Findings: Here we show that PACAP-deficient mice exhibited severe dysfunctions of entrainment in a time-dependent manner. The abnormalities in the mutant mice were intensity-dependent in phase delay and duration-dependent in phase advance. The knockout mice also displayed blunted masking, which was dependent on lighting conditions, but not completely lost. The dysfunctions of masking in the mutant mice were recovered by infusion of PACAP-38. By contrast, these mutant mice show a normal PLR. We examined the retinal morphology and innervations in the mutant mice, and no apparent changes were observed in melanopsin-immunoreactive cells. These data suggest that the dysfunctions of entrainment and masking were caused by the loss of PACAP, not by the loss of light input itself. Moreover, PACAP-deficient mice express an unusually early onset of activities, from approximately four hours before the dark period, without influencing the phase of the endogenous circadian clock. Conclusions/Significance: Although some groups including us reported the abnormalities in photic entrainments in PACAP-and PAC(1)-knockout mice, there were inconsistencies in their results [1,2,3,4]. The time-dependent dysfunctions of photic entrainment in the PACAP-knockout mice described in this paper can integrate the incompatible data in previous reports. The recovery of impaired masking by infusion of PACAP-38 in the mutant mice is the first direct evidence of the relationship between PACAP and masking. These results indicate that PACAP regulates particular nonvisual light responses by conveying parametric light information-that is, intensity and duration. The "early-bird'' phenotype in the mutant mice originally reported in this paper supposed that PACAP also has a critical role in daily behavioral patterns, especially during the light-to-dark transition period.	[Kawaguchi, Chihiro; Shintani, Norihito; Hatanaka, Michiyoshi; Guo, Xiaohong; Hashimoto, Hitoshi; Baba, Akemichi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Isojima, Yasushi; Okumura, Nobuaki; Nagai, Katsuya] Osaka Univ, Inst Prot Res, Osaka, Japan; [Isojima, Yasushi] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa, Japan; [Hashimoto, Hitoshi] Osaka Univ, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Hashimoto, Hitoshi] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Osaka, Japan; [Hashimoto, Hitoshi] Hamamatsu Univ Sch Med, Osaka, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine	Kawaguchi, C (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan.	isojima@gsc.riken.jp	Shintani, Norihito/N-1600-2019; Hashimoto, Hitoshi/D-1209-2010; Shintani, Norihito/D-5860-2014	Shintani, Norihito/0000-0002-7850-9064; Hashimoto, Hitoshi/0000-0001-6548-4016; Shintani, Norihito/0000-0002-7850-9064	Japan Society for the Promotion of Science; Sankyo Foundation of Life Science; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation)	This research was partly supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, the Sankyo Foundation of Life Science, and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAHARA H, 2008, FUTURE SYSTEMS EARHQ, P67; Aschoff J, 1999, JPN J PHYSIOL, V49, P11, DOI 10.2170/jjphysiol.49.11; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; BAUER MS, 1992, AM J PHYSIOL, V263, pR1110, DOI 10.1152/ajpregu.1992.263.5.R1110; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Borba JC, 2005, DEV BRAIN RES, V156, P193, DOI 10.1016/j.devbrainres.2005.02.016; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doyle S, 2007, COLD SPRING HARB SYM, V72, P499, DOI 10.1101/sqb.2007.72.003; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; FANG JD, 1995, BRAIN RES, V686, P23, DOI 10.1016/0006-8993(95)00443-T; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harrington ME, 1999, J NEUROSCI, V19, P6637; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hashimoto H, 2009, J NEUROCHEM, V110, P595, DOI 10.1111/j.1471-4159.2009.06168.x; Hatanaka M, 2008, NEUROSCI LETT, V444, P153, DOI 10.1016/j.neulet.2008.08.030; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Kawaguchi C, 2003, BIOCHEM BIOPH RES CO, V310, P169, DOI 10.1016/j.bbrc.2003.09.004; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; MROSOVSKY N, 1994, CHRONOBIOL INT, V11, P343, DOI 10.3109/07420529409057251; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2000, VISION RES, V40, P575, DOI 10.1016/S0042-6989(99)00207-2; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Redlin U, 2001, CHRONOBIOL INT, V18, P737, DOI 10.1081/CBI-100107511; Silveira MS, 2002, J BIOL CHEM, V277, P16075, DOI 10.1074/jbc.M110106200; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370	43	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9286	10.1371/journal.pone.0009286	http://dx.doi.org/10.1371/journal.pone.0009286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174586	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700016
J	Mtove, G; Amos, B; von Seidlein, L; Hendriksen, I; Mwambuli, A; Kimera, J; Mallahiyo, R; Kim, DR; Ochiai, RL; Clemens, JD; Reyburn, H; Magesa, S; Deen, JL				Mtove, George; Amos, Ben; von Seidlein, Lorenz; Hendriksen, Ilse; Mwambuli, Abraham; Kimera, Juma; Mallahiyo, Rajabu; Kim, Deok Ryun; Ochiai, R. Leon; Clemens, John D.; Reyburn, Hugh; Magesa, Stephen; Deen, Jacqueline L.			Invasive Salmonellosis among Children Admitted to a Rural Tanzanian Hospital and a Comparison with Previous Studies	PLOS ONE			English	Article							COMMUNITY-ACQUIRED BACTEREMIA; NON-TYPHOIDAL SALMONELLA; MALAWIAN CHILDREN; MALARIA TRANSMISSION; AFRICAN CHILDREN; FEVER; INFECTIONS; DISEASE; KENYA; PNEUMONIA	Background: The importance of invasive salmonellosis in African children is well recognized but there is inadequate information on these infections. We conducted a fever surveillance study in a Tanzanian rural hospital to estimate the case fraction of invasive salmonellosis among pediatric admissions, examine associations with common co-morbidities and describe its clinical features. We compared our main findings with those from previous studies among children in sub-Saharan Africa. Methodology/Principal Findings: From 1 March 2008 to 28 Feb 2009, 1,502 children were enrolled into the study. We collected clinical information and blood for point of care tests, culture, and diagnosis of malaria and HIV. We analyzed the clinical features on admission and outcome by laboratory-confirmed diagnosis. Pathogenic bacteria were isolated from the blood of 156 (10%) children, of which 14 (9%) were S. typhi, 45 (29%) were NTS and 97 (62%) were other pathogenic bacteria. Invasive salmonellosis accounted for 59/156 (38%) bacteremic children. Children with typhoid fever were significantly older and presented with a longer duration of fever. NTS infections were significantly associated with prior antimalarial treatment, malarial complications and with a high risk for death. Conclusions/Significance: Invasive salmonellosis, particularly NTS infection, is an important cause of febrile disease among hospitalized children in our rural Tanzanian setting. Previous studies showed considerable variation in the case fraction of S. typhi and NTS infections. Certain suggestive clinical features (such as older age and long duration of fever for typhoid whereas concomitant malaria, anemia, jaundice and hypoglycemia for NTS infection) may be used to distinguish invasive salmonellosis from other severe febrile illness.	[Mtove, George; Magesa, Stephen] Natl Inst Med Res, Amani Ctr, Tanga, Tanzania; [Mtove, George; Amos, Ben; von Seidlein, Lorenz; Hendriksen, Ilse; Mwambuli, Abraham; Kimera, Juma; Reyburn, Hugh; Magesa, Stephen; Deen, Jacqueline L.] Joint Malaria Programme, Moshi, Tanzania; [Amos, Ben; Kimera, Juma; Mallahiyo, Rajabu] Hosp Teule, Muheza, Tanga, Tanzania; [von Seidlein, Lorenz; Kim, Deok Ryun; Ochiai, R. Leon; Clemens, John D.; Deen, Jacqueline L.] Int Vaccine Inst, Seoul, South Korea; [Hendriksen, Ilse] Mahidol Oxford Res Unit, Bangkok, Thailand; [Reyburn, Hugh] London Sch Hyg & Trop Med, London WC1, England	International Vaccine Institute; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of London; London School of Hygiene & Tropical Medicine	Mtove, G (corresponding author), Natl Inst Med Res, Amani Ctr, Tanga, Tanzania.	mtoveg2002@yahoo.co.uk	Amos, Ben/AAG-6934-2022; Amos, Ben/AFL-6820-2022	Amos, Ben/0000-0002-8569-1650; Amos, Ben/0000-0002-8569-1650; Ochiai, Leon/0000-0002-5079-6786; Mtove, George/0000-0001-5173-0829	Korean International Cooperation Agency through the International Vaccine Institute	Korean International Cooperation Agency through the International Vaccine Institute	This work was funded by a grant from the Korean International Cooperation Agency through the International Vaccine Institute (http://www.ivi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Bahwere P, 2001, Int J Infect Dis, V5, P180, DOI 10.1016/S1201-9712(01)90067-0; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Cheesbrough JS, 1997, PEDIATR INFECT DIS J, V16, P277, DOI 10.1097/00006454-199703000-00005; DUGGAN MB, 1975, ARCH DIS CHILD, V50, P67, DOI 10.1136/adc.50.1.67; Edmonds S, 2009, HIV MED, V10, P26; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Falade AG, 2009, CLIN INFECT DIS, V48, pS190, DOI 10.1086/596500; Giglioli G, 1929, Proc R Soc Med, V23, P165; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; LEPAGE P, 1987, LANCET, V1, P1458; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x; *NACP, 2007, UN REP TANZ; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; ODEMPSEY TJD, 1994, PEDIATR INFECT DIS J, V13, P122, DOI 10.1097/00006454-199402000-00009; Samarasekera U, 2008, LANCET INFECT DIS, V8, P408, DOI 10.1016/S1473-3099(08)70136-1; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; *STAT NBO, 2002, UN REP TANZ NAT CENS; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X; World Health Organization, 2005, POCK HOSP CAR CHILDR	34	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9244	10.1371/journal.pone.0009244	http://dx.doi.org/10.1371/journal.pone.0009244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20168998	gold, Green Accepted, Green Published			2022-12-27	WOS:000274590500022
J	Lukos, JR; Lee, D; Poizner, H; Santello, M				Lukos, Jamie R.; Lee, Dongpyo; Poizner, Howard; Santello, Marco			Anticipatory Modulation of Digit Placement for Grasp Control Is Affected by Parkinson's Disease	PLOS ONE			English	Article							CENTER-OF-MASS; PRECISION GRIP; BASAL GANGLIA; SENSORIMOTOR MEMORY; MANIPULATIVE FORCES; VISUAL CONTROL; OBJECT SHAPE; HAND; COORDINATION; MOTOR	Background: Successful object manipulation relies on the ability to form and retrieve sensorimotor memories of digit forces and positions used in previous object lifts. Past studies of patients affected by Parkinson's disease (PD) have revealed that the basal ganglia play a crucial role in the acquisition and/or retrieval of sensorimotor memories for grasp control. Whereas it is known that PD impairs anticipatory control of digit forces during grasp, learning deficits associated with the planning of digit placement have yet to be explored. This question is motivated by recent work in healthy subjects revealing that anticipatory control of digit placement plays a crucial role for successful manipulation. Methodology/Principal Findings: We asked ten PD patients off medication and ten age-matched controls to reach, grasp and lift an object whose center of mass (CM) was on the left, right or center. The only task requirement was to minimize object roll during lift. The CM remained the same across consecutive trials (blocked condition) or was altered from trial to trial (random condition). We hypothesized that impairment of the basal ganglia-thalamo-cortical circuits in PD patients would reduce their ability to anticipate digit placement appropriate to the CM location. Consequently, we predicted that PD patients would exhibit similar digit placement in the blocked vs. random conditions and produce larger peak object rolls than that of control subjects. In the blocked condition, PD patients exhibited significantly weaker modulation of fingertip contact points to CM location and larger object roll than controls (p < 0.05 and p < 0.01, respectively). Nevertheless, both controls and PD patients minimized object roll more in the blocked than in the random condition (p < 0.01). Conclusions/Significance: Our findings indicate that, even though PD patients may have a residual ability of anticipatory control of digit contact points and forces, they fail to implement a motor plan with the same degree of effectiveness as controls. We conclude that intact basal ganglia-thalamo-cortical circuits are necessary for successful sensorimotor learning of both grasp kinematics and kinetics required for dexterous hand-object interactions.	[Lukos, Jamie R.; Santello, Marco] Arizona State Univ, Dept Kinesiol, Tempe, AZ 85287 USA; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Lee, Dongpyo; Poizner, Howard] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Poizner, Howard] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of California System; University of California San Diego; University of California System; University of California San Diego	Lukos, JR (corresponding author), Arizona State Univ, Dept Kinesiol, Tempe, AZ 85287 USA.	marco.santello@asu.edu		Lukos, Jamie/0000-0002-6955-1965	National Science Foundation [BCS-0819547, BCS-0829488, SBE-0542013]; National Institutes of Health [2-R01-NS036449]; NSF Science of Learning Center; Veterans Administration RRD [B5015R]; Direct For Social, Behav & Economic Scie [0819547, 0819147] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036449] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); Veterans Administration RRD; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by National Science Foundation Grant [BCS-0819547]; National Science Foundation Supplement [BCS-0829488]; National Institutes of Health Grant [2-R01-NS036449]; National Science Foundation Grant [SBE-0542013] to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center; and Veterans Administration RR&D Grant # B5015R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2003, MOVEMENT DISORD, V18, P231, DOI 10.1002/mds.10327; Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chouinard PA, 2005, J NEUROSCI, V25, P2277, DOI 10.1523/JNEUROSCI.4649-04.2005; Christopoulos VN, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000538; Cohen RG, 2004, EXP BRAIN RES, V157, P486, DOI 10.1007/s00221-004-1862-9; Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; Friedman J, 2007, CORTEX, V43, P444, DOI 10.1016/S0010-9452(08)70469-6; FU Q, 2009, SOC NEUROSCI; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; Gordon AM, 2004, P ANN INT IEEE EMBS, V26, P4641; Gordon AM, 1997, EXP NEUROL, V145, P477, DOI 10.1006/exnr.1997.6479; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ingvarsson PE, 1997, EXP NEUROL, V145, P489, DOI 10.1006/exnr.1997.6480; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; KLOCKGETHER T, 1994, MOVEMENT DISORD, V9, P48, DOI 10.1002/mds.870090108; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Muratori LM, 2008, EXP BRAIN RES, V185, P41, DOI 10.1007/s00221-007-1129-3; Nowak DA, 2006, EXP BRAIN RES, V173, P650, DOI 10.1007/s00221-006-0409-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poizner H, 1998, Motor Control, V2, P251; Poizner H, 2000, EXP BRAIN RES, V133, P279, DOI 10.1007/s002210000379; Prodoehl J, 2009, NEUROSCI BIOBEHAV R, V33, P900, DOI 10.1016/j.neubiorev.2009.03.004; Quaney BM, 2004, EXP BRAIN RES, V155, P145, DOI 10.1007/s00221-003-1711-2; Quaney BM, 2003, J NEUROSCI, V23, P1981; Rearick MP, 2002, EXP NEUROL, V177, P428, DOI 10.1006/exnr.2002.8003; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Santello M, 2004, EXP NEUROL, V187, P517, DOI 10.1016/j.expneurol.2004.02.016; Schettino LF, 2009, INT J NEUROSCI, V119, P1905, DOI 10.1080/00207450903245296; Schettino LF, 2006, EXP BRAIN RES, V168, P186, DOI 10.1007/s00221-005-0080-4; Schettino LF, 2004, NEUROPSYCHOLOGIA, V42, P82, DOI 10.1016/S0028-3932(03)00150-7; Seiss E, 2003, EXP BRAIN RES, V148, P308, DOI 10.1007/s00221-002-1291-6; Vaillancourt DE, 2001, EXP BRAIN RES, V138, P118, DOI 10.1007/s002210100699; WESTLING G, 1984, EXP BRAIN RES, V53, P277; ZHANG W, 2009, SOC NEUROSCI	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2010	5	2							e9184	10.1371/journal.pone.0009184	http://dx.doi.org/10.1371/journal.pone.0009184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZC	20169196	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474600005
J	Curriero, FC; Kulldorff, M; Boscoe, FP; Klassen, AC				Curriero, Frank C.; Kulldorff, Martin; Boscoe, Francis P.; Klassen, Ann C.			Using Imputation to Provide Location Information for Nongeocoded Addresses	PLOS ONE			English	Article							POSITIONAL ACCURACY; CANCER; STAGE; ERROR; GRADE	Background: The importance of geography as a source of variation in health research continues to receive sustained attention in the literature. The inclusion of geographic information in such research often begins by adding data to a map which is predicated by some knowledge of location. A precise level of spatial information is conventionally achieved through geocoding, the geographic information system (GIS) process of translating mailing address information to coordinates on a map. The geocoding process is not without its limitations, though, since there is always a percentage of addresses which cannot be converted successfully (nongeocodable). This raises concerns regarding bias since traditionally the practice has been to exclude nongeocoded data records from analysis. Methodology/Principal Findings: In this manuscript we develop and evaluate a set of imputation strategies for dealing with missing spatial information from nongeocoded addresses. The strategies are developed assuming a known zip code with increasing use of collateral information, namely the spatial distribution of the population at risk. Strategies are evaluated using prostate cancer data obtained from the Maryland Cancer Registry. We consider total case enumerations at the Census county, tract, and block group level as the outcome of interest when applying and evaluating the methods. Multiple imputation is used to provide estimated total case counts based on complete data (geocodes plus imputed nongeocodes) with a measure of uncertainty. Results indicate that the imputation strategy based on using available population-based age, gender, and race information performed the best overall at the county, tract, and block group levels. Conclusions/Significance: The procedure allows for the potentially biased and likely under reported outcome, case enumerations based on only the geocoded records, to be presented with a statistically adjusted count (imputed count) with a measure of uncertainty that are based on all the case data, the geocodes and imputed nongeocodes. Similar strategies can be applied in other analysis settings.	[Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kulldorff, Martin] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Kulldorff, Martin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Boscoe, Francis P.] New York State Dept Hlth, New York State Canc Registry, Albany, NY USA; [Klassen, Ann C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Klassen, Ann C.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; State University of New York (SUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Curriero, FC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA.	fcurrier@jhsph.edu	Kulldorff, Martin/H-4282-2011	Kulldorff, Martin/0000-0002-5284-2993	Centers for Disease Control and the Association of Schools of Public Health; Maryland Cigarette Restitution Fund; Department of Defense; Maryland Cancer Registry; Center for Cancer Surveillance and Control; Department of Health and Mental Hygiene; State of Maryland; National Program of Cancer Registries (NPCR); Centers for Disease Control and Prevention (CDC); NATIONAL CANCER INSTITUTE [R21CA124921] Funding Source: NIH RePORTER	Centers for Disease Control and the Association of Schools of Public Health; Maryland Cigarette Restitution Fund; Department of Defense(United States Department of Defense); Maryland Cancer Registry; Center for Cancer Surveillance and Control; Department of Health and Mental Hygiene; State of Maryland; National Program of Cancer Registries (NPCR); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was provided by the following sources: the Centers for Disease Control and the Association of Schools of Public Health, the Maryland Cigarette Restitution Fund, and the Department of Defense. Cancer incidence data have been provided by the Maryland Cancer Registry, Center for Cancer Surveillance and Control, Department of Health and Mental Hygiene, 201 W. Preston Street, Room 400, Baltimore, MD 21201, www.fha.state.md.us/cancer/registry/, 410-767-4055. The author's acknowledge the State of Maryland, the Maryland Cigarette Restitution Fund, and the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC) for the funds that helped support the availability of the cancer registry data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSTEIN KT, 2004, AM J EPIDEMIOL, V160, P51; Bonner MR, 2003, EPIDEMIOLOGY, V14, P408, DOI 10.1097/01.EDE.0000073121.63254.c5; Boscoe FP, 2008, GEOCODING HLTH DATA, P95; BOSCOE FP, 2002, J REGIST MANAG, V29, P117; Cayo Michael R, 2003, Int J Health Geogr, V2, P10, DOI 10.1186/1476-072X-2-10; Cressie N., 2011, STAT SPATIO TEMPORAL; Elliot P., 2000, SPATIAL EPIDEMIOLOGY, P3; Fotheringham AS, 2009, SAGE HDB SPATIAL ANA; Gaffney SH, 2005, ENVIRON HEALTH PERSP, V113, P1712, DOI 10.1289/ehp.8154; *GEOL INC, 1998, CENS CD; Goldberg DW, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-60; Gregorio DI, 1999, HEALTH PLACE, V5, P173, DOI 10.1016/S1353-8292(99)00004-0; Henry KA, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-3; Hinrichsen VL, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-41; Huang L, 2008, STAT MED, V27, P5111, DOI 10.1002/sim.3342; Hurley SE, 2003, EPIDEMIOLOGY, V14, P386, DOI 10.1097/01.EDE.0000073161.66729.89; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Jung I, 2007, STAT MED, V26, P1594, DOI 10.1002/sim.2607; Klassen AC, 2006, AM J PREV MED, V30, pS77, DOI 10.1016/j.amepre.2005.09.010; Klassen AC, 2004, PREV MED, V39, P441, DOI 10.1016/j.ypmed.2004.04.031; Klassen Ann Carroll, 2005, Int J Health Geogr, V4, P1, DOI 10.1186/1476-072X-4-1; Kravets N, 2007, HEALTH PLACE, V13, P293, DOI 10.1016/j.healthplace.2005.08.006; Lawson, 2010, DIMAPPING RISK ASS; Lawson AB, 2004, GIS IN PUBLIC HEALTH PRACTICE, P31; Little R.J.A., 2002, STAT ANAL MISSING DA; Lovasi GS, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-12; Mazumdar S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-13; Oliver M Norman, 2005, Int J Health Geogr, V4, P29, DOI 10.1186/1476-072X-4-29; Pickle Linda Williams, 2005, Int J Health Geogr, V4, P3, DOI 10.1186/1476-072X-4-3; Pollack LA, 2006, CANCER CAUSE CONTROL, V17, P449, DOI 10.1007/s10552-005-0505-1; R Core Team, 2020, R LANG ENV STAT COMP; Rushton G, 2006, AM J PREV MED, V30, pS16, DOI 10.1016/j.amepre.2005.09.011; Rushton G, 2008, GEOCODING HLTH DATA; SHEEHAN TJ, 2004, INT J HEALTH GEOGR, V3, P1; Stillwell John, 2003, APPL GIS SPATIAL ANA; Strickland MJ, 2007, ENVIRON HEALTH-UK, V6, DOI 10.1186/1476-069X-6-10; Wakefield JC, 2000, SPATIAL EPIDEMIOLOGY, P128; Walter SD., 2000, SPATIAL EPIDEMIOLOGY, P223; Ward MH, 2005, EPIDEMIOLOGY, V16, P542, DOI 10.1097/01.ede.0000165364.54925.f3; Whitsel Eric A, 2006, Epidemiol Perspect Innov, V3, P8, DOI 10.1186/1742-5573-3-8; WIGGINS L, 2002, USING GEOGRAPHIC INF, P85; Wilson JP., 2007, HDB GEOGRAPHIC INFOR, V1st; Zandbergen PA, 2007, ENVIRON HEALTH PERSP, V115, P1363, DOI 10.1289/ehp.9668; Zhan FB, 2006, ANN EPIDEMIOL, V16, P842, DOI 10.1016/j.annepidem.2006.08.001; Zimmerman D.L., 2008, GEOCODING HLTH DATA, P165; Zimmerman DL, 2008, STAT MED, V27, P4254, DOI 10.1002/sim.3288; Zimmerman DL, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-1; Zimmerman DL, 2008, BIOMETRICS, V64, P262, DOI 10.1111/j.1541-0420.2007.00870.x	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e8998	10.1371/journal.pone.0008998	http://dx.doi.org/10.1371/journal.pone.0008998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161766	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442700001
J	Lehner, B				Lehner, Ben			Genes Confer Similar Robustness to Environmental, Stochastic, and Genetic Perturbations in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTIONARY PLASTICITY; MORPHOLOGICAL EVOLUTION; INTERACTION NETWORKS; CANALIZATION; CAPACITOR; HSP90; EVOLVABILITY; PHENOTYPE; GENOME	Gene inactivation often has little or no apparent consequence for the phenotype of an organism. This property-enetic (or mutational) robustness-is pervasive, and has important implications for disease and evolution, but is not well understood. Dating back to at least Waddington, it has been suggested that mutational robustness may be related to the requirement to withstand environmental or stochastic perturbations. Here I show that global quantitative data from yeast are largely consistent with this idea. Considering the effects of mutations in all nonessential genes shows that genes that confer robustness to environmental or stochastic change also buffer the effects of genetic change, and with similar efficacy. This means that selection during evolution for environmental or stochastic robustness (also referred to as canalization) may frequently have the side effect of increasing genetic robustness. A dynamic environment may therefore promote the evolution of phenotypic complexity. It also means that "hub'' genes in genetic interaction (synthetic lethal) networks are generally genes that confer environmental resilience and phenotypic stability.	[Lehner, Ben] European Mol Biol Lab, Barcelona, Spain; [Lehner, Ben] Univ Pompeu Fabra, Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	European Molecular Biology Laboratory (EMBL); ICREA; Pompeu Fabra University	Lehner, B (corresponding author), European Mol Biol Lab, Barcelona, Spain.	ben.lehner@crg.es	Lehner, Ben/L-3413-2014; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124	European Research Council; InstitucioCatalana de Recerca i Estudis Avancats; Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestiod'Ajuts Universitaris i de Recerca; European Molecular Biology-Centre for Genomic Regulation Systems Biology; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); InstitucioCatalana de Recerca i Estudis Avancats(ICREA); Ministerio de Ciencia e Innovacion Plan Nacional; Agencia de Gestiod'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Molecular Biology-Centre for Genomic Regulation Systems Biology; ICREA(ICREA)	This research was supported by the European Research Council, InstitucioCatalana de Recerca i Estudis Avancats, Ministerio de Ciencia e Innovacion Plan Nacional, Agencia de Gestiod'Ajuts Universitaris i de Recerca, and the European Molecular Biology-Centre for Genomic Regulation Systems Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689; Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dichtel-Danjoy ML, 2004, TRENDS GENET, V20, P268, DOI 10.1016/j.tig.2004.03.010; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ohya Y, 2005, P NATL ACAD SCI USA, V102, P19015, DOI 10.1073/pnas.0509436102; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Waddington C., 1957, STRATEGY GENES; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]	34	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9035	10.1371/journal.pone.0009035	http://dx.doi.org/10.1371/journal.pone.0009035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140261	Green Published, gold			2022-12-27	WOS:000274474200021
J	Mannige, RV; Brooks, CL				Mannige, Ranjan V.; Brooks, Charles L., III			Periodic Table of Virus Capsids: Implications for Natural Selection and Design	PLOS ONE			English	Article							ELECTRON CRYOMICROSCOPY; RELATIONAL DATABASE; STRUCTURAL VIROLOGY; PROTEIN; TRANSITION; INSIGHTS; HEAD	Background: For survival, most natural viruses depend upon the existence of spherical capsids: protective shells of various sizes composed of protein subunits. So far, general evolutionary pressures shaping capsid design have remained elusive, even though an understanding of such properties may help in rationally impeding the virus life cycle and designing efficient nano- assemblies. Principal Findings: This report uncovers an unprecedented and species-independent evolutionary pressure on virus capsids, based on the the notion that the simplest capsid designs (or those capsids with the lowest "hexamer complexity'', C(h)) are the fittest, which was shown to be true for all available virus capsids. The theories result in a physically meaningful periodic table of virus capsids that uncovers strong and overarching evolutionary pressures, while also offering geometric explanations to other capsid properties (rigidity, pleomorphy, auxiliary requirements, etc.) that were previously considered to be unrelatable properties of the individual virus. Significance: Apart from describing a universal rule for virus capsid evolution, our work (especially the periodic table) provides a language with which highly diverse virus capsids, unified only by geometry, may be described and related to each other. Finally, the available virus structure databases and other published data reiterate the predicted geometry-derived rules, reinforcing the role of geometry in the natural selection and design of virus capsids.	[Mannige, Ranjan V.; Brooks, Charles L., III] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Mannige, Ranjan V.; Brooks, Charles L., III] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Mannige, Ranjan V.; Brooks, Charles L., III] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Mannige, Ranjan V.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Scripps Research Institute	Mannige, RV (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	ranjan@umich.edu; brookscl@umich.edu			National Institutes of Health [RR012255]; National Science Foundation [PHY0216576]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants from the National Institutes of Health (RR012255) and the National Science Foundation (PHY0216576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Choi KH, 2006, STRUCTURE, V14, P1723, DOI 10.1016/j.str.2006.09.007; Conway JF, 2007, J STRUCT BIOL, V158, P224, DOI 10.1016/j.jsb.2006.11.006; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Dokland T, 1997, NATURE, V389, P308, DOI 10.1038/38537; Ferreira D, 2003, VIROLOGY, V307, P54, DOI 10.1016/S0042-6822(02)00034-X; Fokine A, 2005, J MOL BIOL, V352, P117, DOI 10.1016/j.jmb.2005.07.018; Goldberg M., 1937, TOHOKU MATH J, V43, P104; Henrick K, 2003, J STRUCT BIOL, V144, P228, DOI 10.1016/j.jsb.2003.09.009; HORNE R, 1961, VIROLOGY, V28, P348; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; Lidmar J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.051910; LIN C, 1988, MATH APPL DETERMINIS, P490; Mannige RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051902; Mannige RV, 2009, P NATL ACAD SCI USA, V106, P8531, DOI 10.1073/pnas.0811517106; Mettenleiter TC, 2009, VIRUS RES, V143, P222, DOI 10.1016/j.virusres.2009.03.018; Nandhagopal N, 2002, P NATL ACAD SCI USA, V99, P14758, DOI 10.1073/pnas.232580699; Neuman BW, 2005, J VIROL, V79, P3822, DOI 10.1128/JVI.79.6.3822-3830.2005; Nguyen TL, 2005, J STRUCT BIOL, V151, P30, DOI 10.1016/j.jsb.2005.02.013; Nguyen TT, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051923; Overby AK, 2008, P NATL ACAD SCI USA, V105, P2375, DOI 10.1073/pnas.0708738105; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; RUX J, 2008, CURR OPIN STRUC BIOL, V8, P142; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Twarock R, 2004, J THEOR BIOL, V226, P477, DOI 10.1016/j.jtbi.2003.10.006; Yan XD, 2005, J VIROL, V79, P9236, DOI 10.1128/JVI.79.14.9236-9243.2005; Yan XD, 2000, NAT STRUCT BIOL, V7, P101, DOI 10.1038/72360; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619	35	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9423	10.1371/journal.pone.0009423	http://dx.doi.org/10.1371/journal.pone.0009423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209096	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100001
J	Yao, JK; Dougherty, GG; Reddy, RD; Keshavan, MS; Montrose, DM; Matson, WR; McEvoy, J; Kaddurah-Daouk, R				Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.; Keshavan, Matcheri S.; Montrose, Debra M.; Matson, Wayne R.; McEvoy, Joseph; Kaddurah-Daouk, Rima			Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia	PLOS ONE			English	Article							SERUM URIC-ACID; PERFORMANCE LIQUID-CHROMATOGRAPHY; IMPAIRED GLUTATHIONE SYNTHESIS; MULTIPLE-SCLEROSIS PATIENTS; PLASMA ANTIOXIDANTS; OXIDATIVE STRESS; RISK-FACTOR; BRAIN; PEROXYNITRITE; SYSTEM	Background: Purine catabolism may be an unappreciated, but important component of the homeostatic response of mitochondria to oxidant stress. Accumulating evidence suggests a pivotal role of oxidative stress in schizophrenia pathology. Methodology/Principal Findings: Using high-pressure liquid chromatography coupled with a coulometric multi-electrode array system, we compared 6 purine metabolites simultaneously in plasma between first-episode neuroleptic-naive patients with schizophrenia (FENNS, n = 25) and healthy controls (HC, n = 30), as well as between FENNS at baseline (BL) and 4 weeks (4w) after antipsychotic treatment. Significantly higher levels of xanthosine (Xant) and lower levels of guanine (G) were seen in both patient groups compared to HC subjects. Moreover, the ratios of G/guanosine (Gr), uric acid (UA)/Gr, and UA/Xant were significantly lower, whereas the ratio of Xant/G was significantly higher in FENNS-BL than in HC. Such changes remained in FENNS-4w with exception that the ratio of UA/Gr was normalized. All 3 groups had significant correlations between G and UA, and Xan and hypoxanthine (Hx). By contrast, correlations of UA with each of Xan and Hx, and the correlation of Xan with Gr were all quite significant for the HC but not for the FENNS. Finally, correlations of Gr with each of UA and G were significant for both HC and FENNS-BL but not for the FENNS-4w. Conclusions/Significance: During purine catabolism, both conversions of Gr to G and of Xant to Xan are reversible. Decreased ratios of product to precursor suggested a shift favorable to Xant production from Xan, resulting in decreased UA levels in the FENNS. Specifically, the reduced UA/Gr ratio was nearly normalized after 4 weeks of antipsychotic treatment. In addition, there are tightly correlated precursor and product relationships within purine pathways; although some of these correlations persist across disease or medication status, others appear to be lost among FENNS. Taken together, these results suggest that the potential for steady formation of antioxidant UA from purine catabolism is altered early in the course of illness.	[Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Yao, Jeffrey K.; Dougherty, George G., Jr.; Reddy, Ravinder D.; Keshavan, Matcheri S.; Montrose, Debra M.] Univ Pittsburgh, Western Psychiat Inst & Clin, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; [Yao, Jeffrey K.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA; [Keshavan, Matcheri S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Keshavan, Matcheri S.] Harvard Univ, Boston, MA 02115 USA; [Matson, Wayne R.] Bedford VA Med Ctr, Bedford, MA USA; [McEvoy, Joseph; Kaddurah-Daouk, Rima] Duke Univ, Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Duke University	Yao, JK (corresponding author), VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA.	jkyao@pitt.edu		Kaddurah-Daouk, Rima/0000-0003-1858-5732	Department of Veterans Affairs (VA); Veterans Health Administration; Office of Research and Development; Biomedical Laboratory Research Development; VA Pittsburgh Healthcare System; National Institute of Health [MH58141, MH64118, MH45203, R24 GM078233, c UL1 RR024153]; NIH/NCRR/GCRC [M01 RR00056]; Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD); National Alliance for Research on Schizophrenia and Affective Disorders (RKD); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153, M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH064118, R01MH058141, R01MH045203] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Biomedical Laboratory Research Development(US Department of Veterans Affairs); VA Pittsburgh Healthcare System(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD); National Alliance for Research on Schizophrenia and Affective Disorders (RKD)(NARSAD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This material is based upon work supported in part by the grants from the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research & Development [Merit Reviews (JKY) and Senior Research Career Scientist Award (JKY)], VA Pittsburgh Healthcare System (JKY, GGD, RDR), National Institute of Health [MH58141 (JKY), MH64118 (RDR), MH45203 (MSK), R24 GM078233 (RKD), c UL1 RR024153 and NIH/NCRR/GCRC Grant M01 RR00056], Metabolomics Research Network (RKD); Stanley Medical Research Institute (RKD), and National Alliance for Research on Schizophrenia and Affective Disorders (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol O, 2005, PROG NEURO-PSYCHOPH, V29, P123, DOI 10.1016/j.pnpbp.2004.10.014; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Bubber P, 2004, J MOL NEUROSCI, V24, P315, DOI 10.1385/JMN:24:2:315; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; CHOW KC, 1992, VITAMIN E HLTH DIS, P683; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; CORY JG, 1982, TXB BIOCH CLIN CORRE, P489; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Eriksson L., 2001, MULTI MEGAVARIATE DA; ERNSTER I, 1993, ACTIVE OXYGEN SPECIE, P11; Fendri C, 2006, ENCEPHALE, V32, P244; FISCHBACH FT, 1999, MANUAL LAB DIAGNOSTI; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Gysin R, 2009, BRAIN RES BULL, V79, P46, DOI 10.1016/j.brainresbull.2008.10.015; Hanihara T, 1997, J CLIN PSYCHIAT, V58, P256, DOI 10.4088/JCP.v58n0604; HASTIE T, 2001, ELEMENTS STAT LEARNI, P95; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; JOSSA F, 1994, J HUM HYPERTENS, V8, P677; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Keller JN, 1998, J NEUROSCI, V18, P687; KENDALL M, 1990, RANK CORRELATION MET, P60; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Knapp CM, 2004, MULT SCLER, V10, P278, DOI 10.1191/1352458504ms1042oa; Kristal Bruce S., 2007, V358, P159, DOI 10.1007/978-1-59745-244-1_10; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; LEHMANN EL, 1975, NONPARAMETRICS STAT, P20; Linden J., 2006, BASIC NEUROCHEMISTRY, P303; Liu F, 2006, SPINAL CORD, V44, P421, DOI 10.1038/sj.sc.3101878; LOHR JB, 1992, SCHIZOPHR RES, V8, P93, DOI 10.1016/0920-9964(92)90024-Y; Maes M, 1997, PSYCHIAT RES, V66, P1, DOI 10.1016/S0165-1781(96)02915-0; Maes M, 2000, EUR NEUROPSYCHOPHARM, V10, P119, DOI 10.1016/S0924-977X(99)00062-0; MAHADIK SP, 2003, PHOSPHOLIPID SPECTRU, P277; Mannelli P, 2009, HUM PSYCHOPHARM CLIN, V24, P666, DOI 10.1002/hup.1068; Matsuzawa D, 2009, AM J MED GENET B, V150B, P86, DOI 10.1002/ajmg.b.30776; Matsuzawa D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001944; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Muraoka S, 2003, PHARMACOL TOXICOL, V93, P284, DOI 10.1111/j.1600-0773.2003.pto930606.x; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PACHER P, 2007, PHYSIOL REV, V315, P424; Papas AM, 1996, LIPIDS, V31, pS77, DOI 10.1007/BF02637055; Patkar AA, 2009, PSYCHOPHARMACOLOGY, V206, P479, DOI 10.1007/s00213-009-1625-1; PILLAI A, 2007, FATTY ACIDS OXIDATIV, P29; PRYOR WA, 1992, ANN NY ACAD SCI, V686, P29; Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Reddy RD, 1996, PROSTAG LEUKOTR ESS, V55, P33, DOI 10.1016/S0952-3278(96)90143-X; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; SAITO I, 1978, J AM GERIATR SOC, V26, P241, DOI 10.1111/j.1532-5415.1978.tb02396.x; Schiavo S, 2008, ANAL CHEM, V80, P5912, DOI 10.1021/ac800507y; Scott GS, 2002, P NATL ACAD SCI USA, V99, P16303, DOI 10.1073/pnas.212645999; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; Spitsin S, 2001, MULT SCLER, V7, P313, DOI 10.1191/135245801681138013; STEGMAYR B, 1993, INT J VITAM NUTR RES, V63, P195; Strazzullo P, 2007, NUTR METAB CARDIOVAS, V17, P409, DOI 10.1016/j.numecd.2007.02.011; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Virit O, 2009, NEUROPSYCHOBIOLOGY, V60, P87, DOI 10.1159/000239684; Walss-Bass C, 2009, AM J MED GENET B, V150B, P219, DOI 10.1002/ajmg.b.30791; Waring WS, 2000, QJM-INT J MED, V93, P707, DOI 10.1093/qjmed/93.11.707; Watkins SM, 2000, ISRAEL MED ASSOC J, V2, P722; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; Yao J. K., 2009, MOL PSYCHIAT; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 1998, PSYCHIAT RES, V80, P29, DOI 10.1016/S0165-1781(98)00051-1; Yao JK, 2004, SCHIZOPHRENIA BULL, V30, P923, DOI 10.1093/oxfordjournals.schbul.a007142; Yao JK, 2004, J CHROMATOGR B, V810, P93, DOI 10.1016/j.jchromb.2004.07.021; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004	83	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9508	10.1371/journal.pone.0009508	http://dx.doi.org/10.1371/journal.pone.0009508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20209081	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000275063400014
J	Liu, HG; Ren, G; Miao, Z; Zhang, XF; Tang, XD; Han, PZ; Gambhir, SS; Cheng, Z				Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Tang, Xiaodong; Han, Peizhen; Gambhir, Sanjiv S.; Cheng, Zhen			Molecular Optical Imaging with Radioactive Probes	PLOS ONE			English	Article							RGD-BOMBESIN HETERODIMER; SMALL-ANIMAL PET; BREAST-CANCER; NUCLEAR-MEDICINE; BREMSSTRAHLUNG; LIGHT; EXPRESSION; SYMPORTER; ELECTRONS; RADIATION	Background: Optical imaging (OI) techniques such as bioluminescence and fluorescence imaging have been widely used to track diseases in a non-invasive manner within living subjects. These techniques generally require bioluminescent and fluorescent probes. Here we demonstrate the feasibility of using radioactive probes for in vivo molecular OI. Methodology/ Principal Findings: By taking the advantages of low energy window of light (1.2-3.1 eV, 400-1000 nm) resulting from radiation, radionuclides that emit charged particles such as b + and b 2 can be successfully imaged with an OI instrument. In vivo optical images can be obtained for several radioactive probes including 2-deoxy-2-[F-18] fluoro-D-glucose ([F-18] FDG), Na F-18, (NaI)-I-131, (YCI3)-Y-90 and a Y-90 labeled peptide that specifically target tumors. Conclusions/Significance: These studies demonstrate generalizability of radioactive OI technique. It provides a new molecular imaging strategy and will likely have significant impact on both small animal and clinical imaging.	[Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Gambhir, Sanjiv S.; Cheng, Zhen] Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA; [Liu, Hongguang; Ren, Gang; Miao, Zheng; Zhang, Xiaofen; Gambhir, Sanjiv S.; Cheng, Zhen] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [Gambhir, Sanjiv S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tang, Xiaodong] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Liu, Hongguang; Zhang, Xiaofen; Han, Peizhen] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China	Stanford University; Stanford University; Stanford University; University of Notre Dame; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Tsinghua University	Liu, HG (corresponding author), Stanford Univ, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA.	zcheng@stanford.edu	Cheng, Zhen/K-2843-2012; Tang, Xiaodong/F-4891-2016; miao, zheng/A-8851-2012; Ren, Gang/C-1315-2010	Cheng, Zhen/0000-0001-8177-9463; 	Department of Radiology, Stanford University; China Scholarship Council; National Cancer Institute (NCI) [P50 CA114747, R01 CA119053]; NATIONAL CANCER INSTITUTE [R01CA119053, P50CA114747] Funding Source: NIH RePORTER	Department of Radiology, Stanford University(Stanford University); China Scholarship Council(China Scholarship Council); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Department of Radiology, Stanford University (to Z. C.), a China Scholarship Council fellowship (to H. L.), the National Cancer Institute (NCI) In Vivo Cellular Molecular Imaging Center (ICMIC) grant P50 CA114747 (to S. S. G.), and R01 CA119053 (to Z. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breeman WAP, 2004, NUCL MED BIOL, V31, P821, DOI 10.1016/j.nucmedbio.2004.03.008; Buscombe J, 2008, EXPERT REV ANTICANC, V8, P1425, DOI 10.1586/14737140.8.9.1425; Cerenkov PA, 1937, PHYS REV, V52, P0378, DOI 10.1103/PhysRev.52.378; Cheng Z, 2008, J NUCL MED, V49, P804, DOI 10.2967/jnumed.107.047381; Chung JK, 2002, J NUCL MED, V43, P1188; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Iagaru A, 2009, J NUCL MED, V50, P501, DOI 10.2967/jnumed.108.058339; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P1483, DOI 10.1007/s00259-009-1123-z; Liu ZF, 2009, J MED CHEM, V52, P425, DOI 10.1021/jm801285t; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Minarik D, 2008, PHYS MED BIOL, V53, P5689, DOI 10.1088/0031-9155/53/20/008; NAKEL W, 1994, PHYS REP, V243, P317, DOI 10.1016/0370-1573(94)00068-9; Okarvi SM, 2001, EUR J NUCL MED, V28, P929, DOI 10.1007/s002590100508; Oriuchi N, 2005, ANN NUCL MED, V19, P355, DOI 10.1007/BF03027399; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; SELTZER SM, 1985, NUCL INSTRUM METH B, V12, P95, DOI 10.1016/0168-583X(85)90707-4; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; SHEN S, 1994, J NUCL MED, V35, P1381; Siegel JA, 1996, J NUCL MED, V37, P495; van Essen M, 2009, NAT REV ENDOCRINOL, V5, P382, DOI 10.1038/nrendo.2009.105; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123	27	167	174	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9470	10.1371/journal.pone.0009470	http://dx.doi.org/10.1371/journal.pone.0009470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208993	gold, Green Submitted, Green Published			2022-12-27	WOS:000274997100016
J	Arbab, AS; Janic, B; Jafari-Khouzani, K; Iskander, ASM; Kumar, S; Varma, NRS; Knight, RA; Soltanian-Zadeh, H; Brown, SL; Frank, JA				Arbab, Ali S.; Janic, Branislava; Jafari-Khouzani, Kourosh; Iskander, A. S. M.; Kumar, Sanath; Varma, Nadimpalli R. S.; Knight, Robert A.; Soltanian-Zadeh, Hamid; Brown, Stephen L.; Frank, Joseph A.			Differentiation of Glioma and Radiation Injury in Rats Using In Vitro Produce Magnetically Labeled Cytotoxic T-Cells and MRI	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; TUMOR RECURRENCE; RESONANCE-SPECTROSCOPY; IMMUNE-RESPONSES; MALIGNANT GLIOMA; GRADE GLIOMAS; SPINAL-CORD; F-18 FDG	Background: A limitation with current imaging strategies of recurrent glioma undergoing radiotherapy is that tumor and radiation injury cannot be differentiated with post contrast CT or MRI, or with PET or other more complex parametric analyses of MRI data. We propose to address the imaging limitation building on emerging evidence indicating that effective therapy for recurrent glioma can be attained by sensitized T-cells following vaccination of primed dendritic cells (DCs). The purpose of this study was to determine whether cord blood T-cells can be sensitized against glioma cells (U-251) and if these sensitized cytotoxic T-cells (CTLs) can be used as cellular magnetic resonance imaging probes to identify and differentiate glioma from radiation necrosis in rodent models. Methodology/Principal Findings: Cord blood T and CD14+ cells were collected. Isolated CD14+ cells were then converted to dendritic cells (DCs), primed with glioma cell lysate and used to sensitize T-cells. Phenotypical expression of the generated DCs were analyzed to determine the expression level of CD14, CD86, CD83 and HLA-DR. Cells positive for CD25, CD4, CD8 were determined in generated CTLs. Specificity of cytotoxicity of the generated CTLs was also determined by lactate dehydrogenase (LDH) release assay. Secondary proliferation capacity of magnetically labeled and unlabeled CTLs was also determined. Generated CTLs were magnetically labeled and intravenously injected into glioma bearing animals that underwent MRI on days 3 and 7 post-injection. CTLs were also administered to animals with focal radiation injury to determine whether these CTLs accumulated non-specifically to the injury sites. Multi-echo T2- and T2*-weighted images were acquired and R2 and R2* maps created. Our method produced functional, sensitized CTLs that specifically induced U251 cell death in vitro. Both labeled and unlabeled CTLs proliferated equally after the secondary stimulation. There were significantly higher CD25 positive cells (p = <0.006) in CTLs. In addition, T2- and T2*-weighted MR images showed increased low signal intensity areas in animals that received labeled CTLs as compared to the images from animals that received control cells. Histological analysis confirmed the presence of iron positive cells in sites corresponding to MRI low signal intensity regions. Significant differences (p = <0.001) in tumor R2 and R2* values were observed among the groups of animals. Animals with radiation injury exhibited neither MRI hypointense areas nor presence of iron positive cells. Conclusion: Our results indicate that T-cells can be effectively sensitized by in vitro methods and used as cellular probes to identify and differentiate glioma from radiation necrosis.	[Arbab, Ali S.; Janic, Branislava; Jafari-Khouzani, Kourosh; Iskander, A. S. M.; Varma, Nadimpalli R. S.; Soltanian-Zadeh, Hamid] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA; [Knight, Robert A.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kumar, Sanath; Brown, Stephen L.] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA; [Frank, Joseph A.] NIH, Frank Lab Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, Frank Lab, NIH, Bethesda, MD USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Arbab, AS (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Frank, Joseph/W-2021-2019; Soltanian-Zadeh, Hamid/AAD-7027-2022; Soltanian-Zadeh, Hamid/K-2903-2016	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856	National Institutes of Health (NIH) [R21NS058589, R01CA122031, 1R21CA129801]; NATIONAL CANCER INSTITUTE [R21CA129801, R01CA122031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058589] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	The work is supported by National Institutes of Health (NIH) grants R21NS058589, R01CA122031 and 1R21CA129801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger R, 2007, J IMMUNOTHER, V30, P29, DOI 10.1097/01.cji.0000211326.38149.7e; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Anderson SA, 2004, ANN NEUROL, V55, P654, DOI 10.1002/ana.20066; Arbab AS, 2007, MAGN RESON MED, V58, P519, DOI 10.1002/mrm.21343; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab Ali Syed, 2004, Mol Imaging, V3, P24, DOI 10.1162/153535004773861697; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2003, TRANSPLANTATION, V76, P1123, DOI 10.1097/01.TP.0000089237.39220.83; Arbab AS, 2004, BLOOD, V104, P3412; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bolus NE, 2009, J NUCL MED TECHNOL, V37, P63, DOI 10.2967/jnmt.108.060848; BUCHPIGUEL CA, 1995, J NUCL MED, V36, P159; Callera F, 2007, STEM CELLS DEV, V16, P461, DOI 10.1089/scd.2007.0083; Chang Susan M, 2006, Neurosurg Focus, V20, pE4; Dahnke H, 2008, MAGN RESON MED, V60, P595, DOI 10.1002/mrm.21478; Daldrup-Link HE, 2005, EUR RADIOL, V15, P4, DOI 10.1007/s00330-004-2526-7; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Dhermain F, 2005, B CANCER, V92, P333; DOOMS GC, 1986, RADIOLOGY, V158, P149, DOI 10.1148/radiology.158.1.3940373; DOYLE WK, 1987, J COMPUT ASSIST TOMO, V11, P563, DOI 10.1097/00004728-198707000-00001; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Hein PA, 2004, AM J NEURORADIOL, V25, P201; Hentschel Stephen J, 2003, Cancer Control, V10, P109; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; IWAMA T, 1991, Neurological Research, V13, P48; Izumiyama Hitoshi, 2004, Brain Tumor Pathol, V21, P39, DOI 10.1007/BF02482176; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Johnson L. A., 2009, BLOOD; KIM EE, 1992, RADIOGRAPHICS, V12, P269, DOI 10.1148/radiographics.12.2.1561416; Kim JH, 1999, INT J RADIAT ONCOL, V45, P1035, DOI 10.1016/S0360-3016(99)00273-4; Kircher MF, 2003, CANCER RES, V63, P6838; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; Liu W, 2008, NMR BIOMED, V21, P242, DOI 10.1002/nbm.1187; Munter MW, 1999, RADIOLOGY, V212, P475; Nelson SJ, 2003, MOL CANCER THER, V2, P497; Phuphanich S, 1996, SURG NEUROL, V45, P362, DOI 10.1016/0090-3019(95)00243-X; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-28; Remer Sandra, 2004, Clin J Oncol Nurs, V8, P368, DOI 10.1188/04.CJON.368-376; Rock JP, 2004, NEUROSURGERY, V54, P1111, DOI 10.1227/01.NEU.0000119328.56431.A7; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Tada Y, 2003, CANCER GENE THER, V10, P451, DOI 10.1038/sj.cgt.7700584; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Wurker M, 1996, EUR J NUCL MED, V23, P583; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Yamanaka R, 2003, INT J ONCOL, V23, P5; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yu JS, 2001, CANCER RES, V61, P842; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	52	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9365	10.1371/journal.pone.0009365	http://dx.doi.org/10.1371/journal.pone.0009365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195476	Green Published, gold, Green Submitted			2022-12-27	WOS:000274997000005
J	Pavankumar, TL; Sinha, AK; Ray, MK				Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.			All Three Subunits of RecBCD Enzyme Are Essential for DNA Repair and Low-Temperature Growth in the Antarctic Pseudomonas syringae Lz4W	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; CHI-RECOGNITION; RECA PROTEIN; SCHIRMACHER OASIS; NUCLEASE ACTIVITY; GENE REPLACEMENT; MUTANTS; REPLICATION	Background: The recD mutants of the Antarctic Pseudomonas syringae Lz4W are sensitive to DNA-damaging agents and fail to grow at 4 degrees C. Generally, RecD associates with two other proteins (RecB and RecC) to produce RecBCD enzyme, which is involved in homologous recombination and DNA repair in many bacteria, including Escherichia coli. However, RecD is not essential for DNA repair, nor does its deletion cause any growth defects in E. coli. Hence, the assessment of the P. syringae RecBCD pathway was imperative. Methodology/Principal Findings: Mutational analysis and genetic complementation studies were used to establish that the individual null-mutations of all three genes, recC, recB, and recD, or the deletion of whole recCBD operon of P. syringae, lead to growth inhibition at low temperature, and sensitivity to UV and mitomycin C. Viability of the mutant cells dropped drastically at 4 degrees C, and the mutants accumulated linear chromosomal DNA and shorter DNA fragments in higher amounts compared to 22 degrees C. Additional genetic data using the mutant RecBCD enzymes that were inactivated either in the ATPase active site of RecB (RecB(K29Q)) or RecD (RecD(K229Q)), or in the nuclease center of RecB (RecB(D1118A) and RecB(Delta nuc)) suggested that, while the nuclease activity of RecB is not so critical in vivo, the ATP-dependent functions of both RecB and RecD are essential. Surprisingly, E. coli recBCD or recBC alone on plasmid could complement the defects of the Delta recCBD strain of P. syringae. Conclusions/Significance: All three subunits of the RecBCD(Ps) enzyme are essential for DNA repair and growth of P. syringae at low temperatures (4 degrees C). The RecD requirement is only a function of the RecBCD complex in the bacterium. The RecBCD pathway protects the Antarctic bacterium from cold-induced DNA damages, and is critically dependent on the helicase activities of both RecB and RecD subunits, but not on the nuclease of RecBCD(Ps) enzyme.	[Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Pavankumar, TL (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	malay@ccmb.res.in	Sinha, Anurag/L-3936-2019; Sinha, Anurag/GXA-0049-2022; Pavankumar, Theetha L/R-6118-2017	Sinha, Anurag/0000-0002-6051-4930; Pavankumar, Theetha L/0000-0003-1845-9592	Institute, Centre for Cellular and Molecular Biology, Hyderabad; Council of Scientific and Industrial Research (CSIR)	Institute, Centre for Cellular and Molecular Biology, Hyderabad; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	The work was an in-house project of the Institute, Centre for Cellular and Molecular Biology, Hyderabad, which is funded by the Council of Scientific and Industrial Research (CSIR), an autonomous body under the Government of India. The Centre is a nonprofit research organization devoted to basic research. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Bidle KA, 1999, J BACTERIOL, V181, P2330, DOI 10.1128/JB.181.8.2330-2337.1999; Cano DA, 2002, J BACTERIOL, V184, P592, DOI 10.1128/JB.184.2.592-595.2002; CAPALDOK.F, 1971, J BACTERIOL, V106, P204, DOI 10.1128/JB.106.1.204-212.1971; CHAUDHURY AM, 1984, J BACTERIOL, V160, P788, DOI 10.1128/JB.160.2.788-791.1984; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Dermic D, 2006, GENETICS, V172, P2057, DOI 10.1534/genetics.105.052076; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; EMMERSON PT, 1968, GENETICS, V60, P19; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Handa N, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-5; Hebraud Michel, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P211; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; Ivancic-Bace I, 2005, J BACTERIOL, V187, P1350, DOI 10.1128/JB.187.4.1350-1356.2005; Ivancic-Bace I, 2003, GENETICS, V163, P485; Jockovich ME, 2001, MOL MICROBIOL, V41, P949, DOI 10.1046/j.1365-2958.2001.02573.x; KEYER K, 1995, J BACTERIOL, V177, P6782, DOI 10.1128/jb.177.23.6782-6790.1995; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUSHNER SR, 1974, P NATL ACAD SCI USA, V71, P3593, DOI 10.1073/pnas.71.9.3593; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LOVETT ST, 1988, GENETICS, V120, P37; MCKITTRICK NH, 1989, J MOL BIOL, V210, P485, DOI 10.1016/0022-2836(89)90125-3; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Miranda A, 2003, GENETICS, V163, P1255; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; OLIVER DB, 1977, J MOL BIOL, V116, P877, DOI 10.1016/0022-2836(77)90276-5; Purusharth RI, 2007, J BIOL CHEM, V282, P16267, DOI 10.1074/jbc.M605588200; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ray MK, 1998, J BIOSCIENCES, V23, P423, DOI 10.1007/BF02936136; Ray MK, 2006, STRESS RESPONSE MOL, P1; Regha K, 2005, GENETICS, V170, P1473, DOI 10.1534/genetics.104.038943; Russell N J, 1998, Adv Biochem Eng Biotechnol, V61, P1; Salaj-Smic E, 2000, RES MICROBIOL, V151, P769, DOI 10.1016/S0923-2508(00)01142-6; SAMBROOK J, 1989, 10ML LITER; SASAKI M, 1982, BIOCHEM BIOPH RES CO, V109, P414, DOI 10.1016/0006-291X(82)91737-5; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; Shivaji S, 2004, CELL MOL BIOL, V50, P525; SHIVAJI S, 1989, APPL ENVIRON MICROB, V55, P767, DOI 10.1128/AEM.55.3.767-770.1989; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Singh AK, 2009, APPL ENVIRON MICROB, V75, P4419, DOI 10.1128/AEM.01523-08; Smirnova G. V., 2001, Mikrobiologiya, V70, P55; Smith GR, 2001, ANNU REV GENET, V35, P243, DOI 10.1146/annurev.genet.35.102401.090509; Spek EJ, 2001, J BACTERIOL, V183, P131, DOI 10.1128/JB.183.1.131-138.2001; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STAHL FW, 1977, GENETICS, V86, P715; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Viswanathan M, 1998, GENETICS, V149, P7; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	58	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9412	10.1371/journal.pone.0009412	http://dx.doi.org/10.1371/journal.pone.0009412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195537	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924300004
J	Saegerman, C; Mellor, P; Uyttenhoef, A; Hanon, JB; Kirschvink, N; Haubruge, E; Delcroix, P; Houtain, JY; Pourquier, P; Vandenbussche, F; Verheyden, B; De Clercq, K; Czaplicki, G				Saegerman, Claude; Mellor, Philip; Uyttenhoef, Aude; Hanon, Jean-Baptiste; Kirschvink, Nathalie; Haubruge, Eric; Delcroix, Pierre; Houtain, Jean-Yves; Pourquier, Philippe; Vandenbussche, Frank; Verheyden, Bart; De Clercq, Kris; Czaplicki, Guy			The Most Likely Time and Place of Introduction of BTV8 into Belgian Ruminants	PLOS ONE			English	Article							BLUETONGUE-VIRUS SEROTYPE-8; 2006 EPIDEMIC; ANTIBODIES; CATTLE; ELISA; PCR	Background: In northern Europe, bluetongue (BT) caused by the BT virus (BTV), serotype 8, was first notified in August 2006 and numerous ruminant herds were affected in 2007 and 2008. However, the origin and the time and place of the original introduction have not yet been determined. Methods and Principal Findings: Four retrospective epidemiological surveys have been performed to enable determination of the initial spatiotemporal occurrence of this emerging disease in southern Belgium: investigations of the first recorded outbreaks near to the disease epicenter; a large anonymous, random postal survey of cattle herds and sheep flocks; a random historical milk tank survey of samples tested with an indirect ELISA and a follow-up survey of nonspecific health indicators. The original introduction of BTV into the region probably occurred during spring 2006 near to the National Park of Hautes Fagnes and Eifel when Culicoides become active. Conclusions/Significance: The determination of the most likely time and place of introduction of BTV8 into a country is of paramount importance to enhance awareness and understanding and, to improve modeling of vector-borne emerging infectious diseases.	[Saegerman, Claude; Uyttenhoef, Aude; Hanon, Jean-Baptiste] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium; [Mellor, Philip] Inst Anim Hlth, Dept Arbovirol, Woking, Surrey, England; [Kirschvink, Nathalie] Univ Namur, Vet Dept, Namur, Belgium; [Haubruge, Eric] Univ Liege, Dept Funct & Evolutionary Entomol, Gembloux, Belgium; [Delcroix, Pierre] Fed Agcy Safety Food Chain, Brussels, Belgium; [Houtain, Jean-Yves; Czaplicki, Guy] Assoc Reg Sante & Identificat Anim, Loncin, Belgium; [Pourquier, Philippe] ID VET, Montpellier, France; [Vandenbussche, Frank; Verheyden, Bart; De Clercq, Kris] Vet & Agrochem Res Ctr, Dept Virol, Brussels, Belgium	University of Liege; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Namur; University of Liege	Saegerman, C (corresponding author), Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis, Liege, Belgium.	claude.saegerman@ulg.ac.be		Saegerman, Claude/0000-0001-9087-7436; Kirschvink, Nathalie/0000-0003-1788-4212; Haubruge, Eric/0000-0002-8138-0476; Hanon, Jean-Baptiste/0000-0003-1601-9980	Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne [D31-1180]; Fonds speciaux pour la Recherche - Credit de demarrage [D-08/02]; University of Liege, Belgium	Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne; Fonds speciaux pour la Recherche - Credit de demarrage; University of Liege, Belgium(University of Liege)	This research was funded by the "Direction Generale de Agriculture, des Ressources Naturelles et de l'Environnement (DGARNE) de la Region Wallonne'' (contract D31-1180) and by the "Fonds speciaux pour la Recherche - Credit de demarrage'' (contract D-08/02), University of Liege, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Bexiga R., 2008, Bluetongue in northern Europe, P57; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Czaplicki G, 2006, OBSERVATION TERRAIN; Dagnelie P, 1998, STAT THEORIQUE APPL, V2, P659; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Dufour B., 1994, EPIDEMIOL SANTE ANIM, V25, P101; Elbers ARW, 2008, VET MICROBIOL, V129, P156, DOI 10.1016/j.vetmic.2007.10.034; Enserink M, 2006, SCIENCE, V313, P1218; Fassotte C, 2008, PREV VET MED, V87, P74, DOI 10.1016/j.prevetmed.2008.06.007; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; GERBIER G, 2007, B TECH VET, V39, P81; Guyot H., 2008, Bluetongue in northern Europe, P34; KRAMER M, 2006, BERICHT ERSTEN KLIN; Kramps JA, 2008, VET MICROBIOL, V130, P80, DOI 10.1016/j.vetmic.2008.01.004; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Linden A, 2008, VET REC, V162, P459, DOI 10.1136/vr.162.14.459-a; LOSSON B, 2009, VET REC IN PRESS; Meroc E, 2008, VET MICROBIOL, V131, P133, DOI 10.1016/j.vetmic.2008.03.012; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; RIEB JP, 1982, THESIS UER VIE TERRE; Saegerman C, 2007, REV SCI TECH OIE, V26, P395, DOI 10.20506/rst.26.2.1747; Saegerman C, 2005, J CLIN MICROBIOL, V43, P862, DOI 10.1128/JCM.43.2.862-869.2005; SAEGERMAN C, 2007, RENC RECH RUMINANTS, V14, P215; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Toussaint JF, 2007, EMERG INFECT DIS, V13, P614, DOI 10.3201/eid1304.061136; van Schaik G, 2008, VET REC, V163, P441, DOI 10.1136/vr.163.15.441; Vandenbussche F, 2008, VET MICROBIOL, V129, P15, DOI 10.1016/j.vetmic.2007.10.029; VELTHUIS AG, 2009, PREV VET MED	31	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9405	10.1371/journal.pone.0009405	http://dx.doi.org/10.1371/journal.pone.0009405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195379	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924200025
J	Edwards, TL; Turner, SD; Torstenson, ES; Dudek, SM; Martin, ER; Ritchie, MD				Edwards, Todd L.; Turner, Stephen D.; Torstenson, Eric S.; Dudek, Scott M.; Martin, Eden R.; Ritchie, Marylyn D.			A General Framework for Formal Tests of Interaction after Exhaustive Search Methods with Applications to MDR and MDR-PDT	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; LONGITUDINAL DATA-ANALYSIS; LINKAGE DISEQUILIBRIUM; ASSOCIATION ANALYSIS; VALIDATION; EPISTASIS; PATTERNS; POWER; STRATEGIES; PEDIGREES	The initial presentation of multifactor dimensionality reduction (MDR) featured cross-validation to mitigate over-fitting, computationally efficient searches of the epistatic model space, and variable construction with constructive induction to alleviate the curse of dimensionality. However, the method was unable to differentiate association signals arising from true interactions from those due to independent main effects at individual loci. This issue leads to problems in inference and interpretability for the results from MDR and the family-based compliment the MDR-pedigree disequilibrium test (PDT). A suggestion from previous work was to fit regression models post hoc to specifically evaluate the null hypothesis of no interaction for MDR or MDR-PDT models. We demonstrate with simulation that fitting a regression model on the same data as that analyzed by MDR or MDR-PDT is not a valid test of interaction. This is likely to be true for any other procedure that searches for models, and then performs an uncorrected test for interaction. We also show with simulation that when strong main effects are present and the null hypothesis of no interaction is true, that MDR and MDR-PDT reject at far greater than the nominal rate. We also provide a valid regression-based permutation test procedure that specifically tests the null hypothesis of no interaction, and does not reject the null when only main effects are present. The regression-based permutation test implemented here conducts a valid test of interaction after a search for multilocus models, and can be applied to any method that conducts a search to find a multilocus model representing an interaction.	[Edwards, Todd L.] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA; [Edwards, Todd L.; Turner, Stephen D.; Torstenson, Eric S.; Dudek, Scott M.; Ritchie, Marylyn D.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Edwards, Todd L.; Martin, Eden R.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Ctr Genet Epidemiol & Stat Genet, Miami, FL 33136 USA	Vanderbilt University; Vanderbilt University; University of Miami	Edwards, TL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Dept Med,Div Epidemiol, Nashville, TN 37212 USA.	ritchie@chgr.mc.vanderbilt.edu	Turner, Stephen/GXM-4654-2022; Edwards, Todd/B-9750-2012; Ritchie, Marylyn/C-1114-2012		National Institutes of Health (NIH) [R01 AG019757-06, R01 AG020135-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020135, R01AG019757] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants R01 AG019757-06 and R01 AG020135-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh MF, 2007, GENET EPIDEMIOL, V31, P1, DOI 10.1002/gepi.20183; Bass MP, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P93; Bellman R.E, 1961, DYNAMIC PROGRAMMING; Bush WS, 2006, BIOINFORMATICS, V22, P2173, DOI 10.1093/bioinformatics/btl347; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; Coffey CS, 2004, NUTRITION, V20, P69, DOI 10.1016/j.nut.2003.09.012; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Dudek Scott M, 2006, Pac Symp Biocomput, P499, DOI 10.1142/9789812701626_0046; EDWARDS TL, 2009, GENET EPIDEMIOL; EDWARDS TL, 2008, HUMAN HEREDITY; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Edwards TL, 2009, AM J MED GENET B, V150B, P721, DOI 10.1002/ajmg.b.30899; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Feng Z, 2004, PHARMACOGENOMICS, V5, P709, DOI 10.1517/14622416.5.6.709; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hancock DB, 2007, GENET EPIDEMIOL, V31, P883, DOI 10.1002/gepi.20249; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Millstein J, 2006, AM J HUM GENET, V78, P15, DOI 10.1086/498850; Milne RL, 2008, CARCINOGENESIS, V29, P1215, DOI 10.1093/carcin/bgn120; MOORE J. H., 2007, KNOWLEDGE DISCOVERY; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Moore JH, 2004, APPL SOFT COMPUT, V4, P79, DOI 10.1016/j.asoc.2003.08.003; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Owens JD, 2007, COMPUT GRAPH FORUM, V26, P80, DOI 10.1111/j.1467-8659.2007.01012.x; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; SCHLICTING P, 1998, PHENOTYPIC EVOLUTION; Schmidt M, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1133; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Templeton A., 2000, EPISTASIS EVOLUTIONA; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9363	10.1371/journal.pone.0009363	http://dx.doi.org/10.1371/journal.pone.0009363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186329	gold, Green Published, Green Submitted			2022-12-27	WOS:000274924000007
J	Soundararajan, V; Raman, R; Raguram, S; Sasisekharan, V; Sasisekharan, R				Soundararajan, Venkataramanan; Raman, Rahul; Raguram, S.; Sasisekharan, V.; Sasisekharan, Ram			Atomic Interaction Networks in the Core of Protein Domains and Their Native Folds	PLOS ONE			English	Article							STRUCTURE PREDICTION; SECONDARY STRUCTURE; SEQUENCE; EVOLUTION; RECOGNITION; DATABASE; PACKING; YOPM	Vastly divergent sequences populate a majority of protein folds. In the quest to identify features that are conserved within protein domains belonging to the same fold, we set out to examine the entire protein universe on a fold-by-fold basis. We report that the atomic interaction network in the solvent-unexposed core of protein domains are fold-conserved, extraordinary sequence divergence notwithstanding. Further, we find that this feature, termed protein core atomic interaction network (or PCAIN) is significantly distinguishable across different folds, thus appearing to be "signature'' of a domain's native fold. As part of this study, we computed the PCAINs for 8698 representative protein domains from families across the 1018 known protein folds to construct our seed database and an automated framework was developed for PCAIN-based characterization of the protein fold universe. A test set of randomly selected domains that are not in the seed database was classified with over 97% accuracy, independent of sequence divergence. As an application of this novel fold signature, a PCAIN-based scoring scheme was developed for comparative (homology-based) structure prediction, with 1-2 angstroms (mean 1.61A) C-alpha RMSD generally observed between computed structures and reference crystal structures. Our results are consistent across the full spectrum of test domains including those from recent CASP experiments and most notably in the 'twilight' and 'midnight' zones wherein <30% and <10% target-template sequence identity prevails (mean twilight RMSD of 1.69A). We further demonstrate the utility of the PCAIN protocol to derive biological insight into protein structure-function relationships, by modeling the structure of the YopM effector novel E3 ligase (NEL) domain from plague-causative bacterium Yersinia Pestis and discussing its implications for host adaptive and innate immune modulation by the pathogen. Considering the several high-throughput, sequence-identity-independent applications demonstrated in this work, we suggest that the PCAIN is a fundamental fold feature that could be a valuable addition to the arsenal of protein modeling and analysis tools.	[Soundararajan, Venkataramanan] MIT, Koch Inst Integrat Canc Res, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Soundararajan, V (corresponding author), MIT, Koch Inst Integrat Canc Res, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@mit.edu			Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology	Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology	The authors would like to acknowledge support from the Singapore - Massachusetts Institute of Technology (MIT) Alliance for Research and Technology to Ram Sasisekharan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 2007, J MOL BIOL, V371, P283, DOI 10.1016/j.jmb.2007.05.078; Bartoli Lisa, 2008, V413, P199; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Friedberg I, 2004, CURR OPIN STRUC BIOL, V14, P307, DOI 10.1016/j.sbi.2004.04.005; Friedberg I, 2002, PROTEIN SCI, V11, P350, DOI 10.1110/ps.18602; FRIEDBERG I, 2000, INT SYS MOL BIOL, P162; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; IOERGER TR, 1995, MACH LEARN, V21, P151, DOI 10.1007/BF00993383; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Lapaque N, 2009, P NATL ACAD SCI USA, V106, P14052, DOI 10.1073/pnas.0906735106; Lazar GA, 1998, CURR OPIN CHEM BIOL, V2, P675, DOI 10.1016/S1367-5931(98)80102-6; LEE C, 1991, NATURE, V352, P448, DOI 10.1038/352448a0; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Pang CNI, 2008, NUCLEIC ACIDS RES, V36, P578, DOI 10.1093/nar/gkm1070; Petsko G., 2004, PROTEIN STRUCTURE FU; PRATT LR, 1977, J CHEM PHYS, V67, P3683, DOI 10.1063/1.435308; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rojnuckarin A, 1998, P NATL ACAD SCI USA, V95, P4288, DOI 10.1073/pnas.95.8.4288; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rumbley J, 2001, P NATL ACAD SCI USA, V98, P105, DOI 10.1073/pnas.98.1.105; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SASISEKHARAN V, 1970, BIOPOLYMERS, V9, P1249, DOI 10.1002/bip.1970.360091005; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sheffler W, 2009, PROTEIN SCI, V18, P229, DOI 10.1002/pro.8; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	51	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2010	5	2							e9391	10.1371/journal.pone.0009391	http://dx.doi.org/10.1371/journal.pone.0009391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SV	20186337	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924000027
J	Chung, CAB; Boyd, VL; McKernan, KJ; Fu, YT; Monighetti, C; Peckham, HE; Barker, M				Chung, Christina A. Bormann; Boyd, Victoria L.; McKernan, Kevin J.; Fu, Yutao; Monighetti, Cinna; Peckham, Heather E.; Barker, Melissa			Whole Methylome Analysis by Ultra-Deep Sequencing Using Two-Base Encoding	PLOS ONE			English	Article							DNA METHYLATION; ESCHERICHIA-COLI; HUMAN GENOME; BISULFITE; ARABIDOPSIS; LIGATION; REVEALS; SITES; CELLS; WIDE	Methylation, the addition of methyl groups to cytosine (C), plays an important role in the regulation of gene expression in both normal and dysfunctional cells. During bisulfite conversion and subsequent PCR amplification, unmethylated Cs are converted into thymine (T), while methylated Cs will not be converted. Sequencing of this bisulfite-treated DNA permits the detection of methylation at specific sites. Through the introduction of next-generation sequencing technologies (NGS) simultaneous analysis of methylation motifs in multiple regions provides the opportunity for hypothesis-free study of the entire methylome. Here we present a whole methylome sequencing study that compares two different bisulfite conversion methods (in solution versus in gel), utilizing the high throughput of the SOLiD (TM) System. Advantages and disadvantages of the two different bisulfite conversion methods for constructing sequencing libraries are discussed. Furthermore, the application of the SOLiD (TM) bisulfite sequencing to larger and more complex genomes is shown with preliminary in silico created bisulfite converted reads.	[Chung, Christina A. Bormann; Boyd, Victoria L.; Monighetti, Cinna; Barker, Melissa] Life Technol, Foster City, CA USA; [McKernan, Kevin J.; Fu, Yutao; Peckham, Heather E.] Life Technol, Beverly, MA USA	Thermo Fisher Scientific; Thermo Fisher Scientific	Chung, CAB (corresponding author), Life Technol, Foster City, CA USA.	Christina.Chung@lifetech.com		McKernan, Kevin/0000-0002-3908-1122	Life Technologies	Life Technologies	This study was supported by Life Technologies. Data available upon request. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Chen JJ, 1998, NUCLEIC ACIDS RES, V26, P1546, DOI 10.1093/nar/26.6.1546; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Gopalakrishnan S, 2008, MUTAT RES-FUND MOL M, V647, P30, DOI 10.1016/j.mrfmmm.2008.08.006; HODGES E, 2009, GENOME RES, DOI DOI 10.1101/GR.095190.109/; Homer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-175; Korshunova Y, 2008, GENOME RES, V18, P19, DOI 10.1101/gr.6883307; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MARINUS MG, 1987, ANNU REV GENET, V21, P113, DOI 10.1146/annurev.genet.21.1.113; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Ranade SS, 2009, ANAL BIOCHEM, V390, P126, DOI 10.1016/j.ab.2009.04.020; RINGQUIST S, 1992, P NATL ACAD SCI USA, V89, P4539, DOI 10.1073/pnas.89.10.4539; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	20	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9320	10.1371/journal.pone.0009320	http://dx.doi.org/10.1371/journal.pone.0009320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179767	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923900005
J	Dharajiya, N; Vaidya, SV; Murai, H; Cardenas, V; Kurosky, A; Boldogh, I; Sur, SA				Dharajiya, Nilesh; Vaidya, Swapnil V.; Murai, Hiroki; Cardenas, Victor; Kurosky, Alexander; Boldogh, Istvan; Sur, Sanjiv A.			Fc gamma RIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma	PLOS ONE			English	Article							INDUCED AIRWAY HYPERRESPONSIVENESS; BIFUNCTIONAL FUSION PROTEIN; CLASS-SWITCH RECOMBINATION; MAST-CELL ACTIVATION; DENDRITIC CELLS; IFN-GAMMA; RECEPTOR IIB; IN-VIVO; NEGATIVE REGULATION; IMMUNOGLOBULIN-E	Allergic asthma is characterized by airway eosinophilia, increased mucin production and allergen-specific IgE. Fc gamma receptor IIb (Fc gamma RIIb), an inhibitory IgG receptor, has recently emerged as a negative regulator of allergic diseases like anaphylaxis and allergic rhinitis. However, no studies to date have evaluated its role in allergic asthma. Our main objective was to study the role of Fc gamma RIIb in allergic lung inflammation. We used a murine model of allergic airway inflammation. Inflammation was quantified by BAL inflammatory cells and airway mucin production. Fc gamma RIIb expression was measured by qPCR and flow cytometry and the cytokines were quantified by ELISA. Compared to wild type animals, Fc gamma RIIb deficient mice mount a vigorous allergic lung inflammation characterized by increased bronchoalveolar lavage fluid cellularity, eosinophilia and mucin content upon ragweed extract (RWE) challenge. RWE challenge in sensitized mice upregulated Fc gamma RIIb in the lungs. Disruption of IFN-gamma gene abrogated this upregulation. Treatment of naive mice with the Th1-inducing agent CpG DNA increased Fc gamma RIIb expression in the lungs. Furthermore, treatment of sensitized mice with CpG DNA prior to RWE challenge induced greater upregulation of Fc gamma RIIb than RWE challenge alone. These observations indicated that RWE challenge upregulated Fc gamma RIIb in the lungs by IFN-gamma- and Th1-dependent mechanisms. RWE challenge upregulated Fc gamma RIIb on pulmonary CD14+/MHC II+ mononuclear cells and CD11c+ cells. Fc gamma RIIb deficient mice also exhibited an exaggerated RWE-specific IgE response upon sensitization when compared to wild type mice. We propose that Fc gamma RIIb physiologically regulates allergic airway inflammation by two mechanisms: 1) allergen challenge mediates upregulation of Fc gamma RIIb on pulmonary CD14+/MHC II+ mononuclear cells and CD11c+ cells by an IFN-gamma dependent mechanism; and 2) by attenuating the allergen specific IgE response during sensitization. Thus, stimulating Fc gamma RIIb may be a therapeutic strategy in allergic airway disorders.	[Dharajiya, Nilesh] Univ Texas Galveston, Med Branch, NHLBI, Prote Ctr,Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Vaidya, Swapnil V.; Murai, Hiroki; Cardenas, Victor; Sur, Sanjiv A.] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Kurosky, Alexander] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol, Galveston, TX 77550 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Dharajiya, N (corresponding author), Univ Texas Galveston, Med Branch, NHLBI, Prote Ctr,Dept Biochem & Mol Biol, Galveston, TX 77550 USA.	sasur@utmb.edu			National Institutes of Health (NIH) [RO1HL071163]; National Institute of Allergy and Infectious Disease (NIAID) [PO1AI062885-01]; National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative [NO1HV-28184]; National Institute of Environmental Health Sciences (NIEHS) [EOS 006677]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from National Institutes of Health (NIH) RO1HL071163 (S.S.), National Institute of Allergy and Infectious Disease (NIAID), PO1AI062885-01 (I.B., S.S.), National Heart, Lung, and Blood Institute (NHLBI) Proteomics Initiative, NO1HV-28184 (S.S.) and National Institute of Environmental Health Sciences (NIEHS) Center Grant, EOS 006677 (I.B., S.S.). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Bruhns P, 2000, J BIOL CHEM, V275, P37357, DOI 10.1074/jbc.M003518200; Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682; Choudhury BK, 2002, J IMMUNOL, V169, P5955, DOI 10.4049/jimmunol.169.10.5955; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; Dharajiya N, 2007, J ALLERGY CLIN IMMUN, V119, P646, DOI 10.1016/j.jaci.2006.11.634; Dharajiya N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008172; Flaishon L, 2002, J IMMUNOL, V168, P3707, DOI 10.4049/jimmunol.168.8.3707; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fulkerson PC, 2004, P NATL ACAD SCI USA, V101, P1987, DOI 10.1073/pnas.0308544100; Gangur V, 1999, INT ARCH ALLERGY IMM, V118, P387, DOI 10.1159/000024144; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; GOSWAMI S, 2009, NAT IMMUNOL; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Herrick CA, 2003, NAT REV IMMUNOL, V3, P405, DOI 10.1038/nri1084; Hoffmann PR, 2007, J IMMUNOL METHODS, V328, P21, DOI 10.1016/j.jim.2007.07.019; Huang TJ, 2001, J IMMUNOL, V166, P207, DOI 10.4049/jimmunol.166.1.207; Hunt LW, 2002, CLIN EXP ALLERGY, V32, P210, DOI 10.1046/j.1365-2222.2002.01228.x; HUNT LW, 1994, AM J RESP CRIT CARE, V149, P1471, DOI 10.1164/ajrccm.149.6.8004300; Jensen WA, 2001, BIOCHEM SOC T, V29, P840, DOI 10.1042/0300-5127:0290840; JOSEPH M, 1983, J CLIN INVEST, V71, P221, DOI 10.1172/JCI110762; Justice JP, 2001, AM J PHYSIOL-LUNG C, V280, pL363, DOI 10.1152/ajplung.2001.280.2.L363; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Kepley CL, 2000, J ALLERGY CLIN IMMUN, V106, P337, DOI 10.1067/mai.2000.107931; Kitamura K, 2007, J IMMUNOL, V178, P480, DOI 10.4049/jimmunol.178.1.480; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Lee SH, 2004, J ALLERGY CLIN IMMUN, V113, P72, DOI 10.1016/j.jaci.2003.09.039; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Manetz TS, 2001, MOL CELL BIOL, V21, P3763, DOI 10.1128/MCB.21.11.3763-3774.2001; Mertsching E, 2008, J ALLERGY CLIN IMMUN, V121, P441, DOI 10.1016/j.jaci.2007.08.051; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Obayashi K, 2007, INT IMMUNOL, V19, P217, DOI 10.1093/intimm/dxl138; Passalacqua G, 2008, CLIN EXP IMMUNOL, V153, P12, DOI 10.1111/j.1365-2249.2008.03715.x; PHILLIPS NE, 1983, J IMMUNOL, V130, P602; Poulsen LK, 2007, ANN MED, V39, P440, DOI 10.1080/07853890701449354; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Qin DH, 2000, J IMMUNOL, V164, P6268, DOI 10.4049/jimmunol.164.12.6268; Rabinovitch N, 2004, INT ARCH ALLERGY IMM, V133, P285, DOI 10.1159/000076836; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rohr UP, 2002, J VIROL METHODS, V106, P81, DOI 10.1016/S0166-0934(02)00138-6; Saxon A, 2008, J ALLERGY CLIN IMMUN, V121, P320, DOI 10.1016/j.jaci.2007.10.017; Scheurer Michael E, 2007, Infect Agent Cancer, V2, P8, DOI 10.1186/1750-9378-2-8; Stefanescu RN, 2004, J CLIN IMMUNOL, V24, P315, DOI 10.1023/B:JOCI.0000029105.47772.04; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Sur S, 1999, J IMMUNOL, V162, P6284; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Ujike A, 1999, J EXP MED, V189, P1573, DOI 10.1084/jem.189.10.1573; Watanabe T, 2004, AM J RESP CRIT CARE, V169, P105, DOI 10.1164/rccm.200302-239OC; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; WILLIAMS J, 1992, J IMMUNOL, V149, P2823; Yamada T, 2003, J BIOL CHEM, V278, P32818, DOI 10.1074/jbc.M304590200; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187; Zhang K, 2004, J ALLERGY CLIN IMMUN, V114, P321, DOI 10.1016/j.jaci.2004.03.058; Zhang Y, 2009, J IMMUNOL, V182, P554, DOI 10.4049/jimmunol.182.1.554; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518	71	23	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9337	10.1371/journal.pone.0009337	http://dx.doi.org/10.1371/journal.pone.0009337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179765	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923900007
J	Azzopardi, PV; O'Young, J; Lajoie, G; Karttunen, M; Goldberg, HA; Hunter, GK				Azzopardi, Paul V.; O'Young, Jason; Lajoie, Gilles; Karttunen, Mikko; Goldberg, Harvey A.; Hunter, Graeme K.			Roles of Electrostatics and Conformation in Protein-Crystal Interactions	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALLIZATION; BONE SIALOPROTEIN; IN-VITRO; HYDROXYAPATITE FORMATION; CONSTANT COMPOSITION; MOLECULAR-DYNAMICS; POSTTRANSLATIONAL MODIFICATIONS; ACIDIC PROTEINS; OSTEOPONTIN; GROWTH	In vitro studies have shown that the phosphoprotein osteopontin (OPN) inhibits the nucleation and growth of hydroxyapatite (HA) and other biominerals. In vivo, OPN is believed to prevent the calcification of soft tissues. However, the nature of the interaction between OPN and HA is not understood. In the computational part of the present study, we used molecular dynamics simulations to predict the adsorption of 19 peptides, each 16 amino acids long and collectively covering the entire sequence of OPN, to the {100} face of HA. This analysis showed that there is an inverse relationship between predicted strength of adsorption and peptide isoelectric point (P < 0.0001). Analysis of the OPN sequence by PONDR (Predictor of Naturally Disordered Regions) indicated that OPN sequences predicted to adsorb well to HA are highly disordered. In the experimental part of the study, we synthesized phosphorylated and non-phosphorylated peptides corresponding to OPN sequences 65-80 (pSHDHMDDDDDDDDDGD) and 220-235 (pSHEpSTEQSDAIDpSAEK). In agreement with the PONDR analysis, these were shown by circular dichroism spectroscopy to be largely disordered. A constant-composition/seeded growth assay was used to assess the HA-inhibiting potencies of the synthetic peptides. The phosphorylated versions of OPN65-80 (IC50 = 1.93 mu g/ml) and OPN220-235 (IC50 = 1.48 mu g/ml) are potent inhibitors of HA growth, as is the nonphosphorylated version of OPN65-80 (IC50 = 2.97 mu g/ml); the nonphosphorylated version of OPN220-235 has no measurable inhibitory activity. These findings suggest that the adsorption of acidic proteins to Ca2+-rich crystal faces of biominerals is governed by electrostatics and is facilitated by conformational flexibility of the polypeptide chain.	[Azzopardi, Paul V.; O'Young, Jason; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Sch Dent, London, ON, Canada; [Azzopardi, Paul V.; Lajoie, Gilles; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Karttunen, Mikko] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Azzopardi, PV (corresponding author), Univ Western Ontario, Sch Dent, London, ON, Canada.	graeme.hunter@schulich.uwo.ca	Goldberg, Harvey/B-5742-2015; Azzopardi, Paul/C-5694-2013; Karttunen, Mikko/G-4531-2010	Azzopardi, Paul/0000-0001-7386-8191; Karttunen, Mikko/0000-0002-8626-3033	Canadian Institutes of Health Research [MOP-68827]; Natural Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were funded by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) operating grant MOP-68827 and by the Natural Sciences and Engineering Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Addadi L, 2001, Z Kardiol, V90 Suppl 3, P92; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g; ANDALORO G, 1988, CHEM PHYS LETT, V149, P201, DOI 10.1016/0009-2614(88)87222-1; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Chen PH, 2008, J AM CHEM SOC, V130, P2862, DOI 10.1021/ja076607y; Clark RH, 1999, CALCIFIED TISSUE INT, V64, P516, DOI 10.1007/s002239900642; Dahlin S, 1998, EUR J ORAL SCI, V106, P239, DOI 10.1111/j.1600-0722.1998.tb02182.x; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fleet ME, 2004, AM MINERAL, V89, P1422; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; FUJISAWA R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P56; FUREDIMILHOFER H, 1994, CONNECT TISSUE RES, V30, P251, DOI 10.3109/03008209409015041; Gauci S, 2008, PROTEOMICS, V8, P4898, DOI 10.1002/pmic.200800295; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GILMAN H, 1994, J INORG BIOCHEM, V55, P31, DOI 10.1016/0162-0134(94)85130-1; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c; Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hincke M.T., 2000, CHEM BIOL MINERALIZE, P13; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Holt C, 1996, BIOCHEM J, V314, P1035, DOI 10.1042/bj3141035; Hoyer JR, 2001, KIDNEY INT, V60, P77, DOI 10.1046/j.1523-1755.2001.00772.x; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Huq NL, 2000, J MOL MODEL, V6, P35; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jono S, 2000, J BIOL CHEM, V275, P20197, DOI 10.1074/jbc.M909174199; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; Keykhosravani M, 2005, BIOCHEMISTRY-US, V44, P6990, DOI 10.1021/bi050109p; KOUTSOUKOS P, 1980, J AM CHEM SOC, V102, P1553, DOI 10.1021/ja00525a015; Kumar V, 2006, CURR OPIN NEPHROL HY, V15, P374, DOI 10.1097/01.mnh.0000232877.12599.f4; LANGDON A, 2009, CALCIFIED T IN PRESS; LEE WK, 1981, J CHEM PHYS, V75, P3040, DOI 10.1063/1.442399; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mann S., 2001, BIOMINERALIZATION PR; Masica DL, 2009, BIOPHYS J, V96, P3082, DOI 10.1016/j.bpj.2009.01.033; Mo L, 2004, KIDNEY INT, V66, P1159, DOI 10.1111/j.1523-1755.2004.00867.x; Moravec M, 2003, FABULA, V44, P1; NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3; NANCOLLAS GH, 1984, INHIBITORS CRYSTALLI; O'Young J, 2009, CELLS TISSUES ORGANS, V189, P51, DOI 10.1159/000151724; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pampena DA, 2004, BIOCHEM J, V378, P1083, DOI 10.1042/BJ20031150; Pan H., 2007, FRONTIERS CHEM CHINA, V2, P156, DOI DOI 10.1007/S11458-007-0032-6; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Patra M, 2004, J COMPUT CHEM, V25, P678, DOI 10.1002/jcc.10417; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P1447, DOI 10.1073/pnas.73.5.1447; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; SMITH PE, 1991, J CHEM PHYS, V95, P8430, DOI 10.1063/1.461272; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang LJ, 2008, J PHYS CHEM B, V112, P9151, DOI 10.1021/jp804282u; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; WORCESTER EM, 1992, J BONE MINER RES, V7, P1029; Zhang HP, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044110	79	62	62	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9330	10.1371/journal.pone.0009330	http://dx.doi.org/10.1371/journal.pone.0009330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174473	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700027
J	Marley, A; von Zastrow, M				Marley, Aaron; von Zastrow, Mark			Dysbindin Promotes the Post-Endocytic Sorting of G Protein-Coupled Receptors to Lysosomes	PLOS ONE			English	Article							ORGANELLES COMPLEX-1; SCHIZOPHRENIA; BLOC-1; INTERNALIZATION; TRAFFICKING; BIOGENESIS; ENDOSOMES; IDENTIFICATION; DEGRADATION; MECHANISMS	Background: Dysbindin, a cytoplasmic protein long known to function in the biogenesis of specialized lysosome-related organelles (LROs), has been reported to reduce surface expression of D2 dopamine receptors in neurons. Dysbindin is broadly expressed, and dopamine receptors are members of the large family of G protein-coupled receptors (GPCRs) that function in diverse cell types. Thus we asked if dysbindin regulates receptor number in non-neural cells, and further investigated the cellular basis of this regulation. Methodology/Principal Findings: We used RNA interference to deplete endogenous dysbindin in HEK293 and HeLa cells, then used immunochemical and biochemical methods to assess expression and endocytic trafficking of epitope-tagged GPCRs. Dysbindin knockdown up-regulated surface expression of D2 receptors compared to D1 receptors, as reported previously in neurons. This regulation was not mediated by a change in D2 receptor endocytosis. Instead, dysbindin knockdown specifically reduced the subsequent trafficking of internalized D2 receptors to lysosomes. This distinct post-endocytic sorting function explained the minimal effect of dysbindin depletion on D1 receptors, which recycle efficiently and traverse the lysosomal pathway to only a small degree. Moreover, dysbindin regulated the delta opioid receptor, a more distantly related GPCR that is also sorted to lysosomes after endocytosis. Dysbindin was not required for lysosomal trafficking of all signaling receptors, however, as its depletion did not detectably affect down-regulation of the EGF receptor tyrosine kinase. Dysbindin co-immunoprecipitated with GASP-1 (or GPRASP-1), a cytoplasmic protein shown previously to modulate lysosomal trafficking of D2 dopamine and delta opioid receptors by direct interaction, and with HRS that is a core component of the conserved ESCRT machinery mediating lysosome biogenesis and sorting. Conclusions/Significance: These results identify a distinct, and potentially widespread function of dysbindin in promoting the sorting of specific GPCRs to lysosomes after endocytosis.	[Marley, Aaron] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Marley, A (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	mark.vonzastrow@ucsf.edu			National Institutes of Health [DA010711, DA012864]; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, R01DA012864, R01DA010711, R37DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health DA010711, DA012864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chu P, 1997, J BIOL CHEM, V272, P27124, DOI 10.1074/jbc.272.43.27124; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wei LN, 2002, CURR OPIN PHARMACOL, V2, P69, DOI 10.1016/S1471-4892(01)00123-0; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308	37	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9325	10.1371/journal.pone.0009325	http://dx.doi.org/10.1371/journal.pone.0009325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174469	gold, Green Submitted, Green Published			2022-12-27	WOS:000274923700023
J	Phillips, G; Reith, F; Qualls, C; Ali, AM; Spilde, M; Appenzeller, O				Phillips, Genevieve; Reith, Frank; Qualls, Clifford; Ali, Abdul-Mehdi; Spilde, Mike; Appenzeller, Otto			Bacterial Deposition of Gold on Hair: Archeological, Forensic and Toxicological Implications	PLOS ONE			English	Article							STABLE-ISOTOPE; GEOMICROBIOLOGY	Background: Trace metal analyses in hair are used in archeological, forensic and toxicological investigations as proxies for metabolic processes. We show metallophilic bacteria mediating the deposition of gold (Au), used as tracer for microbial activity in hair post mortem after burial, affecting results of such analyses. Methodology/Principal Findings: Human hair was incubated for up to six months in auriferous soils, in natural soil columns (Experiment 1), soils amended with mobile Au(III)-complexes (Experiment 2) and the Au-precipitating bacterium Cupriavidus metallidurans (Experiment 3), in peptone-meat-extract (PME) medium in a culture of C. metallidurans amended with Au(III)complexes (Experiment 4), and in non-auriferous soil (Experiment 5). Hair samples were analyzed using scanning electron microscopy, confocal microscopy and inductively coupled plasma-mass spectrometry. In Experiments 1-4 the Au content increased with time (P = 0.038). The largest increase was observed in Experiment 4 vs. Experiment 1 (mean = 1188 vs. 161 mu g Kg(-1), Fisher's least significance 0.001). The sulfur content, a proxy for hair metabolism, remained unchanged. Notably, the ratios of Au-to-S increased with time (linear trend P = 0.02) and with added Au and bacteria (linear trend, P = 0.005), demonstrating that larger populations of Au-precipitating bacteria and increased availability of Au increased the deposition of Au on the hair. Conclusion/Significance: Interactions of soil biota with hair post mortem may distort results of hair analyses, implying that metal content, microbial activities and the duration of burial must be considered in the interpretation of results of archeological, forensic and toxicological hair analyses, which have hitherto been proxies for pre-mortem metabolic processes.	[Phillips, Genevieve] Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA; [Reith, Frank] Univ Adelaide, Sch Earth & Environm Sci, Ctr Tecton Resources & Explorat, Adelaide, SA, Australia; [Reith, Frank] CSIRO Land & Water, PMB2, Glen Osmond, SA, Australia; [Qualls, Clifford] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Ali, Abdul-Mehdi] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Spilde, Mike] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA	University of New Mexico; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New Mexico; University of New Mexico; University of New Mexico	Phillips, G (corresponding author), Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA.	oarun@unm.edu	Reith, Frank/E-5542-2011		New Mexico Health Enhancement; Marathon Clinics Research Foundation; Albuquerque NM United States of America	New Mexico Health Enhancement; Marathon Clinics Research Foundation; Albuquerque NM United States of America	Funded by New Mexico Health Enhancement and Marathon Clinics Research Foundation, Albuquerque NM United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000636; BIANUCCI R, 2006, PLOS ONE, V3, pE2053, DOI DOI 10.1371/JOURNALPONE.0002053; Egeland GM, 2009, ENVIRON RES, V109, P281, DOI 10.1016/j.envres.2008.11.004; FIRESTEIN S, 2010, SCIENCE, V327, P146; Flanagan RJ, 2009, MED SCI LAW, V49, P153, DOI 10.1258/rsmmsl.49.3.153; Guibaud G, 2005, CHEMOSPHERE, V59, P629, DOI 10.1016/j.chemosphere.2004.10.028; Kintz P, 2006, J ANAL TOXICOL, V30, P621, DOI 10.1093/jat/30.8.621; Lader M, 2009, MED SCI LAW, V49, P1; Lin XL, 2004, ANAL BIOANAL CHEM, V379, P218, DOI 10.1007/s00216-004-2536-y; Mascarelli AL, 2009, NATURE, V459, P770, DOI 10.1038/459770a; NICHOLSON JK, 2010, NATURE, V463, P32; Pringle H, 2009, SCIENCE, V324, P1130, DOI 10.1126/science.324_1130; Reith F., 2008, REGOLITH SCI, P127; Reith F, 2007, ISME J, V1, P567, DOI 10.1038/ismej.2007.75; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Rogers G, 2009, EXP DERMATOL, V18, P541, DOI 10.1111/j.1600-0625.2008.00825.x; Srogi K, 2007, REV ENVIRON CONTAM T, V189, P107, DOI 10.1007/978-0-387-35368-5_5; Wilson AS, 2007, P NATL ACAD SCI USA, V104, P16456, DOI 10.1073/pnas.0704276104	19	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9335	10.1371/journal.pone.0009335	http://dx.doi.org/10.1371/journal.pone.0009335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560SS	20174476	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700028
J	Langendorf, CG; Key, TLG; Fenalti, G; Kan, WT; Buckle, AM; Caradoc-Davies, T; Tuck, KL; Law, RHP; Whisstock, JC				Langendorf, Christopher G.; Key, Trevor L. G.; Fenalti, Gustavo; Kan, Wan-Ting; Buckle, Ashley M.; Caradoc-Davies, Tom; Tuck, Kellie L.; Law, Ruby H. P.; Whisstock, James C.			The X-Ray Crystal Structure of Escherichia coli Succinic Semialdehyde Dehydrogenase; Structural Insights into NADP(+)/Enzyme Interactions	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; ALDEHYDE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; SSADH DEFICIENCY; MOLECULAR-BASIS; INBORN ERROR; GAB CLUSTER; HUMAN-BRAIN; GENE; IDENTIFICATION	Background: In mammals succinic semialdehyde dehydrogenase (SSADH) plays an essential role in the metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) to succinic acid (SA). Deficiency of SSADH in humans results in elevated levels of GABA and gamma-Hydroxybutyric acid (GHB), which leads to psychomotor retardation, muscular hypotonia, non-progressive ataxia and seizures. In Escherichia coli, two genetically distinct forms of SSADHs had been described that are essential for preventing accumulation of toxic levels of succinic semialdehyde (SSA) in cells. Methodology/Principal Findings: Here we structurally characterise SSADH encoded by the E coli gabD gene by X-ray crystallographic studies and compare these data with the structure of human SSADH. In the E. coli SSADH structure, electron density for the complete NADP(+) cofactor in the binding sites is clearly evident; these data in particular revealing how the nicotinamide ring of the cofactor is positioned in each active site. Conclusions/Significance: Our structural data suggest that a deletion of three amino acids in E. coli SSADH permits this enzyme to use NADP(+), whereas in contrast the human enzyme utilises NAD(+). Furthermore, the structure of E. coli SSADH gives additional insight into human mutations that result in disease.	[Langendorf, Christopher G.; Key, Trevor L. G.; Fenalti, Gustavo; Kan, Wan-Ting; Buckle, Ashley M.; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Key, Trevor L. G.; Tuck, Kellie L.] Monash Univ, Sch Chem, Melbourne, Vic 3004, Australia; [Fenalti, Gustavo] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kan, Wan-Ting; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia; [Caradoc-Davies, Tom] Australian Synchrotron, Clayton, Vic, Australia	Monash University; Monash University; Scripps Research Institute; Monash University	Langendorf, CG (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3004, Australia.	Ruby.law@med.monash.edu.au; James.whisstock@med.monash.edu.au	Tuck, Kellie/AAV-2596-2020; Buckle, Ashley/P-8366-2016	Tuck, Kellie/0000-0002-9104-3158; Buckle, Ashley/0000-0003-2943-9044; law, ruby/0000-0001-5432-5781; Langendorf, Christopher/0000-0002-9049-5283; Whisstock, James/0000-0003-4200-5611	National Health and Medical Research Council of Australia; TLGK is an Australia Postgraduate Award scholarship; NHMRC; ARC	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); TLGK is an Australia Postgraduate Award scholarship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	CGL is a National Health and Medical Research Council of Australia biomedical postgraduate research scholarship student, TLGK is an Australia Postgraduate Award scholarship student, AMB is an NHMRC Senior Research Fellow. JCW is an Australian Research Council Federation Fellow and an honorary NHMRC Principal Research Fellow. The authors thank the NHMRC and the ARC for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaboshi S, 2003, HUM MUTAT, V22, P442, DOI 10.1002/humu.10288; Androulakis S, 2008, ACTA CRYSTALLOGR D, V64, P810, DOI 10.1107/S0907444908015540; Aoshima T, 2002, HUM HERED, V53, P42, DOI 10.1159/000048603; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTSCH K, 1990, J BACTERIOL, V172, P7035, DOI 10.1128/jb.172.12.7035-7042.1990; Bekri S, 2004, MOL GENET METAB, V81, P347, DOI 10.1016/j.ymgme.2004.01.012; BLANER WS, 1980, EUR J BIOCHEM, V109, P431, DOI 10.1111/j.1432-1033.1980.tb04812.x; Blasi P, 2002, MOL GENET METAB, V76, P348, DOI 10.1016/S1096-7192(02)00105-1; Blasi P, 2006, J MOL EVOL, V63, P54, DOI 10.1007/s00239-005-0154-8; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CHAMBLISS KL, 1995, J BIOL CHEM, V270, P461, DOI 10.1074/jbc.270.1.461; CHAMBLISS KL, 1992, INT J BIOCHEM, V24, P1493, DOI 10.1016/0020-711X(92)90077-E; Chambliss KL, 1998, AM J HUM GENET, V63, P399, DOI 10.1086/301964; CHO SW, 1993, EUR J BIOCHEM, V211, P757, DOI 10.1111/j.1432-1033.1993.tb17606.x; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; DONNELLY MI, 1981, J BACTERIOL, V145, P1425, DOI 10.1128/JB.145.3.1425-1427.1981; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; Gibson KM, 2003, BIOL PSYCHIAT, V54, P763, DOI 10.1016/S0006-3223(03)00113-6; GIBSON KM, 1983, CLIN CHIM ACTA, V133, P33, DOI 10.1016/0009-8981(83)90018-9; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; Hogema BM, 2001, NAT GENET, V29, P212, DOI 10.1038/ng727; Hogema BM, 2001, MOL GENET METAB, V72, P218, DOI 10.1006/mgme.2000.3145; Jaeger M, 2008, BIOCHEM BIOPH RES CO, V372, P400, DOI 10.1016/j.bbrc.2008.04.183; JAKOBY WB, 1959, J BIOL CHEM, V234, P937; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Knerr I, 2007, J INHERIT METAB DIS, V30, P279, DOI 10.1007/s10545-007-0574-2; KOH Y, 1994, J MOL BIOL, V27, P75; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Lee BR, 1995, MOL CELLS, V5, P611; LESLIE AGW, 1992, NEWSLETTER PROTEIN C, V26; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; MALASPINA P, 2006, CLIN GENET, V69, P284; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; METZER E, 1990, J BACTERIOL, V172, P3250, DOI 10.1128/jb.172.6.3250-3256.1990; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIEGEMANN E, 1993, ARCH MICROBIOL, V160, P454, DOI 10.1007/BF00245306; Novotny EJ, 2003, ANN NEUROL, V54, pS25, DOI 10.1002/ana.10697; Pearl PL, 2006, FUTUR NEUROL, V1, P631, DOI 10.2217/14796708.1.5.631; Pearl PL, 2003, ANN NEUROL, V54, pS73, DOI 10.1002/ana.10629; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; RYZLAK MT, 1988, ARCH BIOCHEM BIOPHYS, V266, P386, DOI 10.1016/0003-9861(88)90270-6; SANCHEZ M, 1989, BIOCHIM BIOPHYS ACTA, V990, P225, DOI 10.1016/S0304-4165(89)80038-8; Schaller M, 1999, EUR J BIOCHEM, V265, P1056, DOI 10.1046/j.1432-1327.1999.00826.x; SKINNER MA, 1982, ARCH MICROBIOL, V132, P270, DOI 10.1007/BF00407964; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Struys EA, 2006, MOL GENET METAB, V88, P53, DOI 10.1016/j.ymgme.2005.12.002; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Trettel F, 1997, ADV EXP MED BIOL, V414, P253; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; WEINER H, 2004, ENCY LIFE SCI, P1	61	27	28	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9280	10.1371/journal.pone.0009280	http://dx.doi.org/10.1371/journal.pone.0009280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174634	gold, Green Submitted, Green Published			2022-12-27	WOS:000274654700014
J	Suzuki, H; Saba, R; Sada, A; Saga, Y				Suzuki, Hitomi; Saba, Rie; Sada, Aiko; Saga, Yumiko			The Nanos3-3 ' UTR Is Required for Germ Cell Specific NANOS3 Expression in Mouse Embryos	PLOS ONE			English	Article							MESSENGER-RNA; TRANSLATIONAL REPRESSION; DROSOPHILA EMBRYOS; LOCALIZATION; PROTEIN; SMAUG; HOMOLOG; GENES; DIFFERENTIATION; IDENTIFICATION	Background: The regulation of gene expression via a 3' untranslated region (UTR) plays essential roles in the discrimination of the germ cell lineage from somatic cells during embryogenesis. This is fundamental to the continuation of a species. Mouse NANOS3 is an essential protein required for the germ cell maintenance and is specifically expressed in these cells. However, the regulatory mechanisms that restrict the expression of this gene in the germ cells is largely unknown at present. Methodology/Principal Findings: In our current study, we show that differences in the stability of Nanos3 mRNA between germ cells and somatic cells is brought about in a 3'UTR-dependent manner in mouse embryos. Although Nanos3 is transcribed in both cell lineages, it is efficiently translated only in the germ lineage. We also find that the translational suppression of NANOS3 in somatic cells is caused by a 3'UTR-mediated mRNA destabilizing mechanism. Surprisingly, even when under the control of the CAG promoter which induces strong ubiquitous transcription in both germ cells and somatic cells, the addition of the Nanos3-3'UTR sequence to the coding region of exogenous gene was effective in restricting protein expression in germ cells. Conclusions/Significance: Our current study thus suggests that Nanos3-3'UTR has an essential role in translational control in the mouse embryo.	[Suzuki, Hitomi; Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Saba, Rie; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Shizuoka, Japan; [Sada, Aiko; Saga, Yumiko] Grad Univ Adv Studies Sokendai, Dept Genet, Shizuoka, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Suzuki, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	ysaga@lab.nig.ac.jp	Sada, Aiko/B-1176-2019	Sada, Aiko/0000-0002-0984-4280	National BioResource Project (NBRP); Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS)	National BioResource Project (NBRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by the National BioResource Project (NBRP) (http://www.nbrp.jp/); the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology, Japan; and Research Fellowships of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to A. S. (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Crucs S, 2000, MOL CELL, V5, P457, DOI 10.1016/S1097-2765(00)80440-2; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Dahanukar A, 1996, GENE DEV, V10, P2610, DOI 10.1101/gad.10.20.2610; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; Gavis ER, 1996, DEV BIOL, V176, P36, DOI 10.1006/dbio.1996.9996; Gavis ER, 1996, DEVELOPMENT, V122, P2791; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; Giorgini F, 2002, DEVELOPMENT, V129, P3669; Giorgini F, 2001, MOL CELL BIOL, V21, P7010, DOI 10.1128/MCB.21.20.7010-7019.2001; Kalifa Y, 2006, DEV CELL, V10, P291, DOI 10.1016/j.devcel.2006.01.001; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Koprunner M, 2001, GENE DEV, V15, P2877; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; MORALES CR, 1991, J CELL SCI, V100, P119; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Oginuma M, 2008, MECH DEVELOP, V125, P432, DOI 10.1016/j.mod.2008.01.010; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Pilon M, 1997, DEVELOPMENT, V124, P1771; Rangan P, 2009, CURR BIOL, V19, P72, DOI 10.1016/j.cub.2008.11.066; RONGO C, 1995, DEVELOPMENT, V121, P2737; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Smibert CA, 1996, GENE DEV, V10, P2600, DOI 10.1101/gad.10.20.2600; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tsuda M, 2006, MECH DEVELOP, V123, P440, DOI 10.1016/j.mod.2006.04.002; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; YAMAJI M, 2009, REPRODUCTION; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649	46	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9300	10.1371/journal.pone.0009300	http://dx.doi.org/10.1371/journal.pone.0009300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174582	Green Published, gold, Green Submitted			2022-12-27	WOS:000274654700024
J	Chu, KM; Boulle, AM; Ford, N; Goemaere, E; Asselman, V; Van Cutsem, G				Chu, Kathryn M.; Boulle, Andrew M.; Ford, Nathan; Goemaere, Eric; Asselman, Valerie; Van Cutsem, Gilles			Nevirapine-Associated Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in a Primary Care ART Programme in South Africa	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; CONTAINING REGIMENS; PREGNANT-WOMEN; LIVER TOXICITY; EFAVIRENZ; SETTINGS; EVENTS; COHORT; COUNT	Background: The majority of antiretroviral treatment programmes in sub-Saharan Africa are scaling up antiretroviral treatment using a fixed dose first-line antiretroviral regimen containing stavudine, lamivudine, and nevirapine. One of the primary concerns with the use of this regimen is nevirapine-associated hepatotoxicity. Methodology/Principal Findings: Study participants were 1809 HIV-infected, antiretroviral naive adults initiating nevirapine-based antiretroviral therapy between November 2002 and December 2006. The primary outcome was early hepatotoxicity. Secondary outcomes were associations with hepatotoxicity and mortality at six months. The cumulative proportion of early hepatotoxicity ranged from 1.0-2.0% giving an incidence-rate at 102 days of 3.6-7.6 per 100 person-years. Median time to hepatotoxicity was 32 (IQR 28-58) days. At 12 weeks, only 8% of patients had alanine aminotransferase monitoring at all the time-points recommended by national guidelines. No association was found between age, gender, baseline CD4 count, concurrent tuberculosis infection, prior participation in a prevention of mother-to-child-transmission program, or baseline weight and early hepatotoxicity. There was no association between early hepatotoxicity and mortality. Conclusions: The cumulative proportion of early hepatotoxicity in nevirapine based antiretroviral therapy was low in this resource-constrained setting. Hepatotoxicity was not associated with mortality. Frequent routine monitoring of alanine aminotransferase proved difficult to implement in this public sector primary care programme. Focused monitoring in the first month may be a more cost-effective and pragmatic option in settings with limited resources. Correlation with clinical signs and symptoms may allow future alanine aminotransferase testing to be dictated by clinical criteria.	[Chu, Kathryn M.; Ford, Nathan] Med Sans Frontieres, S African Med Unit, Johannesburg, South Africa; [Boulle, Andrew M.; Ford, Nathan; Van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Goemaere, Eric; Van Cutsem, Gilles] Med Sans Frontieres, Cape Town, South Africa; [Asselman, Valerie] JF Jooste Hosp, Infect Dis Clin, Cape Town, South Africa	University of Cape Town	Chu, KM (corresponding author), Med Sans Frontieres, S African Med Unit, Johannesburg, South Africa.	kathryn.chu@joburg.msf.org	Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008	Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062	M�decins Sans Fronti�res [09_NAT_ERB_009] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2003, SCALING ANTIRETROVIR; Bartlett J, 2007, MED MANAGEMENT HIV I; *BOEH ING PHARM, VIR PACK INS; Calmy A, 2007, LANCET, V370, P12, DOI 10.1016/S0140-6736(07)61027-7; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Ena J, 2003, INT J STD AIDS, V14, P776, DOI 10.1258/09564620360719840; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Hahn Judith A, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P83, DOI 10.1177/1545109707299356; Jamisse L, 2007, JAIDS-J ACQ IMM DEF, V44, P371, DOI 10.1097/QAI.0b013e318032bbee; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kumarasamy N, 2008, AIDS PATIENT CARE ST, V22, P337, DOI 10.1089/apc.2007.0093; Law WP, 2003, AIDS, V17, P2191, DOI 10.1097/00002030-200310170-00007; Manfredi R, 2006, AIDS, V20, P2233, DOI 10.1097/QAD.0b013e3280110cae; Martinez E, 2001, AIDS, V15, P1261, DOI 10.1097/00002030-200107060-00007; Meyssonnier V, 2008, HIV MED, V9, P62, DOI 10.1111/j.1468-1293.2008.00516.x; *NIH, AIDS CLIN TRIALS GRO; Phanuphak N, 2007, HIV MED, V8, P357, DOI 10.1111/j.1468-1293.2007.00477.x; *PHARM BI, 2005, VIR PACK INS; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Taiwo B, 2006, INT J STD AIDS, V17, P364, DOI 10.1258/095646206777323346; Torti C, 2007, DRUG SAFETY, V30, P1161, DOI 10.2165/00002018-200730120-00008; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1091, DOI 10.1503/cmaj.1040417; Zhou ML, 2006, JAIDS-J ACQ IMM DEF, V43, P501	26	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9183	10.1371/journal.pone.0009183	http://dx.doi.org/10.1371/journal.pone.0009183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174653	Green Published, gold, Green Submitted			2022-12-27	WOS:000274590600005
J	Uziel, O; Beery, E; Dronichev, V; Samocha, K; Gryaznov, S; Weiss, L; Slavin, S; Kushnir, M; Nordenberg, Y; Rabinowitz, C; Rinkevich, B; Zehavi, T; Lahav, M				Uziel, Orit; Beery, Einat; Dronichev, Vladimir; Samocha, Katty; Gryaznov, Sergei; Weiss, Lola; Slavin, Shimon; Kushnir, Michal; Nordenberg, Yardena; Rabinowitz, Claudette; Rinkevich, Baruch; Zehavi, Tania; Lahav, Meir			Telomere Shortening Sensitizes Cancer Cells to Selected Cytotoxic Agents: In Vitro and In Vivo Studies and Putative Mechanisms	PLOS ONE			English	Article							SMALL INTERFERING RNA; HUMAN MISMATCH REPAIR; OVARIAN-CANCER; IONIZING-RADIATION; THERAPEUTIC TARGET; INDUCED APOPTOSIS; MULTIPLE-MYELOMA; DRUG-RESISTANT; TUMOR-CELLS; INHIBITION	Background: Telomere/telomerase system has been recently recognized as an attractive target for anticancer therapy. Telomerase inhibition results in tumor regression and increased sensitivity to various cytotoxic drugs. However, it has not been fully established yet whether the mediator of these effects is telomerase inhibition per se or telomere shortening resulting from inhibition of telomerase activity. In addition, the characteristics and mechanisms of sensitization to cytotoxic drugs caused by telomerase inhibition has not been elucidated in a systematic manner. Methodology/Principal Findings: In this study we characterized the relative importance of telomerase inhibition versus telomere shortening in cancer cells. Sensitization of cancer cells to cytotoxic drugs was achieved by telomere shortening in a length dependent manner and not by telomerase inhibition per se. In our system this sensitization was related to the mechanism of action of the cytotoxic drug. In addition, telomere shortening affected also other cancer cell functions such as migration. Telomere shortening induced DNA damage whose repair was impaired after administration of cisplatinum while doxorubicin or vincristine did not affect the DNA repair. These findings were verified also in in vivo mouse model. The putative explanation underlying the phenotype induced by telomere shortening may be related to changes in expression of various microRNAs triggered by telomere shortening. Conclusions/Significance: To our best knowledge this is the first study characterizing the relative impact of telomerase inhibition and telomere shortening on several aspects of cancer cell phenotype, especially related to sensitivity to cytotoxic drugs and its putative mechanisms. The microRNA changes in cancer cells upon telomere shortening are novel information. These findings may facilitate the development of telomere based approaches in treatment of cancer.	[Uziel, Orit; Beery, Einat; Dronichev, Vladimir; Samocha, Katty; Nordenberg, Yardena; Lahav, Meir] Beilinson Med Ctr, Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Nordenberg, Yardena] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Gryaznov, Sergei] Geron Corp, Menlo Pk, CA USA; [Weiss, Lola; Slavin, Shimon] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel; [Kushnir, Michal] Rosetta Genom Ltd, Rehovot, Israel; [Rabinowitz, Claudette; Rinkevich, Baruch] Natl Inst Oceanog, IL-31080 Haifa, Israel; [Zehavi, Tania] Meir Med Ctr, Dept Pathol, Kefar Sava, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Geron Corporation; Hebrew University of Jerusalem; Israel Oceanographic & Limnological Research Institute; Tel Aviv University; Sackler Faculty of Medicine	Uziel, O (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	mlahav@post.tau.ac.il			Rabin Medical Center Research Authority; Sackler School of Medicine, Tel-Aviv University, Israel	Rabin Medical Center Research Authority; Sackler School of Medicine, Tel-Aviv University, Israel	This work was partially supported by research grants from Rabin Medical Center Research Authority and a research grant from Sackler School of Medicine, Tel-Aviv University, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Akiyama M, 2003, CANCER RES, V63, P6187; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BAGHERI S, P NATL ACAD SCI US, V103, P11306; Boren T, 2009, GYNECOL ONCOL, V113, P249, DOI 10.1016/j.ygyno.2009.01.014; Boukamp P, 2007, EXP DERMATOL, V16, P71, DOI 10.1111/j.1600-0625.2006.00517.x; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; Cerone MA, 2006, ONCOGENE, V25, P7411, DOI 10.1038/sj.onc.1209727; Cerone MA, 2006, MOL CANCER THER, V5, P1669, DOI 10.1158/1535-7163.MCT-06-0033; Chen Z, 2003, CANCER RES, V63, P5917; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Dikmen ZG, 2005, CANCER RES, V65, P7866, DOI 10.1158/0008-5472.CAN-05-1215; Duale N, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-53; El Daly Hesham, 2007, V405, P47, DOI 10.1007/978-1-60327-070-0_6; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; HERINGOVA P, 2009, J BIOL INORG CHEM; Kamer I, 2002, TOXICOL IN VITRO, V16, P177, DOI 10.1016/S0887-2333(01)00118-7; KIM S, J BIOL CHEM, V26, P18158; Kondo Y, 1998, ONCOGENE, V16, P2243, DOI 10.1038/sj.onc.1201754; Larson ED, 2001, J BIOL CHEM, V276, P9775, DOI 10.1074/jbc.M006390200; Lavelle F, 2000, CRIT REV ONCOL HEMAT, V34, P111, DOI 10.1016/S1040-8428(00)00057-3; Lee KH, 2001, P NATL ACAD SCI USA, V98, P3381, DOI 10.1073/pnas.051629198; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Massard C, 2006, ONCOGENE, V25, P4505, DOI 10.1038/sj.onc.1209487; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; O'Driscoll M, 1999, CARCINOGENESIS, V20, P799, DOI 10.1093/carcin/20.5.799; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Park YP, 2008, KOREAN J LAB MED, V28, P430, DOI 10.3343/kjlm.2008.28.6.430; Ram R, 2009, CLIN CANCER RES, V15, P914, DOI 10.1158/1078-0432.CCR-08-0792; Reischer D, 2007, BRIT J PHARMACOL, V150, P738, DOI 10.1038/sj.bjp.0707146; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; RUDD GN, 1995, CANCER CHEMOTH PHARM, V35, P323, DOI 10.1007/BF00689452; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Shammas MA, 2008, LEUKEMIA, V22, P1410, DOI 10.1038/leu.2008.81; Shammas MA, 1999, ONCOGENE, V18, P6191, DOI 10.1038/sj.onc.1203069; Shammas MA, 2004, CLIN CANCER RES, V10, P770, DOI 10.1158/1078-0432.CCR-0793-03; Shammas MA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-24; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Shay JW, 2001, RADIAT RES, V155, P188, DOI 10.1667/0033-7587(2001)155[0188:TATIFC]2.0.CO;2; Shen Y, 2008, CANCER BIOL THER, V7, P228, DOI 10.4161/cbt.7.2.5259; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Taylor EM, 1998, INT J RADIAT BIOL, V74, P277; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Ward RJ, 2005, MOL PHARMACOL, V68, P779, DOI 10.1124/mol.105.011494; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Zhang ZH, 2006, CLIN CANCER RES, V12, P4933, DOI 10.1158/1078-0432.CCR-05-2831	62	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9132	10.1371/journal.pone.0009132	http://dx.doi.org/10.1371/journal.pone.0009132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161752	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442600029
J	Schirmer, P; Lucero, C; Oda, G; Lopez, J; Holodniy, M				Schirmer, Patricia; Lucero, Cynthia; Oda, Gina; Lopez, Jessica; Holodniy, Mark			Effective Detection of the 2009 H1N1 Influenza Pandemic in US Veterans Affairs Medical Centers Using a National Electronic Biosurveillance System	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; EPIDEMICS; ILLNESS	Background: The 2008-09 influenza season was the time in which the Department of Veterans Affairs (VA) utilized an electronic biosurveillance system for tracking and monitoring of influenza trends. The system, known as ESSENCE or Electronic Surveillance System for the Early Notification of Community-based Epidemics, was monitored for the influenza season as well as for a rise in influenza cases at the start of the H1N1 2009 influenza pandemic. We also describe trends noted in influenza-like illness (ILI) outpatient encounter data in VA medical centers during the 2008-09 influenza season, before and after the recognition of pandemic H1N1 2009 influenza virus. Methodology/Principal Findings: We determined prevalence of ILI coded visits using VA's ESSENCE for 2008-09 seasonal influenza (Sept. 28, 2008-April 25, 2009 corresponding to CDC 2008-2009 flu season weeks 40-16) and the early period of pandemic H1N1 2009 (April 26, 2009-July 31, 2009 corresponding to CDC 2008-2009 flu season weeks 17-30). Differences in diagnostic ICD-9-CM code frequencies were analyzed using Chi-square and odds ratios. There were 649,574 ILI encounters captured representing 633,893 patients. The prevalence of VA ILI visits mirrored the CDC's Outpatient ILI Surveillance Network (ILINet) data with peaks in late December, early February, and late April/early May, mirroring the ILINet data; however, the peaks seen in the VA were smaller. Of 31 ILI codes, 6 decreased and 11 increased significantly during the early period of pandemic H1N1 2009. The ILI codes that significantly increased were more likely to be symptom codes. Although influenza with respiratory manifestation (487.1) was the most common code used among 150 confirmed pandemic H1N1 2009 cases, overall it significantly decreased since the start of the pandemic. Conclusions/Significance: VA ESSENCE effectively detected and tracked changing ILI trends during pandemic H1N1 2009 and represents an important temporal alerting system for monitoring health events in VA facilities.	[Schirmer, Patricia; Lucero, Cynthia; Oda, Gina; Lopez, Jessica; Holodniy, Mark] Off Publ Hlth Surveillance & Res, Dept Vet Affairs, Palo Alto, CA USA; [Schirmer, Patricia; Holodniy, Mark] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Schirmer, P (corresponding author), Off Publ Hlth Surveillance & Res, Dept Vet Affairs, Palo Alto, CA USA.	pschirme@stanford.edu		Holodniy, Mark/0000-0002-6655-7982	Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	Funding has been from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; BUCK C, 2008, CLIN MODIFICATION IC, V2, P3; BUCK C, 2008, CLIN MODIFICATION IC, V1, P3; Buck CB, 2008, CELL HOST MICROBE, V3, P3, DOI 10.1016/j.chom.2007.12.006; Burkom Howard S, 2004, MMWR Suppl, V53, P67; *CDC, 2009, 2008 2009 INFL SEAS; *CDC, CDC FLU ACT SURV; *CDC, CDC AB BIOSENSE; *CDC, 2009, CDC H1N1 REP QUEST A; *CDC, 2009, CDC INT GUID INFL SU; *CDC, CDC INFL CLIN INF PR; Chan M., 2009, WORLD NOW START 2009; Chapman WW, 2004, J BIOMED INFORM, V37, P120, DOI 10.1016/j.jbi.2004.03.002; Clothier HJ, 2005, COMMUN DIS INTELL, V29, P231; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; FROEHLING D, 2008, AMIA ANN S P; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gundlapalli AV, 2007, AM J INFECT CONTROL, V35, P163, DOI 10.1016/j.ajic.2006.08.003; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; ODA G, 2007, ADV DIS SURVEILL, V4, P260; *OFF ASS DEP SECR, 2009, SEL VHA STAT FY2008; Pattie David C, 2009, Qual Manag Health Care, V18, P91, DOI 10.1097/QMH.0b013e3181a0274d; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Shimoni Z, 2006, MED HYPOTHESES, V67, P709, DOI 10.1016/j.mehy.2006.04.018; Smith G E, 2006, Euro Surveill, V11, P220; Watts G, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a3076; WHO, 2009, WHO PAND H1N1 2009 U, P112; Yih WK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005260	34	14	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9533	10.1371/journal.pone.0009533	http://dx.doi.org/10.1371/journal.pone.0009533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209055	gold, Green Published, Green Submitted			2022-12-27	WOS:000275197100015
J	Sawka, AM; Ismaila, N; Cranney, A; Thabane, L; Kastner, M; Gafni, A; Woodhouse, LJ; Crilly, R; Cheung, AM; Adachi, JD; Josse, RG; Papaioannou, A				Sawka, Anna M.; Ismaila, Nofisat; Cranney, Ann; Thabane, Lehana; Kastner, Monika; Gafni, Amiram; Woodhouse, Linda J.; Crilly, Richard; Cheung, Angela M.; Adachi, Jonathan D.; Josse, Robert G.; Papaioannou, Alexandra			A Scoping Review of Strategies for the Prevention of Hip Fracture in Elderly Nursing Home Residents	PLOS ONE			English	Review							VITAMIN-D SUPPLEMENTATION; BONE-MINERAL DENSITY; LONG-TERM-CARE; OLDER-PEOPLE; RISK-FACTORS; PROTECTORS DECREASE; ALZHEIMERS-DISEASE; SUNLIGHT EXPOSURE; HYPOVITAMINOSIS-D; CONTROLLED-TRIAL	Background: Elderly nursing home residents are at increased risk of hip fracture; however, the efficacy of fracture prevention strategies in this population is unclear. Objective: We performed a scoping review of randomized controlled trials of interventions tested in the long-term care (LTC) setting, examining hip fracture outcomes. Methods: We searched for citations in 6 respective electronic searches, supplemented by hand searches. Two reviewers independently reviewed all citations and full-text papers; consensus was achieved on final inclusion. Data was abstracted in duplicate. Findings: We reviewed 22,349 abstracts or citations and 949 full-text papers. Data from 20 trials were included: 7-vitamin D (n = 12,875 participants), 2-sunlight exposure (n = 522), 1-alendronate (n = 327), 1-fluoride (n = 460), 4-exercise or multimodal interventions (n = 8,165), and 5-hip protectors (n = 2,594). Vitamin D, particularly vitamin D-3 >= 800 IU orally daily, reduced hip fracture risk. Hip protectors reduced hip fractures in included studies, although a recent large study not meeting inclusion criteria was negative. Fluoride and sunlight exposure did not significantly reduce hip fractures. Falls were reduced in three studies of exercise or multimodal interventions, with one study suggesting reduced hip fractures in a secondary analysis. A staff education and risk assessment strategy did not significantly reduce falls or hip fractures. In a study underpowered for fracture outcomes, alendronate did not significantly reduce hip fractures in LTC. Conclusions: The intervention with the strongest evidence for reduction of hip fractures in LTC is Vitamin D supplementation; more research on other interventions is needed.	[Sawka, Anna M.; Ismaila, Nofisat; Cheung, Angela M.] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Sawka, Anna M.; Cheung, Angela M.; Josse, Robert G.] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Cranney, Ann] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Thabane, Lehana; Gafni, Amiram] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Kastner, Monika] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Woodhouse, Linda J.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Woodhouse, Linda J.] Sunnybrook Hlth Sci Ctr, Holland Orthopaed & Arthrit Hosp, Dept Surg, Toronto, ON M4N 3M5, Canada; [Crilly, Richard] Univ Western Ontario, Dept Med, Div Geriatr, London, ON, Canada; [Cheung, Angela M.] Univ Hlth Network, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [Adachi, Jonathan D.] St Josephs Healthcare, Dept Med, Div Rheumatol, Hamilton, ON, Canada; [Adachi, Jonathan D.] McMaster Univ, Dept Med, Div Rheumatol, Hamilton, ON, Canada; [Josse, Robert G.] St Michaels Hosp, Dept Med, Div Endocrinol, Toronto, ON M5B 1W8, Canada; [Papaioannou, Alexandra] Hamilton Hlth Sci, Dept Med, Div Geriatr, Hamilton, ON, Canada; [Papaioannou, Alexandra] McMaster Univ, Dept Med, Div Geriatr, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; McMaster University; University of Toronto; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University	Sawka, AM (corresponding author), Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada.	sawkaam@yahoo.com	Ismaila, Nofisat/HGC-3899-2022; Sawka, Anna/AAA-4336-2020; Woodhouse, Linda J/AAV-7090-2020	Cheung, Angela M./0000-0001-8332-0744; Woodhouse, Linda J/0000-0002-1615-8895	Canadian Institutes of Health Research [FRN 82616]; Ontario Ministry of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario)	This work was funded by the Canadian Institutes of Health Research (Knowledge Translation - Research Synthesis Competition, FRN 82616) as well as, in part, by the Osteoporosis Strategy Program of the Ontario Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton BA, 2008, CLIN TRIALS, V5, P347, DOI 10.1177/1740774508095120; Beaupre LA, 2007, J GERONTOL A-BIOL, V62, P1127, DOI 10.1093/gerona/62.10.1127; Becker C, 2003, J AM GERIATR SOC, V51, P306, DOI 10.1046/j.1532-5415.2003.51103.x; Berry SD, 2008, J AM GERIATR SOC, V56, P1887, DOI 10.1111/j.1532-5415.2008.01918.x; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; BUCHNER DM, 1987, JAMA-J AM MED ASSOC, V257, P1492, DOI 10.1001/jama.257.11.1492; Butler M, 1996, AGE AGEING, V25, P381, DOI 10.1093/ageing/25.5.381; Chandler JM, 2000, JAMA-J AM MED ASSOC, V284, P972, DOI 10.1001/jama.284.8.972; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cox H, 2008, AGE AGEING, V37, P167, DOI 10.1093/ageing/afm168; Crotty M, 2000, J Qual Clin Pract, V20, P167, DOI 10.1046/j.1440-1762.2000.00385.x; Cumming RG, 1996, AM J EPIDEMIOL, V143, P1191; Ekman A, 1997, LANCET, V350, P563, DOI 10.1016/S0140-6736(05)63140-6; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Greenspan SL, 2002, ANN INTERN MED, V136, P742, DOI 10.7326/0003-4819-136-10-200205210-00009; Harada A, 2001, OSTEOPOROSIS INT, V12, P215, DOI 10.1007/s001980170132; INKOVAARA J, 1975, BMJ-BRIT MED J, V3, P73, DOI 10.1136/bmj.3.5975.73; Jantti PO, 1998, AGE AGEING, V27, P758, DOI 10.1093/ageing/27.6.758; Jensen J, 2002, ANN INTERN MED, V136, P733, DOI 10.7326/0003-4819-136-10-200205210-00008; Jorgensen EB, 2008, KAIS, V2021, P1, DOI [DOI 10.1002/14651858.CD001155.PUB2, 10.1002/mp.15257]; Kiel DP, 2007, JAMA-J AM MED ASSOC, V298, P413, DOI 10.1001/jama.298.4.413; Koike T, 2009, OSTEOPOROSIS INT, V20, P1613, DOI 10.1007/s00198-008-0824-7; KOMAR L, 1993, J AM GERIATR SOC, V41, P1057, DOI 10.1111/j.1532-5415.1993.tb06452.x; Lauritzen JB, 1997, DAN MED BULL, V44, P155; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Maggio D, 2001, CALCIFIED TISSUE INT, V68, P337, DOI 10.1007/s002230001212; Meyer G, 2003, BRIT MED J, V326, P76, DOI 10.1136/bmj.326.7380.76; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; Norton R, 1999, AGE AGEING, V28, P135, DOI 10.1093/ageing/28.2.135; OOMS ME, 1994, OSTEOPOROSIS INT, V4, P6, DOI 10.1007/BF02352254; Papadimitropoulos E, 2000, J SOC OBSTET GYNAECO, V22, P591; Rapp K, 2008, J BONE MINER RES, V23, P1825, DOI 10.1359/JBMR.080702; Sakamoto K, 2006, J ORTHOP SCI, V11, P467, DOI 10.1007/s00776-006-1057-2; Sato Y, 2005, J BONE MINER RES, V20, P1327, DOI 10.1359/JBMR.050402; Sato Y, 2005, CEREBROVASC DIS, V20, P187, DOI 10.1159/000087203; Sato Y, 2003, NEUROLOGY, V61, P338, DOI 10.1212/01.WNL.0000078892.24356.90; Sawka AM, 2005, OSTEOPOROSIS INT, V16, P1461, DOI 10.1007/s00198-005-1932-2; Sawka AM, 2007, J CLIN EPIDEMIOL, V60, P336, DOI 10.1016/j.jclinepi.2006.07.006; Singh S, 2004, J RHEUMATOL, V31, P1607; Vu Man Quang, 2004, J Am Med Dir Assoc, V5, P401, DOI 10.1016/S1525-8610(04)70009-2; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Wiktorowicz ME, 2001, OSTEOPOROSIS INT, V12, P271, DOI 10.1007/s001980170116; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	49	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9515	10.1371/journal.pone.0009515	http://dx.doi.org/10.1371/journal.pone.0009515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	562OZ	20209088	Green Published, Green Submitted, gold			2022-12-27	WOS:000275063400020
J	Fournier, GP; Neumann, JE; Gogarten, JP				Fournier, Gregory P.; Neumann, Justin E.; Gogarten, J. Peter			Inferring the Ancient History of the Translation Machinery and Genetic Code via Recapitulation of Ribosomal Subunit Assembly Orders	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; ORIGIN; SELECTION; ALIGNMENT; EVOLUTION	Universally conserved positions in ribosomal proteins have significant biases in amino acid usage, likely indicating the expansion of the genetic code at the time leading up to the most recent common ancestor(s) (MRCA). Here, we apply this principle to the evolutionary history of the ribosome before the MRCA. It has been proposed that the experimentally determined order of assembly for ribosomal subunits recapitulates their evolutionary chronology. Given this model, we produce a probabilistic evolutionary ordering of the universally conserved small subunit (SSU) and large subunit (LSU) ribosomal proteins. Optimizing the relative ordering of SSU and LSU evolutionary chronologies with respect to minimizing differences in amino acid usage bias, we find strong compositional evidence for a more ancient origin for early LSU proteins. Furthermore, we find that this ordering produces several trends in specific amino acid usages compatible with models of genetic code evolution.	[Fournier, Gregory P.; Gogarten, J. Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Neumann, Justin E.] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Fournier, GP (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	gregory.fournier@uconn.edu		Gogarten, Johann Peter/0000-0001-6459-6518	NASA Exobiology [NNX07AK15G]; NSF Assembling the Tree of Life Program [DEB 0830024]; Division Of Environmental Biology [0830024] Funding Source: National Science Foundation	NASA Exobiology(National Aeronautics & Space Administration (NASA)); NSF Assembling the Tree of Life Program(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The reported work was supported through the NASA Exobiology (NNX07AK15G) (http://exobiology.nasa.gov/) and NSF Assembling the Tree of Life Program (DEB 0830024) (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blaise M, 2005, BIOCHIMIE, V87, P847, DOI 10.1016/j.biochi.2005.03.007; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; Fox GF, 2004, MOL B INT U, P92; Grondek JF, 2004, RNA, V10, P1861, DOI 10.1261/rna.7130504; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; HARTMAN H, 1995, J MOL EVOL, V40, P541; Ibba M, 1997, TRENDS BIOCHEM SCI, V22, P39, DOI 10.1016/S0968-0004(96)20033-7; JUKES TH, 1974, BIOCHEM BIOPH RES CO, V58, P80, DOI 10.1016/0006-291X(74)90893-6; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Mushegian A, 2005, RNA, V11, P1400, DOI 10.1261/rna.2180205; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; Taylor WR, 2006, J THEOR BIOL, V243, P393, DOI 10.1016/j.jtbi.2006.06.015; Taylor WR, 2006, PHILOS T R SOC B, V361, P1751, DOI 10.1098/rstb.2006.1910; Terribilini M, 2006, RNA, V12, P1450, DOI 10.1261/rna.2197306; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifonov EN, 2000, GENE, V261, P139, DOI 10.1016/S0378-1119(00)00476-5; Tumbula-Hansen D, 2002, J BIOL CHEM, V277, P37184, DOI 10.1074/jbc.M204767200; Wolf YI, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-14	21	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2010	5	3							e9437	10.1371/journal.pone.0009437	http://dx.doi.org/10.1371/journal.pone.0009437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RT	20208990	Green Published, Green Submitted, gold			2022-12-27	WOS:000274997100001
J	Bradley, WEC; Raelson, JV; Dubois, DY; Godin, E; Fournier, H; Prive, C; Allard, R; Pinchuk, V; Lapalme, M; Paulussen, RJA; Belouchi, A				Bradley, W. Edward C.; Raelson, John V.; Dubois, Daniel Y.; Godin, Eric; Fournier, Helene; Prive, Charles; Allard, Rene; Pinchuk, Vadym; Lapalme, Micheline; Paulussen, Rene J. A.; Belouchi, Abdelmajid			Hotspots of Large Rare Deletions in the Human Genome	PLOS ONE			English	Article							GENE; PARKIN; ASSOCIATION; DISEASE; BREAKPOINTS; DISRUPTION; PATIENT; CANCER	Background: We have examined the genomic distribution of large rare autosomal deletions in a sample of 440 parent-parent-child trios from the Quebec founder population (QFP) which was recruited for a study of Attention Deficit Hyperactivity Disorder. Methodology/Principal Findings: DNA isolated from blood was genotyped on Illumina Hap300 arrays. PennCNV combined with visual evaluation of images generated by the Beadstudio program was used to determine deletion boundary definition of sufficient precision to discern independent events, with near-perfect concordance between parent and child in about 98% of the 399 events detected in the offspring; the remaining 7 deletions were considered de novo. We defined several genomic regions of very high deletion frequency ('hotspots'), usually of 0.4-0.6 Mb in length where independent rare deletions were found at frequencies of up to 100 fold higher than the average for the genome as a whole. Five of the 7 de novo deletions were in these hotspots. The same hotspots were also observed in three other studies on members of the QFP, those with schizophrenia, with endometriosis and those from a longevity cohort. Conclusions/Significance: Nine of the 13 hotspots carry one gene (7 of which are very long), while the rest contain no known genes. All nine genes have been implicated in disease. The patterns of exon deletions support the proposed roles for some of these genes in human disease, such as NRXN1 and PARKIN, and suggest limited roles or no role at all, for others, including MACROD2 and CTNNA3. Our results also offer an alternative interpretation for the observations of deletions in tumors which have been proposed as reflecting tumor-suppressive activity of genes in these hotspots.	[Bradley, W. Edward C.; Belouchi, Abdelmajid] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Raelson, John V.; Dubois, Daniel Y.; Godin, Eric; Fournier, Helene; Prive, Charles; Allard, Rene; Pinchuk, Vadym; Lapalme, Micheline; Paulussen, Rene J. A.; Belouchi, Abdelmajid] Genizon Biosci Inc, St Laurent, PQ, Canada	Universite de Montreal	Bradley, WEC (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	edward.bradley@umontreal.ca			Cancer Research Society; Genizon Biosciences Inc	Cancer Research Society; Genizon Biosciences Inc	This work was supported in part by the Cancer Research Society (Montreal; www.src-crs.ca) and Genizon Biosciences Inc (Montreal; www.genizon.com). Raw genotyping data collection and analysis were performed by Genizon Biosciences Inc. in the course of research projects designed to identify genes involved in various clinical conditions, and individual employees of Genizon participated in the study as outlined in the Contributions section. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 2009, BIOCHEM BIOPH RES CO, V389, P181, DOI 10.1016/j.bbrc.2009.08.115; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100; Davison EJ, 2005, GENE CHROMOSOME CANC, V44, P384, DOI 10.1002/gcc.20252; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Hedrich K, 2004, MOVEMENT DISORD, V19, P1146, DOI 10.1002/mds.20234; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; Maas NMC, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049510; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sironi M, 2006, FASEB J, V20, P1910, DOI 10.1096/fj.05-5635fje; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437	24	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2010	5	2							e9401	10.1371/journal.pone.0009401	http://dx.doi.org/10.1371/journal.pone.0009401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SY	20195527	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924300003
J	Hou, YL; Wang, YC; Lust, G; Zhu, L; Zhang, ZW; Todhunter, RJ				Hou, Yali; Wang, Yachun; Lust, George; Zhu, Lan; Zhang, Zhiwu; Todhunter, Rory J.			Retrospective Analysis for Genetic Improvement of Hip Joints of Cohort Labrador Retrievers in the United States: 1970-2007	PLOS ONE			English	Article							DORSOLATERAL SUBLUXATION; COXOFEMORAL JOINT; DYSPLASIA SCORE; GORDON SETTERS; DOGS; LAXITY; HERITABILITY; PHENOTYPE; TRAITS	Background: Canine Hip Dysplasia (CHD) is a common inherited disease that affects dog wellbeing and causes a heavy financial and emotional burden to dog owners and breeders due to secondary hip osteoarthritis. The Orthopedic Foundation for Animals (OFA) initiated a program in the 1960's to radiograph hip and elbow joints and release the OFA scores to the public for breeding dogs against CHD. Over last four decades, more than one million radiographic scores have been released. Methodology/Principal Findings: The pedigrees in the OFA database consisted of 258,851 Labrador retrievers, the major breed scored by the OFA (25% of total records). Of these, 154,352 dogs had an OFA hip score reported between 1970 and 2007. The rest of the dogs (104,499) were the ancestors of the 154,352 dogs to link the pedigree relationships. The OFA hip score is based on a 7-point scale with the best ranked as 1 (excellent) and the worst hip dysplasia as 7. A mixed linear model was used to estimate the effects of age, sex, and test year period and to predict the breeding value for each dog. Additive genetic and residual variances were estimated using the average information restricted maximum likelihood procedure. The analysis also provided an inbreeding coefficient for each dog. The hip scores averaged 1.93 (+/-SD = 0.59) and the heritability was 0.21. A steady genetic improvement has accrued over the four decades. The breeding values decreased (improved) linearly. By the end of 2005, the total genetic improvement was 0.1 units, which is equivalent to 17% of the total phenotypic standard deviation. Conclusion/Significance: A steady genetic improvement has been achieved through the selection based on the raw phenotype released by the OFA. As the heritability of the hip score was on the low end (0.21) of reported ranges, we propose that selection based on breeding values will result in more rapid genetic improvement than breeding based on phenotypic selection alone.	[Hou, Yali; Wang, Yachun] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Lust, George] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	China Agricultural University; Cornell University; Oklahoma State University System; Oklahoma State University - Stillwater; Cornell University; Cornell University	Hou, YL (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	zz19@cornell.edu	Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Zhang, Zhiwu/0000-0002-5784-9684; 	National Institutes of Health [1R21AR055228-01A1]; Chinese National Key Technologies RD Program [2006BAD04A01, 2006BAD14B07]; Chinese National Department Public Benefit Research Foundation [NYHYZX07-035]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Key Technologies RD Program(National Key Technology R&D Program); Chinese National Department Public Benefit Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), Chinese National Key Technologies R&D Program (No. 2006BAD04A01, No. 2006BAD14B07) and Chinese National Department Public Benefit Research Foundation (No. NYHYZX07-035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CORLEY EA, 1992, VET CLIN N AM-SMALL, V22, P579, DOI 10.1016/S0195-5616(92)50057-2; CRUDEN D, 1949, J HERED, V40, P248, DOI 10.1093/oxfordjournals.jhered.a106039; EMIK LO, 1949, J HERED, V40, P51, DOI 10.1093/oxfordjournals.jhered.a105986; Farese JP, 1998, VET SURG, V27, P393, DOI 10.1111/j.1532-950X.1998.tb00146.x; Farese JP, 1999, AM J VET RES, V60, P1571; Fluckiger MA, 1999, VET SURG, V28, P1, DOI 10.1053/jvet.1999.0001; Gianola D, 2006, GENETICS, V173, P2247, DOI 10.1534/genetics.105.054197; Ginja MMD, 2008, J SMALL ANIM PRACT, V49, P641, DOI 10.1111/j.1748-5827.2008.00629.x; Henderson C. R, 1984, APPL LINEAR MODELS A; Henricson B, 1966, J Small Anim Pract, V7, P673, DOI 10.1111/j.1748-5827.1966.tb04393.x; HENRY GA, 1992, VET CLIN N AM-SMALL, V22, P559, DOI 10.1016/S0195-5616(92)50056-0; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kaneene JB, 1997, J AM VET MED ASSOC, V211, P1542; Kaneene JB, 2009, VET SURG, V38, P398, DOI 10.1111/j.1532-950X.2008.00475.x; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; Madsen P., 2006, WORLD C GENETICS APP; MADSEN P, 2007, USERS GUIDE DMU DENM; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Swenson L, 1997, J AM VET MED ASSOC, V210, P207; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; VANVLECK LD, 1991, J DAIRY SCI, V74, P4082, DOI 10.3168/jds.S0022-0302(91)78603-7; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; Wood JLN, 2000, PREV VET MED, V46, P87, DOI 10.1016/S0167-5877(00)00141-0; Wood JLN, 2003, VET REC, V152, P69, DOI 10.1136/vr.152.3.69; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	27	37	40	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9410	10.1371/journal.pone.0009410	http://dx.doi.org/10.1371/journal.pone.0009410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195372	Green Submitted, gold, Green Published			2022-12-27	WOS:000274924200030
J	Roussilhon, C; Brasseur, P; Agnamey, P; Perignon, JL; Druilhe, P				Roussilhon, Christian; Brasseur, Philippe; Agnamey, Patrice; Perignon, Jean-Louis; Druilhe, Pierre			Understanding Human-Plasmodium falciparum Immune Interactions Uncovers the Immunological Role of Worms	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; REGULATORY T-CELLS; PROTECTIVE IMMUNITY; SCHISTOSOMA-MANSONI; ASCARIS-LUMBRICOIDES; NEMATODE INFECTION; HUMAN MALARIA; RESPONSES; ANTIBODIES; DISEASES	Background: Former studies have pointed to a monocyte-dependant effect of antibodies in protection against malaria and thereby to cytophilic antibodies IgG1 and IgG3, which trigger monocyte receptors. Field investigations have further documented that a switch from non-cytophilic to cytophilic classes of antimalarial antibodies was associated with protection. The hypothesis that the non-cytophilic isotype imbalance could be related to concomittant helminthic infections was supported by several interventions and case-control studies. Methods and Findings: We investigated here the hypothesis that the delayed acquisition of immunity to malaria could be related to a worm-induced Th2 drive on antimalarial immune responses. IgG1 to IgG4 responses against 6 different parasite-derived antigens were analyzed in sera from 203 Senegalese children, half carrying intestinal worms, presenting 421 clinical malaria attacks over 51 months. Results show a significant correlation between the occurrence of malaria attacks, worm carriage (particularly that of hookworms) and a decrease in cytophilic IgG1 and IgG3 responses and an increase in non-cytophilic IgG4 response to the merozoite stage protein 3 (MSP3) vaccine candidate. Conclusion: The results confirm the association with protection of anti-MSP3 cytophilic responses, confirm in one additional setting that worms increase malaria morbidity and show a Th2 worm-driven pattern of anti-malarial immune responses. They document why large anthelminthic mass treatments may be worth being assessed as malaria control policies.	[Roussilhon, Christian; Perignon, Jean-Louis; Druilhe, Pierre] Inst Pasteur, Unite Parasitol Biomed, Paris, France; [Brasseur, Philippe] Inst Rech Dev, UMR 198, Dakar, Senegal; [Agnamey, Patrice] Hop Sud, CHU Amiens, Lab Parasitol Mycol, Amiens, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Roussilhon, C (corresponding author), Inst Pasteur, Unite Parasitol Biomed, Paris, France.	druilhe@pasteur.fr			French Ministry of Foreign Affairs [FAC 2000]	French Ministry of Foreign Affairs	This work was in part supported by the French Ministry of Foreign Affairs - grant FAC 2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnamey P, 2006, ANTIMICROB AGENTS CH, V50, P1531, DOI 10.1128/AAC.50.4.1531-1534.2006; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; BAILENGER J, 1970, ANN BIOL CLIN-PARIS, V28, P425; Basavaraju SV, 2006, MT SINAI J MED, V73, P1098; Bleay C, 2007, INT J PARASITOL, V37, P1501, DOI 10.1016/j.ijpara.2007.04.023; Borkow G, 2008, TRENDS PARASITOL, V24, P243, DOI 10.1016/j.pt.2008.02.009; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; de Souza B, 2008, MICROBES INFECT, V10, P916, DOI 10.1016/j.micinf.2008.04.015; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Druilhe P, 2006, VACCINE, V24, P4902, DOI 10.1016/j.vaccine.2006.03.018; Elias D, 2008, VACCINE, V26, P3897, DOI 10.1016/j.vaccine.2008.04.083; Elias D, 2007, EXPERT REV ANTI-INFE, V5, P475, DOI 10.1586/14787210.5.3.475; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Helmby H, 1998, INFECT IMMUN, V66, P5167, DOI 10.1128/IAI.66.11.5167-5174.1998; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180; Khan WI, 2008, PARASITOLOGY, V135, P671, DOI 10.1017/S0031182008004381; MANSONBAHR PEC, 2002, MANSONS TROPICAL DIS; McGregor I. A., 1988, Malaria: principles and practice of malariology. Volume 1., P559; Moncayo AL, 2006, INT J BIOCHEM CELL B, V38, P1031, DOI 10.1016/j.biocel.2005.11.003; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; PIERCE EJ, 1991, J EXP MED, V73, P159; PRITCHARD DI, 1992, PARASITE IMMUNOL, V14, P617, DOI 10.1111/j.1365-3024.1992.tb00034.x; Pullan R, 2008, PARASITOLOGY, V135, P783, DOI 10.1017/S0031182008000346; RHODESFEUILLETTE A, 1985, J INTERFERON RES, V5, P169, DOI 10.1089/jir.1985.5.169; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sarthou JL, 1997, INFECT IMMUN, V65, P3271, DOI 10.1128/IAI.65.8.3271-3276.1997; Sergent Ed., 1935, Arch Inst Pasteur Alger, V13, P279; Shin EH, 2007, J PARASITOL, V93, P1036, DOI 10.1645/GE-1203R.1; Singh S, 2004, J INFECT DIS, V190, P1010, DOI 10.1086/423208; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Soe S, 2002, INFECT IMMUN, V70, P7182, DOI 10.1128/IAI.70.12.7182-7184.2002; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Theisen M, 2000, VACCINE, V19, P204, DOI 10.1016/S0264-410X(00)00181-X; Wilson MS, 2006, CHEM IMMUNOL ALLERGY, V90, P176, DOI 10.1159/000088892; Yoshida A, 2000, INT IMMUNOL, V12, P1117, DOI 10.1093/intimm/12.8.1117	46	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9309	10.1371/journal.pone.0009309	http://dx.doi.org/10.1371/journal.pone.0009309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174576	Green Published, Green Submitted, gold			2022-12-27	WOS:000274923700013
J	Tuch, BB; Laborde, RR; Xu, X; Gu, J; Chung, CB; Monighetti, CK; Stanley, SJ; Olsen, KD; Kasperbauer, JL; Moore, EJ; Broomer, AJ; Tan, RY; Brzoska, PM; Muller, MW; Siddiqui, AS; Asmann, YW; Sun, YM; Kuersten, S; Barker, MA; De La Vega, FM; Smith, DI				Tuch, Brian B.; Laborde, Rebecca R.; Xu, Xing; Gu, Jian; Chung, Christina B.; Monighetti, Cinna K.; Stanley, Sarah J.; Olsen, Kerry D.; Kasperbauer, Jan L.; Moore, Eric J.; Broomer, Adam J.; Tan, Ruoying; Brzoska, Pius M.; Muller, Matthew W.; Siddiqui, Asim S.; Asmann, Yan W.; Sun, Yongming; Kuersten, Scott; Barker, Melissa A.; De La Vega, Francisco M.; Smith, David I.			Tumor Transcriptome Sequencing Reveals Allelic Expression Imbalances Associated with Copy Number Alterations	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LASER CAPTURE MICRODISSECTION; GENE-EXPRESSION; RNA-SEQ; CANCER STATISTICS; CYCLIN D1; SUPPRESSOR; HEAD; AGGRESSIVENESS; IDENTIFICATION	Due to growing throughput and shrinking cost, massively parallel sequencing is rapidly becoming an attractive alternative to microarrays for the genome-wide study of gene expression and copy number alterations in primary tumors. The sequencing of transcripts (RNA-Seq) should offer several advantages over microarray-based methods, including the ability to detect somatic mutations and accurately measure allele-specific expression. To investigate these advantages we have applied a novel, strand-specific RNA-Seq method to tumors and matched normal tissue from three patients with oral squamous cell carcinomas. Additionally, to better understand the genomic determinants of the gene expression changes observed, we have sequenced the tumor and normal genomes of one of these patients. We demonstrate here that our RNA-Seq method accurately measures allelic imbalance and that measurement on the genome-wide scale yields novel insights into cancer etiology. As expected, the set of genes differentially expressed in the tumors is enriched for cell adhesion and differentiation functions, but, unexpectedly, the set of allelically imbalanced genes is also enriched for these same cancer-related functions. By comparing the transcriptomic perturbations observed in one patient to his underlying normal and tumor genomes, we find that allelic imbalance in the tumor is associated with copy number mutations and that copy number mutations are, in turn, strongly associated with changes in transcript abundance. These results support a model in which allele-specific deletions and duplications drive allele-specific changes in gene expression in the developing tumor.	[Tuch, Brian B.; Xu, Xing; Chung, Christina B.; Monighetti, Cinna K.; Stanley, Sarah J.; Broomer, Adam J.; Tan, Ruoying; Brzoska, Pius M.; Muller, Matthew W.; Siddiqui, Asim S.; Sun, Yongming; Barker, Melissa A.; De La Vega, Francisco M.] Life Technol Inc, Foster City, CA USA; [Laborde, Rebecca R.; Smith, David I.] Mayo Clin, Div Expt Pathol, Dept Lab Med & Pathol, Rochester, MN USA; [Gu, Jian; Kuersten, Scott] Life Technol Inc, Austin, TX USA; [Olsen, Kerry D.; Kasperbauer, Jan L.; Moore, Eric J.] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN USA; [Asmann, Yan W.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA	Thermo Fisher Scientific; Mayo Clinic; Thermo Fisher Scientific; Mayo Clinic; Mayo Clinic	Tuch, BB (corresponding author), Life Technol Inc, Foster City, CA USA.	francisco.delavega@lifetech.com; smith.david@mayo.edu	Pillay, Nischalan/F-9536-2012; De La Vega, Francisco/H-3832-2011		Mayo Clinic and Life Technologies Inc.	Mayo Clinic and Life Technologies Inc.	This work was supported by the Mayo Clinic and Life Technologies Inc.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Alevizos I, 2001, ONCOGENE, V20, P6196, DOI 10.1038/sj.onc.1204685; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Belbin TJ, 2002, CANCER RES, V62, P1184; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bohen SP, 2003, P NATL ACAD SCI USA, V100, P1926, DOI 10.1073/pnas.0437875100; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Clement G, 2008, CANCER SCI, V99, P46, DOI 10.1111/j.1349-7006.2007.00663.x; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feinberg AP, 1999, CANCER RES, V59, p1743S; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Freier K, 2006, GENE CHROMOSOME CANC, V45, P118, DOI 10.1002/gcc.20270; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Herrick J, 2005, CANCER RES, V65, P1174, DOI 10.1158/0008-5472.CAN-04-2802; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kang CJ, 2009, CANCER LETT, V284, P131, DOI 10.1016/j.canlet.2009.04.014; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; LIOTTA LA, 1986, CANCER RES, V46, P1; LIPSON D, 2004, JOINT ANAL DNA COPY, P135; Lopez P, 1999, ONCOGENE, V18, P7303, DOI 10.1038/sj.onc.1203143; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Miyazawa J, 2004, CANCER RES, V64, P2024, DOI 10.1158/0008-5472.CAN-03-1855; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; *NEXTBIO, 2010, NEXTBIO PROF SYST; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Tsui IFL, 2009, INT J CANCER, V125, P2219, DOI 10.1002/ijc.24611; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yoshinaga K, 2008, ANN SURG ONCOL, V15, P96, DOI 10.1245/s10434-007-9631-1; Yu YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003215; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	73	96	99	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9317	10.1371/journal.pone.0009317	http://dx.doi.org/10.1371/journal.pone.0009317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174472	gold, Green Published, Green Submitted			2022-12-27	WOS:000274923700019
J	Utge, SJ; Soronen, P; Loukola, A; Kronholm, E; Ollila, HM; Pirkola, S; Porkka-Heiskanen, T; Partonen, T; Paunio, T				Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Kronholm, Erkki; Ollila, Hanna M.; Pirkola, Sami; Porkka-Heiskanen, Tarja; Partonen, Timo; Paunio, Tiina			Systematic Analysis of Circadian Genes in a Population-Based Sample Reveals Association of TIMELESS with Depression and Sleep Disturbance	PLOS ONE			English	Article							BIPOLAR-I-DISORDER; CLOCK GENE; DIURNAL PREFERENCE; PHASE SYNDROME; METABOLIC SYNDROME; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTOR; LINKAGE ANALYSES; MOOD DISORDERS; POLYMORPHISM	Disturbances in the circadian pacemaker system are commonly found in individuals with depression and sleep-related problems. We hypothesized that some of the canonical circadian clock genes would be associated with depression accompanied by signs of disturbed sleep, early morning awakening, or daytime fatigue. We tested this hypothesis in a population-based sample of the Health 2000 dataset from Finland, including 384 depressed individuals and 1270 controls, all with detailed information on sleep and daytime vigilance, and analyzed this set of individuals with regard to 113 single-nucleotide polymorphisms of 18 genes of the circadian system. We found significant association between TIMELESS variants and depression with fatigue (D+FAT+) (rs7486220: pointwise P = 0.000099, OR = 1.66; corrected empirical P for the model of D+FAT+ = 0.0056; haplotype 'C-A-A-C' of rs2291739-rs2291738-rs7486220-rs1082214: P = 0.0000075, OR = 1.72) in females, and association to depression with early morning awakening (D+EMA+) (rs1082214: pointwise P = 0.0009, OR = 2.70; corrected empirical P = 0.0374 for the model D+EMA+; haplotype 'G-T' of rs7486220 and rs1082214: P = 0.0001, OR = 3.01) in males. There was significant interaction of gender and TIMELESS (for example with rs1082214, P = 0.000023 to D+EMA+ and P = 0.005 to D+FAT+). We obtained supported evidence for involvement of TIMELESS in sleeping problems in an independent set of control individuals with seasonal changes in mood, sleep duration, energy level and social activity in females (P = 0.036, (R) = 0.123 for rs1082214) and with early morning awakening or fatigue in males (P = 0.038 and P = 0.0016, respectively, for rs1082214). There was also some evidence of interaction between TIMELESS and PER1 in females to D+FAT+ as well as between TIMELESS and ARNTL, RORA or NR1D1 in males to D+EMA+. These findings support a connection between circadian genes and gender-dependent depression and defective sleep regulation.	[Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Ollila, Hanna M.; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Utge, Siddheshwar J.; Ollila, Hanna M.; Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Helsinki, Finland; [Utge, Siddheshwar J.; Soronen, Pia; Pirkola, Sami; Paunio, Tiina] Univ Helsinki, Cent Hosp, Dept Psychiat, Helsinki, Finland; [Utge, Siddheshwar J.; Soronen, Pia; Loukola, Anu; Ollila, Hanna M.; Paunio, Tiina] Univ Helsinki, FIMM, Helsinki, Finland; [Kronholm, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku, Finland; [Pirkola, Sami; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare	Utge, SJ (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland.	Tiina.Paunio@thl.fi	Partonen, Timo/G-1105-2012; Ollila, Hanna M/GQA-6308-2022; Ollila, Hanna M/I-8552-2017	Partonen, Timo/0000-0003-1951-2455; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Loukola, Anu-Maria/0000-0003-0542-5967; Stenberg, Tarja/0000-0003-1843-7625; Pirkola, Sami/0000-0003-0138-3130	European Union [LSHM-CT-2005-518189, MCRTN-CT-2004-512362]; Centre for International Mobility [CIMO, TM-09-6095]; Helsinki University Central Hospital [EVO, TYH6254]; Academy of Finland post-doctoral research fellowship	European Union(European Commission); Centre for International Mobility; Helsinki University Central Hospital; Academy of Finland post-doctoral research fellowship(Academy of Finland)	This study was supported by grants from the European Union (LSHM-CT-2005-518189 and MCRTN-CT-2004-512362), Centre for International Mobility (CIMO, TM-09-6095), and Helsinki University Central Hospital (EVO, TYH6254), and this support is gratefully acknowledged. Dr. Anu Loukola and Dr. Timo Partonen were supported by an Academy of Finland post-doctoral research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benazzi F, 2002, COMPR PSYCHIAT, V43, P263, DOI 10.1053/comp.2002.33496; Benca R M, 1997, Sleep Med Rev, V1, P45, DOI 10.1016/S1087-0792(97)90005-8; Benedetti F, 2003, AM J MED GENET B, V123B, P23, DOI 10.1002/ajmg.b.20038; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Cardoso FRG, 2009, BRAZ J MED BIOL RES, V42, P122, DOI 10.1590/S0100-879X2009000100017; Carpen JD, 2005, J SLEEP RES, V14, P293, DOI 10.1111/j.1365-2869.2005.00471.x; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Dunbar JA, 2008, DIABETES CARE, V31, P2368, DOI 10.2337/dc08-0175; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Emilien G, 1999, IRISH J PSYCHOL MED, V16, P18, DOI 10.1017/S0790966700004985; Franken P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-87; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Hastings M, 1998, BRIT MED J, V317, P1704, DOI 10.1136/bmj.317.7174.1704; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hochstrasser B, 1993, Ther Umsch, V50, P679; Jackson A, 2003, J AFFECT DISORDERS, V74, P209, DOI 10.1016/S0165-0327(02)00266-5; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Jones SH, 2005, BIPOLAR DISORD, V7, P176, DOI 10.1111/j.1399-5618.2005.00187.x; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; KAWATO M, 1982, J THEOR BIOL, V98, P369, DOI 10.1016/0022-5193(82)90125-4; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; KISHI T, 2008, NEUROSCI RES; Klar J, 2005, EUR J HUM GENET, V13, P928, DOI 10.1038/sj.ejhg.5201433; Klinge CM, 1999, J STEROID BIOCHEM, V71, P1, DOI 10.1016/S0960-0760(99)00124-7; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; KUPFER DJ, 1990, ARCH GEN PSYCHIAT, V47, P1100; KUPPERMANN M, 1995, J GEN INTERN MED, V10, P25, DOI 10.1007/BF02599573; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lasky-Su J, 2008, AM J MED GENET B; Lichstein KL, 1997, BEHAV RES THER, V35, P733, DOI 10.1016/S0005-7967(97)00029-6; LIVINGSTON G, 1993, BRIT J GEN PRACT, V43, P445; Mansour HA, 2006, GENES BRAIN BEHAV, V5, P150, DOI 10.1111/j.1601-183X.2005.00147.x; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Paunio T, 2009, AM J EPIDEMIOL, V169, P206, DOI 10.1093/aje/kwn305; Perez-Calatayud J, 2005, MED PHYS, V32, P28, DOI 10.1118/1.1834835; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Pirovano A, 2005, GENET MED, V7, P455, DOI 10.1097/01.GIM.0000170996.58079.6D; Porkka-Heiskanen T, 2003, FRONT BIOSCI-LANDMRK, V8, pS421, DOI 10.2741/1073; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rintamaki R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001482; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Serretti A, 2005, AM J MED GENET B, V137B, P36, DOI 10.1002/ajmg.b.30130; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Shin K, 2005, J AFFECT DISORDERS, V86, P19, DOI 10.1016/j.jad.2004.11.010; Skilton MR, 2007, BIOL PSYCHIAT, V62, P1251, DOI 10.1016/j.biopsych.2007.01.012; Szczepankiewicz A, 2006, NEUROPSYCHOBIOLOGY, V53, P51, DOI 10.1159/000090704; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takano A, 2004, NEUROPSYCHOPHARMACOL, V29, P1901, DOI 10.1038/sj.npp.1300503; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Turek FW, 2007, INT CLIN PSYCHOPHARM, V22, pS1, DOI 10.1097/01.yic.0000277956.93777.6a; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; UTGE S, 2009, AM J MED B IN PRESS; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; VOLLRATH M, 1989, EUR ARCH PSY CLIN N, V239, P113, DOI 10.1007/BF01759584; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Wehr T., 1984, SEASONAL PATTERN ASS; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; NATURE, V437, P1299	89	73	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2010	5	2							e9259	10.1371/journal.pone.0009259	http://dx.doi.org/10.1371/journal.pone.0009259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557FJ	20174623	Green Submitted, Green Published, gold			2022-12-27	WOS:000274654700011
J	Nougairede, A; Ninove, L; Zandotti, C; Salez, N; Mantey, K; Resseguier, N; Gazin, C; Raoult, D; Charrel, RN; de Lamballerie, X				Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; Salez, Nicolas; Mantey, Karine; Resseguier, Noemie; Gazin, Celine; Raoult, Didier; Charrel, Remi N.; de Lamballerie, Xavier			Novel Virus Influenza A (H1N1sw) in South-Eastern France, April-August 2009	PLOS ONE			English	Article							RAPID DETECTION; PCR ASSAY; INFECTION; DIAGNOSIS	Background: In April 2009, the first cases of pandemic (H1N1)-2009 influenza [H1N1sw] virus were detected in France. Virological surveillance was undertaken in reference laboratories of the seven French Defence Zones. Methodology/Principal Findings: We report results of virological analyses performed in the Public Hospitals of Marseille during the first months of the outbreak. (i) Nasal swabs were tested using rapid influenza diagnostic test (RIDT) and two RTPCR assays. Epidemiological characteristics of the 99 first suspected cases were analyzed, including detection of influenza virus and 18 other respiratory viruses. During three months, a total of 1,815 patients were tested (including 236 patients infected H1N1sw virus) and distribution in age groups and results of RIDT were analyzed. (ii) 600 sera received before April 2009 and randomly selected from in-patients were tested by a standard hemagglutination inhibition assay for antibody to the novel H1N1sw virus. (iii) One early (May 2009) and one late (July 2009) viral isolates were characterized by sequencing the complete hemagglutinine and neuraminidase genes. (iiii) Epidemiological characteristics of a cluster of cases that occurred in July 2009 in a summer camp were analyzed. Conclusions/Significance: This study presents new virological and epidemiological data regarding infection by the pandemic A/H1N1 virus in Europe. Distribution in age groups was found to be similar to that previously reported for seasonal H1N1. The first seroprevalence data made available for a European population suggest a previous exposure of individuals over 40 years old to influenza viruses antigenically related to the pandemic (H1N1)-2009 virus. Genomic analysis indicates that strains harbouring a new amino-acid pattern in the neuraminidase gene appeared secondarily and tended to supplant the first strains. Finally, in contrast with previous reports, our data support the use of RIDT for the detection of infection in children, especially in the context of the investigation of grouped cases.	[Nougairede, Antoine; Ninove, Laetitia; Salez, Nicolas; Charrel, Remi N.; de Lamballerie, Xavier] Univ Meditarranee, UMR 190, Unite Virus Emergents, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; Salez, Nicolas; Charrel, Remi N.; de Lamballerie, Xavier] Inst Rech Dev, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; Gazin, Celine; Raoult, Didier; Charrel, Remi N.; de Lamballerie, Xavier] Assistance Publ Hop Marseille, Lab Virol Pole Hosp Microbiol & Malad Infect, Marseille, France; [Mantey, Karine; Resseguier, Noemie] French Inst Publ Hlth Surveillance, S Interreg Epidemiol Unit, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institute of Public Health Surveillance	Nougairede, A (corresponding author), Univ Meditarranee, UMR 190, Unite Virus Emergents, Marseille, France.	xavier.de-lamballerie@univmed.fr	Resseguier, Noémie/E-8427-2017; RAOULT, Didier/A-8434-2008	Resseguier, Noémie/0000-0003-0816-4053; RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital system; Universite de la Mediterranee	AP-HM Public Hospital system; Universite de la Mediterranee	This study has been partly funded by AP-HM Public Hospital system and by Universite de la Mediterranee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Follin P, 2009, EUROSURVEILLANCE, V14; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garbino J, 2004, AM J RESP CRIT CARE, V170, P1197, DOI 10.1164/rccm.200406-781OC; Gouarin S, 2008, J MED VIROL, V80, P1441, DOI 10.1002/jmv.21218; Griscelli F, 2001, J CLIN MICROBIOL, V39, P4362, DOI 10.1128/JCM.39.12.4362-4369.2001; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; LEVYBRUHL D, 2009, EURO SURVEILL, V14; Lindau C, 2009, J CLIN VIROL, V44, P24, DOI 10.1016/j.jcv.2008.09.006; Mackay IM, 2003, J CLIN MICROBIOL, V41, P100, DOI 10.1128/JCM.41.1.100-105.2003; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Munoz Flor M, 2002, Semin Pediatr Infect Dis, V13, P72, DOI 10.1053/spid.2002.122992; NINOVE L, 2009, VECTOR BORNE ZOONOTI; NOUGAIREDE A, 2009, PLOSE CURRENTS INFLU; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; van Elden LJR, 2004, J INFECT DIS, V189, P652, DOI 10.1086/381207; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; WHO, 2009, SEQ PRIM PROT PAND H	26	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9214	10.1371/journal.pone.0009214	http://dx.doi.org/10.1371/journal.pone.0009214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174643	gold, Green Submitted, Green Published			2022-12-27	WOS:000274590600006
J	Thorborn, G; Pomeroy, L; Isohanni, H; Perry, M; Peters, B; Vyakarnam, A				Thorborn, Georgina; Pomeroy, Laura; Isohanni, Heidi; Perry, Melissa; Peters, Barry; Vyakarnam, Annapurna			Increased Sensitivity of CD4+T-Effector Cells to CD4+CD25+Treg Suppression Compensates for Reduced Treg Number in Asymptomatic HIV-1 Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; VIRAL LOAD; SIV INFECTION; CD4(+); ACTIVATION; RESPONSES; DEPLETION; DISEASE	Background: In HIV infection, uncontrolled immune activation and disease progression is attributed to declining CD4+CD25+FoxP3+ regulatory T-cell (Treg) numbers. However, qualitative aspects of Treg function in HIV infection, specifically the balance between Treg cell suppressive potency versus suppressibility of effector cells, remain poorly understood. This report addresses this issue. Methodology/Principal Findings: A classic suppression assay to measure CD4+CD45RO+CD25hi Treg cells to suppress the proliferation of CD4+CD45RO+CD25 - effectors cells (E) following CD3/CD28 polyclonal stimulation was employed to compare the suppressive ability of healthy volunteers (N = 27) and chronic, asymptomatic, treatment naive, HIV-infected subjects (N = 14). HIV-infected subjects displayed significantly elevated Treg-mediated suppression compared to healthy volunteers (p = 0.0047). Cross-over studies comparing Treg cell potency from HIV-infected versus control subjects to suppress the proliferation of a given population of allogeneic effector cells demonstrated increased sensitivity of CD4+CD252 effector cells from HIV-infected subjects to be suppressed, associated with reduced production of the Treg counter-regulatory cytokine, IL-17, rather than an increase in the suppressive potential of their CD4+CD25+ Treg cells. However, compared to controls, HIV+ subjects had significantly fewer absolute numbers of circulating CD4+CD25+FoxP3+ Treg cells. In vitro studies highlighted that one mechanism for this loss could be the preferential infection of Treg cells by HIV. Conclusions/Significance: Together, novel data is provided to support the contention that elevated Treg-mediated suppression may be a natural host response to HIV infection	[Thorborn, Georgina; Vyakarnam, Annapurna] Kings Coll London, Dept Infect Dis, Guys Hosp, London WC2R 2LS, England; [Pomeroy, Laura; Isohanni, Heidi; Perry, Melissa; Peters, Barry] Kings Coll London, Dept Infect Dis, St Thomas Hosp, London WC2R 2LS, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Thorborn, G (corresponding author), Kings Coll London, Dept Infect Dis, Guys Hosp, London WC2R 2LS, England.	anna.Vyakarnam@kcl.ac.uk			National Institute for Health Research (NIHR)	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This work was partly supported by an educational grant from Gilead Pharmaceuticals and partly by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Alvarez R, 2008, J VIROL, V82, P471, DOI 10.1128/JVI.00939-07; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Betti M, 2006, ANN ONCOL, V17, P235; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Holmes D, 2007, J BIOL CHEM, V282, P15973, DOI 10.1074/jbc.M702051200; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; JI J, 2009, INT IMMUNOL; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lenarczyk A, 2000, CLIN EXP IMMUNOL, V122, P41, DOI 10.1046/j.1365-2249.2000.01328.x; Maek-A-Nantawat W, 2007, VIRAL IMMUNOL, V20, P66, DOI 10.1089/vim.2006.0063; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; MONTES M, 2006, AIDS RES HUM RETROV; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; NAKAMURA Z, 1982, CLIN IMMUNOL IMMUNOP, V24, P72, DOI 10.1016/0090-1229(82)90090-3; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pereira LE, 2007, J VIROL, V81, P4445, DOI 10.1128/JVI.00026-07; Roberts AI, 2003, IMMUNOL RES, V28, P285, DOI 10.1385/IR:28:3:285; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Trindade CJ, 2008, FASEB J, V22; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yates J, 2008, CLIN EXP IMMUNOL, V153, P44, DOI 10.1111/j.1365-2249.2008.03665.x; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	57	20	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9254	10.1371/journal.pone.0009254	http://dx.doi.org/10.1371/journal.pone.0009254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174666	gold, Green Published, Green Submitted			2022-12-27	WOS:000274590600011
J	Williams, GJ; Aeby, GS; Cowie, ROM; Davy, SK				Williams, Gareth J.; Aeby, Greta S.; Cowie, Rebecca O. M.; Davy, Simon K.			Predictive Modeling of Coral Disease Distribution within a Reef System	PLOS ONE			English	Article							BLACK-BAND DISEASE; NORTHERN FLORIDA-KEYS; GREAT-BARRIER-REEF; US VIRGIN-ISLANDS; CLIMATE-CHANGE; INDO-PACIFIC; TRANSMISSION DYNAMICS; SCLERACTINIAN CORALS; NUTRIENT ENRICHMENT; REGRESSION TREES	Diseases often display complex and distinct associations with their environment due to differences in etiology, modes of transmission between hosts, and the shifting balance between pathogen virulence and host resistance. Statistical modeling has been underutilized in coral disease research to explore the spatial patterns that result from this triad of interactions. We tested the hypotheses that: 1) coral diseases show distinct associations with multiple environmental factors, 2) incorporating interactions (synergistic collinearities) among environmental variables is important when predicting coral disease spatial patterns, and 3) modeling overall coral disease prevalence (the prevalence of multiple diseases as a single proportion value) will increase predictive error relative to modeling the same diseases independently. Four coral diseases: Porites growth anomalies (PorGA), Porites tissue loss (PorTL), Porites trematodiasis (PorTrem), and Montipora white syndrome (MWS), and their interactions with 17 predictor variables were modeled using boosted regression trees (BRT) within a reef system in Hawaii. Each disease showed distinct associations with the predictors. Environmental predictors showing the strongest overall associations with the coral diseases were both biotic and abiotic. PorGA was optimally predicted by a negative association with turbidity, PorTL and MWS by declines in butterflyfish and juvenile parrotfish abundance respectively, and PorTrem by a modal relationship with Porites host cover. Incorporating interactions among predictor variables contributed to the predictive power of our models, particularly for PorTrem. Combining diseases (using overall disease prevalence as the model response), led to an average six-fold increase in cross-validation predictive deviance over modeling the diseases individually. We therefore recommend coral diseases to be modeled separately, unless known to have etiologies that respond in a similar manner to particular environmental conditions. Predictive statistical modeling can help to increase our understanding of coral disease ecology worldwide.	[Williams, Gareth J.; Cowie, Rebecca O. M.; Davy, Simon K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Aeby, Greta S.] Hawaii Inst Marine Biol, Kaneohe, HI USA	Victoria University Wellington	Williams, GJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	info@garethjwilliams.net; simon.davy@vuw.ac.nz		Davy, Simon/0000-0003-3584-5356; Williams, Dr Gareth J./0000-0001-7837-1619	Victoria University Vice- Chancellor Strategic Research Scholarship; New Zealand International Doctoral Research Scholarship	Victoria University Vice- Chancellor Strategic Research Scholarship; New Zealand International Doctoral Research Scholarship	Gareth J. Williams is supported by a Victoria University Vice- Chancellor Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2007, B MAR SCI, V80, P209; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Altizer SM, 1997, P ROY SOC B-BIOL SCI, V264, P807, DOI 10.1098/rspb.1997.0113; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Baker DM, 2007, MAR ECOL PROG SER, V343, P123, DOI 10.3354/meps06937; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 1998, ECOL LETT, V1, P82; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; BLOESCH J, 1994, HYDROBIOLOGIA, V284, P13, DOI 10.1007/BF00005728; Borger JL, 2005, DIS AQUAT ORGAN, V67, P249, DOI 10.3354/dao067249; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Bruckner AW, 2006, DIS AQUAT ORGAN, V69, P67, DOI 10.3354/dao069067; Bruckner AW, 1997, CORAL REEFS, V16, P260, DOI 10.1007/s003380050081; Bruckner AW, 1998, CORAL REEFS, V17, P350, DOI 10.1007/s003380050138; BRUCKNER AW, 1997, P 8 INT COR REEF S, V1, P601; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Carslaw DC, 2009, ATMOS ENVIRON, V43, P3563, DOI 10.1016/j.atmosenv.2009.04.001; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Colwell RR, 2004, INT MICROBIOL, V7, P285; COX EF, 1986, J EXP MAR BIOL ECOL, V101, P161, DOI 10.1016/0022-0981(86)90047-X; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FRIEDLANDER AM, 2008, 11 NOAA NOS NCCOS CT, P219; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Idjadi JA, 2006, MAR ECOL PROG SER, V319, P117, DOI 10.3354/meps319117; Jackson JA, 2002, PARASITOL RES, V88, P632, DOI 10.1007/s00436-002-0629-0; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kim Kiho, 2002, P813; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Lafferty KD, 1999, LIMNOL OCEANOGR, V44, P925, DOI 10.4319/lo.1999.44.3_part_2.0925; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Lu YN, 2000, J AQUAT ANIM HEALTH, V12, P58, DOI [10.1577/1548-8667(2000)012<0058:DOGTHS>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0058:DOGTHS&gt;2.0.CO;2]; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Richardson LL, 2005, MAR ECOL PROG SER, V297, P147, DOI 10.3354/meps297147; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rodriguez S, 2008, CORAL REEFS, V27, P381, DOI 10.1007/s00338-007-0341-8; Sokolow SH, 2009, J APPL ECOL, V46, P621, DOI 10.1111/j.1365-2664.2009.01649.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	93	67	69	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2010	5	2							e9264	10.1371/journal.pone.0009264	http://dx.doi.org/10.1371/journal.pone.0009264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KU	20174663	Green Submitted, gold, Green Published			2022-12-27	WOS:000274590600019
J	Brolin, KJM; Persson, KEM; Wahlgren, M; Rogerson, SJ; Chen, QJ				Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Rogerson, Stephen J.; Chen, Qijun			Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; VARIANT SURFACE-ANTIGENS; SUB-SAHARAN AFRICA; PLASMODIUM-FALCIPARUM; INFECTED ERYTHROCYTES; STRUCTURAL BASIS; BINDING; PLACENTA; ADHESION; RECEPTOR	Background: Plasmodium falciparum infected red blood cells (iRBC) express variant surface antigens (VSA) of which VAR2CSA is involved in placental sequestration and causes pregnancy-associated malaria (PAM). Primigravidae are most susceptible to PAM whereas antibodies associated with protection are often present at higher levels in multigravid women. However, HIV co-infection with malaria has been shown to alter this parity-dependent acquisition of immunity, with more severe symptoms as well as more malaria episodes in HIV positive women versus HIV negative women of a similar parity. Methods: Using VAR2CSA DBL-domains expressed on the surface of CHO-745 cells we quantified levels of DBL-domain specific IgG in sera from pregnant Malawian women by flow cytometry. Dissociations constants of DBL5 epsilon specific antibodies were determined using a surface plasmon resonance technique, as an indication of antibody affinities. Results: VAR2CSA DBL5 epsilon was recognized in a gender and parity-dependent manner with anti-DBL5 epsilon IgG correlating significantly with IgG levels to VSA-PAM on the iRBC surface. HIV positive women had lower levels of anti-DBL5 epsilon IgG than HIV negative women of similar parity. In primigravidae, antibodies in HIV positive women also showed significantly lower affinity to VAR2CSA DBL5 epsilon. Conclusions: Pregnant women from a malaria-endemic area had increased levels of anti-DBL5 epsilon IgG by parity, indicating this domain of VAR2CSA to be a promising vaccine candidate against PAM. However, it is important to consider co-infection with HIV, as this seems to change the properties of antibody response against malaria. Understanding the characteristics of antibody response against VAR2CSA is undoubtedly imperative in order to design a functional and efficient vaccine against PAM.	[Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Chen, Qijun] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Brolin, Kim J. M.; Persson, Kristina E. M.; Wahlgren, Mats; Chen, Qijun] Swedish Inst Infect Dis Control SMI, Dept Parasitol, Stockholm, Sweden; [Rogerson, Stephen J.] Univ Melbourne, Dept Med RMH WH, Melbourne, Vic, Australia; [Chen, Qijun] Minist Educ, Key Lab Zoonosis, Changchun, Peoples R China; [Chen, Qijun] Jilin Univ, Changchun 130023, Peoples R China; [Chen, Qijun] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100037, Peoples R China	Karolinska Institutet; Swedish Institute for Infectious Disease Control; University of Melbourne; Jilin University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Brolin, KJM (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	sroger@unimelb.edu.au; qijun.chen@smi.se		Rogerson, Stephen/0000-0003-4287-1982; Persson, Kristina E M/0000-0003-2661-3115	National Basic Research Program of China (973 Program) [2007CB513100]; SIDA/SAREC; EU; National Health and Medical Research Council of Australia; Boehringer Ingelheim Fonds; Kvinnor Kan; Wenner-Gren Foundations; O E and Edla Johanssons Foundation; Jeanssons Foundation	National Basic Research Program of China (973 Program)(National Basic Research Program of China); SIDA/SAREC; EU(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Kvinnor Kan; Wenner-Gren Foundations; O E and Edla Johanssons Foundation; Jeanssons Foundation	Q.C. is supported by grants from the National Basic Research Program of China (973 Program, No. 2007CB513100), SIDA/SAREC (www.sida.se) and the EU malaria network of excellence (BioMalPar) program (www.biomalpar.org). S.J.R. is supported by the National Health and Medical Research Council of Australia (www.nhmrc.gov.au). K.J.M.B. was supported in part by a travel grant from Boehringer Ingelheim Fonds (www.bifonds.de) and by Kvinnor Kan (www.kvinnorkan.se). K. E. M. P. is supported by The Wenner-Gren Foundations (www.wennergren.org), Vinnova (www.vinnova.se), O E and Edla Johanssons Foundation (www.oejvetstift.se) and Jeanssons Foundation (www.jeanssonsstiftelser.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2002, INFECT IMMUN, V70, P5412, DOI 10.1128/IAI.70.10.5412-5415.2002; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Creasey AM, 2003, INFECT IMMUN, V71, P4767, DOI 10.1128/IAI.71.8.4767-4771.2003; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2004, MOL MICROBIOL, V53, P445, DOI 10.1111/j.1365-2958.2004.04145.x; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Oleinikov AV, 2008, J INFECT DIS, V197, P1119, DOI 10.1086/529526; Oleinikov AV, 2007, J INFECT DIS, V196, P155, DOI 10.1086/518513; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tebo AE, 2002, CLIN EXP IMMUNOL, V130, P300, DOI 10.1046/j.1365-2249.2002.01972.x; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; WALTER PR, 1982, AM J PATHOL, V109, P330	43	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9230	10.1371/journal.pone.0009230	http://dx.doi.org/10.1371/journal.pone.0009230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169064	gold, Green Published			2022-12-27	WOS:000274590500012
J	Kaneko, K; Hori, S; Morimoto, MM; Nakaoka, T; Paul, RK; Fujiyuki, T; Shirai, K; Wakamoto, A; Tsuboko, S; Takeuchi, H; Kubo, T				Kaneko, Kumi; Hori, Sayaka; Morimoto, Mai M.; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Wakamoto, Akiko; Tsuboko, Satomi; Takeuchi, Hideaki; Kubo, Takeo			In Situ Hybridization Analysis of the Expression of Futsch, Tau, and MESK2 Homologues in the Brain of the European Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; 1ST OPTIC GANGLION; DIVISION-OF-LABOR; MUSHROOM BODIES; CHROMATIC PROPERTIES; WORKER HONEYBEE; MONOPOLAR CELLS; INSECT BRAIN; BEE; DROSOPHILA	Background: The importance of visual sense in Hymenopteran social behavior is suggested by the existence of a Hymenopteran insect-specific neural circuit related to visual processing and the fact that worker honeybee brain changes morphologically according to its foraging experience. To analyze molecular and neural bases that underlie the visual abilities of the honeybees, we used a cDNA microarray to search for gene(s) expressed in a neural cell-type preferential manner in a visual center of the honeybee brain, the optic lobes (OLs). Methodology/Principal Findings: Expression analysis of candidate genes using in situ hybridization revealed two genes expressed in a neural cell-type preferential manner in the OLs. One is a homologue of Drosophila futsch, which encodes a microtubule-associated protein and is preferentially expressed in the monopolar cells in the lamina of the OLs. The gene for another microtubule-associated protein, tau, which functionally overlaps with futsch, was also preferentially expressed in the monopolar cells, strongly suggesting the functional importance of these two microtubule-associated proteins in monopolar cells. The other gene encoded a homologue of Misexpression Suppressor of Dominant-negative Kinase Suppressor of Ras 2 (MESK2), which might activate Ras/MAPK-signaling in Drosophila. MESK2 was expressed preferentially in a subclass of neurons located in the ventral region between the lamina and medulla neuropil in the OLs, suggesting that this subclass is a novel OL neuron type characterized by MESK2-expression. These three genes exhibited similar expression patterns in the worker, drone, and queen brains, suggesting that they function similarly irrespective of the honeybee sex or caste. Conclusions: Here we identified genes that are expressed in a monopolar cell (Amfutsch and Amtau) or ventral medulla-preferential manner (AmMESK2) in insect OLs. These genes may aid in visualizing neurites of monopolar cells and ventral medulla cells, as well as in analyzing the function of these neurons.	[Kaneko, Kumi; Hori, Sayaka; Morimoto, Mai M.; Nakaoka, Takayoshi; Paul, Rajib Kumar; Fujiyuki, Tomoko; Shirai, Kenichi; Tsuboko, Satomi; Takeuchi, Hideaki; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Wakamoto, Akiko] DNA Chip Res Inc, Tsurumi Ku, Kanagawa, Japan	University of Tokyo; DNA Chip Research Inc.	Kaneko, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	stkubo@biol.s.u-tokyo.ac.jp	Sayaka, Hori/AAU-7866-2020; Takeuchi, Hideaki/W-6739-2018; Fujiyuki, Tomoko Kaito/GYD-6398-2022; TAKEUCHI, HIDEAKI/G-4969-2014; KUBO, TAKEO/G-4951-2014; Tsuboko-Ishii, Satomi/J-2713-2019	Takeuchi, Hideaki/0000-0001-6610-3895; Fujiyuki, Tomoko Kaito/0000-0001-5533-4129; Tsuboko-Ishii, Satomi/0000-0003-4374-6200; Morimoto, Mai/0000-0002-9654-3960; Kubo, Takeo/0000-0002-5914-5269	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) and the Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology'' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch G, 2003, J COMP NEUROL, V464, P269, DOI 10.1002/cne.10778; Castella Claude, 2001, Invertebrate Neuroscience, V4, P85; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; Collett TS, 2002, NAT REV NEUROSCI, V3, P542, DOI 10.1038/nrn872; Dehmelt L, 2005, GENOME BIOL, V6; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GRONENBERG W, 1986, J INSECT PHYSIOL, V32, P695, DOI 10.1016/0022-1910(86)90111-3; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Harris RA, 2007, CURR BIOL, V17, P93, DOI 10.1016/j.cub.2006.10.068; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HERTEL H, 1987, J EXP BIOL, V133, P283; HERTEL H, 1987, J EXP BIOL, V133, P301; HERTEL H, 1980, J COMP PHYSIOL, V137, P215, DOI 10.1007/BF00657117; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Huang AM, 2000, GENETICS, V156, P1219; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870; Kamikouchi A, 2000, J COMP NEUROL, V417, P501, DOI 10.1002/(SICI)1096-9861(20000221)417:4&lt;501::AID-CNE8&gt;3.0.CO;2-4; KIEN J, 1977, J COMP PHYSIOL, V113, P17, DOI 10.1007/BF00610451; KIEN J, 1977, J COMP PHYSIOL, V113, P35, DOI 10.1007/BF00610452; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; KUBO T, 2003, GENES BEHAV EVOLUTIO, P3; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Mobbs P.G., 1985, P299; Paul RK, 2006, ZOOL SCI, V23, P1085, DOI 10.2108/zsj.23.1085; Ribi W.A., 1975, Quarterly Review of Biology, V50, P1; RIBI WA, 1976, CELL TISSUE RES, V171, P359, DOI 10.1007/BF00224660; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RIBI WA, 1981, CELL TISSUE RES, V215, P443, DOI 10.1007/BF00233522; Rybak J, 1998, LEARN MEMORY, V5, P133; Sawata M, 2002, RNA, V8, P772, DOI 10.1017/S1355838202028790; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sen Sarma M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006408; SOUZA J D, 1992, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V170, P267; SOUZA JM, 1987, BRAZ J MED BIOL RES, V20, P851; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0; Takeuchi H, 2001, INSECT MOL BIOL, V10, P487, DOI 10.1046/j.0962-1075.2001.00288.x; Uno Y, 2007, FEBS LETT, V581, P97, DOI 10.1016/j.febslet.2006.12.004; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Winston, 1987, BIOL HONEYBEE; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	56	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2010	5	2							e9213	10.1371/journal.pone.0009213	http://dx.doi.org/10.1371/journal.pone.0009213			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556KT	20169065	Green Published, Green Submitted, gold			2022-12-27	WOS:000274590500005
J	Osterstock, G; Escobar, P; Mitutsova, V; Gouty-Colomer, LA; Fontanaud, P; Molino, F; Fehrentz, JA; Carmignac, D; Martinez, J; Guerineau, NC; Robinson, ICAF; Mollard, P; Mery, PF				Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Fehrentz, Jean-Alain; Carmignac, Danielle; Martinez, Jean; Guerineau, Nathalie C.; Robinson, Iain C. A. F.; Mollard, Patrice; Mery, Pierre-Francois			Ghrelin Stimulation of Growth Hormone-Releasing Hormone Neurons Is Direct in the Arcuate Nucleus	PLOS ONE			English	Article							REGULATING ENERGY HOMEOSTASIS; SECRETAGOGUE RECEPTOR 1A; PHARMACOLOGICAL IN-VITRO; STATIONARY POINT PROCESS; PROTEIN TRANSGENIC MICE; AGOUTI-RELATED PROTEIN; NEUROPEPTIDE-Y; GH SECRETAGOGUE; NITRIC-OXIDE; MESSENGER-RNA	Background: Ghrelin targets the arcuate nucleus, from where growth hormone releasing hormone (GHRH) neurones trigger GH secretion. This hypothalamic nucleus also contains neuropeptide Y (NPY) neurons which play a master role in the effect of ghrelin on feeding. Interestingly, connections between NPY and GHRH neurons have been reported, leading to the hypothesis that the GH axis and the feeding circuits might be co-regulated by ghrelin. Principal Findings: Here, we show that ghrelin stimulates the firing rate of identified GHRH neurons, in transgenic GHRHGFP mice. This stimulation is prevented by growth hormone secretagogue receptor-1 antagonism as well as by U-73122, a phospholipase C inhibitor and by calcium channels blockers. The effect of ghrelin does not require synaptic transmission, as it is not antagonized by c-aminobutyric acid, glutamate and NPY receptor antagonists. In addition, this hypothalamic effect of ghrelin is independent of somatostatin, the inhibitor of the GH axis, since it is also found in somatostatin knockout mice. Indeed, ghrelin does not modify synaptic currents of GHRH neurons. However, ghrelin exerts a strong and direct depolarizing effect on GHRH neurons, which supports their increased firing rate. Conclusion: Thus, GHRH neurons are a specific target for ghrelin within the brain, and not activated secondary to altered activity in feeding circuits. These results support the view that ghrelin related therapeutic approaches could be directed separately towards GH deficiency or feeding disorders.	[Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] INSERM, U661, Montpellier, France; [Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Osterstock, Guillaume; Escobar, Pauline; Mitutsova, Violeta; Gouty-Colomer, Laurie-Anne; Fontanaud, Pierre; Molino, Francois; Fehrentz, Jean-Alain; Martinez, Jean; Guerineau, Nathalie C.; Mollard, Patrice; Mery, Pierre-Francois] Univ Montpellier 1, Montpellier, France; [Carmignac, Danielle; Robinson, Iain C. A. F.] MRC Natl Inst Med Res, Div Mol Neuroendocrinol, London, England; [Fehrentz, Jean-Alain; Martinez, Jean] Inst Biomol Max Mousseron, CNRS, UMR 5247, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Osterstock, G (corresponding author), INSERM, U661, Montpellier, France.	pierre-francois.mery@igf.cnrs.fr	Martinez, Jean/R-9421-2019; MERY, Pierre-François/C-5903-2019	Martinez, Jean/0000-0002-9267-4621; Mery, Pierre-Francois/0000-0001-6214-5422; Guerineau, Nathalie/0000-0003-2517-4210	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universities of Montpellier 1 2; National Biophotonics and Imaging Platform (Ireland); Reseau National des Genopoles; Institut Federatif de Recherches 3; Medical Research Council (United Kingdom); Medical Research Council [MC_U117531708] Funding Source: researchfish; MRC [MC_U117531708] Funding Source: UKRI	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universities of Montpellier 1 2; National Biophotonics and Imaging Platform (Ireland); Reseau National des Genopoles; Institut Federatif de Recherches 3; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, the Universities of Montpellier 1 & 2, National Biophotonics and Imaging Platform (Ireland), Reseau National des Genopoles, Institut Federatif de Recherches 3, Region Languedoc Roussillon and by core funding from the Medical Research Council (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2008, REGUL PEPTIDES, V149, P3, DOI 10.1016/j.regpep.2007.10.006; Alonso G, 2007, AGING CELL, V6, P197, DOI 10.1111/j.1474-9726.2007.00276.x; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Baccam N, 2007, J NEUROSCI, V27, P1631, DOI 10.1523/JNEUROSCI.2693-06.2007; Bailey ART, 1998, J NEUROENDOCRINOL, V10, P111; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Beedle AM, 2002, J MEMBRANE BIOL, V187, P225, DOI 10.1007/s00232-001-0166-2; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bitran M, 1999, BRAIN RES, V851, P87, DOI 10.1016/S0006-8993(99)02123-X; BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537, DOI 10.1210/endo-114-5-1537; BRILLINGER DR, 1976, J ROY STAT SOC B MET, V38, P60; Broglio F, 2002, J ENDOCRINOL INVEST, V25, pRC26, DOI 10.1007/BF03345096; Casanueva FF, 2008, P NATL ACAD SCI USA, V105, P20452, DOI 10.1073/pnas.0811680106; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; COX DR, 1965, J ROY STAT SOC B, V27, P332; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; DICKSON SL, 1993, BRAIN RES, V623, P95, DOI 10.1016/0006-8993(93)90015-F; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; Dimaraki EV, 2006, REV ENDOCR METAB DIS, V7, P237, DOI 10.1007/s11154-006-9022-0; Farhy LS, 2007, AM J PHYSIOL-REG I, V292, pR1577, DOI 10.1152/ajpregu.00584.2006; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Gaskin FS, 2003, PEPTIDES, V24, P913, DOI 10.1016/S0196-9781(03)00160-8; Guerlavais V, 2003, J MED CHEM, V46, P1191, DOI 10.1021/jm020985q; GUILLAUME V, 1994, ENDOCRINOLOGY, V135, P1073, DOI 10.1210/en.135.3.1073; Hayashida T, 2002, J ENDOCRINOL, V173, P239, DOI 10.1677/joe.0.1730239; Hewson AK, 1999, J NEUROENDOCRINOL, V11, P919; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Hickey GJ, 1996, J ENDOCRINOL, V148, P371, DOI 10.1677/joe.0.1480371; Hosoda H, 2006, J PHARMACOL SCI, V100, P398, DOI 10.1254/jphs.CRJ06002X; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jordani MC, 2000, MOL CELL BIOCHEM, V210, P153, DOI 10.1023/A:1007185825101; Kamegai J, 1999, J NEUROENDOCRINOL, V11, P299; Katayama M, 2000, NEUROENDOCRINOLOGY, V72, P333, DOI 10.1159/000054602; Kato M, 1999, J NEUROENDOCRINOL, V11, P795; King PJ, 2000, EUR J PHARMACOL, V396, pR1, DOI 10.1016/S0014-2999(00)00230-2; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuramochi M, 2005, REGUL PEPTIDES, V126, P85, DOI 10.1016/j.regpep.2004.08.017; Lall S, 2004, ENDOCRINOLOGY, V145, P1602, DOI 10.1210/en.2003-1509; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lin S, 2007, ENDOCRINOLOGY, V148, P2056, DOI 10.1210/en.2006-1408; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Liu YL, 2002, MOL CELL ENDOCRINOL, V189, P97, DOI 10.1016/S0303-7207(01)00742-0; Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Morley JE, 1999, PEPTIDES, V20, P595, DOI 10.1016/S0196-9781(99)00012-1; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Pinilla L, 2003, NEUROENDOCRINOLOGY, V77, P83, DOI 10.1159/000068652; Popovic V, 2003, J CLIN ENDOCR METAB, V88, P3450, DOI 10.1210/jc.2003-030211; Riediger T, 2003, NEUROSCI LETT, V341, P151, DOI 10.1016/S0304-3940(02)01381-2; Riediger T, 2006, BRAIN RES, V1125, P37, DOI 10.1016/j.brainres.2006.09.049; Rodriguez-Pacheco F, 2008, J NEUROENDOCRINOL, V20, P406, DOI 10.1111/j.1365-2826.2008.01645.x; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Sun YX, 2007, ENDOCRINOLOGY, V148, P1323, DOI 10.1210/en.2006-0782; Tamura H, 2005, REGUL PEPTIDES, V125, P145, DOI 10.1016/j.regpep.2004.08.012; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; Tena-Sempere M, 2008, VITAM HORM, V77, P285, DOI 10.1016/S0083-6729(06)77012-1; Teruyama R, 2007, J NEUROPHYSIOL, V98, P2612, DOI 10.1152/jn.00599.2007; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Traebert M, 2002, J NEUROENDOCRINOL, V14, P580, DOI 10.1046/j.1365-2826.2002.00810.x; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Yanagida H, 2008, PEPTIDES, V29, P912, DOI 10.1016/j.peptides.2008.01.021; ZHENG LX, 1995, ENDOCRINOLOGY, V136, P1079, DOI 10.1210/en.136.3.1079	71	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9159	10.1371/journal.pone.0009159	http://dx.doi.org/10.1371/journal.pone.0009159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161791	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442800005
J	Zhang, YH; Lin, XJ; Wang, GQ; Zhou, JF; Lu, J; Zhao, HL; Zhang, FW; Wu, J; Xu, CQ; Du, N; Li, Z; Zhang, Y; Wang, XY; Bi, SL; Shu, YL; Zhou, HN; Tan, WJ; Wu, XB; Chen, ZH; Wang, Y				Zhang, Yonghui; Lin, Xiaojing; Wang, Guoqin; Zhou, Jianfang; Lu, Jian; Zhao, Honglan; Zhang, Fengwei; Wu, Jia; Xu, Chunqiong; Du, Ning; Li, Zi; Zhang, Ye; Wang, Xiaoyi; Bi, Shengli; Shu, Yuelong; Zhou, Hongning; Tan, Wenjie; Wu, Xiaobing; Chen, Zhihui; Wang, Yue			Neuraminidase and Hemagglutinin Matching Patterns of a Highly Pathogenic Avian and Two Pandemic H1N1 Influenza A Viruses	PLOS ONE			English	Article							ORIGIN; INFECTION; TRANSMISSION; SPECIFICITY; EMERGENCE	Background: Influenza A virus displays strong reassortment characteristics, which enable it to achieve adaptation in human infection. Surveying the reassortment and virulence of novel viruses is important in the prevention and control of an influenza pandemic. Meanwhile, studying the mechanism of reassortment may accelerate the development of anti-influenza strategies. Methodology/Principal Findings: The hemagglutinin (HA) and neuraminidase (NA) matching patterns of two pandemic H1N1 viruses (the 1918 and current 2009 strains) and a highly pathogenic avian influenza A virus (H5N1) were studied using a pseudotyped particle (pp) system. Our data showed that four of the six chimeric HA/NA combinations could produce infectious pps, and that some of the chimeric pps had greater infectivity than did their ancestors, raising the possibility of reassortment among these viruses. The NA of H5N1 (A/Anhui/1/2005) could hardly reassort with the HAs of the two H1N1 viruses. Many biological characteristics of HA and NA, including infectivity, hemagglutinating ability, and NA activity, are dependent on their matching pattern. Conclusions/Significance: Our data suggest the existence of an interaction between HA and NA, and the HA NA matching pattern is critical for valid viral reassortment.	[Zhang, Yonghui; Zhou, Hongning] Dali Univ, Inst Pathogens & Vectors, Dali, Peoples R China; [Chen, Zhihui] Second Mil Med Univ, Dept Infect Dis, Changhai Hosp, Shanghai, Peoples R China; [Lin, Xiaojing; Zhou, Jianfang; Lu, Jian; Zhao, Honglan; Zhang, Fengwei; Wu, Jia; Xu, Chunqiong; Du, Ning; Li, Zi; Zhang, Ye; Wang, Xiaoyi; Bi, Shengli; Shu, Yuelong; Tan, Wenjie; Wu, Xiaobing; Wang, Yue] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China; [Wang, Guoqin] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Sagamihara, Kanagawa 228, Japan	Dali University; Naval Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Kitasato University	Zhang, YH (corresponding author), Dali Univ, Inst Pathogens & Vectors, Dali, Peoples R China.	hchzhi@126.com; euy-tokyo@umin.ac.jp		Bi, Shengli/0000-0002-0380-5790	863 Hi-Tech Research and Development Program of China [2007AA02Z157, 2007AA02Z417]; National Research Programs of China [2009ZX10004-711]	863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Research Programs of China	This study was supported by the 863 Hi-Tech Research and Development Program of China (2007AA02Z157, 2007AA02Z417) and the National Research Programs of China (2009ZX10004-711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gibbs MJ, 2006, NATURE, V440, pE8, DOI 10.1038/nature04823; HINSHAW VS, 1983, VIROLOGY, V128, P260, DOI 10.1016/0042-6822(83)90337-9; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Knipe DM, 2007, FIELD VIROLOGY, V5th; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V390, P1305, DOI 10.1016/j.bbrc.2009.10.142; Lin XJ, 2009, BIOCHEM BIOPH RES CO, V385, P257, DOI 10.1016/j.bbrc.2009.05.068; Luo G, 1993, Virus Res, V29, P321; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Tollis M, 2002, VET J, V164, P202, DOI 10.1053/tvjl.2002.0716; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang YH, 2009, BIOCHEM BIOPH RES CO, V387, P405, DOI 10.1016/j.bbrc.2009.07.040	31	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2010	5	2							e9167	10.1371/journal.pone.0009167	http://dx.doi.org/10.1371/journal.pone.0009167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NX	20161801	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442800013
J	Zhao, Y; Bretz, CA; Hawksworth, SA; Hirsh, J; Johnson, EC				Zhao, Yan; Bretz, Colin A.; Hawksworth, Shane A.; Hirsh, Jay; Johnson, Erik C.			Corazonin Neurons Function in Sexually Dimorphic Circuitry That Shape Behavioral Responses to Stress in Drosophila	PLOS ONE			English	Article							GENE-EXPRESSION; BIOGENIC-AMINES; DOPAMINE; HORMONE; RECEPTOR; IDENTIFICATION; ABLATION; MELANOGASTER; METABOLISM; MODULATION	All organisms are confronted with dynamic environmental changes that challenge homeostasis, which is the operational definition of stress. Stress produces adaptive behavioral and physiological responses, which, in the Metazoa, are mediated through the actions of various hormones. Based on its associated phenotypes and its expression profiles, a candidate stress hormone in Drosophila is the corazonin neuropeptide. We evaluated the potential roles of corazonin in mediating stress-related changes in target behaviors and physiologies through genetic alteration of corazonin neuronal excitability. Ablation of corazonin neurons confers resistance to metabolic, osmotic, and oxidative stress, as measured by survival. Silencing and activation of corazonin neurons lead to differential lifespan under stress, and these effects showed a strong dependence on sex. Additionally, altered corazonin neuron physiology leads to fundamental differences in locomotor activity, and these effects were also sex-dependent. The dynamics of altered locomotor behavior accompanying stress was likewise altered in flies with altered corazonin neuronal function. We report that corazonin transcript expression is altered under starvation and osmotic stress, and that triglyceride and dopamine levels are equally impacted in corazonin neuronal alterations and these phenotypes similarly show significant sexual dimorphisms. Notably, these sexual dimorphisms map to corazonin neurons. These results underscore the importance of central peptidergic processing within the context of stress and place corazonin signaling as a critical feature of neuroendocrine events that shape stress responses and may underlie the inherent sexual dimorphic differences in stress responses.	[Zhao, Yan; Bretz, Colin A.; Hawksworth, Shane A.; Johnson, Erik C.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Hirsh, Jay] Univ Virginia, Dept Biol, Charlottesville, VA USA	Wake Forest University; University of Virginia	Zhao, Y (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	johnsoec@wfu.edu			Science Research Fund; Wake Forest University; NSF IOS [092931]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027318] Funding Source: NIH RePORTER	Science Research Fund; Wake Forest University; NSF IOS(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Science Research Fund, Wake Forest University, and NSF IOS 092931 to ECJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bazazi S, 2008, CURR BIOL, V18, P735, DOI 10.1016/j.cub.2008.04.035; BOERJAN B, 2009, GEN COMP ENDOCRINOL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Choi YJ, 2006, DEVELOPMENT, V133, P2223, DOI 10.1242/dev.02376; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Feng GP, 1996, J NEUROSCI, V16, P3925; Gatti S, 2000, CURR BIOL, V10, P667, DOI 10.1016/S0960-9822(00)00517-0; Gruntenko N, 2004, ARCH INSECT BIOCHEM, V55, P55, DOI 10.1002/arch.10123; Gruntenko NE, 2005, J INSECT PHYSIOL, V51, P417, DOI 10.1016/j.jinsphys.2005.01.007; Harbison ST, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r36; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johnson E, 1997, J COMP PHYSIOL B, V167, P89, DOI 10.1007/s003600050051; Johnson EC, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1069; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee G, 2008, CELL TISSUE RES, V331, P659, DOI 10.1007/s00441-007-0549-5; Levavi-Sivan B, 2004, BIOL REPROD, V70, P1545, DOI 10.1095/biolreprod.103.021998; Li XF, 2004, ENDOCRINOLOGY, V145, P1556, DOI 10.1210/en.2003-1609; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Neckameyer WS, 2005, STRESS, V8, P117, DOI 10.1080/10253890500147381; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; RAUSCHENBACH IY, 1993, J INSECT PHYSIOL, V39, P761, DOI 10.1016/0022-1910(93)90051-R; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; RIVEST S, 1995, J NEUROENDOCRINOL, V7, P501, DOI 10.1111/j.1365-2826.1995.tb00788.x; Scaggiante M, 2006, HORM BEHAV, V50, P107, DOI 10.1016/j.yhbeh.2006.01.011; SELYE H, 1956, METABOLISM, V5, P525; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; STEINMANNZWICKY M, 1994, DEVELOPMENT, V120, P707; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Taylor MM, 2005, BRAIN RES, V1045, P199, DOI 10.1016/j.brainres.2005.03.034; van der Waaij EH, 2004, J ANIM SCI, V82, P973; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; VEENSTRA JA, 2009, INSETCT BIOCH MOL BI; Wang MH, 2004, AGING CELL, V3, P133, DOI 10.1111/j.1474-9728.2004.00098.x; Wise S, 2002, J COMP NEUROL, V447, P366, DOI 10.1002/cne.10242; Yellman C, 1997, P NATL ACAD SCI USA, V94, P4131, DOI 10.1073/pnas.94.8.4131	56	65	65	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2010	5	2							e9141	10.1371/journal.pone.0009141	http://dx.doi.org/10.1371/journal.pone.0009141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NW	20161767	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442700007
J	Yosef, I; Bochkareva, ES; Adler, J; Bibi, E				Yosef, Ido; Bochkareva, Elena S.; Adler, Julia; Bibi, Eitan			Membrane Protein Biogenesis in Ffh- or FtsY-Depleted Escherichia coli	PLOS ONE			English	Article							SIGNAL-RECOGNITION PARTICLE; MULTIDRUG TRANSPORTER MDFA; TARGETING PATHWAYS; RECEPTOR; SRP; RIBOSOMES; INSERTION; REVEAL; MUTANT; DOMAIN	Background: The Escherichia coli version of the mammalian signal recognition particle (SRP) system is required for biogenesis of membrane proteins and contains two essential proteins: the SRP subunit Ffh and the SRP-receptor FtsY. Scattered in vivo studies have raised the possibility that expression of membrane proteins is inhibited in cells depleted of FtsY, whereas Ffh-depletion only affects their assembly. These differential results are surprising in light of the proposed model that FtsY and Ffh play a role in the same pathway of ribosome targeting to the membrane. Therefore, we decided to evaluate these unexpected results systematically. Methodology/Principal Findings: We characterized the following aspects of membrane protein biogenesis under conditions of either FtsY- or Ffh-depletion: (i) Protein expression, stability and localization; (ii) mRNA levels; (iii) folding and activity. With FtsY, we show that it is specifically required for expression of membrane proteins. Since no changes in mRNA levels or membrane protein stability were detected in cells depleted of FtsY, we propose that its depletion may lead to specific inhibition of translation of membrane proteins. Surprisingly, although FtsY and Ffh function in the same pathway, depletion of Ffh did not affect membrane protein expression or localization. Conclusions: Our results suggest that indeed, while FtsY-depletion affects earlier steps in the pathway (possibly translation), Ffh-depletion disrupts membrane protein biogenesis later during the targeting pathway by preventing their functional assembly in the membrane.	[Yosef, Ido; Bochkareva, Elena S.; Adler, Julia; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yosef, I (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.bibi@weizmann.ac.il		Bibi, Eitan/0000-0003-3700-2707	GIF; German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation	GIF(German-Israeli Foundation for Scientific Research and Development); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation)	This work was supported by GIF, the German-Israeli Foundation for Scientific Research and Development, and by the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2004, BIOCHEMISTRY-US, V43, P518, DOI 10.1021/bi035485t; Adler J, 2002, J BACTERIOL, V184, P3313, DOI 10.1128/JB.184.12.3313-3320.2002; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Koch HG, 2003, REV PHYSIOL BIOCH P, V146, P55, DOI 10.1007/s10254-002-0002-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Park SK, 2002, J BACTERIOL, V184, P2642, DOI 10.1128/JB.184.10.2642-2653.2002; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Sigal N, 2006, J MOL MICROB BIOTECH, V11, P308, DOI 10.1159/000095633; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	27	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9130	10.1371/journal.pone.0009130	http://dx.doi.org/10.1371/journal.pone.0009130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161748	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442600027
J	Kabeer, BSA; Raman, B; Thomas, A; Perumal, V; Raja, A				Kabeer, Basirudeen Syed Ahamed; Raman, Balambal; Thomas, Aleyamma; Perumal, Venkatesan; Raja, Alamelu			Role of QuantiFERON-TB Gold, Interferon Gamma Inducible Protein-10 and Tuberculin Skin Test in Active Tuberculosis Diagnosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; WHOLE-BLOOD; RELEASE ASSAYS; IFN-GAMMA; PULMONARY TUBERCULOSIS; LATENT TUBERCULOSIS; PLEURAL EFFUSIONS; HIV; SENSITIVITY; DISEASE	Background: The measurement of Interferon gamma or Interferon gamma inducible protein (IP)-10 in antigen stimulated blood samples is suggested as an alternative method for latent tuberculosis (TB) diagnosis. Nonetheless, their role in active TB diagnosis, particularly in TB endemic settings is yet to be defined. In this study, the sensitivities and specificities of Interferon gamma release assay (IGRA), IP-10 assay and tuberculin skin test (TST) in detecting active TB cases were assessed in human immunodeficiency virus (HIV) sero-negative TB patients and healthy controls respectively. Methods/Principal Findings: A total of 177 adult TB patients and 100 healthy controls were included for this study. QuantiFERON-TB Gold In-tube (QFT-IT) method was used to analyze the sensitivity and specificity of IGRA. QFT-IT, IP-10 and TST yielded the diagnostic sensitivities of 90.6% (95%CI: 86.3%-94.9%), 92.5% (95%CI: 88.6%-96.4%) and 68.9% (95%CI: 60.6%-77.2%) and specificities of 55% (95%CI: 35.2%-54.8%), 48% (95%CI: 38.2%-57.8%) and 75.5% (95%CI: 66.8%84.2%), respectively. The extent of pulmonary involvement or presence of diabetes mellitus did not appear to influence the sensitivities of any of these tests. The combination of any of the two tests among QFT-IT, IP-10 and TST showed >98% sensitivity among smear negative cases and particularly the combination of IP-10, TST and smear microscopy showed 100% sensitivity, however, the specificity was decreased to 44.8%. Conclusions/Significance: QFT-IT and IP-10 were highly sensitive in detecting active TB cases. The combination with TST improved the sensitivity of QFT-IT and IP-10 significantly. Although the higher sensitivity of combination of QFT-IT/IP-10 and TST may be useful in active TB diagnosis, they are limited by their poor specificity due to the high prevalence of latent TB in our settings.	[Kabeer, Basirudeen Syed Ahamed; Raja, Alamelu] TB Res Ctr ICMR, Dept Immunol, Chennai, Tamil Nadu, India; [Raman, Balambal; Thomas, Aleyamma] TB Res Ctr ICMR, Dept Clin, Chennai, Tamil Nadu, India; [Perumal, Venkatesan] TB Res Ctr ICMR, Dept Stat, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Kabeer, BSA (corresponding author), TB Res Ctr ICMR, Dept Immunol, Chennai, Tamil Nadu, India.	alameluraja@gmail.com	Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636	National Institutes of Health [AI064055]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI064055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project is financially supported by National Institutes of Health (R03) grant (AI064055). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetifa IMO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-122; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Bartu V, 2008, J INT MED RES, V36, P434, DOI 10.1177/147323000803600307; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dhillon NK, 2007, J IMMUNOL, V179, P2722, DOI 10.4049/jimmunol.179.5.2722; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dosanjh DPS, 2008, ANN INTERN MED, V148, P325, DOI 10.7326/0003-4819-148-5-200803040-00003; Harada N, 2008, J INFECTION, V56, P348, DOI 10.1016/j.jinf.2008.02.011; Juffermans NP, 1999, INFECT IMMUN, V67, P4295, DOI 10.1128/IAI.67.8.4295-4297.1999; Kabeer BSA, 2010, AIDS, V24, P323, DOI 10.1097/QAD.0b013e328334895e; Kabeer BSA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005718; Lagrange Philippe H, 2008, Open Respir Med J, V2, P52, DOI 10.2174/1874306400802010052; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; *MIN HLTH FAM WELF, 1998, REV NAT TUB CONTR PR; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; *NAT AIDS CONTR OR, 2007, OP GUID INT COUNS TE; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Palazzo R, 2008, CLIN VACCINE IMMUNOL, V15, P327, DOI 10.1128/CVI.00342-07; Raby E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002489; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Rajavelu P, 2005, FEMS IMMUNOL MED MIC, V45, P95, DOI 10.1016/j.femsim.2005.02.011; Ramachandran Geetha, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P251, DOI 10.1177/1545109707301344; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; Samson KTR, 2006, CLIN EXP ALLERGY, V36, P475, DOI 10.1111/j.1365-2222.2006.02470.x; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Selvakumar N, 2006, INDIAN J MED RES, V124, P439; Sodhi A, 1997, CLIN INFECT DIS, V25, P617, DOI 10.1086/513769; Steinbrook R, 2007, NEW ENGL J MED, V356, P1197, DOI 10.1056/NEJMp078011; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2008, GLOB TB DAT BAS TB C; Wu HP, 2007, RESP MED, V101, P48, DOI 10.1016/j.rmed.2006.04.016; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x	45	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2010	5	2							e9051	10.1371/journal.pone.0009051	http://dx.doi.org/10.1371/journal.pone.0009051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZB	20140219	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000274474400010
J	Han, YS; Ogut, O				Han, Young Soo; Ogut, Ozgur			Regulation of Fibre Contraction in a Rat Model of Myocardial Ischemia	PLOS ONE			English	Article							BINDING-PROTEIN-C; SKELETAL-MUSCLE FIBERS; TROPONIN-I PHOSPHORYLATION; CARDIAC TROPONIN; THIN-FILAMENT; HEART-FAILURE; RABBIT PSOAS; KINASE-C; INORGANIC-PHOSPHATE; FORCE GENERATION	Background: The changes in the actomyosin crossbridge cycle underlying altered contractility of the heart are not well described, despite their importance to devising rational treatment approaches. Methodology/Principal Findings: A rat ischemia-reperfusion model was used to determine the transitions of the crossbridge cycle impacted during ischemia. Compared to perfused hearts, the maximum force per cross-sectional area and Ca(2+) sensitivity of fibers from ischemic hearts were both reduced. Muscle activation by photolytic release of Ca(2+) and ATP suggested that the altered contractility was best described as a reduction in the rate of activation of noncycling actomyosin crossbridges to activated, cycling states. More specifically, the apparent forward rate constant of the transition between the nonforce bearing A-M.ADP.Pi state and the bound, force bearing AM*.ADP.Pi state was reduced in ischemic fibers, suggesting that this transition is commensurate with initial crossbridge activation. These results suggested an alteration in the relationship between the activation of thin filament regulatory units and initial crossbridge attachment, prompting an examination of the post-translational state of troponin (Tn) T and I. These analyses indicated a reduction in the diphosphorylated form of TnT during ischemia, along with lower Ser23/24 phosphorylation of Tnl. Treatment of perfused fibers by 8-Br-cAMP increased Ser23/24 phosphorylation of Tnl, altering the reverse rate constant of the Pi isomerization in a manner consistent with the lusitropic effect of beta-adrenergic stimulation. However, similar treatment of ischemic fibers did not change TnI phosphorylation or the kinetics of the Pi isomerization. Conclusions: Ischemia reduces the isomerization from A-M. ADP.Pi to AM*.ADP.Pi, altering the kinetics of crossbridge activation through a mechanism that may be mediated by altered TnT and TnI phosphorylation.	[Han, Young Soo; Ogut, Ozgur] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic	Han, YS (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	Ogut.Ozgur@Mayo.edu			NIH [HL78845, 78845-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078845] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL78845 and 78845-S1 to O. O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo A, 1996, BIOPHYS J, V70, P2316, DOI 10.1016/S0006-3495(96)79797-7; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Bell MG, 2006, BIOPHYS J, V90, P531, DOI 10.1529/biophysj.105.072769; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Biesiadecki BJ, 2002, J BIOL CHEM, V277, P50275, DOI 10.1074/jbc.M206369200; Bodor GS, 1997, CIRCULATION, V96, P1495, DOI 10.1161/01.CIR.96.5.1495; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Brickson S, 2007, AM J PHYSIOL-HEART C, V292, pH1747, DOI 10.1152/ajpheart.01037.2006; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Campbell K, 1997, BIOPHYS J, V72, P254, DOI 10.1016/S0006-3495(97)78664-8; Caremani M, 2008, BIOPHYS J, V95, P5798, DOI 10.1529/biophysj.108.130435; CHASE PB, 1995, AM J PHYSIOL-CELL PH, V268, pC480, DOI 10.1152/ajpcell.1995.268.2.C480; Chen FC, 2006, AM J PHYSIOL-CELL PH, V290, pC719, DOI 10.1152/ajpcell.00419.2005; Christopher B, 2009, J MUSCLE RES CELL M, V30, P111, DOI 10.1007/s10974-009-9180-2; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; GAO WD, 1995, CIRC RES, V76, P1036, DOI 10.1161/01.RES.76.6.1036; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; GODT RE, 1989, J PHYSIOL-LONDON, V412, P155, DOI 10.1113/jphysiol.1989.sp017609; GOLDMAN YE, 1982, NATURE, V300, P701, DOI 10.1038/300701a0; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V354, P577, DOI 10.1113/jphysiol.1984.sp015394; GORDON AM, 1987, J GEN PHYSIOL, V90, P321, DOI 10.1085/jgp.90.3.321; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; HOFMANN PA, 1993, CIRC RES, V72, P50, DOI 10.1161/01.RES.72.1.50; Jideama NM, 1996, J BIOL CHEM, V271, P23277, DOI 10.1074/jbc.271.38.23277; Lu Z, 2001, BIOPHYS J, V81, P334, DOI 10.1016/S0006-3495(01)75703-7; Lymperopoulos A, 2007, NAT MED, V13, P315, DOI 10.1038/nm1553; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; MARTIN H, 1994, BIOPHYS J, V67, P1933, DOI 10.1016/S0006-3495(94)80676-9; MARTIN H, 1994, BIOPHYS J, V66, P1115, DOI 10.1016/S0006-3495(94)80892-6; MCDONALD KS, 1995, CIRC RES, V77, P964, DOI 10.1161/01.RES.77.5.964; McDonald KS, 1998, J MOL CELL CARDIOL, V30, P285, DOI 10.1006/jmcc.1997.0603; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MERCADIER JJ, 1983, CIRC RES, V53, P52, DOI 10.1161/01.RES.53.1.52; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; MILLAR NC, 1992, AM J PHYSIOL, V262, pC1239, DOI 10.1152/ajpcell.1992.262.5.C1239; Nguyen TTT, 1996, CIRC RES, V79, P222, DOI 10.1161/01.RES.79.2.222; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Sanada S, 2004, CIRCULATION, V110, P51, DOI 10.1161/01.CIR.0000133390.12306.C7; SCHIER JJ, 1982, J CLIN INVEST, V69, P816, DOI 10.1172/JCI110521; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solis RS, 2008, J MUSCLE RES CELL M, V29, P203, DOI 10.1007/s10974-009-9168-y; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Swartz DR, 1996, BIOPHYS J, V71, P1891, DOI 10.1016/S0006-3495(96)79388-8; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Tesi C, 2002, J PHYSIOL-LONDON, V541, P187, DOI 10.1113/jphysiol.2001.013418; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; VOCI P, 1995, CIRCULATION, V91, P1714, DOI 10.1161/01.CIR.91.6.1714; Yagi N, 2002, PFLUG ARCH EUR J PHY, V445, P238, DOI 10.1007/s00424-002-0927-5; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; Zakhary DR, 1999, CIRCULATION, V99, P505, DOI 10.1161/01.CIR.99.4.505	60	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2010	5	3							e9528	10.1371/journal.pone.0009528	http://dx.doi.org/10.1371/journal.pone.0009528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	564EW	20209103	Green Published, gold, Green Submitted			2022-12-27	WOS:000275197100013
J	Bansal, S; Pourbohloul, B; Hupert, N; Grenfell, B; Meyers, LA				Bansal, Shweta; Pourbohloul, Babak; Hupert, Nathaniel; Grenfell, Bryan; Meyers, Lauren Ancel			The Shifting Demographic Landscape of Pandemic Influenza	PLOS ONE			English	Article							HONG-KONG INFLUENZA; TRANSMISSION PARAMETERS; ASIAN INFLUENZA; MORTALITY; EPIDEMIC; SPREAD; VIRUS; AGE; SCHOOLCHILDREN; PROTECTION	Background: As Pandemic (H1N1) 2009 influenza spreads around the globe, it strikes school-age children more often than adults. Although there is some evidence of pre-existing immunity among older adults, this alone may not explain the significant gap in age-specific infection rates. Methods and Findings: Based on a retrospective analysis of pandemic strains of influenza from the last century, we show that school-age children typically experience the highest attack rates in primarily naive populations, with the burden shifting to adults during the subsequent season. Using a parsimonious network-based mathematical model which incorporates the changing distribution of contacts in the susceptible population, we demonstrate that new pandemic strains of influenza are expected to shift the epidemiological landscape in exactly this way. Conclusions: Our analysis provides a simple demographic explanation for the age bias observed for H1N1/09 attack rates, and suggests that this bias may shift in coming months. These results have significant implications for the allocation of public health resources for H1N1/09 and future influenza pandemics.	[Bansal, Shweta] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Bansal, Shweta; Grenfell, Bryan] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Pourbohloul, Babak] British Columbia Ctr Dis Control, Div Math Modeling, Vancouver, BC, Canada; [Pourbohloul, Babak] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hupert, Nathaniel] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Hupert, Nathaniel] US Ctr Dis Control & Prevent, Preparedness Modeling Unit, Atlanta, GA USA; [Grenfell, Bryan] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of British Columbia; Cornell University; Centers for Disease Control & Prevention - USA; Princeton University; University of Texas System; University of Texas Austin; The Santa Fe Institute	Bansal, S (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	shweta@sbansal.com	Bansal, Shweta/GPW-8977-2022; Bansal, Shweta/AFV-6623-2022	Bansal, Shweta/0000-0002-1740-5421; Meyers, Lauren/0000-0002-5828-8874	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate; Department of Homeland Security; Fogarty International Center; National Institutes of Health (NIH); James F. McDonnell Foundation; National Science Foundation [DEB-0749097]; NIH Models of Infectious Disease Agent Study (MIDAS) [U01-GM087719-01]; Canadian Institutes of Health Research [PTL97125, PAP93425]; Michael Smith Foundation for Health Research; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James F. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); NIH Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health (NIH); grants from the James F. McDonnell Foundation, National Science Foundation (DEB-0749097), and NIH Models of Infectious Disease Agent Study (MIDAS) (U01-GM087719-01) to L. A. M.; and support from the Canadian Institutes of Health Research (PTL97125 and PAP93425) and the Michael Smith Foundation for Health Research to B. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; BANSAL S, 2009, 09102008 ARX; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Barbour A., 1990, STOCHASTIC PROCESSES, P86; Barry JM, 2008, J INFECT DIS, V198, P1427, DOI 10.1086/592454; Barthelemy M., 2004, PHYS REV LETT, V92; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; *CDC ADV COMM IMM, 2009, NOV H1N1 VACC REC; *CDCP, 2009, FLU VIEW 2009 2010 I; *CDCP, 2009, S OIV CAS COUNT AG S; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention, 2009, 2009 H1N1 FLU NEWS; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M, 2009, INFLUENZA A H1N1 LES; COLLINS S, 1957, PUBLIC HLTH MONOGRAP, V48; Collins SD, 1931, PUBLIC HEALTH REP, V46, P1909, DOI 10.2307/4580139; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; DAUER CC, 1961, AM REV RESPIR DIS, V83, P15; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; DENNISTON G, 1962, 70 COMM DIS CTR; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Eubank S, 2008, NDSSLTR07003 VIRG PO; Ferrari MJ, 2006, P ROY SOC B-BIOL SCI, V273, P2743, DOI 10.1098/rspb.2006.3636; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; Fiore AE, 2010, JAMA-J AM MED ASSOC, V303, P73, DOI 10.1001/jama.2009.1929; FOY HM, 1976, J INFECT DIS, V134, P362, DOI 10.1093/infdis/134.4.362; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; GILBERT VE, 1962, AM J PUBLIC HEALTH N, V52, P1432, DOI 10.2105/AJPH.52.9.1432; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GLEZEN WP, 1997, VIRAL INFECT HUMANS, P473; GREENBERG M, 2009, NEJM, V361; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jordan EO., 1927, EPIDEMIC INFLUENZA S; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; MEDLOCK J, 2009, SCIENCE; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; MEYERS L, 2003, EMERG INFECT DIS, V9; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Moss OR, 2008, INT J NANOTECHNOL, V5, P3, DOI 10.1504/IJNT.2008.016547; MURPHY BR, 1972, NEW ENGL J MED, V286, P1329, DOI 10.1056/NEJM197206222862502; Newman M.E.J., 2002, PHYS REV E, V66; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; NISHIURA H, 2009, EUROSURVEILLANCE, V14, P22; NOBLE GR, 1974, AM J EPIDEMIOL, V100, P517; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; PERROTT GS, 1958, PUBLIC HEALTH REP, V73, P121, DOI 10.2307/4590059; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; SCHULMAN JL, 1970, PROG MED VIROL, V12, P128; *SECR SAL, EST INFL; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; TAYLOR M, 1971, J R COLL GEN PRACTIT, V21; Vazquez A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066130; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	75	61	62	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2010	5	2							e9360	10.1371/journal.pone.0009360	http://dx.doi.org/10.1371/journal.pone.0009360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561RS	20195468	gold, Green Published, Green Submitted			2022-12-27	WOS:000274997000004
J	Hong, CC; Song, MZ				Hong, Chung-Chien; Song, Mingzhou			Optimal In Silico Target Gene Deletion through Nonlinear Programming for Genetic Engineering	PLOS ONE			English	Article							LYCOPENE BIOSYNTHESIS; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; YEAST	Background: Optimal selection of multiple regulatory genes, known as targets, for deletion to enhance or suppress the activities of downstream genes or metabolites is an important problem in genetic engineering. Such problems become more feasible to address in silico due to the availability of more realistic dynamical system models of gene regulatory and metabolic networks. The goal of the computational problem is to search for a subset of genes to knock out so that the activity of a downstream gene or a metabolite is optimized. Methodology/Principal Findings: Based on discrete dynamical system modeling of gene regulatory networks, an integer programming problem is formulated for the optimal in silico target gene deletion problem. In the first result, the integer programming problem is proved to be NP-hard and equivalent to a nonlinear programming problem. In the second result, a heuristic algorithm, called GKONP, is designed to approximate the optimal solution, involving an approach to prune insignificant terms in the objective function, and the parallel differential evolution algorithm. In the third result, the effectiveness of the GKONP algorithm is demonstrated by applying it to a discrete dynamical system model of the yeast pheromone pathways. The empirical accuracy and time efficiency are assessed in comparison to an optimal, but exhaustive search strategy. Significance: Although the in silico target gene deletion problem has enormous potential applications in genetic engineering, one must overcome the computational challenge due to its NP-hardness. The presented solution, which has been demonstrated to approximate the optimal solution in a practical amount of time, is among the few that address the computational challenge. In the experiment on the yeast pheromone pathways, the identified best subset of genes for deletion showed advantage over genes that were selected empirically. Once validated in vivo, the optimal target genes are expected to achieve higher genetic engineering effectiveness than a trial-and-error procedure.	[Hong, Chung-Chien; Song, Mingzhou] New Mexico State Univ, Dept Comp Sci, Las Cruces, NM 88003 USA	New Mexico State University	Hong, CC (corresponding author), Natl Cheng Kung Univ, Dept Stat, Tainan 70101, Taiwan.	joemsong@cs.nmsu.edu		Song, Mingzhou/0000-0002-6883-6547	National Cancer Institute [5U54CA132383]; NATIONAL CANCER INSTITUTE [U54CA132383] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors were supported in part by the National Cancer Institute grant number 5U54CA132383 and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; COLE GM, 1990, MOL CELL BIOL, V10, P510, DOI 10.1128/MCB.10.2.510; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; FARYABI B, 2008, EURASIP J BIOINFORMA, V1, P1; Goutsias J, 2004, BIOPHYS J, V86, P1922, DOI 10.1016/S0006-3495(04)74257-5; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Jin YS, 2007, METAB ENG, V9, P337, DOI 10.1016/j.ymben.2007.03.003; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; LAMPINEN J, 1999, P NOSTR 99, V2, P45; Maguire CA, 2008, MOL THER, V16, P1695, DOI 10.1038/mt.2008.168; Meir E, 2002, J EXP ZOOL, V294, P216, DOI 10.1002/jez.10187; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Shmulevich I, 2002, J BIOL SYST, V10, P431, DOI 10.1142/S0218339002000706; Song M, 2009, IET SYST BIOL, V3, P203, DOI 10.1049/iet-syb.2008.0089; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Storn R.M., 1995, DIFFERENTIAL EVOLUTI, V23; Takahashi K, 2005, FEBS LETT, V579, P1783, DOI 10.1016/j.febslet.2005.01.072; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Zhan XL, 1997, GENE DEV, V11, P1690, DOI 10.1101/gad.11.13.1690	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9331	10.1371/journal.pone.0009331	http://dx.doi.org/10.1371/journal.pone.0009331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195367	Green Published, Green Submitted, gold			2022-12-27	WOS:000274924200007
J	Tregoning, JS; Pribul, PK; Pennycook, AMJ; Hussell, T; Wang, B; Lukacs, N; Schwarze, J; Culley, FJ; Openshaw, PJM				Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Lukacs, Nicholas; Schwarze, Jurgen; Culley, Fiona J.; Openshaw, Peter J. M.			The Chemokine MIP1 alpha/CCL3 Determines Pathology in Primary RSV Infection by Regulating the Balance of T Cell Populations in the Murine Lung	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MICE; BRONCHIOLITIS; RESPONSES; DISEASE; IMMUNOPATHOLOGY; PATHOGENESIS; ENHANCEMENT; EXPRESSION	Background: CD8 T cells assist in the clearance of respiratory syncytial virus (RSV) infection from the lungs. However, disease after RSV infection is in part caused by excessive T cell activity, and a balance is therefore needed between beneficial and harmful cellular immune responses. The chemokine CCL3 (MIP1 alpha) is produced following RSV infection and is broadly chemotactic for both T cells and natural killer (NK) cells. We therefore investigated its role in RSV disease. Methodology/Principal Findings: CCL3 was produced biphasically, in both the early (day 1) and late (day 6-7) stages of infection. CCL3 depletion did not alter the recruitment of natural killer (NK) cells to the lungs during the early stage, but depletion did affect the later adaptive phase. While fewer T cells were recruited to the lungs of either CCL3 knockout or anti-CCL3 treated RSV infected mice, more RSV-specific pro-inflammatory T cells were recruited to the lung when CCL3 responses were impaired. This increase in RSV-specific pro-inflammatory T cells was accompanied by increased weight loss and illness after RSV infection. Conclusions/Significance: CCL3 regulates the balance of T cell populations in the lung and can alter the outcome of RSV infection. Understanding the role of inflammatory mediators in the recruitment of pathogenic T cells to the lungs may lead to novel methods to control RSV disease.	[Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Culley, Fiona J.; Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Ctr Resp Infect Res, London, England; [Tregoning, John S.; Pribul, Philippa K.; Pennycook, Alasdair M. J.; Hussell, Tracy; Wang, Belinda; Culley, Fiona J.; Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, MRC & Asthma UK Ctr Allerg Mech Asthma, Natl Heart & Lung Inst, London, England; [Schwarze, Jurgen] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Lukacs, Nicholas] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Imperial College London; Imperial College London; University of London; King's College London; University of Edinburgh; University of Michigan System; University of Michigan	Tregoning, JS (corresponding author), St Georges Univ London, Div Cellular & Mol Med, Ctr Infect, London, England.	p.openshaw@imperial.ac.uk	Lukacs, Nicholas W/ABH-5583-2020; Hussell, Tracy/O-4630-2014; Schwarze, Jürgen/F-7396-2011; Openshaw, Peter/AAL-9442-2020	Hussell, Tracy/0000-0001-7186-6141; Openshaw, Peter/0000-0002-7220-2555; Wang, Belinda Lei/0000-0002-6963-4963; Tregoning, John/0000-0001-8093-8741; Culley, Fiona/0000-0001-5208-4259; Schwarze, Jurgen/0000-0002-6899-748X	Wellcome Trust [54797/Z/98/Z, 071381/Z/03/Z, 055303/Z/98/Z]; University of London; NIH [036302]; MRC [G0400795] Funding Source: UKRI; Medical Research Council [G0400795, G9900991B] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036302] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); University of London; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Wellcome Trust program grants to PJMO (54797/Z/98/Z and 071381/Z/03/Z) and by a Wellcome Trust prize studentship (055303/Z/98/Z). The purchase of anti-TNF antibodies was covered by a grant from the University of London. NL was supported by NIH grant #036302. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonville CA, 1999, PEDIATR ALLERGY IMMU, V10, P39, DOI 10.1034/j.1399-3038.1999.101005.x; CANNON MJ, 1988, J EXP MED, V168, P1163, DOI 10.1084/jem.168.3.1163; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Culley FJ, 2006, J VIROL, V80, P4521, DOI 10.1128/JVI.80.9.4521-4527.2006; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Ruckwardt TJ, 2009, J VIROL, V83, P3019, DOI 10.1128/JVI.00036-09; Rutigliano JA, 2004, J IMMUNOL, V173, P3408, DOI 10.4049/jimmunol.173.5.3408; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Tregoning JS, 2008, J VIROL, V82, P4115, DOI 10.1128/JVI.02313-07; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09	22	37	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2010	5	2							e9381	10.1371/journal.pone.0009381	http://dx.doi.org/10.1371/journal.pone.0009381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SX	20195359	gold, Green Published, Green Accepted			2022-12-27	WOS:000274924200012
J	Houshdaran, S; Hawley, S; Palmer, C; Campan, M; Olsen, MN; Ventura, AP; Knudsen, BS; Drescher, CW; Urban, ND; Brown, PO; Laird, PW				Houshdaran, Sahar; Hawley, Sarah; Palmer, Chana; Campan, Mihaela; Olsen, Mari N.; Ventura, Aviva P.; Knudsen, Beatrice S.; Drescher, Charles W.; Urban, Nicole D.; Brown, Patrick O.; Laird, Peter W.			DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines	PLOS ONE			English	Article							BRCA1 PROMOTER REGION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; ESOPHAGEAL ADENOCARCINOMA; DRUG-RESISTANCE; CANCER-PATIENTS; X-INACTIVATION; CPG-ISLANDS; XIST GENE; IN-VITRO	Background: Epithelial ovarian carcinoma is a significant cause of cancer mortality in women worldwide and in the United States. Epithelial ovarian cancer comprises several histological subtypes, each with distinct clinical and molecular characteristics. The natural history of this heterogeneous disease, including the cell types of origin, is poorly understood. This study applied recently developed methods for high-throughput DNA methylation profiling to characterize ovarian cancer cell lines and tumors, including representatives of three major histologies. Methodology/Principal Findings: We obtained DNA methylation profiles of 1,505 CpG sites (808 genes) in 27 primary epithelial ovarian tumors and 15 ovarian cancer cell lines. We found that the DNA methylation profiles of ovarian cancer cell lines were markedly different from those of primary ovarian tumors. Aggregate DNA methylation levels of the assayed CpG sites tended to be higher in ovarian cancer cell lines relative to ovarian tumors. Within the primary tumors, those of the same histological type were more alike in their methylation profiles than those of different subtypes. Supervised analyses identified 90 CpG sites (68 genes) that exhibited 'subtype-specific' DNA methylation patterns (FDR, 1%) among the tumors. In ovarian cancer cell lines, we estimated that for at least 27% of analyzed autosomal CpG sites, increases in methylation were accompanied by decreases in transcription of the associated gene. Significance: The significant difference in DNA methylation profiles between ovarian cancer cell lines and tumors underscores the need to be cautious in using cell lines as tumor models for molecular studies of ovarian cancer and other cancers. Similarly, the distinct methylation profiles of the different histological types of ovarian tumors reinforces the need to treat the different histologies of ovarian cancer as different diseases, both clinically and in biomarker studies. These data provide a useful resource for future studies, including those of potential tumor progenitor cells, which may help illuminate the etiology and natural history of these cancers.	[Houshdaran, Sahar; Campan, Mihaela; Laird, Peter W.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Hawley, Sarah; Palmer, Chana] Canary Fdn, Palo Alto, CA USA; [Campan, Mihaela; Laird, Peter W.] Univ So Calif, Dept Surg, Los Angeles, CA USA; [Olsen, Mari N.; Brown, Patrick O.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Ventura, Aviva P.; Knudsen, Beatrice S.; Drescher, Charles W.; Urban, Nicole D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Laird, Peter W.] Univ So Calif, Univ So Calif Epigenome Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; Stanford University; Fred Hutchinson Cancer Center; University of Southern California	Houshdaran, S (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	plaird@usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641	Canary Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P50CA083636, R01CA096958] Funding Source: NIH RePORTER	Canary Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a generous contribution from the Canary Foundation and by the Howard Hughes Medical Institute. The authors thank Don Listwin, founder of the Canary Foundation, for his continuing support and encouragement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P261, DOI 10.1006/gyno.2001.6291; [Anonymous], 2008, R LANGUAGE ENV STAT; Baldwin RL, 2000, CANCER RES, V60, P5329; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; BEHRENS BC, 1987, CANCER RES, V47, P414; BENARD J, 1985, CANCER RES, V45, P4970; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boumil RM, 2006, MOL CELL BIOL, V26, P2109, DOI 10.1128/MCB.26.6.2109-2117.2006; Brock MV, 2003, CLIN CANCER RES, V9, P2912; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; BUICK RN, 1985, CANCER RES, V45, P3668; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Cheng P, 1997, BRIT J CANCER, V75, P396, DOI 10.1038/bjc.1997.64; Chiang JW, 2006, GYNECOL ONCOL, V101, P403, DOI 10.1016/j.ygyno.2005.10.034; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; DISAIA PJ, 1972, AM J OBSTET GYNECOL, V114, P979, DOI 10.1016/0002-9378(72)90109-3; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Esteller M, 1999, CANCER RES, V59, P67; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fleischhacker M, 1999, Eur J Med Res, V4, P488; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Furlong MT, 1999, J NATL CANCER I, V91, P1327, DOI 10.1093/jnci/91.15.1327; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goessl C, 2000, CANCER RES, V60, P5941; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hough CD, 2000, CANCER RES, V60, P6281; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; LAU DHM, 1991, CANCER RES, V51, P5181; LEON SA, 1977, CANCER RES, V37, P646; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Lutz AM, 2008, PLOS MED, V5, P1287, DOI 10.1371/journal.pmed.0050170; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Strathdee G, 1999, ONCOGENE, V18, P2335, DOI 10.1038/sj.onc.1202540; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Wong IHN, 2000, CLIN CANCER RES, V6, P3516; Wong W, 1999, PC WEEK, V16, P73; Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508; ZUCCOTTI M, 1995, NAT GENET, V9, P316, DOI 10.1038/ng0395-316; 2009, STANFORD MICROARRAY; 2000, STANFORD FUNCTIONAL	69	72	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2010	5	2							e9359	10.1371/journal.pone.0009359	http://dx.doi.org/10.1371/journal.pone.0009359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SU	20179752	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923900020
J	Timsit, Y; Varnai, P				Timsit, Youri; Varnai, Peter			Helical Chirality: a Link between Local Interactions and Global Topology in DNA	PLOS ONE			English	Article							POSITIVELY SUPERCOILED DNA; COLI TOPOISOMERASE-IV; II TOPOISOMERASES; ESCHERICHIA-COLI; STRUCTURAL BASIS; REVERSE GYRASE; NUCLEIC-ACIDS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; CHROMATIN FIBER	DNA supercoiling plays a major role in many cellular functions. The global DNA conformation is however intimately linked to local DNA-DNA interactions influencing both the physical properties and the biological functions of the supercoiled molecule. Juxtaposition of DNA double helices in ubiquitous crossover arrangements participates in multiple functions such as recombination, gene regulation and DNA packaging. However, little is currently known about how the structure and stability of direct DNA-DNA interactions influence the topological state of DNA. Here, a crystallographic analysis shows that due to the intrinsic helical chirality of DNA, crossovers of opposite handedness exhibit markedly different geometries. While right-handed crossovers are self-fitted by sequence-specific groove-backbone interaction and bridging Mg2+ sites, lefthanded crossovers are juxtaposed by groove-groove interaction. Our previous calculations have shown that the different geometries result in differential stabilisation in solution, in the presence of divalent cations. The present study reveals that the various topological states of the cell are associated with different inter-segmental interactions. While the unstable lefthanded crossovers are exclusively formed in negatively supercoiled DNA, stable right-handed crossovers constitute the local signature of an unusual topological state in the cell, such as the positively supercoiled or relaxed DNA. These findings not only provide a simple mechanism for locally sensing the DNA topology but also lead to the prediction that, due to their different tertiary intra-molecular interactions, supercoiled molecules of opposite signs must display markedly different physical properties. Sticky inter-segmental interactions in positively supercoiled or relaxed DNA are expected to greatly slow down the slithering dynamics of DNA. We therefore suggest that the intrinsic helical chirality of DNA may have oriented the early evolutionary choices for DNA topology.	[Timsit, Youri] CNRS, UPR2589, Inst Microbiol Mediterranee, Marseille, France; [Varnai, Peter] Univ Sussex, Sch Life Sci, Dept Chem & Biochem, Brighton, E Sussex, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Sussex	Timsit, Y (corresponding author), CNRS, UPR2589, Inst Microbiol Mediterranee, Parc Sci Luminy, Marseille, France.	Youri.Timsit@igs.cnrs-mrs.fr	Varnai, Peter/A-6870-2012; Timsit, Youri/AAL-2412-2021	Timsit, Youri/0000-0003-0601-7201; Varnai, Peter/0000-0003-4267-4671	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants to Y.T. from the Centre National de la Recherche Scientifique (CNRS) and the Agence Nationale de la Recherche (ANR) programme blanc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Benham CJ, 2005, ANNU REV BIOMED ENG, V7, P21, DOI 10.1146/annurev.bioeng.6.062403.132016; BERMAN HM, 1992, BIOPHYS J, V63, P751, DOI 10.1016/S0006-3495(92)81649-1; Brochier-Armanet Celine, 2007, Archaea, V2, P83; CHARBONNIER F, 1994, J BACTERIOL, V176, P1251, DOI 10.1128/jb.176.5.1251-1259.1994; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Cherny DI, 2001, J MOL BIOL, V313, P295, DOI 10.1006/jmbi.2001.5031; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Crisona NJ, 2000, GENE DEV, V14, P2881, DOI 10.1101/gad.838900; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Eichman BF, 2002, J MOL BIOL, V320, P1037, DOI 10.1016/S0022-2836(02)00540-5; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Graille M, 2008, STRUCTURE, V16, P360, DOI 10.1016/j.str.2007.12.020; Guipaud O, 1997, P NATL ACAD SCI USA, V94, P10606, DOI 10.1073/pnas.94.20.10606; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inoue S, 2007, BIOCHEMISTRY-US, V46, P164, DOI 10.1021/bi061539y; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KANAAR R, 1992, CURR OPIN STRUC BIOL, V2, P369, DOI DOI 10.1016/0959-440X(92)90227-X; Katritch V, 1996, NATURE, V384, P142, DOI 10.1038/384142a0; Kornyshev AA, 2007, REV MOD PHYS, V79, P943, DOI 10.1103/RevModPhys.79.943; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Liu ZR, 2006, J MOL BIOL, V361, P268, DOI 10.1016/j.jmb.2006.06.005; Lopez-Garcia P, 1999, J MOL EVOL, V49, P439, DOI 10.1007/PL00006567; Lopez-Garcia P, 2000, J BACTERIOL, V182, P4998, DOI 10.1128/JB.182.17.4998-5000.2000; MARGUET E, 1994, NUCLEIC ACIDS RES, V22, P1681, DOI 10.1093/nar/22.9.1681; MARKO JF, 1995, PHYS REV E, V52, P2912, DOI 10.1103/PhysRevE.52.2912; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Minsky A, 2004, ANNU REV BIOPH BIOM, V33, P317, DOI 10.1146/annurev.biophys.33.110502.133328; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Olson WK, 2000, CURR OPIN STRUC BIOL, V10, P286, DOI 10.1016/S0959-440X(00)00086-5; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Pulleyblank DE, 1997, SCIENCE, V277, P648, DOI 10.1126/science.277.5326.648; Qiu XY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038104; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; SCHLICK T, 1992, SCIENCE, V257, P1110, DOI 10.1126/science.257.5073.1110; Shaw SY, 1997, P NATL ACAD SCI USA, V94, P1692, DOI 10.1073/pnas.94.5.1692; Shlyakhtenko LS, 2003, ULTRAMICROSCOPY, V97, P263, DOI 10.1016/S0304-3991(03)00051-2; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Stasiak A, 1996, NATURE, V384, P122, DOI 10.1038/384122a0; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Stuchinskaya T, 2009, J MOL BIOL, V385, P1397, DOI 10.1016/j.jmb.2008.11.056; Stupina VA, 2004, P NATL ACAD SCI USA, V101, P8608, DOI 10.1073/pnas.0402849101; Tan ZJ, 2006, NUCLEIC ACIDS RES, V34, P6629, DOI 10.1093/nar/gkl810; TIMSIT Y, 1994, EMBO J, V13, P2737, DOI 10.1002/j.1460-2075.1994.tb06567.x; Timsit Y, 1999, J BIOMOL STRUCT DYN, V16, P775, DOI 10.1080/07391102.1999.10508292; TIMSIT Y, 1989, NATURE, V341, P459, DOI 10.1038/341459a0; TIMSIT Y, 1991, NATURE, V354, P167, DOI 10.1038/354167a0; Timsit Y, 1996, Q REV BIOPHYS, V29, P279, DOI 10.1017/S0033583500005862; TIMSIT Y, 1991, J MOL BIOL, V221, P919, DOI 10.1016/0022-2836(91)80184-V; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; Travers A, 2007, EMBO REP, V8, P147, DOI 10.1038/sj.embor.7400898; Trigueros S, 2004, J MOL BIOL, V335, P723, DOI 10.1016/j.jmb.2003.11.011; VARNAI P, 2010, NUCL ACIDS IN PRESS; Vetcher AA, 2002, J BIOL CHEM, V277, P39228, DOI 10.1074/jbc.M205210200; Vologodskii A, 1996, BIOPHYS J, V70, P2548, DOI 10.1016/S0006-3495(96)79826-0; VOLOGODSKII AV, 1994, ANNU REV BIOPH BIOM, V23, P609, DOI 10.1146/annurev.bb.23.060194.003141; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; Xu YC, 1997, NUCLEIC ACIDS RES, V25, P4067, DOI 10.1093/nar/25.20.4067; Yan J, 1999, NATURE, V401, P932, DOI 10.1038/44872; Zakharova SS, 2002, BIOPHYS J, V83, P1106, DOI 10.1016/S0006-3495(02)75234-X; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	74	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9326	10.1371/journal.pone.0009326	http://dx.doi.org/10.1371/journal.pone.0009326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174470	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000274923700024
J	MacLean, D; Studholme, DJ				MacLean, Daniel; Studholme, David J.			A Boolean Model of the Pseudomonas syringae hrp Regulon Predicts a Tightly Regulated System	PLOS ONE			English	Article							III PROTEIN SECRETION; PV. TOMATO DC3000; 2-COMPONENT SYSTEM; NETWORK MODEL; EXPRESSION; GENES; HRPX/HRPY; CASCADE; ACTS	The Type III secretion system (TTSS) is a protein secretion machinery used by certain gram-negative bacterial pathogens of plants and animals to deliver effector molecules to the host and is at the core of the ability to cause disease. Extensive molecular and biochemical study has revealed the components and their interactions within this system but reductive approaches do not consider the dynamical properties of the system as a whole. In order to gain a better understanding of these dynamical behaviours and to create a basis for the refinement of the experimentally derived knowledge we created a Boolean model of the regulatory interactions within the hrp regulon of Pseudomonas syringae pathovar tomato strain DC3000 Pseudomonas syringae. We compared simulations of the model with experimental data and found them to be largely in accordance, though the hrpV node shows some differences in state changes to that expected. Our simulations also revealed interesting dynamical properties not previously predicted. The model predicts that the hrp regulon is a biologically stable two-state system, with each of the stable states being strongly attractive, a feature indicative of selection for a tightly regulated and responsive system. The model predicts that the state of the GacS/GacA node confers control, a prediction that is consistent with experimental observations that the protein has a role as master regulator. Simulated gene "knock out" experiments with the model predict that HrpL is a central information processing point within the network.	[MacLean, Daniel; Studholme, David J.] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	MacLean, D (corresponding author), John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England.	dan.maclean@tsl.ac.uk	Studholme, David/H-6790-2019; MacLean, Dan/C-7046-2013	Studholme, David/0000-0002-3010-6637; MacLean, Dan/0000-0003-1032-0887	Gatsby Charitable Foundation	Gatsby Charitable Foundation	Funding: D. M. and D. J. S. were supported by The Gatsby Charitable Foundation: www.gatsby.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts MJ, 2008, INT J STROKE, V3, P16, DOI 10.1111/j.1747-4949.2008.00174.x; ARNOLD DL, 2000, MOL PLANT PATHOL, V102, P407; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; CHAVES M, 2006, SYST BIOL STEVENAGE, V153, P155; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Fall CP., 2002, COMPUTATIONAL CELL B; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Hendrickson EL, 2000, J BACTERIOL, V182, P3508, DOI 10.1128/JB.182.12.3508-3516.2000; Hutcheson SW, 2001, J BACTERIOL, V183, P5589, DOI 10.1128/JB.183.19.5589-5598.2001; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Mendoza L, 1999, BIOINFORMATICS, V15, P593, DOI 10.1093/bioinformatics/15.7.593; Merighi M, 2003, MOL PLANT MICROBE IN, V16, P238, DOI 10.1094/MPMI.2003.16.3.238; Nizan-Koren R, 2003, MOL PLANT MICROBE IN, V16, P249, DOI 10.1094/MPMI.2003.16.3.249; Preston G, 1998, J BACTERIOL, V180, P4532, DOI 10.1128/JB.180.17.4532-4537.1998; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Thum KE, 2003, PLANT PHYSIOL, V132, P440, DOI 10.1104/pp.103.022780; Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x; Voit E. O., 2000, COMPUTATIONAL ANAL B; Wei WS, 2000, P NATL ACAD SCI USA, V97, P2247, DOI 10.1073/pnas.040570097; Wei ZM, 2000, MOL PLANT MICROBE IN, V13, P1251, DOI 10.1094/MPMI.2000.13.11.1251; Yuh Chiou-Hwa, 2001, P73	31	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2010	5	2							e9101	10.1371/journal.pone.0009101	http://dx.doi.org/10.1371/journal.pone.0009101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZD	20169167	Green Published, Green Submitted, gold			2022-12-27	WOS:000274474700002
J	Nakazawa, T; Sakai, Y; Hsieh, CH; Koitabashi, T; Tayasu, I; Yamamura, N; Okuda, N				Nakazawa, Takefumi; Sakai, Yoichiro; Hsieh, Chih-hao; Koitabashi, Tadatoshi; Tayasu, Ichiro; Yamamura, Norio; Okuda, Noboru			Is the Relationship between Body Size and Trophic Niche Position Time-Invariant in a Predatory Fish? First Stable Isotope Evidence	PLOS ONE			English	Article							ONTOGENIC NICHE; PREY; PRESERVATION; DYNAMICS; SHIFTS; DIET	Characterizing relationships between individual body size and trophic niche position is essential for understanding how population and food-web dynamics are mediated by size-dependent trophic interactions. However, whether (and how) intraspecific size-trophic relationships (i.e., trophic ontogeny pattern at the population level) vary with time remains poorly understood. Using archival specimens of a freshwater predatory fish Gymnogobius isaza (Tanaka 1916) from Lake Biwa, Japan, we assembled a long-term (> 40 years) time-series of the size-dependence of trophic niche position by examining nitrogen stable isotope ratios (delta N-15) of the fish specimens. The size-dependence of trophic niche position was defined as the slope of the relationship between delta N-15 and log body size. Our analyses showed that the slope was significantly positive in about 60% of years and null in other years, changing through time. This is the first quantitative (i.e., stable isotope) evidence of long-term variability in the size-trophic relationship in a predatory fish. This finding had implications for the fish trophic dynamics, despite that about 60% of the yearly values were not statistically different from the long-term average. We proposed hypotheses for the underlying mechanism of the time-varying size-trophic relationship.	[Nakazawa, Takefumi; Sakai, Yoichiro; Koitabashi, Tadatoshi; Tayasu, Ichiro; Okuda, Noboru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Nakazawa, Takefumi; Hsieh, Chih-hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Hsieh, Chih-hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Yamamura, Norio] Res Inst Humanity & Nat, Kyoto, Japan	Kyoto University; National Taiwan University; National Taiwan University; Research Institute for Humanity & Nature (RIHN)	Nakazawa, T (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	tknkzw@ntu.edu.tw	Tayasu, Ichiro/A-9924-2009; Hsieh, Chih-hao/B-3797-2008	Tayasu, Ichiro/0000-0002-3006-7973; Hsieh, Chih-hao/0000-0001-5935-7272	Global COE; National Science Council of Taiwan; Frontier and Innovative Research of National Taiwan University; Japan-Taiwan Interchange Association; Research Fellowship for Young Scientists [2103033]; Japan Society for the Promotion of Science [18770014]	Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Frontier and Innovative Research of National Taiwan University(National Taiwan University); Japan-Taiwan Interchange Association; Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Global COE Program A06 to Kyoto University, National Science Council of Taiwan, the grant for Frontier and Innovative Research of National Taiwan University, and Japan-Taiwan Interchange Association. T. N. and N. O. were supported by Research Fellowship for Young Scientists (2103033) and Grant-in Aid for Young Scientists (B) (18770014), respectively, from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badalamenti F, 2002, MAR BIOL, V141, P561, DOI 10.1007/s00227-002-0844-3; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; de Roos AM, 2002, ECOL MONOGR, V72, P271, DOI 10.1890/0012-9615(2002)072[0271:ONSAFB]2.0.CO;2; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Hildrew Alan G., 2007, P326; Jennings S, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P86; Jennings S, 2002, MAR BIOL, V141, P1085, DOI 10.1007/s00227-002-0905-7; Jennings S, 2007, J ANIM ECOL, V76, P72, DOI 10.1111/j.1365-2656.2006.01180.x; Kelly B, 2006, J FISH BIOL, V69, P1595, DOI 10.1111/j.1095-8649.2006.01226.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; Nagoshi M., 1966, RES POPUL ECOL, V8, P20, DOI [10.1007/BF02524743, DOI 10.1007/BF02524743]; NAKANISHI N, 1984, Japanese Journal of Limnology, V45, P279; Nakazawa T, 2007, ECOL FRESHW FISH, V16, P362, DOI 10.1111/j.1600-0633.2007.00234.x; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Shiga Statistics and Information Office, 1962, ANN REP AGR FOR FISH; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Sweeting CJ, 2007, J EXP MAR BIOL ECOL, V340, P1, DOI 10.1016/j.jembe.2006.07.023; Takimoto G, 2003, AM NAT, V162, P93, DOI 10.1086/375540; Tuljapurkar S., 1997, STRUCTURED POPULATIO; Ward AJW, 2006, FISH FISH, V7, P231, DOI 10.1111/j.1467-2979.2006.00224.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435; Woodward G, 2002, J ANIM ECOL, V71, P1063, DOI 10.1046/j.1365-2656.2002.00669.x; Yamada Yoshihiro, 1998, Japanese Journal of Limnology, V59, P409	33	30	32	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9120	10.1371/journal.pone.0009120	http://dx.doi.org/10.1371/journal.pone.0009120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161751	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442600018
J	Schummer, M; Green, A; Beatty, JD; Karlan, BY; Karlan, S; Gross, J; Thornton, S; McIntosh, M; Urban, N				Schummer, Michel; Green, Ann; Beatty, J. David; Karlan, Beth Y.; Karlan, Scott; Gross, Jenny; Thornton, Sean; McIntosh, Martin; Urban, Nicole			Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; CARDIAC-OUTPUT; REGIONAL DISTRIBUTION; MICROARRAY DATA; CARCINOMAS; BIOMARKER; SURVIVAL; RECEPTOR; ARRAY	This study was initiated to identify biomarkers with potential value for the early detection of poor-outcome breast cancer. Two sets of well-characterized tissues were utilized: one from breast cancer patients with favorable vs. poor outcome and the other from healthy women undergoing reduction mammaplasty. Over 46 differentially expressed genes were identified from a large list of potential targets by a) mining publicly available expression data (identifying 134 genes for quantitative PCR) and b) utilizing a commercial PCR array. Three genes show elevated expression in cancers with poor outcome and low expression in all other tissues, warranting further investigation as potential blood markers for early detection of cancers with poor outcome. Twelve genes showed lower expression in cancers with poor outcome than in cancers with favorable outcome but no differential expression between aggressive cancers and most healthy controls. These genes are more likely to be useful as prognostic tissue markers than as serum markers for early detection of aggressive disease. As a secondary finding was that, when histologically normal breast tissue was removed from a distant site in a breast with cancer, 7 of 38 specimens displayed a cancer-like expression profile, while the remaining 31 were genetically similar to the reduction mammaplasty control group. This finding suggests that some regions of ipsilateral histologically `normal' breast tissue are predisposed to becoming malignant and that normal-appearing tissue with malignant signature might warrant treatment to prevent new primary tumors.	[Schummer, Michel; Green, Ann; McIntosh, Martin; Urban, Nicole] Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, Seattle, WA 98104 USA; [Beatty, J. David] Swedish Canc Inst, Breast Surg Clin, Seattle, WA USA; [Karlan, Beth Y.; Gross, Jenny] Cedars Sinai Med Ctr, Womens Canc Res Inst, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Karlan, Scott] Cedars Sinai Med Ctr, Saul & Joyce Brandman Breast Ctr, Los Angeles, CA 90048 USA; [Thornton, Sean] Cellnetix Pathol & Labs, Seattle, WA USA	Fred Hutchinson Cancer Center; Swedish Cancer Institute; Swedish Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Schummer, M (corresponding author), Fred Hutchinson Canc Res Ctr, Mol Diagnost Program, 1124 Columbia St, Seattle, WA 98104 USA.	mschumme@fhcrc.org	Lester, Jenny/B-5933-2012	Schummer, Michel/0000-0002-7937-7884	Department of Defense's Congressionally Directed Medical Research Programs' DAMD [17-02-1-0691]; NCI/Avon [P50 CA083636]; NATIONAL CANCER INSTITUTE [P50CA083636] Funding Source: NIH RePORTER	Department of Defense's Congressionally Directed Medical Research Programs' DAMD; NCI/Avon(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by Department of Defense's Congressionally Directed Medical Research Programs' DAMD 17-02-1-0691 and by NCI/Avon Grant P50 CA083636. Sean Thornton in employed by Cellnetix. The funders, including Cellnetix, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Charpin C, 2009, INT J ONCOL, V34, P983, DOI 10.3892/ijo_00000224; Covell DG, 2003, MOL CANCER THER, V2, P317; CREAN PA, 1986, BRIT J RADIOL, V59, P209, DOI 10.1259/0007-1285-59-699-209; Dian D, 2009, ARCH GYNECOL OBSTET, V279, P23, DOI 10.1007/s00404-008-0662-z; Dressman M. A., 2001, Pharmacogenomics Journal, V1, P135; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-73; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Hellstrom I, 2003, CANCER RES, V63, P3695; Jacquemier J, 2005, J PATHOL, V207, P260, DOI 10.1002/path.1845; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; LANTZ BMT, 1981, AM J ROENTGENOL, V137, P903, DOI 10.2214/ajr.137.5.903; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Narita D, 2006, FOLIA HISTOCHEM CYTO, V44, P165; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pestalozzi BC, 2008, J CLIN ONCOL, V26, P3006, DOI 10.1200/JCO.2007.14.9336; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Schummer M, 1999, GENE, V238, P375, DOI 10.1016/S0378-1119(99)00342-X; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; SIVRIDIS E, 2009, MED ONCOL, V23, P23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Srour N, 2008, PATHOBIOLOGY, V75, P112, DOI 10.1159/000123849; STRAUSS HW, 1977, J NUCL MED, V18, P1167; Tlsty TD, 2007, NAT CELL BIOL, V9, P135, DOI 10.1038/ncb0207-135; Tot T, 2007, INT J SURG PATHOL, V15, P369, DOI 10.1177/1066896907302225; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	41	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2010	5	2							e9122	10.1371/journal.pone.0009122	http://dx.doi.org/10.1371/journal.pone.0009122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NV	20161755	gold, Green Published			2022-12-27	WOS:000274442600020
J	Donlin, MJ; Cannon, NA; Aurora, R; Li, J; Wahed, AS; Di Bisceglie, AM; Tavis, JE				Donlin, Maureen J.; Cannon, Nathan A.; Aurora, Rajeev; Li, Jia; Wahed, Abdus S.; Di Bisceglie, Adrian M.; Tavis, John E.		Virahep C Study Grp	Contribution of Genome-Wide HCV Genetic Differences to Outcome of Interferon-Based Therapy in Caucasian American and African American Patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OPEN-READING FRAME; PEGINTERFERON ALPHA-2B; PLUS RIBAVIRIN; IL28B; SUBSTITUTIONS; DIVERSITY; EVOLUTION; IMMUNITY; PROTEIN	Background: Hepatitis C virus (HCV) has six major genotypes, and patients infected with genotype 1 respond less well to interferon-based therapy than other genotypes. African American patients respond to interferon a-based therapy at about half the rate of Caucasian Americans. The effect of HCV's genetic variation on treatment outcome in both racial groups is poorly understood. Methodology: We determined the near full-length pre-therapy consensus sequences from 94 patients infected with HCV genotype 1a or 1b undergoing treatment with peginterferon alpha-2a and ribavirin through the Virahep-C study. The sequences were stratified by genotype, race and treatment outcome to identify HCV genetic differences associated with treatment efficacy. Principal Findings: HCV sequences from patients who achieved sustained viral response were more diverse than sequences from non-responders. These inter-patient diversity differences were found primarily in the NS5A gene in genotype 1a and in core and NS2 in genotype 1b. These differences could not be explained by host selection pressures. Genotype 1b but not 1a African American patients had viral genetic differences that correlated with treatment outcome. Conclusions & Significance: Higher inter-patient viral genetic diversity correlated with successful treatment, implying that there are HCV genotype 1 strains with intrinsic differences in sensitivity to therapy. Core, NS3 and NS5A have interferonsuppressive activities detectable through in vitro assays, and hence these activities also appear to function in human patients. Both preferential infection with relatively resistant HCV variants and host-specific factors appear to contribute to the unusually poor response to therapy in African American patients.	[Donlin, Maureen J.; Cannon, Nathan A.; Aurora, Rajeev; Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Li, Jia; Wahed, Abdus S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, St Louis, MO USA; [Donlin, Maureen J.; Di Bisceglie, Adrian M.; Tavis, John E.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA	Saint Louis University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; Saint Louis University	Donlin, MJ (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	tavisje@slu.edu	Donlin, Maureen J./M-4709-2019	Donlin, Maureen/0000-0001-7312-079X; Wahed, Abdus/0000-0001-6911-7221; Aurora, Rajeev/0000-0002-6609-6055	National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute;  [U01 DK60345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060345] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Virahep-C was funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Cancer Institute with further support under a Cooperative Research and Development Agreement with Roche Laboratories, Inc. Funding for this viral genetics project was through U01 DK60345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Cannon NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002123; Combet Christophe, 2004, Appl Bioinformatics, V3, P237, DOI 10.2165/00822942-200403040-00005; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Dentzer TG, 2009, J VIROL, V83, P12702, DOI 10.1128/JVI.01184-09; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jopling CL, 2006, COLD SPRING HARB SYM, V71, P369, DOI 10.1101/sqb.2006.71.022; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2005, AM J MANAG CARE, V11, pS286; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Reddy KR, 1999, HEPATOLOGY, V30, P787, DOI 10.1002/hep.510300319; Rosen HR, 2007, HEPATOLOGY, V46, P350, DOI 10.1002/hep.21714; Saito T, 2008, HEPATOL RES, V38, P115, DOI 10.1111/j.1872-034X.2007.00283.x; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Strait BJ, 1996, BIOPHYS J, V71, P148, DOI 10.1016/S0006-3495(96)79210-X; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Yao E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yi MK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000403; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002; Zhou DH, 2007, J VIROL METHODS, V141, P220, DOI 10.1016/j.jviromet.2006.12.002	41	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9032	10.1371/journal.pone.0009032	http://dx.doi.org/10.1371/journal.pone.0009032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140258	Green Accepted, Green Published, gold			2022-12-27	WOS:000274474200018
J	Drotz, MK; Brodin, T; Nilsson, AN				Drotz, Marcus K.; Brodin, Tomas; Nilsson, Anders N.			Multiple Origins of Elytral Reticulation Modifications in the West Palearctic Agabus bipustulatus Complex (Coleoptera, Dytiscidae)	PLOS ONE			English	Article							DIVING BEETLES COLEOPTERA; GENE FLOW; ULTRAVIOLET-RADIATION; SYMPATRIC SPECIATION; PHYLOGENY; DIMORPHISM; HYPOTHESIS; EVOLUTION; SELECTION; PATTERNS	The Agabus bipustulatus complex includes one of Europe's most widely distributed and common diving beetles. This complex, which is known for its large morphological variation, has a complex demographic and altitudinal variation in elytral reticulation. The various depth of the reticulation imprint, both in smaller and larger meshes, results in both mat and shiny individuals, as well as intermediate forms. The West Palearctic lowland is inhabited by a sexually dimorphic form, with shiny males and mat females. In mountain regions, shiny individuals of both sexes are found intermixed with mat individuals or in pure populations in central and southern areas, whereas pure populations of mat individuals are exclusively found in the northern region at high altitude. Sexual selection is proposed as a driving force in shaping this variation. However, the occurrence of different types of reticulation in both sexes and disjunct geographical distribution patterns suggest an additional function of the reticulation. Here we investigate the phylogeographical history, genetic structure and reticulation variation of several named forms within the Agabus bipustulatus complex including A. nevadensis. The molecular analyses recognised several well-supported clades within the complex. Several of the named forms had two or more independent origins. Few south European populations were uniform in reticulation patterns, and the males were found to display large variation. Reticulation diversity and population genetic variability were clearly correlated to altitude, but no genetic differences were detected among populations with mixed or homogenous forms. Observed reduction in secondary reticulation in female and increased variance in male at high altitude in South Europe may be explained by the occurrence of an additional selective force, beside sexual selection. The combined effect of these selective processes is here demonstrated in an extreme case to generate isolation barriers between populations at high altitudes. Here we discuss this selective force in relation to thermal selection.	[Drotz, Marcus K.] Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Sweden; [Brodin, Tomas; Nilsson, Anders N.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Drotz, MK (corresponding author), Lake Vanern Museum Nat & Cultural Hist, Lidkoping, Sweden.	Marcus.Drotz@lidkoping.se		Brodin, Tomas/0000-0003-1086-7567	Nilsson-Ehle foundation	Nilsson-Ehle foundation	This research project was partially sponsored by Nilsson-Ehle foundation (material and analysis costs) within the Kungl. Fysiografiska Sallskapet (http://www.fysiografen.se/default.asp) and Lidkoping municipality (salary cost for main author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BALFOURBROWNE F, 1950, BRIT WATER BEETLES, V2, P394; Barton NH, 2001, DISPERSAL, P330; Berger J, 2005, THEATER HEUTE, P36; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bergsten J, 2001, BIOL J LINN SOC, V73, P221, DOI 10.1006/bijl.2001.0540; Bergsten J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000522; Bilton DT, 2008, BIOL J LINN SOC, V94, P685, DOI 10.1111/j.1095-8312.2008.01029.x; Bolnick DI, 2003, EVOLUTION, V57, P2433, DOI 10.1554/02-595; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Crow JF, 2003, GENETICS, V164, P1; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Drotz MK, 2001, BIOL J LINN SOC, V73, P11, DOI 10.1006/bijl.2001.0491; DROTZ MK, THESIS U UMEA UMEA; Falkenstrom G, 1940, ARK ZOOL, V32, P1; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franciscolo M.E., 1974, Bollettino Mus Civ Stor nat Verona, VNo. 1, P345; FRANCISCOLO ME, 1979, FAUNA ITALIA, V14, P11; FRESNEDA J, 1988, REV ESPANOLA ENTOMOL, V64, P17; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grahame JW, 2006, EVOLUTION, V60, P268; Gross J, 2004, ENVIRON ENTOMOL, V33, P799, DOI 10.1603/0046-225X-33.4.799; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HOUSTON KJ, 1979, J AUST ENTOMOL SOC, V18, P45; HOWE JW, 2008, PLYMOUTH STUDENT SCI, V1, P56; KHALAF KT, 1980, FLA ENTOMOL, V63, P307, DOI 10.2307/3494627; Kirkpatrick M, 2004, P ROY SOC B-BIOL SCI, V271, P687, DOI 10.1098/rspb.2003.2645; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Knowles LL, 2007, EVOLUTION, V61, P477, DOI 10.1111/j.1558-5646.2007.00043.x; Laurion I, 2000, LIMNOL OCEANOGR, V45, P1274, DOI 10.4319/lo.2000.45.6.1274; Lehuraux Leon., 1931, NOMADISME COLONISATI; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LINDBERG H, 1939, COMMENTATIONES BIOL, V7, P1; Mikhailov Y.E., 2001, Pirineos, V156, P57; Miller KB, 2003, BIOL J LINN SOC, V79, P359, DOI 10.1046/j.1095-8312.2003.00195.x; Nilsson A.N., 2001, DYTISCIDAE COLEOPTER, V3; Nilsson Anders N., 1995, Fauna Entomologica Scandinavica, V32, P1; Nixon K, 1999, WINCLADA VER 0 9 99M; NIXON KC, 1993, CLADISTICS, V9, P413, DOI 10.1111/j.1096-0031.1993.tb00234.x; Nosil P, 2005, EVOLUTION, V59, P705; Parker G.A., 1979, P123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POPE RD, 1977, BIOL J LINN SOC, V9, P331, DOI 10.1111/j.1095-8312.1977.tb00275.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ribera I, 2004, MOL PHYLOGENET EVOL, V30, P545, DOI 10.1016/S1055-7903(03)00224-0; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schmucki DA, 2002, OPT ENG, V41, P3090, DOI 10.1117/1.1516820; Sen N. S., 1993, VERHANDLUNGEN NATURF, V16, P73; SHARP D, 1882, SCI T ROYAL DUBLIN S, V2, P17; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Via S, 2002, AM NAT, V159, pS1, DOI 10.1086/338368; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zimmermann A., 1934, Koleopterologische Rundschau, V20, P138; ZIMMERMANN A, 1919, ARCH NATURGESCH, V83, P107; ZIMMERMANN A, 1920, COLEOPTERORUM CATALO	69	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e9034	10.1371/journal.pone.0009034	http://dx.doi.org/10.1371/journal.pone.0009034			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140264	gold, Green Published, Green Submitted			2022-12-27	WOS:000274474200020
J	Metzgar, D; Myers, CA; Russell, KL; Faix, D; Blair, PJ; Brown, J; Vo, S; Swayne, DE; Thomas, C; Stenger, DA; Lin, B; Malanoski, AP; Wang, Z; Blaney, KM; Long, NC; Schnur, JM; Saad, MD; Borsuk, LA; Lichanska, AM; Lorence, MC; Weslowski, B; Schafer, KO; Tibbetts, C				Metzgar, David; Myers, Christopher A.; Russell, Kevin L.; Faix, Dennis; Blair, Patrick J.; Brown, Jason; Vo, Scott; Swayne, David E.; Thomas, Colleen; Stenger, David A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Blaney, Kate M.; Long, Nina C.; Schnur, Joel M.; Saad, Magdi D.; Borsuk, Lisa A.; Lichanska, Agnieszka M.; Lorence, Matthew C.; Weslowski, Brian; Schafer, Klaus O.; Tibbetts, Clark			Single Assay for Simultaneous Detection and Differential Identification of Human and Avian Influenza Virus Types, Subtypes, and Emergent Variants	PLOS ONE			English	Article							RESEQUENCING DNA MICROARRAYS; PATHOGEN IDENTIFICATION; BACTERIAL PNEUMONIA; PANDEMIC INFLUENZA; BROAD-SPECTRUM; HEMAGGLUTININ; SURVEILLANCE; TOOL	For more than four decades the cause of most type A influenza virus infections of humans has been attributed to only two viral subtypes, A/H1N1 or A/H3N2. In contrast, avian and other vertebrate species are a reservoir of type A influenza virus genome diversity, hosting strains representing at least 120 of 144 combinations of 16 viral hemagglutinin and 9 viral neuraminidase subtypes. Viral genome segment reassortments and mutations emerging within this reservoir may spawn new influenza virus strains as imminent epidemic or pandemic threats to human health and poultry production. Traditional methods to detect and differentiate influenza virus subtypes are either time-consuming and labor-intensive (culture-based) or remarkably insensitive (antibody-based). Molecular diagnostic assays based upon reverse transcriptase-polymerase chain reaction (RT-PCR) have short assay cycle time, and high analytical sensitivity and specificity. However, none of these diagnostic tests determine viral gene nucleotide sequences to distinguish strains and variants of a detected pathogen from one specimen to the next. Decision-quality, strain-and variant-specific pathogen gene sequence information may be critical for public health, infection control, surveillance, epidemiology, or medical/veterinary treatment planning. The Resequencing Pathogen Microarray (RPM-Flu) is a robust, highly multiplexed and target gene sequencing-based alternative to both traditional culture-or biomarker-based diagnostic tests. RPM-Flu is a single, simultaneous differential diagnostic assay for all subtype combinations of type A influenza viruses and for 30 other viral and bacterial pathogens that may cause influenza-like illness. These other pathogen targets of RPM-Flu may co-infect and compound the morbidity and/or mortality of patients with influenza. The informative specificity of a single RPM-Flu test represents specimen-specific viral gene sequences as determinants of virus type, A/HN subtype, virulence, host-range, and resistance to antiviral agents.	[Metzgar, David; Myers, Christopher A.; Russell, Kevin L.; Faix, Dennis; Blair, Patrick J.; Brown, Jason; Vo, Scott] USN, Dept Resp Dis Res, Hlth Res Ctr, San Diego, CA 92152 USA; [Russell, Kevin L.] US Dept Def Global Emerging Infect Surveillance &, Div Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Swayne, David E.; Thomas, Colleen; Blaney, Kate M.] ARS, SE Poultry Res Lab, USDA, Athens, GA USA; [Stenger, David A.; Lin, Baochuan; Malanoski, Anthony P.; Wang, Zheng; Long, Nina C.; Schnur, Joel M.] USN, Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Schnur, Joel M.] George Mason Univ, Manassas, VA USA; [Saad, Magdi D.] Naval Med Res Unit 3, Cairo, Egypt; [Borsuk, Lisa A.; Lichanska, Agnieszka M.; Lorence, Matthew C.; Weslowski, Brian; Schafer, Klaus O.; Tibbetts, Clark] TessArae LLC, Potomac Falls, VA USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Department of Agriculture (USDA); United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Metzgar, D (corresponding author), USN, Dept Resp Dis Res, Hlth Res Ctr, San Diego, CA 92152 USA.	clark.tibbetts@tessarae.com	Swayne, David/AAP-7166-2020; Malanoski, Anthony P/C-7814-2011; Saad, Magdi/H-5561-2013; Stitt, Alan/A-9842-2009; Lin, Baochuan/A-8390-2009; Malanoski, Anthony/P-6975-2019	Malanoski, Anthony P/0000-0001-6192-888X; Saad, Magdi/0000-0003-2111-8115; Stitt, Alan/0000-0002-8647-9918; Lin, Baochuan/0000-0002-9484-0785; Malanoski, Anthony/0000-0001-6192-888X; Swayne, David/0000-0001-7472-1992	TessArae [NCRADA-NRL-06-406]; United States Navy to TessArae [N00244-07-C-0037]; Department of Defense; Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland	TessArae; United States Navy to TessArae; Department of Defense(United States Department of Defense); Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland	No grant funding supported this effort. TessArae and the Naval Research Laboratory worked together under a Cooperative Research and Development Agreement (NCRADA-NRL-06-406), with financial resources contributed from TessArae. TessArae and the Naval Health Research Center worked together under a research services contract (N00244-07-C-0037) from the United States Navy to TessArae. Partial funding for this respiratory disease surveillance initiative was provided by the Department of Defense, Global Emerging Infections Surveillance and Response System (GEIS), a Division of the Armed Forces Health Surveillance Center, Silver Spring, Maryland. TessArae and the Department of Agriculture, Agricultural Research Service, Southeast Poultry Research Laboratory (SEPRL) cooperated under a no-cost cooperative agreement under which SEPRL provided samples (as their respective costs assumed) for testing and TessArae performed the testing (as their respective costs assumed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSTIN FJ, 1990, J GEN VIROL, V71, P2471, DOI 10.1099/0022-1317-71-10-2471; Brammer L., 2008, Morbidity and Mortality Weekly Report, V57, P1329; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dawson ED, 2006, ANAL CHEM, V78, P7610, DOI 10.1021/ac061739f; Freed NE, 2007, MOL CELL PROBE, V21, P103, DOI 10.1016/j.mcp.2006.08.007; Gingeras TR, 1998, GENOME RES, V8, P435, DOI 10.1101/gr.8.5.435; Gupta RK, 2008, EMERG INFECT DIS, V14, P1187, DOI 10.3201/eid1408.070751; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Kamps BS, 2006, INFLUENZA REPORT; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; Lin B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000419; Lin BC, 2009, J CLIN MICROBIOL, V47, P988, DOI 10.1128/JCM.01346-08; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Malanoski AP, 2006, NUCLEIC ACIDS RES, V34, P5300, DOI 10.1093/nar/gkl565; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; *WHO, 2009, INFL A H1N1 VIR RES; *WHO, 2009, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG	27	25	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8995	10.1371/journal.pone.0008995	http://dx.doi.org/10.1371/journal.pone.0008995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140251	Green Published, gold, Green Submitted			2022-12-27	WOS:000274474200003
J	Chen, HL; Yuh, CH; Wu, KK				Chen, Hua-Ling; Yuh, Chiou-Hwa; Wu, Kenneth K.			Nestin Is Essential for Zebrafish Brain and Eye Development through Control of Progenitor Cell Apoptosis	PLOS ONE			English	Article							EXPRESSION; PROTEIN; DEATH; CYTOSKELETON	Background: Nestin is expressed in neural progenitor cells (NPC) of developing brain. Despite its wide use as an NPC marker, the function of nestin in embryo development is unclear. Methodology/Principal Findings: As nestin is conserved in zebrafish and its predicted sequence is clustered with the mammalian nestin orthologue, we used zebrafish as a model to investigate its role in embryogenesis. Injection of nestin morpholino (MO) into fertilized eggs induced time-and dose-dependent brain and eye developmental defects. Nestin morphants exhibited characteristic morphological changes including small head, small eyes and hydrocephalus. Histological examinations show reduced hind-and mid-brain size, dilated ventricle, poorly organized retina and underdeveloped lens. Injection of control nestin MO did not induce brain or eye changes. Nestin MO injection reduced expression of ascl1b (achaete-scute complex-like 1b), a marker of NPCs, without affecting its distribution. Nestin MO did not influence Elavl3/4 (Embryonic lethal, abnormal vision, Drosophila-like 3/4) (a neuronal marker), or otx2 (a midbrain neuronal marker), but severely perturbed cranial motor nerve development and axon distribution. To determine whether the developmental defects are due to excessive NPC apoptosis and/or reduced NPC proliferation, we analyzed apoptosis by TUNEL assay and acridine orange staining and proliferation by BrdU incorporation, pcna and mcm5 expressions. Excessive apoptosis was noted in hindbrain and midbrain cells. Apoptotic signals were colocalized with ascl1b. Proliferation markers were not significantly altered by nestin MO. Conclusion/Significance: These results suggest that nestin is essential for zebrafish brain and eye development probably through control of progenitor cell apoptosis.	[Chen, Hua-Ling; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Yuh, Chiou-Hwa] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Chen, HL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	kkgo@nhri.org.tw	Yuh, Chiou-Hwa/AAL-2938-2020; Yuh, Chiou-Hwa/E-3972-2010; Wu, Kenneth Kun-Yu/B-1070-2010; Yuh, Chiou-Hwa/AAL-3531-2020; Chernyshev, Alexei/A-7195-2014	Kajihara, Hiroshi/0000-0001-6510-9355; Chernyshev, Alexei/0000-0002-2203-3001; Yuh, Chiou-Hwa/0000-0002-2356-1551	National Health Research Institutes, Taiwan; National Science Council, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institutes, Taiwan and National Science Council (Stem Cell Flagship Center Program), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chan TM, 2009, DEV BIOL, V326, P456, DOI 10.1016/j.ydbio.2008.11.010; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gulati-Leekha A, 2006, DEV BIOL, V296, P29, DOI 10.1016/j.ydbio.2006.03.024; Hanington PC, 2008, DEV BIOL, V314, P250, DOI 10.1016/j.ydbio.2007.10.012; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Kageyama R, 1997, INT J BIOCHEM CELL B, V29, P1389, DOI 10.1016/S1357-2725(97)89968-2; Lam CS, 2009, DEV DYNAM, V238, P475, DOI 10.1002/dvdy.21853; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Marvin NJ, 1998, J CELL SCI, V111, P1951; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Qiu GT, 2007, EXP EYE RES, V84, P1047, DOI 10.1016/j.exer.2007.01.014; Rieske P, 2007, EUR J NEUROSCI, V25, P31, DOI 10.1111/j.1460-9568.2006.05254.x; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Shen Q, 2002, DEVELOPMENT, V129, P4843; SJOBERG G, 1994, EXP CELL RES, V214, P447, DOI 10.1006/excr.1994.1281; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6	26	104	111	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2010	5	2							e9318	10.1371/journal.pone.0009318	http://dx.doi.org/10.1371/journal.pone.0009318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560SS	20174467	Green Published, gold, Green Submitted			2022-12-27	WOS:000274923700020
J	Sweeney, E; Roberts, D; Corbo, T; Jacenko, O				Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena			Congenic Mice Confirm That Collagen X Is Required for Proper Hematopoietic Development	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IMMUNO-OSSEOUS DYSPLASIA; STEM-CELL NICHE; HEPARAN-SULFATE PROTEOGLYCANS; CARTILAGE-HAIR-HYPOPLASIA; MARROW-STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; B LYMPHOPOIESIS; NULL MICE	The link between endochondral skeletal development and hematopoiesis in the marrow was established in the collagen X transgenic (Tg) and null (KO) mice. Disrupted function of collagen X, a major hypertrophic cartilage matrix protein, resulted in skeletal and hematopoietic defects in endochondrally derived tissues. Manifestation of the disease phenotype was variable, ranging from perinatal lethality in a subset of mice, to altered lymphopoiesis and impaired immunity in the surviving mice. To exclude contribution of strain specific modifiers to this variable manifestation of the skeleto-hematopoietic phenotype, C57Bl/6 and DBA/2J collagen X congenic lines were established. Comparable disease manifestations confirmed that the skeleto-hematopoietic alterations are an inherent outcome of disrupted collagen X function. Further, colony forming cell assays, complete blood count analysis, serum antibody ELISA, and organ outgrowth studies established altered lymphopoiesis in all collagen X Tg and KO mice and implicated opportunistic infection as a contributor to the severe disease phenotype. These data support a model where endochondral ossification-specific collagen X contributes to the establishment of a hematopoietic niche at the chondro-osseous junction.	[Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Sweeney, E (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	jacenko@vet.upenn.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [DK57904, AR053804 NRSA]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057904, R01DK088334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health; DK57904 (to OJ) and AR053804 NRSA (to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BRUNO E, 1995, EXP HEMATOL, V23, P1212; BUCHINSKY FJ, 1995, J BONE MINER RES, V10, P1556; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campbell MR, 2004, AM J PATHOL, V164, P487, DOI 10.1016/S0002-9440(10)63139-2; CastriotaScanderbeg A, 1997, J MED GENET, V34, P854, DOI 10.1136/jmg.34.10.854; CEDERBAUM SD, 1976, J PEDIATR-US, V89, P737, DOI 10.1016/S0022-3476(76)80793-7; Cham B, 2002, SEMIN HEMATOL, V39, P107, DOI 10.1053/shem.2002.31916; Chan C.K., 2008, NATURE; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; Chung KS, 1997, DEV DYNAM, V208, P544; CORDER WT, 1995, AM J MED GENET, V57, P626, DOI 10.1002/ajmg.1320570422; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dianzani I, 2000, Paediatr Drugs, V2, P345, DOI 10.2165/00128072-200002050-00002; ENG VM, 1995, J EXP MED, V181, P1893, DOI 10.1084/jem.181.5.1893; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Hubbard V, 2006, PEDIATR DERMATOL, V23, P373, DOI 10.1111/j.1525-1470.2006.00260.x; Jacenko O, 1996, ANN NY ACAD SCI, V785, P278, DOI 10.1111/j.1749-6632.1996.tb56283.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Jacenko O, 2001, AM J PATHOL, V159, P2257, DOI 10.1016/S0002-9440(10)63076-3; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JACENKO O, 1998, CELLS MAT, V8, P123; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kuijpers TW, 2004, PEDIATRICS, V114, pE387, DOI 10.1542/peds.2003-0651-F; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemoli RM, 2008, HAEMATOLOGICA, V93, P321, DOI 10.3324/haematol.12616; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Lucke T, 2007, AM J MED GENET A, V143A, P2040, DOI 10.1002/ajmg.a.31878; Marrella V, 2008, TRENDS IMMUNOL, V29, P133, DOI 10.1016/j.it.2007.12.001; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osmond D G, 1990, Semin Immunol, V2, P173; PATCHEN ML, 1991, BLOOD, V77, P472; Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sekhar RV, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e54; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siebertz B, 1999, BIOCHEM J, V344, P937, DOI 10.1042/0264-6021:3440937; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; SOYER AD, 1995, SPINE, V20, P2335, DOI 10.1097/00007632-199511000-00012; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sweeney E, 2008, DEV DYNAM, V237, P2693, DOI 10.1002/dvdy.21594; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Verfaillie CATHERINE M., 1999, Hematology, V4, P321; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yoshimoto M, 2003, EXP HEMATOL, V31, P733, DOI 10.1016/S0301-472X(03)00108-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; JACKSON LABS CONGENI	68	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9518	10.1371/journal.pone.0009518	http://dx.doi.org/10.1371/journal.pone.0009518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20657826	Green Submitted, Green Published, gold			2022-12-27	WOS:000275063400023
